Citrus Sinensis ID: 003134
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 845 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGE0 | 1014 | Probable LRR receptor-lik | yes | no | 0.978 | 0.815 | 0.628 | 0.0 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.972 | 0.805 | 0.520 | 0.0 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.978 | 0.796 | 0.516 | 0.0 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.960 | 0.784 | 0.520 | 0.0 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.905 | 0.802 | 0.496 | 0.0 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.953 | 0.789 | 0.472 | 0.0 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.966 | 0.801 | 0.474 | 0.0 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.950 | 0.778 | 0.412 | 1e-172 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.966 | 0.790 | 0.412 | 1e-171 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.813 | 0.589 | 0.304 | 1e-70 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1019 bits (2636), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 527/839 (62%), Positives = 642/839 (76%), Gaps = 12/839 (1%)
Query: 16 LLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDD 75
++ + + F G + NKLH EV+ALK+IG+KLGKKDW+F DPCS +G W +++
Sbjct: 10 IIVLFTLIFHGRLGFSDNNKLHEAEVRALKEIGKKLGKKDWDFNKDPCSGEGTWIVTTYT 69
Query: 76 KKGFESNVTCDCS----SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS 131
KGFESN+TCDCS +++CHV+ IALK+QNLTG +P E SKLR+LK LDLSRN LTGS
Sbjct: 70 TKGFESNITCDCSFLPQNSSCHVIRIALKSQNLTGIVPPEFSKLRHLKVLDLSRNSLTGS 129
Query: 132 FSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191
+WAS++L +LS MGNRLSGPFPKVLT +T L+NLS+EGN F+G IPPDI +L++L+K
Sbjct: 130 IPKEWASMRLEDLSFMGNRLSGPFPKVLTRLTMLRNLSLEGNQFSGPIPPDIGQLVHLEK 189
Query: 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251
L L SN+FTG L +L L NL D+RISDNNF+G IP+FI W +I KL + G L+GPI
Sbjct: 190 LHLPSNAFTGPLTEKLGLLKNLTDMRISDNNFTGPIPDFISNWTRILKLQMHGCGLDGPI 249
Query: 252 PASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKN 310
P+SIS+LTSLTDLRISDL G S+FP L + ++KTLIL KC I G IP YIGD+ KLK
Sbjct: 250 PSSISSLTSLTDLRISDLGGKPSSFPPLKNLESIKTLILRKCKIIGPIPKYIGDLKKLKT 309
Query: 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD 370
+DLSFN L+G IP++FE + K +F+YLTGNKLTG VP Y NKNVD+S NNFT ESS
Sbjct: 310 LDLSFNLLSGEIPSSFENMKKADFIYLTGNKLTGGVPNYFVERNKNVDVSFNNFTDESSI 369
Query: 371 PI-ECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTG- 428
P +C R + NLVES++ NK K C Q PC P + Y L+INCGG ++
Sbjct: 370 PSHDCNRVTSNLVESFAL-GNKSHKGSTCFLQRMPCVHPKRYHLYKLYINCGGGEVKVDK 428
Query: 429 HTKYEADMEARGASMFY-SSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLS-KVSAVDLE 486
Y+AD E +GASM+ + + WA SSTG FMD+D D D Y NTS LS S+
Sbjct: 429 EITYQADDEPKGASMYVLGANKRWALSSTGNFMDNDDDADEYTVQNTSRLSVNASSPSFG 488
Query: 487 LYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKK 546
LYRTARVSPLSLTYYG+CLGNGNYTV LHFAEIIF +D+T SLGKR+FDIY+Q++LV K
Sbjct: 489 LYRTARVSPLSLTYYGICLGNGNYTVNLHFAEIIFTDDNTLYSLGKRLFDIYVQDQLVIK 548
Query: 547 DFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSN 606
+FNI++ A G+G PI+K+F VT HTLKI L WAG+GTTGIP+RG YGP+ISAISV+ N
Sbjct: 549 NFNIQEAARGSGKPIIKSFLVNVTDHTLKIGLRWAGKGTTGIPIRGVYGPMISAISVEPN 608
Query: 607 FKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLY 666
FKPPV + K+ ++ + V A+ LL+ +I+ + WK K DKELRGLDLQTG +
Sbjct: 609 FKPPVYYDTKDIILKVGVPVAAATLLLFIIVGVF-WKK-RRDKNDIDKELRGLDLQTGTF 666
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
TLRQIKAAT+NFD K+GEGGFGSVYKG LS+G +IAVKQLS+KSRQGNREFVNEIGMI
Sbjct: 667 TLRQIKAATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGMI 726
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
SA QHPNLVKLYGCCVEGNQL+LVYEY++NNCLSRA+FGKD RLKLDW TRKKI +GI
Sbjct: 727 SALQHPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLGI 786
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
A+GL +LHE+SRIKIVHRDIK SNVLLDKDLNAKISDFGLAKL ++ THISTRIAGT+
Sbjct: 787 AKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTI 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 863 bits (2230), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/847 (52%), Positives = 584/847 (68%), Gaps = 25/847 (2%)
Query: 9 KLLLASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQ--- 65
+ LL ++ +SL+ F + +AT L EEV AL+ + L K +WNF VDPC +
Sbjct: 5 RQLLFTYYFIVSLILFSDFVSSAT---LPKEEVDALQSVATALKKSNWNFSVDPCDETLS 61
Query: 66 KGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSR 125
+G W + + KGFE VTC+CSS CHV I LKAQ+L G+LPT+LS L +L++LDL+R
Sbjct: 62 EGGWR-NPNAAKGFEDAVTCNCSSVICHVTNIVLKAQDLQGSLPTDLSGLPFLQELDLTR 120
Query: 126 NCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRK 185
N L GS P+W + L+ +S++GNR+SG PK L N+TTL L +E N +G IPP++
Sbjct: 121 NYLNGSIPPEWGASSLLNISLLGNRISGSIPKELGNLTTLSGLVLEYNQLSGKIPPELGN 180
Query: 186 LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS 245
L NL++L+LSSN+ +GE+P+ KLT L DLRISDN F+G IP+FI WK ++KL IQ S
Sbjct: 181 LPNLKRLLLSSNNLSGEIPSTFAKLTTLTDLRISDNQFTGAIPDFIQNWKGLEKLVIQAS 240
Query: 246 SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGD 304
L GPIP++I L +LTDLRI+DL G ES FP L M ++K LIL C + G++P Y+G
Sbjct: 241 GLVGPIPSAIGLLGTLTDLRITDLSGPESPFPPLRNMTSMKYLILRNCNLTGDLPAYLGQ 300
Query: 305 MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNF 364
KLKN+DLSFN L+G IP T+ L+ +F+Y T N L G VP ++ + +DI+ NNF
Sbjct: 301 NRKLKNLDLSFNKLSGPIPATYSGLSDVDFIYFTSNMLNGQVPSWMVDQGDTIDITYNNF 360
Query: 365 TWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAK 424
+ + ++ EC + SVN S S CL + + C + Y LHINCGG +
Sbjct: 361 SKDKTE--ECQQKSVNTFSSTSPLVANNSSNVSCLSK-YTCP----KTFYGLHINCGGNE 413
Query: 425 INTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKV--SA 482
I + TKY+AD +Y S W S+TG F+DDD + + + S+ K+ S+
Sbjct: 414 ITSNETKYDAD--TWDTPGYYDSKNGWVSSNTGNFLDDDRTNNGKSKWSNSSELKITNSS 471
Query: 483 VDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEK 542
+D LY AR+S +SLTY LCLG GNYTV LHFAEI+F + +++LG+R FDIY+Q K
Sbjct: 472 IDFRLYTQARLSAISLTYQALCLGKGNYTVNLHFAEIMFNEKNMYSNLGRRYFDIYVQGK 531
Query: 543 LVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAIS 602
KDFNI DEA G G +VK FP VT+ L+I L WAG+GT IP+RG YGPLISA+S
Sbjct: 532 REVKDFNIVDEAKGVGKAVVKKFPVMVTNGKLEIRLQWAGKGTQAIPVRGVYGPLISAVS 591
Query: 603 VKSNFKPP-----VVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELR 657
V +F PP + ++ +++ ++V LVLLI I+ W+GCL K +K+ +
Sbjct: 592 VDPDFIPPKEPGTGTGGGSSVGTVVGSVIASTVFLVLLIGGILWWRGCLRPKSQMEKDFK 651
Query: 658 GLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR 717
LD Q ++LRQIK AT+NFDPANK+GEGGFG V+KGI++DGTVIAVKQLS+KS+QGNR
Sbjct: 652 NLDFQISSFSLRQIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNR 711
Query: 718 EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWP 777
EF+NEI MISA QHP+LVKLYGCCVEG+QLLLVYEY++NN L+RA+FG E ++ L+WP
Sbjct: 712 EFLNEIAMISALQHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFGPQ-ETQIPLNWP 770
Query: 778 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837
R+KIC+GIARGLAYLHE+SR+KIVHRDIK +NVLLDK+LN KISDFGLAKL EE+ THI
Sbjct: 771 MRQKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEENTHI 830
Query: 838 STRIAGT 844
STR+AGT
Sbjct: 831 STRVAGT 837
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 845 bits (2184), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/853 (51%), Positives = 582/853 (68%), Gaps = 26/853 (3%)
Query: 1 MASLIPILKLLLASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGV 60
M + K++ L+F+ L F + A L +EV+ L+ I RKL + N
Sbjct: 1 MGFIFSTEKVVYVLLLIFVCLENF-----GSNAQLLPEDEVQTLRTIFRKLQNQTVNIER 55
Query: 61 DPCSQKGNWELSSDDKKGFE-SNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLR 116
CS + NW + SN+TCDC+ S+ C V I LK+ +L G P E L
Sbjct: 56 TSCSDQ-NWNFVVESASNSPTSNITCDCTFNASSVCRVTNIQLKSFSLPGIFPPEFGNLT 114
Query: 117 YLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFT 176
L+++DLSRN L G+ + + L LSV+GNRLSGPFP L +ITTL ++++E NLFT
Sbjct: 115 RLREIDLSRNFLNGTIPTTLSQIPLEILSVIGNRLSGPFPPQLGDITTLTDVNLETNLFT 174
Query: 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
G +P ++ L +L++L+LS+N+FTG++P L+ L NL + RI N+ SGKIP+FIG W
Sbjct: 175 GPLPRNLGNLRSLKELLLSANNFTGQIPESLSNLKNLTEFRIDGNSLSGKIPDFIGNWTL 234
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES-AFPKL-DKMNLKTLILTKCLI 294
+++L +QG+S+EGPIP SIS LT+LT+LRI+DL+G + +FP L + M +K L+L CLI
Sbjct: 235 LERLDLQGTSMEGPIPPSISNLTNLTELRITDLRGQAAFSFPDLRNLMKMKRLVLRNCLI 294
Query: 295 HGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSN 354
G IP+YIG M++LK +DLS N LTG IP TF L NFM+L N LTGPVP++I NS
Sbjct: 295 RGPIPEYIGSMSELKTLDLSSNMLTGVIPDTFRNLDAFNFMFLNNNSLTGPVPQFIINSK 354
Query: 355 KNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHY 414
+N+D+S NNFT + + C + VNL+ SY S + + V CLR+ PC P D
Sbjct: 355 ENLDLSDNNFTQPPT--LSCNQLDVNLISSYPSVTD--NSVQWCLREGLPC--PEDAKQS 408
Query: 415 TLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNT 474
+L INCGG+++ G Y D+ +RG S F S + W +SS+G ++ + Y+ T+
Sbjct: 409 SLFINCGGSRLKIGKDTYTDDLNSRGQSTFSSVSERWGYSSSGVWLGKEDA--GYLATDR 466
Query: 475 STLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRI 534
L ++ E Y+TAR+SP SL YYGLCL G+Y ++LHFAEI+F ND TFNSLG+RI
Sbjct: 467 FNL--INGSTPEYYKTARLSPQSLKYYGLCLRRGSYKLQLHFAEIMFSNDQTFNSLGRRI 524
Query: 535 FDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPA-EVTSHTLKIHLYWAGRGTTGIPLRGT 593
FDIY+Q L+++DFNI + AGG G P ++ +V TL+IHL W G+GT IP RG
Sbjct: 525 FDIYVQGNLLERDFNIAERAGGVGKPFIRQIDGVQVNGSTLEIHLQWTGKGTNVIPTRGV 584
Query: 594 YGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGK-VSA 652
YGPLISAI++ NFK N + ++ A + LL+L I+R G LGGK V
Sbjct: 585 YGPLISAITITPNFKVDTGKPLSNGA-VAGIVIAACAVFGLLVLVILRLTGYLGGKEVDE 643
Query: 653 DKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS 712
++ELRGLDLQTG +TL+QIK ATNNFDP NK+GEGGFG VYKG+L+DG IAVKQLSSKS
Sbjct: 644 NEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKS 703
Query: 713 RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL 772
+QGNREFV EIGMISA QHPNLVKLYGCC+EG +LLLVYEY++NN L+RA+FG + + RL
Sbjct: 704 KQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQ-RL 762
Query: 773 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832
LDW TR KICIGIA+GLAYLHE+SR+KIVHRDIK +NVLLD LNAKISDFGLAKL ++
Sbjct: 763 HLDWSTRNKICIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDD 822
Query: 833 DKTHISTRIAGTM 845
+ THISTRIAGT+
Sbjct: 823 ENTHISTRIAGTI 835
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 835 bits (2156), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/838 (52%), Positives = 569/838 (67%), Gaps = 26/838 (3%)
Query: 16 LLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDD 75
++FI L F + A L +EV+ L+ I RKL + N C + W ++
Sbjct: 14 IIFICLDIF-----GSNAQLLPEDEVQTLRTIFRKLQNQTVNIERTSCLDR-KWNFVAES 67
Query: 76 KKGFE-SNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS 131
SN+TCDC+ S+ C V I L+ NL G +P E L L ++DL N L+G+
Sbjct: 68 TSKLPTSNITCDCTFNASSVCRVTNIQLRGFNLRGIIPPEFGNLTRLTEIDLVLNFLSGT 127
Query: 132 FSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191
+ + L L+V GNRLSGPFP L ITTL ++ +E NLFTG +PP++ L +L++
Sbjct: 128 IPTTLSQIPLEILAVTGNRLSGPFPPQLGQITTLTDVIMESNLFTGQLPPNLGNLRSLKR 187
Query: 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251
L++SSN+ TG +P L+ L NL + RI N+ SGKIP+FIG W ++ +L +QG+S+EGPI
Sbjct: 188 LLISSNNITGRIPESLSNLKNLTNFRIDGNSLSGKIPDFIGNWTRLVRLDLQGTSMEGPI 247
Query: 252 PASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIG-DMTKLK 309
PASIS L +LT+LRI+DL+G S FP L M N++ L+L CLI IP+YIG MT LK
Sbjct: 248 PASISNLKNLTELRITDLRGPTSPFPDLQNMTNMERLVLRNCLIREPIPEYIGTSMTMLK 307
Query: 310 NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESS 369
+DLS N L G IP TF L NFMYL N LTGPVP++I +S +N+D+S NNFT +
Sbjct: 308 LLDLSSNMLNGTIPDTFRSLNAFNFMYLNNNSLTGPVPQFILDSKQNIDLSYNNFTQPPT 367
Query: 370 DPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGH 429
+ C + VNL+ SY S N + V CLR++ PC P D +H +L INCGG ++
Sbjct: 368 --LSCNQLDVNLISSYPSVTN--NSVQWCLRKDLPC--PGDAHHSSLFINCGGNRLKVDK 421
Query: 430 TKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYR 489
+Y D+ RGAS F S + W +SS+G ++ +D Y+ T+T L ++ E Y+
Sbjct: 422 DEYADDLNKRGASTFSSVSERWGYSSSGAWLGNDGA--TYLATDTFNL--INESTPEYYK 477
Query: 490 TARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFN 549
TAR++ SL YYGLC+ G+Y V+L+FAEI+F ND T++SLG+R+FDIY+Q L+++DFN
Sbjct: 478 TARLASQSLKYYGLCMRRGSYKVQLYFAEIMFSNDQTYSSLGRRLFDIYVQGILLERDFN 537
Query: 550 IEDEAGGTGIPIVKNF-PAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFK 608
I AGG G P ++ +V TL+IHL W G+GT IP RG YGPLISAI+V NFK
Sbjct: 538 IAQRAGGVGKPFLRQVDEVQVNGSTLEIHLKWTGKGTNVIPTRGVYGPLISAITVTPNFK 597
Query: 609 PPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGK-VSADKELRGLDLQTGLYT 667
N V + ++ A V LL+L I+R G LGGK V ++ELRGLDLQTG +T
Sbjct: 598 VDTGKPLSNGV-VAGIVIAACVAFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFT 656
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMIS 727
L+QIK ATNNFDP NK+GEGGFG VYKG+L+DG IAVKQLSSKS+QGNREFV EIGMIS
Sbjct: 657 LKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMIS 716
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
A QHPNLVKLYGCC+EG +LLLVYEY++NN L+RA+FG + + RL LDW TR K+CIGIA
Sbjct: 717 ALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQ-RLHLDWSTRNKVCIGIA 775
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
+GLAYLHE+SR+KIVHRDIK +NVLLD LNAKISDFGLAKL EE+ THISTRIAGT+
Sbjct: 776 KGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTI 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 762 bits (1967), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/819 (49%), Positives = 531/819 (64%), Gaps = 54/819 (6%)
Query: 31 ATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSA 90
A++ L +E +A K + L K + + VDPC E+SS +
Sbjct: 22 ASSATLPTQEGEAFKVVLTTLKKTNIDLNVDPC------EVSS--------------TGN 61
Query: 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNR 150
++ LK +NL G+LP EL L L+++DLSRN L GS P+W L LV + ++GNR
Sbjct: 62 EWSTISRNLKRENLQGSLPKELVGLPLLQEIDLSRNYLNGSIPPEWGVLPLVNIWLLGNR 121
Query: 151 LSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL 210
L+GP PK NITTL +L +E N +G +P ++ L N+Q++ILSSN+F GE+P+ KL
Sbjct: 122 LTGPIPKEFGNITTLTSLVLEANQLSGELPLELGNLPNIQQMILSSNNFNGEIPSTFAKL 181
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270
T L D R+SDN SG IP+FI KW K+++L IQ S L GPIP +I++L L DLRISDL
Sbjct: 182 TTLRDFRVSDNQLSGTIPDFIQKWTKLERLFIQASGLVGPIPIAIASLVELKDLRISDLN 241
Query: 271 GSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329
G ES FP+L + ++TLIL C + G++PDY+G +T K +DLSFN L+G IP T+ L
Sbjct: 242 GPESPFPQLRNIKKMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYINL 301
Query: 330 AKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPR 389
++Y TGN L G VP ++ N +D+S NNF+ + ++ + C
Sbjct: 302 RDGGYIYFTGNMLNGSVPDWMVNKGYKIDLSYNNFSVDPTNAV-C--------------- 345
Query: 390 NKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQ 449
K + V C+R N+ C + LHINCGG +++ T YE+D R S +Y S
Sbjct: 346 -KYNNVLSCMR-NYQCPKTFN----ALHINCGGDEMSINGTIYESDKYDRLES-WYESRN 398
Query: 450 YWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGN 509
W ++ G F+DD + T S S+++ VD LY AR+S +SLTYY LCL NGN
Sbjct: 399 GWFSNNVGVFVDDKHVPERV--TIESNSSELNVVDFGLYTQARISAISLTYYALCLENGN 456
Query: 510 YTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEV 569
Y V LHFAEI+F ++ + SLG+R FDIYIQ KL KDFNI EA G ++K FP E+
Sbjct: 457 YNVNLHFAEIMFNGNNNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFPVEI 516
Query: 570 TSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHV---MIMAAIV 626
L+I LYWAGRGTT IP YGPLISAISV S+ P S +N + + +V
Sbjct: 517 KDGKLEIRLYWAGRGTTVIPKERVYGPLISAISVDSSVNP----SPRNGMSTGTLHTLVV 572
Query: 627 GASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGE 686
S+ +V L+ + KG L K +K+ + L+L ++LRQIK ATNNFD AN++GE
Sbjct: 573 ILSIFIVFLVFGTLWKKGYLRSKSQMEKDFKSLELMIASFSLRQIKIATNNFDSANRIGE 632
Query: 687 GGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746
GGFG VYKG L DGT+IAVKQLS+ S+QGNREF+NEIGMISA HPNLVKLYGCCVEG Q
Sbjct: 633 GGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQ 692
Query: 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI 806
LLLVYE+++NN L+RA+FG E +L+LDWPTR+KICIG+ARGLAYLHE+SR+KIVHRDI
Sbjct: 693 LLLVYEFVENNSLARALFGPQ-ETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDI 751
Query: 807 KTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
K +NVLLDK LN KISDFGLAKL EED THISTRIAGT
Sbjct: 752 KATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGTF 790
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 728 bits (1879), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/842 (47%), Positives = 535/842 (63%), Gaps = 36/842 (4%)
Query: 19 ISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKG 78
+++ F Y++ A KL +EV AL+QI LG K W F + C + L+
Sbjct: 27 FAIICFKFYSVNAI--KLPQQEVDALQQIATTLGSKFWKFDAENCKIE-MVGLTETPPPT 83
Query: 79 FESNVTCDCSSAT---CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQ 135
+ + C+CS CHVV A K NL GTLP ++ KL YL+++DL+ N + G+ +
Sbjct: 84 AKQEIECECSPTNDTDCHVVKFAFKDHNLPGTLP-QIVKLPYLREIDLAYNYINGTLPRE 142
Query: 136 WASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILS 195
WAS L +S++ NRLSG PK N ++L L +E N F+G+IP ++ L++L+KL+LS
Sbjct: 143 WASSNLTFISLLVNRLSGEIPKEFGN-SSLTYLDLESNAFSGTIPQELGNLVHLKKLLLS 201
Query: 196 SNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI 255
SN TG LPA L +L N+ D RI+D SG IP +I WK++++L + S L GPIP+ I
Sbjct: 202 SNKLTGTLPASLARLQNMTDFRINDLQLSGTIPSYIQNWKQLERLEMIASGLTGPIPSVI 261
Query: 256 SALTSLTDLRISDLKGSESAFPKLDKMN-LKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 314
S L++L +LRISD++G FP L + L +IL C I G+IP Y+ + +L+ +DLS
Sbjct: 262 SVLSNLVNLRISDIRGPVQPFPSLKNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLS 321
Query: 315 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIEC 374
FN L GGIP+ F + F+ L GN L G P + VD+S NN W+S + C
Sbjct: 322 FNKLVGGIPS-FAQAENLRFIILAGNMLEGDAPDELLRDGITVDLSYNNLKWQSPESRAC 380
Query: 375 -PRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTK-- 431
P ++NL S+ K K PC++ +F C +Y LH+NCGG+ + K
Sbjct: 381 RPNMNLNLNLFQSTSTKKSSKFLPCIK-DFKCP----RYSSCLHVNCGGSDMYVKEKKTK 435
Query: 432 --YEAD--MEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLEL 487
YE D +E A F W FSSTG FMDD N + T+ ++ +L
Sbjct: 436 ELYEGDGNVEGGAAKYFLKPDANWGFSSTGDFMDD-----NNFQNTRFTMFVPASNQSDL 490
Query: 488 YRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKD 547
Y++AR++P+SLTY+ CL NGNYT+ L FAEI F ND +N LG+R+FDIYIQEKLV KD
Sbjct: 491 YKSARIAPVSLTYFHACLENGNYTINLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKD 550
Query: 548 FNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNF 607
FNI DEA G PI+K A VT+H L I L WAG+GTT IP RG YGP+ISAIS+ S+
Sbjct: 551 FNIMDEAKGAQTPIIKPLTAYVTNHFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDS 610
Query: 608 KPPVVHSKKNHVMIMAAI---VGASVLLVLLILFIMRW-KGCLGGKVSADKELRGLDLQT 663
KP K + A I +GA L++ ++ F+ W GCL K+ +L +
Sbjct: 611 KP--CERPKTGMSPGAYIAIGIGAPCLIIFILGFL--WICGCLPRCGRQRKDPYEEELPS 666
Query: 664 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI 723
G +TLRQIK AT++F+P NK+GEGGFG+V+KG+L+DG V+AVKQLSSKSRQGNREF+NEI
Sbjct: 667 GTFTLRQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEI 726
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
G IS QHPNLVKL+G CVE QLLL YEYM+NN LS A+F + ++ +DWPTR KIC
Sbjct: 727 GAISCLQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHK-QIPMDWPTRFKIC 785
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
GIA+GLA+LHE+S +K VHRDIK +N+LLDKDL KISDFGLA+L EE+KTHIST++AG
Sbjct: 786 CGIAKGLAFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAG 845
Query: 844 TM 845
T+
Sbjct: 846 TI 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 706 bits (1823), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/858 (47%), Positives = 534/858 (62%), Gaps = 41/858 (4%)
Query: 8 LKLLLASHLLFISLV--TFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNF-GVDPCS 64
+ ++L S LF +++ + A+ + LHA+E+ ALK+I LG K N DPCS
Sbjct: 1 MSIILWSFFLFFTIILSSLTNITTLASFSSLHADELNALKEIATTLGIKRLNLRDEDPCS 60
Query: 65 QKGNWELSSDD---KKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYL 118
K + D + + CDCS + C + +ALK +L G LP EL+KL YL
Sbjct: 61 SKTLKIIQEVDFVPNLDINNTIGCDCSFNNNTICRITELALKTMSLRGKLPPELTKLPYL 120
Query: 119 KQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 177
K ++L RN L+G+ +WA + L +SV N LSG P L N L L +EGN F+G
Sbjct: 121 KSIELCRNYLSGTIPMEWAKMAYLTSISVCANNLSGNLPAGLQNFKNLTFLGVEGNQFSG 180
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
IP ++ L +L L L+SN FTG LP L +L NL +RI DNNF+G IP +IG W ++
Sbjct: 181 PIPDELGNLTSLTGLELASNKFTGILPGTLARLVNLERVRICDNNFTGIIPAYIGNWTRL 240
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
QKLH+ S L GPIP ++ L +L +L +SD G +S FP L LK LIL + G
Sbjct: 241 QKLHLYASGLTGPIPDAVVRLENLLELSLSDTTGIKS-FPNLSSKGLKRLILRNVGLSGP 299
Query: 298 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY-IFNSNKN 356
IP YI ++T LK +DLSFN L G I + K +YLTGN L+G + + NS
Sbjct: 300 IPSYIWNLTDLKILDLSFNKLNG-IVQGVQNPPKN--IYLTGNLLSGNIESGGLLNSQSY 356
Query: 357 VDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPAD--QYHY 414
+D+S NNF+W SS C +GS S +N L + PC + PA+ +Y
Sbjct: 357 IDLSYNNFSWSSS----CQKGSTINTYQSSYSKNNLTGLPPC-------AVPANCKKYQR 405
Query: 415 TLHINCGGAKINT----GHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYI 470
LHINCGG +++ G Y+ D + + YW S+TG F DD++D D Y
Sbjct: 406 FLHINCGGEEVSIRNSLGKITYQTDNSRQTNAASNQQFDYWGVSNTGDFTDDNSDHDEYY 465
Query: 471 RTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSL 530
TST +S +LY+TAR S LSL YY CL NGNY V+LHF EI F + ++ L
Sbjct: 466 ---TSTNLTLSGDYPDLYKTARRSALSLVYYAFCLENGNYNVKLHFMEIQFSDKEVYSRL 522
Query: 531 GKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPL 590
G+RIFD+Y+Q KL +DFNI EA G P++K A VT+H L+I LYWAG+GTT IP
Sbjct: 523 GRRIFDVYVQGKLFLRDFNINKEANGNMKPVIKEINATVTNHMLEIRLYWAGKGTTLIPK 582
Query: 591 RGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGAS---VLLVLLILFIMRWKGCLG 647
RG YGPLISAIS+ + +P K H + I+GAS V +VLL + I
Sbjct: 583 RGNYGPLISAISLCHSQEPLCGVEKTKHHIKYPLILGASGALVTIVLLAVGIYARGIYRR 642
Query: 648 GKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQ 707
+++LR LQT ++ RQ++ ATNNFD ANK+GEGGFGSV+KG LSDGT+IAVKQ
Sbjct: 643 DNNRRERDLRAQGLQTVCFSWRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQ 702
Query: 708 LSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD 767
LSSKS QGNREFVNEIGMIS HPNLVKLYGCCVE +QLLLVYEYM+NN L+ A+FG++
Sbjct: 703 LSSKSSQGNREFVNEIGMISGLNHPNLVKLYGCCVERDQLLLVYEYMENNSLALALFGQN 762
Query: 768 TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+ LKLDW R+KIC+GIARGL +LH+ S +++VHRDIKT+NVLLD DLNAKISDFGLA
Sbjct: 763 S---LKLDWAARQKICVGIARGLEFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLA 819
Query: 828 KLYEEDKTHISTRIAGTM 845
+L+E + THIST++AGT+
Sbjct: 820 RLHEAEHTHISTKVAGTI 837
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 606 bits (1563), Expect = e-172, Method: Compositional matrix adjust.
Identities = 345/837 (41%), Positives = 493/837 (58%), Gaps = 34/837 (4%)
Query: 32 TANKLHAEEVKALKQI---GRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS 88
T H +E +AL I + ++WN + CS D + + CDCS
Sbjct: 33 TGATTHPDEARALNSIFAAWKIQAPREWNISGELCSGAAIDASVLDSNPAYNPLIKCDCS 92
Query: 89 ---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELS 145
S C + I + A ++ G +P EL L YL L+L +N LTGS P +L ++
Sbjct: 93 FQNSTICRITNIKVYAIDVVGPIPPELWTLTYLTNLNLGQNVLTGSLPPAIGNLTRMQWM 152
Query: 146 VMG-NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP 204
G N LSGP PK + +T L+ L I N F+GSIP +I + LQ++ + S+ +G +P
Sbjct: 153 TFGINALSGPVPKEIGLLTDLRLLGISSNNFSGSIPDEIGRCTKLQQMYIDSSGLSGRIP 212
Query: 205 AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 264
L L I+D + +IP+FIG W K+ L I G+ L GPIP+S S LTSLT+L
Sbjct: 213 LSFANLVQLEQAWIADLEVTDQIPDFIGDWTKLTTLRIIGTGLSGPIPSSFSNLTSLTEL 272
Query: 265 RISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
R+ D+ S+ + M +L L+L + G IP IG+ + L+ +DLSFN L G IP
Sbjct: 273 RLGDISSGSSSLDFIKDMKSLSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIP 332
Query: 324 TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVE 383
+ L++ ++L N L G P S +NVD+S N+ + + P +NLV
Sbjct: 333 ASLFNLSQLTHLFLGNNTLNGSFPTQKTQSLRNVDVSYNDLSGSLPSWVSLPSLKLNLVA 392
Query: 384 SYSSPRNKLDKVHP---CLRQNFPCSAPADQYHYTLHINCGGAKIN--TGHTKYEADMEA 438
+ + ++V P CL++NFPC+ Y INCGG + TG D +
Sbjct: 393 NNFTLEGLDNRVLPGLNCLQKNFPCNRGKGIYS-DFSINCGGPEKRSVTGALFEREDEDF 451
Query: 439 RGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSL 498
AS F S+GQ WA SS G F ++ YI T+ S V+ +D EL+++AR+S S+
Sbjct: 452 GPASFFVSAGQRWAASSVGLFAGSSNNI--YIATSQSQF--VNTLDSELFQSARLSASSV 507
Query: 499 TYYGLCLGNGNYTVRLHFAEI--IFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGG 556
YYGL L NG YTV L FAEI + +T+ LG+R FDIY+Q +LV+KDF++ AG
Sbjct: 508 RYYGLGLENGGYTVTLQFAEIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGD 567
Query: 557 TGIPIVKN-FPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVH-- 613
+ + V+ + A V+ + L++HL+WAG+GT IP++G YGPLISA+S +F P V +
Sbjct: 568 STVRAVQRVYKANVSENHLEVHLFWAGKGTCCIPIQGAYGPLISAVSATPDFTPTVANKP 627
Query: 614 ---SKKNHVMIMAAIVGASVLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTL 668
K I+ IVG +L +L +++F +R + + + D+EL G+D++ ++T
Sbjct: 628 PSKGKNRTGTIVGVIVGVGLLSILAGVVMFTIRKRR---KRYTDDEELLGMDVKPYIFTY 684
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA 728
++K+AT +FDP+NK+GEGGFG VYKG L+DG V+AVK LS SRQG +FV EI IS+
Sbjct: 685 SELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISS 744
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
H NLVKLYGCC EG +LVYEY+ N L +A+FG T L LDW TR +IC+G+AR
Sbjct: 745 VLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKT---LHLDWSTRYEICLGVAR 801
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
GL YLHE++ ++IVHRD+K SN+LLD L +ISDFGLAKLY++ KTHISTR+AGT+
Sbjct: 802 GLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTI 858
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 602 bits (1552), Expect = e-171, Method: Compositional matrix adjust.
Identities = 355/860 (41%), Positives = 499/860 (58%), Gaps = 43/860 (5%)
Query: 16 LLFISLVTFFG--YAIAA---TANKLHAEEVKALKQI---GRKLGKKDWNFGVDPCSQKG 67
LL + + FG Y + A T H +E AL I R ++WN + CS
Sbjct: 11 LLTVWFLCNFGPVYVVRAQNRTGATTHPDEALALNSIFAAWRIRAPREWNISGELCSGAA 70
Query: 68 NWELSSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLS 124
D + + CDCS S C + I + A + G++P +L L YL L+L
Sbjct: 71 IDASVLDSNPAYNPLIKCDCSFENSTICRITNIKVYAMEVVGSIPQQLWTLEYLTNLNLG 130
Query: 125 RNCLTGSFSPQWASLQLVELSVMG-NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI 183
+N LTGS P +L + G N LSGP PK + +T L+ LSI N F+GSIP +I
Sbjct: 131 QNVLTGSLPPALGNLTRMRWMTFGINALSGPIPKEIGLLTDLRLLSISSNNFSGSIPDEI 190
Query: 184 RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ 243
+ LQ++ + S+ +G LP L L I+D +G+IP+FIG W K+ L I
Sbjct: 191 GRCTKLQQIYIDSSGLSGGLPVSFANLVELEQAWIADMELTGQIPDFIGDWTKLTTLRIL 250
Query: 244 GSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYI 302
G+ L GPIPAS S LTSLT+LR+ D+ S+ + M +L L+L + G IP I
Sbjct: 251 GTGLSGPIPASFSNLTSLTELRLGDISNGNSSLEFIKDMKSLSILVLRNNNLTGTIPSNI 310
Query: 303 GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 362
G+ + L+ +DLSFN L G IP + L + ++L N L G +P S NVD+S N
Sbjct: 311 GEYSSLRQLDLSFNKLHGTIPASLFNLRQLTHLFLGNNTLNGSLPTQKGQSLSNVDVSYN 370
Query: 363 NFT-----WESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLH 417
+ + W S + + N + N++ CL++NFPC+ Y
Sbjct: 371 DLSGSLPSWVSLPNLNLNLVANNF--TLEGLDNRVLSGLNCLQKNFPCNRGKGIYS-DFS 427
Query: 418 INCGGAKINT-GHTKYEADMEARG-ASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTS 475
INCGG +I + +E + E G AS S+GQ WA SS G F ++ YI T+ S
Sbjct: 428 INCGGPEIRSVTEAVFEREDEDLGPASFVVSAGQRWAASSVGLFAGSSNNI--YISTSQS 485
Query: 476 TLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEI--IFKNDSTFNSLGKR 533
V+ +D EL+++AR+S SL YYGL L NG YTV L FAEI + +T+ LG+R
Sbjct: 486 QF--VNTLDSELFQSARLSASSLRYYGLGLENGGYTVTLQFAEIQILGSTSNTWRGLGRR 543
Query: 534 IFDIYIQEKLVKKDFNIEDEAGGTGIPIV-KNFPAEVTSHTLKIHLYWAGRGTTGIPLRG 592
FDIY+Q +LV+KDF++ AG + + V + + A V+ + L+IHL+WAG+GT IP++G
Sbjct: 544 RFDIYVQGRLVEKDFDVRRTAGDSTVRAVQREYKANVSQNHLEIHLFWAGKGTCCIPIQG 603
Query: 593 TYGPLISAISVKSNFKP-----PVVHSKKNHVMIMAAIVGASVLLVL--LILFIMRWKGC 645
YGPLISA+ +F P P K I+ IVG +L ++ +++FI+R +
Sbjct: 604 AYGPLISAVGATPDFTPTVGNRPPSKGKSMTGTIVGVIVGVGLLSIISGVVIFIIRKRR- 662
Query: 646 LGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAV 705
+ + D+E+ +D++ +T ++K+AT +FDP+NK+GEGGFG VYKG L+DG +AV
Sbjct: 663 --KRYTDDEEILSMDVKPYTFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAV 720
Query: 706 KQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765
K LS SRQG +FV EI ISA QH NLVKLYGCC EG LLVYEY+ N L +A+FG
Sbjct: 721 KLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFG 780
Query: 766 KDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825
+ T L LDW TR +IC+G+ARGL YLHE++R++IVHRD+K SN+LLD L K+SDFG
Sbjct: 781 EKT---LHLDWSTRYEICLGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFG 837
Query: 826 LAKLYEEDKTHISTRIAGTM 845
LAKLY++ KTHISTR+AGT+
Sbjct: 838 LAKLYDDKKTHISTRVAGTI 857
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (685), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 246/807 (30%), Positives = 374/807 (46%), Gaps = 120/807 (14%)
Query: 97 IALKAQNLTGTLPTELSKL-RYLKQLDLSRNCLTGSFSPQW-ASLQLVELSVMGNRLSGP 154
++L L+G +P ELS L + L LDLS N +G Q+ A + L L++ N LSG
Sbjct: 282 LSLAHNRLSGEIPPELSLLCKTLVILDLSGNTFSGELPSQFTACVWLQNLNLGNNYLSGD 341
Query: 155 F-PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN- 212
F V++ IT + L + N +GS+P + NL+ L LSSN FTG +P+ L +
Sbjct: 342 FLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPSGFCSLQSS 401
Query: 213 --LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRI--SD 268
L + I++N SG +P +GK K ++ + + + L GPIP I L +L+DL + ++
Sbjct: 402 PVLEKILIANNYLSGTVPMELGKCKSLKTIDLSFNELTGPIPKEIWMLPNLSDLVMWANN 461
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328
L G+ + NL+TLIL L+ G IP+ I T + I LS N LTG IP+
Sbjct: 462 LTGTIPEGVCVKGGNLETLILNNNLLTGSIPESISRCTNMIWISLSSNRLTGKIPSGIGN 521
Query: 329 LAKTNFMYLTGNKLTGPVPKYIFNSNKNV--DISLNNFTWESSDPIECPRGSVNLVESYS 386
L+K + L N L+G VP+ + N + D++ NN T + + G V
Sbjct: 522 LSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNLTGDLPGELASQAGLV------- 574
Query: 387 SPRNKLDKVHPCLRQNFPCSAPADQYHYTLH---INCGGAKINTGHTKYEADMEAR---- 439
P S Q+ + + +C GA G ++E R
Sbjct: 575 ----------------MPGSVSGKQFAFVRNEGGTDCRGAG---GLVEFEGIRAERLERL 615
Query: 440 ------GASMFYSSGQYWAFSSTGKFMDDDTD---LDNYIRTNTSTLSKVSAVDLELYRT 490
A+ YS + FS+ G + D + +I + + ++L R
Sbjct: 616 PMVHSCPATRIYSGMTMYTFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNRI 675
Query: 491 ARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTF--NSLGKRIFDIYIQEKLVKKDF 548
P S + GL + ++ N + SLG F D
Sbjct: 676 TGTIPDS--FGGL--------KAIGVLDLSHNNLQGYLPGSLGSLSF---------LSDL 716
Query: 549 NIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFK 608
++ + IP F ++T T + Y G G+PLR P SA +
Sbjct: 717 DVSNNNLTGPIP----FGGQLT--TFPVSRYANNSGLCGVPLR----PCGSAP------R 760
Query: 609 PPV---VHSKKNHVM--IMAAIVGASVLLVLLILFIMRWK-------------------G 644
P+ +H+KK V ++A I + + V+L++ + R + G
Sbjct: 761 RPITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSG 820
Query: 645 CLGGKVSADKELRGLDLQTGLYTLRQIK-----AATNNFDPANKVGEGGFGSVYKGILSD 699
K+S+ E +++ T LR++ ATN F VG GGFG VYK L D
Sbjct: 821 SCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRD 880
Query: 700 GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759
G+V+A+K+L + QG+REF+ E+ I +H NLV L G C G + LLVYEYMK L
Sbjct: 881 GSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSL 940
Query: 760 SRAIFGKDTEY-RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818
+ K ++ + L+W RKKI IG ARGLA+LH I+HRD+K+SNVLLD+D
Sbjct: 941 ETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFE 1000
Query: 819 AKISDFGLAKLYEEDKTHIS-TRIAGT 844
A++SDFG+A+L TH+S + +AGT
Sbjct: 1001 ARVSDFGMARLVSALDTHLSVSTLAGT 1027
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 845 | ||||||
| 302143484 | 1011 | unnamed protein product [Vitis vinifera] | 0.983 | 0.821 | 0.711 | 0.0 | |
| 449444971 | 1028 | PREDICTED: probable LRR receptor-like se | 0.977 | 0.803 | 0.702 | 0.0 | |
| 224080095 | 977 | predicted protein [Populus trichocarpa] | 0.950 | 0.821 | 0.702 | 0.0 | |
| 359485473 | 999 | PREDICTED: probable LRR receptor-like se | 0.962 | 0.813 | 0.694 | 0.0 | |
| 255584521 | 941 | conserved hypothetical protein [Ricinus | 0.880 | 0.790 | 0.757 | 0.0 | |
| 356501491 | 1025 | PREDICTED: probable LRR receptor-like se | 0.986 | 0.813 | 0.662 | 0.0 | |
| 357494365 | 1039 | BED finger-nbs resistance protein [Medic | 0.976 | 0.794 | 0.659 | 0.0 | |
| 317106662 | 927 | JHL10I11.12 [Jatropha curcas] | 0.861 | 0.785 | 0.746 | 0.0 | |
| 345651730 | 1027 | rfls6 protein [Glycine max] | 0.982 | 0.808 | 0.649 | 0.0 | |
| 297849060 | 1012 | hypothetical protein ARALYDRAFT_470791 [ | 0.975 | 0.814 | 0.640 | 0.0 |
| >gi|302143484|emb|CBI22045.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1202 bits (3109), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 597/839 (71%), Positives = 699/839 (83%), Gaps = 8/839 (0%)
Query: 12 LASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWEL 71
+ + + + V F + + + KL A+E+KALK IG +LGK+DW+FG DPCS +GNW
Sbjct: 1 MGAEPIIVFSVLFIFFTVPGFSAKLPADELKALKVIGTRLGKRDWDFGKDPCSGEGNWS- 59
Query: 72 SSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCL 128
S ++KKG ES+VTCDC+ +A+CHVVTIALKAQNL+G+LP ELSKL +LK LDLSRN
Sbjct: 60 SVNEKKGVESSVTCDCTFHHNASCHVVTIALKAQNLSGSLPPELSKLYHLKHLDLSRNLF 119
Query: 129 TGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLIN 188
+GS QWA+++LVELS+MGNRLSGPFPKVLTNITTL+NLSIEGNLF+G IPP+I KLI
Sbjct: 120 SGSIPSQWATMRLVELSLMGNRLSGPFPKVLTNITTLRNLSIEGNLFSGPIPPEIGKLIR 179
Query: 189 LQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248
++K++LSSN+FTGELP L KLTNL D+RI+DN+FSG+IPEFIG W +QKLHIQGSSLE
Sbjct: 180 IEKMVLSSNAFTGELPVALAKLTNLTDMRINDNHFSGRIPEFIGNWTHVQKLHIQGSSLE 239
Query: 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTK 307
GPIP+SISALTSL+DLRISDLKG S FP L + +LKTL+L KCLIHGEIP+YIGDM K
Sbjct: 240 GPIPSSISALTSLSDLRISDLKGRGSTFPPLSTIESLKTLVLRKCLIHGEIPEYIGDMKK 299
Query: 308 LKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWE 367
LK++DLSFN L G IPT+F++LAKT+FMYLTGN LTG +P +I +NKN D+S NNFTW+
Sbjct: 300 LKHLDLSFNELAGEIPTSFQELAKTDFMYLTGNMLTGHIPDWILGTNKNFDLSYNNFTWD 359
Query: 368 SSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKIN- 426
SS P+ECPRGSVNLVESYSS + CL+QNFPCSA ++QYHY+LHINCGG + +
Sbjct: 360 SSSPVECPRGSVNLVESYSSSSVRRSIHS-CLKQNFPCSASSNQYHYSLHINCGGKETSI 418
Query: 427 TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLE 486
G TKYEAD+E GASMFY GQ WAFSSTG FMD+D D D YI NTS+LS VS +D+E
Sbjct: 419 NGSTKYEADLEPTGASMFYL-GQNWAFSSTGNFMDNDVDGDAYIEANTSSLSNVSVLDVE 477
Query: 487 LYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKK 546
LY+ ARVSPLSLTYYGLCLGNGNYTV+LHFAEIIF ND +FNSLG+RIFD+YIQ KLV K
Sbjct: 478 LYKKARVSPLSLTYYGLCLGNGNYTVKLHFAEIIFINDKSFNSLGERIFDVYIQGKLVLK 537
Query: 547 DFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSN 606
DFNIE EAGGTG PI+KNF AEVTSHTLK+ YWAGRGTTGIPLRG YGPLISAISV N
Sbjct: 538 DFNIEKEAGGTGKPIIKNFTAEVTSHTLKVQFYWAGRGTTGIPLRGFYGPLISAISVDPN 597
Query: 607 FKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLY 666
F+PP K + I+ +V+LVLL L I+ KG LGGK S DKELRGLDLQTGL+
Sbjct: 598 FEPPSPPGKNWDIKIVVGAAAVAVVLVLLTLGILWRKGWLGGKTSEDKELRGLDLQTGLF 657
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
TLRQIKAAT NFD NK+GEGGFG+V+KG LSDGTVIAVKQLSSKS+QGNREFVNE+GMI
Sbjct: 658 TLRQIKAATKNFDAENKLGEGGFGAVFKGTLSDGTVIAVKQLSSKSKQGNREFVNEVGMI 717
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
SA QHPNLVKLYGCC+EGNQL LVYEYM+NN LSRA+FG+D Y+LKL+W TR+ IC+GI
Sbjct: 718 SALQHPNLVKLYGCCIEGNQLSLVYEYMENNSLSRALFGRDATYKLKLNWSTRQNICVGI 777
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
ARGLAYLHE+S +KIVHRDIKTSNVLLDKD+NAKISDFGLAKL E+D THISTRIAGT+
Sbjct: 778 ARGLAYLHEESTLKIVHRDIKTSNVLLDKDMNAKISDFGLAKLDEDDNTHISTRIAGTI 836
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449444971|ref|XP_004140247.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Cucumis sativus] gi|449481221|ref|XP_004156118.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1195 bits (3092), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 587/836 (70%), Positives = 690/836 (82%), Gaps = 10/836 (1%)
Query: 15 HLLF-ISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSS 73
H + I L+ F + +AA A KLH EEVKALK+I +KLGK DW+F +DPCS +G W +
Sbjct: 17 HFFYAILLLQFATFGLAAAA-KLHREEVKALKEIEKKLGKNDWDFNIDPCSGEGKWHVV- 74
Query: 74 DDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTG 130
+ +KGFES+VTCDCS ++TCH+V IALK+QNL+G +P E SKLR+LKQLDLSRNCLTG
Sbjct: 75 NGRKGFESSVTCDCSFNHNSTCHIVAIALKSQNLSGIVPPEFSKLRFLKQLDLSRNCLTG 134
Query: 131 SFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQ 190
QWA+++LVELS MGN+LSGPFPKVLTNITTL+NLSIEGN F+G IPP+I KL+NL+
Sbjct: 135 FVPSQWATMRLVELSFMGNKLSGPFPKVLTNITTLRNLSIEGNQFSGRIPPEIGKLVNLE 194
Query: 191 KLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250
KL+LSSN TGELP L KL+NL D+RISDNNFSGKIPEFI W +I+KLHIQG SLEGP
Sbjct: 195 KLVLSSNGLTGELPKGLAKLSNLTDMRISDNNFSGKIPEFISNWAQIEKLHIQGCSLEGP 254
Query: 251 IPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLK 309
IP SIS +TSLTDLRISDLKG S FP L + ++KTLIL KC I GEIP YIGDM KLK
Sbjct: 255 IPLSISTMTSLTDLRISDLKGGRSPFPPLSNIKSMKTLILRKCFIFGEIPKYIGDMKKLK 314
Query: 310 NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESS 369
N+DLS+N+LTG +P TFE+L K ++++LT NKL G +P +I SNKNVD+S NNFTWE+S
Sbjct: 315 NLDLSYNDLTGEVPATFERLDKIDYIFLTANKLNGIIPGWILGSNKNVDLSNNNFTWENS 374
Query: 370 DPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGH 429
P ECPRGSVNLVE+YS KL ++HPCL++NFPCSA +++HY+L INCGG + +
Sbjct: 375 SPAECPRGSVNLVETYSPSAEKLTRIHPCLKRNFPCSASREEHHYSLRINCGGKETSIRG 434
Query: 430 TKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYR 489
+YEAD E GASMFY+ GQ WAFSSTG FMD+D D DNYI TNTS LS VSA ELY
Sbjct: 435 ERYEADRE--GASMFYT-GQNWAFSSTGSFMDNDVDADNYIVTNTSALSNVSATYSELYT 491
Query: 490 TARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFN 549
AR SP SLTYYGLCL NGNYTV+LHFAEI+F NDS+FNSLG+R+FD+YIQEKLV KDF+
Sbjct: 492 KARNSPQSLTYYGLCLINGNYTVKLHFAEIVFINDSSFNSLGRRVFDVYIQEKLVLKDFD 551
Query: 550 IEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKP 609
IE EAGGTG PI+K VTSHTLKIH YWAGRGTTGIPLRG YGPLISAISV NF P
Sbjct: 552 IEHEAGGTGKPIIKKITVAVTSHTLKIHFYWAGRGTTGIPLRGNYGPLISAISVDPNFTP 611
Query: 610 PVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLR 669
P H KK+ +I+ A+ +L+LL+L IMR KG LGGK S KELRG+DLQTGL+T+R
Sbjct: 612 PKNHGKKDFTIIIIGTAAAAFVLLLLVLCIMRRKGWLGGKASVYKELRGIDLQTGLFTIR 671
Query: 670 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ 729
QIKAAT NFD ANKVGEGGFG+VYKG+LSDGT+IAVKQLSSKS+QGNREFVNEIGMISA
Sbjct: 672 QIKAATKNFDAANKVGEGGFGAVYKGLLSDGTIIAVKQLSSKSKQGNREFVNEIGMISAL 731
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
QHPNLVKLYGCC++GNQL+L+YEYM+NNCLSRA+F D +LKLDWPTR+KIC+GIARG
Sbjct: 732 QHPNLVKLYGCCIDGNQLMLIYEYMENNCLSRALFRNDPGSKLKLDWPTRQKICLGIARG 791
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
LAYLHE+SR+KIVHRDIKTSNVLLDKD +AKISDFGLAKL+E+D THISTR+AGT+
Sbjct: 792 LAYLHEESRLKIVHRDIKTSNVLLDKDFSAKISDFGLAKLHEDDNTHISTRVAGTI 847
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224080095|ref|XP_002306015.1| predicted protein [Populus trichocarpa] gi|222848979|gb|EEE86526.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1181 bits (3055), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 570/811 (70%), Positives = 672/811 (82%), Gaps = 8/811 (0%)
Query: 41 VKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS---SATCHVVTI 97
V+ L++IG+KLGKKDW+F DPCS +GNW + D++KGFE++VTCDCS +++CH+V+I
Sbjct: 1 VRVLREIGKKLGKKDWDFNKDPCSGEGNWSIL-DERKGFENSVTCDCSFNNNSSCHLVSI 59
Query: 98 ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPK 157
ALK+QNL+G +P E SK RYLKQLDLSRN TG PQW +L+L E SVMGNRLSGPFPK
Sbjct: 60 ALKSQNLSGIIPPEFSKFRYLKQLDLSRNLFTGVIPPQWGTLRLEEFSVMGNRLSGPFPK 119
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
VLTN+TTL+NLSIEGN F+G IPP+I +LINLQKL+ SSN+ TG LPAEL KL NL D+R
Sbjct: 120 VLTNMTTLRNLSIEGNHFSGPIPPEIGRLINLQKLVFSSNALTGNLPAELGKLVNLTDVR 179
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277
I+DNNFSGK+P FI KW K+QKLH+QG+SL+GPIP+SI++LT L+DLRISDL G S FP
Sbjct: 180 INDNNFSGKLPTFISKWTKVQKLHLQGTSLKGPIPSSIASLTKLSDLRISDLTGRGSPFP 239
Query: 278 KLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336
L M ++KTLIL CLI+GEIP+Y+G M KLK++D+SFNNL G IP+TF +LA+ +F+Y
Sbjct: 240 PLSDMESMKTLILRNCLIYGEIPEYVGQMEKLKHLDVSFNNLRGEIPSTFIQLARIDFLY 299
Query: 337 LTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 396
LTGNKLTG VP ++ NKNVD+S NNFTW+SS P EC RGSVN+VES+S P K H
Sbjct: 300 LTGNKLTGSVPPWLLERNKNVDLSYNNFTWQSSSPDECARGSVNIVESFS-PSTIKSKAH 358
Query: 397 PCLRQNFPCSAPADQYHYTLHINCGGAKINT-GHTKYEADMEARGASMFYS-SGQYWAFS 454
CL+QNFPCSA +Q HYTLHINCGG +I G+T Y+ D E RGASMFYS Q WAFS
Sbjct: 359 SCLKQNFPCSASRNQQHYTLHINCGGNEITVDGNTTYQDDKEPRGASMFYSHPSQEWAFS 418
Query: 455 STGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRL 514
STG FMDDD++ D Y +TN S +S VSA +LY TARVSPLSLTYYGLCL NGNYTV+L
Sbjct: 419 STGNFMDDDSEADAYTKTNKSAISNVSATIAQLYTTARVSPLSLTYYGLCLMNGNYTVKL 478
Query: 515 HFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTL 574
HFAEIIF NDS+ SLGKRIFD+YIQ KLV KDFNIEDEAGG IP+VK F A VT +TL
Sbjct: 479 HFAEIIFTNDSSLTSLGKRIFDVYIQGKLVLKDFNIEDEAGGVAIPLVKTFIAAVTHNTL 538
Query: 575 KIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVL 634
KI LYWAGRGTTGIPLRG YGPLISAISV NFKPP SK+N V+I+ V ++ L
Sbjct: 539 KIRLYWAGRGTTGIPLRGIYGPLISAISVDPNFKPPSNGSKRNVVIIVTGAVAGAIFLAF 598
Query: 635 LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYK 694
L+L +M G L GK +ADKEL+GLDLQTGL+TLRQ+KAATNNFD NKVGEGGFGSVYK
Sbjct: 599 LVLGVMWRNGWLCGKAAADKELKGLDLQTGLFTLRQMKAATNNFDAENKVGEGGFGSVYK 658
Query: 695 GILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
G LSDGTVIAVK LSSKS+QGNREFVNEIGMISA QHPNLVKLYGCCVEGNQL++VYEYM
Sbjct: 659 GSLSDGTVIAVKLLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLMIVYEYM 718
Query: 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 814
+NNCLSRA+ GK++++R+KLDWPTR+KIC+G+A+GL YLHE+S IKIVHRDIKTSNVLLD
Sbjct: 719 ENNCLSRALLGKESKFRMKLDWPTRQKICLGVAKGLMYLHEESIIKIVHRDIKTSNVLLD 778
Query: 815 KDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
K+LNAKISDFGLAKL E+D THISTRIAGT+
Sbjct: 779 KELNAKISDFGLAKLNEDDDTHISTRIAGTI 809
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485473|ref|XP_002278131.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1171 bits (3030), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 587/845 (69%), Positives = 688/845 (81%), Gaps = 32/845 (3%)
Query: 12 LASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWEL 71
+ + + + V F + + + KL A+E+KALK IG +LGK+DW+FG DPCS +GNW
Sbjct: 1 MGAEPIIVFSVLFIFFTVPGFSAKLPADELKALKVIGTRLGKRDWDFGKDPCSGEGNWS- 59
Query: 72 SSDDKKGFESNVTCDCS---SATCHVVTI------ALKAQNLTGTLPTELSKLRYLKQLD 122
S ++KKG ES+VTCDC+ +A+CHVVT+ ALKAQNL+G+LP ELSKL +LK LD
Sbjct: 60 SVNEKKGVESSVTCDCTFHHNASCHVVTMVYVNCRALKAQNLSGSLPPELSKLYHLKHLD 119
Query: 123 LSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPD 182
LSRN +GS QWA+++LVELS+MGNRLSGPFPKVLTNITTL+NLSIEGNLF+G IPP+
Sbjct: 120 LSRNLFSGSIPSQWATMRLVELSLMGNRLSGPFPKVLTNITTLRNLSIEGNLFSGPIPPE 179
Query: 183 IRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 242
I KLI ++K++LSSN+FTGELP L KLTNL D+RI+DN+FSG+IPEFIG W +QKLHI
Sbjct: 180 IGKLIRIEKMVLSSNAFTGELPVALAKLTNLTDMRINDNHFSGRIPEFIGNWTHVQKLHI 239
Query: 243 QGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDY 301
QGSSLEGPIP+SISALTSL+DLRISDLKG S FP L + +LKTL+L KCLIHGEIP+Y
Sbjct: 240 QGSSLEGPIPSSISALTSLSDLRISDLKGRGSTFPPLSTIESLKTLVLRKCLIHGEIPEY 299
Query: 302 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 361
IGDM KLK++DLSFN L G IPT+F++LAKT+FMYLTGN LTG +P +I +NKN D+S
Sbjct: 300 IGDMKKLKHLDLSFNELAGEIPTSFQELAKTDFMYLTGNMLTGHIPDWILGTNKNFDLSY 359
Query: 362 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 421
NNFTW+SS P+ECPRGSVNLVESYSS +R+N HY+LHINCG
Sbjct: 360 NNFTWDSSSPVECPRGSVNLVESYSSS---------SVRRN----------HYSLHINCG 400
Query: 422 GAKIN-TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKV 480
G + + G TKYEAD+E GASMFY GQ WAFSSTG FMD+D D D YI NTS+LS V
Sbjct: 401 GKETSINGSTKYEADLEPTGASMFYL-GQNWAFSSTGNFMDNDVDGDAYIEANTSSLSNV 459
Query: 481 SAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQ 540
S +D+ELY+ ARVSPLSLTYYGLCLGNGNYTV+LHFAEIIF ND +FNSLG+RIFD+YIQ
Sbjct: 460 SVLDVELYKKARVSPLSLTYYGLCLGNGNYTVKLHFAEIIFINDKSFNSLGERIFDVYIQ 519
Query: 541 EKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISA 600
KLV KDFNIE EAGGTG PI+KNF AEVTSHTLK+ YWAGRGTTGIPLRG YGPLISA
Sbjct: 520 GKLVLKDFNIEKEAGGTGKPIIKNFTAEVTSHTLKVQFYWAGRGTTGIPLRGFYGPLISA 579
Query: 601 ISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLD 660
ISV NF+PP K + I+ +V+LVLL L I+ KG LGGK S DKELRGLD
Sbjct: 580 ISVDPNFEPPSPPGKNWDIKIVVGAAAVAVVLVLLTLGILWRKGWLGGKTSEDKELRGLD 639
Query: 661 LQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFV 720
LQTGL+TLRQIKAAT NFD NK+GEGGFG+V+KG LSDGTVIAVKQLSSKS+QGNREFV
Sbjct: 640 LQTGLFTLRQIKAATKNFDAENKLGEGGFGAVFKGTLSDGTVIAVKQLSSKSKQGNREFV 699
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
NE+GMISA QHPNLVKLYGCC+EGNQL LVYEYM+NN LSRA+FG+D Y+LKL+W TR+
Sbjct: 700 NEVGMISALQHPNLVKLYGCCIEGNQLSLVYEYMENNSLSRALFGRDATYKLKLNWSTRQ 759
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
IC+GIARGLAYLHE+S +KIVHRDIKTSNVLLDKD+NAKISDFGLAKL E+D THISTR
Sbjct: 760 NICVGIARGLAYLHEESTLKIVHRDIKTSNVLLDKDMNAKISDFGLAKLDEDDNTHISTR 819
Query: 841 IAGTM 845
IAGT+
Sbjct: 820 IAGTI 824
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584521|ref|XP_002532988.1| conserved hypothetical protein [Ricinus communis] gi|223527234|gb|EEF29396.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1166 bits (3017), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 568/750 (75%), Positives = 648/750 (86%), Gaps = 6/750 (0%)
Query: 98 ALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPK 157
ALK+QNL+G +P + SKL Y++ LDLSRNCLTGS QWA+++LV+LS MGN+LSGPFPK
Sbjct: 6 ALKSQNLSGIVPPDFSKLHYIELLDLSRNCLTGSIPSQWATMRLVDLSFMGNQLSGPFPK 65
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
LTNITTLKNLSIEGN F+G IPP+I KLINL+KL LSSN+FTG+LP EL KL NL D+R
Sbjct: 66 ALTNITTLKNLSIEGNNFSGPIPPEIGKLINLEKLTLSSNAFTGKLPRELAKLVNLTDMR 125
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277
ISD NFSG+IP+FI +WK+IQKLHIQGSSLEGPIP+SIS LT L+DLRISDLKG S+FP
Sbjct: 126 ISDANFSGQIPDFISRWKQIQKLHIQGSSLEGPIPSSISGLTRLSDLRISDLKGQSSSFP 185
Query: 278 KLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336
LD M ++KTLIL KCL+ G+IP+YIG M KLKN+DLSFNNLTG IP TF LAK +FMY
Sbjct: 186 HLDNMESMKTLILRKCLLSGKIPEYIGHMKKLKNLDLSFNNLTGEIPATFSHLAKVDFMY 245
Query: 337 LTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 396
LTGNKLTGP+P+++ NKNVDIS NNFTW+SS IECPRGSVNLVESYSS NKL KVH
Sbjct: 246 LTGNKLTGPIPEWVLERNKNVDISDNNFTWDSSSQIECPRGSVNLVESYSSSTNKLSKVH 305
Query: 397 PCLRQNFPCSAPADQYHYTLHINCGGAKINTG-HTKYEADMEARGASMFYSSGQYWAFSS 455
CL+QNFPCS+ + +Y LHINCGG +I G + Y AD+EARGASM+YSS Q WAFSS
Sbjct: 306 SCLKQNFPCSSKPN--NYALHINCGGKEIIAGSNITYNADLEARGASMYYSS-QNWAFSS 362
Query: 456 TGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLH 515
TG FMD+D D D YI+ NTS +S VSA+D +LY+TARVSPLSL+YYGLCL NGNYTV+LH
Sbjct: 363 TGNFMDNDIDADPYIQINTSAISNVSALDAQLYKTARVSPLSLSYYGLCLINGNYTVKLH 422
Query: 516 FAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLK 575
FAEI+F +D+TFNSLGKRIFD+YIQEKLV KDFNI +EAGGTG PIVK F VTSHTLK
Sbjct: 423 FAEIVFTDDNTFNSLGKRIFDVYIQEKLVLKDFNIAEEAGGTGRPIVKMFTVAVTSHTLK 482
Query: 576 IHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLL 635
IH YWAGRGTTGIP+RG YGPLISAISV NFKPP + KKN V+I+A V A+V LVLL
Sbjct: 483 IHFYWAGRGTTGIPVRGIYGPLISAISVDPNFKPPSDNDKKN-VIIVATTVSAAVFLVLL 541
Query: 636 ILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKG 695
IL IM KGCLG VSADKELRGLDLQTG++TLRQIKAAT NFDPANK+GEGGFGSVYKG
Sbjct: 542 ILGIMWRKGCLGDNVSADKELRGLDLQTGIFTLRQIKAATKNFDPANKLGEGGFGSVYKG 601
Query: 696 ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755
+LSDGT+IAVKQLSSKS+QGNREFVNEIGMIS QHPNLVKLYGCCVEGNQLLL+YEYM+
Sbjct: 602 LLSDGTIIAVKQLSSKSKQGNREFVNEIGMISGLQHPNLVKLYGCCVEGNQLLLIYEYME 661
Query: 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 815
NNCLSRA+FGK++ RLKLDWPTR+KIC+G+ARGLAYLHE+S IKIVHRDIKTSNVLLDK
Sbjct: 662 NNCLSRALFGKNSTSRLKLDWPTRQKICLGVARGLAYLHEESIIKIVHRDIKTSNVLLDK 721
Query: 816 DLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
DLNAKISDFGLAKL E++ THISTRIAGT+
Sbjct: 722 DLNAKISDFGLAKLNEDENTHISTRIAGTI 751
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501491|ref|XP_003519558.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1139 bits (2945), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 558/842 (66%), Positives = 681/842 (80%), Gaps = 8/842 (0%)
Query: 9 KLLLASHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGN 68
K+L L SL+ FF +A KL+ +EVKALK+IG K+GKKDW+FGVDPCS KGN
Sbjct: 9 KMLFLLLLGSTSLIFFFPQLASAATPKLNTQEVKALKEIGSKIGKKDWDFGVDPCSGKGN 68
Query: 69 WELSSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSR 125
W +S D +KGFES+V CDCS +++CHVV+I+LKAQNL+G+L + SKL +L++LDLSR
Sbjct: 69 WNVS-DARKGFESSVICDCSFDHNSSCHVVSISLKAQNLSGSLSPDFSKLHHLQELDLSR 127
Query: 126 NCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRK 185
N +TG+ PQW +++LVELS MGN+LSGPFPKVLTNITTL+NLSIEGN F+G IP +I K
Sbjct: 128 NIITGAIPPQWGTMRLVELSFMGNKLSGPFPKVLTNITTLRNLSIEGNQFSGHIPTEIGK 187
Query: 186 LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS 245
L NL+KLILSSN FTG LP L+KLT L DLRISDNNF GKIP+FI W I+KLH+ G
Sbjct: 188 LTNLEKLILSSNGFTGALPPTLSKLTKLIDLRISDNNFFGKIPDFISNWTLIEKLHMHGC 247
Query: 246 SLEGPIPASISALTSLTDLRISDLKGSES-AFPKLDKM-NLKTLILTKCLIHGEIPDYIG 303
SLEGPIP+SISALT L+DLRI+DLKGS+S AFP L+ + ++KTL+L KC+I GEIP YIG
Sbjct: 248 SLEGPIPSSISALTRLSDLRIADLKGSKSSAFPPLNNLKSMKTLVLRKCMIKGEIPAYIG 307
Query: 304 DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
M KLK +DLS+N L+G IP +F +L K +FMYLTGNKL+G +P ++ +NKN+DIS NN
Sbjct: 308 RMEKLKILDLSYNGLSGEIPESFAQLDKVDFMYLTGNKLSGIIPGWVLANNKNIDISDNN 367
Query: 364 FTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGA 423
F+W+SS P ECPRGS+NLVESYSS N +K+H CL++NFPC++ ++YHY+++INCGG
Sbjct: 368 FSWDSSSPTECPRGSINLVESYSSSVNTQNKIHSCLKRNFPCTSSVNKYHYSMNINCGGN 427
Query: 424 KINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAV 483
+ N YEAD E +GA+M Y +GQ WA SSTG FMD+D D D Y+ NTS L+ VSA+
Sbjct: 428 EANISGQIYEADREQKGAAMLYYTGQDWALSSTGNFMDNDIDSDPYVVANTSRLN-VSAL 486
Query: 484 DLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKL 543
+ +LY TARVSPL+LTYYGLCL NGNYTV+LHFAEIIF ND + SLG+R+FD+YIQ L
Sbjct: 487 NSQLYTTARVSPLALTYYGLCLINGNYTVKLHFAEIIFINDRSLYSLGRRVFDVYIQGNL 546
Query: 544 VKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV 603
V KDF+I+ EAGGTG PIVK A VT HTL+IH YWAG+GTTGIP RG YGPLISAISV
Sbjct: 547 VLKDFDIQREAGGTGKPIVKTLNASVTQHTLEIHFYWAGKGTTGIPTRGVYGPLISAISV 606
Query: 604 KSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQT 663
NFKPP K+ + M+ IV +++VLL+L +MR G LGGK KELRG+DLQT
Sbjct: 607 NPNFKPPSGDGKRTYFMLAIGIVAGVLVVVLLVLVLMRRMGWLGGKDPVYKELRGIDLQT 666
Query: 664 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI 723
GL+TLRQIKAAT NFD NK+GEGGFG V+KG+LSDGT+IAVKQLSSKS+QGNREFVNE+
Sbjct: 667 GLFTLRQIKAATKNFDAENKIGEGGFGCVFKGLLSDGTIIAVKQLSSKSKQGNREFVNEM 726
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
G+IS QHPNLVKLYGCCVEGNQL+L+YEYM+NNCLSR +FG+D + KLDWPTRKKIC
Sbjct: 727 GLISGLQHPNLVKLYGCCVEGNQLILIYEYMENNCLSRILFGRDPN-KTKLDWPTRKKIC 785
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
+GIA+ LAYLHE+SRIKI+HRDIK SNVLLDKD NAK+SDFGLAKL E+DKTHISTR+AG
Sbjct: 786 LGIAKALAYLHEESRIKIIHRDIKASNVLLDKDFNAKVSDFGLAKLIEDDKTHISTRVAG 845
Query: 844 TM 845
T+
Sbjct: 846 TI 847
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357494365|ref|XP_003617471.1| BED finger-nbs resistance protein [Medicago truncatula] gi|355518806|gb|AET00430.1| BED finger-nbs resistance protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1128 bits (2917), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 561/851 (65%), Positives = 666/851 (78%), Gaps = 26/851 (3%)
Query: 18 FISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKK 77
F SL+ +A AAT KL+ +EVKALK+IG K+GKKDW+FGVDPCS KG W +S D +K
Sbjct: 14 FTSLIFISHFASAATL-KLNTQEVKALKEIGNKIGKKDWDFGVDPCSGKGKWNVS-DSRK 71
Query: 78 GFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSP 134
GFES V C+CS +++CHVV+I LKAQNL+GTL E SKL +LK LDLSRN +TGS
Sbjct: 72 GFESAVICNCSFNHNSSCHVVSIFLKAQNLSGTLSPEFSKLPHLKILDLSRNIITGSIPQ 131
Query: 135 QWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLIL 194
QWA + LV+LS MGNR SGPFP VLTNITTLKNLSIEGN F+G IP DI KLINL+KL+L
Sbjct: 132 QWAKMNLVDLSFMGNRFSGPFPTVLTNITTLKNLSIEGNQFSGFIPEDIGKLINLEKLVL 191
Query: 195 SSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPAS 254
SN FTG LP+ +KLT LNDLRISDN+FSGKIP+FI KW I+KLHI+G SLEGPIP+S
Sbjct: 192 QSNRFTGALPSAFSKLTKLNDLRISDNDFSGKIPDFISKWTLIEKLHIEGCSLEGPIPSS 251
Query: 255 ISALTSLTDLRISDLKGSESA-FPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNID 312
ISALT L+DLRI+DL+GS S+ FP L M ++KTL+L KCLI GEIP+YIG+M KLK +D
Sbjct: 252 ISALTVLSDLRITDLRGSRSSTFPPLSNMKSMKTLVLRKCLIKGEIPEYIGEMAKLKVLD 311
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPI 372
LSFN+L+G IP +F L K +FMYLT N L+G +P ++ +NKN+D+S NNF WESS P
Sbjct: 312 LSFNSLSGKIPESFRDLDKVDFMYLTRNNLSGTIPDWVLKNNKNIDVSYNNFEWESSSPT 371
Query: 373 ECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKY 432
EC RGSVNLVESYS K +H CL++NFPC++ + HY+L INCGG + N Y
Sbjct: 372 ECQRGSVNLVESYSLSATKKSNIHSCLKRNFPCTS-KNPRHYSLRINCGGNEANVSGNIY 430
Query: 433 EADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTAR 492
AD+E +GASM Y S + WA SSTG FMD+D D D YI TNTS+L VS ++ +LY TAR
Sbjct: 431 TADIERKGASMLYISAEDWALSSTGSFMDNDIDSDPYIVTNTSSLQNVSVINSKLYTTAR 490
Query: 493 VSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIED 552
VSPLSLTYYGLC+ NGNYTV+LHFAEIIF ND + NSLG+RIFD+YIQ KLV +DF+IE
Sbjct: 491 VSPLSLTYYGLCMINGNYTVQLHFAEIIFINDRSLNSLGRRIFDVYIQGKLVLRDFDIER 550
Query: 553 EAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVV 612
EAGG PIVK F A VT +TLKI YWAG+GTTGIP RG YGPL+SAISV NFKPP
Sbjct: 551 EAGGAEKPIVKKFNATVTENTLKIQFYWAGKGTTGIPTRGVYGPLVSAISVDPNFKPPSE 610
Query: 613 HSKKNHVMIMA-AIVGASVLLVLLILFIMRWKGCLGGKVSADK----------------- 654
H + V+++A IV + +VL+++ +MR KG LGGK K
Sbjct: 611 HGNRTRVILLAVGIVCGFLAVVLIMVAVMRRKGLLGGKDPVYKGKVINFVIESKFPFFFS 670
Query: 655 ELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ 714
ELRG+DLQTGL+TLRQIK AT NFD ANK+GEGGFGSVYKG LSDGTVIAVKQLSSKS+Q
Sbjct: 671 ELRGIDLQTGLFTLRQIKVATKNFDAANKLGEGGFGSVYKGQLSDGTVIAVKQLSSKSKQ 730
Query: 715 GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKL 774
GNREFVNEIGMIS QHPNLVKL+GCCVEGNQL+L+YEYM+NNCLSR +FGK +E + KL
Sbjct: 731 GNREFVNEIGMISGLQHPNLVKLHGCCVEGNQLILIYEYMENNCLSRILFGKGSESKKKL 790
Query: 775 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
DW TRKKIC+GIA+ LAYLHE+SRIKI+HRDIK SNVLLDKD NAK+SDFGLAKL E+DK
Sbjct: 791 DWLTRKKICLGIAKALAYLHEESRIKIIHRDIKASNVLLDKDFNAKVSDFGLAKLIEDDK 850
Query: 835 THISTRIAGTM 845
TH+STRIAGT+
Sbjct: 851 THVSTRIAGTV 861
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|317106662|dbj|BAJ53166.1| JHL10I11.12 [Jatropha curcas] | Back alignment and taxonomy information |
|---|
Score = 1118 bits (2893), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 548/734 (74%), Positives = 624/734 (85%), Gaps = 6/734 (0%)
Query: 114 KLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173
KLR+L+ LDLSRNC TGS QWA+L+LV LS MGNRLSG FPKVLTNITTL NLS+EGN
Sbjct: 1 KLRHLQLLDLSRNCFTGSIPSQWATLRLVNLSFMGNRLSGSFPKVLTNITTLTNLSVEGN 60
Query: 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGK 233
F+GSIP +I KLINLQK ILSSN+FTG+LP EL+KLTNL D+RISDNNFSG IP FI K
Sbjct: 61 RFSGSIPREIGKLINLQKFILSSNAFTGKLPTELSKLTNLTDMRISDNNFSGTIPTFINK 120
Query: 234 WKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKC 292
W IQKLHIQGS LEGPIP+SISAL +L+DLRISDLKG S FP L M ++K LIL C
Sbjct: 121 WTHIQKLHIQGSGLEGPIPSSISALKNLSDLRISDLKGKGSTFPPLSNMESIKALILRNC 180
Query: 293 LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN 352
L+ EIP+YIG M KLKN+DLSFNNLTG IPT+F L K +FMYLTGNKLTG VP+++
Sbjct: 181 LLSDEIPEYIGHMKKLKNLDLSFNNLTGEIPTSFSYLGKADFMYLTGNKLTGSVPEWVLE 240
Query: 353 SNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQY 412
NKNVDIS NNF+WESS PIECPRGSVNLVESYSS KL KVH CL+QNFPCS+ ++
Sbjct: 241 RNKNVDISDNNFSWESSSPIECPRGSVNLVESYSSSTEKLSKVHSCLKQNFPCSS--NKK 298
Query: 413 HYTLHINCGGAK-INTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIR 471
+Y+L+INCGG + I G+T Y+AD+E RGASMFY+S Q WAFSSTG FMD++ D D YI+
Sbjct: 299 YYSLYINCGGEEMIAGGNTTYQADLEPRGASMFYTS-QSWAFSSTGNFMDNNIDSDPYIQ 357
Query: 472 TNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLG 531
NTS +S VS+ D +LY TARVSP+SLTYYGLCL NGNYTV LHFAEI+F NDS+FNSLG
Sbjct: 358 INTSAISNVSSPDAQLYTTARVSPISLTYYGLCLINGNYTVNLHFAEIVFINDSSFNSLG 417
Query: 532 KRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLR 591
+RIFD+YIQEKLV KDFNI +EAGGTG PIVK F VTSHTLKIH YWAG+GTTGIP+R
Sbjct: 418 RRIFDVYIQEKLVLKDFNIVEEAGGTGRPIVKKFTVTVTSHTLKIHFYWAGKGTTGIPVR 477
Query: 592 GTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVS 651
GTYGPLISAISV NFKPP + +K +++ + + GA V LVLL+L IM KGCLGGKV
Sbjct: 478 GTYGPLISAISVDPNFKPPSDNDEKEKIIVSSTVAGA-VFLVLLVLCIMWRKGCLGGKVY 536
Query: 652 ADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK 711
ADKELRGLDLQTG++TL+QIKAAT NFD ANKVGEGGFGSVYKG LSDGT+IAVKQLSSK
Sbjct: 537 ADKELRGLDLQTGIFTLKQIKAATKNFDAANKVGEGGFGSVYKGQLSDGTIIAVKQLSSK 596
Query: 712 SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR 771
S+QGNREFVNEIGMISA QHPNLVKLYGCCVEGNQLLL+YEYM+NNCLSRA+FGK+ R
Sbjct: 597 SKQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLLLIYEYMENNCLSRALFGKNPTSR 656
Query: 772 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831
LKLDWPTR+KIC+G+ARGLAYLHE+S IKIVHRDIKTSNVL+DKDLNAKISDFGLAKL E
Sbjct: 657 LKLDWPTRQKICLGVARGLAYLHEESIIKIVHRDIKTSNVLIDKDLNAKISDFGLAKLNE 716
Query: 832 EDKTHISTRIAGTM 845
+D THISTR+AGT+
Sbjct: 717 DDNTHISTRVAGTI 730
|
Source: Jatropha curcas Species: Jatropha curcas Genus: Jatropha Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345651730|gb|AEO14875.1| rfls6 protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1103 bits (2854), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 547/842 (64%), Positives = 667/842 (79%), Gaps = 12/842 (1%)
Query: 14 SHLLFISLV-----TFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGN 68
S +LF+ L+ F + +A KL+ +EVKALK+IG K+GKKDWNFGVDPCS KGN
Sbjct: 8 SKMLFLLLLGSTSLIFLSHLASAATPKLNTQEVKALKEIGSKIGKKDWNFGVDPCSGKGN 67
Query: 69 WELSSDDKKGFESNVTCDCS---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSR 125
W + K S+V CDCS +++CHVV+I KAQNL+G+L E SKL YL++LDLSR
Sbjct: 68 WNVPDARKAFVMSSVICDCSFNHNSSCHVVSIYWKAQNLSGSLSPEFSKLHYLQKLDLSR 127
Query: 126 NCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRK 185
N +TGS PQW +++LVELS+MGN+LSGPFPKVLTNITTL+NLSIEGN F+G IP +I K
Sbjct: 128 NIITGSIPPQWGTMRLVELSLMGNKLSGPFPKVLTNITTLRNLSIEGNQFSGHIPTEIGK 187
Query: 186 LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS 245
L NL+KL+LSSN FTG LP L+KLT L DLRISDNNF GKIP+FI W I+KLH+ G
Sbjct: 188 LTNLEKLVLSSNGFTGALPPVLSKLTKLIDLRISDNNFLGKIPDFISNWTLIEKLHMHGC 247
Query: 246 SLEGPIPASISALTSLTDLRISDLKGSES-AFPKLDKM-NLKTLILTKCLIHGEIPDYIG 303
SLEGPIP+SISALT L+DLRI+DLKGS+S AFP L+ + ++KTL+L KC+I GEIP+YIG
Sbjct: 248 SLEGPIPSSISALTRLSDLRITDLKGSKSSAFPPLNNLKSMKTLVLRKCMIKGEIPEYIG 307
Query: 304 DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
M KLK +DLS+N L+G IP +F +L K +FMYLTGNKL+G +P+++ +N+N+DIS NN
Sbjct: 308 RMEKLKILDLSYNGLSGEIPESFAQLDKVDFMYLTGNKLSGIIPRWVLANNENIDISDNN 367
Query: 364 FTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGA 423
F+W+SS P EC RGSVNLVESYSS N K++ CL++NF C+A QY Y+L+INCGG
Sbjct: 368 FSWDSSSPTECQRGSVNLVESYSSSVNTQTKINSCLKKNFLCTASPSQYRYSLNINCGGN 427
Query: 424 KINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAV 483
+ N YEAD E +GA+M Y + Q WA SSTG F D+D D D YI NTS L+ VSA+
Sbjct: 428 EANVSGNIYEADREQKGAAMLYYTSQDWALSSTGNFTDNDIDSDPYIVANTSRLN-VSAL 486
Query: 484 DLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKL 543
+ +LY TARVSPL+LTYYGLCL NGNYTV+LHFAEIIF ND + NSLG+R+FD+YIQ L
Sbjct: 487 NSKLYTTARVSPLALTYYGLCLINGNYTVKLHFAEIIFINDRSLNSLGRRVFDVYIQGNL 546
Query: 544 VKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV 603
V KDF+I EAGGTG I K F A VT HTLKIH YWAG+GTTGIP RG YGPL+SAISV
Sbjct: 547 VLKDFDIRREAGGTGKSIEKTFNASVTQHTLKIHFYWAGKGTTGIPTRGVYGPLVSAISV 606
Query: 604 KSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQT 663
NFKPP K+ ++++ IV +++VLL+L ++R G LGGK KELRG+DLQT
Sbjct: 607 NPNFKPPSGEGKRTYLILAIIIVAGVLVVVLLVLVLLRRMGWLGGKDPVYKELRGIDLQT 666
Query: 664 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI 723
GL+TLRQIKAAT NFD NK+GEGGFG VYKG SDGT+IAVKQLSSKS+QGNREFVNE+
Sbjct: 667 GLFTLRQIKAATKNFDALNKIGEGGFGCVYKGQQSDGTMIAVKQLSSKSKQGNREFVNEM 726
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
G+IS QHPNLVKLYGCCVEGNQL+L+YEYM+NNCLSR +FG+D + KLDWPTRKKIC
Sbjct: 727 GLISGLQHPNLVKLYGCCVEGNQLILIYEYMENNCLSRILFGRDPN-KTKLDWPTRKKIC 785
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
+GIA+ LAYLHE+SRIKI+HRD+K SNVLLDKD NAK+SDFGLAKL E++KTHISTR+AG
Sbjct: 786 LGIAKALAYLHEESRIKIIHRDVKASNVLLDKDFNAKVSDFGLAKLIEDEKTHISTRVAG 845
Query: 844 TM 845
T+
Sbjct: 846 TI 847
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297849060|ref|XP_002892411.1| hypothetical protein ARALYDRAFT_470791 [Arabidopsis lyrata subsp. lyrata] gi|297338253|gb|EFH68670.1| hypothetical protein ARALYDRAFT_470791 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1050 bits (2714), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 538/840 (64%), Positives = 653/840 (77%), Gaps = 16/840 (1%)
Query: 16 LLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDD 75
++ + +TF G + KLH EV+ALK+IG KLGKKDWNF DPCS +GNW +++
Sbjct: 10 IIVLFTLTFHGRLGFSDNTKLHEAEVRALKEIGEKLGKKDWNFNKDPCSGEGNWVVTTYT 69
Query: 76 KKGFESNVTCDCS----SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS 131
K FESN+TCDCS +++CHV+ IALK+QNLTG +P+E SKLR+LK LDLSRN LTGS
Sbjct: 70 TKEFESNITCDCSFLPPNSSCHVIRIALKSQNLTGIVPSEFSKLRHLKVLDLSRNSLTGS 129
Query: 132 FSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191
+WAS++L +LS MGNRLSGPFPKVLT ITTL+NLS+EGN F+G IPPDI KL++L+K
Sbjct: 130 IPKEWASMRLEDLSFMGNRLSGPFPKVLTRITTLRNLSLEGNQFSGPIPPDIGKLVHLEK 189
Query: 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251
L L SN+FTG L +L L NL D+RISDNNF+G IP+FIG W ++ KL + G L+GPI
Sbjct: 190 LHLPSNAFTGPLTEKLGLLKNLTDMRISDNNFTGPIPDFIGNWTRVMKLQMHGCGLDGPI 249
Query: 252 PASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKN 310
P+SIS LTSLTDLRISDL G S+FP+L + ++KTLIL KC ++G IP YIGD+ KLK
Sbjct: 250 PSSISTLTSLTDLRISDLGGKPSSFPQLKNLESIKTLILRKCNLNGPIPKYIGDLMKLKT 309
Query: 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD 370
+DLSFN L+G IP++FEK+ K +F+YLTGNKLTG VP Y NKNVD+S NNFT ESS
Sbjct: 310 LDLSFNLLSGEIPSSFEKMKKADFIYLTGNKLTGGVPNYFVERNKNVDVSYNNFTDESSI 369
Query: 371 PI--ECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGA--KIN 426
P +C R S N+VE ++ NK K C Q+FPC+ P + Y L+INCGG K++
Sbjct: 370 PKNGDCNRVSFNMVEGFA--LNKSHKNSTCFLQHFPCAHPKRHHTYKLYINCGGGEVKVD 427
Query: 427 TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLS-KVSAVDL 485
G T Y+ D E +GASM Y G++WA SSTG FMD+D D D+Y NTS LS S+
Sbjct: 428 KGIT-YQTDDEPKGASM-YVLGKHWALSSTGNFMDNDDDADDYTVQNTSRLSVNASSPSF 485
Query: 486 ELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVK 545
ELYRTARVSPLSLTYYGLCLGNGNYTV LHFAEIIF +D+T SLGKR+FDIY+Q++LV
Sbjct: 486 ELYRTARVSPLSLTYYGLCLGNGNYTVNLHFAEIIFTDDNTLYSLGKRLFDIYVQDQLVI 545
Query: 546 KDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKS 605
K+FNI++ A G+G PI+K+F VT HTLKI L WAG+GTTGIP+RG YGP+ISAISV+
Sbjct: 546 KNFNIQEAARGSGKPIIKSFMVNVTDHTLKIGLRWAGKGTTGIPIRGVYGPMISAISVEP 605
Query: 606 NFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGL 665
NFKPPV + K ++ V A+ LL+ +I+ + WK K + DKELRGLDLQTG
Sbjct: 606 NFKPPVYYDIKGIILKAGVPVAAATLLLFIIVGVF-WKK-RRDKNAIDKELRGLDLQTGT 663
Query: 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM 725
+TLRQIKAAT+NFD A K+GEGGFGSVYKG LS+G +IAVKQLS+KSRQGNREFVNEIGM
Sbjct: 664 FTLRQIKAATDNFDVAKKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGM 723
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
ISA QHPNLVKLYGCCVEGNQL+LVYEY++NNCLSRA+FGKD RLKLDW TRKKI +G
Sbjct: 724 ISALQHPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLG 783
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
IA+GL +LHE+SRIKIVHRDIK SNVLLDKDLNAKISDFGLAKL ++ THISTRIAGT+
Sbjct: 784 IAKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTI 843
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 845 | ||||||
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.949 | 0.774 | 0.529 | 1.1e-220 | |
| TAIR|locus:2203847 | 1021 | RKF1 "receptor-like kinase in | 0.950 | 0.786 | 0.477 | 4e-193 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.931 | 0.730 | 0.476 | 2.1e-187 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.652 | 0.568 | 0.438 | 4.1e-186 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.950 | 0.778 | 0.418 | 3.1e-161 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.887 | 0.786 | 0.445 | 5.2e-152 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.857 | 0.692 | 0.373 | 1.1e-117 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.209 | 0.136 | 0.458 | 2.3e-71 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.210 | 0.152 | 0.480 | 7.5e-69 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.314 | 0.275 | 0.365 | 1.9e-67 |
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2131 (755.2 bits), Expect = 1.1e-220, P = 1.1e-220
Identities = 436/823 (52%), Positives = 564/823 (68%)
Query: 31 ATANKLHAEEVKALKQIGRKLGKKDWNFGVDPC-SQKGNWELSSDDKKGFESNVTCDCS- 88
+ A L +EV+ L+ I RKL + N C +K N+ S K SN+TCDC+
Sbjct: 24 SNAQLLPEDEVQTLRTIFRKLQNQTVNIERTSCLDRKWNFVAESTSKLP-TSNITCDCTF 82
Query: 89 --SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSV 146
S+ C V I L+ NL G +P E L L ++DL N L+G+ + + L L+V
Sbjct: 83 NASSVCRVTNIQLRGFNLRGIIPPEFGNLTRLTEIDLVLNFLSGTIPTTLSQIPLEILAV 142
Query: 147 MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE 206
GNRLSGPFP L ITTL ++ +E NLFTG +PP++ L +L++L++SSN+ TG +P
Sbjct: 143 TGNRLSGPFPPQLGQITTLTDVIMESNLFTGQLPPNLGNLRSLKRLLISSNNITGRIPES 202
Query: 207 LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRI 266
L+ L NL + RI N+ SGKIP+FIG W ++ +L +QG+S+EGPIPASIS L +LT+LRI
Sbjct: 203 LSNLKNLTNFRIDGNSLSGKIPDFIGNWTRLVRLDLQGTSMEGPIPASISNLKNLTELRI 262
Query: 267 SDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIG-DMTKLKNIDLSFNNLTGGIPT 324
+DL+G S FP L M N++ L+L CLI IP+YIG MT LK +DLS N L G IP
Sbjct: 263 TDLRGPTSPFPDLQNMTNMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSNMLNGTIPD 322
Query: 325 TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVES 384
TF L NFMYL N LTGPVP++I +S +N+D+S NNFT + + C + VNL+ S
Sbjct: 323 TFRSLNAFNFMYLNNNSLTGPVPQFILDSKQNIDLSYNNFTQPPT--LSCNQLDVNLISS 380
Query: 385 YSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMF 444
Y S N + V CLR++ PC P D +H +L INCGG ++ +Y D+ RGAS F
Sbjct: 381 YPSVTN--NSVQWCLRKDLPC--PGDAHHSSLFINCGGNRLKVDKDEYADDLNKRGASTF 436
Query: 445 YSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLC 504
S + W +SS+G ++ +D Y+ T+T L S E Y+TAR++ SL YYGLC
Sbjct: 437 SSVSERWGYSSSGAWLGNDGA--TYLATDTFNLINESTP--EYYKTARLASQSLKYYGLC 492
Query: 505 LGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKN 564
+ G+Y V+L+FAEI+F ND T++SLG+R+FDIY+Q L+++DFNI AGG G P ++
Sbjct: 493 MRRGSYKVQLYFAEIMFSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQ 552
Query: 565 FP-AEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMA 623
+V TL+IHL W G+GT IP RG YGPLISAI+V NFK N V +
Sbjct: 553 VDEVQVNGSTLEIHLKWTGKGTNVIPTRGVYGPLISAITVTPNFKVDTGKPLSNGV-VAG 611
Query: 624 AIVGASVLLVLLILFIMRWKGCLGGK-VSADKELRGLDLQTGLYTLRQIKAATNNFDPAN 682
++ A V LL+L I+R G LGGK V ++ELRGLDLQTG +TL+QIK ATNNFDP N
Sbjct: 612 IVIAACVAFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPEN 671
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+GEGGFG VYKG+L+DG IAVKQLSSKS+QGNREFV EIGMISA QHPNLVKLYGCC+
Sbjct: 672 KIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCI 731
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
EG +LLLVYEY++NN L+RA+FG + + RL LDW TR K+CIGIA+GLAYLHE+SR+KIV
Sbjct: 732 EGKELLLVYEYLENNSLARALFGTEKQ-RLHLDWSTRNKVCIGIAKGLAYLHEESRLKIV 790
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
HRDIK +NVLLD LNAKISDFGLAKL EE+ THISTRIAGT+
Sbjct: 791 HRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTI 833
|
|
| TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1871 (663.7 bits), Expect = 4.0e-193, P = 4.0e-193
Identities = 401/839 (47%), Positives = 537/839 (64%)
Query: 22 VTFFGYAIAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFES 81
+ F Y++ A KL +EV AL+QI LG K W F + C + L+ +
Sbjct: 30 ICFKFYSVNAI--KLPQQEVDALQQIATTLGSKFWKFDAENCKIE-MVGLTETPPPTAKQ 86
Query: 82 NVTCDCSSAT---CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS 138
+ C+CS CHVV A K NL GTLP ++ KL YL+++DL+ N + G+ +WAS
Sbjct: 87 EIECECSPTNDTDCHVVKFAFKDHNLPGTLP-QIVKLPYLREIDLAYNYINGTLPREWAS 145
Query: 139 LQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198
L +S++ NRLSG PK N ++L L +E N F+G+IP ++ L++L+KL+LSSN
Sbjct: 146 SNLTFISLLVNRLSGEIPKEFGN-SSLTYLDLESNAFSGTIPQELGNLVHLKKLLLSSNK 204
Query: 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
TG LPA L +L N+ D RI+D SG IP +I WK++++L + S L GPIP+ IS L
Sbjct: 205 LTGTLPASLARLQNMTDFRINDLQLSGTIPSYIQNWKQLERLEMIASGLTGPIPSVISVL 264
Query: 259 TSLTDLRISDLKGSESAFPKLDKMN-LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 317
++L +LRISD++G FP L + L +IL C I G+IP Y+ + +L+ +DLSFN
Sbjct: 265 SNLVNLRISDIRGPVQPFPSLKNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLSFNK 324
Query: 318 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIEC-PR 376
L GGIP+ F + F+ L GN L G P + VD+S NN W+S + C P
Sbjct: 325 LVGGIPS-FAQAENLRFIILAGNMLEGDAPDELLRDGITVDLSYNNLKWQSPESRACRPN 383
Query: 377 GSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAK--INTGHTK--Y 432
++NL S+ K K PC++ +F C P +Y LH+NCGG+ + TK Y
Sbjct: 384 MNLNLNLFQSTSTKKSSKFLPCIK-DFKC--P--RYSSCLHVNCGGSDMYVKEKKTKELY 438
Query: 433 EAD--MEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRT 490
E D +E A F W FSSTG FMDD+ N+ T T+ ++ +LY++
Sbjct: 439 EGDGNVEGGAAKYFLKPDANWGFSSTGDFMDDN----NFQNTRF-TMFVPASNQSDLYKS 493
Query: 491 ARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNI 550
AR++P+SLTY+ CL NGNYT+ L FAEI F ND +N LG+R+FDIYIQEKLV KDFNI
Sbjct: 494 ARIAPVSLTYFHACLENGNYTINLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNI 553
Query: 551 EDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPP 610
DEA G PI+K A VT+H L I L WAG+GTT IP RG YGP+ISAIS+ S+ KP
Sbjct: 554 MDEAKGAQTPIIKPLTAYVTNHFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDSKP- 612
Query: 611 VVHSKKNHVMIMAAI---VGASVLLVLLILFIMRWK-GCLGGKVSADKELRGLDLQTGLY 666
K + A I +GA L++ ++ F+ W GCL K+ +L +G +
Sbjct: 613 -CERPKTGMSPGAYIAIGIGAPCLIIFILGFL--WICGCLPRCGRQRKDPYEEELPSGTF 669
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
TLRQIK AT++F+P NK+GEGGFG+V+KG+L+DG V+AVKQLSSKSRQGNREF+NEIG I
Sbjct: 670 TLRQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAI 729
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
S QHPNLVKL+G CVE QLLL YEYM+NN LS A+F + ++ +DWPTR KIC GI
Sbjct: 730 SCLQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHK-QIPMDWPTRFKICCGI 788
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
A+GLA+LHE+S +K VHRDIK +N+LLDKDL KISDFGLA+L EE+KTHIST++AGT+
Sbjct: 789 AKGLAFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTI 847
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1817 (644.7 bits), Expect = 2.1e-187, P = 2.1e-187
Identities = 400/840 (47%), Positives = 527/840 (62%)
Query: 29 IAATANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDD-KKGFESNVTCDC 87
+ + + LH +EV+ALK I LG K N DPC K ++ D K+G S + CDC
Sbjct: 32 VLSASPSLHPDEVEALKDIALTLGVKHLNLSEDPCLTK-TLVITQDVLKEGQNSTIRCDC 90
Query: 88 ---SSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVE 143
++ TCH+ LK +L G LP E SKLRYL+ +DL RN L GS +WASL L
Sbjct: 91 HFNNNNTCHITHFVLKTFSLPGRLPPEFSKLRYLEFIDLCRNYLYGSIPMEWASLPYLKS 150
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGEL 203
+SV NRL+G PK L L L +E N F+G+IP ++ L+NL+ L SSN G +
Sbjct: 151 ISVCANRLTGDIPKGLGKFINLTQLGLEANQFSGTIPKELGNLVNLEGLAFSSNQLVGGV 210
Query: 204 PAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTD 263
P L +L L +LR SDN +G IPEFIG K+Q+L + S L+ PIP SI L +L D
Sbjct: 211 PKTLARLKKLTNLRFSDNRLNGSIPEFIGNLSKLQRLELYASGLKDPIPYSIFRLENLID 270
Query: 264 LRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
LRISD P + +LK L+L + G IP + D+ L +DLSFN LTG +P
Sbjct: 271 LRISDTAAGLGQVPLITSKSLKFLVLRNMNLTGPIPTSLWDLPNLMTLDLSFNRLTGEVP 330
Query: 324 TTFEKLAKTNFMYLTGNKLTGPVPKYIF-NSNKNVDISLNNFTWESSDPIECPRGSVNLV 382
+ + YL GN L+G V F ++ N+D+S NNFTW S C N +
Sbjct: 331 AD---ASAPKYTYLAGNMLSGKVESGPFLTASTNIDLSYNNFTWSQS----CKER--NNI 381
Query: 383 ESYSSPR--NKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKI----NTGHTKYEADM 436
+Y+S R N L ++ PC N C Y+ +LHINCGG + + G YE D
Sbjct: 382 NTYASSRSTNSLTRLLPCSAINL-CQ----NYNRSLHINCGGPDVTIENSRGRFLYEGDN 436
Query: 437 EARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPL 496
S G+ W FS+TG FMDD D Y S+ S VSA +LY+ AR SPL
Sbjct: 437 YGLTGSATNYYGKNWGFSNTGDFMDDAITEDTY---TVSSESAVSAKYPDLYQNARRSPL 493
Query: 497 SLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGG 556
SL Y+ +C NG+Y V+LHFAEI F ++ F+ L KR+F+IY+Q KL+ +DF+I +EA G
Sbjct: 494 SLAYFAICFENGSYNVKLHFAEIQFSDEEPFSRLAKRVFNIYVQGKLIWEDFSIREEANG 553
Query: 557 TGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV----KSNFKPPV- 611
T ++K VT +TL+I LYWAG+GTT IP RG YG LISAISV +S PV
Sbjct: 554 THKEVIKEVNTTVTDNTLEIRLYWAGKGTTIIPKRGNYGSLISAISVCPSSESECGVPVQ 613
Query: 612 VH--SKKNHVMIMA-AIVGASVLLV---LLILFIMRWKGCLGGKVSADKELRGLDLQTGL 665
+H +K+ H I+G + L+V LIL + W+ C+ +AD E RG
Sbjct: 614 IHPVTKQQHKQRKYHLILGIAALIVSLSFLILGALYWRICVS---NADGEKRGS------ 664
Query: 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM 725
++LRQ+K AT++F+P NK+GEGGFGSVYKG L +GT+IAVK+LSSKS QGN+EF+NEIG+
Sbjct: 665 FSLRQLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGI 724
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
I+ QHPNLVKLYGCCVE QLLLVYEY++NNCL+ A+FG+ LKLDW TR KIC+G
Sbjct: 725 IACLQHPNLVKLYGCCVEKTQLLLVYEYLENNCLADALFGRSG---LKLDWRTRHKICLG 781
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
IARGLA+LHEDS +KI+HRDIK +N+LLDKDLN+KISDFGLA+L+E+D++HI+TR+AGT+
Sbjct: 782 IARGLAFLHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGTI 841
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1082 (385.9 bits), Expect = 4.1e-186, Sum P(2) = 4.1e-186
Identities = 254/579 (43%), Positives = 330/579 (56%)
Query: 36 LHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDC---SSATC 92
LH +EV+ALK I LG K N DPC K K+G S + CDC + +TC
Sbjct: 39 LHPDEVEALKDITETLGVKHLNLSEDPCLTKTLVISQGVLKEGQNSTIRCDCHFNNYSTC 98
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRL 151
H+ L+ NL G LP L K R+L+ +DL N L GS +WASL L +SV NRL
Sbjct: 99 HIKHFVLQKFNLPGRLPPMLYKFRHLESIDLYNNYLYGSIPMEWASLPYLKSISVCANRL 158
Query: 152 SGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
SG PK L L L +E N F+G+IP ++ L+NLQ L LSSN G LP L KLT
Sbjct: 159 SGDIPKGLGKFINLTLLVLEANQFSGTIPKELGNLVNLQGLGLSSNQLVGGLPKTLAKLT 218
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271
L +L +SDN +G IPEFIGK K+Q+L + S L GPIP SI L +L D+RISD
Sbjct: 219 KLTNLHLSDNRLNGSIPEFIGKLPKLQRLELYASGLRGPIPDSIFHLENLIDVRISDTVA 278
Query: 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
P++ +LK L+L + G IP I D+ L +DLSFN LTG IP + K
Sbjct: 279 GLGHVPQITSTSLKYLVLRNINLSGPIPTSIWDLPSLMTLDLSFNRLTGEIPA-YATAPK 337
Query: 332 TNFMYLTGNKLTGPVPKYIF-NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRN 390
+ YL GN L+G V F ++ N+D+S NNFTW P+ R ++N ES S +N
Sbjct: 338 --YTYLAGNMLSGKVETGAFLTASTNIDLSYNNFTWS---PMCKERKNINTYES-SHSKN 391
Query: 391 KLDKVHPC--LRQNFPCSAPADQYHYTLHINCGGAKI---NT-GHTKYEADMEARGASMF 444
+L ++ PC ++Q C Y +LHINCGG + N+ G YE D S
Sbjct: 392 RLTRLLPCSAIKQ---CQ----NYSRSLHINCGGPDVTIENSRGRFLYEGDNYGLTGSAT 444
Query: 445 YSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLC 504
+ W +S+TG FMDD D Y S+ S VSA +LY+ AR SPLSL YY C
Sbjct: 445 NYYRKNWGYSNTGDFMDDAITEDTY---TVSSESAVSAKYPDLYQNARRSPLSLAYYAFC 501
Query: 505 LGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKN 564
NG+Y V+LHFAEI F + + L KR+F+IYIQ KL+ +DF+I +EA GT +++
Sbjct: 502 FENGSYNVKLHFAEIQFSDVEPYTKLAKRVFNIYIQGKLIWEDFSIREEANGTHKEVIRE 561
Query: 565 FPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISV 603
VT +TL+I LYWAG+GT IP RG YG LISA+SV
Sbjct: 562 VNTTVTDNTLEIRLYWAGKGTMIIPQRGYYGSLISAVSV 600
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1570 (557.7 bits), Expect = 3.1e-161, P = 3.1e-161
Identities = 350/837 (41%), Positives = 499/837 (59%)
Query: 32 TANKLHAEEVKALKQI--GRKL-GKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCS 88
T H +E +AL I K+ ++WN + CS D + + CDCS
Sbjct: 33 TGATTHPDEARALNSIFAAWKIQAPREWNISGELCSGAAIDASVLDSNPAYNPLIKCDCS 92
Query: 89 ---SATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELS 145
S C + I + A ++ G +P EL L YL L+L +N LTGS P +L ++
Sbjct: 93 FQNSTICRITNIKVYAIDVVGPIPPELWTLTYLTNLNLGQNVLTGSLPPAIGNLTRMQWM 152
Query: 146 VMG-NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP 204
G N LSGP PK + +T L+ L I N F+GSIP +I + LQ++ + S+ +G +P
Sbjct: 153 TFGINALSGPVPKEIGLLTDLRLLGISSNNFSGSIPDEIGRCTKLQQMYIDSSGLSGRIP 212
Query: 205 AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 264
L L I+D + +IP+FIG W K+ L I G+ L GPIP+S S LTSLT+L
Sbjct: 213 LSFANLVQLEQAWIADLEVTDQIPDFIGDWTKLTTLRIIGTGLSGPIPSSFSNLTSLTEL 272
Query: 265 RISDLKGSESAFPKL-DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
R+ D+ S+ + D +L L+L + G IP IG+ + L+ +DLSFN L G IP
Sbjct: 273 RLGDISSGSSSLDFIKDMKSLSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIP 332
Query: 324 TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVE 383
+ L++ ++L N L G P S +NVD+S N+ + + P +NLV
Sbjct: 333 ASLFNLSQLTHLFLGNNTLNGSFPTQKTQSLRNVDVSYNDLSGSLPSWVSLPSLKLNLVA 392
Query: 384 SYSSPRNKLDKVHP---CLRQNFPCSAPADQYHYTLHINCGGA-KINTGHTKYEADMEAR 439
+ + ++V P CL++NFPC+ Y INCGG K + +E + E
Sbjct: 393 NNFTLEGLDNRVLPGLNCLQKNFPCNRGKGIYS-DFSINCGGPEKRSVTGALFEREDEDF 451
Query: 440 G-ASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSL 498
G AS F S+GQ WA SS G F ++ YI T+ S V+ +D EL+++AR+S S+
Sbjct: 452 GPASFFVSAGQRWAASSVGLFAGSSNNI--YIATSQSQF--VNTLDSELFQSARLSASSV 507
Query: 499 TYYGLCLGNGNYTVRLHFAEI--IFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGG 556
YYGL L NG YTV L FAEI + +T+ LG+R FDIY+Q +LV+KDF++ AG
Sbjct: 508 RYYGLGLENGGYTVTLQFAEIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGD 567
Query: 557 TGIPIVKN-FPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVH-- 613
+ + V+ + A V+ + L++HL+WAG+GT IP++G YGPLISA+S +F P V +
Sbjct: 568 STVRAVQRVYKANVSENHLEVHLFWAGKGTCCIPIQGAYGPLISAVSATPDFTPTVANKP 627
Query: 614 -SK-KNHV-MIMAAIVGASVLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTL 668
SK KN I+ IVG +L +L +++F +R + + + D+EL G+D++ ++T
Sbjct: 628 PSKGKNRTGTIVGVIVGVGLLSILAGVVMFTIRKRR---KRYTDDEELLGMDVKPYIFTY 684
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA 728
++K+AT +FDP+NK+GEGGFG VYKG L+DG V+AVK LS SRQG +FV EI IS+
Sbjct: 685 SELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISS 744
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
H NLVKLYGCC EG +LVYEY+ N L +A+FG T L LDW TR +IC+G+AR
Sbjct: 745 VLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKT---LHLDWSTRYEICLGVAR 801
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
GL YLHE++ ++IVHRD+K SN+LLD L +ISDFGLAKLY++ KTHISTR+AGT+
Sbjct: 802 GLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTI 858
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1483 (527.1 bits), Expect = 5.2e-152, P = 5.2e-152
Identities = 350/785 (44%), Positives = 458/785 (58%)
Query: 79 FESNVTCDCSSATCH-VVTIALKAQNLTGTL-PTELSKLRYLKQLDLSRNC----LTGSF 132
F S+ T VV LK N+ + P E+S + +SRN L GS
Sbjct: 21 FASSATLPTQEGEAFKVVLTTLKKTNIDLNVDPCEVSSTGN-EWSTISRNLKRENLQGSL 79
Query: 133 SPQWASLQLV-ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191
+ L L+ E+ + N L+G P + L N+ + GN TG IP + + L
Sbjct: 80 PKELVGLPLLQEIDLSRNYLNGSIPPEW-GVLPLVNIWLLGNRLTGPIPKEFGNITTLTS 138
Query: 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251
L+L +N +GELP EL L N+ + +S NNF+G+IP K ++ + + L G I
Sbjct: 139 LVLEANQLSGELPLELGNLPNIQQMILSSNNFNGEIPSTFAKLTTLRDFRVSDNQLSGTI 198
Query: 252 PASISALTSLTDLRI--SDLKGS-ESAFPKLDKMNLKTLILTKCLIHG-EIP-DYIGDMT 306
P I T L L I S L G A L + LK L ++ ++G E P + ++
Sbjct: 199 PDFIQKWTKLERLFIQASGLVGPIPIAIASL--VELKDLRISD--LNGPESPFPQLRNIK 254
Query: 307 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW 366
K++ + L NLTG +P K+ F+ L+ NKL+G +P N I
Sbjct: 255 KMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYINLRDGGYIYFTGNML 314
Query: 367 ESSDPIECPRGSVNLVESYSS----PRN---KLDKVHPCLRQNFPCSAPADQYHYTLHIN 419
S P + SY++ P N K + V C+R N+ C + LHIN
Sbjct: 315 NGSVPDWMVNKGYKIDLSYNNFSVDPTNAVCKYNNVLSCMR-NYQCPKTFN----ALHIN 369
Query: 420 CGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSK 479
CGG +++ T YE+D R S +Y S W ++ G F+DD + T S S+
Sbjct: 370 CGGDEMSINGTIYESDKYDRLES-WYESRNGWFSNNVGVFVDDKHVPERV--TIESNSSE 426
Query: 480 VSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYI 539
++ VD LY AR+S +SLTYY LCL NGNY V LHFAEI+F ++ + SLG+R FDIYI
Sbjct: 427 LNVVDFGLYTQARISAISLTYYALCLENGNYNVNLHFAEIMFNGNNNYQSLGRRFFDIYI 486
Query: 540 QEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLIS 599
Q KL KDFNI EA G ++K FP E+ L+I LYWAGRGTT IP YGPLIS
Sbjct: 487 QRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKDGKLEIRLYWAGRGTTVIPKERVYGPLIS 546
Query: 600 AISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGL 659
AISV S+ P + + ++ S+ +V L+ + KG L K +K+ + L
Sbjct: 547 AISVDSSVNPSPRNGMSTGTLHTLVVI-LSIFIVFLVFGTLWKKGYLRSKSQMEKDFKSL 605
Query: 660 DLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREF 719
+L ++LRQIK ATNNFD AN++GEGGFG VYKG L DGT+IAVKQLS+ S+QGNREF
Sbjct: 606 ELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREF 665
Query: 720 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 779
+NEIGMISA HPNLVKLYGCCVEG QLLLVYE+++NN L+RA+FG E +L+LDWPTR
Sbjct: 666 LNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQ-ETQLRLDWPTR 724
Query: 780 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
+KICIG+ARGLAYLHE+SR+KIVHRDIK +NVLLDK LN KISDFGLAKL EED THIST
Sbjct: 725 RKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHIST 784
Query: 840 RIAGT 844
RIAGT
Sbjct: 785 RIAGT 789
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1159 (413.0 bits), Expect = 1.1e-117, P = 1.1e-117
Identities = 289/774 (37%), Positives = 436/774 (56%)
Query: 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSG 153
+T + A L+G +P E+ L L+ L +S N +GS + S +L ++ + + LSG
Sbjct: 127 MTFGINA--LSGPIPKEIGLLTDLRLLGISSNNFSGSLPAEIGSCTKLQQMYIDSSGLSG 184
Query: 154 PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL 213
P N L+ I TG IP I L L + +G +P+ + L L
Sbjct: 185 GIPLSFANFVELEVAWIMDVELTGRIPDFIGFWTKLTTLRILGTGLSGPIPSSFSNLIAL 244
Query: 214 NDLRISD-NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL--TDLRISDLK 270
+LR+ D +N S + +FI K + L ++ ++L G IP++I TSL DL + L
Sbjct: 245 TELRLGDISNGSSSL-DFIKDMKSLSVLVLRNNNLTGTIPSTIGGYTSLQQVDLSFNKLH 303
Query: 271 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE--- 327
G A + L L L ++G +P G L N+D+S+N+L+G +P+
Sbjct: 304 GPIPA-SLFNLSRLTHLFLGNNTLNGSLPTLKGQ--SLSNLDVSYNDLSGSLPSWVSLPD 360
Query: 328 ---KLAKTNFMY--LTGNKLTG-PVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNL 381
L NF L L+G + F N+ I N P + +N
Sbjct: 361 LKLNLVANNFTLEGLDNRVLSGLHCLQKNFPCNRGEGICKCN----KKIPSQIMFSMLN- 415
Query: 382 VESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINT--GHTKYEADMEAR 439
V++Y N L + + C + F D Y INCGG +I + G + D +
Sbjct: 416 VQTYGQGSNVLLEKN-CFK-TFAIDWCLD---YNFSINCGGPEIRSVSGALFEKEDADLG 470
Query: 440 GASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLT 499
AS S+ + WA SS G F ++ YI T+ + ++ +D EL+++AR+S SL
Sbjct: 471 PASFVVSAAKRWAASSVGNFAGSSNNI--YIATSLAQF--INTMDSELFQSARLSASSLR 526
Query: 500 YYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGI 559
YYGL L NG YTV L FAE+ + +++ +G+R F+IY+Q +LV+KDF+I AGG+ +
Sbjct: 527 YYGLGLENGGYTVTLQFAEVQIEGSNSWKGIGRRRFNIYVQGRLVEKDFDIRRTAGGSSV 586
Query: 560 PIV-KNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVH---SK 615
V + + V+ + L++HL+WAG+GT IP++G YGPLI+A+S +F P V + SK
Sbjct: 587 RAVQREYKTNVSENHLEVHLFWAGKGTCCIPIQGAYGPLIAAVSATPDFTPTVANRPPSK 646
Query: 616 -KNHV-MIMAAIVGASVLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQI 671
K+ I+ IVG +L + +++ ++R + + D+E+ +D++ +T ++
Sbjct: 647 GKSRTGTIVGVIVGVGLLSIFAGVVILVIRKRR---KPYTDDEEILSMDVKPYTFTYSEL 703
Query: 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH 731
K AT +FD +NK+GEGGFG+VYKG L+DG +AVKQLS SRQG +FV EI IS+ H
Sbjct: 704 KNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIAISSVLH 763
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
NLVKLYGCC EG+ LLVYEY+ N L +A+FG + L LDW TR +IC+G+ARGL
Sbjct: 764 RNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKS---LHLDWSTRYEICLGVARGLV 820
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
YLHE++ ++I+HRD+K SN+LLD +L K+SDFGLAKLY++ KTHISTR+AGT+
Sbjct: 821 YLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGTI 874
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 406 (148.0 bits), Expect = 2.3e-71, Sum P(2) = 2.3e-71
Identities = 82/179 (45%), Positives = 115/179 (64%)
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-QGNREFVNEIGM 725
T I AT NF + +G+GGFG+VYK L +G +A+K+L + QG+REF+ E+
Sbjct: 991 TADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGDREFLAEMET 1050
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
I +HPNLV L G CV G++ L+YEYM+N L + + L WP R KIC+G
Sbjct: 1051 IGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEA-LGWPDRLKICLG 1109
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
ARGLA+LH I+HRD+K+SN+LLD++ ++SDFGLA++ +TH+ST IAGT
Sbjct: 1110 SARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACETHVSTDIAGT 1168
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 415 (151.1 bits), Expect = 7.5e-69, Sum P(2) = 7.5e-69
Identities = 86/179 (48%), Positives = 115/179 (64%)
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
T + ATN F + +G GGFG VYK L+DG+V+A+K+L + QG+REF+ E+ I
Sbjct: 847 TFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETI 906
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
+H NLV L G C G + LLVYEYMK L + K + + LDW RKKI IG
Sbjct: 907 GKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGA 966
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS-TRIAGT 844
ARGLA+LH I+HRD+K+SNVLLD+D A++SDFG+A+L TH+S + +AGT
Sbjct: 967 ARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGT 1025
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 407 (148.3 bits), Expect = 1.9e-67, Sum P(2) = 1.9e-67
Identities = 102/279 (36%), Positives = 154/279 (55%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPK 157
L LTG +P+EL + L L L+ N L G+ P+ L QL EL++ NRL GP P
Sbjct: 317 LHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPS 376
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
+++ L ++ GNL +GSIP R L +L L LSSN+F G++P EL + NL+ L
Sbjct: 377 NISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLD 436
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277
+S NNFSG IP +G + + L++ + L G +PA L S+ + +S P
Sbjct: 437 LSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVS-FNLLSGVIP 495
Query: 278 -KLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT--TFEKLAKTN 333
+L ++ NL +LIL +HG+IPD + + L N+++SFNNL+G +P F + A +
Sbjct: 496 TELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPAS 555
Query: 334 FM---YLTGN---KLTGPVPKY-IFNSNKNVDISLNNFT 365
F+ YL GN + GP+PK +F+ + I L T
Sbjct: 556 FVGNPYLCGNWVGSICGPLPKSRVFSRGALICIVLGVIT 594
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGE0 | Y1765_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6281 | 0.9786 | 0.8155 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00018818001 | SubName- Full=Chromosome chr12 scaffold_18, whole genome shotgun sequence; (1010 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 845 | |||
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 5e-59 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-38 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-36 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-34 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-09 | |
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 4e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.001 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.003 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.003 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 5e-59
Identities = 86/192 (44%), Positives = 101/192 (52%), Gaps = 32/192 (16%)
Query: 414 YTLHINCGGAKINTGH-TKYEAD-MEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIR 471
L INCGG + YEAD G++ +Y S + S G D
Sbjct: 1 VVLAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNGSSSIAG--TTDP-------- 50
Query: 472 TNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLG 531
ELY+T R SP S +YY CL NGNYTV LHFAEI F D LG
Sbjct: 51 --------------ELYQTERYSPSSFSYYIPCLENGNYTVILHFAEIYFGED----GLG 92
Query: 532 KRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNF-PAEVTSHTLKIHLYWAGRGTTGIPL 590
+R+FD+Y+Q KLV KDF+I EAGG G K + P VT TL+IH YWAG+GT IP
Sbjct: 93 RRVFDVYVQGKLVLKDFDIVAEAGGKGKTAHKEYIPVTVTDGTLEIHFYWAGKGTLLIPF 152
Query: 591 RGTYG-PLISAI 601
RG YG P ISAI
Sbjct: 153 RGVYGNPKISAI 164
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 62/170 (36%), Positives = 84/170 (49%), Gaps = 16/170 (9%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
K+GEG FG VYKG L T +AVK L S + ++F+ E ++ HPN+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 737 LYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
L G C E L LV EYM+ L SR +F + L L I IA+G+
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKD--LLSFAIQIAKGM 118
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
YL K VHRD+ N L+ +DL KISDFGL++ +D +
Sbjct: 119 EYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT 165
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (380), Expect = 1e-40
Identities = 58/160 (36%), Positives = 79/160 (49%), Gaps = 13/160 (8%)
Query: 683 KVGEGGFGSVYKGILSD-----GTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
K+GEG FG VYKG L +AVK L S Q EF+ E ++ HPN+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
L G C E L +V EYM+ L + + R KL + IARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
+HRD+ N L+ ++L KISDFGL++ +D +
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 158
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 3e-40
Identities = 56/158 (35%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 683 KVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
K+GEG FG VYKG L +AVK L S Q EF+ E ++ HPN+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
L G C E L++V EYM L + + + +L + IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPK-ELSLSDLLSFALQIARGMEYLE-- 120
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
+HRD+ N L+ ++L KISDFGL++ +D
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 7e-39
Identities = 57/161 (35%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 683 KVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVK 736
K+GEG FG VYKG L T +AVK L + + R EF+ E ++ HPN+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLAY 792
L G C +G L +V EYM L ++ KL ++ + IA+G+ Y
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLL--------DFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
L VHRD+ N L+ ++L KISDFGL++ ED
Sbjct: 118 LES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED 155
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 7e-38
Identities = 61/165 (36%), Positives = 83/165 (50%), Gaps = 11/165 (6%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGCC 741
+GEGGFG+VY G +A+K + + E + EI ++ HPN+VKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ N L LV EY + L + E KL +I + I GL YLH I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK----ENEGKLSEDEILRILLQILEGLEYLHS---NGI 113
Query: 802 VHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTM 845
+HRD+K N+LLD D K++DFGL+KL DK + I GT
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTP 157
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 2e-36
Identities = 101/293 (34%), Positives = 150/293 (51%), Gaps = 29/293 (9%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
NLTG +P+ L L+ L+ L L +N L+G P SLQ L+ L + N LSG P+++
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+ L+ L + N FTG IP + L LQ L L SN F+GE+P L K NL L +S N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS-ESAFPK 278
N +G+IPE + + KL + +SLEG IP S+ A SL +R+ D G S F K
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426
Query: 279 L----------------------DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN 316
L D +L+ L L + G +PD G +L+N+DLS N
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRN 485
Query: 317 NLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK--NVDISLNNFTWE 367
+G +P L++ + L+ NKL+G +P + + K ++D+S N + +
Sbjct: 486 QFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 58/165 (35%), Positives = 86/165 (52%), Gaps = 12/165 (7%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYG 739
K+G G FG+VYK G ++AVK L +S + ++ EI ++ HPN+V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ + L LV EY + L + L KKI + I RGL YLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLHSNG-- 118
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
I+HRD+K N+LLD++ KI+DFGLAK + + ++T GT
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGT 161
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 55/171 (32%), Positives = 87/171 (50%), Gaps = 16/171 (9%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 735
++ K+GEG FG VY G ++A+K + K + +RE + EI ++ +HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+LY + ++L LV EY + L + G+ +E + I L YL
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-------FYLRQILSALEYL 113
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
H IVHRD+K N+LLD+D + K++DFGLA+ + + T GT
Sbjct: 114 HS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 4e-34
Identities = 118/396 (29%), Positives = 183/396 (46%), Gaps = 76/396 (19%)
Query: 14 SHLLFISLVTFFGYAIAATANKLHAEEVKALKQIGRKLGK-----KDWNFGVDPCSQKG- 67
+L+F+ F +++ LHAEE++ L + +WN D C +G
Sbjct: 10 PYLIFMLFFLFLNFSM------LHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGI 63
Query: 68 ----NWELSSDDKKGFESNVTCDCSSATCH---VVTIALKAQNLTGTLPTEL----SKLR 116
+ + S D G N++ SSA + TI L L+G +P ++ S LR
Sbjct: 64 TCNNSSRVVSIDLSG--KNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLR 121
Query: 117 YL-------------------KQLDLSRNCLTGSFSPQ----WASLQLVELSVMGNRLSG 153
YL + LDLS N L+G P ++SL++++L GN L G
Sbjct: 122 YLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEI-PNDIGSFSSLKVLDLG--GNVLVG 178
Query: 154 PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL 213
P LTN+T+L+ L++ N G IP ++ ++ +L+ + L N+ +GE+P E+ LT+L
Sbjct: 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSL 238
Query: 214 NDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE 273
N L + NN +G IP +G K +Q L + + L GPIP SI +L L L +SD S
Sbjct: 239 NHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS- 297
Query: 274 SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333
GEIP+ + + L+ + L NN TG IP L +
Sbjct: 298 ----------------------GEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQ 335
Query: 334 FMYLTGNKLTGPVPKYIFNSNK--NVDISLNNFTWE 367
+ L NK +G +PK + N +D+S NN T E
Sbjct: 336 VLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 66/171 (38%), Positives = 89/171 (52%), Gaps = 18/171 (10%)
Query: 682 NKVGEGGFGSVYKGILSD-GTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+G G FGSVY + D G ++AVK LS S + EI ++S+ QHPN+V+ Y
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 739 GCCV--EGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
G E N L + EY+ LS + FGK E P +K I GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAYLH 118
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGT 844
+ IVHRDIK +N+L+D D K++DFG AK + +T T + GT
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 55/169 (32%), Positives = 86/169 (50%), Gaps = 10/169 (5%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
F+ K+G+GGFG VYK G +A+K + +S++ + +NEI ++ +HPN+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
YG ++ ++L +V E+ L + K T L +C + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIA--YVCKELLKGLEYLHS- 116
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
I+HRDIK +N+LL D K+ DFGL+ T + GT
Sbjct: 117 --NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTP 161
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-28
Identities = 88/272 (32%), Positives = 141/272 (51%), Gaps = 9/272 (3%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWA---SLQLVELSVMGNRLSGPF 155
L + N TG +P L+ L L+ L L N +G +L +++LS N L+G
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST--NNLTGEI 372
Query: 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLND 215
P+ L + L L + N G IP + +L+++ L NSF+GELP+E TKL +
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA 275
L IS+NN G+I +Q L + + G +P S + L +L +S + S +
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAV 491
Query: 276 FPKLDKMN-LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 334
KL ++ L L L++ + GEIPD + KL ++DLS N L+G IP +F ++ +
Sbjct: 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ 551
Query: 335 MYLTGNKLTGPVPKYIFN--SNKNVDISLNNF 364
+ L+ N+L+G +PK + N S V+IS N+
Sbjct: 552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 54/173 (31%), Positives = 81/173 (46%), Gaps = 22/173 (12%)
Query: 682 NKVGEGGFGSVYKG-ILSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQHPNLVKLY 738
++G+G FG VY SDG + +K++ S + RE NE+ ++ HPN++K Y
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-------LDWPTRKKICIGIARGLA 791
E +L +V EY LS+ I K + K LDW + + L
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDW------FVQLCLALK 117
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
YLH KI+HRDIK N+ L + K+ DFG++K+ T + GT
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 52/156 (33%), Positives = 86/156 (55%), Gaps = 13/156 (8%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQH 731
+ K+GEG G VYK + G +A+K+ L ++++ +NEI ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKH 74
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
PN+V Y + G++L +V EYM L+ I T+ ++++ P +C + +GL
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVLQGLE 130
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
YLH + I HRDIK+ N+LL KD + K++DFG A
Sbjct: 131 YLHSQNVI---HRDIKSDNILLSKDGSVKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 52/161 (32%), Positives = 79/161 (49%), Gaps = 15/161 (9%)
Query: 682 NKVGEGGFGSVYKG---ILSDGT--VIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 735
++GEG FG V L D T +AVK L+ S Q +F EI ++ H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 736 KLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
K G C + G L L+ EY+ + L + +R +++ I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
+ +HRD+ N+L++ + KISDFGLAK+ EDK
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 59/177 (33%), Positives = 91/177 (51%), Gaps = 24/177 (13%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHPN 733
N+ + +G G FG VYKG+ L G +A+KQ+S + + + EI ++ +HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA---R 788
+VK G + L ++ EY +N L + I FG E L + + + +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE-SL---------VAVYVYQVLQ 110
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGT 844
GLAYLHE ++HRDIK +N+L KD K++DFG+A KL + K + GT
Sbjct: 111 GLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 57/164 (34%), Positives = 78/164 (47%), Gaps = 24/164 (14%)
Query: 684 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743
+G+G FG V G V AVK L S F+ E +++ +HPNLV+L G ++
Sbjct: 14 IGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 744 GNQLLLVYEYMKNNCL-------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
GN L +V EYM L RA+ + LD + G+ YL E
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD----------VCEGMEYLEEK 121
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
VHRD+ NVL+ +DL AK+SDFGLAK E + S +
Sbjct: 122 ---NFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGK 160
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 56/167 (33%), Positives = 88/167 (52%), Gaps = 20/167 (11%)
Query: 684 VGEGGFGSVYKGILS------DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVK 736
+GEG FG V+ G D ++AVK L + S ++F E +++ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRK-------KICIGIA 787
YG C EG+ ++V+EYM++ L++ + G D + D P + +I + IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
G+ YL + VHRD+ T N L+ DL KI DFG+++ +Y D
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD 176
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 52/167 (31%), Positives = 81/167 (48%), Gaps = 11/167 (6%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGN-REFVNEIGMISAQQHPNLVKLY 738
NK+G G FG VY + L G ++AVK++ + +E +E+ ++ +HPNLVK Y
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G V ++ + EY L + E+ LD + + + GLAYLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-----EHGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
IVHRDIK +N+ LD + K+ DFG A + + T + +
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 48/167 (28%), Positives = 86/167 (51%), Gaps = 13/167 (7%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS-RQG-NREFVNEIGMISAQQHPNL 734
++ ++GEG +G VYK G ++A+K++ ++ ++G + EI ++ +HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 735 VKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
V+L + +V+EYM ++ L+ + +K K + GL Y
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHD-LTGLL----DSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
LH I+HRDIK SN+L++ D K++DFGLA+ Y + + T
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 53/154 (34%), Positives = 80/154 (51%), Gaps = 16/154 (10%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
FD K+GEG +GSVYK I G V+A+K + + +E + EI ++ P +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI---CIGIARGLAYL 793
YG + L +V EY +S + K T L T ++I +GL YL
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTL-----TEEEIAAILYQTLKGLEYL 115
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
H K +HRDIK N+LL+++ AK++DFG++
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 18/153 (11%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLS-----SKSRQGNREFVNEIGMISAQQHPNLVKL 737
+G G FGSVY+G+ L DG AVK++S ++ ++ EI ++S QHPN+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
G E + L + E + L++ + +G E ++L TR+ I GL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL--YTRQ-----ILLGLEYLHD 120
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
VHRDIK +N+L+D + K++DFG+AK
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 59/173 (34%), Positives = 91/173 (52%), Gaps = 14/173 (8%)
Query: 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 733
+F+ NK+G+G FG V+K + +D V A+KQ LS +R+ E ++E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD--WPTRKKICIGIARGLA 791
+++ Y ++ +L +V EY +N L + L D W + I I GLA
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDL-HKLLKMQRGRPLPEDQVW----RFFIQILLGLA 115
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+LH KI+HRDIK+ N+ LD N KI D G+AKL D T+ + I GT
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 55/154 (35%), Positives = 79/154 (51%), Gaps = 13/154 (8%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKLYG 739
K+G G FG V+ G + T +AVK L + G F+ E ++ +H LV+LY
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
C E + +V EYM L F K E + KL P + IA G+AYL
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLD--FLKSGEGK-KLRLPQLVDMAAQIAEGMAYLE---SR 122
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+HRD+ N+L+ ++L KI+DFGLA+L E+D
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 5e-23
Identities = 49/153 (32%), Positives = 79/153 (51%), Gaps = 15/153 (9%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF----VNEIGMISAQQHPNLVKL 737
K+GEG +G VYK G ++A+K++ + + EI ++ +HPN+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
+L LV+EY + L + + D L K I + RGLAY H
Sbjct: 64 LDVIHTERKLYLVFEYCDMD-LKKYL---DK-RPGPLSPNLIKSIMYQLLRGLAYCH--- 115
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
+I+HRD+K N+L+++D K++DFGLA+ +
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAF 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-22
Identities = 74/245 (30%), Positives = 121/245 (49%), Gaps = 27/245 (11%)
Query: 87 CSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVE-LS 145
CSS ++ + L + +L G +P L R L+++ L N +G ++ L LV L
Sbjct: 377 CSSG--NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434
Query: 146 VMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA 205
+ N L G ++ +L+ LS+ N F G + PD L+ L LS N F+G +P
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQFSGAVPR 493
Query: 206 ELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR 265
+L L+ L L++S+N SG+IP+ + KK+ L + + L G IPAS S + L+ L
Sbjct: 494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQL- 552
Query: 266 ISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325
DL ++ + GEIP +G++ L +++S N+L G +P+T
Sbjct: 553 --DLSQNQ--------------------LSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
Query: 326 FEKLA 330
LA
Sbjct: 591 GAFLA 595
|
Length = 968 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 59/183 (32%), Positives = 88/183 (48%), Gaps = 28/183 (15%)
Query: 676 NNFDPANKVGEGGFGSVYK----GILS--DGTVIAVKQLSSK-SRQGNREFVNEIGMISA 728
NN + +G+G FG V++ G+L T++AVK L + S +F E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMK----NNCL-------------SRAIFGKDTEYR 771
HPN+VKL G C G + L++EYM N L S + K
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 772 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLY 830
L L + I +A G+AYL E K VHRD+ T N L+ +++ KI+DFGL+ +Y
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 831 EED 833
D
Sbjct: 182 SAD 184
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 54/160 (33%), Positives = 89/160 (55%), Gaps = 18/160 (11%)
Query: 685 GEGGFGSVYKGI---LSDGTVI--AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
G G FG+VYKG+ + I A+K L S + N+E ++E ++++ HP++V+L
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY--RLKLDWPTRKKICIGIARGLAYLHED 796
G C+ +Q+ L+ + M CL + + L+W C+ IA+G++YL E+
Sbjct: 76 GICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL-EE 127
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
R+ VHRD+ NVL+ + KI+DFGLAKL + D+
Sbjct: 128 KRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGC 740
+G+G G VYK G + A+K++ + R + + E+ + + + P +VK YG
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800
+ ++ +V EYM L+ + + K+ P I I +GL YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYLHTKR--H 120
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAK 828
I+HRDIK SN+L++ KI+DFG++K
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISK 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 53/166 (31%), Positives = 91/166 (54%), Gaps = 16/166 (9%)
Query: 683 KVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
++GEG G V+K G +A+K+++ + +G + + EI + A QHP +VKL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
G+ +LV EYM ++ LS + + L K + +G+AY+H +
Sbjct: 67 VFPHGSGFVLVMEYMPSD-LSEVL----RDEERPLPEAQVKSYMRMLLKGVAYMHAN--- 118
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK----TH-ISTR 840
I+HRD+K +N+L+ D KI+DFGLA+L+ E++ +H ++TR
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR 164
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 47/156 (30%), Positives = 82/156 (52%), Gaps = 6/156 (3%)
Query: 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL 737
F K+G G FG V++G+ + +A+K L S ++F E+ + +H +L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
+ C G + ++ E M+ L F + E ++ L + + +A G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ- 123
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+HRD+ N+L+ +DL K++DFGLA+L +ED
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 738
+G G FG V +G L +A+K L + S R +F+ E ++ HPN+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EYRLKLDWPTRKKICIGIARGLAYLHE 795
G + ++++ EYM+N L D E K + GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEYMENGSL-------DKFLRENDGKFTVGQLVGMLRGIASGMKYL-- 122
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
S + VHRD+ N+L++ +L K+SDFGL++ E+ + +T+
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 14/160 (8%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V+ G + +A+K + R+G +F+ E ++ HP LV+LYG
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
C E + + LV+E+M++ CLS + + R K T +C+ + G+AYL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLESSN-- 120
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
++HRD+ N L+ ++ K+SDFG+ + +D+ ST
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 54/175 (30%), Positives = 89/175 (50%), Gaps = 20/175 (11%)
Query: 683 KVGEGGFGSVY----KGIL--SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++GEG FG V+ +L D ++AVK L S ++F E +++ QH ++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----------KLDWPTRKKICIGI 786
YG C EG LL+V+EYM++ L+R + + ++ +L I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTR 840
A G+ YL + + VHRD+ T N L+ + L KI DFG+++ +Y D + R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 183
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 684 VGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVK 736
+G+G FG VY+G+ T +A+K ++ + R EF+NE ++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGK--DTEYRLKLDWPTRKKI---CIGIARGLA 791
L G G L+V E M L + + + E L PT +K IA G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
YL K VHRD+ N ++ +DL KI DFG+ + +YE D
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 62/171 (36%), Positives = 100/171 (58%), Gaps = 15/171 (8%)
Query: 677 NFDPANKVGEGGFGSVYK-GILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 733
+F K+G+G +GSVYK LSD A+K+ L S S++ + VNEI ++++ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL---KLDWPTRKKICIGIARGL 790
++ ++GN+L +V EY LS+AI + + +L + W +I I + RGL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGL 116
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHIST 839
LHE KI+HRD+K++N+LL + KI D G++K+ +++ KT I T
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 48/171 (28%), Positives = 88/171 (51%), Gaps = 14/171 (8%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMISAQQ 730
++ K+GEG + VYK G ++A+K++ R+ ++ +N EI ++ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
HPN++ L + + LV+E+M+ + L + I KD L K + RGL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETD-LEKVI--KDKSIVLTP--ADIKSYMLMTLRGL 115
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 841
YLH + I+HRD+K +N+L+ D K++DFGLA+ + ++ ++
Sbjct: 116 EYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQV 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 49/151 (32%), Positives = 80/151 (52%), Gaps = 7/151 (4%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G G FG V++G+ ++ T +AVK L + +F+ E ++ +HP L++LY C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
+ +V E MK L + LKL P + +A G+AYL + I
Sbjct: 72 LEEPIYIVTELMKYGSLLEYL-QGGAGRALKL--PQLIDMAAQVASGMAYLEAQNYI--- 125
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
HRD+ NVL+ ++ K++DFGLA++ +ED
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKED 156
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 53/168 (31%), Positives = 83/168 (49%), Gaps = 14/168 (8%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMIS 727
NF K+G+G F VYK I L DG V+A+K+ + +K+RQ + + EI ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
HPN++K +E N+L +V E LSR I + RL + T K + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLC 116
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
L ++H +I+HRDIK +NV + K+ D GL + + T
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 92.9 bits (229), Expect = 5e-20
Identities = 56/164 (34%), Positives = 78/164 (47%), Gaps = 12/164 (7%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISA-QQHPNLVKLY 738
K+GEG FG VY D ++A+K L+ K + F+ EI ++++ PN+VKLY
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+ L LV EY+ L + K + L I I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEYLHS--- 119
Query: 799 IKIVHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDKTHISTRI 841
I+HRDIK N+LLD+D K+ DFGLAKL + + S
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA 163
|
Length = 384 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 48/151 (31%), Positives = 78/151 (51%), Gaps = 19/151 (12%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGC 740
+G+G FG VYK I V+A+K + + + E + EI +S + P + K YG
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 741 CVEGNQLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 796
++G++L ++ EY +CL GK E I + GL YLHE+
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDE----------TYIAFILREVLLGLEYLHEE 117
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+I HRDIK +N+LL ++ + K++DFG++
Sbjct: 118 GKI---HRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 15/175 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVN---EIGMISAQ 729
++F +GEG F +V A+K L + ++ ++V E+ +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLN 59
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
HP ++KLY + L V EY N L + I LD + I
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-----RKYGSLDEKCTRFYAAEILLA 114
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
L YLH I+HRD+K N+LLDKD++ KI+DFG AK+ + + + S + T
Sbjct: 115 LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 46/158 (29%), Positives = 84/158 (53%), Gaps = 11/158 (6%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
D K+GEG G V S G +AVK++ + +Q NE+ ++ QHPN+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
++Y + G++L +V E+++ L+ D +++ +C+ + + L++LH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLAVLKALSFLHA 133
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGL-AKLYEE 832
++HRDIK+ ++LL D K+SDFG A++ +E
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 61/177 (34%), Positives = 89/177 (50%), Gaps = 30/177 (16%)
Query: 684 VGEGGFGSVYKGI------LSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVK 736
+GEG FG V K + T +AVK L + R+ ++E ++ HP+++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 737 LYGCCVEGNQLLLVYEYMKNNCL------SRAI----FGKD-TEYRLKLDWPTRKKICIG 785
LYG C + LLL+ EY K L SR + G D LD P + + +G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 786 --------IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
I+RG+ YL E +K+VHRD+ NVL+ + KISDFGL++ +YEED
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 31/173 (17%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--------VNEIGMISA-QQHP 732
++G+G FGSVY G ++A+K++ ++F + E+ + +HP
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG--KDTEYRLKLDWPTRKKICIGIARGL 790
N+VKL E ++L V+EYM+ N ++ KD + + + I I +GL
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEGN-----LYQLMKDRKGKP-FSESVIRSIIYQILQGL 112
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH---ISTR 840
A++H + HRD+K N+L+ KI+DFGLA+ + +STR
Sbjct: 113 AHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR 162
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 56/159 (35%), Positives = 92/159 (57%), Gaps = 18/159 (11%)
Query: 684 VGEGGFGSVYKGI-LSDGTVI----AVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 737
+G G FG+VYKGI + +G + A+K L+ + + N EF++E ++++ HP+LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
G C+ + LV + M + CL + + +L L+W C+ IA+G+ YL E
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
++VHRD+ NVL+ + KI+DFGLA+L E D+
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 51/155 (32%), Positives = 84/155 (54%), Gaps = 14/155 (9%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYG 739
K+G G FG V+ G + T +A+K L +QG+ F+ E ++ QHP LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
V + ++ EYM+N L + T +KL + IA G+A++ + I
Sbjct: 69 V-VTQEPIYIITEYMENGSLVDFL---KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
HRD++ +N+L+ + L KI+DFGLA+L E+++
Sbjct: 125 ---HRDLRAANILVSETLCCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 50/174 (28%), Positives = 86/174 (49%), Gaps = 32/174 (18%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREF-VNEIGM---ISAQQH 731
++ ++GEG +G+VYK L+ G +A+K++ S +G + EI + + + +H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 732 PNLVKLYGCCV-----EGNQLLLVYEYMK-------NNCLSRAIFGKDTEYRLKLDWPTR 779
PN+V+L C +L LV+E++ + C L T
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-----------LPPETI 109
Query: 780 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
K + + RG+ +LH +IVHRD+K N+L+ D KI+DFGLA++Y +
Sbjct: 110 KDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 54/161 (33%), Positives = 76/161 (47%), Gaps = 32/161 (19%)
Query: 682 NKVGEGGFGSVYKGI--LSDGTVI--AVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVK 736
++G G FGSV KG+ + G + AVK L G +EF+ E +++ HP +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 737 LYGCCVEGNQLLLVYE---------YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
L G C +G L+LV E Y+K R I LK + +A
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKR---REI----PVSDLKE-LAHQ------VA 105
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
G+AYL VHRD+ NVLL AKISDFG+++
Sbjct: 106 MGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 8/151 (5%)
Query: 684 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743
+G G FG V+ G +A+K + + +F+ E ++ HPNLV+LYG C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH 803
+ +V EYM N CL + ++ + +L +W +C + + YL + I H
Sbjct: 71 QRPIFIVTEYMANGCLLN--YLRERKGKLGTEWLL--DMCSDVCEAMEYLESNGFI---H 123
Query: 804 RDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
RD+ N L+ +D K+SDFGLA+ +D+
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 55/166 (33%), Positives = 86/166 (51%), Gaps = 18/166 (10%)
Query: 683 KVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++GEG FG V+ D ++AVK L S ++F E +++ QH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKK------ICIGIAR 788
YG CVEG+ L++V+EYMK+ L++ + G D + + P I IA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
G+ YL VHRD+ T N L+ ++L KI DFG+++ +Y D
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 174
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 33/180 (18%)
Query: 674 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ-LSSKSRQGNREF----VNEIGMIS 727
+++ K+GEG FG VYK + G V+A+K+ L + G F + EI ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY------------RLKLD 775
+HPN+V L + + E + R T Y +KL
Sbjct: 63 KLKHPNVVPL---------IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT 113
Query: 776 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
K + + G+ YLHE+ I+HRDIK +N+L+D KI+DFGLA+ Y+
Sbjct: 114 ESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 46/154 (29%), Positives = 81/154 (52%), Gaps = 14/154 (9%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++ ++G G +G VYK ++ G ++A+K + + EI M+ +HPN+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+G + ++L +V EY L + G +E ++ +C +GLAYL
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-------VCRETLKGLAYL 117
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
HE +I HRDIK +N+LL +D + K++DFG++
Sbjct: 118 HETGKI---HRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGCC 741
K+G+G FG VYKG+L T +AVK S + F+ E ++ HPN+VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
V+ + +V E + L + K +K ++ + A G+ YL + I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK----KLLQMSLDAAAGMEYLESKNCI-- 115
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
HRD+ N L+ ++ KISDFG+++ EE+
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSR--EEE 144
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 51/168 (30%), Positives = 87/168 (51%), Gaps = 14/168 (8%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 738
+G G FG V++GIL +A+K L + R +F++E ++ H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 797
G + +++ EYM+N L + + D E+ +L R GIA G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYL---S 124
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
+ VHRD+ N+L++ +L K+SDFGL+++ E+D T G +
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 56/169 (33%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 684 VGEGGFGSVYKGIL------SDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVK 736
+GEG FG VYKG L T +A+K L + +EF E ++S QHPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIF-----------GKDTEYRLKLDWPTRKKICIG 785
L G C + +++EY+ + L + D + LD I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEED 833
IA G+ YL S VHRD+ N L+ + L KISDFGL++ Y D
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 15/165 (9%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYG 739
K+GEG +G VYK G ++A+K++ + + + EI ++ HPN++KL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
L LV+E+M + KD + L K + +GLA+ H
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYK---LIKD--RQRGLPESLIKSYLYQLLQGLAFCH---SH 117
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK---TH-ISTR 840
I+HRD+K N+L++ + K++DFGLA+ + TH + TR
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR 162
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 16/159 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKG-ILSDGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 732
++ + ++G G G V K G ++AVK +L ++ + E+ ++ P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSP 59
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW-PTR--KKICIGIARG 789
+V YG + + EYM L D + P R KI + + +G
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSL-------DKILKEVQGRIPERILGKIAVAVLKG 112
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
L YLHE KI+HRD+K SN+L++ K+ DFG++
Sbjct: 113 LTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 51/153 (33%), Positives = 83/153 (54%), Gaps = 18/153 (11%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR-QGNREFV-----NEIGMISAQQHPNLV 735
K+GEG +G VYK G ++A+K K R + E V EI ++ HPN+V
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALK----KIRLETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+L N+L LV+E++ + L + + D+ LD P K + +G+AY H
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLD-LKKYM---DSSPLTGLDPPLIKSYLYQLLQGIAYCH- 116
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
S +++HRD+K N+L+D++ K++DFGLA+
Sbjct: 117 -SH-RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 53/182 (29%), Positives = 92/182 (50%), Gaps = 27/182 (14%)
Query: 683 KVGEGGFGSVY----KGILS-----------DGTVIAVKQLSSKSRQGNR-EFVNEIGMI 726
K+GEG FG V+ +G+ ++AVK L + + R +F+ EI ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKL--DWPTRKK--- 781
S ++PN+++L G CV + L ++ EYM+N L++ + ++ E + P+
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 782 --ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 838
+ + IA G+ YL + + VHRD+ T N L+ KI+DFG+++ LY D I
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 839 TR 840
R
Sbjct: 189 GR 190
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 14/156 (8%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYG 739
+G G VY I L + +A+K++ + Q + + + E+ +S HPN+VK Y
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 740 CCVEGNQLLLVYEYMK-NNCLS--RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
V G++L LV Y+ + L ++ + + LD + + +GL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-----LDEAIIATVLKEVLKGLEYLHSN 121
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGL-AKLYE 831
+I HRDIK N+LL +D + KI+DFG+ A L +
Sbjct: 122 GQI---HRDIKAGNILLGEDGSVKIADFGVSASLAD 154
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 58/167 (34%), Positives = 82/167 (49%), Gaps = 14/167 (8%)
Query: 684 VGEGGFGSVYK---GILSDGT--VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+G+G FGSV L D T V+AVK+L + + R+F EI ++ + QH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 739 GCCVEG--NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
G C L LV EY+ L R K E +LD I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSL-RDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSK 127
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
+ VHRD+ T N+L++ + KI DFGL K+ +DK + R G
Sbjct: 128 ---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPG 171
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-18
Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 21/169 (12%)
Query: 683 KVGEGGFGSVYKG------ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++GEG FG V+ D ++AVK L + ++F E +++ QH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK-----------ICIG 785
YG C +G+ L++V+EYMK+ L++ + + + +D R+ I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
IA G+ YL VHRD+ T N L+ +L KI DFG+++ +Y D
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 52/164 (31%), Positives = 76/164 (46%), Gaps = 21/164 (12%)
Query: 679 DPANK------VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISA-QQ 730
DP +GEG +G VYK G ++A+K + + E E ++
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 731 HPNLVKLYGC------CVEGNQLLLVYEYMKNNCLSRAIFG-KDTEYRLKLDWPTRKKIC 783
HPN+ YG +QL LV E ++ + G + RLK +W I
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--IL 119
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
RGLAYLHE+ K++HRDIK N+LL K+ K+ DFG++
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 52/155 (33%), Positives = 91/155 (58%), Gaps = 10/155 (6%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNL 734
NF K+GEG + +VYKG + G ++A+K++ + +G + EI ++ +H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIARGLAYL 793
V+L+ N+L+LV+EYM + L + + DT R LD T K + +G+A+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-LKKYM---DTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
HE+ +++HRD+K N+L++K K++DFGLA+
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 48/158 (30%), Positives = 85/158 (53%), Gaps = 14/158 (8%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 738
+G G FG V +G L +A+K L S + + R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 797
G + ++++ E+M+N L + D ++ ++L R GIA G+ YL E
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLSE-- 124
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
+ VHRD+ N+L++ +L K+SDFGL++ E+D +
Sbjct: 125 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 50/169 (29%), Positives = 89/169 (52%), Gaps = 12/169 (7%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+G+G FG+V K SDG ++ K++ + + + ++ V+E+ ++ +HPN+V+ Y
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 739 GCCV-EGNQLL-LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH-- 794
+ NQ L +V EY + L++ I K + R ++ +I + L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED----KTHIST 839
D ++HRD+K +N+ LD + N K+ DFGLAK+ D KT++ T
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREF----VNEIGMISAQQ 730
N ++ VGEG +G V K G ++A+K+ K + + + + E+ ++ +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
H N+V L +L LV+EY++ L L + + + +
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL-----EASPGGLPPDAVRSYIWQLLQAI 113
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
AY H I+HRDIK N+L+ + K+ DFG A+
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 48/155 (30%), Positives = 82/155 (52%), Gaps = 18/155 (11%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL---SSKSRQGNREFVN---EIGMISAQQHPNLV 735
+G+G +G+VY G+ + G +IAVKQ+ +S +E+ E+ ++ + +H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+ G C++ N + + E++ +S + FG E P K I G+AYL
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE-------PVFCKYTKQILDGVAYL 118
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
H + +VHRDIK +NV+L + K+ DFG A+
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 50/175 (28%), Positives = 87/175 (49%), Gaps = 18/175 (10%)
Query: 677 NFDPANKVGEGGFGS--VYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 732
++ P +G+G FG +Y+ D +++ K+ L+ S + R+ +NEI ++S QHP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EYRLKLDWPTRKKICIGIARG 789
N++ Y ++ N LL+ EY L I + E + L + I
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY------LFQIVSA 113
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
++Y+H+ I+HRDIKT N+ L K K+ DFG++K+ + + T + GT
Sbjct: 114 VSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 54/162 (33%), Positives = 93/162 (57%), Gaps = 22/162 (13%)
Query: 684 VGEGGFGSVYKGI-LSDGTVI----AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+G G FG+VYKGI + DG + A+K L + S + N+E ++E +++ P + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTRKKICIGIARGLAYL 793
G C+ + + LV + M CL + ++ + R+ L+W C+ IA+G++YL
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYV--RENKDRIGSQDLLNW------CVQIAKGMSYL 125
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
E +++VHRD+ NVL+ + KI+DFGLA+L + D+T
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 54/153 (35%), Positives = 83/153 (54%), Gaps = 10/153 (6%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G G FG V+ G + T +AVK L + F+ E ++ +H LV+LY
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
E + +V EYM L F KD E R LKL P + +A G+AY+ R+
Sbjct: 72 E-EPIYIVTEYMSKGSL--LDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNY 123
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
+HRD++++N+L+ L KI+DFGLA+L E+++
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 54/173 (31%), Positives = 86/173 (49%), Gaps = 22/173 (12%)
Query: 684 VGEGGFGSVYKGILS--DGTV--IAVK--QLSSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+GEG FGSV +G LS DG+ +AVK +L + EF++E + HPN++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 738 YGCCVEGNQL------LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK--KICIGIARG 789
G C E + L +++ +MK+ L + L P + K + IA G
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALG 125
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED---KTHIS 838
+ YL S +HRD+ N +L +D+ ++DFGL+ K+Y D + I+
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 7/152 (4%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G G FG V+ G ++ T +AVK L + + F+ E ++ QH LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
+ + ++ EYM L F K E K+ P IA G+AY+ + I
Sbjct: 72 KEEPIYIITEYMAKGSLLD--FLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERKNYI--- 125
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
HRD++ +NVL+ + L KI+DFGLA++ E+++
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNE 157
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 49/152 (32%), Positives = 83/152 (54%), Gaps = 8/152 (5%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G+G FG V+ G + T +A+K L + F+ E ++ +H LV+LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
E + +V EYM L + G+ +Y L P + IA G+AY+ R+ V
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 124
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
HRD++ +N+L+ ++L K++DFGLA+L E+++
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 22/164 (13%)
Query: 684 VGEGGFGSVYKGILSD------GTVIAVKQL-SSKSRQGNREFVNEIGMI-SAQQHPNLV 735
+GEG FG V K + +AVK L + + + V+E+ M+ +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKI--------CI 784
L G C + L +V EY + L RA P + +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+ARG+ +L S+ K +HRD+ NVL+ +D KI+DFGLA+
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 57/164 (34%), Positives = 74/164 (45%), Gaps = 39/164 (23%)
Query: 684 VGEGGFGSVYKGIL------SDGT--VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNL 734
+GEG FG V L +DGT ++AVK L + Q N + EI ++ H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 735 VKLYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG------- 785
VK GCC E L L+ EY+ L D+ + K+ +
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSL--------------RDYLPKHKLNLAQLLLFAQ 114
Query: 786 -IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
I G+AYLH I HRD+ NVLLD D KI DFGLAK
Sbjct: 115 QICEGMAYLHSQHYI---HRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 28/183 (15%)
Query: 683 KVGEGGFGSVY----KGIL-------------SDGTVIAVKQLSSKSRQGNR-EFVNEIG 724
K+GEG FG V+ +G+ + ++AVK L + + R +F+ EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLK--LDWPT 778
++S + PN+++L C+ + L ++ EYM+ N LSR + E + + T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHI 837
+ IA G+ YL S + VHRD+ T N L+ K+ KI+DFG+++ LY D I
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 838 STR 840
R
Sbjct: 189 QGR 191
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 54/171 (31%), Positives = 89/171 (52%), Gaps = 15/171 (8%)
Query: 677 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLS-SKSRQG-NREFVNEIGMISAQQHPN 733
F+ N++GEG +G VY+ + G ++A+K++ R G + EI ++ +HPN
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 734 LVKLYGCCVEGNQL---LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
+V+L V G L LV EY + + L+ + T + K + + + RGL
Sbjct: 68 IVELKEV-VVGKHLDSIFLVMEYCEQD-LASLLDNMPTPFSE----SQVKCLMLQLLRGL 121
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 841
YLHE+ I+HRD+K SN+LL KI+DFGLA+ Y ++ ++
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 53/167 (31%), Positives = 85/167 (50%), Gaps = 18/167 (10%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQL-----SSKSRQGNREFVN----EIGMISAQQHPN 733
+G G FGSVY G+ S G ++AVKQ+ S+ S+ R ++ EI ++ QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+V+ G ++ + L + EY+ ++ + Y + + I +GL YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL----NNYG-AFEETLVRNFVRQILKGLNYL 122
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
H +R I+HRDIK +N+L+D KISDFG++K E + T
Sbjct: 123 H--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 50/161 (31%), Positives = 92/161 (57%), Gaps = 22/161 (13%)
Query: 684 VGEGGFGSVYKGI-LSDGTVI----AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+G G FG+VYKG+ + +G + A+K+L + S + N+E ++E ++++ +P++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTRKKICIGIARGLAYL 793
G C+ + + L+ + M CL + ++ + + L+W C+ IA+G+ YL
Sbjct: 75 LGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIAKGMNYL 125
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
E ++VHRD+ NVL+ + KI+DFGLAKL D+
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 30/168 (17%)
Query: 683 KVGEGGFGSVYKG--ILSDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKL 737
K+G+G FG V +G S G VI AVK L S +F+ E ++ + H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 738 YGCCVEGNQLLLV---------YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
YG V + L++V + ++ + L + +Y + IA
Sbjct: 62 YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------------AVQIAN 108
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
G+ YL + +HRD+ N+LL D KI DFGL + +++ H
Sbjct: 109 GMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 47/146 (32%), Positives = 78/146 (53%), Gaps = 8/146 (5%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAV-KQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
++G+G FG VYK + V+A K + +KS + +++ EI ++++ HPN+VKL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
N L ++ E+ C A+ E L P + +C L YLHE+ KI
Sbjct: 72 YYENNLWILIEF----CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KI 124
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLA 827
+HRD+K N+L D + K++DFG++
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 738
+G G FG V G L +A+K L + + + R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 797
G + +++V EYM+N L + D ++ ++L R GIA G+ YL S
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-----GIASGMKYL---S 123
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
+ VHRD+ N+L++ +L K+SDFGL+++ E+D T G
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 169
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 51/161 (31%), Positives = 75/161 (46%), Gaps = 18/161 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQ-----LSSKSRQGNREFVNEIGMISAQ 729
N+ +G+G FG VY D G +AVKQ S ++++ EI ++
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 787
QH +V+ YGC + L + EYM + + +G TE +K I
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE-------TVTRKYTRQIL 114
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
G+ YLH + IVHRDIK +N+L D N K+ DFG +K
Sbjct: 115 EGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 53/166 (31%), Positives = 80/166 (48%), Gaps = 19/166 (11%)
Query: 684 VGEGGFGSVYKG----ILSDGT---VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLV 735
+G G FG VY+G IL G+ +AVK L + Q +EF+ E ++S HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFG--KDTEYRLKLDWPTRKKICIGIARGLAYL 793
KL G C+ ++ E M+ L + + L IC+ +A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 794 HEDSRIKIVHRDIKTSNVLL-----DKDLNAKISDFGLAK-LYEED 833
++ +HRD+ N L+ D D KI DFGLA+ +Y+ D
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD 165
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 49/164 (29%), Positives = 87/164 (53%), Gaps = 19/164 (11%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREF----VNEIGMISAQQ 730
++ N++ EG +G VY+ G ++A+K+L K ++G F + EI ++ Q
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQ 62
Query: 731 HPNLVKLYGCCVEGN--QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
HPN+V + V N ++ +V EY++++ L + + K + + +
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEHD-LKSLMETMKQPFLQ----SEVKCLMLQLLS 117
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832
G+A+LH++ I+HRD+KTSN+LL+ KI DFGLA+ Y
Sbjct: 118 GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 8/152 (5%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
++G G FG V G +A+K + S + EF+ E ++ H LV+LYG C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
+ + +V EYM N CL + E+ + ++C + G+AYL + +
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLESK---QFI 122
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
HRD+ N L+D K+SDFGL++ +D+
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 48/146 (32%), Positives = 78/146 (53%), Gaps = 8/146 (5%)
Query: 683 KVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
++G+G FG VYK + G + A K + +KS + +++ EI +++ HP +VKL G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+L ++ E+ C A+ E L P + IC + L YLH +KI
Sbjct: 79 YWDGKLWIMIEF----CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKI 131
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLA 827
+HRD+K NVLL D + K++DFG++
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 49/150 (32%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
+G+G +G VY LS IA+K++ + + + EI + S +H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 743 EGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
E + E + LS R+ +G LK + T I GL YLH++
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGP-----LKDNEQTIIFYTKQILEGLKYLHDN--- 127
Query: 800 KIVHRDIKTSNVLLDKDLNA-KISDFGLAK 828
+IVHRDIK NVL++ KISDFG +K
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 24/156 (15%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGN--REFVNEIGMISAQQHPNLVK 736
+G G F S Y+ + GT++AVKQ++ + S Q EI +++ HP++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ G E + L E+M +S + +G E + + RGL+YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-------INYTEQLLRGLSYLH 120
Query: 795 EDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLA 827
E+ +I+HRD+K +N+L+D + L +I+DFG A
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRL--RIADFGAA 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 42/145 (28%), Positives = 78/145 (53%), Gaps = 10/145 (6%)
Query: 683 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+GEG G V + S G ++AVK++ + +Q NE+ ++ QH N+V++Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ G++L +V E+++ L+ D +++ +C+ + + L+ LH +
Sbjct: 87 LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---V 137
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGL 826
+HRDIK+ ++LL D K+SDFG
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 54/168 (32%), Positives = 85/168 (50%), Gaps = 21/168 (12%)
Query: 684 VGEGGFGSVYKGI-LSDGTVI----AVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 737
+G G FG+V+KGI + +G I A+K + +S RQ +E + + + + H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 738 YGCCVEGNQLLLVYEYMKNNCL---SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
G C G L LV + L R RL L+W C+ IA+G+ YL
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL-LNW------CVQIAKGMYYLE 126
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 841
E ++VHR++ N+LL D +I+DFG+A LY +DK + +
Sbjct: 127 EH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHPN 733
++ K+GEG +G+V+K ++A+K +L + EI ++ +H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 734 LVKLYGCCVEGNQLLLVYEY----MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
+V+LY +L LV+EY +K S +D K + +G
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDS---------CNGDIDPEIVKSFMFQLLKG 111
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
LA+ H ++HRD+K N+L++K+ K++DFGLA+ +
Sbjct: 112 LAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 8/154 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPN 733
+++GEG GSV K L + G + A+K +++ ++ + E+ + + + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 734 LVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
+VK YG ++ + + + EY + L +I+ K + ++ KI + +GL+
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825
YLH KI+HRDIK SN+LL + K+ DFG
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIA---VKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+++G G FG V G G A VK+L +S + F+ E+ HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
G C+E LLV E+ L + +++ +A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
+ +H D+ N L DL+ KI D+GLA + Y ED
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 50/153 (32%), Positives = 74/153 (48%), Gaps = 24/153 (15%)
Query: 684 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743
+G+G FG V G G +AVK + K+ + F+ E +++ +H NLV+L G VE
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 744 GN-QLLLVYEYMKNNCL-------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
L +V EYM L R++ G D + LD + + YL
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD----------VCEAMEYLEA 120
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
++ VHRD+ NVL+ +D AK+SDFGL K
Sbjct: 121 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 55/178 (30%), Positives = 87/178 (48%), Gaps = 21/178 (11%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMISAQ 729
NF K+G G F VY+ L DG +A+K+ + +K+R + + EI ++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL---KLDWPTRKKICIGI 786
HPN++K Y +E N+L +V E LSR I + RL K W ++C
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC--- 116
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
L ++H SR +++HRDIK +NV + K+ D GL + + KT + + GT
Sbjct: 117 -SALEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 50/152 (32%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G+G FG V+ G + T +A+K L + F+ E ++ +H LV LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
E + +V E+M L + D +Y LKL P + IA G+AY+ R+ +
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFLKEGDGKY-LKL--PQLVDMAAQIADGMAYIE---RMNYI 124
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
HRD++ +N+L+ +L KI+DFGLA+L E+++
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 10/157 (6%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 733
NF K+GEG +G VYK G V+A+K+ L +++ + EI ++ HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+VKL N+L LV+E++ + L + + D + P K + +GLA+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
H +++HRD+K N+L++ + K++DFGLA+ +
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 24/155 (15%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN------REFVNEIGMISAQQHPNL 734
N++G G G+VYK I G + A+K + GN R+ EI ++ HPN+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
VK + ++ ++ E+M L + L R+ I G+AYLH
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF----LADVARQ-----ILSGIAYLH 185
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829
R IVHRDIK SN+L++ N KI+DFG++++
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217
|
Length = 353 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 682 NKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
+K+G G +G VY+G+ +AVK L + + EF+ E ++ +HPNLV+L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 741 CVEGNQLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
C ++ E+M N L + ++ R +++ + I+ + YL + + I
Sbjct: 71 CTREPPFYIITEFMTYGNLLD---YLRECN-RQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
HRD+ N L+ ++ K++DFGL++L D
Sbjct: 127 ---HRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 51/181 (28%), Positives = 91/181 (50%), Gaps = 30/181 (16%)
Query: 684 VGEGGFGSVYKGILSDG--TVIAVKQLS---------SKSRQGN-REFVNEIGMISAQ-Q 730
+G G FG VYK + ++A+K+++ + R + + V+E+ +I Q +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF------GKDTEYRLKLDWPTRKKICI 784
HPN+V+ Y +E ++L +V + ++ L + TE R+ W I +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI---W----NIFV 120
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ L YLH++ RI VHRD+ +N++L +D I+DFGLAK + + T + GT
Sbjct: 121 QMVLALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGT 176
Query: 845 M 845
+
Sbjct: 177 I 177
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKLY 738
++G G FG+VY V+A+K++S +Q N ++ + E+ + +HPN ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
GC + + LV EY CL A + ++ L IC G +GLAYLH R
Sbjct: 82 GCYLREHTAWLVMEY----CLGSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
I HRDIK N+LL + K++DFG A L + + T
Sbjct: 137 I---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGT 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 58/183 (31%), Positives = 86/183 (46%), Gaps = 22/183 (12%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKG-ILSDGTVIAVKQLSSKSRQGNREFVNEIGM-- 725
++ A N+ + ++G G G VYK G V+AVKQ+ R GN+E I M
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDL 64
Query: 726 -ISAQQH--PNLVKLYGCCVEGNQLLLVYEYMKNNC--LSRAIFGKDTEYRLKLDWPTRK 780
+ + H P +VK YG + + + + E M L + I G E L
Sbjct: 65 DVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG------- 117
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
K+ + I + L YL E ++HRD+K SN+LLD N K+ DFG++ + K TR
Sbjct: 118 KMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173
Query: 841 IAG 843
AG
Sbjct: 174 SAG 176
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 49/163 (30%), Positives = 71/163 (43%), Gaps = 14/163 (8%)
Query: 677 NFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQG-NREFVNEIGMISAQ 729
N +G G FG V+ KGI +G T++ VK L + EF E+ M
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLK-LDWPTRKKICIG 785
H N+V+L G C E ++ EY L RA KD + + L + +C
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
IA G+ +L S + VHRD+ N L+ K+S L+K
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 43/145 (29%), Positives = 78/145 (53%), Gaps = 10/145 (6%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G+G G+VY I ++ G +A+KQ++ + + +NEI ++ +HPN+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ G++L +V EY+ L+ D +D +C + L +LH + ++
Sbjct: 86 LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 136
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGL 826
+HRDIK+ N+LL D + K++DFG
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 34/179 (18%)
Query: 683 KVGEGGFGSVY----------------KGILSDGTV-IAVKQL----SSKSRQGNREFVN 721
K+GEG FG V+ + +D V +AVK L S +R+ +F+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE---DFLK 68
Query: 722 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDT--EYRLKLD 775
E+ ++S PN+ +L G C L ++ EYM+ N L + + L
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 776 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
+ T + IA G+ YL + VHRD+ T N L+ K+ KI+DFG+++ LY D
Sbjct: 129 FSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 44/161 (27%), Positives = 84/161 (52%), Gaps = 10/161 (6%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G+G G+VY I ++ G +A+KQ++ + + +NEI ++ ++PN+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ G++L +V EY+ L+ D +D +C + L +LH + ++
Sbjct: 86 LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALDFLHSN---QV 136
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA 842
+HRDIK+ N+LL D + K++DFG +++ ST +
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 27/166 (16%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V+ G +A+K + +G +F+ E ++ HP LV+LYG
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 740 CCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
C + L +V E+M+N CL + KD +C + G+ YL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL----------SMCQDVCEGMEYL 116
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
+S I HRD+ N L+ K+SDFG+ + Y D + S+
Sbjct: 117 ERNSFI---HRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSS 158
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 47/170 (27%), Positives = 72/170 (42%), Gaps = 22/170 (12%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+G FG V D + A+K ++ + + R +NE ++ HP LV L+
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGLAYLHE 795
+ + LV + + G D Y L K K I L YLH
Sbjct: 68 SFQDEENMYLVVDLL---------LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
I+HRDIK N+LLD+ + I+DF +A D ++T +GT
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTP 163
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 9/157 (5%)
Query: 684 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGCCV 742
+G+G FG V+KG L D T +AVK Q + +F++E ++ HPN+VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
+ + +V E + + K E + K K + A G+AYL + +
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTK----QLVKFALDAAAGMAYLESKN---CI 115
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
HRD+ N L+ ++ KISDFG+++ E+D + S+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSS 151
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 23/158 (14%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQL------SSKSRQGNREFV----NEIGMISAQQHP 732
+G+G +G VY + ++ G ++AVKQ+ + + ++ V +EI + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGL 790
N+V+ G L + EY+ + + +G+ E + + GL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-------QLVRFFTEQVLEGL 121
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
AYLH I+HRD+K N+L+D D KISDFG++K
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 41/165 (24%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 678 FDPANKVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQH 731
++ +G G +G VYK DG A+K+ Q ++ EI ++ +H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 732 PNLVKLYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
N+V L +E + L+++Y +++ F + + R+ + K + I G
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNG 120
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNA----KISDFGLAKLY 830
+ YLH + ++HRD+K +N+L+ + KI D GLA+L+
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 13/165 (7%)
Query: 684 VGEGGFGSVYK-GILSDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+G FG V G + A+K L K R+ + E ++S HP +VKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+L LV EY L + + + I L YLH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL-----SKEGRFSEERARFYAAEIVLALEYLH---SL 112
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
I++RD+K N+LLD D + K++DFGLAK + + +T GT
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 10/145 (6%)
Query: 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+GEG G V G +AVK++ + +Q NE+ ++ H N+V +Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ G++L +V E+++ L+ D +++ +C+ + R L+YLH +
Sbjct: 89 LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---V 139
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGL 826
+HRDIK+ ++LL D K+SDFG
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 48/146 (32%), Positives = 75/146 (51%), Gaps = 10/146 (6%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
+GEG FG+V +G + G +AVK + K + F+ E +++ H NLV+L G +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
N L +V E M L + T R + + + +A G+ YL K+V
Sbjct: 70 H-NGLYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAK 828
HRD+ N+L+ +D AK+SDFGLA+
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 50/163 (30%), Positives = 73/163 (44%), Gaps = 23/163 (14%)
Query: 682 NKVGEGGFGSVYKGILS--DGTV----IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNL 734
+G G FG VY+G+ DG +AVK L S S Q +F+ E ++S H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK------KICIGIAR 788
V+L G E ++ E M L + E R + + P+ +A+
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFL----RENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAK 828
G YL E+ +HRDI N LL AKI+DFG+A+
Sbjct: 128 GCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 683 KVGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
VGEG +G V K + G ++A+K+ S + + + EI M+ +H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+L LV+E++ + L D E Y LD +K I RG+ + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD------DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN- 120
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
I+HRDIK N+L+ + K+ DFG A+
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 50/156 (32%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 683 KVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G FG V G ++ G + VK+L S S Q +F+ E + QH NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G C E LLV E+ L + + D T +++ IA GL +LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEED 833
+H D+ N LL DL KI D+GL+ Y+ED
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 16/160 (10%)
Query: 677 NFDPANKVGEGGFGSVY--KGILSDGTVI----AVKQLSSKSRQGNREFVNEIGMISAQQ 730
++ VG G FG V+ + VI V+Q++ R + NE ++
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLS 57
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
HPN+++ Y +E L++V EY L+ I + LD T + I L
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL---LDEDTILHFFVQILLAL 114
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLN-AKISDFGLAKL 829
++H I+HRD+KT N+LLDK KI DFG++K+
Sbjct: 115 HHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKI 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 13/163 (7%)
Query: 683 KVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKL 737
+GEG FG VY+G+ ++ +AVK + + RE F+ E ++ HP++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
G E N + +V E L + + LD + ++ LAYL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTALAYLES-- 125
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
+ VHRDI NVL+ K+ DFGL++ E++ + +++
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK 167
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 51/162 (31%), Positives = 81/162 (50%), Gaps = 12/162 (7%)
Query: 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKL 737
+++G G FG+VY S V+AVK++S +Q N ++ + E+ + +HPN ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
GC ++ + LV EY CL A + ++ L I G +GLAYLH +
Sbjct: 87 KGCYLKEHTAWLVMEY----CLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN 141
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
I HRDIK N+LL + K++DFG A + + T
Sbjct: 142 MI---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGT 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 40/145 (27%), Positives = 78/145 (53%), Gaps = 10/145 (6%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G+G G+VY + ++ G +A++Q++ + + +NEI ++ ++PN+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ G++L +V EY+ L+ D +D +C + L +LH + ++
Sbjct: 87 LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGL 826
+HRDIK+ N+LL D + K++DFG
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 12/166 (7%)
Query: 678 FDPANKVGEGGFGSVY-KGILSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 733
F ++G G FG+VY + V+A+K++S +Q N ++ + E+ + +HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
++ GC + + LV EY CL A + ++ L I G +GLAYL
Sbjct: 87 SIEYKGCYLREHTAWLVMEY----CLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYL 141
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
H + ++HRDIK N+LL + K++DFG A + + + T
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGT 184
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 47/184 (25%), Positives = 91/184 (49%), Gaps = 10/184 (5%)
Query: 660 DLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE 718
++ L T+ I + K+G+G G+V+ I ++ G +A+KQ++ + +
Sbjct: 3 EIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL 62
Query: 719 FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
+NEI ++ ++PN+V + G++L +V EY+ L+ D +D
Sbjct: 63 IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT------DVVTETCMDEAQ 116
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838
+C + L +LH + +++HRDIK+ NVLL D + K++DFG +++ S
Sbjct: 117 IAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 839 TRIA 842
T +
Sbjct: 174 TMVG 177
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 45/150 (30%), Positives = 83/150 (55%), Gaps = 11/150 (7%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
K+GEG +G VYKG G ++A+K+ L S+ + EI ++ QHPN+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-LDWPTRKKICIGIARGLAYLHEDSR 798
++ ++L L++E++ + L + + D+ + + +D K I +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSMD-LKKYL---DSLPKGQYMDAELVKSYLYQILQGILFCH---S 119
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+++HRD+K N+L+D K++DFGLA+
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 42/194 (21%)
Query: 683 KVGEGGFGSVY--------------------KGILSDGTVIAVKQLSSKSRQGNR-EFVN 721
K+GEG FG V+ KG ++AVK L + + R +F+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG---RPLLVAVKILRPDANKNARNDFLK 68
Query: 722 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR---------- 771
E+ ++S + PN+++L G CV+ + L ++ EYM+N L++ + + +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 772 ----LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+ + + + + IA G+ YL S + VHRD+ T N L+ ++L KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 828 K-LYEEDKTHISTR 840
+ LY D I R
Sbjct: 186 RNLYAGDYYRIQGR 199
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 42/175 (24%)
Query: 39 EEVKALKQIGRKLG---KKDWNFGVDPCS-QKGNWELSSDDKKGFESNVTC--DCSSATC 92
EEV AL+ + LG + WN DPC Q+ W S C D +
Sbjct: 372 EEVSALQTLKSSLGLPLRFGWNG--DPCVPQQHPW-----------SGADCQFDSTKGKW 418
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ + L Q L G +P ++SKLR+L+ ++LS GN +
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLS-----------------------GNSIR 455
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL 207
G P L +IT+L+ L + N F GSIP + +L +L+ L L+ NS +G +PA L
Sbjct: 456 GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 10/152 (6%)
Query: 683 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+GEG G V G +AVK + + +Q NE+ ++ QH N+V++Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ G +L ++ E+++ L+ D + +L+ +C + + L YLH +
Sbjct: 88 LVGEELWVLMEFLQGGALT------DIVSQTRLNEEQIATVCESVLQALCYLHSQG---V 138
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+HRDIK+ ++LL D K+SDFG +D
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 12/166 (7%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 733
F ++G G FG+VY + + V+A+K++S +Q N ++ + E+ + +HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
++ GC + + LV EY CL A + ++ L + G +GLAYL
Sbjct: 77 TIQYRGCYLREHTAWLVMEY----CLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYL 131
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
H + ++HRD+K N+LL + K+ DFG A + + T
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGT 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 17/155 (10%)
Query: 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLV 735
F ++G+G FG V+KGI + V+A+K + + + E + EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 736 KLYGCCVEGNQLLLVYEYMKNNC---LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
K YG ++G +L ++ EY+ L RA G E+++ + I +GL Y
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIA-------TMLKEILKGLDY 116
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
LH + +I HRDIK +NVLL + + K++DFG+A
Sbjct: 117 LHSEKKI---HRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 45/170 (26%), Positives = 86/170 (50%), Gaps = 29/170 (17%)
Query: 678 FDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNREF--VNEIGMI---SAQQ 730
++ ++GEG +G V+K + + G +A+K++ ++ + + E+ ++ +
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 731 HPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWP-----TRK 780
HPN+V+L+ C +L LV+E++ + T Y K+ P T K
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL---------TTYLDKVPEPGVPTETIK 113
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
+ + RGL +LH ++VHRD+K N+L+ K++DFGLA++Y
Sbjct: 114 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 677 NFDPANKVGEGGFGSVY--KG-ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
++ K+GEG FG +Y K S+ VI L+ + E+ +++ +HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 734 LVKLYGCCVEGNQLLLVYEY------MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
+V + E +L +V EY MK R + + + L W + I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI---LSW------FVQIS 111
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGT 844
GL ++H+ KI+HRDIK+ N+ L K+ + AK+ DFG+A+ D ++ GT
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 56/155 (36%), Positives = 79/155 (50%), Gaps = 21/155 (13%)
Query: 684 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 738
+G+G FG VY G L SDG I AVK L+ + E F+ E ++ HPN++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 739 GCCVEGNQL-LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG----IARGLAYL 793
G C+ L+V YMK+ L I R + PT K + IG +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI-------RSETHNPTVKDL-IGFGLQVAKGMEYL 114
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
K VHRD+ N +LD+ K++DFGLA+
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 9/154 (5%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743
G+G FG VYK G A K + +S + +F+ EI ++S +HPN+V LY
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73
Query: 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH 803
N+L ++ E+ C A+ E L P + +C + L +LH K++H
Sbjct: 74 ENKLWILIEF----CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 804 RDIKTSNVLLDKDLNAKISDFGL-AKLYEEDKTH 836
RD+K N+LL D + K++DFG+ AK +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 54/159 (33%), Positives = 81/159 (50%), Gaps = 17/159 (10%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLV 735
F+ VG G +G VYKG + G + A+K + + E EI M+ H N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 736 KLYGCCVEGN------QLLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIAR 788
YG ++ N QL LV E+ ++ I K+T+ LK +W IC I R
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAY--ICREILR 122
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
GL++LH+ K++HRDIK NVLL ++ K+ DFG++
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 16/164 (9%)
Query: 683 KVGEGGFGSVYKGILSD------GTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 735
++G+G FG VY+G D T +AVK ++ S S + EF+NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKI---CIGIARGL 790
+L G +G L+V E M + L + + E PT +++ IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
AYL+ K VHRD+ N ++ D KI DFG+ + +YE D
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 53/163 (32%), Positives = 82/163 (50%), Gaps = 23/163 (14%)
Query: 678 FDPANKVGEGGFGSVYKGILSD---GTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 732
++ K+GEG +G VYK D IA+K+ L + + EI ++ QH
Sbjct: 4 YEKVEKIGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 733 NLVKLYGCCVEGNQLLLVYEY----MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
N+V+L +L LV+EY +K + S F K+ RL K I R
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKN--PRLI------KTYLYQILR 113
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLY 830
G+AY H +++HRD+K N+L+D+ NA K++DFGLA+ +
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153
|
Length = 294 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 40/164 (24%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNRE---FVNEIGMI-SAQQHPNLVKLY 738
+G G FG+V K + GT++AVK++ S +E + ++ ++ + P +VK Y
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 739 G-------C--CVE------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
G C C+E VYE + + + I GK I
Sbjct: 70 GALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGK---------------IA 113
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+ + L YL E+ +KI+HRD+K SN+LLD++ N K+ DFG++
Sbjct: 114 VATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-13
Identities = 34/82 (41%), Positives = 52/82 (63%)
Query: 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
G IP DI KL +LQ + LS NS G +P L +T+L L +S N+F+G IPE +G+
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 237 IQKLHIQGSSLEGPIPASISAL 258
++ L++ G+SL G +PA++
Sbjct: 492 LRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 47/163 (28%), Positives = 88/163 (53%), Gaps = 16/163 (9%)
Query: 684 VGEGGFGSVYKGILS-DGTV--IAVK--QLSSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+GEG FGSV +G L+ D ++ +AVK +++ +R +F++E + HPN+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 739 GCCVEGNQL------LLVYEYMKNNCL-SRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
G C++ + +++ +MK+ L S ++ + + L K IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
YL S +HRD+ N +L++++N ++DFGL+ K+Y D
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 16/164 (9%)
Query: 683 KVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLV 735
++G+G FG VY KG++ D T +A+K ++ + R EF+NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICI---GIARGL 790
+L G +G L++ E M L + + E P+ KK+ IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
AYL+ + K VHRD+ N ++ +D KI DFG+ + +YE D
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 8/152 (5%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
K+G G FG V+ + T +AVK + S F+ E ++ QH LVKL+ V
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV-V 70
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
+ ++ E+M L F K E K P IA G+A++ + + I
Sbjct: 71 TKEPIYIITEFMAKGSLLD--FLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYI--- 124
Query: 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
HRD++ +N+L+ L KI+DFGLA++ E+++
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 54/159 (33%), Positives = 80/159 (50%), Gaps = 17/159 (10%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLV 735
F+ VG G +G VYKG + G + A+K + + E EI M+ H N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 736 KLYGCCVE------GNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIAR 788
YG ++ +QL LV E+ ++ + K+T+ LK DW IC I R
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAY--ICREILR 132
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
GLA+LH K++HRDIK NVLL ++ K+ DFG++
Sbjct: 133 GLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-12
Identities = 44/171 (25%), Positives = 76/171 (44%), Gaps = 37/171 (21%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIGMISAQQHPN 733
+G G +G V + G +A+K++ + F + EI ++ +H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 734 LVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IG 785
++ L + N + +V E M+ + L + I + L T I
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETD-LHKVI-----KSPQPL---TDDHIQYFLYQ 111
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
I RGL YLH ++HRD+K SN+L++ + + KI DFGLA+ + D+
Sbjct: 112 ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMISAQ 729
NF K+G G F VY+ L D +A+K+ + +K+RQ + V EI ++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK--KICIGIA 787
HPN++K +E N+L +V E LS+ I + RL P R K + +
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL---IPERTVWKYFVQLC 116
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ ++H SR +++HRDIK +NV + K+ D GL + + KT + + GT
Sbjct: 117 SAVEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 49/156 (31%), Positives = 79/156 (50%), Gaps = 19/156 (12%)
Query: 678 FDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLV 735
F ++G+G FG VYKGI + V+A+K + + + E + EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLA 791
+ YG ++G +L ++ EY+ G + L P + I R GL
Sbjct: 66 RYYGSYLKGTKLWIIMEYL----------GGGSALDLLKPGPLEETYIATILREILKGLD 115
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
YLH + +I HRDIK +NVLL + + K++DFG+A
Sbjct: 116 YLHSERKI---HRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 24/164 (14%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGM----------I 726
+GEG +G V K G ++A+K++ S +R+ V G+ +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
+ +H N++ L VEG+ + LV + M ++ L + + + +++L K I + I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV-----DRKIRLTESQVKCILLQI 128
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
GL LH+ +HRD+ +N+ ++ KI+DFGLA+ Y
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRY 169
|
Length = 335 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 18/164 (10%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--VNEIGMI---SAQQH 731
++P ++G G +G+VYK G +A+K + ++ + V E+ ++ A H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 732 PNLVKLYGCCVEGN-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
PN+V+L C ++ LV+E++ + R K L + T K +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDL--RTYLDKVPPPGLPAE--TIKDLMRQF 117
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
RGL +LH + IVHRD+K N+L+ K++DFGLA++Y
Sbjct: 118 LRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-12
Identities = 62/251 (24%), Positives = 112/251 (44%), Gaps = 32/251 (12%)
Query: 118 LKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT-TLKNLSIEGNLFT 176
L LDL+ N L + S L L + N ++ P ++ + LK L + N
Sbjct: 95 LPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE 153
Query: 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
S+P +R L NL+ L LS N + +LP L+ L+NLN+L +S N S +P I
Sbjct: 154 -SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSA 210
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG 296
+++L + +S+ + +S+S L +L+ L +S+ K
Sbjct: 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE------------------------ 245
Query: 297 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 356
++P+ IG+++ L+ +DLS N ++ ++ L + L+GN L+ +P
Sbjct: 246 DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLL 303
Query: 357 VDISLNNFTWE 367
+ T +
Sbjct: 304 ELLLNLLLTLK 314
|
Length = 394 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 48/173 (27%), Positives = 85/173 (49%), Gaps = 29/173 (16%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQH---PNLVKLY 738
+G G +G+VY+G + G V+A+K ++ + + + E+ ++S + PN+ K Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 739 GCCVEGNQLLLVYEYMKNN---CLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLA 791
G ++G +L ++ EY + L +A P +K I R L
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKA-------------GPIAEKYISVIIREVLVALK 115
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
Y+H+ ++HRDIK +N+L+ N K+ DFG+A L ++ + ST GT
Sbjct: 116 YIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 12/165 (7%)
Query: 683 KVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 738
++G G FG V KG+ +A+K L +++ + R E + E ++ +P +V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G C E L+LV E L++ + GK E + ++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVS----NVVELMHQVSMGMKYLEGKN- 115
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
VHRD+ NVLL AKISDFGL+K D ++ R AG
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 9/156 (5%)
Query: 683 KVGEGGFGSVYKGILSDGTVIA---VKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G FG V + T +A VK+L ++ S + EF+ + QHPN+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G CVE LLV+EY + L ++ ++ +R +++ IA G+ ++H +
Sbjct: 62 GQCVEAIPYLLVFEYCELGDL-KSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
+H D+ N L DL K+ D+G+ Y+ED
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 15/165 (9%)
Query: 683 KVGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
K+GEG +G V+K + G ++A+K+ S + + EI M+ +HPNLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+L LV+EY + L+ + + KKI + + + H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL-----EKNPRGVPEHLIKKIIWQTLQAVNFCHKH--- 119
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKL---YEEDKT-HISTR 840
+HRD+K N+L+ K K+ DFG A++ +D T +++TR
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 8e-12
Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 11/152 (7%)
Query: 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLV 735
F K+G+G FG V+KGI + V+A+K + + + E + EI ++S P +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
K YG ++ +L ++ EY+ D LD I I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS------ALDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+ +I HRDIK +NVLL + K++DFG+A
Sbjct: 120 EKKI---HRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 54/170 (31%), Positives = 79/170 (46%), Gaps = 22/170 (12%)
Query: 683 KVGEGGFGSVYKGILSDGT------VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 735
++GE FG VYKG L +A+K L K+ RE F +E M S QHPN+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK-----------DTEYRLKLDWPTRKKICI 784
L G + L +++ Y ++ L + + D + L+ I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
IA G+ +L S +VH+D+ T NVL+ LN KISD GL + +Y D
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 684 VGEGGFGSVYKGILS-DGTVI--AVKQLSS-KSRQGNREFVNEIGMISA-QQHPNLVKLY 738
+GEG FG V + ++ DG + A+K L S +R+F E+ ++ HPN++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 739 GCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIGIA 787
G C L + EY L SR + F K+ L + +A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
G+ YL E + +HRD+ NVL+ ++L +KI+DFGL++
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 53/163 (32%), Positives = 83/163 (50%), Gaps = 35/163 (21%)
Query: 683 KVGEGGFGSVYKGIL----SDGTVIAVKQ-----LSSKSRQGNREFVNEIGMISAQQHPN 733
K+GEG FG K IL DG +K+ +S K R+ +R+ E+ ++S +HPN
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPN 60
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-------FGKDTEYRLKLDWPTRKKICIGI 786
+V+ E L +V +Y + L + I F +D LDW +IC+
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ----ILDWFV--QICLA- 113
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829
L ++H+ KI+HRDIK+ N+ L KD K+ DFG+A++
Sbjct: 114 ---LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNE--IGMISAQQHPNLVKLYGC 740
G G +G V K + GT++AVK++ ++ + Q + + + I M S P V YG
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVD-CPYTVTFYGA 68
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR------KKICIGIARGLAYLH 794
+ + E M L D Y+ D KI + I + L YLH
Sbjct: 69 LFREGDVWICMEVMDT-SL-------DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
++ ++HRD+K SNVL++++ K+ DFG++
Sbjct: 121 S--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 12/167 (7%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
L + T+ ++ +G+G +G VYK DG++ AVK L + E E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIEAEYNIL 72
Query: 727 -SAQQHPNLVKLYGCCVE-----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
S HPN+VK YG + G QL LV E ++ + G +LD
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL-LICGQRLDEAMIS 131
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
I G GL +LH + +I+HRD+K +N+LL + K+ DFG++
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 24/168 (14%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN------REFVNEIGMISA 728
+ ++ K+GEG +G VYK + G ++A+K+ + + RE ++ + M+S
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALRE-ISLLQMLS- 58
Query: 729 QQHPNLVKLYGCCVEGN-------QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 781
+ +V+L VE L LV+EY+ ++ L + + L T K
Sbjct: 59 -ESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKS 114
Query: 782 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAK 828
+ +G+A+ H+ ++HRD+K N+L+DK KI+D GL +
Sbjct: 115 FMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 22/170 (12%)
Query: 683 KVGEGGFGSVYKGIL-----SDGTVIAVKQLSS-KSRQGNREFVNEIGMISAQQHPNLVK 736
++GE FG +YKG L ++A+K L + Q EF E +++ HPN+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIF------------GKDTEYRLKLDWPTRKKICI 784
L G + + +++EY+ L + +D + LD I I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
IA G+ YL S VH+D+ N+L+ + L+ KISD GL++ +Y D
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 52/156 (33%), Positives = 80/156 (51%), Gaps = 22/156 (14%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVN----EIGMISAQQHPNLVK 736
+G G FG VY +D G +AVKQ+ S++ ++E VN EI ++ +H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68
Query: 737 LYGCCV--EGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAY 792
YGC E +L + EYM + + +G TE ++ I +G++Y
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE-------NVTRRYTRQILQGVSY 121
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
LH + IVHRDIK +N+L D N K+ DFG +K
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 49/170 (28%), Positives = 86/170 (50%), Gaps = 27/170 (15%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE--F----VNEIGMISA 728
+ ++ K+G+G FG V+K ++A+K K N + F + EI ++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALK----KVLMENEKEGFPITALREIKILQL 67
Query: 729 QQHPNLVKLYGCC----VEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
+H N+V L C N LV+E+ +++ L+ + K+ ++ L K
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLLSNKNVKFTL----SEIK 122
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
K+ + GL Y+H R KI+HRD+K +N+L+ KD K++DFGLA+ +
Sbjct: 123 KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 49/164 (29%), Positives = 78/164 (47%), Gaps = 20/164 (12%)
Query: 683 KVGEGGFGSVYKGIL-SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
++G G FG V+ G L +D T +AVK + +F+ E ++ HPN+V+L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK-----KICIGIARGLAYLHE 795
C + + +V E ++ G D L+ + P K ++ A G+ YL
Sbjct: 62 CTQKQPIYIVMELVQ---------GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
I HRD+ N L+ + KISDFG+++ EED + ST
Sbjct: 113 KHCI---HRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYAST 152
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 17/166 (10%)
Query: 684 VGEGGFGSVY------KGILSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVK 736
+GEG FG V +G + G +AVK L +S + + EI ++ H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 737 LYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
G C E GN + L+ E++ + L + + LK + K + I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK----QQLKYAVQICKGMDYL- 125
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
SR + VHRD+ NVL++ + KI DFGL K E DK + + +
Sbjct: 126 -GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 48/150 (32%), Positives = 77/150 (51%), Gaps = 14/150 (9%)
Query: 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGC 740
K+GEG + +VYKGI +G ++A+K +S K+ +G + E ++ +H N+V L+
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
L V+EYM + I G Y ++L + RGLAY+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIH---G 121
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
I+HRD+K N+L+ K++DFGLA+
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 51/182 (28%), Positives = 79/182 (43%), Gaps = 36/182 (19%)
Query: 676 NNFDPANKVGEGGFGSVYK----GILSDGTVI--AVKQLSSKSRQGNRE-FVNEIGMIS- 727
NN +G G FG V + G+ V+ AVK L + RE ++E+ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK------ 781
H N+V L G C G +L++ EY C Y L++ RK+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEY----CC----------YGDLLNFLRRKRESFLTL 140
Query: 782 ---ICIG--IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
+ +A+G+A+L + +HRD+ NVLL KI DFGLA+ D +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197
Query: 837 IS 838
+
Sbjct: 198 VV 199
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 678 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGN-RE-----FVNEIGMISAQQ 730
FD ++GEG +G VYK D G ++A+K K R N +E + EI ++
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK----KVRLDNEKEGFPITAIREIKILRQLN 64
Query: 731 HPNLVKLYGCCVEGNQLL----------LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
H N+V L + L LV+EYM ++ + G + K
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIK 119
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+ GL Y H+ + +HRDIK SN+LL+ K++DFGLA+LY +
Sbjct: 120 SFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 13/155 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
++++ +VG G +G VYK L G + AVK + + EI M+ +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRA--IFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
V +G + +L + EY L + G +E ++ +C +GLAY
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-------VCRETLQGLAY 121
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
LH ++ HRDIK +N+LL + + K++DFG+A
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 22/155 (14%)
Query: 682 NKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 738
+K+GEG + +VYKG L+D ++A+K++ + +G + E+ ++ +H N+V L+
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-----LDWPTRKKICIGIARGLAYL 793
L LV+EY+ KD + L ++ K + RGL Y
Sbjct: 71 DIIHTEKSLTLVFEYLD----------KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
H R K++HRD+K N+L+++ K++DFGLA+
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 48/171 (28%), Positives = 71/171 (41%), Gaps = 23/171 (13%)
Query: 687 GGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF---VNEIGMISAQQHPNLVKLYGCCV 742
G +G V+ S G + A+K + + + E ++S Q P +VKLY
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 743 EGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800
L LV EY+ L+ + G LD + I L YLH
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGS-------LDEDVARIYIAEIVLALEYLH---SNG 113
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHIST-----RIAGT 844
I+HRD+K N+L+D + + K++DFGL+K L RI GT
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 684 VGEGGFGSVYKG-ILSDGTVI--AVKQLSS-KSRQGNREFVNEIGMISA-QQHPNLVKLY 738
+GEG FG V K I DG + A+K++ S+ +R+F E+ ++ HPN++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 739 GCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIGIA 787
G C L L EY + L SR + F L +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
RG+ YL S+ + +HRD+ N+L+ ++ AKI+DFGL++
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 22/155 (14%)
Query: 682 NKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 738
K+GEG + +V+KG L++ ++A+K++ + +G + E+ ++ +H N+V L+
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-----LDWPTRKKICIGIARGLAYL 793
L LV+EY+ KD + + + K I RGLAY
Sbjct: 71 DIVHTDKSLTLVFEYLD----------KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
H R K++HRD+K N+L+++ K++DFGLA+
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 38/152 (25%), Positives = 76/152 (50%), Gaps = 9/152 (5%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+F+ ++G G +G VYK ++ G + A+K + + + EI M+ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+G + ++L + E+ L ++ + +R+ + +GL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHS 124
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
++ HRDIK +N+LL + + K++DFG++
Sbjct: 125 KGKM---HRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 50/155 (32%), Positives = 77/155 (49%), Gaps = 20/155 (12%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLS--SKSRQGNREFVN---EIGMISAQQHPNLVKL 737
+G+G FG VY D G +A KQ+ +S + ++E EI ++ QH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 738 YGCCVE-GNQLLLVY-EYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
YGC + + L ++ EYM + + +G TE +K I G++YL
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE-------SVTRKYTRQILEGMSYL 122
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
H + IVHRDIK +N+L D N K+ DFG +K
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 684 VGEGGFGSVYKGIL--SDGTV--IAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKL 737
+G+G FGSV + L DG+ +AVK L + S EF+ E + HPN++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 738 YGCCVEGNQL------LLVYEYMKNNCL-SRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
G + +++ +MK+ L + + + E L T + I IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
YL S +HRD+ N +L++++ ++DFGL+ K+Y D
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 45/181 (24%)
Query: 676 NNFDPANKVGEGGFGSV----YKG--------ILSDGTVIAVKQLSSKSRQGNREFVNEI 723
++F+ +G G FG V +KG ILS ++ +KQ+ +NE
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE--------HVLNEK 52
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
++ + +HP LV LYG + + L LV EY + G + L+ +
Sbjct: 53 RILQSIRHPFLVNLYGSFQDDSNLYLVMEY---------VPGGELFSHLR----KSGRFP 99
Query: 784 IGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
+AR L YLH + IV+RD+K N+LLD D KI+DFG AK + +T
Sbjct: 100 EPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRT 155
Query: 836 H 836
+
Sbjct: 156 Y 156
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 684 VGEGGFGSVYKGILS-DGTVI--AVKQLSS-KSRQGNREFVNEIGMISA-QQHPNLVKLY 738
+GEG FG V K + DG + A+K++ S+ +R+F E+ ++ HPN++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 739 GCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIGIA 787
G C L L EY + L SR + F L +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
RG+ YL + + +HRD+ N+L+ ++ AKI+DFGL++
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 29/169 (17%)
Query: 684 VGEGGFGSVY--KGILSDGTVIAVKQLS-----SKSRQGNREFVNEIGMISAQQHPNLVK 736
+ +G FGSVY K + G A+K L +K++ N + I MI + P + K
Sbjct: 4 ISKGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES-PYVAK 61
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK------LDWPTRKKICIGIARGL 790
LY + L LV EY+ G D +K DW K+ + G+
Sbjct: 62 LYYSFQSKDYLYLVMEYLN---------GGDCASLIKTLGGLPEDWA--KQYIAEVVLGV 110
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
LH+ I+HRDIK N+L+D+ + K++DFGL++ E+K + T
Sbjct: 111 EDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGT 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 53/172 (30%), Positives = 77/172 (44%), Gaps = 27/172 (15%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA----QQHPNLVK 736
K+GEG F V K G A+K + K + E VN + I A HPN+++
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 737 LYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
L + +L LV+E M N L I G+ + L K + + L ++H
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMN-LYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL------YEEDKTHISTR 840
R I HRDIK N+L+ D+ K++DFG + Y E +ISTR
Sbjct: 118 ---RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTE---YISTR 162
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 4e-10
Identities = 52/165 (31%), Positives = 86/165 (52%), Gaps = 32/165 (19%)
Query: 678 FDPANKVGEGGFGSVYKGILSD---GTVIAVK------QLSSKSRQGNRE--FVNEIGMI 726
++ K+G+G +G V+K I D V+A+K + ++ +++ RE F+ E+G
Sbjct: 9 YEILQKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-- 64
Query: 727 SAQQHPNLVKLYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK-IC 783
HPN+VKL N + LV+EYM+ + L I R + K+ I
Sbjct: 65 ---DHPNIVKLLNVIKAENDKDIYLVFEYMETD-LHAVI-------RANILEDVHKRYIM 113
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+ + L Y+H S ++HRD+K SN+LL+ D K++DFGLA+
Sbjct: 114 YQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 49/167 (29%), Positives = 69/167 (41%), Gaps = 11/167 (6%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+GGFG V + G + A K+L K R+G + +NE ++ +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ L LV M L I+ I GL +LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEP---GFPEARAIFYAAQIICGLEHLHQR--- 114
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTM 845
+IV+RD+K NVLLD N +ISD GLA +L K G M
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYM 161
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 733
++++ K+GEG + +VYKG +G ++A+K + + +G + E ++ +H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+V L+ L LV+EY+ + ++ L K + RGL+Y+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYM-----DKHPGGLHPENVKLFLFQLLRGLSYI 119
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
H+ I+HRD+K N+L+ K++DFGLA+
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 28/170 (16%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLY---- 738
+G G G V+ + SD +AVK++ Q + + EI +I H N+VK+Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 739 ----------GCCVEGNQLLLVYEYMKNNCLSRAI-FGKDTEYRLKLDWPTRKKICIGIA 787
G E N + +V EYM+ + L+ + G +E +L +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVLEQGPLSEEHARL-------FMYQLL 124
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTH 836
RGL Y+H + ++HRD+K +NV ++ +DL KI DFGLA++ + +H
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 45/171 (26%), Positives = 84/171 (49%), Gaps = 23/171 (13%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G G G+VYK L ++AVK + + + ++ ++E+ ++ P ++ YG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
N++ + E+M L ++ K E+ L +I + + +GL YL +KI
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHVLG-------RIAVAVVKGLTYLWS---LKI 116
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHIST-------RIAG 843
+HRD+K SN+L++ K+ DFG++ KT++ T RI+G
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISG 167
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 50/169 (29%), Positives = 76/169 (44%), Gaps = 20/169 (11%)
Query: 683 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKL 737
++G G FG+V KG+ +AVK L + + E + E ++ +P +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI---CIGIARGLAYLH 794
G C E +LV E A G ++ K T K I ++ G+ YL
Sbjct: 62 IGIC-EAESWMLVMEL--------AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
E + VHRD+ NVLL AKISDFGL+K D+ + + G
Sbjct: 113 ETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 16/105 (15%)
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKIC 783
A +HP L +L+ C ++L V EY+ G D + + + D P +
Sbjct: 52 AGKHPFLTQLHSCFQTKDRLFFVMEYVN---------GGDLMFHIQRSGRFDEPRARFYA 102
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
I GL +LHE I++RD+K NVLLD + + KI+DFG+ K
Sbjct: 103 AEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 43/156 (27%), Positives = 79/156 (50%), Gaps = 24/156 (15%)
Query: 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYG 739
+K+GEG + +V+KG ++A+K++ + +G + E+ ++ +H N+V L+
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD-------WPTRKKICIGIARGLAY 792
L LV+EY+ D++ + LD K + RGL+Y
Sbjct: 71 IIHTERCLTLVFEYL------------DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
H+ KI+HRD+K N+L+++ K++DFGLA+
Sbjct: 119 CHKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 36/117 (30%), Positives = 49/117 (41%), Gaps = 24/117 (20%)
Query: 231 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILT 290
GKW I L + L G IP IS L L + +S
Sbjct: 415 KGKWF-IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNS-------------------- 453
Query: 291 KCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 347
I G IP +G +T L+ +DLS+N+ G IP + +L + L GN L+G VP
Sbjct: 454 ---IRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 684 VGEGGFGSVYKGILS----DGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+G G FG + +G L +A+ L + S + R F+ E + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G GN +++V EYM N L F + E +L + G+A G+ YL E
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDS--FLRKHEGQLVAG--QLMGMLPGLASGMKYLSE--- 125
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
+ VH+ + VL++ DL KIS F +L E+ I T ++G
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSG 168
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 21/157 (13%)
Query: 686 EGGFGSVYKGILSDGT--------VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL 737
EG FG ++ GIL D V VK +S+ Q + E ++ H N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEI-QVTL-LLQESCLLYGLSHQNILPI 73
Query: 738 YGCCVEGNQLLLV-YEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIG--IARGLA 791
C+E + V Y YM L +F + E T++ + + IA G++
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
YLH + ++H+DI N ++D++L KI+D L++
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 51/156 (32%), Positives = 79/156 (50%), Gaps = 22/156 (14%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVN----EIGMISAQQHPNLVK 736
+G+G FG VY +D G +AVKQ+ +S + ++E VN EI ++ H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKNLLHERIVQ 68
Query: 737 LYGCCVEGNQ--LLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAY 792
YGC + + L + E+M + + +G TE +K I G++Y
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-------NVTRKYTRQILEGVSY 121
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
LH + IVHRDIK +N+L D N K+ DFG +K
Sbjct: 122 LHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 50/166 (30%), Positives = 76/166 (45%), Gaps = 24/166 (14%)
Query: 684 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 733
+GEG FG V GI D +AVK L + + + + V+E+ M+ +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKL----DWPTRKKICIG- 785
++ L G C + L ++ EY L RA EY + D K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 786 ---IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+ARG+ YL K +HRD+ NVL+ ++ KI+DFGLA+
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 51/162 (31%), Positives = 71/162 (43%), Gaps = 38/162 (23%)
Query: 685 GEGGFGSV----YKG--------ILSDGTVIA---VKQLSSKSRQGNREFVNEIGMISAQ 729
G G FG V YK L G +IA V+ L + R + E +++
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKR------IFET--ANSE 59
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR- 788
+HP LV L+ C + + V EY G D + D + + A
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAA---------GGDLMMHIHTDVFSEPRAVFYAACV 110
Query: 789 --GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
GL YLHE+ KIV+RD+K N+LLD + KI+DFGL K
Sbjct: 111 VLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK 149
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 24/166 (14%)
Query: 684 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 733
+GEG FG V GI D +AVK L + + + V+E+ M+ +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEY---RLKLDWPTRKKI--- 782
++ L G C + L ++ EY L +R G D + +L + T K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 783 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+ARG+ YL K +HRD+ NVL+ +D KI+DFGLA+
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 43/177 (24%), Positives = 60/177 (33%), Gaps = 47/177 (26%)
Query: 451 WAFSSTGKFM--DDDT-------DLDNYIRTNTSTLSKVSAVD--------LELYRTARV 493
F + + DD + + ST V + +TA
Sbjct: 175 LNFGGSEGTIRYPDDVYDRIWEPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVT 234
Query: 494 -----SPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDF 548
+PL+ T+ L N Y V LHFAEI SL R FDIYI K V D
Sbjct: 235 PTNASAPLNFTW-DLVDPNFEYYVYLHFAEI--------QSLETREFDIYINGKTVYGDV 285
Query: 549 NIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLR----GTYGPLISAI 601
+ G + +FP + +G G I L T PL++A+
Sbjct: 286 SP-KYLGTDTGALYLDFP-----------VNVSGGGLLNISLVPTSGSTLPPLLNAL 330
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 43/155 (27%), Positives = 79/155 (50%), Gaps = 24/155 (15%)
Query: 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGC 740
K+GEG + +VYKG G ++A+K++ + +G + E ++ +H N+V L+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW------PTRKKICI-GIARGLAYL 793
L LV+EY+ DT+ + +D ++ + + RGLAY
Sbjct: 72 IHTKKTLTLVFEYL------------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
H + +++HRD+K N+L+ + K++DFGLA+
Sbjct: 120 H---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 54/166 (32%), Positives = 82/166 (49%), Gaps = 18/166 (10%)
Query: 684 VGEGGFGSV----YKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKL 737
VG+G +G V ++ +DG +K+L+ + SR+ + E ++S +HPN+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-A 63
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI--CIGIARGLAYLHE 795
Y EG LL Y M C ++ K E + KL P + + + IA L YLHE
Sbjct: 64 YRESWEGEDGLL-YIVM-GFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHE 120
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 841
I+HRD+KT NV L + K+ D G+A++ E ST I
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 23/159 (14%)
Query: 683 KVGEGGFGSVYKGILSDGTVIA------VKQLSSKSRQGNREFVN---EIGMISAQQHPN 733
++G+G FG+VY ++ D +A +K++ N E V E ++S HP
Sbjct: 7 RLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPN-ETVQANQEAQLLSKLDHPA 63
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGL 790
+VK + +E + ++ EY C R + K E + + ++C I + G+
Sbjct: 64 IVKFHASFLERDAFCIITEY----CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829
Y+H+ +I+HRD+K N+ L +L KI DFG+++L
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRL 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 24/166 (14%)
Query: 684 VGEGGFGSVYK----GILSDG----TVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 733
+GEG FG V G+ + T +AVK L S + + + + ++E+ M+ +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIG----- 785
++ L G C + L ++ EY L RA EY +++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 786 ---IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+ARG+ YL + K +HRD+ NVL+ +D KI+DFGLA+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 40/177 (22%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN---------EIGMISAQQHPN 733
VG G +G V + G +A+K+LS R F + E+ ++ H N
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 734 LVKLYGCCVEG------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI--- 784
++ L + LV M G D +K + I
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLM----------GADLNNIVKCQKLSDDHIQFLVY 125
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTR 840
I RGL Y+H I+HRD+K SN+ +++D KI DFGLA+ +++ T +++TR
Sbjct: 126 QILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR 179
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 44/146 (30%), Positives = 75/146 (51%), Gaps = 9/146 (6%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGCC 741
+G G GSV K + GTV+A K + ++ R + + E+ ++ + P +V YG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ N + + E+M L R I+ K +++ KI + + GL YL+ RI
Sbjct: 73 LNENNICMCMEFMDCGSLDR-IYKKGGPIPVEI----LGKIAVAVVEGLTYLYNVHRI-- 125
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLA 827
+HRDIK SN+L++ K+ DFG++
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 25/54 (46%), Positives = 34/54 (62%), Gaps = 3/54 (5%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
I RGL YLH I+HRDIK N+L++ + KI DFGLA++ E D++ T
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 37/166 (22%)
Query: 685 GEGGFGSVYKGIL---SDG--------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
G+G F ++YKG+L SD + +K L S R + F ++S H +
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKH 62
Query: 734 LVKLYGCCV-EGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
LVKLYG CV + N +V EY+K + L R ++L + +A
Sbjct: 63 LVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAK--------QLAS 112
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKD-------LNAKISDFGLA 827
L YL + K+VH ++ N+L+ + K+SD G+
Sbjct: 113 ALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 40/154 (25%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 676 NNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 733
++F+ +++G G G V K G ++A K + + + R + + E+ ++ P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+V YG ++ + E+M L + + E + ++ K+ I + RGLAYL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAK-RIPEEILGKVSIAVLRGLAYL 119
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
E + +I+HRD+K SN+L++ K+ DFG++
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 684 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQHPNLVKLYG 739
+G GGFG V + S A+K + + G +E + +E ++ HP +VKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ + ++ EY L + +D R D T + + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL--RD---RGLFDEYTARFYIACVVLAFEYLHNRG-- 113
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTH 836
I++RD+K N+LLD + K+ DFG AK L KT
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW 150
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 13/150 (8%)
Query: 684 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREF---VNEIGMIS-AQQHPNLVKLY 738
+G+G FG V L G + AVK L + + + E ++S A+ HP L +LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
C ++L V E++ L I + + D + I L +LH+
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHI-----QKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
I++RD+K NVLLD + + K++DFG+ K
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 46/172 (26%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 675 TNNFDPANKVGEGGFGSV--YKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQ 730
TN + VG G FG V + L+ G +A+K++ + + E+ ++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 731 HPNLVKLYGCCVEGNQ-LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
H N++ L + + + V E + + L R + + E + + I RG
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTD-LHRLLTSRPLEKQFI------QYFLYQILRG 120
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTR 840
L Y+H +VHRD+K SN+L++++ + KI DFGLA++ + T ++STR
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR 169
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 48/149 (32%), Positives = 68/149 (45%), Gaps = 10/149 (6%)
Query: 684 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+GGFG V + + G + A K+L+ K R+G + E I A+ H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVE-KRILAKVHSRFIVSLA 59
Query: 740 CCVEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+ L LV M L I+ D E P I GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+I++RD+K NVLLD D N +ISD GLA
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 24/166 (14%)
Query: 684 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 733
+GEG FG V + GI +AVK L + + + ++E+ ++ +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRL------KLDWPTRKKI 782
++ L G C + L ++ EY L +R G D + + +L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 783 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+ARG+ YL +SR + +HRD+ NVL+ +D KI+DFGLA+
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 17/181 (9%)
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 723
T+ ++ N P VG G +GSV G +AVK+LS +S + E+
Sbjct: 11 TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 67
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 782
++ +H N++ L L E + L + G D +K T +
Sbjct: 68 RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 123
Query: 783 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 839
I RGL Y+H I+HRD+K SN+ +++D KI DFGLA+ +++ T +++T
Sbjct: 124 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 180
Query: 840 R 840
R
Sbjct: 181 R 181
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 14/152 (9%)
Query: 682 NKVGEGGFGSVYKGILS-DGTVIAVKQL-----SSKSRQGNREFVNEIGMISAQQHPNLV 735
+++G+G +GSVYK + G +A+K++ SK Q + E+ ++ P +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ----IIMELDILHKAVSPYIV 62
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
YG + + EYM L + G + ++I + +GL +L E
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGI--PEDVLRRITYAVVKGLKFLKE 120
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+ I+HRD+K +NVL++ + K+ DFG++
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 42/158 (26%), Positives = 79/158 (50%), Gaps = 17/158 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 733
++F+ +++G G G V+K G ++A K + + + R + + E+ ++ P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 734 LVKLYGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
+V YG ++ + E+M + L +A G+ E L K+ I + +G
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILG-------KVSIAVIKG 115
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
L YL E + KI+HRD+K SN+L++ K+ DFG++
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 40/182 (21%), Positives = 79/182 (43%), Gaps = 30/182 (16%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPN 733
+ P +G G +G V I G +A+K++ + + E+ ++ +H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 734 LVKLYGCCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GI 786
++ + + + +V + M+++ L I L + I +
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMESD-LHHIIHSDQP---LTEE-----HIRYFLYQL 116
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY----EEDKT----HIS 838
RGL Y+H ++HRD+K SN+L+++D +I DFG+A+ E K +++
Sbjct: 117 LRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 839 TR 840
TR
Sbjct: 174 TR 175
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-08
Identities = 43/121 (35%), Positives = 60/121 (49%), Gaps = 19/121 (15%)
Query: 487 LYRTARVS----PLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEK 542
LY++A VS P L+Y N NY+V LHFAEI D++ + GKR+FD+ I
Sbjct: 254 LYQSALVSTDTQP-DLSYTMDVDPNRNYSVWLHFAEI----DNSITAEGKRVFDVLINGD 308
Query: 543 LVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAIS 602
KD +I +G +V N V+ TL I L P +GT+ +I+AI
Sbjct: 309 TAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQ---------PKKGTHA-IINAIE 358
Query: 603 V 603
V
Sbjct: 359 V 359
|
Length = 623 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 23/173 (13%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNE---IGMISAQQHPNLVK 736
+G GGFG VY +D G + A+K L K +QG +NE + ++S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAY 792
+ ++L + + M G D Y L +K I GL +
Sbjct: 62 MTYAFHTPDKLCFILDLMN---------GGDLHYHLSQHGVFSEKEMRFYATEIILGLEH 112
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
+H +R +V+RD+K +N+LLD+ + +ISD GLA + + K H S G M
Sbjct: 113 MH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM 162
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 8e-08
Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 27/175 (15%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPN 733
+ + +GEG +G V G +A+K++S Q R + EI ++ +H N
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHEN 64
Query: 734 LVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---G 785
++ + N + +V E M+ + L + I + I
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETD-LYKLIKTQHLSN---------DHIQYFLYQ 114
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
I RGL Y+H + ++HRD+K SN+LL+ + + KI DFGLA++ D H T
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTG 164
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 26/157 (16%)
Query: 684 VGEGGFGS--VYKGILSDGTVIAVKQL----SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
VGEG FG + + + SD A+K++ SS + + +R+ E +++ +HPN+V
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAF 63
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-----KLDWPTRKKICIGIARGLAY 792
L +V EY L + I K +L L W ++C+G+ +
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFV--QMCLGVQ----H 115
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829
+HE +++HRDIK+ N+ L ++ K+ DFG A+L
Sbjct: 116 IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 47/156 (30%), Positives = 65/156 (41%), Gaps = 25/156 (16%)
Query: 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMIS------AQQHPNLVK 736
+G+G FG V+ L A+K L + + E M+ A +HP L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFLTH 60
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGLAY 792
LY L V EY+ G D + + K D P I GL +
Sbjct: 61 LYCTFQTKENLFFVMEYLN---------GGDLMFHIQSCHKFDLPRATFYAAEIICGLQF 111
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
LH IV+RD+K N+LLD D + KI+DFG+ K
Sbjct: 112 LHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 16/153 (10%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGC- 740
+G+G +G V+K + +G+ AVK L + E E ++ A HPN+VK YG
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 741 ----CVEGNQLLLVYEYMKNNCLSRAIFG--KDTEYRLKLDWPTRKKICIGIARGLAYLH 794
G+QL LV E ++ + G K E +++ P I GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE---RMEEPIIAYILHEALMGLQHLH 141
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+ K +HRD+K +N+LL + K+ DFG++
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 23/173 (13%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNE---IGMISAQQHPNLVK 736
+G GGFG VY +D G + A+K L K +QG +NE + ++S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTRKKICIGIARGLAY 792
+ ++L + + M G D Y L + I GL +
Sbjct: 62 MSYAFHTPDKLSFILDLMN---------GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEH 112
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
+H +V+RD+K +N+LLD+ + +ISD GLA + + K H S G M
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM 162
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 42/173 (24%), Positives = 69/173 (39%), Gaps = 44/173 (25%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
+F +VG+GG+G V+ D G ++A+K++ R + E +++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
LVKL + L L EY+ G D +R L G+
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVP---------GGD--FRTLL-----------NNLGV- 97
Query: 792 YLHEDS----------------RIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
L ED + +HRD+K N L+D + K++DFGL+K
Sbjct: 98 -LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 17/155 (10%)
Query: 684 VGEGGFGSVYKGI---LSDG-----TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+G+G F ++KGI + D T + +K L R + F M+S H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY-LH 794
YG CV G++ ++V EY+K L + K + + + W + +A+ LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLD--TYLKKNKNLINISWK------LEVAKQLAWALH 114
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829
+ H ++ NVLL ++ + K + KL
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL 149
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 21/165 (12%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREF----VNEIGMISAQQ 730
N F+ VGEG +G V K + ++A+K+ K + N E + E+ M+ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT---RKKICIGIA 787
N+V+L +L LV+EY++ N L L + P +K+ I
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNML-----------ELLEEMPNGVPPEKVRSYIY 107
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832
+ + +H + IVHRDIK N+L+ + K+ DFG A+ E
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 38/108 (35%), Positives = 53/108 (49%), Gaps = 14/108 (12%)
Query: 725 MISAQQHPNLVKLYGCCVEGNQ-LLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKK 781
+ A +HP L L+ C + + L V EY+ L I G+ E R R
Sbjct: 49 LALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR------ARFY 101
Query: 782 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829
I GL +LH+ I++RD+K NVLLDKD + KI+DFG+ K
Sbjct: 102 AA-EIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE 145
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 34/113 (30%), Positives = 52/113 (46%), Gaps = 11/113 (9%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
N + G G+ YKG + V + + + ++G + QHPN+VKL G C
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKL---QHPNIVKLIGLC 752
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
L++EY++ LS + L W R+KI IGIA+ L +LH
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLH 797
|
Length = 968 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 51/177 (28%), Positives = 73/177 (41%), Gaps = 20/177 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS---RQGNREFVNEIGMISA 728
++F+ +G G FG V+ L G V A+K L KS ++ V I A
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDILA 56
Query: 729 QQH-PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
P +VKLY + L LV EYM L + KD + R IA
Sbjct: 57 DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV---FPEET-AR----FYIA 108
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ L ++ +HRDIK N+L+D D + K++DFGL K + K
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 24/169 (14%)
Query: 684 VGEGGFGSV---YKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLY 738
VG G +GSV Y L +AVK+LS +S R E+ ++ +H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 739 GCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
N++ LV M + + K ++ ++ + + RGL Y
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-------LIYQLLRGLKY 133
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTR 840
+H I+HRD+K SNV +++D +I DFGLA+ +++ T +++TR
Sbjct: 134 IHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR 179
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 12/165 (7%)
Query: 684 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+GGFG V + + G + A K+L K + G + + E ++ P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
L LV M L I+ L+ I G+ +LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGER---GLEMERVIHYSAQITCGILHLHS---M 114
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
IV+RD+K NVLLD N ++SD GLA ++ KT T+ AGT
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGT 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 22/161 (13%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQHP 732
+ + VG G FG V+ A+K ++ R + V NE ++ HP
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRLKLDWPTRKKICIGIA 787
+++L+ + L ++ EY+ L + F T + + +C
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL-----FYASEIVC---- 112
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
L YLH IV+RD+K N+LLDK+ + K++DFG AK
Sbjct: 113 -ALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 21/167 (12%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKL--- 737
VG G +GSV I G +A+K+LS +S + E+ ++ QH N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 738 YGCCVEGNQL---LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ V G++ LV YM+ + L + + +E K+ + + +C GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD-LQKIMGHPLSED--KVQYLVYQMLC-----GLKYIH 134
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTR 840
I+HRD+K N+ +++D KI DFGLA+ + + T ++ TR
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 178
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 11/98 (11%)
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARG 789
P +V YG ++ + E+M L + + G+ E L KI I + RG
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-------KISIAVLRG 111
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
L YL E + KI+HRD+K SN+L++ K+ DFG++
Sbjct: 112 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-06
Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 22/184 (11%)
Query: 678 FDPANKVGEGGFGSVYKGILSD---GTVIAVKQ----LSSKSRQGNREFVNEIGMISAQQ 730
+D +G+GG G VY D +A+K+ LS R F+ E + +
Sbjct: 4 YDIIRLIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKR-FLREAKIAADLI 60
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDT---EYRLKLDWPTRKKICI 784
HP +V +Y C +G+ + Y++ L ++++ K++ E K I
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK---LYEEDKTHISTRI 841
I + Y+H S+ ++HRD+K N+LL I D+G A L EED I
Sbjct: 121 KICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 842 AGTM 845
Sbjct: 178 RNIC 181
|
Length = 932 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 18/153 (11%)
Query: 684 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEI----GMISAQQHPNLVKLY 738
+ G FG VY G ++ + AVK + K+ N+ V+++ ++ + P +V LY
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 739 GCCVEGNQLLLVYEYMKNNCLSR--AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
N + LV EY+ + I+G D K +A L YLH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYGY-------FDEEMAVKYISEVALALDYLH-- 121
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829
R I+HRD+K N+L+ + + K++DFGL+K+
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 46/161 (28%), Positives = 72/161 (44%), Gaps = 13/161 (8%)
Query: 684 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIG----MISAQQHPNLVKLY 738
+G+G FG V SDG+ AVK L K+ +E + + ++ +HP LV L+
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+L V +Y+ L F E P + +A + YLH
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFL--EPRARFYAAEVASAIGYLHS--- 114
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
+ I++RD+K N+LLD + ++DFGL K E + ST
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 22/161 (13%)
Query: 677 NFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKS--RQGNREFVN-EIGMISAQ 729
+F+ +G G FG V +KG G A+K L + + + V E ++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT--RKKICIGIA 787
HP +V + + N++ + E++ + +F T R +P K +
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFV----VGGELF---THLRKAGRFPNDVAKFYHAELV 128
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
YLH I++RD+K N+LLD + K++DFG AK
Sbjct: 129 LAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 46/154 (29%), Positives = 66/154 (42%), Gaps = 21/154 (13%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ--------QHPNL 734
+G+G FG V +DG AVK L K+ E I A+ +HP L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK----KEQKHIMAERNVLLKNVKHPFL 58
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
V L+ ++L V +Y+ L F E P + IA L YLH
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFP--EPRARFYAAEIASALGYLH 113
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+ I++RD+K N+LLD + ++DFGL K
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 26/157 (16%)
Query: 684 VGEGGFGSVY---KGILSD-GTVIAVKQL---SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G+G FG V+ K D G + A+K L + K R R E +++ HP +VK
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62
Query: 737 L-YGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
L Y EG +L L+ ++++ LS+ + + + + L +A L
Sbjct: 63 LHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL---------AELALALD 112
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+LH + I++RD+K N+LLD++ + K++DFGL+K
Sbjct: 113 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 12/157 (7%)
Query: 684 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+GGFG V + + G + A K+L K R+G +NE ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGK-DTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+ L LV M L I+ + + +IC G L LH++
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE-- 121
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
+IV+RD+K N+LLD + +ISD GLA E +T
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 12/103 (11%)
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT--RKKICIG 785
A +P LV L+ C ++L LV EY+ L +F + +L + +ICI
Sbjct: 52 ASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIA 108
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
L +LHE I++RD+K NVLLD D + K++D+G+ K
Sbjct: 109 ----LNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 16/101 (15%)
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 787
P L +L+ C ++L V EY+ G D Y + K P IA
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVN---------GGDLMYHIQQVGKFKEPHAVFYAAEIA 111
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
GL +LH I++RD+K NV+LD + + KI+DFG+ K
Sbjct: 112 IGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 43/174 (24%), Positives = 78/174 (44%), Gaps = 24/174 (13%)
Query: 677 NFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ--- 729
NF+ +G G +G V+ G G + A+K L K+ + E Q
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLK-KATIVQKAKTAEHTRTERQVLE 59
Query: 730 ---QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG- 785
+ P LV L+ +L L+ +Y+ L ++ ++ ++ I
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTES---EVRVYIAE 113
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY---EEDKTH 836
I L +LH+ + I++RDIK N+LLD + + ++DFGL+K + EE++ +
Sbjct: 114 IVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY 164
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 21/43 (48%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
I L YLH +V+RD+K N++LDKD + KI+DFGL K
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
A HP LV L+ C ++L V EY+ L +F + +L + I +A
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA 108
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
L YLHE I++RD+K NVLLD + + K++D+G+ K
Sbjct: 109 --LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 31/150 (20%), Positives = 53/150 (35%), Gaps = 29/150 (19%)
Query: 687 GGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 744
+ K T++AVK+ L S S++ + EI QHPN++ +
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 745 NQLLLVYEYM---------KNNCLSRAIFG-KDTEYRLKLDWPTRKKICIGIARGLAYLH 794
++L +V M K + G + I + L Y+H
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTHFPE----GLPELAIAF---------ILKDVLNALDYIH 118
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824
+HR +K S++LL D +S
Sbjct: 119 ---SKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 23/99 (23%)
Query: 225 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNL 284
G IP I K + +Q +++ G+S+ G IP S+ ++TSL L DL +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL---DLSYNS----------- 477
Query: 285 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
+G IP+ +G +T L+ ++L+ N+L+G +P
Sbjct: 478 ---------FNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYG 739
KVG G +G VYK DG K+ + K +G + EI ++ +HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 740 CCVEGN--QLLLVYEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ + ++ L+++Y +++ F K + ++L K + I G+ YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 795 EDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLY 830
+ ++HRD+K +N+L+ + KI+D G A+L+
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 20/43 (46%), Positives = 31/43 (72%), Gaps = 3/43 (6%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+ RGL Y+H + ++HRD+K SN+LL+ + + KI DFGLA+
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 46/150 (30%), Positives = 67/150 (44%), Gaps = 13/150 (8%)
Query: 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIG-MISAQQHPNLVKLY 738
+G+G FG V DG AVK L K +R+ + + E ++ +HP LV L+
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+L V +++ L F E P + IA L YLH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRER--SFPEPRARFYAAEIASALGYLHS--- 114
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
I IV+RD+K N+LLD + ++DFGL K
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 676 NNFDPANKVGEGGFGSV--YKGILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQ 729
++F+ +G G FG V + + G + A+K+L KS +E V E +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDT-GHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEA 58
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
+P +VKLY + N L L+ EY+ + + KDT T ++ IA
Sbjct: 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTF--------TEEETRFYIAET 110
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
+ + ++ +HRDIK N+LLD + K+SDFGL + K+H +
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK--KSHRTE 158
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 31/105 (29%), Positives = 52/105 (49%), Gaps = 16/105 (15%)
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKIC 783
A +HP L L+ C ++L V EY+ G D +++ K D P +
Sbjct: 52 AAKHPFLTALHCCFQTKDRLFFVMEYVN---------GGDLMFQIQRSRKFDEPRSRFYA 102
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+ L +LH R +++RD+K N+LLD + + K++DFG+ K
Sbjct: 103 AEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 45/187 (24%), Positives = 83/187 (44%), Gaps = 35/187 (18%)
Query: 677 NFDPANKVGEGGFGSVY---------------KGILSDGTVIAVKQLSSKSRQGNREFVN 721
NF+ +G G +G V+ +L T++ + + +R R+ +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT-ERQVLE 59
Query: 722 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTR 779
I +Q P LV L+ +L L+ +Y+ L + ++ E ++
Sbjct: 60 HI-----RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQ------ 108
Query: 780 KKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838
I G I L +LH ++ I++RDIK N+LLD + + ++DFGL+K + ED+ +
Sbjct: 109 --IYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA 163
Query: 839 TRIAGTM 845
GT+
Sbjct: 164 YSFCGTI 170
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 15/171 (8%)
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTV--IAVKQLSS----KSRQGNREFV 720
R+ K +F+ +G G FG V + +A+K+ K +Q + F
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF- 79
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
+E +++ HP V LYG + + L LV E++ + F T R +P
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFV----IGGEFF---TFLRRNKRFPNDV 132
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831
C A+ + + IV+RD+K N+LLDKD K++DFG AK+ +
Sbjct: 133 G-CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182
|
Length = 340 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 34/171 (19%)
Query: 684 VGEGGFGSVYKGILSDGT----VIAVKQLSS----KSRQGNREFVNEIGMISAQQHPNLV 735
+G+GG+G V++ G + A+K L ++++ E ++ A +HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRLKLDWPTRKKICI---GIA 787
L G +L L+ EY+ L IF +DT C I+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA-------------CFYLSEIS 110
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTH 836
L +LH+ I++RD+K N+LLD + K++DFGL K ++E TH
Sbjct: 111 LALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 7e-06
Identities = 21/60 (35%), Positives = 28/60 (46%)
Query: 283 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
NLK+L L+ + + LK +DLS NNLT P F L + L+GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
+A HP LV L+ C ++L V E++ L +F + +L + I +
Sbjct: 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISL 107
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
A L +LHE I++RD+K NVLLD + + K++D+G+ K
Sbjct: 108 A--LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 21/165 (12%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLY 738
+G+G FG V ++ AVK L K+ ++ + ++E ++ +HP LV L+
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW----PTRKKICIGIARGLAYLH 794
++L V +Y I G + Y L+ + P + IA L YLH
Sbjct: 63 FSFQTADKLYFVLDY---------INGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 113
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
+ IV+RD+K N+LLD + ++DFGL K E ST
Sbjct: 114 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 16/101 (15%)
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 787
P L +L+ C ++L V EY+ G D Y + K P I+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVN---------GGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
GL +LH I++RD+K NV+LD + + KI+DFG+ K
Sbjct: 112 VGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 28/114 (24%), Positives = 47/114 (41%), Gaps = 28/114 (24%)
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLV--------YEYMKNNCLSRAIFGKDTEYRLKLDW 776
++ HP+++++ V G +V Y Y+ SR +
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKR--SRPL------------- 154
Query: 777 PTRKKICI--GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
P + + I I GL YLH +I+HRD+KT N+ ++ I D G A+
Sbjct: 155 PIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 683 KVGEGGFGSVYKGILSDG---TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
KVG G +G VYK DG A+KQ+ + EI ++ +HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65
Query: 740 CCVE--GNQLLLVYEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ ++ L+++Y +++ F K + ++L K + I G+ YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 795 EDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLY 830
+ ++HRD+K +N+L+ + KI+D G A+L+
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 47/183 (25%), Positives = 80/183 (43%), Gaps = 20/183 (10%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSS---KSRQGNREFV 720
+R+++ ++D +G G FG V +K S V A+K LS R + F
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
E +++ P +V+L+ + L +V EYM L + + Y + W K
Sbjct: 92 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWA--K 145
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIST 839
+ L +H + ++HRD+K N+LLDK + K++DFG K+ E T
Sbjct: 146 FYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202
Query: 840 RIA 842
+
Sbjct: 203 AVG 205
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 46/153 (30%), Positives = 67/153 (43%), Gaps = 17/153 (11%)
Query: 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIG------MISAQQHPNLVK 736
+G+G FG VY+ D + A+K LS K +E + IG + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG-IARGLAYLHE 795
L + L LV +YM + E R D R K I + L +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYM---SGGELFWHLQKEGRFSED---RAKFYIAELVLALEHLHK 114
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
IV+RD+K N+LLD + + DFGL+K
Sbjct: 115 YD---IVYRDLKPENILLDATGHIALCDFGLSK 144
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 28/67 (41%), Positives = 35/67 (52%), Gaps = 8/67 (11%)
Query: 784 IGIARGL----AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIS 838
I I R L AYLH I+HRD+KT N+ LD+ NA + DFG A KL T
Sbjct: 188 ITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244
Query: 839 TRIAGTM 845
+GT+
Sbjct: 245 YGWSGTL 251
|
Length = 392 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 43/179 (24%)
Query: 672 KAATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQGNREFVNEIGMISAQQ 730
++ ++ N +G G FG VY+ I D + +A+K++ + NRE + ++
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLN 117
Query: 731 HPNLVKL----YGCCVEGNQ--LLL----------VYEYMK----NNCLSRAIFGKDTEY 770
H N++ L Y C + N+ + L V++YMK NN K Y
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 771 RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAK 828
+L R LAY+H I HRD+K N+L+D + + K+ DFG AK
Sbjct: 178 QL--------------CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 40/141 (28%), Positives = 64/141 (45%), Gaps = 27/141 (19%)
Query: 700 GTVIAVKQLS------SKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV------EGNQL 747
G +AVK+LS + +++ RE V ++ H N++ L E +
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELV----LLKCVNHKNIISLLNVFTPQKSLEEFQDV 101
Query: 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 807
LV E M N L + I ++LD + + G+ +LH I+HRD+K
Sbjct: 102 YLVMELMDAN-LCQVI-------HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150
Query: 808 TSNVLLDKDLNAKISDFGLAK 828
SN+++ D KI DFGLA+
Sbjct: 151 PSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 29/164 (17%)
Query: 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS------SKSRQGNREFVNEIGMISAQQ 730
N P +G + Y +L +A+K+LS + +++ RE V ++
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV----LMKCVN 74
Query: 731 HPNLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 784
H N++ L E + LV E M N L + I +++LD +
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVI-------QMELDHERMSYLLY 126
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+ G+ +LH I+HRD+K SN+++ D KI DFGLA+
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 25/180 (13%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGNRE----FVNEIGMISA 728
+FD + VG G FG V ++ + G + A+K + KS +E F E ++S
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSI 57
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKICI 784
P + +L + + L LV EY + L+R Y + D +
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR--------YEDQFDEDMAQFYLA 109
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ + +H+ + VHRDIK NVL+D+ + K++DFG A +K S GT
Sbjct: 110 ELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGT 166
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 44/152 (28%), Positives = 65/152 (42%), Gaps = 18/152 (11%)
Query: 684 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+GGFG V + + G + A K+L K R+G +NE ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDT----EYRLKLDWPTRKKICIGIARGLAYLHE 795
+ L LV M L I+ E R +I G L LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF---YAAEILCG----LEDLHR 120
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
++ V+RD+K N+LLD + +ISD GLA
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 27/138 (19%)
Query: 703 IAVKQLS------SKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV------EGNQLLLV 750
+A+K+LS + +++ RE V ++ H N++ L E + LV
Sbjct: 44 VAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99
Query: 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 810
E M N L + I ++ LD + + G+ +LH I+HRD+K SN
Sbjct: 100 MELMDAN-LCQVI-------QMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 148
Query: 811 VLLDKDLNAKISDFGLAK 828
+++ D KI DFGLA+
Sbjct: 149 IVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 16/101 (15%)
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 787
P L +L+ C ++L V EY+ G D Y++ + P IA
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVN---------GGDLMYQIQQVGRFKEPHAVFYAAEIA 111
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
GL +LH I++RD+K NV+LD + + KI+DFG+ K
Sbjct: 112 IGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 13/150 (8%)
Query: 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNRE----FVNEIGMISAQQHPNLVKLY 738
+G+G FG V L G AVK L + + V + + A ++P L LY
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
L V E++ L I K + + + +C GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-----GLQFLHSKG- 116
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
I++RD+K NV+LD+D + KI+DFG+ K
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 49/157 (31%), Positives = 70/157 (44%), Gaps = 28/157 (17%)
Query: 684 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREF---VNEIGMISAQQHPNLVK 736
+G+G FG V IL + G A+K L + E + E ++ +HP L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 737 LYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTRKKICIGIARGLA 791
L ++L V EY+ LSR +F +D + I L
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE----------IVSALD 109
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
YLH KIV+RD+K N++LDKD + KI+DFGL K
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 22/43 (51%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
I L YLH +V+RDIK N++LDKD + KI+DFGL K
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 41/167 (24%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
VG G +G+V + G +A+K+L +S + E+ ++ +H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 741 CV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ LV +M + K +E R++ + + +GL Y+H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYIH 135
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTR 840
I+HRD+K N+ +++D KI DFGLA+ + + T ++ TR
Sbjct: 136 AAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR 179
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 29/164 (17%)
Query: 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS------SKSRQGNREFVNEIGMISAQQ 730
N P +G + Y IL +A+K+LS + +++ RE V ++
Sbjct: 28 NLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV----LMKCVN 81
Query: 731 HPNLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 784
H N++ L E + +V E M N L + I +++LD +
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHERMSYLLY 133
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+ G+ +LH I+HRD+K SN+++ D KI DFGLA+
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-05
Identities = 20/49 (40%), Positives = 31/49 (63%), Gaps = 3/49 (6%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
I GL Y+H + ++HRD+K N+L++ D KI DFGLA+ + E+
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
I L YLH + +V+RD+K N++LDKD + KI+DFGL K
Sbjct: 104 IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 46/161 (28%), Positives = 71/161 (44%), Gaps = 20/161 (12%)
Query: 684 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+GGFG V + + G + A K+L K R+G +NE ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIF-----GKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ L LV M L I+ G D + + ++C G L
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY----AAELCCG-------LE 116
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
+ R +IV+RD+K N+LLD + +ISD GLA E +T
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 46/165 (27%), Positives = 65/165 (39%), Gaps = 28/165 (16%)
Query: 678 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHP 732
F +G+G G V+ L G + A+K L K R V E +++ HP
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHP 61
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR---- 788
L LY L LV +Y L R L K + +AR
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRL-----------LQRQPGKCLSEEVARFYAA 110
Query: 789 ----GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829
L YLH + IV+RD+K N+LL + + +SDF L+K
Sbjct: 111 EVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQ 152
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 36/137 (26%), Positives = 59/137 (43%), Gaps = 15/137 (10%)
Query: 700 GTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYGCCVEGNQLLL-VYEYMK 755
G +A+K L + + + + F E + + HPN+V L LL V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-- 813
L R + D L ++ + + LA H IVHRD+K N+++
Sbjct: 63 GRTL-REVLAADG----ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQ 114
Query: 814 -DKDLNAKISDFGLAKL 829
+AK+ DFG+ L
Sbjct: 115 TGVRPHAKVLDFGIGTL 131
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 46/152 (30%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 684 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 739
+G+GGFG V + + G + A K+L K R+G +NE ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIF----GKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+ L LV M L I+ E R +I G L LH
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF---YAAEITCG----LEDLH- 119
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
R +IV+RD+K N+LLD + +ISD GLA
Sbjct: 120 --RERIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 30/175 (17%)
Query: 676 NNFDPANKVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQ 730
+F +G+G FG V G + A+K L KS ++ + E +++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL-KSEMFKKDQLAHVKAERDVLAESD 59
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRLKLDWPTRKKI--C 783
P +V LY + L L+ E++ L F +D TR + C
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---------TRFYMAEC 110
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838
+ + +H ++ +HRDIK N+L+D+ + K+SDFGL+ + K H S
Sbjct: 111 V---LAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH--KQHDS 157
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 27/158 (17%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQ-------LSSKSRQGNREFVNEIGMISAQQHPNLV 735
+G+G +G V I G +A+K+ +S +R + EI ++ +HP++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-----ILREIKLLRLLRHPDIV 62
Query: 736 KLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
++ + E + +V+E M+++ L + I D L + + R L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKAND-----DLTPEHHQFFLYQLLRAL 116
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
Y+H + + HRD+K N+L + D KI DFGLA+
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 32/123 (26%), Positives = 51/123 (41%), Gaps = 28/123 (22%)
Query: 713 RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL 772
R G E ++ A HP++++L G + Y K CL + D L
Sbjct: 127 RGGT---ATEAHILRAINHPSIIQLKG----------TFTYNKFTCLILPRYKTDLYCYL 173
Query: 773 KLDWPTRKKICI--------GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824
++ I I + R + YLHE+ I+HRDIK N+ ++ + + DF
Sbjct: 174 A----AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDF 226
Query: 825 GLA 827
G A
Sbjct: 227 GAA 229
|
Length = 391 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 677 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL- 734
+F+ +G G FG V D G V A+K L R+ + ++G I A++ +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKIL----RKADMLEKEQVGHIRAERDILVE 57
Query: 735 ------VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
VK++ + L L+ E++ + + KDT T ++ IA
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTL--------TEEETQFYIAE 109
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826
+ + ++ +HRDIK N+LLD + K+SDFGL
Sbjct: 110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 27/150 (18%), Positives = 55/150 (36%), Gaps = 17/150 (11%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLV-KLYGC 740
+ G VY + + +K S+ + +RE E+ ++ + V K+
Sbjct: 5 LLKGGLTNRVYL-LGTKDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800
L+ E+++ G+ + + + I +A LA LH+ +
Sbjct: 62 GESDGWSYLLMEWIE---------GETLDEVSEEEKE---DIAEQLAELLAKLHQLPLLV 109
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
+ H D+ N+L+D I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSS---KSRQGNREFV 720
+R ++ +++ +G G FG V +K S V A+K LS R + F
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
E +++ P +V+L+ + L +V EYM L + + Y + W +
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWA--R 145
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825
+ L +H + +HRD+K N+LLDK + K++DFG
Sbjct: 146 FYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSS---KSRQGNREFV 720
+ +++ +FD +G G FG V +K S V A+K LS R + F
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFW 91
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
E +++ +V+L+ + L +V EYM L + + Y + W
Sbjct: 92 EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWARFY 147
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825
+ +A L +H + +HRD+K N+LLDK + K++DFG
Sbjct: 148 TAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 21/60 (35%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
I L +LH ++ IV+RDIK N+LLD + + ++DFGL+K + ++ + GT+
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 8e-04
Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 11/100 (11%)
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARG 789
+PN +KLY +L+ +Y+K+ L F D + KL KKI +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----F--DLLKKEGKLSEAEVKKIIRQLVEA 121
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLN-AKISDFGLAK 828
L LH + I+H DIK NVL D+ + + D+GL K
Sbjct: 122 LNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158
|
Length = 267 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 18/41 (43%), Positives = 28/41 (68%), Gaps = 1/41 (2%)
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
LA H S+ ++HRDIK++N+LL + K+ DFG +K+Y
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMY 193
|
Length = 496 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 6/107 (5%)
Query: 113 SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172
KLR L+ C+ +F P+ LV+L + G++L + V ++T L+N+ + G
Sbjct: 589 PKLRLLRWDKYPLRCMPSNFRPE----NLVKLQMQGSKLEKLWDGV-HSLTGLRNIDLRG 643
Query: 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ IP D+ NL+ L LS S ELP+ + L L DL +S
Sbjct: 644 SKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 34/133 (25%), Positives = 63/133 (47%), Gaps = 10/133 (7%)
Query: 700 GTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757
GT++ V+ L + + + + NE+ + +HPN++ + G+ L ++ +M
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 817
+ + T + + I G RGL YLH++ I HR+IK S++L+ D
Sbjct: 85 SANSLL---KTYFPEGMSEALIGNILFGALRGLNYLHQNGYI---HRNIKASHILISGDG 138
Query: 818 NAKISDFGLAKLY 830
+S GL+ LY
Sbjct: 139 LVSLS--GLSHLY 149
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 54/223 (24%), Positives = 88/223 (39%), Gaps = 68/223 (30%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGI---LSDGTVIAVKQLSSKS------------- 712
+ ++++F +K+G G FG ++G+ D V +L+++
Sbjct: 138 ANSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMD 197
Query: 713 RQGNR-EFVNEIGMISAQQHPNLVKLYGC------------CVE---------------- 743
RQG R +F+ + +V+ Y C C E
Sbjct: 198 RQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTK 257
Query: 744 GNQLLLVYEYMKNNCLSRAIFGKDTEY------------RLKLDWPTRKK---ICIGIAR 788
G+Q L V+++ + L A+ GK + ++ + P K+ + G+ R
Sbjct: 258 GSQWL-VWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMR 316
Query: 789 ----GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
GL LH RI IVHRDIK N+L+ D KI DFG A
Sbjct: 317 QVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 37/155 (23%), Positives = 66/155 (42%), Gaps = 12/155 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI----GMISAQQH 731
++F+ +G G FG V D I ++ K+ +E V I ++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
+VK++ + L L+ E++ + + KDT + + IA +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTL--------SEEATQFYIAETVL 112
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826
+ ++ +HRDIK N+LLD + K+SDFGL
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 14/29 (48%), Positives = 23/29 (79%)
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGL 826
++ +HRDIK N+L+D+D + K++DFGL
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 26/95 (27%), Positives = 40/95 (42%), Gaps = 18/95 (18%)
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
V+ + L+V EY++ L A+ R + + R + LH + I
Sbjct: 69 VDPDNGLIVMEYIEGELLKDAL------------EEARPDLLREVGRLVGKLH---KAGI 113
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKL--YEEDK 834
VH D+ TSN++L DFGL + EDK
Sbjct: 114 VHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVEDK 147
|
Length = 204 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.003
Identities = 17/58 (29%), Positives = 27/58 (46%), Gaps = 4/58 (6%)
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
++ + +A LH+ IVH D+ TSN ++ D I DFGL K + +
Sbjct: 430 NPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIVRDDRLYLI-DFGLGKYSDLIEDK 483
|
Length = 535 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 20/47 (42%), Positives = 27/47 (57%)
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
++ VHRDIK NVLLDK+ + +++DFG D T S GT
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGT 166
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 39/146 (26%), Positives = 64/146 (43%), Gaps = 20/146 (13%)
Query: 684 VGEGGFGSVYKGIL-------SDGTV------IAVKQLSSKSRQGNREFVNEIGMISAQQ 730
+G G +Y GIL DG + +K L R + F M+
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
H ++V LYG CV + ++V E+++ L + K L P + K+ +A L
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD----VLTTPWKFKVAKQLASAL 118
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKD 816
+YL ED +VH ++ T N+LL ++
Sbjct: 119 SYL-EDK--DLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+ARG+ +L SR K +HRD+ N+LL ++ KI DFGLA+
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 20/52 (38%), Positives = 29/52 (55%), Gaps = 3/52 (5%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837
+A+G+ +L + I HRD+ NVLL AKI DFGLA+ D ++
Sbjct: 221 VAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 21/52 (40%), Positives = 33/52 (63%), Gaps = 3/52 (5%)
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837
+ARG+ +L SR K +HRD+ N+LL ++ KI DFGLA+ +D ++
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 231
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 845 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.97 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.96 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.95 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.95 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.95 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.94 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.94 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.94 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.94 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.94 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.94 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.94 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.93 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.93 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.93 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.93 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.93 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.93 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.93 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.93 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.93 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.92 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.92 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.92 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.91 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.91 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.91 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.91 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.91 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.9 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.9 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.9 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.9 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.9 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.9 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.9 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.9 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.9 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.9 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.9 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.9 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.9 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.9 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.89 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.89 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.89 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.89 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.89 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.89 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.89 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.89 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.89 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.89 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.89 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.89 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.89 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.89 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.89 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.89 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.89 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.89 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.88 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.88 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.88 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.88 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.88 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.88 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.88 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.88 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.88 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.88 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.88 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.88 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.88 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.88 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.88 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.88 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.88 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.88 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.88 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.88 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.87 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.87 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.87 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.87 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.87 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.87 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.87 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.87 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.87 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.87 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.87 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.87 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.87 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.87 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.87 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.87 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.87 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.86 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.86 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.86 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.86 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.86 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.86 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.86 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.86 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.86 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.86 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.86 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.86 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.86 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.86 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.86 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.86 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.86 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.86 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.86 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.86 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.86 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.86 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.86 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.86 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.86 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.86 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.86 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.86 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.86 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.86 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.85 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.85 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.85 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.85 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.85 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.85 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.85 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.85 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.85 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.85 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.85 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.85 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.85 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.85 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.85 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.85 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.85 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.85 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.85 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.85 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.85 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.85 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.85 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.85 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.85 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.85 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.85 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.84 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.84 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.84 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.84 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.84 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.84 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.84 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.84 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.84 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.84 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.84 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.84 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.84 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.84 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.84 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.84 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.84 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.84 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.84 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.84 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.84 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.84 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.84 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.84 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.84 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.84 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.84 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.84 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.83 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.83 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.83 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.83 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.83 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.83 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.83 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.83 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.83 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.83 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.83 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.83 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.83 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.83 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.83 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.83 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.83 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.83 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.83 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.83 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.83 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.83 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.83 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.83 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.83 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.82 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.82 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.82 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.82 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.82 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.82 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.82 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.82 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.82 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.82 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.82 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.82 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.82 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.82 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.82 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.82 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.82 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.82 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.81 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.81 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.81 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.81 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.81 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.81 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.81 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.81 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.81 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.81 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.81 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.8 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.8 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.8 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.8 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.8 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.8 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.8 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.8 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.8 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.8 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.8 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.8 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.8 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.8 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.8 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.79 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.79 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.79 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.79 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.79 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.79 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.79 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.79 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.78 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.78 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.78 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.78 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.78 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.78 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.78 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.78 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.78 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.78 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.78 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.77 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.77 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.77 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.77 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.77 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.77 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.76 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.76 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.76 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.76 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.76 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.76 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.76 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.76 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.75 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.74 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.73 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.72 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.69 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.69 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.67 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.65 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.64 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.64 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.54 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.53 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.48 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.24 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.15 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.15 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.1 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.03 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.01 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.0 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.0 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.97 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.97 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.97 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.94 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.6 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.58 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.57 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.55 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.52 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.52 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.43 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.38 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.35 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.29 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.27 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.26 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.25 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.23 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.19 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.16 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-59 Score=588.72 Aligned_cols=316 Identities=31% Similarity=0.547 Sum_probs=211.4
Q ss_pred CHHHHHHHHHHHHHhCCC-----CCCCCCCCCCCCCCccccCCCCCCCccceeecCCCCcceEEEEEecCCCccccCCcc
Q 003134 37 HAEEVKALKQIGRKLGKK-----DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTE 111 (845)
Q Consensus 37 ~~~~~~aL~~~~~~~~~~-----~W~~~~d~c~~~~~w~~~~~~~~~~~~~v~C~~~~~~~~v~~L~l~~~~l~g~~p~~ 111 (845)
+++|+.||++||+++++. +|+.+.|||. |. ||+|+. ..+|+.|+|++++++|.+|+.
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~----w~-----------gv~c~~---~~~v~~L~L~~~~i~~~~~~~ 88 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCL----WQ-----------GITCNN---SSRVVSIDLSGKNISGKISSA 88 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCc----Cc-----------ceecCC---CCcEEEEEecCCCccccCChH
Confidence 578999999999998632 6877778884 64 799974 358999999999999999999
Q ss_pred ccCCCCCCEEeccCCcccCCCccccc-cc-ceeEEEecCCCCCC----------------------Ccccccccccccce
Q 003134 112 LSKLRYLKQLDLSRNCLTGSFSPQWA-SL-QLVELSVMGNRLSG----------------------PFPKVLTNITTLKN 167 (845)
Q Consensus 112 l~~L~~L~~L~Ls~N~l~~~~~~~~~-~l-~L~~L~Ls~N~l~~----------------------~~p~~~~~l~~L~~ 167 (845)
|..+++|++|+|++|++++.+|..+. .+ +|++|+|++|++++ .+|..++++++|++
T Consensus 89 ~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~ 168 (968)
T PLN00113 89 IFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKV 168 (968)
T ss_pred HhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCE
Confidence 99999999999999999887776554 44 56666666665554 44445555555555
Q ss_pred eEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcC
Q 003134 168 LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247 (845)
Q Consensus 168 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 247 (845)
|+|++|.+.+.+|..|+++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++
T Consensus 169 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 248 (968)
T PLN00113 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248 (968)
T ss_pred EECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCcee
Confidence 55555555555555555555555555555555555555555555555555555555555555555555566666666655
Q ss_pred CCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhh
Q 003134 248 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF 326 (845)
Q Consensus 248 ~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 326 (845)
++.+|..++++++|+.|++++|.+.+..+..+... +|+.|+|++|.+.+.+|..+.++++|+.|+|++|.+++.+|..+
T Consensus 249 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~ 328 (968)
T PLN00113 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328 (968)
T ss_pred ccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhH
Confidence 55555556666666666666655554443333332 66666666666666666666666677777777777666666666
Q ss_pred hcCCCcCEEEccCCcccCCCChhhh--cCCceEEeecCCCcCCCCC
Q 003134 327 EKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSD 370 (845)
Q Consensus 327 ~~l~~L~~L~L~~N~l~g~ip~~~~--~~l~~L~ls~N~l~~~~p~ 370 (845)
..+++|+.|+|++|++++.+|..+. ..|+.|++++|++++.+|.
T Consensus 329 ~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~ 374 (968)
T PLN00113 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374 (968)
T ss_pred hcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCCh
Confidence 6777777777777777766666553 3566777777776666653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=320.69 Aligned_cols=168 Identities=60% Similarity=0.977 Sum_probs=154.4
Q ss_pred ccCcccHHHHHHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEE
Q 003134 662 QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741 (845)
Q Consensus 662 ~~~~~~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 741 (845)
....|++++++.||++|...+.||+|+||.||+|...+++.||||++.....+..++|..|++++++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988775443156799999999999999999999999
Q ss_pred EeCC-EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEE
Q 003134 742 VEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 820 (845)
Q Consensus 742 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~k 820 (845)
.+.+ +.+||||||++|+|.++++..... +++|.+|++||.++|+||+|||+.+.++||||||||+|||+|+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9998 599999999999999999876432 789999999999999999999999988999999999999999999999
Q ss_pred EEeeccceecCC
Q 003134 821 ISDFGLAKLYEE 832 (845)
Q Consensus 821 l~DFGla~~~~~ 832 (845)
|+|||+|+....
T Consensus 218 lsDFGLa~~~~~ 229 (361)
T KOG1187|consen 218 LSDFGLAKLGPE 229 (361)
T ss_pred ccCccCcccCCc
Confidence 999999977654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=352.08 Aligned_cols=538 Identities=27% Similarity=0.424 Sum_probs=342.0
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|++++|.+++.+|..+.++++|++|+|++|.+++.+|..+..+ +|++|++++|.+.+.+|..+..+++|+.|+|
T Consensus 260 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L 339 (968)
T PLN00113 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339 (968)
T ss_pred CCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEEC
Confidence 357788888888888888888888888888888888888888888777 7888888888888888888888888888888
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCC
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 250 (845)
++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|+|++|++++.
T Consensus 340 ~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~ 419 (968)
T PLN00113 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE 419 (968)
T ss_pred cCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeE
Confidence 88888888888888888888888888888777777777777777777777777777777777777777777777777766
Q ss_pred cchhhhcCCCCCEEEcCCCCCCCCCCcc------------------------cccCCccEEEccCCcCcccCcccccCCC
Q 003134 251 IPASISALTSLTDLRISDLKGSESAFPK------------------------LDKMNLKTLILTKCLIHGEIPDYIGDMT 306 (845)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~n~~~~~~~~~------------------------l~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 306 (845)
+|..|.++++|+.|++++|.+.+..+.. +...+|+.|+|++|++++.+|..|.+++
T Consensus 420 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~ 499 (968)
T PLN00113 420 LPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS 499 (968)
T ss_pred CChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhh
Confidence 6666666666666666666665543332 2223455555555555555555555555
Q ss_pred CcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhh--cCCceEEeecCCCcCCCCCCCCCCCCCceeeee
Q 003134 307 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDPIECPRGSVNLVES 384 (845)
Q Consensus 307 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~ 384 (845)
+|+.|+|++|++++.+|..+.++++|++|+|++|+++|.+|..+. ..|+.|||++|+++|.+|..+ ..+..++.
T Consensus 500 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l----~~l~~L~~ 575 (968)
T PLN00113 500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL----GNVESLVQ 575 (968)
T ss_pred ccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhH----hcCcccCE
Confidence 555555555555555555555555555555555555555555442 245555555555555555333 12233444
Q ss_pred ecCCCCCCCCccCcccCCCCCCCCCCccccceeeecCCcccccCCcccccccccccccccccCCceeEEEeeeeeecCCC
Q 003134 385 YSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDT 464 (845)
Q Consensus 385 l~~~~n~~~~~~~c~~~~~~c~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (845)
++.+.|++.+..|.. +.... +. +
T Consensus 576 l~ls~N~l~~~~p~~----------------------~~~~~-----~~-------~----------------------- 598 (968)
T PLN00113 576 VNISHNHLHGSLPST----------------------GAFLA-----IN-------A----------------------- 598 (968)
T ss_pred EeccCCcceeeCCCc----------------------chhcc-----cC-------h-----------------------
Confidence 444444444322210 00000 00 0
Q ss_pred CCCCceeeccceecccccchhhhhhccccCCCCCceEEeecCCceEEEEEeeeeeEEcCCccccccccEEEEEEeccccc
Q 003134 465 DLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLV 544 (845)
Q Consensus 465 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~v~~i~i~~~~~ 544 (845)
+.+ .+++.+|...
T Consensus 599 ----------~~~----~~n~~lc~~~----------------------------------------------------- 611 (968)
T PLN00113 599 ----------SAV----AGNIDLCGGD----------------------------------------------------- 611 (968)
T ss_pred ----------hhh----cCCccccCCc-----------------------------------------------------
Confidence 000 0000000000
Q ss_pred cccCccccccCCCCCceEeeeeeeeecceeEEEEeecCCceeeecCCCCCCCCcccccccccCCCCccCCCCcceeeehh
Q 003134 545 KKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAA 624 (845)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~p~~~~~~~~~~ii~~ 624 (845)
+..+ .|+ . ..........+++++
T Consensus 612 --------------------------------------------~~~~--~~~------c-----~~~~~~~~~~~~~~~ 634 (968)
T PLN00113 612 --------------------------------------------TTSG--LPP------C-----KRVRKTPSWWFYITC 634 (968)
T ss_pred --------------------------------------------cccC--CCC------C-----ccccccceeeeehhH
Confidence 0000 000 0 000001122333333
Q ss_pred HHHHHHHHHHHHHHhhhhccccCCCc-Ccccccccccc------ccCcccHHHHHHHhcCCCCCCcccccCcEEEEEEEE
Q 003134 625 IVGASVLLVLLILFIMRWKGCLGGKV-SADKELRGLDL------QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGIL 697 (845)
Q Consensus 625 ~v~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~ 697 (845)
+++++++++++++++++++++++.+. +...+....+. ....++++++ ...|...+.||+|+||.||+|+.
T Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~ 711 (968)
T PLN00113 635 TLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKS 711 (968)
T ss_pred HHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEE
Confidence 44443333333333333322211111 11100000110 0112333333 34577888999999999999997
Q ss_pred -CCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCH
Q 003134 698 -SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW 776 (845)
Q Consensus 698 -~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~ 776 (845)
.++..||||+++..... ..+|++++++++|||||+++++|.+++..++||||+++|+|.++++ .++|
T Consensus 712 ~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--------~l~~ 779 (968)
T PLN00113 712 IKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--------NLSW 779 (968)
T ss_pred CCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--------cCCH
Confidence 46899999998654322 2356889999999999999999999999999999999999999984 3789
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 777 PTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 777 ~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
.++.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+...
T Consensus 780 ~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred HHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 9999999999999999997766679999999999999999988875 7766543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=276.33 Aligned_cols=161 Identities=30% Similarity=0.576 Sum_probs=141.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
..+|...+.||+|+|++||+|+++ ++..||||.+... .....+.+..|+++|+.++|||||++++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888889999999999999986 4899999999776 4445667889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC------CcEEEEeec
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD------LNAKISDFG 825 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~------~~~kl~DFG 825 (845)
|||.||+|.++++..+ .+++..++.++.|+|.||++||+++ ||||||||+||||+.. -.+||+|||
T Consensus 89 EyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 9999999999997653 6899999999999999999999997 9999999999999764 458999999
Q ss_pred cceecCCCCceeeeeeccCC
Q 003134 826 LAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 826 la~~~~~~~~~~~t~~~GT~ 845 (845)
+||.+.... ...+.+|||
T Consensus 161 fAR~L~~~~--~a~tlcGSp 178 (429)
T KOG0595|consen 161 FARFLQPGS--MAETLCGSP 178 (429)
T ss_pred hhhhCCchh--HHHHhhCCc
Confidence 999997432 233467765
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=294.25 Aligned_cols=301 Identities=20% Similarity=0.247 Sum_probs=243.5
Q ss_pred CcceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCccccccccccccee
Q 003134 90 ATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL 168 (845)
Q Consensus 90 ~~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 168 (845)
..+|++.|+|.+|.|+..-.+++..++.|++||||.|.|+.+.-+.|..- ++++|+|++|+|+..-...|.++.+|..|
T Consensus 123 ~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tl 202 (873)
T KOG4194|consen 123 ESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTL 202 (873)
T ss_pred cccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheee
Confidence 45789999999999998888889999999999999999998888888774 89999999999998888888888899999
Q ss_pred EeecccCCCCCCcccccCCCccEEEeecCcCccc------------------------CChhhhCCCCCCcEEeecCcCc
Q 003134 169 SIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE------------------------LPAELTKLTNLNDLRISDNNFS 224 (845)
Q Consensus 169 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~------------------------~p~~~~~l~~L~~L~Ls~N~l~ 224 (845)
.|+.|+++...+..|.+|++|+.|+|..|+|.-. -...|..|.++++|+|+.|+++
T Consensus 203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~ 282 (873)
T KOG4194|consen 203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ 282 (873)
T ss_pred ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh
Confidence 9999999866666777888888888888887622 1223444556667777777777
Q ss_pred ccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCccccc
Q 003134 225 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIG 303 (845)
Q Consensus 225 ~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~ 303 (845)
..-..++.++++|+.|+||+|.|+...++++..+++|+.|+|+.|+++..+...+..+ .|+.|+|++|+|+..-..+|.
T Consensus 283 ~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~ 362 (873)
T KOG4194|consen 283 AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFV 362 (873)
T ss_pred hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHH
Confidence 6666777778888888888888888888888888888888888888888877777666 788888888888877778888
Q ss_pred CCCCcCEEeCCCCCCCCCCch---hhhcCCCcCEEEccCCcccCCCChhhh---cCCceEEeecCCCcCCCCC-------
Q 003134 304 DMTKLKNIDLSFNNLTGGIPT---TFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESSD------- 370 (845)
Q Consensus 304 ~l~~L~~L~Ls~N~l~g~~p~---~~~~l~~L~~L~L~~N~l~g~ip~~~~---~~l~~L~ls~N~l~~~~p~------- 370 (845)
.+++|+.|||++|.|++.|.+ .|..|++|+.|+|.+|+|. .||+.-+ +.|+.|||.+|.+...-|+
T Consensus 363 ~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~L 441 (873)
T KOG4194|consen 363 GLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMEL 441 (873)
T ss_pred HhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcceeecccccccchh
Confidence 888899999999988876654 4788999999999999998 6665543 4788999999988765444
Q ss_pred --------CCCCCCCCceeeeeecCCCCC
Q 003134 371 --------PIECPRGSVNLVESYSSPRNK 391 (845)
Q Consensus 371 --------~~~c~~~~~~~l~~l~~~~n~ 391 (845)
.|-|||...|+..|+....-.
T Consensus 442 k~Lv~nSssflCDCql~Wl~qWl~~~~lq 470 (873)
T KOG4194|consen 442 KELVMNSSSFLCDCQLKWLAQWLYRRKLQ 470 (873)
T ss_pred hhhhhcccceEEeccHHHHHHHHHhcccc
Confidence 478999999999999765544
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-31 Score=284.71 Aligned_cols=277 Identities=21% Similarity=0.198 Sum_probs=222.6
Q ss_pred cceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeE
Q 003134 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (845)
Q Consensus 91 ~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 169 (845)
...++.+++..|.|+ .||.......+|+.|+|.+|.|+.+...++..+ .|+.||||.|.|+.+.-..|..-.+|++|+
T Consensus 101 l~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~ 179 (873)
T KOG4194|consen 101 LPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLN 179 (873)
T ss_pred CCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEe
Confidence 346889999999999 678777777789999999999999999998888 899999999999987777888889999999
Q ss_pred eecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCC
Q 003134 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (845)
Q Consensus 170 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 249 (845)
|++|+|+..-...|..+.+|..|.|++|+++...+..|.+|++|+.|+|..|+|.-.---.|.++++|+.|.|..|.++.
T Consensus 180 La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~k 259 (873)
T KOG4194|consen 180 LASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISK 259 (873)
T ss_pred eccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccc
Confidence 99999998888899999999999999999997777889999999999999999984445678888888888888888887
Q ss_pred CcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhc
Q 003134 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328 (845)
Q Consensus 250 ~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 328 (845)
.-...|..+.+++.|+|+.|++.......+..+ .|+.|+||+|.|..+-++.+.-.++|++||||+|+|+...+.+|..
T Consensus 260 L~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~ 339 (873)
T KOG4194|consen 260 LDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRV 339 (873)
T ss_pred ccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHH
Confidence 777788888888888888888777665554433 6777777777777777777777777777777777777766777776
Q ss_pred CCCcCEEEccCCcccCCCChhh---hcCCceEEeecCCCcCCCC
Q 003134 329 LAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFTWESS 369 (845)
Q Consensus 329 l~~L~~L~L~~N~l~g~ip~~~---~~~l~~L~ls~N~l~~~~p 369 (845)
|..|+.|+|++|+++. +.+.. ..+|+.|||++|.++|.+.
T Consensus 340 L~~Le~LnLs~Nsi~~-l~e~af~~lssL~~LdLr~N~ls~~IE 382 (873)
T KOG4194|consen 340 LSQLEELNLSHNSIDH-LAEGAFVGLSSLHKLDLRSNELSWCIE 382 (873)
T ss_pred HHHhhhhcccccchHH-HHhhHHHHhhhhhhhcCcCCeEEEEEe
Confidence 6666666666666652 22222 2355666666666665443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=261.48 Aligned_cols=162 Identities=28% Similarity=0.450 Sum_probs=138.8
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccccc-------chHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-------GNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 745 (845)
..+.|...+.+|+|+||.|-+|..+ +|+.||||++++.... ......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456778899999999999999864 6999999999765321 1234579999999999999999999999999
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC---CcEEEE
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKIS 822 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~---~~~kl~ 822 (845)
..|+|||||+||+|.+.+-... .+.+..-..+++|++.|+.|||++| |+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence 9999999999999999996542 5677788899999999999999998 9999999999999755 789999
Q ss_pred eeccceecCCCCceeeeeeccCC
Q 003134 823 DFGLAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 823 DFGla~~~~~~~~~~~t~~~GT~ 845 (845)
|||+|+...+ .....+.+|||
T Consensus 322 DFGlAK~~g~--~sfm~TlCGTp 342 (475)
T KOG0615|consen 322 DFGLAKVSGE--GSFMKTLCGTP 342 (475)
T ss_pred ccchhhcccc--ceehhhhcCCc
Confidence 9999999863 33445588986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=272.01 Aligned_cols=161 Identities=32% Similarity=0.540 Sum_probs=146.1
Q ss_pred cCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcc---cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
..|...+.||+|+|+.+|.++. ..|+.||+|++.+. .....+...+||++.+.++|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688999999999999999998 77999999999774 2344678899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|+|++|+|.++++. +.++++.+++.+.+||+.||.|||+.+ |||||||..|+++++++++||+|||+|..++
T Consensus 98 ELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999999863 247999999999999999999999997 9999999999999999999999999999998
Q ss_pred CCCceeeeeeccCC
Q 003134 832 EDKTHISTRIAGTM 845 (845)
Q Consensus 832 ~~~~~~~t~~~GT~ 845 (845)
.++....| ++|||
T Consensus 170 ~~~Erk~T-lCGTP 182 (592)
T KOG0575|consen 170 YDGERKKT-LCGTP 182 (592)
T ss_pred Ccccccce-ecCCC
Confidence 76554444 89997
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=258.20 Aligned_cols=155 Identities=30% Similarity=0.514 Sum_probs=137.0
Q ss_pred CCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-EEEEEEeccCC
Q 003134 680 PANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-QLLLVYEYMKN 756 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~Ey~~~ 756 (845)
..+.||+|..|+|||++++ +++.+|+|.+.... ....+++.+|++++.+.+||+||++||.|..++ ++.|+||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 4689999999999999986 58999999995543 344678999999999999999999999999998 59999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCCce
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~~~ 836 (845)
|||++.+... ..+++....+|+.+|++||.|||+.. +||||||||+|||++..|+|||||||.++.+...
T Consensus 163 GSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 163 GSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 9999998654 35899999999999999999999742 4999999999999999999999999999998654
Q ss_pred eeeeeccC
Q 003134 837 ISTRIAGT 844 (845)
Q Consensus 837 ~~t~~~GT 844 (845)
...+++||
T Consensus 233 ~a~tfvGT 240 (364)
T KOG0581|consen 233 IANTFVGT 240 (364)
T ss_pred hccccccc
Confidence 44567777
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=256.56 Aligned_cols=162 Identities=28% Similarity=0.433 Sum_probs=143.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
.++|+..++||+|+||+||.++.+ +++.+|+|++++.. ....+...+|..+|.+++||.||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 457889999999999999999976 48999999998763 23456778999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
+||+.||.|..+|... ..+++..+.-++.+|+.||.|||+++ ||||||||+|||+|++|+++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999643 36899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCceeeeeeccCC
Q 003134 831 EEDKTHISTRIAGTM 845 (845)
Q Consensus 831 ~~~~~~~~t~~~GT~ 845 (845)
...++. +.+++||+
T Consensus 176 ~~~~~~-t~tfcGT~ 189 (357)
T KOG0598|consen 176 LKDGDA-TRTFCGTP 189 (357)
T ss_pred ccCCCc-cccccCCc
Confidence 655443 33489985
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=266.03 Aligned_cols=160 Identities=38% Similarity=0.630 Sum_probs=137.0
Q ss_pred CCCcccccCcEEEEEEEECCCcEEEEEEcCcccccc--hHHHHHHHHHHhcCCCCceeeEEEEEEeCC-EEEEEEeccCC
Q 003134 680 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYGCCVEGN-QLLLVYEYMKN 756 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~Ey~~~ 756 (845)
..+.+|+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345699999999999999755559999997653322 569999999999999999999999999887 79999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-cEEEEeeccceecCCCCc
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEEDKT 835 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~-~~kl~DFGla~~~~~~~~ 835 (845)
|+|.++++.. ....+++..+++++.|||+||+|||++.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999999874 23479999999999999999999999863 99999999999999998 99999999999886543
Q ss_pred eeeeeeccCC
Q 003134 836 HISTRIAGTM 845 (845)
Q Consensus 836 ~~~t~~~GT~ 845 (845)
...+...||+
T Consensus 199 ~~~~~~~GT~ 208 (362)
T KOG0192|consen 199 TSMTSVAGTY 208 (362)
T ss_pred ccccCCCCCc
Confidence 2223366774
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=259.46 Aligned_cols=153 Identities=33% Similarity=0.552 Sum_probs=134.7
Q ss_pred cCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV 750 (845)
+.|+..++||+|.||.||+|+. .+|+.||+|++.... .....-..+||.+|++++||||+++.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4567788999999999999996 469999999997654 34456678999999999999999999998876 689999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
+|||+. +|.-++... ...+++.++..++.|++.||+|+|.++ |+|||||.+|||||.+|.+||+|||||+++
T Consensus 197 FeYMdh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred Eecccc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999987 788888543 247899999999999999999999997 999999999999999999999999999999
Q ss_pred CCCCce
Q 003134 831 EEDKTH 836 (845)
Q Consensus 831 ~~~~~~ 836 (845)
......
T Consensus 269 ~~~~~~ 274 (560)
T KOG0600|consen 269 TPSGSA 274 (560)
T ss_pred cCCCCc
Confidence 766544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-29 Score=248.23 Aligned_cols=166 Identities=28% Similarity=0.472 Sum_probs=140.1
Q ss_pred CCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEE-EEeCCE-EEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGC-CVEGNQ-LLLVY 751 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~-~~~~~~-~~lV~ 751 (845)
+|.+.++||+|.||+|||+.. .+|..+|.|.++-. .....+....|+.+|++++|||||+++++ +.++.+ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 456778999999999999984 57999999999754 33445678899999999999999999984 444555 89999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK--IVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||+..|+|...++.... ....+++..+++++.|++.||.++|++- ++ |+||||||.||+|+.+|.|||+|||++|.
T Consensus 100 E~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999965433 2357899999999999999999999953 23 99999999999999999999999999999
Q ss_pred cCCCCceeeeeeccCC
Q 003134 830 YEEDKTHISTRIAGTM 845 (845)
Q Consensus 830 ~~~~~~~~~t~~~GT~ 845 (845)
+..+. ...+..+|||
T Consensus 178 l~s~~-tfA~S~VGTP 192 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTP 192 (375)
T ss_pred hcchh-HHHHhhcCCC
Confidence 97544 3455688986
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-28 Score=243.55 Aligned_cols=151 Identities=28% Similarity=0.461 Sum_probs=130.7
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
+.|+...++|+|+||+||||+.++ |+.||||++.... +.-.+-.++|+++|++++|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457788999999999999999875 9999999996542 2234567899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|++..-|.++- . ....++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+||.+..
T Consensus 82 ~~dhTvL~eLe-~----~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHELE-R----YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHHHH-h----ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99985444443 2 2235788999999999999999999997 99999999999999999999999999999975
Q ss_pred CC
Q 003134 833 DK 834 (845)
Q Consensus 833 ~~ 834 (845)
.+
T Consensus 154 pg 155 (396)
T KOG0593|consen 154 PG 155 (396)
T ss_pred Cc
Confidence 43
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=233.42 Aligned_cols=152 Identities=32% Similarity=0.551 Sum_probs=135.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccccc--chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.+|...+++|+|.||.||+|++. +|+.||||+++..... -.....+|++.|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35777899999999999999964 6999999999876332 24678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
||+. +|+..++... ..++..++..++.++++||+|||++. |+||||||.|+||+.+|.+||+|||+|+.+..
T Consensus 82 fm~t-dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred eccc-cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 9986 8999996653 47899999999999999999999997 99999999999999999999999999999975
Q ss_pred CCc
Q 003134 833 DKT 835 (845)
Q Consensus 833 ~~~ 835 (845)
...
T Consensus 154 p~~ 156 (318)
T KOG0659|consen 154 PNR 156 (318)
T ss_pred CCc
Confidence 443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=233.26 Aligned_cols=158 Identities=31% Similarity=0.435 Sum_probs=140.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccc---hHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.+|.|+||.|..++.+ +|..+|+|++++..... .+...+|..+|+.+.||.++++++.+.+.+.+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35677899999999999999975 58899999998764333 345668999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||++||.|..+++.. .++++..++-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999664 36899999999999999999999997 9999999999999999999999999999885
Q ss_pred CCCceeeeeeccCC
Q 003134 832 EDKTHISTRIAGTM 845 (845)
Q Consensus 832 ~~~~~~~t~~~GT~ 845 (845)
.. +.+.+|||
T Consensus 196 ~r----T~TlCGTP 205 (355)
T KOG0616|consen 196 GR----TWTLCGTP 205 (355)
T ss_pred Cc----EEEecCCc
Confidence 42 45688986
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=245.01 Aligned_cols=148 Identities=34% Similarity=0.568 Sum_probs=129.3
Q ss_pred CCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhc--CCCCceeeEEEEEEeCC----EEEEEE
Q 003134 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEGN----QLLLVY 751 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~lV~ 751 (845)
....+.||+|+||.||||++. ++.||||++... ..+.|..|-++.+. ++|+||++++++-.... +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345688999999999999995 689999999654 44677888777664 69999999999987665 899999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED------SRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
||.+.|+|.++|+.+ .++|.+..+|+.-+++||+|||+. .+++|+|||||++|||+..|++..|+|||
T Consensus 288 ~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999654 689999999999999999999976 45789999999999999999999999999
Q ss_pred cceecCCCCc
Q 003134 826 LAKLYEEDKT 835 (845)
Q Consensus 826 la~~~~~~~~ 835 (845)
+|.++.....
T Consensus 362 LAl~~~p~~~ 371 (534)
T KOG3653|consen 362 LALRLEPGKP 371 (534)
T ss_pred eeEEecCCCC
Confidence 9999875443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-27 Score=252.60 Aligned_cols=153 Identities=32% Similarity=0.467 Sum_probs=136.9
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc---cccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCE
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 746 (845)
+....+|...+.||+|+|++|++|+.. .++.+|||++.+. .+...+-...|-++|.++ .||.|++|+..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 334567889999999999999999965 5899999999765 233345667888899999 89999999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
+|+|+||+++|+|.++|+..+ .+++..++.++.+|+.||+|||++| ||||||||+|||+|+||++||+|||-
T Consensus 149 LYFvLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccc
Confidence 999999999999999997653 6899999999999999999999997 99999999999999999999999999
Q ss_pred ceecCC
Q 003134 827 AKLYEE 832 (845)
Q Consensus 827 a~~~~~ 832 (845)
|+.+..
T Consensus 221 AK~l~~ 226 (604)
T KOG0592|consen 221 AKILSP 226 (604)
T ss_pred cccCCh
Confidence 999864
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=246.96 Aligned_cols=160 Identities=27% Similarity=0.496 Sum_probs=140.8
Q ss_pred cCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.+|++.+.+|+|.||.|-+|.. ..|+.||||.+++... ++.-.+.+|+++|+.++||||+.+|++|++.+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4577788999999999999986 5699999999987643 34456789999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||..+|.|++++.+. ..|++.++.++++||..|+.|+|.+. ++|||||.+|||+|+++++||+|||++..+.
T Consensus 133 EYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 133 EYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999665 36999999999999999999999986 9999999999999999999999999999887
Q ss_pred CCCceeeeeeccCC
Q 003134 832 EDKTHISTRIAGTM 845 (845)
Q Consensus 832 ~~~~~~~t~~~GT~ 845 (845)
+++ .-++++|+|
T Consensus 205 ~~k--fLqTFCGSP 216 (668)
T KOG0611|consen 205 DKK--FLQTFCGSP 216 (668)
T ss_pred ccc--HHHHhcCCc
Confidence 543 233466653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=249.81 Aligned_cols=148 Identities=34% Similarity=0.605 Sum_probs=134.2
Q ss_pred CCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 680 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
..+.||+|-||.||.|.+.....||+|.++.. ....+.|.+|+++|.+++|+|||+++|+|..++.+|||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 46789999999999999988889999999876 44567899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
.++|.... ...+...+.+.++.|||+||+||+++. +|||||.++|||++++..+||+|||+||...++.
T Consensus 289 l~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 289 LDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred HHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 99997632 346889999999999999999999997 9999999999999999999999999999655443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=234.62 Aligned_cols=152 Identities=30% Similarity=0.469 Sum_probs=132.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccccc--chHHHHHHHHHHhcCCCCceeeEEEEEEe--CCEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV 750 (845)
++|+..+.|++|+||.||+|+++ +++.||+|+++..... ..-.-.+||.+|.+++|||||.+..+... -+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 35677899999999999999975 5899999999865422 23456799999999999999999998764 4689999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
||||+. +|..+++... .++...++..++.|+++|++|||.+. |+|||||++|+|+...|.+||+|||+||.+
T Consensus 156 Me~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 999987 8999987653 47889999999999999999999998 999999999999999999999999999999
Q ss_pred CCCCc
Q 003134 831 EEDKT 835 (845)
Q Consensus 831 ~~~~~ 835 (845)
+....
T Consensus 228 gsp~k 232 (419)
T KOG0663|consen 228 GSPLK 232 (419)
T ss_pred cCCcc
Confidence 87643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-27 Score=251.15 Aligned_cols=151 Identities=28% Similarity=0.465 Sum_probs=132.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcccccch-HHHHHHHHHHhcCC-CCceeeEEEEEEeCC-EEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQ-HPNLVKLYGCCVEGN-QLLLV 750 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~-~~~lV 750 (845)
.++|...++||.|.||.||+|+- .++..||||+++....... -.=.+|+..|++++ |||||++.+++.+.+ .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 45678889999999999999995 4689999999987643322 23358999999998 999999999999888 99999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
||||+. +|+++++++ +..+++.+++.|+.||++||+|+|.+| +.|||+||||||+.....+||+|||+||.+
T Consensus 89 fE~Md~-NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred HHhhhh-hHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 999986 799999765 348999999999999999999999998 999999999999998889999999999998
Q ss_pred CCC
Q 003134 831 EED 833 (845)
Q Consensus 831 ~~~ 833 (845)
...
T Consensus 161 ~Sk 163 (538)
T KOG0661|consen 161 RSK 163 (538)
T ss_pred ccC
Confidence 643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=249.35 Aligned_cols=160 Identities=31% Similarity=0.498 Sum_probs=144.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+..+ .+.+.+.+|+++++.++|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999965 588999999976533 345678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+.| +|..++... ..++++++..|+.++..||.|||+.. |+|||+||.|||++..|.+|++|||+||.+..
T Consensus 82 ~a~g-~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9987 999999543 37999999999999999999999986 99999999999999999999999999999875
Q ss_pred CCceeeeeeccCC
Q 003134 833 DKTHISTRIAGTM 845 (845)
Q Consensus 833 ~~~~~~t~~~GT~ 845 (845)
++++-+++.|||
T Consensus 153 -~t~vltsikGtP 164 (808)
T KOG0597|consen 153 -NTSVLTSIKGTP 164 (808)
T ss_pred -CceeeeeccCcc
Confidence 456778899996
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=241.30 Aligned_cols=165 Identities=31% Similarity=0.454 Sum_probs=135.1
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--------------cchHHHHHHHHHHhcCCCCceeeE
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------------QGNREFVNEIGMISAQQHPNLVKL 737 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~nIv~l 737 (845)
..-++|+..+.||+|.||.|-+|+.. +++.||||++.+... ...+...+||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999975 699999999976421 112578899999999999999999
Q ss_pred EEEEEeC--CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC
Q 003134 738 YGCCVEG--NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 815 (845)
Q Consensus 738 ~~~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~ 815 (845)
+++..+. +.+|||+|||..|.+...=- ....+++.++++|++++..||+|||.++ ||||||||+|+||++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 9998754 68999999999987744321 1123899999999999999999999997 999999999999999
Q ss_pred CCcEEEEeeccceecCCC----CceeeeeeccCC
Q 003134 816 DLNAKISDFGLAKLYEED----KTHISTRIAGTM 845 (845)
Q Consensus 816 ~~~~kl~DFGla~~~~~~----~~~~~t~~~GT~ 845 (845)
+|+|||+|||.+...... ....-.+.+|||
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTP 279 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTP 279 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCc
Confidence 999999999999877322 111223477876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-26 Score=244.53 Aligned_cols=150 Identities=25% Similarity=0.399 Sum_probs=136.0
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
..++|+....||+|+||.||.|+-+ +|..+|+|++++.. ....+.++.|-.+|...++|.||+++..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999965 59999999998763 3344567889999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||++||++..+|...+ .|++..+..++.+++-|++-||..| ||||||||+|+|||..|++||+||||++-
T Consensus 219 iMEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 999999999999996543 6899999999999999999999997 99999999999999999999999999965
Q ss_pred cC
Q 003134 830 YE 831 (845)
Q Consensus 830 ~~ 831 (845)
+.
T Consensus 291 l~ 292 (550)
T KOG0605|consen 291 LD 292 (550)
T ss_pred hh
Confidence 53
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-28 Score=263.44 Aligned_cols=276 Identities=25% Similarity=0.341 Sum_probs=188.7
Q ss_pred ceEEEEEecCCCcc-ccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeE
Q 003134 92 CHVVTIALKAQNLT-GTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (845)
Q Consensus 92 ~~v~~L~l~~~~l~-g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 169 (845)
.+++++++.+|+|. .-||+.|..|..|+.||||+|+++.. |..+... ++..|+||+|+|..+....|.+|+.|-+||
T Consensus 78 p~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~Ev-P~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLD 156 (1255)
T KOG0444|consen 78 PRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREV-PTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLD 156 (1255)
T ss_pred hhhHHHhhhccccccCCCCchhcccccceeeecchhhhhhc-chhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhc
Confidence 34566677777764 35788888888899999999988854 4445544 788889999998866666788888888999
Q ss_pred eecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCc-ccCchhhcCCcccceEEecCCcCC
Q 003134 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS-GKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 170 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
||+|++. .+|+.+..|..|++|+|++|.+.-.--..+..+++|+.|.+++.+=+ ..+|.++..+.+|..+|||.|.|.
T Consensus 157 LS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp 235 (1255)
T KOG0444|consen 157 LSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP 235 (1255)
T ss_pred cccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC
Confidence 9999988 77888888888888888888875322223344556666666666544 346777777777777777777777
Q ss_pred CCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCC-C-------
Q 003134 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT-G------- 320 (845)
Q Consensus 249 g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-g------- 320 (845)
.+|..+-++.+|+.|+||+|+++......-...+|++|+||+|+++ .+|++++++++|+.|++.+|+|+ .
T Consensus 236 -~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIG 313 (1255)
T KOG0444|consen 236 -IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIG 313 (1255)
T ss_pred -cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchh
Confidence 6677777777777777777777766544433346777777777776 56666666667666666666665 2
Q ss_pred ----------------CCchhhhcCCCcCEEEccCCcccCCCChhh--hcCCceEEeecCCCcCCCCCCC
Q 003134 321 ----------------GIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPI 372 (845)
Q Consensus 321 ----------------~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~--~~~l~~L~ls~N~l~~~~p~~~ 372 (845)
..|+.++.+.+|+.|.|+.|+|- .+|+.+ ...++.||+..|.-.-.+|.|-
T Consensus 314 KL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~ 382 (1255)
T KOG0444|consen 314 KLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPN 382 (1255)
T ss_pred hhhhhHHHHhhccccccCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcc
Confidence 34445555555555555555554 445444 3456666666665555555443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=248.32 Aligned_cols=160 Identities=29% Similarity=0.552 Sum_probs=144.8
Q ss_pred cCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
..|+.-++||+|+.|.||.|+. .+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4677788999999999999985 468899999998887777778899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
+||+|.+.+... .+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+....
T Consensus 353 ~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred CCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999998543 5899999999999999999999997 9999999999999999999999999999997765
Q ss_pred ceeeeeeccCC
Q 003134 835 THISTRIAGTM 845 (845)
Q Consensus 835 ~~~~t~~~GT~ 845 (845)
.. .++++|||
T Consensus 424 ~K-R~TmVGTP 433 (550)
T KOG0578|consen 424 SK-RSTMVGTP 433 (550)
T ss_pred Cc-cccccCCC
Confidence 53 44588986
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=251.15 Aligned_cols=154 Identities=30% Similarity=0.551 Sum_probs=138.2
Q ss_pred CCCCcccccCcEEEEEEEECC----CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 679 DPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 679 ~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.+.++||.|.||.|++|+++- ...||||.++... ...+.+|+.|+.||.+..||||++|.|+........||.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 456889999999999999752 4589999998874 44567999999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
|++|+|+.+|+.+++ ++++.+...+.++||.||+||-+.+ +|||||.++|||++.+...||+|||++|.++++
T Consensus 712 MENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 999999999987764 5888999999999999999999886 999999999999999999999999999999776
Q ss_pred Cceeee
Q 003134 834 KTHIST 839 (845)
Q Consensus 834 ~~~~~t 839 (845)
.....+
T Consensus 785 ~~~~yt 790 (996)
T KOG0196|consen 785 PEAAYT 790 (996)
T ss_pred CCcccc
Confidence 644433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=235.48 Aligned_cols=163 Identities=35% Similarity=0.546 Sum_probs=137.5
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC--EEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~E 752 (845)
.+|...+.||+|+||+||++...+ |+..|||.+........+.+.+|+++|++++|||||+++|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 346678899999999999999764 8999999997763333667899999999999999999999865554 6899999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCcEEEEeeccceecC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYE 831 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~-~~~~kl~DFGla~~~~ 831 (845)
|+++|+|.+++..... .+++..++++.+||++||+|||+++ ||||||||+|||++. ++.+||+|||+|+...
T Consensus 97 y~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred ccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999965432 5899999999999999999999997 999999999999999 7999999999999886
Q ss_pred C--CCceeeeeeccCC
Q 003134 832 E--DKTHISTRIAGTM 845 (845)
Q Consensus 832 ~--~~~~~~t~~~GT~ 845 (845)
. ........+.||+
T Consensus 170 ~~~~~~~~~~~~~Gtp 185 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTP 185 (313)
T ss_pred cccccccccccccCCc
Confidence 3 2222233466664
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-25 Score=244.17 Aligned_cols=164 Identities=27% Similarity=0.443 Sum_probs=140.3
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc----cc-cchHHHHHHHHHHhcCC-CCceeeEEEEEEeCC
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK----SR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN 745 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~ 745 (845)
....+|...+.||+|+||+|+.|+.. +++.||+|.+... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34567889999999999999999864 5899999977664 11 22456678999999999 999999999999999
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CcEEEEee
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDF 824 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~-~~~kl~DF 824 (845)
.+|+||||+.||+|.+++... .++.+.++.++++|++.|++|+|+++ |+||||||+|||+|.+ +++||+||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence 999999999999999999652 36888999999999999999999997 9999999999999999 99999999
Q ss_pred ccceecCCCCceeeeeeccCC
Q 003134 825 GLAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 825 Gla~~~~~~~~~~~t~~~GT~ 845 (845)
|++..... ......+.+||+
T Consensus 166 G~s~~~~~-~~~~l~t~cGsp 185 (370)
T KOG0583|consen 166 GLSAISPG-EDGLLKTFCGSP 185 (370)
T ss_pred ccccccCC-CCCcccCCCCCc
Confidence 99999851 222334567774
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-25 Score=233.21 Aligned_cols=165 Identities=25% Similarity=0.382 Sum_probs=144.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..++||.|..++||+|+. +.++.||||++..+.- .....+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 35788899999999999999995 4689999999987643 335889999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
||.+||+.++++.... ..+++..+..|.+++++||.|||.+| .||||||+.||||+.+|.|||+|||....+.+
T Consensus 105 fMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999976533 35899999999999999999999997 99999999999999999999999999887766
Q ss_pred CCceeeee---eccCC
Q 003134 833 DKTHISTR---IAGTM 845 (845)
Q Consensus 833 ~~~~~~t~---~~GT~ 845 (845)
.+.+..++ ++||+
T Consensus 179 ~G~R~~~rf~tfvgtp 194 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTP 194 (516)
T ss_pred cCceeeEeeccccCcc
Confidence 55444433 56664
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-27 Score=246.58 Aligned_cols=303 Identities=19% Similarity=0.213 Sum_probs=227.3
Q ss_pred cceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEE-EecCCCCCCCccccccccccccee
Q 003134 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVEL-SVMGNRLSGPFPKVLTNITTLKNL 168 (845)
Q Consensus 91 ~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L 168 (845)
++..+.|+|..|.|+.+-|.+|+.+++|++||||+|+|+.+.|.+|..+ ++..| ++++|+|+...-+.|++|..|+.|
T Consensus 66 P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrL 145 (498)
T KOG4237|consen 66 PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRL 145 (498)
T ss_pred CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHH
Confidence 4567788888888887767788888888888888888888888888888 65555 445588887777788888888888
Q ss_pred EeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcC------------cccCchhhcCCcc
Q 003134 169 SIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF------------SGKIPEFIGKWKK 236 (845)
Q Consensus 169 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l------------~~~~p~~~~~l~~ 236 (845)
.+.-|++.-...+.|..|++|..|.|..|.+...--.+|..+.+++++.+..|.+ -...|..++...-
T Consensus 146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc 225 (498)
T KOG4237|consen 146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARC 225 (498)
T ss_pred hcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccccee
Confidence 8888888877777888888888888888888733334788888888888888872 2334455555555
Q ss_pred cceEEecCCcCCCCcchhhhcC-CCCC-EEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeC
Q 003134 237 IQKLHIQGSSLEGPIPASISAL-TSLT-DLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDL 313 (845)
Q Consensus 237 L~~L~Ls~N~l~g~~p~~~~~l-~~L~-~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 313 (845)
..-..|.++++....+..|... .++. .+...++....-+..-+..+ +|+.|+|++|+|+++-+.+|.++..|++|.|
T Consensus 226 ~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L 305 (498)
T KOG4237|consen 226 VSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL 305 (498)
T ss_pred cchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence 5555666666655544444322 1111 11222222222232334444 8999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhh--hcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCC
Q 003134 314 SFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNK 391 (845)
Q Consensus 314 s~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~--~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~ 391 (845)
..|+|...-...|.++..|+.|+|.+|+|+..-|..+ ..+|..|+|-.| ||.|+|...|+.+|++...
T Consensus 306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~N--------p~~CnC~l~wl~~Wlr~~~-- 375 (498)
T KOG4237|consen 306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSN--------PFNCNCRLAWLGEWLRKKS-- 375 (498)
T ss_pred CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccC--------cccCccchHHHHHHHhhCC--
Confidence 9999998888899999999999999999997777666 348899999999 9999999999999998877
Q ss_pred CCCccCcccCCC
Q 003134 392 LDKVHPCLRQNF 403 (845)
Q Consensus 392 ~~~~~~c~~~~~ 403 (845)
..+..+|..+.+
T Consensus 376 ~~~~~~Cq~p~~ 387 (498)
T KOG4237|consen 376 VVGNPRCQSPGF 387 (498)
T ss_pred CCCCCCCCCCch
Confidence 555566665443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=220.15 Aligned_cols=163 Identities=28% Similarity=0.458 Sum_probs=141.4
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
+-++|+..+.+|+|.||.||.|+.+ ++-.||+|++.+.. .+-.+++.+|+++-+.++||||+++|+||.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3457888999999999999999965 58899999997652 3346789999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
++||..+|++...+.+... .++++.....++.|+|.||.|+|.+. ||||||||+|+|++.++..||+|||-+..
T Consensus 100 ilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceee
Confidence 9999999999999975433 36888899999999999999999986 99999999999999999999999999886
Q ss_pred cCCCCceeeeeeccCC
Q 003134 830 YEEDKTHISTRIAGTM 845 (845)
Q Consensus 830 ~~~~~~~~~t~~~GT~ 845 (845)
-...+ ..+.+||+
T Consensus 174 ~p~~k---R~tlcgt~ 186 (281)
T KOG0580|consen 174 APSNK---RKTLCGTL 186 (281)
T ss_pred cCCCC---ceeeeccc
Confidence 54222 23477875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=231.38 Aligned_cols=149 Identities=30% Similarity=0.461 Sum_probs=129.3
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhc--CCCCceeeEEEEEEeC----CEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEG----NQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~~~l 749 (845)
.+....+.||+|+||.||+|.++ |+.||||++... +++.+.+|.++.+. ++|+||+.+++.-..+ .++||
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 46677899999999999999995 889999999643 44667777777764 5999999999876543 37899
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-----DSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-----~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
|+||.+.|||+|+|... .++....++++.-+|.||+|||. +++|.|.|||||++|||+.+++...|+|+
T Consensus 287 vTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred eeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 99999999999999553 68999999999999999999995 47889999999999999999999999999
Q ss_pred ccceecCCCC
Q 003134 825 GLAKLYEEDK 834 (845)
Q Consensus 825 Gla~~~~~~~ 834 (845)
|+|.....+.
T Consensus 361 GLAv~h~~~t 370 (513)
T KOG2052|consen 361 GLAVRHDSDT 370 (513)
T ss_pred eeeEEecccC
Confidence 9999886553
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=243.17 Aligned_cols=152 Identities=30% Similarity=0.570 Sum_probs=134.7
Q ss_pred HHHHHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCE
Q 003134 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 669 ~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 746 (845)
++..+..+.+...+.||+|+||+||+|+|. ..||||+++... .+..+.|+.|+.++++-+|.||+-+.|||..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 444455555667899999999999999994 469999998764 3456789999999999999999999999998887
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.||+.+|+|.+|+.++|..+ ..++..+.+.|++|||+||.|||.++ |||||||..||++.++++|||+|||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred -eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 99999999999999998764 36888999999999999999999997 99999999999999999999999999
Q ss_pred ceec
Q 003134 827 AKLY 830 (845)
Q Consensus 827 a~~~ 830 (845)
|..-
T Consensus 535 atvk 538 (678)
T KOG0193|consen 535 ATVK 538 (678)
T ss_pred eeee
Confidence 9754
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-26 Score=252.57 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=216.6
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
..++.|||++|.|+ ..|..+..-+++-+|+||+|+|..++-+.|.++ .|..||||+|++. .+|+.+..|.+|++|+|
T Consensus 103 ~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~L 180 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKL 180 (1255)
T ss_pred ccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhc
Confidence 35789999999998 689999999999999999999998888888888 8999999999998 67778888999999999
Q ss_pred ecccCC-------------------------CCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcc
Q 003134 171 EGNLFT-------------------------GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 225 (845)
Q Consensus 171 s~N~l~-------------------------g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~ 225 (845)
++|.+. ..+|.++..|.+|..+|||.|++. ..|+.+-++++|+.|+||+|+|+
T Consensus 181 s~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it- 258 (1255)
T KOG0444|consen 181 SNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT- 258 (1255)
T ss_pred CCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-
Confidence 998754 146777888899999999999998 88999999999999999999998
Q ss_pred cCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCC-CcccccC-CccEEEccCCcCcccCccccc
Q 003134 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA-FPKLDKM-NLKTLILTKCLIHGEIPDYIG 303 (845)
Q Consensus 226 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~-~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~ 303 (845)
.+....+.+.+|++|+||.|+|+ .+|.++..++.|+.|.+.+|+++-.. +..++.+ +|+.+..++|.+. .+|..++
T Consensus 259 eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglc 336 (1255)
T KOG0444|consen 259 ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLC 336 (1255)
T ss_pred eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhh
Confidence 56667778889999999999999 78999999999999999999987443 3445555 8999999999998 8999999
Q ss_pred CCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCccc
Q 003134 304 DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (845)
Q Consensus 304 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~ 343 (845)
.|.+|+.|.|+.|+|- .+|+++--|+.|+.|||..|.=-
T Consensus 337 RC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 337 RCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred hhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 9999999999999998 79999999999999999999644
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=234.91 Aligned_cols=152 Identities=33% Similarity=0.576 Sum_probs=135.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccc-hHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.+...+.++||+|.||.|..|....+..||||+++...... .++|.+|+++|.+++||||++++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34556789999999999999999878999999999875544 58999999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|++|+|..++...... .++-...++||.|||.||+||.+.. +|||||.+.|+|+|.++++||+|||++|.+-.
T Consensus 617 mEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999765322 2455667889999999999999875 99999999999999999999999999996543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=241.10 Aligned_cols=164 Identities=26% Similarity=0.352 Sum_probs=138.9
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 747 (845)
....++|+..+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|+++++.++||||+++++++..++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344568999999999999999999986 48899999986532 22345678999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
|+||||+++|+|.+++... .+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999998532 4788899999999999999999987 999999999999999999999999999
Q ss_pred eecCCCCceeeeeeccC
Q 003134 828 KLYEEDKTHISTRIAGT 844 (845)
Q Consensus 828 ~~~~~~~~~~~t~~~GT 844 (845)
+.+............||
T Consensus 190 ~~~~~~~~~~~~~~~gt 206 (370)
T cd05621 190 MKMDETGMVRCDTAVGT 206 (370)
T ss_pred eecccCCceecccCCCC
Confidence 98754333222234455
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=225.32 Aligned_cols=153 Identities=29% Similarity=0.473 Sum_probs=130.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCc-eeeEEEEEEeCC------
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPN-LVKLYGCCVEGN------ 745 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~------ 745 (845)
..|+..++||+|+||+||+|+.. +|+.||+|++..... .......+|+.++++++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45666788999999999999965 689999999976643 23456789999999999999 999999999877
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
.+++|+||++. +|..++....... ..++...++.++.|+++||+|||+++ |+||||||.||||+++|.+||+|||
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 88999999975 8999886543211 34677889999999999999999997 9999999999999999999999999
Q ss_pred cceecCCC
Q 003134 826 LAKLYEED 833 (845)
Q Consensus 826 la~~~~~~ 833 (845)
+|+.+.-+
T Consensus 166 lAra~~ip 173 (323)
T KOG0594|consen 166 LARAFSIP 173 (323)
T ss_pred hHHHhcCC
Confidence 99977633
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=249.08 Aligned_cols=153 Identities=34% Similarity=0.578 Sum_probs=135.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCccccc-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 747 (845)
+.+....+.||+|+||+||+|+.. +...||||.++..... ...+|++|+++++.++|||||+++|.|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344556789999999999999853 3568999999887655 678999999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCccc---------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEY---------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~ 818 (845)
++|+|||..|||.++|....... ..+|+..+.+.||.|||.||+||-+++ +|||||-.+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999996432211 234899999999999999999999987 999999999999999999
Q ss_pred EEEEeeccceec
Q 003134 819 AKISDFGLAKLY 830 (845)
Q Consensus 819 ~kl~DFGla~~~ 830 (845)
|||+|||++|..
T Consensus 642 VKIsDfGLsRdi 653 (774)
T KOG1026|consen 642 VKISDFGLSRDI 653 (774)
T ss_pred EEecccccchhh
Confidence 999999999865
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=239.64 Aligned_cols=162 Identities=29% Similarity=0.456 Sum_probs=140.0
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 748 (845)
..++|...++||+|+||+|+.+..+ +++.+|||++++.. ..+.+..+.|.+|+... +||.++.++..|+..+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3457889999999999999999986 58899999998873 34456777888887766 5999999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
.||||+.||++..+.+. ..+++..+.-++..|+.||+|||+++ ||+||||.+|||+|.+|++||+|||+++
T Consensus 446 fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999996555532 36899999999999999999999997 9999999999999999999999999999
Q ss_pred ecCCCCceeeeeeccCC
Q 003134 829 LYEEDKTHISTRIAGTM 845 (845)
Q Consensus 829 ~~~~~~~~~~t~~~GT~ 845 (845)
.--..+. .+++++|||
T Consensus 517 e~m~~g~-~TsTfCGTp 532 (694)
T KOG0694|consen 517 EGMGQGD-RTSTFCGTP 532 (694)
T ss_pred ccCCCCC-ccccccCCh
Confidence 7653333 456699996
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-25 Score=228.32 Aligned_cols=153 Identities=35% Similarity=0.508 Sum_probs=126.4
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----EEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLLLV 750 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV 750 (845)
.|...+++|+|+||.||+|... +++.||||++-...+. -.+|.++|++++|||||++..+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566889999999999999975 4789999998654332 236899999999999999999887532 24589
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CcEEEEeecccee
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKL 829 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~-~~~kl~DFGla~~ 829 (845)
||||+. +|.+.++.. ...+..++...+.-+..|+.+||.|||+.+ |+||||||+|+|+|.+ |.+||||||.|+.
T Consensus 101 leymP~-tL~~~~r~~-~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHY-TRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHhchH-HHHHHHHHH-hhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 999986 899998653 123456888889999999999999999976 9999999999999976 9999999999999
Q ss_pred cCCCCceee
Q 003134 830 YEEDKTHIS 838 (845)
Q Consensus 830 ~~~~~~~~~ 838 (845)
+..++..++
T Consensus 176 L~~~epniS 184 (364)
T KOG0658|consen 176 LVKGEPNIS 184 (364)
T ss_pred eccCCCcee
Confidence 976665443
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=236.32 Aligned_cols=148 Identities=24% Similarity=0.347 Sum_probs=132.3
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||+||+|+.. +++.||+|+++... ......+.+|++++.+++|+||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999875 58899999997542 223456788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 999999999998643 36899999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=237.25 Aligned_cols=169 Identities=24% Similarity=0.349 Sum_probs=142.7
Q ss_pred cHHHHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEE
Q 003134 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCV 742 (845)
Q Consensus 667 ~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 742 (845)
.++++....++|+..+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 35556666789999999999999999999976 58899999986432 223456788999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEE
Q 003134 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822 (845)
Q Consensus 743 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~ 822 (845)
.++..++||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~ 184 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA 184 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999998542 4788899999999999999999987 9999999999999999999999
Q ss_pred eeccceecCCCCceeeeeeccC
Q 003134 823 DFGLAKLYEEDKTHISTRIAGT 844 (845)
Q Consensus 823 DFGla~~~~~~~~~~~t~~~GT 844 (845)
|||+|+..............||
T Consensus 185 DfG~a~~~~~~~~~~~~~~~gt 206 (371)
T cd05622 185 DFGTCMKMNKEGMVRCDTAVGT 206 (371)
T ss_pred eCCceeEcCcCCcccccCcccC
Confidence 9999998754433222334455
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-24 Score=237.57 Aligned_cols=151 Identities=25% Similarity=0.338 Sum_probs=133.2
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
..++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3567889999999999999999975 58899999986532 2234557889999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 121 v~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999998542 4788889999999999999999987 99999999999999999999999999987
Q ss_pred cCCC
Q 003134 830 YEED 833 (845)
Q Consensus 830 ~~~~ 833 (845)
....
T Consensus 192 ~~~~ 195 (370)
T cd05596 192 MDAN 195 (370)
T ss_pred ccCC
Confidence 7543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-24 Score=235.99 Aligned_cols=148 Identities=26% Similarity=0.401 Sum_probs=132.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999975 58999999997542 223456788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999998643 25899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=230.63 Aligned_cols=162 Identities=25% Similarity=0.304 Sum_probs=137.4
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+++.. +++.||+|.+.... ......+.+|..++..++|+||+++++++..++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999976 57899999986532 223455788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999996532 25889999999999999999999987 9999999999999999999999999998876
Q ss_pred CCCceeeeeeccC
Q 003134 832 EDKTHISTRIAGT 844 (845)
Q Consensus 832 ~~~~~~~t~~~GT 844 (845)
.+.........||
T Consensus 154 ~~~~~~~~~~~gt 166 (331)
T cd05624 154 QDGTVQSSVAVGT 166 (331)
T ss_pred CCCceeeccccCC
Confidence 5443322233454
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=231.18 Aligned_cols=152 Identities=26% Similarity=0.327 Sum_probs=133.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999975 58899999986531 223456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 9999999999985432 35889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCC
Q 003134 832 EDK 834 (845)
Q Consensus 832 ~~~ 834 (845)
...
T Consensus 154 ~~~ 156 (331)
T cd05597 154 ADG 156 (331)
T ss_pred CCC
Confidence 433
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-24 Score=236.15 Aligned_cols=147 Identities=36% Similarity=0.609 Sum_probs=130.5
Q ss_pred CCCCCcccccCcEEEEEEEECC--C--cE-EEEEEcCcc---cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 678 FDPANKVGEGGFGSVYKGILSD--G--TV-IAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
....++||+|+||.||+|++.. + .. ||||..+.. .....++|.+|+++|++++|||||++||++.....+++
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 3445899999999999999753 2 23 899999853 34557899999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
|||+|.||+|.++|..... .++..++.+++.++|.||+|||++. +|||||-++|+|++.++.+||+|||+++.
T Consensus 239 vmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 9999999999999976532 5899999999999999999999997 99999999999999999999999999886
Q ss_pred cC
Q 003134 830 YE 831 (845)
Q Consensus 830 ~~ 831 (845)
-.
T Consensus 312 ~~ 313 (474)
T KOG0194|consen 312 GS 313 (474)
T ss_pred Cc
Confidence 53
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=233.30 Aligned_cols=156 Identities=26% Similarity=0.450 Sum_probs=130.9
Q ss_pred HhcCCCCCCcccccCcEEEEEEEE------CCCcEEEEEEcCcccc-cchHHHHHHHHHHhcC-CCCceeeEEEEEEeC-
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG- 744 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~- 744 (845)
..++|++.++||+|+||.||+|.+ .+++.||+|+++.... ...+.+.+|++++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788999999999999999974 2356899999975432 2346789999999999 899999999988764
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcc-------------------------------------------------------
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTE------------------------------------------------------- 769 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~------------------------------------------------------- 769 (845)
+..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999998653210
Q ss_pred --cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 770 --YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 770 --~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
....+++.++.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 0135888999999999999999999986 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=234.47 Aligned_cols=163 Identities=29% Similarity=0.480 Sum_probs=143.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCE-EEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ-LLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lV~ 751 (845)
++|...+++|+|+||.++.++.+ ++..+++|.+..... ..++...+|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999875 578899999976532 334577899999999999999999999998887 99999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+|++||++.+.+.... ...++++.+..++.|++.|+.|||++. |+|||||+.||+++.+..|||+|||+|+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999997654 347899999999999999999999876 9999999999999999999999999999998
Q ss_pred CCCceeeeeeccCC
Q 003134 832 EDKTHISTRIAGTM 845 (845)
Q Consensus 832 ~~~~~~~t~~~GT~ 845 (845)
.+.... ..++||+
T Consensus 158 ~~~~~a-~tvvGTp 170 (426)
T KOG0589|consen 158 PEDSLA-STVVGTP 170 (426)
T ss_pred Cchhhh-heecCCC
Confidence 766443 4478886
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=226.59 Aligned_cols=154 Identities=29% Similarity=0.541 Sum_probs=131.8
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-----------------CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-----------------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 737 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l 737 (845)
++|...++||+|+||.||+|.+.+ +..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999998532 3479999987643 2335679999999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChhhhhhcCCc--------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 003134 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT--------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH 803 (845)
Q Consensus 738 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH 803 (845)
++++...+..++||||+++|+|.+++..... .....+++.++.+++.|++.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999999999998854321 11235788999999999999999999987 999
Q ss_pred CCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 804 RDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 804 rDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|||||+|||+++++.+||+|||+++.+..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~ 190 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYA 190 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceeccc
Confidence 99999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=230.33 Aligned_cols=153 Identities=26% Similarity=0.335 Sum_probs=135.4
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999975 588999999976422 33456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 9999999999996542 36899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCCc
Q 003134 832 EDKT 835 (845)
Q Consensus 832 ~~~~ 835 (845)
....
T Consensus 154 ~~~~ 157 (330)
T cd05601 154 ANKM 157 (330)
T ss_pred CCCc
Confidence 5443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=234.91 Aligned_cols=146 Identities=23% Similarity=0.353 Sum_probs=130.6
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.|+..+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++.+++|+||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999875 58899999997542 2234578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 99999999998643 25889999999999999999999986 999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=228.66 Aligned_cols=141 Identities=28% Similarity=0.350 Sum_probs=126.1
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~g 757 (845)
+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999975 58999999997542 223456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 999998543 36899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=230.41 Aligned_cols=149 Identities=23% Similarity=0.393 Sum_probs=133.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+|+.. +++.||+|.++... ....+.+.+|++++++++||||+++++++..++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999986 58899999986542 233467889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999998643 25788999999999999999999987 9999999999999999999999999999775
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 170 ~ 170 (329)
T PTZ00263 170 D 170 (329)
T ss_pred C
Confidence 4
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=234.55 Aligned_cols=147 Identities=23% Similarity=0.378 Sum_probs=131.3
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999875 68999999986542 223457888999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999998543 35789999999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=230.50 Aligned_cols=149 Identities=25% Similarity=0.379 Sum_probs=133.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|++++.+++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999986 48899999997642 223457889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 999999999999543 25889999999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 153 ~ 153 (333)
T cd05600 153 T 153 (333)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=228.55 Aligned_cols=162 Identities=25% Similarity=0.316 Sum_probs=136.8
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..++||+|+||.||+++... ++.+|+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999999764 7889999986532 222345788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 9999999999996432 25889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCceeeeeeccC
Q 003134 832 EDKTHISTRIAGT 844 (845)
Q Consensus 832 ~~~~~~~t~~~GT 844 (845)
...........||
T Consensus 154 ~~~~~~~~~~~gt 166 (332)
T cd05623 154 EDGTVQSSVAVGT 166 (332)
T ss_pred cCCcceecccccC
Confidence 4433333334455
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=230.18 Aligned_cols=150 Identities=26% Similarity=0.373 Sum_probs=132.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC--CcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD--GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
.++|+..+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+++++.++||||+++++++..++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468889999999999999998643 3689999986532 2334578899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 109 v~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999998643 35889999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 003134 830 YEE 832 (845)
Q Consensus 830 ~~~ 832 (845)
...
T Consensus 181 ~~~ 183 (340)
T PTZ00426 181 VDT 183 (340)
T ss_pred cCC
Confidence 753
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-24 Score=213.86 Aligned_cols=164 Identities=29% Similarity=0.453 Sum_probs=140.7
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc----cc----hHHHHHHHHHHhcC-CCCceeeEEEEE
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR----QG----NREFVNEIGMISAQ-QHPNLVKLYGCC 741 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l-~H~nIv~l~~~~ 741 (845)
+..-++|+..+.+|+|..++|.++..+ +|..+|+|++..... .. .+.-.+|+.+|+++ .||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 334567889999999999999998865 588999999865421 11 23456799999987 799999999999
Q ss_pred EeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEE
Q 003134 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821 (845)
Q Consensus 742 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl 821 (845)
+.+..+++|+|.|+.|.|.+++.+. ..+++++..+|++|+.+|++|||... ||||||||+|||+|++.++||
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~i 164 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKI 164 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEE
Confidence 9999999999999999999999554 47999999999999999999999987 999999999999999999999
Q ss_pred EeeccceecCCCCceeeeeeccCC
Q 003134 822 SDFGLAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 822 ~DFGla~~~~~~~~~~~t~~~GT~ 845 (845)
+|||+|+.++..+. -...+|||
T Consensus 165 sDFGFa~~l~~Gek--LrelCGTP 186 (411)
T KOG0599|consen 165 SDFGFACQLEPGEK--LRELCGTP 186 (411)
T ss_pred eccceeeccCCchh--HHHhcCCC
Confidence 99999999976553 24577775
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=222.60 Aligned_cols=149 Identities=30% Similarity=0.382 Sum_probs=130.9
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677889999999999999974 68999999986542 22334678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 82 MNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred cCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999998885432 235899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=250.01 Aligned_cols=170 Identities=28% Similarity=0.326 Sum_probs=154.2
Q ss_pred HHHHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc---cccchHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 003134 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (845)
Q Consensus 668 ~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 743 (845)
+.+++...++|++.++||+|+||.|..++++ ++++||+|++.+. ......-|..|-.+|..-+.+-|+.++..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4566667789999999999999999999986 5899999999873 34445678999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEe
Q 003134 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (845)
Q Consensus 744 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~D 823 (845)
+.++|+|||||+||+|-.++...+ ++++..+..++..|.-||.-||+.| +|||||||+|||||..|++||+|
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeecc
Confidence 999999999999999999995442 6899999999999999999999987 99999999999999999999999
Q ss_pred eccceecCCCCceeeeeeccCC
Q 003134 824 FGLAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 824 FGla~~~~~~~~~~~t~~~GT~ 845 (845)
||-+-.+..++...+...+|||
T Consensus 219 FGsClkm~~dG~V~s~~aVGTP 240 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTP 240 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCC
Confidence 9999999988888888899997
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=228.18 Aligned_cols=160 Identities=25% Similarity=0.349 Sum_probs=134.4
Q ss_pred CCCCCCcccccCcEEEEEEEEC----CCcEEEEEEcCccc----ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 747 (845)
+|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+..|++++.++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999999852 57899999986532 22245678899999999 599999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 9999999999999998543 25889999999999999999999987 999999999999999999999999999
Q ss_pred eecCCCCceeeeeeccC
Q 003134 828 KLYEEDKTHISTRIAGT 844 (845)
Q Consensus 828 ~~~~~~~~~~~t~~~GT 844 (845)
+.+............||
T Consensus 153 ~~~~~~~~~~~~~~~gt 169 (332)
T cd05614 153 KEFLSEEKERTYSFCGT 169 (332)
T ss_pred ccccccCCCccccccCC
Confidence 87644333223334454
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-23 Score=226.88 Aligned_cols=142 Identities=29% Similarity=0.357 Sum_probs=126.6
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~g 757 (845)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999975 58999999997542 233467888999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+|..++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 999888543 26899999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=224.66 Aligned_cols=140 Identities=24% Similarity=0.340 Sum_probs=125.2
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 684 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
||+|+||.||+|+.. +++.||+|+++... ......+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 48899999986532 23346778899999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 81 FHHLQRE-----GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM 144 (312)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence 9998643 25899999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=226.77 Aligned_cols=160 Identities=28% Similarity=0.426 Sum_probs=140.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccccc---chHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l 749 (845)
...|+..+.||+|.||.||+|+... |+.+|+|.+.+.... ..+.+.+|+++|+++. |||||.+++.|++.+.+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4568888999999999999999765 999999999776443 3468999999999998 9999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC----CcEEEEeec
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKISDFG 825 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~----~~~kl~DFG 825 (845)
|||++.||.|.+.+... .+++..+..++.|++.|++|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 114 vmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 99999999999999654 2899999999999999999999987 9999999999999533 579999999
Q ss_pred cceecCCCCceeeeeeccCC
Q 003134 826 LAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 826 la~~~~~~~~~~~t~~~GT~ 845 (845)
+|..... ......++||+
T Consensus 185 la~~~~~--~~~~~~~~Gtp 202 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTP 202 (382)
T ss_pred CceEccC--CceEeeecCCc
Confidence 9999976 33445578885
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-23 Score=225.51 Aligned_cols=149 Identities=26% Similarity=0.374 Sum_probs=132.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999976 58999999986532 223456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 999999999998543 25889999999999999999999987 9999999999999999999999999998765
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 153 ~ 153 (291)
T cd05612 153 D 153 (291)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=226.49 Aligned_cols=141 Identities=30% Similarity=0.361 Sum_probs=125.7
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~g 757 (845)
+.||+|+||.||+++.. +++.||+|+++... ......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999975 58999999997642 223456778999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
+|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 999888543 26899999999999999999999987 999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=231.44 Aligned_cols=147 Identities=22% Similarity=0.359 Sum_probs=131.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999975 58999999986542 223456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+
T Consensus 81 E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 999999999999543 25788899999999999999999987 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-25 Score=220.16 Aligned_cols=158 Identities=32% Similarity=0.524 Sum_probs=140.1
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
|++++++|+|+||.||+|.++ .|+++|+|.+... .+.+++.+|+.+|++.+.+++|++||.|.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 456889999999999999976 5999999998764 4578899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCCce
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~~~ 836 (845)
|+..+.++.+ ++++++.++..|.+..++||+|||... -||||||+.|||++.+|.+|++|||.|..+.+.-..
T Consensus 113 GSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 113 GSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 9999999654 358999999999999999999999874 799999999999999999999999999988754433
Q ss_pred eeeeeccCC
Q 003134 837 ISTRIAGTM 845 (845)
Q Consensus 837 ~~t~~~GT~ 845 (845)
. .++.|||
T Consensus 186 R-NTVIGTP 193 (502)
T KOG0574|consen 186 R-NTVIGTP 193 (502)
T ss_pred h-CccccCc
Confidence 3 3467875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=223.91 Aligned_cols=142 Identities=28% Similarity=0.347 Sum_probs=125.3
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~g 757 (845)
+.||+|+||.||+++.. +++.||+|.++... .....++..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999975 58999999997642 223456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+|..++... ..+++.++..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 999888543 268999999999999999999997 55 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-23 Score=232.13 Aligned_cols=146 Identities=23% Similarity=0.356 Sum_probs=130.3
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.|+..++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++.+.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999975 58899999987542 2234578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 99999999998543 25788899999999999999999987 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=228.55 Aligned_cols=148 Identities=23% Similarity=0.362 Sum_probs=132.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+++.. +++.||+|+++... ......+.+|++++.+++|+||+++++.+...+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999975 58999999997532 233457788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 999999999998543 25889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=233.53 Aligned_cols=161 Identities=29% Similarity=0.511 Sum_probs=136.7
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeC------CEEEE
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQLLL 749 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~l 749 (845)
+...+.||+|+||.||+++.+ .|+.||||.++.... ...+...+|+++|++++|+|||++++.-... ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445678999999999999965 699999999987643 3456788999999999999999999886543 35689
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec--CCCc--EEEEeec
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLN--AKISDFG 825 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld--~~~~--~kl~DFG 825 (845)
|||||.+|||...+.... ....|++.+.+.+..++..||.|||+++ |+||||||.||++- .+|+ -||+|||
T Consensus 95 vmEyC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEeecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 999999999999997653 3457999999999999999999999987 99999999999993 3343 7999999
Q ss_pred cceecCCCCceeeeeeccCC
Q 003134 826 LAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 826 la~~~~~~~~~~~t~~~GT~ 845 (845)
.||..+++. ..+.++||.
T Consensus 170 ~Arel~d~s--~~~S~vGT~ 187 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTE 187 (732)
T ss_pred ccccCCCCC--eeeeecCch
Confidence 999997665 567788984
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-23 Score=229.16 Aligned_cols=150 Identities=29% Similarity=0.433 Sum_probs=134.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|...+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999976 58999999997542 233567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999999654 36899999999999999999999986 9999999999999999999999999998775
Q ss_pred CC
Q 003134 832 ED 833 (845)
Q Consensus 832 ~~ 833 (845)
..
T Consensus 153 ~~ 154 (350)
T cd05573 153 KA 154 (350)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-23 Score=220.31 Aligned_cols=148 Identities=26% Similarity=0.467 Sum_probs=130.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|...++||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999975 58899999987543 23345778999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++ +|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 985 8988885432 25788999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=217.13 Aligned_cols=147 Identities=27% Similarity=0.344 Sum_probs=132.6
Q ss_pred CCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 678 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
|+..+.||+|.-|+||.++.++ +..+|+|++.+.. .....+.+.|.+||+.++||.++.||+.++.++..|+||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 4456899999999999999875 6899999998763 33456778899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+||+|..+.+... ...+++..++-++.+|+-||+|||-.| ||.|||||+||||-++|++-|+||.++...
T Consensus 159 CpGGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred CCCccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999987653 347999999999999999999999987 999999999999999999999999998876
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.9e-23 Score=229.04 Aligned_cols=155 Identities=28% Similarity=0.449 Sum_probs=132.6
Q ss_pred hcCCCCCCcccccCcEEEEEEEE------CCCcEEEEEEcCccc-ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 746 (845)
.++|+..+.||+|+||.||+|++ .++..||||+++... ....+.+.+|++++..+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45688899999999999999974 235689999997543 23346788999999999 89999999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcc---------------------------------------------------------
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTE--------------------------------------------------------- 769 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~--------------------------------------------------------- 769 (845)
.++||||+++|+|.++++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999998653210
Q ss_pred -------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 770 -------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 770 -------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
....+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 0125789999999999999999999986 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-23 Score=220.50 Aligned_cols=149 Identities=26% Similarity=0.422 Sum_probs=130.4
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999986 58899999987542 2334678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|++++.+..+... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9999877655422 135889999999999999999999986 99999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=228.37 Aligned_cols=147 Identities=30% Similarity=0.436 Sum_probs=132.4
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
-|+..+.||.|+.|.|..|++. +|+.+|||++.+... .....+.+|+.+|+-+.||||+++|+++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4667889999999999999964 699999999977632 224567899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|+++|-|++++..+ .++++.++.+++.||+.|+.|+|..+ |+|||+||+|+|+|..+++||+|||+|..-.
T Consensus 93 yv~gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred ecCCchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 99999999999654 36899999999999999999999987 9999999999999999999999999998653
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=222.21 Aligned_cols=144 Identities=26% Similarity=0.369 Sum_probs=127.0
Q ss_pred CcccccCcEEEEEEEE----CCCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 682 NKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
+.||+|+||.||+++. .+++.||+|+++.... .....+..|++++++++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3578999999976432 234567789999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 99999998543 35899999999999999999999987 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=238.26 Aligned_cols=150 Identities=27% Similarity=0.374 Sum_probs=131.2
Q ss_pred CCCCCCcccccCcEEEEEEEECCC-cEEEEEEcCcccccchHHHHHHHHHHhcCC-CCceeeEEE-EEEeC------CEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILSDG-TVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYG-CCVEG------NQL 747 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~-~~~~~------~~~ 747 (845)
++++.+.|.+|+|+.||.|....+ ..||+|++-.......+...+|+++|++++ |+|||.+++ ..... -++
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 445678999999999999998765 999999997777778889999999999996 999999999 33321 268
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
+|.||||+||.|-+++..+.. ..|++.++++|+.|+++|+++||.. ++||||||||-|||||+.+++.||||||-|
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 899999999999999965432 3599999999999999999999998 578999999999999999999999999998
Q ss_pred eec
Q 003134 828 KLY 830 (845)
Q Consensus 828 ~~~ 830 (845)
.-.
T Consensus 194 tt~ 196 (738)
T KOG1989|consen 194 TTK 196 (738)
T ss_pred ccc
Confidence 643
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=220.05 Aligned_cols=149 Identities=28% Similarity=0.483 Sum_probs=130.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999986 588999999875432 234567889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|++ ++|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 57877775432 35789999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=222.53 Aligned_cols=142 Identities=28% Similarity=0.400 Sum_probs=125.1
Q ss_pred CcccccCcEEEEEEEEC----CCcEEEEEEcCccc----ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 682 NKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+.||+|+||.||+++.. +++.||+|.++... ......+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999852 47899999987532 22335678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 82 LSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 9999999998543 25788899999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=234.36 Aligned_cols=152 Identities=21% Similarity=0.280 Sum_probs=132.6
Q ss_pred CCCCCCcccccCcEEEEEEEEC-C-CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-D-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.|...+.||+|++|.||+|... + ++.||+|.+..........+..|+++++.++||||+++++++...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3788899999999999999864 3 6788888876554444567788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++|+|.++++... ....++++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 148 ~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 148 SGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 9999999886432 12346889999999999999999999986 99999999999999999999999999998754
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=222.53 Aligned_cols=151 Identities=25% Similarity=0.444 Sum_probs=133.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..+.||+|+||.||+++.. ++..+|+|.+.... ....+++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367899999999999999999976 58899999987642 2334678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999998543 25889999999999999999999864 499999999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-23 Score=227.26 Aligned_cols=144 Identities=31% Similarity=0.526 Sum_probs=125.8
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
+|+..++||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3445788999999999999975 589999999865422 23467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++|+|.+.. ..++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 155 ~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 155 DGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 999986432 3466788899999999999999987 99999999999999999999999999987753
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=214.20 Aligned_cols=148 Identities=28% Similarity=0.552 Sum_probs=132.7
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
++|+..+.||+|+||.||++.+.++..+|+|.+... ....+++.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788999999999999999988888999988643 3345688999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+|+|.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 999999986532 25889999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=221.13 Aligned_cols=146 Identities=29% Similarity=0.390 Sum_probs=127.7
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCC-ceeeEEEEEEeCCEEEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHP-NLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~ 751 (845)
+|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999976 47899999997542 23346778899999999765 5888999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 999999999988543 25789999999999999999999986 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=222.81 Aligned_cols=145 Identities=32% Similarity=0.478 Sum_probs=125.4
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHH---hcCCCCceeeEEEEEEeCCEEEEE
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMI---SAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
|++.+.||+|+||.||+|... +++.||||+++... ....+.+..|++++ ++++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999975 58999999997542 22234566666554 567899999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++|+|...++.. .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 9999999999888532 5899999999999999999999987 999999999999999999999999998864
Q ss_pred C
Q 003134 831 E 831 (845)
Q Consensus 831 ~ 831 (845)
.
T Consensus 152 ~ 152 (324)
T cd05589 152 M 152 (324)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=227.56 Aligned_cols=141 Identities=23% Similarity=0.304 Sum_probs=125.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.+|+..+.||+|+||.||+|... +++.||+|.... ..+.+|++++++++||||+++++++...+..++||||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 56899999999999999999975 588999997532 35678999999999999999999999999999999998
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
. ++|.+++... ..+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 166 ~-~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 166 K-TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred C-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 6 6888887543 25789999999999999999999986 9999999999999999999999999998654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-23 Score=194.85 Aligned_cols=148 Identities=26% Similarity=0.497 Sum_probs=129.4
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..++||+|.||+||+|+.+ +++.||+|+++... ..-.....+|+.+++.++|.|||++++....+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 5667889999999999999965 58999999987543 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|.. +|..+..... ..++.+.+..++.|+++||.|+|+++ +.|||+||.|.||+.+|+.|++|||+||.+.-
T Consensus 83 cdq-dlkkyfdsln----g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred hhH-HHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 975 6777765443 36889999999999999999999997 99999999999999999999999999997753
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=215.83 Aligned_cols=149 Identities=28% Similarity=0.435 Sum_probs=131.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC----CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
.++|+..+.||+|+||.||+|.+. .+..||+|.++.... ...+.|.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 346788899999999999999863 367899999976532 334578999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+++ ++||||||+||+++.++.+|++|||.+..
T Consensus 84 v~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccc
Confidence 999999999999986532 36899999999999999999999986 99999999999999999999999998765
Q ss_pred c
Q 003134 830 Y 830 (845)
Q Consensus 830 ~ 830 (845)
.
T Consensus 157 ~ 157 (266)
T cd05064 157 D 157 (266)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=219.96 Aligned_cols=142 Identities=30% Similarity=0.433 Sum_probs=122.6
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhc-CCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||.||+|+.. +++.||+|.++... ....+.+..|.+++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 47899999997542 2233455667777764 4899999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|+|..++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 9999988543 25889999999999999999999986 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=220.29 Aligned_cols=142 Identities=28% Similarity=0.438 Sum_probs=124.6
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
++||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++..+ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999976 47899999997642 23345677888888865 899999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|+|...+... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 9999888543 25889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.1e-23 Score=213.19 Aligned_cols=150 Identities=27% Similarity=0.478 Sum_probs=130.9
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCc--ccccchHHHHHHHHHHhcCCCCceeeEEEEEEe-----CC
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-----GN 745 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----~~ 745 (845)
....|...+.||+|+||.|+.+... +|+.||+|++.. ......++..+|+++|+.++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3445666789999999999999975 589999999974 344556788999999999999999999999875 25
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
.+|+|+|+|+ -+|...++.. ..++...+..++.|+++||+|+|+.+ |+||||||+|+|++.+...||+|||
T Consensus 100 DvYiV~elMe-tDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence 7899999995 5899998654 24899999999999999999999997 9999999999999999999999999
Q ss_pred cceecCC
Q 003134 826 LAKLYEE 832 (845)
Q Consensus 826 la~~~~~ 832 (845)
+||....
T Consensus 171 LAR~~~~ 177 (359)
T KOG0660|consen 171 LARYLDK 177 (359)
T ss_pred ceeeccc
Confidence 9999854
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=226.65 Aligned_cols=157 Identities=29% Similarity=0.462 Sum_probs=132.8
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcccc-cchHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 744 (845)
...++|+..+.||+|+||.||+|+.. ++..||+|+++.... ...+.+.+|+++++++ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 33457888999999999999999842 245799999976432 2345688999999999 899999999999999
Q ss_pred CEEEEEEeccCCCChhhhhhcCCc--------------------------------------------------------
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDT-------------------------------------------------------- 768 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 768 (845)
+..++||||+++|+|.++++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999998854211
Q ss_pred ---------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 769 ---------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 769 ---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
.....+++.++++++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 01125788999999999999999999986 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=220.51 Aligned_cols=141 Identities=28% Similarity=0.386 Sum_probs=124.1
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46899999999999975 58899999997642 22345677888888776 899999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+|..++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 9999888543 36899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=221.11 Aligned_cols=141 Identities=26% Similarity=0.373 Sum_probs=124.9
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999975 58899999997642 22345678899999888 799999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 9999888543 36899999999999999999999987 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=223.02 Aligned_cols=162 Identities=25% Similarity=0.453 Sum_probs=140.1
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
....|.+...||+|.|+.|..|++. ++..||+|.+++..- ...+.+.+|+++|..++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3567888999999999999999975 589999999987643 2335588999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+.+|.+++++...+ .+.+..+..++.|+.+|++|+|++. |||||||++||||+.++++||+|||++..+
T Consensus 134 ~eya~~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEeccCchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 99999999999997653 3455788999999999999999997 999999999999999999999999999999
Q ss_pred CCCCceeeeeeccCC
Q 003134 831 EEDKTHISTRIAGTM 845 (845)
Q Consensus 831 ~~~~~~~~t~~~GT~ 845 (845)
... ......+|++
T Consensus 206 ~~~--~~lqt~cgsp 218 (596)
T KOG0586|consen 206 DYG--LMLQTFCGSP 218 (596)
T ss_pred ccc--ccccccCCCC
Confidence 643 2334456653
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=219.83 Aligned_cols=147 Identities=28% Similarity=0.386 Sum_probs=127.6
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
+|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|.+++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5778899999999999999976 47899999987542 22234567788888777 5899999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+.+... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 999999999888543 25889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=214.80 Aligned_cols=145 Identities=32% Similarity=0.412 Sum_probs=126.3
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 684 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
||+|+||+||++... +++.||+|.+..... ...+.+..|++++++++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999975 588999999865422 2235678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
..++.... .....+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 98875432 12346899999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=212.80 Aligned_cols=151 Identities=30% Similarity=0.564 Sum_probs=134.7
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.++|+..++||+|++|.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35688899999999999999998888899999986542 33578899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++|+|.++++... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 84 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 84 AKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999986532 236789999999999999999999986 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=219.52 Aligned_cols=142 Identities=30% Similarity=0.470 Sum_probs=124.7
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++... +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999975 58899999987542 23345677888888876 799999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 9999988543 25889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=220.02 Aligned_cols=150 Identities=25% Similarity=0.448 Sum_probs=132.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..++||+|+||.||++... ++..+|+|.+.... ....+++.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999986 58889999887542 2334678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999998543 25788999999999999999999853 49999999999999999999999999998664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=215.31 Aligned_cols=150 Identities=30% Similarity=0.372 Sum_probs=131.5
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
+|+..+.||+|+||.||++... +++.||+|++..... .....+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999975 588999999865422 223567789999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 999999998885432 236899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=219.28 Aligned_cols=141 Identities=30% Similarity=0.439 Sum_probs=121.9
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHH-HHhcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||.||+|+.. +|+.||+|++.... ....+++..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999975 58999999986542 222345555654 46779999999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+|..++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9999888543 36899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=219.28 Aligned_cols=141 Identities=28% Similarity=0.429 Sum_probs=121.3
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHH-HHhcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||.||+|+.. +++.||+|++.... .....++..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999985 58899999986542 122344555554 67889999999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+|..++... ..+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9999888542 35788899999999999999999986 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=211.13 Aligned_cols=149 Identities=28% Similarity=0.540 Sum_probs=132.8
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
++|+..+.||+|++|.||+|.+.++..+|+|.++.. .....++.+|++++.+++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 357788999999999999999877778999998754 3345679999999999999999999999998889999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+|+|.+++.... ..+++.++++++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.++....
T Consensus 83 ~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 83 NGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999986532 25899999999999999999999986 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=218.70 Aligned_cols=141 Identities=30% Similarity=0.454 Sum_probs=121.7
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHH-HHhcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||+||+|+.. +++.||+|++.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999985 58999999986542 122344555554 56789999999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 9999988543 36889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=213.24 Aligned_cols=150 Identities=33% Similarity=0.533 Sum_probs=132.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-----CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLL 748 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 748 (845)
++|+..+.||+|+||.||++... ++..||+|.++.......+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46788899999999999999842 4789999999776555567899999999999999999999987643 4689
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 84 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 9999999999999986432 25899999999999999999999986 9999999999999999999999999999
Q ss_pred ecCC
Q 003134 829 LYEE 832 (845)
Q Consensus 829 ~~~~ 832 (845)
....
T Consensus 157 ~~~~ 160 (284)
T cd05081 157 VLPQ 160 (284)
T ss_pred cccC
Confidence 7654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-23 Score=209.31 Aligned_cols=154 Identities=27% Similarity=0.470 Sum_probs=132.6
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC-----CcEEEEEEcCccccc--chHHHHHHHHHHhcCCCCceeeEEEEEEe-CCE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~ 746 (845)
-..|+....||+|.||.||+|.-.+ ...+|+|+++.++.. -.....+|+..++.++||||+.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568889999999999999996432 347899999876432 24567899999999999999999999887 778
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC----CcEEEE
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKIS 822 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~----~~~kl~ 822 (845)
+++++||.+. +|...|+-.+......++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 7888887555444568999999999999999999999998 9999999999999877 899999
Q ss_pred eeccceecCC
Q 003134 823 DFGLAKLYEE 832 (845)
Q Consensus 823 DFGla~~~~~ 832 (845)
|||+||.+..
T Consensus 179 DlGlaR~~~~ 188 (438)
T KOG0666|consen 179 DLGLARLFNN 188 (438)
T ss_pred cccHHHHhhc
Confidence 9999999864
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=224.26 Aligned_cols=155 Identities=26% Similarity=0.414 Sum_probs=132.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC------CcEEEEEEcCcccc-cchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 746 (845)
.++|.+.+.||+|+||.||+|++.. +..||||+++.... ...+.+.+|+++++++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 5678889999999999999998631 34799999975433 33467899999999996 9999999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcc---------------------------------------------------------
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTE--------------------------------------------------------- 769 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~--------------------------------------------------------- 769 (845)
.|+||||+++|+|.++++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999988653210
Q ss_pred ----------------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC
Q 003134 770 ----------------------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 815 (845)
Q Consensus 770 ----------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~ 815 (845)
....+++.++.+++.|+++||+|||+.+ |+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0124788899999999999999999986 999999999999999
Q ss_pred CCcEEEEeeccceecCC
Q 003134 816 DLNAKISDFGLAKLYEE 832 (845)
Q Consensus 816 ~~~~kl~DFGla~~~~~ 832 (845)
++.+||+|||+++....
T Consensus 273 ~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 273 GKIVKICDFGLARDIMH 289 (400)
T ss_pred CCEEEEEeCCcceeccc
Confidence 99999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=211.90 Aligned_cols=146 Identities=27% Similarity=0.431 Sum_probs=124.8
Q ss_pred CcccccCcEEEEEEEECC---CcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCC
Q 003134 682 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~g 757 (845)
+.||+|+||.||+|...+ ...+|+|.+..... .....+.+|+++++.++|+||+++++++...+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997543 45788888765432 33457889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
+|.+++...........++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 9999997654332334578889999999999999999986 999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-22 Score=217.34 Aligned_cols=141 Identities=30% Similarity=0.441 Sum_probs=123.2
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhc-CCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||.||+|+.. +++.||+|.++... ....+.+..|.+++.. .+||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 58899999997642 2234556778888775 4899999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+|..++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 9999988543 25789999999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=218.85 Aligned_cols=147 Identities=29% Similarity=0.386 Sum_probs=127.6
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 751 (845)
+|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677889999999999999975 58899999987542 223456778888888885 577888999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 999999999998543 25899999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.8e-22 Score=216.21 Aligned_cols=141 Identities=33% Similarity=0.472 Sum_probs=123.4
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhc-CCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999976 47899999997642 2334556778888876 4999999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999998543 25789999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-23 Score=224.98 Aligned_cols=155 Identities=30% Similarity=0.506 Sum_probs=134.3
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccc---hHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
|...+.||.|+||.||.|++. +.++||||++....++. ..++.+|+..|.+++|||++.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 455778999999999999964 68899999997654433 45788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
|-| |-.+++.-. .+++.+-++..|+.+.+.||.|||+.+ .||||||+.|||+.+.|.||++|||.|.++.+-
T Consensus 108 ClG-SAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 108 CLG-SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred Hhc-cHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 964 788887433 347889999999999999999999997 899999999999999999999999999988653
Q ss_pred CceeeeeeccCC
Q 003134 834 KTHISTRIAGTM 845 (845)
Q Consensus 834 ~~~~~t~~~GT~ 845 (845)
. .++|||
T Consensus 180 n-----sFvGTP 186 (948)
T KOG0577|consen 180 N-----SFVGTP 186 (948)
T ss_pred h-----cccCCc
Confidence 3 477775
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=209.52 Aligned_cols=147 Identities=30% Similarity=0.551 Sum_probs=131.7
Q ss_pred CCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+|+..+.||+|++|.||++.+.++..+|+|.+... .....++.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 47788999999999999999877778999998653 23346788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 84 ~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 84 GCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecc
Confidence 99999986532 25899999999999999999999987 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-22 Score=236.27 Aligned_cols=152 Identities=24% Similarity=0.392 Sum_probs=132.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..++||+|+||.||+|+.. +++.||+|++..... ...+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47889999999999999999975 489999999975422 22467899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCC------cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 752 EYMKNNCLSRAIFGKD------TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
||++||+|.+++.... ......+++..+++++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 111235677889999999999999999986 9999999999999999999999999
Q ss_pred cceec
Q 003134 826 LAKLY 830 (845)
Q Consensus 826 la~~~ 830 (845)
+|+..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99977
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.6e-22 Score=217.39 Aligned_cols=141 Identities=28% Similarity=0.377 Sum_probs=124.6
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 478999999976422 2345678899998888 699999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+|..++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 9999888533 36899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-22 Score=209.97 Aligned_cols=150 Identities=30% Similarity=0.575 Sum_probs=135.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.++|+..+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998778889999987543 34577999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++++|.+++.... ...+++.++.+++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 84 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 84 KYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred cCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999996542 236899999999999999999999987 9999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-22 Score=217.71 Aligned_cols=142 Identities=29% Similarity=0.409 Sum_probs=120.8
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHH-HHHhcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEI-GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|. .+++.++|+||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 47889999986542 12223444444 456788999999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 81 GELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 9999998543 25778889999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-22 Score=213.71 Aligned_cols=156 Identities=28% Similarity=0.451 Sum_probs=131.6
Q ss_pred CCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCC
Q 003134 681 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~g 757 (845)
.+++|+|.||+||-|+++ +|+.||||++.+.. ...+.++++|+.||++++||.||.+-..|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 578999999999999975 69999999998763 344578899999999999999999999999999999999999765
Q ss_pred ChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC---CcEEEEeeccceecCCCC
Q 003134 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~---~~~kl~DFGla~~~~~~~ 834 (845)
-|+-.+.... ..+++.....++.||+.||.|||.++ |+|+||||+|||+... -++||||||+||++.+..
T Consensus 649 MLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 649 MLEMILSSEK----GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred HHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 5555553332 36888888999999999999999997 9999999999999643 369999999999997543
Q ss_pred ceeeeeeccCC
Q 003134 835 THISTRIAGTM 845 (845)
Q Consensus 835 ~~~~t~~~GT~ 845 (845)
....++|||
T Consensus 722 --FRrsVVGTP 730 (888)
T KOG4236|consen 722 --FRRSVVGTP 730 (888)
T ss_pred --hhhhhcCCc
Confidence 334578886
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-22 Score=217.86 Aligned_cols=150 Identities=32% Similarity=0.622 Sum_probs=129.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCc----EEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
.+|+..+.||+|+||.||+|++. +++ .||+|.++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999864 333 48999987543 33456889999999999999999999998765 5779
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
|+||+++|+|.+++.... ..+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999996542 25789999999999999999999986 99999999999999999999999999998
Q ss_pred cCCC
Q 003134 830 YEED 833 (845)
Q Consensus 830 ~~~~ 833 (845)
+...
T Consensus 159 ~~~~ 162 (316)
T cd05108 159 LGAD 162 (316)
T ss_pred ccCC
Confidence 7543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-23 Score=219.90 Aligned_cols=161 Identities=28% Similarity=0.479 Sum_probs=141.9
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
..|...+.||+|+||.||||.+. .++.||+|++..+.. ...++.++|+.++++++++||.++|+.|..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35667789999999999999975 589999999987643 3457888999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
|.||++.+.+.... .+++.++.-|+++++.||.|||.+. .+|||||+.|||+..+|.||++|||+|..+...
T Consensus 93 ~~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred hcCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence 99999999995542 4578888889999999999999997 999999999999999999999999999999765
Q ss_pred CceeeeeeccCC
Q 003134 834 KTHISTRIAGTM 845 (845)
Q Consensus 834 ~~~~~t~~~GT~ 845 (845)
.... .+++|||
T Consensus 165 ~~rr-~tfvGTP 175 (467)
T KOG0201|consen 165 VKRR-KTFVGTP 175 (467)
T ss_pred hhcc-ccccccc
Confidence 5544 5688986
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-22 Score=212.26 Aligned_cols=153 Identities=29% Similarity=0.552 Sum_probs=138.1
Q ss_pred HhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+..+|+..++||+|+||.||+|...++..+|+|.+.........++..|+++++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568889999999999999999988999999999876555567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++|+|.+++..... ..+++.++.+++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 84 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 84 MEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred cccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 999999999975432 36899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-22 Score=219.45 Aligned_cols=146 Identities=25% Similarity=0.465 Sum_probs=126.2
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----CEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQLL 748 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~ 748 (845)
+|+..+.||+|+||.||+|+.. +++.||+|+++... .....++.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999975 58999999987532 23345788999999999999999999988643 2589
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+||||++ ++|.+++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999996 6898888543 25899999999999999999999987 9999999999999999999999999998
Q ss_pred ecC
Q 003134 829 LYE 831 (845)
Q Consensus 829 ~~~ 831 (845)
...
T Consensus 152 ~~~ 154 (338)
T cd07859 152 VAF 154 (338)
T ss_pred ccc
Confidence 653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9e-24 Score=207.31 Aligned_cols=161 Identities=29% Similarity=0.421 Sum_probs=136.6
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
+++|+..+.||+|+|+.||++... +|+.+|+|++... +..+.+++.+|+++-+.++|||||++.+.+.+.+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456778889999999999999864 6899999988654 3346788999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCcEEEEeeccce
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAK 828 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~---~~~~kl~DFGla~ 828 (845)
|+|+||+|..-|-.. ..+++..+-.+++||++||.|+|.++ |||||+||+|+|+-. ..-+|++|||+|.
T Consensus 90 e~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999998766432 25788899999999999999999997 999999999999943 3459999999999
Q ss_pred ecCCCCceeeeeeccCC
Q 003134 829 LYEEDKTHISTRIAGTM 845 (845)
Q Consensus 829 ~~~~~~~~~~t~~~GT~ 845 (845)
.+. + .......+|||
T Consensus 162 ~l~-~-g~~~~G~~GtP 176 (355)
T KOG0033|consen 162 EVN-D-GEAWHGFAGTP 176 (355)
T ss_pred EeC-C-ccccccccCCC
Confidence 997 2 23334567775
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-22 Score=221.91 Aligned_cols=147 Identities=30% Similarity=0.469 Sum_probs=128.3
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----EEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLL 748 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 748 (845)
+|+..+.||+|+||.||++... +++.||+|++.... ....+++.+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999974 68999999986532 233467889999999999999999999998776 789
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+||||+. ++|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 81 lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecccccee
Confidence 9999997 5788777432 36899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCC
Q 003134 829 LYEE 832 (845)
Q Consensus 829 ~~~~ 832 (845)
....
T Consensus 152 ~~~~ 155 (372)
T cd07853 152 VEEP 155 (372)
T ss_pred eccc
Confidence 7643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=208.62 Aligned_cols=149 Identities=29% Similarity=0.458 Sum_probs=133.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.++|+..+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357889999999999999999974 6889999999765444556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++++|.++++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 88 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 88 CGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 9999999998543 25789999999999999999999986 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=208.88 Aligned_cols=143 Identities=30% Similarity=0.412 Sum_probs=124.9
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 684 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
||+|+||.||+++.. +|+.||+|.+..... ...+.+..|++++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999975 589999999865321 2234566799999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 98885432 235889999999999999999999986 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=211.90 Aligned_cols=150 Identities=28% Similarity=0.529 Sum_probs=124.4
Q ss_pred cCCCCCCcccccCcEEEEEEEEC--CCcEEEEEEcCcccc--cchHHHHHHHHHHhcC---CCCceeeEEEEEEe-----
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQ---QHPNLVKLYGCCVE----- 743 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~----- 743 (845)
++|+..+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+++++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999873 468899999865422 2234566777776665 69999999999862
Q ss_pred CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEe
Q 003134 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (845)
Q Consensus 744 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~D 823 (845)
....++||||+. ++|.+++..... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcc
Confidence 356899999997 589888864322 35899999999999999999999987 99999999999999999999999
Q ss_pred eccceecCC
Q 003134 824 FGLAKLYEE 832 (845)
Q Consensus 824 FGla~~~~~ 832 (845)
||+++....
T Consensus 154 fg~~~~~~~ 162 (290)
T cd07862 154 FGLARIYSF 162 (290)
T ss_pred ccceEeccC
Confidence 999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=209.51 Aligned_cols=149 Identities=31% Similarity=0.541 Sum_probs=132.7
Q ss_pred cCCCCCCcccccCcEEEEEEEECC----CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
++|+..+.||+|+||.||+|.+.. ...||+|.++... .....+|.+|+.++++++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999999742 4579999987543 23346789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++++|.+++.... ..+++.++.+++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 84 TEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999996542 26899999999999999999999986 999999999999999999999999999987
Q ss_pred C
Q 003134 831 E 831 (845)
Q Consensus 831 ~ 831 (845)
.
T Consensus 157 ~ 157 (266)
T cd05033 157 E 157 (266)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.8e-22 Score=209.77 Aligned_cols=151 Identities=30% Similarity=0.556 Sum_probs=132.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC----CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
.+|+..+.||+|+||.||+|+.. .+..+|+|.++... ....+.+..|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999863 23479999987542 22346789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||+++.+
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 84 TEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999996542 35899999999999999999999987 999999999999999999999999999877
Q ss_pred CCC
Q 003134 831 EED 833 (845)
Q Consensus 831 ~~~ 833 (845)
...
T Consensus 157 ~~~ 159 (267)
T cd05066 157 EDD 159 (267)
T ss_pred ccc
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=214.20 Aligned_cols=148 Identities=27% Similarity=0.466 Sum_probs=129.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|...+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888999999999999999975 578899999875432 3345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++ +|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 985 7888775432 25789999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-22 Score=237.19 Aligned_cols=152 Identities=34% Similarity=0.568 Sum_probs=133.7
Q ss_pred cCCCCCCcccccCcEEEEEEEECC--Cc----EEEEEEcCcc-cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD--GT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
.+.+..+.||+|+||.||+|...+ +. .||+|.+++. +.+...+|.+|..+|++++|||||+++|+|.+.+..+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344567789999999999999754 43 4899999776 4556789999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCcc--cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 749 LVYEYMKNNCLSRAIFGKDTE--YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
|++|||++|+|..+|++.+.. ....++....+.++.|||+|++|||+++ +|||||..+|+|++....|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999775322 1346888999999999999999999997 99999999999999999999999999
Q ss_pred ceec
Q 003134 827 AKLY 830 (845)
Q Consensus 827 a~~~ 830 (845)
||.+
T Consensus 849 ArDi 852 (1025)
T KOG1095|consen 849 ARDI 852 (1025)
T ss_pred hHhh
Confidence 9944
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.7e-25 Score=228.29 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=222.5
Q ss_pred EEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeec
Q 003134 94 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (845)
Q Consensus 94 v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 172 (845)
...+.+++|.++ .+.+.+.+|..|.+|++++|+++.. |++++.+ .++.|+.++|+++ .+|..++.+.+|+.|++++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~l-p~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQL-PAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhhhC-CHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 457889999998 5667799999999999999999965 4556666 8999999999999 7888999999999999999
Q ss_pred ccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcc
Q 003134 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (845)
Q Consensus 173 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 252 (845)
|++. .+|+.++.+..|+.|+..+|+++ ..|+.+.++.+|..|++.+|+++...|+.+. |+.|++||...|.++ .+|
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP 199 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLP 199 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCC
Confidence 9999 78889999999999999999999 7888899999999999999999966555555 999999999999998 789
Q ss_pred hhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCccc-ccCCCCcCEEeCCCCCCCCCCchhhhcCCC
Q 003134 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDY-IGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331 (845)
Q Consensus 253 ~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 331 (845)
..++.+.+|+.|+|..|++...+ ++-+...|++|+++.|+|+ .+|.+ ..++++|..|||.+|+|+ ..|+.++-+.+
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrs 276 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRS 276 (565)
T ss_pred hhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhh
Confidence 99999999999999999988766 3334447889999999998 45555 458999999999999998 88999999999
Q ss_pred cCEEEccCCcccCCCChhhhc-CCceEEeecCCCc
Q 003134 332 TNFMYLTGNKLTGPVPKYIFN-SNKNVDISLNNFT 365 (845)
Q Consensus 332 L~~L~L~~N~l~g~ip~~~~~-~l~~L~ls~N~l~ 365 (845)
|++||+++|.++ .+|..+.+ .++.|-+-+|.+-
T Consensus 277 L~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 277 LERLDLSNNDIS-SLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred hhhhcccCCccc-cCCcccccceeeehhhcCCchH
Confidence 999999999998 45655544 6778888888544
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=208.33 Aligned_cols=150 Identities=31% Similarity=0.545 Sum_probs=131.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.++|++.++||+|+||.||+|++.+...||+|+++... ...+++.+|++++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35688899999999999999998777789999997542 34567899999999999999999999874 45689999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++|+|.+++.... ...+++..+..++.|+++||+|+|+.+ |+||||||+||++++++.+||+|||.++.+..
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 83 SKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred CCCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 9999999996532 235789999999999999999999986 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=234.65 Aligned_cols=149 Identities=27% Similarity=0.403 Sum_probs=133.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|.+.++||+|+||.||+|++. +++.||+|+++.... ...+.+..|+.++..++|+||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999986 589999999975432 22367889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++++|.+++... ..+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 Ey~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~ 155 (669)
T cd05610 84 EYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155 (669)
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence 999999999998543 25788999999999999999999986 9999999999999999999999999999765
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 156 ~ 156 (669)
T cd05610 156 N 156 (669)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=210.46 Aligned_cols=153 Identities=29% Similarity=0.521 Sum_probs=131.1
Q ss_pred cCCCCCCcccccCcEEEEEEEE-----CCCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
++|+..+.||+|+||.||+|.. ..+..||+|.+.... .....++.+|++++++++||||+++++++..++..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567789999999999999985 246789999997543 2334678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCc------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC
Q 003134 750 VYEYMKNNCLSRAIFGKDT------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 817 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~ 817 (845)
||||+++|+|.+++..... .....+++.++..++.|++.||+|||+++ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 11235889999999999999999999987 99999999999999999
Q ss_pred cEEEEeeccceecC
Q 003134 818 NAKISDFGLAKLYE 831 (845)
Q Consensus 818 ~~kl~DFGla~~~~ 831 (845)
.+||+|||+++...
T Consensus 162 ~~kl~dfg~~~~~~ 175 (283)
T cd05090 162 HVKISDLGLSREIY 175 (283)
T ss_pred cEEecccccccccc
Confidence 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=214.32 Aligned_cols=141 Identities=32% Similarity=0.472 Sum_probs=124.5
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||.||+|+.. +++.||+|+++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999976 47899999997642 23345677888888877 799999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+|..++... ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 9999888543 26899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=209.66 Aligned_cols=144 Identities=21% Similarity=0.340 Sum_probs=125.8
Q ss_pred CCCcccccCcEEEEEEEECCCcEEEEEEcCcccccc---hHHHHHHHHHHhcCCCCceeeEEEEEEe----CCEEEEEEe
Q 003134 680 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVYE 752 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~E 752 (845)
....||+|++|.||+|.+ +|+.||||.++...... .+.|.+|+++|.+++||||+++++++.+ ....++|||
T Consensus 24 ~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 24 TSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred CCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 346799999999999998 68899999997653333 4678899999999999999999999877 357899999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|+++|+|.+++... ..+++....+++.|++.||+|||+.. +++||||||+|||+++++.+||+|||+++.+.
T Consensus 103 y~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 103 YCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred eCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 99999999999653 25889999999999999999999852 27899999999999999999999999998654
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=206.71 Aligned_cols=149 Identities=30% Similarity=0.558 Sum_probs=131.6
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
++|++.+.||+|++|.||+|...++..+|+|.+..... ..+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788999999999999999988888899999876432 4567999999999999999999999875 456899999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++|.++++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 84 KGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred CCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999965322 35899999999999999999999987 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=208.38 Aligned_cols=150 Identities=27% Similarity=0.513 Sum_probs=133.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.+|+..+.||+|++|.||+|... .++.||+|.+... ....+++.+|++++++++|+||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777889999999999999975 4889999998754 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 85 ~~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 85 TYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999986542 235899999999999999999999986 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=208.15 Aligned_cols=147 Identities=30% Similarity=0.431 Sum_probs=125.9
Q ss_pred CcccccCcEEEEEEEECC---CcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCC
Q 003134 682 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~g 757 (845)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 46799999876532 33457889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+|.++++..........++..+.+++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999997543222335678888999999999999999986 9999999999999999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=210.44 Aligned_cols=154 Identities=34% Similarity=0.586 Sum_probs=134.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357888999999999999999852 34678999997665555678999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCc--------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEE
Q 003134 749 LVYEYMKNNCLSRAIFGKDT--------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 820 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~k 820 (845)
+||||+++++|.+++..... .....+++.++..++.|++.||+|||+++ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 99999999999999864321 11235899999999999999999999986 99999999999999999999
Q ss_pred EEeeccceecC
Q 003134 821 ISDFGLAKLYE 831 (845)
Q Consensus 821 l~DFGla~~~~ 831 (845)
|+|||+++...
T Consensus 161 l~dfg~~~~~~ 171 (288)
T cd05093 161 IGDFGMSRDVY 171 (288)
T ss_pred eccCCcccccc
Confidence 99999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-22 Score=219.37 Aligned_cols=148 Identities=29% Similarity=0.486 Sum_probs=129.2
Q ss_pred CCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 680 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
..+-+|.|+.|.||+|+++ ++.||||+++... ..+|+-|++++|+||+.+.|+|...-.+|||||||+.|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 4678999999999999995 7789999986432 3578889999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCCceeee
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~~~~~t 839 (845)
+..|+..+ .+.....+.+..+||.||.|||.+. |||||||+-||||..+..|||+|||.++...+..+ ..
T Consensus 200 ~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST--kM 269 (904)
T KOG4721|consen 200 YEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKST--KM 269 (904)
T ss_pred HHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhh--hh
Confidence 99997653 6778888999999999999999985 99999999999999999999999999998865432 23
Q ss_pred eeccCC
Q 003134 840 RIAGTM 845 (845)
Q Consensus 840 ~~~GT~ 845 (845)
.++||.
T Consensus 270 SFaGTV 275 (904)
T KOG4721|consen 270 SFAGTV 275 (904)
T ss_pred hhhhhH
Confidence 467773
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=214.93 Aligned_cols=139 Identities=28% Similarity=0.359 Sum_probs=119.9
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcC---CCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQ---QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 684 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
||+|+||+||+|+.. +++.||+|++..... .....+..|..++.+. +||||+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999975 589999999865422 1223455666776655 799999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+|.+++... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 9999888543 35899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=207.20 Aligned_cols=151 Identities=28% Similarity=0.513 Sum_probs=125.9
Q ss_pred CCCCcccccCcEEEEEEEECC-Cc--EEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeC------CEE
Q 003134 679 DPANKVGEGGFGSVYKGILSD-GT--VIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQL 747 (845)
Q Consensus 679 ~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~ 747 (845)
.+.+.||+|+||.||+|++.+ +. .+|+|.++.. .....+.+..|++++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 457889999999999999754 32 6899988754 233456788999999999999999999987532 246
Q ss_pred EEEEeccCCCChhhhhhcCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
++||||+++|+|.+++..... .....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999988743221 22345899999999999999999999986 99999999999999999999999999
Q ss_pred ceecCC
Q 003134 827 AKLYEE 832 (845)
Q Consensus 827 a~~~~~ 832 (845)
++.+..
T Consensus 159 ~~~~~~ 164 (272)
T cd05075 159 SKKIYN 164 (272)
T ss_pred ccccCc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=206.12 Aligned_cols=149 Identities=32% Similarity=0.587 Sum_probs=132.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.++|+..++||+|+||.||+|...+++.||+|.+.... ...+++.+|++++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 45788899999999999999998889999999987543 34568899999999999999999999864 56789999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++...
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 83 ENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999986532 236899999999999999999999886 9999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=209.69 Aligned_cols=150 Identities=29% Similarity=0.550 Sum_probs=135.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.++|++.+.||+|++|.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888999999999999999975 5889999999766555567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 99999999985432 36899999999999999999999987 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.7e-22 Score=227.81 Aligned_cols=157 Identities=22% Similarity=0.310 Sum_probs=133.3
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC---
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--- 745 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--- 745 (845)
....++|.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344578999999999999999999864 68999999986542 333467889999999999999999988775432
Q ss_pred -----EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEE
Q 003134 746 -----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 820 (845)
Q Consensus 746 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~k 820 (845)
.+++||||+++|+|.++++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 36899999999999999865322 2346899999999999999999999986 99999999999999999999
Q ss_pred EEeeccceecCC
Q 003134 821 ISDFGLAKLYEE 832 (845)
Q Consensus 821 l~DFGla~~~~~ 832 (845)
|+|||+++.+..
T Consensus 184 L~DFGls~~~~~ 195 (496)
T PTZ00283 184 LGDFGFSKMYAA 195 (496)
T ss_pred EEecccCeeccc
Confidence 999999987753
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=219.08 Aligned_cols=155 Identities=27% Similarity=0.453 Sum_probs=131.8
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCccccc-chHHHHHHHHHHhcCC-CCceeeEEEEEEeCC
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN 745 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~ 745 (845)
..++|...+.||+|+||.||+|++. .+..||+|+++..... ..+.+.+|++++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3446778899999999999999864 2468999999765322 2457889999999997 999999999999999
Q ss_pred EEEEEEeccCCCChhhhhhcCCcc--------------------------------------------------------
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTE-------------------------------------------------------- 769 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~-------------------------------------------------------- 769 (845)
..++||||+++|+|.++++.....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 999999999999999999754210
Q ss_pred -------------------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 003134 770 -------------------------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 812 (845)
Q Consensus 770 -------------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NIL 812 (845)
....+++..+++++.|++.||+|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1124788889999999999999999886 999999999999
Q ss_pred ecCCCcEEEEeeccceecC
Q 003134 813 LDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 813 ld~~~~~kl~DFGla~~~~ 831 (845)
+++++.+||+|||+++.+.
T Consensus 272 l~~~~~~kL~DfGla~~~~ 290 (401)
T cd05107 272 ICEGKLVKICDFGLARDIM 290 (401)
T ss_pred EeCCCEEEEEecCcceecc
Confidence 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=205.43 Aligned_cols=150 Identities=33% Similarity=0.589 Sum_probs=135.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.++|.+.+.||+|++|.||+|...++..+|+|.+.... ...+++.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46788899999999999999998878889999987542 34578999999999999999999999999889999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++++|.+++..... ..+++.++..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.+.
T Consensus 84 ~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 84 SKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred CCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence 99999999965432 36899999999999999999999987 9999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=208.66 Aligned_cols=148 Identities=28% Similarity=0.357 Sum_probs=129.8
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
|+..+.||+|+||+||+|... +++.||+|.+..... .....+.+|++++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999975 588999999865422 2234578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999998886432 236899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=205.24 Aligned_cols=143 Identities=28% Similarity=0.505 Sum_probs=126.9
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999975 68999999886542 23356789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 99986432 25889999999999999999999987 9999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=209.08 Aligned_cols=155 Identities=27% Similarity=0.470 Sum_probs=132.2
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 746 (845)
.+++|+..+.||+|+||.||+|.+. .+..||+|++.... .....++.+|+.++++++|+||+++++++..++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999753 25679999986542 2334578899999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEE
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl 821 (845)
.++||||+++|+|.+++...... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653211 1234688899999999999999999986 999999999999999999999
Q ss_pred EeeccceecC
Q 003134 822 SDFGLAKLYE 831 (845)
Q Consensus 822 ~DFGla~~~~ 831 (845)
+|||+++...
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05062 161 GDFGMTRDIY 170 (277)
T ss_pred CCCCCccccC
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=209.69 Aligned_cols=148 Identities=28% Similarity=0.534 Sum_probs=134.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.+|+..+.||+|++|.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 57889999999999999999964 68999999997655555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++++|.+++... .+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 99 ~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred CCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 999999998532 5788999999999999999999986 99999999999999999999999999987644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=210.68 Aligned_cols=149 Identities=26% Similarity=0.447 Sum_probs=131.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|+..+.||+|+||.||++... ++..+|+|.++... .....++.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999975 57889999987542 22345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++++|.++++.. ..+++..+..++.|+++||+|||+.. +++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999999643 35889999999999999999999842 49999999999999999999999999988654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-22 Score=220.75 Aligned_cols=157 Identities=26% Similarity=0.481 Sum_probs=131.1
Q ss_pred CCCcccccCcEEEEEEEEC-CCcEEEEEEcCc---c-cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCE--EEEEEe
Q 003134 680 PANKVGEGGFGSVYKGILS-DGTVIAVKQLSS---K-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ--LLLVYE 752 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~---~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--~~lV~E 752 (845)
..++||+|+|-+||||.+. +|-.||---++. . +....++|..|+.+|+.++|+||+++|.+|.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3568999999999999975 477776332221 1 23445899999999999999999999999987654 788999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCcEEEEeeccceecC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYE 831 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~-~~~~kl~DFGla~~~~ 831 (845)
.|..|+|..++++.+ .++.+.+++||+||++||.|||++. |||||||||-+||+|+. -|.|||+|.|+|+.+.
T Consensus 124 L~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred cccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999996643 5788899999999999999999996 67999999999999975 5899999999999986
Q ss_pred CCCceeeeeeccCC
Q 003134 832 EDKTHISTRIAGTM 845 (845)
Q Consensus 832 ~~~~~~~t~~~GT~ 845 (845)
.... ..+.|||
T Consensus 198 ~s~a---ksvIGTP 208 (632)
T KOG0584|consen 198 KSHA---KSVIGTP 208 (632)
T ss_pred cccc---ceeccCc
Confidence 5433 3478987
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=202.88 Aligned_cols=143 Identities=31% Similarity=0.523 Sum_probs=127.5
Q ss_pred CcccccCcEEEEEEEECCCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCChh
Q 003134 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 760 (845)
+.||+|+||.||+|...+++.+|+|.++.... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988889999999876532 22457889999999999999999999999999999999999999999
Q ss_pred hhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 761 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 761 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++.... ..+++.++..++.|++.||.|+|+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 9985432 25789999999999999999999986 9999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=204.82 Aligned_cols=149 Identities=34% Similarity=0.601 Sum_probs=134.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.++|+..+.||+|++|.||+|... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356888999999999999999875 78899999976643 5678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++++|.+++..... ..+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.++...
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 83 AKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 99999999865422 25899999999999999999999987 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=207.39 Aligned_cols=149 Identities=30% Similarity=0.378 Sum_probs=130.1
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
|+..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++++++|++|+++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999975 588999999865422 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++++|.+++..... ..+++.++..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 82 ~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 82 MNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred cCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 999999998854321 35899999999999999999999986 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=206.01 Aligned_cols=145 Identities=24% Similarity=0.442 Sum_probs=128.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35778899999999999999864 68899999986542 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 81 MDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999996542 4678889999999999999999987 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=208.84 Aligned_cols=153 Identities=32% Similarity=0.571 Sum_probs=133.6
Q ss_pred cCCCCCCcccccCcEEEEEEEECC------CcEEEEEEcCccccc-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
++|.+.+.||+|+||.||+|...+ +..||+|.++..... ..+.+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457788999999999999998643 478999999765443 4578999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCc---------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcE
Q 003134 749 LVYEYMKNNCLSRAIFGKDT---------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~ 819 (845)
+||||+++|+|.+++..... .....+++.++..++.|++.|++|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 99999999999999975431 11235889999999999999999999987 9999999999999999999
Q ss_pred EEEeeccceecC
Q 003134 820 KISDFGLAKLYE 831 (845)
Q Consensus 820 kl~DFGla~~~~ 831 (845)
||+|||+++...
T Consensus 162 kl~d~g~~~~~~ 173 (280)
T cd05049 162 KIGDFGMSRDVY 173 (280)
T ss_pred EECCcccceecc
Confidence 999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=203.66 Aligned_cols=143 Identities=31% Similarity=0.531 Sum_probs=123.6
Q ss_pred cccccCcEEEEEEEEC---CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCC
Q 003134 683 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (845)
Q Consensus 683 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gs 758 (845)
.||+|+||.||+|.+. .+..||+|.+..... ...+++.+|++++++++|+||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 356799999976532 23467899999999999999999999875 457899999999999
Q ss_pred hhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 759 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 759 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
|.+++.... ..+++.++++++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.+..+
T Consensus 81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 999986432 36899999999999999999999986 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=221.24 Aligned_cols=144 Identities=24% Similarity=0.305 Sum_probs=127.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
...|.+.+.||+|+||.||+|.... ++.||||.... ..+.+|++++++++|+|||++++++..++..++||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578899999999999999999864 78899996432 3457899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+. ++|.+++.... ..+++.+++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 242 ~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 242 YR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred cC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 95 68888875432 26899999999999999999999987 99999999999999999999999999987654
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-21 Score=206.55 Aligned_cols=147 Identities=29% Similarity=0.563 Sum_probs=131.3
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
|+..+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999976 4788899998765555567889999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++|..++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 87 GAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 99998875432 36899999999999999999999986 9999999999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=210.40 Aligned_cols=154 Identities=29% Similarity=0.518 Sum_probs=131.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC---------------CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD---------------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLY 738 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~ 738 (845)
.++|++.+.||+|+||.||+|+... ...||+|.++... ......|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578889999999999999987632 2358999987642 23345789999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCChhhhhhcCCcc-------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCE
Q 003134 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE-------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV 811 (845)
Q Consensus 739 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NI 811 (845)
+++...+..++||||+++++|.+++...... ....+++.++++++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 9999999999999999999999998643211 1124789999999999999999999987 99999999999
Q ss_pred EecCCCcEEEEeeccceecC
Q 003134 812 LLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 812 Lld~~~~~kl~DFGla~~~~ 831 (845)
++++++.+||+|||+++...
T Consensus 161 ll~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred EEcCCCcEEecccccccccc
Confidence 99999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=206.49 Aligned_cols=148 Identities=26% Similarity=0.438 Sum_probs=132.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
++|...+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999875 58899999987654444567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 89 GGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 999999998543 25899999999999999999999987 9999999999999999999999999997664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=208.45 Aligned_cols=152 Identities=33% Similarity=0.517 Sum_probs=129.9
Q ss_pred CCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
+|+..+.||+|+||.||+|+.. ....+|+|.+..... ...+++.+|++++++++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4678899999999999999853 235789998875432 334678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCc-------------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 003134 750 VYEYMKNNCLSRAIFGKDT-------------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 810 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~N 810 (845)
||||+.+|+|.+++..... .....+++.+++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999864211 11235889999999999999999999986 9999999999
Q ss_pred EEecCCCcEEEEeeccceecC
Q 003134 811 VLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 811 ILld~~~~~kl~DFGla~~~~ 831 (845)
|++++++.+||+|||+++...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred EEEcCCCcEEecccccccccc
Confidence 999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=204.32 Aligned_cols=149 Identities=30% Similarity=0.527 Sum_probs=130.0
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
++|...+.||+|++|.||+|....+..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577889999999999999998777789999886542 34567899999999999999999998875 456899999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+|+|.++++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 84 KGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999996532 235789999999999999999999986 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=207.12 Aligned_cols=149 Identities=31% Similarity=0.507 Sum_probs=126.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCc----EEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
++|+..+.||+|+||.||+|.+. +++ .+++|.+..... ...+++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45778899999999999999974 344 478888754322 23467788888999999999999999875 455788
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 86 i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 999999999999996532 36899999999999999999999986 99999999999999999999999999987
Q ss_pred cCC
Q 003134 830 YEE 832 (845)
Q Consensus 830 ~~~ 832 (845)
...
T Consensus 159 ~~~ 161 (279)
T cd05111 159 LYP 161 (279)
T ss_pred ccC
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-24 Score=225.51 Aligned_cols=241 Identities=24% Similarity=0.412 Sum_probs=218.9
Q ss_pred eEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeec
Q 003134 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 172 (845)
-.+.+++.+|.+. .+|++++.+..++.|+.++|++...++......++..|++++|.+. ..|+.++.+..|+.|+..+
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATN 146 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccc
Confidence 3678999999999 6899999999999999999999966555544559999999999999 6788899999999999999
Q ss_pred ccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcc
Q 003134 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (845)
Q Consensus 173 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 252 (845)
|+++ ..|+.++++.+|..|++.+|++. ..|+..-+++.|++||.-.|-++ .+|+.++.+.+|+.|||.+|+|. .+|
T Consensus 147 N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP 222 (565)
T KOG0472|consen 147 NQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP 222 (565)
T ss_pred cccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC
Confidence 9999 78889999999999999999999 45555555999999999999998 88999999999999999999999 566
Q ss_pred hhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCC
Q 003134 253 ASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331 (845)
Q Consensus 253 ~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 331 (845)
+|.++..|.+|+++.|.+...+...+... +|..|||..|+++ ..|+.++-+.+|++||||+|.|+ ..|.++++| +
T Consensus 223 -ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-h 298 (565)
T KOG0472|consen 223 -EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-H 298 (565)
T ss_pred -CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-e
Confidence 89999999999999999998888777555 8999999999999 88999999999999999999999 678899999 9
Q ss_pred cCEEEccCCccc
Q 003134 332 TNFMYLTGNKLT 343 (845)
Q Consensus 332 L~~L~L~~N~l~ 343 (845)
|++|-+.+|.+.
T Consensus 299 L~~L~leGNPlr 310 (565)
T KOG0472|consen 299 LKFLALEGNPLR 310 (565)
T ss_pred eeehhhcCCchH
Confidence 999999999987
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=207.22 Aligned_cols=153 Identities=31% Similarity=0.527 Sum_probs=132.4
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEeC------
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG------ 744 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~------ 744 (845)
.+++.|+..+.||+|+||.||+|... +++.||+|.+... .....++..|++++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888999999999999999975 5889999998654 23456788999999998 799999999998753
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
...|+||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccC
Confidence 46899999999999999986532 236889999999999999999999986 999999999999999999999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|+++....
T Consensus 156 g~~~~~~~ 163 (272)
T cd06637 156 GVSAQLDR 163 (272)
T ss_pred CCceeccc
Confidence 99987643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=209.53 Aligned_cols=155 Identities=28% Similarity=0.454 Sum_probs=131.4
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 746 (845)
..++|++.+.||+|+||.||+|..+ .+..||+|.++.... .....+.+|+.++++++|+||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567899999999999999999753 245899999865432 234568889999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEE
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl 821 (845)
.++||||+++|+|.+++...... .....++..+..++.|++.||.|||+++ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999643211 1234677889999999999999999986 999999999999999999999
Q ss_pred EeeccceecC
Q 003134 822 SDFGLAKLYE 831 (845)
Q Consensus 822 ~DFGla~~~~ 831 (845)
+|||+++...
T Consensus 161 ~Dfg~~~~~~ 170 (288)
T cd05061 161 GDFGMTRDIY 170 (288)
T ss_pred CcCCcccccc
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-21 Score=206.95 Aligned_cols=149 Identities=30% Similarity=0.544 Sum_probs=133.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.+.|++.+.||+|+||.||+|+... ++.+|+|.+........+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3568889999999999999999764 889999999776555567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
+++++|..++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 91 CPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 99999988875432 25899999999999999999999986 999999999999999999999999998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=208.87 Aligned_cols=147 Identities=27% Similarity=0.537 Sum_probs=133.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.+|+..+.||+|++|.||+|+.. +++.||+|.+........+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 47888899999999999999964 58899999997665555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++++|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 100 ~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred CCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 999999998532 4788999999999999999999987 9999999999999999999999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=206.28 Aligned_cols=145 Identities=39% Similarity=0.690 Sum_probs=125.8
Q ss_pred CCcccccCcEEEEEEEEC-----CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 681 ANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.+.||.|+||.||+|.+. .+..|+||.++... ....++|.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 568999999999999986 26789999996543 234688999999999999999999999999888899999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++|+|.++++... ...+++.++.+|+.|+++||+|||+++ |+|+||+++||++++++.+||+|||+++...
T Consensus 84 ~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 84 PGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 9999999997652 236899999999999999999999986 9999999999999999999999999999873
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=205.04 Aligned_cols=151 Identities=29% Similarity=0.575 Sum_probs=132.6
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC-C---cEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD-G---TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
.++|+..+.||+|+||.||+|+... + ..+|+|.++... ....+++..|++++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567888999999999999999752 3 379999987552 3335678999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999986532 36899999999999999999999986 99999999999999999999999999987
Q ss_pred cCC
Q 003134 830 YEE 832 (845)
Q Consensus 830 ~~~ 832 (845)
...
T Consensus 157 ~~~ 159 (268)
T cd05063 157 LED 159 (268)
T ss_pred ccc
Confidence 753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=208.89 Aligned_cols=154 Identities=29% Similarity=0.523 Sum_probs=131.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-----------------CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceee
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-----------------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVK 736 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 736 (845)
.++|+..+.||+|+||.||++... +...+|+|.+.... .....++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356889999999999999998632 23468999997543 233568899999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCChhhhhhcCCcc------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 003134 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 810 (845)
Q Consensus 737 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~N 810 (845)
+++++...+..++||||+++|+|.+++...... ....+++.++.+++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 999999999999999999999999998654211 1135788999999999999999999987 9999999999
Q ss_pred EEecCCCcEEEEeeccceecC
Q 003134 811 VLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 811 ILld~~~~~kl~DFGla~~~~ 831 (845)
|++++++.+||+|||+++.+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred EEEcCCCCEEeccCccccccc
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=207.36 Aligned_cols=141 Identities=23% Similarity=0.367 Sum_probs=121.1
Q ss_pred cccccCcEEEEEEEECC-------------------------CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeE
Q 003134 683 KVGEGGFGSVYKGILSD-------------------------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL 737 (845)
Q Consensus 683 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 737 (845)
.||+|+||.||+|.+.. ...||+|.+........++|.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 68999999999997421 23589999876544445678899999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC
Q 003134 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 817 (845)
Q Consensus 738 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~ 817 (845)
++++.+.+..++||||+++|+|..++.... ..+++.++.+++.|+++||+|||+++ |+||||||+|||+++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence 999999999999999999999999985432 36889999999999999999999986 99999999999997644
Q ss_pred -------cEEEEeeccceec
Q 003134 818 -------NAKISDFGLAKLY 830 (845)
Q Consensus 818 -------~~kl~DFGla~~~ 830 (845)
.+|++|||++...
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cccCccceeeecCCcccccc
Confidence 3899999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=207.38 Aligned_cols=153 Identities=34% Similarity=0.581 Sum_probs=131.5
Q ss_pred cCCCCCCcccccCcEEEEEEEECC------CcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
++|+..+.||+|+||.||+|.... ...||+|.++.... ....+|.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357788999999999999998643 25799999875432 23467899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCccc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEY-----------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 817 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~ 817 (845)
++|||+++|+|.+++....... ...+++.++..++.|++.||+|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 9999999999999996542211 146889999999999999999999987 99999999999999999
Q ss_pred cEEEEeeccceecC
Q 003134 818 NAKISDFGLAKLYE 831 (845)
Q Consensus 818 ~~kl~DFGla~~~~ 831 (845)
.+||+|||+++...
T Consensus 162 ~~~L~dfg~~~~~~ 175 (283)
T cd05048 162 TVKISDFGLSRDIY 175 (283)
T ss_pred cEEECCCcceeecc
Confidence 99999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=205.16 Aligned_cols=154 Identities=29% Similarity=0.355 Sum_probs=134.5
Q ss_pred HHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 671 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 671 l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3456677777789999999999999965 578899999877655566789999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCcEEEEeecc
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKL--DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGL 826 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~-~~~~kl~DFGl 826 (845)
||||+++++|.+++.... ..+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 83 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchh
Confidence 999999999999996432 134 78889999999999999999986 999999999999986 67999999999
Q ss_pred ceecC
Q 003134 827 AKLYE 831 (845)
Q Consensus 827 a~~~~ 831 (845)
+....
T Consensus 156 ~~~~~ 160 (268)
T cd06624 156 SKRLA 160 (268)
T ss_pred heecc
Confidence 98664
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=209.71 Aligned_cols=158 Identities=27% Similarity=0.466 Sum_probs=134.8
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEECC------CcEEEEEEcCccc-ccchHHHHHHHHHHhcC-CCCceeeEEEEEEe
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE 743 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 743 (845)
....++|+..+.||+|+||.||++.... ...+|+|.+.... .....++.+|++++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 4445678889999999999999998642 3689999987542 23345688999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCChhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 003134 744 GNQLLLVYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 812 (845)
Q Consensus 744 ~~~~~lV~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NIL 812 (845)
++..++||||+++|+|.++++.... .....+++..+++++.|++.||+|||+.+ |+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 9999999999999999999964321 12346899999999999999999999986 999999999999
Q ss_pred ecCCCcEEEEeeccceecCC
Q 003134 813 LDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 813 ld~~~~~kl~DFGla~~~~~ 832 (845)
+++++.+||+|||+++.+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHH 184 (293)
T ss_pred EcCCCeEEeCcccccccccc
Confidence 99999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.1e-22 Score=200.28 Aligned_cols=152 Identities=24% Similarity=0.400 Sum_probs=133.6
Q ss_pred cHHHHHHHhcCCCCCCcccccCcEEEEEEE-ECCCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 003134 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (845)
Q Consensus 667 ~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 744 (845)
+++|+.+.| .+.+|+|+|+.|--++ ..++..+|||++.+.....+.+..+|++++.+. .|+||+++++||+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 356666665 4689999999999988 568999999999887666678899999999988 699999999999999
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc---EEE
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKI 821 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~---~kl 821 (845)
+.+|||||-|.||+|..+|++. ..+++.++.++.++|+.||+|||.++ |.|||+||+|||-.+... +||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceee
Confidence 9999999999999999999654 36899999999999999999999998 999999999999965443 899
Q ss_pred EeeccceecC
Q 003134 822 SDFGLAKLYE 831 (845)
Q Consensus 822 ~DFGla~~~~ 831 (845)
+||.++.-+.
T Consensus 221 CDfDLgSg~k 230 (463)
T KOG0607|consen 221 CDFDLGSGIK 230 (463)
T ss_pred eccccccccc
Confidence 9999987553
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=207.00 Aligned_cols=145 Identities=34% Similarity=0.538 Sum_probs=128.5
Q ss_pred CCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccch--HHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 678 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
|+..+.||+|+||+||+++... ++.+|+|.+........ ....+|+.++.+++||||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999864 67899999977643322 23456999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
++++|.+++. ....+++.++..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||.+..+
T Consensus 81 ~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ-----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH-----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc-----cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999996 2246899999999999999999999986 999999999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=207.02 Aligned_cols=150 Identities=31% Similarity=0.506 Sum_probs=130.5
Q ss_pred cCCCCCCcccccCcEEEEEEEE-----CCCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL 747 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 747 (845)
..|+..+.||+|+||.||++++ .++..||+|.++... ....+.+.+|++++++++|+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999984 247889999987553 33346789999999999999999999998875 578
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+++++|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccc
Confidence 99999999999999985432 25899999999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+.+..
T Consensus 157 ~~~~~ 161 (284)
T cd05079 157 KAIET 161 (284)
T ss_pred ccccc
Confidence 87654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-21 Score=202.33 Aligned_cols=148 Identities=32% Similarity=0.503 Sum_probs=131.3
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-----cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-----QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
++|+..+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999874 589999999864321 123568889999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++++|.+++... ..+++..+.+++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999998543 25788999999999999999999987 99999999999999999999999999987
Q ss_pred cC
Q 003134 830 YE 831 (845)
Q Consensus 830 ~~ 831 (845)
..
T Consensus 154 ~~ 155 (263)
T cd06625 154 LQ 155 (263)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-21 Score=205.45 Aligned_cols=146 Identities=36% Similarity=0.562 Sum_probs=127.3
Q ss_pred CCCCCcccccCcEEEEEEEE-----CCCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEEEE
Q 003134 678 FDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLL 749 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 749 (845)
|+..+.||+|+||+||++.. .++..||+|.++.... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988753 3578899999876432 3456788999999999999999999988754 46899
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++|+|.+++... .+++.++..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.
T Consensus 86 v~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence 99999999999998542 5899999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 003134 830 YEE 832 (845)
Q Consensus 830 ~~~ 832 (845)
+..
T Consensus 157 ~~~ 159 (283)
T cd05080 157 VPE 159 (283)
T ss_pred cCC
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=202.56 Aligned_cols=150 Identities=33% Similarity=0.504 Sum_probs=133.4
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..+.||+|++|.||+|... +++.|++|.+... .....+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999975 5889999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++++|.++++... ...+++.++.+++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 81 AENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred CCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 99999999997542 236899999999999999999999986 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=211.14 Aligned_cols=152 Identities=29% Similarity=0.535 Sum_probs=129.7
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCc--EEEEEEcCccc-ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGT--VIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 749 (845)
.++|+..+.||+|+||.||+|.+. ++. .+|+|.++... ....+++.+|++++.++ +|+||+++++++..++..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999975 343 46788776432 33456788999999999 89999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc
Q 003134 750 VYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~ 818 (845)
||||+++|+|.++++.... .....+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999965421 11235889999999999999999999986 999999999999999999
Q ss_pred EEEEeecccee
Q 003134 819 AKISDFGLAKL 829 (845)
Q Consensus 819 ~kl~DFGla~~ 829 (845)
+||+|||+++.
T Consensus 163 ~kl~dfg~~~~ 173 (303)
T cd05088 163 AKIADFGLSRG 173 (303)
T ss_pred EEeCccccCcc
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=207.48 Aligned_cols=150 Identities=32% Similarity=0.461 Sum_probs=133.4
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999975 58999999986542 223467889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 999999999998543 36889999999999999999999986 9999999999999999999999999998765
Q ss_pred CC
Q 003134 832 ED 833 (845)
Q Consensus 832 ~~ 833 (845)
..
T Consensus 153 ~~ 154 (290)
T cd05580 153 GR 154 (290)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=214.52 Aligned_cols=154 Identities=27% Similarity=0.467 Sum_probs=129.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEE------CCCcEEEEEEcCcccc-cchHHHHHHHHHHhcC-CCCceeeEEEEEEeC-C
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG-N 745 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~ 745 (845)
.++|+..+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|++++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999974 2468899999975432 2345688999999999 689999999988654 5
Q ss_pred EEEEEEeccCCCChhhhhhcCCcc--------------------------------------------------------
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTE-------------------------------------------------------- 769 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~-------------------------------------------------------- 769 (845)
..++||||+++|+|.++++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 689999999999999998643210
Q ss_pred ------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 770 ------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 770 ------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
....+++.++.+++.|+++||+|||+++ |+||||||+||++++++.+||+|||+++.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 0124788999999999999999999986 9999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-21 Score=207.44 Aligned_cols=154 Identities=30% Similarity=0.503 Sum_probs=133.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC-----------------CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceee
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD-----------------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVK 736 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 736 (845)
.++|+..+.||+|+||.||+|.... +..||+|.+.... ....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999998642 2468999987653 234567889999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCChhhhhhcCCccc------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 003134 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 810 (845)
Q Consensus 737 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~N 810 (845)
+++++..++..++||||+++++|.+++....... ...+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999996543211 236899999999999999999999986 9999999999
Q ss_pred EEecCCCcEEEEeeccceecC
Q 003134 811 VLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 811 ILld~~~~~kl~DFGla~~~~ 831 (845)
|+++.++.+||+|||+++...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred eeecCCCceEEccccceeecc
Confidence 999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.6e-21 Score=202.00 Aligned_cols=153 Identities=30% Similarity=0.493 Sum_probs=134.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|++|.||+|... +++.||+|.++... ....+++.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999986 68999999886432 223567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++.... .....+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++.+.
T Consensus 82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 9999999999886432 12246899999999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 158 ~ 158 (267)
T cd08224 158 S 158 (267)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=211.87 Aligned_cols=145 Identities=25% Similarity=0.268 Sum_probs=117.3
Q ss_pred HHHHHhcCCCCCCcccccCcEEEEEEEEC--CCcEEEEEEcCccc-----ccchHHHHHHHHHHhcCCCCceee-EEEEE
Q 003134 670 QIKAATNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVK-LYGCC 741 (845)
Q Consensus 670 ~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~ 741 (845)
++....++|...+.||+|+||+||+|++. +++.||||++.... ....+.|.+|+++|++++|+|+++ +++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 44556678999999999999999999875 47788999875331 122456899999999999999985 443
Q ss_pred EeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCCEEecCCCcEE
Q 003134 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI-KTSNVLLDKDLNAK 820 (845)
Q Consensus 742 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDL-Kp~NILld~~~~~k 820 (845)
.+..|+||||++|++|... .. .. ...++.++++||+|||+.+ |+|||| ||+|||++.++.+|
T Consensus 90 --~~~~~LVmE~~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred --cCCcEEEEEccCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence 2467999999999999632 11 01 1467889999999999987 999999 99999999999999
Q ss_pred EEeeccceecCCC
Q 003134 821 ISDFGLAKLYEED 833 (845)
Q Consensus 821 l~DFGla~~~~~~ 833 (845)
|+|||+|+.+...
T Consensus 153 LiDFGlA~~~~~~ 165 (365)
T PRK09188 153 VIDFQLASVFRRR 165 (365)
T ss_pred EEECccceecccC
Confidence 9999999987543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-21 Score=213.75 Aligned_cols=155 Identities=27% Similarity=0.458 Sum_probs=129.7
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcccc-cchHHHHHHHHHHhcC-CCCceeeEEEEEEeC-C
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG-N 745 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~ 745 (845)
.++|++.+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357888999999999999999742 247899999875432 2345678899999999 899999999988754 5
Q ss_pred EEEEEEeccCCCChhhhhhcCCcc--------------------------------------------------------
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTE-------------------------------------------------------- 769 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~-------------------------------------------------------- 769 (845)
..+++|||+++|+|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 789999999999999998543210
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 770 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 770 ~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 0136899999999999999999999986 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-21 Score=203.06 Aligned_cols=153 Identities=26% Similarity=0.434 Sum_probs=132.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47889999999999999999975 68999999876432 223457889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++..... ....+++.++..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||+++.+.
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999988853221 1235789999999999999999999986 9999999999999999999999999998764
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 158 ~ 158 (267)
T cd08228 158 S 158 (267)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.9e-21 Score=200.39 Aligned_cols=150 Identities=25% Similarity=0.368 Sum_probs=132.3
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc-cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
+|+..+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999975 5889999998643 2334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++|+|.+++.... ...+++..+..++.|++.||.|||+++ |+|+||||+||++++++.++++|||+++....
T Consensus 81 ~~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 9999999885432 235789999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-21 Score=205.30 Aligned_cols=152 Identities=26% Similarity=0.425 Sum_probs=131.9
Q ss_pred cCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCccccc-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
++|+..+.||+|+||.||+|+.. +.+.|++|.+...... ..+++.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999964 2467999988765433 3567999999999999999999999999989999
Q ss_pred EEEeccCCCChhhhhhcCCccc----ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
+||||+++|+|.+++....... ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+|++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999996543211 125899999999999999999999987 999999999999999999999999
Q ss_pred ccceec
Q 003134 825 GLAKLY 830 (845)
Q Consensus 825 Gla~~~ 830 (845)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-21 Score=207.27 Aligned_cols=153 Identities=31% Similarity=0.565 Sum_probs=133.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
.+|...+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999852 355789999876655556789999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc
Q 003134 750 VYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~ 818 (845)
||||+++++|.+++..... .....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999965321 11235899999999999999999999987 999999999999999999
Q ss_pred EEEEeeccceecC
Q 003134 819 AKISDFGLAKLYE 831 (845)
Q Consensus 819 ~kl~DFGla~~~~ 831 (845)
+||+|||+++...
T Consensus 162 ~~l~dfg~a~~~~ 174 (291)
T cd05094 162 VKIGDFGMSRDVY 174 (291)
T ss_pred EEECCCCcccccC
Confidence 9999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-21 Score=205.28 Aligned_cols=149 Identities=31% Similarity=0.575 Sum_probs=131.0
Q ss_pred CCCCCCcccccCcEEEEEEEECC-C---cEEEEEEcCcc-cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILSD-G---TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
+|+..+.||+|+||.||+|.... + ..||+|.++.. .....++|..|++++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999999753 3 36999998764 2334568999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 85 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 85 EFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred ecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999986542 25899999999999999999999986 9999999999999999999999999998764
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 158 ~ 158 (269)
T cd05065 158 D 158 (269)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-21 Score=201.14 Aligned_cols=151 Identities=28% Similarity=0.476 Sum_probs=133.5
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..+.||+|+||.||.++.. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788999999999999999864 5889999998654 234456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+++|+|.+++.... ...+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999996542 236899999999999999999999986 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=203.62 Aligned_cols=152 Identities=31% Similarity=0.511 Sum_probs=128.6
Q ss_pred CCCCCcccccCcEEEEEEEECC----CcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCE-----
Q 003134 678 FDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ----- 746 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 746 (845)
|+..+.||+|+||.||+|.... +..||+|+++... .....++.+|++.+++++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 3689999987542 2234678999999999999999999998876544
Q ss_pred -EEEEEeccCCCChhhhhhcCCcc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 747 -LLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 747 -~~lV~Ey~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
.++||||+++|+|..++...... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999998543221 2246899999999999999999999986 999999999999999999999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05035 158 GLSKKIYS 165 (273)
T ss_pred cceeeccc
Confidence 99987653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-21 Score=208.61 Aligned_cols=155 Identities=26% Similarity=0.474 Sum_probs=132.6
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC--------CCcEEEEEEcCccc-ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 744 (845)
.++|.+.+.||+|+||.||+|+.. ++..||+|.++... ....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456788899999999999999741 24579999987542 23456789999999999 899999999999999
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl 813 (845)
+..++||||+++|+|.+++...... ....+++.++..++.|+++||+|||+++ |+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 9999999999999999999654211 1235889999999999999999999987 9999999999999
Q ss_pred cCCCcEEEEeeccceecCC
Q 003134 814 DKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 814 d~~~~~kl~DFGla~~~~~ 832 (845)
++++.+||+|||+++.+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 171 TENNVMKIADFGLARDVNN 189 (304)
T ss_pred cCCCcEEECCCccceeccc
Confidence 9999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-21 Score=202.86 Aligned_cols=150 Identities=27% Similarity=0.505 Sum_probs=132.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.++|+..+.||+|+||.||++...++..+|+|.+... ....+.+.+|++++++++|+||+++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3568889999999999999999877888999988754 2335678999999999999999999999887 7789999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.++....
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 83 AKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999996532 235789999999999999999999986 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-21 Score=206.98 Aligned_cols=162 Identities=27% Similarity=0.458 Sum_probs=136.1
Q ss_pred ccHHHHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEE-
Q 003134 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCV- 742 (845)
Q Consensus 666 ~~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~- 742 (845)
+.++.+..+.++|+..+.||+|+||.||+|... +++.+|+|.+... .....++..|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344556667889999999999999999999975 4789999987653 22346788899999999 7999999999884
Q ss_pred ----eCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc
Q 003134 743 ----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (845)
Q Consensus 743 ----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~ 818 (845)
.++..++||||+++++|.++++... .....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence 3457899999999999999885421 12236889999999999999999999986 999999999999999999
Q ss_pred EEEEeeccceecCC
Q 003134 819 AKISDFGLAKLYEE 832 (845)
Q Consensus 819 ~kl~DFGla~~~~~ 832 (845)
+||+|||+++.+..
T Consensus 163 ~kl~dfg~~~~~~~ 176 (286)
T cd06638 163 VKLVDFGVSAQLTS 176 (286)
T ss_pred EEEccCCceeeccc
Confidence 99999999987643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-21 Score=220.16 Aligned_cols=149 Identities=26% Similarity=0.374 Sum_probs=122.6
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeC--------C
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--------N 745 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------~ 745 (845)
..+|+..+.||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457899999999999999999975 58899999885432 2345799999999999999999987532 2
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-cEEEEee
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDF 824 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~-~~kl~DF 824 (845)
.+++||||+++ +|.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 46799999985 6777664321 12246899999999999999999999987 99999999999998664 7999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|+|+.+..
T Consensus 216 Gla~~~~~ 223 (440)
T PTZ00036 216 GSAKNLLA 223 (440)
T ss_pred ccchhccC
Confidence 99997754
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=205.26 Aligned_cols=150 Identities=32% Similarity=0.599 Sum_probs=128.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCc----EEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
.++|+..++||+|+||+||+|++. +++ .||+|.++... ....+++.+|+.++..++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 356788899999999999999853 344 48999987543 23356788999999999999999999998754 578
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
++|||+++|+|.++++... ..+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 85 l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCcee
Confidence 9999999999999996532 25899999999999999999999986 9999999999999999999999999999
Q ss_pred ecCC
Q 003134 829 LYEE 832 (845)
Q Consensus 829 ~~~~ 832 (845)
.+..
T Consensus 158 ~~~~ 161 (279)
T cd05109 158 LLDI 161 (279)
T ss_pred eccc
Confidence 7753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-22 Score=201.49 Aligned_cols=161 Identities=29% Similarity=0.357 Sum_probs=139.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHH---HHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+++|+|.||.|..++-+ .++.+|+|+++++......+ -..|-++|+..+||.+..+...|+..+.+|.||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 46778899999999999999865 59999999998875444333 456889999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||..||.|.-++... ..+++.....+..+|..||.|||+++ ||.||||.+|.|+|+||++||+|||+++.-.
T Consensus 248 eyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 248 EYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999888543 36888888899999999999999986 9999999999999999999999999999766
Q ss_pred CCCceeeeeeccCC
Q 003134 832 EDKTHISTRIAGTM 845 (845)
Q Consensus 832 ~~~~~~~t~~~GT~ 845 (845)
..+.. +.+++|||
T Consensus 320 ~~g~t-~kTFCGTP 332 (516)
T KOG0690|consen 320 KYGDT-TKTFCGTP 332 (516)
T ss_pred cccce-eccccCCh
Confidence 55543 34589986
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-21 Score=204.77 Aligned_cols=144 Identities=26% Similarity=0.466 Sum_probs=121.9
Q ss_pred CcccccCcEEEEEEEECCC---cEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCC
Q 003134 682 NKVGEGGFGSVYKGILSDG---TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~g 757 (845)
+.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3689999999999985433 356677765442 234578999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
+|.++++..... ....++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 999999754221 234677788899999999999999986 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-22 Score=195.44 Aligned_cols=157 Identities=27% Similarity=0.328 Sum_probs=138.5
Q ss_pred HHhcCCCCCCcccccCcEEEEEEE-ECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----CE
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 746 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 746 (845)
...++|.+.+.+|+|+|+-||.++ ..++..+|+|++...+.++.+..++|++.-++++|||+++++++...+ .+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345679999999999999999998 467899999999887777788999999999999999999999887543 35
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.||+++|+..|+|.+.+..... ....+++.+.++|+.+|.+||++||+.. ++++||||||.|||+.+++.+++.|||.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 8999999999999999976532 2347999999999999999999999986 5799999999999999999999999999
Q ss_pred ceecC
Q 003134 827 AKLYE 831 (845)
Q Consensus 827 a~~~~ 831 (845)
++...
T Consensus 176 ~~~a~ 180 (302)
T KOG2345|consen 176 ATQAP 180 (302)
T ss_pred ccccc
Confidence 88653
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-22 Score=220.88 Aligned_cols=161 Identities=25% Similarity=0.485 Sum_probs=137.8
Q ss_pred CCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 677 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
.|.++..+|.|+||.||+|+.++ +-..|.|++...+....++++-||+||+..+||+||++++.|+.++.+|++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 35567889999999999999875 44557788887777788899999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCCc
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~~ 835 (845)
||-....+-+. ...|.+.++..+|+|++.||.|||++. |||||||+.|||++-||.++|+|||.+........
T Consensus 113 GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 113 GGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred CchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 99998888554 347999999999999999999999996 99999999999999999999999999875533222
Q ss_pred eeeeeeccCC
Q 003134 836 HISTRIAGTM 845 (845)
Q Consensus 836 ~~~t~~~GT~ 845 (845)
. ...+.|||
T Consensus 186 k-RDsFIGTP 194 (1187)
T KOG0579|consen 186 K-RDSFIGTP 194 (1187)
T ss_pred h-hccccCCc
Confidence 1 22366775
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.6e-21 Score=201.41 Aligned_cols=150 Identities=29% Similarity=0.522 Sum_probs=135.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.++|+..+.||+|++|.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888999999999999999975 5788999999766555667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 82 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 82 CGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred CCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhh
Confidence 99999999886532 36889999999999999999999986 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.6e-21 Score=202.53 Aligned_cols=143 Identities=27% Similarity=0.423 Sum_probs=123.2
Q ss_pred CcccccCcEEEEEEEECC-------------CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 682 NKVGEGGFGSVYKGILSD-------------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
+.||+|+||.||+|+... ...||+|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358899887655555568889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc-------EEE
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-------AKI 821 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~-------~kl 821 (845)
+||||+++|+|..+++... ..+++.++.+++.|+++||+|||+++ |+||||||+|||++.++. +|+
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999998885432 35899999999999999999999986 999999999999987664 899
Q ss_pred EeeccceecC
Q 003134 822 SDFGLAKLYE 831 (845)
Q Consensus 822 ~DFGla~~~~ 831 (845)
+|||++....
T Consensus 154 ~d~g~~~~~~ 163 (262)
T cd05077 154 SDPGIPITVL 163 (262)
T ss_pred CCCCCCcccc
Confidence 9999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-21 Score=213.97 Aligned_cols=143 Identities=22% Similarity=0.297 Sum_probs=125.4
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
...+|.+.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++|+||+++++++...+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999976 4778999975432 23569999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+. ++|.+++... ...+++.++.+|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 138 ~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 138 HYS-SDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred ccC-CcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 995 5888887543 236899999999999999999999987 999999999999999999999999999854
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-21 Score=212.40 Aligned_cols=151 Identities=28% Similarity=0.424 Sum_probs=129.0
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC----
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG---- 744 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~---- 744 (845)
....++|...+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++|+||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 344578999999999999999999974 58899999987542 22345678899999999999999999987543
Q ss_pred --CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEE
Q 003134 745 --NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822 (845)
Q Consensus 745 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~ 822 (845)
...|+++|++ +++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEc
Confidence 4579999987 7789888743 25899999999999999999999987 9999999999999999999999
Q ss_pred eeccceecCC
Q 003134 823 DFGLAKLYEE 832 (845)
Q Consensus 823 DFGla~~~~~ 832 (845)
|||+++....
T Consensus 161 Dfg~~~~~~~ 170 (343)
T cd07878 161 DFGLARQADD 170 (343)
T ss_pred CCccceecCC
Confidence 9999987654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=200.38 Aligned_cols=148 Identities=29% Similarity=0.626 Sum_probs=132.2
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
.+|+..+.||+|+||.||++.+.++..+|+|.+... .....+|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 467788999999999999999877889999998754 2335678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++|.+++.... ..++++.+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 83 HGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVL 151 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecc
Confidence 999999986542 25789999999999999999999987 9999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-21 Score=208.51 Aligned_cols=154 Identities=28% Similarity=0.470 Sum_probs=131.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC--------CCcEEEEEEcCccc-ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 744 (845)
.++|.+.+.||+|+||.||+++.. +...+|+|.++... .....++..|++++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356889999999999999999853 13579999997642 23345788899999999 799999999999999
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl 813 (845)
+..++||||+++|+|.+++...... ....+++.++++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 9999999999999999999654211 1135899999999999999999999986 9999999999999
Q ss_pred cCCCcEEEEeeccceecC
Q 003134 814 DKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 814 d~~~~~kl~DFGla~~~~ 831 (845)
++++.+||+|||+++...
T Consensus 174 ~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 174 TEDNVMKIADFGLARDIH 191 (307)
T ss_pred cCCCcEEECCCccccccc
Confidence 999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-21 Score=202.25 Aligned_cols=142 Identities=27% Similarity=0.471 Sum_probs=123.1
Q ss_pred CcccccCcEEEEEEEECC-C----------cEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 682 NKVGEGGFGSVYKGILSD-G----------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
+.||+|+||.||+|.+.+ + ..+++|.+...... ...|.+|+.++++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999999864 3 25788877654333 6789999999999999999999999988 778999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-------cEEEEe
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-------NAKISD 823 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~-------~~kl~D 823 (845)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++ .+||+|
T Consensus 79 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999986542 16889999999999999999999986 99999999999999888 799999
Q ss_pred eccceecCC
Q 003134 824 FGLAKLYEE 832 (845)
Q Consensus 824 FGla~~~~~ 832 (845)
||+++....
T Consensus 152 fg~a~~~~~ 160 (259)
T cd05037 152 PGIPITVLS 160 (259)
T ss_pred CCccccccc
Confidence 999987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=202.88 Aligned_cols=149 Identities=28% Similarity=0.471 Sum_probs=131.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|+..+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999986 58999999986542 2234568899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++++|..++... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99999888776432 25899999999999999999999986 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=213.30 Aligned_cols=147 Identities=27% Similarity=0.420 Sum_probs=125.7
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----- 745 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 745 (845)
..++|+..+.||+|+||.||++... +++.||+|++... ......++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999975 5899999998654 2233567889999999999999999999986543
Q ss_pred -EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 746 -QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 746 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
..|+||||+++ +|.+.++. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecC
Confidence 57999999976 56555532 4788899999999999999999987 999999999999999999999999
Q ss_pred ccceecC
Q 003134 825 GLAKLYE 831 (845)
Q Consensus 825 Gla~~~~ 831 (845)
|+++...
T Consensus 168 g~a~~~~ 174 (359)
T cd07876 168 GLARTAC 174 (359)
T ss_pred CCccccc
Confidence 9998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-22 Score=221.78 Aligned_cols=153 Identities=35% Similarity=0.590 Sum_probs=133.4
Q ss_pred CCCCcccccCcEEEEEEEE-CCC----cEEEEEEcCcc-cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 679 DPANKVGEGGFGSVYKGIL-SDG----TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 679 ~~~~~ig~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
...++||+|+||+||||.+ +.| -+||+|++... ..+..+++.+|+-+|++++|||+++++|+|.... +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3568999999999999986 333 47899998665 3455789999999999999999999999998776 889999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
||+.|+|.++++..+ ..+-....+.|+.|||+||.|||++. +|||||-.+|||+..-..+||.|||+|+....
T Consensus 778 ~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred hcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999997654 36778889999999999999999886 99999999999999999999999999999987
Q ss_pred CCceeee
Q 003134 833 DKTHIST 839 (845)
Q Consensus 833 ~~~~~~t 839 (845)
++....+
T Consensus 851 d~~ey~~ 857 (1177)
T KOG1025|consen 851 DEKEYSA 857 (1177)
T ss_pred ccccccc
Confidence 7665444
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=224.76 Aligned_cols=167 Identities=19% Similarity=0.317 Sum_probs=127.3
Q ss_pred HhcCCCCCCcccccCcEEEEEEEECC--CcEEEEEEc--------------Cc---ccccchHHHHHHHHHHhcCCCCce
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILSD--GTVIAVKQL--------------SS---KSRQGNREFVNEIGMISAQQHPNL 734 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~H~nI 734 (845)
..++|++.+.||+|+||+||+|..+. +..++.|.+ .+ ........+.+|++++++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999987542 222222211 00 011224568899999999999999
Q ss_pred eeEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec
Q 003134 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 814 (845)
Q Consensus 735 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld 814 (845)
+++++++...+..|+|+|++. ++|.+++..............++..|+.||+.||+|||+++ ||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999986 47777775433222223446678899999999999999987 99999999999999
Q ss_pred CCCcEEEEeeccceecCCCCceeeeeeccC
Q 003134 815 KDLNAKISDFGLAKLYEEDKTHISTRIAGT 844 (845)
Q Consensus 815 ~~~~~kl~DFGla~~~~~~~~~~~t~~~GT 844 (845)
.++.+||+|||+|+.+............||
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt 331 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGT 331 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCC
Confidence 999999999999998865443333334455
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-21 Score=204.63 Aligned_cols=155 Identities=28% Similarity=0.458 Sum_probs=132.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC------CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 747 (845)
.++|...+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+++++.++|+||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578889999999999999998642 4689999987543 23345788999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEE
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~ 822 (845)
++||||+++|+|.+++...... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999999654321 1234789999999999999999999986 9999999999999999999999
Q ss_pred eeccceecCC
Q 003134 823 DFGLAKLYEE 832 (845)
Q Consensus 823 DFGla~~~~~ 832 (845)
|||+++.+..
T Consensus 162 dfg~~~~~~~ 171 (277)
T cd05032 162 DFGMTRDIYE 171 (277)
T ss_pred Ccccchhhcc
Confidence 9999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9e-21 Score=206.19 Aligned_cols=148 Identities=26% Similarity=0.477 Sum_probs=129.9
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999975 58899999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 58988885432 25789999999999999999999986 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=203.55 Aligned_cols=149 Identities=33% Similarity=0.538 Sum_probs=132.9
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999975 58999999987653 23356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+ +++|.+++.... ..+++.++..++.|+++||+|||+.+ |+|+||||+||+++.++.++|+|||+++.....
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999986432 36899999999999999999999986 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-21 Score=205.44 Aligned_cols=148 Identities=32% Similarity=0.544 Sum_probs=131.3
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccccc-----chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-----GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
+|+..+.||+|++|.||+|... +++.||+|.++..... ....+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999975 5899999999765322 234677899999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+ +|+|.+++.... ..+++.++..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 899999996532 26899999999999999999999987 999999999999999999999999999877
Q ss_pred CC
Q 003134 831 EE 832 (845)
Q Consensus 831 ~~ 832 (845)
..
T Consensus 153 ~~ 154 (298)
T cd07841 153 GS 154 (298)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=202.88 Aligned_cols=149 Identities=29% Similarity=0.522 Sum_probs=130.1
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..+.||+|++|.||+|+.. +++.||+|+++... ....+.+.+|+.++.+++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 58999999986542 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++ ++|.+++..... ...+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 98 588888754321 236899999999999999999999986 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-21 Score=205.51 Aligned_cols=154 Identities=32% Similarity=0.558 Sum_probs=133.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 747 (845)
.++|+..+.||+|+||.||+|... ++..||+|.+.... ....+++.+|++++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457889999999999999999863 46789999987543 23346789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCc-----------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 003134 748 LLVYEYMKNNCLSRAIFGKDT-----------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 810 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~N 810 (845)
++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999964311 11235789999999999999999999986 9999999999
Q ss_pred EEecCCCcEEEEeeccceecC
Q 003134 811 VLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 811 ILld~~~~~kl~DFGla~~~~ 831 (845)
|++++++.+||+|||+++.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred eEecCCCceEECccccceecc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-21 Score=215.65 Aligned_cols=144 Identities=24% Similarity=0.297 Sum_probs=126.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC---CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
..+|.+.+.||+|+||.||+|... .+..||+|.+... +.+.+|++++++++||||+++++++...+..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 346889999999999999999753 3578999988643 34568999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+. ++|.+++... ..+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 166 e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred hhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 9986 5788888322 36899999999999999999999987 9999999999999999999999999998765
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 237 ~ 237 (392)
T PHA03207 237 A 237 (392)
T ss_pred c
Confidence 4
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-21 Score=214.45 Aligned_cols=148 Identities=27% Similarity=0.420 Sum_probs=129.6
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCC-C-----CceeeEEEEEEeCCEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-H-----PNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~~~~~~~~~~~l 749 (845)
+|++.+.||+|+||.|.+|.+. +++.||||+++... ....+-..|+.+|..++ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999975 59999999998763 33456678999999997 4 389999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC--CcEEEEeeccc
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD--LNAKISDFGLA 827 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~--~~~kl~DFGla 827 (845)
|+|.++. +|+++++.... ..++...++.|+.||+.||.+||+.+ |||+|||||||||.+- ..+||+|||.|
T Consensus 266 VfELL~~-NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eehhhhh-hHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 9999865 89999987643 36999999999999999999999987 9999999999999653 46999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
....+
T Consensus 339 c~~~q 343 (586)
T KOG0667|consen 339 CFESQ 343 (586)
T ss_pred cccCC
Confidence 87643
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=199.56 Aligned_cols=148 Identities=34% Similarity=0.549 Sum_probs=131.5
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-----ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 68999999986532 22346788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++..
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999998543 25889999999999999999999987 999999999999999999999999999876
Q ss_pred CC
Q 003134 831 EE 832 (845)
Q Consensus 831 ~~ 832 (845)
..
T Consensus 153 ~~ 154 (258)
T cd06632 153 VE 154 (258)
T ss_pred cc
Confidence 43
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=204.20 Aligned_cols=148 Identities=26% Similarity=0.369 Sum_probs=130.0
Q ss_pred CCCCCCcccccCcEEEEEEEE----CCCcEEEEEEcCcccc----cchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEE
Q 003134 677 NFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSR----QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 747 (845)
+|+..+.||+|+||.||+++. .+|..||+|++..... ...+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 3688999999875422 2346778899999999 599999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccc
Confidence 9999999999999998543 25788999999999999999999986 999999999999999999999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+....
T Consensus 153 ~~~~~ 157 (290)
T cd05613 153 KEFHE 157 (290)
T ss_pred eeccc
Confidence 87654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-21 Score=205.40 Aligned_cols=152 Identities=24% Similarity=0.491 Sum_probs=132.3
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|+..+.||+|+||.||++... ++..||+|.++... .....++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788999999999999999986 68999999886542 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++++|..++.... ....+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 81 MDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred cCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999999886531 1236899999999999999999999742 49999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=206.43 Aligned_cols=146 Identities=28% Similarity=0.481 Sum_probs=120.7
Q ss_pred CCcccccCcEEEEEEEEC---CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEe--CCEEEEEEeccC
Q 003134 681 ANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVYEYMK 755 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~Ey~~ 755 (845)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999964 46789999986542 23567889999999999999999998864 457899999986
Q ss_pred CCChhhhhhcCCc----ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----cCCCcEEEEeeccc
Q 003134 756 NNCLSRAIFGKDT----EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLA 827 (845)
Q Consensus 756 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl----d~~~~~kl~DFGla 827 (845)
+ +|.+++..... .....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 78877743211 11235899999999999999999999987 9999999999999 45678999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+.+..
T Consensus 160 ~~~~~ 164 (317)
T cd07868 160 RLFNS 164 (317)
T ss_pred eccCC
Confidence 87754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.5e-21 Score=206.43 Aligned_cols=152 Identities=28% Similarity=0.513 Sum_probs=129.5
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-C--cEEEEEEcCcc-cccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-G--TVIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 750 (845)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998754 3 34788888743 233356789999999999 799999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcE
Q 003134 751 YEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~ 819 (845)
|||+++|+|.++++..... ....+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 9999999999999653210 1135889999999999999999999986 9999999999999999999
Q ss_pred EEEeeccceec
Q 003134 820 KISDFGLAKLY 830 (845)
Q Consensus 820 kl~DFGla~~~ 830 (845)
||+|||++...
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=203.49 Aligned_cols=153 Identities=33% Similarity=0.556 Sum_probs=133.4
Q ss_pred cCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
.+|...++||+|+||.||++... ++..+|+|.+..........+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999742 356899999877655556789999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcE
Q 003134 750 VYEYMKNNCLSRAIFGKDTE----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~ 819 (845)
||||+++|+|.+++...... ....+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 99999999999998654211 1135889999999999999999999987 9999999999999999999
Q ss_pred EEEeeccceecC
Q 003134 820 KISDFGLAKLYE 831 (845)
Q Consensus 820 kl~DFGla~~~~ 831 (845)
||+|||+++.+.
T Consensus 162 kL~dfg~~~~~~ 173 (280)
T cd05092 162 KIGDFGMSRDIY 173 (280)
T ss_pred EECCCCceeEcC
Confidence 999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=200.38 Aligned_cols=146 Identities=30% Similarity=0.537 Sum_probs=130.1
Q ss_pred CCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccc------cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
+|...+.||+|+||.||+|...+++.+|+|.++.... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999998864321 1235688899999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999998543 25789999999999999999999986 999999999999999999999999998865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.5e-21 Score=202.41 Aligned_cols=149 Identities=30% Similarity=0.471 Sum_probs=129.0
Q ss_pred cCCCCCCcccccCcEEEEEEEECC----CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
++|...+.||+|+||.||+|.+.+ ...||+|...... ....+.+.+|+.++++++||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998643 3478999887654 3445689999999999999999999998875 557899
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 85 MELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999996532 25899999999999999999999986 999999999999999999999999999876
Q ss_pred CC
Q 003134 831 EE 832 (845)
Q Consensus 831 ~~ 832 (845)
..
T Consensus 158 ~~ 159 (270)
T cd05056 158 ED 159 (270)
T ss_pred cc
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=203.13 Aligned_cols=154 Identities=29% Similarity=0.428 Sum_probs=131.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC------CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 747 (845)
+++|...+.||+|++|.||+|.+.. +..||+|.+.... ......|..|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678889999999999999999753 5688999886543 23345789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCc--ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC---cEEEE
Q 003134 748 LLVYEYMKNNCLSRAIFGKDT--EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKIS 822 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~---~~kl~ 822 (845)
++||||+++++|.++++.... .....+++.++++++.||+.||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999965432 11235899999999999999999999987 99999999999998654 59999
Q ss_pred eeccceecC
Q 003134 823 DFGLAKLYE 831 (845)
Q Consensus 823 DFGla~~~~ 831 (845)
|||+++...
T Consensus 162 dfg~~~~~~ 170 (277)
T cd05036 162 DFGMARDIY 170 (277)
T ss_pred cCccccccC
Confidence 999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=199.44 Aligned_cols=142 Identities=30% Similarity=0.510 Sum_probs=123.6
Q ss_pred cccccCcEEEEEEEEC---CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCC
Q 003134 683 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (845)
Q Consensus 683 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~g 757 (845)
+||+|+||.||+|.++ ++..+|+|+++.... ...+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 478899999865432 23567899999999999999999999875 45678999999999
Q ss_pred ChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+|.+++... ..+++..+.+++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 999998543 25889999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=202.74 Aligned_cols=149 Identities=33% Similarity=0.638 Sum_probs=129.7
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-Cc----EEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GT----VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
.+|+..+.||+|+||.||+|.+.+ ++ .+|+|.+..... ....++.+|++++++++|+||+++++++.. +..++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 457788999999999999998643 32 689998876533 345678899999999999999999999987 78899
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 86 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999996542 25899999999999999999999986 99999999999999999999999999987
Q ss_pred cCC
Q 003134 830 YEE 832 (845)
Q Consensus 830 ~~~ 832 (845)
...
T Consensus 159 ~~~ 161 (279)
T cd05057 159 LDV 161 (279)
T ss_pred ccC
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.5e-21 Score=207.40 Aligned_cols=154 Identities=26% Similarity=0.466 Sum_probs=131.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC--------CCcEEEEEEcCccc-ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 744 (845)
.++|...+.||+|+||.||+|+.. ....+|+|.++... .....++..|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356788999999999999999742 24578999987542 23345788999999999 699999999999999
Q ss_pred CEEEEEEeccCCCChhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl 813 (845)
+..++||||+++|+|.+++..... .....+++.++.+++.|++.||+|||+++ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999965321 11235899999999999999999999986 9999999999999
Q ss_pred cCCCcEEEEeeccceecC
Q 003134 814 DKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 814 d~~~~~kl~DFGla~~~~ 831 (845)
++++.+||+|||+++...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 168 TEDNVMKIADFGLARGVH 185 (314)
T ss_pred cCCCcEEEcccccccccc
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=223.18 Aligned_cols=257 Identities=25% Similarity=0.322 Sum_probs=182.1
Q ss_pred EEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeeccc
Q 003134 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (845)
Q Consensus 95 ~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 174 (845)
..|+|+.++|+ .+|+.+. ++|+.|+|++|+|+.++ .. ..+|++|+|++|+|+. +|.. .++|+.|+|++|.
T Consensus 204 ~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP-~l--p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~ 273 (788)
T PRK15387 204 AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLP-AL--PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNP 273 (788)
T ss_pred cEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCC-CC--CCCCcEEEecCCccCc-ccCc---ccccceeeccCCc
Confidence 46889999998 6788775 48999999999998753 21 1389999999999985 4543 3688889999998
Q ss_pred CCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchh
Q 003134 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPAS 254 (845)
Q Consensus 175 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 254 (845)
|+ .+|.. ..+|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++ +|... .+|+.|++++|+|++ +|..
T Consensus 274 L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l 340 (788)
T PRK15387 274 LT-HLPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL 340 (788)
T ss_pred hh-hhhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cccc
Confidence 88 45543 356888889999888 45542 4678899999998885 45432 457788888888874 4432
Q ss_pred hhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCE
Q 003134 255 ISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 334 (845)
Q Consensus 255 ~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 334 (845)
..+|+.|+|++|+++..+.. ..+|+.|++++|+|+. +|.. ..+|+.|+|++|+|++ +|.. .++|+.
T Consensus 341 ---p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~ 406 (788)
T PRK15387 341 ---PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKE 406 (788)
T ss_pred ---ccccceEecCCCccCCCCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCE
Confidence 24788888888888865431 2367888888888884 5543 3568888888888884 5543 357888
Q ss_pred EEccCCcccCCCChhhhcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCCCCCc
Q 003134 335 MYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKV 395 (845)
Q Consensus 335 L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~~~~~ 395 (845)
|++++|+|++ +|.. ...++.|++++|+++ .+|..+ | .+..+..++..+|++++.
T Consensus 407 LdLS~N~Lss-IP~l-~~~L~~L~Ls~NqLt-~LP~sl-~---~L~~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 407 LMVSGNRLTS-LPML-PSGLLSLSVYRNQLT-RLPESL-I---HLSSETTVNLEGNPLSER 460 (788)
T ss_pred EEccCCcCCC-CCcc-hhhhhhhhhccCccc-ccChHH-h---hccCCCeEECCCCCCCch
Confidence 8888888874 6643 346778888888887 345433 2 223445667777777654
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.6e-21 Score=228.79 Aligned_cols=160 Identities=25% Similarity=0.379 Sum_probs=132.0
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe--CCE
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQ 746 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~ 746 (845)
....++|.+.+.||+|+||.||+|+.. .+..||+|.+.... ......|..|+.++++++|||||++++++.. .+.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344568999999999999999999975 47789999886542 2335678899999999999999999998865 357
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeCCCCCCCEEecCC------
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR----IKIVHRDIKTSNVLLDKD------ 816 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~----~~ivHrDLKp~NILld~~------ 816 (845)
+|+||||+++|+|.++|..... ....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 8999999999999999865321 12368999999999999999999998542 349999999999999642
Q ss_pred -----------CcEEEEeeccceecCC
Q 003134 817 -----------LNAKISDFGLAKLYEE 832 (845)
Q Consensus 817 -----------~~~kl~DFGla~~~~~ 832 (845)
..+||+|||+++.+..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccc
Confidence 3489999999987643
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.5e-21 Score=204.28 Aligned_cols=152 Identities=32% Similarity=0.473 Sum_probs=129.5
Q ss_pred CCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCccccc-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
+|...+.||+|+||.||+|... ++..||+|+++..... ..+.+.+|++++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556789999999999999863 2578999999755332 24578899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc
Q 003134 750 VYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~ 818 (845)
++||+++++|.+++..... .....+++..+.+++.|++.||+|+|+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 9999999999999853210 11235889999999999999999999987 999999999999999999
Q ss_pred EEEEeeccceecC
Q 003134 819 AKISDFGLAKLYE 831 (845)
Q Consensus 819 ~kl~DFGla~~~~ 831 (845)
+||+|||+++...
T Consensus 163 ~kl~Dfg~~~~~~ 175 (283)
T cd05091 163 VKISDLGLFREVY 175 (283)
T ss_pred eEecccccccccc
Confidence 9999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=202.22 Aligned_cols=149 Identities=30% Similarity=0.509 Sum_probs=131.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-----CCcEEEEEEcCccccc-chHHHHHHHHHHhcCCCCceeeEEEEEEe--CCEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQL 747 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 747 (845)
..|+..+.||+|+||.||+|.+. ++..+|+|.++..... ..++|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677889999999999999864 3689999999765432 45789999999999999999999999887 5578
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccc
Confidence 99999999999999996542 25899999999999999999999987 999999999999999999999999999
Q ss_pred eecC
Q 003134 828 KLYE 831 (845)
Q Consensus 828 ~~~~ 831 (845)
....
T Consensus 157 ~~~~ 160 (284)
T cd05038 157 KVLP 160 (284)
T ss_pred cccc
Confidence 8875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=204.08 Aligned_cols=147 Identities=28% Similarity=0.490 Sum_probs=129.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|+..+.||+|++|.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999976 588999999865432 2235677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
+++ +|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 985 8999886432 26789999999999999999999986 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=206.00 Aligned_cols=152 Identities=29% Similarity=0.449 Sum_probs=132.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcccc-cchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 746 (845)
.++|...+.||+|+||.||++... .+..||+|+++.... ...+.+.+|+++++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 356888999999999999999742 255899999876532 2345788999999999 79999999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.++||||+++|+|.++++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999965322 24899999999999999999999986 99999999999999999999999999
Q ss_pred ceecCC
Q 003134 827 AKLYEE 832 (845)
Q Consensus 827 a~~~~~ 832 (845)
++.+..
T Consensus 188 ~~~~~~ 193 (302)
T cd05055 188 ARDIMN 193 (302)
T ss_pred cccccC
Confidence 987644
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=199.47 Aligned_cols=144 Identities=31% Similarity=0.507 Sum_probs=127.8
Q ss_pred CcccccCcEEEEEEEECC--C--cEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILSD--G--TVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+++.+|++++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999743 3 3689999987655 456789999999999999999999999988 889999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999966432 36899999999999999999999986 99999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=204.20 Aligned_cols=161 Identities=31% Similarity=0.498 Sum_probs=137.1
Q ss_pred ccHHHHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEe
Q 003134 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE 743 (845)
Q Consensus 666 ~~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 743 (845)
++++++..++++|+..+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455666777899999999999999999999975 58899999986532 2346778899999998 89999999999875
Q ss_pred C-----CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc
Q 003134 744 G-----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (845)
Q Consensus 744 ~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~ 818 (845)
. +..++||||+++|+|.++++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 4 368999999999999998864321 2236899999999999999999999986 999999999999999999
Q ss_pred EEEEeeccceecC
Q 003134 819 AKISDFGLAKLYE 831 (845)
Q Consensus 819 ~kl~DFGla~~~~ 831 (845)
+||+|||+++...
T Consensus 167 ~kl~dfg~~~~~~ 179 (291)
T cd06639 167 VKLVDFGVSAQLT 179 (291)
T ss_pred EEEeecccchhcc
Confidence 9999999988654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=198.66 Aligned_cols=147 Identities=31% Similarity=0.508 Sum_probs=128.6
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEE-eCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV-EGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lV~Ey~ 754 (845)
.+|+..+.||+|+||.||++... +..+|+|.++.. ...+.+.+|+.++++++|+|++++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999875 778999998653 23467899999999999999999999765 456789999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++++|.+++..... ..+++..+.+++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 83 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecc
Confidence 99999999865422 25889999999999999999999986 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=204.73 Aligned_cols=146 Identities=23% Similarity=0.395 Sum_probs=130.4
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||++... .++.||+|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999976 47899999987543 223457889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 999999999999543 25899999999999999999999986 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=198.43 Aligned_cols=149 Identities=38% Similarity=0.618 Sum_probs=131.2
Q ss_pred CcccccCcEEEEEEEECC----CcEEEEEEcCcccccc-hHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||.||+|.... +..||+|.++...... .+++.+|++++..++|+||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999753 7889999997764333 67889999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCcc----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 757 NCLSRAIFGKDTE----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 757 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++|.+++...... ....+++.++..++.|++.||+|||+++ |+||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999664211 1246899999999999999999999986 99999999999999999999999999998764
Q ss_pred C
Q 003134 833 D 833 (845)
Q Consensus 833 ~ 833 (845)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=202.89 Aligned_cols=149 Identities=30% Similarity=0.548 Sum_probs=124.1
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcC---CCCceeeEEEEEEe-----CC
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQ---QHPNLVKLYGCCVE-----GN 745 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~-----~~ 745 (845)
+|+..+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999976 588999999875422 2234566777777655 79999999998864 34
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
..++||||+.+ +|.+++..... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccC
Confidence 68999999985 88888854321 35899999999999999999999987 9999999999999999999999999
Q ss_pred cceecCC
Q 003134 826 LAKLYEE 832 (845)
Q Consensus 826 la~~~~~ 832 (845)
+++....
T Consensus 154 ~~~~~~~ 160 (288)
T cd07863 154 LARIYSC 160 (288)
T ss_pred ccccccC
Confidence 9987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=202.44 Aligned_cols=152 Identities=25% Similarity=0.469 Sum_probs=127.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHH-HhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGM-ISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|++.+.||+|+||.||+++.. +|+.||+|+++.... ....++..|+.+ ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999976 589999999876422 233455666665 566799999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|++ |+|.+++..... ....+++..+..++.|++.||+|||++. +++||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 997 688887754321 2246899999999999999999999862 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-21 Score=205.63 Aligned_cols=161 Identities=32% Similarity=0.413 Sum_probs=140.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc---cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
+.|..-++||+|+||.||-++.+ +|+.+|+|++.+. .++.....+.|-.+|.++..+.||.+-..|++.+.+++||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 45778899999999999999976 5999999999665 2344566788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
..|.||+|.-+|..... ..+++..++-++.+|+.||++||+.. ||.||+||+|||+|+.|+++|+|.|+|..+.
T Consensus 265 tlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999988876543 46899999999999999999999986 9999999999999999999999999999997
Q ss_pred CCCceeeeeeccC
Q 003134 832 EDKTHISTRIAGT 844 (845)
Q Consensus 832 ~~~~~~~t~~~GT 844 (845)
+.+.+. ..+||
T Consensus 339 ~g~~~~--~rvGT 349 (591)
T KOG0986|consen 339 EGKPIR--GRVGT 349 (591)
T ss_pred CCCccc--cccCc
Confidence 665442 22566
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=197.27 Aligned_cols=148 Identities=33% Similarity=0.575 Sum_probs=134.4
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
++|+..+.||+|++|.||+|...+ ++.+|+|.+..... .+++.+|++++++++|+||+++++++..+...|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999999865 78999999876533 678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 81 GAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 9999999985432 36899999999999999999999986 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=202.59 Aligned_cols=150 Identities=31% Similarity=0.486 Sum_probs=129.1
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++++|...+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3567889999999999999999875 588999999865432 22356788999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+. +++.+.+.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9996 67777664321 25788889999999999999999986 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.3e-21 Score=201.97 Aligned_cols=153 Identities=28% Similarity=0.479 Sum_probs=133.1
Q ss_pred cCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|++|.||+|.. .+++.+|||.+.... .....++.+|+++++.++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999996 468999999886532 223457889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++++|.+++..... ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.+.
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999998864221 2246899999999999999999999987 9999999999999999999999999988764
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 158 ~ 158 (267)
T cd08229 158 S 158 (267)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=199.60 Aligned_cols=147 Identities=32% Similarity=0.547 Sum_probs=129.7
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccc---------hHHHHHHHHHHhcCCCCceeeEEEEEEeCCE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG---------NREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 746 (845)
+|.....||+|++|.||+|... +++.+|+|.+....... .+.+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667889999999999999875 58899999886542211 2467889999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCC
Confidence 99999999999999999543 25788999999999999999999986 99999999999999999999999999
Q ss_pred ceecC
Q 003134 827 AKLYE 831 (845)
Q Consensus 827 a~~~~ 831 (845)
++...
T Consensus 153 ~~~~~ 157 (267)
T cd06628 153 SKKLE 157 (267)
T ss_pred Ccccc
Confidence 98775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=204.32 Aligned_cols=148 Identities=28% Similarity=0.540 Sum_probs=133.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.+|+..+.||.|++|.||+|... +++.||+|.+........+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 45888899999999999999864 68999999997655555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++++|.+++... .+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 99 AGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 999999988532 5799999999999999999999987 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=197.26 Aligned_cols=143 Identities=34% Similarity=0.580 Sum_probs=128.3
Q ss_pred CcccccCcEEEEEEEECCCcEEEEEEcCccccc-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCChh
Q 003134 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 760 (845)
++||+|++|.||++...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999877999999998765333 4568899999999999999999999999999999999999999999
Q ss_pred hhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 761 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 761 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++.... ..+++..+..++.+++.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 9986532 25789999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.5e-21 Score=204.42 Aligned_cols=149 Identities=29% Similarity=0.469 Sum_probs=131.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|+..+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999986 489999999865422 234678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++++|.++.... ..+++.++..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99999998876432 24899999999999999999999986 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-21 Score=212.97 Aligned_cols=153 Identities=26% Similarity=0.501 Sum_probs=137.3
Q ss_pred HhcCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
...+....++||-|.||.||.|.|+. .-.||||.++.. ....++|++|+.+|+.++|||+|+++|+|..+-.+|||+|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 34455677899999999999999975 678999999865 4557899999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
||..|+|.++|++.+.. .++.-..+.++.||+.||+||..++ +|||||..+|.|+.++-.|||+|||++|++..
T Consensus 344 fM~yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred cccCccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 99999999999876543 5777788999999999999999886 99999999999999999999999999999965
Q ss_pred C
Q 003134 833 D 833 (845)
Q Consensus 833 ~ 833 (845)
+
T Consensus 418 D 418 (1157)
T KOG4278|consen 418 D 418 (1157)
T ss_pred C
Confidence 4
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-21 Score=205.05 Aligned_cols=152 Identities=27% Similarity=0.414 Sum_probs=133.4
Q ss_pred cCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCccccc--chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.-|+..+.||+|.|..|-.|++ -+|+.||||++.+..-. ....+.+|++.|+.++|||||++|++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3466778899999999999985 37999999999876432 34578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe-cCCCcEEEEeeccceecC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-DKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl-d~~~~~kl~DFGla~~~~ 831 (845)
.=.+|+|+++|.+... .+.+..+.+++.||+.|+.|+|..+ +|||||||+||.+ .+-|-|||.|||++-.+.
T Consensus 98 LGD~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred ecCCchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 9999999999966543 5889999999999999999999987 9999999999987 566889999999999887
Q ss_pred CCC
Q 003134 832 EDK 834 (845)
Q Consensus 832 ~~~ 834 (845)
..+
T Consensus 171 PG~ 173 (864)
T KOG4717|consen 171 PGK 173 (864)
T ss_pred Ccc
Confidence 544
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.1e-21 Score=211.29 Aligned_cols=148 Identities=26% Similarity=0.386 Sum_probs=126.1
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC------
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 744 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 744 (845)
..++|+..+.||+|+||.||++... .++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999875 58899999997542 22346778899999999999999999988643
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence 357999999976 56666532 4788899999999999999999987 999999999999999999999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|+++....
T Consensus 164 g~~~~~~~ 171 (355)
T cd07874 164 GLARTAGT 171 (355)
T ss_pred cccccCCC
Confidence 99987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.8e-21 Score=205.89 Aligned_cols=145 Identities=29% Similarity=0.563 Sum_probs=129.2
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
|.....||+|+||.||++... ++..||+|.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 344567999999999999875 5889999998765555567789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++|.+++... .+++.++..++.|++.||+|||+++ |+||||||+||++++++.+||+|||++....
T Consensus 104 ~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 104 GALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 9999988432 5789999999999999999999986 9999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=199.70 Aligned_cols=145 Identities=29% Similarity=0.551 Sum_probs=123.9
Q ss_pred CcccccCcEEEEEEEECC-Cc--EEEEEEcCccc-ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILSD-GT--VIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||.||+|+..+ +. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999754 43 56888887532 33456788999999999 899999999999999999999999999
Q ss_pred CChhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 757 NCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 757 gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
|+|.+++..... .....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999965421 11235789999999999999999999986 9999999999999999999999999
Q ss_pred ccee
Q 003134 826 LAKL 829 (845)
Q Consensus 826 la~~ 829 (845)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=199.44 Aligned_cols=147 Identities=28% Similarity=0.459 Sum_probs=128.9
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---c-------chHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---Q-------GNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 745 (845)
+|...+.||+|++|.||+|... +++.||+|.++.... . ..+.+.+|++++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999864 588999998854211 0 1246788999999999999999999999999
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999998653 36889999999999999999999986 9999999999999999999999999
Q ss_pred cceecC
Q 003134 826 LAKLYE 831 (845)
Q Consensus 826 la~~~~ 831 (845)
+++...
T Consensus 154 ~~~~~~ 159 (272)
T cd06629 154 ISKKSD 159 (272)
T ss_pred cccccc
Confidence 998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=196.90 Aligned_cols=150 Identities=36% Similarity=0.626 Sum_probs=132.0
Q ss_pred CCCCCcccccCcEEEEEEEECC-----CcEEEEEEcCccccc-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 678 FDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
+++.+.||+|+||.||+++..+ +..||+|.++..... ..+.+..|++++.+++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3467899999999999999754 388999999765433 4678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999965422 12899999999999999999999986 9999999999999999999999999998775
Q ss_pred CC
Q 003134 832 ED 833 (845)
Q Consensus 832 ~~ 833 (845)
..
T Consensus 155 ~~ 156 (258)
T smart00219 155 DD 156 (258)
T ss_pred cc
Confidence 43
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=199.66 Aligned_cols=148 Identities=30% Similarity=0.464 Sum_probs=128.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-----ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL 747 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 747 (845)
.+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999975 58999999885321 12235788899999999999999999988764 568
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+++++|.+++... ..+++..+++++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccc
Confidence 8999999999999998543 25788899999999999999999987 999999999999999999999999999
Q ss_pred eecC
Q 003134 828 KLYE 831 (845)
Q Consensus 828 ~~~~ 831 (845)
+...
T Consensus 154 ~~~~ 157 (265)
T cd06652 154 KRLQ 157 (265)
T ss_pred cccc
Confidence 8653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=204.42 Aligned_cols=150 Identities=27% Similarity=0.377 Sum_probs=133.2
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccccc---chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|++|.||+|...+ ++.||+|.+...... ..+.+..|++++++++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999999764 899999999765322 3467889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 9999999999986432 236899999999999999999999987 9999999999999999999999999988664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=207.29 Aligned_cols=154 Identities=27% Similarity=0.464 Sum_probs=131.2
Q ss_pred cCCCCCCcccccCcEEEEEEEECC--------CcEEEEEEcCccc-ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 745 (845)
.+|.+.+.||+|+||.||+|+... ...||+|.++... ....+++.+|++++.++ +|+||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 457889999999999999997521 2368999887542 23356789999999999 8999999999999999
Q ss_pred EEEEEEeccCCCChhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 814 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld 814 (845)
..++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+++ |+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 99999999999999999865321 11235889999999999999999999987 99999999999999
Q ss_pred CCCcEEEEeeccceecCC
Q 003134 815 KDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 815 ~~~~~kl~DFGla~~~~~ 832 (845)
+++.+||+|||+++....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 169 EDNVMKIADFGLARDVHN 186 (334)
T ss_pred CCCcEEECCcccceeccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=202.02 Aligned_cols=155 Identities=25% Similarity=0.426 Sum_probs=132.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC-----CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEe-CCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~ 747 (845)
.++|...+.||+|+||.||+|.+.. +..|++|.+.... ....+.+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999765 6889999987542 2335678899999999999999999998876 4678
Q ss_pred EEEEeccCCCChhhhhhcCCcc---cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTE---YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
++++||+++|+|.+++...... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654211 1146899999999999999999999986 999999999999999999999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|+++.+..
T Consensus 162 g~~~~~~~ 169 (280)
T cd05043 162 ALSRDLFP 169 (280)
T ss_pred CCcccccC
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=196.48 Aligned_cols=143 Identities=34% Similarity=0.579 Sum_probs=124.4
Q ss_pred CcccccCcEEEEEEEECC----CcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
++||+|+||.||+|++.. +..+|+|.+..... ...+++.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998632 26899999976543 24567899999999999999999999876 4568999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+...
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 99999996532 5899999999999999999999986 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=209.65 Aligned_cols=148 Identities=25% Similarity=0.379 Sum_probs=126.2
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC------
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 744 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 744 (845)
..++|...+.||+|+||.||+|+.. .++.||||++.... ....+++.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3468999999999999999999975 58899999997542 23346788999999999999999999987643
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeC
Confidence 357999999975 67666632 4788899999999999999999986 999999999999999999999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|+|+....
T Consensus 171 G~a~~~~~ 178 (364)
T cd07875 171 GLARTAGT 178 (364)
T ss_pred CCccccCC
Confidence 99987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-20 Score=204.57 Aligned_cols=145 Identities=19% Similarity=0.263 Sum_probs=125.4
Q ss_pred CCCccccc--CcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 680 PANKVGEG--GFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 680 ~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
..++||+| +|++||++..+ +|+.||+|+++... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 67899999875 68999999997642 223456778999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++|||.+...
T Consensus 82 ~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 99999999854321 25899999999999999999999987 999999999999999999999999865443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=197.64 Aligned_cols=148 Identities=33% Similarity=0.561 Sum_probs=132.7
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccccc--chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..+.||+|++|.||+|... +++.||+|.++..... ..+.+..|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999975 6889999998765332 467889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 81 CSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred CCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 9999999998643 24788999999999999999999987 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=200.94 Aligned_cols=151 Identities=26% Similarity=0.432 Sum_probs=131.9
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|+..+.||+|++|.||+|... +++.||+|+++... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999976 48899999987542 2335688999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|++++.+..+.... ..+++.++..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99987776655332 25789999999999999999999986 99999999999999999999999999988755
Q ss_pred CC
Q 003134 833 DK 834 (845)
Q Consensus 833 ~~ 834 (845)
..
T Consensus 153 ~~ 154 (288)
T cd07833 153 RP 154 (288)
T ss_pred Cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-20 Score=195.67 Aligned_cols=150 Identities=27% Similarity=0.403 Sum_probs=129.9
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe-CCEEEEEEe
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYE 752 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~E 752 (845)
+|+..+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999975 47889999986542 2334578899999999999999999998764 456899999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++++|.+++.... ...+++.++..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 999999999986532 235899999999999999999999987 99999999999999999999999999987753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=203.67 Aligned_cols=152 Identities=27% Similarity=0.461 Sum_probs=129.3
Q ss_pred CCCCCCcccccCcEEEEEEEEC---CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLL 748 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 748 (845)
.|+..+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999975 47899999997743 33346778899999999999999999999988 8899
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC----CCcEEEEee
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK----DLNAKISDF 824 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~----~~~~kl~DF 824 (845)
+||||+++ +|.+.+..........+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999985 6766664332222236889999999999999999999987 999999999999999 899999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|+++.+..
T Consensus 157 g~~~~~~~ 164 (316)
T cd07842 157 GLARLFNA 164 (316)
T ss_pred ccccccCC
Confidence 99987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=201.90 Aligned_cols=149 Identities=27% Similarity=0.437 Sum_probs=131.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|+..+.||+|+||+||++... +++.||+|++.... ....+++.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46778899999999999999975 58899999886543 33457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++++|.+++... ..+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||+++...
T Consensus 85 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 85 MDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred CCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 9999999988543 25899999999999999999999742 39999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=203.84 Aligned_cols=143 Identities=29% Similarity=0.513 Sum_probs=128.3
Q ss_pred CCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCC
Q 003134 680 PANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gs 758 (845)
....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999875 689999999876555556778899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 759 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 759 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 105 L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 105 LTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred HHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence 9988743 25789999999999999999999987 9999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=198.07 Aligned_cols=149 Identities=30% Similarity=0.508 Sum_probs=133.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++++..+...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999976 58899999987553 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+++++|.+++... .+++.++..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999998542 6899999999999999999999986 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=196.76 Aligned_cols=148 Identities=31% Similarity=0.493 Sum_probs=128.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-----cchHHHHHHHHHHhcCCCCceeeEEEEEEe--CCEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-----QGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQL 747 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 747 (845)
.+|+..+.||+|+||.||+|... ++..||+|++..... ...+.+.+|++++++++|+||+++++++.. ++..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999975 588999998864321 223568889999999999999999998875 3678
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
+++|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 9999999999999998543 25789999999999999999999886 999999999999999999999999999
Q ss_pred eecC
Q 003134 828 KLYE 831 (845)
Q Consensus 828 ~~~~ 831 (845)
+...
T Consensus 154 ~~~~ 157 (266)
T cd06651 154 KRLQ 157 (266)
T ss_pred cccc
Confidence 8653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=197.74 Aligned_cols=148 Identities=26% Similarity=0.529 Sum_probs=131.3
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCC---CCceeeEEEEEEeCCEEEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.|+..+.||+|+||.||+|.+. +++.||+|.++... .....++.+|++++++++ |||++++++++..++..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777899999999999999974 68999999987542 334567889999999986 999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++..+.
T Consensus 82 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 82 EYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred ecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 999999999988432 6889999999999999999999987 9999999999999999999999999998775
Q ss_pred CC
Q 003134 832 ED 833 (845)
Q Consensus 832 ~~ 833 (845)
..
T Consensus 153 ~~ 154 (277)
T cd06917 153 QN 154 (277)
T ss_pred CC
Confidence 43
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=220.57 Aligned_cols=240 Identities=27% Similarity=0.344 Sum_probs=189.8
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEee
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 171 (845)
.+++.|++.+|+|+. +|. .+++|++|+|++|+|+.+ |... .+|+.|+|++|.|+. +|..+ ++|+.|+|+
T Consensus 222 ~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsL-P~lp--~sL~~L~Ls~N~L~~-Lp~lp---~~L~~L~Ls 290 (788)
T PRK15387 222 AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSL-PVLP--PGLLELSIFSNPLTH-LPALP---SGLCKLWIF 290 (788)
T ss_pred cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcc-cCcc--cccceeeccCCchhh-hhhch---hhcCEEECc
Confidence 368899999999995 664 258999999999999976 3321 289999999999984 44433 678899999
Q ss_pred cccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCc
Q 003134 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251 (845)
Q Consensus 172 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 251 (845)
+|+|+ .+|.. +++|++|+|++|+|++ +|... .+|+.|++++|+|++ +|.. ..+|++|+|++|+|++ +
T Consensus 291 ~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-L 357 (788)
T PRK15387 291 GNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-L 357 (788)
T ss_pred CCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCC-C
Confidence 99999 55653 5789999999999995 55432 468889999999985 5642 2589999999999995 4
Q ss_pred chhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCC
Q 003134 252 PASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331 (845)
Q Consensus 252 p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 331 (845)
|.. ..+|+.|++++|+++..+.. ..+|+.|+|++|+|++ +|.. .++|+.|+|++|+|++ +|..+ .+
T Consensus 358 P~l---p~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~ 423 (788)
T PRK15387 358 PTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SG 423 (788)
T ss_pred CCC---CcccceehhhccccccCccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hh
Confidence 543 35788899999999865421 1379999999999995 5543 3689999999999995 67543 46
Q ss_pred cCEEEccCCcccCCCChhhh--cCCceEEeecCCCcCCCCC
Q 003134 332 TNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSD 370 (845)
Q Consensus 332 L~~L~L~~N~l~g~ip~~~~--~~l~~L~ls~N~l~~~~p~ 370 (845)
|+.|+|++|+|+ .+|..+. ..++.|+|++|+|++..+.
T Consensus 424 L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 424 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred hhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 788999999998 7898874 4899999999999987664
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-20 Score=198.47 Aligned_cols=148 Identities=28% Similarity=0.475 Sum_probs=130.2
Q ss_pred CCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcccc------cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
+|+..+.||+|++|.||++.. .+++.||+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 4688999999865421 124678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-cEEEEeeccce
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAK 828 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~-~~kl~DFGla~ 828 (845)
||||+++++|.+++... .++++..+..++.|++.||+|||+++ ++||||||+||+++.++ .+||+|||+++
T Consensus 81 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 99999999999998543 36889999999999999999999987 99999999999998776 59999999998
Q ss_pred ecCC
Q 003134 829 LYEE 832 (845)
Q Consensus 829 ~~~~ 832 (845)
.+..
T Consensus 153 ~~~~ 156 (268)
T cd06630 153 RLAA 156 (268)
T ss_pred cccc
Confidence 7753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=189.65 Aligned_cols=142 Identities=14% Similarity=0.166 Sum_probs=109.9
Q ss_pred CCcccccCcEEEEEEEECCCcEEEEEEcCccccc--c-------hHH-----------------HHHHHHHHhcCCCCce
Q 003134 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--G-------NRE-----------------FVNEIGMISAQQHPNL 734 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~nI 734 (845)
.+.||+|++|.||+|...+|+.||||+++..... . ..+ ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999754211 1 112 2349999999988776
Q ss_pred eeEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeCCCCCCCEEe
Q 003134 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL-HEDSRIKIVHRDIKTSNVLL 813 (845)
Q Consensus 735 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrDLKp~NILl 813 (845)
.....+... ..++||||++++++....... ..+++.++..++.|++.+|+|+ |+.+ |+||||||+|||+
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 544333222 238999999998776543211 2578999999999999999999 6776 9999999999999
Q ss_pred cCCCcEEEEeeccceecCCC
Q 003134 814 DKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 814 d~~~~~kl~DFGla~~~~~~ 833 (845)
+ ++.++|+|||+|...+.+
T Consensus 152 ~-~~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHDHP 170 (190)
T ss_pred E-CCcEEEEEccccccCCCc
Confidence 8 578999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=195.35 Aligned_cols=150 Identities=27% Similarity=0.448 Sum_probs=132.2
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..+.||+|+||.+|+++.. +++.||+|.+.... ....+++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999975 58899999986532 23346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++++|.+++..... ..+++.++.+++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 999999999865322 25789999999999999999999986 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=197.31 Aligned_cols=146 Identities=29% Similarity=0.521 Sum_probs=127.5
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
++|+..+.||+|+||.||++.. .++.||+|.++... ..+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999975 57789999986532 346789999999999999999999998654 4799999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 9999999965422 35789999999999999999999986 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.4e-20 Score=197.53 Aligned_cols=147 Identities=30% Similarity=0.541 Sum_probs=131.0
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.|+..+.||.|+||.||+|... ++..||+|.+.... ......+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4677889999999999999975 58899999987542 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++|+|.+++... .+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 85 GGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 999999998532 5788999999999999999999986 99999999999999999999999999987653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-20 Score=200.52 Aligned_cols=148 Identities=28% Similarity=0.547 Sum_probs=132.9
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
++|+..+.||+|+||.||++... ++..||+|.+........+.+.+|+.++++++||||+++++++...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888999999999999999864 58899999987654455677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++++|.+++... .+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 999999998542 4788999999999999999999987 99999999999999999999999999876643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.5e-20 Score=201.41 Aligned_cols=146 Identities=28% Similarity=0.488 Sum_probs=120.3
Q ss_pred CCcccccCcEEEEEEEECC---CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEe--CCEEEEEEeccC
Q 003134 681 ANKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVYEYMK 755 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~Ey~~ 755 (845)
..+||+|+||.||+|+..+ +..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4689999999999999653 5789999986542 23567889999999999999999998864 467899999987
Q ss_pred CCChhhhhhcCCc----ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----cCCCcEEEEeeccc
Q 003134 756 NNCLSRAIFGKDT----EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLA 827 (845)
Q Consensus 756 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl----d~~~~~kl~DFGla 827 (845)
+ +|.+++..... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+|
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 77777643211 11235889999999999999999999987 9999999999999 56679999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+.+..
T Consensus 160 ~~~~~ 164 (317)
T cd07867 160 RLFNS 164 (317)
T ss_pred eccCC
Confidence 87754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-21 Score=202.12 Aligned_cols=164 Identities=28% Similarity=0.416 Sum_probs=134.2
Q ss_pred cCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCccc-cc------chHHHHHHHHHHhcCCCCceeeEEEEEEe-CCE
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQ------GNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQ 746 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~ 746 (845)
++|-....+|+|+|+.||+|.+ ...+.||||+-.... .. ..+...+|.++-+.++||.||++|+|+.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 3566778999999999999985 457889999864331 11 12346789999999999999999999974 567
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec---CCCcEEEEe
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISD 823 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld---~~~~~kl~D 823 (845)
+|-|+|||+|.+|.-+++.. ..++++++..|+.||..||.||.+. .+||||-||||.|||+. .-|.+||+|
T Consensus 543 FCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 89999999999999999654 3689999999999999999999998 47899999999999995 457899999
Q ss_pred eccceecCCCCce------eeeeeccCC
Q 003134 824 FGLAKLYEEDKTH------ISTRIAGTM 845 (845)
Q Consensus 824 FGla~~~~~~~~~------~~t~~~GT~ 845 (845)
||++++++++... .+...+|||
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTY 644 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTY 644 (775)
T ss_pred cchhhhccCCccCcccceeeecccCcee
Confidence 9999999765432 233466765
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.6e-20 Score=196.84 Aligned_cols=147 Identities=31% Similarity=0.526 Sum_probs=130.1
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
-|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667889999999999999874 58899999986542 233467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++++|.+++.. ..+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 85 ~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 85 GGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 99999999853 25789999999999999999999986 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=201.41 Aligned_cols=146 Identities=31% Similarity=0.553 Sum_probs=129.2
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 455678999999999999875 57899999987543 3334678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++|.+++.. ..+++..+..++.|+++|+.|||+++ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 86 ~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 86 GGSALDLLKP------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999998853 25789999999999999999999986 99999999999999999999999999987653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=200.47 Aligned_cols=143 Identities=27% Similarity=0.455 Sum_probs=123.6
Q ss_pred CcccccCcEEEEEEEECC--------CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 682 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+.||+|+||.||+|.... ...+|+|.+........+++.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888888665445557889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc--------EEEEeec
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN--------AKISDFG 825 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~--------~kl~DFG 825 (845)
+++|+|.++++... ..+++..+++++.||+.||+|||+++ |+||||||+||+++.++. +|++|||
T Consensus 81 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999996543 25889999999999999999999986 999999999999987765 6999999
Q ss_pred cceecC
Q 003134 826 LAKLYE 831 (845)
Q Consensus 826 la~~~~ 831 (845)
++....
T Consensus 154 ~~~~~~ 159 (258)
T cd05078 154 ISITVL 159 (258)
T ss_pred cccccC
Confidence 987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=199.42 Aligned_cols=158 Identities=31% Similarity=0.522 Sum_probs=135.0
Q ss_pred cHHHHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEe-
Q 003134 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE- 743 (845)
Q Consensus 667 ~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~- 743 (845)
++.++..+.+.|+..+.||+|+||.||+|+.. +++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45566667788999999999999999999975 58899999986542 2345688899999998 79999999999853
Q ss_pred -----CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc
Q 003134 744 -----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (845)
Q Consensus 744 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~ 818 (845)
.+..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 4678999999999999999865322 35788889999999999999999987 999999999999999999
Q ss_pred EEEEeeccceecC
Q 003134 819 AKISDFGLAKLYE 831 (845)
Q Consensus 819 ~kl~DFGla~~~~ 831 (845)
+||+|||+++...
T Consensus 160 ~~l~dfg~~~~~~ 172 (282)
T cd06636 160 VKLVDFGVSAQLD 172 (282)
T ss_pred EEEeeCcchhhhh
Confidence 9999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-20 Score=199.77 Aligned_cols=150 Identities=30% Similarity=0.486 Sum_probs=130.4
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV 750 (845)
++|+..+.||+|++|.||+|... +++.+|+|.++.... .....+.+|++++.+++||||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999986 588999999975432 2234677899999999999999999999877 899999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++ +|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 85 ~e~~~~-~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVEH-DLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcCc-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 999975 8988885432 25899999999999999999999987 999999999999999999999999999877
Q ss_pred CCC
Q 003134 831 EED 833 (845)
Q Consensus 831 ~~~ 833 (845)
...
T Consensus 157 ~~~ 159 (293)
T cd07843 157 GSP 159 (293)
T ss_pred cCC
Confidence 543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=198.06 Aligned_cols=149 Identities=33% Similarity=0.582 Sum_probs=130.8
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
+|+..+.||+|++|.||+|+.. +++.||+|.++.... .....+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999985 588999999876533 23467788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++ +|.+++..... ...+++.++.+++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 DK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred Cc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 85 88888754322 236899999999999999999999986 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=201.49 Aligned_cols=148 Identities=28% Similarity=0.514 Sum_probs=128.8
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..+.||+|++|.||+|+.. +|+.||+|.++... ......+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999975 58899999986542 22235678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++ +|.+++.... ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 81 CDQ-DLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred CCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 974 7887775432 35899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-20 Score=196.09 Aligned_cols=143 Identities=31% Similarity=0.518 Sum_probs=121.7
Q ss_pred CcccccCcEEEEEEEECC----CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEe-CCEEEEEEeccC
Q 003134 682 NKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYEYMK 755 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~Ey~~ 755 (845)
+.||+|+||.||+|.+.+ ...||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998632 4579999986432 3345688899999999999999999998764 556899999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+|+|.+++.... ...++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999996532 24677888999999999999999986 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.7e-20 Score=194.54 Aligned_cols=153 Identities=29% Similarity=0.504 Sum_probs=134.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|+..+.||.|++|.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999965 57899999986542 23457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+++++|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999965322 136899999999999999999999987 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.9e-20 Score=199.53 Aligned_cols=152 Identities=26% Similarity=0.419 Sum_probs=129.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCE-----
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQ----- 746 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~----- 746 (845)
++|+..+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999975 589999999865432 23467888999999995 6999999999987665
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCcEEEEeec
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFG 825 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~-~~~~kl~DFG 825 (845)
.|+||||+++ +|.+++..........+++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 7888886543222346899999999999999999999986 999999999999998 8899999999
Q ss_pred cceecC
Q 003134 826 LAKLYE 831 (845)
Q Consensus 826 la~~~~ 831 (845)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=198.78 Aligned_cols=148 Identities=28% Similarity=0.411 Sum_probs=132.8
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
+|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999986 588999999975432 345688999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++++|.+++... ..+++.++..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999998543 36889999999999999999999986 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-20 Score=211.25 Aligned_cols=170 Identities=29% Similarity=0.497 Sum_probs=143.3
Q ss_pred HHHHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEe--
Q 003134 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE-- 743 (845)
Q Consensus 668 ~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~-- 743 (845)
+..+...++-|++.+.||+|.+|.||+++.. +++.+|+|++.... ...++.+.|.++++.. .|||++.++|+|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3444455677889999999999999999954 68889999987753 3446777888888876 79999999999873
Q ss_pred ---CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEE
Q 003134 744 ---GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 820 (845)
Q Consensus 744 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~k 820 (845)
++++|||||||.+||..++++... ...+.|+.+..|+++++.|+.+||.+. ++|||||-.|||++.++.||
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 578999999999999999997764 357999999999999999999999986 99999999999999999999
Q ss_pred EEeeccceecCCCCceeeeeeccCC
Q 003134 821 ISDFGLAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 821 l~DFGla~~~~~~~~~~~t~~~GT~ 845 (845)
+.|||++..+....... .+..|||
T Consensus 164 LvDFGvSaQldsT~grR-nT~iGtP 187 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGRR-NTFIGTP 187 (953)
T ss_pred Eeeeeeeeeeecccccc-cCcCCCc
Confidence 99999999986544333 3366775
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=201.87 Aligned_cols=149 Identities=35% Similarity=0.656 Sum_probs=126.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCc----EEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
++|+..+.||+|+||.||+|.+. ++. .||+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46778899999999999999864 343 578898865432 2234788999999999999999999998754 4678
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 999999999999986532 25789999999999999999999986 99999999999999999999999999987
Q ss_pred cCC
Q 003134 830 YEE 832 (845)
Q Consensus 830 ~~~ 832 (845)
+..
T Consensus 159 ~~~ 161 (303)
T cd05110 159 LEG 161 (303)
T ss_pred ccC
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-20 Score=194.77 Aligned_cols=149 Identities=30% Similarity=0.528 Sum_probs=134.9
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|+..+.||+|++|.||+|+... ++.||+|++..... ...+++.+|++++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468889999999999999999864 89999999876543 3457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++++|.+++... ..+++..+..++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999643 368999999999999999999999 76 99999999999999999999999999987754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=195.51 Aligned_cols=148 Identities=30% Similarity=0.496 Sum_probs=128.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc-----cccchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL 747 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 747 (845)
.+|+..+.||+|++|.||+|... ++..||+|.+... .....+.+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999975 5899999987532 122345788999999999999999999998764 468
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+++++|.+++... ..+++..+.+++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccc
Confidence 8999999999999998543 25789999999999999999999987 999999999999999999999999999
Q ss_pred eecC
Q 003134 828 KLYE 831 (845)
Q Consensus 828 ~~~~ 831 (845)
+...
T Consensus 154 ~~~~ 157 (264)
T cd06653 154 KRIQ 157 (264)
T ss_pred cccc
Confidence 8653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=205.45 Aligned_cols=159 Identities=26% Similarity=0.369 Sum_probs=133.2
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccc--------cchHHHHHHHHHHhcCC---CCceeeEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQ---HPNLVKLYGCCVE 743 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~ 743 (845)
.+|...+.+|+|+||.|+.|.++. ...|++|.+.++.. ...-..-.|++||+.++ |+||+|++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468889999999999999999864 67899999876521 11123456999999998 9999999999999
Q ss_pred CCEEEEEEecc-CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEE
Q 003134 744 GNQLLLVYEYM-KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822 (845)
Q Consensus 744 ~~~~~lV~Ey~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~ 822 (845)
++.+||+||-. ++-+|.++|.- ...+++.++..|++||+.|+++||+++ |||||||=+||.+|.+|-+||+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence 99999999976 45688999843 357999999999999999999999998 9999999999999999999999
Q ss_pred eeccceecCCCCceeeeeeccCC
Q 003134 823 DFGLAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 823 DFGla~~~~~~~~~~~t~~~GT~ 845 (845)
|||.|.......- ..++||+
T Consensus 713 dfgsaa~~ksgpf---d~f~gtv 732 (772)
T KOG1152|consen 713 DFGSAAYTKSGPF---DVFVGTV 732 (772)
T ss_pred eccchhhhcCCCc---ceeeeec
Confidence 9999986643321 2356664
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-21 Score=223.27 Aligned_cols=150 Identities=33% Similarity=0.525 Sum_probs=123.9
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEe-------
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE------- 743 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------- 743 (845)
+-..+|+..+.||+|+||.||+++.+ ||+.||||++.... ........+|+..+++++|||||+++..|.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34467888899999999999999976 89999999997653 3334577889999999999999999865421
Q ss_pred ------------------------------------------------C-------------------------------
Q 003134 744 ------------------------------------------------G------------------------------- 744 (845)
Q Consensus 744 ------------------------------------------------~------------------------------- 744 (845)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHH
Q 003134 745 ---------------------------------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791 (845)
Q Consensus 745 ---------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~ 791 (845)
-.+||-||||+.-.+.++++.+.... .....++++++|++||.
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLA 711 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHH
Confidence 12477889998887877776543210 35678899999999999
Q ss_pred HHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 792 yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
|+|+++ ||||||||.||++|++..|||+|||+|+.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 999997 99999999999999999999999999997
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-20 Score=197.28 Aligned_cols=142 Identities=32% Similarity=0.410 Sum_probs=125.3
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 684 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
||+|+||+||+|... +++.||+|.+.... ....+.+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 58899999986532 22345677899999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
.+++..... ..+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 999865432 36899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=207.59 Aligned_cols=155 Identities=32% Similarity=0.424 Sum_probs=133.6
Q ss_pred CcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCChh
Q 003134 682 NKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 760 (845)
-++|+|.||+||.|++.+ ...+|||.+........+.+.+|+..-++++|.|||+++|.+.+++++-|.||-++||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999999764 6789999998877777788899999999999999999999999999999999999999999
Q ss_pred hhhhcCCcccccCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCcEEEEeeccceecCCCCcee
Q 003134 761 RAIFGKDTEYRLKL--DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHI 837 (845)
Q Consensus 761 ~~l~~~~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld-~~~~~kl~DFGla~~~~~~~~~~ 837 (845)
+++..+= .++ .+.++-.+.+||++||.|||++. |||||||-+|||++ -.|.+||+|||.++++..-.. .
T Consensus 661 sLLrskW----GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~ 732 (1226)
T KOG4279|consen 661 SLLRSKW----GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-C 732 (1226)
T ss_pred HHHHhcc----CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc-c
Confidence 9996542 244 67788889999999999999997 99999999999996 578999999999998864332 2
Q ss_pred eeeeccC
Q 003134 838 STRIAGT 844 (845)
Q Consensus 838 ~t~~~GT 844 (845)
+.++.||
T Consensus 733 TETFTGT 739 (1226)
T KOG4279|consen 733 TETFTGT 739 (1226)
T ss_pred ccccccc
Confidence 2346666
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-20 Score=199.74 Aligned_cols=152 Identities=30% Similarity=0.510 Sum_probs=130.3
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC----
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN---- 745 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 745 (845)
...++|+..+.||+|++|.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999986 58899999986543 223456788999999999999999999987654
Q ss_pred ------EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcE
Q 003134 746 ------QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (845)
Q Consensus 746 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~ 819 (845)
..++|+||+++ ++...+... ...+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcE
Confidence 78999999986 676766443 236899999999999999999999986 9999999999999999999
Q ss_pred EEEeeccceecCC
Q 003134 820 KISDFGLAKLYEE 832 (845)
Q Consensus 820 kl~DFGla~~~~~ 832 (845)
||+|||+++.+..
T Consensus 156 kl~dfg~~~~~~~ 168 (302)
T cd07864 156 KLADFGLARLYNS 168 (302)
T ss_pred EeCcccccccccC
Confidence 9999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-22 Score=209.41 Aligned_cols=289 Identities=20% Similarity=0.238 Sum_probs=220.4
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeec-c
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG-N 173 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N 173 (845)
.++.++.+|+ .+|..+. +.-..++|..|+|+.+++.+|..+ +|+.||||+|+|+.+-|++|.+|.+|..|-+.+ |
T Consensus 50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred eEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 4566777777 4565554 345789999999999999999999 999999999999999999999999988887766 9
Q ss_pred cCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCC-----
Q 003134 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE----- 248 (845)
Q Consensus 174 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~----- 248 (845)
+|+...-..|++|..|+.|.+.-|++.-...+.|..|++|..|.|.+|.+..+--..|..+..++.+.+..|.+-
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNL 206 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccccc
Confidence 999766678999999999999999999888888999999999999999999554458999999999999999842
Q ss_pred -------CCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC--CccEEEccCCcCcccCcc-cccCCCCcCEEeCCCCCC
Q 003134 249 -------GPIPASISALTSLTDLRISDLKGSESAFPKLDKM--NLKTLILTKCLIHGEIPD-YIGDMTKLKNIDLSFNNL 318 (845)
Q Consensus 249 -------g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~--~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l 318 (845)
...|..++...-..-..+.+.++.......+... .+..-..+.+..-++-|. .|..+++|+.|+|++|+|
T Consensus 207 ~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i 286 (498)
T KOG4237|consen 207 PWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKI 286 (498)
T ss_pred chhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCcc
Confidence 2234444444444444444444444433333222 122122233444445554 599999999999999999
Q ss_pred CCCCchhhhcCCCcCEEEccCCcccCCCChhhhc---CCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCCC
Q 003134 319 TGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN---SNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKL 392 (845)
Q Consensus 319 ~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~---~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~~ 392 (845)
+++-+.+|.++..+++|+|..|+|. .+....+. .|+.|+|.+|+++...|..| .....+..++.-.|.+
T Consensus 287 ~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF----~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 287 TRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAF----QTLFSLSTLNLLSNPF 358 (498)
T ss_pred chhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecccc----cccceeeeeehccCcc
Confidence 9999999999999999999999998 44444443 78999999999998888777 3445555555544444
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.4e-20 Score=198.71 Aligned_cols=148 Identities=31% Similarity=0.567 Sum_probs=129.9
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..+.||+|++|.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999975 58899999987543 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+. ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 96 58988886532 236899999999999999999999986 9999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.9e-20 Score=211.31 Aligned_cols=156 Identities=26% Similarity=0.348 Sum_probs=122.9
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEE-----------------CCCcEEEEEEcCcccccchHH--------------HHH
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGIL-----------------SDGTVIAVKQLSSKSRQGNRE--------------FVN 721 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~ 721 (845)
...++|++.++||+|+||.||+|.. ..++.||||+++.......++ +..
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3467899999999999999999964 235689999987543322223 344
Q ss_pred HHHHHhcCCCCce-----eeEEEEEEe--------CCEEEEEEeccCCCChhhhhhcCCcc-------------------
Q 003134 722 EIGMISAQQHPNL-----VKLYGCCVE--------GNQLLLVYEYMKNNCLSRAIFGKDTE------------------- 769 (845)
Q Consensus 722 E~~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~~------------------- 769 (845)
|+.++.+++|.++ ++++++|.. .+..+|||||+++|+|.++++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777776654 677787753 35689999999999999999753211
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 770 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 770 ~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 0124578889999999999999999986 9999999999999999999999999997654
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=189.77 Aligned_cols=150 Identities=33% Similarity=0.636 Sum_probs=135.6
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999986 688999999987655566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||.+......
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999999986542 36899999999999999999999976 999999999999999999999999999887654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=191.06 Aligned_cols=149 Identities=33% Similarity=0.562 Sum_probs=133.8
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999875 578999999976643 3456889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999998543 36899999999999999999999986 999999999999999999999999999987543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=194.33 Aligned_cols=154 Identities=27% Similarity=0.523 Sum_probs=128.7
Q ss_pred CCCCCCcccccCcEEEEEEEECC--CcEEEEEEcCccc----------ccchHHHHHHHHHHhc-CCCCceeeEEEEEEe
Q 003134 677 NFDPANKVGEGGFGSVYKGILSD--GTVIAVKQLSSKS----------RQGNREFVNEIGMISA-QQHPNLVKLYGCCVE 743 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~ 743 (845)
+|+..+.||+|+||.||+|.... ++.+|+|.+.... .....++..|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999764 6889999875321 1223457788888865 799999999999999
Q ss_pred CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEe
Q 003134 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (845)
Q Consensus 744 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~D 823 (845)
++..++||||+++++|.+++.... .....+++..+++++.|++.||.|||+.. +++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999998875321 11236899999999999999999999632 499999999999999999999999
Q ss_pred eccceecCCC
Q 003134 824 FGLAKLYEED 833 (845)
Q Consensus 824 FGla~~~~~~ 833 (845)
||++......
T Consensus 158 fg~~~~~~~~ 167 (269)
T cd08528 158 FGLAKQKQPE 167 (269)
T ss_pred ccceeecccc
Confidence 9999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.9e-20 Score=196.23 Aligned_cols=148 Identities=31% Similarity=0.557 Sum_probs=130.3
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEEEEEEe
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVYE 752 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~E 752 (845)
|+..+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999976 48899999997653 33346788999999999999999999999988 89999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++ +|.+++.... ..+++.++..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMDH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred cccc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 9985 8888885432 36899999999999999999999986 99999999999999999999999999987754
Q ss_pred C
Q 003134 833 D 833 (845)
Q Consensus 833 ~ 833 (845)
.
T Consensus 153 ~ 153 (287)
T cd07840 153 R 153 (287)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.3e-20 Score=195.31 Aligned_cols=151 Identities=28% Similarity=0.488 Sum_probs=126.0
Q ss_pred CCCCCcccccCcEEEEEEEEC----CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC------
Q 003134 678 FDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------ 745 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 745 (845)
|...+.||+|+||.||+|.+. ++..||+|.+.... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999863 36889999987542 233567889999999999999999999886532
Q ss_pred EEEEEEeccCCCChhhhhhcCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
..++++||+++|+|.+++..... .....+++..+.+++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 34789999999999988753221 11235789999999999999999999986 999999999999999999999999
Q ss_pred ccceecC
Q 003134 825 GLAKLYE 831 (845)
Q Consensus 825 Gla~~~~ 831 (845)
|+++...
T Consensus 158 g~~~~~~ 164 (273)
T cd05074 158 GLSKKIY 164 (273)
T ss_pred ccccccc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-20 Score=193.07 Aligned_cols=150 Identities=30% Similarity=0.474 Sum_probs=131.0
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++|+||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999975 58899999986542 23356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~-~~~kl~DFGla~~~~~ 832 (845)
+++++|.+++.... ...+++..+.+++.|++.||+|||+++ |+||||||+||+++++ +.+||+|||+++....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999996532 235899999999999999999999986 9999999999999855 4689999999987753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.8e-20 Score=219.72 Aligned_cols=243 Identities=24% Similarity=0.347 Sum_probs=146.3
Q ss_pred EEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeecc
Q 003134 94 VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173 (845)
Q Consensus 94 v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 173 (845)
.+.|++++++++ .+|..+. ++|+.|+|++|+|+.++.. +. .+|++|+|++|+|+. +|..+. .+|+.|+|++|
T Consensus 180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~~-l~-~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N 251 (754)
T PRK15370 180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPEN-LQ-GNIKTLYANSNQLTS-IPATLP--DTIQEMELSIN 251 (754)
T ss_pred ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCChh-hc-cCCCEEECCCCcccc-CChhhh--ccccEEECcCC
Confidence 456777777776 3555443 4677777777777754332 22 267777777777763 454442 36777777777
Q ss_pred cCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcch
Q 003134 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA 253 (845)
Q Consensus 174 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 253 (845)
+++ .+|..+. .+|+.|+|++|+|+ .+|..+. ++|++|+|++|+|++ +|..+. ++|+.|++++|+++. +|.
T Consensus 252 ~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~ 321 (754)
T PRK15370 252 RIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPE 321 (754)
T ss_pred ccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCc
Confidence 777 5565553 36777777777777 4565443 467777777777773 444332 357777777777764 343
Q ss_pred hhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcC
Q 003134 254 SISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333 (845)
Q Consensus 254 ~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 333 (845)
.+ .++|+.|++++|.++..+.... .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ..|+
T Consensus 322 ~l--~~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~ 391 (754)
T PRK15370 322 TL--PPGLKTLEAGENALTSLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQ 391 (754)
T ss_pred cc--cccceeccccCCccccCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHH
Confidence 32 2466777777776665432211 36777777777766 3454443 46777777777776 3454443 2566
Q ss_pred EEEccCCcccCCCChhhh------cCCceEEeecCCCc
Q 003134 334 FMYLTGNKLTGPVPKYIF------NSNKNVDISLNNFT 365 (845)
Q Consensus 334 ~L~L~~N~l~g~ip~~~~------~~l~~L~ls~N~l~ 365 (845)
.|++++|+|+ .+|..+. ..+..|++.+|.|+
T Consensus 392 ~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 392 IMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 6777777776 4554431 24556677777543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-20 Score=204.81 Aligned_cols=148 Identities=21% Similarity=0.351 Sum_probs=128.6
Q ss_pred cCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.-|..++.||-|+||.|..+.. ++...+|+|.+++... ........|..||+..+.+-||+||..|++.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 3467788899999999999874 4577899999977632 33345678999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||++||++-.+|-..+ -+.+..++.++.++..|+++.|..| +|||||||+|||||.||++||+||||+.-+.
T Consensus 709 dYIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence 9999999999886543 5778888889999999999999887 9999999999999999999999999987543
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-20 Score=196.58 Aligned_cols=149 Identities=26% Similarity=0.491 Sum_probs=132.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|+..+.||+|++|.||++... +++.+|+|.+.... ....+++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778899999999999999986 58899999987653 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++++|.+++.... ..+++..+.+++.|++.||+|||+ .+ ++||||||+||++++++.+||+|||.+....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999986532 368899999999999999999998 65 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-20 Score=196.24 Aligned_cols=154 Identities=32% Similarity=0.533 Sum_probs=132.9
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCC-----
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN----- 745 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~----- 745 (845)
.++++|+..+.||+|++|.||+|... +++.+++|.+..... ..+++.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999985 578999999875432 346789999999998 7999999999997644
Q ss_pred -EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 746 -QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 746 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
..++||||+++++|.+++.... .....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence 5899999999999999885432 11246899999999999999999999986 999999999999999999999999
Q ss_pred ccceecC
Q 003134 825 GLAKLYE 831 (845)
Q Consensus 825 Gla~~~~ 831 (845)
|++....
T Consensus 158 ~~~~~~~ 164 (275)
T cd06608 158 GVSAQLD 164 (275)
T ss_pred ccceecc
Confidence 9988654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.3e-20 Score=193.40 Aligned_cols=157 Identities=27% Similarity=0.489 Sum_probs=131.2
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe--CCEEEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVY 751 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ 751 (845)
+|+..+.||.|+||.||++... +++.+|+|.+.... ....+++..|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999864 58899999986532 2334678899999999999999999998764 45689999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS--RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||+++++|.+++.... .....+++..++.++.|++.||+|||..+ ..+|+||||||+||+++.++.+||+|||+++.
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999986532 12346899999999999999999999332 23499999999999999999999999999998
Q ss_pred cCCCC
Q 003134 830 YEEDK 834 (845)
Q Consensus 830 ~~~~~ 834 (845)
.....
T Consensus 160 ~~~~~ 164 (265)
T cd08217 160 LGHDS 164 (265)
T ss_pred ccCCc
Confidence 75433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.9e-20 Score=196.95 Aligned_cols=152 Identities=27% Similarity=0.454 Sum_probs=130.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 751 (845)
++|+..+.||.|++|.||+|... +++.+|+|.+..... ...+++.+|++++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999985 588999999875432 3456789999999999999999999998654 4789999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999988753221 2235889999999999999999999986 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=194.85 Aligned_cols=141 Identities=29% Similarity=0.382 Sum_probs=118.4
Q ss_pred cccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHH---hcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMI---SAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 683 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..++ ...+|+||+++++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 588999998865421 1123344444433 34479999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 99999988543 36899999999999999999999987 9999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=194.96 Aligned_cols=146 Identities=29% Similarity=0.563 Sum_probs=130.3
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
.|...+.||+|++|.||++... +++.+++|+++.......+.+.+|+.++++++|+||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3555679999999999999964 688999999876544556678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 100 ~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 100 GGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred CCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 9999999854 25789999999999999999999987 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=196.77 Aligned_cols=148 Identities=31% Similarity=0.529 Sum_probs=128.3
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
..|+..+.||+|+||.||+|... +++.||+|.+..... ...+++.+|++++++++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999975 589999999864322 22357889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+. |++.+.+.... ..+++.++..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++...
T Consensus 95 e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9997 57777664321 35899999999999999999999986 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.4e-20 Score=197.54 Aligned_cols=148 Identities=26% Similarity=0.375 Sum_probs=128.8
Q ss_pred CCCCCCcccccCcEEEEEEEEC----CCcEEEEEEcCccc----ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 747 (845)
+|+..+.||+|++|.||+++.. +++.||||.++... ....+.+.+|++++.++ +|+||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677889999999999999852 47889999986532 22345688999999999 599999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccc
Confidence 9999999999999998542 25789999999999999999999986 999999999999999999999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+....
T Consensus 153 ~~~~~ 157 (288)
T cd05583 153 KEFLA 157 (288)
T ss_pred ccccc
Confidence 87643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=192.32 Aligned_cols=141 Identities=26% Similarity=0.390 Sum_probs=126.2
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 684 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
||+|++|.||+|+.. +++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999986 488999999865422 3346789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 9999653 24789999999999999999999986 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.8e-20 Score=193.99 Aligned_cols=141 Identities=29% Similarity=0.463 Sum_probs=126.2
Q ss_pred ccccCcEEEEEEEECC-CcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 684 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
||+|+||.||+++... ++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+..++..|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 89999999876533 3456788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
.+++... ..+++..+..++.||++||+|||+.+ ++||||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 9998643 26899999999999999999999987 99999999999999999999999999886543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.4e-20 Score=212.70 Aligned_cols=151 Identities=22% Similarity=0.305 Sum_probs=121.6
Q ss_pred HHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCC------CceeeEEEEEE
Q 003134 670 QIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH------PNLVKLYGCCV 742 (845)
Q Consensus 670 ~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~nIv~l~~~~~ 742 (845)
++...+++|++.++||+|+||+||+|+.. .++.||||+++... ...+++..|++++.+++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 33445678999999999999999999975 57899999996532 223455667777766654 46899999887
Q ss_pred eC-CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCC---
Q 003134 743 EG-NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDL--- 817 (845)
Q Consensus 743 ~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivHrDLKp~NILld~~~--- 817 (845)
.. +..++|||++ +++|.+++... ..+++.++..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV 272 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence 65 5789999988 67888888543 2689999999999999999999974 5 99999999999998765
Q ss_pred -------------cEEEEeeccceec
Q 003134 818 -------------NAKISDFGLAKLY 830 (845)
Q Consensus 818 -------------~~kl~DFGla~~~ 830 (845)
.+||+|||.+...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred ccccccccCCCCceEEECCCCccccC
Confidence 4999999988653
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-20 Score=203.24 Aligned_cols=158 Identities=31% Similarity=0.547 Sum_probs=134.5
Q ss_pred HHHHHhcCCCCCCcccccCcEEEEEEEECC---C--cEEEEEEcCcc-cccchHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 003134 670 QIKAATNNFDPANKVGEGGFGSVYKGILSD---G--TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (845)
Q Consensus 670 ~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 743 (845)
+.+...+.....++||.|-||.||+|.+.+ | -.||||.-+.. .....+.|..|..+|++++||||++++|.|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 333344455567899999999999999643 3 36888988764 44557889999999999999999999999975
Q ss_pred CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEe
Q 003134 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (845)
Q Consensus 744 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~D 823 (845)
...|||||.++-|.|..++..+. ..++......++.|+..||.|||+.. +|||||..+|||+....-||++|
T Consensus 463 -~P~WivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred -cceeEEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecc
Confidence 46899999999999999996543 36888999999999999999999985 99999999999999999999999
Q ss_pred eccceecCCCCc
Q 003134 824 FGLAKLYEEDKT 835 (845)
Q Consensus 824 FGla~~~~~~~~ 835 (845)
||++|.++++.-
T Consensus 535 FGLSR~~ed~~y 546 (974)
T KOG4257|consen 535 FGLSRYLEDDAY 546 (974)
T ss_pred cchhhhccccch
Confidence 999998876543
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=196.43 Aligned_cols=143 Identities=28% Similarity=0.557 Sum_probs=127.9
Q ss_pred CCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 681 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
..+||+|+||.||++... +++.||+|++..........+.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 467999999999999874 6899999998665445566789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
.+++... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 105 TDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 9887432 5789999999999999999999986 99999999999999999999999999876643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=182.56 Aligned_cols=141 Identities=16% Similarity=0.177 Sum_probs=112.4
Q ss_pred CCcccccCcEEEEEEEECCCcEEEEEEcCccccc---------------------c-----hHHHHHHHHHHhcCCCCce
Q 003134 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ---------------------G-----NREFVNEIGMISAQQHPNL 734 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~nI 734 (845)
...||+|++|.||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998764211 0 1123578999999999987
Q ss_pred eeEEEEEEeCCEEEEEEeccCCCChhhh-hhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEE
Q 003134 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRA-IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVL 812 (845)
Q Consensus 735 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDLKp~NIL 812 (845)
.....+.... .++||||++++++... +.. ..++..+..+++.|++.++.|+|+ .+ |+||||||+||+
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl 150 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL 150 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence 5544443332 4899999998865433 321 256788999999999999999999 76 999999999999
Q ss_pred ecCCCcEEEEeeccceecCCC
Q 003134 813 LDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 813 ld~~~~~kl~DFGla~~~~~~ 833 (845)
++ ++.++|+|||+|+....+
T Consensus 151 l~-~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred EE-CCCEEEEEcccceecCCC
Confidence 99 889999999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=193.94 Aligned_cols=150 Identities=33% Similarity=0.616 Sum_probs=134.9
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++.|+..+.||+|++|.||+|... ++..+|+|.+..... ..+.+.+|++++++++|+|++++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999986 588999999976543 46778899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|+++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 96 ~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 96 YMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred ccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 999999999996542 36899999999999999999999986 9999999999999999999999999887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=193.99 Aligned_cols=149 Identities=30% Similarity=0.514 Sum_probs=127.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|+..+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999975 588999999865422 234678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCcEEEEeeccceecC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYE 831 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~-~~~~kl~DFGla~~~~ 831 (845)
|++ ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||+++...
T Consensus 82 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 47877774432 124678889999999999999999986 999999999999985 5679999999998653
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.5e-20 Score=192.78 Aligned_cols=150 Identities=27% Similarity=0.489 Sum_probs=130.9
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999976 48899999986542 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-cEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~-~~kl~DFGla~~~~~ 832 (845)
+++++|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999999865322 35799999999999999999999987 99999999999999875 479999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=189.25 Aligned_cols=153 Identities=27% Similarity=0.476 Sum_probs=135.2
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..+.||+|++|.||++... ++..+|+|++..... ...+++.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999976 588999999976533 4456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+++++|.+++..... ....+++.++..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999865421 1247899999999999999999999986 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.81 E-value=9e-20 Score=194.57 Aligned_cols=147 Identities=33% Similarity=0.543 Sum_probs=125.5
Q ss_pred CcccccCcEEEEEEEECC-------CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 682 NKVGEGGFGSVYKGILSD-------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+.||+|+||.||+|+..+ +..+|+|.+.... .....++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2579999886543 23456889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcc--cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-----cEEEEeecc
Q 003134 754 MKNNCLSRAIFGKDTE--YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-----NAKISDFGL 826 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~-----~~kl~DFGl 826 (845)
+++|+|.+++...... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++ .+|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999653221 1235789999999999999999999886 99999999999999877 899999999
Q ss_pred ceecC
Q 003134 827 AKLYE 831 (845)
Q Consensus 827 a~~~~ 831 (845)
++...
T Consensus 158 ~~~~~ 162 (269)
T cd05044 158 ARDIY 162 (269)
T ss_pred ccccc
Confidence 98653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=196.83 Aligned_cols=150 Identities=33% Similarity=0.540 Sum_probs=129.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 749 (845)
.++|+..+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457889999999999999999975 589999999865432 2234567899999999999999999998765 57899
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++ +|.+++.... ..+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 86 v~e~~~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeee
Confidence 9999975 7888875432 36899999999999999999999987 99999999999999999999999999987
Q ss_pred cCC
Q 003134 830 YEE 832 (845)
Q Consensus 830 ~~~ 832 (845)
+..
T Consensus 158 ~~~ 160 (309)
T cd07845 158 YGL 160 (309)
T ss_pred cCC
Confidence 754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=200.06 Aligned_cols=149 Identities=31% Similarity=0.552 Sum_probs=127.9
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc--cccchHHHHHHHHHHhcC-CCCceeeEEEEEEeC--CEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG--NQL 747 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~--~~~ 747 (845)
..++|+..+.||+|+||.||+|... +++.+|+|++... .......+.+|+++++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999976 5889999988543 223345677899999999 999999999998754 468
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||++ ++|..++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccch
Confidence 99999997 5898888542 5788899999999999999999986 999999999999999999999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+....
T Consensus 155 ~~~~~ 159 (337)
T cd07852 155 RSLSE 159 (337)
T ss_pred hcccc
Confidence 87643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.6e-22 Score=194.49 Aligned_cols=149 Identities=29% Similarity=0.563 Sum_probs=125.1
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEe--------C
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--------G 744 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~ 744 (845)
..|+...+||+|.||.||+|+..+ |+.||+|++-.+ .........+|+++|..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345667899999999999999754 778898876432 33345677899999999999999999988863 2
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
..+|+||++|+. +|..++... ...++..++.+++.++..||.|+|... |+|||+||+|+||+.+|.+||+||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecc
Confidence 358999999987 788888433 346899999999999999999999986 999999999999999999999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|+||.+..
T Consensus 169 Glar~fs~ 176 (376)
T KOG0669|consen 169 GLARAFST 176 (376)
T ss_pred ccccceec
Confidence 99987753
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.9e-20 Score=217.55 Aligned_cols=226 Identities=25% Similarity=0.327 Sum_probs=184.2
Q ss_pred CCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEee
Q 003134 116 RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILS 195 (845)
Q Consensus 116 ~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 195 (845)
.+...|+|+++.++.+ |..+. -.|+.|+|++|+|+. +|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|+
T Consensus 178 ~~~~~L~L~~~~LtsL-P~~Ip-~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 178 NNKTELRLKILGLTTI-PACIP-EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred cCceEEEeCCCCcCcC-Ccccc-cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 4678999999999965 43332 279999999999995 555443 58999999999999 5677664 479999999
Q ss_pred cCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCC
Q 003134 196 SNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA 275 (845)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~ 275 (845)
+|+++ .+|..+. .+|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +|..+. .+|+.|++++|.++..+
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~LP 320 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTALP 320 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccccCC
Confidence 99999 7787775 58999999999999 5677664 589999999999995 454443 47899999999998754
Q ss_pred CcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCc
Q 003134 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 355 (845)
Q Consensus 276 ~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~ 355 (845)
.... .+|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+...|+
T Consensus 321 ~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~sL~ 391 (754)
T PRK15370 321 ETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLPAALQ 391 (754)
T ss_pred cccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHHHHHH
Confidence 3222 489999999999996 666654 79999999999998 5777663 68999999999999 67888878899
Q ss_pred eEEeecCCCcCC
Q 003134 356 NVDISLNNFTWE 367 (845)
Q Consensus 356 ~L~ls~N~l~~~ 367 (845)
.|++++|+|+..
T Consensus 392 ~LdLs~N~L~~L 403 (754)
T PRK15370 392 IMQASRNNLVRL 403 (754)
T ss_pred HHhhccCCcccC
Confidence 999999999843
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-19 Score=188.11 Aligned_cols=149 Identities=37% Similarity=0.569 Sum_probs=133.8
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEEEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVY 751 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 751 (845)
+|+..+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++|+||+++++.+... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999986 688999999876542 4467889999999999999999999999988 8999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++++|.+++.... .+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 9999999999985432 6899999999999999999999986 9999999999999999999999999999876
Q ss_pred CC
Q 003134 832 ED 833 (845)
Q Consensus 832 ~~ 833 (845)
..
T Consensus 153 ~~ 154 (260)
T cd06606 153 DI 154 (260)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=199.55 Aligned_cols=151 Identities=25% Similarity=0.426 Sum_probs=129.1
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC---
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--- 745 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--- 745 (845)
....++|+..+.||+|+||.||++... ++..||||++.... ....+.+.+|++++++++|+||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 334678999999999999999999864 68999999986532 223456889999999999999999999987543
Q ss_pred ---EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEE
Q 003134 746 ---QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822 (845)
Q Consensus 746 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~ 822 (845)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 468999998 6789888743 25889999999999999999999987 9999999999999999999999
Q ss_pred eeccceecCC
Q 003134 823 DFGLAKLYEE 832 (845)
Q Consensus 823 DFGla~~~~~ 832 (845)
|||+++....
T Consensus 161 dfg~~~~~~~ 170 (343)
T cd07880 161 DFGLARQTDS 170 (343)
T ss_pred eccccccccc
Confidence 9999987643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.4e-19 Score=194.53 Aligned_cols=147 Identities=30% Similarity=0.518 Sum_probs=127.0
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
|+..+.||+|+||.||+++.. ++..+|+|++..... ...+++.+|++++++++|+|++++++++..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566788999999999999975 588999999864322 2235788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+.+ +|.+.+... ...+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 107 ~~g-~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 107 CLG-SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 974 777776432 235899999999999999999999987 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=200.01 Aligned_cols=148 Identities=28% Similarity=0.459 Sum_probs=127.4
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----CEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 747 (845)
+++|+..+.||+|++|.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999865 58999999986432 23346788899999999999999999987654 358
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+++ +|.+.+.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 84 YIVQELMET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEehhccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence 999999975 78777743 25899999999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+....
T Consensus 154 ~~~~~ 158 (336)
T cd07849 154 RIADP 158 (336)
T ss_pred eeccc
Confidence 87643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=195.60 Aligned_cols=149 Identities=29% Similarity=0.525 Sum_probs=126.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-------
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------- 745 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------- 745 (845)
++|+..++||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999975 58999999886542 222345678999999999999999999987653
Q ss_pred -EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 746 -QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 746 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
..++||||+.+ +|.+.+.... ..+++.++..++.|++.||+|||+++ ++||||||+||+++.++.+||+||
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 45999999975 7887775432 25899999999999999999999986 999999999999999999999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|++..+..
T Consensus 164 g~~~~~~~ 171 (310)
T cd07865 164 GLARAFSL 171 (310)
T ss_pred CCcccccC
Confidence 99987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=192.48 Aligned_cols=147 Identities=31% Similarity=0.569 Sum_probs=129.1
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
|+..+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|+|++++++++..++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999975 69999999987543 223467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+ ++|.+++..... ..+++..+.+++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 689998865421 36899999999999999999999986 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-19 Score=191.36 Aligned_cols=141 Identities=28% Similarity=0.379 Sum_probs=118.5
Q ss_pred cccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHH---HHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 683 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIG---MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 683 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
.||+|+||.||+|... +++.||+|.+..... .....+..|.. .++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 588999999865421 11223344433 4445689999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 99999888532 36899999999999999999999986 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=198.81 Aligned_cols=155 Identities=29% Similarity=0.435 Sum_probs=132.3
Q ss_pred cHHHHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 003134 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (845)
Q Consensus 667 ~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 743 (845)
..+++...+++|+..+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++.+++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 45567778899999999999999999999864 68899999987542 2234678889999999999999999998864
Q ss_pred C------CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC
Q 003134 744 G------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 817 (845)
Q Consensus 744 ~------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~ 817 (845)
. ...++++|++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 3 3468888886 77998887432 5889999999999999999999987 99999999999999999
Q ss_pred cEEEEeeccceecC
Q 003134 818 NAKISDFGLAKLYE 831 (845)
Q Consensus 818 ~~kl~DFGla~~~~ 831 (845)
.+||+|||+++...
T Consensus 158 ~~kl~dfg~~~~~~ 171 (345)
T cd07877 158 ELKILDFGLARHTD 171 (345)
T ss_pred CEEEeccccccccc
Confidence 99999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.6e-19 Score=187.68 Aligned_cols=152 Identities=26% Similarity=0.346 Sum_probs=125.0
Q ss_pred HHHHHHHhcCCCCCCcc--cccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhc-CCCCceeeEEEEEEe
Q 003134 668 LRQIKAATNNFDPANKV--GEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCCVE 743 (845)
Q Consensus 668 ~~~l~~~~~~y~~~~~i--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~ 743 (845)
..+.....++|++.+.+ |+|+||.||+++.. ++..+|+|.+........ |+..... .+|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34455556677777777 99999999999975 588899999865422111 2222221 279999999999999
Q ss_pred CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-cEEEE
Q 003134 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKIS 822 (845)
Q Consensus 744 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~-~~kl~ 822 (845)
.+..++||||+++|+|.+++... ..+++.++..++.|+++||+|||+.+ ++||||||+||+++.++ .++|+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEe
Confidence 99999999999999999999643 26899999999999999999999987 99999999999999988 99999
Q ss_pred eeccceecCC
Q 003134 823 DFGLAKLYEE 832 (845)
Q Consensus 823 DFGla~~~~~ 832 (845)
|||+++....
T Consensus 153 dfg~~~~~~~ 162 (267)
T PHA03390 153 DYGLCKIIGT 162 (267)
T ss_pred cCccceecCC
Confidence 9999987653
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=194.65 Aligned_cols=149 Identities=32% Similarity=0.471 Sum_probs=133.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV 750 (845)
++|...+.||+|++|.||+|... +++.||+|++.... ....+.+..|.+++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999975 68999999987632 233467888999999998 99999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++++|.+++... ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 9999999999998543 26899999999999999999999987 999999999999999999999999999876
Q ss_pred CC
Q 003134 831 EE 832 (845)
Q Consensus 831 ~~ 832 (845)
..
T Consensus 153 ~~ 154 (280)
T cd05581 153 DP 154 (280)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=193.47 Aligned_cols=152 Identities=28% Similarity=0.481 Sum_probs=124.4
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556788999999999999975 58999999987543 234567889999999996 99999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+.. ++.++...........+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 874 5544332111111246899999999999999999999752 39999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-19 Score=190.18 Aligned_cols=146 Identities=27% Similarity=0.405 Sum_probs=124.2
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCC-CCceeeEEEEEEeC--CEEEEEEe
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEG--NQLLLVYE 752 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~E 752 (845)
|+..+.||+|+||.||+|... +++.||+|+++.... .......+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999975 588999999876422 22334557888898885 99999999999987 88999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|++ |+|.+.+.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++. +.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 57888775432 36899999999999999999999987 999999999999999 9999999999987643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.3e-19 Score=187.75 Aligned_cols=142 Identities=28% Similarity=0.386 Sum_probs=120.3
Q ss_pred CcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHH-hcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMI-SAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|++|.||+|... +++.||+|.+..... .....+..|..++ ...+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999975 588999999865422 1223344555443 455899999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 9999998543 25889999999999999999999986 9999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-19 Score=198.06 Aligned_cols=148 Identities=26% Similarity=0.404 Sum_probs=126.9
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeC------
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 744 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 744 (845)
..++|+..+.||+|+||.||+|... +++.||+|.+... .....+++.+|++++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999975 6899999998653 223345678899999999999999999988643
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
...|+||||+.+ +|.+.+.. .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence 357999999964 78777732 2788899999999999999999986 999999999999999999999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|+++....
T Consensus 163 g~~~~~~~ 170 (353)
T cd07850 163 GLARTAGT 170 (353)
T ss_pred ccceeCCC
Confidence 99987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.1e-20 Score=183.78 Aligned_cols=150 Identities=27% Similarity=0.518 Sum_probs=126.8
Q ss_pred CCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 680 PANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
....||.|+.|.||+++.+ .|..+|||.+.+.. .+..+++...++++.+-+ .|.||+.+|||..+...++.||.|..
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 4578999999999999976 48999999997763 445677888888877664 89999999999999999999999864
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCCce
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~~~ 836 (845)
.++.+++.- ..++++.-+-++...+..||.||.+++ +|+|||+||+|||+|+.|++|+||||++.++-+...+
T Consensus 176 -C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 176 -CAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred -HHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 566666432 346888888899999999999999987 7999999999999999999999999999988665443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.9e-20 Score=176.63 Aligned_cols=152 Identities=24% Similarity=0.434 Sum_probs=125.1
Q ss_pred CCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCccc-ccchHHHHHHHHHHh-cCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS-RQGNREFVNEIGMIS-AQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+......||+|++|.|-+-++ .+|...|+|.+...- .+..++..+|+.+.. ....|.+|.+||.+......|+.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 334567899999999988886 469999999997653 344567778887654 45899999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|.- ||..+-.+- -.....+++...-+|+..|.+||.|||++- .|||||+||+||||+.+|++|+||||++..+.+
T Consensus 127 M~t-Sldkfy~~v-~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 127 MDT-SLDKFYRKV-LKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred hhh-hHHHHHHHH-HhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 974 776655332 122347889999999999999999999975 699999999999999999999999999887643
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.8e-20 Score=201.77 Aligned_cols=151 Identities=29% Similarity=0.468 Sum_probs=132.6
Q ss_pred CCCcccccCcEEEEEEEECC--C--cEEEEEEcCccccc-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 680 PANKVGEGGFGSVYKGILSD--G--TVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
..++||+|.||.|++|.|.. | -.||||+++..... ...+|++|+.+|.+++|+|+++|||...+ ....+|||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 45889999999999999863 4 36899999877544 57899999999999999999999999887 6788999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
+.|||.+.|++. .+..|-......++.|||.||.||..++ .|||||..+|+|+-..-.|||+|||+.|-+...+
T Consensus 193 plGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 193 PLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred ccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999772 2346777888999999999999999986 9999999999999999999999999999987766
Q ss_pred cee
Q 003134 835 THI 837 (845)
Q Consensus 835 ~~~ 837 (845)
++.
T Consensus 267 d~Y 269 (1039)
T KOG0199|consen 267 DMY 269 (1039)
T ss_pred cce
Confidence 543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=198.30 Aligned_cols=149 Identities=23% Similarity=0.455 Sum_probs=128.6
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe----CCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~ 747 (845)
.++|+..+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368889999999999999999975 58999999987542 2335677889999999999999999998763 3568
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+. |+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999996 5898888543 25899999999999999999999986 999999999999999999999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+....
T Consensus 155 ~~~~~ 159 (334)
T cd07855 155 RGLSS 159 (334)
T ss_pred eeecc
Confidence 87643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-19 Score=196.18 Aligned_cols=152 Identities=27% Similarity=0.445 Sum_probs=130.6
Q ss_pred HHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe-CC
Q 003134 670 QIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GN 745 (845)
Q Consensus 670 ~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~ 745 (845)
++...+++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44556788999999999999999999865 68999999886432 2335678899999999999999999999876 56
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg 153 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFG 153 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccc
Confidence 789999998 56898887532 4788888999999999999999987 9999999999999999999999999
Q ss_pred cceecC
Q 003134 826 LAKLYE 831 (845)
Q Consensus 826 la~~~~ 831 (845)
+++...
T Consensus 154 ~~~~~~ 159 (328)
T cd07856 154 LARIQD 159 (328)
T ss_pred cccccC
Confidence 998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=189.19 Aligned_cols=152 Identities=34% Similarity=0.542 Sum_probs=132.8
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|+..++||+|++|.||+++.. +++.+|+|.+.... .....++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 58899999987542 23345778899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++++|.+++.... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 99999999986532 12246899999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.2e-19 Score=195.49 Aligned_cols=147 Identities=28% Similarity=0.462 Sum_probs=126.6
Q ss_pred cCCCC-CCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccc--------------hHHHHHHHHHHhcCCCCceeeEEE
Q 003134 676 NNFDP-ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG--------------NREFVNEIGMISAQQHPNLVKLYG 739 (845)
Q Consensus 676 ~~y~~-~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~~ 739 (845)
++|.. .+.||+|+||.||+|... +++.||+|++....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 467999999999999975 58999999986542211 125778999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcE
Q 003134 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (845)
Q Consensus 740 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~ 819 (845)
++..++..++||||++ |+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 9999999999999997 5898888532 35889999999999999999999987 9999999999999999999
Q ss_pred EEEeeccceecC
Q 003134 820 KISDFGLAKLYE 831 (845)
Q Consensus 820 kl~DFGla~~~~ 831 (845)
||+|||+++...
T Consensus 159 kl~dfg~~~~~~ 170 (335)
T PTZ00024 159 KIADFGLARRYG 170 (335)
T ss_pred EECCccceeecc
Confidence 999999998765
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-21 Score=190.42 Aligned_cols=149 Identities=28% Similarity=0.475 Sum_probs=122.8
Q ss_pred CCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHH-hcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 680 PANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMI-SAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
....||.|+||+|+|-.++ .|+.+|||+++.... .+.++++.|.+.. +.-+.||||++||.+..++..|+.||.|.-
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~ 147 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI 147 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence 3578999999999998875 599999999987643 4567888888764 445899999999999999999999999964
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||..+.+.-..-....+++.-.-.|......||+||-+.. .|||||+||+|||+|..|.+||||||++..+.
T Consensus 148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 6655443222223446888888889999999999998875 69999999999999999999999999987663
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-19 Score=190.98 Aligned_cols=148 Identities=30% Similarity=0.482 Sum_probs=128.6
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEEEEecc
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
|++.+.||+|++|+||+|+.. +++.||+|++..... .......+|++.+.+++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999986 478999999876432 22334567999999999 999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+|+|.+.+.... ...+++.++..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||+++....
T Consensus 81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 789998886543 236899999999999999999999986 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-19 Score=196.74 Aligned_cols=148 Identities=28% Similarity=0.473 Sum_probs=130.6
Q ss_pred CCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----EEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLL 748 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 748 (845)
+|++.+.||+|++|.||+|+... ++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47888999999999999999764 8999999997653 334568899999999999999999999988765 789
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+||||+++ +|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 81 lv~e~~~~-~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELMET-DLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchhh-hHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 99999984 898888543 26899999999999999999999987 9999999999999999999999999999
Q ss_pred ecCCC
Q 003134 829 LYEED 833 (845)
Q Consensus 829 ~~~~~ 833 (845)
.....
T Consensus 152 ~~~~~ 156 (330)
T cd07834 152 GVDPD 156 (330)
T ss_pred eeccc
Confidence 87554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.2e-19 Score=196.41 Aligned_cols=149 Identities=28% Similarity=0.490 Sum_probs=128.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----CE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 746 (845)
.++|...+.||+|+||+||+|+.. +++.||+|.++.. ......++.+|++++++++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888999999999999999975 5899999998753 233345678899999999999999999987644 35
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.++||||+. ++|.+++... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcc
Confidence 899999996 6888888543 36899999999999999999999986 99999999999999999999999999
Q ss_pred ceecCC
Q 003134 827 AKLYEE 832 (845)
Q Consensus 827 a~~~~~ 832 (845)
++....
T Consensus 155 ~~~~~~ 160 (337)
T cd07858 155 ARTTSE 160 (337)
T ss_pred ccccCC
Confidence 987654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.8e-19 Score=194.53 Aligned_cols=142 Identities=23% Similarity=0.354 Sum_probs=123.0
Q ss_pred Cccccc--CcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEG--GFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
..||+| +||+||++++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999975 69999999987542 22346788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|++|||.+..
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 999999865422 35889999999999999999999986 99999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.6e-19 Score=193.19 Aligned_cols=143 Identities=20% Similarity=0.200 Sum_probs=120.4
Q ss_pred CcccccCcEEEEEEEECCCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
+.+|.|+++.||++.. +++.||+|++... .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3344445544444444 5899999998754 234456899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+..+.
T Consensus 87 ~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 87 EDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred HHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 999965322 35889999999999999999999986 9999999999999999999999999987653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-20 Score=217.41 Aligned_cols=151 Identities=32% Similarity=0.507 Sum_probs=132.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
+-++....+||.|.||.||-|.. .+|...|+|-++... ....+...+|+.++..++|||+|+++|+-..++..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 44677788999999999999985 469999999886542 333567789999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|||++|+|.+.+...+ -.++.....+..|++.|+.|||++| ||||||||+||+++.+|.+|.+|||.|+.+.
T Consensus 1314 EyC~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHhccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 9999999999985432 4566677788899999999999998 9999999999999999999999999999886
Q ss_pred CC
Q 003134 832 ED 833 (845)
Q Consensus 832 ~~ 833 (845)
..
T Consensus 1386 ~~ 1387 (1509)
T KOG4645|consen 1386 NN 1387 (1509)
T ss_pred Cc
Confidence 54
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.7e-19 Score=192.32 Aligned_cols=161 Identities=27% Similarity=0.417 Sum_probs=135.2
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcc--cccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
..|++.++||+|+.+.||++...+.+.+|+|++... ..+....|..|++.|.++ .|.+||++++|-..++.+|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 457889999999999999999988889999887543 344567899999999999 58999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
| ..-+|..+|..+... ..+| .++.+..||+.|+.++|+++ |||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 441 ~-Gd~DL~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 441 C-GDIDLNKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred c-ccccHHHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 8 455899999765332 3334 78899999999999999997 99999999999995 57999999999999987
Q ss_pred CCceeee-eeccCC
Q 003134 833 DKTHIST-RIAGTM 845 (845)
Q Consensus 833 ~~~~~~t-~~~GT~ 845 (845)
+.+.+.. .-+||+
T Consensus 512 DTTsI~kdsQvGT~ 525 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTV 525 (677)
T ss_pred cccceeeccccCcc
Confidence 6655432 356774
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=186.83 Aligned_cols=148 Identities=32% Similarity=0.536 Sum_probs=124.8
Q ss_pred CCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccccc--chHHHHHHHHHHhcC---CCCceeeEEEEEEeCCE-----
Q 003134 678 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ--GNREFVNEIGMISAQ---QHPNLVKLYGCCVEGNQ----- 746 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~----- 746 (845)
|++.+.||+|++|.||+|+... ++.||+|+++..... ....+.+|++++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999864 899999999754222 234566787776655 69999999999988776
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.+++|||+.+ +|.+++..... ..+++.++..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCc
Confidence 9999999975 79888854321 25899999999999999999999986 99999999999999999999999999
Q ss_pred ceecCC
Q 003134 827 AKLYEE 832 (845)
Q Consensus 827 a~~~~~ 832 (845)
+..+..
T Consensus 154 ~~~~~~ 159 (287)
T cd07838 154 ARIYSF 159 (287)
T ss_pred ceeccC
Confidence 988754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=8e-19 Score=188.54 Aligned_cols=148 Identities=30% Similarity=0.528 Sum_probs=129.9
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccccc--chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
|+..+.||+|++|.||+|... +++.+++|.++..... ....+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999975 6889999998765322 3567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
++ +|.+.+.... ..+++.++..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||.+......
T Consensus 81 ~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 75 8888875432 36899999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=188.48 Aligned_cols=145 Identities=32% Similarity=0.528 Sum_probs=125.2
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
|...++||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++|+|++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999975 588999999865422 2235678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
+. |++.+.+... ...+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 96 5777777432 236899999999999999999999987 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.5e-21 Score=217.11 Aligned_cols=240 Identities=23% Similarity=0.330 Sum_probs=160.5
Q ss_pred CCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEee
Q 003134 116 RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILS 195 (845)
Q Consensus 116 ~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 195 (845)
++|+.|+.++|.++ ..-..+...+|+++++++|++++. |++++.+.+|+.|+..+|+|+ .+|..+..+++|+.|.+.
T Consensus 219 ~~l~~L~a~~n~l~-~~~~~p~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~ 295 (1081)
T KOG0618|consen 219 PSLTALYADHNPLT-TLDVHPVPLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAA 295 (1081)
T ss_pred cchheeeeccCcce-eeccccccccceeeecchhhhhcc-hHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhh
Confidence 44555555555555 222223333555555555555532 355555555555555555554 455555555555555555
Q ss_pred cCcCcccCChhhhCCCCCCcEEeecCcCcccCchhh--------------------------cCCcccceEEecCCcCCC
Q 003134 196 SNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI--------------------------GKWKKIQKLHIQGSSLEG 249 (845)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--------------------------~~l~~L~~L~Ls~N~l~g 249 (845)
+|.++ .+|....+++.|++|+|..|+|. ..|+.+ ..++.|+.|++.+|.|+.
T Consensus 296 ~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd 373 (1081)
T KOG0618|consen 296 YNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD 373 (1081)
T ss_pred hhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence 55555 44444455555555555555554 222211 124567888888888887
Q ss_pred CcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhc
Q 003134 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328 (845)
Q Consensus 250 ~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 328 (845)
..-..+.+...|+.|+|++|++...+...+.++ .|+.|+||+|+++ .+|..+.++..|++|...+|+|. ..| .+..
T Consensus 374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~ 450 (1081)
T KOG0618|consen 374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQ 450 (1081)
T ss_pred cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhh
Confidence 777778888888888888888887777777666 7888888888888 66788888888888888888887 666 7888
Q ss_pred CCCcCEEEccCCcccC-CCChhhh-cCCceEEeecCC
Q 003134 329 LAKTNFMYLTGNKLTG-PVPKYIF-NSNKNVDISLNN 363 (845)
Q Consensus 329 l~~L~~L~L~~N~l~g-~ip~~~~-~~l~~L~ls~N~ 363 (845)
++.|+++||+.|+|+. .+|.... +.|+.|||++|.
T Consensus 451 l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 451 LPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred cCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 9999999999999875 5666665 789999999995
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=190.39 Aligned_cols=148 Identities=28% Similarity=0.499 Sum_probs=127.1
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.|+..+.||+|++|.||+|+.. +++.+|+|.+.... ....+++.+|++++++++|+|++++++++...+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999975 57899999886432 2234568889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+. |++.+.+.... ..+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 997 57877764322 35889999999999999999999986 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.6e-19 Score=189.77 Aligned_cols=150 Identities=29% Similarity=0.543 Sum_probs=126.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccc-ccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.++|+..+.||+|++|.||+|.+.+ ++.||||.++... .....++..|++++.+.. |+||+++++++......++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567889999999999999999875 8999999997542 223456677887777664 999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++ ++.+++.... ..+++..+.+++.|++.||+|||+.. +|+||||||+||++++++.+||+|||++..+.
T Consensus 94 e~~~~-~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMST-CLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccCc-CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99854 6777664321 26899999999999999999999742 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-19 Score=182.68 Aligned_cols=147 Identities=27% Similarity=0.357 Sum_probs=121.8
Q ss_pred hcCCCC-CCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHh-cCCCCceeeEEEEEEe----CCEE
Q 003134 675 TNNFDP-ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMIS-AQQHPNLVKLYGCCVE----GNQL 747 (845)
Q Consensus 675 ~~~y~~-~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~----~~~~ 747 (845)
+++|.+ .++||-|-.|.|..|..+ +++.+|+|++... ...++|++.-- .-.|||||.++++|.+ ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 455554 368999999999999875 5899999998653 34566777533 3379999999999874 3567
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCcEEEEee
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDF 824 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~---~~~~kl~DF 824 (845)
.+|||.|+||.|...+.+.+. ..+++.++..|+.||+.|+.|||+.. |.||||||+|+|... +..+||+||
T Consensus 135 LiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred EeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 899999999999999976543 47999999999999999999999986 999999999999964 557999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|+|+.-..
T Consensus 209 GFAK~t~~ 216 (400)
T KOG0604|consen 209 GFAKETQE 216 (400)
T ss_pred ccccccCC
Confidence 99998754
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.3e-19 Score=188.29 Aligned_cols=147 Identities=33% Similarity=0.537 Sum_probs=130.1
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
|+..+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+..|++++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999976 48999999997653 333467888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+ ++|.+++.... ..+++.++.+++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||+++....
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 8 58999996542 36899999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=192.74 Aligned_cols=146 Identities=28% Similarity=0.468 Sum_probs=124.7
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC------C
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------N 745 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 745 (845)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368989999999999999999975 58999999986532 22345688999999999999999999998754 3
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
..++|+||+.. +|..+.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEeccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCC
Confidence 56999999974 6766541 25789999999999999999999986 9999999999999999999999999
Q ss_pred cceecC
Q 003134 826 LAKLYE 831 (845)
Q Consensus 826 la~~~~ 831 (845)
+++...
T Consensus 163 ~~~~~~ 168 (342)
T cd07879 163 LARHAD 168 (342)
T ss_pred CCcCCC
Confidence 998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-20 Score=204.60 Aligned_cols=267 Identities=19% Similarity=0.226 Sum_probs=164.6
Q ss_pred EEecCCCcc-ccCCccccCCCCCCEEeccCCcccCC----Cccccccc-ceeEEEecCCCCCC------Ccccccccccc
Q 003134 97 IALKAQNLT-GTLPTELSKLRYLKQLDLSRNCLTGS----FSPQWASL-QLVELSVMGNRLSG------PFPKVLTNITT 164 (845)
Q Consensus 97 L~l~~~~l~-g~~p~~l~~L~~L~~L~Ls~N~l~~~----~~~~~~~l-~L~~L~Ls~N~l~~------~~p~~~~~l~~ 164 (845)
|+|..+.+. +.....+..++.|++|+|+++.++.. ++..+... ++++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 556666665 33444556666677777777776543 22222222 47777777776652 23445666777
Q ss_pred cceeEeecccCCCCCCcccccCCC---ccEEEeecCcCcc----cCChhhhCC-CCCCcEEeecCcCccc----Cchhhc
Q 003134 165 LKNLSIEGNLFTGSIPPDIRKLIN---LQKLILSSNSFTG----ELPAELTKL-TNLNDLRISDNNFSGK----IPEFIG 232 (845)
Q Consensus 165 L~~L~Ls~N~l~g~~p~~~~~l~~---L~~L~Ls~N~l~g----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~~~~ 232 (845)
|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 777777777777656666655555 7777777777763 233345555 7777777777777732 334455
Q ss_pred CCcccceEEecCCcCCCC----cchhhhcCCCCCEEEcCCCCCCCCCCccc----c-cCCccEEEccCCcCcccCccccc
Q 003134 233 KWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKL----D-KMNLKTLILTKCLIHGEIPDYIG 303 (845)
Q Consensus 233 ~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l----~-~~~L~~L~Ls~N~l~~~~p~~~~ 303 (845)
.+++|++|+|++|.+++. ++..+..+++|+.|++++|.+++.....+ . ..+|+.|++++|.+++.....+.
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~ 242 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA 242 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHH
Confidence 666777777777777742 33445555677777777777654332221 1 12577777777777753333322
Q ss_pred -----CCCCcCEEeCCCCCCC----CCCchhhhcCCCcCEEEccCCcccCC----CChhh---hcCCceEEeecCC
Q 003134 304 -----DMTKLKNIDLSFNNLT----GGIPTTFEKLAKTNFMYLTGNKLTGP----VPKYI---FNSNKNVDISLNN 363 (845)
Q Consensus 304 -----~l~~L~~L~Ls~N~l~----g~~p~~~~~l~~L~~L~L~~N~l~g~----ip~~~---~~~l~~L~ls~N~ 363 (845)
..++|++|++++|.++ ..+...+..+++|++|++++|.++.. +...+ ...++.|++.+|.
T Consensus 243 ~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 243 SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred HHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 2367888888888886 22344566677888888888888754 22222 1367777777773
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=191.13 Aligned_cols=146 Identities=26% Similarity=0.422 Sum_probs=123.4
Q ss_pred CCCCCCcccccCcEEEEEEEEC-C--CcEEEEEEcCccc--ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeC----CE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-D--GTVIAVKQLSSKS--RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG----NQ 746 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~ 746 (845)
+|+..+.||+|+||.||+++.. . +..||+|++.... ....+.+.+|++++.++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999975 3 7789999986532 22346788899999999 599999999875432 45
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.++++||+. ++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 789999986 5898888542 36899999999999999999999987 99999999999999999999999999
Q ss_pred ceecC
Q 003134 827 AKLYE 831 (845)
Q Consensus 827 a~~~~ 831 (845)
++.+.
T Consensus 152 a~~~~ 156 (332)
T cd07857 152 ARGFS 156 (332)
T ss_pred ceecc
Confidence 98764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=190.54 Aligned_cols=149 Identities=35% Similarity=0.555 Sum_probs=126.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeC-------
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEG------- 744 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------- 744 (845)
.++|+..+.||+|++|.||+|... +++.+|+|++..... .....+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468899999999999999999975 588999999865422 2234678899999999999999999987543
Q ss_pred -CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEe
Q 003134 745 -NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (845)
Q Consensus 745 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~D 823 (845)
...++||||+.+ ++...+... ...+++.++..++.|+++||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence 347999999875 677766442 236899999999999999999999987 99999999999999999999999
Q ss_pred eccceecC
Q 003134 824 FGLAKLYE 831 (845)
Q Consensus 824 FGla~~~~ 831 (845)
||+++...
T Consensus 159 fg~~~~~~ 166 (311)
T cd07866 159 FGLARPYD 166 (311)
T ss_pred Cccchhcc
Confidence 99998764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=181.74 Aligned_cols=141 Identities=31% Similarity=0.403 Sum_probs=125.9
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEcCccccc---chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 684 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 684 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
||+|++|.||++... +++.+|+|.+...... ....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999976 4889999998765322 345788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 9998543 25899999999999999999999986 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=193.79 Aligned_cols=146 Identities=30% Similarity=0.488 Sum_probs=126.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeC----------
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG---------- 744 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~---------- 744 (845)
.+|...+.||+|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888999999999999999975 5889999998766555667889999999999999999999876543
Q ss_pred ----CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCcE
Q 003134 745 ----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNA 819 (845)
Q Consensus 745 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld-~~~~~ 819 (845)
...++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++ +++.+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35799999997 588888743 25889999999999999999999987 99999999999997 45678
Q ss_pred EEEeeccceecC
Q 003134 820 KISDFGLAKLYE 831 (845)
Q Consensus 820 kl~DFGla~~~~ 831 (845)
|++|||+++...
T Consensus 155 kl~dfg~~~~~~ 166 (342)
T cd07854 155 KIGDFGLARIVD 166 (342)
T ss_pred EECCcccceecC
Confidence 999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.5e-19 Score=186.15 Aligned_cols=151 Identities=24% Similarity=0.359 Sum_probs=124.9
Q ss_pred CCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcc-----cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
+|.+.+.||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998753 444555555432 122344677899999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++++|.+++.... .....+++.+++.++.|+++||+|||+.+ ++|+||||+||++++ +.+||+|||+++..
T Consensus 81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeec
Confidence 99999999999886432 12246899999999999999999999986 999999999999975 56999999999876
Q ss_pred CC
Q 003134 831 EE 832 (845)
Q Consensus 831 ~~ 832 (845)
..
T Consensus 156 ~~ 157 (260)
T cd08222 156 MG 157 (260)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-19 Score=176.46 Aligned_cols=147 Identities=25% Similarity=0.488 Sum_probs=126.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcccccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCC--EEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN--QLLLV 750 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~~lV 750 (845)
.++|++.+++|+|.|+.||.|.. .+.+.++||+++... .+.+.+|+.+|..+. ||||+++++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46788999999999999999984 568899999997643 467889999999996 999999999988754 56899
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CcEEEEeecccee
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKL 829 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~-~~~kl~DFGla~~ 829 (845)
+||+.+.+...+. ..++...+..++.+++.||.|+|+.| |+|||+||.|++||.. -..+|+|+|+|.+
T Consensus 114 FE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 9999987765543 25677789999999999999999998 9999999999999964 5699999999999
Q ss_pred cCCCCc
Q 003134 830 YEEDKT 835 (845)
Q Consensus 830 ~~~~~~ 835 (845)
+.....
T Consensus 183 YHp~~e 188 (338)
T KOG0668|consen 183 YHPGKE 188 (338)
T ss_pred cCCCce
Confidence 976543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.1e-19 Score=195.65 Aligned_cols=150 Identities=27% Similarity=0.453 Sum_probs=129.4
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCE---
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ--- 746 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--- 746 (845)
...++|+..+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999986 58899999986532 2234567789999999999999999998876554
Q ss_pred ---EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEe
Q 003134 747 ---LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (845)
Q Consensus 747 ---~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~D 823 (845)
.++|+||+ +++|.+++.. ..+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcc
Confidence 89999998 5699988853 25899999999999999999999986 99999999999999999999999
Q ss_pred eccceecCC
Q 003134 824 FGLAKLYEE 832 (845)
Q Consensus 824 FGla~~~~~ 832 (845)
||++.....
T Consensus 162 fg~~~~~~~ 170 (343)
T cd07851 162 FGLARHTDD 170 (343)
T ss_pred ccccccccc
Confidence 999987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=174.05 Aligned_cols=139 Identities=14% Similarity=0.268 Sum_probs=107.9
Q ss_pred CCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcC-----CCCceeeEEEEEEeCC---E-EE
Q 003134 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-----QHPNLVKLYGCCVEGN---Q-LL 748 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~---~-~~ 748 (845)
+...+.||+|++|.||. ++.....+||++........+++.+|+++++++ .||||++++|++.++. . +.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34568899999999996 433233368988765445567899999999999 6799999999999873 4 34
Q ss_pred EEEec--cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeCCCCCCCEEecC----CCcEEE
Q 003134 749 LVYEY--MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL-AYLHEDSRIKIVHRDIKTSNVLLDK----DLNAKI 821 (845)
Q Consensus 749 lV~Ey--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~ivHrDLKp~NILld~----~~~~kl 821 (845)
+|+|| +.+|+|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 5589999999542 24444 35677888777 9999997 999999999999974 347999
Q ss_pred Ee-ecccee
Q 003134 822 SD-FGLAKL 829 (845)
Q Consensus 822 ~D-FGla~~ 829 (845)
+| ||.+..
T Consensus 151 iDg~G~~~~ 159 (210)
T PRK10345 151 CDNIGESTF 159 (210)
T ss_pred EECCCCcce
Confidence 99 555444
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-18 Score=184.62 Aligned_cols=149 Identities=21% Similarity=0.294 Sum_probs=112.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC----CcEEEEEEcCcccccc-----------hHHHHHHHHHHhcCCCCceeeEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQG-----------NREFVNEIGMISAQQHPNLVKLYG 739 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l~~ 739 (845)
.++|.+.+.||+|+||.||+|...+ +..+|+|+........ ......+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3578899999999999999999754 3456666543322111 011223344566779999999999
Q ss_pred EEEeCC----EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC
Q 003134 740 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 815 (845)
Q Consensus 740 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~ 815 (845)
++.... ..++++|++.. ++.+.+... ...++..+..|+.|++.||+|||+.+ |+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 876543 44778887654 565555322 23578889999999999999999986 999999999999999
Q ss_pred CCcEEEEeeccceecCC
Q 003134 816 DLNAKISDFGLAKLYEE 832 (845)
Q Consensus 816 ~~~~kl~DFGla~~~~~ 832 (845)
++.+||+|||+|+.+..
T Consensus 162 ~~~~~l~DFGla~~~~~ 178 (294)
T PHA02882 162 NNRGYIIDYGIASHFII 178 (294)
T ss_pred CCcEEEEEcCCceeecc
Confidence 99999999999988743
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.4e-20 Score=202.10 Aligned_cols=151 Identities=28% Similarity=0.509 Sum_probs=137.2
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
..++|+....+|.|.||.|||+++. .++..|+|+++........-..+|+-+++..+|||||.++|.|...+..|++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3567889999999999999999975 589999999988766666777889999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
||.+|+|++.-+.. .++++.++..+++..++||+|||+++ -+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 93 ycgggslQdiy~~T-----gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred ecCCCcccceeeec-----ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh
Confidence 99999999987553 47999999999999999999999997 68999999999999999999999999887753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-18 Score=201.68 Aligned_cols=153 Identities=25% Similarity=0.336 Sum_probs=108.3
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-C----CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEE------EE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-D----GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC------CV 742 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~------~~ 742 (845)
..++|+..+.||+|+||.||+|++. + +..||+|++..... .+.+..| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999975 4 68999998764321 1111111 1122222222222211 23
Q ss_pred eCCEEEEEEeccCCCChhhhhhcCCccc---------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 003134 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEY---------------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 807 (845)
Q Consensus 743 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLK 807 (845)
.++..++||||+++++|.+++....... .....+..+..++.|++.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 5568999999999999999986542110 001123456689999999999999986 9999999
Q ss_pred CCCEEecC-CCcEEEEeeccceecCCC
Q 003134 808 TSNVLLDK-DLNAKISDFGLAKLYEED 833 (845)
Q Consensus 808 p~NILld~-~~~~kl~DFGla~~~~~~ 833 (845)
|+|||+++ ++.+||+|||+|+.+...
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~ 309 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG 309 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc
Confidence 99999985 589999999999876543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-17 Score=211.60 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=126.3
Q ss_pred eEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEee
Q 003134 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 171 (845)
.++.|+|.++.+. .++..+..+++|+.|+|++|...+.+|. +..+ +|+.|+|++|..-..+|..+.++++|+.|+|+
T Consensus 612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 3444555555444 3444455555555555555443333332 3333 55555555554444555555555555555555
Q ss_pred cccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhh--------------------
Q 003134 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI-------------------- 231 (845)
Q Consensus 172 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-------------------- 231 (845)
+|..-+.+|..+ ++++|++|+|++|...+.+|.. .++|++|+|++|.++ .+|..+
T Consensus 690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~ 764 (1153)
T PLN03210 690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWE 764 (1153)
T ss_pred CCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhhccc
Confidence 543333444433 4555555555555433333321 234555556666554 333321
Q ss_pred ----------cCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCccc
Q 003134 232 ----------GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDY 301 (845)
Q Consensus 232 ----------~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~ 301 (845)
...++|+.|+|++|...+.+|..++++++|+.|++++|......+......+|+.|+|++|..-..+|..
T Consensus 765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~ 844 (1153)
T PLN03210 765 RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDI 844 (1153)
T ss_pred cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccccc
Confidence 0113455555555555555566666666666666655432222222222335566666655443333332
Q ss_pred ccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccC-CcccCCCChhh--hcCCceEEeecC
Q 003134 302 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG-NKLTGPVPKYI--FNSNKNVDISLN 362 (845)
Q Consensus 302 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~-N~l~g~ip~~~--~~~l~~L~ls~N 362 (845)
.++|+.|+|++|.|+ .+|..+..+++|++|+|++ |+|+ .+|..+ ...|+.++++++
T Consensus 845 ---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 845 ---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred ---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 245566666666665 4555566666666666655 3333 233332 234555555544
|
syringae 6; Provisional |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.3e-19 Score=185.59 Aligned_cols=163 Identities=28% Similarity=0.369 Sum_probs=134.0
Q ss_pred HhcCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccc---cchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSR---QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 748 (845)
...+|....+||+|+||.|..|..+. .+.+|||++++... .+.+--+.|-++|+.. +-|.+++++.+++.-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 34578889999999999999998764 67899999987632 2223334566666655 6789999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
.||||+.||+|--++... ..+.+..++-+|.+||-||-|||+++ ||.||||.+|||+|.+|++||+|||+++
T Consensus 427 FVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence 999999999998888543 25777889999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCCceeeeeeccCC
Q 003134 829 LYEEDKTHISTRIAGTM 845 (845)
Q Consensus 829 ~~~~~~~~~~t~~~GT~ 845 (845)
.---+.. .+.+++|||
T Consensus 499 Eni~~~~-TTkTFCGTP 514 (683)
T KOG0696|consen 499 ENIFDGV-TTKTFCGTP 514 (683)
T ss_pred ccccCCc-ceeeecCCC
Confidence 7544433 334588986
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-17 Score=210.94 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=155.2
Q ss_pred cccCCccccCCC-CCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCccc
Q 003134 105 TGTLPTELSKLR-YLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI 183 (845)
Q Consensus 105 ~g~~p~~l~~L~-~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 183 (845)
...+|..|..++ +|+.|++.+|.++.. |..|..-+|+.|+|++|+|. .++..+..+++|+.|+|++|...+.+| .+
T Consensus 577 ~~~lp~~~~~lp~~Lr~L~~~~~~l~~l-P~~f~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~l 653 (1153)
T PLN03210 577 RWHLPEGFDYLPPKLRLLRWDKYPLRCM-PSNFRPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DL 653 (1153)
T ss_pred eeecCcchhhcCcccEEEEecCCCCCCC-CCcCCccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-cc
Confidence 334555555553 466677766666433 44443336666777666665 345556666667777776655433555 35
Q ss_pred ccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCE
Q 003134 184 RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTD 263 (845)
Q Consensus 184 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 263 (845)
+.+++|++|+|++|.....+|..+.++++|+.|+|++|..-+.+|..+ ++++|+.|+|++|...+.+|.. ..+|+.
T Consensus 654 s~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~ 729 (1153)
T PLN03210 654 SMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISW 729 (1153)
T ss_pred ccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCe
Confidence 666667777776665555666666666666667666654333555544 5666666666666544444432 235555
Q ss_pred EEcCCCCCCCCCCcc------------------------------cccCCccEEEccCCcCcccCcccccCCCCcCEEeC
Q 003134 264 LRISDLKGSESAFPK------------------------------LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDL 313 (845)
Q Consensus 264 L~Ls~n~~~~~~~~~------------------------------l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 313 (845)
|++++|.+...+... ....+|+.|+|++|...+.+|..++++++|+.|+|
T Consensus 730 L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~L 809 (1153)
T PLN03210 730 LDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEI 809 (1153)
T ss_pred eecCCCccccccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEEC
Confidence 666555544322110 01126778888888777778888888888888888
Q ss_pred CCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcC
Q 003134 314 SFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW 366 (845)
Q Consensus 314 s~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~ 366 (845)
++|+.-+.+|..+ ++++|+.|+|++|.....+|.. ..+++.|+|++|.++.
T Consensus 810 s~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~-~~nL~~L~Ls~n~i~~ 860 (1153)
T PLN03210 810 ENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI-STNISDLNLSRTGIEE 860 (1153)
T ss_pred CCCCCcCeeCCCC-CccccCEEECCCCCcccccccc-ccccCEeECCCCCCcc
Confidence 8775444666655 6778888888887655555543 3567788888887764
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-20 Score=213.89 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=216.3
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeecccC
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLF 175 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 175 (845)
.|+|+.|.+. --.+.++.+|+.|....|++... .+.+.+|+.|+.++|.+....+... -.+|+++++++|++
T Consensus 182 ~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l---~~~g~~l~~L~a~~n~l~~~~~~p~--p~nl~~~dis~n~l 253 (1081)
T KOG0618|consen 182 QLDLRYNEME---VLDLSNLANLEVLHCERNQLSEL---EISGPSLTALYADHNPLTTLDVHPV--PLNLQYLDISHNNL 253 (1081)
T ss_pred eeecccchhh---hhhhhhccchhhhhhhhcccceE---EecCcchheeeeccCcceeeccccc--cccceeeecchhhh
Confidence 5788888776 24577888999999999988754 2344589999999999984333222 35899999999999
Q ss_pred CCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhh
Q 003134 176 TGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI 255 (845)
Q Consensus 176 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 255 (845)
+ .+|.+++.+.+|+.|+..+|+|+ .+|..+..+++|+.|++.+|.+. .+|+...+++.|++|+|..|+|....+..+
T Consensus 254 ~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l 330 (1081)
T KOG0618|consen 254 S-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFL 330 (1081)
T ss_pred h-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHH
Confidence 9 67799999999999999999996 89999999999999999999999 788889999999999999999985443332
Q ss_pred hc-------------------------CCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcC
Q 003134 256 SA-------------------------LTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLK 309 (845)
Q Consensus 256 ~~-------------------------l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 309 (845)
.- +..|+.|.+.+|.+++..++.+... +|+.|+|++|+|.......+.++..|+
T Consensus 331 ~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~Le 410 (1081)
T KOG0618|consen 331 AVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELE 410 (1081)
T ss_pred hhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhH
Confidence 21 2335667778888888888877766 899999999999977777799999999
Q ss_pred EEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhh-hcCCceEEeecCCCcCC
Q 003134 310 NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-FNSNKNVDISLNNFTWE 367 (845)
Q Consensus 310 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~-~~~l~~L~ls~N~l~~~ 367 (845)
+|+||+|+|+ .+|+.+.+++.|+.|...+|+|. ..|+.. .+.|+.+|+|.|+++..
T Consensus 411 eL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 411 ELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred HHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccchhhhh
Confidence 9999999999 88899999999999999999998 677433 46899999999999843
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-18 Score=178.21 Aligned_cols=162 Identities=25% Similarity=0.348 Sum_probs=136.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 749 (845)
.++|+...+||+|+|.+|..+++. +.+.+|+|+++++.. ++..-.+.|-.+..+. +||.+|.+..+|+.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 457889999999999999999975 578999999987632 2233445565555544 89999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
|.||++||+|--++.. ...++++.+..+..+|.-||.|||+.+ ||.||||.+|+|+|.+|++|++|+|+++.
T Consensus 329 vieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999777643 347999999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCceeeeeeccCC
Q 003134 830 YEEDKTHISTRIAGTM 845 (845)
Q Consensus 830 ~~~~~~~~~t~~~GT~ 845 (845)
--.+++. +.+++|||
T Consensus 401 ~l~~gd~-tstfcgtp 415 (593)
T KOG0695|consen 401 GLGPGDT-TSTFCGTP 415 (593)
T ss_pred CCCCCcc-cccccCCC
Confidence 7655544 34588986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.2e-18 Score=178.57 Aligned_cols=132 Identities=24% Similarity=0.252 Sum_probs=114.7
Q ss_pred cCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCChhhhhhc
Q 003134 687 GGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765 (845)
Q Consensus 687 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 765 (845)
|.+|.||+++.. +++.||+|.+.... .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999975 58899999997643 233455555566899999999999999999999999999999999854
Q ss_pred CCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 766 KDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 766 ~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+....
T Consensus 79 ~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~ 136 (237)
T cd05576 79 F-----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136 (237)
T ss_pred h-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence 3 25899999999999999999999986 9999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.5e-20 Score=182.10 Aligned_cols=149 Identities=31% Similarity=0.503 Sum_probs=125.9
Q ss_pred CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----EEEE
Q 003134 678 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLLL 749 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~l 749 (845)
.+..+.||-|+||.||.+.+. +|+.||.|++... +-...+++.+|+++|.-.+|.|++..++..+-.. ++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 445688999999999999874 6999999998654 2234578899999999999999999998876543 5788
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
|+|.|.. +|.+.|-.. ..++...+.-+..||++||+|||+.+ |.||||||.|.|++.+...||+|||+||.
T Consensus 135 ~TELmQS-DLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHh-hhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 8998864 787777432 46888889999999999999999987 99999999999999999999999999998
Q ss_pred cCCCCc
Q 003134 830 YEEDKT 835 (845)
Q Consensus 830 ~~~~~~ 835 (845)
.+.++.
T Consensus 206 ee~d~~ 211 (449)
T KOG0664|consen 206 WDQRDR 211 (449)
T ss_pred cchhhh
Confidence 876544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=171.43 Aligned_cols=149 Identities=38% Similarity=0.582 Sum_probs=133.1
Q ss_pred CCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccccc-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 678 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
|+..+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999875 889999999876444 56788999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+++|.+++..... .+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+..+...
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999999865421 1789999999999999999999986 999999999999999999999999999988654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.9e-19 Score=195.94 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=196.4
Q ss_pred eEEEEEecCCCccc----cCCccccCCCCCCEEeccCCcccC------CCccccccc-ceeEEEecCCCCCCCccccccc
Q 003134 93 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRNCLTG------SFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161 (845)
Q Consensus 93 ~v~~L~l~~~~l~g----~~p~~l~~L~~L~~L~Ls~N~l~~------~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~ 161 (845)
.++.+++.++.++. .++..+...+.|+.|+++++.+.+ .++..+..+ +|++|+|++|.+.+..+..+..
T Consensus 24 ~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~ 103 (319)
T cd00116 24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLES 103 (319)
T ss_pred hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHH
Confidence 38899999999854 356678888999999999998873 223445555 8999999999999877777777
Q ss_pred ccc---cceeEeecccCCC----CCCcccccC-CCccEEEeecCcCccc----CChhhhCCCCCCcEEeecCcCccc---
Q 003134 162 ITT---LKNLSIEGNLFTG----SIPPDIRKL-INLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGK--- 226 (845)
Q Consensus 162 l~~---L~~L~Ls~N~l~g----~~p~~~~~l-~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~--- 226 (845)
+.+ |++|++++|++++ .+...+..+ ++|++|+|++|.+++. ++..+..+++|++|+|++|.+++.
T Consensus 104 l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 183 (319)
T cd00116 104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183 (319)
T ss_pred HhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHH
Confidence 776 9999999999984 233455667 8999999999999953 344577788999999999999843
Q ss_pred -CchhhcCCcccceEEecCCcCCCC----cchhhhcCCCCCEEEcCCCCCCCCCCccc------ccCCccEEEccCCcCc
Q 003134 227 -IPEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKL------DKMNLKTLILTKCLIH 295 (845)
Q Consensus 227 -~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l------~~~~L~~L~Ls~N~l~ 295 (845)
++..+..+++|++|+|++|.+++. ++..+..+++|+.|++++|.+++.....+ ....|+.|++++|.++
T Consensus 184 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 184 ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 344566778999999999999854 34556778899999999999886332221 1248999999999997
Q ss_pred c----cCcccccCCCCcCEEeCCCCCCCCC----CchhhhcC-CCcCEEEccCCcc
Q 003134 296 G----EIPDYIGDMTKLKNIDLSFNNLTGG----IPTTFEKL-AKTNFMYLTGNKL 342 (845)
Q Consensus 296 ~----~~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l-~~L~~L~L~~N~l 342 (845)
. .+...+..+++|++|++++|+++.. ....+... +.|++|++.+|++
T Consensus 264 ~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 264 DDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred cHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 2 3455677789999999999999955 44455556 7899999999864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.2e-20 Score=173.25 Aligned_cols=175 Identities=27% Similarity=0.465 Sum_probs=137.8
Q ss_pred cccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccc
Q 003134 159 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ 238 (845)
Q Consensus 159 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 238 (845)
+.++++++.|.||+|+++ .+|+.+..+.+|+.|++++|+|+ .+|.+++.|++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445677888888999988 77888888899999999999988 78888888899999999988887 7888888888888
Q ss_pred eEEecCCcCCC-CcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCC
Q 003134 239 KLHIQGSSLEG-PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 317 (845)
Q Consensus 239 ~L~Ls~N~l~g-~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 317 (845)
.|||..|++.. .+|..|..++.|+.| +|+.|.+. .+|..++++++||.|.+.+|.
T Consensus 106 vldltynnl~e~~lpgnff~m~tlral-----------------------yl~dndfe-~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRAL-----------------------YLGDNDFE-ILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHH-----------------------HhcCCCcc-cCChhhhhhcceeEEeeccCc
Confidence 88888888863 456666555554444 55555555 678888999999999999999
Q ss_pred CCCCCchhhhcCCCcCEEEccCCcccCCCChhhhc-----CCceEEeecC
Q 003134 318 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN-----SNKNVDISLN 362 (845)
Q Consensus 318 l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~-----~l~~L~ls~N 362 (845)
+- .+|..++.+.+|++|.+.+|+++ .+|..+.. +-+.+.+.+|
T Consensus 162 ll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~N 209 (264)
T KOG0617|consen 162 LL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEEN 209 (264)
T ss_pred hh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhC
Confidence 87 78999999999999999999998 66655532 2234445555
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-19 Score=192.05 Aligned_cols=159 Identities=23% Similarity=0.324 Sum_probs=136.7
Q ss_pred CCCCCCcccccCcEEEEEEEECCCc-EEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 677 NFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
+++....+|-|+||.|-.+...... .+|+|++++.. ....+....|-.+|...+.|.||++|..|.+..++|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4445678999999999999875433 48889887652 2334556779999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
-|-||.|...+... ..++...+..++..+.+|++|||.++ ||.|||||+|.++|.+|.+||.|||+|+.+..
T Consensus 501 aClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 501 ACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999654 36888899999999999999999997 99999999999999999999999999999976
Q ss_pred CCceeeeeeccCC
Q 003134 833 DKTHISTRIAGTM 845 (845)
Q Consensus 833 ~~~~~~t~~~GT~ 845 (845)
.+ .+.+++|||
T Consensus 573 g~--KTwTFcGTp 583 (732)
T KOG0614|consen 573 GR--KTWTFCGTP 583 (732)
T ss_pred CC--ceeeecCCc
Confidence 54 356799996
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.1e-18 Score=198.50 Aligned_cols=162 Identities=29% Similarity=0.451 Sum_probs=135.7
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEEC----C----CcEEEEEEcCcccc-cchHHHHHHHHHHhcC-CCCceeeEEEEE
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILS----D----GTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCC 741 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 741 (845)
+...++....+.+|+|+||.|++|... . ...||||.++.... .+.+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 334445556679999999999999842 1 45799999986533 4567899999999998 699999999999
Q ss_pred EeCCEEEEEEeccCCCChhhhhhcCC---------cccc--cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 003134 742 VEGNQLLLVYEYMKNNCLSRAIFGKD---------TEYR--LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 810 (845)
Q Consensus 742 ~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~N 810 (845)
..++..++|+||++.|+|.++++..+ .... ..++..+.+.++.|||.|++||++.. +|||||-++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99999999999999999999998765 1111 13889999999999999999999985 9999999999
Q ss_pred EEecCCCcEEEEeeccceecCCCCce
Q 003134 811 VLLDKDLNAKISDFGLAKLYEEDKTH 836 (845)
Q Consensus 811 ILld~~~~~kl~DFGla~~~~~~~~~ 836 (845)
||+.++..+||+|||+||....++..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y 474 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYY 474 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCce
Confidence 99999999999999999976554433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.6e-17 Score=162.85 Aligned_cols=143 Identities=38% Similarity=0.649 Sum_probs=127.6
Q ss_pred ccccCcEEEEEEEECC-CcEEEEEEcCccccc-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCChhh
Q 003134 684 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR 761 (845)
Q Consensus 684 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 761 (845)
||+|.+|.||++.... ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999999765432 34689999999999999999999999999999999999999999999
Q ss_pred hhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCcEEEEeeccceecCCC
Q 003134 762 AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYEED 833 (845)
Q Consensus 762 ~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~-~~~~kl~DFGla~~~~~~ 833 (845)
++.... ..+++..+..++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 986432 35889999999999999999999986 999999999999999 899999999999877543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.3e-20 Score=170.90 Aligned_cols=186 Identities=26% Similarity=0.439 Sum_probs=104.4
Q ss_pred ccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCcc
Q 003134 112 LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQ 190 (845)
Q Consensus 112 l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 190 (845)
+.++.+++.|.||+|.++...| .++.+ +|+.|++++|+|. .+|..++.|+.|+.|+++-|++. ..|..|+.++-|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~~vpp-nia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTVVPP-NIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCceeecCC-cHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 3445556666666666663322 22222 4444444444444 34555555555555555555555 5555555555555
Q ss_pred EEEeecCcCcc-cCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCC
Q 003134 191 KLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDL 269 (845)
Q Consensus 191 ~L~Ls~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n 269 (845)
.|||.+|++.. .+|..|..++.|+.|+|++|.|. .+|..++++++|+.|.+..|.+-
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll--------------------- 163 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL--------------------- 163 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh---------------------
Confidence 55555555542 34555555555555555555554 44555555555555554444443
Q ss_pred CCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCc---CEEEccCCcccCCC
Q 003134 270 KGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT---NFMYLTGNKLTGPV 346 (845)
Q Consensus 270 ~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L---~~L~L~~N~l~g~i 346 (845)
..|..++.++.|++|.+.+|+++ .+|..++++.-+ +.+.+.+|.....|
T Consensus 164 ---------------------------~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pI 215 (264)
T KOG0617|consen 164 ---------------------------SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPI 215 (264)
T ss_pred ---------------------------hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChH
Confidence 45667777777888888888887 667666665432 55677888777655
Q ss_pred Chhh
Q 003134 347 PKYI 350 (845)
Q Consensus 347 p~~~ 350 (845)
.+.+
T Consensus 216 aeQf 219 (264)
T KOG0617|consen 216 AEQF 219 (264)
T ss_pred HHHH
Confidence 5443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=167.84 Aligned_cols=141 Identities=16% Similarity=0.147 Sum_probs=116.4
Q ss_pred HhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHH---------HHHHHHHHhcCCCCceeeEEEEEEeC
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE---------FVNEIGMISAQQHPNLVKLYGCCVEG 744 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H~nIv~l~~~~~~~ 744 (845)
..++|...+.+|.|+||.||.+.. ++..+|+|.++.......+. +.+|++.+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 367899999999999999999766 57789999997653332222 68899999999999999999886643
Q ss_pred --------CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC
Q 003134 745 --------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD 816 (845)
Q Consensus 745 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~ 816 (845)
+..++||||++|.+|.++. .++. ....+++.+|..+|+.+ ++|||+||+||+++.+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~---------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP---------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh---------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 3579999999999997763 1222 24569999999999997 9999999999999998
Q ss_pred CcEEEEeeccceecCC
Q 003134 817 LNAKISDFGLAKLYEE 832 (845)
Q Consensus 817 ~~~kl~DFGla~~~~~ 832 (845)
+ ++|+|||..+...+
T Consensus 172 g-i~liDfg~~~~~~e 186 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQ 186 (232)
T ss_pred C-EEEEECCCcccccc
Confidence 8 99999999887754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.7e-17 Score=189.41 Aligned_cols=144 Identities=20% Similarity=0.274 Sum_probs=115.5
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccc-------cchHHHHHHHHHHhcCCCCceeeEEEEEEeC
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-------QGNREFVNEIGMISAQQHPNLVKLYGCCVEG 744 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 744 (845)
......|...+.||+|+||.||++.+.....++.++..+... ...+++.+|++++.+++|++++....++...
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 333455667899999999999999986544333222222111 1235688999999999999999888888887
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
+..++||||+++++|.+++. ....++.+++++|.|||+.+ |+||||||+|||+ +++.++|+||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeC
Confidence 78899999999999988873 35679999999999999987 9999999999999 6789999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|+|+....
T Consensus 472 Gla~~~~~ 479 (535)
T PRK09605 472 GLGKYSDL 479 (535)
T ss_pred cccccCCc
Confidence 99987643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-17 Score=166.93 Aligned_cols=146 Identities=22% Similarity=0.411 Sum_probs=121.8
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEE-EEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGC-CVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~-~~~~~~~~lV~E 752 (845)
+.|++.+.+|+|.||.+-.++++. .+.+++|.+... ....++|.+|...--.+ .|.||+.-|+. |+..+.+..++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 457788999999999999999874 788999998764 34467899888754444 68999987764 677788899999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe-c-CCCcEEEEeeccceec
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-D-KDLNAKISDFGLAKLY 830 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl-d-~~~~~kl~DFGla~~~ 830 (845)
|++.|+|.+-+... .+.+....+++.|+++|++|||++. +||||||.+|||| + +..++||||||+.+..
T Consensus 103 ~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred cCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999887442 4667788999999999999999997 9999999999999 3 3457999999998865
Q ss_pred C
Q 003134 831 E 831 (845)
Q Consensus 831 ~ 831 (845)
+
T Consensus 174 g 174 (378)
T KOG1345|consen 174 G 174 (378)
T ss_pred C
Confidence 4
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.4e-17 Score=169.94 Aligned_cols=146 Identities=16% Similarity=0.151 Sum_probs=113.0
Q ss_pred CCCCCCcccccCcEEEEEEE--ECCCcEEEEEEcCccccc------------------------chHHHHHHHHHHhcCC
Q 003134 677 NFDPANKVGEGGFGSVYKGI--LSDGTVIAVKQLSSKSRQ------------------------GNREFVNEIGMISAQQ 730 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 730 (845)
-|.+.+.||+|++|.||+|. ..+|+.||+|.++..... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46678899999999999998 457999999998653210 0123568999999997
Q ss_pred CC--ceeeEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 003134 731 HP--NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT 808 (845)
Q Consensus 731 H~--nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp 808 (845)
+. .+++++++ ...++||||+++++|....... ..++..+...++.|++.+++|||+.+ +|+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence 63 34455543 2358999999998887654221 23556677899999999999999885 499999999
Q ss_pred CCEEecCCCcEEEEeeccceecCCCC
Q 003134 809 SNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 809 ~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
+||+++ ++.++|+|||.|.......
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCCcc
Confidence 999999 8899999999999776543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=159.93 Aligned_cols=134 Identities=17% Similarity=0.116 Sum_probs=107.5
Q ss_pred CCCCcccccCcEEEEEEEECCCcEEEEEEcCccccc----chHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEEEEec
Q 003134 679 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ----GNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 679 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.+...+++|+||+||.+.. ++..++.+.+.....- ....|.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997665 6778887777654321 1235889999999995 5889999886 446999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI-KTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDL-Kp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++|.+|...+.. ....++.|++++|+++|+++ |+|||| ||+|||++.++.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999998654311 12357789999999999997 999999 79999999999999999999996653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.7e-17 Score=165.41 Aligned_cols=136 Identities=22% Similarity=0.306 Sum_probs=114.7
Q ss_pred CcccccCcEEEEEEEECCCcEEEEEEcCccccc--------chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+.||+|++|.||+|.. ++..+++|+....... ...++.+|++++..++|++++....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999988 6778899986543211 124678899999999999998888787778888999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++|++|.+++... .+ ++..++.+++.+|.++|+.+ ++|||++|+|||++ ++.++|+|||.++...
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999988432 12 78899999999999999987 99999999999999 7899999999998653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.3e-17 Score=163.92 Aligned_cols=146 Identities=19% Similarity=0.176 Sum_probs=113.4
Q ss_pred HHHHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccc----------------------cchHHHHHHHHHHh
Q 003134 670 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----------------------QGNREFVNEIGMIS 727 (845)
Q Consensus 670 ~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~ 727 (845)
++......|...+.||+|+||.||++...+|+.||||++..... .....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 33333344778899999999999999988899999998754320 01123667888898
Q ss_pred cCCCC--ceeeEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 003134 728 AQQHP--NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRD 805 (845)
Q Consensus 728 ~l~H~--nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrD 805 (845)
++.|+ .+++.++ .+..++||||+++++|.+.... ....+++.+++.++.++|+.+ |+|||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 88887 4444443 2455899999999998765420 245678899999999999986 99999
Q ss_pred CCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 806 IKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 806 LKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
|||+||++++++.++|+|||+|.....+
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCCc
Confidence 9999999999999999999999877543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.2e-17 Score=186.13 Aligned_cols=151 Identities=32% Similarity=0.458 Sum_probs=120.1
Q ss_pred CCCCCcccccCcE-EEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 678 FDPANKVGEGGFG-SVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 678 y~~~~~ig~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
|...+.+|.|+.| .||+|.+ +++.||||++-.+ ...-..+|+..|+.- +|||||++++.-.++...||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4445678899887 5899998 5889999998543 234567899998877 79999999999889999999999997
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---C--CcEEEEeeccceec
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---D--LNAKISDFGLAKLY 830 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~---~--~~~kl~DFGla~~~ 830 (845)
. +|++++.....+. ....-...+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.+
T Consensus 587 ~-sL~dlie~~~~d~-~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDV-EMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hHHHHHhccccch-hhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5 8999997631111 11111456788899999999999976 999999999999975 3 46999999999999
Q ss_pred CCCCcee
Q 003134 831 EEDKTHI 837 (845)
Q Consensus 831 ~~~~~~~ 837 (845)
..+....
T Consensus 662 ~~~~sS~ 668 (903)
T KOG1027|consen 662 AGGKSSF 668 (903)
T ss_pred CCCcchh
Confidence 7666543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=165.82 Aligned_cols=137 Identities=31% Similarity=0.558 Sum_probs=123.9
Q ss_pred CcEEEEEEEECC-CcEEEEEEcCcccccc-hHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCChhhhhhc
Q 003134 688 GFGSVYKGILSD-GTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 765 (845)
Q Consensus 688 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 765 (845)
+||.||+|+... ++.+|+|++....... .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8999999998765444 68899999999999999999999999999999999999999999999854
Q ss_pred CCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 766 KDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 766 ~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
.. .+++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~ 139 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDP 139 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence 32 2789999999999999999999986 99999999999999999999999999998754
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.2e-17 Score=158.42 Aligned_cols=149 Identities=25% Similarity=0.386 Sum_probs=125.2
Q ss_pred hcCCCCCCcccccCcEEEEEEE-ECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCC-CceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~E 752 (845)
..+|..+++||.|+||.+|.|. ..+|+.||+|.-..... ..++..|..+...++| ..|+.+..|..+.+.-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4688999999999999999998 46799999998765432 3466778888888865 678888888889999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC---CcEEEEeecccee
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISDFGLAKL 829 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~---~~~kl~DFGla~~ 829 (845)
.+ |-||+++..-.. ..++.++++-++.|++.-++|+|.++ +|||||||+|+|..-+ ..+.++|||+|+.
T Consensus 92 LL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 87 569999885442 36788899999999999999999998 9999999999999643 4599999999998
Q ss_pred cCCC
Q 003134 830 YEED 833 (845)
Q Consensus 830 ~~~~ 833 (845)
+.+.
T Consensus 164 y~d~ 167 (341)
T KOG1163|consen 164 YRDI 167 (341)
T ss_pred hccc
Confidence 8653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=163.45 Aligned_cols=150 Identities=26% Similarity=0.387 Sum_probs=126.5
Q ss_pred cCCCCCCcccccCcEEEEEEE-ECCCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
-+|.+.++||+|+||.++.|+ +-+++.||||.-...+ ...++..|.+..+.+ ..++|..++.|..++-+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368889999999999999998 4579999999875543 335677788877776 468999999888888888999998
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-----CcEEEEeeccce
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-----LNAKISDFGLAK 828 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~-----~~~kl~DFGla~ 828 (845)
+ |-||+++..-++ ..++.+++..||.|++.-++|+|++. .|.|||||+|+||..- ..+.|+|||+|+
T Consensus 106 L-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred h-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 7 569999886554 36899999999999999999999997 9999999999999643 349999999999
Q ss_pred ecCCCCc
Q 003134 829 LYEEDKT 835 (845)
Q Consensus 829 ~~~~~~~ 835 (845)
.+.+.++
T Consensus 178 ~YrDp~T 184 (449)
T KOG1165|consen 178 EYRDPKT 184 (449)
T ss_pred hhcCccc
Confidence 9976543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=160.99 Aligned_cols=133 Identities=26% Similarity=0.334 Sum_probs=108.6
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEcCcccc--------cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 683 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.||+|++|.||+|.+ ++..+++|....... ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 577889998654321 11356778999999999887766666666677789999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+|++|.+.+.... . .++.+++.+|.++|+.+ ++|||+||+||+++ ++.++++|||+++....
T Consensus 80 ~g~~l~~~~~~~~-----------~-~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~ 141 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------D-ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE 141 (199)
T ss_pred CCccHHHHHhhcH-----------H-HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence 9999998874321 0 78999999999999987 99999999999999 88999999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.1e-17 Score=180.20 Aligned_cols=147 Identities=28% Similarity=0.397 Sum_probs=123.1
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.++.|.....+|.|+|+.|.++... +++..+||++.+.. .+-.+|+.++... +||||+++.+.+.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3556777888999999999999865 58889999997652 2233566555544 8999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe-cCCCcEEEEeeccceec
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-DKDLNAKISDFGLAKLY 830 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl-d~~~~~kl~DFGla~~~ 830 (845)
|++.||-+.+.+.... ....++..|+.+|+.|+.|||++| ||||||||+|||+ ++.++++|+|||.++..
T Consensus 396 e~l~g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred hhccccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 9999998888875432 222678889999999999999987 9999999999999 58999999999999988
Q ss_pred CCC
Q 003134 831 EED 833 (845)
Q Consensus 831 ~~~ 833 (845)
+.+
T Consensus 467 ~~~ 469 (612)
T KOG0603|consen 467 ERS 469 (612)
T ss_pred chh
Confidence 655
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.1e-16 Score=167.77 Aligned_cols=163 Identities=19% Similarity=0.306 Sum_probs=132.7
Q ss_pred ccHHHHHHHhcCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCCC--C----ceeeEE
Q 003134 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--P----NLVKLY 738 (845)
Q Consensus 666 ~~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~----nIv~l~ 738 (845)
+-++.....+++|.+...+|+|.||.|-.+.++. +..||+|+++... ...+..+-|++++.++.+ | -+|.+.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 3333333447899999999999999999999754 7899999997653 334566779999999943 2 378888
Q ss_pred EEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---
Q 003134 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--- 815 (845)
Q Consensus 739 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~--- 815 (845)
+||.-.++.+||+|.+ |-|+.+++..+.. .+++...+..|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEY 230 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccce
Confidence 9999999999999987 4589999976533 47899999999999999999999986 999999999999921
Q ss_pred -----------------CCcEEEEeeccceecCCCCce
Q 003134 816 -----------------DLNAKISDFGLAKLYEEDKTH 836 (845)
Q Consensus 816 -----------------~~~~kl~DFGla~~~~~~~~~ 836 (845)
+..+||+|||-|+.-.+.++.
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~ 268 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHST 268 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCcce
Confidence 235999999999988766543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.5e-16 Score=167.94 Aligned_cols=135 Identities=25% Similarity=0.411 Sum_probs=113.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCC-----C---CceeeEEEEEEe--
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----H---PNLVKLYGCCVE-- 743 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~~~~~~-- 743 (845)
..+|.+.++||.|.|++||.|.+. +.+.||+|+.+.. ..-.+..+.||++|++++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 367899999999999999999975 5788999999765 334567788999999883 3 479999999974
Q ss_pred --CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC
Q 003134 744 --GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD 816 (845)
Q Consensus 744 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~ 816 (845)
+.++++|+|++ |-+|..+|..... +-++...+.+|++||+.||.|||.++ +|||-||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 45899999998 4578888865432 36899999999999999999999987 79999999999999644
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.7e-16 Score=167.00 Aligned_cols=148 Identities=32% Similarity=0.515 Sum_probs=128.3
Q ss_pred HHHHhcCCCCCCcccccCcEEEEEEEEC----CCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 003134 671 IKAATNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (845)
Q Consensus 671 l~~~~~~y~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 745 (845)
+....+.|...++||+|.|++||++.+. ..+.||+|.+...+. ..+...|+++|..+ .+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445567899999999999999999853 367899999977643 35688999999998 5899999999999999
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCcEEEEee
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDF 824 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~-~~~~kl~DF 824 (845)
...+|+||++...-.++.. .++..++..+++.+..||+|+|.+| ||||||||+|+|.+. -+.-.|.||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred eeEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEec
Confidence 9999999999988877763 4678899999999999999999998 999999999999985 467899999
Q ss_pred ccceecC
Q 003134 825 GLAKLYE 831 (845)
Q Consensus 825 Gla~~~~ 831 (845)
|+|..++
T Consensus 178 gLA~~~d 184 (418)
T KOG1167|consen 178 GLAQRYD 184 (418)
T ss_pred hhHHHHH
Confidence 9998653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-15 Score=167.99 Aligned_cols=146 Identities=23% Similarity=0.297 Sum_probs=122.3
Q ss_pred CCCCCCcccccCcEEEEEEEECCC--cEEEEEEcCcccccchHHHHHHHHHHhcCCC----CceeeEEEEE-EeCCEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILSDG--TVIAVKQLSSKSRQGNREFVNEIGMISAQQH----PNLVKLYGCC-VEGNQLLL 749 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~~~~-~~~~~~~l 749 (845)
+|.+.+.||+|+||.||.+..... ..+|+|............+..|+.++..+.. +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999997653 5788888766543333377889999888863 6899999999 47788999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-----CcEEEEee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-----LNAKISDF 824 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~-----~~~kl~DF 824 (845)
||+.+ |.+|.++..... ...++..++.+|+.|++.+|++||+.| ++||||||+|+++... -.++|.||
T Consensus 99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99976 669999875443 347899999999999999999999998 9999999999999754 36999999
Q ss_pred cccee
Q 003134 825 GLAKL 829 (845)
Q Consensus 825 Gla~~ 829 (845)
|+|+.
T Consensus 172 Glar~ 176 (322)
T KOG1164|consen 172 GLARR 176 (322)
T ss_pred CCCcc
Confidence 99993
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.9e-16 Score=160.94 Aligned_cols=146 Identities=28% Similarity=0.456 Sum_probs=121.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeC------CE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQ 746 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~ 746 (845)
.+|.....+|.|.- .|..+.+. .+++||+|++... .....++..+|...+..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666778888887 55555543 4889999988554 334567888999999999999999999998643 36
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.|+|||||.. +|...++ ..++.+.+..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+
T Consensus 96 ~y~v~e~m~~-nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL-------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HHHHHHhhhh-HHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 7999999975 7888775 25788899999999999999999997 99999999999999999999999999
Q ss_pred ceecCCC
Q 003134 827 AKLYEED 833 (845)
Q Consensus 827 a~~~~~~ 833 (845)
|+.-..+
T Consensus 165 ar~e~~~ 171 (369)
T KOG0665|consen 165 ARTEDTD 171 (369)
T ss_pred hcccCcc
Confidence 9976543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.9e-15 Score=143.45 Aligned_cols=137 Identities=18% Similarity=0.194 Sum_probs=116.2
Q ss_pred CCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCC--CceeeEEEEEEeCCEEEEEEeccCCC
Q 003134 680 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--PNLVKLYGCCVEGNQLLLVYEYMKNN 757 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~Ey~~~g 757 (845)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|++++..++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999854 7899999866533 5678899999999977 58999999888888899999999987
Q ss_pred ChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
.+... +......++.+++++++++|.....+++|+|+||+||++++++.++++|||.++...
T Consensus 79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 66433 455677889999999999998754569999999999999998999999999998654
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.4e-15 Score=149.60 Aligned_cols=138 Identities=20% Similarity=0.251 Sum_probs=100.2
Q ss_pred CCcccccCcEEEEEEEECCCcEEEEEEcCccccc--chHH----------------------HHHHHHHHhcCCCCc--e
Q 003134 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--GNRE----------------------FVNEIGMISAQQHPN--L 734 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--I 734 (845)
.+.||+|+||.||+|...+++.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998653211 1111 134566666654443 4
Q ss_pred eeEEEEEEeCCEEEEEEeccCCCChhhh-hhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEE
Q 003134 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRA-IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVL 812 (845)
Q Consensus 735 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDLKp~NIL 812 (845)
.+.+++ ...++||||++++.+... +... ... .+...++.+++.++.++|. .+ |+||||||+||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 444443 245899999999654321 1110 011 5678899999999999998 65 999999999999
Q ss_pred ecCCCcEEEEeeccceecCCC
Q 003134 813 LDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 813 ld~~~~~kl~DFGla~~~~~~ 833 (845)
++ ++.++++|||.|.....+
T Consensus 148 i~-~~~~~liDfg~a~~~~~~ 167 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEIDHP 167 (187)
T ss_pred EE-CCcEEEEECcccccccCc
Confidence 99 899999999999877653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.9e-15 Score=174.97 Aligned_cols=155 Identities=35% Similarity=0.588 Sum_probs=106.5
Q ss_pred cCCCHHHHHHHHHHHHHhCCC---CCCCCCCCCCC-CCCccccCCCCCCCccceeecCCCC--cceEEEEEecCCCcccc
Q 003134 34 NKLHAEEVKALKQIGRKLGKK---DWNFGVDPCSQ-KGNWELSSDDKKGFESNVTCDCSSA--TCHVVTIALKAQNLTGT 107 (845)
Q Consensus 34 ~~~~~~~~~aL~~~~~~~~~~---~W~~~~d~c~~-~~~w~~~~~~~~~~~~~v~C~~~~~--~~~v~~L~l~~~~l~g~ 107 (845)
....+.|..||+++|++++.. +|+ .|||.. ...|. ||.|..... ..+|+.|+|++|++.|.
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~~~W~--g~~C~p~~~~w~-----------Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ 433 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLRFGWN--GDPCVPQQHPWS-----------GADCQFDSTKGKWFIDGLGLDNQGLRGF 433 (623)
T ss_pred cccCchHHHHHHHHHHhcCCcccCCCC--CCCCCCcccccc-----------cceeeccCCCCceEEEEEECCCCCcccc
Confidence 345678999999999998753 685 467742 12354 899964322 23688899999999998
Q ss_pred CCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCC
Q 003134 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI 187 (845)
Q Consensus 108 ~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 187 (845)
+|+.|++|++|+.|+|++|+|+|. +|..++.+++|+.|+|++|+|+|.+|..+++|+
T Consensus 434 ip~~i~~L~~L~~L~Ls~N~l~g~-----------------------iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~ 490 (623)
T PLN03150 434 IPNDISKLRHLQSINLSGNSIRGN-----------------------IPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490 (623)
T ss_pred CCHHHhCCCCCCEEECCCCcccCc-----------------------CChHHhCCCCCCEEECCCCCCCCCCchHHhcCC
Confidence 998888888888888887776655 455555566666666666666666666666666
Q ss_pred CccEEEeecCcCcccCChhhhCC-CCCCcEEeecCcCc
Q 003134 188 NLQKLILSSNSFTGELPAELTKL-TNLNDLRISDNNFS 224 (845)
Q Consensus 188 ~L~~L~Ls~N~l~g~~p~~~~~l-~~L~~L~Ls~N~l~ 224 (845)
+|++|+|++|+++|.+|..+..+ .++..+++.+|...
T Consensus 491 ~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 491 SLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred CCCEEECcCCcccccCChHHhhccccCceEEecCCccc
Confidence 66666666666666666665543 35566667666543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.3e-14 Score=149.91 Aligned_cols=137 Identities=18% Similarity=0.212 Sum_probs=106.7
Q ss_pred CCccc-ccCcEEEEEEEECCCcEEEEEEcCccc-------------ccchHHHHHHHHHHhcCCCCce--eeEEEEEEeC
Q 003134 681 ANKVG-EGGFGSVYKGILSDGTVIAVKQLSSKS-------------RQGNREFVNEIGMISAQQHPNL--VKLYGCCVEG 744 (845)
Q Consensus 681 ~~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~ 744 (845)
...|| .|+.|+||++... +..+++|.+.... .....++.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45677 7889999999885 6778999885421 1223567889999999998875 7777765443
Q ss_pred -C---EEEEEEeccCC-CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcE
Q 003134 745 -N---QLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (845)
Q Consensus 745 -~---~~~lV~Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~ 819 (845)
. ..++||||++| .+|.+++... .++.. .+.+++.+|.+||+.+ |+||||||+|||++.++.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKF 181 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCE
Confidence 2 23599999997 6898887432 33433 3578999999999997 9999999999999998999
Q ss_pred EEEeeccceecC
Q 003134 820 KISDFGLAKLYE 831 (845)
Q Consensus 820 kl~DFGla~~~~ 831 (845)
+|+|||.++...
T Consensus 182 ~LIDfg~~~~~~ 193 (239)
T PRK01723 182 WLIDFDRGELRT 193 (239)
T ss_pred EEEECCCcccCC
Confidence 999999998865
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1e-13 Score=150.24 Aligned_cols=149 Identities=36% Similarity=0.552 Sum_probs=128.4
Q ss_pred CCCCCcccccCcEEEEEEEECCCcEEEEEEcCccccc---chHHHHHHHHHHhcCCCC-ceeeEEEEEEeCCEEEEEEec
Q 003134 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHP-NLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~Ey 753 (845)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++++++...+..++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999986 78899999766433 367899999999999988 799999999877888999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-cEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~-~~kl~DFGla~~~~~ 832 (845)
+.++++.+++...... ..++......++.|++.+++|+|+.+ ++|||+||+||+++..+ .++++|||.++.+..
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999776543211 25788899999999999999999997 99999999999999988 799999999987654
Q ss_pred C
Q 003134 833 D 833 (845)
Q Consensus 833 ~ 833 (845)
.
T Consensus 155 ~ 155 (384)
T COG0515 155 P 155 (384)
T ss_pred C
Confidence 3
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.8e-15 Score=158.27 Aligned_cols=165 Identities=20% Similarity=0.322 Sum_probs=135.4
Q ss_pred cCcccHHHHHHHhcCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCC------CCcee
Q 003134 663 TGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQ------HPNLV 735 (845)
Q Consensus 663 ~~~~~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv 735 (845)
-+.|.+.-.+.....|.+....|+|-|++|.+|.+.. |..||||++...... .+.=+.|+++|.+++ --|++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHH
Confidence 3456666566667889999999999999999999764 889999999765222 233467999999985 34899
Q ss_pred eEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC
Q 003134 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 815 (845)
Q Consensus 736 ~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~ 815 (845)
+++..|...+++|||+|-+.- +|.+.++..+. ...|....+..++.|+.-||..|-..+ |+|.||||.|||+++
T Consensus 498 rl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHhhhcceeEEEehhhhc-hHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEecc
Confidence 999999999999999998754 79999976543 346788899999999999999999876 999999999999986
Q ss_pred C-CcEEEEeeccceecCCCC
Q 003134 816 D-LNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 816 ~-~~~kl~DFGla~~~~~~~ 834 (845)
. ..+||||||-|....+.+
T Consensus 572 ~k~iLKLCDfGSA~~~~ene 591 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENE 591 (752)
T ss_pred CcceeeeccCcccccccccc
Confidence 5 568999999998876544
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.2e-13 Score=144.69 Aligned_cols=160 Identities=21% Similarity=0.360 Sum_probs=132.3
Q ss_pred HHHHHHHhcCCCCCCcccccCcEEEEEEEECC------CcEEEEEEcCcc-cccchHHHHHHHHHHhcCCCCceeeEEEE
Q 003134 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGC 740 (845)
Q Consensus 668 ~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~ 740 (845)
.+++.....+++....+-+|.||.||+|.+++ .+.|-+|.++.. ++-....+..|.-.+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34555556678888889999999999997653 345677877654 33445678889999999999999999999
Q ss_pred EEeC-CEEEEEEeccCCCChhhhhhcC---CcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC
Q 003134 741 CVEG-NQLLLVYEYMKNNCLSRAIFGK---DTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD 816 (845)
Q Consensus 741 ~~~~-~~~~lV~Ey~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~ 816 (845)
+.++ +..+.+|.++.-|+|..++.-. +......++-.+.+.++.|++.|++|||.++ |||.||..+|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8765 5678899999999999998622 2233456788899999999999999999997 9999999999999999
Q ss_pred CcEEEEeeccceec
Q 003134 817 LNAKISDFGLAKLY 830 (845)
Q Consensus 817 ~~~kl~DFGla~~~ 830 (845)
.++||+|=.++|.+
T Consensus 433 LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 433 LQVKLTDSALSRDL 446 (563)
T ss_pred eeEEeccchhcccc
Confidence 99999999999865
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.1e-15 Score=162.45 Aligned_cols=178 Identities=27% Similarity=0.351 Sum_probs=122.1
Q ss_pred eeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeec
Q 003134 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220 (845)
Q Consensus 141 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 220 (845)
-...||+.|+++ .+|..+..+..|+.|.|.+|.|. .+|..+.++..|++|||+.|+++ .+|..+..|+ |+.|-+++
T Consensus 77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sN 152 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSN 152 (722)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEec
Confidence 344566667766 67777777777888888888877 77777888888888888888887 6777777665 77788888
Q ss_pred CcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcc
Q 003134 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPD 300 (845)
Q Consensus 221 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~ 300 (845)
|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++...+.+.. .+.|..||+|.|++. .+|-
T Consensus 153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNkis-~iPv 228 (722)
T KOG0532|consen 153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKIS-YLPV 228 (722)
T ss_pred Cccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCcee-ecch
Confidence 8887 67777777778888888888877 567777777777777666666554443333 345555566666555 4555
Q ss_pred cccCCCCcCEEeCCCCCCCCCCchhhh
Q 003134 301 YIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (845)
Q Consensus 301 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 327 (845)
.|.+|+.|++|-|.+|.|+ ..|..++
T Consensus 229 ~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 229 DFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred hhhhhhhheeeeeccCCCC-CChHHHH
Confidence 5666666666666666665 4444443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.7e-15 Score=162.00 Aligned_cols=182 Identities=22% Similarity=0.371 Sum_probs=162.4
Q ss_pred ccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccce
Q 003134 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239 (845)
Q Consensus 160 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 239 (845)
-.|+.-...||+.|++. ++|..+..+..|+.|.|+.|.+. .+|..+.+|..|++|||+.|+++ .+|..+..++ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 34667778999999999 89999999999999999999999 89999999999999999999999 7888888875 999
Q ss_pred EEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCC
Q 003134 240 LHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (845)
Q Consensus 240 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (845)
|.+++|+++ .+|..++.+..|..||.+.|.+...+.......+|+.|.+..|++. .+|..++. -.|..||+|+|+++
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis 224 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKIS 224 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCcee
Confidence 999999998 7899999999999999999999888777777779999999999998 56666774 56999999999999
Q ss_pred CCCchhhhcCCCcCEEEccCCcccCCCChhh
Q 003134 320 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI 350 (845)
Q Consensus 320 g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~ 350 (845)
.+|..|.+|+.|++|-|.+|.|+ ..|..+
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence 89999999999999999999998 444444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.6e-13 Score=163.48 Aligned_cols=151 Identities=25% Similarity=0.322 Sum_probs=118.0
Q ss_pred HHHHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCC---CCceeeEEEEEEeCCE
Q 003134 670 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 670 ~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~ 746 (845)
+.+.....|.+.+.||+|+||+||+|...+|+.||+|.-+....- +|.--.+++.+++ -+-|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 444455678899999999999999999888999999998765332 2222233344444 1345555555666778
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-------CCCcE
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-------KDLNA 819 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld-------~~~~~ 819 (845)
-+||+||.+.|+|.+++.. ...++|.-++.++.|+++.+++||..+ |||+||||+|.||. +...+
T Consensus 769 S~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred ceeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence 8999999999999999963 346899999999999999999999987 99999999999993 23459
Q ss_pred EEEeeccceecC
Q 003134 820 KISDFGLAKLYE 831 (845)
Q Consensus 820 kl~DFGla~~~~ 831 (845)
+|+|||-+-.+.
T Consensus 841 ~lIDfG~siDm~ 852 (974)
T KOG1166|consen 841 YLIDFGRSIDMK 852 (974)
T ss_pred EEEecccceeee
Confidence 999999986653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.7e-13 Score=151.32 Aligned_cols=142 Identities=22% Similarity=0.248 Sum_probs=101.0
Q ss_pred CCcccccCcEEEEEEEECCCcEEEEEEcCcccccc----------------------------------------hHHHH
Q 003134 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG----------------------------------------NREFV 720 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 720 (845)
.+.||.|++|.||+|++++|+.||||+.+...... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986542110 00244
Q ss_pred HHHHHHhcC----CCCceeeEEEEE-EeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHH-HHHHHH
Q 003134 721 NEIGMISAQ----QHPNLVKLYGCC-VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR-GLAYLH 794 (845)
Q Consensus 721 ~E~~~l~~l----~H~nIv~l~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-aL~yLH 794 (845)
+|++.+.++ +|.+-+.+-..+ ...+..+|||||++|++|.+....... .. .+.+++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHH
Confidence 455555544 232222322222 224457999999999999887642211 11 24567776666 478889
Q ss_pred hCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 795 ~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
..+ ++|+|+||.||+++++++++++|||++..+.+
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 886 99999999999999999999999999998864
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.38 E-value=6.1e-13 Score=150.51 Aligned_cols=183 Identities=30% Similarity=0.508 Sum_probs=98.4
Q ss_pred cccccceeEeecccCCCCCCcccccCC-CccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccce
Q 003134 161 NITTLKNLSIEGNLFTGSIPPDIRKLI-NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239 (845)
Q Consensus 161 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 239 (845)
.++.++.|++.+|.++ .+|+....+. +|++|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.
T Consensus 114 ~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~ 190 (394)
T COG4886 114 ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN 190 (394)
T ss_pred cccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhh
Confidence 3355555555555555 4444444443 5555555555555 44444555555555555555555 34444445555555
Q ss_pred EEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCC
Q 003134 240 LHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (845)
Q Consensus 240 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (845)
|++++|+++ .+|.....+..|+.|.+++|.........-...++..|.+++|++.. .+..++.+++|+.|++++|+++
T Consensus 191 L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 191 LDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred eeccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee-ccchhccccccceecccccccc
Confidence 555555555 34444334444555555544322221111112244444555555542 2566667777777777777777
Q ss_pred CCCchhhhcCCCcCEEEccCCcccCCCChhh
Q 003134 320 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI 350 (845)
Q Consensus 320 g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~ 350 (845)
. ++. ++.+.+|+.|++++|.++...|...
T Consensus 269 ~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 269 S-ISS-LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred c-ccc-ccccCccCEEeccCccccccchhhh
Confidence 3 333 7777777777777777776555443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-12 Score=148.21 Aligned_cols=202 Identities=30% Similarity=0.425 Sum_probs=162.8
Q ss_pred EEeccCCcccCCCcccccccceeEEEecCCCCCCCccccccccc-ccceeEeecccCCCCCCcccccCCCccEEEeecCc
Q 003134 120 QLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT-TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198 (845)
Q Consensus 120 ~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 198 (845)
.|+++.|.+...+......-.++.|++.+|+++ .+|.....++ +|+.|++++|++. .+|..+..+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 688888887655444333337899999999999 5666677774 9999999999999 677788999999999999999
Q ss_pred CcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcc
Q 003134 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK 278 (845)
Q Consensus 199 l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~ 278 (845)
++ .+|...+.+++|+.|++++|+++ .+|........|++|.+++|++. ..+..+.++.++..|.+.+|++...+...
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~ 251 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESI 251 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeeccchh
Confidence 99 77776768899999999999998 67877767778999999999644 46778889999999999998887642222
Q ss_pred cccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhc
Q 003134 279 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328 (845)
Q Consensus 279 l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 328 (845)
-...+|++|++++|+++...+ ++.+.+|+.|++++|.++...|.....
T Consensus 252 ~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~ 299 (394)
T COG4886 252 GNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALL 299 (394)
T ss_pred ccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhcc
Confidence 222369999999999996555 899999999999999999777765443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1e-11 Score=122.82 Aligned_cols=132 Identities=19% Similarity=0.142 Sum_probs=98.5
Q ss_pred CCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCce-eeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-VKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
.+.++.|.++.||++... +..+++|....... ....+..|++++..+.+.++ ++++++. .+..++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 456889999999999875 77899999865432 23356789999888865554 4455443 3345899999999877
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS--RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
.+.- .....++.+++++|+.||..+ +..++|+|++|.||+++ ++.++++|||.|..-
T Consensus 79 ~~~~-------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 79 LTED-------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccc-------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 5430 012345678999999999886 23469999999999999 678999999998854
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.3e-12 Score=123.22 Aligned_cols=166 Identities=40% Similarity=0.634 Sum_probs=100.8
Q ss_pred eeeecCCccc-ccCCcccccccccccccccccCCceeEEEeeeeeecCCCCCCCceee-ccceecccccchhhhhhcccc
Q 003134 416 LHINCGGAKI-NTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRT-NTSTLSKVSAVDLELYRTARV 493 (845)
Q Consensus 416 ~~~~c~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 493 (845)
+.++|||... ...+..|..|....+.+.-| ... .. ...+ ......-....+..||++.|.
T Consensus 3 ~~IN~Gg~~~~~~~g~~w~~D~~~~~g~~~y--------~~~------~~----~~~~~~~~~~~i~~t~d~~Lyqt~R~ 64 (174)
T PF11721_consen 3 LRINAGGPAYTDSSGIVWEADQYYTGGSWGY--------YVS------SD----NNGSTSSTNSSIPGTTDDPLYQTERY 64 (174)
T ss_dssp EEEEETSSSEEETTTEEE-SSSSSTTSS-----------------------------SSTTS--TTS-HHHHHTTT----
T ss_pred EEEECCCCcccCCCCCEEcCCCCCCCCCccc--------ccc------cc----cccccccccccccCCCchhhhHhhcC
Confidence 5689999877 33467777776554443311 000 00 0000 001111123678899999999
Q ss_pred CCCCCceEEeecCCceEEEEEeeeeeEEcCCccccccccEEEEEEeccccccccCccccccCCCCCceEeee-eeeeecc
Q 003134 494 SPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNF-PAEVTSH 572 (845)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~v~~i~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 572 (845)
.+.+++|...++.+|.|.|+|||||+.+..+......|+|||+|+|+.+.+.+++||..+.++..+++...| .+.+++.
T Consensus 65 g~~~f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg 144 (174)
T PF11721_consen 65 GPSSFSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDG 144 (174)
T ss_dssp -SSSEEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETT
T ss_pred CCCceEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCC
Confidence 988999888889999999999999999888777788999999999999999999999999999887777666 8999999
Q ss_pred eeEEEEeecCCceeeecCCCCCC-CCcc
Q 003134 573 TLKIHLYWAGRGTTGIPLRGTYG-PLIS 599 (845)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~-p~~~ 599 (845)
.+.++|.+++++.+.+|..+..+ |.++
T Consensus 145 ~L~i~f~~~~~~~~~i~~~~~~~~p~Is 172 (174)
T PF11721_consen 145 TLNIQFVWAGKGTLCIPFIGSYGNPLIS 172 (174)
T ss_dssp EEETTEEEE--SEEEEEEESSSSSSSEE
T ss_pred cEEEEEEecCCCcEEeeccccCCCcEEe
Confidence 99999999999999888654443 5444
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=6e-12 Score=144.51 Aligned_cols=146 Identities=17% Similarity=0.209 Sum_probs=95.6
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccccc----------------------------------chH---
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ----------------------------------GNR--- 717 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~--- 717 (845)
..|+. +.||+|++|.||+|++++ |+.||||++++.... ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35766 789999999999999987 999999999754210 011
Q ss_pred ---HHHHHHHHHhcC----CCCceeeEEEEEEe-CCEEEEEEeccCCCChhhhh--hcCCcccccCCCHHHHHHHHHHHH
Q 003134 718 ---EFVNEIGMISAQ----QHPNLVKLYGCCVE-GNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 787 (845)
Q Consensus 718 ---~~~~E~~~l~~l----~H~nIv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l--~~~~~~~~~~l~~~~~~~i~~~ia 787 (845)
+|.+|+..+.++ .+...+.+-.++.+ ....+|||||++|+.+.+.- ..... ....+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHHHHH-
Confidence 234444444444 23333443333332 45678999999999997742 21110 01122222233333333
Q ss_pred HHHHHHHhCCCCCeEeCCCCCCCEEecCCC----cEEEEeeccceecCCC
Q 003134 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISDFGLAKLYEED 833 (845)
Q Consensus 788 ~aL~yLH~~~~~~ivHrDLKp~NILld~~~----~~kl~DFGla~~~~~~ 833 (845)
+..+ ++|+|+||.||+++.++ +++++|||++..+.+.
T Consensus 277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 4455 99999999999999888 9999999999988643
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.1e-11 Score=147.28 Aligned_cols=109 Identities=34% Similarity=0.584 Sum_probs=101.0
Q ss_pred ccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEec
Q 003134 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ 243 (845)
Q Consensus 164 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 243 (845)
.++.|+|++|.++|.+|..+.++++|++|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..++++++|++|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 48899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCcchhhhcC-CCCCEEEcCCCCCC
Q 003134 244 GSSLEGPIPASISAL-TSLTDLRISDLKGS 272 (845)
Q Consensus 244 ~N~l~g~~p~~~~~l-~~L~~L~Ls~n~~~ 272 (845)
+|+++|.+|..++.+ .++..+++.+|...
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccc
Confidence 999999999998874 46778888888653
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.15 E-value=9.9e-12 Score=126.30 Aligned_cols=222 Identities=23% Similarity=0.237 Sum_probs=121.3
Q ss_pred ceEEEEEecCC--------CccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCccccccccc
Q 003134 92 CHVVTIALKAQ--------NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT 163 (845)
Q Consensus 92 ~~v~~L~l~~~--------~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~ 163 (845)
|++..|-++.. -+...+|-.+.-+++|..+.+|++.-..+..-......|+++.+.+..++. .| .+--.+
T Consensus 182 ~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~-~~-~l~pe~ 259 (490)
T KOG1259|consen 182 TQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQD-VP-SLLPET 259 (490)
T ss_pred hheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchhheeceeecCchhheeeeecccccc-cc-cccchh
Confidence 46666666542 233445556677788888888877544433333333467777776655541 11 111111
Q ss_pred ccceeEeec-ccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEe
Q 003134 164 TLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 242 (845)
Q Consensus 164 ~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 242 (845)
.+..+.-+. .-.+|..-..+....-|++||||+|.|+ .+..+..-++.++.|++|+|.|+. + +.+..+++|+.|||
T Consensus 260 ~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDL 336 (490)
T KOG1259|consen 260 ILADPSGSEPSTSNGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDL 336 (490)
T ss_pred hhcCccCCCCCccCCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeec
Confidence 222111111 1122333333344455777777777776 555666666777777777777762 2 22666777777777
Q ss_pred cCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCC
Q 003134 243 QGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322 (845)
Q Consensus 243 s~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 322 (845)
|+|.++.. ...-..+-| +++|.|+.|.|.. -..++++-+|..||+++|+|....
T Consensus 337 S~N~Ls~~-~Gwh~KLGN-----------------------IKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ld 390 (490)
T KOG1259|consen 337 SGNLLAEC-VGWHLKLGN-----------------------IKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELD 390 (490)
T ss_pred ccchhHhh-hhhHhhhcC-----------------------EeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHH
Confidence 77776622 111122222 3344444444431 223556667777777777776322
Q ss_pred c-hhhhcCCCcCEEEccCCcccC
Q 003134 323 P-TTFEKLAKTNFMYLTGNKLTG 344 (845)
Q Consensus 323 p-~~~~~l~~L~~L~L~~N~l~g 344 (845)
. ..+++||-|+.|.|.+|.|.+
T Consensus 391 eV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 391 EVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred HhcccccccHHHHHhhcCCCccc
Confidence 1 346777778888888888874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.4e-11 Score=149.62 Aligned_cols=89 Identities=13% Similarity=0.140 Sum_probs=68.5
Q ss_pred CCC-CceeeEEEEE-------EeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 003134 729 QQH-PNLVKLYGCC-------VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800 (845)
Q Consensus 729 l~H-~nIv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 800 (845)
++| +||.++++++ ...+.++.++||+ +++|.+++.... ..+++.+++.++.||++||+|||+++
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 355 5788888877 2334677889987 559999996432 35899999999999999999999987
Q ss_pred eEeCCCCCCCEEecCCCcEEEEeec
Q 003134 801 IVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 801 ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
|+||||||+||||+..+.+|++|||
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~ 125 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESA 125 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeecc
Confidence 9999999999999654444433333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.4e-11 Score=142.37 Aligned_cols=144 Identities=27% Similarity=0.371 Sum_probs=112.2
Q ss_pred CCCcccccCcEEEEEEEEC-CCcEEEEEEcC----cc-cc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 680 PANKVGEGGFGSVYKGILS-DGTVIAVKQLS----SK-SR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~----~~-~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
..+.+|.|++|.|+.+... .....+.|... .. .. .....+..|..+-..+.|+|++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999988877643 34444444433 11 11 111225667778888999999888877777666666699
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++ +|..++... ..+...++..++.|++.|++|+|+.| |.|||+|++|+++..+|.+||+|||.+..+.-
T Consensus 402 ~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred cccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 9999 999998653 25777889999999999999999998 99999999999999999999999999987753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.3e-10 Score=116.19 Aligned_cols=144 Identities=19% Similarity=0.266 Sum_probs=112.4
Q ss_pred CCcccccCcEEEEEEEECCCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCC--ceeeEEEEEEeC---CEEEEEEecc
Q 003134 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHP--NLVKLYGCCVEG---NQLLLVYEYM 754 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~~~---~~~~lV~Ey~ 754 (845)
.+.++.|..+.+|++...+|+.+++|....... ....++..|.++++.+++. .+++++.+.... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 356899999999999987678899999865432 2356788999999998764 467778776654 3568999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS------------------------------------- 797 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------------------------------------- 797 (845)
+|.++.+.+.. ..++..+...++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99988766521 14677788888899999999998531
Q ss_pred ----------------CCCeEeCCCCCCCEEecC--CCcEEEEeeccceec
Q 003134 798 ----------------RIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKLY 830 (845)
Q Consensus 798 ----------------~~~ivHrDLKp~NILld~--~~~~kl~DFGla~~~ 830 (845)
+..++|+|++|.||+++. ++.+.|+||+.+..-
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 667899999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-11 Score=123.66 Aligned_cols=138 Identities=26% Similarity=0.491 Sum_probs=116.9
Q ss_pred CCCcccccCcEEEEEEEECCCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCC
Q 003134 680 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~g 757 (845)
...+|.+...|..|+|+++ |..+++|+++.. .....++|.+|.-.|+-..||||+.++|.|.......++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 4567888999999999996 445666777544 2334578999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEE
Q 003134 758 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822 (845)
Q Consensus 758 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~ 822 (845)
||+..+|+... ..++..++++++.+||+|++|||+..+. |..--|.+..++||++.++||+
T Consensus 273 slynvlhe~t~---vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 273 SLYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhhee
Confidence 99999988643 4688899999999999999999998632 4555799999999999998875
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.6e-10 Score=111.38 Aligned_cols=139 Identities=15% Similarity=0.119 Sum_probs=100.6
Q ss_pred CCcccccCcEEEEEEEECC-------CcEEEEEEcCcccc----------------------cchHHHH----HHHHHHh
Q 003134 681 ANKVGEGGFGSVYKGILSD-------GTVIAVKQLSSKSR----------------------QGNREFV----NEIGMIS 727 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~~----~E~~~l~ 727 (845)
...||.|-=+.||.|...+ +..+|||+.+.... ...+.+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 47899998753210 0012233 7999998
Q ss_pred cCCC--CceeeEEEEEEeCCEEEEEEeccCCCChhh-hhhcCCcccccCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEe
Q 003134 728 AQQH--PNLVKLYGCCVEGNQLLLVYEYMKNNCLSR-AIFGKDTEYRLKLDWPTRKKICIGIARGLAYL-HEDSRIKIVH 803 (845)
Q Consensus 728 ~l~H--~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivH 803 (845)
++.. -++++++++ ...++||||+.++.+.. .++. ..++..+...+..+++.+|.++ |..+ |||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVH 148 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVH 148 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 8854 466777764 45689999998754422 2211 1344556778889999999999 7765 999
Q ss_pred CCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 804 RDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 804 rDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+||++.||+++ ++.++|+|||.|...+.+
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCCCC
Confidence 99999999997 468999999999877543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.3e-12 Score=132.20 Aligned_cols=239 Identities=15% Similarity=0.214 Sum_probs=105.1
Q ss_pred eEEEEEecCCCccc----cCCccccCCCCCCEEeccCC---cccCCCcccccc-------c-ceeEEEecCCCCCCCccc
Q 003134 93 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRN---CLTGSFSPQWAS-------L-QLVELSVMGNRLSGPFPK 157 (845)
Q Consensus 93 ~v~~L~l~~~~l~g----~~p~~l~~L~~L~~L~Ls~N---~l~~~~~~~~~~-------l-~L~~L~Ls~N~l~~~~p~ 157 (845)
.++.|+|++|.+.- .+.+.+.+.++|+..++|.= ++...+|+.+.. . +|++|+||+|.|.-..+.
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~ 110 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIR 110 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchH
Confidence 56777777776642 33445666777777777642 222223332211 1 455566666655533333
Q ss_pred cc----ccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCccc----Cch
Q 003134 158 VL----TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK----IPE 229 (845)
Q Consensus 158 ~~----~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 229 (845)
.| .+++.|++|+|.+|.+.-.-...++. -|.+|. .| .-...-+.|+.+..++|++... +..
T Consensus 111 ~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~-------kk~~~~~~Lrv~i~~rNrlen~ga~~~A~ 179 (382)
T KOG1909|consen 111 GLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VN-------KKAASKPKLRVFICGRNRLENGGATALAE 179 (382)
T ss_pred HHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HH-------hccCCCcceEEEEeeccccccccHHHHHH
Confidence 22 23455555555555554110001000 000000 00 0011123444444444444311 112
Q ss_pred hhcCCcccceEEecCCcCCC----CcchhhhcCCCCCEEEcCCCCCCCCCCccc----ccC-CccEEEccCCcCcccCcc
Q 003134 230 FIGKWKKIQKLHIQGSSLEG----PIPASISALTSLTDLRISDLKGSESAFPKL----DKM-NLKTLILTKCLIHGEIPD 300 (845)
Q Consensus 230 ~~~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l----~~~-~L~~L~Ls~N~l~~~~p~ 300 (845)
.|...+.|+.+.++.|.|.. .+...|..++.|+.|||.+|.++......+ ..+ +|+.|++++|.++.....
T Consensus 180 ~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~ 259 (382)
T KOG1909|consen 180 AFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAI 259 (382)
T ss_pred HHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHH
Confidence 23334444444444444431 122334444555555554444433211111 111 344455555555443333
Q ss_pred cc-----cCCCCcCEEeCCCCCCCC----CCchhhhcCCCcCEEEccCCcc
Q 003134 301 YI-----GDMTKLKNIDLSFNNLTG----GIPTTFEKLAKTNFMYLTGNKL 342 (845)
Q Consensus 301 ~~-----~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~L~~N~l 342 (845)
+| ...++|+.|.|.+|.++. .+..++...+.|..|+|++|.+
T Consensus 260 a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 260 AFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 22 134667777777776662 2223445566666666666666
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.4e-11 Score=137.75 Aligned_cols=144 Identities=26% Similarity=0.306 Sum_probs=119.1
Q ss_pred cccccCcEEEEEEE----ECCCcEEEEEEcCccccc--chHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEEEEeccC
Q 003134 683 KVGEGGFGSVYKGI----LSDGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 683 ~ig~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
.+|+|+||.|+.++ .+.+..+|+|.+++.... .......|..++..++ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36899999999875 234778899988765321 1124556788888886 9999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
+|.|...+.... .+++.....+...++-|++++|..+ |+|||+|++||+++.+|++|+.|||+.+..-+.+
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 999988885542 4566777778889999999999997 9999999999999999999999999999875443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-09 Score=105.62 Aligned_cols=136 Identities=23% Similarity=0.300 Sum_probs=103.0
Q ss_pred CcccccCcEEEEEEEECCCcEEEEEEcCccc-c-------cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKS-R-------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~-------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
..+++|+=+.+|.+.+.+ ..+++|.-.++. . -..++-.+|++++.+++--.|...+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 457899999999997753 335555432221 1 1134567899999998776766666667788888999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
++|-.|.+.+... +..++..|-.-+.-||..+ |+|+||.++||++..+. +.++|||++.+-...
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~ 144 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEV 144 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccH
Confidence 9999888888432 2467778888889999997 99999999999997654 999999999976543
Q ss_pred C
Q 003134 834 K 834 (845)
Q Consensus 834 ~ 834 (845)
+
T Consensus 145 E 145 (204)
T COG3642 145 E 145 (204)
T ss_pred H
Confidence 3
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.2e-11 Score=126.95 Aligned_cols=208 Identities=21% Similarity=0.226 Sum_probs=116.0
Q ss_pred ceEEEEEecCC---CccccCCc-------cccCCCCCCEEeccCCcccCCCccccccc-----ceeEEEecCCCCCCCcc
Q 003134 92 CHVVTIALKAQ---NLTGTLPT-------ELSKLRYLKQLDLSRNCLTGSFSPQWASL-----QLVELSVMGNRLSGPFP 156 (845)
Q Consensus 92 ~~v~~L~l~~~---~l~g~~p~-------~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-----~L~~L~Ls~N~l~~~~p 156 (845)
..++..+++.. .+...+|+ ++-..++|++||||.|.|.-..+..|..+ .|++|+|.+|.+.-.--
T Consensus 58 ~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag 137 (382)
T KOG1909|consen 58 KELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAG 137 (382)
T ss_pred ccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHH
Confidence 35666666542 22223443 45566799999999999998777777665 69999999999873322
Q ss_pred ccc-------------ccccccceeEeecccCCCCCC----cccccCCCccEEEeecCcCccc----CChhhhCCCCCCc
Q 003134 157 KVL-------------TNITTLKNLSIEGNLFTGSIP----PDIRKLINLQKLILSSNSFTGE----LPAELTKLTNLND 215 (845)
Q Consensus 157 ~~~-------------~~l~~L~~L~Ls~N~l~g~~p----~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~ 215 (845)
..+ ..-++|+++..+.|++..... ..|...+.|+++.++.|.|... +...|..+++|+.
T Consensus 138 ~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~Lev 217 (382)
T KOG1909|consen 138 GRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEV 217 (382)
T ss_pred HHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCccee
Confidence 222 223445555555555542111 1233344555555555554311 1122344455555
Q ss_pred EEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCc----cccc--CCccEEEc
Q 003134 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP----KLDK--MNLKTLIL 289 (845)
Q Consensus 216 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~----~l~~--~~L~~L~L 289 (845)
|||.+|-|+..-.. .+...+..++.|+.|+++++.+...... .+.. .+|+.|.|
T Consensus 218 Ldl~DNtft~egs~--------------------~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l 277 (382)
T KOG1909|consen 218 LDLRDNTFTLEGSV--------------------ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLEL 277 (382)
T ss_pred eecccchhhhHHHH--------------------HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceecc
Confidence 55555544421110 1223334444555555555444332211 1111 26888888
Q ss_pred cCCcCccc----CcccccCCCCcCEEeCCCCCCC
Q 003134 290 TKCLIHGE----IPDYIGDMTKLKNIDLSFNNLT 319 (845)
Q Consensus 290 s~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 319 (845)
.+|.|+.. +...+...+.|..|+|++|++.
T Consensus 278 ~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 278 AGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred CcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 88888753 2334556889999999999994
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.7e-10 Score=113.31 Aligned_cols=123 Identities=28% Similarity=0.346 Sum_probs=46.4
Q ss_pred ceeEEEecCCCCCCCcccccc-cccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhh-hCCCCCCcEE
Q 003134 140 QLVELSVMGNRLSGPFPKVLT-NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLR 217 (845)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~ 217 (845)
++++|+|.+|+|+.+ +.++ .+.+|+.|+|++|.|+. ++ .+..+++|++|+|++|+|+. +...+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence 455555555555532 2344 46777778888887773 32 46677888888888888873 44444 3577888888
Q ss_pred eecCcCcccCc-hhhcCCcccceEEecCCcCCCCc---chhhhcCCCCCEEEcC
Q 003134 218 ISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPI---PASISALTSLTDLRIS 267 (845)
Q Consensus 218 Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~---p~~~~~l~~L~~L~Ls 267 (845)
|++|+|...-. ..+..+++|+.|+|.+|.+.... ...+..+++|+.||-.
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 88888764221 45667788888888888886432 2356778888888643
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.6e-11 Score=136.64 Aligned_cols=128 Identities=24% Similarity=0.322 Sum_probs=67.1
Q ss_pred CCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEE
Q 003134 114 KLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKL 192 (845)
Q Consensus 114 ~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 192 (845)
.+..++.+++..|.|+.+ -..+..+ +|..|++.+|+|..+.. .+..+++|++|+|++|+|+... .+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~~-~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAKI-LNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhhh-hcccccccceeeeeccccchhhccc-chhhhhcchheecccccccccc--chhhccchhhh
Confidence 445555556666666541 1222333 56666666666653322 2455566666666666666332 24455556666
Q ss_pred EeecCcCcccCChhhhCCCCCCcEEeecCcCcccCc-hhhcCCcccceEEecCCcCC
Q 003134 193 ILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 193 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 248 (845)
++++|.|+. + ..+..+++|+.+++++|+++..-+ . ...+.+|+.+++.+|.+.
T Consensus 146 ~l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 146 NLSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR 199 (414)
T ss_pred eeccCcchh-c-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence 666666652 1 223445566666666666653333 1 345555666666666554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.2e-11 Score=120.57 Aligned_cols=128 Identities=18% Similarity=0.231 Sum_probs=80.2
Q ss_pred CCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccC
Q 003134 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTK 291 (845)
Q Consensus 212 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~ 291 (845)
.|++||||+|.|+ .+.++..-+++++.|++|+|.|...- .+..+. +|+.||||+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~-----------------------~L~~LDLS~ 338 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ--NLAELP-----------------------QLQLLDLSG 338 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh--hhhhcc-----------------------cceEeeccc
Confidence 4555555555555 44444545555555555555554211 133344 455556666
Q ss_pred CcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCC-hhh--hcCCceEEeecCCCcCCC
Q 003134 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP-KYI--FNSNKNVDISLNNFTWES 368 (845)
Q Consensus 292 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip-~~~--~~~l~~L~ls~N~l~~~~ 368 (845)
|.++ .+..+-.++-+++.|.|+.|.|.. -..+.+|-+|.+||+++|++...-. ..+ .+.|+.+.|.+|.+.+..
T Consensus 339 N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 339 NLLA-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred chhH-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 6665 334444567889999999999872 2356778889999999999973111 122 347889999999877654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.00 E-value=7.2e-11 Score=126.24 Aligned_cols=134 Identities=19% Similarity=0.234 Sum_probs=67.9
Q ss_pred ceeEEEecCCCCCCCcc-cccccccccceeEeecccCCCCC--CcccccCCCccEEEeecCcCcccCChhh-hCCCCCCc
Q 003134 140 QLVELSVMGNRLSGPFP-KVLTNITTLKNLSIEGNLFTGSI--PPDIRKLINLQKLILSSNSFTGELPAEL-TKLTNLND 215 (845)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~--p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~ 215 (845)
+|+...|.+..+.-..- .....+++++.|||+.|-|..-. -.....|++|+.|+|+.|++.-...... ..++.|+.
T Consensus 122 kL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~ 201 (505)
T KOG3207|consen 122 KLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQ 201 (505)
T ss_pred hhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhhe
Confidence 45555555555442211 24455666666666666665211 1123456666666666666653322221 23456666
Q ss_pred EEeecCcCccc-CchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCC
Q 003134 216 LRISDNNFSGK-IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE 273 (845)
Q Consensus 216 L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~ 273 (845)
|.|+.+.|+.. +...+..+++|+.|+|..|...+.-......+..|+.|||++|.+..
T Consensus 202 L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~ 260 (505)
T KOG3207|consen 202 LVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID 260 (505)
T ss_pred EEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc
Confidence 66666666621 22233445666666666664332333333444555555555555443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.97 E-value=8.5e-11 Score=125.70 Aligned_cols=215 Identities=20% Similarity=0.235 Sum_probs=148.2
Q ss_pred ccCCCCCCEEeccCCcccCCCcc-ccccc-ceeEEEecCCCCCCCcc--cccccccccceeEeecccCCCCCCccc-ccC
Q 003134 112 LSKLRYLKQLDLSRNCLTGSFSP-QWASL-QLVELSVMGNRLSGPFP--KVLTNITTLKNLSIEGNLFTGSIPPDI-RKL 186 (845)
Q Consensus 112 l~~L~~L~~L~Ls~N~l~~~~~~-~~~~l-~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l 186 (845)
=+++.+|+.+.|.+......... ....+ +++.|||+.|-|....| .....|++|+.|+|+.|++.-...... ..+
T Consensus 117 Qsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 117 QSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 35778899999988777644332 23334 88999999998885443 455679999999999999884443322 357
Q ss_pred CCccEEEeecCcCcccC-ChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCC-cchhhhcCCCCCEE
Q 003134 187 INLQKLILSSNSFTGEL-PAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP-IPASISALTSLTDL 264 (845)
Q Consensus 187 ~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L 264 (845)
+.|+.|.|+.+.|+-.- -..+...++|+.|+|..|..-+.-.....-++.|++|+|++|++-.. .-...+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 88999999999998322 22345679999999999964444455556678999999999998632 23567788888888
Q ss_pred EcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCc--hhhhcCCCcCEEEccCCcc
Q 003134 265 RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP--TTFEKLAKTNFMYLTGNKL 342 (845)
Q Consensus 265 ~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~L~~N~l 342 (845)
.++.+.+.....+.... -.-...+++|++|+++.|++. ..+ ..+..+++|+.|....|.|
T Consensus 277 nls~tgi~si~~~d~~s-----------------~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~l 338 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVES-----------------LDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYL 338 (505)
T ss_pred hccccCcchhcCCCccc-----------------hhhhcccccceeeecccCccc-cccccchhhccchhhhhhcccccc
Confidence 88888776554333211 001234567777777777775 222 2345566777777777777
Q ss_pred cC
Q 003134 343 TG 344 (845)
Q Consensus 343 ~g 344 (845)
+.
T Consensus 339 n~ 340 (505)
T KOG3207|consen 339 NK 340 (505)
T ss_pred cc
Confidence 64
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.7e-10 Score=110.95 Aligned_cols=125 Identities=25% Similarity=0.305 Sum_probs=46.7
Q ss_pred ccCCCCCCEEeccCCcccCCCccccc-cc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCccc-ccCCC
Q 003134 112 LSKLRYLKQLDLSRNCLTGSFSPQWA-SL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLIN 188 (845)
Q Consensus 112 l~~L~~L~~L~Ls~N~l~~~~~~~~~-~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~ 188 (845)
+.+...+++|+|++|.|+.+. .++ .+ +|+.|+|++|+|+.. +.+..+++|+.|+|++|+|+. +++.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccccc--chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 445556777888888777653 233 34 677888888888743 246778888888888888884 44445 36888
Q ss_pred ccEEEeecCcCcccCC-hhhhCCCCCCcEEeecCcCcccCc----hhhcCCcccceEEe
Q 003134 189 LQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNFSGKIP----EFIGKWKKIQKLHI 242 (845)
Q Consensus 189 L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L 242 (845)
|++|+|++|+|...-- ..+..+++|+.|+|.+|.++.. + ..+..+|+|+.||-
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 8888888888874322 4567788888889988888743 3 24566788888874
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.7e-11 Score=134.44 Aligned_cols=217 Identities=24% Similarity=0.187 Sum_probs=129.5
Q ss_pred ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEee
Q 003134 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219 (845)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 219 (845)
.++.+++..|.|.. +-..+..+++|+.|+|.+|+|.. +...+..+++|++|+|++|+|+...+ +..++.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhhheec
Confidence 56666677777763 33446667778888888888773 33336677788888888888774433 4556667888888
Q ss_pred cCcCcccCchhhcCCcccceEEecCCcCCCCcc-hhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccC
Q 003134 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP-ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEI 298 (845)
Q Consensus 220 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~ 298 (845)
+|.|+.. ..+..+.+|+.+++++|++...-+ . ...+.+|+.+++.+|.+.....-.... .+..+++..|.++-.-
T Consensus 149 ~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~~~~~~-~l~~~~l~~n~i~~~~ 224 (414)
T KOG0531|consen 149 GNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEGLDLLK-KLVLLSLLDNKISKLE 224 (414)
T ss_pred cCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccchHHHH-HHHHhhcccccceecc
Confidence 8887732 345557778888888888775444 2 466777777777777765443211110 3334466666665333
Q ss_pred cccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCc
Q 003134 299 PDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365 (845)
Q Consensus 299 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~ 365 (845)
+-....+..|+.+++++|++. .++..+..+..+..|++.+|++...-.......+..+.+..|.+.
T Consensus 225 ~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 225 GLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred CcccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccccccccchHHHhccCcchhc
Confidence 221111112667777777776 333555666666777777776664333333334444445555444
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.2e-09 Score=99.67 Aligned_cols=146 Identities=18% Similarity=0.258 Sum_probs=105.7
Q ss_pred CCCcccccCcEEEEEEEECCCcEEEEEEc-Cccc-------ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 680 PANKVGEGGFGSVYKGILSDGTVIAVKQL-SSKS-------RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
....+-+|+=+.|+++.+. |+.+.||.- .+.- .-..++..+|++.+.+++--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678889999999999985 666666643 2221 112456778999999887656655555666666678899
Q ss_pred eccCC-CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC---cEEEEeeccc
Q 003134 752 EYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKISDFGLA 827 (845)
Q Consensus 752 Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~---~~kl~DFGla 827 (845)
||++| -++.+++...... .........+++.|-+.+.-||.++ |||+||..+||++..++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 99987 3677776543221 2222233688899999999999997 99999999999997655 3689999998
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
..-..
T Consensus 164 ~~s~~ 168 (229)
T KOG3087|consen 164 SVSRL 168 (229)
T ss_pred hcccC
Confidence 76543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.3e-09 Score=113.37 Aligned_cols=90 Identities=27% Similarity=0.521 Sum_probs=71.0
Q ss_pred CCCceeeEEEEEEe---------------------------CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHH
Q 003134 730 QHPNLVKLYGCCVE---------------------------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 782 (845)
Q Consensus 730 ~H~nIv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 782 (845)
+|||||++.++|.+ +..+|+||.-++. +|.+++... ..+...+.-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~------~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR------HRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC------CCchHHHHHH
Confidence 68888888777643 2257999988765 899888654 3455567778
Q ss_pred HHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe--cCCC--cEEEEeecccee
Q 003134 783 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLL--DKDL--NAKISDFGLAKL 829 (845)
Q Consensus 783 ~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl--d~~~--~~kl~DFGla~~ 829 (845)
..|+++|+.|||.++ |.|||+|++|||+ |+|+ ...|+|||.+--
T Consensus 347 laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA 394 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLA 394 (598)
T ss_pred HHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeee
Confidence 899999999999997 9999999999999 4444 378999998753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.5e-09 Score=109.88 Aligned_cols=149 Identities=21% Similarity=0.242 Sum_probs=95.1
Q ss_pred CCCcccccCcEEEEEEEECC-CcEEEEEEcCccc---ccchHHHHHHHHHHhcCCC----------CceeeEEEEEE---
Q 003134 680 PANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQH----------PNLVKLYGCCV--- 742 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H----------~nIv~l~~~~~--- 742 (845)
..+.||.|+++.||.+.+.. ++.+|+|.+.... ....+++.+|.-....+.+ -.++.-++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 46789999999999999864 8999999985432 2234566666655544322 22333333322
Q ss_pred ------eC---C-----EEEEEEeccCCCChhhhhhcCCccc--ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC
Q 003134 743 ------EG---N-----QLLLVYEYMKNNCLSRAIFGKDTEY--RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI 806 (845)
Q Consensus 743 ------~~---~-----~~~lV~Ey~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDL 806 (845)
.. + ..+++|+-+ .++|.+.+..-.... ...+....++.+..|+++.+++||+.+ +||+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 11 1 235677776 458887764211110 112344556677789999999999998 999999
Q ss_pred CCCCEEecCCCcEEEEeeccceecCC
Q 003134 807 KTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 807 Kp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
||+|++++.+|.++|+||+.....++
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~ 197 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT 197 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc
Confidence 99999999999999999998877643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.3e-08 Score=99.92 Aligned_cols=128 Identities=26% Similarity=0.273 Sum_probs=85.6
Q ss_pred EEEEEEECCCcEEEEEEcCccc--------------c-------c-----chHHHHHHHHHHhcCCCC--ceeeEEEEEE
Q 003134 691 SVYKGILSDGTVIAVKQLSSKS--------------R-------Q-----GNREFVNEIGMISAQQHP--NLVKLYGCCV 742 (845)
Q Consensus 691 ~Vy~~~~~~~~~vavK~~~~~~--------------~-------~-----~~~~~~~E~~~l~~l~H~--nIv~l~~~~~ 742 (845)
.||.|...+|..+|+|..+... . . ......+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999899999999875321 0 0 013467899999999766 567776542
Q ss_pred eCCEEEEEEeccC--CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeCCCCCCCEEecCCCcE
Q 003134 743 EGNQLLLVYEYMK--NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL-HEDSRIKIVHRDIKTSNVLLDKDLNA 819 (845)
Q Consensus 743 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrDLKp~NILld~~~~~ 819 (845)
+ -.|||||++ |..+..+... .++..+...++.+++..+..+ |..+ |+|+|+.+.||+++++ .+
T Consensus 80 -~--~~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 -R--NVIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp -T--TEEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred -C--CEEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 2 379999999 6555443321 112345677888888866665 5665 9999999999999887 99
Q ss_pred EEEeeccceecCCC
Q 003134 820 KISDFGLAKLYEED 833 (845)
Q Consensus 820 kl~DFGla~~~~~~ 833 (845)
.|+|||.|.....+
T Consensus 146 ~iIDf~qav~~~~p 159 (188)
T PF01163_consen 146 YIIDFGQAVDSSHP 159 (188)
T ss_dssp EE--GTTEEETTST
T ss_pred EEEecCcceecCCc
Confidence 99999999877543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.7e-10 Score=131.72 Aligned_cols=142 Identities=21% Similarity=0.262 Sum_probs=112.2
Q ss_pred CCCCCCcccccCcEEEEEEEECCCcEEEEEEcCccc-ccchHHHHHHHHH--HhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS-RQGNREFVNEIGM--ISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+|...+.+|+++|=+|.+|+++.|. |+||++-+.. .-..+.|.++++- ...++|||.+.+.-+-..+...|||=+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667889999999999999998787 8899886553 3344455444333 4556999999988776666677888888
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
..+ +|+|.+..+ .-+...+-+-|+.|++.||.-+|..+ |+|||||.+||||+.=.=+.|+||.--+
T Consensus 103 vkh-nLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred Hhh-hhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 765 788888432 34677788889999999999999997 9999999999999877678899997554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.1e-08 Score=102.70 Aligned_cols=141 Identities=15% Similarity=0.039 Sum_probs=101.0
Q ss_pred CcccccCcEEEEEEEECCCcEEEEEEcCcccc-----------cchHHHHHHHHHHhcCCCCc--eeeEEEEEEe-----
Q 003134 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-----------QGNREFVNEIGMISAQQHPN--LVKLYGCCVE----- 743 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~----- 743 (845)
+.+-+.....|++..+ +|+.+.||....... .....+.+|.+.+.++...+ +++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444445777766 577899997744321 11124778998888874433 3445666653
Q ss_pred CCEEEEEEeccCCC-ChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-------
Q 003134 744 GNQLLLVYEYMKNN-CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK------- 815 (845)
Q Consensus 744 ~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~------- 815 (845)
...-+||||++++- +|.+++.... ....+...+..++.+++..+.-||..+ |+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence 23578999999986 7888874211 123456678899999999999999997 999999999999975
Q ss_pred CCcEEEEeecccee
Q 003134 816 DLNAKISDFGLAKL 829 (845)
Q Consensus 816 ~~~~kl~DFGla~~ 829 (845)
++.+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999999865
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.6e-09 Score=84.95 Aligned_cols=59 Identities=29% Similarity=0.472 Sum_probs=30.2
Q ss_pred CccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCc
Q 003134 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSS 246 (845)
Q Consensus 188 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 246 (845)
+|++|+|++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555553333445555555555555555554444455555555555555554
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.8e-09 Score=85.41 Aligned_cols=60 Identities=35% Similarity=0.495 Sum_probs=35.6
Q ss_pred ccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcC
Q 003134 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223 (845)
Q Consensus 164 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 223 (845)
+|++|+|++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455666666666644445555666666666666666655555566666666666666654
|
... |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.6e-08 Score=110.03 Aligned_cols=100 Identities=34% Similarity=0.575 Sum_probs=90.3
Q ss_pred HhcCCCCceeeEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 003134 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRD 805 (845)
Q Consensus 726 l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrD 805 (845)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...++|.....++++++.||+|+|+-- . -.|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeee
Confidence 45689999999999999999999999999999999999653 247899999999999999999999863 2 29999
Q ss_pred CCCCCEEecCCCcEEEEeeccceecC
Q 003134 806 IKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 806 LKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
++++|.++|....+||+|||+.....
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred eccccceeeeeEEEEechhhhccccc
Confidence 99999999999999999999988774
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.60 E-value=7.8e-09 Score=121.45 Aligned_cols=151 Identities=27% Similarity=0.388 Sum_probs=119.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC--CcEEEEEEcCccc--ccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD--GTVIAVKQLSSKS--RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l 749 (845)
...|...+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+=..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3456777889999999998887643 4566777765543 222233444666656665 9999999999999999999
Q ss_pred EEeccCCCChhhhh-hcCCcccccCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCCCCCEEecCCC-cEEEEeecc
Q 003134 750 VYEYMKNNCLSRAI-FGKDTEYRLKLDWPTRKKICIGIARGLAYLH-EDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGL 826 (845)
Q Consensus 750 V~Ey~~~gsL~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ivHrDLKp~NILld~~~-~~kl~DFGl 826 (845)
++||..++++.+.+ +... ...+......+..|+..++.|+| +.+ +.||||||+|.+++..+ ..|++|||+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred ccCcccccccccccccCCc----cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchh
Confidence 99999999999888 3321 13556678889999999999999 776 99999999999999999 999999999
Q ss_pred ceecCC
Q 003134 827 AKLYEE 832 (845)
Q Consensus 827 a~~~~~ 832 (845)
|..+..
T Consensus 172 At~~~~ 177 (601)
T KOG0590|consen 172 ATAYRN 177 (601)
T ss_pred hccccc
Confidence 998866
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2e-07 Score=105.88 Aligned_cols=123 Identities=18% Similarity=0.232 Sum_probs=101.4
Q ss_pred ECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCH
Q 003134 697 LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW 776 (845)
Q Consensus 697 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~ 776 (845)
..++.+|.|...+...........+-++.|+.+|||||+++++.+..++..|||+|-+. -|..++.+ +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHH
Confidence 34688888888876655334556677888999999999999999999999999999876 46666643 234
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 777 PTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 777 ~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
....-.+.||+.||.|||+.+ .++|++|..+-|+++..|+.||++|-++....
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 566677889999999999876 69999999999999999999999999886553
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=4.3e-08 Score=119.30 Aligned_cols=203 Identities=19% Similarity=0.251 Sum_probs=131.7
Q ss_pred cCCCCCCEEeccCCcccCCCcccccccceeEEEecCCC--CCCCcccccccccccceeEeecccCCCCCCcccccCCCcc
Q 003134 113 SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNR--LSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQ 190 (845)
Q Consensus 113 ~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 190 (845)
.+....+...+.+|.+..+ +......+|++|-+..|. +.......|..++.|+.|||++|.=-+.+|..+++|-+|+
T Consensus 520 ~~~~~~rr~s~~~~~~~~~-~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIEHI-AGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred cchhheeEEEEeccchhhc-cCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence 3446677777777777643 233333378888888886 5545555678899999999998876678899999999999
Q ss_pred EEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcC--CCCcchhhhcCCCCCEEEcCC
Q 003134 191 KLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL--EGPIPASISALTSLTDLRISD 268 (845)
Q Consensus 191 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l--~g~~p~~~~~l~~L~~L~Ls~ 268 (845)
+|+|++..++ .+|..+.+|..|.+|++..+.-...+|.....+++|++|.+..-.. ....-..+.++..|+.|....
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~ 677 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITI 677 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeec
Confidence 9999999988 8888999999999999998887666778888899999998866542 223333444455555444422
Q ss_pred CCCCCCCCcccccC----CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCC
Q 003134 269 LKGSESAFPKLDKM----NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (845)
Q Consensus 269 n~~~~~~~~~l~~~----~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (845)
... .......... ..+.+.+..+... ..+..+..+.+|+.|.+.+..++
T Consensus 678 ~s~-~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~ 730 (889)
T KOG4658|consen 678 SSV-LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGIS 730 (889)
T ss_pred chh-HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCc
Confidence 211 0000011111 1222222222222 34445666777777777777765
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.4e-07 Score=114.94 Aligned_cols=147 Identities=21% Similarity=0.288 Sum_probs=98.2
Q ss_pred eEEEEEecCCCccccCCccccCCCCCCEEeccCCc--ccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeE
Q 003134 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNC--LTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~--l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 169 (845)
.++.+.+-+|.+. .++... ..+.|++|-+..|. +.......|..+ .|+.|||++|.=-+.+|..+++|-+|++|+
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 4555555555554 222222 22367888888886 555555556666 788888888776677888888888888888
Q ss_pred eecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCc--ccCchhhcCCcccceEEe
Q 003134 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS--GKIPEFIGKWKKIQKLHI 242 (845)
Q Consensus 170 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L 242 (845)
|++..++ .+|..+.+|.+|.+|++..+.-...+|..+..|.+|++|.|..-... ...-..+..+.+|+.|..
T Consensus 602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence 8888888 78888888888888888887766566666677888888888665422 222233444455555444
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.8e-09 Score=119.01 Aligned_cols=21 Identities=29% Similarity=0.423 Sum_probs=14.2
Q ss_pred CccccCCCCCCEEeccCCccc
Q 003134 109 PTELSKLRYLKQLDLSRNCLT 129 (845)
Q Consensus 109 p~~l~~L~~L~~L~Ls~N~l~ 129 (845)
|-.|..+.+|++|.|.++.|.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~ 122 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLS 122 (1096)
T ss_pred CceeccccceeeEEecCcchh
Confidence 445666777777777777665
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.2e-07 Score=98.75 Aligned_cols=143 Identities=19% Similarity=0.264 Sum_probs=113.0
Q ss_pred cEEEEEEEE-CCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEe----CCEEEEEEeccCC-CChhhh
Q 003134 689 FGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVYEYMKN-NCLSRA 762 (845)
Q Consensus 689 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~Ey~~~-gsL~~~ 762 (845)
..+.||+.. .||..|++|+++....+....-..-+++++++.|.|||++.+++.. +..+++||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357899985 4799999999966544443334456788999999999999998873 3468999999985 467666
Q ss_pred hhcCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 763 IFGKDTE----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 763 l~~~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
-...... .....++...+.++.|+..||.++|+.| ..-+=|.|.+||++.+.+++|+.-|+......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5432211 1345788999999999999999999997 88899999999999999999999888887765
Q ss_pred CC
Q 003134 833 DK 834 (845)
Q Consensus 833 ~~ 834 (845)
+.
T Consensus 446 d~ 447 (655)
T KOG3741|consen 446 DP 447 (655)
T ss_pred CC
Confidence 55
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=7.6e-07 Score=91.51 Aligned_cols=137 Identities=23% Similarity=0.216 Sum_probs=100.4
Q ss_pred CCCCcccccCcEEEEEEEECCCcEEEEEEcCccc----------------------ccchHHHHHHHHHHhcCCCC--ce
Q 003134 679 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS----------------------RQGNREFVNEIGMISAQQHP--NL 734 (845)
Q Consensus 679 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~H~--nI 734 (845)
.+.+.||.|-=+.||.|..+.|.++|||.=+... .......++|.++|.++... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4568999999999999999999999999643210 00123457899999998655 67
Q ss_pred eeEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec
Q 003134 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 814 (845)
Q Consensus 735 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld 814 (845)
++.+++ +...+||||++|--|... +++.+....|+..|++-+.-.-..| |||+|+.+=||+++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~----------r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRL----------RLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCcccc----ccceeeeehcccceeecc----------cCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 776654 456899999998655433 2233445556666666555555555 99999999999999
Q ss_pred CCCcEEEEeeccceecCC
Q 003134 815 KDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 815 ~~~~~kl~DFGla~~~~~ 832 (845)
+||.+.++||--+.....
T Consensus 237 ~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 237 EDGDIVVIDWPQAVPISH 254 (304)
T ss_pred cCCCEEEEeCcccccCCC
Confidence 999999999987776543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.6e-06 Score=88.78 Aligned_cols=108 Identities=19% Similarity=0.213 Sum_probs=85.3
Q ss_pred hHHHHHHHHHHhcCCCC--ceeeEEEEEEeCC----EEEEEEeccCCC-ChhhhhhcCCcccccCCCHHHHHHHHHHHHH
Q 003134 716 NREFVNEIGMISAQQHP--NLVKLYGCCVEGN----QLLLVYEYMKNN-CLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788 (845)
Q Consensus 716 ~~~~~~E~~~l~~l~H~--nIv~l~~~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 788 (845)
.....+|...+.++... .+++.+++..... ..++|+|++++- +|.+++.... ..+......++.++++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence 45677888877777433 4566777766532 458999999984 7888885421 2556678899999999
Q ss_pred HHHHHHhCCCCCeEeCCCCCCCEEecCCC---cEEEEeeccceecC
Q 003134 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKISDFGLAKLYE 831 (845)
Q Consensus 789 aL~yLH~~~~~~ivHrDLKp~NILld~~~---~~kl~DFGla~~~~ 831 (845)
.+.-||+.+ |+|+|+++.|||++.+. .+.++||+-++...
T Consensus 130 ~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 130 LIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999998 99999999999999887 89999999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.3e-08 Score=114.87 Aligned_cols=195 Identities=19% Similarity=0.243 Sum_probs=119.9
Q ss_pred ceeEEEecCCCCCCCc-ccccccccccceeEeecccCCCCCCcccccC-CCccEEEeecCcCc----------ccCChhh
Q 003134 140 QLVELSVMGNRLSGPF-PKVLTNITTLKNLSIEGNLFTGSIPPDIRKL-INLQKLILSSNSFT----------GELPAEL 207 (845)
Q Consensus 140 ~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l-~~L~~L~Ls~N~l~----------g~~p~~~ 207 (845)
+++.|.+-.-.=.+.. |-.+..+..|+.|.|.+..|.. ...+..+ .+|++|-- +|.+. |.+-.++
T Consensus 85 kt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~ 161 (1096)
T KOG1859|consen 85 KTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSP 161 (1096)
T ss_pred hheeeeecccCCCCCCCCceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccch
Confidence 3444444433333333 5567778888888888888773 1112111 23444422 22222 1111111
Q ss_pred hCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEE
Q 003134 208 TKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTL 287 (845)
Q Consensus 208 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L 287 (845)
. -..|...+.++|+|+ ....++.-++.|+.|+|++|+++... .+..|+.|++|||+.|.+...+--......|+.|
T Consensus 162 ~-Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L 237 (1096)
T KOG1859|consen 162 V-WNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLL 237 (1096)
T ss_pred h-hhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhhheee
Confidence 1 135677777888887 56667777778888888888887443 6677777777877777776655444444468888
Q ss_pred EccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCc-hhhhcCCCcCEEEccCCccc
Q 003134 288 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP-TTFEKLAKTNFMYLTGNKLT 343 (845)
Q Consensus 288 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~L~~N~l~ 343 (845)
.|++|.++.. ..+.++.+|+.|||++|-|.+--- .-+..|..|+.|+|.+|.+.
T Consensus 238 ~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 238 NLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred eecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 8888887633 345677888888888888764222 22456777788888888775
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2e-08 Score=91.66 Aligned_cols=104 Identities=21% Similarity=0.286 Sum_probs=53.1
Q ss_pred eeEEEecCCCCCCCccccccc---ccccceeEeecccCCCCCCcccc-cCCCccEEEeecCcCcccCChhhhCCCCCCcE
Q 003134 141 LVELSVMGNRLSGPFPKVLTN---ITTLKNLSIEGNLFTGSIPPDIR-KLINLQKLILSSNSFTGELPAELTKLTNLNDL 216 (845)
Q Consensus 141 L~~L~Ls~N~l~~~~p~~~~~---l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 216 (845)
+..++|+.++|- .+++.... ...|+..+|++|.|. ..|+.|. ..+.++.|+|++|+|+ .+|..+..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 444555555554 33333332 233444456666655 3333333 3335555555555555 455555555555555
Q ss_pred EeecCcCcccCchhhcCCcccceEEecCCcCC
Q 003134 217 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 217 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
+++.|.|. ..|..+..+.+|..|+..+|.+.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 55555555 44454545555555555555544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.9e-06 Score=86.37 Aligned_cols=140 Identities=18% Similarity=0.223 Sum_probs=87.2
Q ss_pred CcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCc--eeeEEEEEEeCCEEEEEEeccCCCC-
Q 003134 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN--LVKLYGCCVEGNQLLLVYEYMKNNC- 758 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~Ey~~~gs- 758 (845)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +++.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 24567888886532 3345688999998886443 4677888877888899999999963
Q ss_pred hhhh---------------------hhcCCcccccCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeEeC
Q 003134 759 LSRA---------------------IFGKDTEYRLKLDWPTRK-KICI----------GIAR-GLAYLHED-SRIKIVHR 804 (845)
Q Consensus 759 L~~~---------------------l~~~~~~~~~~l~~~~~~-~i~~----------~ia~-aL~yLH~~-~~~~ivHr 804 (845)
+... +|..... ........ ++-. .+.+ ..++|... ..+.++|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~---~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD---TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC---CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 2111 1111000 00100000 0000 0111 12222211 23457899
Q ss_pred CCCCCCEEecCCCcEEEEeeccceec
Q 003134 805 DIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 805 DLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+.|.||++++++ +.|+||+.|..-
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCcC
Confidence 9999999999888 999999988743
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.5e-08 Score=90.13 Aligned_cols=110 Identities=20% Similarity=0.279 Sum_probs=73.3
Q ss_pred ceeEEEecCCCCCCCcccccc-cccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEe
Q 003134 140 QLVELSVMGNRLSGPFPKVLT-NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218 (845)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 218 (845)
.|+..+|++|.+.. +|..|. ..+.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|.-+..|.+|.+|+.
T Consensus 54 el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 54 ELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred eEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 45566666666663 444444 3457888888888888 67778888888888888888887 66666777888888888
Q ss_pred ecCcCcccCchhhcCCcccceEEecCCcCCCCcch
Q 003134 219 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA 253 (845)
Q Consensus 219 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 253 (845)
.+|.+. .+|-.+---+..-..++.++.+.+.-+.
T Consensus 131 ~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 131 PENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred CCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 888877 4444332222233334456666654443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.7e-07 Score=104.00 Aligned_cols=151 Identities=23% Similarity=0.252 Sum_probs=118.3
Q ss_pred HHHHhcCCCCCCcccccCcEEEEEEEEC--CCcEEEEEEcCcccccchH--HHHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 003134 671 IKAATNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKSRQGNR--EFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (845)
Q Consensus 671 l~~~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 745 (845)
....+.+|..+..||.|.|+.|+++..+ ++..+++|.+......... .-..|+-+...+ -|.++++++..+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3444567888999999999999998754 5788999988665332222 123444444444 5888888888777777
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CcEEEEee
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDF 824 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~-~~~kl~DF 824 (845)
..|+--||++++++...+. ....+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.||
T Consensus 340 ~~~ip~e~~~~~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred cccCchhhhcCcchhhhhH-----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccc
Confidence 7889999999999877662 2235788889999999999999999886 9999999999999875 88899999
Q ss_pred cccee
Q 003134 825 GLAKL 829 (845)
Q Consensus 825 Gla~~ 829 (845)
|.+..
T Consensus 412 ~~~t~ 416 (524)
T KOG0601|consen 412 GCWTR 416 (524)
T ss_pred ccccc
Confidence 99874
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.5e-05 Score=80.39 Aligned_cols=141 Identities=16% Similarity=0.122 Sum_probs=102.9
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEcCcc---c---ccchHHHHHHHHHHhcCCCCc--eeeEEEEEEeC----CEEEEE
Q 003134 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSK---S---RQGNREFVNEIGMISAQQHPN--LVKLYGCCVEG----NQLLLV 750 (845)
Q Consensus 683 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~----~~~~lV 750 (845)
--|+|+-+.|++.... |..+=+|..... + +.....|.+|...+.++...+ +++...+.... -.-+||
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 3467888899998774 446788877522 1 335678999999998885432 45555222221 246899
Q ss_pred EeccCC-CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc--EEEEeeccc
Q 003134 751 YEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN--AKISDFGLA 827 (845)
Q Consensus 751 ~Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~--~kl~DFGla 827 (845)
+|-+++ -+|.+++..... .+.+..+...+..++++.+.-||+.+ +.|+|+.+.||+++.++. ++++||--+
T Consensus 104 Te~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 997653 478888744311 24577778899999999999999997 999999999999986666 999999877
Q ss_pred eec
Q 003134 828 KLY 830 (845)
Q Consensus 828 ~~~ 830 (845)
+..
T Consensus 178 r~~ 180 (216)
T PRK09902 178 RRR 180 (216)
T ss_pred chh
Confidence 643
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.4e-07 Score=96.64 Aligned_cols=112 Identities=25% Similarity=0.356 Sum_probs=57.0
Q ss_pred ccCCCCCCEEeccCCcccCCCc-cccccc--ceeEEEecCCCCCC--CcccccccccccceeEeecccCCCCCCcccccC
Q 003134 112 LSKLRYLKQLDLSRNCLTGSFS-PQWASL--QLVELSVMGNRLSG--PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL 186 (845)
Q Consensus 112 l~~L~~L~~L~Ls~N~l~~~~~-~~~~~l--~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 186 (845)
++.+..++.|-|.+..|-..-. ..|+.. .++.|||.+|.|+. .+-..+.+|+.|+.|+|+.|.+...|...-..+
T Consensus 41 v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~ 120 (418)
T KOG2982|consen 41 VSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPL 120 (418)
T ss_pred eccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccc
Confidence 3444445555555554432211 122222 56666666666662 234445566666666666666664332211345
Q ss_pred CCccEEEeecCcCcccC-ChhhhCCCCCCcEEeecCcC
Q 003134 187 INLQKLILSSNSFTGEL-PAELTKLTNLNDLRISDNNF 223 (845)
Q Consensus 187 ~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l 223 (845)
.+|+.|-|.+..+.-.- -..+..++.++.|++|.|.+
T Consensus 121 ~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~ 158 (418)
T KOG2982|consen 121 KNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL 158 (418)
T ss_pred cceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchh
Confidence 56666666666554211 22345556666666666633
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.25 E-value=2e-06 Score=85.33 Aligned_cols=61 Identities=23% Similarity=0.234 Sum_probs=53.4
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+|.++++... ..+++.++..|+.|+++||+|||+++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence 68999986432 36999999999999999999999874 999999999999999 999987754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.5e-05 Score=80.62 Aligned_cols=139 Identities=18% Similarity=0.226 Sum_probs=90.6
Q ss_pred HhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHH---------HHHHHHHhcCCC---CceeeEEEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREF---------VNEIGMISAQQH---PNLVKLYGCC 741 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~H---~nIv~l~~~~ 741 (845)
..++|...+++-......|.+-.. +|..+++|..+.......+.| .+++..+.+++. -....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 356777777777666666666555 578899998876543322222 233333333322 2223323332
Q ss_pred Ee-----CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC
Q 003134 742 VE-----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD 816 (845)
Q Consensus 742 ~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~ 816 (845)
.. ....++||||++|..|.+.. .++. .++..+.+++.-+|..| ++|+|..|.|++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~---------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE---------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch---------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 21 23567899999998876553 1222 35566778899999997 9999999999999865
Q ss_pred CcEEEEeeccceec
Q 003134 817 LNAKISDFGLAKLY 830 (845)
Q Consensus 817 ~~~kl~DFGla~~~ 830 (845)
.++++||+..+..
T Consensus 172 -~i~iID~~~k~~~ 184 (229)
T PF06176_consen 172 -GIRIIDTQGKRMS 184 (229)
T ss_pred -cEEEEECcccccc
Confidence 4999999887653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=4.2e-06 Score=95.99 Aligned_cols=141 Identities=19% Similarity=0.257 Sum_probs=92.5
Q ss_pred CcccccCcEEEEEEEECCCcEEEEEEcCccccc--------------------------ch--------H------HHHH
Q 003134 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--------------------------GN--------R------EFVN 721 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~--------~------~~~~ 721 (845)
+.|+.++-|.||+|++++|+.||||+.++.-.. .. + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 679999999999999999999999998654110 00 1 1333
Q ss_pred HHHHHhcC-----CCCceeeEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHH-HHHHHh
Q 003134 722 EIGMISAQ-----QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG-LAYLHE 795 (845)
Q Consensus 722 E~~~l~~l-----~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~a-L~yLH~ 795 (845)
|..-+.++ +.+++.-..=|+.-.+...|+|||++|-.+.+...-.. ..++. ..++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~---k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDR---KELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCH---HHHHHHHHHHHHHHHHh
Confidence 44444443 23333222223333566789999999998888742211 12342 2333333332 223333
Q ss_pred CCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 796 ~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
.+ ++|.|..|.||+++.+|++.+.|||+...+.+
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 44 99999999999999999999999999988754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=9.5e-07 Score=104.59 Aligned_cols=110 Identities=25% Similarity=0.428 Sum_probs=75.3
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.+|+.++.|..|+||.||.++++. .+++|+| +.+..- +.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee-------------------
Confidence 468889999999999999999864 6788884 332211 0110 23333333333
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|+=...++... +++- +++.+++|+|+.+ |+|||+||+|.+|..-|++|+.|||+.+..
T Consensus 136 --gDc~tllk~~g-----~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 --GDCATLLKNIG-----PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred --chhhhhcccCC-----CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 33333332221 2222 2278999999987 999999999999999999999999998753
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.7e-07 Score=93.45 Aligned_cols=39 Identities=21% Similarity=0.432 Sum_probs=19.2
Q ss_pred cccccceeEeecccCCCCCCccc----ccCCCccEEEeecCcC
Q 003134 161 NITTLKNLSIEGNLFTGSIPPDI----RKLINLQKLILSSNSF 199 (845)
Q Consensus 161 ~l~~L~~L~Ls~N~l~g~~p~~~----~~l~~L~~L~Ls~N~l 199 (845)
.+++|+..+||.|.|....|+.+ ++-+.|++|.|++|.+
T Consensus 90 kcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGl 132 (388)
T COG5238 90 KCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGL 132 (388)
T ss_pred cCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCC
Confidence 34555555555555554444332 3334555555555554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.4e-06 Score=98.17 Aligned_cols=150 Identities=23% Similarity=0.233 Sum_probs=119.0
Q ss_pred CCCCCCcccc--cCcEEEEEEEE--C-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEE
Q 003134 677 NFDPANKVGE--GGFGSVYKGIL--S-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 677 ~y~~~~~ig~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 748 (845)
.|.....+|+ |.+|.+|.+.. + ++..+|+|+-+... ......=.+|+..-.++ .|+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556778899 99999999987 3 57889999854432 23333445566666666 4999999888999999999
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeCCCCCCCEEecCC-CcEEEEe
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISD 823 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~ivHrDLKp~NILld~~-~~~kl~D 823 (845)
+-+|++. .+|..+.+.... .++....+.+..+..+ ||.++|... ++|-|+||.||++..+ ...+++|
T Consensus 195 iqtE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 9999986 688888765432 3667777888888888 999999986 9999999999999999 8899999
Q ss_pred eccceecCCCC
Q 003134 824 FGLAKLYEEDK 834 (845)
Q Consensus 824 FGla~~~~~~~ 834 (845)
||+...+.+..
T Consensus 267 f~~v~~i~~~~ 277 (524)
T KOG0601|consen 267 FGLVSKISDGN 277 (524)
T ss_pred cceeEEccCCc
Confidence 99999886544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 845 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-41 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-35 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-35 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-27 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-21 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 359 bits (925), Expect = e-118
Identities = 85/196 (43%), Positives = 127/196 (64%), Gaps = 3/196 (1%)
Query: 652 ADKELRGLDL-QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS 710
+E + L Q ++LR+++ A++NF N +G GGFG VYKG L+DGT++AVK+L
Sbjct: 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 64
Query: 711 KSRQGN-REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE 769
+ QG +F E+ MIS H NL++L G C+ + LLVY YM N ++ + + E
Sbjct: 65 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP-E 123
Query: 770 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829
+ LDWP R++I +G ARGLAYLH+ KI+HRD+K +N+LLD++ A + DFGLAKL
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 830 YEEDKTHISTRIAGTM 845
+ TH++T + GT+
Sbjct: 184 MDYKDTHVTTAVRGTI 199
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 328 bits (844), Expect = e-106
Identities = 81/204 (39%), Positives = 118/204 (57%), Gaps = 17/204 (8%)
Query: 653 DKELRGLDLQTGLYTLRQIKAATNNFDP------ANKVGEGGFGSVYKGILSDGTVIAVK 706
+K L D + ++ ++K TNNFD NK+GEGGFG VYKG + + T +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 707 QLSS----KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRA 762
+L++ + + ++F EI +++ QH NLV+L G +G+ L LVY YM N L
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 763 IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822
+ D L W R KI G A G+ +LHE+ I HRDIK++N+LLD+ AKIS
Sbjct: 121 LSCLD--GTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKIS 175
Query: 823 DFGLAKLY-EEDKTHISTRIAGTM 845
DFGLA+ + +T +++RI GT
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTT 199
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 327 bits (840), Expect = e-105
Identities = 82/181 (45%), Positives = 119/181 (65%), Gaps = 5/181 (2%)
Query: 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM 725
L ++ ATNNFD +G G FG VYKG+L DG +A+K+ + +S QG EF EI
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
+S +HP+LV L G C E N+++L+Y+YM+N L R ++G D + + W R +ICIG
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIG 147
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGT 844
ARGL YLH + I+HRD+K+ N+LLD++ KI+DFG++K E D+TH+ST + GT
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 845 M 845
+
Sbjct: 205 L 205
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 5e-60
Identities = 76/321 (23%), Positives = 121/321 (37%), Gaps = 47/321 (14%)
Query: 37 HAEEVKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATC 92
+ ++ +AL QI + LG W D C+ W V CD + T
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTW-----------LGVLCDTDTQTY 50
Query: 93 HVVTIALKAQNLTGT--LPTELSKLRYLKQLDLS-RNCLTGSFSPQWASLQ-LVELSVMG 148
V + L NL +P+ L+ L YL L + N L G P A L L L +
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 149 NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT 208
+SG P L+ I TL L N +G++PP I L NL + N +G +P
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 209 KLTNL-NDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRIS 267
+ L + IS N +GKIP + + + + LEG + +
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQ----- 224
Query: 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327
+ L K + ++ +G L +DL N + G +P
Sbjct: 225 ------------------KIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLT 265
Query: 328 KLAKTNFMYLTGNKLTGPVPK 348
+L + + ++ N L G +P+
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQ 286
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 8e-53
Identities = 65/270 (24%), Positives = 106/270 (39%), Gaps = 32/270 (11%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
G L ++ + LDLS L P P L N+
Sbjct: 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKP---------------------YPIPSSLANL 75
Query: 163 TTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
L L I G N G IPP I KL L L ++ + +G +P L+++ L L S N
Sbjct: 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL-TDLRISD--LKGSESAFPK 278
SG +P I + + G+ + G IP S + + L T + IS L G P
Sbjct: 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK---IPP 192
Query: 279 -LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 337
+NL + L++ ++ G+ G + I L+ N+L + N + L
Sbjct: 193 TFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDL 251
Query: 338 TGNKLTGPVPKYIFNSN--KNVDISLNNFT 365
N++ G +P+ + ++++S NN
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-42
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 28/223 (12%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
N++G +P LS+++ L LD S N L+G+ P +SL LV ++ GNR+SG P +
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 162 ITTL-KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
+ L +++I N TG IPP L NL + LS N G+ N + ++
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLD 280
N+ + + + +G K + L ++ + + G +P ++ L L L +S
Sbjct: 231 NSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF------------ 277
Query: 281 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
N + GEIP G++ + + N G P
Sbjct: 278 --NN---------LCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-56
Identities = 74/276 (26%), Positives = 122/276 (44%), Gaps = 19/276 (6%)
Query: 103 NLTGTLPTEL---SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVL 159
+++G LK L +S N ++G + L L V N S P L
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDV-DVSRCVNLEFLDVSSNNFSTGIP-FL 219
Query: 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ + L++L I GN +G I L+ L +SSN F G +P L +L L ++
Sbjct: 220 GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLA 277
Query: 220 DNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS--ES 274
+N F+G+IP+F+ G + L + G+ G +P + + L L +S G
Sbjct: 278 ENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD 337
Query: 275 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMT-KLKNIDLSFNNLTGGIPTTFEKLAKTN 333
K+ LK L L+ GE+P+ + +++ L +DLS NN +G I + K
Sbjct: 338 TLLKMR--GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 334 --FMYLTGNKLTGPVPKYIFN-SN-KNVDISLNNFT 365
+YL N TG +P + N S ++ +S N +
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-55
Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 24/279 (8%)
Query: 103 NLTGTLPTE-LSKLRYLKQLDLSRNCLTGSFSPQWASL----QLVELSVMGNRLSGPFPK 157
L KL L+ LDLS N ++G+ W +L L++ GN++SG
Sbjct: 137 TLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD- 195
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
++ L+ L + N F+ IP + LQ L +S N +G+ ++ T L L
Sbjct: 196 -VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLN 253
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISA-LTSLTDLRISD--LKGSES 274
IS N F G IP K +Q L + + G IP +S +LT L +S G+
Sbjct: 254 ISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA-- 309
Query: 275 AFPK-LDKM-NLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
P L++L L+ GE+P D + M LK +DLSFN +G +P + L+
Sbjct: 310 -VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA 368
Query: 332 T-NFMYLTGNKLTGPVPKYIFNSNKN----VDISLNNFT 365
+ + L+ N +GP+ + + KN + + N FT
Sbjct: 369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-54
Identities = 73/272 (26%), Positives = 125/272 (45%), Gaps = 14/272 (5%)
Query: 103 NLTGTLPTELSK--LRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVL 159
N +G + L + L++L L N TG P ++ +LV L + N LSG P L
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+++ L++L + N+ G IP ++ + L+ LIL N TGE+P+ L+ TNLN + +S
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFP 277
+N +G+IP++IG+ + + L + +S G IPA + SL L ++ G+ P
Sbjct: 499 NNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT---IP 555
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN--NLTGGIPTTFEKLAKTNFM 335
M ++ + I G+ YI + K + N G +L+ N
Sbjct: 556 A--AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC 613
Query: 336 YLTGNKLTGPVPKYIFNSNK--NVDISLNNFT 365
+T G N+ +D+S N +
Sbjct: 614 NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 645
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 5e-53
Identities = 73/270 (27%), Positives = 127/270 (47%), Gaps = 12/270 (4%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
L G +P EL ++ L+ L L N LTG ++ L +S+ NRL+G PK +
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+ L L + N F+G+IP ++ +L L L++N F G +PA + K + I+ N
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAAN 568
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGS--SLEGPIPASISALTSLTDLRISD--LKGSESAFP 277
+GK +I ++ H G+ +G ++ L++ I+ G S
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 337
+ ++ L ++ ++ G IP IG M L ++L N+++G IP L N + L
Sbjct: 629 DNNG-SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDL 687
Query: 338 TGNKLTGPVPKYI--FNSNKNVDISLNNFT 365
+ NKL G +P+ + +D+S NN +
Sbjct: 688 SSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-52
Identities = 78/323 (24%), Positives = 127/323 (39%), Gaps = 59/323 (18%)
Query: 55 DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLT---GTLPTE 111
DW+ +PC+ ++ G VTC V +I L ++ L + +
Sbjct: 32 DWSSNKNPCT----FD-------G----VTCR----DDKVTSIDLSSKPLNVGFSAVSSS 72
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV--LTNITTLKNLS 169
L L L+ L LS + + GS S S L L + N LSGP + L + + LK L+
Sbjct: 73 LLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLN 132
Query: 170 IEGNLFTGSIP-PDIRKLINLQKLILSSNSFTGELPAELT---KLTNLNDLRISDNNFSG 225
+ N KL +L+ L LS+NS +G L L IS N SG
Sbjct: 133 VSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISG 192
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLK 285
+ + + ++ L + ++ IP + ++L L IS
Sbjct: 193 DVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISG----------------- 232
Query: 286 TLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP 345
+ G+ I T+LK +++S N G IP L ++ L NK TG
Sbjct: 233 ------NKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGE 284
Query: 346 VPKYIFNSNKN---VDISLNNFT 365
+P ++ + +D+S N+F
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFY 307
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-45
Identities = 60/248 (24%), Positives = 93/248 (37%), Gaps = 30/248 (12%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
LTG +P + +L L L LS N +G+ + L+ L + N +G P +
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN--SFTGELPAELTKLTNLNDLRIS 219
+ I N G I+ ++ + N F G +L +L+ N I+
Sbjct: 561 QSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 279
+ G + L + + L G IP I ++ L L +
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG------------ 664
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339
N I G IPD +GD+ L +DLS N L G IP L + L+
Sbjct: 665 --HND---------ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713
Query: 340 NKLTGPVP 347
N L+GP+P
Sbjct: 714 NNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-42
Identities = 57/225 (25%), Positives = 85/225 (37%), Gaps = 28/225 (12%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+ +G +P EL R L LDL+ N G+ + N ++G + N
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG---KIAANFIAGKRYVYIKND 581
Query: 163 TTLKNLSIEGNL--FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
K GNL F G + +L ++S + G ++ L +S
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLD 280
N SG IP+ IG + L++ + + G IP + L L L +S
Sbjct: 642 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS------------ 689
Query: 281 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325
N L G IP + +T L IDLS NNL+G IP
Sbjct: 690 --NK----LD-----GRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 4e-56
Identities = 53/190 (27%), Positives = 79/190 (41%), Gaps = 20/190 (10%)
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
+ + G FG V+K L +AVK + +Q + E+ +
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYSL 72
Query: 727 SAQQHPNLVKLYGCCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 782
+H N+++ G G L L+ + + LS + + W I
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHI 126
Query: 783 CIGIARGLAYLHED-------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
+ARGLAYLHED + I HRDIK+ NVLL +L A I+DFGLA +E K+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 836 HI-STRIAGT 844
+ GT
Sbjct: 187 AGDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-49
Identities = 54/191 (28%), Positives = 82/191 (42%), Gaps = 30/191 (15%)
Query: 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQH 731
+N +G G +G+VYKG L D +AVK S +RQ F+NE I + +H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEH 66
Query: 732 PNLVKLYGCCVEGN-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
N+ + + LLV EY N L + + DW + ++ +
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSV 120
Query: 787 ARGLAYLHED------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK------ 834
RGLAYLH + + I HRD+ + NVL+ D ISDFGL+ ++
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 835 -THISTRIAGT 844
+ + GT
Sbjct: 181 EDNAAISEVGT 191
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-45
Identities = 51/323 (15%), Positives = 109/323 (33%), Gaps = 27/323 (8%)
Query: 43 ALKQIGRKLGKKDWNFGVDPCSQKGNWELSSD-DKKGFESNVTCDCSSATCHVVTIALKA 101
ALK+I L K+W+ NW + + D G + V+ + + V ++L+
Sbjct: 34 ALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNG---RVTGLSLEG 90
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS-----LQLVELSVMGNRLSGPFP 156
+G +P + +L L+ L L + + + + M F
Sbjct: 91 FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150
Query: 157 KVLT--NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLN 214
+ + L I + SI R + ++ SN+ T + + +LT L
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLR 209
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES 274
+ ++ F + + + + L LTD+ + +
Sbjct: 210 QFYMGNSPFVAENICEAWENENSEYA-----QQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 275 AFPKLDKM-NLKTLILTKCLIHG--------EIPDYIGDMTKLKNIDLSFNNLTGG-IPT 324
L + ++ + + + K++ I + +NNL + T
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324
Query: 325 TFEKLAKTNFMYLTGNKLTGPVP 347
+ +K+ K + N+L G +P
Sbjct: 325 SLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-39
Identities = 40/285 (14%), Positives = 83/285 (29%), Gaps = 31/285 (10%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSG-PFPKVL 159
L G LP L L+L+ N +T + Q+ LS N+L P
Sbjct: 341 QLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDA 398
Query: 160 TNITTLKNLSIEGNLFTG-------SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
+++ + + N + P K IN+ + LS+N + + +
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458
Query: 213 LNDLRISDNNFSG-------KIPEFIGKWKKIQKLHIQGSSLEGPIPASISA--LTSLTD 263
L+ + + N + E + + ++ + L + A L L
Sbjct: 459 LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVG 517
Query: 264 LRISD--LKG-SESAF--PKLDKMNLKT-LILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 317
+ +S L ++ E P+ I L + + N+
Sbjct: 518 IDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577
Query: 318 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 362
+ + + + + N Y+ + L
Sbjct: 578 IRKVNEKITPNI---SVLDIKDNPNISIDLSYVCPYIEAGMYMLF 619
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-35
Identities = 42/290 (14%), Positives = 95/290 (32%), Gaps = 32/290 (11%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPK 157
+ + ++ Q+ N +T S L L + + +
Sbjct: 166 INSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENIC 224
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
+ + L +L + + + +LP L L + +
Sbjct: 225 EAWENENSEYAQ-----QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279
Query: 218 ISDNNF--------SGKIPEFIGKWKKIQKLHIQGSSL-EGPIPASISALTSLTDLRISD 268
++ N + +KIQ ++I ++L P+ S+ + L L
Sbjct: 280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLY 339
Query: 269 --LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF 326
L+G AF + L +L L I ++ G +++N+ + N L IP F
Sbjct: 340 NQLEGKLPAFGSE--IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIF 396
Query: 327 E--KLAKTNFMYLTGNKLTG-------PVPKYIFNSNK--NVDISLNNFT 365
+ ++ + + + N++ P+ F ++++S N +
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-26
Identities = 30/226 (13%), Positives = 70/226 (30%), Gaps = 18/226 (7%)
Query: 151 LSGPFPKV-LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTG----ELPA 205
+ G P V L + + LS+EG +G +P I +L L+ L L S+ P
Sbjct: 68 MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPK 127
Query: 206 ELTKLTNLNDLRISDNNFSGKIPEFIGKWK--KIQKLHIQGSSLEGPIPASISALTSLTD 263
++ + + ++ ++ + + K I + I S T
Sbjct: 128 GISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187
Query: 264 LRISD--LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG 321
+ + A +L L+ + E +N + +
Sbjct: 188 IGQLSNNITFVSKAVMRL--TKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKT 240
Query: 322 IPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN-SN-KNVDISLNNFT 365
++ L + + +P ++ + ++++ N
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI 286
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-20
Identities = 31/210 (14%), Positives = 55/210 (26%), Gaps = 32/210 (15%)
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
N + E +++ + + L L +G +P + +LT L L + +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRISDLKGSE-SAFPKLDKMN 283
F P ISA S + + P+ D +
Sbjct: 121 ERLF--------------------GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160
Query: 284 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
L + I K I NN+T + +L K Y+ +
Sbjct: 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFV 219
Query: 344 GPVPK--------YIFNSNKNVDISLNNFT 365
K D+ +N
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLK 249
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 53/165 (32%), Positives = 85/165 (51%), Gaps = 7/165 (4%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
K+G G FG+V++ G+ +AVK L + EF+ E+ ++ +HPN+V G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ L +V EY+ L R + + R +LD R + +A+G+ YLH
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLL--HKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
IVHR++K+ N+L+DK K+ DFGL++L + S AGT
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGT 202
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 53/164 (32%), Positives = 77/164 (46%), Gaps = 12/164 (7%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
VG G FG V K +A+KQ+ S+S + + F+ E+ +S HPN+VKLYG C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ N + LV EY + L + G + C+ ++G+AYLH +
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 802 VHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDKTHISTRIAGT 844
+HRD+K N+LL KI DFG A D T G+
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGS 166
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 8/160 (5%)
Query: 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
+G+G FG K G V+ +K+L + R F+ E+ ++ +HPN++K G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800
+ +L + EY+K L I D+ + W R IA G+AYLH +
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
I+HRD+ + N L+ ++ N ++DFGLA+L ++KT
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 51/176 (28%), Positives = 88/176 (50%), Gaps = 24/176 (13%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-------REFVNEIGMISAQQHPN 733
++G+GGFG V+KG + D +V+A+K L +G +EF E+ ++S HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+VKLYG N +V E++ L + K + W + ++ + IA G+ Y+
Sbjct: 85 IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYM 138
Query: 794 HEDSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ IVHRD+++ N+ L + AK++DFGL++ H + + G
Sbjct: 139 Q-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGN 189
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 53/175 (30%), Positives = 86/175 (49%), Gaps = 22/175 (12%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL----SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+G GGFG VY+ G +AVK Q E + + +HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
G C++ L LV E+ + L+R + GK ++ + IARG+ YLH+++
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 798 RIKIVHRDIKTSNVLLDKDL--------NAKISDFGLAKLYEEDKTHISTRIAGT 844
+ I+HRD+K+SN+L+ + + KI+DFGLA+ E +T + AG
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSA-AGA 177
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 43/177 (24%), Positives = 73/177 (41%), Gaps = 24/177 (13%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 739
++G+G +G V+ G G +AVK + + E I +H N++
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 740 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
++G QL L+ +Y +N L + LD + K+ GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 796 D-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIAGT 844
+ + I HRD+K+ N+L+ K+ I+D GLA + D + GT
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-41
Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 24/177 (13%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 739
VG+G +G V++G G +AVK SS + + + E + +H N++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 740 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+ QL L+ Y + L + LD + +I + IA GLA+LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 796 D-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIAGT 844
+ + I HRD+K+ N+L+ K+ I+D GLA ++ + + + GT
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-41
Identities = 37/167 (22%), Positives = 65/167 (38%), Gaps = 15/167 (8%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
K+ E G ++KG G I VK L + R+F E + HPN++ + G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 740 CCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
C L+ +M L + +D K + +ARG+A+LH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLH-TL 130
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
I + + +V++D+D+ A+IS + ++ S
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYA 171
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-40
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 13/166 (7%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
++G G FG+VYKG G V AVK L+ + + F NE+G++ +H N++ G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
L +V ++ + + L + +T K + I ARG+ YLH
Sbjct: 88 YSTAPQ-LAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLH---AK 139
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEEDKTHISTRIAGT 844
I+HRD+K++N+ L +D KI DFGLA +H +++G+
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-39
Identities = 53/270 (19%), Positives = 96/270 (35%), Gaps = 9/270 (3%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
L ++ L LD+ N ++ L L L++ N LS K
Sbjct: 36 QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
T L L + N K NL L LS N + +L NL +L +S+N
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
Query: 222 NFSGKIPEFIG--KWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA---- 275
E + ++KL + + ++ P A+ L L +++++ S
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDM--TKLKNIDLSFNNLTGGIPTTFEKLAKTN 333
+L +++ L L+ + + T L +DLS+NNL +F L +
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275
Query: 334 FMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
+ +L N + + ++L
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-37
Identities = 53/293 (18%), Positives = 90/293 (30%), Gaps = 25/293 (8%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGS----FSPQWASLQLVELSVMGNRLSGPFPKV 158
+ P + L L L+ L S + A+ + LS+ ++LS
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 159 LTN--ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 216
T L L + N L L+ L N+ L L N+ L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 217 R---------ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL--- 264
IS + K ++ L+++ + + G + L +L L
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 265 --RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322
S + F L L L LTK I D + L+ +DL N + +
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 323 P-TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFTWESSDP 371
+ L +YL+ NK + + F + + + S P
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQ-LTRNSFALVPSLQRLMLRRVALKNVDSSP 473
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-36
Identities = 50/283 (17%), Positives = 94/283 (33%), Gaps = 20/283 (7%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSP-----QWASLQLVELSVMGNRLSGPFPK 157
++ G + L LK L LS + + A L L++ N++S
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPD-IRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 216
+ + L+ L + N + R L N+ ++ LS N + + +L L
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459
Query: 217 RISDNNFSG--KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDL 269
+ P + + L + +++ + L L L ++ L
Sbjct: 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL 519
Query: 270 KGSESAFPKLDKM----NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325
+ + + +L L L + D+ +LK IDL NNL +
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
Query: 326 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
F + L N +T K + +N +D+ N F
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-33
Identities = 55/289 (19%), Positives = 108/289 (37%), Gaps = 25/289 (8%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPK 157
+ +L L+ L+ L++ N + G S + L L LS+ + S
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 158 VLT----NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA-ELTKLTN 212
T + L L++ N + L +L+ L L N EL E L N
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG--PIPASISALTSLTDLRISD-- 268
+ ++ +S N + +Q+L ++ +L+ P+ L +LT L +S+
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491
Query: 269 LKG-SESAFPKLDKMNLKTLILTKCLIH--------GEIPDYIGDMTKLKNIDLSFNNLT 319
+ ++ L+ L+ L L + G ++ ++ L ++L N
Sbjct: 492 IANINDDMLEGLE--KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549
Query: 320 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
F+ L + + L N L +P +FN+ + +++ N T
Sbjct: 550 EIPVEVFKDLFELKIIDLGLNNLNT-LPASVFNNQVSLKSLNLQKNLIT 597
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-33
Identities = 50/262 (19%), Positives = 85/262 (32%), Gaps = 18/262 (6%)
Query: 117 YLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFT 176
+ D S LT P + L++ N+L T + L +L + N +
Sbjct: 5 SHEVADCSHLKLTQV--PDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
P +KL L+ L L N + TNL +L + N+ K K
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTK 291
+ L + + L + L +L +L +I L +LK L L+
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL--KSEELDIFANSSLKKLELSS 180
Query: 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF---EKLAKTNFMYLTGNKLTGPVPK 348
I P + +L + L+ L + + L+ ++L+
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST-TSN 239
Query: 349 YIFNSNKNV-----DISLNNFT 365
F K D+S NN
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLN 261
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-17
Identities = 30/158 (18%), Positives = 58/158 (36%), Gaps = 10/158 (6%)
Query: 106 GTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLS--------GPFP 156
+ P+ LR L LDLS N + L +L L + N L+ G
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529
Query: 157 KVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 216
L ++ L L++E N F + L L+ + L N+ + +L L
Sbjct: 530 YFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSL 589
Query: 217 RISDNNFSGKIPE-FIGKWKKIQKLHIQGSSLEGPIPA 253
+ N + + F ++ + +L ++ + + +
Sbjct: 590 NLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-39
Identities = 36/207 (17%), Positives = 63/207 (30%), Gaps = 40/207 (19%)
Query: 409 ADQYHYTLHINCGGAKIN-TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLD 467
AD+ + +N GG Y D + G+ + + + +
Sbjct: 3 ADKVIW--AVNAGGESHVDVHGIHYRKD------PLEGRVGRASDYGMKLPILRSNPE-- 52
Query: 468 NYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTF 527
D LY+T R + S Y G Y + L FAE F
Sbjct: 53 ----------------DQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAE------VYF 90
Query: 528 NSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHL---YWAGRG 584
+++FD+ + V KD +I D G + P + L + + G+
Sbjct: 91 AQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEVSTFTGKL 149
Query: 585 TTGIPLRGTYGPLISAISVKSNFKPPV 611
+ P + A+ + K
Sbjct: 150 SVEFVKGYYDNPKVCALFI---MKGTA 173
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-39
Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 24/177 (13%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 739
+G+G FG V++G G +AVK SS + R + E I +H N++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 740 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+ N QL LV +Y ++ L + R + K+ + A GLA+LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 796 D-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIAGT 844
+ + I HRD+K+ N+L+ K+ I+D GLA ++ I GT
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 41/169 (24%), Positives = 67/169 (39%), Gaps = 16/169 (9%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 739
+G+G FG VY G G V A++ + + + + F E+ +H N+V G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
C+ L ++ K L + LD ++I I +G+ YLH
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKI----VLDVNKTRQIAQEIVKGMGYLH---AK 149
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKL----YEEDKTHISTRIAGT 844
I+H+D+K+ NV D I+DFGL + + G
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-36
Identities = 47/272 (17%), Positives = 95/272 (34%), Gaps = 17/272 (6%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV-LTN 161
+ S + L+L P L L+ N+ F +V L +
Sbjct: 293 TIERVKD--FSYNFGWQHLELVNCKFGQF--PTLKLKSLKRLTFTSNKGGNAFSEVDLPS 348
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+ L +LS G F G +L+ L LS N + + L L L +
Sbjct: 349 LEFL-DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 406
Query: 222 NFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS--ESAF 276
N + + L I + + L+SL L+++ + + F
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 277 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336
+L NL L L++C + P ++ L+ +++S NN ++ L +
Sbjct: 467 TELR--NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 524
Query: 337 LTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
+ N + + + + + ++++ N+F
Sbjct: 525 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 46/270 (17%), Positives = 95/270 (35%), Gaps = 15/270 (5%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLT--GSFSPQWASL-QLVELSVMGNRLSGPFPKVL 159
+ G L L+ LDLSRN L+ G S L L + N +
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392
Query: 160 TNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
+ L++L + + + L NL L +S L++L L++
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 219 SDNNFSGKI-PEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SES 274
+ N+F P+ + + + L + LE P + ++L+SL L +S
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512
Query: 275 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDM-TKLKNIDLSFNNLTGGIPTT--FEKLAK 331
+ L+ +L+ L + I + + L ++L+ N+ + +
Sbjct: 513 PYKCLN--SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKD 570
Query: 332 TNFMYLTGNKLTGPVPKYIFNSN-KNVDIS 360
+ + ++ P +++I+
Sbjct: 571 QRQLLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-30
Identities = 52/308 (16%), Positives = 89/308 (28%), Gaps = 43/308 (13%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQW----ASLQLVELSVMGNRLSGPFPKV 158
+ P ++R L +L L N + + A L++ L + R G K
Sbjct: 188 PMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 159 -LTNITTLKNLSIEGN------LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
+ + L NL+IE + I L N+ L S + +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNF 304
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS---------------------SLEGP 250
L + + F + K++ +G S +G
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 251 IPASISALTSLTDLRISD--LKGSESAFPKLDKMNLKTLILTKCLIHGEIP-DYIGDMTK 307
S TSL L +S + S F L L+ L + +
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVITMSSNFLGL--EQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 308 LKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNF 364
L +D+S + F L+ + + GN IF +N+ D+S
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 365 TWESSDPI 372
S
Sbjct: 483 EQLSPTAF 490
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-29
Identities = 40/214 (18%), Positives = 73/214 (34%), Gaps = 14/214 (6%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
+ KNL + N LQ L LS L++L+ L ++ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSE--SAFPK 278
+QKL ++L I L +L +L ++ ++ + F
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 279 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKN----IDLSFNNLTGGIPTTFEKLAKTNF 334
L NL+ L L+ I + + ++ +DLS N + P F+++ + +
Sbjct: 148 LT--NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHK 204
Query: 335 MYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
+ L N + V K + L F
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-28
Identities = 52/296 (17%), Positives = 91/296 (30%), Gaps = 51/296 (17%)
Query: 82 NVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQL 141
N+T C N +P L K LDLS
Sbjct: 9 NITYQCME------------LNFY-KIPDNLP--FSTKNLDLS----------------- 36
Query: 142 VELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTG 201
N L + L+ L + + L +L LIL+ N
Sbjct: 37 ------FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90
Query: 202 ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTS 260
+ L++L L + N + IG K +++L++ + ++ +P S LT+
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 261 LTDLRISD--LKG-SESAFPKLDKMNLK--TLILTKCLIHGEIPDYIGDMTKLKNIDLSF 315
L L +S ++ + L +M L +L L+ ++ I +L + L
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRN 209
Query: 316 NNLTGGIP-TTFEKLAKTNFMYLTGNKLTG-----PVPKYIFNSNKNVDISLNNFT 365
N + + T + LA L + K N+ I
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 20/169 (11%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++GEG FG V+ + ++AVK L S ++F E +++ QH ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCL----------SRAIFGKDTEYRLKLDWPTRKKICIG 785
+ +G C EG LL+V+EYM++ L ++ + G + L +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
+A G+ YL + + VHRD+ T N L+ + L KI DFG+++ +Y D
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 21/170 (12%)
Query: 682 NKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++GEG FG V+ D ++AVK L + ++F E +++ QH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCL-----------SRAIFGKDTEYRLKLDWPTRKKICI 784
K YG C +G+ L++V+EYMK+ L + G+ + + +L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
IA G+ YL + VHRD+ T N L+ +L KI DFG+++ +Y D
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++G+G FGSV + G V+AVK+L + + R+F EI ++ + QH N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 737 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAY 792
G C + L L+ EY+ L +D +++ ++D + I +G+ Y
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSL------RDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
L + +HRD+ T N+L++ + KI DFGL K+ +DK + G
Sbjct: 130 LGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNL 734
++G+G FG VY+G+ T +A+K ++ + R EF+NE ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK---KICIGIAR 788
V+L G +G L++ E M L R++ L P+ ++ IA
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
G+AYL+ K VHRD+ N ++ +D KI DFG+ +YE D
Sbjct: 150 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
++G+G FGSV + G V+AVK+L + + R+F EI ++ + QH N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 737 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
G C + L L+ EY+ L + + + R+ + I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDH--IKLLQYTSQICKGMEYLG 162
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
+ +HRD+ T N+L++ + KI DFGL K+ +DK
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 9/153 (5%)
Query: 683 KVGEGGFGSVYKGILSDGTV-IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
++G G FG V+ G L +AVK + +F+ E ++ HPN+V+L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800
C + + +V E ++ F + RL++ T ++ A G+ YL
Sbjct: 181 CTQKQPIYIVMELVQGGDFLT--FLRTEGARLRV--KTLLQMVGDAAAGMEYLES---KC 233
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+HRD+ N L+ + KISDFG+++ +
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 15/170 (8%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+GEG FG V + G +AVK L + EI ++ H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 736 KLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
K G C E GN + L+ E++ + L + + ++ L + K + I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINL--KQQLKYAVQICKGMDYL 142
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
+ VHRD+ NVL++ + KI DFGL K E DK + + +
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR 189
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 52/171 (30%), Positives = 75/171 (43%), Gaps = 22/171 (12%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 734
++GE FG VYKG L +A+K L K EF +E + + QHPN+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCL-----------SRAIFGKDTEYRLKLDWPTRKKIC 783
V L G + L +++ Y + L D + L+ P +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
IA G+ YL S +VH+D+ T NVL+ LN KISD GL ++Y D
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 51/163 (31%), Positives = 68/163 (41%), Gaps = 21/163 (12%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+GEG FG V G ++AVK L + Q + EI ++ H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 736 KLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEY--RLKLDWPTRKKICIGIARGLA 791
K GCC + L LV EY+ L +Y R + I G+A
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLR--------DYLPRHSIGLAQLLLFAQQICEGMA 148
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
YLH +HRD+ NVLLD D KI DFGLAK E
Sbjct: 149 YLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 52/162 (32%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 682 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 736
+++G+G FGSV + G ++AVKQL R+F EI ++ A +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 737 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAY 792
G + L LV EY+ + CL +D +R +LD I +G+ Y
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCL------RDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
L + VHRD+ N+L++ + + KI+DFGLAKL DK
Sbjct: 143 LGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 41/155 (26%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 682 NKVGEGGFGSVYKGILSDGTV-IAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+K+G G +G VY+G+ ++ +AVK L + + EF+ E ++ +HPNLV+L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G C ++ E+M L + ++ R ++ + I+ + YL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLD--YLRECN-RQEVSAVVLLYMATQISSAMEYL---EK 129
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+HRD+ N L+ ++ K++DFGL++L D
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 19/163 (11%)
Query: 682 NKVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPNLVK 736
+ +GEG FG V K + A+K++ S+ +R+F E+ + HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK--------KICIG 785
L G C L L EY + L R +T+ + T
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+ARG+ YL S+ + +HRD+ N+L+ ++ AKI+DFGL++
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 53/179 (29%), Positives = 81/179 (45%), Gaps = 30/179 (16%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNL 734
+GEG FG V K T +AVK L + S R+ ++E ++ HP++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK-------- 780
+KLYG C + LLL+ EY K L SR + + +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 781 -----KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
I++G+ YL + +K+VHRD+ N+L+ + KISDFGL+ +YEED
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 12/154 (7%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V G +A+K + S S EF+ E ++ H LV+LYG
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYG 86
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
C + + ++ EYM N CL + ++ +R + ++C + + YL
Sbjct: 87 VCTKQRPIFIITEYMANGCLLN--YLREMRHRFQT--QQLLEMCKDVCEAMEYL---ESK 139
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+ +HRD+ N L++ K+SDFGL++ +D
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-33
Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 14/165 (8%)
Query: 682 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+G G FG+VYKG+ +A+K+L + S + N+E ++E ++++ +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+L G C+ + + L+ + M CL + E++ + C+ IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
++VHRD+ NVL+ + KI+DFGLAKL ++
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-33
Identities = 44/170 (25%), Positives = 69/170 (40%), Gaps = 21/170 (12%)
Query: 682 NKVGEGGFGSVYKGILSD------GTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 733
+G G FG V + +AVK L S+ ++E+ M QH N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK---KICI 784
+V L G C G +L++ EY L + D + + + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
+A+G+A+L + +HRD+ NVLL AKI DFGLA + +
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 53/179 (29%), Positives = 82/179 (45%), Gaps = 30/179 (16%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 734
+GEG FG V++ T++AVK L + S +F E +++ +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCL-----------SRAIFGKDTEYRLKLDWPTRK--- 780
VKL G C G + L++EYM L ++ D R ++ P
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 781 -----KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
I +A G+AYL S K VHRD+ T N L+ +++ KI+DFGL+ +Y D
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-33
Identities = 52/352 (14%), Positives = 104/352 (29%), Gaps = 57/352 (16%)
Query: 29 IAATANKLHAEEVKALKQIGRKLGKKDWNF---GVDPCSQKGNWELSSD-DKKGFESNVT 84
I + ++ KALK I L K+W + ++ NW + + D G + V
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD 318
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTG--------SFSPQW 136
D + V ++L G +P + +L LK L + T +P
Sbjct: 319 LDNNG---RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375
Query: 137 ASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG------------------- 177
+ + + + ++ + + L L++
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTN 435
Query: 178 ---SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKW 234
I I++L LQ + +++ FT + A + N
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS-----DYAKQYENEELSWSNL 490
Query: 235 KKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLI 294
K + + + +P + L L L I+ N
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC--------------NRGISAAQLKAD 536
Query: 295 HGEIPDYIGDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNFMYLTGNKLTGP 345
+ D K++ + +NNL + +K+ K + NK+
Sbjct: 537 WTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL 588
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-30
Identities = 55/304 (18%), Positives = 97/304 (31%), Gaps = 47/304 (15%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+ L+ L+ + SL+ ++ + NR++ K + +
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRL 447
Query: 163 TTLKNLSIEGNLFTG-------------------SIPPDIRKLINLQKLILSSNSFTGEL 203
T L+ + + FT + L +L + L + +L
Sbjct: 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507
Query: 204 PAELTKLTNLNDLRISDNNFSG---------KIPEFIGKWKKIQKLHIQGSSLEG-PIPA 253
P L L L L I+ N ++ + KIQ ++ ++LE P A
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA 567
Query: 254 SISALTSLTDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIG-DMTKLKNI 311
S+ + L L K AF L L L I EIP+ +++ +
Sbjct: 568 SLQKMVKLGLLDCVHNKVRHLEAFGTNV--KLTDLKLDYNQIE-EIPEDFCAFTDQVEGL 624
Query: 312 DLSFNNLTGGIPTTFE--KLAKTNFMYLTGNKLTGPVPKYIFNSNKN--------VDISL 361
S N L IP F + + + NK+ + I S + V +S
Sbjct: 625 GFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSY 682
Query: 362 NNFT 365
N
Sbjct: 683 NEIQ 686
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-29
Identities = 37/293 (12%), Positives = 78/293 (26%), Gaps = 38/293 (12%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSG-PFPKVLTNIT 163
L L L N + + + Q+ L N+L P ++
Sbjct: 586 RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVY 644
Query: 164 TLKNLSIEGNLFTG-----SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
+ ++ N S D K IN + LS N + ++ + +
Sbjct: 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704
Query: 219 SDNNFS-------GKIPEFIGKWKKIQKLHIQGSSLEGPIPASI--SALTSLTDL----- 264
S+N + + + ++ + L + + L L+++
Sbjct: 705 SNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYN 763
Query: 265 RISDLKGSESAFPKLDKMNL-KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323
S +L + I + P I L + + N++
Sbjct: 764 CFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDE 823
Query: 324 TTFEKLAKTNFMYLTGNKLT-GPVP---------KYIFNSNKNVDISLNNFTW 366
+L + + N V Y+ +K DI +
Sbjct: 824 KLTPQL---YILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALG 873
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 4e-21
Identities = 43/267 (16%), Positives = 85/267 (31%), Gaps = 45/267 (16%)
Query: 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPD----------------- 182
++ LS+ G G P + +T LK LS + T S
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 183 --------IRKLINLQKLILSSNSFTGEL---PAELTKLTNLNDLRISD-NNFSGKIPEF 230
+ L L ++ P + +L D +I + N I +
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKA 443
Query: 231 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILT 290
I + K+Q ++ S A + + + E ++ L +L + L
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQ--YENEELSWSNLK--DLTDVELY 499
Query: 291 KCLIHGEIPDYIGDMTKLKNIDLSFNNLTG---------GIPTTFEKLAKTNFMYLTGNK 341
C ++PD++ D+ +L++++++ N + + K Y+ N
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559
Query: 342 LTG-PVPKYIFNSNK--NVDISLNNFT 365
L P + K +D N
Sbjct: 560 LEEFPASASLQKMVKLGLLDCVHNKVR 586
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 3e-17
Identities = 35/145 (24%), Positives = 49/145 (33%), Gaps = 15/145 (10%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVM---GNRLSGPFPKV 158
+N L +DL N LT S S + + L LS M N S FP
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQ 771
Query: 159 LTNITTLKNLSIEGNL------FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
N + LK I P I +L +L + SN ++ +L
Sbjct: 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQ 828
Query: 213 LNDLRISDN-NFSGKIPEFIGKWKK 236
L L I+DN N S + +
Sbjct: 829 LYILDIADNPNISIDVTSVCPYIEA 853
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 9e-17
Identities = 29/227 (12%), Positives = 69/227 (30%), Gaps = 29/227 (12%)
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
N + E +++ D+ + L L+ G +P + +LT L L ++ +
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPI-PASISALTSLTDLRISDLKGSE----SAFPKLDK 281
F + + + + L + + K +
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422
Query: 282 MNLKTLILTKC--LIHGEIPDYIGDMTKLKNIDLSFNNLTG------------------- 320
++LK + I I I +TKL+ I + + T
Sbjct: 423 ISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481
Query: 321 GIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK--NVDISLNNFT 365
++ L + L +P ++++ + +++I+ N
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGI 528
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 12/154 (7%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V+ G + +A+K + + S + +F+ E ++ HP LV+LYG
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYG 70
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
C+E + LV E+M++ CLS + + T +C+ + G+AYL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSD--YLRTQRGLFAA--ETLLGMCLDVCEGMAYL---EEA 123
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
++HRD+ N L+ ++ K+SDFG+ + +D
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 46/174 (26%), Positives = 72/174 (41%), Gaps = 25/174 (14%)
Query: 682 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSK-SRQGNREFVNEIG-MISAQQH 731
+GEG FG V +AVK L + + + V+E+ M +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK-------- 780
N++ L G C + L ++ EY L RA EY ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
+ARG+ YL + K +HRD+ NVL+ ++ KI+DFGLA + D
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
++G G FG V G +AVK + S S EF E + HP LVK YG
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLAYLHED 796
C + + +V EY+ N CL Y L+ ++C + G+A+L
Sbjct: 72 CSKEYPIYIVTEYISNGCLL--------NYLRSHGKGLEPSQLLEMCYDVCEGMAFL--- 120
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+ +HRD+ N L+D+DL K+SDFG+ + +D
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 24/173 (13%)
Query: 682 NKVGEGGFGSVYKGIL------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 733
+G G FG V + + +AVK L + +R ++E+ +I H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 734 LVKLYGCC-VEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK--------K 781
+V L G C G L+++ E+ K LS R+ + Y++ + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 782 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
+A+G+ +L + K +HRD+ N+LL + KI DFGLA +Y++
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 46/174 (26%), Positives = 72/174 (41%), Gaps = 25/174 (14%)
Query: 682 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSK-SRQGNREFVNEIG-MISAQQH 731
+GEG FG V +AVK L + + + V+E+ M +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK-------- 780
N++ L G C + L ++ EY L RA EY ++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
+ARG+ YL + K +HRD+ NVL+ ++ KI+DFGLA + D
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-32
Identities = 46/272 (16%), Positives = 96/272 (35%), Gaps = 12/272 (4%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
+ L L L+ N L + + L L + +S L N
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN 127
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS-D 220
TL++L + N + P L+ L +N+ +++ L +L ++ +
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASIS--ALTSLTDLRISDLKG---SESA 275
N I Q L+ G+ I + + SL D+ S +
Sbjct: 188 GNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
F L +M+++++ L K + + L+ +DL+ +L+ +P+ L+ +
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKL 306
Query: 336 YLTGNKLTGPVPKYIFNSNKNV---DISLNNF 364
L+ NK + + ++ ++ I N
Sbjct: 307 VLSANKFEN-LCQISASNFPSLTHLSIKGNTK 337
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-31
Identities = 54/272 (19%), Positives = 96/272 (35%), Gaps = 16/272 (5%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGP-FPKVLTNITT 164
LP+ L L LK+L LS N ++ L LS+ GN L N+
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
Query: 165 LKNLSIEGNLFTGS--IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
L+ L + + S +R L +LQ L LS N + L L ++
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411
Query: 223 FSGKIPE-FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD------LKGSESA 275
K + ++ L++ S L+ L +L L + ++
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
L L+ L+L+ C + + + ++DLS N LT L ++
Sbjct: 472 LQTLG--RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YL 528
Query: 336 YLTGNKLTGPVPK--YIFNSNKNVDISLNNFT 365
L N ++ +P I + + +++ N
Sbjct: 529 NLASNHISIILPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-29
Identities = 40/279 (14%), Positives = 93/279 (33%), Gaps = 15/279 (5%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 158
G + + L D+ ++ + + + +++ +
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
+ L+ L + + +P + L L+KL+LS+N F + +L L I
Sbjct: 274 FHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332
Query: 219 SDNNFSGKI-PEFIGKWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD--LKGSE 273
N ++ + + +++L + +E + L+ L L +S +
Sbjct: 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLK 392
Query: 274 S-AFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
+ AF + L+ L L + + ++ LK ++LS + L F+ L
Sbjct: 393 TEAFKECP--QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA 450
Query: 332 TNFMYLTGNKLTG--PVPKYIFNSNKNV---DISLNNFT 365
+ L GN + + +S + +
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-25
Identities = 43/229 (18%), Positives = 77/229 (33%), Gaps = 14/229 (6%)
Query: 103 NLTGTLPTE-LSKLRYLKQLDLSRNCLTGS--FSPQWASL-QLVELSVMGNRLSGPFPKV 158
L T L L L++LDLS + + S + Q +L L L++ N +
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
L+ L + + L L+ L LS + L L L
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455
Query: 218 ISDNNFSGKI---PEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG- 271
+ N+F + +++ L + L + ++L + + +S L
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515
Query: 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320
S A L L L I +P + +++ + I+L N L
Sbjct: 516 SIEALSHL---KGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-23
Identities = 35/258 (13%), Positives = 72/258 (27%), Gaps = 16/258 (6%)
Query: 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGS 178
K + L P L N L + + L L +
Sbjct: 15 KTYNCENLGLN-EI-PGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 179 IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ 238
+ L L+L++N L+ L L S + K ++
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 239 KLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCL 293
L++ + + L L I L S+ L + +L L
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL--SKEDMSSLQQATNLSLNLNGND 190
Query: 294 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIP-----TTFEKLAKTNFMYLTGNKLTGPVPK 348
I I D ++++ I +T + L F + ++ V +
Sbjct: 191 I-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249
Query: 349 YIFNSN-KNVDISLNNFT 365
+ + +++++ + F
Sbjct: 250 GLCEMSVESINLQKHYFF 267
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 9e-08
Identities = 21/122 (17%), Positives = 45/122 (36%), Gaps = 4/122 (3%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+L+ + L+ + +DLS N LT S + L+ + L++ N +S P +L +
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPIL 546
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
+ + +++ N + + + L +R+SD
Sbjct: 547 SQQRTINLRQNPLDCT--CSNIYFLEW--YKENMQKLEDTEDTLCENPPLLRGVRLSDVT 602
Query: 223 FS 224
S
Sbjct: 603 LS 604
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
+G+G +G VY G LS+ IA+K++ + + ++ EI + +H N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 743 EGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
E + + E + LS R+ +G LK + T I GL YLH++
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTIGFYTKQILEGLKYLHDN--- 141
Query: 800 KIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+IVHRDIK NVL++ KISDFG +K T GT
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGT 186
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 21/168 (12%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLV 735
+G+G FGSV + L +AVK L + EF+ E + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 736 KLYGCCVEG------NQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGI 786
KL G + +++ +MK+ L A + + L L T + + I
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL--QTLVRFMVDI 146
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
A G+ YL S +HRD+ N +L +D+ ++DFGL+ K+Y D
Sbjct: 147 ACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 41/174 (23%), Positives = 64/174 (36%), Gaps = 25/174 (14%)
Query: 682 NKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIG-MISAQQHPN 733
+G G FG V + +AVK L + R ++E+ + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK------- 780
+V L G C G L++ EY L R F ++
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
+A+G+A+L + +HRD+ N+LL KI DFGLA + +
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 20/167 (11%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLV 735
+GEG FGSV +G L +AVK + + S++ EF++E + HPN++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 736 KLYGCCVEGN-----QLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIA 787
+L G C+E + + +++ +MK L + + L T K + IA
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL--QTLLKFMVDIA 157
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
G+ YL S +HRD+ N +L D+ ++DFGL+K +Y D
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 47/166 (28%), Positives = 68/166 (40%), Gaps = 18/166 (10%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 734
+G G FG VY+G +S +AVK L S Q +F+ E +IS H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
V+ G ++ ++ E M L R + ++ L + IA G
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQ 154
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAK-LYEED 833
YL +HRDI N LL AKI DFG+A+ +Y
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 197
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 682 NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G G G V G L +A+K L + + + R+F++E ++ HPN+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
L G G ++V EYM+N L F + + + + + G+ G+ YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTI--MQLVGMLRGVGAGMRYL--- 167
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
S + VHRD+ NVL+D +L K+SDFGL+++ E+D
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 41/179 (22%), Positives = 60/179 (33%), Gaps = 30/179 (16%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 733
+G G FG V +AVK L ++E+ M H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK------- 780
+V L G C + L++EY L R F +D +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 781 -----KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
+A+G+ +L VHRD+ NVL+ KI DFGLA + +
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 48/167 (28%), Positives = 88/167 (52%), Gaps = 13/167 (7%)
Query: 683 KVGEGGFGSVYKGILSDGTV-----IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G G FG VYKG+L + +A+K L + + + +F+ E G++ H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
L G + ++++ EYM+N L + F ++ + + + GIA G+ YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSV--LQLVGMLRGIAAGMKYL--- 163
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
+ + VHRD+ N+L++ +L K+SDFGL+++ E+D T G
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 42/167 (25%), Positives = 71/167 (42%), Gaps = 14/167 (8%)
Query: 682 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+G G FG+V+KG+ + +K + RQ + + + I + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+L G C G+ L LV +Y+ L + L + IA+G+ YL
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSLLD--HVRQHRGALGP--QLLLNWGVQIAKGMYYL-- 131
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA 842
+VHR++ NVLL +++DFG+A L D + A
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 177
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 36/167 (21%), Positives = 72/167 (43%), Gaps = 23/167 (13%)
Query: 683 KVGEGGFGSVYKGIL--------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+G+G F ++KG+ T + +K L R + F M+S H +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
V YG CV G++ +LV E++K L + K + + + + ++ +A + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINI--LWKLEVAKQLAAAMHFL- 129
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLN--------AKISDFGLAKLYEED 833
++H ++ N+LL ++ + K+SD G++
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 46/163 (28%), Positives = 71/163 (43%), Gaps = 22/163 (13%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G G FG VY G L D AVK L +F+ E ++ HPN++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 737 LYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLA 791
L G C+ L+V YMK+ L + + +A+G+
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDL--------RNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
YL K VHRD+ N +LD+ K++DFGLA+ +Y+++
Sbjct: 143 YLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 12/154 (7%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
++G G FG V+ G + T +AVK L S S F+ E ++ QH LV+LY
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYA 75
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ + ++ EYM+N L F K +KL + IA G+A++
Sbjct: 76 VVTQ-EPIYIITEYMENGSLVD--FLKTPS-GIKLTINKLLDMAAQIAEGMAFI---EER 128
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+HRD++ +N+L+ L+ KI+DFGLA+L E++
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 25/174 (14%)
Query: 682 NKVGEGGFGSVYKGIL--------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQH 731
+GEG FG V + T +AVK L S + + + ++E+ M +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIG--- 785
N++ L G C + L ++ EY L +A EY +++
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 786 -----IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED 833
+ARG+ YL + K +HRD+ NVL+ +D KI+DFGLA ++ D
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 683 KVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G FGSV +G+ +A+K L + E + E ++ +P +V+L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G C + L+LV E L + + GK ++ ++ ++ G+ YL
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYL---EE 128
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
VHRD+ NVLL AKISDFGL+K D ++ + R AG
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 46/167 (27%), Positives = 85/167 (50%), Gaps = 14/167 (8%)
Query: 682 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 735
+G G FG+VYKG+ +A+K+L + S + N+E ++E ++++ +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+L G C+ + + L+ + M CL + E++ + C+ IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA 842
++VHRD+ NVL+ + KI+DFGLAKL ++
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 14/159 (8%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G+G FG VY G D A+K L Q F+ E ++ HPN++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 737 LYGCCVEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
L G + ++ YM + L + F + + + + +ARG+ YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTV--KDLISFGLQVARGMEYL-- 140
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
+ K VHRD+ N +LD+ K++DFGLA+ + + +
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-31
Identities = 40/156 (25%), Positives = 75/156 (48%), Gaps = 12/156 (7%)
Query: 682 NKVGEGGFGSVYKGIL-SDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
+K+G G +G VY+G+ +AVK L + + EF+ E ++ +HPNLV+L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 282
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G C ++ E+M L + ++ R ++ + I+ + YL +
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLD--YLRECN-RQEVSAVVLLYMATQISSAMEYL---EK 336
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
+HR++ N L+ ++ K++DFGL++L D
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 13/156 (8%)
Query: 683 KVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+GEG FG V++GI +A+K + S +F+ E + HP++VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
G E N + ++ E L F + +Y L L + ++ LAYL
Sbjct: 82 IGVITE-NPVWIIMELCTLGELRS--FLQVRKYSLDL--ASLILYAYQLSTALAYL---E 133
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+ VHRDI NVL+ + K+ DFGL++ E+
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 47/166 (28%), Positives = 65/166 (39%), Gaps = 18/166 (10%)
Query: 682 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 734
+G G FG VY+G +S +AVK L S Q +F+ E +IS H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
V+ G ++ ++ E M L R L + IA G
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAK-LYEED 833
YL +HRDI N LL AKI DFG+A+ +Y
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG 238
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 683 KVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+GEG FG VY+G+ + +AVK + +F++E ++ HP++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
G E ++ E L + + + LK+ T + I + +AYL
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGH--YLERNKNSLKV--LTLVLYSLQICKAMAYL---E 130
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
I VHRDI N+L+ K+ DFGL++ E++
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 12/161 (7%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G+G FG V G V AVK + K+ + F+ E +++ +H NLV+L G
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKV-AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 742 VEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800
VE L +V EYM L + + R L K + + + YL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVD--YLRSRG-RSVLGGDCLLKFSLDVCEAMEYL---EGNN 137
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 841
VHRD+ NVL+ +D AK+SDFGL K E T + ++
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL 176
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 682 NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
VG G FG V G L +A+K L + + R+F+ E ++ HPN+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
L G + +++V EYM+N L F + + + + + GIA G+ YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTV--IQLVGMLRGIASGMKYL--- 163
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
S + VHRD+ N+L++ +L K+SDFGL ++ E+D
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 19/178 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL------SSKSRQGNREFVNEIGMISA 728
NF K+G G F VY+ L DG +A+K++ +K+R + + EI ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQ 88
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGI 786
HPN++K Y +E N+L +V E LSR I F K + T K + +
Sbjct: 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL---IPERTVWKYFVQL 145
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
L ++H +++HRDIK +NV + K+ D GL + + T + + GT
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GT 199
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 44/167 (26%), Positives = 84/167 (50%), Gaps = 16/167 (9%)
Query: 668 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 720
L ++++ + DP K+G+G G+VY + ++ G +A++Q++ + + +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
NEI ++ ++PN+V + G++L +V EY+ L+ D +D
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIA 119
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+C + L +LH + I HRDIK+ N+LL D + K++DFG
Sbjct: 120 AVCRECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 16/167 (9%)
Query: 668 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 720
++ + DP K+GEG G V G +AVK + + +Q
Sbjct: 31 KAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF 90
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
NE+ ++ QH N+V++Y + G +L ++ E+++ L+ D +++L+
Sbjct: 91 NEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT------DIVSQVRLNEEQIA 144
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+C + + LAYLH I HRDIK+ ++LL D K+SDFG
Sbjct: 145 TVCEAVLQALAYLHAQGVI---HRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 45/163 (27%), Positives = 72/163 (44%), Gaps = 22/163 (13%)
Query: 682 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 736
+G G FG VY G L D AVK L +F+ E ++ HPN++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 737 LYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLA 791
L G C+ L+V YMK+ L + + +A+G+
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLR--------NFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 833
+L + K VHRD+ N +LD+ K++DFGLA+ +Y+++
Sbjct: 207 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 16/168 (9%)
Query: 683 KVGEGGFGSVYKGIL----SDGTVIAVKQL---SSKSRQGNREFVNEIGMISAQQHPNLV 735
K+G+G FG V +G +AVK L + +F+ E+ + + H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+LYG + + +V E L + + L T + + +A G+ YL
Sbjct: 85 RLYGVVLT-PPMKMVTELAPLGSLLD--RLRKHQGHFLL--GTLSRYAVQVAEGMGYL-- 137
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIA 842
+ +HRD+ N+LL KI DFGL + L + D ++
Sbjct: 138 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-30
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 683 KVGEGGFGSVYKGIL--SDGTV-IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G FGSV +G+ + +A+K L + E + E ++ +P +V+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 739 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
G C + L+LV E L + + R ++ ++ ++ G+ YL
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYL---EE 454
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
VHR++ NVLL AKISDFGL+K D ++ + R AG
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 20/169 (11%)
Query: 683 KVGEGGFGSVYKGIL---SDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
++G G FG+V KG +AVK L + E + E ++ +P +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY---RLKLDWPTRKKICIGIARGLAYLH 794
G C E +LV E + L+ +Y + ++ ++ G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLN--------KYLQQNRHVKDKNIIELVHQVSMGMKYL- 133
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
VHRD+ NVLL AKISDFGL+K D+ + + G
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 43/167 (25%), Positives = 79/167 (47%), Gaps = 14/167 (8%)
Query: 668 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 720
R+ + + DP ++G+G FG VYK G + A K + +KS + +++
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI 64
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
EI +++ HP +VKL G +L ++ E+ + + E L P +
Sbjct: 65 VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM----LELDRGLTEPQIQ 120
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+C + L +LH I HRD+K NVL+ + + +++DFG++
Sbjct: 121 VVCRQMLEALNFLHSKRII---HRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 43/170 (25%), Positives = 65/170 (38%), Gaps = 23/170 (13%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
+VG G FG V++ G AVK++ + + V E+ + P +V LYG
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 741 CVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
EG + + E ++ + + G E GL YLH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQ--MGCLPE-------DRALYYLGQALEGLEYLHTR 169
Query: 797 SRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTM 845
+I+H D+K NVLL D A + DFG A + D S +
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-30
Identities = 49/155 (31%), Positives = 83/155 (53%), Gaps = 12/155 (7%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
K+G+G FG V+ G + T +A+K L + S + F+ E ++ +H LV+LY
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYA 246
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
E + +V EYM L + G+ L P + IA G+AY+ R+
Sbjct: 247 VVSE-EPIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYV---ERM 299
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
VHRD++ +N+L+ ++L K++DFGLA+L E+++
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-30
Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G+G FG V G V AVK + K+ + F+ E +++ +H NLV+L G
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKV-AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 742 VEGN-QLLLVYEYMKNNCLSRAIFGKD---TEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
VE L +V EYM L D + R L K + + + YL
Sbjct: 256 VEEKGGLYIVTEYMAKGSL------VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---E 306
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 841
VHRD+ NVL+ +D AK+SDFGL K E T + ++
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL 348
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 10/172 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 732
+ K+GEG FG DG +K+ +S S + E E+ +++ +HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
N+V+ E L +V +Y + L + I + + I L +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL---FQEDQILDWFVQICLALKH 140
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+H+ KI+HRDIK+ N+ L KD ++ DFG+A++ I GT
Sbjct: 141 VHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GT 188
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-29
Identities = 50/158 (31%), Positives = 82/158 (51%), Gaps = 18/158 (11%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
K+G+G FG V+ G + T +A+K L + S + F+ E ++ +H LV+LY
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYA 329
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKD---TEYRLKLDWPTRKKICIGIARGLAYLHED 796
E + +V EYM L D E L P + IA G+AY+
Sbjct: 330 VVSE-EPIYIVTEYMSKGSL------LDFLKGETGKYLRLPQLVDMAAQIASGMAYV--- 379
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
R+ VHRD++ +N+L+ ++L K++DFGLA+L E+++
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 8/153 (5%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G G FG V+ + T +AVK + S F+ E ++ QH LVKL+
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+ + ++ E+M L F K E K P IA G+A++ +
Sbjct: 253 TK-EPIYIITEFMAKGSLLD--FLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNY 305
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
+HRD++ +N+L+ L KI+DFGLA++ E+++
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 47/234 (20%), Positives = 85/234 (36%), Gaps = 20/234 (8%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPK 157
L++ L P + +L +L+ + + L L L++ N L P
Sbjct: 88 LRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPA 144
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDI---------RKLINLQKLILSSNSFTGELPAELT 208
+ ++ L+ LSI +P + + L+NLQ L L LPA +
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA 203
Query: 209 KLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
L NL L+I ++ S + I K+++L ++G + P L L + D
Sbjct: 204 NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD 262
Query: 269 LKGSES---AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319
+ +L L+ L L C+ +P I + I + +
Sbjct: 263 CSNLLTLPLDIHRLT--QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 52/251 (20%), Positives = 89/251 (35%), Gaps = 20/251 (7%)
Query: 107 TLPTELSKLRY--LKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNIT 163
L L+L L F Q L L +++ L P +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFA 127
Query: 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL---------TKLTNLN 214
L+ L++ N ++P I L L++L + + ELP L L NL
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES 274
LR+ +P I + ++ L I+ S L + +I L L +L + +
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRN 244
Query: 275 AFPK-LDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332
+P LK LIL C +P I +T+L+ +DL +P+ +L
Sbjct: 245 -YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 333 NFMYLTGNKLT 343
+ + +
Sbjct: 304 CIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 42/244 (17%), Positives = 81/244 (33%), Gaps = 38/244 (15%)
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG-------------------SIPP 181
L G+ P+ VL+ N +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATAD 73
Query: 182 DIRKL--INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239
+ L L S + P + +L++L + I ++P+ + ++ ++
Sbjct: 74 LLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLET 131
Query: 240 LHIQGSSLEGPIPASISALTSLTDLRISDLK---------GSESAFPKLDKM-NLKTLIL 289
L + + L +PASI++L L +L I S A + + NL++L L
Sbjct: 132 LTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190
Query: 290 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG-NKLTGPVPK 348
I +P I ++ LK++ + + L+ + L K + L G L P
Sbjct: 191 EWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRN-YPP 247
Query: 349 YIFN 352
Sbjct: 248 IFGG 251
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 32/156 (20%), Positives = 55/156 (35%), Gaps = 3/156 (1%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTNITTL 165
E L L+ L L + S A+LQ L L + + LS + ++ L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231
Query: 166 KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 225
+ L + G + PP L++LIL S LP ++ +LT L L +
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL 261
++P I + + + A +
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 19/167 (11%), Positives = 44/167 (26%), Gaps = 28/167 (16%)
Query: 177 GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
GS + L ++ L++ + + + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN------- 54
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG 296
S + LK + + L L +
Sbjct: 55 -------------------SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP- 94
Query: 297 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
+ PD ++ L+++ + L +P T ++ A + L N L
Sbjct: 95 QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-29
Identities = 59/280 (21%), Positives = 97/280 (34%), Gaps = 39/280 (13%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
+LP L L L S L +L + GN+L+ P + L+
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLPALPS------GLCKLWIFGNQLTS-LPVLPPG---LQ 144
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
LS+ N S+P L KL +N T LP + L L+ +SDN +
Sbjct: 145 ELSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQELS---VSDNQLA-S 195
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRISDLKGSESAFPKLDKMNL 284
+P + K+ + + +SL PA S L L R++ L S L
Sbjct: 196 LPTLPSELYKLWAYNNRLTSL----PALPSGLKELIVSGNRLTSLPVLPS--------EL 243
Query: 285 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344
K L+++ + +P L ++ + N LT +P + L+ + L GN L+
Sbjct: 244 KELMVSGNRL-TSLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS- 297
Query: 345 PVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVES 384
+ PR + L +
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA 337
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 4e-16
Identities = 34/181 (18%), Positives = 67/181 (37%), Gaps = 26/181 (14%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
L++ + T ++P + ++ L++ N+ T LPA +L L +S N
Sbjct: 40 NGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQ 92
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 282
+ +P ++ + L PA S L L + + L P
Sbjct: 93 LT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKL-WIFGNQLTSLPVLPP----- 141
Query: 283 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
L+ L ++ + +P ++ KL N LT +P L + + ++ N+L
Sbjct: 142 GLQELSVSDNQL-ASLPALPSELCKL---WAYNNQLT-SLPMLPSGLQE---LSVSDNQL 193
Query: 343 T 343
Sbjct: 194 A 194
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-29
Identities = 49/293 (16%), Positives = 99/293 (33%), Gaps = 36/293 (12%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL----------------QLV 142
N + L + + L+ + +W SL L
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLK 331
Query: 143 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFT--GSIPPDIRKLINLQKLILSSNSFT 200
L++ N+ S F + +L L + N + G +L+ L LS N
Sbjct: 332 SLTLTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389
Query: 201 GELPAELTKLTNLNDLRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPASISALT 259
+ A L L L + +K+ L I ++ + LT
Sbjct: 390 -IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448
Query: 260 SLTDLRISD--LKGS--ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSF 315
SL L+++ K + + F NL L L+KC + + +L+ +++S
Sbjct: 449 SLNTLKMAGNSFKDNTLSNVFANTT--NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH 506
Query: 316 NNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
NNL + + +L + + + N++ + + K+ +++ N+
Sbjct: 507 NNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-27
Identities = 48/303 (15%), Positives = 91/303 (30%), Gaps = 39/303 (12%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVE 143
C +T Q L+ +P ++ K +DLS N L S +++ +L
Sbjct: 7 CIEV---VPNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQW 60
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGEL 203
L + + K + L NL + GN P L +L+ L+
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120
Query: 204 PAELTKLTNLNDLRISDNNFSG-KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT 262
+ +L L L ++ N K+P + + + + + ++ + L
Sbjct: 121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP 180
Query: 263 DLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322
+ +L ++ I I D KL + L N + I
Sbjct: 181 QV-------------------NLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNI 220
Query: 323 P-TTFEKLAKTNFMYLTGNKLTGPVPKYIFN----------SNKNVDISLNNFTWESSDP 371
T + LA + L + IF + ++ N +
Sbjct: 221 MKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK 280
Query: 372 IEC 374
C
Sbjct: 281 FHC 283
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 53/279 (18%), Positives = 90/279 (32%), Gaps = 17/279 (6%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
L S L+ LDLSR + W L L L + GN + P +
Sbjct: 43 PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISD 220
+T+L+NL I +LI L+KL ++ N +LPA + LTNL + +S
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 221 NNFSGKIPEFIGKWKK----IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 276
N + ++ L + + ++ I L +L + S +
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIM 221
Query: 277 PKLDKM--NLKTLILTKCLIHGEI------PDYIGDMTKL--KNIDLSFNNLTGGIPTTF 326
+ L L E P + + + L++ N F
Sbjct: 222 KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF 281
Query: 327 EKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
LA + M L G + +++ I
Sbjct: 282 HCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK 320
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-23
Identities = 46/286 (16%), Positives = 83/286 (29%), Gaps = 26/286 (9%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQ---------WASLQLVELSVMGNRLS 152
N + + T L L L L + + + + E +
Sbjct: 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
+ + +S+ G D+ K Q L + + P L
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPTL--DLPF 329
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD-- 268
L L ++ N S + + + L + ++L G S SL L +S
Sbjct: 330 LKSLTLTMNKGSI-SFKKVA-LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNG 387
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFE 327
+ F L+ L+ L + + KL +D+S+ N F
Sbjct: 388 AIIMSANFMGLE--ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445
Query: 328 KLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFTWESSD 370
L N + + GN +F + N+ D+S S
Sbjct: 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-22
Identities = 45/257 (17%), Positives = 86/257 (33%), Gaps = 32/257 (12%)
Query: 130 GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI-TTLKNLSIEGNLFTGSIPPDIRKLIN 188
GS +P + + M +LS KV +I ++ KN+ + N
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLS----KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 189 LQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248
LQ L LS L +L++L ++ N P ++ L + L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKL 308
I L +L L ++ N + ++P Y ++T L
Sbjct: 118 SLESFPIGQLITLKKLNVAH--------------NF--------IHSCKLPAYFSNLTNL 155
Query: 309 KNIDLSFNNLTGGIPTTFEKLAKTNFM----YLTGNKLTGPVPKYIFNSNKNVDISLNNF 364
++DLS+N + + L + + ++ N + + F K +++L
Sbjct: 156 VHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGN 214
Query: 365 TWESSDPIECPRGSVNL 381
S+ C + L
Sbjct: 215 FNSSNIMKTCLQNLAGL 231
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-16
Identities = 25/170 (14%), Positives = 53/170 (31%), Gaps = 5/170 (2%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSGPFPKVLT 160
N L L L ++ N + + L L + +L V
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 161 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
+ L+ L++ N +L +L L S N +L +++
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL--TSLTDLRISD 268
N+ + I E + +++ ++E A+ + + + D S
Sbjct: 555 NSVA-CICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNNST 603
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 41/162 (25%), Positives = 69/162 (42%), Gaps = 14/162 (8%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
++G G F +VYKG+ +A + ++ + F E M+ QHPN+V+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 740 CCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
++LV E M + L + ++ + + C I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFK-VMKIKVLRSWCRQILKGLQFLHT 147
Query: 796 DSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTH 836
+ I+HRD+K N+ + + KI D GLA L
Sbjct: 148 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 188
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-28
Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 13/156 (8%)
Query: 683 KVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 737
+GEG FG V++GI +A+K + S +F+ E + HP++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
G E N + ++ E L F + ++ L L + ++ LAYL
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRS--FLQVRKFSLDL--ASLILYAYQLSTALAYL---E 508
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+ VHRDI NVL+ + K+ DFGL++ E+
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 43/160 (26%), Positives = 65/160 (40%), Gaps = 20/160 (12%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQ-QH 731
+F +++G G +G V+K DG + AVK+ S +G ++ + E+G QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNC---LSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
P V+L EG L L E C L + + L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL----CGPSLQQHC----EAWGASLPEAQVWGYLRDTLL 168
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
LA+LH +VH D+K +N+ L K+ DFGL
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV 205
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 54/167 (32%), Positives = 84/167 (50%), Gaps = 16/167 (9%)
Query: 668 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 720
L+++ + P K+GEG +GSVYK I G ++A+KQ+ +S +E +
Sbjct: 15 LKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEII 72
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
EI ++ P++VK YG + L +V EY +S I + L D
Sbjct: 73 KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIAT- 129
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
I +GL YLH +I HRDIK N+LL+ + +AK++DFG+A
Sbjct: 130 -ILQSTLKGLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADFGVA 172
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 42/188 (22%), Positives = 70/188 (37%), Gaps = 27/188 (14%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQ-Q 730
T F K+G G FGSV+K + DG + A+K+ + + E+ + Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
H ++V+ + E + +L+ EY L+ AI K + + + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY-FKEAELKDLLLQVGRGL 128
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKD-------------------LNAKISDFGLAKLYE 831
Y+H +VH DIK SN+ + + + KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 832 EDKTHIST 839
+
Sbjct: 186 SPQVEEGD 193
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 22/178 (12%)
Query: 662 QTGLYTLRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ 714
+ G + DP ++G G FG+VY + + V+A+K++S +Q
Sbjct: 34 RAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ 93
Query: 715 GNREF---VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC--LSRAIFGKDTE 769
N ++ + E+ + +HPN ++ GC + + LV EY + L E
Sbjct: 94 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 153
Query: 770 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+ + G +GLAYLH + I HRD+K N+LL + K+ DFG A
Sbjct: 154 VEIAA-------VTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 47/186 (25%), Positives = 74/186 (39%), Gaps = 29/186 (15%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+F +G GGFG V+K DG +K++ + N + E+ ++ H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 735 VKLYGCCVE----------------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
V GC L + E+ L + I + E LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK---LDKVL 123
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838
++ I +G+ Y+H K+++RD+K SN+ L KI DFGL + D
Sbjct: 124 ALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178
Query: 839 TRIAGT 844
TR GT
Sbjct: 179 TRSKGT 184
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 22/173 (12%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
++F+ +G+G FG V K D A+K++ + + ++E+ ++++ H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 734 LVKLYGCCVEGNQ-------------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
+V+ Y +E L + EY +N L I L
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYW 119
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
++ I L+Y+H I+HRD+K N+ +D+ N KI DFGLAK
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 9/176 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 732
+++ +G G +G K SDG ++ K+ S + + V+E+ ++ +HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 733 NLVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
N+V+ Y ++ L +V EY + L+ I K T+ R LD ++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 791 AYLHE--DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
H D ++HRD+K +NV LD N K+ DFGLA++ D + T + GT
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GT 179
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMIS 727
+ ++ K+GEGGF V L DG A+K++ +Q E E M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 728 AQQHPNLVKLYGCCVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
HPN+++L C+ ++ L+ + K L I + + L +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLL 140
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+GI RGL +H HRD+K +N+LL + + D G
Sbjct: 141 LGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 44/279 (15%), Positives = 96/279 (34%), Gaps = 26/279 (9%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
+L L + +K+LDLS N L+ + A +L L++ N L L +
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LES 78
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
++TL+ L + N ++ +++ L ++N+ + + ++ +++N
Sbjct: 79 LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANN 130
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDL-----RISDLKGSESA 275
+ G ++Q L ++ + ++ ++ +L L I D+
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQV 188
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
LKTL L+ + + + I L N L I
Sbjct: 189 VFA----KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 336 YLTGNKLT-GPVPKYIFNSNKNVDISLNNFTWESSDPIE 373
L GN G + + + + ++ + E
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 54/289 (18%), Positives = 108/289 (37%), Gaps = 22/289 (7%)
Query: 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 166
+ K ++ + L + + S + EL + GN LS L T L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
L++ N+ D+ L L+ L L++N EL ++ L ++NN S +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM--NL 284
+ + + + +++ + + + + L + + F +L L
Sbjct: 114 VSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 285 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344
+ L L I+ ++ + KLK +DLS N L + F+ A ++ L NKL
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL 228
Query: 345 PVPKYIFNSN--KNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNK 391
+ K + S ++ D+ N F + V++ + K
Sbjct: 229 -IEKALRFSQNLEHFDLRGNGF---HCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 40/178 (22%), Positives = 77/178 (43%), Gaps = 19/178 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 733
+F+P +G GGFG V++ D A+K++ +R+ RE + E+ ++ +HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 734 LVKLYGCCVEGNQ------------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 781
+V+ + +E N L + + + L + + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLH 122
Query: 782 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
I + IA + +LH ++HRD+K SN+ D K+ DFGL ++D+ +
Sbjct: 123 IFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 8e-27
Identities = 53/243 (21%), Positives = 98/243 (40%), Gaps = 23/243 (9%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
T + L L L++L L+ + ++ SP ++ L++ N L+N+T L
Sbjct: 101 TDISALQNLTNLRELYLNEDNIS-DISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLN 158
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
L++ + P I L +L L L+ N P L LT+L+ N +
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI 214
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDK 281
P + ++ L I + + P ++ L+ LT L +ISD+ +A L
Sbjct: 215 TP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI----NAVKDLT- 265
Query: 282 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 341
LK L + I + ++++L ++ L+ N L L ++L+ N
Sbjct: 266 -KLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 342 LTG 344
+T
Sbjct: 323 ITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 23/238 (9%)
Query: 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170
L+ L + L+L N SP L L+V +++ P + N+T L +LS+
Sbjct: 127 PLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184
Query: 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEF 230
N P + L +L N T P + +T LN L+I +N + P
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238
Query: 231 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLK 285
+ ++ L I + + + LT L L +ISD+ S L L
Sbjct: 239 LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISDI----SVLNNLS--QLN 290
Query: 286 TLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
+L L + E + IG +T L + LS N++T P L+K + +
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-24
Identities = 52/281 (18%), Positives = 110/281 (39%), Gaps = 33/281 (11%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ L+ ++T + +L + +L ++ + S L L++ GN+++
Sbjct: 23 EGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQGIEYLTNLEYLNLNGNQIT 79
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
P L+N+ L NL I N T ++ L NL++L L+ ++ + + L LT
Sbjct: 80 DISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTK 133
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RIS 267
+ L + N+ + + L + S ++ P I+ LT L L +I
Sbjct: 134 MYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE 190
Query: 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327
D+ S L +L I P + +MT+L ++ + N +T P
Sbjct: 191 DI----SPLASLT--SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LA 240
Query: 328 KLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 365
L++ ++ + N+++ +++ N +
Sbjct: 241 NLSQLTWLEIGTNQISDINA---VKDLTKLKMLNVGSNQIS 278
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 49/236 (20%), Positives = 99/236 (41%), Gaps = 17/236 (7%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ L + L + +T + + + +L V G +++ + + +T L+ L+
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQEELE-SITKLVVAGEKVAS--IQGIEYLTNLEYLN 72
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
+ GN T P + L+ L L + +N T + L LTNL +L ++++N S P
Sbjct: 73 LNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISP- 127
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKMNLKTLI 288
+ K+ L++ + + +S +T L L +++ K + + L +L +L
Sbjct: 128 -LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLT--DLYSLS 183
Query: 289 LTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344
L I P + +T L N +T P + + N + + NK+T
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 5e-21
Identities = 44/250 (17%), Positives = 88/250 (35%), Gaps = 19/250 (7%)
Query: 118 LKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 177
L + P + + + ++ + ++ L + G
Sbjct: 2 AATLATLPAPIN-QIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA- 57
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
SI I L NL+ L L+ N T P L+ L L +L I N + + +
Sbjct: 58 SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNL 112
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKMNLKTLILTKCLIH 295
++L++ ++ P ++ LT + L + S + L L +T+ +
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMT--GLNYLTVTESKVK 168
Query: 296 GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 355
P I ++T L ++ L++N + P L ++ N++T P
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLN 224
Query: 356 NVDISLNNFT 365
++ I N T
Sbjct: 225 SLKIGNNKIT 234
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 8e-20
Identities = 34/159 (21%), Positives = 68/159 (42%), Gaps = 9/159 (5%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ L+ L L N +T +P +L L + N+++ P L N++ L L
Sbjct: 193 SPLASLTSLHYFTAYVNQIT-DITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE 249
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
I N + I ++ L L+ L + SN + + L L+ LN L +++N + E
Sbjct: 250 IGTNQIS-DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
IG + L + + + P +++L+ + ++
Sbjct: 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFAN 342
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 13/153 (8%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 735
F K+G+G FG V+KGI V+A+K + + + E EI ++S P +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAI-FGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
K YG ++ +L ++ EY+ + G E ++ I I +GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKGLDYLH 136
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
+ +I HRDIK +NVLL + K++DFG+A
Sbjct: 137 SEKKI---HRDIKAANVLLSEHGEVKLADFGVA 166
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 8/157 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 733
++++ +G G V +A+K+++ + Q + + + EI +S HPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
+V Y V ++L LV + + + + I K LD T I + GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
YLH++ +I HRD+K N+LL +D + +I+DFG++
Sbjct: 135 EYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVS 168
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 46/279 (16%), Positives = 97/279 (34%), Gaps = 26/279 (9%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
+L L + +K+LDLS N L+ + A +L L++ N L L +
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LES 78
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
++TL+ L + N ++ +++ L ++N+ + + ++ +++N
Sbjct: 79 LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANN 130
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDL-----RISDLKGSESA 275
+ G ++Q L ++ + ++ ++ +L L I D+
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQV 188
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
LKTL L+ + + + I L N L I
Sbjct: 189 VFA----KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 336 YLTGNKLTGPVPKYIFNSNKNV-DISLNNFTWESSDPIE 373
L GN + F+ N+ V ++ + E
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 52/259 (20%), Positives = 102/259 (39%), Gaps = 19/259 (7%)
Query: 115 LRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173
K ++ + L + + S + EL + GN LS L T L+ L++ N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGK 233
+ D+ L L+ L L++N EL ++ L ++NN S ++ +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SR 118
Query: 234 WKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM--NLKTLILTK 291
+ + +++ + + + + L + + F +L L+ L L
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
I+ ++ + KLK +DLS N L + F+ A ++ L NKL + K +
Sbjct: 179 NFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALR 234
Query: 352 NSN--KNVDISLNNFTWES 368
S ++ D+ N F +
Sbjct: 235 FSQNLEHFDLRGNGFHCGT 253
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 9e-25
Identities = 35/270 (12%), Positives = 76/270 (28%), Gaps = 17/270 (6%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKV 158
+T + ++ LDL N + + +L+ L++ N +
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE--HLNLQYNFIYD-VKG- 186
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
LK L + N + P+ + + + L +N + L NL +
Sbjct: 187 QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDL 244
Query: 219 SDNNFS-GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277
N F G + +F K +++Q + Q + +L + + F
Sbjct: 245 RGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304
Query: 278 ----KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333
L + L + + + + ID I +
Sbjct: 305 DRLIALKRKEHALLSGQGSET-ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKI 363
Query: 334 FMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
+ L ++ +D +L
Sbjct: 364 TLEQKKKALD-EQVSNGRRAHAELDGTLQQ 392
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 35/216 (16%), Positives = 71/216 (32%), Gaps = 22/216 (10%)
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
+ N K + + ++ + N+++L LS N + A+L T L L
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGS 272
+S N + ++ L + + ++ + S+ L IS + S
Sbjct: 65 LSSNVLYE-TLDL-ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV--S 115
Query: 273 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG-GIPTTFEKLAK 331
S K + L I G ++++ +DL N +
Sbjct: 116 CSRGQ-----GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 332 TNFMYLTGNKLTGPVPKYIFNSN-KNVDISLNNFTW 366
+ L N + V + + K +D+S N +
Sbjct: 171 LEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLAF 205
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 27/218 (12%), Positives = 59/218 (27%), Gaps = 5/218 (2%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
+ L + L+ DL N + S +V + + T
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILS----SNSFTGELPAELTKLTNLNDLRISDNN 222
P +LI L++ + S T L E ++
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 282
+ I + + + L + +L+ + A L + E ++
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQS 407
Query: 283 NLKTLI-LTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319
L+ L + K + +++ D+ + T
Sbjct: 408 PLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-26
Identities = 46/199 (23%), Positives = 80/199 (40%), Gaps = 24/199 (12%)
Query: 654 KELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR 713
E D +T + + +I F P + +G G G++ + D +AVK++ +
Sbjct: 7 LEQDDGDEETSVVIVGKIS-----FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF 61
Query: 714 QGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL 772
E+ + + +HPN+++ + + + E L + KD +
Sbjct: 62 SFAD---REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAAT-LQEYVEQKDFAHLG 117
Query: 773 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-----DKDLNAKISDFGLA 827
+ GLA+LH + IVHRD+K N+L+ + A ISDFGL
Sbjct: 118 LE----PITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
Query: 828 KLYEEDKTHISTR--IAGT 844
K + S R + GT
Sbjct: 171 KKLAVGRHSFSRRSGVPGT 189
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 57/262 (21%), Positives = 103/262 (39%), Gaps = 20/262 (7%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
+ + L+KL L+ L + N ++ +P L ELS+ GN+L L ++T L
Sbjct: 190 SDISVLAKLTNLESLIATNNQIS-DITPLGILTNLDELSLNGNQLKDI--GTLASLTNLT 246
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK 226
+L + N + P + L L +L L +N + P L LT L +L +++N
Sbjct: 247 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 302
Query: 227 IPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKM-N 283
P I K + L + +++ P +S+LT L L + + L + N
Sbjct: 303 SP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD----VSSLANLTN 354
Query: 284 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
+ L I P + ++T++ + L+ T ++ N + L
Sbjct: 355 INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI 412
Query: 344 GPVPKYIFNSNKNVDISLNNFT 365
P S DI+ N +
Sbjct: 413 APATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-25
Identities = 42/254 (16%), Positives = 93/254 (36%), Gaps = 17/254 (6%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171
+ L + L + +T + Q Q+ L + + + L ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDT-VSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 76
Query: 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 231
N T P ++ L L +++++N L LTNL L + +N + P +
Sbjct: 77 NNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--L 130
Query: 232 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTK 291
+ +L + +++ +S LTSL L + L L+ L ++
Sbjct: 131 KNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTDLKPLANLT--TLERLDISS 186
Query: 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+ + +T L+++ + N ++ P L + + L GN+L
Sbjct: 187 NKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASL 242
Query: 352 NSNKNVDISLNNFT 365
+ ++D++ N +
Sbjct: 243 TNLTDLDLANNQIS 256
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-24
Identities = 69/274 (25%), Positives = 110/274 (40%), Gaps = 21/274 (7%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ L N+T T+ + L + L R + S L +++ N+L+
Sbjct: 25 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLT 81
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
P L N+T L ++ + N P + L NL L L +N T P L LTN
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTN 135
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
LN L +S N S + +Q+L G+ + P ++ LT+L L IS K S
Sbjct: 136 LNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVS 190
Query: 273 ESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
+ L K+ NL++LI T I P +G +T L + L+ N L T L
Sbjct: 191 D--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTN 244
Query: 332 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+ L N+++ P + + N +
Sbjct: 245 LTDLDLANNQISNLAPLSGLTKLTELKLGANQIS 278
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 8e-15
Identities = 34/186 (18%), Positives = 67/186 (36%), Gaps = 17/186 (9%)
Query: 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
L + +I + I D L K +L + T + T L + L+
Sbjct: 2 PLGSATITQDTPINQIFTDT-ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 224 SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDK 281
+ + + +++ + L P + LT L D+ +++ + + L
Sbjct: 59 K--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-TPLANLT- 112
Query: 282 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 341
NL L L I P + ++T L ++LS N ++ + L + GN+
Sbjct: 113 -NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQ 166
Query: 342 LTGPVP 347
+T P
Sbjct: 167 VTDLKP 172
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 27/141 (19%), Positives = 51/141 (36%), Gaps = 7/141 (4%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ +S L+ L L L N ++ SP + +L L N++S L N+T + LS
Sbjct: 303 SPISNLKNLTYLTLYFNNIS-DISPVSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLS 359
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
N + P + L + +L L+ ++T ++ N ++ P
Sbjct: 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APA 415
Query: 230 FIGKWKKIQKLHIQGSSLEGP 250
I + I +
Sbjct: 416 TISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 25/154 (16%), Positives = 56/154 (36%), Gaps = 10/154 (6%)
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
L I+ + +I + K + +++ + + L +T L+ L
Sbjct: 3 LGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59
Query: 273 E-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
L+ NL + + + P + ++TKL +I ++ N + P L
Sbjct: 60 SIDGVEYLN--NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN 113
Query: 332 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+ L N++T P + +++S N +
Sbjct: 114 LTGLTLFNNQITDIDPLKNLTNLNRLELSSNTIS 147
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 24/142 (16%), Positives = 51/142 (35%), Gaps = 28/142 (19%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ +S L L++L N ++ S + LS N++S P L N+T + L
Sbjct: 325 SPVSSLTKLQRLFFYNNKVS-DVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 381
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN-------- 221
+ +T + P + + +++ + + PA ++ + + I+ N
Sbjct: 382 LNDQAWT-NAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYTNEV 439
Query: 222 ---------------NFSGKIP 228
FSG +
Sbjct: 440 SYTFSQPVTIGKGTTTFSGTVT 461
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 39/153 (25%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNEIGMI-SAQQHP 732
+ ++G G +GSV K + G ++AVK++ S+ + ++ + ++ ++ + P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
+V+ YG + E M + + + + KI + + L +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825
L E+ KI+HRDIK SN+LLD+ N K+ DFG
Sbjct: 141 LKENL--KIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 49/166 (29%), Positives = 88/166 (53%), Gaps = 14/166 (8%)
Query: 671 IKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIG 724
+K+ ++ + +GEG F +VYK + ++A+K++ R ++ +N EI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 784
++ HPN++ L + + LV+++M+ + L I KD L L K +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII--KDN--SLVLTPSHIKAYML 119
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
+GL YLH+ I+HRD+K +N+LLD++ K++DFGLAK +
Sbjct: 120 MTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 40/184 (21%), Positives = 76/184 (41%), Gaps = 14/184 (7%)
Query: 658 GLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQG 715
G+DL T + + + ++G GG V++ + + A+K L Q
Sbjct: 10 GVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT 69
Query: 716 NREFVNEIGMISAQQHPNL--VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK 773
+ NEI ++ Q + ++LY + + +V E N L+ + + +
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-----KKKKS 123
Query: 774 LDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+D RK + + +H+ IVH D+K +N L+ K+ DFG+A + D
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPD 179
Query: 834 KTHI 837
T +
Sbjct: 180 TTSV 183
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 37/155 (23%), Positives = 77/155 (49%), Gaps = 7/155 (4%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQ-QHP 732
++ +P ++G G +G V K + G ++AVK++ ++ + Q + + ++ + P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
V YG + + E M + L + + + + + KI + I + L +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
LH S++ ++HRD+K SNVL++ K+ DFG++
Sbjct: 125 LH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 15/165 (9%)
Query: 673 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMI 726
++++ F K+G G + +VYKG+ + G +A+K + + + E EI ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK----EVKLDSEEGTPSTAIREISLM 57
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-LDWPTRKKICIG 785
+H N+V+LY N+L LV+E+M N+ L + + + + L+ K
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
+ +GLA+ HE+ KI+HRD+K N+L++K K+ DFGLA+ +
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 51/158 (32%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLV 735
F+ VG G +G VYKG + G + A+K + E EI M+ H N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 736 KLYGC------CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
YG +QL LV E+ ++ I K+T+ L IC I RG
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGN-TLKEEWIAYICREILRG 141
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
L++LH+ K++HRDIK NVLL ++ K+ DFG++
Sbjct: 142 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN-REFVN-----EIGM 725
+ + KVGEG +G VYK S G ++A+K + R E + EI +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALK----RIRLDAEDEGIPSTAIREISL 72
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
+ HPN+V L L LV+E+M+ + L + + E + L K
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL----DENKTGLQDSQIKIYLYQ 127
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
+ RG+A+ H+ +I+HRD+K N+L++ D K++DFGLA+ +
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF 169
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 51/162 (31%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
NF K+GEG +G VYK G V+A+K K R E V EI ++
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALK----KIRLDTETEGVPSTAIREISLLKE 58
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
HPN+VKL N+L LV+E++ + L + + D + P K + +
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASALTGIPLPLIKSYLFQLLQ 114
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
GLA+ H +++HRD+K N+L++ + K++DFGLA+ +
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 36/160 (22%), Positives = 68/160 (42%), Gaps = 14/160 (8%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNL--VKL 737
++G GG V++ + + A+K L Q + NEI ++ Q + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
Y + + +V E N L+ + + + +D RK + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQH- 127
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837
IVH D+K +N L+ K+ DFG+A + D T +
Sbjct: 128 --GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV 164
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 36/160 (22%), Positives = 68/160 (42%), Gaps = 14/160 (8%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNL--VKL 737
++G GG V++ + + A+K L Q + NEI ++ Q + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 797
Y + + +V E N L+ + + + +D RK + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQH- 174
Query: 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837
IVH D+K +N L+ K+ DFG+A + D T +
Sbjct: 175 --GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV 211
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 8e-25
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 19/162 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
++ K+GEG +G V+K G ++A+K K + + EI M+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
+HPNLV L +L LV+EY + + + Y+ + K I +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHEL----DRYQRGVPEHLVKSITWQTLQ 113
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
+ + H+ +HRD+K N+L+ K K+ DFG A+L
Sbjct: 114 AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL 152
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 30/158 (18%), Positives = 59/158 (37%), Gaps = 11/158 (6%)
Query: 675 TNNFDPANKVGEG--GFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQ 729
++ +G+G +V G + V++ L + S + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
HPN+V + N+L +V +M I T + ++ I G+ +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKA 140
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
L Y+H + HR +K S++L+ D +S
Sbjct: 141 LDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSN 175
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 54/210 (25%), Positives = 82/210 (39%), Gaps = 23/210 (10%)
Query: 640 MRWKGCLGGKVSADK-ELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-L 697
M G LGG D+ + G ++ G LR + + EGGF VY+ +
Sbjct: 1 MAGPGSLGGASGRDQSDFVGQTVELGELRLRVRR----------VLAEGGFAFVYEAQDV 50
Query: 698 SDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGCCV-------EGNQLLL 749
G A+K+L S + NR + E+ M HPN+V+ G L
Sbjct: 51 GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110
Query: 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTS 809
+ + L + K E R L T KI R + ++H + I+HRD+K
Sbjct: 111 LLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVE 167
Query: 810 NVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
N+LL K+ DFG A + +
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPN 733
++F+ +++G G G V+K G V+A K + + + + + E+ ++ P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLA 791
+V YG ++ + E+M L + + G+ E L K+ I + +GL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVSIAVIKGLT 145
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
YL E KI+HRD+K SN+L++ K+ DFG++
Sbjct: 146 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS 179
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
++ VGEG +G V K G ++A+K K + + + V EI ++
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLLKQ 80
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
+H NLV L C + + LV+E++ + + + + LD+ +K I
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDL----ELFPNGLDYQVVQKYLFQIIN 135
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
G+ + H I+HRDIK N+L+ + K+ DFG A+
Sbjct: 136 GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 18/161 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISAQ 729
+ K+GEG +G VYK + G A+K K R E + EI ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALK----KIRLEKEDEGIPSTTIREISILKEL 57
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
+H N+VKLY +L+LV+E++ + L + + L+ T K + + G
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL----DVCEGGLESVTAKSFLLQLLNG 112
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
+AY H+ +++HRD+K N+L++++ KI+DFGLA+ +
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF 150
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 3e-24
Identities = 40/162 (24%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
++ K+GEG +G+V+K ++A+K + R + E V EI ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK----RVRLDDDDEGVPSSALREICLLKE 57
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
+H N+V+L+ +L LV+E+ + L + LD K + +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYF----DSCNGDLDPEIVKSFLFQLLK 112
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
GL + H ++HRD+K N+L++++ K+++FGLA+ +
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF 151
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 21/171 (12%)
Query: 674 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIG--- 724
AT+ ++P ++G G +G+VYK G +A+K + + G + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 725 MISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 779
+ A +HPN+V+L C ++ LV+E++ + L + D L T
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL---DKAPPPGLPAETI 122
Query: 780 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
K + RGL +LH + IVHRD+K N+L+ K++DFGLA++Y
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY 170
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-24
Identities = 63/312 (20%), Positives = 120/312 (38%), Gaps = 40/312 (12%)
Query: 85 CDCSSATCHV------------------VTIALKAQNLTGTLPTELSKLRYLKQLDLSRN 126
C+CS+ V + L + E + +L++L+L+ N
Sbjct: 7 CECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 127 CLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPD 182
++ G+F+ +L+ + L NRL V T ++ L L I N +
Sbjct: 67 IVSAVEPGAFNNL-FNLRTLGLR--SNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDY 122
Query: 183 I-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPE--FIGKWKKIQ 238
+ + L NL+ L + N + + L +L L + N + IP +
Sbjct: 123 MFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSH-LHGLI 179
Query: 239 KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK-LDKMNLKTLILTKCLIHGE 297
L ++ ++ S L L L IS ++ P L +NL +L +T C +
Sbjct: 180 VLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-A 238
Query: 298 IPDY-IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 356
+P + + L+ ++LS+N ++ + +L + + L G +L V Y F
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNY 297
Query: 357 V---DISLNNFT 365
+ ++S N T
Sbjct: 298 LRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-22
Identities = 51/248 (20%), Positives = 86/248 (34%), Gaps = 21/248 (8%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
+P + L L +LD+S N + F L L V N L + +
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDL---YNLKSLEVGDNDLVYISHRAFSG 150
Query: 162 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
+ +L+ L++E T SIP + L L L L + +L L L IS
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESA 275
+ + + L I +L ++ L L L IS + S
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI--EGSM 267
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 334
+L L+ + L + + Y + L+ +++S N LT + F +
Sbjct: 268 LHELL--RLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLET 324
Query: 335 MYLTGNKL 342
+ L N L
Sbjct: 325 LILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 26/135 (19%), Positives = 47/135 (34%), Gaps = 11/135 (8%)
Query: 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRL 151
+ + T+ L L ++ LT + L+ + LS N +
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHL-VYLRFLNLS--YNPI 260
Query: 152 SGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TK 209
S +L + L+ + + G + P R L L+ L +S N T L +
Sbjct: 261 STIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
Query: 210 LTNLNDLRISDNNFS 224
+ NL L + N +
Sbjct: 319 VGNLETLILDSNPLA 333
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 43/161 (26%), Positives = 78/161 (48%), Gaps = 18/161 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMISAQ 729
+ +K+GEG + +VYKG ++A+K + R + E E+ ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDL 57
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
+H N+V L+ L LV+EY+ + L + + + ++ K + RG
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYL----DDCGNIINMHNVKLFLFQLLRG 112
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
LAY H K++HRD+K N+L+++ K++DFGLA+
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK 150
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 45/188 (23%), Positives = 72/188 (38%), Gaps = 26/188 (13%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNL 734
N +G G G+V G +AVK++ + EI + + HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAY 792
++ Y L + E N L + E + IA G+A+
Sbjct: 72 IRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 793 LHEDSRIKIVHRDIKTSNVLLD-------------KDLNAKISDFGLAKLYEEDKTHIST 839
LH +KI+HRD+K N+L+ ++L ISDFGL K + ++ T
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 840 R---IAGT 844
+GT
Sbjct: 188 NLNNPSGT 195
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 20/186 (10%)
Query: 648 GKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK 706
G + + G G ++ +A N+ + ++G G G V+K G VIAVK
Sbjct: 1 GSSGSSGKQTGYLTIGG----QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 707 QL-SSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS---R 761
Q+ S +++ N+ + ++ ++ P +V+ +G + + + E M C +
Sbjct: 57 QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKK 115
Query: 762 AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821
+ G E L K+ + I + L YL E ++HRD+K SN+LLD+ K+
Sbjct: 116 RMQGPIPERILG-------KMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKL 166
Query: 822 SDFGLA 827
DFG++
Sbjct: 167 CDFGIS 172
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 36/160 (22%), Positives = 69/160 (43%), Gaps = 13/160 (8%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGC 740
+G+G +V++G G + A+K ++ S + + E ++ H N+VKL+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 741 --CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+L+ E+ L + ++ L + + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLRE--- 130
Query: 799 IKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDK 834
IVHR+IK N++ D K++DFG A+ E+D+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-23
Identities = 55/299 (18%), Positives = 99/299 (33%), Gaps = 34/299 (11%)
Query: 99 LKAQNLTGTLPTE-LSKLRYLKQLDLSRNCLTGSFSPQW-ASLQ-LVELSVMGNRLSGPF 155
L +Q T+ E L L+ LDL + + P L L EL + LS
Sbjct: 55 LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAV 113
Query: 156 --PKVLTNITTLKNLSIEGNLFTG-SIPPDIRKLINLQKLILSSNSFTGELPAELTKLT- 211
N+ L L + N + P KL +L+ + SSN EL L
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173
Query: 212 -NLNDLRISDNNFSGKIPEFIGKWKK------IQKLHIQGSSLEGPIPA---------SI 255
L+ ++ N+ ++ GK ++ L + G+ I
Sbjct: 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQA 233
Query: 256 SALTSLTDLRISDLKG------SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLK 309
+L + + ++ F L + +++ L L+ + + LK
Sbjct: 234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLK 293
Query: 310 NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 365
++L++N + F L + L+ N L + F V D+ N+
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE-LYSSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-22
Identities = 47/275 (17%), Positives = 96/275 (34%), Gaps = 24/275 (8%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRLSGPFPKVLTN 161
+ L+ LK L+L+ N + + L L L++ N L +
Sbjct: 277 FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG 336
Query: 162 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
+ + + ++ N I + L LQ L L N+ T + + ++ D+ +S
Sbjct: 337 LPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSG 390
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDLRISDLK----GSESA 275
N +H+ + LE I + + L L ++ + +
Sbjct: 391 NKLV----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQT 446
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYI-----GDMTKLKNIDLSFNNLTGGIPTTFEKLA 330
+ +L+ L L + ++ + ++ L+ + L+ N L P F L
Sbjct: 447 PSENP--SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT 504
Query: 331 KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+ L N+LT + + + +DIS N
Sbjct: 505 ALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLL 539
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 4e-20
Identities = 41/276 (14%), Positives = 89/276 (32%), Gaps = 20/276 (7%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQW-ASL-QLVELSVMGNRLSGPFPKVLT 160
+ + L L+ L+L + + +L L L + +++ P
Sbjct: 35 YIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94
Query: 161 NITTLKNLSIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLR 217
+ L L + + ++ D R L L +L LS N L KL +L +
Sbjct: 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154
Query: 218 ISDNNFSGKIPE-FIG-KWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGSES 274
S N + K + + +SL + + ++ + L S +
Sbjct: 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214
Query: 275 AFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN- 333
+ N I + + F+N+ TF LA+++
Sbjct: 215 GWTVDITGNFSN------AISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSV 268
Query: 334 -FMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 365
+ L+ + + +F + K++ +++ N
Sbjct: 269 RHLDLSHGFVFS-LNSRVFETLKDLKVLNLAYNKIN 303
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 45/271 (16%), Positives = 91/271 (33%), Gaps = 43/271 (15%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTN 161
+ L L+ L+LS N L +S + L ++ + + N ++ +
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTG-------------------- 201
+ L+ L + N T I + ++ + LS N
Sbjct: 361 LEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLEN 415
Query: 202 -ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIPASI--SA 257
++ L ++ +L L ++ N FS + +++L + + L+ +
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDV 475
Query: 258 LTSLTDLRISDLKG------SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNI 311
L+ L++ L F L L+ L L + + L+ +
Sbjct: 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLT--ALRGLSLNSNRLT-VLSHND-LPANLEIL 531
Query: 312 DLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
D+S N L P F L + + +T NK
Sbjct: 532 DISRNQLLAPNPDVFVSL---SVLDITHNKF 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-16
Identities = 51/297 (17%), Positives = 89/297 (29%), Gaps = 51/297 (17%)
Query: 84 TCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVE 143
+C + NLT +P L+ L LS N +
Sbjct: 1 SCSFDGRIAF-----YRFCNLT-QVPQVLNTTERL---LLSFN-------------YIRT 38
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGE 202
++ + L+ L + +I + R L NL+ L L S+
Sbjct: 39 VT----------ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-F 87
Query: 203 LPAE-LTKLTNLNDLRISDNNFSGKI--PEFIGKWKKIQKLHIQGSSLEG-PIPASISAL 258
L + L +L +LR+ S + + K + +L + + + + S L
Sbjct: 88 LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL 147
Query: 259 TSLTDLRISDLK---GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTK------LK 309
SL + S + E L L L ++ + G L+
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207
Query: 310 NIDLSFNNLTGGIPTTFEK-LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+D+S N T I F ++K+ L F + D N F
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA---GFGFHNIKDPDQNTFA 261
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-15
Identities = 43/210 (20%), Positives = 68/210 (32%), Gaps = 22/210 (10%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKI-PEFIGKWKK 236
+P + ++L+LS N + L L L + I E
Sbjct: 18 QVPQVLN---TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTK 291
++ L + S + P + L L +L +SD + F L L L L+K
Sbjct: 75 LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK--ALTRLDLSK 132
Query: 292 CLIHG-EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN--FMYLTGNKLTGPVPK 348
I + G + LK+ID S N + E L F L N L V
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192
Query: 349 YIFNSNKN--------VDISLNNFTWESSD 370
+D+S N +T + +
Sbjct: 193 DWGKCMNPFRNMVLEILDVSGNGWTVDITG 222
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 4e-15
Identities = 43/298 (14%), Positives = 98/298 (32%), Gaps = 44/298 (14%)
Query: 111 ELSKLRYLKQLDLSRNCLT----GSFSPQWASLQ---------LVELSVMGNRLSGPFPK 157
+ L+ LD+S N T G+FS + Q ++ + + P
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258
Query: 158 VLTNI--TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLN 214
+ +++++L + S+ + L +L+ L L+ N L NL
Sbjct: 259 TFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDL 269
L +S N K+ + +Q + + + L L L ++ +
Sbjct: 318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI 377
Query: 270 KGSES------------AFPKLDKMNLKTLILTKCLIHG-EIPDYIGDMTKLKNIDLSFN 316
S PK++ + + L++ + +I ++ + L+ + L+ N
Sbjct: 378 HFIPSIPDIFLSGNKLVTLPKIN-LTANLIHLSENRLENLDILYFLLRVPHLQILILNQN 436
Query: 317 NLTGGIPT-TFEKLAKTNFMYLTGNKLTGP----VPKYIFNSNKNV---DISLNNFTW 366
+ T + ++L N L + +F ++ ++ N
Sbjct: 437 RFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS 494
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 40/197 (20%), Positives = 73/197 (37%), Gaps = 17/197 (8%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSG-PFPK 157
L+ +L T + + + + LS N L + + L+ LS NRL
Sbjct: 364 LQTLDLRDNALTTIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLS--ENRLENLDILY 420
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTGELPAELTK-----L 210
L + L+ L + N F+ S D + +L++L L N EL L
Sbjct: 421 FLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGL 479
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD-- 268
++L L ++ N + P ++ L + + L + + +L L IS
Sbjct: 480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-LSHN-DLPANLEILDISRNQ 537
Query: 269 -LKGSESAFPKLDKMNL 284
L + F L +++
Sbjct: 538 LLAPNPDVFVSLSVLDI 554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 29/125 (23%), Positives = 48/125 (38%), Gaps = 7/125 (5%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPK 157
L+ T L +L+ L L+ N L ++ L L LS+ NRL+
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHN 522
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDL 216
L L+ L I N + PD+ ++L L ++ N F E + N ++
Sbjct: 523 DLP--ANLEILDISRNQLL-APNPDV--FVSLSVLDITHNKFICECELSTFINWLNHTNV 577
Query: 217 RISDN 221
I+
Sbjct: 578 TIAGP 582
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 14/154 (9%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
G+GGF ++ V A K + K Q + EI + + H ++V +G
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHG 82
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ + + +V E + L + R L P + I G YLH R
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLH---RN 134
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+++HRD+K N+ L++DL KI DFGLA E D
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 45/240 (18%), Positives = 81/240 (33%), Gaps = 39/240 (16%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTL 165
LP L ++ N L P+ +L L + N L P + + L
Sbjct: 167 KLPDLPPSLEFI---AAGNNQLE--ELPELQNLPFLTAIYADNNSLKK-LPDLPLS---L 217
Query: 166 KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 225
+++ N+ P+++ L L + +N LP L LN + DN +
Sbjct: 218 ESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYLT- 270
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRISDLKGSESAFPKLDKMN 283
+PE + S L L L I L +
Sbjct: 271 DLPELPQSLTFLDVSENIFSGL----SELPPNLYYLNASSNEIRSLCDLPP--------S 318
Query: 284 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
L+ L ++ + E+P +L+ + SFN+L +P + L + +++ N L
Sbjct: 319 LEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLKQ---LHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-21
Identities = 50/251 (19%), Positives = 95/251 (37%), Gaps = 39/251 (15%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
EL L +L + N L + SL+ L+V N L+ P++ ++T L
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE--ALNVRDNYLTD-LPELPQSLTFLD 283
Query: 167 NLSIEGNLFTGSIPPDIRKLI--------------NLQKLILSSNSFTGELPAELTKLTN 212
+ + +PP++ L +L++L +S+N ELPA +L
Sbjct: 284 VSENIFSGLS-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER 341
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
L S N+ + ++PE +++LH++ + L P S+ DLR++
Sbjct: 342 LI---ASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPE---SVEDLRMNSHLAE 390
Query: 273 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332
P+ NLK L + + E PD ++++ ++ + E K
Sbjct: 391 VPELPQ----NLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKL 442
Query: 333 NFMYLTGNKLT 343
+
Sbjct: 443 EDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-21
Identities = 46/258 (17%), Positives = 93/258 (36%), Gaps = 46/258 (17%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--------------QLVELSVMG 148
NLT +P E ++ + + + + P Q EL +
Sbjct: 22 NLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNN 80
Query: 149 NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT 208
LS P++ + L++L N T +P + L +L + + + +LP L
Sbjct: 81 LGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-DLPPLLE 134
Query: 209 KLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRI 266
L +S+N K+PE + ++ + + +SL+ +P +L + + ++
Sbjct: 135 Y------LGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQL 185
Query: 267 SDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325
+L P+L + L + + ++PD L++I N L
Sbjct: 186 EEL-------PELQNLPFLTAIYADNNSLK-KLPDLPL---SLESIVAGNNILE--ELPE 232
Query: 326 FEKLAKTNFMYLTGNKLT 343
+ L +Y N L
Sbjct: 233 LQNLPFLTTIYADNNLLK 250
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-15
Identities = 32/196 (16%), Positives = 71/196 (36%), Gaps = 35/196 (17%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL------------ 210
T L+ + T +P + + + + + + + P +
Sbjct: 11 TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 211 -TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT--DLRIS 267
++L +++ S +PE ++ L +SL +P +L SL + +
Sbjct: 70 DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 124
Query: 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327
L S P L+ L ++ + ++P+ + + + LK ID+ N+L +P
Sbjct: 125 AL----SDLPP----LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPP 173
Query: 328 KLAKTNFMYLTGNKLT 343
L + N+L
Sbjct: 174 SLEF---IAAGNNQLE 186
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-23
Identities = 55/298 (18%), Positives = 102/298 (34%), Gaps = 51/298 (17%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQ 140
C CS+ V+ +NL +P +S + L+L N + SF
Sbjct: 39 CSCSNQFSKVI---CVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLR---H 89
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 199
L L + N + + L L + N T +IP L L++L L +N
Sbjct: 90 LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI 148
Query: 200 TGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
+P+ ++ +L L + + ++ +I + EG L
Sbjct: 149 E-SIPSYAFNRIPSLRRLDLGELK-------------RLS--YISEGAFEG--------L 184
Query: 259 TSLTDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 317
++L L ++ E L L L L+ + P + L+ + + +
Sbjct: 185 SNLRYLNLAMCNLREIPNLTPLI--KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242
Query: 318 LTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN-VDISLNNFTWESSDPIEC 374
+ F+ L + L N LT +P +F + I L++ +P C
Sbjct: 243 IQVIERNAFDNLQSLVEINLAHNNLTL-LPHDLFTPLHHLERIHLHH------NPWNC 293
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 46/172 (26%), Positives = 83/172 (48%), Gaps = 29/172 (16%)
Query: 676 NNFDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGN----------REFVNEI 723
++ ++GEG +G V+K + + G +A+K + R RE V +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALK----RVRVQTGEEGMPLSTIRE-VAVL 65
Query: 724 GMISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
+ +HPN+V+L+ C +L LV+E++ + L+ + D + T
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL---DKVPEPGVPTET 121
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
K + + RGL +LH ++VHRD+K N+L+ K++DFGLA++Y
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-23
Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 25/167 (14%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
+ + K+GEG +G VYK I +A+K + R + E V E+ ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIK----RIRLEHEEEGVPGTAIREVSLLKE 89
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
QH N+++L ++L L++EY +N+ L + + + + K +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYM-----DKNPDVSMRVIKSFLYQLIN 143
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-----KISDFGLAKLY 830
G+ + H + +HRD+K N+LL + KI DFGLA+ +
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 24/182 (13%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
+ F G+G FG+V G G +A+K++ R NRE + + ++ HPN
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 734 LVKLYGCCVEGNQ-------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR--KKICI 784
+V+L + L +V EY+ + L R YR ++ P K
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCC---RNYYRRQVAPPPILIKVFLF 136
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAKLYEEDKTHIS--- 838
+ R + LH S + HRDIK NVL+++ L K+ DFG AK + +++
Sbjct: 137 QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEPNVAYIC 193
Query: 839 TR 840
+R
Sbjct: 194 SR 195
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 14/154 (9%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
G+GGF ++ V A K + K Q + EI + + H ++V +G
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHG 108
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ + + +V E + L + R L P + I G YLH R
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLH---RN 160
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+++HRD+K N+ L++DL KI DFGLA E D
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 37/160 (23%), Positives = 68/160 (42%), Gaps = 13/160 (8%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGC 740
+G+G +V++G G + A+K ++ S + + E ++ H N+VKL+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 741 --CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
+L+ E+ L + Y L + + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVVGGMNHLRE--- 130
Query: 799 IKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDK 834
IVHR+IK N++ D K++DFG A+ E+D+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 40/181 (22%), Positives = 76/181 (41%), Gaps = 23/181 (12%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFV--------------- 720
N++ + +G F + D A+K+ + R+F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 721 --NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL---SRAIFGKDTEYRLKLD 775
NE+ +I+ ++ + G +++ ++YEYM+N+ + F D Y +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 776 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
K I + +Y+H + I HRD+K SN+L+DK+ K+SDFG ++ + K
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 836 H 836
Sbjct: 208 K 208
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 53/295 (17%), Positives = 106/295 (35%), Gaps = 45/295 (15%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVE 143
C CS+ VV + L+ +P + + L+L N + + + L L
Sbjct: 50 CSCSNQFSKVV---CTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEV 103
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGE 202
L + N + + +L L + N T IP L L++L L +N
Sbjct: 104 LQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-S 161
Query: 203 LPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL 261
+P+ ++ +L L + + K++ +I + EG L +L
Sbjct: 162 IPSYAFNRVPSLMRLDLGELK-------------KLE--YISEGAFEG--------LFNL 198
Query: 262 TDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320
L + + L L+ L ++ P ++ LK + + + ++
Sbjct: 199 KYLNLGMCNIKDMPNLTPLV--GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL 256
Query: 321 GIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN-VDISLNNFTWESSDPIEC 374
F+ LA + L N L+ +P +F + V++ L++ +P C
Sbjct: 257 IERNAFDGLASLVELNLAHNNLSS-LPHDLFTPLRYLVELHLHH------NPWNC 304
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 52/178 (29%), Positives = 76/178 (42%), Gaps = 23/178 (12%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+ +G G FG V++ L + +A+K++ R NR E+ ++ +HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94
Query: 735 VKLYGCCVEGNQ------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR--KKICIGI 786
V L L LV EY+ + RA +LK P K +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRAS---RHYAKLKQTMPMLLIKLYMYQL 150
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDK--TH-ISTR 840
R LAY+H I I HRDIK N+LLD K+ DFG AK+ + I +R
Sbjct: 151 LRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 45/170 (26%), Positives = 83/170 (48%), Gaps = 27/170 (15%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 728
+ ++ K+G+G FG V+K G +A+K K N +E EI ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQL 72
Query: 729 QQHPNLVKLYGCCVE--------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 780
+H N+V L C + LV+++ +++ L+ + + +K K
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL----SNVLVKFTLSEIK 127
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
++ + GL Y+H + KI+HRD+K +NVL+ +D K++DFGLA+ +
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 174
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-22
Identities = 41/166 (24%), Positives = 75/166 (45%), Gaps = 14/166 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQ 730
+F+ +G+G FG+VY ++A+K L K+ ++ E+ + S +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
HPN+++LYG + ++ L+ EY + + + + K D +A L
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLS-KFDEQRTATYITELANAL 122
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
+Y H +++HRDIK N+LL KI+DFG + +
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 165
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 8e-22
Identities = 40/200 (20%), Positives = 81/200 (40%), Gaps = 26/200 (13%)
Query: 649 KVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ 707
K + + + + + L K +DP + +G G V + + + G AVK
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 708 LSSKSRQGNREFV--------NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758
+ + + + E + E + HP+++ L + + LV++ M+
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 759 LSRAIF--GKDTEYRLKLDWPTRK--KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 814
L + +E ++ I + +++LH IVHRD+K N+LLD
Sbjct: 187 LFDYLTEKVALSE---------KETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLD 234
Query: 815 KDLNAKISDFGLAKLYEEDK 834
++ ++SDFG + E +
Sbjct: 235 DNMQIRLSDFGFSCHLEPGE 254
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 1e-21
Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 16/161 (9%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLY---- 738
G GGFG V + I G +A+KQ + NRE EI ++ HPN+V
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 739 --GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
+ LL EY + L + + + LK + + I+ L YLHE
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG--PIRTLLSDISSALRYLHE- 139
Query: 797 SRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDK 834
+I+HRD+K N++L + L KI D G AK ++ +
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-21
Identities = 40/160 (25%), Positives = 75/160 (46%), Gaps = 17/160 (10%)
Query: 683 KVGEGGFGSVYKGI---LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
KVG G +G VYK D A+KQ+ + EI ++ +HPN++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85
Query: 740 CCVE--GNQLLLVYEYMKN---NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ ++ L+++Y ++ + + K + ++L K + I G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNA----KISDFGLAKLY 830
+ ++HRD+K +N+L+ + KI+D G A+L+
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 52/179 (29%), Positives = 76/179 (42%), Gaps = 24/179 (13%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
++ +G G FG VY+ L D G ++A+K++ R NRE + ++ H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCN 108
Query: 734 LVKLYGCCVEGNQ------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR--KKICIG 785
+V+L + L LV +Y+ + R R K P K
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVA---RHYSRAKQTLPVIYVKLYMYQ 164
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDK--TH-ISTR 840
+ R LAY+H I HRDIK N+LLD D K+ DFG AK + I +R
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 53/268 (19%), Positives = 85/268 (31%), Gaps = 50/268 (18%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQ 140
C C + + Q L +P + +++ L N ++ SF
Sbjct: 6 CVCYNEPKVTTS--CPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRAC---RN 57
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 199
L L + N L+ T + L+ L + N S+ P L L L L
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 200 TGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
EL L L L + DN + + L
Sbjct: 118 Q-ELGPGLFRGLAALQYLYLQDNALQ----------------ALPDDTFRD--------L 152
Query: 259 TSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNID 312
+LT L RIS + E AF L +L L+L + + + + D+ +L +
Sbjct: 153 GNLTHLFLHGNRISSV--PERAFRGLH--SLDRLLLHQNRVA-HVHPHAFRDLGRLMTLY 207
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
L NNL+ L ++ L N
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 50/219 (22%), Positives = 81/219 (36%), Gaps = 21/219 (9%)
Query: 159 LTNI-----TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTN 212
L + + + + GN + +P R NL L L SN A T L
Sbjct: 23 LQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 213 LNDLRISDNNFSGKIPE--FIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD- 268
L L +SDN + F G ++ LH+ L+ + + L +L L + D
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHG-LGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDN 139
Query: 269 -LKG-SESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTT 325
L+ + F L NL L L I +P+ + L + L N + P
Sbjct: 140 ALQALPDDTFRDL--GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 326 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV-DISLNN 363
F L + +YL N L+ +P + + + LN+
Sbjct: 197 FRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLND 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 34/119 (28%), Positives = 49/119 (41%), Gaps = 13/119 (10%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 166
L L+ L L N L +F L L L + GNR+S + + +L
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFR----DLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 167 NLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNF 223
L + N + P R L L L L +N+ + LP E L L L LR++DN +
Sbjct: 181 RLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 41/166 (24%), Positives = 75/166 (45%), Gaps = 14/166 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQ 730
++FD +G+G FG+VY + ++A+K L KS+ EI + S +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF-KSQLEKEGVEHQLRREIEIQSHLR 72
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
HPN++++Y + ++ L+ E+ L + + ++ + D +A L
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHG-RFDEQRSATFMEELADAL 127
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
Y H K++HRDIK N+L+ KI+DFG + +
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 7e-21
Identities = 52/271 (19%), Positives = 91/271 (33%), Gaps = 43/271 (15%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
NL+ +LP L + L++++N L S ASL+ L NRLS P++ +
Sbjct: 70 NLS-SLPDNLPPQ--ITVLEITQNALI-SLPELPASLE--YLDACDNRLST-LPELPAS- 121
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
LK+L ++ N T +P L+ + +N T LP T L L+ + +N
Sbjct: 122 --LKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTSLEVLS---VRNNQ 171
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 282
+ +PE ++ L + + LE +PA + I
Sbjct: 172 LT-FLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIF--------------- 211
Query: 283 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
+ I IP+ I + I L N L+ I + + +
Sbjct: 212 ----FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
Query: 343 TGPVPKYIFNSNKNVDISLNNFTWESSDPIE 373
+ + D F +
Sbjct: 267 SMSDGQQNTLHRPLADAVTAWFPENKQSDVS 297
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 1e-14
Identities = 43/278 (15%), Positives = 87/278 (31%), Gaps = 43/278 (15%)
Query: 149 NRLSGPFPKVLTNITTLKNLSIEGNLFTG--SIPPDIRKLINLQKLILSSNSFTGELPAE 206
N +SG + + + ++ G S+ + + +L L+ + + LP
Sbjct: 20 NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC-LINQFSELQLNRLNLS-SLPDN 77
Query: 207 LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSL----- 261
L + L I+ N +PE ++ L + L +P ++L L
Sbjct: 78 L--PPQITVLEITQNALI-SLPELPA---SLEYLDACDNRLST-LPELPASLKHLDVDNN 130
Query: 262 ---------TDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNI 311
L + ++ + P+L +L+ L + + +P+ + L
Sbjct: 131 QLTMLPELPALLEYINADNNQLTMLPELPT-SLEVLSVRNNQL-TFLPELPESLEAL--- 185
Query: 312 DLSFNNLTGGIPTTFEKLAK----TNFMYLTGNKLTGPVPKYIFN--SNKNVDISLNNFT 365
D+S N L +P + F N++T +P+ I + + + N
Sbjct: 186 DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPL- 242
Query: 366 WESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNF 403
S I Y PR
Sbjct: 243 ---SSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 36/246 (14%), Positives = 69/246 (28%), Gaps = 18/246 (7%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
N LP + L L + N LT SL+ L V N L P V
Sbjct: 149 NNQLTMLPELPTSLEVL---SVRNNQLT-FLPELPESLE--ALDVSTNLLES-LPAVPVR 201
Query: 162 ITTLKN----LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
+ N T IP +I L +IL N + + L++ T D
Sbjct: 202 NHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYH 260
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277
FS + + + + + +S + + + +
Sbjct: 261 GPRIYFSMSDGQQNTLHRPLA--DAVTAWFPENKQSDVSQIWH----AFEHEEHANTFSA 314
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 337
LD+++ ++ ++ ++ + + + E + L
Sbjct: 315 FLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNL 374
Query: 338 TGNKLT 343
L
Sbjct: 375 RKTLLV 380
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 8e-21
Identities = 45/244 (18%), Positives = 98/244 (40%), Gaps = 24/244 (9%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
LP L R ++ L+L+ + +F+ ++Q + + N + P V N
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA-HTIQKLYMG--FNAIRYLPPHVFQN 115
Query: 162 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRIS 219
+ L L +E N + S+P I L L +S+N+ + + T+L +L++S
Sbjct: 116 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 173
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 279
N + + + + ++ + L +++ ++ +L S +
Sbjct: 174 SNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV--VRGP 223
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339
+ L L L + + + + L +DLS+N L + F K+ + +Y++
Sbjct: 224 VNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281
Query: 340 NKLT 343
N+L
Sbjct: 282 NRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 48/275 (17%), Positives = 92/275 (33%), Gaps = 38/275 (13%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 167
+ L L L RN L+ G F +L LS+ N L T+L+N
Sbjct: 113 FQNVPLLTVLVLERNDLSSLPRGIFHNT---PKLTTLSMSNNNLERIEDDTFQATTSLQN 169
Query: 168 LSIEGNLFTGSIPPD-----------------IRKLINLQKLILSSNSFTGELPAELTKL 210
L + N T + + I +++L S NS + +
Sbjct: 170 LQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--N 225
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD-- 268
L L++ NN + + + + ++ + + LE + + L L IS+
Sbjct: 226 VELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328
L + LK L L+ + + +L+N+ L N++ +T
Sbjct: 284 LVALNLYGQPIP--TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHT 340
Query: 329 LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
L + L+ N + +F + + +
Sbjct: 341 LKN---LTLSHNDWDCNSLRALFRNVARPAVDDAD 372
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 49/284 (17%), Positives = 101/284 (35%), Gaps = 31/284 (10%)
Query: 80 ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQ 135
+SN+ DC + V I ++ Q++ E L K + + +
Sbjct: 14 DSNLQYDC---VFYDVHIDMQTQDVYFGF--EDITLNNQKIVTFKNSTMRKLPAALLDSF 68
Query: 136 WASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLIL 194
++L+ L+ ++ T++ L + N +PP + + + L L+L
Sbjct: 69 -RQVELLNLN--DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 124
Query: 195 SSNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIP 252
N + LP + L L +S+NN +I + + +Q L + + L +
Sbjct: 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VD 181
Query: 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID 312
+S + SL +S S + ++ L + I+ + +L +
Sbjct: 182 --LSLIPSLFHANVSYNLLST--LAIP--IAVEELDASHNSIN-VVRG--PVNVELTILK 232
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 356
L NNLT + L+ N+L + + F +
Sbjct: 233 LQHNNLTD--TAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQR 273
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 33/171 (19%), Positives = 71/171 (41%), Gaps = 11/171 (6%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 158
L N++ L + L+ +++LD S N + +++L L + N L+
Sbjct: 188 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGP-VNVELTILKLQHNNLTD--TAW 243
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLR 217
L N L + + N I K+ L++L +S+N L + L L
Sbjct: 244 LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 301
Query: 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
+S N+ + ++ +++ L++ +S+ + +S +L +L +S
Sbjct: 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSH 348
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 41/236 (17%), Positives = 78/236 (33%), Gaps = 36/236 (15%)
Query: 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLN 214
L ++ I+ + L N + + +++ +LPA L +
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 72
Query: 215 DLRISDNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDL-----RIS 267
L ++D +I + IQKL++ +++ +P + + LT L +S
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 130
Query: 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIP--- 323
L F L TL ++ + I D T L+N+ LS N LT +
Sbjct: 131 SL--PRGIFHNTP--KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 184
Query: 324 --------------TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+T + + N + V + + + NN T
Sbjct: 185 IPSLFHANVSYNLLSTLAIPIAVEELDASHNSINV-VRGPVNVELTILKLQHNNLT 239
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 8e-21
Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 739
G+G F VY+ + G +A+K + K+ R NE+ + +HP++++LY
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELYN 78
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ N + LV E N ++R + K+ + R + I G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFS-ENEARHFM-HQIITGMLYLH---SH 131
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
I+HRD+ SN+LL +++N KI+DFGLA +
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 44/179 (24%), Positives = 72/179 (40%), Gaps = 23/179 (12%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK--------QLSSKSRQGNREF 719
N++P +G G V + I AVK S++ Q RE
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 720 V-NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLD 775
E+ + HPN+++L LV++ MK L + +E
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE------ 123
Query: 776 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
+KI + + LH+ + IVHRD+K N+LLD D+N K++DFG + + +
Sbjct: 124 -KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 1e-20
Identities = 21/188 (11%), Positives = 51/188 (27%), Gaps = 35/188 (18%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE------------------------- 718
G+ + + G V R +
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 719 ---FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY---RL 772
F+ ++ Q ++++ + L + Y + + +
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 773 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832
L R ++ + + R LA LH +VH ++ +++LD+ ++ F
Sbjct: 202 SLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 833 DKTHISTR 840
+R
Sbjct: 259 RVVSSVSR 266
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 2e-20
Identities = 28/177 (15%), Positives = 52/177 (29%), Gaps = 20/177 (11%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNREFVNE 722
+ + + + +GEG F VY+ D +K +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 723 IGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 782
+ + +K Y + N +LV E L AI +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 783 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-----------DKDLNAKISDFGLAK 828
+ + + +H+ +I+H DIK N +L D + D G +
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 47/179 (26%), Positives = 75/179 (41%), Gaps = 25/179 (13%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
T+ ++ +G G + + I + AVK + R E EI ++ QHPN
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPN 77
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRK--KICIGIARG 789
++ L +G + +V E MK L I + +E R+ + I +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE---------REASAVLFTITKT 128
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLL-DKDLNA---KISDFGLAKLYEEDKTHISTRIAGT 844
+ YLH +VHRD+K SN+L D+ N +I DFG AK + + T T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYT 183
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 2e-20
Identities = 50/269 (18%), Positives = 107/269 (39%), Gaps = 27/269 (10%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
LP L R ++ L+L+ + +F+ ++Q + + N + P V N
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYA-HTIQKLYMG--FNAIRYLPPHVFQN 121
Query: 162 ITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRIS 219
+ L L +E N + S+P I L L +S+N+ + + T+L +L++S
Sbjct: 122 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 179
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 279
N + + + + ++ + L +++ ++ +L S +
Sbjct: 180 SNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS--INVVRGP 229
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339
+ L L L + + + + L +DLS+N L + F K+ + +Y++
Sbjct: 230 VNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287
Query: 340 NKLTGPVPKYIFNSN--KNVDISLNNFTW 366
N+L + Y K +D+S N+
Sbjct: 288 NRLVA-LNLYGQPIPTLKVLDLSHNHLLH 315
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 3e-18
Identities = 51/307 (16%), Positives = 101/307 (32%), Gaps = 44/307 (14%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 167
+ L L L RN L+ G F +L LS+ N L T+L+N
Sbjct: 119 FQNVPLLTVLVLERNDLSSLPRGIFHNTP---KLTTLSMSNNNLERIEDDTFQATTSLQN 175
Query: 168 LSIEGNLFTGSIPPD-----------------IRKLINLQKLILSSNSFTGELPAELTKL 210
L + N T + + I +++L S NS + +
Sbjct: 176 LQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--N 231
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD-- 268
L L++ NN + + + + ++ + + LE + + L L IS+
Sbjct: 232 VELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 289
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328
L + LK L L+ + + +L+N+ L N++ +T
Sbjct: 290 LVALNLYGQPIP--TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHT 346
Query: 329 LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSP 388
L + L+ N + +F + + + + + + S
Sbjct: 347 LKN---LTLSHNDWDCNSLRALFRNVARPAVDDADQH------CKIDYQLEHGLCCKESD 397
Query: 389 RNKLDKV 395
+ LD++
Sbjct: 398 KPYLDRL 404
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 88.1 bits (218), Expect = 4e-18
Identities = 49/284 (17%), Positives = 101/284 (35%), Gaps = 31/284 (10%)
Query: 80 ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQ 135
+SN+ DC + V I ++ Q++ E L K + + +
Sbjct: 20 DSNLQYDC---VFYDVHIDMQTQDVYFGF--EDITLNNQKIVTFKNSTMRKLPAALLDSF 74
Query: 136 WASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLIL 194
++L+ L+ ++ T++ L + N +PP + + + L L+L
Sbjct: 75 -RQVELLNLN--DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 130
Query: 195 SSNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIP 252
N + LP + L L +S+NN +I + + +Q L + + L +
Sbjct: 131 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VD 187
Query: 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID 312
+S + SL +S S + ++ L + I+ + +L +
Sbjct: 188 --LSLIPSLFHANVSYNLLST--LAIP--IAVEELDASHNSIN-VVRG--PVNVELTILK 238
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 356
L NNLT + L+ N+L + + F +
Sbjct: 239 LQHNNLTD--TAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQR 279
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 2e-13
Identities = 36/217 (16%), Positives = 74/217 (34%), Gaps = 38/217 (17%)
Query: 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLN 214
L ++ I+ + L N + + +++ +LPA L +
Sbjct: 20 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 78
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL-----RISDL 269
L ++D +I+++ + + ++ L I L
Sbjct: 79 LLNLNDL--------------QIEEID----------TYAFAYAHTIQKLYMGFNAIRYL 114
Query: 270 KGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEK 328
F + L L+L + + +P I + KL + +S NNL TF+
Sbjct: 115 --PPHVFQNVP--LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 169
Query: 329 LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
+ L+ N+LT V + S + ++S N +
Sbjct: 170 TTSLQNLQLSSNRLTH-VDLSLIPSLFHANVSYNLLS 205
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-20
Identities = 56/271 (20%), Positives = 94/271 (34%), Gaps = 28/271 (10%)
Query: 108 LPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNIT 163
+ + L + L + S++ W L+LV + K L +T
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF--GQFPTLKLKSLKRLT 331
Query: 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN--SFTGELPAELTKLTNLNDLRISDN 221
N L +L+ L LS N SF G T+L L +S N
Sbjct: 332 FTSNKGGNAFSEVD--------LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGS---ESAFP 277
+ ++++ L Q S+L+ S+ +L +L L IS F
Sbjct: 384 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336
L +L+ L + I ++ L +DLS L PT F L+ +
Sbjct: 443 GL--SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 337 LTGNKLTGPVPKYIFNSNKN---VDISLNNF 364
+ N+L VP IF+ + + + N +
Sbjct: 501 MASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-19
Identities = 61/352 (17%), Positives = 108/352 (30%), Gaps = 68/352 (19%)
Query: 61 DPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQ 120
+PC + N+T C N +P L K
Sbjct: 1 EPCVEVVP-------------NITYQCME------------LNFY-KIPDNLP--FSTKN 32
Query: 121 LDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIP 180
LDLS N L L + L+ L + +I
Sbjct: 33 LDLSFN-------------PLRHLG----------SYSFFSFPELQVLDLSRCEIQ-TIE 68
Query: 181 PD-IRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239
+ L +L LIL+ N + L++L L + N + IG K +++
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 240 LHIQGSSL-EGPIPASISALTSLTDLRISD--LKG-SESAFPKLDKMNLK--TLILTKCL 293
L++ + + +P S LT+L L +S ++ + L +M L +L L+
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 294 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIP-TTFEKLAKTNFMYLTGNKLTG-----PVP 347
++ I +L + L N + + T + LA L +
Sbjct: 189 MN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 348 KYIFNSNKNVDISLNNFTWESSDPIECPRGSVNL--VESYSSPRNKLDKVHP 397
K N+ I + + L V S+S +++V
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 46/283 (16%), Positives = 85/283 (30%), Gaps = 29/283 (10%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNC---------LTGSFSPQWASLQLVELSVMGNRLS 152
+ + T + L L+ L S +L + E +
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 153 G-PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
+ +T + + S+ D Q L L + F + P KL
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFG-QFPTL--KLK 325
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD- 268
+L L + N + ++ L + + L G S TSL L +S
Sbjct: 326 SLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 269 -LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI--GDMTKLKNIDLSFNNLTGGIPTT 325
+ S F L L+ L + ++ ++ + L +D+S +
Sbjct: 384 GVITMSSNFLGL--EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 326 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 365
F L+ + + GN IF +N+ D+S
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 8e-12
Identities = 33/140 (23%), Positives = 55/140 (39%), Gaps = 8/140 (5%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPK-VLTNITTLKNLS 169
LR L LD+S +F+ + L L L + GN F + T + L L
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 170 IEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKI 227
+ + P L +LQ L ++SN +P +LT+L + + N +
Sbjct: 477 LSQCQLE-QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 534
Query: 228 P--EFIGKWKKIQKLHIQGS 245
P +++ +W QGS
Sbjct: 535 PRIDYLSRWLNKNSQKEQGS 554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 103 NLTGTLPTE-LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLT 160
+ + ++LR L LDLS+ L + SL L L++ N+L +
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515
Query: 161 NITTLKNLSIEGNLFTGSIPPDIRKLIN 188
+T+L+ + + N + S P I L
Sbjct: 516 RLTSLQKIWLHTNPWDCS-CPRIDYLSR 542
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 3e-20
Identities = 18/186 (9%), Positives = 36/186 (19%), Gaps = 34/186 (18%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYGC 740
G V+ + A+K + + E + + +
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 741 C--------------------------VEGNQLLLVYEYMK-NNCLSRAIFGKDTEYRLK 773
LL+ + L + +R
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190
Query: 774 LDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833
+ + R A L +VH N+ + D + D
Sbjct: 191 EGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247
Query: 834 KTHIST 839
S
Sbjct: 248 GPASSV 253
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 45/179 (25%), Positives = 81/179 (45%), Gaps = 22/179 (12%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQ 730
++ +G+G FG V K AVK ++ K+ N++ + E+ ++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLD 79
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIAR 788
HPN++KL+ + + +V E L I + +E+ +I +
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFS 132
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
G+ Y+H+ IVHRD+K N+LL +KD + KI DFGL+ ++++ GT
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGT 186
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 51/291 (17%), Positives = 101/291 (34%), Gaps = 36/291 (12%)
Query: 81 SNVTCDCSSA---------TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT-- 129
N C SS T V ++ L +T ++L + L+ L L+ N +
Sbjct: 32 RNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTI 91
Query: 130 --GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI--RK 185
SFS L L + N LS +++L L++ GN + ++
Sbjct: 92 EEDSFSSLG---SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSH 147
Query: 186 LINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPE--FIGKWKKIQKLHI 242
L LQ L + + ++ + LT L +L I ++ + L +
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQ-NVSHLIL 205
Query: 243 QGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL---------DKMNLKTLILTKCL 293
+ + +S+ L + D F +L K + + +T
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES 265
Query: 294 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGNKLT 343
+ ++ + ++ L ++ S N L +P F++L ++L N
Sbjct: 266 LF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 39/211 (18%), Positives = 77/211 (36%), Gaps = 41/211 (19%)
Query: 159 LTNI-----TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLT 211
L +I +K+L + N T I ++ +NLQ L+L+SN + + + L
Sbjct: 43 LNSIPSGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLG 100
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--L 269
+L L +S N + L + L+SLT L +
Sbjct: 101 SLEHLDLSYN--------------YLSNLS----------SSWFKPLSSLTFLNLLGNPY 136
Query: 270 K--GSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTF 326
K G S F L L+ L + +I +T L+ +++ ++L P +
Sbjct: 137 KTLGETSLFSHL--TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSL 194
Query: 327 EKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV 357
+ + + + L + + + + +V
Sbjct: 195 KSIQNVSHLILHMKQHIL-LLEIFVDVTSSV 224
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-20
Identities = 51/214 (23%), Positives = 78/214 (36%), Gaps = 22/214 (10%)
Query: 640 MRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LS 698
M L G++ + + + K+G G +G V
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 699 DGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755
A+K + K+ + E+ ++ HPN++KLY + LV E K
Sbjct: 61 THVERAIKIIR-KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 756 NNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813
L I + E I + G+ YLH+ IVHRD+K N+LL
Sbjct: 120 GGELFDEIIHRMKFNEV-------DAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLL 169
Query: 814 ---DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+KD KI DFGL+ ++E K GT
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKM--KERLGT 201
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 54/276 (19%), Positives = 100/276 (36%), Gaps = 36/276 (13%)
Query: 109 PTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITT 164
+ L++L L L N ++ +FSP +L +L + N L P + ++
Sbjct: 71 KDDFKGLQHLYALVLVNNKISKIHEKAFSPL---RKLQKLYISKNHLVEIPPNLPSS--- 124
Query: 165 LKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFT-GELPAELTKLTNLNDLRISDNN 222
L L I N +P + L N+ + + N LN LRIS+
Sbjct: 125 LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA-SISALTSLTDL-----RISDLKGSESAF 276
+ IP+ + + +LH+ + ++ I + + L L +I + +
Sbjct: 184 LT-GIPK--DLPETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMI--ENGSL 237
Query: 277 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT---- 332
L L+ L L + +P + D+ L+ + L NN+T F +
Sbjct: 238 SFLP--TLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRA 294
Query: 333 --NFMYLTGNKLT-GPVPKYIFNSNKN-VDISLNNF 364
N + L N + V F + + I N+
Sbjct: 295 YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 58/273 (21%), Positives = 96/273 (35%), Gaps = 32/273 (11%)
Query: 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELS 145
CH+ + L +P E+S LDL N ++ F L L L
Sbjct: 32 HCHLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFK----GLQHLYALV 84
Query: 146 VMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA 205
++ N++S K + + L+ L I N IPP++ +L +L + N
Sbjct: 85 LVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKG 141
Query: 206 ELTKLTNLNDLRISDNNF-SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL 264
+ L N+N + + N + K+ L I + L G IP +L +L
Sbjct: 142 VFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPK--DLPETLNEL 198
Query: 265 -----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNL 318
+I + + L L L I I + + L+ + L N L
Sbjct: 199 HLDHNKIQAI--ELEDLLRYS--KLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKL 253
Query: 319 TGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+ +P L +YL N +T V F
Sbjct: 254 S-RVPAGLPDLKLLQVVYLHTNNITK-VGVNDF 284
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 44/187 (23%), Positives = 73/187 (39%), Gaps = 23/187 (12%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE--FIGKWK 235
++P +I + L L +N + + L +L L + +N S KI E F +
Sbjct: 47 AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSP-LR 102
Query: 236 KIQKLHIQGSSLEGPIPASISALTSLTDLR-----ISDLKGSESAFPKLDKMNLKTLILT 290
K+QKL+I + L IP + +SL +LR I + + F L N+ + +
Sbjct: 103 KLQKLYISKNHLVE-IPP--NLPSSLVELRIHDNRIRKV--PKGVFSGLR--NMNCIEMG 155
Query: 291 K-CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY 349
L + D KL + +S LTG E L N ++L NK+ +
Sbjct: 156 GNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETL---NELHLDHNKIQA-IELE 211
Query: 350 IFNSNKN 356
Sbjct: 212 DLLRYSK 218
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 23/173 (13%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYGC 740
K+G G FG V+ S G +K ++ Q E + EI ++ + HPN++K++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 741 CVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ + + +V E + L ++A +E + ++ + LAY H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-------ELMKQMMNALAYFH 141
Query: 795 EDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+VH+D+K N+L KI DFGLA+L++ D+ T AGT
Sbjct: 142 S---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGT 189
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 56/281 (19%), Positives = 99/281 (35%), Gaps = 56/281 (19%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL- 139
C CS ++ LT ++PT + +L+L N L G F L
Sbjct: 5 CSCSGTEIR-----CNSKGLT-SVPTGIPS--SATRLELESNKLQSLPHGVFD----KLT 52
Query: 140 QLVELSVMGNRLS--GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN 197
QL +LS+ N LS G + T+LK L + N ++ + L L+ L +
Sbjct: 53 QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 111
Query: 198 SFTGELPAE--LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI 255
+ ++ L NL L IS + G
Sbjct: 112 NLK-QMSEFSVFLSLRNLIYLDISHTHTR----------------VAFNGIFNG------ 148
Query: 256 SALTSLTDLRISDLKGSES----AFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKN 310
L+SL L+++ E+ F +L NL L L++C + ++ ++ L+
Sbjct: 149 --LSSLEVLKMAGNSFQENFLPDIFTELR--NLTFLDLSQCQLE-QLSPTAFNSLSSLQV 203
Query: 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+++S NN ++ L + + N + K
Sbjct: 204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQEL 243
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 38/168 (22%), Positives = 62/168 (36%), Gaps = 8/168 (4%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQW-ASL-QLVELSVMGNRLSGPFPKVLTNITT 164
T+ + L L+ LD + L SL L+ L + F + +++
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 151
Query: 165 LKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNN 222
L+ L + GN F + PDI +L NL L LS +L L++L L +S NN
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNN 210
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI--SALTSLTDLRISD 268
F +Q L + + +SL L ++
Sbjct: 211 FFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFLNLTQ 257
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 49/249 (19%), Positives = 80/249 (32%), Gaps = 41/249 (16%)
Query: 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASL---QLVELSVMGNRLSGPFPKVLTNI----- 162
+ + L++L L +TG+ P L L++ + L +
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLK 148
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT----KLTNLNDLRI 218
LK LSI +R L L LS N GE K L L +
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 219 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRIS--DLKGSESAF 276
+ + G A +A L L +S L+ + A
Sbjct: 209 RNAGM---------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247
Query: 277 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336
L +L L+ + ++P + KL +DLS+N L P + ++L + +
Sbjct: 248 SCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNP-SPDELPQVGNLS 302
Query: 337 LTGNKLTGP 345
L GN
Sbjct: 303 LKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 49/296 (16%), Positives = 84/296 (28%), Gaps = 57/296 (19%)
Query: 86 DCSSATCHVVTIALKAQNLTGTLPTELSK-LRYLKQLDLSRNCLTGSFSPQWA--SLQLV 142
CS A N G EL R L+ L + SL L
Sbjct: 12 SCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLK 71
Query: 143 ELSVMGNRLSGPFPK---VLTNITTLKNLSIEGNLFTGSIPPDIRKLI--NLQKLILSSN 197
L+V R+ + I+ L+ L++E TG+ PP + + +L L L +
Sbjct: 72 RLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131
Query: 198 SFTGELPAELTKL-----TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252
S+ A L +L L L I+ + E + + + L + + G
Sbjct: 132 SWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID 312
+ FP L + L+ + G +L+ +D
Sbjct: 191 LISALC--------------PLKFPTLQVLALRNAGMET--PSGVCSALAAARVQLQGLD 234
Query: 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 365
LS N+L + + ++S
Sbjct: 235 LSHNSL------------------------RDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 27/246 (10%), Positives = 63/246 (25%), Gaps = 51/246 (20%)
Query: 168 LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL---TNLNDLRISDNNFS 224
L DI K ++L++L + + + ++ + L +L + + +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 225 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNL 284
G P + + L L + ++
Sbjct: 109 GTAPPPLLEAT----------------------GPDLNILNLRNVS-------------- 132
Query: 285 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344
T+ E+ ++ LK + ++ + + + L+ N G
Sbjct: 133 ---WATRDAWLAELQQWL--KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187
Query: 345 PVP------KYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 398
F + + + + S V L S N L
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLS-HNSLRDAAGA 246
Query: 399 LRQNFP 404
++P
Sbjct: 247 PSCDWP 252
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 8e-20
Identities = 52/196 (26%), Positives = 80/196 (40%), Gaps = 23/196 (11%)
Query: 659 LDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR 717
L G++ ++ + +G+G FG V G AVK +S K + +
Sbjct: 9 LHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-KRQVKQK 67
Query: 718 EFV----NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYR 771
E+ ++ HPN++KLY + LV E L I + +E
Sbjct: 68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD 127
Query: 772 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAK 828
+I + G+ Y+H+ KIVHRD+K N+LL KD N +I DFGL+
Sbjct: 128 A-------ARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 829 LYEEDKTHISTRIAGT 844
+E K GT
Sbjct: 178 HFEASKKM--KDKIGT 191
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 91.3 bits (226), Expect = 1e-19
Identities = 21/194 (10%), Positives = 53/194 (27%), Gaps = 37/194 (19%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE------------------------ 718
+G+ + + G V R +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 719 ----FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC----LSRAIFGKDTEY 770
F+ ++ Q ++++ + L + Y + + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 771 RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
+ L R ++ + + R LA LH +VH ++ +++LD+ ++ F
Sbjct: 206 K-SLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 831 EEDKTHISTRIAGT 844
R
Sbjct: 262 GASAVSPIGRGFAP 275
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 47/153 (30%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 683 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQHPNLV 735
K+G GG +VY IL +A+K + + E + E+ S H N+V
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+ E + LV EY++ LS I E L T I G+ + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQILDGIKHAH- 128
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
++IVHRDIK N+L+D + KI DFG+AK
Sbjct: 129 --DMRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 40/164 (24%), Positives = 66/164 (40%), Gaps = 21/164 (12%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLS--------SKSRQGNREFVNEIGMISAQQHPN 733
+G G G V +A++ +S ++ EI ++ HP
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
++K+ + +V E M+ L + G +L T K + + YL
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYL 255
Query: 794 HEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDK 834
HE I+HRD+K NVLL ++D KI+DFG +K+ E
Sbjct: 256 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 39/168 (23%), Positives = 64/168 (38%), Gaps = 18/168 (10%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G G +G V + A K++ + F EI ++ + HPN+++LY
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 742 VEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ + LV E L + E +I + +AY H+ +
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-------RIMKDVLSAVAYCHK---L 125
Query: 800 KIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ HRD+K N L D K+ DFGLA ++ K GT
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGT 171
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 22/173 (12%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKL 737
+G+G FG V K AVK ++ K+ N++ + E+ ++ HPN++KL
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAYLHE 795
+ + + +V E L I + +E+ +I + G+ Y+H+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-------ARIIKQVFSGITYMHK 139
Query: 796 DSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
IVHRD+K N+LL +KD + KI DFGL+ ++++ GT
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTA 187
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 20/175 (11%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+G G FG V+K + G +A K + ++ + E NEI +++ H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLA 791
+LY N ++LV EY+ L I + T I + G+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL-------TELD-TILFMKQICEGIR 201
Query: 792 YLHEDSRIKIVHRDIKTSNVLL-DKDLNA-KISDFGLAKLYEEDKTHISTRIAGT 844
++H+ + I+H D+K N+L ++D KI DFGLA+ Y+ + GT
Sbjct: 202 HMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGT 251
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-19
Identities = 44/177 (24%), Positives = 77/177 (43%), Gaps = 20/177 (11%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
+ +D ++G G FG V++ + + G V K +++ NEI +++ HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----G 789
L+ L+ + +++L+ E++ L I +D + + + I R G
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM-------SEAE-VINYMRQACEG 161
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
L ++HE IVH DIK N++ K + KI DFGLA D+ T
Sbjct: 162 LKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTAT 213
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 6e-19
Identities = 43/178 (24%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHP 732
+++D ++G G FG V++ + G A K + + ++E V EI +S +HP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHP 214
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR---- 788
LV L+ + N+++++YE+M L + + + + + + R
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM-------SEDE-AVEYMRQVCK 266
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLL-DKDLNA-KISDFGLAKLYEEDKTHISTRIAGT 844
GL ++HE VH D+K N++ K N K+ DFGL + ++ GT
Sbjct: 267 GLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGT 319
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 44/171 (25%), Positives = 71/171 (41%), Gaps = 25/171 (14%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGC 740
+GEG F K + AVK +S + + EI + + HPN+VKL+
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEV 74
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRK--KICIGIARGLAYLHED 796
+ LV E + L I K +E + I + ++++H+
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSE---------TEASYIMRKLVSAVSHMHD- 124
Query: 797 SRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ +VHRD+K N+L + +L KI DFG A+L D + T T
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFT 172
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 43/171 (25%), Positives = 69/171 (40%), Gaps = 25/171 (14%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYGC 740
+G G F V+ G + A+K + KS + NEI ++ +H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGIARGLAYLHED 796
LV + + L I G TE + + + + YLHE
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTE---------KDASLVIQQVLSAVKYLHE- 124
Query: 797 SRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
IVHRD+K N+L +++ I+DFGL+K+ + + GT
Sbjct: 125 --NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGT 170
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 37/161 (22%), Positives = 60/161 (37%), Gaps = 21/161 (13%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGCCV 742
GEG V I L AVK + + E+ + Q H N+++L
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRK--KICIGIARGLAYLHEDSR 798
E ++ LV+E M+ + I + E + + +A L +LH
Sbjct: 82 EEDRFYLVFEKMRGGSILSHIHKRRHFNE---------LEASVVVQDVASALDFLHN--- 129
Query: 799 IKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTH 836
I HRD+K N+L ++ KI DF L + +
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 9e-19
Identities = 40/164 (24%), Positives = 64/164 (39%), Gaps = 26/164 (15%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIGMISAQQHPNL 734
G G FG V+ + + VK + K + ++ EI ++S +H N+
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRKKICIGIARGL 790
+K+ LV E + G D + +LD P I + +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGS--------GLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
YL I+HRDIK N+++ +D K+ DFG A E K
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 9e-19
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 649 KVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ 707
+ +G+ + G+Y ++ ++ K+G G +G V + + A+K
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 708 LS------------SKSRQGNREFV-NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754
+ +K+ + E + NEI ++ + HPN++KL+ + LV E+
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 755 KNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 812
+ L I K E I I G+ YLH+ IVHRDIK N+L
Sbjct: 129 EGGELFEQIINRHKFDECDA-------ANIMKQILSGICYLHK---HNIVHRDIKPENIL 178
Query: 813 L---DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
L + LN KI DFGL+ + +D GT
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGT 211
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-19
Identities = 41/261 (15%), Positives = 91/261 (34%), Gaps = 25/261 (9%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
+L + L LK L+L N S P +LQ + + + S
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV-ETFSEIRRIDFAG 146
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+T+L L I+ ++ + ++ L L + L L+++ L + D
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 222 N---FSGKIPEFIGKWKKIQKLHIQGSSLE----GPIPASISALTSLTDLRISDLKGSE- 273
N F ++KL +GS L + + + L+++ D +
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL 266
Query: 274 -----------SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322
S K++ + ++ L + + + ++ + K+K I + + +
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVP 326
Query: 323 PTTFEKLAKTNFMYLTGNKLT 343
+ + L F+ L+ N +
Sbjct: 327 CSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-19
Identities = 47/276 (17%), Positives = 95/276 (34%), Gaps = 29/276 (10%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS---------LQLVELSVMGNRLSGPFPK 157
L + +L ++ D + N L + + + L + L
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGEL---PAELTKLTNL 213
V + + +K +++E + +P + L +L+ L LS N E A +L
Sbjct: 305 VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363
Query: 214 NDLRISDNNFS--GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271
L +S N+ K E + K + L I ++ P+P S + L +S
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI 422
Query: 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331
L+ L ++ + + +L+ + +S N L +
Sbjct: 423 RV--VKTCIPQTLEVLDVSNNNL-DSFSL---FLPRLQELYISRNKLKTLPDASL--FPV 474
Query: 332 TNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNF 364
M ++ N+L VP IF+ + + + N +
Sbjct: 475 LLVMKISRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 6e-18
Identities = 50/299 (16%), Positives = 112/299 (37%), Gaps = 29/299 (9%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRL 151
+ + +KA +L L +R + L L + L + L + L
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208
Query: 152 SGPFP---KVLTNITTLKNLSIEGNLFT----GSIPPDIRKLINLQKLILSSNSFTG--- 201
+ V + +K L+ G++ T + +R ++ L ++ + G
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268
Query: 202 ------ELPAELTKL--TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA 253
++ +EL K+ + L I + +K++++ ++ S + +
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS 328
Query: 254 SISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIH--GEIPDYIGDMT 306
L SL L + + SA K +L+TL+L++ + + + + +
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNSAC-KGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387
Query: 307 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
L ++D+S N +P + + K F+ L+ + V I + + +D+S NN
Sbjct: 388 NLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRV-VKTCIPQTLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-17
Identities = 51/341 (14%), Positives = 105/341 (30%), Gaps = 77/341 (22%)
Query: 80 ESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL 139
+++ CD S ++ T ++P+ L+ +K LDLS N +T +
Sbjct: 5 DASGVCDGRS------------RSFT-SIPSGLT--AAMKSLDLSFNKIT--------YI 41
Query: 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNS 198
L L+ L ++ + +I D L +L+ L LS N
Sbjct: 42 G---------------HGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNH 85
Query: 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
+ + L++L L + N + + + L
Sbjct: 86 LSSLSSSWFGPLSSLKYLNLMGNPYQ-----------------------TLGVTSLFPNL 122
Query: 259 TSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 314
T+L LRI +++ F L +L L + + + + + ++ L
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLT--SLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180
Query: 315 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTG-----PVPKYIFNSNKNVDISLNNFTWESS 369
+ + + L+ ++ L L + + K + + T ES
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240
Query: 370 DPI---ECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSA 407
+ + ++ VE N L +P
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 30/173 (17%), Positives = 55/173 (31%), Gaps = 19/173 (10%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLT------GSFSPQWASLQLVELSVMGNRLSGPF 155
L+ L LS+N L +L +++S N P
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL-TLKNLTSLDIS--RNTFH-PM 402
Query: 156 PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLND 215
P ++ L++ + I L+ L +S+N+ L +L L
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELY- 457
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
IS N +P+ + + + I + L+ LTSL + +
Sbjct: 458 --ISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 27/146 (18%), Positives = 54/146 (36%), Gaps = 10/146 (6%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
+N +P ++ L+LS + + +L+++++S N L F L
Sbjct: 396 RNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVS--NNNLDS-FSLFLPR 452
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
L+ L I N ++P L + +S N +LT+L + + N
Sbjct: 453 ---LQELYISRNKLK-TLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 222 NFSG--KIPEFIGKWKKIQKLHIQGS 245
+ +++ +W QGS
Sbjct: 508 PWDCSCPRIDYLSRWLNKNSQKEQGS 533
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 20/178 (11%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQH 731
++N+D ++G+G F V + + + G A K ++ K + + + E + QH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARG 789
PN+V+L+ E + LV++ + L I +E I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD-------ASHCIQQILES 117
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+AY H IVHR++K N+LL K K++DFGLA + + AGT
Sbjct: 118 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGT 170
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 43/186 (23%), Positives = 74/186 (39%), Gaps = 31/186 (16%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV-NEIGMIS 727
++++ ++G G F V K G A K +LSS R +RE + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMK-----NNCLSRAIFGKDTEYRLKLDWPTRKKI 782
+HPN++ L+ ++L+ E + + + TE +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL---TE-------DEATQF 113
Query: 783 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHIS 838
I G+ YLH +I H D+K N++L + K+ DFG+A E
Sbjct: 114 LKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-- 168
Query: 839 TRIAGT 844
I GT
Sbjct: 169 KNIFGT 174
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 43/216 (19%), Positives = 70/216 (32%), Gaps = 49/216 (22%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISA 728
+ +G+G +G V I + A+K ++ + + E+ ++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTR------- 779
HPN+ +LY + + LV E L + F D+ + +D
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 780 --------------------------KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813
I I L YLH I HRDIK N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201
Query: 814 DKDLNA--KISDFGLAKLYEEDKTHISTR---IAGT 844
+ + K+ DFGL+K + + AGT
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 41/172 (23%), Positives = 69/172 (40%), Gaps = 21/172 (12%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--------SKSRQGNREFVNEIGM 725
+ + + +G G G V +A+K +S ++ EI +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
+ HP ++K+ + +V E M+ L + G +L T K
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQ 122
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDK 834
+ + YLHE I+HRD+K NVLL ++D KI+DFG +K+ E
Sbjct: 123 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 34/204 (16%)
Query: 658 GLDLQTGLYTLRQIKAATNNFDPANKV-GEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQ 714
G+DL T + ++ N + +K G G F V + I S G A K L + Q
Sbjct: 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 715 GNREFV-NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK-----NNCLSRAIFGKD 767
R + +EI + A+ P ++ L+ ++++L+ EY + CL
Sbjct: 70 DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL-AEMV 128
Query: 768 TEYRLKLDWPTRKKICIGIAR----GLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAK 820
+E I + + G+ YLH+ IVH D+K N+LL + K
Sbjct: 129 SE-----------NDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIK 174
Query: 821 ISDFGLAKLYEEDKTHISTRIAGT 844
I DFG+++ I GT
Sbjct: 175 IVDFGMSRKIGHACEL--REIMGT 196
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 32/178 (17%), Positives = 68/178 (38%), Gaps = 23/178 (12%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHP 732
+ A +G G FG V++ + S K + K ++ V EI +++ +H
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHR 61
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR---- 788
N++ L+ +L++++E++ + I E ++ +
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL-------NERE-IVSYVHQVCE 113
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
L +LH + I H DI+ N++ + KI +FG A+ + +
Sbjct: 114 ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTA 166
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 50/153 (32%), Positives = 66/153 (43%), Gaps = 18/153 (11%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGCCV 742
GEG +G V + +AVK + K E + EI + H N+VK YG
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAYLHEDSR 798
EGN L EY L I + ++ + G+ YLH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDI---GMPEP-DAQRFFHQLMA-----GVVYLH---G 123
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831
I I HRDIK N+LLD+ N KISDFGLA ++
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFR 156
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 41/176 (23%), Positives = 65/176 (36%), Gaps = 14/176 (7%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQQH 731
++ +G+G F V + I G AVK + +S + E + +H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
P++V+L L +V+E+M L I + I L
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF-VYSEAVASHYMRQILEALR 144
Query: 792 YLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
Y H+ I+HRD+K VLL + K+ FG+A E R+ GT
Sbjct: 145 YCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 50/153 (32%), Positives = 66/153 (43%), Gaps = 18/153 (11%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGCCV 742
GEG +G V + +AVK + K E + EI + H N+VK YG
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAYLHEDSR 798
EGN L EY L I + ++ + G+ YLH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDI---GMPEP-DAQRFFHQLMA-----GVVYLH---G 123
Query: 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831
I I HRDIK N+LLD+ N KISDFGLA ++
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFR 156
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 49/194 (25%), Positives = 78/194 (40%), Gaps = 26/194 (13%)
Query: 664 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNR 717
G+ T +Q + + +D ++G G F V K S G A K Q + R R
Sbjct: 1 GMETFKQ-QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR 59
Query: 718 EFV-NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKL 774
E + E+ ++ HPN++ L+ ++L+ E + L + K+ +E
Sbjct: 60 EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-- 117
Query: 775 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLY 830
I G+ YLH KI H D+K N++L + K+ DFGLA
Sbjct: 118 -----TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 831 EEDKTHISTRIAGT 844
E+ I GT
Sbjct: 170 EDGVEF--KNIFGT 181
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 47/183 (25%), Positives = 75/183 (40%), Gaps = 25/183 (13%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV-NEIGMIS 727
+ +D ++G G F V K S G A K Q + R +RE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIG 785
H N++ L+ ++L+ E + L + K+ +E
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-------TSFIKQ 123
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLL-DKDLNA---KISDFGLAKLYEEDKTHISTRI 841
I G+ YLH KI H D+K N++L DK++ K+ DFGLA E+ I
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNI 178
Query: 842 AGT 844
GT
Sbjct: 179 FGT 181
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 38/153 (24%), Positives = 68/153 (44%), Gaps = 11/153 (7%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFVN-EIGMISAQQHPNLVKLYGCC 741
G+G F V + G +A+K + ++ + + + E+ ++ HPN+VKL+
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
L L+ EY + + ++ + I + Y H + +I
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCH---QKRI 135
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
VHRD+K N+LLD D+N KI+DFG + +
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 49/199 (24%), Positives = 76/199 (38%), Gaps = 59/199 (29%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQ--------- 730
G+G +G V +D T A+K LS + R +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 731 -------------HPNLVKLYGCCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK 773
HPN+VKL V + L +V+E + +
Sbjct: 82 QVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPV-------------- 125
Query: 774 LDWPTRKKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825
++ PT K + AR G+ YLH KI+HRDIK SN+L+ +D + KI+DFG
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 826 LAKLYEEDKTHISTRIAGT 844
++ ++ +S GT
Sbjct: 183 VSNEFKGSDALLSNT-VGT 200
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 40/164 (24%), Positives = 59/164 (35%), Gaps = 28/164 (17%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-----------QHP 732
GEG +G V + + AVK L ++ + I A +H
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKIL-------KKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 733 NLVKLYG--CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
N+++L E ++ +V EY + E R C + GL
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFP-VCQAHGYFC-QLIDGL 122
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
YLH IVH+DIK N+LL KIS G+A+
Sbjct: 123 EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-18
Identities = 46/266 (17%), Positives = 86/266 (32%), Gaps = 23/266 (8%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 158
L +++ L LD S N +T Q L L+ N ++
Sbjct: 153 LDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLN--RLNCDTNNITKL---D 207
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
L L L N T I D+ L L S N T EL ++ L+ L L
Sbjct: 208 LNQNIQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHC 261
Query: 219 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPK 278
+ +I + ++ +G + ++ T L L +E +
Sbjct: 262 IQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITELDLSQ 316
Query: 279 LDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLT 338
L L L + E+ + TKLK++ ++ + K+ N +
Sbjct: 317 N--PKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEA 369
Query: 339 GNKLTGPVPKYIFNSNKNVDISLNNF 364
+ + + N++ + +S +
Sbjct: 370 EGQTITMPKETLTNNSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 47/263 (17%), Positives = 91/263 (34%), Gaps = 24/263 (9%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+ T +L L LD + +T + L +L N ++ L+
Sbjct: 29 EMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNITT-LD--LSQN 84
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
T L L+ + N T ++ + L L L +N T +L +++ L L + N
Sbjct: 85 TNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNT 138
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM 282
+ +I + ++ +L + + ++ T LT L S K +E +
Sbjct: 139 LT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELDVSQNK-- 191
Query: 283 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
L L I ++ + +L +D S N LT I L + + + N L
Sbjct: 192 LLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPL 245
Query: 343 TGPVPKYIFNSNKNVDISLNNFT 365
T + + + +
Sbjct: 246 T-ELDVSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-16
Identities = 44/261 (16%), Positives = 81/261 (31%), Gaps = 26/261 (9%)
Query: 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
++S+ + L +L+ N +T QL L N+L+ +T +T L
Sbjct: 186 DVSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFD 239
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
N T + + L L L E+ LT T L + ++
Sbjct: 240 CSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD- 292
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKMNLKTL 287
+ ++ L Q + + + +S L L +++ L + LK+L
Sbjct: 293 -VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL----TELDVSHNTKLKSL 344
Query: 288 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 347
I + +G + L N + T + T + G
Sbjct: 345 SCVNAHI-QDFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPM 402
Query: 348 KYIFNSNKNVDISLNNFTWES 368
D + N TWE+
Sbjct: 403 NIEPGDGGVYDQATNTITWEN 423
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 31/179 (17%), Positives = 62/179 (34%), Gaps = 15/179 (8%)
Query: 165 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS 224
+ + +L L L ++S T ++ + KLT L L + NN +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 225 GKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNL 284
+ + + + L + L + ++ LT LT L K ++ + L
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTKLDVSQNP--LL 129
Query: 285 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
L + + EI + T+L +D N + + + + NK+T
Sbjct: 130 TYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 27/178 (15%), Positives = 55/178 (30%), Gaps = 13/178 (7%)
Query: 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247
N + ++ +L L L +++ + + I K + KL +++
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNI 76
Query: 248 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTK 307
+ +S T+LT L K + L L L + ++ +
Sbjct: 77 TT-LD--LSQNTNLTYLACDSNKLTNLDVTPLT--KLTYLNCDTNKLT-KLD--VSQNPL 128
Query: 308 LKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
L ++ + N LT + + NK + +D S N T
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT 183
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 5e-18
Identities = 32/155 (20%), Positives = 61/155 (39%), Gaps = 21/155 (13%)
Query: 683 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 738
+ GG G +Y ++ V +K L + + E ++ HP++V+++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPV-VLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 739 GCCVEGNQLL-----LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
++ +V EY+ L R+ K L + I L+YL
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-------LPVAEAIAYLLEILPALSYL 198
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
H I +V+ D+K N++L ++ K+ D G
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-18
Identities = 39/180 (21%), Positives = 73/180 (40%), Gaps = 23/180 (12%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQH 731
T + ++G+G F V + + + G A ++ K + + + E + +H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGIA 787
PN+V+L+ E L+++ + L I +E I
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE---------ADASHCIQQIL 120
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ + H+ + +VHR++K N+LL K K++DFGLA E ++ AGT
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGT 176
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 56/280 (20%), Positives = 103/280 (36%), Gaps = 25/280 (8%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ + IA N+T T+ + L + L +T + L+ L + N+++
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQIT 76
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
P L N+T + L + GN ++ I L +++ L L+S T P L L+N
Sbjct: 77 DLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSN 130
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
L L + N + I + +Q L I + + ++ L +L+ L +
Sbjct: 131 LQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-----DLTPLANLSKLTTLKADDN 183
Query: 273 E-SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 330
+ S L + NL + L I P + + + L + L+ +T L
Sbjct: 184 KISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLV 241
Query: 331 KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD 370
N + P I + N + N TW +
Sbjct: 242 VPNVVKGPSGAPI--APATISD---NGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 30/167 (17%), Positives = 64/167 (38%), Gaps = 16/167 (9%)
Query: 179 IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ 238
I PD L N K+ ++ T + L + L + I E + +
Sbjct: 12 IFPD-PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLI 66
Query: 239 KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTLILTKCLIHG 296
L ++ + + ++ L +LT + +L G+ + + ++KTL LT I
Sbjct: 67 GLELKDNQIT-----DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD 121
Query: 297 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
P + ++ L+ + L N +T P L ++ + +++
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS 164
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 45/198 (22%), Positives = 76/198 (38%), Gaps = 39/198 (19%)
Query: 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV 720
T+ + + + +D ++G G F V K S G A K + S R +RE +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 721 -NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK-----NNCLSRAIFGKDTEYRLKL 774
E+ ++ QHPN++ L+ ++L+ E + + + TE
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TE----- 113
Query: 775 DWPTRKKICIGIAR----GLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGL 826
+ + G+ YLH ++I H D+K N++L KI DFGL
Sbjct: 114 ------EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 827 AKLYEEDKTHISTRIAGT 844
A + I GT
Sbjct: 165 AHKIDFGNEF--KNIFGT 180
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 9e-18
Identities = 42/261 (16%), Positives = 91/261 (34%), Gaps = 19/261 (7%)
Query: 117 YLKQLDLSRNCLTGSFSPQWAS----LQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172
L ++ + N W + + + + G F T++ L +
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285
Query: 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG 232
++F N+ + + +K++ L S+N + + E G
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345
Query: 233 KWKKIQKLHIQGSSLE--GPIPASISALTSLTDLRISD----LKGSESAFPKLDKMNLKT 286
+++ L +Q + L+ I + + SL L IS + +L +
Sbjct: 346 HLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK--SLLS 403
Query: 287 LILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPV 346
L ++ ++ I + ++K +DL N + IP KL + + N+L V
Sbjct: 404 LNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-V 459
Query: 347 PKYIFNSNKN---VDISLNNF 364
P IF+ + + + N +
Sbjct: 460 PDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 37/170 (21%), Positives = 64/170 (37%), Gaps = 7/170 (4%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLS--GPFPKVL 159
SK+ LD S N LT + L +L L + N+L ++
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT 370
Query: 160 TNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218
T + +L+ L I N + +L L +SSN T + L + L +
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDL 428
Query: 219 SDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
N IP+ + K + +Q+L++ + L+ LTSL + +
Sbjct: 429 HSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 44/304 (14%), Positives = 90/304 (29%), Gaps = 34/304 (11%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSG-PFPK 157
++ +++ L L+ L +S N + F +L L + N+L
Sbjct: 32 YISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQ---ELEYLDLSHNKLVKISCHP 88
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTGELPAELTKLTNLND 215
N LK+L + N F ++P + L+ L LS+ + L
Sbjct: 89 -TVN---LKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKV 143
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA 275
L + + K + + LHI + + ++ ++ +L +S++K
Sbjct: 144 LLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED 203
Query: 276 ----------FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNI-DLSFNNLT----- 319
L L L I + + S +N+
Sbjct: 204 NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQL 263
Query: 320 --GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRG 377
+ L + + + P YI+ N++I + + CP
Sbjct: 264 DFRDFDYSGTSLKALSIHQVVSDVFGFP-QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSK 322
Query: 378 SVNL 381
Sbjct: 323 ISPF 326
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 35/209 (16%), Positives = 67/209 (32%), Gaps = 7/209 (3%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDN 221
L+I N + DI L L+ LI+S N L L L +S N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHN 79
Query: 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDLRISDLKGSESAFPKLD 280
KI ++ L + ++ + PI ++ L L +S +S+ +
Sbjct: 80 KLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 281 KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
+N+ ++L +GE D + L T ++ L +
Sbjct: 137 HLNISKVLLVLGETYGEKED-PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195
Query: 341 KLTGPVPKYIFNSNKNVDISLNNFTWESS 369
+ + + ++ L S+
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSN 224
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 34/243 (13%), Positives = 68/243 (27%), Gaps = 27/243 (11%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
+P D+ L +S N + +++ L+ L L IS N +++
Sbjct: 14 HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
+ L + + L S +L L +S L + K
Sbjct: 72 EYLDLSHNKLVK---ISCHPTVNLKHLDLSFNA-------------FDALPICK------ 109
Query: 298 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV 357
G+M++LK + LS +L L + + + G
Sbjct: 110 ---EFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166
Query: 358 DISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLH 417
+ + T + I S+ + L+ + + L
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLT 226
Query: 418 INC 420
+N
Sbjct: 227 LNN 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 36/164 (21%), Positives = 63/164 (38%), Gaps = 29/164 (17%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMI-----------SAQQHP 732
G+GGFG+V+ G L+D +A+K + ++R +++ + HP
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRKKICIGIAR 788
+++L +LV E +D + L + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLP--------AQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYE 831
+ + H +VHRDIK N+L+D AK+ DFG L
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 84.2 bits (207), Expect = 1e-17
Identities = 42/210 (20%), Positives = 68/210 (32%), Gaps = 45/210 (21%)
Query: 662 QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQL--------SSKSR 713
Q G T K+GEG FG V++ I D T +A+K + + +
Sbjct: 7 QKGPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 714 QGNREFVNEIGM---------ISAQQHPNLVKLYGC-CVEGN---QLLLVYEYMKNNCLS 760
+ E + EI + + + L CV+G+ LL +++ + S
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 761 ----RAIFGKDTEYRL----------------KLDWPTRKKICIGIARGLAYLHEDSRIK 800
F D + + T K I + LA ++
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLR 182
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830
HRD+ NVLL K K+ K
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHPNLVKLYG 739
G G FG V G G +AVK L+ + + + + V EI + +HP+++KLY
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+V EY+ L I +++ +++ I + Y H R
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCH---RH 130
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
+VHRD+K NVLLD +NAKI+DFGL+ + + +
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 54/286 (18%), Positives = 102/286 (35%), Gaps = 50/286 (17%)
Query: 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELS 145
CH+ + L +P +L LDL N +T G F +L L L
Sbjct: 30 QCHLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFK----NLKNLHTLI 82
Query: 146 VMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA 205
++ N++S P + L+ L + N +P + LQ+L + N T +
Sbjct: 83 LINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKS 139
Query: 206 ELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR 265
L + + + N ++ I+ + +G + L+ +R
Sbjct: 140 VFNGLNQMIVVELGTN--------------PLKSSGIENGAFQG--------MKKLSYIR 177
Query: 266 ISD--LKG-SESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGG 321
I+D + + P +L L L I ++ + L + LSFN+++
Sbjct: 178 IADTNITTIPQGLPP-----SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAV 231
Query: 322 IPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSN--KNVDISLNNFT 365
+ ++L NKL VP + + + V + NN +
Sbjct: 232 DNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 43/249 (17%), Positives = 84/249 (33%), Gaps = 33/249 (13%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 167
+ L L++L LS+N L L EL V N ++ V + +
Sbjct: 96 FAPLVKLERLYLSKNQLKELPEKMPK------TLQELRVHENEITKVRKSVFNGLNQMIV 149
Query: 168 LSIEGN-LFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 225
+ + N L + I + + L + ++ + T +P L +L +L + N +
Sbjct: 150 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT- 205
Query: 226 KIPE--FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDK 281
K+ G + KL + +S+ S++ L +L +++ L
Sbjct: 206 KVDAASLKGL-NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH-- 262
Query: 282 MNLKTLILTKCLIHGEIPD-------YIGDMTKLKNIDLSFNNLTGGI--PTTFEKLAKT 332
++ + L I I Y + L N + P+TF +
Sbjct: 263 KYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 321
Query: 333 NFMYLTGNK 341
+ L K
Sbjct: 322 AAVQLGNYK 330
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 35/167 (20%), Positives = 62/167 (37%), Gaps = 24/167 (14%)
Query: 683 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQHPNLV 735
+G GG V+ +AVK L + + F E +A HP +V
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 736 KLY--GCCVEGNQLLLVY---EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
+Y G E L Y EY+ L + + ++ + L
Sbjct: 76 AVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQAL 129
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837
+ H + I+HRD+K +N+++ K+ DFG+A+ + +
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 55/274 (20%), Positives = 84/274 (30%), Gaps = 60/274 (21%)
Query: 84 TCDCSSAT--CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWA 137
+ T C N +P L K LDLS N L SF
Sbjct: 4 VEVVPNITYQCM-------ELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFF---- 49
Query: 138 SL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILS 195
S +L L + + +++ L L + GN S+ L +LQKL+
Sbjct: 50 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAV 108
Query: 196 SNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPAS 254
+ L L L +L ++ N IQ +P
Sbjct: 109 ETNLA-SLENFPIGHLKTLKELNVAHN--------------LIQSF---------KLPEY 144
Query: 255 ISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIH---GEIPDYIGDMT 306
S LT+L L +I + + L + L L+ L I
Sbjct: 145 FSNLTNLEHLDLSSNKIQSI--YCTDLRVLH--QMPLLNLSLDLSLNPMNFIQPGAFKEI 200
Query: 307 KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
+LK + L N L F++L ++L N
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 36/218 (16%), Positives = 70/218 (32%), Gaps = 63/218 (28%)
Query: 160 TNI-TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDL 216
N+ + KNL + N + LQ L LS + L++L+ L
Sbjct: 24 DNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTL 81
Query: 217 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 276
++ N + SL + AF
Sbjct: 82 ILTGNP-----------------------------------IQSL----------ALGAF 96
Query: 277 PKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNF 334
L +L+ L+ + + + ++ G + LK ++++ N + +P F L
Sbjct: 97 SGL--SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 153
Query: 335 MYLTGNKLTGPVPKYIFNS-------NKNVDISLNNFT 365
+ L+ NK+ + N ++D+SLN
Sbjct: 154 LDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 45/181 (24%), Positives = 75/181 (41%), Gaps = 26/181 (14%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQ 730
++N+D ++G+G F V + + + G A K ++ + R+ E + Q
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQ 86
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGI 786
HPN+V+L+ E + LV++ + L I +E I
Sbjct: 87 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---------ADASHCIQQI 137
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
+AY H IVHR++K N+LL K K++DFGLA + + AG
Sbjct: 138 LESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAG 192
Query: 844 T 844
T
Sbjct: 193 T 193
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 41/164 (25%), Positives = 64/164 (39%), Gaps = 30/164 (18%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-- 741
G G G V + G A+K L S + +E + A P++V +
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEV--DH-HWQASGGPHIVCILDVYEN 93
Query: 742 --VEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRK--KICIGIARGLAYL 793
LL++ E M+ L I + TE R+ +I I + +L
Sbjct: 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE---------REAAEIMRDIGTAIQFL 144
Query: 794 HEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDK 834
H I HRD+K N+L +KD K++DFG AK ++
Sbjct: 145 HS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 35/153 (22%), Positives = 57/153 (37%), Gaps = 18/153 (11%)
Query: 683 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQHPNLV 735
VG GG G VY+ + ++A+K +S + + F E Q P++V
Sbjct: 41 LVGRGGMGDVYEAEDTVR--ERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
++ QL + + L+ + + L I I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVA--IVRQIGSALDAAHA 152
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
HRD+K N+L+ D A + DFG+A
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIAS 182
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 7e-17
Identities = 36/218 (16%), Positives = 72/218 (33%), Gaps = 54/218 (24%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPN 733
+F+P +G GGFG V++ D A+K++ +R+ RE V E+ ++ +HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI----------- 782
+V+ + +E E + + + + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 783 -----------------CIG------IARGLAYLHEDSRI------------------KI 801
C + R + + + +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
+HRD+K SN+ D K+ DFGL ++D+ +
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 8e-17
Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHPNLVKLYG 739
G G FG V G G +AVK L+ + + + + V EI + +HP+++KLY
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+ + +V EY+ L I +LD +++ I G+ Y H R
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCH---RH 135
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
+VHRD+K NVLLD +NAKI+DFGL+ + + +
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 19/159 (11%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-------EIGMISAQQH--PNL 734
G GGFGSVY GI +SD +A+K + K R + + E+ ++ +
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
++L + +L+ E + + +F TE R L + + + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 166
Query: 795 EDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEE 832
++HRDIK N+L+D + K+ DFG L ++
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 48/170 (28%), Positives = 68/170 (40%), Gaps = 24/170 (14%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
++G G VY+ A+K L + EIG++ HPN++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKLKEIF 117
Query: 742 VEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGIARGLAYLHEDS 797
++ LV E + L I G +E R I +AYLHE
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSE---------RDAADAVKQILEAVAYLHE-- 166
Query: 798 RIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
IVHRD+K N+L D KI+DFGL+K+ E + GT
Sbjct: 167 -NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGT 213
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.5 bits (203), Expect = 2e-16
Identities = 44/257 (17%), Positives = 87/257 (33%), Gaps = 18/257 (7%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171
+ +L + +T Q + ++ + + + + + L +
Sbjct: 17 DDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 73
Query: 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 231
GN T I P + L NL L L N +L + L L L L + N S I +
Sbjct: 74 GNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGL 127
Query: 232 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTLIL 289
+++ L++ + + I+ L+ LT L L+ ++ S L + L+ L L
Sbjct: 128 VHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYL 182
Query: 290 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY 349
+K I + + L ++L L N + T L P
Sbjct: 183 SKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
Query: 350 IFNSNKNVDISLNNFTW 366
+ ++ + +
Sbjct: 241 DDGDYEKPNVKWHLPEF 257
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.0 bits (194), Expect = 3e-15
Identities = 47/300 (15%), Positives = 103/300 (34%), Gaps = 19/300 (6%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
+ LK +++T + ++L + Q+ + + + S + +L + GN+L+
Sbjct: 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKLT 78
Query: 153 GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN 212
P LTN+ L L ++ N + ++ L L+ L L N + ++ L L
Sbjct: 79 DIKP--LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQ 132
Query: 213 LNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272
L L + +N + + + K+ L ++ + + I L LT L+ L +
Sbjct: 133 LESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-----DIVPLAGLTKLQNLYLSKN 185
Query: 273 E-SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 330
S L + NL L L + ++ ++ + + +L +
Sbjct: 186 HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-TPEIISDDGD 244
Query: 331 KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRN 390
+IF + + F + P++ V+
Sbjct: 245 YEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTK 304
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 7e-08
Identities = 44/275 (16%), Positives = 83/275 (30%), Gaps = 17/275 (6%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171
L L L+ L L N +T + +L LS+ N++S P L +T L+NL +
Sbjct: 127 LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 183
Query: 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 231
N + + + L NL L L S + + L N ++ +D + PE I
Sbjct: 184 KNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEII 239
Query: 232 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTK 291
+K +++ E S + I K + T+
Sbjct: 240 SDDGDYEKPNVKWHLPEFTNEVS---FIFYQPVTIGKAKARFHGRVTQPLKEVYTVS--- 293
Query: 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
++ + ++ F+ N T + F
Sbjct: 294 ----YDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDF 349
Query: 352 NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYS 386
T + ++ RG+ + +
Sbjct: 350 TLYAVFKAETTEKTVNLTRYVKYIRGNAGIYKLPR 384
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 27/166 (16%), Positives = 64/166 (38%), Gaps = 6/166 (3%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNI 162
+ T +++ L + L+ +T + + + +L++ + P ++ +
Sbjct: 31 GQSSTANITEAQMNSLTYITLANINVT-DLTGIEYAHNIKDLTINNIHATNYNP--ISGL 87
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
+ L+ L I G T P++ L +L L +S ++ + ++ L +N + +S N
Sbjct: 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
I + +++ L+IQ + I L L
Sbjct: 148 AITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-16
Identities = 31/168 (18%), Positives = 62/168 (36%), Gaps = 20/168 (11%)
Query: 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ +L +++ T + I N++ L +++ T P ++ L+NL LRI
Sbjct: 41 AQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIM 96
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDL------RISDLKGSE 273
+ + + + L I S+ + I I+ L + + I+D+
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-- 154
Query: 274 SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320
L + LK+L + +H I D KL + + G
Sbjct: 155 -----LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 29/163 (17%), Positives = 56/163 (34%), Gaps = 33/163 (20%)
Query: 181 PDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL 240
PD +L +S A++ LT + +++ N +
Sbjct: 18 PD-STFKAYLNGLLGQSSTANITEAQMNSLTYIT---LANINVT---------------- 57
Query: 241 HIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKMNLKTLILTKCLIHGEIP 299
L G I ++ DL I+++ + + L NL+ L + + +
Sbjct: 58 -----DLTG-----IEYAHNIKDLTINNIHATNYNPISGLS--NLERLRIMGKDVTSDKI 105
Query: 300 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
+ +T L +D+S + I T L K N + L+ N
Sbjct: 106 PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 45/165 (27%), Positives = 64/165 (38%), Gaps = 30/165 (18%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG---- 739
G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYEN 126
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRK--KICIGIARGLAYL 793
LL+V E + L I + TE R+ +I I + YL
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE---------REASEIMKSIGEAIQYL 177
Query: 794 HEDSRIKIVHRDIKTSNVLL-DKDLNA--KISDFGLAKLYEEDKT 835
H I I HRD+K N+L K NA K++DFG AK +
Sbjct: 178 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 9e-16
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 23/179 (12%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNE-- 722
I N+F +G GGFG VY +D G + A+K L K +QG +NE
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 723 -IGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWP 777
+ ++S P +V + ++L + + M G D Y L
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN---------GGDLHYHLSQHGVFSEA 292
Query: 778 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
+ I GL ++H +V+RD+K +N+LLD+ + +ISD GLA + + K H
Sbjct: 293 DMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 15/155 (9%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHPNLVKLYG 739
GEG FG V +A+K +S + + EI + +HP+++KLY
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 799
+++V EY +F E + ++ ++ I + Y H R
Sbjct: 77 VITTPTDIVMVIEYAGGE-----LFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RH 127
Query: 800 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
KIVHRD+K N+LLD +LN KI+DFGL+ + +
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 41/211 (19%), Positives = 75/211 (35%), Gaps = 56/211 (26%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
+ + +G G FG V + + G A+K++ R NRE + ++ H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 734 LVKLYGC--------------------------------------CVEGNQLLLVYEYMK 755
++KL + L ++ EY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 756 NNCLSRAIFGKDTEYRLKLDWPTR--KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813
+ L + + + R P + R + ++H + I HRDIK N+L+
Sbjct: 122 DT-LHKVL---KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174
Query: 814 D-KDLNAKISDFGLAKLYEEDKTHIS---TR 840
+ KD K+ DFG AK + ++ +R
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSR 205
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 46/183 (25%), Positives = 77/183 (42%), Gaps = 35/183 (19%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 724
+ VG G +GSV I G +A+K+LS R F + E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 725 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
++ QH N++ L LV +M+ + L + + LK
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-LQKIM-------GLKFSEEK 127
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-I 837
+ + + +GL Y+H +VHRD+K N+ +++D KI DFGLA+ + + T +
Sbjct: 128 IQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV 184
Query: 838 STR 840
TR
Sbjct: 185 VTR 187
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 45/158 (28%), Positives = 63/158 (39%), Gaps = 30/158 (18%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-- 741
G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYEN 82
Query: 742 --VEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRK--KICIGIARGLAYL 793
LL+V E + L I + TE R+ +I I + YL
Sbjct: 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE---------REASEIMKSIGEAIQYL 133
Query: 794 HEDSRIKIVHRDIKTSNVLL-DKDLNA--KISDFGLAK 828
H I I HRD+K N+L K NA K++DFG AK
Sbjct: 134 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 39/156 (25%), Positives = 58/156 (37%), Gaps = 20/156 (12%)
Query: 685 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743
G G FG ++AVK + + + EI + +HPN+V+ +
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAYLHEDSRI 799
L ++ EY L I R D R + G++Y H +
Sbjct: 88 PTHLAIIMEYASGGELYERICNAG---RFSED-EARFFFQQLLS-----GVSYCH---SM 135
Query: 800 KIVHRDIKTSNVLLDKD--LNAKISDFGLAKLYEED 833
+I HRD+K N LLD KI DFG +K
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 43/186 (23%), Positives = 79/186 (42%), Gaps = 29/186 (15%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS--SKSRQGNREFVN---------EI 723
+ + + G +G+V G+ S+G +A+K++ + + EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 724 GMISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
+++ HPN++ L V ++L LV E M+ + L++ I D +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVI--HDQRIVISPQ--- 134
Query: 779 RKKICI-GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-- 835
+ + I GL LHE +VHRD+ N+LL + + I DF LA+ D
Sbjct: 135 HIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191
Query: 836 -HISTR 840
+++ R
Sbjct: 192 HYVTHR 197
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 44/254 (17%), Positives = 88/254 (34%), Gaps = 18/254 (7%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171
+ +L + +T Q + ++ + + + + + L +
Sbjct: 20 DDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI 231
GN T I P + L NL L L N +L + L L L L + N S I +
Sbjct: 77 GNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGL 130
Query: 232 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTLIL 289
+++ L++ + + I+ L+ LT L L+ ++ S L + L+ L L
Sbjct: 131 VHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYL 185
Query: 290 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY 349
+K I ++ + + L ++L L N + T L P
Sbjct: 186 SKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 243
Query: 350 IFNSNKNVDISLNN 363
+ ++ +
Sbjct: 244 DDGDYEKPNVKWHL 257
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 44/173 (25%), Positives = 64/173 (36%), Gaps = 9/173 (5%)
Query: 99 LKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKV 158
L L L L QL+L R LT L L + N+L P +
Sbjct: 38 LSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQS-LPLL 95
Query: 159 LTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDL 216
+ L L + N T S+P R L LQ+L L N LP L T L L
Sbjct: 96 GQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKL 153
Query: 217 RISDNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
+++NN + ++P + + + L +Q +SL IP L +
Sbjct: 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHG 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 46/195 (23%), Positives = 73/195 (37%), Gaps = 17/195 (8%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
++PPD+ + L LS N A L T L L + + K+ G +
Sbjct: 24 ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVL 79
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKC 292
L + + L+ +P L +LT L R++ L A L L+ L L
Sbjct: 80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSL--PLGALRGLG--ELQELYLKGN 134
Query: 293 LIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+ +P + KL+ + L+ NNLT L + + L N L +PK F
Sbjct: 135 ELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFF 192
Query: 352 NSNKNVDISLNNFTW 366
S+ L+ W
Sbjct: 193 GSHLLPFAFLHGNPW 207
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 16/151 (10%), Positives = 40/151 (26%), Gaps = 18/151 (11%)
Query: 683 KVGEGGFGSVYKGILSD---GTVIAVKQL---SSKSRQGNREFVNEIGMISAQQHPNLVK 736
G ++ + D +A+ + +E ++ +S P + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
+ L+V E+++ L + +A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIRAMQSLAAAADAAH-- 146
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
R + S V + D + ++
Sbjct: 147 -RAGVALSIDHPSRVRVSIDGDVVLAYPATM 176
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 64/272 (23%), Positives = 99/272 (36%), Gaps = 38/272 (13%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL- 139
C CS+ + +T +P++L R +L L G+FS
Sbjct: 7 CHCSNRVFL-----CQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFS----GFG 54
Query: 140 QLVELSVMGNR-LSGPFPKVLTNITTLKNLSIE-GNLFTGSIPPDI-RKLINLQKLILSS 196
L ++ + N L V +N+ L + IE N I P+ + L NLQ L++S+
Sbjct: 55 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISN 113
Query: 197 NSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPE--FIGKWKKIQKLHIQGSSLEGPIPA 253
LP L I DN I F+G + L + + ++ I
Sbjct: 114 TGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHN 171
Query: 254 SISALTSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKCLIHGEIPDYI-GDMTKL 308
S T L +L +SD F L +++ IH +P Y ++ KL
Sbjct: 172 SAFNGTQLDELNLSDNNNLEELPNDVFHGAS--GPVILDISRTRIH-SLPSYGLENLKKL 228
Query: 309 KNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
+ S NL +P T EKL LT
Sbjct: 229 RA--RSTYNLK-KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 32/213 (15%), Positives = 62/213 (29%), Gaps = 37/213 (17%)
Query: 163 TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISD 220
L I +L+K+ +S N + A+ + L L+++RI
Sbjct: 30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SESAFP 277
N + ++ P + L +L L IS+ +K +
Sbjct: 89 AN-------------NLLYIN----------PEAFQNLPNLQYLLISNTGIKHLPDVHKI 125
Query: 278 KLDKMNLKTLILTKCLIHGEIPDYI--GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
+ L + + I G + + L+ N + + F
Sbjct: 126 HS--LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELN 183
Query: 336 YLTGNKLTGPVPKYIF---NSNKNVDISLNNFT 365
N L +P +F + +DIS
Sbjct: 184 LSDNNNLEE-LPNDVFHGASGPVILDISRTRIH 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 35/249 (14%), Positives = 75/249 (30%), Gaps = 29/249 (11%)
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 199
+ + + N ++ + + L+ L +E I + R L +L L L N F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 200 TGELPAE-LTKLTNLNDLRISDNNF-SGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASI- 255
+L L NL L ++ N + ++ L ++ ++++ PAS
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 256 SALTSLTDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKN 310
+ L ++ + E + L L + +
Sbjct: 151 LNMRRFHVLDLTFNKVKSIC--EEDLLNFQGKHFTLLRL----------------SSITL 192
Query: 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD 370
D++ L K + L+GN + K F++ I + +
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252
Query: 371 PIECPRGSV 379
+
Sbjct: 253 GSSFGHTNF 261
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 51/293 (17%), Positives = 99/293 (33%), Gaps = 54/293 (18%)
Query: 114 KLRYLKQLDLSRNCLT-----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTL--- 165
L L+ L L N + F +++L+ N++ + L N
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLN-MRRFHVLDLT--FNKVKSICEEDLLNFQGKHFT 183
Query: 166 -------KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLR- 217
+ + K ++ L LS N F + ++
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243
Query: 218 ------------ISDNNFSGKIPE--FIG-KWKKIQKLHIQGSSLEGPIPASI-SALTSL 261
NF F G + ++ + S + + S+ S T L
Sbjct: 244 LILSNSYNMGSSFGHTNFK-DPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDL 301
Query: 262 TDL-----RISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSF 315
L I+ + ++AF L +L L L++ + G I + + + KL+ +DLS+
Sbjct: 302 EQLTLAQNEINKI--DDNAFWGLT--HLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSY 356
Query: 316 NNLTGGIPT-TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNF 364
N++ + +F L + L N+L VP IF+ + + + N +
Sbjct: 357 NHIRA-LGDQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 54/280 (19%), Positives = 93/280 (33%), Gaps = 40/280 (14%)
Query: 107 TLPTE-LSKLRYLKQLDLSRNCLTGSFSPQ--WASL-QLVELSVMGNRLSGPFPK-VLTN 161
L T + L L+ L L++ L G+ + L L L + N + P N
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152
Query: 162 ITTLKNLSIEGNLFTGSIPPDI-----------RKLINLQKLILSSNSFTGELPAELTKL 210
+ L + N SI + +L ++ ++ E K
Sbjct: 153 MRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKL--------HIQGSSLEGPIPASISALT--- 259
T++ L +S N F + + K+ + GSS T
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271
Query: 260 -SLTDLRISDLKG------SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNI 311
+ ++ DL +S F +L+ L L + I+ +I D +T L +
Sbjct: 272 LEASGVKTCDLSKSKIFALLKSVFSHFT--DLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328
Query: 312 DLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351
+LS N L FE L K + L+ N + + F
Sbjct: 329 NLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSF 367
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 35/258 (13%), Positives = 78/258 (30%), Gaps = 46/258 (17%)
Query: 163 TTLKNLSIEGNLFTGSIPP-DIRKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLRISD 220
+ + + N + +L +LQ L + + + L++L L++
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGS---ESA 275
N + +L + + L +L L ++ L G+ +
Sbjct: 89 N--------------QFLQLE----------TGAFNGLANLEVLTLTQCNLDGAVLSGNF 124
Query: 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 334
F L +L+ L+L I P M + +DL+FN + +F
Sbjct: 125 FKPLT--SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHF 182
Query: 335 --MYLTGNKLT-------GPVPKYIFNSNKNVDI-SLNNFTWESSDPIECPRGSVNLVES 384
+ L+ L G N ++ L+ ++ S + ++ +
Sbjct: 183 TLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES-MAKRFFDAIAGTKI 241
Query: 385 YSSPRNKLDKVHPCLRQN 402
S + +
Sbjct: 242 QSLILSNSYNMGSSFGHT 259
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 43/260 (16%), Positives = 80/260 (30%), Gaps = 37/260 (14%)
Query: 113 SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMG-----------NRLSGPFPKVLTN 161
+R LDL+ N + + Q +++ L
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLI-------------LSSNSFTGELPAELT 208
T++ L + GN F S+ I K+ +F
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
Query: 209 KL--TNLNDLRISDNNFSGKIPEFIGKW-KKIQKLHIQGSSLEGPIPASI-SALTSLTDL 264
L + + +S + + + + +++L + + + I + LT L L
Sbjct: 271 GLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328
Query: 265 RISD--LKG-SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTG 320
+S L F LD L+ L L+ I + D + LK + L N L
Sbjct: 329 NLSQNFLGSIDSRMFENLD--KLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKS 385
Query: 321 GIPTTFEKLAKTNFMYLTGN 340
F++L ++L N
Sbjct: 386 VPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 26/129 (20%), Positives = 54/129 (41%), Gaps = 16/129 (12%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFP 156
L ++ + + L L L++N + +F L L++L++ N L
Sbjct: 288 FALLKSVFSHFTDLEQL---TLAQNEINKIDDNAF----WGLTHLLKLNLSQNFLGSIDS 340
Query: 157 KVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE-LTKLTNLN 214
++ N+ L+ L + N ++ L NL++L L +N +P +LT+L
Sbjct: 341 RMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQ 398
Query: 215 DLRISDNNF 223
+ + N +
Sbjct: 399 KIWLHTNPW 407
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 38/181 (20%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 724
+ ++ + +G G +G V + + V+A+K++ R F + EI
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 725 MISAQQHPNLVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 779
+++ H ++VK+ + ++L +V E ++ + T L
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKKLF---RTPVYLTEL--HI 158
Query: 780 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
K + + G+ Y+H I+HRD+K +N L+++D + K+ DFGLA+ + + S
Sbjct: 159 KTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 840 R 840
Sbjct: 216 L 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 4e-14
Identities = 50/181 (27%), Positives = 73/181 (40%), Gaps = 25/181 (13%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
+ F +G GGFG V+ + G + A K+L+ K R+G + + E +++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR--- 788
+V L L LV M G D Y + A
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMN---------GGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 789 -----GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
GL +LH+ I++RD+K NVLLD D N +ISD GLA + +T AG
Sbjct: 296 AQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AG 351
Query: 844 T 844
T
Sbjct: 352 T 352
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 44/185 (23%), Positives = 73/185 (39%), Gaps = 37/185 (20%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN---------EIG 724
+ +G G G V + +A+K+LS R F N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 725 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
++ H N++ L E + +V E M N L + I +++LD
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHER 128
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT--- 835
+ + G+ +LH I+HRD+K SN+++ D KI DFGLA+
Sbjct: 129 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185
Query: 836 HISTR 840
++ TR
Sbjct: 186 YVVTR 190
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 47/190 (24%), Positives = 75/190 (39%), Gaps = 26/190 (13%)
Query: 661 LQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKS--RQ 714
LQ + K +F +GEG F +V + A+K L + ++
Sbjct: 15 LQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKE 71
Query: 715 GNREFVN-EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTE 769
+V E ++S HP VKLY + +L Y KN + + G E
Sbjct: 72 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDE 129
Query: 770 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829
+ I L YLH I+HRD+K N+LL++D++ +I+DFG AK+
Sbjct: 130 TCTRF-------YTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 179
Query: 830 YEEDKTHIST 839
+
Sbjct: 180 LSPESKQARA 189
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 42/183 (22%), Positives = 77/183 (42%), Gaps = 34/183 (18%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 724
+ VG G +G+V + G +A+K+L R F + E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 725 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
++ +H N++ L + LV +M + L + + KL
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLM------KHEKLGEDR 129
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HI 837
+ + + +GL Y+H I+HRD+K N+ +++D KI DFGLA+ + + T ++
Sbjct: 130 IQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV 186
Query: 838 STR 840
TR
Sbjct: 187 VTR 189
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 46/185 (24%), Positives = 73/185 (39%), Gaps = 37/185 (20%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 724
+ +G G G V +A+K+LS R F N E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 725 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 778
++ H N++ L E + LV E M N L + I +++LD
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-------QMELDHER 165
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT--- 835
+ + G+ +LH S I+HRD+K SN+++ D KI DFGLA+
Sbjct: 166 MSYLLYQMLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222
Query: 836 HISTR 840
++ TR
Sbjct: 223 YVVTR 227
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 36/184 (19%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN---------EIG 724
+ + VG G +GSV + G +AVK+LS R F + E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 725 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWP 777
++ +H N++ L E N + LV M + L+ + + T+ ++
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQF--- 136
Query: 778 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-H 836
+ I RGL Y+H S I+HRD+K SN+ +++D KI DFGLA+ ++ T +
Sbjct: 137 ----LIYQILRGLKYIH--SA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 837 ISTR 840
++TR
Sbjct: 190 VATR 193
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 39/171 (22%), Positives = 76/171 (44%), Gaps = 21/171 (12%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQH 731
+ + +GEG +G V + +A+K++S R EI ++ +H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 84
Query: 732 PNLVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRKKICIG 785
N++ + + + +V + M+ + L + + + + +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICY-------FLYQ 136
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
I RGL Y+H + ++HRD+K SN+LL+ + KI DFGLA++ + D H
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 44/183 (24%), Positives = 81/183 (44%), Gaps = 32/183 (17%)
Query: 676 NNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFV----NEIGMIS 727
++F+ +G+G FG V + A+K ++ K + R V E+ ++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMN-KQKCVERNEVRNVFKELQIMQ 70
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKIC 783
+HP LV L+ + + +V + + L + E +KL + IC
Sbjct: 71 GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKL-F-----IC 122
Query: 784 -IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA 842
+ +A L YL +I+HRD+K N+LLD+ + I+DF +A + + + +A
Sbjct: 123 ELVMA--LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MA 175
Query: 843 GTM 845
GT
Sbjct: 176 GTK 178
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 47/302 (15%), Positives = 96/302 (31%), Gaps = 22/302 (7%)
Query: 55 DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSK 114
N V+ + +D+ + ++ + L+ T +L +
Sbjct: 212 QVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQ 271
Query: 115 L---RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMG------NRLSGPFPKVLTNITTL 165
R ++ L++ +T + + L + + + +
Sbjct: 272 FFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEM 331
Query: 166 K--NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
LSI F + P + L + N FT + + L L L + N
Sbjct: 332 NIKMLSISDTPFIHMVCPPS--PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
Query: 224 SGKIPEFIGKWKKIQKLHIQGSSL----EGPIPASISALTSLTDLRISDLKGSESAFPKL 279
+ K + L SL + + S+ L +S + S F L
Sbjct: 390 K-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLT 338
+K L L I IP + + L+ ++++ N L +P F++L +++L
Sbjct: 449 -PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505
Query: 339 GN 340
N
Sbjct: 506 DN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 9e-13
Identities = 39/246 (15%), Positives = 89/246 (36%), Gaps = 16/246 (6%)
Query: 118 LKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP-----FPKVLTNITTLKNLSIEG 172
L+ ++ + C F W + L++ ++ F T + +L ++
Sbjct: 256 LQHIETTWKCSVKLFQFFWPR-PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314
Query: 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG 232
+F S + +LS + ++ L + N F+ + +
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCS 374
Query: 233 KWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG---SESAFPKL--DKMNLKTL 287
K++Q L +Q + L+ +++ L D+ + A+ + ++ L
Sbjct: 375 TLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL 433
Query: 288 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 347
L+ ++ G + + K+K +DL N + IP L + + N+L VP
Sbjct: 434 NLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKS-VP 489
Query: 348 KYIFNS 353
+F+
Sbjct: 490 DGVFDR 495
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 35/191 (18%), Positives = 64/191 (33%), Gaps = 10/191 (5%)
Query: 158 VLTNI-TTLKNLSIEGNLFTGSIPP-DIRKLINLQKLILSSNSFTGELPAEL-TKLTNLN 214
V ++ K LS+ N + + DI L L+ L LS N L + +L
Sbjct: 46 VPKDLPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLE 103
Query: 215 DLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLTDLRISDLKGSE 273
L +S N I ++ L + + + P+ LT LT L +S K +
Sbjct: 104 YLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160
Query: 274 SAFPKLDKMNLKTLIL-TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332
+ ++L ++L + + L F+ + +
Sbjct: 161 LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNAL 220
Query: 333 NFMYLTGNKLT 343
+ L+ KL
Sbjct: 221 GHLQLSNIKLN 231
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 52/333 (15%), Positives = 107/333 (32%), Gaps = 39/333 (11%)
Query: 80 ESNVTCDCSSATCHVV--TIALKAQNL-------TGTLPTELSKLRYLKQLDLSRNCLT- 129
E D S+ V + + + L + ++S L L+ L LS N +
Sbjct: 31 ELESMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS 90
Query: 130 ---GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPP--DIR 184
F L L V NRL + + L++L + N F +P +
Sbjct: 91 LDFHVFLFNQ---DLEYLDVSHNRLQNISCCPMAS---LRHLDLSFNDFD-VLPVCKEFG 143
Query: 185 KLINLQKLILSSNSFTGELPAELTKL-TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ 243
L L L LS+ F + L + L + + G E + LH+
Sbjct: 144 NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQI-PNTTVLHLV 202
Query: 244 GSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM------NLKTLILTKCLIHGE 297
++ +L L++S++K ++ +L L +T I
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262
Query: 298 IPDYIGDM-----TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPV----PK 348
+ ++ +++ +T I ++T L + V +
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 349 YIFNSNKNVDISLNNFTWESSDPIECPRGSVNL 381
+++ ++I + + + + CP +
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSF 355
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 32/116 (27%), Positives = 55/116 (47%), Gaps = 9/116 (7%)
Query: 112 LSKLRYLKQLDLSRNCLT-GSFSP--QWASLQLVELSVMGNRLSGPFPKVLTNITTLKNL 168
+ L+ LD+S N L ++ WA ++ L++ N L+G + L +K L
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAE-SILVLNLSSNMLTGSVFRCLP--PKVKVL 455
Query: 169 SIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNF 223
+ N SIP D+ L LQ+L ++SN +P +LT+L + + DN +
Sbjct: 456 DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 7e-13
Identities = 52/179 (29%), Positives = 74/179 (41%), Gaps = 24/179 (13%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
N F +G+GGFG V + G + A K+L K R+G +NE ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT-----RKKICIG- 785
+V L + L LV M G D ++ + R
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMN---------GGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
I GL LH + +IV+RD+K N+LLD + +ISD GLA E +T I R GT
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGR-VGT 348
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 33/233 (14%), Positives = 71/233 (30%), Gaps = 35/233 (15%)
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSF 199
L ++ L +N+ + + + ++ + L + + + +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 200 TGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
+ + L +L L L I + ++ P + +
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNT--------------GLKMF---------PDLTKVYST 129
Query: 259 TSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 314
L I+D +AF L TL L + Y + TKL + L+
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNE-TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187
Query: 315 FNNLTGGIPT-TFEKLAKT-NFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
N I F + + + ++ +T +P K + I+ N +T
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSKGLEHLKEL-IARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 39/195 (20%), Positives = 67/195 (34%), Gaps = 43/195 (22%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
S+PP + Q L L +P+ + L N++ + +S +
Sbjct: 28 SLPP------STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDV-------------T 67
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG----SESAFPKLDKMNLKTLILTKC 292
+Q+L S L+ +T + I + + A +L LK L +
Sbjct: 68 LQQLE----------SHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP--LLKFLGIFNT 115
Query: 293 LIHGEIPDY--IGDMTKLKNIDLSFNNLTGGIPT-TFEKLAK-TNFMYLTGNKLTGPVPK 348
+ PD + ++++ N IP F+ L T + L N T V
Sbjct: 116 GLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQG 173
Query: 349 YIFNSNKNVDISLNN 363
Y FN K + LN
Sbjct: 174 YAFNGTKLDAVYLNK 188
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 45/196 (22%), Positives = 76/196 (38%), Gaps = 41/196 (20%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKS--RQGNREFVN 721
++Q++ +F+ +G G FG V K V A+K L+ ++
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFR 122
Query: 722 -EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDW 776
E ++ + L+ + N L LV +Y LS+ E RL +
Sbjct: 123 EERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF------EDRLPEEM 176
Query: 777 PTRKKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
AR + +H+ + VHRDIK N+L+D + + +++DFG
Sbjct: 177 ----------ARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 829 LYEEDKTHISTRIAGT 844
ED T S+ GT
Sbjct: 224 KLMEDGTVQSSVAVGT 239
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 38/169 (22%), Positives = 81/169 (47%), Gaps = 21/169 (12%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQH 731
+++F + +GEG +G V G ++A+K++ K R EI ++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKH 68
Query: 732 PNLVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRKKICIG 785
N++ ++ N++ ++ E M+ + L R I + ++ ++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTD-LHRVISTQMLSDDHIQY-------FIYQ 120
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
R + LH + ++HRD+K SN+L++ + + K+ DFGLA++ +E
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 42/179 (23%), Positives = 81/179 (45%), Gaps = 32/179 (17%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS-KSRQGNREFVNEIGMISA---- 728
+++ K+G G + V++ I +++ + VK L K ++ RE I
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-------IKILENL 87
Query: 729 QQHPNLVKLYGCCV---EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
+ PN++ L V LV+E++ NN + ++ T+Y ++
Sbjct: 88 RGGPNIITLA-DIVKDPVSRTPALVFEHV-NNTDFKQLYQTLTDYDIR-------FYMYE 138
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKT---HISTR 840
I + L Y H S I+HRD+K NV++D + ++ D+GLA+ Y + +++R
Sbjct: 139 ILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 194
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 46/179 (25%), Positives = 84/179 (46%), Gaps = 28/179 (15%)
Query: 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 733
+ + +G GG G V+ + +D +A+K++ Q + + EI +I H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 734 LVKLY--------------GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPT 778
+VK++ G E N + +V EYM+ + L+ + E +L
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQGPLLEEHARL---- 124
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTH 836
+ RGL Y+H + ++HRD+K +N+ ++ +DL KI DFGLA++ + +H
Sbjct: 125 ---FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 41/179 (22%), Positives = 81/179 (45%), Gaps = 35/179 (19%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 724
+N+ + +G G +G VY + +A+K+++ R F + EI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77
Query: 725 MISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWP 777
+++ + +++LY + + ++L +V E ++ L + TE +K
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-LKKLFKTPIFLTEEHIKT--- 133
Query: 778 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
I + G ++HE I+HRD+K +N LL++D + K+ DFGLA+ +K
Sbjct: 134 ----ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 40/216 (18%)
Query: 160 TNI-TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDL 216
+NI K L ++ N + S+P +L L+ L L+ N LPA + +L NL L
Sbjct: 33 SNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETL 90
Query: 217 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD--LKG-S 272
++DN K+Q L P + L +L +LR+ LK
Sbjct: 91 WVTDN--------------KLQAL-----------PIGVFDQLVNLAELRLDRNQLKSLP 125
Query: 273 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAK 331
F L L L L + +P + D +T LK + L N L F+KL +
Sbjct: 126 PRVFDSL--TKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTE 182
Query: 332 TNFMYLTGNKLTGPVPKYIFNSNKNV-DISLNNFTW 366
+ L N+L VP+ F+S + + + L W
Sbjct: 183 LKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQENPW 217
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 44/174 (25%), Positives = 72/174 (41%), Gaps = 15/174 (8%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPK 157
L+ +L L+ L L+ N L G F L L L V N+L
Sbjct: 48 KLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFK----ELKNLETLWVTDNKLQALPIG 103
Query: 158 VLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLND 215
V + L L ++ N S+PP + L L L L N LP + KLT+L +
Sbjct: 104 VFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKE 161
Query: 216 LRISDNNFSGKIPEFI-GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
LR+ +N ++PE K +++ L + + L+ + +L L L++ +
Sbjct: 162 LRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 45/193 (23%), Positives = 73/193 (37%), Gaps = 37/193 (19%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNRE----F 719
+R ++ +++ +G G FG V K V A+K LS K R F
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLS-KFEMIKRSDSAFF 116
Query: 720 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 779
E +++ P +V+L+ + L +V EYM G D +
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP---------GGDLVNLMS-----N 162
Query: 780 KKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831
+ AR L +H + +HRD+K N+LLDK + K++DFG
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 832 EDKTHISTRIAGT 844
++ GT
Sbjct: 220 KEGMVRCDTAVGT 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 31/178 (17%)
Query: 672 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFV----NEI 723
A + FD +G G FG V K G A+K L K + + + NE
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILD-KQKVVKLKQIEHTLNEK 92
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTR 779
++ A P LVKL + + L +V EY+ + L R G+ +E
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPH-------- 142
Query: 780 KKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
+ I YLH + +++RD+K N+L+D+ +++DFG AK + +T
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTW 196
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 44/180 (24%), Positives = 65/180 (36%), Gaps = 31/180 (17%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
NF K+G G FG + G L +A+K KSR +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDGI 67
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK---KICIGIA---- 787
++Y G +V E + G E D R K + IA
Sbjct: 68 PQVYYFGPCGKYNAMVLELL----------GPSLED--LFDLCDRTFSLKTVLMIAIQLI 115
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK-----ISDFGLAKLYEEDKT--HISTR 840
+ Y+H + +++RD+K N L+ + N I DF LAK Y + +T HI R
Sbjct: 116 SRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 43/175 (24%), Positives = 79/175 (45%), Gaps = 32/175 (18%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 724
++ K+G+G +G V+K I G V+AVK++ F N EI
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 725 MISA-QQHPNLVKLYGCCV--EGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRK 780
+++ H N+V L + LV++YM+ + L I +
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD-LHAVIRANILEPVHKQY------ 113
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
+ + + + YLH S ++HRD+K SN+LL+ + + K++DFGL++ + +
Sbjct: 114 -VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 43/197 (21%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNRE----F 719
L++++ ++F+ +G G F V K G V A+K ++ K R F
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMN-KWDMLKRGEVSCF 108
Query: 720 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLD 775
E ++ + +L+ + N L LV EY LS+ R+ +
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF------GERIPAE 162
Query: 776 WPTRKKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827
AR + +H + VHRDIK N+LLD+ + +++DFG
Sbjct: 163 M----------ARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSC 209
Query: 828 KLYEEDKTHISTRIAGT 844
D T S GT
Sbjct: 210 LKLRADGTVRSLVAVGT 226
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 27/176 (15%)
Query: 672 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKS--RQGNREFV-NEIG 724
K + +F +G G FG V+ + +G A+K L + R E +E
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRK 780
M+S HP +++++G + Q+ ++ +Y++ + L ++ + K
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKF------ 110
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
+ L YLH I++RD+K N+LLDK+ + KI+DFG AK Y D T+
Sbjct: 111 -YAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-YVPDVTY 161
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 46/178 (25%), Positives = 70/178 (39%), Gaps = 27/178 (15%)
Query: 672 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREF---VNEIG 724
+ N F+ +G+G FG V K G A+K L + E + E
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRK 780
++ +HP L L ++L V EY G + + L +
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYAN---------GGELFFHLSRERVFSEDRAR 251
Query: 781 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTH 836
I L YLH S +V+RD+K N++LDKD + KI+DFGL K + +
Sbjct: 252 FYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 307
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 42/170 (24%), Positives = 67/170 (39%), Gaps = 27/170 (15%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGC 740
K+G G FG +Y G ++ G +A+K K++ E + Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-----KLDWPTRKKICIGIARGLAYLHE 795
EG+ ++V E + G E K T + + + Y+H
Sbjct: 74 GAEGDYNVMVMELL----------GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAK---ISDFGLAKLYEEDKT--HISTR 840
+ +HRD+K N L+ I DFGLAK Y + +T HI R
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 45/228 (19%), Positives = 77/228 (33%), Gaps = 67/228 (29%)
Query: 682 NKVGEGGFGSVYKGIL------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 733
+G G FG V + + +AVK L + +R ++E+ +I H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 734 LVKLYGCC-VEGNQLLLVYEYMKNNCLS--------------------------RAIFGK 766
+V L G C G L+++ E+ K LS
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 767 DTEYRLKLDWPTRKKICIGI--ARGLAYLHEDSRIKIVHRDIKTSNVLLD---------- 814
D + RL ++ G + L+ + E+ + +++D T L+
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 815 ---------KDLNA-----------KISDFGLAKLYEEDKTHISTRIA 842
+DL A KI DFGLA+ +D ++ A
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 1e-10
Identities = 44/182 (24%), Positives = 78/182 (42%), Gaps = 32/182 (17%)
Query: 672 KAATNNFDPANKVGEGGFGSVY---KGILSD-GTVIAVKQLSSKSRQGNREFV----NEI 723
K F+ +G+GG+G V+ K ++ G + A+K L N + E
Sbjct: 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWP 777
++ +HP +V L G +L L+ EY+ G + E D
Sbjct: 73 NILEEVKHPFIVDLIYAFQTGGKLYLILEYLS---------GGELFMQLEREGIFMED-- 121
Query: 778 TRKKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDK 834
+ I+ L +LH+ I++RD+K N++L+ + K++DFGL K +++
Sbjct: 122 -TACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177
Query: 835 TH 836
TH
Sbjct: 178 TH 179
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 26/186 (13%), Positives = 58/186 (31%), Gaps = 33/186 (17%)
Query: 676 NNFDPANKVGEGGFGSVYKGI---------LSDGTVIAVKQLSSKSRQGNREFVNEIGMI 726
+ + G +Y+ ++K L +K + E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI----FGKDTEYRLKLDWPTRKK- 781
Q KLY + + + + R + G+ + LD +
Sbjct: 101 KPLQVNKWKKLYSTPLLA--IPTCMGFGVHQDKYRFLVLPSLGRSLQS--ALDVSPKHVL 156
Query: 782 -----ICIG---IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI--SDFGLAKLYE 831
+ + + L +LHE+ VH ++ N+ +D + +++ + +G A Y
Sbjct: 157 SERSVLQVACRLLDA-LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 832 EDKTHI 837
H+
Sbjct: 213 PSGKHV 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 32/181 (17%)
Query: 672 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVN---EIG 724
KA + F+ +G+G FG V+ + A+K L K+ R+ V E
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERD 78
Query: 725 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWPT 778
++ HP +VKL+ +L L+ ++++ G D E +
Sbjct: 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLR---------GGDLFTRLSKEVMFTEE--- 126
Query: 779 RKKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKT 835
K + +A L +LH + I++RD+K N+LLD++ + K++DFGL+K + E K
Sbjct: 127 DVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183
Query: 836 H 836
+
Sbjct: 184 Y 184
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 36/210 (17%)
Query: 647 GGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY---KGILSD-GTV 702
GG +L+T T K NF+ +G G +G V+ K D G +
Sbjct: 25 GGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL 84
Query: 703 IAVKQLSSKSRQGNREFV------NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756
A+K L + + ++ + +Q P LV L+ +L L+ +Y+
Sbjct: 85 YAMKVLKKATIVQKAKTTEHTRTERQV-LEHIRQSPFLVTLHYAFQTETKLHLILDYIN- 142
Query: 757 NCLSRAIFGKD------TEYRLKLDWPTRKKICIG-IARGLAYLHEDSRIKIVHRDIKTS 809
G + R +I +G I L +LH+ + I++RDIK
Sbjct: 143 --------GGELFTHLSQRERFTEH---EVQIYVGEIVLALEHLHK---LGIIYRDIKLE 188
Query: 810 NVLLDKDLNAKISDFGLAKL---YEEDKTH 836
N+LLD + + ++DFGL+K E ++ +
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETERAY 218
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 42/173 (24%), Positives = 66/173 (38%), Gaps = 31/173 (17%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
++GEG FG +++G L + +A+K +S + +Y
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTGIPNVYYFG 75
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK---KICIGIA----RGLAYLH 794
EG +LV + + G E LD RK K A + +H
Sbjct: 76 QEGLHNVLVIDLL----------GPSLED--LLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAK-----ISDFGLAKLYEEDKT--HISTR 840
E S +V+RDIK N L+ + + + DFG+ K Y + T HI R
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 41/259 (15%), Positives = 83/259 (32%), Gaps = 20/259 (7%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
L + +L + +T Q + + + + + T LK L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELH 69
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
+ N + + P ++ L L++L ++ N L+ L + +N +
Sbjct: 70 LSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRD--TD 122
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTL 287
+ K ++ L I+ + L+ SI L L+ L + DL G+E + L ++ + +
Sbjct: 123 SLIHLKNLEILSIRNNKLK-----SIVMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWI 177
Query: 288 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG-PV 346
LT E Y ++ + P +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVYTDE 235
Query: 347 PKYIFNSNKNVDISLNNFT 365
Y F+ NV + F
Sbjct: 236 VSYKFSEYINVGETEAIFD 254
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 52/183 (28%), Positives = 74/183 (40%), Gaps = 31/183 (16%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVNEIG 724
QIK +F +G+G FG V +K A+K L K + V
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALK-KDVVLMDDDVECTM 65
Query: 725 M-----ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLD 775
+ A +HP L ++ L V EY+ G D Y + K D
Sbjct: 66 VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN---------GGDLMYHIQSCHKFD 116
Query: 776 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEED 833
I GL +LH IV+RD+K N+LLDKD + KI+DFG+ K + +
Sbjct: 117 LSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173
Query: 834 KTH 836
KT+
Sbjct: 174 KTN 176
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 46/175 (26%), Positives = 70/175 (40%), Gaps = 45/175 (25%)
Query: 684 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIG----MISAQQHPNLV 735
+G+G FG V K + AVK L K+ +E + + ++ +HP LV
Sbjct: 46 IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 736 KLYGCCVEGNQLLLVYEYM----------KNNCLS--RAIFGKDTEYRLKLDWPTRKKIC 783
L+ ++L V +Y+ + C RA F Y
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-----Y------------A 145
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTH 836
IA L YLH + IV+RD+K N+LLD + ++DFGL K + T
Sbjct: 146 AEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS 197
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 31/180 (17%)
Query: 672 KAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM-- 725
+ +F+ +G+G FG V KG + AVK L K + V +
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILK-KDVVIQDDDVECTMVEK 392
Query: 726 ---ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPT 778
+ P L +L+ C ++L V EY+ G D Y + + P
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN---------GGDLMYHIQQVGRFKEPH 443
Query: 779 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTH 836
IA GL +L I++RD+K NV+LD + + KI+DFG+ K +++ T
Sbjct: 444 AVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK 500
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 44/170 (25%), Positives = 70/170 (41%), Gaps = 27/170 (15%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGC 740
K+G G FG +Y G + +A+K + K++ + + + E + Q + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-----KLDWPTRKKICIGIARGLAYLHE 795
VEG+ +LV + + G E KL T + + + ++H
Sbjct: 72 GVEGDYNVLVMDLL----------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAK---ISDFGLAKLYEEDKT--HISTR 840
S +HRDIK N L+ A I DFGLAK Y + T HI R
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 9e-10
Identities = 86/569 (15%), Positives = 169/569 (29%), Gaps = 178/569 (31%)
Query: 35 KLH---AEEVKALKQIGRKLGKKDWNF--GVDPCSQKGNWELSSD---DKK---GFESNV 83
K + + L+Q +L GV G ++ D K + +
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS---GKTWVALDVCLSYKVQCKMDFKI 184
Query: 84 ------TCDCSSAT-------CHVVTIALKAQ-NLTGTLPTEL----SKLRYLKQLDLSR 125
C+ + + ++ + + + + ++LR L +
Sbjct: 185 FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 126 NCLTGSFSPQWASLQLVELSVMGNRLSGPFP---KVLTNITTLKNLSIEGNLFTGSIPPD 182
NCL LV L+V + F K+L +TT + + T +
Sbjct: 245 NCL------------LVLLNVQNAKAWNAFNLSCKIL--LTT-RFKQV-----TDFLSAA 284
Query: 183 IRKLINLQKL-----------ILSS--NSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229
I+L +L + +LP E+ N R+S + I +
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT---NPRRLS--IIAESIRD 339
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR--ISDLKGSESAFPKLDKMNLKTL 287
+ W + H+ L I +S++ L + R L S FP + L
Sbjct: 340 GLATWDNWK--HVNCDKLTTIIESSLNVLEP-AEYRKMFDRL----SVFPPSAHIPTILL 392
Query: 288 ILTKCLIHGEIPDYIGD--MTKLKN---IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 342
LI ++ + KL ++ T IP+ +YL +L
Sbjct: 393 ----SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS----------IYL---EL 435
Query: 343 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 402
+ + +L+ ++V+ Y+ P+ +
Sbjct: 436 KVKLEN---------EYALHR----------------SIVDHYNIPK--------TFDSD 462
Query: 403 FPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMF---Y-----------SSG 448
DQY Y+ HI GH + R ++F +
Sbjct: 463 DLIPPYLDQYFYS-HI---------GHHLKNIEHPER-MTLFRMVFLDFRFLEQKIRHDS 511
Query: 449 QYWAFSSTGKFMDDDTDLDNY---IRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCL 505
W +++G ++ L Y I N ++ + + L L
Sbjct: 512 TAW--NASGSILNTLQQLKFYKPYICDNDPKYERLVN-AILDF---------LPKIEENL 559
Query: 506 GNGNYTVRLHFAEIIFKNDSTFNSLGKRI 534
YT L A ++ ++++ F K++
Sbjct: 560 ICSKYTDLLRIA-LMAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 6e-06
Identities = 57/341 (16%), Positives = 98/341 (28%), Gaps = 103/341 (30%)
Query: 532 KRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTS-----HTLKI--------HL 578
K I ++ +F+ +D V++ P + S H + L
Sbjct: 19 KDILSVFEDA--FVDNFDCKD---------VQDMPKSILSKEEIDHIIMSKDAVSGTLRL 67
Query: 579 YWA--GRGTTGI------PLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASV 630
+W + + LR Y L+S I + +P S + I +
Sbjct: 68 FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR-QP----SMMTRMYIEQRDRLYND 122
Query: 631 LLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKV---GEG 687
V + R + L L+ L LR PA V G
Sbjct: 123 NQVFAKYNVSRLQ-----PY--------LKLRQALLELR----------PAKNVLIDGVL 159
Query: 688 GFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747
G G K T +A+ S Q + +I ++ C +
Sbjct: 160 GSG---K------TWVALDVCLSYKVQ--CKMDFKIFWLN----------LKNCNSPETV 198
Query: 748 L-----LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802
L L+Y+ N SR+ + + R+ R L +V
Sbjct: 199 LEMLQKLLYQIDPNWT-SRSDHSSNIKLRIH-SIQAEL-------RRLLKSKPYENCLLV 249
Query: 803 HRDIKTSNVLLDKDLNAKI----SDFGLA-KLYEEDKTHIS 838
+++ + +L+ KI + L THIS
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 32/142 (22%), Positives = 50/142 (35%), Gaps = 16/142 (11%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 166
++L L L LS N L +F + L L + N L + +++ L+
Sbjct: 60 PTRLTNLHSLLLSHNHLNFISSEAFV----PVPNLRYLDLSSNHLHTLDEFLFSDLQALE 115
Query: 167 NLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAE----LTKLTNLNDLRISDN 221
L + N + + + LQKL LS N + P E KL L L +S N
Sbjct: 116 VLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSN 173
Query: 222 NFSGKIPEFIGKWKKIQKLHIQ 243
+ K K +
Sbjct: 174 KLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 43/198 (21%), Positives = 71/198 (35%), Gaps = 43/198 (21%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAE--LTKLTNLNDLRISDNNFSGKIPEFIGKWK 235
++P + L LS N+ + L AE T+LTNL+ L +S N
Sbjct: 32 NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHN-------------- 74
Query: 236 KIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SESAFPKLDKMNLKTLILTKC 292
+ + + + +L L +S L E F L L+ L+L
Sbjct: 75 HLNFIS----------SEAFVPVPNLRYLDLSSNHLHTLDEFLFSDL--QALEVLLLYNN 122
Query: 293 LIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTF---EKLAKTNFMYLTGNKLTGPVPK 348
I + DM +L+ + LS N ++ KL K + L+ NKL +P
Sbjct: 123 HIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK-LPL 180
Query: 349 YIFN---SNKNVDISLNN 363
+ + L+N
Sbjct: 181 TDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 31/123 (25%), Positives = 45/123 (36%), Gaps = 16/123 (13%)
Query: 112 LSKLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLK 166
+ L+ LDLS N L FS L L L + N + ++ L+
Sbjct: 84 FVPVPNLRYLDLSSNHLHTLDEFLFS----DLQALEVLLLYNNHIVVVDRNAFEDMAQLQ 139
Query: 167 NLSIEGNLFTGSIPPDI----RKLINLQKLILSSNSFTGELPAELTKLTNL--NDLRISD 220
L + N + P ++ KL L L LSSN +L KL N L + +
Sbjct: 140 KLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
Query: 221 NNF 223
N
Sbjct: 199 NPL 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 35/181 (19%), Positives = 64/181 (35%), Gaps = 37/181 (20%)
Query: 683 KVGEGGFGSVYKGILSDGTVI------AVKQLSSKSRQ-----------GNREFVNEIGM 725
+G+GGFG +Y ++ + VK S + E + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 726 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK----- 780
++ + K +G + + FG D + + ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKN------GKSYRFMIMDRFGSDLQK--IYEANAKRFSRKT 153
Query: 781 --KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI--SDFGLAKLYEEDKTH 836
++ + I L Y+HE VH DIK SN+LL+ ++ D+GLA Y + H
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 837 I 837
Sbjct: 211 K 211
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 49/179 (27%), Positives = 71/179 (39%), Gaps = 30/179 (16%)
Query: 672 KAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVN----EI 723
K N+FD +G+G FG V K G A+K L K ++ V E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILR-KEVIIAKDEVAHTVTES 56
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTR 779
++ +HP L L ++L V EY G + + L
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN---------GGELFFHLSRERVFTEERA 107
Query: 780 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTH 836
+ I L YLH +V+RDIK N++LDKD + KI+DFGL K + +
Sbjct: 108 RFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 33/176 (18%), Positives = 61/176 (34%), Gaps = 30/176 (17%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ--------------GNREFVNEIGMIS 727
K+G GGFG +Y + A + + ++ ++ + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKIC 783
+ + YG G Y + G D + T ++
Sbjct: 104 QLDYLGIPLFYGS---GLTEFKGRSY---RFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI--SDFGLAKLYEEDKTHI 837
I + L Y+HE+ VH DIK +N+LL ++ +D+GL+ Y + H
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 44/168 (26%), Positives = 70/168 (41%), Gaps = 31/168 (18%)
Query: 684 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIGM-----ISAQQHPNL 734
+G+G FG V K G + AVK L K + V A+ HP L
Sbjct: 31 LGKGSFGKVMLARVKE---TGDLYAVKVLK-KDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGL 790
+L+ C ++L V E++ G D + + + D + I L
Sbjct: 87 TQLFCCFQTPDRLFFVMEFVN---------GGDLMFHIQKSRRFDEARARFYAAEIISAL 137
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTH 836
+LH+ I++RD+K NVLLD + + K++DFG+ K + T
Sbjct: 138 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA 182
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 29/167 (17%)
Query: 684 VGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVNEIG----MISAQQHPNLV 735
+G+G FG V KG + AVK L + + + + + P L
Sbjct: 28 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGLA 791
+L+ C ++L V EY+ G D Y + + P IA GL
Sbjct: 85 QLHSCFQTMDRLYFVMEYVN---------GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTH 836
+L I++RD+K NV+LD + + KI+DFG+ K +++ T
Sbjct: 136 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK 179
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 31/160 (19%), Positives = 58/160 (36%), Gaps = 25/160 (15%)
Query: 85 CDCSSAT--CH--------------VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCL 128
C CS+ C + I L+ + P S + L+++DLS N +
Sbjct: 9 CTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI 68
Query: 129 T----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI- 183
+ +F L L + GN+++ + + +L+ L + N + D
Sbjct: 69 SELAPDAFQGL---RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAF 124
Query: 184 RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
+ L NL L L N + L + + ++ N F
Sbjct: 125 QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 41/247 (16%), Positives = 82/247 (33%), Gaps = 62/247 (25%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
IP ++ + ++ L N+ P + L + +S+N +I
Sbjct: 25 EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN--------------QI 68
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
+L + AF L +L +L+L I E
Sbjct: 69 SEL-------------------------------APDAFQGL--RSLNSLVLYGNKIT-E 94
Query: 298 IPDYIGD-MTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 355
+P + + + L+ + L+ N + + F+ L N + L NKL + K F+ +
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQT-IAKGTFSPLR 152
Query: 356 NV-DISLNNFTWES-------SDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSA 407
+ + L + +D + + S R ++ + F CSA
Sbjct: 153 AIQTMHLAQNPFICDCHLKWLADYLHTNPIETSGARCTSPRRLANKRIGQIKSKKFRCSA 212
Query: 408 PADQYHY 414
A +H+
Sbjct: 213 AAHHHHH 219
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 41/193 (21%), Positives = 60/193 (31%), Gaps = 60/193 (31%)
Query: 157 KVLTNI-----TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TK 209
K LT I T+ + +E N IPP L+++ LS+N + EL +
Sbjct: 21 KGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQG 78
Query: 210 LTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD 268
L +LN L + N KI +L P S+ L SL L
Sbjct: 79 LRSLNSLVLYGN--------------KITEL-----------PKSLFEGLFSLQLL---- 109
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFE 327
L+ + + + L + L N L TF
Sbjct: 110 ---------LLNANKINC-----------LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 328 KLAKTNFMYLTGN 340
L M+L N
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 43/171 (25%), Positives = 71/171 (41%), Gaps = 37/171 (21%)
Query: 684 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIG-----MISAQQHPNL 734
+G G + V K + A++ + K + E ++ + A HP L
Sbjct: 60 IGRGSYAKVLLVRLKK---TDRIYAMRVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWPTRKKICIG-IA 787
V L+ C ++L V EY+ G D + +L + + I+
Sbjct: 116 VGLHSCFQTESRLFFVIEYVN---------GGDLMFHMQRQRKLPEE---HARFYSAEIS 163
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTH 836
L YLHE I++RD+K NVLLD + + K++D+G+ K L D T
Sbjct: 164 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 211
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 44/171 (25%), Positives = 71/171 (41%), Gaps = 37/171 (21%)
Query: 684 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIG-----MISAQQHPNL 734
+G G + V K + A+K + K + E ++ + A HP L
Sbjct: 17 IGRGSYAKVLLVRLKK---TDRIYAMKVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWPTRKKICIG-IA 787
V L+ C ++L V EY+ G D + +L + + I+
Sbjct: 73 VGLHSCFQTESRLFFVIEYVN---------GGDLMFHMQRQRKLPEE---HARFYSAEIS 120
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTH 836
L YLHE I++RD+K NVLLD + + K++D+G+ K L D T
Sbjct: 121 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 168
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 4e-09
Identities = 27/159 (16%), Positives = 57/159 (35%), Gaps = 9/159 (5%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ +R DL L + + + L + L+ L + + +L
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLD 469
Query: 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG-KIP 228
+ N ++PP + L L+ L S N+ + + L L +L + +N
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAI 526
Query: 229 EFIGKWKKIQKLHIQG---SSLEGPIPASISALTSLTDL 264
+ + ++ L++QG EG L S++ +
Sbjct: 527 QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.8 bits (131), Expect = 8e-08
Identities = 50/310 (16%), Positives = 95/310 (30%), Gaps = 31/310 (10%)
Query: 55 DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSK 114
++ + S+ G L D+ T D + HV L A +L LP +
Sbjct: 260 CFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFR 319
Query: 115 LRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP----FPKVLTNITTLKNLSI 170
+ + L W + + LS L + L+ L
Sbjct: 320 VIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEP 379
Query: 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD-----NNFSG 225
E +I +R L L E + L ++ +R + + F
Sbjct: 380 ENKWCLLTIILLMRALDPLLYEK--------ETLQYFSTLKAVDPMRAAYLDDLRSKFLL 431
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKGSESAFPKLDKMN 283
+ ++ ++ LH+ L + + L +T L +S L+ A L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALR--C 487
Query: 284 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN---FMYLTGN 340
L+ L + + + + ++ +L+ + L N L + L + L GN
Sbjct: 488 LEVLQASDNAL-ENVDG-VANLPRLQELLLCNNRLQQ--SAAIQPLVSCPRLVLLNLQGN 543
Query: 341 KLTGPVPKYI 350
L
Sbjct: 544 SLCQE-EGIQ 552
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 3/84 (3%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSG-PFPKVLTNITTL 165
LP L+ LR L+ L S N L + +L EL + NRL + L + L
Sbjct: 477 ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535
Query: 166 KNLSIEGNLFTGSIPPDIRKLINL 189
L+++GN +L +
Sbjct: 536 VLLNLQGNSLC-QEEGIQERLAEM 558
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 37/161 (22%), Positives = 58/161 (36%), Gaps = 26/161 (16%)
Query: 85 CDCSSAT--CH--------------VVTIALKAQNLTGTLPT-ELSKLRYLKQLDLSRNC 127
C C T C + L T T KL L++++ S N
Sbjct: 9 CRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNK 68
Query: 128 LT----GSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI 183
+T G+F + E+ + NRL K+ + +LK L + N T + D
Sbjct: 69 ITDIEEGAFEGA---SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDS 124
Query: 184 -RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
L +++ L L N T P L +L+ L + N F
Sbjct: 125 FIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 33/168 (19%), Positives = 61/168 (36%), Gaps = 34/168 (20%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK 236
IP I +L L++N FT E KL L + S+N K
Sbjct: 25 KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNN--------------K 68
Query: 237 IQKLHIQGSSLEGPIPASISALTSLTDLRISD--LKG-SESAFPKLDKMNLKTLILTKCL 293
I + + + + ++ ++ L+ F L+ +LKTL+L
Sbjct: 69 ITDIE----------EGAFEGASGVNEILLTSNRLENVQHKMFKGLE--SLKTLMLRSNR 116
Query: 294 IHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
I + + ++ ++ + L N +T P F+ L + + L N
Sbjct: 117 IT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-08
Identities = 56/306 (18%), Positives = 106/306 (34%), Gaps = 53/306 (17%)
Query: 88 SSATCHVVTIALKAQNLTGT----LPTELSKLRYLKQLDLSRNCLTGSFSPQWASL---- 139
+ +C + ++L+ LTG L + L L L++L LS N L +
Sbjct: 81 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDP 140
Query: 140 --QLVELSVMGNRLS----GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL------- 186
+L +L + LS P VL K L++ N + +R L
Sbjct: 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA---GVRVLCQGLKDS 197
Query: 187 -INLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGKIPEFIGKW-----KK 236
L+ L L S T + L + +L +L + N + +
Sbjct: 198 PCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSR 257
Query: 237 IQKLHIQGSSL--EG--PIPASISALTSLTDLRISDLK-GSESA---FPKLDKMN--LKT 286
++ L I + +G + + A SL +L ++ + G E A L + L++
Sbjct: 258 LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES 317
Query: 287 LILTKCLIHGEIPDYIGDM----TKLKNIDLSFNNLT-GGIPTTFEKLAKTN----FMYL 337
L + C + + L + +S N L G+ + L + ++L
Sbjct: 318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL 377
Query: 338 TGNKLT 343
++
Sbjct: 378 ADCDVS 383
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 50/281 (17%), Positives = 95/281 (33%), Gaps = 55/281 (19%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWA------SLQLVELSVMGNRLS----GPFPKVLTN 161
L L +L+L N L S ++ +LS+ L+ G L
Sbjct: 52 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLI--------NLQKLILSSNSFTGE----LPAELTK 209
+ TL+ L + NL + ++ L L+KL L S + L + L
Sbjct: 112 LPTLQELHLSDNLLGDA---GLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168
Query: 210 LTNLNDLRISDNNFSGKIPEFIGK-----WKKIQKLHIQGSSLEGPIPASISAL------ 258
+ +L +S+N+ + + + +++ L ++ + + L
Sbjct: 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT---SDNCRDLCGIVAS 225
Query: 259 -TSLTDLRISD----LKGSESAFPKLDKMN--LKTLILTKCLIHGEIPDYIGDM----TK 307
SL +L + G P L + L+TL + +C I + + +
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES 285
Query: 308 LKNIDLSFNNLTG-GIPTTFEKLAKTNFM----YLTGNKLT 343
LK + L+ N L G E L + ++ T
Sbjct: 286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 44/242 (18%), Positives = 85/242 (35%), Gaps = 46/242 (19%)
Query: 118 LKQLDLSRNCLTGSFSPQWASL-----QLVELSVMGNRLS----GPFPKVLTNITTLKNL 168
++ LD+ L+ +WA L Q + + L+ L L L
Sbjct: 5 IQSLDIQCEELS---DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 169 SIEGNLFTGSIPPDIRKL--------INLQKLILSSNSFTGE----LPAELTKLTNLNDL 216
++ N + + +QKL L + TG L + L L L +L
Sbjct: 62 NLRSNELGDV---GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 217 RISDNNFSGKIPEFIGK-----WKKIQKLHIQGSSL--EG--PIPASISALTSLTDLRIS 267
+SDN + + + +++KL ++ SL P+ + + A +L +S
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178
Query: 268 DLKGSESAFPKLDKM------NLKTLILTKCLIHGEIPDYIGDM----TKLKNIDLSFNN 317
+ +E+ L + L+ L L C + + + + L+ + L N
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238
Query: 318 LT 319
L
Sbjct: 239 LG 240
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 28/180 (15%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR---QGNRE-----FVNEIGMI--SAQQH 731
K+G G F +V+ + + T +A+K + E VN+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 732 PNLVKLYGC----CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
+++KL G +++V+E + N L+ K E+R + K+I +
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA---LIKKYEHR-GIPLIYVKQISKQLL 141
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLD------KDLNAKISDFGLAKLYEEDKT-HISTR 840
GL Y+H R I+H DIK NVL++ + KI+D G A Y+E T I TR
Sbjct: 142 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 39/152 (25%), Positives = 63/152 (41%), Gaps = 9/152 (5%)
Query: 119 KQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 177
++LDL L + L +L L++ N+L V ++T L L + N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 178 SIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLRISDNNFSGKIPE--FIGK 233
S+P + L L KL L N LP+ + +LT L +LR++ N IP F K
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF-DK 153
Query: 234 WKKIQKLHIQGSSLEGPIPASISALTSLTDLR 265
+Q L + + L+ + L L +
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 45/190 (23%), Positives = 65/190 (34%), Gaps = 36/190 (18%)
Query: 158 VLTNI-TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAEL-TKLTNLND 215
V + I + L ++ R L L L L N L A + LT L
Sbjct: 29 VPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGT 87
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISD--LKG- 271
L +++N ++ L P + LT L L + LK
Sbjct: 88 LGLANN--------------QLASL-----------PLGVFDHLTQLDKLYLGGNQLKSL 122
Query: 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLA 330
F +L LK L L + IP D +T L+ + LS N L F++L
Sbjct: 123 PSGVFDRL--TKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLG 179
Query: 331 KTNFMYLTGN 340
K + L GN
Sbjct: 180 KLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 37/116 (31%), Positives = 47/116 (40%), Gaps = 11/116 (9%)
Query: 114 KLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL 168
L L L L+ N L G F L QL +L + GN+L V +T LK L
Sbjct: 81 DLTELGTLGLANNQLASLPLGVFD----HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL 136
Query: 169 SIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223
+ N SIP KL NLQ L LS+N +L L + + N F
Sbjct: 137 RLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 19/114 (16%), Positives = 38/114 (33%), Gaps = 7/114 (6%)
Query: 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL----QLVELSV 146
H + ++ L L +L + + L +L L++
Sbjct: 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHL--ELRDLRGLGELRNLTI 63
Query: 147 MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT 200
+ + L P L L++ N S+ + ++LQ+L+LS N
Sbjct: 64 VKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 9/98 (9%)
Query: 251 IPASISALTSLTDLRISDLKGSES----AFPKLDKMNLKTLILTKCLIHGEIPDYI-GDM 305
+ +LT+L I + + + L L+ L + K + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLG--ELRNLTIVKSGLR-FVAPDAFHFT 79
Query: 306 TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343
+L ++LSFN L T + L+ + L+GN L
Sbjct: 80 PRLSRLNLSFNALESLSWKTVQGLSLQE-LVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 17/94 (18%), Positives = 34/94 (36%), Gaps = 6/94 (6%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPE--FIGKW 234
+ NL +L + + L L L L +L I + + F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFT- 79
Query: 235 KKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
++ +L++ ++LE + SL +L +S
Sbjct: 80 PRLSRLNLSFNALES-LSWKTVQGLSLQELVLSG 112
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 4/105 (3%)
Query: 119 KQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTG 177
+ L L N +T + SL L EL + N+L V ++T L L + N T
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 178 SIPPDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221
+P + +L++L++L + N T ELP + +LT+L L + N
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 43/193 (22%), Positives = 80/193 (41%), Gaps = 16/193 (8%)
Query: 658 GLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--- 713
G D Y ++ + + ++ + +G+G FG V K + +A+K + +K
Sbjct: 36 GYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN 95
Query: 714 QGNRE--FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR 771
Q E + + + +V L + N L LV+E + N L + ++T +R
Sbjct: 96 QAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLL--RNTNFR 152
Query: 772 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKL 829
+ +K + L +L + I+H D+K N+LL K KI DFG +
Sbjct: 153 -GVSLNLTRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-C 209
Query: 830 YEEDK--THISTR 840
+ +I +R
Sbjct: 210 QLGQRIYQYIQSR 222
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 39/282 (13%), Positives = 85/282 (30%), Gaps = 71/282 (25%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQ-----------LVELSVMGNRLSG----PFP 156
++ + L+ + S +L+ L + + N P
Sbjct: 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115
Query: 157 KVLTNITTLKNLSIEGN-------------LFTGSIPPDIRKLINLQKLILSSNSFTGE- 202
L+ T L++L + N L ++ + L+ +I N
Sbjct: 116 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS 175
Query: 203 ---LPAELTKLTNLNDLRISDNNFSGK-----IPEFIGKWKKIQKLHIQGSSLEGPIPAS 254
L+ +++ N + + E + ++++ L +Q ++ + +S
Sbjct: 176 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF-THLGSS 234
Query: 255 I--SALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDM------T 306
AL S NL+ L L CL+ + D
Sbjct: 235 ALAIALKSWP--------------------NLRELGLNDCLLSARGAAAVVDAFSKLENI 274
Query: 307 KLKNIDLSFNNLTGGIPTTFEKLAKTN-----FMYLTGNKLT 343
L+ + L +N + T + + F+ L GN+ +
Sbjct: 275 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 36/235 (15%), Positives = 76/235 (32%), Gaps = 43/235 (18%)
Query: 141 LVELSVMGNRLSG----PFPKVLTNITTLKNLSIEGNLFTG----SIPPDIRKLINLQKL 192
+ S+ + ++ VL ++K + + GN + +I +L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 193 ILSSNSFTGELPAE-----------LTKLTNLNDLRISDNNFSGK----IPEFIGKWKKI 237
S FTG + E L K L+ +R+SDN F + +F+ K +
Sbjct: 66 EFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
+ L++ + L P + + + L+ + L+++I + +
Sbjct: 125 EHLYLHNNGLG---PQAGAKIARA-------LQELAVNKKAKNAPPLRSIICGRNRLENG 174
Query: 298 IPDYIGDM----TKLKNIDLSFNNLTG-GIPTTFEKLAKTN----FMYLTGNKLT 343
L + + N + GI + + L N T
Sbjct: 175 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 39/168 (23%), Positives = 71/168 (42%), Gaps = 20/168 (11%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHP---NLVK 736
+G+G FG V K +A+K + ++ R Q E + + + Q N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKDNTMNVIH 163
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
+ N + + +E + N K +++ P +K I + L LH
Sbjct: 164 MLENFTFRNHICMTFELLSMNLYE---LIKKNKFQ-GFSLPLVRKFAHSILQCLDALH-- 217
Query: 797 SRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEEDK--THISTR 840
+ +I+H D+K N+LL K+ DFG + YE + T+I +R
Sbjct: 218 -KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-YEHQRVYTYIQSR 263
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 39/115 (33%), Positives = 52/115 (45%), Gaps = 13/115 (11%)
Query: 114 KLRYLKQLDLSRNCLT----GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL 168
+L L L L+ N L G F L L EL ++ N+L V +T L L
Sbjct: 83 ELTNLTYLILTGNQLQSLPNGVF----DKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL 138
Query: 169 SIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-TKLTNLNDLRISDN 221
++ N S+P + KL NL +L LS N LP + KLT L DLR+ N
Sbjct: 139 NLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 35/192 (18%), Positives = 75/192 (39%), Gaps = 34/192 (17%)
Query: 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222
+++ T +L ++ ++I +++ + + L N+ L + N
Sbjct: 19 AETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNK 74
Query: 223 FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI-SALTSLTDLRISDLKGSESAFPKLDK 281
I + + L + G+ L+ +P + LT+L +L L +
Sbjct: 75 LH-DISAL-KELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELV-------------LVE 118
Query: 282 MNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340
L++L PD + D +T L ++L+ N L F+KL + L+ N
Sbjct: 119 NQLQSL-----------PDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYN 167
Query: 341 KLTGPVPKYIFN 352
+L +P+ +F+
Sbjct: 168 QLQS-LPEGVFD 178
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 39/140 (27%), Positives = 61/140 (43%), Gaps = 13/140 (9%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVE 143
C CS T + + + +P + LDL N L + + L L +
Sbjct: 5 CSCSGTTVECYSQGRTS--VPTGIPAQT------TYLDLETNSLKSLPNGVFDELTSLTQ 56
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGE 202
L + GN+L V +T+L L++ N S+P + KL L++L L++N
Sbjct: 57 LYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-S 114
Query: 203 LPAEL-TKLTNLNDLRISDN 221
LP + KLT L DLR+ N
Sbjct: 115 LPDGVFDKLTQLKDLRLYQN 134
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 40/171 (23%), Positives = 73/171 (42%), Gaps = 20/171 (11%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMI-----SAQQHPN--- 733
K+G G F +V+ + +A+K + S ++EI ++ S PN
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102
Query: 734 LVKLYGC----CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
+V+L V G + +V+E + ++ L + + Y+ L P KKI + +G
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLK---WIIKSNYQG-LPLPCVKKIIQQVLQG 158
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
L YLH ++ +I+H DIK N+LL + A ++ +
Sbjct: 159 LDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 143 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTG 201
EL + GN+ + PK L+N L + + N + ++ + L LILS N
Sbjct: 35 ELYLDGNQFTLV-PKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 202 ELPAELT-KLTNLNDLRISDNNFSGKIPE 229
+P L +L L + N+ S +PE
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPE 119
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 7/116 (6%)
Query: 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 167
+ LS L+ K L LS N + S L LS+ N + + TL+
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKK-IENLDAVADTLEE 97
Query: 168 LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDN 221
L I N S+ I KL+NL+ L +S+N T GE+ +L L L DL ++ N
Sbjct: 98 LWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 30/129 (23%), Positives = 54/129 (41%), Gaps = 12/129 (9%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTG-SFSPQWASLQLVELSVMGNRLSGPFPKVLT 160
++ G + ++ L+ L L L S P+ L+ +ELS NR+ G +
Sbjct: 35 KSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELS--ENRIFGGLDMLAE 92
Query: 161 NITTLKNLSIEGNLFT--GSIPPDIRKLINLQKLILSSNSFTGE------LPAELTKLTN 212
+ L +L++ GN ++ P ++KL L+ L L + T + L +LT
Sbjct: 93 KLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTY 151
Query: 213 LNDLRISDN 221
L+ D
Sbjct: 152 LDGYDREDQ 160
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 31/235 (13%), Positives = 76/235 (32%), Gaps = 30/235 (12%)
Query: 112 LSKLRYLKQLDLSRNCLT-------GSFSPQWASLQLVELSVMGNRLSGP--FPKVLTNI 162
++ R +K L + + + + SL+++ + P + N
Sbjct: 160 VTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219
Query: 163 TTLKNLSIEG--NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220
+L ++ + L L L+ + E L L L +S
Sbjct: 220 RSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY 279
Query: 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG--SESAFPK 278
+ +P +I+KL + + LE + + +L + + + +
Sbjct: 280 MGPNE-MPILFPFAAQIRKLDLLYALLETE--DHCTLIQKCPNLEVLETRNVIGDRGLEV 336
Query: 279 LDKM--NLKTLILTKCLIHGEIPDYIGDMT------------KLKNIDLSFNNLT 319
L + LK L + + + D G ++ +L+ + + +++T
Sbjct: 337 LAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDIT 391
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 24/117 (20%), Positives = 42/117 (35%), Gaps = 11/117 (9%)
Query: 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLS 169
+ + ++LDL + + Q + N + + L L+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRRLK 67
Query: 170 ---IEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDN 221
+ N + L +L +LIL++NS G+L L L +L L I N
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 26/86 (30%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 140 QLVELSVMGNRLS-GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198
+ EL + +R + G + L+ LS T SI ++ KL L+KL LS N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNR 75
Query: 199 FTGELPAELTKLTNLNDLRISDNNFS 224
+G L K NL L +S N
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 26/112 (23%), Positives = 48/112 (42%), Gaps = 5/112 (4%)
Query: 161 NITTLKNLSIEGNLFT-GSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ +K L ++ + G + + L+ L + T + A L KL L L +S
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271
DN SG + K + L++ G+ ++ ++I L L +L+ DL
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFN 122
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 25/122 (20%), Positives = 38/122 (31%), Gaps = 28/122 (22%)
Query: 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161
++ G L + L+ L LT ++ L
Sbjct: 28 RSNEGKLEGLTDEFEELEFLSTINVGLT--------------------SIAN-----LPK 62
Query: 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRIS 219
+ LK L + N +G + K NL L LS N + L KL NL L +
Sbjct: 63 LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLF 121
Query: 220 DN 221
+
Sbjct: 122 NC 123
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 30/166 (18%), Positives = 53/166 (31%), Gaps = 13/166 (7%)
Query: 112 LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMG------NRLSGPFPKVLTNITT 164
+++ LK L L+R + QL EL G + L+
Sbjct: 207 VTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKE 266
Query: 165 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE-LPAELTKLTNLNDLRISDNNF 223
L+ LS + +P L L LS + L L + L L + D
Sbjct: 267 LRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIE 326
Query: 224 SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDL 269
+ K +++L + S P + +LT+ + +
Sbjct: 327 DAGLEVLASTCKDLRELRVFPSE-----PFVMEPNVALTEQGLVSV 367
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 32/213 (15%), Positives = 81/213 (38%), Gaps = 13/213 (6%)
Query: 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG-NLFTG 177
+ LDL+ L + + S ++ + + P + + ++++ + +
Sbjct: 50 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVS 108
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD-NNFSGKIPEFIGK-WK 235
++ + + LQ L L + + L K +NL L +S + FS + +
Sbjct: 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 168
Query: 236 KIQKLHIQGSSL---EGPIPASISALTSLTDLRISDLKG--SESAFPKLDKM--NLKTLI 288
++ +L++ + A ++T L +S + +S L + NL L
Sbjct: 169 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228
Query: 289 LTKC-LIHGEIPDYIGDMTKLKNIDLSF-NNLT 319
L+ ++ + + L+++ LS ++
Sbjct: 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII 261
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 20/82 (24%), Positives = 33/82 (40%), Gaps = 5/82 (6%)
Query: 143 ELSVMGNRLSG-PFPKVLTNITTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFT 200
EL + N L + + L L ++ N T I P+ ++Q+L L N
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 201 GELPAEL-TKLTNLNDLRISDN 221
E+ ++ L L L + DN
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDN 112
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 845 | |||
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.98 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.98 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.98 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.98 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.98 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.98 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.98 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.98 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.98 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.98 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.97 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.97 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.97 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.97 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.97 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.97 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.97 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.96 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.96 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.95 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.94 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.94 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.94 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.94 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.93 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.93 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.93 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.93 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.93 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.93 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.93 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.92 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.92 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.92 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.92 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.92 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.92 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.92 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.92 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.92 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.92 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.92 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.92 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.92 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.92 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.92 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.92 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.92 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.92 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.92 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.92 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.92 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.92 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.91 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.91 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.91 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.91 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.91 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.91 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.91 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.91 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.91 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.91 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.91 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.91 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.91 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.91 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.91 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.91 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.91 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.91 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.91 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.91 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.91 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.91 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.91 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.91 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.91 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.91 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.91 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.91 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.9 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.9 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.9 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.9 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.9 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.9 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.9 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.9 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.9 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.9 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.9 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.9 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.9 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.9 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.9 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.9 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.9 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.9 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.9 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.9 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.9 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.9 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.9 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.9 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.9 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.9 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.9 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.9 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.9 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.9 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.9 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.9 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.9 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.9 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.9 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.9 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.9 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.9 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.9 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.9 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.9 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.9 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.89 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.89 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.89 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.89 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.89 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.89 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.89 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.89 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.89 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.89 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.89 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.89 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.89 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.89 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.89 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.89 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.89 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.89 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.89 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.89 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.89 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.89 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.89 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.89 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.89 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.89 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.89 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.89 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.89 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.89 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.89 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.89 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.89 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.89 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.89 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.89 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.89 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.89 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.89 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.89 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.89 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.89 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.89 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.89 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.89 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.89 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.89 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.89 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.89 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.89 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.89 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.89 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.89 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.89 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.89 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.88 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.88 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.88 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.88 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.88 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.88 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.88 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.88 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.88 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.88 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.88 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.88 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.88 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.88 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.88 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.88 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.88 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.88 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.88 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.88 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.88 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.88 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.88 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.88 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.88 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.88 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.88 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.87 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.87 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.87 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.87 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.87 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.87 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.87 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.87 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.87 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.87 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.87 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.87 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.87 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.87 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.86 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.86 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.86 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.86 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.86 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.86 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.86 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.86 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.86 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.86 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.85 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.85 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.85 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.85 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.85 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.85 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.84 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.79 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.6 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.59 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.42 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.39 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.35 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.33 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.29 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.26 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.02 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.02 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.97 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.86 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.79 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.72 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.58 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.55 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.55 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.51 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.34 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.34 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 98.32 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.96 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.76 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.61 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.59 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.57 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.5 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.39 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.34 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.19 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.08 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.06 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.03 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.03 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.96 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.92 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.86 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.59 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.41 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.98 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.47 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.05 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.09 |
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=374.91 Aligned_cols=295 Identities=26% Similarity=0.435 Sum_probs=252.1
Q ss_pred CCCHHHHHHHHHHHHHhCCC----CCCCCCCCCCCCCCccccCCCCCCCccceeecCCCCcceEEEEEecCCCccc--cC
Q 003134 35 KLHAEEVKALKQIGRKLGKK----DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTG--TL 108 (845)
Q Consensus 35 ~~~~~~~~aL~~~~~~~~~~----~W~~~~d~c~~~~~w~~~~~~~~~~~~~v~C~~~~~~~~v~~L~l~~~~l~g--~~ 108 (845)
.|+++|++||++||+++++. +|+.+.|||. +.|. ||+|+.....++|+.|+|++++++| .+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~--~~w~-----------gv~C~~~~~~~~l~~L~L~~~~l~~~~~~ 68 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTWL-----------GVLCDTDTQTYRVNNLDLSGLNLPKPYPI 68 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT--TCST-----------TEEECCSSSCCCEEEEEEECCCCSSCEEC
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCc--CCCc-----------ceEeCCCCCCceEEEEECCCCCccCCccc
Confidence 58899999999999999763 7988888884 2475 8999865444799999999999999 99
Q ss_pred CccccCCCCCCEEeccC-CcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccC
Q 003134 109 PTELSKLRYLKQLDLSR-NCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL 186 (845)
Q Consensus 109 p~~l~~L~~L~~L~Ls~-N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 186 (845)
|+.|.++++|++|+|++ |.+++.+|..+..+ +|++|+|++|++++.+|..|.++++|++|+|++|++++.+|..|..+
T Consensus 69 ~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 148 (313)
T 1ogq_A 69 PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148 (313)
T ss_dssp CGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC
T ss_pred ChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcC
Confidence 99999999999999995 99999999999888 89999999999998999999999999999999999999999999999
Q ss_pred CCccEEEeecCcCcccCChhhhCCC-CCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEE
Q 003134 187 INLQKLILSSNSFTGELPAELTKLT-NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLR 265 (845)
Q Consensus 187 ~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 265 (845)
++|++|+|++|++++.+|..+.+++ +|++|+|++|++++.+|..|..++ |++|+|++|++++.+|..|..+++|+.|+
T Consensus 149 ~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 227 (313)
T 1ogq_A 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIH 227 (313)
T ss_dssp TTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred CCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEE
Confidence 9999999999999989999999988 899999999999999999998887 99999999999988888888887776665
Q ss_pred cCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCC
Q 003134 266 ISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP 345 (845)
Q Consensus 266 Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ 345 (845)
|++|.+++.+|. +..+++|++|+|++|+|++.+|..|..+++|++|+|++|+++|.
T Consensus 228 -----------------------L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 283 (313)
T 1ogq_A 228 -----------------------LAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283 (313)
T ss_dssp -----------------------CCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred -----------------------CCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccccc
Confidence 455555555555 67778888888888888888888888888888888888888888
Q ss_pred CChhh-hcCCceEEeecCC-CcCC
Q 003134 346 VPKYI-FNSNKNVDISLNN-FTWE 367 (845)
Q Consensus 346 ip~~~-~~~l~~L~ls~N~-l~~~ 367 (845)
+|..- ...++.+++++|+ +.|.
T Consensus 284 ip~~~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 284 IPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp CCCSTTGGGSCGGGTCSSSEEEST
T ss_pred CCCCccccccChHHhcCCCCccCC
Confidence 88753 3577888888887 4443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=399.30 Aligned_cols=349 Identities=20% Similarity=0.277 Sum_probs=294.2
Q ss_pred CHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCccccCCCCCCCc---cceeecCCCCcceEEEEEecCCCccccCCcccc
Q 003134 37 HAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFE---SNVTCDCSSATCHVVTIALKAQNLTGTLPTELS 113 (845)
Q Consensus 37 ~~~~~~aL~~~~~~~~~~~W~~~~d~c~~~~~w~~~~~~~~~~~---~~v~C~~~~~~~~v~~L~l~~~~l~g~~p~~l~ 113 (845)
...|++||.++++++++..|....++|....+|.... .++.| .||+|+.. +||+.|+|+++++.|.+|++|+
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~--~~c~w~~~~GV~C~~~---~~V~~L~L~~~~l~g~lp~~l~ 102 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNK--ELDMWGAQPGVSLNSN---GRVTGLSLEGFGASGRVPDAIG 102 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSS--CGGGTTCCTTEEECTT---CCEEEEECTTSCCEEEECGGGG
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCC--CcccccCCCCeEEcCC---CCEEEEEecCcccCCcCChHHh
Confidence 3569999999999999999998777776666897432 23456 89999854 7999999999999999999999
Q ss_pred CCCCCCEEeccCCc------------------------------------------------------------------
Q 003134 114 KLRYLKQLDLSRNC------------------------------------------------------------------ 127 (845)
Q Consensus 114 ~L~~L~~L~Ls~N~------------------------------------------------------------------ 127 (845)
+|++|++|+|++|.
T Consensus 103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 182 (636)
T 4eco_A 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182 (636)
T ss_dssp GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred cCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence 99999999999984
Q ss_pred ------------ccCCCccccccc-ceeEEEecCCCCCCC-----------------cccccc--cccccceeEeecccC
Q 003134 128 ------------LTGSFSPQWASL-QLVELSVMGNRLSGP-----------------FPKVLT--NITTLKNLSIEGNLF 175 (845)
Q Consensus 128 ------------l~~~~~~~~~~l-~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~Ls~N~l 175 (845)
+++ +|..++.+ +|++|+|++|+|++. +|..++ ++++|++|+|++|++
T Consensus 183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l 261 (636)
T 4eco_A 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261 (636)
T ss_dssp CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence 445 77888888 999999999999996 999999 999999999999999
Q ss_pred CCCCCcccccCCCccEEEeecCc-Ccc-cCChhhhCC------CCCCcEEeecCcCcccCch--hhcCCcccceEEecCC
Q 003134 176 TGSIPPDIRKLINLQKLILSSNS-FTG-ELPAELTKL------TNLNDLRISDNNFSGKIPE--FIGKWKKIQKLHIQGS 245 (845)
Q Consensus 176 ~g~~p~~~~~l~~L~~L~Ls~N~-l~g-~~p~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N 245 (845)
.+.+|..|+++++|++|+|++|+ ++| .+|..++++ ++|++|+|++|+++ .+|. .|+++++|++|+|++|
T Consensus 262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N 340 (636)
T 4eco_A 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYN 340 (636)
T ss_dssp CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSC
T ss_pred CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCC
Confidence 99999999999999999999998 998 899998887 99999999999999 7888 9999999999999999
Q ss_pred cCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCC-ccEEEccCCcCcccCcccccCCC--CcCEEeCCCCCCCCCC
Q 003134 246 SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMN-LKTLILTKCLIHGEIPDYIGDMT--KLKNIDLSFNNLTGGI 322 (845)
Q Consensus 246 ~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~g~~ 322 (845)
+++|.+| .++++++|+.|++++|.+...+.......+ |+.|+|++|.++ .+|..+..++ +|+.|+|++|++++.+
T Consensus 341 ~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~ 418 (636)
T 4eco_A 341 QLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVD 418 (636)
T ss_dssp CCEEECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTT
T ss_pred cCccchh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcc
Confidence 9999999 999999999999999998855444333336 999999999999 7888887765 8999999999999999
Q ss_pred chhhh-------cCCCcCEEEccCCcccCCCChhhh---cCCceEEeecCCCcCCCCCC-CCCC---CCCceeeeeecCC
Q 003134 323 PTTFE-------KLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESSDP-IECP---RGSVNLVESYSSP 388 (845)
Q Consensus 323 p~~~~-------~l~~L~~L~L~~N~l~g~ip~~~~---~~l~~L~ls~N~l~~~~p~~-~~c~---~~~~~~l~~l~~~ 388 (845)
|..|. .+++|++|+|++|+++ .+|..++ ..|+.|+|++|+++ .+|.. +... +..+..++.++.+
T Consensus 419 p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls 496 (636)
T 4eco_A 419 GKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLR 496 (636)
T ss_dssp TCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECC
T ss_pred hhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECc
Confidence 99888 8889999999999999 6776653 57899999999999 44432 2211 2233367888888
Q ss_pred CCCCCCcc
Q 003134 389 RNKLDKVH 396 (845)
Q Consensus 389 ~n~~~~~~ 396 (845)
.|++....
T Consensus 497 ~N~l~~lp 504 (636)
T 4eco_A 497 FNKLTKLS 504 (636)
T ss_dssp SSCCCBCC
T ss_pred CCcCCccC
Confidence 88888543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=393.31 Aligned_cols=352 Identities=19% Similarity=0.243 Sum_probs=285.0
Q ss_pred cCCCHHHHHHHHHHHHHhCCCCCCCCC-----CC--CCCCCCccccCC-CCCCCccceeecCCCCcceEEEEEecCCCcc
Q 003134 34 NKLHAEEVKALKQIGRKLGKKDWNFGV-----DP--CSQKGNWELSSD-DKKGFESNVTCDCSSATCHVVTIALKAQNLT 105 (845)
Q Consensus 34 ~~~~~~~~~aL~~~~~~~~~~~W~~~~-----d~--c~~~~~w~~~~~-~~~~~~~~v~C~~~~~~~~v~~L~l~~~~l~ 105 (845)
++...+|++||++||+++++.+|+.+. +| |. |....+ +..+...||+|++ .+||+.|+|+++++.
T Consensus 264 ~~~~~~d~~ALl~~k~~l~~~~W~~~~~~~~~~~~~C~----W~~~~~~~~w~~~~GV~C~~---~~~V~~L~Ls~~~L~ 336 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLN----WNFNKELDMWGDQPGVDLDN---NGRVTGLSLAGFGAK 336 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTTGGGCCCCCSSCSSCCCCCS----CCCSSCGGGTTCCTTEEECT---TSCEEEEECTTTCCE
T ss_pred cccchHHHHHHHHHHHHcCCCCCCcCCCcccccCCccc----cccccccccccCcCceEecC---CCCEEEEECccCCCC
Confidence 345578999999999999988998765 67 64 632211 1111226999986 479999999999999
Q ss_pred ccCCccccCCCCCCEEec-cCCcccCC-----------------------------------------------------
Q 003134 106 GTLPTELSKLRYLKQLDL-SRNCLTGS----------------------------------------------------- 131 (845)
Q Consensus 106 g~~p~~l~~L~~L~~L~L-s~N~l~~~----------------------------------------------------- 131 (845)
|.+|++|++|++|++|+| ++|.++|.
T Consensus 337 G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~ 416 (876)
T 4ecn_A 337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416 (876)
T ss_dssp EEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred CcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence 999999999999999999 77866554
Q ss_pred -----------------------Cccccccc-ceeEEEecCCCCCC-----------------Ccccccc--ccccccee
Q 003134 132 -----------------------FSPQWASL-QLVELSVMGNRLSG-----------------PFPKVLT--NITTLKNL 168 (845)
Q Consensus 132 -----------------------~~~~~~~l-~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~L~~L 168 (845)
+|..+..+ +|++|+|++|+|++ .+|..++ ++++|++|
T Consensus 417 i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L 496 (876)
T 4ecn_A 417 IKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV 496 (876)
T ss_dssp CCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred cccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEE
Confidence 67778888 89999999999998 3888877 99999999
Q ss_pred EeecccCCCCCCcccccCCCccEEEeecCc-Ccc-cCChhhhCCC-------CCCcEEeecCcCcccCch--hhcCCccc
Q 003134 169 SIEGNLFTGSIPPDIRKLINLQKLILSSNS-FTG-ELPAELTKLT-------NLNDLRISDNNFSGKIPE--FIGKWKKI 237 (845)
Q Consensus 169 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~--~~~~l~~L 237 (845)
+|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..+++++ +|++|+|++|+|+ .+|. .|+++++|
T Consensus 497 ~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L 575 (876)
T 4ecn_A 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKL 575 (876)
T ss_dssp EEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTC
T ss_pred ECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCC
Confidence 999999999999999999999999999998 998 8888777665 9999999999999 7888 89999999
Q ss_pred ceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCC-ccEEEccCCcCcccCcccccCCCC--cCEEeCC
Q 003134 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMN-LKTLILTKCLIHGEIPDYIGDMTK--LKNIDLS 314 (845)
Q Consensus 238 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~Ls 314 (845)
++|+|++|+++ .+| .|+++++|+.|+|++|.+...+.......+ |+.|+|++|.|+ .+|..+..++. |+.|+|+
T Consensus 576 ~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls 652 (876)
T 4ecn_A 576 GLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFS 652 (876)
T ss_dssp CEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECC
T ss_pred CEEECCCCCcc-cch-hhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECc
Confidence 99999999999 778 899999999999999999844433333336 999999999999 78888877755 9999999
Q ss_pred CCCCCCCCchhh---h--cCCCcCEEEccCCcccCCCChhhh---cCCceEEeecCCCcCCCCCCCCCC---CCCceeee
Q 003134 315 FNNLTGGIPTTF---E--KLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESSDPIECP---RGSVNLVE 383 (845)
Q Consensus 315 ~N~l~g~~p~~~---~--~l~~L~~L~L~~N~l~g~ip~~~~---~~l~~L~ls~N~l~~~~p~~~~c~---~~~~~~l~ 383 (845)
+|+|+|.+|... . .+++|+.|+|++|+++ .+|..++ ..|+.|+|++|+++...+..+... |..+..++
T Consensus 653 ~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~ 731 (876)
T 4ecn_A 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT 731 (876)
T ss_dssp SSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCC
T ss_pred CCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCcc
Confidence 999998776432 2 3458999999999999 7787765 578999999999983333222211 33445788
Q ss_pred eecCCCCCCCCccC
Q 003134 384 SYSSPRNKLDKVHP 397 (845)
Q Consensus 384 ~l~~~~n~~~~~~~ 397 (845)
.++.+.|++.....
T Consensus 732 ~L~Ls~N~L~~lp~ 745 (876)
T 4ecn_A 732 TIDLRFNKLTSLSD 745 (876)
T ss_dssp EEECCSSCCCCCCG
T ss_pred EEECCCCCCccchH
Confidence 88888888885443
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=396.43 Aligned_cols=336 Identities=27% Similarity=0.390 Sum_probs=249.2
Q ss_pred hcCCCHHHHHHHHHHHHHhCC----CCCCCCCCCCCCCCCccccCCCCCCCccceeecCCCCcceEEEEEecCCCcccc-
Q 003134 33 ANKLHAEEVKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGT- 107 (845)
Q Consensus 33 ~~~~~~~~~~aL~~~~~~~~~----~~W~~~~d~c~~~~~w~~~~~~~~~~~~~v~C~~~~~~~~v~~L~l~~~~l~g~- 107 (845)
++...++|++||++||+++.+ .+|+.+.|||. |+ ||+|+ .+||+.|+|+++++.|.
T Consensus 6 ~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C~----w~-----------gv~C~----~~~v~~L~L~~~~l~g~~ 66 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCT----FD-----------GVTCR----DDKVTSIDLSSKPLNVGF 66 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGGG----ST-----------TEEEE----TTEEEEEECTTSCCCEEH
T ss_pred cccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCcC----Cc-----------ceEEC----CCcEEEEECCCCCcCCcc
Confidence 334467899999999999864 37987788884 65 89998 37999999999999987
Q ss_pred --CC-----------------------ccccCCCCCCEEeccCCcccCCCcc--ccccc-ceeEEEecCCCCCCCccccc
Q 003134 108 --LP-----------------------TELSKLRYLKQLDLSRNCLTGSFSP--QWASL-QLVELSVMGNRLSGPFPKVL 159 (845)
Q Consensus 108 --~p-----------------------~~l~~L~~L~~L~Ls~N~l~~~~~~--~~~~l-~L~~L~Ls~N~l~~~~p~~~ 159 (845)
+| ..|+++++|++|+|++|.++|.+|. .++.+ +|++|+|++|.+++.+|..+
T Consensus 67 ~~l~~~l~~L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~ 146 (768)
T 3rgz_A 67 SAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSG 146 (768)
T ss_dssp HHHHHHTTTCTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCS
T ss_pred CccChhHhccCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHH
Confidence 55 4566777788888888888777776 77777 78888888888777777665
Q ss_pred -ccccccceeEeecccCCCCCCcc---cccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCc
Q 003134 160 -TNITTLKNLSIEGNLFTGSIPPD---IRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWK 235 (845)
Q Consensus 160 -~~l~~L~~L~Ls~N~l~g~~p~~---~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 235 (845)
.++++|++|+|++|++++..|.. +.++++|++|+|++|++++.+|. .++++|++|+|++|++++.+|. +++++
T Consensus 147 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~ 223 (768)
T 3rgz_A 147 GLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCS 223 (768)
T ss_dssp CCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCC
T ss_pred hccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCC
Confidence 67777888888888777776665 66777777777777777765553 6788888888888888887777 88888
Q ss_pred ccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCC-CCcCEEeCC
Q 003134 236 KIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDM-TKLKNIDLS 314 (845)
Q Consensus 236 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls 314 (845)
+|++|+|++|++++.+|..++++++|+.|++++|.+.+..+.. ...+|++|+|++|++++.+|..+..+ ++|++|+|+
T Consensus 224 ~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls 302 (768)
T 3rgz_A 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLS 302 (768)
T ss_dssp SCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC-CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECC
T ss_pred CCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc-ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECc
Confidence 9999999999998888888888889999988888876544433 33467777777777777777776654 777777777
Q ss_pred CCCCCCCCchhhhcCCCcCEEEccCCcccCCCChh-h--hcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCC
Q 003134 315 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY-I--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNK 391 (845)
Q Consensus 315 ~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~-~--~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~ 391 (845)
+|++++.+|..|+++++|++|+|++|+++|.+|.. + ...|+.|++++|++++.+|..+..- ..-++.++.+.|+
T Consensus 303 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l---~~~L~~L~Ls~N~ 379 (768)
T 3rgz_A 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNL---SASLLTLDLSSNN 379 (768)
T ss_dssp SSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHH---TTTCSEEECCSSE
T ss_pred CCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhh---hcCCcEEEccCCC
Confidence 77777777777777777777777777777777765 3 2367777777777776666443110 0134445555555
Q ss_pred CCC
Q 003134 392 LDK 394 (845)
Q Consensus 392 ~~~ 394 (845)
+.+
T Consensus 380 l~~ 382 (768)
T 3rgz_A 380 FSG 382 (768)
T ss_dssp EEE
T ss_pred cCC
Confidence 543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=377.01 Aligned_cols=277 Identities=30% Similarity=0.497 Sum_probs=163.5
Q ss_pred EEEEEecCCCccccCCccccC--CCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 94 VVTIALKAQNLTGTLPTELSK--LRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 94 v~~L~l~~~~l~g~~p~~l~~--L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
++.|++++|.++|.+|+.+.. +++|++|+|++|++++.+|..+..+ +|++|+|++|++++.+|..|.++++|++|+|
T Consensus 370 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 449 (768)
T 3rgz_A 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449 (768)
T ss_dssp CSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC
T ss_pred CcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEEC
Confidence 334444444444444444433 4455555555555555555555555 5666666666666666666666666666666
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCC
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 250 (845)
++|++++.+|..|..+++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|..|+.+++|++|+|++|+++|.
T Consensus 450 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 529 (768)
T 3rgz_A 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529 (768)
T ss_dssp CSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEE
T ss_pred CCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCc
Confidence 66666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cchhhhcCCCCCEEEcCCCCCCCCCCccc---------------------------------------------------
Q 003134 251 IPASISALTSLTDLRISDLKGSESAFPKL--------------------------------------------------- 279 (845)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l--------------------------------------------------- 279 (845)
+|..++++++|+.|++++|.+++..+..+
T Consensus 530 ~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 609 (768)
T 3rgz_A 530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLST 609 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGG
T ss_pred CCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcccc
Confidence 66666666666666666665543222111
Q ss_pred -------------------cc-CCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccC
Q 003134 280 -------------------DK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339 (845)
Q Consensus 280 -------------------~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~ 339 (845)
.. .+|+.|+|++|+++|.+|..|+++++|+.|+|++|+|+|.+|..|+++++|+.|||++
T Consensus 610 ~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~ 689 (768)
T 3rgz_A 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS 689 (768)
T ss_dssp TCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCS
T ss_pred ccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCC
Confidence 00 1455666666666666666666666666666666666666666666666666666666
Q ss_pred CcccCCCChhhh--cCCceEEeecCCCcCCCCC
Q 003134 340 NKLTGPVPKYIF--NSNKNVDISLNNFTWESSD 370 (845)
Q Consensus 340 N~l~g~ip~~~~--~~l~~L~ls~N~l~~~~p~ 370 (845)
|+++|.+|..+. ..|+.||+++|+++|.+|.
T Consensus 690 N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~ 722 (768)
T 3rgz_A 690 NKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722 (768)
T ss_dssp SCCEECCCGGGGGCCCCSEEECCSSEEEEECCS
T ss_pred CcccCcCChHHhCCCCCCEEECcCCcccccCCC
Confidence 666666666553 3566666666666666663
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=343.84 Aligned_cols=278 Identities=17% Similarity=0.207 Sum_probs=209.2
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCC-ccccccc-ceeEEEecCCCCCCCcccccccccccceeE
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSF-SPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~-~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 169 (845)
.+++.|+|++|.+++..|..|+++++|++|+|++|.+.+.+ +..|..+ +|++|+|++|++++..|..|.++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 57899999999999988999999999999999999998655 5678888 999999999999999999999999999999
Q ss_pred eecccCCCCCCcc--cccCCCccEEEeecCcCcccCChh-hhCCCCCCcEEeecCcCcccCchhhcCC------------
Q 003134 170 IEGNLFTGSIPPD--IRKLINLQKLILSSNSFTGELPAE-LTKLTNLNDLRISDNNFSGKIPEFIGKW------------ 234 (845)
Q Consensus 170 Ls~N~l~g~~p~~--~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------------ 234 (845)
|++|++++.+|.. |.++++|++|+|++|++++..|.. +.++++|++|+|++|++++..|..+..+
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 9999999865555 899999999999999999887876 8899999999999999998888766544
Q ss_pred ----------------------cccceEEecCCcCCCCcchhhhcC----------------------------------
Q 003134 235 ----------------------KKIQKLHIQGSSLEGPIPASISAL---------------------------------- 258 (845)
Q Consensus 235 ----------------------~~L~~L~Ls~N~l~g~~p~~~~~l---------------------------------- 258 (845)
++|++|+|++|++++..|..+..+
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~ 269 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTT
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccccc
Confidence 567777777777766555444322
Q ss_pred -----CCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCc
Q 003134 259 -----TSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332 (845)
Q Consensus 259 -----~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 332 (845)
++|+.|++++|.+....+..+... +|+.|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|
T Consensus 270 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 349 (455)
T 3v47_A 270 KGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKL 349 (455)
T ss_dssp GGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTC
T ss_pred ccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccC
Confidence 356666666666655544444433 56666666666666666666666666666666666665556666666666
Q ss_pred CEEEccCCcccCCCChhhh--cCCceEEeecCCCcCCCC
Q 003134 333 NFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESS 369 (845)
Q Consensus 333 ~~L~L~~N~l~g~ip~~~~--~~l~~L~ls~N~l~~~~p 369 (845)
++|+|++|++++..|..+. ..|+.|+|++|++++..+
T Consensus 350 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 388 (455)
T 3v47_A 350 EVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPD 388 (455)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CEEECCCCcccccChhhccccccccEEECCCCccccCCH
Confidence 6666666666655555543 356666666666665444
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=339.71 Aligned_cols=286 Identities=20% Similarity=0.220 Sum_probs=215.2
Q ss_pred cceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeE
Q 003134 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (845)
Q Consensus 91 ~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 169 (845)
..+++.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+ +|++|+|++|+|++..+..|.++++|++|+
T Consensus 31 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 110 (477)
T 2id5_A 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLD 110 (477)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEE
T ss_pred CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEE
Confidence 3478899999999999888999999999999999999999999999998 999999999999988888899999999999
Q ss_pred eecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCC
Q 003134 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (845)
Q Consensus 170 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 249 (845)
|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|+.|+|++|++.+
T Consensus 111 Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~ 190 (477)
T 2id5_A 111 ISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA 190 (477)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCE
T ss_pred CCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcE
Confidence 99999998888899999999999999999998888899999999999999999998877889999999999999999988
Q ss_pred CcchhhhcCCCCCEEEcCCCCCCCCCCc-ccccCC------------------------ccEEEccCCcCcccCcccccC
Q 003134 250 PIPASISALTSLTDLRISDLKGSESAFP-KLDKMN------------------------LKTLILTKCLIHGEIPDYIGD 304 (845)
Q Consensus 250 ~~p~~~~~l~~L~~L~Ls~n~~~~~~~~-~l~~~~------------------------L~~L~Ls~N~l~~~~p~~~~~ 304 (845)
..+..|..+++|+.|++++|......+. .+...+ |+.|+|++|.|++..+..|.+
T Consensus 191 ~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 270 (477)
T 2id5_A 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHE 270 (477)
T ss_dssp ECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTT
T ss_pred eChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccc
Confidence 8888888888888877777654332221 122224 455555555555444444555
Q ss_pred CCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhh--hcCCceEEeecCCCcCCCCCCCCCCCCCceee
Q 003134 305 MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLV 382 (845)
Q Consensus 305 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~--~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l 382 (845)
+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..+ ..+|+.|+|++| +|.|+|...|+.
T Consensus 271 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N--------~l~c~c~~~~~~ 342 (477)
T 2id5_A 271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN--------PLACDCRLLWVF 342 (477)
T ss_dssp CTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS--------CEECSGGGHHHH
T ss_pred cccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC--------CccCccchHhHH
Confidence 5555555555555554445555555555555555555553222222 124555555555 566777666555
Q ss_pred ee
Q 003134 383 ES 384 (845)
Q Consensus 383 ~~ 384 (845)
.|
T Consensus 343 ~~ 344 (477)
T 2id5_A 343 RR 344 (477)
T ss_dssp TT
T ss_pred hh
Confidence 44
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=346.60 Aligned_cols=284 Identities=19% Similarity=0.273 Sum_probs=252.7
Q ss_pred CccccCCccccCCCCCCEEeccCCcccCC-----------------Cccccc--cc-ceeEEEecCCCCCCCcccccccc
Q 003134 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGS-----------------FSPQWA--SL-QLVELSVMGNRLSGPFPKVLTNI 162 (845)
Q Consensus 103 ~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~-----------------~~~~~~--~l-~L~~L~Ls~N~l~~~~p~~~~~l 162 (845)
+++| +|+.|+++++|++|+|++|+|++. +|..++ .+ +|++|+|++|++.+.+|..|+++
T Consensus 194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 272 (636)
T 4eco_A 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272 (636)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence 4556 899999999999999999999996 899988 88 99999999999999999999999
Q ss_pred cccceeEeeccc-CCC-CCCcccccC------CCccEEEeecCcCcccCCh--hhhCCCCCCcEEeecCcCcccCchhhc
Q 003134 163 TTLKNLSIEGNL-FTG-SIPPDIRKL------INLQKLILSSNSFTGELPA--ELTKLTNLNDLRISDNNFSGKIPEFIG 232 (845)
Q Consensus 163 ~~L~~L~Ls~N~-l~g-~~p~~~~~l------~~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 232 (845)
++|++|+|++|+ ++| .+|..++++ ++|++|+|++|+++ .+|. .|+++++|++|+|++|+++|.+| .|.
T Consensus 273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~ 350 (636)
T 4eco_A 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG 350 (636)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCE
T ss_pred CCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhC
Confidence 999999999999 998 899999887 99999999999999 8898 89999999999999999999999 999
Q ss_pred CCcccceEEecCCcCCCCcchhhhcCCC-CCEEEcCCCCCCCCCCcccccC---CccEEEccCCcCcccCccccc-----
Q 003134 233 KWKKIQKLHIQGSSLEGPIPASISALTS-LTDLRISDLKGSESAFPKLDKM---NLKTLILTKCLIHGEIPDYIG----- 303 (845)
Q Consensus 233 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~-L~~L~Ls~n~~~~~~~~~l~~~---~L~~L~Ls~N~l~~~~p~~~~----- 303 (845)
.+++|++|+|++|+++ .+|..+.++++ |+.|++++|.++..+. .+... +|+.|+|++|.+++.+|..|.
T Consensus 351 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~ 428 (636)
T 4eco_A 351 SEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPN-IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428 (636)
T ss_dssp EEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCS-CCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSS
T ss_pred CCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccch-hhhhcccCccCEEECcCCcCCCcchhhhcccccc
Confidence 9999999999999999 88999999999 9999999999995543 33332 799999999999999999998
Q ss_pred --CCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhc----------CCceEEeecCCCcCCCCCC
Q 003134 304 --DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN----------SNKNVDISLNNFTWESSDP 371 (845)
Q Consensus 304 --~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~----------~l~~L~ls~N~l~~~~p~~ 371 (845)
.+++|++|+|++|+|+...+..+..+++|++|+|++|+++ .+|...+. .|+.|+|++|+++ .+|..
T Consensus 429 ~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~ 506 (636)
T 4eco_A 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDD 506 (636)
T ss_dssp CCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGG
T ss_pred cccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChh
Confidence 8899999999999999655556777999999999999999 88877654 8999999999999 45543
Q ss_pred CCCCCCCceeeeeecCCCCCCCCc
Q 003134 372 IECPRGSVNLVESYSSPRNKLDKV 395 (845)
Q Consensus 372 ~~c~~~~~~~l~~l~~~~n~~~~~ 395 (845)
+. ...+..++.++.+.|++.+.
T Consensus 507 ~~--~~~l~~L~~L~Ls~N~l~~i 528 (636)
T 4eco_A 507 FR--ATTLPYLVGIDLSYNSFSKF 528 (636)
T ss_dssp GS--TTTCTTCCEEECCSSCCSSC
T ss_pred hh--hccCCCcCEEECCCCCCCCc
Confidence 31 01345577788999988863
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=339.81 Aligned_cols=308 Identities=19% Similarity=0.229 Sum_probs=238.1
Q ss_pred cceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeE
Q 003134 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (845)
Q Consensus 91 ~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 169 (845)
+..++.|||++|.|++..+.+|.++++|++|||++|+|+++.+.+|..+ +|++|+|++|+|++..+..|.++++|++|+
T Consensus 51 p~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 51 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred CcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 3578999999999998888899999999999999999999999999999 999999999999988888999999999999
Q ss_pred eecccCCCCCCcccccCCCccEEEeecCcCcc-cCChhhhCCCCCCcEEeecCcCcccCchhhcC---------------
Q 003134 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGK--------------- 233 (845)
Q Consensus 170 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--------------- 233 (845)
|++|+|++..+..|+++++|++|+|++|++++ .+|..+.++++|++|+|++|+|++..|..|..
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~ 210 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 210 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhccc
Confidence 99999998877789999999999999999986 46888999999999999999887654432211
Q ss_pred --------------------------------------------------------------------------------
Q 003134 234 -------------------------------------------------------------------------------- 233 (845)
Q Consensus 234 -------------------------------------------------------------------------------- 233 (845)
T Consensus 211 n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~ 290 (635)
T 4g8a_A 211 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 290 (635)
T ss_dssp CCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred CcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 003134 234 -------------------------------------------------------------------------------W 234 (845)
Q Consensus 234 -------------------------------------------------------------------------------l 234 (845)
+
T Consensus 291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l 370 (635)
T 4g8a_A 291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 370 (635)
T ss_dssp CCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBC
T ss_pred hcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccc
Confidence 1
Q ss_pred cccceEEecCCcCCCC--c------------------------------------------------chhhhcCCCCCEE
Q 003134 235 KKIQKLHIQGSSLEGP--I------------------------------------------------PASISALTSLTDL 264 (845)
Q Consensus 235 ~~L~~L~Ls~N~l~g~--~------------------------------------------------p~~~~~l~~L~~L 264 (845)
++|+.|++++|.+... . +..+..+.+++.+
T Consensus 371 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l 450 (635)
T 4g8a_A 371 PSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 450 (635)
T ss_dssp TTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEE
T ss_pred cccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccc
Confidence 2333344444433210 0 0112233334444
Q ss_pred EcCCCCCCCCC-------------------------CcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCC
Q 003134 265 RISDLKGSESA-------------------------FPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNL 318 (845)
Q Consensus 265 ~Ls~n~~~~~~-------------------------~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 318 (845)
+++.|.+.... +..+... +|+.|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 451 ~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l 530 (635)
T 4g8a_A 451 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 530 (635)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred cccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcC
Confidence 44444432221 1222222 788899999999988888888899999999999999
Q ss_pred CCCCchhhhcCCCcCEEEccCCcccCCCChhhh---cCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCCCCCc
Q 003134 319 TGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKV 395 (845)
Q Consensus 319 ~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~---~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~~~~~ 395 (845)
++..|..|.++++|++|+|++|+|++..|..+. .+|+.|+|++| ||.|+|...+++.|+......+...
T Consensus 531 ~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~N--------p~~C~C~~~~~~~wl~~~~~~~~~~ 602 (635)
T 4g8a_A 531 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN--------DFACTCEHQSFLQWIKDQRQLLVEV 602 (635)
T ss_dssp CBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTC--------CBCCSGGGHHHHHHHHHTTTTBSCG
T ss_pred CCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCC--------CCcccCCcHHHHHHHHhCCCccCCC
Confidence 888888888899999999999999888887763 47888999998 8999999999999997665544332
Q ss_pred cCcccCCCCCCCCCCc
Q 003134 396 HPCLRQNFPCSAPADQ 411 (845)
Q Consensus 396 ~~c~~~~~~c~~~~~~ 411 (845)
....|..|...
T Consensus 603 -----~~~~C~~P~~~ 613 (635)
T 4g8a_A 603 -----ERMECATPSDK 613 (635)
T ss_dssp -----GGCBBCSSTTT
T ss_pred -----CCceeCCchHH
Confidence 23446555443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=312.86 Aligned_cols=246 Identities=26% Similarity=0.405 Sum_probs=185.1
Q ss_pred CCCCEEeccCCcccC--CCccccccc-ceeEEEecC-CCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccE
Q 003134 116 RYLKQLDLSRNCLTG--SFSPQWASL-QLVELSVMG-NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191 (845)
Q Consensus 116 ~~L~~L~Ls~N~l~~--~~~~~~~~l-~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 191 (845)
.+++.|+|++|.+++ .+|..+..+ +|++|+|++ |++.+.+|..|+++++|++|+|++|++++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 356677777777776 666666666 666666663 6666666666666666666666666666666666666666666
Q ss_pred EEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCc-ccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCC
Q 003134 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWK-KIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270 (845)
Q Consensus 192 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~ 270 (845)
|+|++|++++.+|..|.++++|++|+|++|+|++.+|..+..++ +|++|+|++|++++.+|..+..+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l------------ 197 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL------------ 197 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC------------
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCC------------
Confidence 66666666666666666666666666666666666666666665 66666666666666666665554
Q ss_pred CCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhh
Q 003134 271 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI 350 (845)
Q Consensus 271 ~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~ 350 (845)
+|+.|+|++|.+++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+
T Consensus 198 ------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l 264 (313)
T 1ogq_A 198 ------------NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp ------------CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGG
T ss_pred ------------cccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHH
Confidence 456778888899999999999999999999999999977776 8899999999999999999999988
Q ss_pred h--cCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCC
Q 003134 351 F--NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNK 391 (845)
Q Consensus 351 ~--~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~ 391 (845)
. ..|+.|+|++|+++|.+|.. ..+..++.++...|+
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~-----~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQG-----GNLQRFDVSAYANNK 302 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCS-----TTGGGSCGGGTCSSS
T ss_pred hcCcCCCEEECcCCcccccCCCC-----ccccccChHHhcCCC
Confidence 5 48999999999999999853 345556667777665
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=311.19 Aligned_cols=277 Identities=20% Similarity=0.307 Sum_probs=209.6
Q ss_pred hhcCCCHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCcccc--CCCCCCCccceeecCC------CCcceEEEEEecCCC
Q 003134 32 TANKLHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELS--SDDKKGFESNVTCDCS------SATCHVVTIALKAQN 103 (845)
Q Consensus 32 ~~~~~~~~~~~aL~~~~~~~~~~~W~~~~d~c~~~~~w~~~--~~~~~~~~~~v~C~~~------~~~~~v~~L~l~~~~ 103 (845)
+......+|+.||++||+++. .|+|.|.+.|... .....+.|.|+.|+.. ....+|+.|+|++|+
T Consensus 20 ~~~~~~~~~~~aLl~~k~~~~-------~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~ 92 (328)
T 4fcg_A 20 QGSTALRPYHDVLSQWQRHYN-------ADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVP 92 (328)
T ss_dssp C--CCCCCHHHHHHHHHHHHH-------HCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSC
T ss_pred eccccCchHHHHHHHHHHhcc-------CCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCC
Confidence 334455679999999999873 3455555555311 1122223457888521 123578889999988
Q ss_pred ccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcc
Q 003134 104 LTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPD 182 (845)
Q Consensus 104 l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 182 (845)
++ .+|+.+.++++|++|+|++|.|+ .+|..+..+ +|++|+|++|+|+ .+|..|.++++|++|+|++|++.+.+|..
T Consensus 93 l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~ 169 (328)
T 4fcg_A 93 LP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEP 169 (328)
T ss_dssp CS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSC
T ss_pred ch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChh
Confidence 88 77888888889999999888888 677777777 8888888888888 67878888888888888888888888877
Q ss_pred ccc---------CCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcch
Q 003134 183 IRK---------LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA 253 (845)
Q Consensus 183 ~~~---------l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 253 (845)
+.. +++|++|+|++|+|+ .+|..+.++++|++|+|++|++++ +|..+..+++|++|+|++|++.+.+|.
T Consensus 170 ~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~ 247 (328)
T 4fcg_A 170 LASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPP 247 (328)
T ss_dssp SEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCC
T ss_pred HhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHH
Confidence 654 788888888888887 777778888888888888888874 555677788888888888888777777
Q ss_pred hhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcC
Q 003134 254 SISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333 (845)
Q Consensus 254 ~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 333 (845)
.++++++|+.| +|++|.+.+.+|..+.++++|++|+|++|++.+.+|..+.++++|+
T Consensus 248 ~~~~l~~L~~L-----------------------~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~ 304 (328)
T 4fcg_A 248 IFGGRAPLKRL-----------------------ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304 (328)
T ss_dssp CTTCCCCCCEE-----------------------ECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTC
T ss_pred HhcCCCCCCEE-----------------------ECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCce
Confidence 77766655544 5666667778888888888999999999888888998899999988
Q ss_pred EEEccCCccc
Q 003134 334 FMYLTGNKLT 343 (845)
Q Consensus 334 ~L~L~~N~l~ 343 (845)
.+++..|.+.
T Consensus 305 ~l~l~~~~~~ 314 (328)
T 4fcg_A 305 IILVPPHLQA 314 (328)
T ss_dssp EEECCGGGSC
T ss_pred EEeCCHHHHH
Confidence 8888877665
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=334.08 Aligned_cols=288 Identities=20% Similarity=0.295 Sum_probs=168.6
Q ss_pred eEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEee
Q 003134 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 171 (845)
+++.|++++|.+++..+..|.++++|++|+|++|+++ .+|..+..+ +|++|+|++|++++..|..+.++++|++|+|+
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 333 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECC
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECC
Confidence 5677777777777666666777777777777777766 344555555 67777777777766666666666666666666
Q ss_pred cccCCCCCCcc-cccCCCccEEEeecCcCcccC--ChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCC
Q 003134 172 GNLFTGSIPPD-IRKLINLQKLILSSNSFTGEL--PAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 172 ~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
+|.+.+.+|.. +..+++|++|+|++|++++.. |..+.++++|++|+|++|++++..|..|..+++|++|++++|+++
T Consensus 334 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 413 (606)
T 3t6q_A 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413 (606)
T ss_dssp SCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEE
T ss_pred CCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCC
Confidence 66666555443 555666666666666665444 445555555555555555555555555555555555555555555
Q ss_pred CCcch-hhhcCCCCCEEEcCCCCCCCCCCcccccC----------------------------CccEEEccCCcCcccCc
Q 003134 249 GPIPA-SISALTSLTDLRISDLKGSESAFPKLDKM----------------------------NLKTLILTKCLIHGEIP 299 (845)
Q Consensus 249 g~~p~-~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~----------------------------~L~~L~Ls~N~l~~~~p 299 (845)
+..|. .+.++++|+.|++++|.+....+..+... +|+.|+|++|++++..|
T Consensus 414 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 493 (606)
T 3t6q_A 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493 (606)
T ss_dssp CCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECT
T ss_pred CcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccCh
Confidence 44332 24555555555555555444433333222 45555555555555555
Q ss_pred ccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhh--hcCCceEEeecCCCcCCCCCCCCCCCC
Q 003134 300 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRG 377 (845)
Q Consensus 300 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~--~~~l~~L~ls~N~l~~~~p~~~~c~~~ 377 (845)
..|.++++|++|+|++|++++.+|..|.++++| +|+|++|++++..|..+ ...++.|++++| ||.|+|.
T Consensus 494 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N--------~~~c~c~ 564 (606)
T 3t6q_A 494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQN--------PLDCTCS 564 (606)
T ss_dssp TTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTC--------CEECSGG
T ss_pred hhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCC--------CccccCC
Confidence 555555555555555555555555555555555 55555555554444433 234555555555 7899999
Q ss_pred CceeeeeecCCCC
Q 003134 378 SVNLVESYSSPRN 390 (845)
Q Consensus 378 ~~~~l~~l~~~~n 390 (845)
..++++|+.....
T Consensus 565 ~~~~~~w~~~~~~ 577 (606)
T 3t6q_A 565 NIYFLEWYKENMQ 577 (606)
T ss_dssp GHHHHHHHHHCGG
T ss_pred cHHHHHHHHhCcc
Confidence 9999999876543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=332.09 Aligned_cols=134 Identities=28% Similarity=0.323 Sum_probs=86.1
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|+|++|.+++..+..|.++++|++|+|++|+++++.|..|..+ +|++|+|++|++++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 456677777777776666666677777777777777766666666666 6666666666666666666666666666666
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcc-cCChhhhCCCCCCcEEeecCcCcc
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSG 225 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~~ 225 (845)
++|++++..|..|+++++|++|+|++|++++ .+|..|+++++|++|+|++|++++
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~ 167 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee
Confidence 6666665555556666666666666666654 345556666666665555555544
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-33 Score=316.23 Aligned_cols=295 Identities=20% Similarity=0.198 Sum_probs=253.9
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCc-ccccccccccceeEeecc
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPF-PKVLTNITTLKNLSIEGN 173 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N 173 (845)
.++..+++++ .+|. +. ++|++|+|++|.|++..|..|..+ +|++|+|++|.+.+.+ +..|.++++|++|+|++|
T Consensus 14 ~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n 89 (455)
T 3v47_A 14 NAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89 (455)
T ss_dssp EEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred ccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence 4566677776 4565 33 789999999999999999999999 9999999999998665 568999999999999999
Q ss_pred cCCCCCCcccccCCCccEEEeecCcCcccCChh--hhCCCCCCcEEeecCcCcccCchh-hcCCcccceEEecCCcCCCC
Q 003134 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAE--LTKLTNLNDLRISDNNFSGKIPEF-IGKWKKIQKLHIQGSSLEGP 250 (845)
Q Consensus 174 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~--~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~g~ 250 (845)
++++..|..|.++++|++|+|++|++++.+|.. |.++++|++|+|++|++++..|.. +.++++|++|+|++|++++.
T Consensus 90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 169 (455)
T 3v47_A 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSI 169 (455)
T ss_dssp TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCC
T ss_pred ccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccccc
Confidence 999988999999999999999999999866655 999999999999999999888876 89999999999999999998
Q ss_pred cchhhhcC----------------------------------CCCCEEEcCCCCCCCCCCc-------------------
Q 003134 251 IPASISAL----------------------------------TSLTDLRISDLKGSESAFP------------------- 277 (845)
Q Consensus 251 ~p~~~~~l----------------------------------~~L~~L~Ls~n~~~~~~~~------------------- 277 (845)
.|..+..+ ++|+.|++++|.+.+..+.
T Consensus 170 ~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~ 249 (455)
T 3v47_A 170 CEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249 (455)
T ss_dssp CTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTC
T ss_pred ChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccc
Confidence 88877665 5788888888876532111
Q ss_pred ---------------------ccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEE
Q 003134 278 ---------------------KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336 (845)
Q Consensus 278 ---------------------~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 336 (845)
.+...+|+.|+|++|.+++..|..|..+++|++|+|++|++++..|..|.++++|++|+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 329 (455)
T 3v47_A 250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLN 329 (455)
T ss_dssp TTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEE
Confidence 11123799999999999999999999999999999999999999999999999999999
Q ss_pred ccCCcccCCCChhhh--cCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCCCCCccCc
Q 003134 337 LTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 398 (845)
Q Consensus 337 L~~N~l~g~ip~~~~--~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~~~~~~~c 398 (845)
|++|++++..|..+. ..|+.|+|++|++++..|..+. .+..++.++.+.|++.+..+-
T Consensus 330 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----~l~~L~~L~L~~N~l~~~~~~ 389 (455)
T 3v47_A 330 LSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFL----GLPNLKELALDTNQLKSVPDG 389 (455)
T ss_dssp CCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTT----TCTTCCEEECCSSCCSCCCTT
T ss_pred CCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcc----ccccccEEECCCCccccCCHh
Confidence 999999977777763 5899999999999998886662 345677888999999876543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=317.53 Aligned_cols=297 Identities=18% Similarity=0.201 Sum_probs=261.3
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeeccc
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 174 (845)
.+++++++++ .+|..+. ++|++|+|++|+|++..+..|..+ +|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 4677778887 5676654 689999999999999999999999 99999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchh
Q 003134 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPAS 254 (845)
Q Consensus 175 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 254 (845)
+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 171 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA 171 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHH
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhH
Confidence 99776677899999999999999999999999999999999999999999999999999999999999999999988889
Q ss_pred hhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcC
Q 003134 255 ISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333 (845)
Q Consensus 255 ~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 333 (845)
|.++++|+.|++++|.+.......+... +|+.|+|++|.+.+.+|..+....+|+.|+|++|+|++..+..|..+++|+
T Consensus 172 l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 251 (477)
T 2id5_A 172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR 251 (477)
T ss_dssp HTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCC
T ss_pred hcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccC
Confidence 9999999999999999988777666655 899999999998888888777777999999999999976667899999999
Q ss_pred EEEccCCcccCCCChhhh--cCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCCCCCccCcc
Q 003134 334 FMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCL 399 (845)
Q Consensus 334 ~L~L~~N~l~g~ip~~~~--~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~~~~~~~c~ 399 (845)
.|+|++|++++..+..+. ..|+.|+|++|++++..|..+. .+..++.++.+.|++....+..
T Consensus 252 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----~l~~L~~L~L~~N~l~~~~~~~ 315 (477)
T 2id5_A 252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFR----GLNYLRVLNVSGNQLTTLEESV 315 (477)
T ss_dssp EEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBT----TCTTCCEEECCSSCCSCCCGGG
T ss_pred eeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhc----CcccCCEEECCCCcCceeCHhH
Confidence 999999999876665553 4789999999999988776652 3455777888888888765543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=341.10 Aligned_cols=93 Identities=19% Similarity=0.212 Sum_probs=77.9
Q ss_pred ccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCCC---------
Q 003134 300 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD--------- 370 (845)
Q Consensus 300 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p~--------- 370 (845)
..|.++++|+.|+|++|+|++.+|..|.++++|+.|+|++|+|++..|..+..+|+.|||++|++++.+|.
T Consensus 474 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~ 553 (844)
T 3j0a_A 474 DVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLD 553 (844)
T ss_dssp SCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEE
T ss_pred hhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEE
Confidence 34667788888888888888888888999999999999999999877777778899999999999988774
Q ss_pred ----CCCCCCCCceeeeeecCCCCCC
Q 003134 371 ----PIECPRGSVNLVESYSSPRNKL 392 (845)
Q Consensus 371 ----~~~c~~~~~~~l~~l~~~~n~~ 392 (845)
||.|+|...++..|+......+
T Consensus 554 l~~Np~~C~c~~~~f~~~~~~~~~~~ 579 (844)
T 3j0a_A 554 ITHNKFICECELSTFINWLNHTNVTI 579 (844)
T ss_dssp EEEECCCCSSSCCSHHHHHHHTTTTT
T ss_pred ecCCCcccccccHHHHHHHHhcCccc
Confidence 7899999999999987655443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=319.56 Aligned_cols=136 Identities=16% Similarity=0.169 Sum_probs=98.9
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|+|++|.+++..|..|.++++|++|+|++|+|++..|..|..+ +|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 467788888888887766778888888888888888888777788777 7888888888887 34544 6788888888
Q ss_pred ecccCCC-CCCcccccCCCccEEEeecCcCcccCChhhhCCCCC--CcEEeecCcC--cccCchhhcC
Q 003134 171 EGNLFTG-SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL--NDLRISDNNF--SGKIPEFIGK 233 (845)
Q Consensus 171 s~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~ 233 (845)
++|++++ .+|..|+++++|++|+|++|++++ ..+..+++| ++|+|++|++ ++..|..+..
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~ 162 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQD 162 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTT
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccc
Confidence 8888876 467778888888888888887764 334555555 6666666666 4455544444
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=303.49 Aligned_cols=160 Identities=27% Similarity=0.526 Sum_probs=144.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
..|+..++||+|+||+||+|++. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888899999999999999986 59999999998766666678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
+||+|.+++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.+..+.
T Consensus 154 ~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 154 EGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp TTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 99999999853 25899999999999999999999997 9999999999999999999999999999886544
Q ss_pred ceeeeeeccCC
Q 003134 835 THISTRIAGTM 845 (845)
Q Consensus 835 ~~~~t~~~GT~ 845 (845)
.. .+.++||+
T Consensus 225 ~~-~~~~~GTp 234 (346)
T 4fih_A 225 PR-RKSLVGTP 234 (346)
T ss_dssp CC-BCCCCSCG
T ss_pred Cc-ccccccCc
Confidence 33 34577885
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-32 Score=326.83 Aligned_cols=293 Identities=18% Similarity=0.216 Sum_probs=240.2
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCC--Cccccccc---ceeEEEecCCCCCCCcccccccccccc
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS--FSPQWASL---QLVELSVMGNRLSGPFPKVLTNITTLK 166 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~--~~~~~~~l---~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 166 (845)
.+++.|++++|.+++..+..|.++++|++|+|++|.++.. ....|..+ +|+.|+|++|++++..|..|..+++|+
T Consensus 329 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 408 (680)
T 1ziw_A 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE 408 (680)
T ss_dssp TTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCC
Confidence 3567777778888777777778888888888887765432 22333333 688888888888888888899999999
Q ss_pred eeEeecccCCCCCC-cccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCc--ccCchhhcCCcccceEEec
Q 003134 167 NLSIEGNLFTGSIP-PDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS--GKIPEFIGKWKKIQKLHIQ 243 (845)
Q Consensus 167 ~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls 243 (845)
+|+|++|++++.+| ..|.++++|++|+|++|++++..+..|..+++|++|++++|+++ +.+|..|.++++|++|+|+
T Consensus 409 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls 488 (680)
T 1ziw_A 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS 488 (680)
T ss_dssp EEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECC
T ss_pred EEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECC
Confidence 99999999987666 57888999999999999998888888999999999999999887 5788899999999999999
Q ss_pred CCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCc--------ccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCC
Q 003134 244 GSSLEGPIPASISALTSLTDLRISDLKGSESAFP--------KLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 314 (845)
Q Consensus 244 ~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~--------~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 314 (845)
+|++++..+..|.++++|+.|++++|.++..... .+... +|+.|+|++|+|+...+..|.++++|+.|+|+
T Consensus 489 ~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 568 (680)
T 1ziw_A 489 NNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECC
Confidence 9999988888899999999999999998764221 23333 89999999999996666679999999999999
Q ss_pred CCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhh---hcCCceEEeecCCCcCCCCCCCCCCCCC-ceeeeeecCCCC
Q 003134 315 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFTWESSDPIECPRGS-VNLVESYSSPRN 390 (845)
Q Consensus 315 ~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~---~~~l~~L~ls~N~l~~~~p~~~~c~~~~-~~~l~~l~~~~n 390 (845)
+|+|++..+..|.++++|+.|+|++|+|++..|..+ +.+++.|++++| ||.|+|.. .++..|+.....
T Consensus 569 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N--------~~~c~c~~~~~~~~~~~~~~~ 640 (680)
T 1ziw_A 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN--------PFDCTCESIAWFVNWINETHT 640 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTC--------CCCBCCCCCSSEECCSSCC--
T ss_pred CCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCC--------CcccCCccHHHHHHHHHhcCc
Confidence 999998888888999999999999999998776654 468999999999 89999996 899999876554
Q ss_pred CC
Q 003134 391 KL 392 (845)
Q Consensus 391 ~~ 392 (845)
.+
T Consensus 641 ~~ 642 (680)
T 1ziw_A 641 NI 642 (680)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-32 Score=319.02 Aligned_cols=296 Identities=20% Similarity=0.213 Sum_probs=224.4
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|+|++|.+++..|..|.++++|++|+|++|+|++..|..|..+ +|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 578899999999998888899999999999999999999999999998 8999999999999 45655 7999999999
Q ss_pred ecccCCC-CCCcccccCCCccEEEeecCcCcccCChhhhCCCCC--CcEEeecCcC--cccCchhhcCCc----------
Q 003134 171 EGNLFTG-SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL--NDLRISDNNF--SGKIPEFIGKWK---------- 235 (845)
Q Consensus 171 s~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~---------- 235 (845)
++|++++ .+|..|+++++|++|+|++|++++. .+..+++| ++|+|++|++ ++..|..|..+.
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 205 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHP 205 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECS
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecC
Confidence 9999996 4568999999999999999999863 34455555 9999999998 777776665543
Q ss_pred -----------------------------------------------------------------------ccceEEecC
Q 003134 236 -----------------------------------------------------------------------KIQKLHIQG 244 (845)
Q Consensus 236 -----------------------------------------------------------------------~L~~L~Ls~ 244 (845)
+|++|++++
T Consensus 206 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~ 285 (562)
T 3a79_B 206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285 (562)
T ss_dssp SSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEE
T ss_pred ccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEec
Confidence 677788888
Q ss_pred CcCCCCcchhh-----------------------------------------------------hcCCCCCEEEcCCCCC
Q 003134 245 SSLEGPIPASI-----------------------------------------------------SALTSLTDLRISDLKG 271 (845)
Q Consensus 245 N~l~g~~p~~~-----------------------------------------------------~~l~~L~~L~Ls~n~~ 271 (845)
|+++|.+|..+ ..+++|+.|++++|.+
T Consensus 286 n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l 365 (562)
T 3a79_B 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365 (562)
T ss_dssp EEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCC
T ss_pred cEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCcc
Confidence 88887777655 5566777777777777
Q ss_pred CCCCCcccccC-CccEEEccCCcCccc--CcccccCCCCcCEEeCCCCCCCCCCch-hhhcCCCcCEEEccCCcccCCCC
Q 003134 272 SESAFPKLDKM-NLKTLILTKCLIHGE--IPDYIGDMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGNKLTGPVP 347 (845)
Q Consensus 272 ~~~~~~~l~~~-~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~L~~N~l~g~ip 347 (845)
++..+..+... +|+.|+|++|++++. +|..|.++++|+.|+|++|++++.+|. .+..+++|++|+|++|++++.+|
T Consensus 366 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 445 (562)
T 3a79_B 366 TDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVF 445 (562)
T ss_dssp CTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGG
T ss_pred ccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchh
Confidence 76555555444 677777777777763 345677777777777777777764443 46677777777777777777666
Q ss_pred hhhhcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCCCCCccCc
Q 003134 348 KYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 398 (845)
Q Consensus 348 ~~~~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~~~~~~~c 398 (845)
..+...|+.|+|++|+++. +|..+. .+..++.++.+.|++......
T Consensus 446 ~~l~~~L~~L~L~~N~l~~-ip~~~~----~l~~L~~L~L~~N~l~~l~~~ 491 (562)
T 3a79_B 446 RCLPPKVKVLDLHNNRIMS-IPKDVT----HLQALQELNVASNQLKSVPDG 491 (562)
T ss_dssp SSCCTTCSEEECCSSCCCC-CCTTTT----SSCCCSEEECCSSCCCCCCTT
T ss_pred hhhcCcCCEEECCCCcCcc-cChhhc----CCCCCCEEECCCCCCCCCCHH
Confidence 6665677778888887773 332221 334566677777777765443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-32 Score=317.11 Aligned_cols=284 Identities=20% Similarity=0.246 Sum_probs=199.3
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCC-CcccccccccccceeE
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSG-PFPKVLTNITTLKNLS 169 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ 169 (845)
.+++.|+|++|.+++..|..|+++++|++|+|++|+|+.+ |.. .+ +|++|+|++|+|++ .+|..|+++++|++|+
T Consensus 45 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l-p~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~ 121 (520)
T 2z7x_B 45 SKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI-SCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121 (520)
T ss_dssp TTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEE-ECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEE
T ss_pred ccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeec-Ccc--ccCCccEEeccCCccccccchhhhccCCcceEEE
Confidence 4788999999999998899999999999999999999854 444 45 89999999999987 4788899899888888
Q ss_pred eecccCCC-------------------------CCCcccccCC-------------------------------------
Q 003134 170 IEGNLFTG-------------------------SIPPDIRKLI------------------------------------- 187 (845)
Q Consensus 170 Ls~N~l~g-------------------------~~p~~~~~l~------------------------------------- 187 (845)
|++|+|++ ..|..|..+.
T Consensus 122 L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 201 (520)
T 2z7x_B 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVL 201 (520)
T ss_dssp EEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECC
T ss_pred ecCcccchhhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccc
Confidence 88887753 2333333321
Q ss_pred ----------------------------------------------CccEEEeecCcCcccCChhh--------------
Q 003134 188 ----------------------------------------------NLQKLILSSNSFTGELPAEL-------------- 207 (845)
Q Consensus 188 ----------------------------------------------~L~~L~Ls~N~l~g~~p~~~-------------- 207 (845)
+|++|++++|+++|.+|..+
T Consensus 202 ~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l 281 (520)
T 2z7x_B 202 EDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH 281 (520)
T ss_dssp STTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEE
T ss_pred cccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEec
Confidence 45555666666665555443
Q ss_pred ---------------------------------------hCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCC
Q 003134 208 ---------------------------------------TKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 208 ---------------------------------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
..+++|++|+|++|++++.+|..++.+++|++|+|++|+++
T Consensus 282 ~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 361 (520)
T 2z7x_B 282 QVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361 (520)
T ss_dssp EEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCC
T ss_pred cccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccC
Confidence 45566666677777776666666666777777777777776
Q ss_pred C--CcchhhhcCCCCCEEEcCCCCCCC-CCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCch
Q 003134 249 G--PIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT 324 (845)
Q Consensus 249 g--~~p~~~~~l~~L~~L~Ls~n~~~~-~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 324 (845)
+ .+|..++.+++|+.|++++|.+.. .+...+... +|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|.
T Consensus 362 ~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~ 438 (520)
T 2z7x_B 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPK 438 (520)
T ss_dssp BHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCG
T ss_pred ccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccch
Confidence 5 445666677777777777777665 333323332 677777777777766666554 67777777777777 6666
Q ss_pred hhhcCCCcCEEEccCCcccCCCChh-h--hcCCceEEeecCCCcCCCCCCCCCCCCCcee-eeeecCCCC
Q 003134 325 TFEKLAKTNFMYLTGNKLTGPVPKY-I--FNSNKNVDISLNNFTWESSDPIECPRGSVNL-VESYSSPRN 390 (845)
Q Consensus 325 ~~~~l~~L~~L~L~~N~l~g~ip~~-~--~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~-l~~l~~~~n 390 (845)
.+..+++|++|+|++|+|+ .+|.. + ...|+.|++++| +|.|+|...++ ..|+.....
T Consensus 439 ~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N--------~~~c~c~~~~~~~~~~~~~~~ 499 (520)
T 2z7x_B 439 QVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN--------PWDCSCPRIDYLSRWLNKNSQ 499 (520)
T ss_dssp GGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSS--------CBCCCHHHHHHHHHHHHHTTT
T ss_pred hhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCC--------CCcccCCchHHHHHHHHhccc
Confidence 6667777777777777777 45554 3 236777777777 67788887777 777765443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-33 Score=301.55 Aligned_cols=167 Identities=31% Similarity=0.531 Sum_probs=140.9
Q ss_pred cCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
++|...+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..||
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46777899999999999999864 378899999987766667889999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCc--------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEE
Q 003134 750 VYEYMKNNCLSRAIFGKDT--------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl 821 (845)
|||||++|+|.++++.... .....++|.++++|+.|||+||+|||+++ ||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 9999999999999975431 12347999999999999999999999986 999999999999999999999
Q ss_pred EeeccceecCCCCce-eeeeeccCC
Q 003134 822 SDFGLAKLYEEDKTH-ISTRIAGTM 845 (845)
Q Consensus 822 ~DFGla~~~~~~~~~-~~t~~~GT~ 845 (845)
+|||+|+........ ......||+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~ 194 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPI 194 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECG
T ss_pred CCcccceecCCCCceeecCceecCh
Confidence 999999987544332 222345653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-33 Score=302.62 Aligned_cols=167 Identities=29% Similarity=0.498 Sum_probs=134.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
++|...++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34566789999999999999864 378999999987766667889999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcE
Q 003134 750 VYEYMKNNCLSRAIFGKDTE----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~ 819 (845)
|||||++|+|.++++..... ...+++|.++++|+.|||+||+|||+++ ||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 99999999999999764321 1246999999999999999999999986 9999999999999999999
Q ss_pred EEEeeccceecCCCCc-eeeeeeccCC
Q 003134 820 KISDFGLAKLYEEDKT-HISTRIAGTM 845 (845)
Q Consensus 820 kl~DFGla~~~~~~~~-~~~t~~~GT~ 845 (845)
||+|||+|+....... ...+..+||+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~ 224 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPI 224 (329)
T ss_dssp EECCCC----------------CCCCG
T ss_pred EEcccccceeccCCCcceecCcccccc
Confidence 9999999998754332 2334566764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=296.56 Aligned_cols=162 Identities=28% Similarity=0.411 Sum_probs=143.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc---cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46889999999999999999975 5899999999754 2344678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||++||+|.+++... ..+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+.
T Consensus 112 Ey~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 999999999999543 36899999999999999999999997 9999999999999999999999999999986
Q ss_pred CCCc-eeeeeeccCC
Q 003134 832 EDKT-HISTRIAGTM 845 (845)
Q Consensus 832 ~~~~-~~~t~~~GT~ 845 (845)
.+.. .....++||+
T Consensus 184 ~~~~~~~~~~~~GTp 198 (311)
T 4aw0_A 184 PESKQARANSFVGTA 198 (311)
T ss_dssp TTTTCCCBCCCCSCG
T ss_pred CCCCcccccCcccCc
Confidence 5433 3345678885
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.1e-32 Score=317.18 Aligned_cols=296 Identities=20% Similarity=0.203 Sum_probs=219.9
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|+|++|.+++..|..|.++++|++|+|++|++++..|..|..+ +|++|+|++|++++..|..|+++++|++|+|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 478999999999999889999999999999999999999999999998 9999999999999988888999999999999
Q ss_pred ecccCCC-CCCcccccCCCccEEEeecCcCcccCC-hhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCC
Q 003134 171 EGNLFTG-SIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 171 s~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
++|++++ ..|..|.++++|++|+|++|++.+.+| ..|.++++|++|+|++|++++..|..+..+++|++|+++.|.+.
T Consensus 106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~ 185 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185 (549)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST
T ss_pred CCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc
Confidence 9999996 357789999999999999999555555 67999999999999999999888888776555555555444443
Q ss_pred CCcchhhhcCCCCCEEEcCCCCCCC-------------------------------------------------------
Q 003134 249 GPIPASISALTSLTDLRISDLKGSE------------------------------------------------------- 273 (845)
Q Consensus 249 g~~p~~~~~l~~L~~L~Ls~n~~~~------------------------------------------------------- 273 (845)
...+..+..+++|+.|++++|.+.+
T Consensus 186 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~ 265 (549)
T 2z81_A 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265 (549)
T ss_dssp THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEEC
T ss_pred ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccc
Confidence 2211122233444444444433332
Q ss_pred -----------------------------------------------------------CCCcccc-cCCccEEEccCCc
Q 003134 274 -----------------------------------------------------------SAFPKLD-KMNLKTLILTKCL 293 (845)
Q Consensus 274 -----------------------------------------------------------~~~~~l~-~~~L~~L~Ls~N~ 293 (845)
.+...+. ..+|+.|+|++|+
T Consensus 266 ~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~ 345 (549)
T 2z81_A 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENL 345 (549)
T ss_dssp CSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSC
T ss_pred cccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCc
Confidence 1111111 2378888888888
Q ss_pred CcccCcc---cccCCCCcCEEeCCCCCCCCCCc--hhhhcCCCcCEEEccCCcccCCCChhhh--cCCceEEeecCCCcC
Q 003134 294 IHGEIPD---YIGDMTKLKNIDLSFNNLTGGIP--TTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTW 366 (845)
Q Consensus 294 l~~~~p~---~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~l~~L~ls~N~l~~ 366 (845)
+++.+|. .++.+++|+.|+|++|+|++..+ ..+..+++|++|+|++|+++ .+|..+. ..|+.|++++|.++.
T Consensus 346 l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~ 424 (549)
T 2z81_A 346 MVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV 424 (549)
T ss_dssp CCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC
T ss_pred cccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc
Confidence 8887643 36778888888888888885533 45788888888888888888 5666553 477888888887764
Q ss_pred CCCCCCCCCCCCceeeeeecCCCCCCCCc
Q 003134 367 ESSDPIECPRGSVNLVESYSSPRNKLDKV 395 (845)
Q Consensus 367 ~~p~~~~c~~~~~~~l~~l~~~~n~~~~~ 395 (845)
... .+ ...++.++.+.|++++.
T Consensus 425 l~~-~~------~~~L~~L~Ls~N~l~~~ 446 (549)
T 2z81_A 425 VKT-CI------PQTLEVLDVSNNNLDSF 446 (549)
T ss_dssp CCT-TS------CTTCSEEECCSSCCSCC
T ss_pred ccc-hh------cCCceEEECCCCChhhh
Confidence 322 11 12355666667666653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.4e-32 Score=320.43 Aligned_cols=300 Identities=16% Similarity=0.146 Sum_probs=241.9
Q ss_pred cceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeE
Q 003134 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (845)
Q Consensus 91 ~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 169 (845)
+.+++.|+|++|.+++..|..|+++++|++|+|++|+++++.|..|..+ +|++|+|++|++++..|..|+++++|++|+
T Consensus 32 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 111 (606)
T 3t6q_A 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111 (606)
T ss_dssp CTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEE
T ss_pred CCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEee
Confidence 3578999999999999889999999999999999999999999999999 999999999999999999999999999999
Q ss_pred eecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccc--eEEecCCcC
Q 003134 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ--KLHIQGSSL 247 (845)
Q Consensus 170 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~--~L~Ls~N~l 247 (845)
|++|++++..|..|.++++|++|+|++|++++..+..+.++++|++|+|++|++++..|..|+.+++|+ .|++++|++
T Consensus 112 L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l 191 (606)
T 3t6q_A 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191 (606)
T ss_dssp CTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred ccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence 999999987788899999999999999999975545566699999999999999988899999999999 889999998
Q ss_pred CCCcchhhhcC---------------------------------------------------CCCCEEEcCCCCCCCCCC
Q 003134 248 EGPIPASISAL---------------------------------------------------TSLTDLRISDLKGSESAF 276 (845)
Q Consensus 248 ~g~~p~~~~~l---------------------------------------------------~~L~~L~Ls~n~~~~~~~ 276 (845)
++..|..+... .+|+.|++++|.+.....
T Consensus 192 ~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~ 271 (606)
T 3t6q_A 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271 (606)
T ss_dssp CEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCT
T ss_pred CccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCH
Confidence 87766554321 056667777777776666
Q ss_pred cccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhh---hc
Q 003134 277 PKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FN 352 (845)
Q Consensus 277 ~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~---~~ 352 (845)
..+... +|++|+|++|+++ .+|..+.++++|++|+|++|++++..|..+.++++|++|++++|.+.+.+|... ..
T Consensus 272 ~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~ 350 (606)
T 3t6q_A 272 NTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350 (606)
T ss_dssp TTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT
T ss_pred HHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccC
Confidence 655554 7888888888877 667777778888888888888887777778888888888888888777776553 24
Q ss_pred CCceEEeecCCCcCCC--CCCCCCCCCCceeeeeecCCCCCCCCc
Q 003134 353 SNKNVDISLNNFTWES--SDPIECPRGSVNLVESYSSPRNKLDKV 395 (845)
Q Consensus 353 ~l~~L~ls~N~l~~~~--p~~~~c~~~~~~~l~~l~~~~n~~~~~ 395 (845)
.|+.|++++|.+++.. |..+ ..+..++.++.+.|++...
T Consensus 351 ~L~~L~l~~n~l~~~~~~~~~~----~~l~~L~~L~l~~n~l~~~ 391 (606)
T 3t6q_A 351 NLRELDLSHDDIETSDCCNLQL----RNLSHLQSLNLSYNEPLSL 391 (606)
T ss_dssp TCCEEECCSSCCCEEEESTTTT----TTCTTCCEEECCSCSCEEE
T ss_pred cCCEEECCCCccccccCcchhc----ccCCCCCEEECCCCcCCcC
Confidence 6777888888777654 3222 2233455666666666544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-33 Score=303.45 Aligned_cols=163 Identities=25% Similarity=0.423 Sum_probs=136.3
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+++.+|+++|++++|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999975 59999999997542 2345689999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
||+||+|.+++.... ...+++.+++.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+..
T Consensus 104 y~~gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 999999999996532 235789999999999999999999997 99999999999999999999999999998754
Q ss_pred CCceeeeeeccCC
Q 003134 833 DKTHISTRIAGTM 845 (845)
Q Consensus 833 ~~~~~~t~~~GT~ 845 (845)
... ..+..+||+
T Consensus 178 ~~~-~~~~~~GT~ 189 (350)
T 4b9d_A 178 TVE-LARACIGTP 189 (350)
T ss_dssp HHH-HHHHHHSCC
T ss_pred Ccc-cccccCCCc
Confidence 322 234467875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.8e-32 Score=303.62 Aligned_cols=286 Identities=16% Similarity=0.137 Sum_probs=230.5
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.+++.++.++...+..|..+++|++|+|++|.+++..+..|..+ +|++|+|++|++++..|..|.++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 467889999999886555568999999999999999999988899988 8999999999999999999999999999999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccc------------
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ------------ 238 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~------------ 238 (845)
++|+++...+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++.. +..+++|+
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSEE
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeeccccccccc
Confidence 999999555555789999999999999999888888999999999999999999653 33344444
Q ss_pred -------eEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCccccc-CCccEEEccCCcCcccCcccccCCCCcCE
Q 003134 239 -------KLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKN 310 (845)
Q Consensus 239 -------~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 310 (845)
+|++++|+++.. |. ...++|+.|++++|.+++. +.+.. .+|+.|+|++|.+++..|..|..+++|++
T Consensus 202 ~~~~~L~~L~l~~n~l~~~-~~--~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 276 (390)
T 3o6n_A 202 AIPIAVEELDASHNSINVV-RG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 276 (390)
T ss_dssp ECCSSCSEEECCSSCCCEE-EC--CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCE
T ss_pred CCCCcceEEECCCCeeeec-cc--cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCE
Confidence 444444544432 22 1235788888888888765 33333 38999999999999988999999999999
Q ss_pred EeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhh--hcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCC
Q 003134 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSP 388 (845)
Q Consensus 311 L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~--~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~ 388 (845)
|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+ +..|+.|++++|+++.... .....++.++..
T Consensus 277 L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~~-------~~~~~L~~L~l~ 347 (390)
T 3o6n_A 277 LYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKL-------STHHTLKNLTLS 347 (390)
T ss_dssp EECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCC-------CTTCCCSEEECC
T ss_pred EECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeCc-------hhhccCCEEEcC
Confidence 9999999985 5667788899999999999998 456555 4689999999999886532 233456677788
Q ss_pred CCCCCC
Q 003134 389 RNKLDK 394 (845)
Q Consensus 389 ~n~~~~ 394 (845)
.|++.+
T Consensus 348 ~N~~~~ 353 (390)
T 3o6n_A 348 HNDWDC 353 (390)
T ss_dssp SSCEEH
T ss_pred CCCccc
Confidence 887765
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=305.11 Aligned_cols=160 Identities=27% Similarity=0.528 Sum_probs=144.3
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
+.|+..++||+|+||.||+|++. +|+.||||++........+.+.+|+++|++++|||||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56889999999999999999986 59999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
+||+|.+++... .+++.++..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.+..+.
T Consensus 231 ~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 231 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999998532 5899999999999999999999997 9999999999999999999999999999886544
Q ss_pred ceeeeeeccCC
Q 003134 835 THISTRIAGTM 845 (845)
Q Consensus 835 ~~~~t~~~GT~ 845 (845)
.. .+.++||+
T Consensus 302 ~~-~~~~~GTp 311 (423)
T 4fie_A 302 PR-RKSLVGTP 311 (423)
T ss_dssp CC-BCCCEECT
T ss_pred cc-ccccccCc
Confidence 33 34577885
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.8e-32 Score=319.62 Aligned_cols=287 Identities=16% Similarity=0.117 Sum_probs=233.2
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.+++.++.++...+..|.++++|++|+|++|.|++..|..|..+ +|++|+|++|.|++..|..|+++++|++|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 356788999999987666678999999999999999999999899988 8999999999999999999999999999999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCC-
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG- 249 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g- 249 (845)
++|.|++..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+ +.+++|+.|++++|.+++
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~---~~l~~L~~L~l~~n~l~~l 207 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL---SLIPSLFHANVSYNLLSTL 207 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCG---GGCTTCSEEECCSSCCSEE
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcCh---hhhhhhhhhhcccCccccc
Confidence 9999997666667999999999999999999888899999999999999999997643 344555555555554443
Q ss_pred ------------------CcchhhhcCCCCCEEEcCCCCCCCCCCccccc-CCccEEEccCCcCcccCcccccCCCCcCE
Q 003134 250 ------------------PIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKN 310 (845)
Q Consensus 250 ------------------~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 310 (845)
..+.. .++|+.|+|++|.+++. ..+.. .+|+.|+|++|.|++.+|..|..+++|+.
T Consensus 208 ~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 282 (597)
T 3oja_B 208 AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 282 (597)
T ss_dssp ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCE
T ss_pred cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCE
Confidence 22111 24788888888888764 33333 38999999999999999999999999999
Q ss_pred EeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhh--hcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCC
Q 003134 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSP 388 (845)
Q Consensus 311 L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~--~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~ 388 (845)
|+|++|+|++ +|..+..+++|+.|+|++|+++ .+|..+ +..|+.|+|++|.+++... .....+..++.+
T Consensus 283 L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~-------~~~~~L~~L~l~ 353 (597)
T 3oja_B 283 LYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKL-------STHHTLKNLTLS 353 (597)
T ss_dssp EECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCC-------CTTCCCSEEECC
T ss_pred EECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcCh-------hhcCCCCEEEee
Confidence 9999999985 5777788999999999999998 567666 4589999999999886632 233456677788
Q ss_pred CCCCCCc
Q 003134 389 RNKLDKV 395 (845)
Q Consensus 389 ~n~~~~~ 395 (845)
.|.+.+.
T Consensus 354 ~N~~~~~ 360 (597)
T 3oja_B 354 HNDWDCN 360 (597)
T ss_dssp SSCEEHH
T ss_pred CCCCCCh
Confidence 8877643
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=314.04 Aligned_cols=284 Identities=18% Similarity=0.182 Sum_probs=206.3
Q ss_pred cceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCC-ccccccccccccee
Q 003134 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGP-FPKVLTNITTLKNL 168 (845)
Q Consensus 91 ~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L 168 (845)
..+++.|+|++|.+++..|..|.++++|++|+|++|+|+.+. .. .+ +|++|+|++|++++. +|..|+++++|++|
T Consensus 75 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp-~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L 151 (562)
T 3a79_B 75 LSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNIS-CC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFL 151 (562)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEEC-SC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEE
T ss_pred CCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccC-cc--ccccCCEEECCCCCccccCchHhhcccCcccEE
Confidence 357899999999999988999999999999999999999544 33 45 899999999999874 56889999999999
Q ss_pred EeecccCCCC-------------------------CCcccccCC------------------------------------
Q 003134 169 SIEGNLFTGS-------------------------IPPDIRKLI------------------------------------ 187 (845)
Q Consensus 169 ~Ls~N~l~g~-------------------------~p~~~~~l~------------------------------------ 187 (845)
+|++|++++. .|..|..+.
T Consensus 152 ~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 231 (562)
T 3a79_B 152 GLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN 231 (562)
T ss_dssp EEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECC
T ss_pred ecCCCccccCchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEeccccc
Confidence 9888887642 232332221
Q ss_pred ---------------------------------------------CccEEEeecCcCcccCChhh---------------
Q 003134 188 ---------------------------------------------NLQKLILSSNSFTGELPAEL--------------- 207 (845)
Q Consensus 188 ---------------------------------------------~L~~L~Ls~N~l~g~~p~~~--------------- 207 (845)
+|++|++++|+++|.+|..+
T Consensus 232 ~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~ 311 (562)
T 3a79_B 232 DENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEH 311 (562)
T ss_dssp STTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEE
T ss_pred ccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhh
Confidence 45555555555555555543
Q ss_pred --------------------------------------hCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCC
Q 003134 208 --------------------------------------TKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (845)
Q Consensus 208 --------------------------------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 249 (845)
..+++|++|+|++|++++.+|..+.++++|++|+|++|++++
T Consensus 312 ~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 391 (562)
T 3a79_B 312 VKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN 391 (562)
T ss_dssp EEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCB
T ss_pred cccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCC
Confidence 456677777777777777677777777777777777777776
Q ss_pred --CcchhhhcCCCCCEEEcCCCCCCC-CCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchh
Q 003134 250 --PIPASISALTSLTDLRISDLKGSE-SAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325 (845)
Q Consensus 250 --~~p~~~~~l~~L~~L~Ls~n~~~~-~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 325 (845)
.+|..+.++++|+.|++++|.+.. .+...+... +|+.|+|++|+|++.+|..+. ++|+.|+|++|+|+ .+|..
T Consensus 392 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~ 468 (562)
T 3a79_B 392 FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKD 468 (562)
T ss_dssp TTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTT
T ss_pred cccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChh
Confidence 335567777777777777777766 443333333 777777777777776666554 67888888888887 56666
Q ss_pred hhcCCCcCEEEccCCcccCCCChh-h--hcCCceEEeecCCCcCCCCCCCCCCCCCceeee-eecCCC
Q 003134 326 FEKLAKTNFMYLTGNKLTGPVPKY-I--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVE-SYSSPR 389 (845)
Q Consensus 326 ~~~l~~L~~L~L~~N~l~g~ip~~-~--~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~-~l~~~~ 389 (845)
+..+++|++|+|++|+|+ .+|.. + ...++.|++++| ||.|+|...+++. |.....
T Consensus 469 ~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N--------~~~c~c~~~~~~~~~~~~~~ 527 (562)
T 3a79_B 469 VTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN--------PWDCTCPGIRYLSEWINKHS 527 (562)
T ss_dssp TTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSC--------CBCCCHHHHHHHHHHHHHTT
T ss_pred hcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCC--------CcCCCcchHHHHHHHHHhcC
Confidence 668888888888888888 45554 3 346778888888 7889998888866 765444
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=293.44 Aligned_cols=161 Identities=27% Similarity=0.492 Sum_probs=132.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.+++...++||+|+||+||+|++.+ .||||+++... ....++|.+|+++|++++|||||+++|++. ++.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEE
Confidence 3567788999999999999998753 58999987542 334578999999999999999999999875 456899999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
||++|+|.++++... ..++|.++++|+.|||+||+|||+++ ||||||||+|||+++++++||+|||+|+....
T Consensus 112 y~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred cCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999997543 36999999999999999999999986 99999999999999999999999999998754
Q ss_pred CC-ceeeeeeccCC
Q 003134 833 DK-THISTRIAGTM 845 (845)
Q Consensus 833 ~~-~~~~t~~~GT~ 845 (845)
.. ....+..+||+
T Consensus 185 ~~~~~~~~~~~GT~ 198 (307)
T 3omv_A 185 WSGSQQVEQPTGSV 198 (307)
T ss_dssp ---------CCCCT
T ss_pred CCcceeecccccCC
Confidence 33 23344567885
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=327.95 Aligned_cols=301 Identities=15% Similarity=0.169 Sum_probs=250.7
Q ss_pred cceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCC-ccccccc-ceeEEEecCCCCCCCccccccccccccee
Q 003134 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSF-SPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL 168 (845)
Q Consensus 91 ~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~-~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 168 (845)
+.+++.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|..+ +|++|+|++|+|++..|..|.++++|++|
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 457899999999999999999999999999999999666555 7889998 99999999999999999999999999999
Q ss_pred EeecccCCCCCCcc--cccCCCccEEEeecCcCcccCC-hhhhCCCCCCcEEeecCcCcccCchhhcCC--cccceEEec
Q 003134 169 SIEGNLFTGSIPPD--IRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNFSGKIPEFIGKW--KKIQKLHIQ 243 (845)
Q Consensus 169 ~Ls~N~l~g~~p~~--~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls 243 (845)
+|++|++++.+|.. |.++++|++|+|++|++++..+ ..|+++++|++|+|++|++++..|..|..+ ++|+.|+|+
T Consensus 103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~ 182 (844)
T 3j0a_A 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182 (844)
T ss_dssp ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEEC
T ss_pred eCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECC
Confidence 99999999877765 9999999999999999998765 579999999999999999999999998887 889999999
Q ss_pred CCcCCCCcchhhhcCCC------CCEEEcCCCCCCCCCCccc--------------------------------------
Q 003134 244 GSSLEGPIPASISALTS------LTDLRISDLKGSESAFPKL-------------------------------------- 279 (845)
Q Consensus 244 ~N~l~g~~p~~~~~l~~------L~~L~Ls~n~~~~~~~~~l-------------------------------------- 279 (845)
+|.+.+..|..++.+.+ |+.|++++|.++...+..+
T Consensus 183 ~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~ 262 (844)
T 3j0a_A 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG 262 (844)
T ss_dssp CSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTT
T ss_pred CCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhc
Confidence 99999888887777665 8899998886654322111
Q ss_pred -ccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhh--cCCce
Q 003134 280 -DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKN 356 (845)
Q Consensus 280 -~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~l~~ 356 (845)
...+|+.|+|++|.+++..|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..+. ..|+.
T Consensus 263 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 342 (844)
T 3j0a_A 263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342 (844)
T ss_dssp TTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred cccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence 113688888888888888888888888888888888888888888888888888888888888877776663 47888
Q ss_pred EEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCCCCCc
Q 003134 357 VDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKV 395 (845)
Q Consensus 357 L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~~~~~ 395 (845)
|++++|++++..+..+ ..+.-++.++.+.|.+...
T Consensus 343 L~L~~N~i~~~~~~~~----~~l~~L~~L~Ls~N~l~~i 377 (844)
T 3j0a_A 343 IDLQKNHIAIIQDQTF----KFLEKLQTLDLRDNALTTI 377 (844)
T ss_dssp EECCSCCCCCCCSSCS----CSCCCCCEEEEETCCSCCC
T ss_pred EECCCCCCCccChhhh----cCCCCCCEEECCCCCCCcc
Confidence 8888888877766555 2234455666666666543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=324.21 Aligned_cols=262 Identities=20% Similarity=0.270 Sum_probs=181.2
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCc-ccC-CCccccccc--------ceeEEEecCCCCCCCccc--cc
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNC-LTG-SFSPQWASL--------QLVELSVMGNRLSGPFPK--VL 159 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~-l~~-~~~~~~~~l--------~L~~L~Ls~N~l~~~~p~--~~ 159 (845)
.+++.|+|++|++.|.+|..|++|++|++|+|++|+ +++ .+|..+..+ +|++|+|++|+|+ .+|. .|
T Consensus 491 ~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l 569 (876)
T 4ecn_A 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL 569 (876)
T ss_dssp TTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHH
T ss_pred CCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhh
Confidence 478999999999999999999999999999999998 998 788776654 6999999999999 7888 89
Q ss_pred ccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCC-CCcEEeecCcCcccCchhhcCCcc--
Q 003134 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTN-LNDLRISDNNFSGKIPEFIGKWKK-- 236 (845)
Q Consensus 160 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~-- 236 (845)
+++++|+.|+|++|+|+ .+| .|+++++|++|+|++|+++ .+|..+.++++ |++|+|++|+|+ .+|..+..++.
T Consensus 570 ~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~ 645 (876)
T 4ecn_A 570 QKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYV 645 (876)
T ss_dssp TTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSC
T ss_pred hcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCC
Confidence 99999999999999999 888 8999999999999999999 88888999998 999999999998 77877766543
Q ss_pred cceEEecCCcCCCCcchh---hh--cCCCCCEEEcCCCCCCCCCCccccc-CCccEEEccCCcCcccCcccc-cC-----
Q 003134 237 IQKLHIQGSSLEGPIPAS---IS--ALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYI-GD----- 304 (845)
Q Consensus 237 L~~L~Ls~N~l~g~~p~~---~~--~l~~L~~L~Ls~n~~~~~~~~~l~~-~~L~~L~Ls~N~l~~~~p~~~-~~----- 304 (845)
|+.|+|++|++++.+|.. +. .+.+|+.|+|++|.+...+...+.. .+|+.|+|++|+|+ .+|..+ ..
T Consensus 646 L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l 724 (876)
T 4ecn_A 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNY 724 (876)
T ss_dssp EEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCC
T ss_pred CCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccc
Confidence 777777777776655422 11 1224555555555555333322211 24455555555544 222221 11
Q ss_pred --CCCcCEEeCCCCCCCCCCchhhh--cCCCcCEEEccCCcccCCCChhhh--cCCceEEeec
Q 003134 305 --MTKLKNIDLSFNNLTGGIPTTFE--KLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISL 361 (845)
Q Consensus 305 --l~~L~~L~Ls~N~l~g~~p~~~~--~l~~L~~L~L~~N~l~g~ip~~~~--~~l~~L~ls~ 361 (845)
+++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+. .+|+.|+|++
T Consensus 725 ~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~ 785 (876)
T 4ecn_A 725 KNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785 (876)
T ss_dssp TTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCC
T ss_pred cccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCC
Confidence 114455555555544 3444443 44455555555555544 343332 2444444433
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=295.08 Aligned_cols=165 Identities=29% Similarity=0.438 Sum_probs=138.0
Q ss_pred CCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 678 FDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
++..++||+|+||+||+|++. +++.||||+++.... ...++|.+|+++|++++|||||+++|+|.+++..+||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 455788999999999999863 467899999976533 3467899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcE
Q 003134 751 YEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~ 819 (845)
||||++|+|.++|+.... .....++|.++++|+.|||+||+|||+++ ||||||||+|||+++++++
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence 999999999999965421 11346999999999999999999999986 9999999999999999999
Q ss_pred EEEeeccceecCCCCc-eeeeeeccCC
Q 003134 820 KISDFGLAKLYEEDKT-HISTRIAGTM 845 (845)
Q Consensus 820 kl~DFGla~~~~~~~~-~~~t~~~GT~ 845 (845)
||+|||+|+....... ...+...||+
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~ 211 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPI 211 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCG
T ss_pred EECCcccceeccCCCceeEecccccCC
Confidence 9999999997754322 2233455663
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=305.06 Aligned_cols=257 Identities=15% Similarity=0.167 Sum_probs=194.7
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeeccc
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 174 (845)
.++..+.+++ .+|..+. ++|++|+|++|+|+++.+..|..+ +|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 58 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 58 KVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 4566677777 4666554 678888888888888877777777 77778887777777777777777777777777777
Q ss_pred CCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeec-CcCcccCchhhcCCcccceEEecCCcCCCCcch
Q 003134 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD-NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA 253 (845)
Q Consensus 175 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 253 (845)
|++..+..|.++++|++|+|++|+|+...+..|.++++|++|+|++ |.++...+..|.++++|++|+|++|++++. |
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~- 212 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P- 212 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-
Confidence 7766666677777777777777777766666677777777777777 444444444577777777777777777643 2
Q ss_pred hhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcC
Q 003134 254 SISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333 (845)
Q Consensus 254 ~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 333 (845)
.+..++ +|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+
T Consensus 213 ~~~~l~-----------------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 269 (452)
T 3zyi_A 213 NLTPLV-----------------------GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLV 269 (452)
T ss_dssp CCTTCT-----------------------TCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred cccccc-----------------------cccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCC
Confidence 233333 566777888888888888899999999999999999988888899999999
Q ss_pred EEEccCCcccCCCChhh--hcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCC
Q 003134 334 FMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSP 388 (845)
Q Consensus 334 ~L~L~~N~l~g~ip~~~--~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~ 388 (845)
.|+|++|+|++..+..+ ..+|+.|+|++| ||.|+|...++..|+...
T Consensus 270 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N--------p~~CdC~~~~l~~~l~~~ 318 (452)
T 3zyi_A 270 ELNLAHNNLSSLPHDLFTPLRYLVELHLHHN--------PWNCDCDILWLAWWLREY 318 (452)
T ss_dssp EEECCSSCCSCCCTTSSTTCTTCCEEECCSS--------CEECSTTTHHHHHHHHHH
T ss_pred EEECCCCcCCccChHHhccccCCCEEEccCC--------CcCCCCCchHHHHHHHHh
Confidence 99999999986555544 347889999999 899999999999888653
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=311.42 Aligned_cols=302 Identities=18% Similarity=0.166 Sum_probs=188.4
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+ +|++|+|++|++++..|..|.++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 356667777777776666667777777777777777776666666666 6777777777776666666666666666666
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcc-cCChhhhCCCCCCcEEeecCcCcccCchhhcCC---------------
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKW--------------- 234 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--------------- 234 (845)
++|++++..+..|+++++|++|+|++|++++ .+|..|.++++|++|++++|++++..|..++.+
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 6666665444456666666666666666665 346666666666666666666554433322222
Q ss_pred --------------------------------------------------------------------------------
Q 003134 235 -------------------------------------------------------------------------------- 234 (845)
Q Consensus 235 -------------------------------------------------------------------------------- 234 (845)
T Consensus 188 ~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 267 (570)
T 2z63_A 188 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267 (570)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEET
T ss_pred CceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcc
Confidence
Q ss_pred --------------cccceEEecCCc------------------------------------------------------
Q 003134 235 --------------KKIQKLHIQGSS------------------------------------------------------ 246 (845)
Q Consensus 235 --------------~~L~~L~Ls~N~------------------------------------------------------ 246 (845)
++|++|++++|.
T Consensus 268 ~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 347 (570)
T 2z63_A 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP 347 (570)
T ss_dssp TEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCT
T ss_pred hhhhhhchhhhcCcCcccEEEecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCC
Confidence 222233332222
Q ss_pred -----------CCCCc--chhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCc-ccccCCCCcCEEe
Q 003134 247 -----------LEGPI--PASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP-DYIGDMTKLKNID 312 (845)
Q Consensus 247 -----------l~g~~--p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ 312 (845)
+++.. |..+.++++|+.|++++|.+...+.......+|+.|++++|.+++..| ..|.++++|++|+
T Consensus 348 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 427 (570)
T 2z63_A 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427 (570)
T ss_dssp TCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEE
T ss_pred CCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEe
Confidence 22211 233333444444444444433332221122267777777777776655 4577778888888
Q ss_pred CCCCCCCCCCchhhhcCCCcCEEEccCCccc-CCCChhhh--cCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCC
Q 003134 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT-GPVPKYIF--NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPR 389 (845)
Q Consensus 313 Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~-g~ip~~~~--~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~ 389 (845)
|++|++++..|..|.++++|++|+|++|+++ +.+|..+. ..|+.|++++|++++..|..+. .+..++.++.+.
T Consensus 428 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~----~l~~L~~L~l~~ 503 (570)
T 2z63_A 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN----SLSSLQVLNMAS 503 (570)
T ss_dssp CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT----TCTTCCEEECCS
T ss_pred CcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhh----cccCCCEEeCCC
Confidence 8888888777778888888888888888887 56776653 4788888888888877775552 234466677777
Q ss_pred CCCCCccC
Q 003134 390 NKLDKVHP 397 (845)
Q Consensus 390 n~~~~~~~ 397 (845)
|++.+..+
T Consensus 504 n~l~~~~~ 511 (570)
T 2z63_A 504 NQLKSVPD 511 (570)
T ss_dssp SCCSCCCT
T ss_pred CcCCCCCH
Confidence 77776544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=313.15 Aligned_cols=178 Identities=15% Similarity=0.153 Sum_probs=97.8
Q ss_pred CCCCcEEeecCcCcccC--chhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCC-cccccC-CccE
Q 003134 211 TNLNDLRISDNNFSGKI--PEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF-PKLDKM-NLKT 286 (845)
Q Consensus 211 ~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~-~~l~~~-~L~~ 286 (845)
++|++|++++|++++.. |..+..+++|++|++++|++.+..+. +..+++|+.|++++|.+....+ ..+... +|++
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 425 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCE
T ss_pred CCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCE
Confidence 34444555555554332 45566677777777777777654443 6666666666666666654433 222222 5555
Q ss_pred EEccCCcCcccCcccccCCCCcCEEeCCCCCCC-CCCchhhhcCCCcCEEEccCCcccCCCChhhh--cCCceEEeecCC
Q 003134 287 LILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT-GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNN 363 (845)
Q Consensus 287 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~l~~L~ls~N~ 363 (845)
|+|++|.+++..|..|.++++|+.|+|++|+++ +.+|..|..+++|++|+|++|++++..|..+. .+|+.|++++|+
T Consensus 426 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 505 (570)
T 2z63_A 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505 (570)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCc
Confidence 555555555555555555555555555555554 34555555555555555555555554454442 345555555555
Q ss_pred CcCCCCC----------------CCCCCCCCceee-eeecCCC
Q 003134 364 FTWESSD----------------PIECPRGSVNLV-ESYSSPR 389 (845)
Q Consensus 364 l~~~~p~----------------~~~c~~~~~~~l-~~l~~~~ 389 (845)
+++.+|. +|.|+|...+++ .|+....
T Consensus 506 l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~ 548 (570)
T 2z63_A 506 LKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNS 548 (570)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTG
T ss_pred CCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhcc
Confidence 5554432 455556555555 5555443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-32 Score=298.18 Aligned_cols=266 Identities=18% Similarity=0.187 Sum_probs=134.9
Q ss_pred CCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEee
Q 003134 117 YLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILS 195 (845)
Q Consensus 117 ~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 195 (845)
+|++|+|++|++++..+..+..+ +|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 132 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL 132 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence 45555555555555444444444 45555555555554444455555555555555555553322234555555555555
Q ss_pred cCcCcccCC-hhhhCCCCCCcEEeecC-cCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCC
Q 003134 196 SNSFTGELP-AELTKLTNLNDLRISDN-NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSE 273 (845)
Q Consensus 196 ~N~l~g~~p-~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~ 273 (845)
+|++++..+ ..|.++++|++|++++| .+++..+..|.++++|++|++++|++++..|..+.++++|+.|++++|.+..
T Consensus 133 ~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~ 212 (353)
T 2z80_A 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL 212 (353)
T ss_dssp TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT
T ss_pred CCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc
Confidence 555552222 24455555555555555 2444444445555555555555555555445555555555555555555433
Q ss_pred CCCcccc-cCCccEEEccCCcCcccCccccc---CCCCcCEEeCCCCCCCC----CCchhhhcCCCcCEEEccCCcccCC
Q 003134 274 SAFPKLD-KMNLKTLILTKCLIHGEIPDYIG---DMTKLKNIDLSFNNLTG----GIPTTFEKLAKTNFMYLTGNKLTGP 345 (845)
Q Consensus 274 ~~~~~l~-~~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~L~~N~l~g~ 345 (845)
.+...+. ..+|+.|+|++|.+++..+..+. ....++.++|++|.+++ .+|..+..+++|+.|+|++|+++ .
T Consensus 213 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~ 291 (353)
T 2z80_A 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-S 291 (353)
T ss_dssp HHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-C
T ss_pred chhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-c
Confidence 3222222 12455555555555554433322 24455566666666654 34555666666666666666666 4
Q ss_pred CChhhh---cCCceEEeecCCCcCCCCCCCCCCCC-CceeeeeecCCCCC
Q 003134 346 VPKYIF---NSNKNVDISLNNFTWESSDPIECPRG-SVNLVESYSSPRNK 391 (845)
Q Consensus 346 ip~~~~---~~l~~L~ls~N~l~~~~p~~~~c~~~-~~~~l~~l~~~~n~ 391 (845)
+|..++ .+|+.|+|++| +|.|+|. ..++..|+......
T Consensus 292 i~~~~~~~l~~L~~L~L~~N--------~~~~~~~~l~~l~~~~~~~~~~ 333 (353)
T 2z80_A 292 VPDGIFDRLTSLQKIWLHTN--------PWDCSCPRIDYLSRWLNKNSQK 333 (353)
T ss_dssp CCTTTTTTCTTCCEEECCSS--------CBCCCHHHHHHHHHHHHHTTTT
T ss_pred cCHHHHhcCCCCCEEEeeCC--------CccCcCCCcHHHHHHHHhcccc
Confidence 554432 35666666666 5667775 34455666554433
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=301.96 Aligned_cols=257 Identities=17% Similarity=0.183 Sum_probs=199.6
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeeccc
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 174 (845)
.++..+.+++ .+|..+. ++|+.|+|++|+|+++.+..|..+ +|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 47 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 47 KVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp EEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred EEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 5677777777 5676665 688999999999988888888887 78888888888887777888888888888888888
Q ss_pred CCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeec-CcCcccCchhhcCCcccceEEecCCcCCCCcch
Q 003134 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD-NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA 253 (845)
Q Consensus 175 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 253 (845)
|++..+..|..+++|++|+|++|+|+...+..|.++++|++|+|++ |.++...+..|.++++|++|+|++|+++. +|
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~- 201 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP- 201 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-
Confidence 8866666788888888888888888866666788888888888887 44554444567778888888888887773 23
Q ss_pred hhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcC
Q 003134 254 SISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333 (845)
Q Consensus 254 ~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 333 (845)
.+..++ +|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+
T Consensus 202 ~~~~l~-----------------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 258 (440)
T 3zyj_A 202 NLTPLI-----------------------KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLV 258 (440)
T ss_dssp CCTTCS-----------------------SCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCC
T ss_pred ccCCCc-----------------------ccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCC
Confidence 233333 566667777777777788888888888888888888888888888888888
Q ss_pred EEEccCCcccCCCChhh--hcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCC
Q 003134 334 FMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSP 388 (845)
Q Consensus 334 ~L~L~~N~l~g~ip~~~--~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~ 388 (845)
.|+|++|+|++..+..+ ...|+.|+|++| ||.|+|...++..|+...
T Consensus 259 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N--------p~~CdC~l~~l~~~~~~~ 307 (440)
T 3zyj_A 259 EINLAHNNLTLLPHDLFTPLHHLERIHLHHN--------PWNCNCDILWLSWWIKDM 307 (440)
T ss_dssp EEECTTSCCCCCCTTTTSSCTTCCEEECCSS--------CEECSSTTHHHHHHHHTT
T ss_pred EEECCCCCCCccChhHhccccCCCEEEcCCC--------CccCCCCchHHHHHHHhc
Confidence 88888888885555444 247888888888 899999999999998754
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=285.20 Aligned_cols=273 Identities=20% Similarity=0.299 Sum_probs=229.8
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
|+++.+++++++++ .+|..+. +.|++|+|++|+|++..+..|..+ +|++|+|++|++++..|..|.++++|++|+|
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 45677889988888 4676554 689999999999999988888888 8999999999999888999999999999999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcc--cCchhhcCCcccceEEecCCcCC
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG--KIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
++|+++ .+|..+. ++|++|++++|++++..+..|.++++|++|+|++|+++. ..+..|.++++|++|++++|+++
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 999999 6676654 799999999999998777789999999999999999963 77888999999999999999998
Q ss_pred CCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhh
Q 003134 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (845)
Q Consensus 249 g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 327 (845)
. +|..+. ++|+.|++++|.++...+..+... +|+.|+|++|.+++..+..|..+++|++|+|++|+|+ .+|..+.
T Consensus 185 ~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~ 260 (330)
T 1xku_A 185 T-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260 (330)
T ss_dssp S-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTT
T ss_pred c-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhc
Confidence 5 454443 789999999999888776666655 8999999999999888888999999999999999998 7888899
Q ss_pred cCCCcCEEEccCCcccCCCChhhh--------cCCceEEeecCCCcC--CCCCCCCC
Q 003134 328 KLAKTNFMYLTGNKLTGPVPKYIF--------NSNKNVDISLNNFTW--ESSDPIEC 374 (845)
Q Consensus 328 ~l~~L~~L~L~~N~l~g~ip~~~~--------~~l~~L~ls~N~l~~--~~p~~~~c 374 (845)
.+++|++|+|++|++++..+..+. ..++.|++++|.+.. ..|..+.|
T Consensus 261 ~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~ 317 (330)
T 1xku_A 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317 (330)
T ss_dssp TCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred cCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccccc
Confidence 999999999999999865554442 357789999998763 33444544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=313.39 Aligned_cols=297 Identities=19% Similarity=0.199 Sum_probs=249.7
Q ss_pred cceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeE
Q 003134 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (845)
Q Consensus 91 ~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 169 (845)
..+++.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+ +|++|+|++|+|++..+..|+++++|++|+
T Consensus 24 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp CTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 3578999999999998877889999999999999999999999999998 999999999999987777899999999999
Q ss_pred eecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhc--CCcccceEEecCCcC
Q 003134 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG--KWKKIQKLHIQGSSL 247 (845)
Q Consensus 170 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l 247 (845)
|++|++++..|..|+++++|++|+|++|++++..|..+.++++|++|+|++|++++..+..+. .+++|++|++++|++
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence 999999988888999999999999999999999999999999999999999999988888765 458999999999999
Q ss_pred CCCcchhhhcC---------------------------CCCCEEEcCCCCCCCCCCcccccC---CccEEEccCCcCccc
Q 003134 248 EGPIPASISAL---------------------------TSLTDLRISDLKGSESAFPKLDKM---NLKTLILTKCLIHGE 297 (845)
Q Consensus 248 ~g~~p~~~~~l---------------------------~~L~~L~Ls~n~~~~~~~~~l~~~---~L~~L~Ls~N~l~~~ 297 (845)
++..|..+..+ ++|+.|++++|.+.+..+..+... +|+.|+|++|++++.
T Consensus 184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~ 263 (680)
T 1ziw_A 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263 (680)
T ss_dssp CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEE
T ss_pred cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCcc
Confidence 99888877765 456777777777776655555443 599999999999998
Q ss_pred CcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCC-----CCh----hh--hcCCceEEeecCCCcC
Q 003134 298 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP-----VPK----YI--FNSNKNVDISLNNFTW 366 (845)
Q Consensus 298 ~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~-----ip~----~~--~~~l~~L~ls~N~l~~ 366 (845)
.|..|..+++|++|+|++|++++..|..|.++++|+.|++++|...+. +|. .+ ...|+.|++++|++++
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~ 343 (680)
T 1ziw_A 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence 889999999999999999999988888888888888888888766542 332 22 2478889999998888
Q ss_pred CCCCCCCCCCCCceeeeeecCCCCC
Q 003134 367 ESSDPIECPRGSVNLVESYSSPRNK 391 (845)
Q Consensus 367 ~~p~~~~c~~~~~~~l~~l~~~~n~ 391 (845)
..|..+. . +.-++.++.+.|.
T Consensus 344 ~~~~~~~-~---l~~L~~L~Ls~n~ 364 (680)
T 1ziw_A 344 IKSNMFT-G---LINLKYLSLSNSF 364 (680)
T ss_dssp CCTTTTT-T---CTTCCEEECTTCB
T ss_pred CChhHhc-c---ccCCcEEECCCCc
Confidence 7765442 2 2234444555444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=309.96 Aligned_cols=118 Identities=25% Similarity=0.288 Sum_probs=100.6
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCC-cccccccccccceeE
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGP-FPKVLTNITTLKNLS 169 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ 169 (845)
.+++.|+|++|.+++..|..|+++++|++|+|++|++++..|..|..+ +|++|+|++|++++. .|..|+++++|++|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 478899999999999888899999999999999999999988888888 899999999999873 577888999999999
Q ss_pred eecccCCCCCC-cccccCCCccEEEeecCcCcccCChhhhC
Q 003134 170 IEGNLFTGSIP-PDIRKLINLQKLILSSNSFTGELPAELTK 209 (845)
Q Consensus 170 Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 209 (845)
|++|++.+.+| ..|.++++|++|+|++|++++..|..+.+
T Consensus 130 L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 170 (549)
T 2z81_A 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170 (549)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT
T ss_pred CCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhc
Confidence 99998544554 57888888888888888888777766544
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=286.91 Aligned_cols=271 Identities=21% Similarity=0.306 Sum_probs=229.8
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
|+++.+++++++++ .+|..+. ++|++|+|++|++++..+..|..+ +|++|+|++|+|++..|..|.++++|++|+|
T Consensus 33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 46678899999988 6777664 789999999999999988889888 8999999999999988999999999999999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCc--ccCchhhcCCcccceEEecCCcCC
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS--GKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
++|+++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++ +..|..+..+ +|++|++++|+++
T Consensus 110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT 185 (332)
T ss_dssp CSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred CCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence 999999 6676665 79999999999999777778999999999999999996 4778888888 9999999999999
Q ss_pred CCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhh
Q 003134 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (845)
Q Consensus 249 g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 327 (845)
+ +|..+. ++|+.|++++|.+....+..+... +|+.|+|++|++++..+..|..+++|++|+|++|+|+ .+|..+.
T Consensus 186 ~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~ 261 (332)
T 2ft3_A 186 G-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261 (332)
T ss_dssp S-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGG
T ss_pred c-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhh
Confidence 6 555443 789999999999988876666555 8999999999999888888999999999999999998 7888899
Q ss_pred cCCCcCEEEccCCcccCCCChhhh--------cCCceEEeecCCCc--CCCCCCCC
Q 003134 328 KLAKTNFMYLTGNKLTGPVPKYIF--------NSNKNVDISLNNFT--WESSDPIE 373 (845)
Q Consensus 328 ~l~~L~~L~L~~N~l~g~ip~~~~--------~~l~~L~ls~N~l~--~~~p~~~~ 373 (845)
.+++|+.|+|++|++++..+..+. ..++.|++++|.+. +..|..+.
T Consensus 262 ~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~ 317 (332)
T 2ft3_A 262 DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317 (332)
T ss_dssp GCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGT
T ss_pred cCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccccc
Confidence 999999999999999865555442 34788999999876 44444343
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=291.19 Aligned_cols=161 Identities=24% Similarity=0.344 Sum_probs=132.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC----CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
++|++.+.||+|+||+||+|+.. .++.||||+++... .....++.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56899999999999999999863 37899999997642 2334578899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
|||||+||+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999543 36899999999999999999999997 99999999999999999999999999997
Q ss_pred cCCCCceeeeeeccCC
Q 003134 830 YEEDKTHISTRIAGTM 845 (845)
Q Consensus 830 ~~~~~~~~~t~~~GT~ 845 (845)
...... ..+..+||+
T Consensus 176 ~~~~~~-~~~~~~GT~ 190 (304)
T 3ubd_A 176 SIDHEK-KAYSFCGTV 190 (304)
T ss_dssp -----C-CCCSCCCCG
T ss_pred ccCCCc-cccccccCc
Confidence 654333 234467885
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=282.49 Aligned_cols=159 Identities=30% Similarity=0.516 Sum_probs=126.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|++.+.||+|+||+||+|+.. +++.||+|++++.. ....+++.+|+++|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999975 59999999996542 233567999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+ +|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 67999998543 36999999999999999999999997 9999999999999999999999999999875
Q ss_pred CCCceeeeeeccCC
Q 003134 832 EDKTHISTRIAGTM 845 (845)
Q Consensus 832 ~~~~~~~t~~~GT~ 845 (845)
+.. ..+..+||+
T Consensus 164 ~~~--~~~~~~GT~ 175 (275)
T 3hyh_A 164 DGN--FLKTSCGSP 175 (275)
T ss_dssp -------------C
T ss_pred CCC--ccCCeeECc
Confidence 433 234467875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=284.79 Aligned_cols=158 Identities=28% Similarity=0.475 Sum_probs=134.1
Q ss_pred CCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe----CCEEEEEE
Q 003134 679 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVY 751 (845)
Q Consensus 679 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ 751 (845)
...++||+|+||+||+|.+. ++..||+|++.... ....++|.+|+++|++++|||||+++++|.+ ++.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999986 58899999996542 3335679999999999999999999999875 34689999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCcEEEEeeccceec
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLY 830 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld-~~~~~kl~DFGla~~~ 830 (845)
|||++|+|.++++.. ..+++.++..|+.||+.||+|||+++ ++||||||||+|||++ .++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999643 36899999999999999999999985 4599999999999998 4799999999999865
Q ss_pred CCCCceeeeeeccCC
Q 003134 831 EEDKTHISTRIAGTM 845 (845)
Q Consensus 831 ~~~~~~~~t~~~GT~ 845 (845)
... ..+.++||+
T Consensus 183 ~~~---~~~~~~GTp 194 (290)
T 3fpq_A 183 RAS---FAKAVIGTP 194 (290)
T ss_dssp CTT---SBEESCSSC
T ss_pred CCC---ccCCcccCc
Confidence 432 234578886
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=290.03 Aligned_cols=157 Identities=29% Similarity=0.342 Sum_probs=133.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
+.|...++||+|+||+||+|++. +|+.||||+++.... ..+|+++|++++|||||++++++.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777889999999999999985 589999999975422 246999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-cEEEEeeccceecCCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEED 833 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~-~~kl~DFGla~~~~~~ 833 (845)
+||+|.++++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+..+
T Consensus 133 ~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 133 EGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp TTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999643 36999999999999999999999987 99999999999999987 6999999999988654
Q ss_pred Ccee----eeeeccCC
Q 003134 834 KTHI----STRIAGTM 845 (845)
Q Consensus 834 ~~~~----~t~~~GT~ 845 (845)
.... ...++||+
T Consensus 205 ~~~~~~~~~~~~~GT~ 220 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTE 220 (336)
T ss_dssp ---------CCCCCCG
T ss_pred CcccceecCCccccCc
Confidence 3221 22357885
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=286.02 Aligned_cols=153 Identities=26% Similarity=0.505 Sum_probs=126.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCC--------
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-------- 745 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-------- 745 (845)
++|+..+.||+|+||+||+|+.. +++.||||+++.... ...+++.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888999999999999999975 589999999965432 33567899999999999999999999987544
Q ss_pred ----EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEE
Q 003134 746 ----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821 (845)
Q Consensus 746 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl 821 (845)
.+|+|||||++|+|.+++..... ....++..++.|+.||++||+|||+++ ||||||||+|||++.++.+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence 37999999999999999976432 224567788999999999999999997 999999999999999999999
Q ss_pred EeeccceecCCC
Q 003134 822 SDFGLAKLYEED 833 (845)
Q Consensus 822 ~DFGla~~~~~~ 833 (845)
+|||+|+.+..+
T Consensus 160 ~DFGla~~~~~~ 171 (299)
T 4g31_A 160 GDFGLVTAMDQD 171 (299)
T ss_dssp CCCCCC------
T ss_pred ccCccceecCCC
Confidence 999999988654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=286.68 Aligned_cols=161 Identities=29% Similarity=0.388 Sum_probs=130.3
Q ss_pred CCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC----EEEEEEe
Q 003134 677 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----QLLLVYE 752 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV~E 752 (845)
+|...++||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||++++++.+++ .+|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 466778999999999999998 589999999975422 1223345666667889999999999998654 6899999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
||++|+|.++++.. .++|.++.+|+.|+++||+|||++ +.++||||||||+|||+|.++++||+|||+|
T Consensus 82 y~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp CCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999643 589999999999999999999986 2346999999999999999999999999999
Q ss_pred eecCCCCcee---eeeeccCC
Q 003134 828 KLYEEDKTHI---STRIAGTM 845 (845)
Q Consensus 828 ~~~~~~~~~~---~t~~~GT~ 845 (845)
+......... .+..+||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~ 176 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTK 176 (303)
T ss_dssp EEEETTTTEESCC-----CCG
T ss_pred ccccCCCCceeeecccccccc
Confidence 9886544332 22456774
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=287.09 Aligned_cols=259 Identities=20% Similarity=0.247 Sum_probs=208.0
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCC--cccccccccccceeEeec
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGP--FPKVLTNITTLKNLSIEG 172 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~ 172 (845)
.+++++++++ .+|..+. ++|++|+|++|+++.+.+..|..+ +|++|+|++|+++.. .+..+..+++|++|+|++
T Consensus 11 ~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred EEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 5677777777 4566553 689999999999997777777777 899999999998843 366777889999999999
Q ss_pred ccCCCCCCcccccCCCccEEEeecCcCcccCC-hhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCC-C
Q 003134 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG-P 250 (845)
Q Consensus 173 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ 250 (845)
|.++ .+|..+..+++|++|+|++|++++..+ ..+.++++|++|+|++|++++..+..|..+++|++|+|++|++++ .
T Consensus 88 n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 166 (306)
T 2z66_A 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166 (306)
T ss_dssp CSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred Cccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccccc
Confidence 9988 567778889999999999999886555 578888999999999999988888888888999999999998886 5
Q ss_pred cchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCC
Q 003134 251 IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 330 (845)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 330 (845)
+|..+..+++|+.| +|++|++++..|..|..+++|+.|+|++|++++..+..|..++
T Consensus 167 ~~~~~~~l~~L~~L-----------------------~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 223 (306)
T 2z66_A 167 LPDIFTELRNLTFL-----------------------DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223 (306)
T ss_dssp ECSCCTTCTTCCEE-----------------------ECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCT
T ss_pred chhHHhhCcCCCEE-----------------------ECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcc
Confidence 67777777666555 5566666666777788888888888888888877777788888
Q ss_pred CcCEEEccCCcccCCCChhhh---cCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCC
Q 003134 331 KTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPR 389 (845)
Q Consensus 331 ~L~~L~L~~N~l~g~ip~~~~---~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~ 389 (845)
+|++|+|++|++++..|..+. ..++.|+|++| +|.|+|...++.+|+....
T Consensus 224 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N--------~~~~~c~~~~~~~~l~~~~ 277 (306)
T 2z66_A 224 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN--------DFACTCEHQSFLQWIKDQR 277 (306)
T ss_dssp TCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTC--------CEECSGGGHHHHHHHHHTG
T ss_pred cCCEeECCCCCCcccCHHHHHhhhccCCEEEccCC--------CeecccChHHHHHHHHhhh
Confidence 888888888888877776653 36788888888 7779999999999987544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-30 Score=305.28 Aligned_cols=156 Identities=19% Similarity=0.254 Sum_probs=143.1
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeeccc
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 174 (845)
++++++++++ .+|..+. ++|++|+|++|++++..+..|..+ +|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 5777888888 5677665 899999999999999999999999 99999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcc-cCchhhcCCcccceEEecCCcCCCCcch
Q 003134 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG-KIPEFIGKWKKIQKLHIQGSSLEGPIPA 253 (845)
Q Consensus 175 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 253 (845)
+++..|..|+++++|++|+|++|++++..+..|+++++|++|+|++|++++ .+|..|+++++|++|+|++|++++..|.
T Consensus 92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 999889999999999999999999998887889999999999999999986 5799999999999999999998876554
Q ss_pred h
Q 003134 254 S 254 (845)
Q Consensus 254 ~ 254 (845)
.
T Consensus 172 ~ 172 (606)
T 3vq2_A 172 D 172 (606)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-29 Score=276.49 Aligned_cols=265 Identities=20% Similarity=0.238 Sum_probs=231.3
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|..+ +|++|+|++|+|+. +|..+. ++|++|+|
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCc-cChhhc--ccccEEEC
Confidence 468899999999998888899999999999999999999999999998 99999999999994 555554 79999999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcc--cCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCC
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTG--ELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
++|++++..+..|.++++|++|+|++|+++. ..+..|.++++|++|++++|+++. +|..+. ++|++|+|++|+++
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~ 205 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKIT 205 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCC
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCC
Confidence 9999998877889999999999999999964 778889999999999999999994 565554 79999999999999
Q ss_pred CCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhh
Q 003134 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (845)
Q Consensus 249 g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 327 (845)
+..|..|.++++|+.|++++|.++......+... +|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|.
T Consensus 206 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~ 284 (330)
T 1xku_A 206 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284 (330)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred ccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcC
Confidence 9989999999999999999999998777666554 8999999999999 7888899999999999999999988888776
Q ss_pred cC------CCcCEEEccCCcccC-CCC-hhh--hcCCceEEeecCC
Q 003134 328 KL------AKTNFMYLTGNKLTG-PVP-KYI--FNSNKNVDISLNN 363 (845)
Q Consensus 328 ~l------~~L~~L~L~~N~l~g-~ip-~~~--~~~l~~L~ls~N~ 363 (845)
.. +.|+.|++++|.+.. .++ ..+ ...++.++|++|+
T Consensus 285 ~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 43 789999999999964 343 333 2478999999984
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-29 Score=284.40 Aligned_cols=271 Identities=18% Similarity=0.185 Sum_probs=228.8
Q ss_pred cCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccE
Q 003134 113 SKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191 (845)
Q Consensus 113 ~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 191 (845)
-.+++|++|++++|.++...+..+..+ +|++|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|++
T Consensus 42 ~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 42 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp GGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 457899999999999999888888888 9999999999999988889999999999999999999888888999999999
Q ss_pred EEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCC
Q 003134 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271 (845)
Q Consensus 192 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~ 271 (845)
|+|++|+++...+..|.++++|++|+|++|++++..|..|..+++|++|++++|++++.. +..+++|+.|++++|.+
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLL 198 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCC
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccccc
Confidence 999999999555555799999999999999999988999999999999999999999753 44555666655555554
Q ss_pred CC-------------------CCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCc
Q 003134 272 SE-------------------SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332 (845)
Q Consensus 272 ~~-------------------~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 332 (845)
+. .+... ..+|+.|+|++|.+++. ..+..+++|++|+|++|++++..|..|..+++|
T Consensus 199 ~~~~~~~~L~~L~l~~n~l~~~~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 274 (390)
T 3o6n_A 199 STLAIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 274 (390)
T ss_dssp SEEECCSSCSEEECCSSCCCEEECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSC
T ss_pred cccCCCCcceEEECCCCeeeeccccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccC
Confidence 43 22111 13799999999999874 578999999999999999999999999999999
Q ss_pred CEEEccCCcccCCCChhh--hcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCCCCCcc
Q 003134 333 NFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 396 (845)
Q Consensus 333 ~~L~L~~N~l~g~ip~~~--~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~~~~~~ 396 (845)
+.|+|++|++++ +|... ...|+.|++++|++++.++. + ..+..++.++...|++....
T Consensus 275 ~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~-~----~~l~~L~~L~L~~N~i~~~~ 334 (390)
T 3o6n_A 275 ERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERN-Q----PQFDRLENLYLDHNSIVTLK 334 (390)
T ss_dssp CEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCCCGGG-H----HHHTTCSEEECCSSCCCCCC
T ss_pred CEEECCCCcCcc-cCcccCCCCCCCEEECCCCcceecCcc-c----cccCcCCEEECCCCccceeC
Confidence 999999999996 44443 46899999999999865432 2 23455778889999988763
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=301.53 Aligned_cols=270 Identities=18% Similarity=0.184 Sum_probs=230.8
Q ss_pred CCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEE
Q 003134 114 KLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKL 192 (845)
Q Consensus 114 ~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 192 (845)
.+++++.|++++|.++.+++..|..+ +|++|+|++|.|++..|..|..+++|++|+|++|.|++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 46889999999999999988888888 99999999999999999999999999999999999999888899999999999
Q ss_pred EeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCC
Q 003134 193 ILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272 (845)
Q Consensus 193 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~ 272 (845)
+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++.. ++.+++|+.|++++|.++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccc
Confidence 99999999766666899999999999999999999999999999999999999999764 444566666666655554
Q ss_pred C-------------------CCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcC
Q 003134 273 E-------------------SAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333 (845)
Q Consensus 273 ~-------------------~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 333 (845)
. .+... ..+|+.|+|++|.+++ +..+..+++|+.|+|++|+|++.+|..|..+++|+
T Consensus 206 ~l~~~~~L~~L~ls~n~l~~~~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 281 (597)
T 3oja_B 206 TLAIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 281 (597)
T ss_dssp EEECCTTCSEEECCSSCCCEEECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCC
T ss_pred cccCCchhheeeccCCccccccccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCC
Confidence 3 22111 1379999999999987 47799999999999999999999999999999999
Q ss_pred EEEccCCcccCCCChhh--hcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCCCCCcc
Q 003134 334 FMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 396 (845)
Q Consensus 334 ~L~L~~N~l~g~ip~~~--~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~~~~~~ 396 (845)
.|+|++|++++ +|..+ ...|+.|+|++|.+++.++ .+ ..+..++.++.+.|++.+..
T Consensus 282 ~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~i~~-~~----~~l~~L~~L~L~~N~l~~~~ 340 (597)
T 3oja_B 282 RLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVER-NQ----PQFDRLENLYLDHNSIVTLK 340 (597)
T ss_dssp EEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCCCGG-GH----HHHTTCSEEECCSSCCCCCC
T ss_pred EEECCCCCCCC-CCcccccCCCCcEEECCCCCCCccCc-cc----ccCCCCCEEECCCCCCCCcC
Confidence 99999999997 45444 4689999999999995433 22 23455778889999988764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-29 Score=277.58 Aligned_cols=264 Identities=20% Similarity=0.251 Sum_probs=231.3
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|++++|.+++..|..|.++++|++|+|++|++++..|..|..+ +|++|+|++|+++ .+|..+. ++|++|+|
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 478999999999998888899999999999999999999999999998 9999999999999 4555554 89999999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCc--ccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCC
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~--g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
++|++++..+..|.++++|++|+|++|+++ +..|..+..+ +|++|++++|++++ +|..+. ++|++|+|++|+++
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~ 206 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQ 206 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCC
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCC
Confidence 999999777778999999999999999996 4778888888 99999999999996 666554 79999999999999
Q ss_pred CCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhh
Q 003134 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE 327 (845)
Q Consensus 249 g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 327 (845)
+..+..+.++++|+.|++++|.+.......+... +|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|.
T Consensus 207 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 285 (332)
T 2ft3_A 207 AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285 (332)
T ss_dssp CCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSS
T ss_pred ccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcc
Confidence 9999999999999999999999999887666655 8999999999999 7888899999999999999999988888777
Q ss_pred cC------CCcCEEEccCCccc--CCCChhh--hcCCceEEeecCC
Q 003134 328 KL------AKTNFMYLTGNKLT--GPVPKYI--FNSNKNVDISLNN 363 (845)
Q Consensus 328 ~l------~~L~~L~L~~N~l~--g~ip~~~--~~~l~~L~ls~N~ 363 (845)
.+ +.|+.|++++|.+. +..|..+ ...++.+++++|+
T Consensus 286 ~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 64 67999999999997 4445444 3478999999983
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=297.37 Aligned_cols=155 Identities=21% Similarity=0.256 Sum_probs=138.7
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeeccc
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 174 (845)
+.+.++.+|+ .+|..+. +++++|||++|+|+++.+..|..+ +|++|+|++|+|+++.|.+|.+|++|++|+|++|+
T Consensus 35 ~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~ 111 (635)
T 4g8a_A 35 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 111 (635)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence 3466677787 5676653 589999999999999999999999 99999999999999989999999999999999999
Q ss_pred CCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcc-cCchhhcCCcccceEEecCCcCCCCcch
Q 003134 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG-KIPEFIGKWKKIQKLHIQGSSLEGPIPA 253 (845)
Q Consensus 175 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 253 (845)
|++..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++|+|++ .+|..++.+++|++|+|++|+|++..|.
T Consensus 112 l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 191 (635)
T 4g8a_A 112 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 191 (635)
T ss_dssp CCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred CCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccc
Confidence 997777789999999999999999998777789999999999999999986 4688899999999999999998765443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=272.60 Aligned_cols=238 Identities=19% Similarity=0.229 Sum_probs=170.2
Q ss_pred EEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecc
Q 003134 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173 (845)
Q Consensus 95 ~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 173 (845)
+.+++++++++. +|..+ .++|++|+|++|++++..+..|..+ +|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 567888888874 56544 4688888888888887777777766 7777777777777766777777777777777777
Q ss_pred c-CCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcc
Q 003134 174 L-FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (845)
Q Consensus 174 ~-l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 252 (845)
+ ++...|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 6 665556677777777777777777776666667777777777777777776655666777777777777777765554
Q ss_pred hhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCc
Q 003134 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT 332 (845)
Q Consensus 253 ~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 332 (845)
..|.++++| +.|+|++|.+++..|..|..+++|+.|+|++|+|++..+..|..+++|
T Consensus 171 ~~~~~l~~L-----------------------~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 227 (285)
T 1ozn_A 171 RAFRGLHSL-----------------------DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL 227 (285)
T ss_dssp TTTTTCTTC-----------------------CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTC
T ss_pred HHhcCcccc-----------------------CEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCccc
Confidence 455555544 444556666666677777778888888888888887666777777777
Q ss_pred CEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCC
Q 003134 333 NFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSP 388 (845)
Q Consensus 333 ~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~ 388 (845)
++|+|++| +|.|+|...+++.|+...
T Consensus 228 ~~L~l~~N------------------------------~~~c~~~~~~~~~~l~~~ 253 (285)
T 1ozn_A 228 QYLRLNDN------------------------------PWVCDCRARPLWAWLQKF 253 (285)
T ss_dssp CEEECCSS------------------------------CEECSGGGHHHHHHHHHC
T ss_pred CEEeccCC------------------------------CccCCCCcHHHHHHHHhc
Confidence 77777777 555777777777776543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=285.98 Aligned_cols=177 Identities=25% Similarity=0.390 Sum_probs=145.3
Q ss_pred ccHHHHHHHhcCCCCCCcccccCcEEEEEEEECC------CcEEEEEEcCcccc-cchHHHHHHHHHHhcCCC-CceeeE
Q 003134 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQH-PNLVKL 737 (845)
Q Consensus 666 ~~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H-~nIv~l 737 (845)
+...+.+...++|+..+.||+|+||+||+|++.. ++.||||+++.... ...++|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3444555567889999999999999999998642 46899999976533 335689999999999966 899999
Q ss_pred EEEEEeC-CEEEEEEeccCCCChhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 003134 738 YGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRD 805 (845)
Q Consensus 738 ~~~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrD 805 (845)
+|+|.+. +.++||||||++|+|.++|+..... ....++|.+++.|+.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 5789999999999999999754321 1245899999999999999999999987 99999
Q ss_pred CCCCCEEecCCCcEEEEeeccceecCCCCce-eeeeeccCC
Q 003134 806 IKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTM 845 (845)
Q Consensus 806 LKp~NILld~~~~~kl~DFGla~~~~~~~~~-~~t~~~GT~ 845 (845)
|||+|||+++++.+||+|||+|+.+..+... ..+...||+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~ 251 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECG
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccc
Confidence 9999999999999999999999987654443 233456663
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-28 Score=267.22 Aligned_cols=224 Identities=22% Similarity=0.304 Sum_probs=176.7
Q ss_pred CCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEE
Q 003134 114 KLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKL 192 (845)
Q Consensus 114 ~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 192 (845)
..++++.|+|++|.++ .+|..+..+ +|++|+|++|+|+ .+|..|+++++|++|+|++|+++ .+|..|.++++|++|
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 3477888888888888 445556656 7788888888877 67777777788888888888777 667777777888888
Q ss_pred EeecCcCcccCChhhhC---------CCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCE
Q 003134 193 ILSSNSFTGELPAELTK---------LTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTD 263 (845)
Q Consensus 193 ~Ls~N~l~g~~p~~~~~---------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 263 (845)
+|++|++.+.+|..+.. +++|++|+|++|+|+ .+|..+.++++|++|+|++|++++ +|..++.+++
T Consensus 156 ~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~--- 230 (328)
T 4fcg_A 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPK--- 230 (328)
T ss_dssp EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTT---
T ss_pred ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCC---
Confidence 88877777777776554 677777777777776 666667777777777777777774 4445666555
Q ss_pred EEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCccc
Q 003134 264 LRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (845)
Q Consensus 264 L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~ 343 (845)
|+.|+|++|.+.+.+|..|.++++|++|+|++|++.+.+|..+.++++|++|+|++|++.
T Consensus 231 --------------------L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 231 --------------------LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp --------------------CCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred --------------------CCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 455577778888889999999999999999999999999999999999999999999999
Q ss_pred CCCChhhhc--CCceEEeecCCCc
Q 003134 344 GPVPKYIFN--SNKNVDISLNNFT 365 (845)
Q Consensus 344 g~ip~~~~~--~l~~L~ls~N~l~ 365 (845)
+.+|..+.. .++.+++..|.+.
T Consensus 291 ~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 291 SRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhccHHHhhccCceEEeCCHHHHH
Confidence 999999854 7899999888554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-28 Score=266.49 Aligned_cols=259 Identities=20% Similarity=0.278 Sum_probs=172.9
Q ss_pred eEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEee
Q 003134 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 171 (845)
+++.|++++|.+++. ++ +..+++|++|+|++|.++.. +.+..+ +|++|+|++|++++..+ +..+++|++|+++
T Consensus 67 ~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~ 140 (347)
T 4fmz_A 67 NLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLG 140 (347)
T ss_dssp TCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECT
T ss_pred CccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEECcCCcccCchh--hccCCceeEEECC
Confidence 566777777777643 33 67777777777777777664 245555 67777777777765433 6667777777777
Q ss_pred cccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCc
Q 003134 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251 (845)
Q Consensus 172 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 251 (845)
+|.....++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|++++..+ +..+++|++|++++|.+++..
T Consensus 141 ~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~ 215 (347)
T 4fmz_A 141 ANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT 215 (347)
T ss_dssp TCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCG
T ss_pred CCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCc
Confidence 775553333 36777777777777777764333 6677777777777777764333 666777777777777777554
Q ss_pred chhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCC
Q 003134 252 PASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331 (845)
Q Consensus 252 p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 331 (845)
+ +..+++|+.|++++|.++..+. .....+|++|++++|.+++. ..+..+++|++|++++|++++. ..+..+++
T Consensus 216 ~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~ 288 (347)
T 4fmz_A 216 P--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQ 288 (347)
T ss_dssp G--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTT
T ss_pred h--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCC
Confidence 4 6677777777777777766544 22223677777777777753 3567777777777777777754 35677777
Q ss_pred cCEEEccCCcccCCCChhhh--cCCceEEeecCCCcCCCC
Q 003134 332 TNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESS 369 (845)
Q Consensus 332 L~~L~L~~N~l~g~ip~~~~--~~l~~L~ls~N~l~~~~p 369 (845)
|+.|++++|++++..|..+. .+|+.|++++|++++..|
T Consensus 289 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp CSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred CCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 77777777777766666553 467777777777776655
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-28 Score=277.18 Aligned_cols=280 Identities=25% Similarity=0.337 Sum_probs=159.1
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|+|++|.+++..+ +.++++|++|+|++|++++..+ +..+ +|++|+|++|++++..+ +.++++|++|+|
T Consensus 68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l 141 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLEL 141 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEE
T ss_pred cCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEEC
Confidence 468889999998886543 8899999999999999988766 7777 89999999999887644 888899999999
Q ss_pred ecccCCCCCCcccccCCCccEEEe---------------------ecCcCcccCChhhhCCCCCCcEEeecCcCcccCch
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLIL---------------------SSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE 229 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~L---------------------s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 229 (845)
++|++++. + .+..+++|++|++ ++|++++. ..+..+++|++|++++|++++..|
T Consensus 142 ~~n~l~~~-~-~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~- 216 (466)
T 1o6v_A 142 SSNTISDI-S-ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP- 216 (466)
T ss_dssp EEEEECCC-G-GGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred CCCccCCC-h-hhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc-
Confidence 99988853 3 3444544444444 44444421 124444444444444444443332
Q ss_pred hhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcC
Q 003134 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLK 309 (845)
Q Consensus 230 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 309 (845)
++.+++|++|++++|++++. ..+..+++|+.|++++|.+..... .....+|+.|+|++|.+++..+ +..+++|+
T Consensus 217 -~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~ 290 (466)
T 1o6v_A 217 -LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP--LAGLTALT 290 (466)
T ss_dssp -GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCS
T ss_pred -ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc--ccCCCccC
Confidence 34444444444444444432 234444555555555554444332 1111245555555555554333 45555555
Q ss_pred EEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCC
Q 003134 310 NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPR 389 (845)
Q Consensus 310 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~ 389 (845)
.|+|++|++++..| +..+++|+.|+|++|++++..|-.-...|+.|++++|.+++.. . ...+.-+++++...
T Consensus 291 ~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~--~----l~~l~~L~~L~l~~ 362 (466)
T 1o6v_A 291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVS--S----LANLTNINWLSAGH 362 (466)
T ss_dssp EEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCCG--G----GTTCTTCCEEECCS
T ss_pred eEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCch--h----hccCCCCCEEeCCC
Confidence 55555555554333 4555555555555555555444333345555555555555431 1 11223344555555
Q ss_pred CCCCCcc
Q 003134 390 NKLDKVH 396 (845)
Q Consensus 390 n~~~~~~ 396 (845)
|++.+..
T Consensus 363 n~l~~~~ 369 (466)
T 1o6v_A 363 NQISDLT 369 (466)
T ss_dssp SCCCBCG
T ss_pred CccCccc
Confidence 5555443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=279.30 Aligned_cols=245 Identities=20% Similarity=0.218 Sum_probs=134.9
Q ss_pred cCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCC-CCCcccccc-------cccccceeEeecccCCCCCCccc-
Q 003134 113 SKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRL-SGPFPKVLT-------NITTLKNLSIEGNLFTGSIPPDI- 183 (845)
Q Consensus 113 ~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~g~~p~~~- 183 (845)
+.+++|+.|++++|.+ .+|..+... |+.|+|++|++ .+.+|..+. ++++|++|+|++|++++.+|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~-L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 116 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI-IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH-HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH-HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence 3445555566666665 344433332 55555555555 233444443 45666666666666665555554
Q ss_pred -ccCCCccEEEeecCcCcccCChhhhCC-----CCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCC--cchhh
Q 003134 184 -RKLINLQKLILSSNSFTGELPAELTKL-----TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP--IPASI 255 (845)
Q Consensus 184 -~~l~~L~~L~Ls~N~l~g~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~--~p~~~ 255 (845)
..+++|++|+|++|++++. |..+..+ ++|++|+|++|+|++..|..|+++++|++|+|++|++.+. .|..+
T Consensus 117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 195 (312)
T 1wwl_A 117 EATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195 (312)
T ss_dssp SCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHS
T ss_pred HhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHH
Confidence 5566666666666666654 5555554 5666666666666655555666666666666666665543 22333
Q ss_pred --hcCCCCCEEEcCCCCCCCCCC---ccccc-CCccEEEccCCcCcccCc-ccccCCCCcCEEeCCCCCCCCCCchhhhc
Q 003134 256 --SALTSLTDLRISDLKGSESAF---PKLDK-MNLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328 (845)
Q Consensus 256 --~~l~~L~~L~Ls~n~~~~~~~---~~l~~-~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 328 (845)
.++++|+.|++++|.++.... ..+.. .+|+.|+|++|+|++.+| ..+..+++|++|+|++|+|+ .+|..+.
T Consensus 196 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~- 273 (312)
T 1wwl_A 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP- 273 (312)
T ss_dssp CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-
T ss_pred HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-
Confidence 555666666666665553211 11111 256666666666666554 33445566666666666666 5555444
Q ss_pred CCCcCEEEccCCcccCCCChhh--hcCCceEEeecCCCcC
Q 003134 329 LAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTW 366 (845)
Q Consensus 329 l~~L~~L~L~~N~l~g~ip~~~--~~~l~~L~ls~N~l~~ 366 (845)
++|++|+|++|+|++. |. + ...|+.|++++|++++
T Consensus 274 -~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 274 -AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp -SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred -CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 5666666666666654 43 2 2355666666666554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-28 Score=276.32 Aligned_cols=280 Identities=18% Similarity=0.120 Sum_probs=224.7
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|++++|.+++. | .|+.+++|++|+|++|+|++. | +..+ +|++|+|++|+|++. + ++++++|++|+|
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence 4788999999999974 5 799999999999999999986 2 6777 899999999999985 3 889999999999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCC
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 250 (845)
++|++++ +| ++.+++|++|++++|++++. + ++++++|++|++++|+..+.+ .+..+++|++|++++|++++.
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l 185 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL 185 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcccee
Confidence 9999996 44 88999999999999999974 3 788999999999999766666 478899999999999999974
Q ss_pred cchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCC
Q 003134 251 IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 330 (845)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 330 (845)
| ++.+++|+.|++++|.++...+. ...+|+.|+|++|+|++ +| ++.+++|+.|++++|+|++..+..+.+|.
T Consensus 186 -~--l~~l~~L~~L~l~~N~l~~~~l~--~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~ 257 (457)
T 3bz5_A 186 -D--VSQNKLLNRLNCDTNNITKLDLN--QNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLT 257 (457)
T ss_dssp -C--CTTCTTCCEEECCSSCCSCCCCT--TCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCC
T ss_pred -c--cccCCCCCEEECcCCcCCeeccc--cCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCC
Confidence 4 88899999999999999887422 22389999999999998 55 88899999999999999987766666655
Q ss_pred -------CcCEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCCCCCCC----CCCCceeeeeecCCCCCCCCc
Q 003134 331 -------KTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIEC----PRGSVNLVESYSSPRNKLDKV 395 (845)
Q Consensus 331 -------~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p~~~~c----~~~~~~~l~~l~~~~n~~~~~ 395 (845)
+|+.|++++|++.|.+|..-...|+.|++++|.+.+.+|..+.. +-.....++.++.+.|++++.
T Consensus 258 ~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l 333 (457)
T 3bz5_A 258 TLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL 333 (457)
T ss_dssp EEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC
T ss_pred EEeccCCCCCEEECCCCccCCcccccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc
Confidence 56677777777777777555678888899998887777632210 011223456666777777664
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=271.05 Aligned_cols=255 Identities=17% Similarity=0.212 Sum_probs=210.0
Q ss_pred cceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCC--Cccccccc-ceeEEEecCCCCCCCcccccccccccce
Q 003134 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS--FSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKN 167 (845)
Q Consensus 91 ~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~--~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 167 (845)
..+++.|+|++|.++...+..|.++++|++|+|++|+++.. .+..+..+ +|++|+|++|+++ .+|..+..+++|++
T Consensus 27 ~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~ 105 (306)
T 2z66_A 27 PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH 105 (306)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCE
T ss_pred CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCE
Confidence 35789999999999965455689999999999999999854 35556566 9999999999999 46777999999999
Q ss_pred eEeecccCCCCCC-cccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcc-cCchhhcCCcccceEEecCC
Q 003134 168 LSIEGNLFTGSIP-PDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG-KIPEFIGKWKKIQKLHIQGS 245 (845)
Q Consensus 168 L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N 245 (845)
|+|++|++++..+ ..+..+++|++|+|++|++++..|..|.++++|++|+|++|++++ .+|..+..+++|++|+|++|
T Consensus 106 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n 185 (306)
T 2z66_A 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185 (306)
T ss_dssp EECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred EECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCC
Confidence 9999999997655 589999999999999999999999999999999999999999997 68999999999999999999
Q ss_pred cCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchh
Q 003134 246 SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325 (845)
Q Consensus 246 ~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 325 (845)
++++..|..+..+++|+.|+ |++|++++..+..|..+++|+.|+|++|++++..|..
T Consensus 186 ~l~~~~~~~~~~l~~L~~L~-----------------------L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 242 (306)
T 2z66_A 186 QLEQLSPTAFNSLSSLQVLN-----------------------MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242 (306)
T ss_dssp CCCEECTTTTTTCTTCCEEE-----------------------CTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSS
T ss_pred CcCCcCHHHhcCCCCCCEEE-----------------------CCCCccCccChhhccCcccCCEeECCCCCCcccCHHH
Confidence 99988888888888776665 5555555566666778888888888888888888888
Q ss_pred hhcCC-CcCEEEccCCcccCCCCh-hh---hcCCceEEeecCCCcCCCC
Q 003134 326 FEKLA-KTNFMYLTGNKLTGPVPK-YI---FNSNKNVDISLNNFTWESS 369 (845)
Q Consensus 326 ~~~l~-~L~~L~L~~N~l~g~ip~-~~---~~~l~~L~ls~N~l~~~~p 369 (845)
+..++ +|++|+|++|++++..+. ++ ....+.+.+..|.+.+..|
T Consensus 243 ~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p 291 (306)
T 2z66_A 243 LQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 291 (306)
T ss_dssp CCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred HHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence 88884 888888888888875432 12 2234455555665555554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-28 Score=264.83 Aligned_cols=258 Identities=20% Similarity=0.286 Sum_probs=224.6
Q ss_pred cceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeE
Q 003134 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (845)
Q Consensus 91 ~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 169 (845)
..+++.|++++|.++.. +.|.++++|++|+|++|++++..+ +..+ +|++|++++|.....++. +..+++|++|+
T Consensus 87 l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~ 161 (347)
T 4fmz_A 87 LVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLT 161 (347)
T ss_dssp CTTCCEEECCSSCCCCC--GGGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEE
T ss_pred CCcCCEEEccCCcccCc--hHHcCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCcccccc-hhhCCCCcEEE
Confidence 35789999999999863 579999999999999999998755 6677 999999999976655544 89999999999
Q ss_pred eecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCC
Q 003134 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (845)
Q Consensus 170 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 249 (845)
+++|.+.+..+ +..+++|++|++++|++++..+ +..+++|++|++++|++++..+ +..+++|++|++++|++++
T Consensus 162 l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~ 235 (347)
T 4fmz_A 162 VTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235 (347)
T ss_dssp CCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred ecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC
Confidence 99999995543 8999999999999999985443 8899999999999999996655 8899999999999999997
Q ss_pred CcchhhhcCCCCCEEEcCCCCCCCCCCccccc-CCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhc
Q 003134 250 PIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328 (845)
Q Consensus 250 ~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 328 (845)
..+ +..+++|+.|++++|.++.. +.+.. .+|+.|++++|++++. ..+..+++|+.|+|++|++++..|..|..
T Consensus 236 ~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 309 (347)
T 4fmz_A 236 LSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGG 309 (347)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHT
T ss_pred Ccc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhc
Confidence 655 89999999999999999875 33333 3899999999999975 46889999999999999999999999999
Q ss_pred CCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCc
Q 003134 329 LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365 (845)
Q Consensus 329 l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~ 365 (845)
+++|++|+|++|++++..|-.-...|+.|++++|.++
T Consensus 310 l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 310 LTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVIK 346 (347)
T ss_dssp CTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC---
T ss_pred cccCCEEEccCCccccccChhhhhccceeehhhhccc
Confidence 9999999999999998877455679999999999765
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=274.24 Aligned_cols=280 Identities=25% Similarity=0.346 Sum_probs=206.2
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|++.++++.. +| .+..+++|++|+|++|.+++..+ +..+ +|++|+|++|++++..+ +.++++|++|+|
T Consensus 46 ~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 119 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119 (466)
T ss_dssp HTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred ccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence 478899999999985 55 48899999999999999998866 7777 99999999999997766 999999999999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcccCC-------------------hhhhCCCCCCcEEeecCcCcccCchhh
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP-------------------AELTKLTNLNDLRISDNNFSGKIPEFI 231 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p-------------------~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 231 (845)
++|++++. +. +.++++|++|+|++|++++... ..+.++++|++|++++|++++. ..+
T Consensus 120 ~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l 195 (466)
T 1o6v_A 120 FNNQITDI-DP-LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVL 195 (466)
T ss_dssp CSSCCCCC-GG-GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGG
T ss_pred CCCCCCCC-hH-HcCCCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhh
Confidence 99999965 33 9999999999999999985321 1245556666666777766643 236
Q ss_pred cCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCccccc-CCccEEEccCCcCcccCcccccCCCCcCE
Q 003134 232 GKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKN 310 (845)
Q Consensus 232 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 310 (845)
..+++|++|++++|++++..| ++.+++|+.|++++|.+.... .+.. .+|+.|++++|.+++..| +..+++|+.
T Consensus 196 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 269 (466)
T 1o6v_A 196 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 269 (466)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred ccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccch--hhhcCCCCCEEECCCCccccchh--hhcCCCCCE
Confidence 666777777777777766554 566777777777777766542 2322 267777777777776655 677777777
Q ss_pred EeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCC
Q 003134 311 IDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRN 390 (845)
Q Consensus 311 L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n 390 (845)
|+|++|++++..+ +..+++|+.|+|++|++++..|-.-..+|+.|++++|++++..| + ..+..++.++...|
T Consensus 270 L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~--~----~~l~~L~~L~l~~n 341 (466)
T 1o6v_A 270 LKLGANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--V----SSLTKLQRLFFYNN 341 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG--G----GGCTTCCEEECCSS
T ss_pred EECCCCccCcccc--ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCchh--h----ccCccCCEeECCCC
Confidence 7777777775444 77777788888888877765553334577788888887777655 1 23344566666777
Q ss_pred CCCCc
Q 003134 391 KLDKV 395 (845)
Q Consensus 391 ~~~~~ 395 (845)
++.+.
T Consensus 342 ~l~~~ 346 (466)
T 1o6v_A 342 KVSDV 346 (466)
T ss_dssp CCCCC
T ss_pred ccCCc
Confidence 66654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-29 Score=276.17 Aligned_cols=243 Identities=20% Similarity=0.260 Sum_probs=208.8
Q ss_pred eEEEEEecCCCccccCCccccCCCCCCEEeccCCccc-CCCccccc-------cc-ceeEEEecCCCCCCCccccc--cc
Q 003134 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLT-GSFSPQWA-------SL-QLVELSVMGNRLSGPFPKVL--TN 161 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~-~~~~~~~~-------~l-~L~~L~Ls~N~l~~~~p~~~--~~ 161 (845)
+++.+++++|.+ .+|..+... |+.|+|++|+++ ..+|..+. .+ +|++|+|++|++++.+|..+ ..
T Consensus 44 ~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 119 (312)
T 1wwl_A 44 SLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119 (312)
T ss_dssp ECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCC
T ss_pred CceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhc
Confidence 466778889998 788877655 999999999994 55666554 45 89999999999999999986 89
Q ss_pred ccccceeEeecccCCCCCCcccccC-----CCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCccc--Cchhh--c
Q 003134 162 ITTLKNLSIEGNLFTGSIPPDIRKL-----INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK--IPEFI--G 232 (845)
Q Consensus 162 l~~L~~L~Ls~N~l~g~~p~~~~~l-----~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~--~ 232 (845)
+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|.++++|++|+|++|++++. .|..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 99999999999999977 8888888 9999999999999988889999999999999999999876 34455 8
Q ss_pred CCcccceEEecCCcCCC--Ccc-hhhhcCCCCCEEEcCCCCCCCCCC-ccccc-CCccEEEccCCcCcccCcccccCCCC
Q 003134 233 KWKKIQKLHIQGSSLEG--PIP-ASISALTSLTDLRISDLKGSESAF-PKLDK-MNLKTLILTKCLIHGEIPDYIGDMTK 307 (845)
Q Consensus 233 ~l~~L~~L~Ls~N~l~g--~~p-~~~~~l~~L~~L~Ls~n~~~~~~~-~~l~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~ 307 (845)
.+++|++|+|++|+|++ .++ ..+.++++|+.|++++|.+.+..+ ..+.. .+|+.|+|++|+|+ .+|..+. ++
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~ 275 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AK 275 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CC
Confidence 89999999999999994 223 455788999999999999988663 33433 48999999999999 7787776 89
Q ss_pred cCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCC
Q 003134 308 LKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP 345 (845)
Q Consensus 308 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ 345 (845)
|++|||++|+|++. |. +..+++|++|+|++|++++.
T Consensus 276 L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 276 LSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp EEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred ceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 99999999999976 66 99999999999999999863
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-29 Score=277.57 Aligned_cols=161 Identities=22% Similarity=0.402 Sum_probs=135.9
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe------CCE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE------GNQ 746 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~ 746 (845)
++|++.+.||+|+||+||+|++. +|+.||||+++... ....+++.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57899999999999999999985 69999999997542 2334678899999999999999999999764 357
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
+|||||||+ |+|.+++... ..+++.++..|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence 899999996 6799998653 36999999999999999999999997 99999999999999999999999999
Q ss_pred ceecCCCC---ceeeeeeccCC
Q 003134 827 AKLYEEDK---THISTRIAGTM 845 (845)
Q Consensus 827 a~~~~~~~---~~~~t~~~GT~ 845 (845)
|+.+.... ....+..+||+
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~ 226 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATR 226 (398)
T ss_dssp CBCC-------CCCCCSSCCCC
T ss_pred eeecccCccccccccccceeCh
Confidence 99874322 22334567875
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=276.13 Aligned_cols=228 Identities=22% Similarity=0.250 Sum_probs=205.7
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
..++.|+|++|++++..+..|.++++|++|+|++|+|+++.+..|..+ +|++|+|++|+|++..+..|..+++|++|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 467899999999999989999999999999999999999999999998 9999999999999888889999999999999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecC-cCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCC
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSN-SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 249 (845)
++|+|++..+..|.++++|++|+|++| .+....+..|.++++|++|+|++|+|+ .+| .+..+++|++|+|++|+|++
T Consensus 144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~ 221 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSA 221 (440)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCE
T ss_pred CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCc
Confidence 999999877779999999999999995 455444557999999999999999999 455 48899999999999999999
Q ss_pred CcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcC
Q 003134 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329 (845)
Q Consensus 250 ~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 329 (845)
..|..|.++++|+.| +|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+
T Consensus 222 ~~~~~~~~l~~L~~L-----------------------~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 222 IRPGSFQGLMHLQKL-----------------------WMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp ECTTTTTTCTTCCEE-----------------------ECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred cChhhhccCccCCEE-----------------------ECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 889999888876665 566677777788889999999999999999998888889999
Q ss_pred CCcCEEEccCCcccC
Q 003134 330 AKTNFMYLTGNKLTG 344 (845)
Q Consensus 330 ~~L~~L~L~~N~l~g 344 (845)
++|+.|+|++|.+.-
T Consensus 279 ~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 279 HHLERIHLHHNPWNC 293 (440)
T ss_dssp TTCCEEECCSSCEEC
T ss_pred cCCCEEEcCCCCccC
Confidence 999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=270.71 Aligned_cols=146 Identities=24% Similarity=0.429 Sum_probs=131.2
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC----CCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 748 (845)
..++|++.++||+|+||+||+|+.+ +++.||+|++... ....++.+|+++|.++ +|||||++++++.+.+..|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999863 4688999998654 3346788999999988 6999999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CcEEEEeeccc
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLA 827 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~-~~~kl~DFGla 827 (845)
+||||+++|+|.+++. .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 97 lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 9999999999999982 4789999999999999999999997 9999999999999877 79999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+...+
T Consensus 166 ~~~~~ 170 (361)
T 4f9c_A 166 QGTHD 170 (361)
T ss_dssp EECTT
T ss_pred cccCC
Confidence 97654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=285.25 Aligned_cols=159 Identities=27% Similarity=0.388 Sum_probs=136.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHH---HHHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFV---NEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
++|++.++||+|+||+||+|+.. +|+.||||++++.. ......+. .++++++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56899999999999999999986 59999999997542 22223333 3466778889999999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+|||||+||+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+
T Consensus 269 lVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999543 36899999999999999999999997 9999999999999999999999999999
Q ss_pred ecCCCCceeeeeeccCC
Q 003134 829 LYEEDKTHISTRIAGTM 845 (845)
Q Consensus 829 ~~~~~~~~~~t~~~GT~ 845 (845)
.+..... ...+||+
T Consensus 341 ~~~~~~~---~t~~GTp 354 (689)
T 3v5w_A 341 DFSKKKP---HASVGTH 354 (689)
T ss_dssp ECSSCCC---CSCCSCG
T ss_pred ecCCCCC---CCccCCc
Confidence 8865432 3467885
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=258.94 Aligned_cols=219 Identities=20% Similarity=0.259 Sum_probs=167.2
Q ss_pred cCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCC
Q 003134 100 KAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGS 178 (845)
Q Consensus 100 ~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 178 (845)
.+.+++ .+|..+. ++|++|+|++|++++..+..|..+ +|++|+|++|++++..+..|.++++|++|+|++|++++.
T Consensus 15 ~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 91 (276)
T 2z62_A 15 MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91 (276)
T ss_dssp TTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred cCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCcc
Confidence 344444 3555553 578899999999888877777777 788888888888877777888888888888888888877
Q ss_pred CCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCccc-CchhhcCCcccceEEecCCcCCCCcchhhhc
Q 003134 179 IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK-IPEFIGKWKKIQKLHIQGSSLEGPIPASISA 257 (845)
Q Consensus 179 ~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 257 (845)
.+..|.++++|++|++++|++++..+..+.++++|++|+|++|++++. +|..|.++++|++|+|++|++++..+..+..
T Consensus 92 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 171 (276)
T 2z62_A 92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171 (276)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH
T ss_pred ChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhh
Confidence 777788888888888888888876666788888888888888888763 5778888888888888888888776777766
Q ss_pred CCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEc
Q 003134 258 LTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 337 (845)
Q Consensus 258 l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 337 (845)
+.+|+.|.+ .|++++|.+++..+..+.. .+|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 172 l~~L~~l~l-------------------~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 231 (276)
T 2z62_A 172 LHQMPLLNL-------------------SLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWL 231 (276)
T ss_dssp HHTCTTCCE-------------------EEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEEC
T ss_pred hhhccccce-------------------eeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEc
Confidence 666553211 5677777777666655554 47888889888888777777788888888888
Q ss_pred cCCc
Q 003134 338 TGNK 341 (845)
Q Consensus 338 ~~N~ 341 (845)
++|+
T Consensus 232 ~~N~ 235 (276)
T 2z62_A 232 HTNP 235 (276)
T ss_dssp CSSC
T ss_pred cCCc
Confidence 8883
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=269.72 Aligned_cols=256 Identities=19% Similarity=0.228 Sum_probs=226.7
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|++++|++++..+..|.++++|++|+|++|++++..+..|..+ +|++|+|++|+|++..+..|.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 478999999999998777799999999999999999999999999998 9999999999999877777999999999999
Q ss_pred ecccCCCCCC-cccccCCCccEEEeecC-cCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCC
Q 003134 171 EGNLFTGSIP-PDIRKLINLQKLILSSN-SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 171 s~N~l~g~~p-~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
++|++++..+ ..|.++++|++|++++| .+++..+..|.++++|++|++++|++++..|..|..+++|++|++++|+++
T Consensus 132 ~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred CCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 9999995444 47899999999999999 577677788999999999999999999999999999999999999999998
Q ss_pred CCcchhhhcCCCCCEEEcCCCCCCCCCCccccc----CCccEEEccCCcCcc----cCcccccCCCCcCEEeCCCCCCCC
Q 003134 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDK----MNLKTLILTKCLIHG----EIPDYIGDMTKLKNIDLSFNNLTG 320 (845)
Q Consensus 249 g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~----~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g 320 (845)
...+..+..+++|+.|++++|.++...+..+.. ..++.++|++|.+++ .+|..+..+++|+.|+|++|+|+.
T Consensus 212 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~ 291 (353)
T 2z80_A 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS 291 (353)
T ss_dssp THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC
T ss_pred cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc
Confidence 655556677999999999999999876655432 268899999999987 478889999999999999999995
Q ss_pred CCchhhhcCCCcCEEEccCCcccCCCC
Q 003134 321 GIPTTFEKLAKTNFMYLTGNKLTGPVP 347 (845)
Q Consensus 321 ~~p~~~~~l~~L~~L~L~~N~l~g~ip 347 (845)
..+..|.++++|++|+|++|++++..|
T Consensus 292 i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 292 VPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 444447999999999999999998776
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-29 Score=270.66 Aligned_cols=264 Identities=17% Similarity=0.140 Sum_probs=225.5
Q ss_pred eEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEee
Q 003134 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 171 (845)
+....+++.+++...+...+..+++|++|+|++|++++..|..|..+ +|++|+|++|++++..+ |..+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 56667888888887766777888999999999999999999999998 99999999999997665 9999999999999
Q ss_pred cccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCc
Q 003134 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251 (845)
Q Consensus 172 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 251 (845)
+|+|++. ...++|++|++++|++++..+.. +++|++|+|++|++++..+..+..+++|++|+|++|++++..
T Consensus 89 ~n~l~~l-----~~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (317)
T 3o53_A 89 NNYVQEL-----LVGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (317)
T ss_dssp SSEEEEE-----EECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred CCccccc-----cCCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence 9999843 34589999999999999766543 678999999999999988889999999999999999999988
Q ss_pred chhhh-cCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCC
Q 003134 252 PASIS-ALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 330 (845)
Q Consensus 252 p~~~~-~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 330 (845)
+..+. .+++|+.|++++|.++..+... ...+|+.|+|++|+|++..+. |..+++|+.|+|++|+|+ .+|..+..++
T Consensus 161 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~l~~L~~L~Ls~N~l~~l~~~-~~~l~~L~~L~L~~N~l~-~l~~~~~~l~ 237 (317)
T 3o53_A 161 FAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQ 237 (317)
T ss_dssp GGGGGGGTTTCCEEECTTSCCCEEECCC-CCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCC-EECTTCCCCT
T ss_pred HHHHhhccCcCCEEECCCCcCccccccc-ccccCCEEECCCCcCCcchhh-hcccCcccEEECcCCccc-chhhHhhcCC
Confidence 88774 7999999999999998763322 345899999999999976554 889999999999999999 5788899999
Q ss_pred CcCEEEccCCccc-CCCChhhh--cCCceEEee-cCCCcCCCC
Q 003134 331 KTNFMYLTGNKLT-GPVPKYIF--NSNKNVDIS-LNNFTWESS 369 (845)
Q Consensus 331 ~L~~L~L~~N~l~-g~ip~~~~--~~l~~L~ls-~N~l~~~~p 369 (845)
+|+.|+|++|+++ +.+|..+. ..++.|+++ .+.++|..|
T Consensus 238 ~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp TCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred CCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence 9999999999998 66666664 367888888 444555544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-28 Score=282.14 Aligned_cols=161 Identities=24% Similarity=0.430 Sum_probs=142.3
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
++|++.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+++|++++|||||++++++.+++.+|+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57999999999999999999986 59999999997765555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC--CcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD--LNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~--~~~kl~DFGla~~~~~ 832 (845)
+||+|.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 237 ~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 237 SGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred CCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 9999999985432 26899999999999999999999997 9999999999999854 8999999999999865
Q ss_pred CCceeeeeeccCC
Q 003134 833 DKTHISTRIAGTM 845 (845)
Q Consensus 833 ~~~~~~t~~~GT~ 845 (845)
... .+..+||+
T Consensus 310 ~~~--~~~~~GT~ 320 (573)
T 3uto_A 310 KQS--VKVTTGTA 320 (573)
T ss_dssp TSE--EEEECSSG
T ss_pred CCc--eeeeEECc
Confidence 432 34467874
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=282.39 Aligned_cols=248 Identities=18% Similarity=0.156 Sum_probs=199.6
Q ss_pred cCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCC
Q 003134 100 KAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGS 178 (845)
Q Consensus 100 ~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 178 (845)
...++...+......+++|++|+|++|.|++..|..|..+ +|++|+|++|.|++..| |..+++|++|+|++|.|++.
T Consensus 18 ~~~~l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l 95 (487)
T 3oja_A 18 TDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL 95 (487)
T ss_dssp CTTTHHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEE
T ss_pred chhhhHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCC
Confidence 3334433333333444589999999999999888888888 89999999999987766 88899999999999998843
Q ss_pred CCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhh-c
Q 003134 179 IPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASIS-A 257 (845)
Q Consensus 179 ~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~ 257 (845)
. ..++|++|+|++|+|++..+. .+++|++|+|++|+|++..|..|+.+++|++|+|++|.|++.+|..+. .
T Consensus 96 ~-----~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~ 167 (487)
T 3oja_A 96 L-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS 167 (487)
T ss_dssp E-----ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGG
T ss_pred C-----CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhh
Confidence 2 348999999999999976654 357899999999999988888999999999999999999998888886 7
Q ss_pred CCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEc
Q 003134 258 LTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 337 (845)
Q Consensus 258 l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 337 (845)
+++|+.|+|++|.++..+... ...+|+.|+|++|.|++..|. |..+++|+.|+|++|+|++ +|..+..+++|+.|+|
T Consensus 168 l~~L~~L~Ls~N~l~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l 244 (487)
T 3oja_A 168 SDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDL 244 (487)
T ss_dssp TTTCCEEECTTSCCCEEECCC-CCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEEC
T ss_pred CCcccEEecCCCccccccccc-cCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEc
Confidence 899999999999988763322 344899999999999976665 8889999999999999995 6778899999999999
Q ss_pred cCCccc-CCCChhhhc--CCceEEee
Q 003134 338 TGNKLT-GPVPKYIFN--SNKNVDIS 360 (845)
Q Consensus 338 ~~N~l~-g~ip~~~~~--~l~~L~ls 360 (845)
++|.++ +.+|..+.. .++.++++
T Consensus 245 ~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 245 RGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp TTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCCCCcCcchHHHHHhCCCCcEEecc
Confidence 999987 556655532 45555554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-27 Score=268.74 Aligned_cols=231 Identities=18% Similarity=0.193 Sum_probs=207.6
Q ss_pred cceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeE
Q 003134 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (845)
Q Consensus 91 ~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 169 (845)
..+++.|+|++|++++..|..|.++++|++|+|++|+|+++.+..|..+ +|++|+|++|+|++..+..|.++++|++|+
T Consensus 74 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 153 (452)
T 3zyi_A 74 PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW 153 (452)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEE
T ss_pred CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEE
Confidence 3578999999999999999999999999999999999999999999998 999999999999988888999999999999
Q ss_pred eecccCCCCCCcccccCCCccEEEeecC-cCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCC
Q 003134 170 IEGNLFTGSIPPDIRKLINLQKLILSSN-SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 170 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
|++|+|++..+..|.++++|++|+|++| .+....+..|.++++|++|+|++|+|++. | .+..+++|++|+|++|+|+
T Consensus 154 L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~ 231 (452)
T 3zyi_A 154 LRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFP 231 (452)
T ss_dssp CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCS
T ss_pred CCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCc
Confidence 9999999777778999999999999994 55544445799999999999999999954 4 5889999999999999999
Q ss_pred CCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhc
Q 003134 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328 (845)
Q Consensus 249 g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 328 (845)
+..|..|.++++|+.| +|++|+|++..|..|.++++|+.|+|++|+|++..+..|..
T Consensus 232 ~~~~~~~~~l~~L~~L-----------------------~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 288 (452)
T 3zyi_A 232 EIRPGSFHGLSSLKKL-----------------------WVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288 (452)
T ss_dssp EECGGGGTTCTTCCEE-----------------------ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred ccCcccccCccCCCEE-----------------------EeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence 9999999988876665 56667777788888999999999999999999888888999
Q ss_pred CCCcCEEEccCCcccCCC
Q 003134 329 LAKTNFMYLTGNKLTGPV 346 (845)
Q Consensus 329 l~~L~~L~L~~N~l~g~i 346 (845)
+++|+.|+|++|.+.-.-
T Consensus 289 l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 289 LRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp CTTCCEEECCSSCEECST
T ss_pred ccCCCEEEccCCCcCCCC
Confidence 999999999999987543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=266.06 Aligned_cols=267 Identities=19% Similarity=0.160 Sum_probs=222.5
Q ss_pred CCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCC
Q 003134 102 QNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIP 180 (845)
Q Consensus 102 ~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 180 (845)
.+..+..+..++++++|++|+|++|.|++. | .+..+ +|++|+|++|+|++. | ++.+++|++|+|++|+|++. |
T Consensus 28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~ 101 (457)
T 3bz5_A 28 FEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D 101 (457)
T ss_dssp TTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C
T ss_pred cCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e
Confidence 344555567889999999999999999986 4 57777 999999999999985 3 89999999999999999974 4
Q ss_pred cccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCC
Q 003134 181 PDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTS 260 (845)
Q Consensus 181 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 260 (845)
++++++|++|+|++|++++ +| +.++++|++|++++|+|++. + ++.+++|++|++++|+..+.+ .++.+++
T Consensus 102 --~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~ 171 (457)
T 3bz5_A 102 --VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQ 171 (457)
T ss_dssp --CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTT
T ss_pred --cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCc
Confidence 8999999999999999997 45 89999999999999999974 3 889999999999999776666 5889999
Q ss_pred CCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCC
Q 003134 261 LTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340 (845)
Q Consensus 261 L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N 340 (845)
|+.|++++|.++..+.. ...+|+.|++++|++++. .++.+++|+.|+|++|+|++ +| +..+++|++|++++|
T Consensus 172 L~~L~ls~n~l~~l~l~--~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N 243 (457)
T 3bz5_A 172 LTTLDCSFNKITELDVS--QNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVN 243 (457)
T ss_dssp CCEEECCSSCCCCCCCT--TCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSS
T ss_pred CCEEECCCCccceeccc--cCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCC
Confidence 99999999999986522 233899999999999986 48899999999999999997 56 889999999999999
Q ss_pred cccCCCChhhh---------cCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCCCCCccCc
Q 003134 341 KLTGPVPKYIF---------NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 398 (845)
Q Consensus 341 ~l~g~ip~~~~---------~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~~~~~~~c 398 (845)
++++..+..+. +.++.|++++|.+.+.+|. ..+..++.++.+.|+..+..+|
T Consensus 244 ~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~------~~l~~L~~L~Ls~n~~l~~l~~ 304 (457)
T 3bz5_A 244 PLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQA------EGCRKIKELDVTHNTQLYLLDC 304 (457)
T ss_dssp CCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEEC------TTCTTCCCCCCTTCTTCCEEEC
T ss_pred cCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcccc------cccccCCEEECCCCcccceecc
Confidence 99986544332 1456667777776666652 2334567777888877666655
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.2e-27 Score=247.73 Aligned_cols=224 Identities=22% Similarity=0.332 Sum_probs=132.4
Q ss_pred ceeecCCCCcceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCccccccc
Q 003134 82 NVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTN 161 (845)
Q Consensus 82 ~v~C~~~~~~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~ 161 (845)
|+.|+|.. ..+.+++++++++. +|..+. ++|++|+|++|++++ ..+..|.+
T Consensus 9 ~~~C~c~~---~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~-----------------------~~~~~~~~ 59 (270)
T 2o6q_A 9 GGVCSCNN---NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSS-----------------------LPSKAFHR 59 (270)
T ss_dssp TCSBEEET---TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSC-----------------------CCTTSSSS
T ss_pred CCCCEeCC---CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCe-----------------------eCHHHhcC
Confidence 67787642 23456777777663 454443 445555555555544 44445555
Q ss_pred ccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEE
Q 003134 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLH 241 (845)
Q Consensus 162 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 241 (845)
+++|++|+|++|+++...+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+
T Consensus 60 l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 139 (270)
T 2o6q_A 60 LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139 (270)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence 56666666666666544444455566666666666666654445555666666666666666655555555666666666
Q ss_pred ecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCC
Q 003134 242 IQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG 321 (845)
Q Consensus 242 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 321 (845)
|++|++++..+..|..+++|+.| +|++|+|++..+..|.++++|++|+|++|+|++.
T Consensus 140 Ls~n~l~~~~~~~~~~l~~L~~L-----------------------~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (270)
T 2o6q_A 140 LGYNELQSLPKGVFDKLTSLKEL-----------------------RLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRV 196 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEE-----------------------ECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCCcCCccCHhHccCCccccee-----------------------EecCCcCcEeChhHhccCCCcCEEECCCCcCCcC
Confidence 66666554444444444443333 3344444444455566677777777777777766
Q ss_pred CchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCCCCCCCCCC-CceeeeeecC
Q 003134 322 IPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRG-SVNLVESYSS 387 (845)
Q Consensus 322 ~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p~~~~c~~~-~~~~l~~l~~ 387 (845)
.+..|..+++|+.|+|++| ||.|+|. ..++..|+..
T Consensus 197 ~~~~~~~l~~L~~L~l~~N------------------------------~~~c~c~~~~~~~~~l~~ 233 (270)
T 2o6q_A 197 PEGAFDSLEKLKMLQLQEN------------------------------PWDCTCNGIIYMAKWLKK 233 (270)
T ss_dssp CTTTTTTCTTCCEEECCSS------------------------------CBCCSSSSSHHHHHHHHH
T ss_pred CHHHhccccCCCEEEecCC------------------------------CeeCCCccHHHHHHHHHh
Confidence 6666777777777777666 7778886 4566677654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=255.22 Aligned_cols=236 Identities=17% Similarity=0.174 Sum_probs=204.1
Q ss_pred cceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCC-CCCCccccccccccccee
Q 003134 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNR-LSGPFPKVLTNITTLKNL 168 (845)
Q Consensus 91 ~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L 168 (845)
..+++.|++++|.+++..+..|.++++|++|+|++|.+++..|..|..+ +|++|+|++|+ ++...|..|..+++|++|
T Consensus 31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 4578999999999999888899999999999999999999999999998 99999999998 888889999999999999
Q ss_pred EeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCC
Q 003134 169 SIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 169 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+++
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccc
Confidence 99999999888999999999999999999999877778999999999999999999877778999999999999999999
Q ss_pred CCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhc
Q 003134 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328 (845)
Q Consensus 249 g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 328 (845)
+..|..|.++++|+.| +|++|.|++..+..|..+++|+.|+|++|+++...+.. .-
T Consensus 191 ~~~~~~~~~l~~L~~L-----------------------~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~ 246 (285)
T 1ozn_A 191 HVHPHAFRDLGRLMTL-----------------------YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PL 246 (285)
T ss_dssp EECTTTTTTCTTCCEE-----------------------ECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HH
T ss_pred ccCHhHccCcccccEe-----------------------eCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HH
Confidence 9889998888776666 55566666666777888999999999999988654421 11
Q ss_pred CCCcCEEEccCCcccCCCChhh
Q 003134 329 LAKTNFMYLTGNKLTGPVPKYI 350 (845)
Q Consensus 329 l~~L~~L~L~~N~l~g~ip~~~ 350 (845)
+..++.+..+.|.+....|..+
T Consensus 247 ~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 247 WAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp HHHHHHCCSEECCCBEEESGGG
T ss_pred HHHHHhcccccCccccCCchHh
Confidence 2234445567777777777665
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=269.66 Aligned_cols=246 Identities=19% Similarity=0.235 Sum_probs=134.9
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-c-------------eeEEEecCCCCCCCccc
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-Q-------------LVELSVMGNRLSGPFPK 157 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~-------------L~~L~Ls~N~l~~~~p~ 157 (845)
.+++.+++++|++ |.+|++|++|++|++|+|++|+++|.+|..++.+ + +++|++++|++++. |.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-PE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-CS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-CC
Confidence 4788899999999 7899999999999999999999999999888876 4 38888888888863 33
Q ss_pred ccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCccc
Q 003134 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237 (845)
Q Consensus 158 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 237 (845)
. .++|++|+|++|++++ +|.. +++|++|++++|++++ +|.. .++|++|+|++|++++ +| .|+++++|
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L 155 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFL 155 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTC
T ss_pred C---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCC
Confidence 2 3577778888887775 5543 2566666666666663 2221 1456666666666664 44 36666666
Q ss_pred ceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCC
Q 003134 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN 316 (845)
Q Consensus 238 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 316 (845)
++|++++|++++ +|..+ .+|+.|++++|.+...+ .+... +|+.|++++|++++ +|... ++|++|++++|
T Consensus 156 ~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~--~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n 225 (454)
T 1jl5_A 156 KIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEELP--ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNN 225 (454)
T ss_dssp CEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSCC--CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSS
T ss_pred CEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcCc--cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCC
Confidence 666666666664 33322 35666666666665532 22222 56666666666654 23221 35666666666
Q ss_pred CCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcC
Q 003134 317 NLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW 366 (845)
Q Consensus 317 ~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~ 366 (845)
+++ .+| .+..+++|++|++++|++++ +|. ...+++.|++++|++++
T Consensus 226 ~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~-~~~~L~~L~l~~N~l~~ 271 (454)
T 1jl5_A 226 ILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD-LPPSLEALNVRDNYLTD 271 (454)
T ss_dssp CCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS-CCTTCCEEECCSSCCSC
T ss_pred cCC-ccc-ccCCCCCCCEEECCCCcCCc-ccc-cccccCEEECCCCcccc
Confidence 665 444 25566666666666666653 332 22455666666665554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=270.18 Aligned_cols=172 Identities=24% Similarity=0.312 Sum_probs=149.0
Q ss_pred cHHHHHHHhcCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEE
Q 003134 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCV 742 (845)
Q Consensus 667 ~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 742 (845)
.+++++...++|+..++||+|+||+||+|+... ++.||+|++++.. ....+.+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 345666667899999999999999999999864 8899999997532 222345889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEE
Q 003134 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822 (845)
Q Consensus 743 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~ 822 (845)
+.+..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEc
Confidence 9999999999999999999996532 36899999999999999999999987 9999999999999999999999
Q ss_pred eeccceecCCCCceeeeeeccCC
Q 003134 823 DFGLAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 823 DFGla~~~~~~~~~~~t~~~GT~ 845 (845)
|||+|+....+.....+..+||+
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~ 240 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTP 240 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCG
T ss_pred chhhhhhcccCCCcccccccCCc
Confidence 99999988766555555567774
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=248.64 Aligned_cols=216 Identities=22% Similarity=0.170 Sum_probs=133.2
Q ss_pred ccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccE
Q 003134 112 LSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191 (845)
Q Consensus 112 l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 191 (845)
+.++++|++|++++|.++.+++.. . .+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+ ...+++|++
T Consensus 6 ~~~l~~l~~l~~~~~~l~~ip~~~-~-~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 81 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTALPPDL-P-KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGT 81 (290)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCC-C-TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCE
T ss_pred ccccCCccEEECCCCCCCcCCCCC-C-CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCE
Confidence 567778888888888887544322 1 256677777777776666677777777777777777764322 256666777
Q ss_pred EEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCC
Q 003134 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271 (845)
Q Consensus 192 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~ 271 (845)
|+|++|+|+ .+|..+.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|
T Consensus 82 L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---------------- 144 (290)
T 1p9a_G 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL---------------- 144 (290)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTT----------------
T ss_pred EECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhc----------------
Confidence 777777666 555566666666666666666665555566666666666666666554444333
Q ss_pred CCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhh
Q 003134 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF 351 (845)
Q Consensus 272 ~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~ 351 (845)
..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..++
T Consensus 145 -------------------------------~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~ 192 (290)
T 1p9a_G 145 -------------------------------TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192 (290)
T ss_dssp -------------------------------TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTT
T ss_pred -------------------------------ccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhc
Confidence 34444444455555554444444444555555555555554 3444433
Q ss_pred c--CCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCC
Q 003134 352 N--SNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSP 388 (845)
Q Consensus 352 ~--~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~ 388 (845)
. .++.|+|++| ||.|+|...++..|+...
T Consensus 193 ~~~~L~~l~L~~N--------p~~C~c~~~~l~~wl~~~ 223 (290)
T 1p9a_G 193 GSHLLPFAFLHGN--------PWLCNCEILYFRRWLQDN 223 (290)
T ss_dssp TTCCCSEEECCSC--------CBCCSGGGHHHHHHHHHT
T ss_pred ccccCCeEEeCCC--------CccCcCccHHHHHHHHhC
Confidence 2 3555666666 889999999999998754
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-25 Score=257.65 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=134.1
Q ss_pred eEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeec
Q 003134 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 172 (845)
+++.|++++|.+++ +| +|+++++|++|++++|++++. |..+ .+|++|++++|++++ +| .++++++|++|++++
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~l-p~~~--~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~ 204 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKL-PDLP--PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADN 204 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCC-CCCC--TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCccc-CCCc--ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCC
Confidence 34455555555553 34 355555555555555555542 2211 145555555555554 23 355555555555555
Q ss_pred ccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcc
Q 003134 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (845)
Q Consensus 173 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 252 (845)
|++++ +|... ++|++|++++|+++ .+|. +.++++|++|++++|++++ +|.. +++|++|++++|++++ +|
T Consensus 205 N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~ 273 (454)
T 1jl5_A 205 NSLKK-LPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LP 273 (454)
T ss_dssp SCCSS-CCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CC
T ss_pred CcCCc-CCCCc---CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cC
Confidence 55553 33221 34555555555555 3442 5555555555555555553 3321 2455555555555554 23
Q ss_pred hhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCC-CCcCEEeCCCCCCCCCCchhhhcCCC
Q 003134 253 ASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDM-TKLKNIDLSFNNLTGGIPTTFEKLAK 331 (845)
Q Consensus 253 ~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~g~~p~~~~~l~~ 331 (845)
.. +++|+.|++++|.+++.+. + ..+|+.|++++|++++. ..+ ++|+.|+|++|++++ +|.. +++
T Consensus 274 ~~---~~~L~~L~ls~N~l~~l~~--~-~~~L~~L~l~~N~l~~i-----~~~~~~L~~L~Ls~N~l~~-lp~~---~~~ 338 (454)
T 1jl5_A 274 EL---PQSLTFLDVSENIFSGLSE--L-PPNLYYLNASSNEIRSL-----CDLPPSLEELNVSNNKLIE-LPAL---PPR 338 (454)
T ss_dssp CC---CTTCCEEECCSSCCSEESC--C-CTTCCEEECCSSCCSEE-----CCCCTTCCEEECCSSCCSC-CCCC---CTT
T ss_pred cc---cCcCCEEECcCCccCcccC--c-CCcCCEEECcCCcCCcc-----cCCcCcCCEEECCCCcccc-cccc---CCc
Confidence 22 2455555555555554211 0 02566666666666542 123 478888888888885 5543 578
Q ss_pred cCEEEccCCcccCCCChhhhcCCceEEeecCCCcC--CCCCCC
Q 003134 332 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW--ESSDPI 372 (845)
Q Consensus 332 L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~--~~p~~~ 372 (845)
|++|++++|+++ .+|. ....++.|++++|++++ .+|..+
T Consensus 339 L~~L~L~~N~l~-~lp~-~l~~L~~L~L~~N~l~~l~~ip~~l 379 (454)
T 1jl5_A 339 LERLIASFNHLA-EVPE-LPQNLKQLHVEYNPLREFPDIPESV 379 (454)
T ss_dssp CCEEECCSSCCS-CCCC-CCTTCCEEECCSSCCSSCCCCCTTC
T ss_pred CCEEECCCCccc-cccc-hhhhccEEECCCCCCCcCCCChHHH
Confidence 888888888888 4666 56788888888888888 555443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=253.30 Aligned_cols=181 Identities=44% Similarity=0.810 Sum_probs=155.6
Q ss_pred cCcccHHHHHHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEE
Q 003134 663 TGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCC 741 (845)
Q Consensus 663 ~~~~~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 741 (845)
...++++++....++|...+.||+|+||.||+|+..+++.||||++..... ....++.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 356888999999999999999999999999999988899999999976532 2344789999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEE
Q 003134 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821 (845)
Q Consensus 742 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl 821 (845)
...+..++||||+++|+|.+++..... ....+++..+..|+.|++.||+|||+++.++|+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999976532 2346999999999999999999999983334999999999999999999999
Q ss_pred EeeccceecCCCCceeeeeeccC
Q 003134 822 SDFGLAKLYEEDKTHISTRIAGT 844 (845)
Q Consensus 822 ~DFGla~~~~~~~~~~~t~~~GT 844 (845)
+|||+|+..............||
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt 198 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGT 198 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSC
T ss_pred ccCccccccCcccccccccccCC
Confidence 99999998865555444445565
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.6e-28 Score=261.93 Aligned_cols=245 Identities=17% Similarity=0.121 Sum_probs=214.8
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|+|++|.+++..|..|..+++|++|+|++|++++..+ +..+ +|++|+|++|+|++.. ..++|++|+|
T Consensus 34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l 106 (317)
T 3o53_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHA 106 (317)
T ss_dssp GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEEC
T ss_pred CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEEC
Confidence 478999999999999888899999999999999999998765 7777 9999999999998543 4489999999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhc-CCcccceEEecCCcCCC
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG-KWKKIQKLHIQGSSLEG 249 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g 249 (845)
++|++++..+. .+++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+. .+++|++|+|++|++++
T Consensus 107 ~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 183 (317)
T 3o53_A 107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (317)
T ss_dssp CSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc
Confidence 99999966544 368899999999999988888899999999999999999988887774 78999999999999996
Q ss_pred CcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCC-CCCchhhhc
Q 003134 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT-GGIPTTFEK 328 (845)
Q Consensus 250 ~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-g~~p~~~~~ 328 (845)
. + ....+++|+.|++++|.++..+.......+|+.|+|++|+|++ +|..+..+++|+.|+|++|+++ +.+|..+..
T Consensus 184 ~-~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~ 260 (317)
T 3o53_A 184 V-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (317)
T ss_dssp E-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHT
T ss_pred c-c-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhc
Confidence 6 3 2335899999999999999876664444599999999999995 6888999999999999999999 888999999
Q ss_pred CCCcCEEEcc-CCcccCCCChh
Q 003134 329 LAKTNFMYLT-GNKLTGPVPKY 349 (845)
Q Consensus 329 l~~L~~L~L~-~N~l~g~ip~~ 349 (845)
+++|+.|+++ .+.++|..|..
T Consensus 261 ~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 261 NQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp CHHHHHHHHHHHHHHHSSSSCC
T ss_pred cccceEEECCCchhccCCchhc
Confidence 9999999998 55677766654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=261.66 Aligned_cols=169 Identities=24% Similarity=0.344 Sum_probs=146.1
Q ss_pred HHHHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc---cccchHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 003134 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (845)
Q Consensus 668 ~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 743 (845)
+++++...++|+..+.||+|+||.||+|+.. +++.||+|++++. .....+.+.+|+++++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455566789999999999999999999986 4889999999653 12334568899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEe
Q 003134 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 823 (845)
Q Consensus 744 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~D 823 (845)
.+..|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEec
Confidence 99999999999999999998542 5899999999999999999999997 99999999999999999999999
Q ss_pred eccceecCCCCceeeeeeccCC
Q 003134 824 FGLAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 824 FGla~~~~~~~~~~~t~~~GT~ 845 (845)
||+|+.+...........+||+
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~ 233 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTP 233 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCG
T ss_pred cceeEeeccCCcccccCCcCCc
Confidence 9999988765544444566764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=251.65 Aligned_cols=161 Identities=47% Similarity=0.837 Sum_probs=144.4
Q ss_pred HHHHHHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE
Q 003134 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 668 ~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 747 (845)
+.++..++++|+..+.||+|+||.||+|++.+++.||+|++........+++.+|++++++++||||+++++++...+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33445577899999999999999999999888999999999877666678899999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 999999999999999965432 2346899999999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+....
T Consensus 187 ~~~~~ 191 (321)
T 2qkw_B 187 KKGTE 191 (321)
T ss_dssp EECSS
T ss_pred ccccc
Confidence 87653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-26 Score=244.02 Aligned_cols=152 Identities=26% Similarity=0.531 Sum_probs=138.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.++|+..+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 457999999999999999999964 6899999999876666678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+++|+|.+++... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 99 ~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999998543 5899999999999999999999997 999999999999999999999999999987654
Q ss_pred Cc
Q 003134 834 KT 835 (845)
Q Consensus 834 ~~ 835 (845)
..
T Consensus 170 ~~ 171 (297)
T 3fxz_A 170 QS 171 (297)
T ss_dssp TC
T ss_pred cc
Confidence 43
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-26 Score=246.47 Aligned_cols=163 Identities=31% Similarity=0.518 Sum_probs=144.5
Q ss_pred ccCcccHHHHHHHhcC----------CCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCC
Q 003134 662 QTGLYTLRQIKAATNN----------FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ 730 (845)
Q Consensus 662 ~~~~~~~~~l~~~~~~----------y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 730 (845)
+.+.++.++++.+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence 3456788888887764 566778999999999999986 69999999998766666788999999999999
Q ss_pred CCceeeEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 003134 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 810 (845)
Q Consensus 731 H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~N 810 (845)
||||+++++++...+..++||||+++|+|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+|
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N 171 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDS 171 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999999999999999999999999999999998532 5899999999999999999999987 9999999999
Q ss_pred EEecCCCcEEEEeeccceecCCC
Q 003134 811 VLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 811 ILld~~~~~kl~DFGla~~~~~~ 833 (845)
||++.++.+||+|||+++.....
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSS
T ss_pred EEECCCCcEEEeeeeeeeecccC
Confidence 99999999999999999987654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.5e-26 Score=245.94 Aligned_cols=151 Identities=30% Similarity=0.572 Sum_probs=137.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
++|...+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56778899999999999999985 58999999987766666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
++|+|.+++.... ..+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 90 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 90 KGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp TTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999996532 36899999999999999999999997 999999999999999999999999999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=261.01 Aligned_cols=172 Identities=24% Similarity=0.288 Sum_probs=147.7
Q ss_pred cHHHHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEE
Q 003134 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCV 742 (845)
Q Consensus 667 ~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 742 (845)
.+++.....++|+..+.||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|.+++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44555566789999999999999999999985 68999999997532 223345889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEE
Q 003134 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822 (845)
Q Consensus 743 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~ 822 (845)
+.+..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEe
Confidence 9999999999999999999996431 36899999999999999999999987 9999999999999999999999
Q ss_pred eeccceecCCCCceeeeeeccCC
Q 003134 823 DFGLAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 823 DFGla~~~~~~~~~~~t~~~GT~ 845 (845)
|||+|+.+..+........+||+
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~ 227 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTP 227 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCG
T ss_pred echhheeccCCCccccceecccc
Confidence 99999988765544444456764
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-27 Score=271.08 Aligned_cols=236 Identities=16% Similarity=0.107 Sum_probs=210.3
Q ss_pred cceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeE
Q 003134 91 TCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (845)
Q Consensus 91 ~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 169 (845)
..+++.|+|++|.+++..|..|+.+++|++|+|++|.|++..| +..+ +|++|+|++|.|++..+ .++|++|+
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~ 105 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLH 105 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEE
Confidence 3479999999999999888899999999999999999998776 7777 99999999999996543 38999999
Q ss_pred eecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhc-CCcccceEEecCCcCC
Q 003134 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG-KWKKIQKLHIQGSSLE 248 (845)
Q Consensus 170 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~ 248 (845)
|++|+|++..+. .+++|++|+|++|+|++..|..|+++++|++|+|++|+|++.+|..+. .+++|++|+|++|.|+
T Consensus 106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~ 182 (487)
T 3oja_A 106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (487)
T ss_dssp CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence 999999976554 468999999999999999899999999999999999999998898886 7999999999999999
Q ss_pred CCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCC-CCCchhhh
Q 003134 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT-GGIPTTFE 327 (845)
Q Consensus 249 g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-g~~p~~~~ 327 (845)
+..+ +..+++|+.|+|++|.+++.++......+|+.|+|++|.|++ +|..+..+++|+.|+|++|.+. +.+|..+.
T Consensus 183 ~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~ 259 (487)
T 3oja_A 183 DVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (487)
T ss_dssp EEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred cccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence 7633 346999999999999999877664445599999999999996 6778999999999999999998 78888899
Q ss_pred cCCCcCEEEccC
Q 003134 328 KLAKTNFMYLTG 339 (845)
Q Consensus 328 ~l~~L~~L~L~~ 339 (845)
.++.|+.|+++.
T Consensus 260 ~l~~L~~l~~~~ 271 (487)
T 3oja_A 260 KNQRVQTVAKQT 271 (487)
T ss_dssp TCHHHHHHHHHH
T ss_pred hCCCCcEEeccc
Confidence 999999888863
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=239.85 Aligned_cols=208 Identities=20% Similarity=0.213 Sum_probs=184.0
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
..++.|++++|.+++..+..|.++++|++|+|++|++++..+..|..+ +|++|+|++|++++..+..|.++++|++|+|
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 468999999999998888899999999999999999999999899988 9999999999999998999999999999999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCccc-CChhhhCCCCCCcEEeecCcCcccCchhhcCCcccc----eEEecCC
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGE-LPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQ----KLHIQGS 245 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N 245 (845)
++|++++..+..+.++++|++|+|++|++++. +|..|.++++|++|+|++|++++..+..|..+++|+ +|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 99999988777899999999999999999974 699999999999999999999988888888877777 7788888
Q ss_pred cCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCc
Q 003134 246 SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323 (845)
Q Consensus 246 ~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 323 (845)
++++..+..+. ..+|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|
T Consensus 188 ~l~~~~~~~~~------------------------~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 188 PMNFIQPGAFK------------------------EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCCEECTTSSC------------------------SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cccccCccccC------------------------CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 87754443332 2257777888888888777788999999999999999996543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.3e-26 Score=267.14 Aligned_cols=260 Identities=25% Similarity=0.286 Sum_probs=202.0
Q ss_pred eEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEee
Q 003134 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 171 (845)
.++.|++++++|+ .+|..+. ++|++|+|++|+|+.+.+ .+ +|++|+|++|+|++ +|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence 5789999999999 7788776 899999999999996544 34 89999999999985 454 67999999999
Q ss_pred cccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCc
Q 003134 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPI 251 (845)
Q Consensus 172 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 251 (845)
+|+|++ +|. .+++|++|+|++|+|++ +|.. +++|++|+|++|+|++ +|. .+++|+.|++++|+|++ +
T Consensus 110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l 176 (622)
T 3g06_A 110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-L 176 (622)
T ss_dssp SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-C
T ss_pred CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-C
Confidence 999995 454 57889999999999995 5653 4899999999999985 454 34678899999999986 4
Q ss_pred chhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCC
Q 003134 252 PASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK 331 (845)
Q Consensus 252 p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 331 (845)
| ..+++|+.|++++|.++..+.. ..+|+.|++++|.|+. +|. .+++|+.|+|++|+|++ +| ..+++
T Consensus 177 ~---~~~~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~ 242 (622)
T 3g06_A 177 P---MLPSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTS-LP---VLPSE 242 (622)
T ss_dssp C---CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSC-CC---CCCTT
T ss_pred c---ccCCCCcEEECCCCCCCCCCCc---cchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCc-CC---CCCCc
Confidence 4 4568899999999988865432 2478888888888884 443 24788888999888885 55 45678
Q ss_pred cCEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCCCCCccC
Q 003134 332 TNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 397 (845)
Q Consensus 332 L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~~~~~~~ 397 (845)
|+.|+|++|+|+ .+|. ...+|+.|+|++|+++ .+|..+ ..+..+..++.+.|++++..+
T Consensus 243 L~~L~Ls~N~L~-~lp~-~~~~L~~L~Ls~N~L~-~lp~~l----~~l~~L~~L~L~~N~l~~~~~ 301 (622)
T 3g06_A 243 LKELMVSGNRLT-SLPM-LPSGLLSLSVYRNQLT-RLPESL----IHLSSETTVNLEGNPLSERTL 301 (622)
T ss_dssp CCEEECCSSCCS-CCCC-CCTTCCEEECCSSCCC-SCCGGG----GGSCTTCEEECCSCCCCHHHH
T ss_pred CcEEECCCCCCC-cCCc-ccccCcEEeCCCCCCC-cCCHHH----hhccccCEEEecCCCCCCcCH
Confidence 888888888888 4665 5567888888888888 445333 233446677788888876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=246.42 Aligned_cols=160 Identities=30% Similarity=0.372 Sum_probs=138.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc---cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+|+.. +++.||+|+++.. .....+.+.+|++++++++||||+++++++...+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999986 5899999999764 2344567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+...
T Consensus 85 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999998542 36899999999999999999999997 9999999999999999999999999998754
Q ss_pred CCCceeeeeeccC
Q 003134 832 EDKTHISTRIAGT 844 (845)
Q Consensus 832 ~~~~~~~t~~~GT 844 (845)
..... ....+||
T Consensus 157 ~~~~~-~~~~~gt 168 (337)
T 1o6l_A 157 SDGAT-MKTFCGT 168 (337)
T ss_dssp CTTCC-BCCCEEC
T ss_pred cCCCc-ccccccC
Confidence 33222 2234555
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=246.59 Aligned_cols=151 Identities=26% Similarity=0.458 Sum_probs=135.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.++|+..+.||+|+||.||+|++ .+|+.||||++.... ....+++.+|++++++++||||+++++++...+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788999999999999999998 469999999996542 234567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 94 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp CCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred ECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999998543 36899999999999999999999997 9999999999999999999999999998775
Q ss_pred CC
Q 003134 832 ED 833 (845)
Q Consensus 832 ~~ 833 (845)
..
T Consensus 166 ~~ 167 (328)
T 3fe3_A 166 VG 167 (328)
T ss_dssp SS
T ss_pred CC
Confidence 43
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=247.90 Aligned_cols=163 Identities=28% Similarity=0.436 Sum_probs=135.7
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc---cccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 748 (845)
..++|+..+.||+|+||.||+|+.. +++.||+|+++.. .....+.+.+|.+++..+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3468999999999999999999986 5899999999764 233456788999999988 7999999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+
T Consensus 101 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccccee
Confidence 999999999999998543 36899999999999999999999997 9999999999999999999999999998
Q ss_pred ecCCCCceeeeeeccCC
Q 003134 829 LYEEDKTHISTRIAGTM 845 (845)
Q Consensus 829 ~~~~~~~~~~t~~~GT~ 845 (845)
....... .....+||+
T Consensus 173 ~~~~~~~-~~~~~~gt~ 188 (353)
T 3txo_A 173 EGICNGV-TTATFCGTP 188 (353)
T ss_dssp CSCC----------CCG
T ss_pred ecccCCc-cccccCCCc
Confidence 7543322 223455663
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=240.97 Aligned_cols=162 Identities=30% Similarity=0.408 Sum_probs=134.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
.++|+..+.||+|+||.||+|+.. +++.||+|++..... ...+++.+|++++++++||||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357889999999999999999975 589999999854322 3346789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.+
T Consensus 90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999543 36899999999999999999999997 999999999999999999999999999877
Q ss_pred CCCCceeeeeeccC
Q 003134 831 EEDKTHISTRIAGT 844 (845)
Q Consensus 831 ~~~~~~~~t~~~GT 844 (845)
............||
T Consensus 162 ~~~~~~~~~~~~gt 175 (294)
T 4eqm_A 162 SETSLTQTNHVLGT 175 (294)
T ss_dssp -------------C
T ss_pred ccccccccCccccC
Confidence 55433333334455
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-25 Score=236.73 Aligned_cols=166 Identities=44% Similarity=0.707 Sum_probs=147.3
Q ss_pred ccCcccHHHHHHHhcCCCCC------CcccccCcEEEEEEEECCCcEEEEEEcCccc----ccchHHHHHHHHHHhcCCC
Q 003134 662 QTGLYTLRQIKAATNNFDPA------NKVGEGGFGSVYKGILSDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQH 731 (845)
Q Consensus 662 ~~~~~~~~~l~~~~~~y~~~------~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H 731 (845)
....+++.++..++++|... +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34668999999999999887 8999999999999987 58899999986532 2335688999999999999
Q ss_pred CceeeEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCE
Q 003134 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV 811 (845)
Q Consensus 732 ~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NI 811 (845)
|||+++++++...+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+++ |+||||||+||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Ni 164 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANI 164 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHE
Confidence 999999999999999999999999999999996532 2346899999999999999999999987 99999999999
Q ss_pred EecCCCcEEEEeeccceecCCC
Q 003134 812 LLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 812 Lld~~~~~kl~DFGla~~~~~~ 833 (845)
+++.++.+||+|||+++.....
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSC
T ss_pred EEcCCCcEEEeecccccccccc
Confidence 9999999999999999987653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=236.62 Aligned_cols=203 Identities=19% Similarity=0.260 Sum_probs=124.8
Q ss_pred cccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceE
Q 003134 161 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL 240 (845)
Q Consensus 161 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 240 (845)
.+++|+.|++++|.++. + +.+..+++|++|+|++|++++. ..+.++++|++|+|++|++++..+..|.++++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 114 (272)
T 3rfs_A 39 ELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKEL 114 (272)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred cccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEE
Confidence 34444444444444441 1 1244444444444444444431 234444444444444444444444444444444444
Q ss_pred EecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCC
Q 003134 241 HIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (845)
Q Consensus 241 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (845)
+|++|++++..+..|+++++|+.|++++|.++..+...+... +|+.|+|++|+|++..+..|..+++|++|+|++|+++
T Consensus 115 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 115 VLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 444444444444444444444444444444444433333222 5666677778888777778889999999999999999
Q ss_pred CCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCCCCC
Q 003134 320 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPI 372 (845)
Q Consensus 320 g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p~~~ 372 (845)
+..|..|..+++|++|+|++|++++..| .++.|+++.|.++|.+|..+
T Consensus 195 ~~~~~~~~~l~~L~~L~l~~N~~~~~~~-----~l~~l~~~~n~~~g~ip~~~ 242 (272)
T 3rfs_A 195 SVPDGVFDRLTSLQYIWLHDNPWDCTCP-----GIRYLSEWINKHSGVVRNSA 242 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCCTT-----TTHHHHHHHHHTGGGBBCTT
T ss_pred ccCHHHHhCCcCCCEEEccCCCccccCc-----HHHHHHHHHHhCCCcccCcc
Confidence 8888889999999999999999988766 57788889999999988544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-25 Score=241.33 Aligned_cols=154 Identities=24% Similarity=0.459 Sum_probs=133.6
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-------
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------- 745 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------- 745 (845)
.++|+..+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999986 69999999997543 334578999999999999999999999986543
Q ss_pred --------------------------------------------------EEEEEEeccCCCChhhhhhcCCcccccCCC
Q 003134 746 --------------------------------------------------QLLLVYEYMKNNCLSRAIFGKDTEYRLKLD 775 (845)
Q Consensus 746 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~ 775 (845)
..++||||+++|+|.+++..... ....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchh
Confidence 38999999999999999976532 23567
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 776 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 776 ~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+..+++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 7889999999999999999987 999999999999999999999999999988654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-25 Score=234.33 Aligned_cols=152 Identities=30% Similarity=0.569 Sum_probs=137.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.++|+..+.||+|+||.||+|...++..||+|+++... ...+++.+|++++.+++||||+++++++...+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 45788899999999999999999888899999997653 34578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
++++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 86 SNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp TTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred CCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999543 235899999999999999999999997 9999999999999999999999999999876544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=242.61 Aligned_cols=152 Identities=30% Similarity=0.545 Sum_probs=133.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC----CCcEEEEEEcCcc-cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
++|...+.||+|+||.||+|++. .+..||||+++.. .....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46778899999999999999984 3557999999765 233456899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 129 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred eeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999996542 36899999999999999999999997 999999999999999999999999999988
Q ss_pred CCCC
Q 003134 831 EEDK 834 (845)
Q Consensus 831 ~~~~ 834 (845)
....
T Consensus 202 ~~~~ 205 (325)
T 3kul_A 202 EDDP 205 (325)
T ss_dssp C---
T ss_pred ccCc
Confidence 6543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=249.24 Aligned_cols=162 Identities=26% Similarity=0.370 Sum_probs=137.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 749 (845)
.++|+..++||+|+||.||+|+.. +++.||+|++++.. ....+.+..|..++.++ +||||+++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 356888999999999999999986 48899999997653 22334678899999876 89999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.
T Consensus 131 V~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999998542 36899999999999999999999997 99999999999999999999999999987
Q ss_pred cCCCCceeeeeeccCC
Q 003134 830 YEEDKTHISTRIAGTM 845 (845)
Q Consensus 830 ~~~~~~~~~t~~~GT~ 845 (845)
...... .....+||+
T Consensus 203 ~~~~~~-~~~~~~gt~ 217 (396)
T 4dc2_A 203 GLRPGD-TTSTFCGTP 217 (396)
T ss_dssp CCCTTC-CBCCCCBCG
T ss_pred cccCCC-ccccccCCc
Confidence 433322 233456663
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=237.61 Aligned_cols=149 Identities=29% Similarity=0.594 Sum_probs=135.6
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
++|+..+.||+|+||.||+|++.+++.||+|++... ....+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 568888999999999999999988999999999765 3345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 89 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999996542 36899999999999999999999997 99999999999999999999999999987643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=4.8e-25 Score=240.21 Aligned_cols=149 Identities=28% Similarity=0.457 Sum_probs=134.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999986 58999999997642 234567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 86 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 86 DYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999643 36899999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 158 ~ 158 (318)
T 1fot_A 158 D 158 (318)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=9.9e-25 Score=238.13 Aligned_cols=152 Identities=20% Similarity=0.327 Sum_probs=135.7
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.++|+..+.||+|+||.||+|... +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467889999999999999999986 5889999998754 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC--CCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~--~~~~kl~DFGla~~~~ 831 (845)
+++|+|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.+.
T Consensus 83 ~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 83 ISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999996532 36899999999999999999999997 999999999999987 7899999999999886
Q ss_pred CCC
Q 003134 832 EDK 834 (845)
Q Consensus 832 ~~~ 834 (845)
...
T Consensus 156 ~~~ 158 (321)
T 1tki_A 156 PGD 158 (321)
T ss_dssp TTC
T ss_pred CCC
Confidence 543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=247.04 Aligned_cols=159 Identities=25% Similarity=0.446 Sum_probs=139.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999976 48899999986542 344578899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 95 e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp CCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999653 36899999999999999999999997 9999999999999999999999999999875
Q ss_pred CCCceeeeeeccC
Q 003134 832 EDKTHISTRIAGT 844 (845)
Q Consensus 832 ~~~~~~~t~~~GT 844 (845)
.... .+...||
T Consensus 167 ~~~~--~~~~~gt 177 (384)
T 4fr4_A 167 RETQ--ITTMAGT 177 (384)
T ss_dssp TTCC--BCCCCSC
T ss_pred CCCc--eeccCCC
Confidence 4322 2334555
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=243.96 Aligned_cols=164 Identities=29% Similarity=0.416 Sum_probs=138.9
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCE
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 746 (845)
....++|...+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445678999999999999999999986 58999999997642 33456788899999876 99999999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.|+||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChh
Confidence 99999999999999998542 36899999999999999999999997 99999999999999999999999999
Q ss_pred ceecCCCCceeeeeeccC
Q 003134 827 AKLYEEDKTHISTRIAGT 844 (845)
Q Consensus 827 a~~~~~~~~~~~t~~~GT 844 (845)
|+....... .....+||
T Consensus 165 a~~~~~~~~-~~~~~~gt 181 (345)
T 1xjd_A 165 CKENMLGDA-KTNTFCGT 181 (345)
T ss_dssp CBCCCCTTC-CBCCCCSC
T ss_pred hhhcccCCC-cccCCCCC
Confidence 987543222 22345565
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-25 Score=242.58 Aligned_cols=151 Identities=25% Similarity=0.376 Sum_probs=135.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccccc------chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 747 (845)
.++|+..+.||+|+||.||+|+.. +|+.||+|.++..... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457889999999999999999986 5899999999764321 357899999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC----cEEEEe
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISD 823 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~----~~kl~D 823 (845)
++||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999543 36899999999999999999999987 99999999999998877 799999
Q ss_pred eccceecCCC
Q 003134 824 FGLAKLYEED 833 (845)
Q Consensus 824 FGla~~~~~~ 833 (845)
||+++.+...
T Consensus 163 FG~a~~~~~~ 172 (361)
T 2yab_A 163 FGLAHEIEDG 172 (361)
T ss_dssp CSSCEECCTT
T ss_pred cCCceEcCCC
Confidence 9999987653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-27 Score=269.48 Aligned_cols=274 Identities=19% Similarity=0.218 Sum_probs=205.4
Q ss_pred eEEEEEecCCCccc----cCCccccCCCCCCEEeccCCcccCCCcccccc-----c-ceeEEEecCCCCCCCc----ccc
Q 003134 93 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS-----L-QLVELSVMGNRLSGPF----PKV 158 (845)
Q Consensus 93 ~v~~L~l~~~~l~g----~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~-----l-~L~~L~Ls~N~l~~~~----p~~ 158 (845)
+++.|+|++|.++. .++..|..+++|++|+|++|.+++..+..+.. . +|++|+|++|++++.. +..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 68888888888883 56788888888888888888887655544432 2 6888888888888643 556
Q ss_pred cccccccceeEeecccCCCCCCccccc-----CCCccEEEeecCcCccc----CChhhhCCCCCCcEEeecCcCcccC--
Q 003134 159 LTNITTLKNLSIEGNLFTGSIPPDIRK-----LINLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGKI-- 227 (845)
Q Consensus 159 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~-----l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~-- 227 (845)
+..+++|++|+|++|.+++..+..+.. +++|++|+|++|++++. ++..+..+++|++|+|++|+++...
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~ 245 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA 245 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHH
Confidence 667788888888888887544444432 56888888888888863 5677778888888999888887543
Q ss_pred ---chhhcCCcccceEEecCCcCCCC----cchhhhcCCCCCEEEcCCCCCCCCCCccccc------CCccEEEccCCcC
Q 003134 228 ---PEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKLDK------MNLKTLILTKCLI 294 (845)
Q Consensus 228 ---p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~------~~L~~L~Ls~N~l 294 (845)
+..+..+++|++|+|++|+++.. ++..+.++++|+.|++++|.++......+.. .+|+.|+|++|.+
T Consensus 246 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l 325 (461)
T 1z7x_W 246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCC
Confidence 23334578888899988888864 6777778888889998888876543332221 2788889988888
Q ss_pred ccc----CcccccCCCCcCEEeCCCCCCCCCCchhhhc-----CCCcCEEEccCCcccC----CCChhh--hcCCceEEe
Q 003134 295 HGE----IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK-----LAKTNFMYLTGNKLTG----PVPKYI--FNSNKNVDI 359 (845)
Q Consensus 295 ~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~-----l~~L~~L~L~~N~l~g----~ip~~~--~~~l~~L~l 359 (845)
++. ++..+..+++|++|+|++|++++..+..+.. .++|+.|+|++|++++ .+|..+ ...|+.|++
T Consensus 326 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l 405 (461)
T 1z7x_W 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 405 (461)
T ss_dssp BGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEEC
T ss_pred chHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEEC
Confidence 876 4666777888889999988888665655553 6788889999888886 566665 357888888
Q ss_pred ecCCCcC
Q 003134 360 SLNNFTW 366 (845)
Q Consensus 360 s~N~l~~ 366 (845)
++|++++
T Consensus 406 ~~N~i~~ 412 (461)
T 1z7x_W 406 SNNCLGD 412 (461)
T ss_dssp CSSSCCH
T ss_pred CCCCCCH
Confidence 8887764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.8e-25 Score=243.04 Aligned_cols=160 Identities=27% Similarity=0.380 Sum_probs=137.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 750 (845)
++|+..+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|.+++.++ +||||+++++++...+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888999999999999999986 589999999976532 2345678899999987 899999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++|+|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999998542 36899999999999999999999997 999999999999999999999999999875
Q ss_pred CCCCceeeeeeccC
Q 003134 831 EEDKTHISTRIAGT 844 (845)
Q Consensus 831 ~~~~~~~~t~~~GT 844 (845)
..... .....+||
T Consensus 161 ~~~~~-~~~~~~gt 173 (345)
T 3a8x_A 161 LRPGD-TTSTFCGT 173 (345)
T ss_dssp CCTTC-CBCCCCSC
T ss_pred cCCCC-cccccCCC
Confidence 43322 22334565
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-25 Score=241.26 Aligned_cols=150 Identities=33% Similarity=0.496 Sum_probs=132.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357889999999999999999986 689999999865432 234678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 86 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred cCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999998543 35899999999999999999999987 99999999999999999999999999987753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=248.15 Aligned_cols=151 Identities=32% Similarity=0.579 Sum_probs=127.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC----CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
++|+..+.||+|+||.||+|++. ++..||||+++... ....++|.+|++++++++||||+++++++...+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999864 47789999997653 33456899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++|+|.++++... ..+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 125 ~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999996542 36899999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 003134 831 EED 833 (845)
Q Consensus 831 ~~~ 833 (845)
...
T Consensus 198 ~~~ 200 (373)
T 2qol_A 198 EDD 200 (373)
T ss_dssp ---
T ss_pred ccC
Confidence 654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=236.60 Aligned_cols=222 Identities=20% Similarity=0.241 Sum_probs=134.3
Q ss_pred CCCEEeccCCcccCCCccc----ccccceeEEEecCCCCCCCccccc--ccccccceeEeecccCCCCCC----cccccC
Q 003134 117 YLKQLDLSRNCLTGSFSPQ----WASLQLVELSVMGNRLSGPFPKVL--TNITTLKNLSIEGNLFTGSIP----PDIRKL 186 (845)
Q Consensus 117 ~L~~L~Ls~N~l~~~~~~~----~~~l~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~g~~p----~~~~~l 186 (845)
.++.|.+.++.++...-.. +...+|++|+|++|++++..|..+ ..+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 4667777776665321111 111157777777777777777776 777777888888777776555 234567
Q ss_pred CCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCccc--Cc--hhhcCCcccceEEecCCcCCCCcc--h-hhhcCC
Q 003134 187 INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGK--IP--EFIGKWKKIQKLHIQGSSLEGPIP--A-SISALT 259 (845)
Q Consensus 187 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~--~p--~~~~~l~~L~~L~Ls~N~l~g~~p--~-~~~~l~ 259 (845)
++|++|+|++|++++..|..|.++++|++|+|++|++.+. ++ ..+..+++|++|+|++|+++...+ . .+++++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~ 224 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGV 224 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTC
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCC
Confidence 7777777777777776677777777777777777777642 21 223567777777777777763211 1 246667
Q ss_pred CCCEEEcCCCCCCCCCCccccc----CCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEE
Q 003134 260 SLTDLRISDLKGSESAFPKLDK----MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335 (845)
Q Consensus 260 ~L~~L~Ls~n~~~~~~~~~l~~----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 335 (845)
+|+.|+|++|.+....+..+.. .+|++|+|++|+|+ .+|..+. ++|+.|||++|+|++. |. +..+++|+.|
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L 299 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNL 299 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCE
T ss_pred CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEE
Confidence 7777766666665553322222 15555555555555 3444442 4555555555555543 22 4455555555
Q ss_pred EccCCccc
Q 003134 336 YLTGNKLT 343 (845)
Q Consensus 336 ~L~~N~l~ 343 (845)
+|++|+|+
T Consensus 300 ~L~~N~l~ 307 (310)
T 4glp_A 300 TLDGNPFL 307 (310)
T ss_dssp ECSSTTTS
T ss_pred ECcCCCCC
Confidence 55555554
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-25 Score=246.80 Aligned_cols=166 Identities=19% Similarity=0.196 Sum_probs=137.9
Q ss_pred HhcCCCCCCcccccCcEEEEEEE------ECCCcEEEEEEcCcccccchHHHHHHHHHHhcCC---CCceeeEEEEEEeC
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGI------LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEG 744 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~ 744 (845)
..++|...+.||+|+||.||+|. ..+++.||+|+++.. ...++..|++++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34678889999999999999994 345889999999754 3467788888888886 99999999999999
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---------
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--------- 815 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~--------- 815 (845)
+..++||||+++|+|.+++..........+++.+++.|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999996532222346999999999999999999999987 999999999999998
Q ss_pred --CCcEEEEeeccceecCC-CCceeeeeeccCC
Q 003134 816 --DLNAKISDFGLAKLYEE-DKTHISTRIAGTM 845 (845)
Q Consensus 816 --~~~~kl~DFGla~~~~~-~~~~~~t~~~GT~ 845 (845)
++.+||+|||+|+.+.. ......+..+||+
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 249 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTT
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCC
Confidence 89999999999987642 2223334456663
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=234.68 Aligned_cols=206 Identities=22% Similarity=0.210 Sum_probs=122.4
Q ss_pred ccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCcc
Q 003134 112 LSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQ 190 (845)
Q Consensus 112 l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 190 (845)
+..+++|+.|++++|.++... .+..+ +|++|+|++|++++. ..+.++++|++|+|++|++++..+..|.++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~~~--~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKSVQ--GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCCCCT--TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCccccc--ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 344556666666666555321 23333 455555555555432 2444455555555555555544444444555555
Q ss_pred EEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCC
Q 003134 191 KLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270 (845)
Q Consensus 191 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~ 270 (845)
+|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..+++++
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~----------- 181 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLT----------- 181 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-----------
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCc-----------
Confidence 555555555544444444555555555555555544444444455555555555555444444444444
Q ss_pred CCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhh
Q 003134 271 GSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI 350 (845)
Q Consensus 271 ~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~ 350 (845)
+|+.|+|++|++++..|..|..+++|+.|+|++|.+.+. +++|++|++..|+++|.+|..+
T Consensus 182 ------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~ 242 (272)
T 3rfs_A 182 ------------QLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSA 242 (272)
T ss_dssp ------------TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTT
T ss_pred ------------cCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcc
Confidence 566667788888888888899999999999999999865 4578899999999999999875
Q ss_pred h
Q 003134 351 F 351 (845)
Q Consensus 351 ~ 351 (845)
.
T Consensus 243 ~ 243 (272)
T 3rfs_A 243 G 243 (272)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.8e-25 Score=242.42 Aligned_cols=162 Identities=27% Similarity=0.358 Sum_probs=138.8
Q ss_pred HhcCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccc---ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 748 (845)
..++|+..+.||+|+||.||+|+... ++.||+|+++... ....+.+..|.+++..+ +||||+++++++...+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34679999999999999999999864 8899999997642 34456788999999988 8999999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+||||+++|+|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+
T Consensus 98 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 999999999999998542 36899999999999999999999997 9999999999999999999999999998
Q ss_pred ecCCCCceeeeeeccC
Q 003134 829 LYEEDKTHISTRIAGT 844 (845)
Q Consensus 829 ~~~~~~~~~~t~~~GT 844 (845)
....... .....+||
T Consensus 170 ~~~~~~~-~~~~~~gt 184 (353)
T 2i0e_A 170 ENIWDGV-TTKTFCGT 184 (353)
T ss_dssp CCCCTTC-CBCCCCSC
T ss_pred ccccCCc-ccccccCC
Confidence 7543322 22335565
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=242.24 Aligned_cols=159 Identities=31% Similarity=0.566 Sum_probs=132.6
Q ss_pred HHHHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE
Q 003134 670 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 670 ~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 747 (845)
++....++|++.+.||+|+||.||+|+. +++.||||++.... ....+++.+|++++++++||||+++++++...+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3334456788999999999999999987 58899999987653 23346789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+++ ++|+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999976432 235899999999999999999999985 34999999999999999999999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+....
T Consensus 187 ~~~~~ 191 (309)
T 3p86_A 187 RLKAS 191 (309)
T ss_dssp -----
T ss_pred ccccc
Confidence 86643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.3e-25 Score=236.26 Aligned_cols=151 Identities=28% Similarity=0.450 Sum_probs=128.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--------------------------cchHHHHHHHHHHh
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------------------------QGNREFVNEIGMIS 727 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 727 (845)
.++|+..+.||+|+||.||+|+.. +++.||||++..... ...+++.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357889999999999999999975 589999999865421 11356889999999
Q ss_pred cCCCCceeeEEEEEEe--CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 003134 728 AQQHPNLVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRD 805 (845)
Q Consensus 728 ~l~H~nIv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrD 805 (845)
+++||||+++++++.. .+..++||||+++++|.+++.. ..+++.++..++.|++.||+|||+++ |+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 9999999999999987 5789999999999999876532 36899999999999999999999997 99999
Q ss_pred CCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 806 IKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 806 LKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
|||+|||++.++.+||+|||+++.+....
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 191 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSD 191 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSS
T ss_pred CCHHHEEECCCCCEEEecCCCcccccccc
Confidence 99999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.3e-25 Score=237.59 Aligned_cols=151 Identities=30% Similarity=0.499 Sum_probs=132.7
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..+.||+|+||+||+|+..+++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 467889999999999999999998899999999975432 224678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++ +|.+.+.... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 100 ~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 100 FMEK-DLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CCSE-EHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred CCCC-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 9985 7888875532 35899999999999999999999997 99999999999999999999999999998754
Q ss_pred C
Q 003134 833 D 833 (845)
Q Consensus 833 ~ 833 (845)
.
T Consensus 172 ~ 172 (311)
T 3niz_A 172 P 172 (311)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=8.3e-25 Score=241.59 Aligned_cols=149 Identities=26% Similarity=0.379 Sum_probs=135.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56888999999999999999986 58999999996542 234578889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 121 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999542 36899999999999999999999997 9999999999999999999999999999875
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 193 ~ 193 (350)
T 1rdq_E 193 G 193 (350)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-25 Score=240.58 Aligned_cols=150 Identities=25% Similarity=0.377 Sum_probs=125.4
Q ss_pred hcCCCCCCcccccCcEEEEEEEE----CCCcEEEEEEcCccc----ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 746 (845)
.++|+..+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788999999999999999997 468999999997642 2234567889999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.|+||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999998542 36889999999999999999999997 99999999999999999999999999
Q ss_pred ceecCC
Q 003134 827 AKLYEE 832 (845)
Q Consensus 827 a~~~~~ 832 (845)
++....
T Consensus 168 ~~~~~~ 173 (327)
T 3a62_A 168 CKESIH 173 (327)
T ss_dssp C-----
T ss_pred cccccc
Confidence 987543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-25 Score=236.37 Aligned_cols=150 Identities=26% Similarity=0.513 Sum_probs=133.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.++|+..+.||+|+||.||+|.+.++..||+|+++... ...+++.+|++++.+++||||+++++++...+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 45688889999999999999999888899999997653 34578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++|+|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 102 ANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp TTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 9999999996532 36899999999999999999999997 99999999999999999999999999987643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.8e-25 Score=242.06 Aligned_cols=155 Identities=25% Similarity=0.398 Sum_probs=134.4
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-----ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888999999999999999975 58999999986432 1245789999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc---EEEEeecc
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKISDFGL 826 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~---~kl~DFGl 826 (845)
||||+++|+|.+.+.... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 104 v~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEECCSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEeCCCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999988875432 12235899999999999999999999997 999999999999986654 99999999
Q ss_pred ceecCCCC
Q 003134 827 AKLYEEDK 834 (845)
Q Consensus 827 a~~~~~~~ 834 (845)
++......
T Consensus 180 a~~~~~~~ 187 (351)
T 3c0i_A 180 AIQLGESG 187 (351)
T ss_dssp CEECCTTS
T ss_pred eeEecCCC
Confidence 99886543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-25 Score=239.92 Aligned_cols=152 Identities=33% Similarity=0.509 Sum_probs=131.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC----EEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----QLLLV 750 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV 750 (845)
.++|+..+.||+|+||.||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 457889999999999999999985 7899999997543 23445667999999999999999999998743 47999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEeCCCCCCCEEecCCCcEEEEe
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-------SRIKIVHRDIKTSNVLLDKDLNAKISD 823 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-------~~~~ivHrDLKp~NILld~~~~~kl~D 823 (845)
|||+++|+|.+++... .+++.++..++.|++.||+|||+. +.++|+||||||+|||++.++.+||+|
T Consensus 101 ~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999543 589999999999999999999987 011399999999999999999999999
Q ss_pred eccceecCCCC
Q 003134 824 FGLAKLYEEDK 834 (845)
Q Consensus 824 FGla~~~~~~~ 834 (845)
||+|+.+....
T Consensus 175 Fg~a~~~~~~~ 185 (322)
T 3soc_A 175 FGLALKFEAGK 185 (322)
T ss_dssp CTTCEEECTTS
T ss_pred CCccccccccc
Confidence 99998876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.1e-25 Score=244.13 Aligned_cols=155 Identities=26% Similarity=0.478 Sum_probs=134.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC--------CCcEEEEEEcCccc-ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 744 (845)
.++|...+.||+|+||.||+|++. ++..||||+++... ....+++.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357888899999999999999862 35679999997653 23356799999999999 899999999999999
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl 813 (845)
+..|+||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 9999999999999999999754311 1235899999999999999999999997 9999999999999
Q ss_pred cCCCcEEEEeeccceecCC
Q 003134 814 DKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 814 d~~~~~kl~DFGla~~~~~ 832 (845)
+.++.+||+|||+|+.+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~ 255 (370)
T 2psq_A 237 TENNVMKIADFGLARDINN 255 (370)
T ss_dssp CTTCCEEECCCSSCEETTC
T ss_pred CCCCCEEEccccCCcccCc
Confidence 9999999999999997754
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=8.1e-24 Score=224.96 Aligned_cols=157 Identities=22% Similarity=0.280 Sum_probs=94.9
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
..++.|+|++|.+++..+..|.++++|++|+|++|+|+.+.+..|..+ +|++|+|++|++++..+..|.++++|++|+|
T Consensus 37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 468899999999998777789999999999999998886655555554 5555555555555554455555555555555
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCC
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+++
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCC
Confidence 555555444444555555555555555555433334444555555555555554443334444444444444444443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=241.94 Aligned_cols=153 Identities=27% Similarity=0.441 Sum_probs=136.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.++|+..+.||+|+||.||+|... +++.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357889999999999999999986 5889999999766555566889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC--CCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~--~~~~kl~DFGla~~~~ 831 (845)
+++|+|.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 130 ~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 130 LSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999986432 35899999999999999999999997 999999999999974 5789999999999886
Q ss_pred CCC
Q 003134 832 EDK 834 (845)
Q Consensus 832 ~~~ 834 (845)
...
T Consensus 203 ~~~ 205 (387)
T 1kob_A 203 PDE 205 (387)
T ss_dssp TTS
T ss_pred CCc
Confidence 543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=236.12 Aligned_cols=150 Identities=25% Similarity=0.366 Sum_probs=134.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc------cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
++|...+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46888999999999999999986 589999999865432 23578999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC----cEEEEee
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISDF 824 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~----~~kl~DF 824 (845)
+||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 91 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999543 36899999999999999999999987 99999999999999887 7999999
Q ss_pred ccceecCCC
Q 003134 825 GLAKLYEED 833 (845)
Q Consensus 825 Gla~~~~~~ 833 (845)
|+|+.+...
T Consensus 163 g~a~~~~~~ 171 (326)
T 2y0a_A 163 GLAHKIDFG 171 (326)
T ss_dssp TTCEECCTT
T ss_pred CCCeECCCC
Confidence 999987543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=232.26 Aligned_cols=150 Identities=25% Similarity=0.462 Sum_probs=131.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|+..+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999986 589999999975432 234678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++ ++.+.+... ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~-~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9986 555555332 236899999999999999999999997 99999999999999999999999999998754
Q ss_pred C
Q 003134 833 D 833 (845)
Q Consensus 833 ~ 833 (845)
.
T Consensus 154 ~ 154 (292)
T 3o0g_A 154 P 154 (292)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=252.10 Aligned_cols=163 Identities=30% Similarity=0.386 Sum_probs=141.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+++|++++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888999999999999999986 59999999996542 33456788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+
T Consensus 263 mEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999996543 235899999999999999999999997 999999999999999999999999999988
Q ss_pred CCCCceeeeeeccCC
Q 003134 831 EEDKTHISTRIAGTM 845 (845)
Q Consensus 831 ~~~~~~~~t~~~GT~ 845 (845)
..... .+..+||+
T Consensus 337 ~~~~~--~~~~~GT~ 349 (576)
T 2acx_A 337 PEGQT--IKGRVGTV 349 (576)
T ss_dssp CTTCC--EECCCSCG
T ss_pred ccCcc--ccccCCCc
Confidence 65432 22345663
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=233.95 Aligned_cols=149 Identities=30% Similarity=0.519 Sum_probs=133.5
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|+..+.||+|+||.||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688899999999999999999889999999986543 23357889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++ +|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CSE-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred cCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 986 8998886532 36899999999999999999999997 99999999999999999999999999987653
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=224.53 Aligned_cols=202 Identities=17% Similarity=0.176 Sum_probs=122.8
Q ss_pred cCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCC-CCCCcccccccccccceeEeec-ccCCCCCCccc
Q 003134 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNR-LSGPFPKVLTNITTLKNLSIEG-NLFTGSIPPDI 183 (845)
Q Consensus 107 ~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~ 183 (845)
.+|. +. ++|++|+|++|+|+++.+..|..+ +|++|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 4555 43 377777777777776666666555 56666666665 5555555666666666666665 66665544556
Q ss_pred ccCCCccEEEeecCcCcccCChhhhCCCCCC---cEEeecC-cCcccCchhhcCCcccc-eEEecCCcCCCCcchhhhcC
Q 003134 184 RKLINLQKLILSSNSFTGELPAELTKLTNLN---DLRISDN-NFSGKIPEFIGKWKKIQ-KLHIQGSSLEGPIPASISAL 258 (845)
Q Consensus 184 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~g~~p~~~~~l 258 (845)
.++++|++|+|++|++++ +|. |..+++|+ +|++++| ++++..+..|.++++|+ +|+|++|+++ .+|.
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~----- 173 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQG----- 173 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECT-----
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCH-----
Confidence 666666666666666664 444 55555555 6666666 56555455555555555 5555555555 2222
Q ss_pred CCCCEEEcCCCCCCCCCCcccccCCccEEEccCCc-CcccCcccccCC-CCcCEEeCCCCCCCCCCchhhhcCCCcCEEE
Q 003134 259 TSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCL-IHGEIPDYIGDM-TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 336 (845)
Q Consensus 259 ~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 336 (845)
..+...+|+.|+|++|+ +++..+..|.++ ++|+.|+|++|+|++..+. .+++|+.|+
T Consensus 174 ------------------~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~ 232 (239)
T 2xwt_C 174 ------------------YAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELI 232 (239)
T ss_dssp ------------------TTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEE
T ss_pred ------------------hhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceee
Confidence 22222345666777774 776666677777 7777788877777743333 566777777
Q ss_pred ccCC
Q 003134 337 LTGN 340 (845)
Q Consensus 337 L~~N 340 (845)
++++
T Consensus 233 l~~~ 236 (239)
T 2xwt_C 233 ARNT 236 (239)
T ss_dssp CTTC
T ss_pred ccCc
Confidence 7665
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-25 Score=237.52 Aligned_cols=152 Identities=31% Similarity=0.540 Sum_probs=132.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEE-----CCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 747 (845)
.++|+..+.||+|+||.||+|++ .+++.||||++........+++.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35788899999999999999985 25889999999876666667899999999999999999999998653 568
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred EEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 99999999999999996542 25899999999999999999999987 999999999999999999999999999
Q ss_pred eecCCC
Q 003134 828 KLYEED 833 (845)
Q Consensus 828 ~~~~~~ 833 (845)
+.+...
T Consensus 162 ~~~~~~ 167 (295)
T 3ugc_A 162 KVLPQD 167 (295)
T ss_dssp C-----
T ss_pred ccccCC
Confidence 987543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-26 Score=252.22 Aligned_cols=259 Identities=18% Similarity=0.238 Sum_probs=188.8
Q ss_pred EEecCCCccccCCccccCCCCCCEEeccCCcccCCCc----cccccc--ceeEEEecCCCCCCCcccccccc-----ccc
Q 003134 97 IALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFS----PQWASL--QLVELSVMGNRLSGPFPKVLTNI-----TTL 165 (845)
Q Consensus 97 L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~----~~~~~l--~L~~L~Ls~N~l~~~~p~~~~~l-----~~L 165 (845)
.++++++++|.+|..+...++|++|+|++|.|++..+ ..+..+ +|++|+|++|+|++..+..|..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 5788899999888888888889999999999998877 566555 69999999999998888888776 889
Q ss_pred ceeEeecccCCCCCCccccc----C-CCccEEEeecCcCcccCChhhh----C-CCCCCcEEeecCcCcccC----chhh
Q 003134 166 KNLSIEGNLFTGSIPPDIRK----L-INLQKLILSSNSFTGELPAELT----K-LTNLNDLRISDNNFSGKI----PEFI 231 (845)
Q Consensus 166 ~~L~Ls~N~l~g~~p~~~~~----l-~~L~~L~Ls~N~l~g~~p~~~~----~-l~~L~~L~Ls~N~l~~~~----p~~~ 231 (845)
++|+|++|++++..+..+.. + ++|++|+|++|+|++..+..+. . .++|++|+|++|+|+... +..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 99999999998777665544 3 8899999999999876665543 3 368999999999988543 3445
Q ss_pred cCCc-ccceEEecCCcCCCCcchhhhc----C-CCCCEEEcCCCCCCCCCCcc----ccc--CCccEEEccCCcCcccCc
Q 003134 232 GKWK-KIQKLHIQGSSLEGPIPASISA----L-TSLTDLRISDLKGSESAFPK----LDK--MNLKTLILTKCLIHGEIP 299 (845)
Q Consensus 232 ~~l~-~L~~L~Ls~N~l~g~~p~~~~~----l-~~L~~L~Ls~n~~~~~~~~~----l~~--~~L~~L~Ls~N~l~~~~p 299 (845)
..++ +|++|+|++|++++..+..+.. + ++|+.|+|++|.++...... +.. .+|+.|+|++|.|++..+
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 242 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence 5565 8999999999998777755543 4 58888888888877643221 211 267777777777776554
Q ss_pred ----ccccCCCCcCEEeCCCCCCCCCCch-------hhhcCCCcCEEEccCCcccCCCChhhhcCCc
Q 003134 300 ----DYIGDMTKLKNIDLSFNNLTGGIPT-------TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNK 355 (845)
Q Consensus 300 ----~~~~~l~~L~~L~Ls~N~l~g~~p~-------~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~ 355 (845)
..+..+++|+.|+|++|++.+..+. .+..+++|++||+++|++.+..+..+.+.++
T Consensus 243 ~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~~~~l~ 309 (362)
T 3goz_A 243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIR 309 (362)
T ss_dssp HHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHHHHHHH
T ss_pred HHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHHHHHHH
Confidence 2345667777777777775544433 4556677777777777777665555544333
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.8e-25 Score=242.95 Aligned_cols=161 Identities=28% Similarity=0.401 Sum_probs=129.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHH-HhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGM-ISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
++|+..+.||+|+||.||+|+.. +++.||+|++++... ...+.+..|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56888999999999999999986 488999999976532 233456677776 5778999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+..
T Consensus 118 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999998542 36889999999999999999999997 999999999999999999999999999875
Q ss_pred CCCCceeeeeeccCC
Q 003134 831 EEDKTHISTRIAGTM 845 (845)
Q Consensus 831 ~~~~~~~~t~~~GT~ 845 (845)
..... .....+||+
T Consensus 190 ~~~~~-~~~~~~gt~ 203 (373)
T 2r5t_A 190 IEHNS-TTSTFCGTP 203 (373)
T ss_dssp BCCCC-CCCSBSCCC
T ss_pred ccCCC-ccccccCCc
Confidence 43322 223455663
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=234.26 Aligned_cols=154 Identities=24% Similarity=0.366 Sum_probs=135.2
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC--EEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~ 751 (845)
++|...+.||+|+||.||+|+... ++.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 568889999999999999999864 8999999997653 344677889999999999999999999998765 789999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----cCCCcEEEEeeccc
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLA 827 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl----d~~~~~kl~DFGla 827 (845)
||+++|+|.+++..... ...+++.+++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+|
T Consensus 89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp ECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred eCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999976432 234899999999999999999999997 9999999999999 78888999999999
Q ss_pred eecCCCC
Q 003134 828 KLYEEDK 834 (845)
Q Consensus 828 ~~~~~~~ 834 (845)
+.+....
T Consensus 164 ~~~~~~~ 170 (319)
T 4euu_A 164 RELEDDE 170 (319)
T ss_dssp EECCTTC
T ss_pred eecCCCC
Confidence 9876543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7e-25 Score=244.85 Aligned_cols=151 Identities=26% Similarity=0.482 Sum_probs=134.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|...+.||+|+||.||+|++. +++.||||.++.... ...++|.+|+++|++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457788899999999999999986 689999999975432 234578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++|+|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 193 ~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp CCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred cCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999643 235899999999999999999999997 99999999999999999999999999987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=239.67 Aligned_cols=152 Identities=26% Similarity=0.417 Sum_probs=134.3
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
..++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567899999999999999999986 58999999996542 23346788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC---CcEEEEeeccc
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISDFGLA 827 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~---~~~kl~DFGla 827 (845)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 107 ~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp ECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 9999999999998543 36899999999999999999999997 9999999999999865 45999999999
Q ss_pred eecCCC
Q 003134 828 KLYEED 833 (845)
Q Consensus 828 ~~~~~~ 833 (845)
+.....
T Consensus 179 ~~~~~~ 184 (362)
T 2bdw_A 179 IEVNDS 184 (362)
T ss_dssp BCCTTC
T ss_pred eEecCC
Confidence 987643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=237.72 Aligned_cols=149 Identities=29% Similarity=0.476 Sum_probs=133.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|...+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57888999999999999999974 68999999986542 233568899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+ +|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 89 E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp CCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred ECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 999 67898888543 36899999999999999999999997 9999999999999999999999999998775
Q ss_pred CC
Q 003134 832 ED 833 (845)
Q Consensus 832 ~~ 833 (845)
..
T Consensus 160 ~~ 161 (336)
T 3h4j_B 160 DG 161 (336)
T ss_dssp TS
T ss_pred CC
Confidence 43
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=227.95 Aligned_cols=151 Identities=25% Similarity=0.413 Sum_probs=137.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.++|+..+.||+|+||.||+|.... +..||+|++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4568889999999999999999864 779999999876666778999999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---cCCCcEEEEeeccceec
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLY 830 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl---d~~~~~kl~DFGla~~~ 830 (845)
+++++|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||+++.+
T Consensus 88 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 88 CTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999988542 36899999999999999999999997 9999999999999 78899999999999987
Q ss_pred CCC
Q 003134 831 EED 833 (845)
Q Consensus 831 ~~~ 833 (845)
...
T Consensus 160 ~~~ 162 (277)
T 3f3z_A 160 KPG 162 (277)
T ss_dssp CTT
T ss_pred cCc
Confidence 644
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=233.57 Aligned_cols=154 Identities=31% Similarity=0.550 Sum_probs=121.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457889999999999999999975 58999999997543 2345788999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 753 YMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|++ |+|.+++..... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 599998854321 11235899999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 160 ~ 160 (317)
T 2pmi_A 160 I 160 (317)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=249.33 Aligned_cols=165 Identities=30% Similarity=0.405 Sum_probs=142.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|...+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999986 59999999997542 234567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||++||+|.+++..... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+.
T Consensus 265 E~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp CCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999865432 2346899999999999999999999997 9999999999999999999999999999876
Q ss_pred CCCceeeeeeccCC
Q 003134 832 EDKTHISTRIAGTM 845 (845)
Q Consensus 832 ~~~~~~~t~~~GT~ 845 (845)
..... ....+||+
T Consensus 341 ~~~~~-~~~~~GT~ 353 (543)
T 3c4z_A 341 AGQTK-TKGYAGTP 353 (543)
T ss_dssp TTCCC-BCCCCSCT
T ss_pred CCCcc-cccccCCc
Confidence 54332 23356764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-25 Score=250.02 Aligned_cols=161 Identities=28% Similarity=0.359 Sum_probs=128.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc---cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
.++|+..+.||+|+||.||+|+.. +++.||||+++.. .......+.+|++++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 356888999999999999999975 5899999999754 223346778899999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 227 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp ECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999998542 368999999999999999999998 76 99999999999999999999999999987
Q ss_pred cCCCCceeeeeeccC
Q 003134 830 YEEDKTHISTRIAGT 844 (845)
Q Consensus 830 ~~~~~~~~~t~~~GT 844 (845)
....... .+..+||
T Consensus 299 ~~~~~~~-~~~~~gt 312 (446)
T 4ejn_A 299 GIKDGAT-MKTFCGT 312 (446)
T ss_dssp TCC------CCSSSC
T ss_pred ccCCCcc-cccccCC
Confidence 5443322 2334555
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=240.07 Aligned_cols=146 Identities=29% Similarity=0.454 Sum_probs=126.7
Q ss_pred CCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 681 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
.+.||+|+||.||+|+.. +++.||+|+++.......+++.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999975 5899999999876555667899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe--cCCCcEEEEeeccceecCCC
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl--d~~~~~kl~DFGla~~~~~~ 833 (845)
.+++.... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 174 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 174 FDRIIDES----YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp HHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 99886432 36899999999999999999999997 9999999999999 56789999999999988654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.6e-25 Score=252.53 Aligned_cols=152 Identities=26% Similarity=0.507 Sum_probs=136.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
..+|+..+.||+|+||.||+|++.. +..||||.++... ...++|.+|+++|++++||||+++++++...+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4567888999999999999999875 8899999997653 3467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....+
T Consensus 298 ~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 298 MTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred cCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999965322 36899999999999999999999997 999999999999999999999999999987543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.91 E-value=7.6e-25 Score=250.75 Aligned_cols=153 Identities=27% Similarity=0.497 Sum_probs=136.1
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
....++|+..+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34456788899999999999999999888999999997653 45788999999999999999999999986 66789999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.++++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 262 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp CCCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred eecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 9999999999996532 236889999999999999999999997 9999999999999999999999999999764
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 336 ~ 336 (454)
T 1qcf_A 336 D 336 (454)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=245.63 Aligned_cols=162 Identities=23% Similarity=0.356 Sum_probs=137.1
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
..++|+..+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3567889999999999999999975 68999999986543 23356789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec---CCCcEEEEeeccc
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLA 827 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld---~~~~~kl~DFGla 827 (845)
|||+++|+|.+.+... ..+++.++..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+|
T Consensus 89 ~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp ECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 9999999999998653 36899999999999999999999997 99999999999998 5678999999999
Q ss_pred eecCCCCceeeeeeccC
Q 003134 828 KLYEEDKTHISTRIAGT 844 (845)
Q Consensus 828 ~~~~~~~~~~~t~~~GT 844 (845)
+........ .....||
T Consensus 161 ~~~~~~~~~-~~~~~gt 176 (444)
T 3soa_A 161 IEVEGEQQA-WFGFAGT 176 (444)
T ss_dssp BCCCTTCCB-CCCSCSC
T ss_pred EEecCCCce-eecccCC
Confidence 887654332 2234455
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=9.1e-25 Score=241.88 Aligned_cols=161 Identities=26% Similarity=0.360 Sum_probs=138.6
Q ss_pred cCCCCCCcccccCcEEEEEEEE----CCCcEEEEEEcCccc----ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCE
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 746 (845)
++|+..+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5688899999999999999997 368999999997642 23345677899999999 69999999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.++||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999542 36899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCCceeeeeeccC
Q 003134 827 AKLYEEDKTHISTRIAGT 844 (845)
Q Consensus 827 a~~~~~~~~~~~t~~~GT 844 (845)
|+.+............||
T Consensus 206 a~~~~~~~~~~~~~~~gt 223 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGT 223 (355)
T ss_dssp EEECCGGGGGGGCGGGSC
T ss_pred CeecccCCCCcccCcccC
Confidence 998754443333344555
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=230.24 Aligned_cols=148 Identities=29% Similarity=0.479 Sum_probs=127.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhc--CCCCceeeEEEEEEeC----CEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEG----NQLL 748 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~~~ 748 (845)
.++|+..+.||+|+||.||+|++ +++.||||++... ..+.+..|.+++.. ++||||+++++++... +..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46788999999999999999998 6899999998653 34556667776665 7999999999987643 4689
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeCCCCCCCEEecCCCcEE
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH--------EDSRIKIVHRDIKTSNVLLDKDLNAK 820 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~ivHrDLKp~NILld~~~~~k 820 (845)
+||||+++|+|.++++.. .+++.++.+++.|++.||+||| +.+ |+||||||+|||++.++.+|
T Consensus 83 lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEECCCTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EehhhccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 999999999999999432 5899999999999999999999 654 99999999999999999999
Q ss_pred EEeeccceecCCCCc
Q 003134 821 ISDFGLAKLYEEDKT 835 (845)
Q Consensus 821 l~DFGla~~~~~~~~ 835 (845)
|+|||+|+.......
T Consensus 154 l~Dfg~a~~~~~~~~ 168 (301)
T 3q4u_A 154 IADLGLAVMHSQSTN 168 (301)
T ss_dssp ECCCTTCEEEETTTT
T ss_pred EeeCCCeeecccccc
Confidence 999999988765443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=246.40 Aligned_cols=148 Identities=26% Similarity=0.349 Sum_probs=125.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCccc--------ccchHHHHHHHHHHhcCC---------CCceeeE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--------RQGNREFVNEIGMISAQQ---------HPNLVKL 737 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~nIv~l 737 (845)
.++|+..+.||+|+||.||+|+. +++.||||+++... ....+.+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35678899999999999999998 68999999997642 223478899999988885 8888888
Q ss_pred EEEEE------------------------------eCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHH
Q 003134 738 YGCCV------------------------------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787 (845)
Q Consensus 738 ~~~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia 787 (845)
.+.+. ..+..|+||||+++|++.+.+.. ..+++.+++.|+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 77653 26789999999999987766633 2579999999999999
Q ss_pred HHHHHHH-hCCCCCeEeCCCCCCCEEecCCC--------------------cEEEEeeccceecCC
Q 003134 788 RGLAYLH-EDSRIKIVHRDIKTSNVLLDKDL--------------------NAKISDFGLAKLYEE 832 (845)
Q Consensus 788 ~aL~yLH-~~~~~~ivHrDLKp~NILld~~~--------------------~~kl~DFGla~~~~~ 832 (845)
.||+||| +++ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 9999999 886 99999999999999887 899999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=246.00 Aligned_cols=150 Identities=31% Similarity=0.512 Sum_probs=135.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888999999999999999986 69999999997542 233567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 96 E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999643 36899999999999999999999987 9999999999999999999999999999876
Q ss_pred CC
Q 003134 832 ED 833 (845)
Q Consensus 832 ~~ 833 (845)
..
T Consensus 168 ~~ 169 (476)
T 2y94_A 168 DG 169 (476)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=228.82 Aligned_cols=151 Identities=31% Similarity=0.576 Sum_probs=134.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.++|+..+.||+|+||.||+|...++..||+|.++... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 45788899999999999999999888899999997643 34678999999999999999999999986 45689999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
++++|.+++.... ...+++.++..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 90 ENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp TTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999995431 236899999999999999999999997 999999999999999999999999999987654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=234.01 Aligned_cols=150 Identities=28% Similarity=0.343 Sum_probs=127.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..++||+|+||+||+|+.. +++.||||++..... ....++..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56888999999999999999986 699999999865422 2234555666665555 9999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+ +++|.+++... ...+++.++..|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 137 e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp ECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred ecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 999 67898888543 236999999999999999999999987 9999999999999999999999999998875
Q ss_pred CC
Q 003134 832 ED 833 (845)
Q Consensus 832 ~~ 833 (845)
..
T Consensus 209 ~~ 210 (311)
T 3p1a_A 209 TA 210 (311)
T ss_dssp --
T ss_pred cC
Confidence 43
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-24 Score=238.65 Aligned_cols=157 Identities=31% Similarity=0.521 Sum_probs=136.6
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 745 (845)
...++|+..+.||+|+||.||+|+.. +++.||+|+++.... ...+++.+|++++++++||||+++++++...+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578889999999999999999974 348999999976532 33567999999999999999999999999999
Q ss_pred EEEEEEeccCCCChhhhhhcCCcc-------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTE-------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI 806 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDL 806 (845)
..++||||+++|+|.+++...... ....+++.+++.++.||++||+|||+++ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 999999999999999999753211 0146899999999999999999999997 999999
Q ss_pred CCCCEEecCCCcEEEEeeccceecCC
Q 003134 807 KTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 807 Kp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
||+|||++.++.+||+|||+++....
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~ 226 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYS 226 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred CcceEEECCCCeEEEeecCCCccccc
Confidence 99999999999999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-24 Score=238.35 Aligned_cols=148 Identities=25% Similarity=0.360 Sum_probs=130.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.++|+..+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457889999999999999999986 68999999997542 3346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc--EEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN--AKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~--~kl~DFGla~~~~ 831 (845)
+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+|+...
T Consensus 98 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 98 ASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999998542 36899999999999999999999987 999999999999987765 9999999998543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-24 Score=235.78 Aligned_cols=151 Identities=22% Similarity=0.356 Sum_probs=128.7
Q ss_pred hcCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCccccc---chHHHHHHHHHHhcCCCCceeeEEEEEEeCC----E
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHPNLVKLYGCCVEGN----Q 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~ 746 (845)
.++|+..+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|++++++++||||+++++++...+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788999999999999999997 46899999999765322 2457889999999999999999999987653 4
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 59999999999999999542 36899999999999999999999997 99999999999999999999999999
Q ss_pred ceecCCC
Q 003134 827 AKLYEED 833 (845)
Q Consensus 827 a~~~~~~ 833 (845)
++.+...
T Consensus 163 a~~~~~~ 169 (311)
T 3ork_A 163 ARAIADS 169 (311)
T ss_dssp C------
T ss_pred ccccccc
Confidence 9887543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=6.1e-25 Score=235.34 Aligned_cols=154 Identities=27% Similarity=0.513 Sum_probs=137.7
Q ss_pred HhcCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
..++|+..+.||+|+||.||+|.+.. +..||+|.+... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45678889999999999999999864 889999999754 3345789999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++++|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp CCTTEEHHHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred cCCCCcHHHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 999999999996542 236899999999999999999999997 99999999999999999999999999998765
Q ss_pred CC
Q 003134 833 DK 834 (845)
Q Consensus 833 ~~ 834 (845)
..
T Consensus 164 ~~ 165 (288)
T 3kfa_A 164 DT 165 (288)
T ss_dssp SS
T ss_pred Cc
Confidence 44
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.5e-24 Score=230.20 Aligned_cols=152 Identities=32% Similarity=0.517 Sum_probs=131.7
Q ss_pred cCCCCCCcccccCcEEEEEEEE-----CCCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL 747 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 747 (845)
+.|+..+.||+|+||.||+|++ .+++.||+|+++... ....+.+.+|++++++++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4577889999999999999984 358899999997553 33457899999999999999999999999876 668
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence 99999999999999995432 36899999999999999999999997 999999999999999999999999999
Q ss_pred eecCCCC
Q 003134 828 KLYEEDK 834 (845)
Q Consensus 828 ~~~~~~~ 834 (845)
+.+....
T Consensus 174 ~~~~~~~ 180 (302)
T 4e5w_A 174 KAIETDK 180 (302)
T ss_dssp EECCTTC
T ss_pred ccccCCC
Confidence 9886544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=8.5e-25 Score=239.78 Aligned_cols=252 Identities=18% Similarity=0.281 Sum_probs=186.6
Q ss_pred eEEEEEecCCCccccCCccccCC--CCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCC-cccccccccccceeE
Q 003134 93 HVVTIALKAQNLTGTLPTELSKL--RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP-FPKVLTNITTLKNLS 169 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L--~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ 169 (845)
.++.++++++.+. +..+..+ ++|+.|++++|.+++..+..+...+|++|+|++|.+++. +|..+..+++|++|+
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 3557888888776 4556666 888899999988888877655433788888888887765 677777888888888
Q ss_pred eecccCCCCCCcccccCCCccEEEeecC-cCccc-CChhhhCCCCCCcEEeecC-cCccc-CchhhcCCc-ccceEEecC
Q 003134 170 IEGNLFTGSIPPDIRKLINLQKLILSSN-SFTGE-LPAELTKLTNLNDLRISDN-NFSGK-IPEFIGKWK-KIQKLHIQG 244 (845)
Q Consensus 170 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~g~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~-~L~~L~Ls~ 244 (845)
|++|++++..|..++.+++|++|+|++| .+++. ++..+.++++|++|+|++| ++++. ++..+..++ +|++|+|++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 8888887777777778888888888888 56653 5666777888888888888 77754 566777777 888888888
Q ss_pred C--cCC-CCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCc-CcccCcccccCCCCcCEEeCCCCCCCC
Q 003134 245 S--SLE-GPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCL-IHGEIPDYIGDMTKLKNIDLSFNNLTG 320 (845)
Q Consensus 245 N--~l~-g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~g 320 (845)
| .++ +.+|..+.++++|+.| +|++|. +++..+..+..+++|++|+|++|. +
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L-----------------------~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~ 259 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHL-----------------------DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--D 259 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEE-----------------------ECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--T
T ss_pred CcccCCHHHHHHHHhhCCCCCEE-----------------------eCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--C
Confidence 7 454 4556666666666555 555565 566667778888999999999996 3
Q ss_pred CCch---hhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCCCCCC
Q 003134 321 GIPT---TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIE 373 (845)
Q Consensus 321 ~~p~---~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p~~~~ 373 (845)
..+. .+.++++|+.|+|++| ++...-..+...+..|++++|++++..|..+.
T Consensus 260 ~~~~~~~~l~~~~~L~~L~l~~~-i~~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 260 IIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp CCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred CCHHHHHHHhcCCCCCEEeccCc-cCHHHHHHHHhhCcceEEecccCccccCCccc
Confidence 3344 6888999999999998 44322233345688999999999998886553
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.4e-25 Score=241.72 Aligned_cols=165 Identities=26% Similarity=0.445 Sum_probs=139.9
Q ss_pred ccHHHHHHHhcCCCCCCcccccCcEEEEEEEE------CCCcEEEEEEcCccc-ccchHHHHHHHHHHhcC-CCCceeeE
Q 003134 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKL 737 (845)
Q Consensus 666 ~~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l 737 (845)
+...+.....++|...+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 45556666778999999999999999999984 236899999997643 23346799999999999 88999999
Q ss_pred EEEEEeCC-EEEEEEeccCCCChhhhhhcCCccc----------------------------------------------
Q 003134 738 YGCCVEGN-QLLLVYEYMKNNCLSRAIFGKDTEY---------------------------------------------- 770 (845)
Q Consensus 738 ~~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~---------------------------------------------- 770 (845)
++++...+ ..++||||+++|+|.++++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998765 4899999999999999997653210
Q ss_pred ---------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 771 ---------------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 771 ---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122899999999999999999999997 999999999999999999999999999977543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-24 Score=229.39 Aligned_cols=148 Identities=29% Similarity=0.580 Sum_probs=134.8
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
++|+..+.||+|+||.||+|...+++.||+|++.... ...+++.+|++++++++||||+++++++...+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 5678889999999999999999888999999997653 345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 87 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp TCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccc
Confidence 999999996532 35899999999999999999999997 9999999999999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-24 Score=248.04 Aligned_cols=151 Identities=31% Similarity=0.554 Sum_probs=132.0
Q ss_pred HhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
..++|...+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346688889999999999999999888889999998653 346789999999999999999999999865 678999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++|+|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 260 ~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 260 MSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hcCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999542 1235899999999999999999999987 99999999999999999999999999998754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.2e-24 Score=225.86 Aligned_cols=150 Identities=29% Similarity=0.503 Sum_probs=134.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|...+.||+|+||.||+|+.. +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 56888999999999999999974 68999999996542 223478899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++++|.+++.... ..+++.++..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp ECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999996532 36899999999999999999999997 9999999999999999999999999999875
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 164 ~ 164 (278)
T 3cok_A 164 M 164 (278)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.2e-24 Score=238.12 Aligned_cols=151 Identities=19% Similarity=0.264 Sum_probs=135.1
Q ss_pred hcCCCCCCccccc--CcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 675 TNNFDPANKVGEG--GFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
.++|+..+.||+| +||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++..++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578899999999 99999999986 59999999997653 2334678889999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++|+|.+++..... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+..
T Consensus 104 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999965422 35899999999999999999999997 99999999999999999999999999876
Q ss_pred cC
Q 003134 830 YE 831 (845)
Q Consensus 830 ~~ 831 (845)
..
T Consensus 178 ~~ 179 (389)
T 3gni_B 178 MI 179 (389)
T ss_dssp CE
T ss_pred ec
Confidence 53
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.9e-24 Score=229.38 Aligned_cols=150 Identities=27% Similarity=0.452 Sum_probs=133.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|+..+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999986 489999999865432 224678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+|+....
T Consensus 83 ~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999887543 35899999999999999999999997 99999999999999999999999999998764
Q ss_pred C
Q 003134 833 D 833 (845)
Q Consensus 833 ~ 833 (845)
.
T Consensus 155 ~ 155 (311)
T 4agu_A 155 P 155 (311)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-26 Score=260.75 Aligned_cols=274 Identities=18% Similarity=0.215 Sum_probs=139.0
Q ss_pred eEEEEEecCCCccc----cCCccccCCCCCCEEeccCCcccCCCcccccc-c-----ceeEEEecCCCCCC----Ccccc
Q 003134 93 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRNCLTGSFSPQWAS-L-----QLVELSVMGNRLSG----PFPKV 158 (845)
Q Consensus 93 ~v~~L~l~~~~l~g----~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~-l-----~L~~L~Ls~N~l~~----~~p~~ 158 (845)
+++.|+|++|.++. .++..+..+++|++|+|++|.++...+..+.. + +|++|+|++|+|+. .++..
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 108 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHH
Confidence 34555566555553 23444555566666666666555433322221 1 25666666666553 33555
Q ss_pred cccccccceeEeecccCCCCCCccccc-----CCCccEEEeecCcCcccC----ChhhhCCCCCCcEEeecCcCcccCch
Q 003134 159 LTNITTLKNLSIEGNLFTGSIPPDIRK-----LINLQKLILSSNSFTGEL----PAELTKLTNLNDLRISDNNFSGKIPE 229 (845)
Q Consensus 159 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~-----l~~L~~L~Ls~N~l~g~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~ 229 (845)
+..+++|++|+|++|.+++..+..+.. +++|++|+|++|++++.. +..+..+++|++|+|++|.++...+.
T Consensus 109 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 188 (461)
T 1z7x_W 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVR 188 (461)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHH
Confidence 555666666666666655333332221 345666666666655422 34444555666666666665544333
Q ss_pred hhcC-----CcccceEEecCCcCCCC----cchhhhcCCCCCEEEcCCCCCCCCCCccc------ccCCccEEEccCCcC
Q 003134 230 FIGK-----WKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKL------DKMNLKTLILTKCLI 294 (845)
Q Consensus 230 ~~~~-----l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l------~~~~L~~L~Ls~N~l 294 (845)
.+.. .++|++|+|++|.+++. ++..+..+++|+.|++++|.++......+ ...+|++|+|++|.+
T Consensus 189 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l 268 (461)
T 1z7x_W 189 VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268 (461)
T ss_dssp HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCC
Confidence 3322 34566666666666543 35555555666666666665543221111 122566666666665
Q ss_pred ccc----CcccccCCCCcCEEeCCCCCCCCCCchhhhcC-----CCcCEEEccCCcccCCC----Chhh--hcCCceEEe
Q 003134 295 HGE----IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL-----AKTNFMYLTGNKLTGPV----PKYI--FNSNKNVDI 359 (845)
Q Consensus 295 ~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l-----~~L~~L~L~~N~l~g~i----p~~~--~~~l~~L~l 359 (845)
+.. ++..+..+++|++|+|++|++++..+..+... ++|+.|+|++|.+++.. |..+ ...|+.|++
T Consensus 269 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L 348 (461)
T 1z7x_W 269 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 348 (461)
T ss_dssp CHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEEC
T ss_pred CHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEc
Confidence 543 34445555666666666665554333333322 45666666666555432 2222 135556666
Q ss_pred ecCCCcC
Q 003134 360 SLNNFTW 366 (845)
Q Consensus 360 s~N~l~~ 366 (845)
++|.+++
T Consensus 349 s~n~i~~ 355 (461)
T 1z7x_W 349 SNNRLED 355 (461)
T ss_dssp CSSBCHH
T ss_pred cCCcccc
Confidence 6665543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.6e-24 Score=234.48 Aligned_cols=150 Identities=24% Similarity=0.301 Sum_probs=132.4
Q ss_pred hcCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35788899999999999999997 468999999986543 234688999999999 99999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc-----EEEEeeccc
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-----AKISDFGLA 827 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~-----~kl~DFGla 827 (845)
|+ +++|.+++... ...+++.+++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+|
T Consensus 86 ~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 86 LL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp CC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred eC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99 99999999653 236899999999999999999999997 999999999999998887 999999999
Q ss_pred eecCCCC
Q 003134 828 KLYEEDK 834 (845)
Q Consensus 828 ~~~~~~~ 834 (845)
+.+....
T Consensus 158 ~~~~~~~ 164 (330)
T 2izr_A 158 KEYIDPE 164 (330)
T ss_dssp EESBCTT
T ss_pred eeeecCC
Confidence 9875433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.4e-24 Score=230.11 Aligned_cols=151 Identities=27% Similarity=0.443 Sum_probs=123.7
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC----CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
.++|+..+.||+|+||.||+|.+.. +..||+|.++... ....+.+.+|+.++++++||||+++++++ .++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 4578889999999999999999743 5679999987643 33356789999999999999999999997 4567899
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999996432 35899999999999999999999987 99999999999999999999999999998
Q ss_pred cCCC
Q 003134 830 YEED 833 (845)
Q Consensus 830 ~~~~ 833 (845)
....
T Consensus 166 ~~~~ 169 (281)
T 1mp8_A 166 MEDS 169 (281)
T ss_dssp ----
T ss_pred cCcc
Confidence 7543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.1e-24 Score=236.06 Aligned_cols=148 Identities=30% Similarity=0.429 Sum_probs=121.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.++|+..+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 467888999999999999999986 48899999997542 346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCcEEEEeeccceec
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAKLY 830 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~---~~~~kl~DFGla~~~ 830 (845)
+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 130 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 130 VTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999998643 25899999999999999999999997 999999999999975 889999999999977
Q ss_pred CC
Q 003134 831 EE 832 (845)
Q Consensus 831 ~~ 832 (845)
..
T Consensus 202 ~~ 203 (349)
T 2w4o_A 202 EH 203 (349)
T ss_dssp --
T ss_pred Cc
Confidence 54
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-24 Score=229.59 Aligned_cols=150 Identities=25% Similarity=0.444 Sum_probs=134.4
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC-C-------cEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD-G-------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 746 (845)
.++|...+.||+|+||.||+|+... + ..||+|++........+++.+|++++++++||||+++++++..++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3568888999999999999998653 3 5799999987766677889999999999999999999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc--------
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-------- 818 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~-------- 818 (845)
.++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccce
Confidence 999999999999999996542 24899999999999999999999997 999999999999998887
Q ss_pred EEEEeeccceecC
Q 003134 819 AKISDFGLAKLYE 831 (845)
Q Consensus 819 ~kl~DFGla~~~~ 831 (845)
+||+|||+++...
T Consensus 160 ~kl~Dfg~~~~~~ 172 (289)
T 4fvq_A 160 IKLSDPGISITVL 172 (289)
T ss_dssp EEECCCCSCTTTS
T ss_pred eeeccCccccccc
Confidence 9999999997654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4e-24 Score=231.87 Aligned_cols=157 Identities=31% Similarity=0.508 Sum_probs=135.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEE------CCCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 747 (845)
.++|...+.||+|+||.||+|.. .+++.||+|+++... ....+++.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788899999999999999986 235889999997643 33456789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCcc-------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTE-------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT 808 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp 808 (845)
++||||+++|+|.+++...... ....+++.++.+++.|+++||+|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 9999999999999999754320 1134899999999999999999999997 99999999
Q ss_pred CCEEecCCCcEEEEeeccceecCCCC
Q 003134 809 SNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 809 ~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
+||+++.++.+||+|||+++......
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~ 204 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEED 204 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTS
T ss_pred heEEEcCCCCEEEccccccccccccc
Confidence 99999999999999999999875443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-24 Score=245.60 Aligned_cols=148 Identities=23% Similarity=0.432 Sum_probs=121.9
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----CEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQL 747 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 747 (845)
++|+..+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+++|++++||||+++++++... +..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57889999999999999999976 58999999986542 23456789999999999999999999998543 578
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
|+||||+. |+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 133 ~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEECCCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeccc-cchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 99999985 6899988543 36899999999999999999999997 999999999999999999999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+....
T Consensus 204 ~~~~~ 208 (458)
T 3rp9_A 204 RTVDY 208 (458)
T ss_dssp BCTTS
T ss_pred hhccC
Confidence 98753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.2e-24 Score=239.98 Aligned_cols=155 Identities=28% Similarity=0.458 Sum_probs=134.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC--------CCcEEEEEEcCccc-ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 744 (845)
.++|...+.||+|+||.||+|+.. .+..||||+++... ....+++.+|+++++++ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 457888899999999999999862 24689999997653 23357789999999999 999999999999999
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl 813 (845)
+..++||||+++|+|.+++...... ....+++.+++.|+.|++.||+|||+++ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 9999999999999999999754311 1235899999999999999999999997 9999999999999
Q ss_pred cCCCcEEEEeeccceecCC
Q 003134 814 DKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 814 d~~~~~kl~DFGla~~~~~ 832 (845)
+.++.+||+|||+|+....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~ 243 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHH 243 (382)
T ss_dssp CTTCCEEECSCSCCCCSSC
T ss_pred cCCCcEEEcccCccccccc
Confidence 9999999999999997754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-24 Score=236.46 Aligned_cols=158 Identities=26% Similarity=0.476 Sum_probs=123.2
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEECC-C---cEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILSD-G---TVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 745 (845)
....++|+..+.||+|+||.||+|++.. + ..||||+++.. .....+++.+|++++++++||||+++++++...+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3445689999999999999999999754 3 27999999765 2344578999999999999999999999998776
Q ss_pred EE------EEEEeccCCCChhhhhhcCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc
Q 003134 746 QL------LLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 818 (845)
Q Consensus 746 ~~------~lV~Ey~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~ 818 (845)
.. ++||||+++|+|.+++..... .....+++.++.+++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 55 999999999999999854321 11235899999999999999999999997 999999999999999999
Q ss_pred EEEEeeccceecCC
Q 003134 819 AKISDFGLAKLYEE 832 (845)
Q Consensus 819 ~kl~DFGla~~~~~ 832 (845)
+||+|||+|+....
T Consensus 176 ~kl~Dfg~a~~~~~ 189 (323)
T 3qup_A 176 VCVADFGLSRKIYS 189 (323)
T ss_dssp EEECCCCC------
T ss_pred EEEeeccccccccc
Confidence 99999999987754
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.3e-23 Score=217.69 Aligned_cols=180 Identities=21% Similarity=0.279 Sum_probs=128.7
Q ss_pred ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEee
Q 003134 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219 (845)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 219 (845)
..++++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 3556777777776 3444443 467777777777776666667777777777777777776666667777777777777
Q ss_pred cCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCc
Q 003134 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP 299 (845)
Q Consensus 220 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p 299 (845)
+|+|++..+..|..+++|++|+|++|+|++..+..|.++++| +.|+|++|+|++..+
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-----------------------~~L~Ls~N~l~~~~~ 148 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKL-----------------------KELRLNTNQLQSIPA 148 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-----------------------CEEECCSSCCCCCCT
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcc-----------------------cEEECcCCcCCccCH
Confidence 777776666666777777777777777776555555555544 445666667776667
Q ss_pred ccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCC
Q 003134 300 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP 345 (845)
Q Consensus 300 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ 345 (845)
..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 149 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 7788888888889988888887777888888888888888877765
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-24 Score=228.16 Aligned_cols=154 Identities=25% Similarity=0.404 Sum_probs=133.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|...+.||+|+||.||+|+.. ++..||+|++.... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888999999999999999975 58899999987653 33467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---cCCCcEEEEeeccceec
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLY 830 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl---d~~~~~kl~DFGla~~~ 830 (845)
+++|+|.+.+.... .....+++..+..++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||+|+.+
T Consensus 102 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 102 CEGGELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CSCCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred CCCCcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999885432 12246899999999999999999999997 9999999999999 45688999999999877
Q ss_pred CCC
Q 003134 831 EED 833 (845)
Q Consensus 831 ~~~ 833 (845)
...
T Consensus 178 ~~~ 180 (285)
T 3is5_A 178 KSD 180 (285)
T ss_dssp ---
T ss_pred CCc
Confidence 543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.90 E-value=5.5e-24 Score=225.76 Aligned_cols=151 Identities=32% Similarity=0.579 Sum_probs=124.6
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccc----cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+|++. ++.||||+++.... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888899999999999999985 88999999876432 23567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC--------CCcEEEEe
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--------DLNAKISD 823 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~--------~~~~kl~D 823 (845)
||+++++|.+++.. ..+++.++..++.|++.||+|||+++..+|+||||||+||+++. ++.+||+|
T Consensus 86 e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 86 EFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp ECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999853 26899999999999999999999987556999999999999986 67899999
Q ss_pred eccceecCCC
Q 003134 824 FGLAKLYEED 833 (845)
Q Consensus 824 FGla~~~~~~ 833 (845)
||+++.+...
T Consensus 160 fg~~~~~~~~ 169 (271)
T 3dtc_A 160 FGLAREWHRT 169 (271)
T ss_dssp CCC-------
T ss_pred CCcccccccc
Confidence 9999877543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-24 Score=235.37 Aligned_cols=159 Identities=23% Similarity=0.373 Sum_probs=134.5
Q ss_pred HHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc-----cccchHHHHHHHHHHhcCCCCceeeEEEEEEeC
Q 003134 671 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 744 (845)
Q Consensus 671 l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 744 (845)
+....++|+..+.||+|+||.||+|+.. +++.||+|++... .....+++.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4556678999999999999999999975 5889999998654 234457899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChhhhhhcCCc-----------------------------------ccccCCCHHHHHHHHHHHHHH
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDT-----------------------------------EYRLKLDWPTRKKICIGIARG 789 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~-----------------------------------~~~~~l~~~~~~~i~~~ia~a 789 (845)
+..++||||+++|+|.+++..... .....+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999852100 001234677888999999999
Q ss_pred HHHHHhCCCCCeEeCCCCCCCEEecCCC--cEEEEeeccceecCC
Q 003134 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDL--NAKISDFGLAKLYEE 832 (845)
Q Consensus 790 L~yLH~~~~~~ivHrDLKp~NILld~~~--~~kl~DFGla~~~~~ 832 (845)
|+|||+++ |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 99999997 99999999999998776 899999999997744
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.7e-24 Score=241.87 Aligned_cols=150 Identities=25% Similarity=0.443 Sum_probs=131.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----CE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 746 (845)
.++|...+.||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467889999999999999999975 58899999997542 23456889999999999999999999999866 57
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.|+||||++ |+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCC
Confidence 999999987 5999998643 36899999999999999999999997 99999999999999999999999999
Q ss_pred ceecCCC
Q 003134 827 AKLYEED 833 (845)
Q Consensus 827 a~~~~~~ 833 (845)
|+.....
T Consensus 176 a~~~~~~ 182 (432)
T 3n9x_A 176 ARTINSE 182 (432)
T ss_dssp CEEC---
T ss_pred ccccccc
Confidence 9987543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=226.13 Aligned_cols=150 Identities=25% Similarity=0.389 Sum_probs=134.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356888999999999999999986 48899999986542 23356788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++++|.+++... ..+++.++..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999988532 36899999999999999999999997 999999999999999999999999999987
Q ss_pred CC
Q 003134 831 EE 832 (845)
Q Consensus 831 ~~ 832 (845)
..
T Consensus 166 ~~ 167 (294)
T 2rku_A 166 EY 167 (294)
T ss_dssp CS
T ss_pred cc
Confidence 54
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-24 Score=231.39 Aligned_cols=228 Identities=17% Similarity=0.204 Sum_probs=181.7
Q ss_pred cccccceeEEEecCCCCCCCccc---ccccccccceeEeecccCCCCCCccc--ccCCCccEEEeecCcCcccCC----h
Q 003134 135 QWASLQLVELSVMGNRLSGPFPK---VLTNITTLKNLSIEGNLFTGSIPPDI--RKLINLQKLILSSNSFTGELP----A 205 (845)
Q Consensus 135 ~~~~l~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~g~~p~~~--~~l~~L~~L~Ls~N~l~g~~p----~ 205 (845)
.+..++++.|.+.++.++...-. .+..+++|++|+|++|++++..|..+ ..+++|++|+|++|++++..+ .
T Consensus 60 ~~~~~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~ 139 (310)
T 4glp_A 60 TVKALRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAEL 139 (310)
T ss_dssp GGSSCCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHH
T ss_pred HhhhcceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHH
Confidence 34445788999999887632211 12345779999999999999999988 899999999999999998666 4
Q ss_pred hhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCC--cc--hhhhcCCCCCEEEcCCCCCCCCCCc---c
Q 003134 206 ELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP--IP--ASISALTSLTDLRISDLKGSESAFP---K 278 (845)
Q Consensus 206 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~--~p--~~~~~l~~L~~L~Ls~n~~~~~~~~---~ 278 (845)
.+..+++|++|+|++|++++..|..|..+++|++|+|++|++.+. ++ ..++.+++|+.|+|++|+++..+.. .
T Consensus 140 ~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l 219 (310)
T 4glp_A 140 QQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAAL 219 (310)
T ss_dssp HTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHH
T ss_pred HhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHH
Confidence 456899999999999999999899999999999999999998763 22 3347899999999999998754322 1
Q ss_pred ccc-CCccEEEccCCcCcccCcccccCC---CCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCC-CChhhhcC
Q 003134 279 LDK-MNLKTLILTKCLIHGEIPDYIGDM---TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP-VPKYIFNS 353 (845)
Q Consensus 279 l~~-~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~-ip~~~~~~ 353 (845)
+.. .+|++|+|++|+|++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. .+ .-...
T Consensus 220 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~~-~~l~~ 295 (310)
T 4glp_A 220 AAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQP-DELPE 295 (310)
T ss_dssp HHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCCT-TSCCC
T ss_pred HhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCchh-hhCCC
Confidence 222 489999999999998888777776 68999999999998 6676664 7899999999999873 32 22467
Q ss_pred CceEEeecCCCcC
Q 003134 354 NKNVDISLNNFTW 366 (845)
Q Consensus 354 l~~L~ls~N~l~~ 366 (845)
|+.|+|++|+|+.
T Consensus 296 L~~L~L~~N~l~~ 308 (310)
T 4glp_A 296 VDNLTLDGNPFLV 308 (310)
T ss_dssp CSCEECSSTTTSC
T ss_pred ccEEECcCCCCCC
Confidence 8899999997763
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=227.97 Aligned_cols=148 Identities=24% Similarity=0.364 Sum_probs=130.4
Q ss_pred cCCCCC-CcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
+.|.+. +.||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 457664 78999999999999965 6899999999776555678899999999884 79999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc---EEEEeecccee
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKISDFGLAKL 829 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~---~kl~DFGla~~ 829 (845)
|+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 92 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred cCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999543 36899999999999999999999997 999999999999998776 99999999987
Q ss_pred cC
Q 003134 830 YE 831 (845)
Q Consensus 830 ~~ 831 (845)
..
T Consensus 164 ~~ 165 (316)
T 2ac3_A 164 IK 165 (316)
T ss_dssp --
T ss_pred cc
Confidence 64
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=8.2e-24 Score=241.87 Aligned_cols=148 Identities=32% Similarity=0.517 Sum_probs=132.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC-EEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-QLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~Ey 753 (845)
.++|+..+.||+|+||.||+|.+. ++.||||+++... ..++|.+|+++|++++||||+++++++...+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 456788899999999999999985 7899999997653 4678999999999999999999999988765 79999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 269 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CTTCBHHHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999996532 224789999999999999999999997 9999999999999999999999999999664
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.4e-24 Score=231.60 Aligned_cols=152 Identities=33% Similarity=0.520 Sum_probs=135.5
Q ss_pred cCCCCCCcccccCcEEEEEEEE-----CCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEE--eCCEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV--EGNQLL 748 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~~ 748 (845)
++|+..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. ..+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999984 358899999998766666678999999999999999999999987 456799
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 103 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999996432 35899999999999999999999987 9999999999999999999999999999
Q ss_pred ecCCCC
Q 003134 829 LYEEDK 834 (845)
Q Consensus 829 ~~~~~~ 834 (845)
......
T Consensus 176 ~~~~~~ 181 (327)
T 3lxl_A 176 LLPLDK 181 (327)
T ss_dssp ECCTTC
T ss_pred ecccCC
Confidence 876544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=231.12 Aligned_cols=150 Identities=27% Similarity=0.410 Sum_probs=134.2
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|...+.||+|+||.||+++..+ ++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 567888999999999999999864 7899999986542 233567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++++|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 121 e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 121 ELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp CCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999988542 36899999999999999999999997 9999999999999999999999999999875
Q ss_pred CC
Q 003134 832 ED 833 (845)
Q Consensus 832 ~~ 833 (845)
..
T Consensus 193 ~~ 194 (335)
T 2owb_A 193 YD 194 (335)
T ss_dssp ST
T ss_pred cC
Confidence 43
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=218.71 Aligned_cols=179 Identities=17% Similarity=0.177 Sum_probs=157.1
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCc-ccCCCccccccc-ceeEEEecC-CCCCCCccccccccccccee
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNC-LTGSFSPQWASL-QLVELSVMG-NRLSGPFPKVLTNITTLKNL 168 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~-l~~~~~~~~~~l-~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L 168 (845)
.+++.|++++|.+++..+..|.++++|++|+|++|+ ++.+.+..|..+ +|++|+|++ |+|++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 478999999999998888899999999999999997 999888899988 999999999 99998888899999999999
Q ss_pred EeecccCCCCCCcccccCCCcc---EEEeecC-cCcccCChhhhCCCCCC-cEEeecCcCcccCchhhcCCcccceEEec
Q 003134 169 SIEGNLFTGSIPPDIRKLINLQ---KLILSSN-SFTGELPAELTKLTNLN-DLRISDNNFSGKIPEFIGKWKKIQKLHIQ 243 (845)
Q Consensus 169 ~Ls~N~l~g~~p~~~~~l~~L~---~L~Ls~N-~l~g~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 243 (845)
+|++|++++ +|. |..+++|+ +|++++| ++++..+..|.++++|+ +|+|++|+++...+..|.. ++|++|+|+
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN 187 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence 999999996 676 88899998 9999999 99977777899999999 9999999999544445555 899999999
Q ss_pred CCc-CCCCcchhhhcC-CCCCEEEcCCCCCCC
Q 003134 244 GSS-LEGPIPASISAL-TSLTDLRISDLKGSE 273 (845)
Q Consensus 244 ~N~-l~g~~p~~~~~l-~~L~~L~Ls~n~~~~ 273 (845)
+|+ +++..+..|.++ ++|+.|++++|.++.
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~ 219 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA 219 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCCC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCcccc
Confidence 995 997777888888 777777666555543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.2e-24 Score=234.63 Aligned_cols=152 Identities=26% Similarity=0.394 Sum_probs=134.4
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--------cchHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 745 (845)
.++|+..+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 467899999999999999999975 589999999876421 12346778999999999999999999999999
Q ss_pred EEEEEEeccCCC-ChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 746 QLLLVYEYMKNN-CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 746 ~~~lV~Ey~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
..++||||+.+| +|.+++... ..+++..+..|+.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 999999999777 999998653 25899999999999999999999997 999999999999999999999999
Q ss_pred ccceecCCCC
Q 003134 825 GLAKLYEEDK 834 (845)
Q Consensus 825 Gla~~~~~~~ 834 (845)
|+++......
T Consensus 175 g~a~~~~~~~ 184 (335)
T 3dls_A 175 GSAAYLERGK 184 (335)
T ss_dssp TTCEECCTTC
T ss_pred ccceECCCCC
Confidence 9999886543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=228.22 Aligned_cols=142 Identities=28% Similarity=0.396 Sum_probs=125.8
Q ss_pred CCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEEEEeccCCCC
Q 003134 681 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~Ey~~~gs 758 (845)
.+.||+|+||.||+|+.. +++.||||++... ....+.+|++++.++. ||||+++++++.+.+..|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999986 5899999998643 3467789999999997 9999999999999999999999999999
Q ss_pred hhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC---cEEEEeeccceecCCC
Q 003134 759 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKISDFGLAKLYEED 833 (845)
Q Consensus 759 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~---~~kl~DFGla~~~~~~ 833 (845)
|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 93 L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 93 LFERIKKK-----KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 99999653 36899999999999999999999997 99999999999998765 8999999999977543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.3e-24 Score=237.78 Aligned_cols=153 Identities=24% Similarity=0.366 Sum_probs=134.3
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC--EEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~ 751 (845)
++|...+.||+|+||.||+|++.. ++.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 468889999999999999999864 8999999997653 344577889999999999999999999998765 789999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----cCCCcEEEEeeccc
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLA 827 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl----d~~~~~kl~DFGla 827 (845)
||+++|+|.+++..... ...+++.+++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+|
T Consensus 89 e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp CCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred ecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999965422 224899999999999999999999997 9999999999999 77888999999999
Q ss_pred eecCCC
Q 003134 828 KLYEED 833 (845)
Q Consensus 828 ~~~~~~ 833 (845)
+.....
T Consensus 164 ~~~~~~ 169 (396)
T 4eut_A 164 RELEDD 169 (396)
T ss_dssp EECCCG
T ss_pred eEccCC
Confidence 987543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=224.77 Aligned_cols=155 Identities=28% Similarity=0.462 Sum_probs=134.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 750 (845)
.++|+..+.||+|+||.||+|+.. +++.||+|+++... .....++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467889999999999999999986 68999999987542 23456788999999999 999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC--------------
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-------------- 816 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~-------------- 816 (845)
|||+++|+|.+++.... .....+++.++..++.||+.||+|||+++ |+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 90 NEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EECCTTCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEecCCCcHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999996532 11246899999999999999999999997 9999999999999844
Q ss_pred -----CcEEEEeeccceecCCC
Q 003134 817 -----LNAKISDFGLAKLYEED 833 (845)
Q Consensus 817 -----~~~kl~DFGla~~~~~~ 833 (845)
..+||+|||+++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~ 187 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP 187 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS
T ss_pred ccCCceEEEEcccccccccCCc
Confidence 47999999999987653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.90 E-value=9.5e-24 Score=252.60 Aligned_cols=163 Identities=27% Similarity=0.353 Sum_probs=140.2
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc---cccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 748 (845)
..++|+..+.||+|+||.||+|+.. +++.||||+++.. .....+.+..|.+++..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3567999999999999999999976 5889999999754 234456788999999987 7999999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+||||+++|+|.+++... ..+++.+++.|+.||+.||+|||+++ ||||||||+|||++.++++||+|||+|+
T Consensus 419 lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999643 36899999999999999999999997 9999999999999999999999999999
Q ss_pred ecCCCCceeeeeeccCC
Q 003134 829 LYEEDKTHISTRIAGTM 845 (845)
Q Consensus 829 ~~~~~~~~~~t~~~GT~ 845 (845)
........ ....+||+
T Consensus 491 ~~~~~~~~-~~~~~GT~ 506 (674)
T 3pfq_A 491 ENIWDGVT-TKTFCGTP 506 (674)
T ss_dssp ECCCTTCC-BCCCCSCS
T ss_pred ccccCCcc-cccccCCC
Confidence 75443322 33456764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.8e-24 Score=236.85 Aligned_cols=150 Identities=28% Similarity=0.536 Sum_probs=123.9
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc--cccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCC--E
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN--Q 746 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~ 746 (845)
...++|+..+.||+|+||.||+|.+. +++.||||++... .....+++.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999975 5899999998654 2334567889999999997 999999999998654 7
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.|+||||++ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 899999998 5899888542 6899999999999999999999997 99999999999999999999999999
Q ss_pred ceecCC
Q 003134 827 AKLYEE 832 (845)
Q Consensus 827 a~~~~~ 832 (845)
|+.+..
T Consensus 156 a~~~~~ 161 (388)
T 3oz6_A 156 SRSFVN 161 (388)
T ss_dssp CEESSS
T ss_pred cccccc
Confidence 997643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=228.29 Aligned_cols=151 Identities=23% Similarity=0.308 Sum_probs=130.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccc---hHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
.++|...+.||+|+||.||+|+.. +++.||+|++....... .+.+.+|++++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999976 58899999997653322 46789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++++|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 113 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999542 36899999999999999999999997 999999999999999999999999999877
Q ss_pred CCC
Q 003134 831 EED 833 (845)
Q Consensus 831 ~~~ 833 (845)
...
T Consensus 185 ~~~ 187 (309)
T 2h34_A 185 TDE 187 (309)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=229.20 Aligned_cols=151 Identities=25% Similarity=0.360 Sum_probs=135.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccccc------chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 747 (845)
.++|+..+.||+|+||.||+|+.. +++.||+|.++..... ..+++.+|++++++++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999986 5899999998754321 357899999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC----cEEEEe
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISD 823 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~----~~kl~D 823 (845)
++||||+++++|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++ .+||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999643 35889999999999999999999997 99999999999999888 799999
Q ss_pred eccceecCCC
Q 003134 824 FGLAKLYEED 833 (845)
Q Consensus 824 FGla~~~~~~ 833 (845)
||+++.....
T Consensus 163 fg~~~~~~~~ 172 (321)
T 2a2a_A 163 FGLAHEIEDG 172 (321)
T ss_dssp CTTCEECCTT
T ss_pred CccceecCcc
Confidence 9999987653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.6e-24 Score=234.69 Aligned_cols=162 Identities=26% Similarity=0.353 Sum_probs=140.5
Q ss_pred cCcccHHHHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCC-----CCceee
Q 003134 663 TGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----HPNLVK 736 (845)
Q Consensus 663 ~~~~~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~ 736 (845)
...+++++.....++|.+.++||+|+||.||+|+.. +++.||||+++.. ....+.+..|++++.+++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 445666666677889999999999999999999985 5889999999753 233466788999999886 999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-
Q 003134 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK- 815 (845)
Q Consensus 737 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~- 815 (845)
+++++...+..++||||+ +++|.+++..... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP 173 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence 999999999999999999 8999999965432 25899999999999999999999987 999999999999975
Q ss_pred ------------------------CCcEEEEeeccceecCC
Q 003134 816 ------------------------DLNAKISDFGLAKLYEE 832 (845)
Q Consensus 816 ------------------------~~~~kl~DFGla~~~~~ 832 (845)
++.+||+|||+|+....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 78999999999997654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3e-23 Score=222.96 Aligned_cols=199 Identities=22% Similarity=0.203 Sum_probs=174.1
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.+++++++++ .+|..+. ++|++|+|++|+|++..+..|..+ +|++|+|++|+|++..+. +.+++|++|+|
T Consensus 10 ~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~L 84 (290)
T 1p9a_G 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDL 84 (290)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEEC
T ss_pred CCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEEC
Confidence 46788999999998 5676664 789999999999999999999998 999999999999976543 78999999999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCC
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 250 (845)
++|+|+ .+|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++.
T Consensus 85 s~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 163 (290)
T 1p9a_G 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (290)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred CCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCcc
Confidence 999999 7888999999999999999999988888999999999999999999988888899999999999999999987
Q ss_pred cchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCC
Q 003134 251 IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320 (845)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 320 (845)
.+..|..+++|+.|+|++| +|+ .+|..+..+.+|+.|+|++|.+..
T Consensus 164 ~~~~~~~l~~L~~L~L~~N-----------------------~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 164 PAGLLNGLENLDTLLLQEN-----------------------SLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CTTTTTTCTTCCEEECCSS-----------------------CCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CHHHhcCcCCCCEEECCCC-----------------------cCC-ccChhhcccccCCeEEeCCCCccC
Confidence 7777788887777655554 454 456666677889999999998873
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=228.82 Aligned_cols=154 Identities=26% Similarity=0.457 Sum_probs=129.1
Q ss_pred HHHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcC--CCCceeeEEEEEEeC----
Q 003134 671 IKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ--QHPNLVKLYGCCVEG---- 744 (845)
Q Consensus 671 l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~---- 744 (845)
.....++|+..+.||+|+||.||+|++. ++.||||++... ....+..|.+++... +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3444578999999999999999999985 899999998543 234555566666554 999999999999987
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeCCCCCCCEEecCCCcE
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS-----RIKIVHRDIKTSNVLLDKDLNA 819 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivHrDLKp~NILld~~~~~ 819 (845)
+..++||||+++|+|.++++.. .+++.++..++.|++.||+|||+++ .++|+||||||+|||++.++.+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 7899999999999999999542 5899999999999999999999871 1239999999999999999999
Q ss_pred EEEeeccceecCCCC
Q 003134 820 KISDFGLAKLYEEDK 834 (845)
Q Consensus 820 kl~DFGla~~~~~~~ 834 (845)
||+|||+|+.+....
T Consensus 182 kl~Dfg~a~~~~~~~ 196 (337)
T 3mdy_A 182 CIADLGLAVKFISDT 196 (337)
T ss_dssp EECCCTTCEECC---
T ss_pred EEEeCCCceeecccc
Confidence 999999998775433
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=224.76 Aligned_cols=149 Identities=28% Similarity=0.458 Sum_probs=132.7
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 457888999999999999999976 47799999986542 23356789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999998543 36899999999999999999999986 999999999999999999999999998765
Q ss_pred C
Q 003134 831 E 831 (845)
Q Consensus 831 ~ 831 (845)
.
T Consensus 160 ~ 160 (279)
T 3fdn_A 160 P 160 (279)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-23 Score=226.61 Aligned_cols=148 Identities=33% Similarity=0.538 Sum_probs=131.5
Q ss_pred CCCCCcccccCcEEEEEEEEC-----CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEEEE
Q 003134 678 FDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLL 749 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 749 (845)
|+..+.||+|+||.||++.+. +++.||||+++... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998753 58899999997653 23456789999999999999999999999884 68899
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++|+|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 113 v~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999543 4899999999999999999999997 99999999999999999999999999998
Q ss_pred cCCCC
Q 003134 830 YEEDK 834 (845)
Q Consensus 830 ~~~~~ 834 (845)
+....
T Consensus 184 ~~~~~ 188 (318)
T 3lxp_A 184 VPEGH 188 (318)
T ss_dssp CCTTC
T ss_pred ccccc
Confidence 86543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-23 Score=222.96 Aligned_cols=151 Identities=30% Similarity=0.400 Sum_probs=132.0
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
+|.....||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3555669999999999999975 588999999977655566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCcEEEEeeccceecCC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYEE 832 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~-~~~~kl~DFGla~~~~~ 832 (845)
+++|.+++..... ...+++..+..++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||+++....
T Consensus 103 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 103 GGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999965422 235678899999999999999999987 999999999999987 89999999999998754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.3e-24 Score=232.69 Aligned_cols=151 Identities=30% Similarity=0.503 Sum_probs=129.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCc----EEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
++|+..+.||+|+||.||+|++. +++ .||+|.+.... ....+++.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46788899999999999999975 344 37888875442 333456788999999999999999999886 456899
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 92 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999996542 36889999999999999999999997 99999999999999999999999999998
Q ss_pred cCCCC
Q 003134 830 YEEDK 834 (845)
Q Consensus 830 ~~~~~ 834 (845)
+....
T Consensus 165 ~~~~~ 169 (325)
T 3kex_A 165 LPPDD 169 (325)
T ss_dssp SCCCT
T ss_pred cCccc
Confidence 75543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=222.87 Aligned_cols=151 Identities=26% Similarity=0.427 Sum_probs=133.7
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999976 58999999986543 233467889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc---EEEEeeccce
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKISDFGLAK 828 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~---~kl~DFGla~ 828 (845)
||+++++|.+.+... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++. +||+|||++.
T Consensus 85 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp CCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred ecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999888543 36899999999999999999999997 999999999999986655 9999999998
Q ss_pred ecCCC
Q 003134 829 LYEED 833 (845)
Q Consensus 829 ~~~~~ 833 (845)
.....
T Consensus 157 ~~~~~ 161 (284)
T 3kk8_A 157 EVNDS 161 (284)
T ss_dssp ECCSS
T ss_pred EcccC
Confidence 87643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=231.92 Aligned_cols=158 Identities=28% Similarity=0.439 Sum_probs=134.0
Q ss_pred HhcCCCCCCcccccCcEEEEEEEE------CCCcEEEEEEcCccc-ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 745 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 745 (845)
..++|...+.||+|+||.||+|++ .++..||+|+++... ....+.+.+|++++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346788899999999999999996 235689999997542 33457899999999999 9999999999999999
Q ss_pred EEEEEEeccCCCChhhhhhcCCcc------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTE------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 807 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLK 807 (845)
..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999764321 0124899999999999999999999987 9999999
Q ss_pred CCCEEecCCCcEEEEeeccceecCCCC
Q 003134 808 TSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 808 p~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
|+|||++.++.+||+|||+++......
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~ 226 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDS 226 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCc
Confidence 999999999999999999999775443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=8.6e-24 Score=233.12 Aligned_cols=154 Identities=31% Similarity=0.515 Sum_probs=127.7
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccccc-----chHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-----GNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 745 (845)
....++|+..+.||+|+||.||+|+.. +++.||+|+++..... ..+.+.+|++++++++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344578999999999999999999975 5899999999754221 1347889999999999999999999999999
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
..++||||+++ +|.+++.... ..+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred ceEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence 99999999986 8888885532 36889999999999999999999997 9999999999999999999999999
Q ss_pred cceecCCC
Q 003134 826 LAKLYEED 833 (845)
Q Consensus 826 la~~~~~~ 833 (845)
+|+.+...
T Consensus 158 ~a~~~~~~ 165 (346)
T 1ua2_A 158 LAKSFGSP 165 (346)
T ss_dssp GGSTTTSC
T ss_pred cceeccCC
Confidence 99987543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=6e-25 Score=243.99 Aligned_cols=248 Identities=16% Similarity=0.159 Sum_probs=199.7
Q ss_pred EEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcc----ccccccc-ccceeEeecccCCCCCCcccccC-----CC
Q 003134 120 QLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFP----KVLTNIT-TLKNLSIEGNLFTGSIPPDIRKL-----IN 188 (845)
Q Consensus 120 ~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l-----~~ 188 (845)
.++|+.|.+++.+|..+... +|++|+|++|+|++..+ ..|.+++ +|++|+|++|+|++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 47899999999999888877 59999999999998887 7788888 89999999999998888888776 99
Q ss_pred ccEEEeecCcCcccCChhhh----CC-CCCCcEEeecCcCcccCchhhcC-----CcccceEEecCCcCCCCc----chh
Q 003134 189 LQKLILSSNSFTGELPAELT----KL-TNLNDLRISDNNFSGKIPEFIGK-----WKKIQKLHIQGSSLEGPI----PAS 254 (845)
Q Consensus 189 L~~L~Ls~N~l~g~~p~~~~----~l-~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~g~~----p~~ 254 (845)
|++|+|++|++++..+..+. .+ ++|++|+|++|+|++..+..+.. .++|++|+|++|+++... +..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 99999999999977776544 44 89999999999999877765543 369999999999999644 445
Q ss_pred hhcCC-CCCEEEcCCCCCCCCCCcccc----c--CCccEEEccCCcCccc----CcccccC-CCCcCEEeCCCCCCCCCC
Q 003134 255 ISALT-SLTDLRISDLKGSESAFPKLD----K--MNLKTLILTKCLIHGE----IPDYIGD-MTKLKNIDLSFNNLTGGI 322 (845)
Q Consensus 255 ~~~l~-~L~~L~Ls~n~~~~~~~~~l~----~--~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~g~~ 322 (845)
+..++ +|+.|+|++|.++......+. . .+|+.|+|++|.|++. ++..+.. .++|++|||++|+|++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 56665 999999999999876654332 2 3899999999999874 4555555 459999999999999776
Q ss_pred chh----hhcCCCcCEEEccCCcccCCCChhh---------hcCCceEEeecCCCcCC
Q 003134 323 PTT----FEKLAKTNFMYLTGNKLTGPVPKYI---------FNSNKNVDISLNNFTWE 367 (845)
Q Consensus 323 p~~----~~~l~~L~~L~L~~N~l~g~ip~~~---------~~~l~~L~ls~N~l~~~ 367 (845)
+.. +..+++|+.|+|++|.+.+..+..+ ...|+.||+++|++...
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 643 4667899999999999775444322 12578899999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=222.74 Aligned_cols=150 Identities=33% Similarity=0.496 Sum_probs=134.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357888999999999999999986 689999999875432 335788999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++++|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 86 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999998543 35899999999999999999999987 99999999999999999999999999987643
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.7e-25 Score=246.99 Aligned_cols=240 Identities=19% Similarity=0.272 Sum_probs=143.3
Q ss_pred cCCccccCCCCCCEEeccCCcccCCCccc----cccc-ceeEEEecCC---CCCCCccccc-------ccccccceeEee
Q 003134 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQ----WASL-QLVELSVMGN---RLSGPFPKVL-------TNITTLKNLSIE 171 (845)
Q Consensus 107 ~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~----~~~l-~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~Ls 171 (845)
.++..+..+++|++|+|++|+|+...+.. +..+ +|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 45667778888888888888888764433 4444 6777777774 4445555544 566777777777
Q ss_pred cccCCC----CCCcccccCCCccEEEeecCcCcccCChhhh----CC---------CCCCcEEeecCcCc-ccCc---hh
Q 003134 172 GNLFTG----SIPPDIRKLINLQKLILSSNSFTGELPAELT----KL---------TNLNDLRISDNNFS-GKIP---EF 230 (845)
Q Consensus 172 ~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~----~l---------~~L~~L~Ls~N~l~-~~~p---~~ 230 (845)
+|+|++ .+|..+..+++|++|+|++|+|+...+..+. .+ ++|++|+|++|+|+ +.+| ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 777775 3566677777777777777777644333333 33 67777777777776 3344 35
Q ss_pred hcCCcccceEEecCCcCC--C---CcchhhhcCCCCCEEEcCCCCCCC----CCCccccc-CCccEEEccCCcCccc---
Q 003134 231 IGKWKKIQKLHIQGSSLE--G---PIPASISALTSLTDLRISDLKGSE----SAFPKLDK-MNLKTLILTKCLIHGE--- 297 (845)
Q Consensus 231 ~~~l~~L~~L~Ls~N~l~--g---~~p~~~~~l~~L~~L~Ls~n~~~~----~~~~~l~~-~~L~~L~Ls~N~l~~~--- 297 (845)
+..+++|++|+|++|+++ | ..|..+..+++|+.|+|++|.++. ..+..+.. .+|+.|+|++|.|++.
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence 566777777777777776 2 234366666666666666655531 11111211 2455555555555544
Q ss_pred -Cccccc--CCCCcCEEeCCCCCCCC----CCchhh-hcCCCcCEEEccCCcccCCC
Q 003134 298 -IPDYIG--DMTKLKNIDLSFNNLTG----GIPTTF-EKLAKTNFMYLTGNKLTGPV 346 (845)
Q Consensus 298 -~p~~~~--~l~~L~~L~Ls~N~l~g----~~p~~~-~~l~~L~~L~L~~N~l~g~i 346 (845)
+|..+. .+++|+.|+|++|+|++ .+|..+ .++++|++|+|++|++++..
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 334442 25555555555555554 244444 44555555555555555444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=220.26 Aligned_cols=185 Identities=20% Similarity=0.265 Sum_probs=159.4
Q ss_pred ceeecCCCCcceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccc
Q 003134 82 NVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLT 160 (845)
Q Consensus 82 ~v~C~~~~~~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~ 160 (845)
|++|.. ..+.+++++++++ .+|..+. ++|+.|+|++|++++..+..|..+ +|++|+|++|+|++..+..|.
T Consensus 9 gC~C~~-----~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 80 (251)
T 3m19_A 9 GCTCNE-----GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFD 80 (251)
T ss_dssp SSEEEG-----GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTT
T ss_pred ceEcCC-----CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhc
Confidence 566642 2346899999998 5676665 689999999999999999888888 899999999999998888899
Q ss_pred cccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceE
Q 003134 161 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL 240 (845)
Q Consensus 161 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 240 (845)
++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|
T Consensus 81 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 160 (251)
T 3m19_A 81 DLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTL 160 (251)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEE
Confidence 99999999999999998777888999999999999999997777778899999999999999998777789999999999
Q ss_pred EecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCC
Q 003134 241 HIQGSSLEGPIPASISALTSLTDLRISDLKGSES 274 (845)
Q Consensus 241 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~ 274 (845)
+|++|+|++..+..|..+++|+.|++++|.+...
T Consensus 161 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 161 SLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred ECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999999988888888888888887777776543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=229.35 Aligned_cols=170 Identities=24% Similarity=0.367 Sum_probs=140.4
Q ss_pred ccccccCcccHHHHHHHhcCCCCC-CcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcC-CCC
Q 003134 658 GLDLQTGLYTLRQIKAATNNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQ-QHP 732 (845)
Q Consensus 658 ~~~~~~~~~~~~~l~~~~~~y~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~ 732 (845)
+++...+-..++......+.|... +.||+|+||.||+|+.. +++.||+|+++... .....++.+|+.++.++ +||
T Consensus 10 ~~~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 89 (327)
T 3lm5_A 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89 (327)
T ss_dssp ------CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCT
T ss_pred cccccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCC
Confidence 445555555566666777778777 88999999999999986 58999999997643 33467899999999999 569
Q ss_pred ceeeEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 003134 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 812 (845)
Q Consensus 733 nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NIL 812 (845)
||+++++++...+..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+++ |+||||||+|||
T Consensus 90 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl 163 (327)
T 3lm5_A 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNIL 163 (327)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEE
Confidence 99999999999999999999999999999985432 236899999999999999999999997 999999999999
Q ss_pred ecC---CCcEEEEeeccceecCCC
Q 003134 813 LDK---DLNAKISDFGLAKLYEED 833 (845)
Q Consensus 813 ld~---~~~~kl~DFGla~~~~~~ 833 (845)
++. ++.+||+|||+++.....
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC---
T ss_pred EecCCCCCcEEEeeCccccccCCc
Confidence 987 789999999999987543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.89 E-value=9.9e-24 Score=238.88 Aligned_cols=151 Identities=26% Similarity=0.412 Sum_probs=128.8
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--------cchHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 743 (845)
...++|...+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999975 589999999865421 11235789999999999999999999975
Q ss_pred CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC---CcEE
Q 003134 744 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAK 820 (845)
Q Consensus 744 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~---~~~k 820 (845)
.+..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEE
T ss_pred cCceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEE
Confidence 55689999999999999988543 36899999999999999999999997 9999999999999654 4599
Q ss_pred EEeeccceecCC
Q 003134 821 ISDFGLAKLYEE 832 (845)
Q Consensus 821 l~DFGla~~~~~ 832 (845)
|+|||+|+....
T Consensus 283 l~DFG~a~~~~~ 294 (419)
T 3i6u_A 283 ITDFGHSKILGE 294 (419)
T ss_dssp ECCSSTTTSCC-
T ss_pred EeecccceecCC
Confidence 999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-24 Score=251.73 Aligned_cols=151 Identities=31% Similarity=0.554 Sum_probs=134.3
Q ss_pred HhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
..++|+..+.||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++|+||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 456788889999999999999999888889999997653 346789999999999999999999999865 678999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++|+|.+++... ....+++.+++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 343 ~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 343 MSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CTTEEHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hcCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999542 1235899999999999999999999987 99999999999999999999999999987643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=231.84 Aligned_cols=158 Identities=24% Similarity=0.427 Sum_probs=138.5
Q ss_pred HHHHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--------cchHHHHHHHHHHhcC-CCCceeeE
Q 003134 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQ-QHPNLVKL 737 (845)
Q Consensus 668 ~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~nIv~l 737 (845)
........++|+..+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|++++.++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444555678999999999999999999986 699999999865431 1135678899999998 89999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC
Q 003134 738 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 817 (845)
Q Consensus 738 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~ 817 (845)
++++...+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 99999999999999999999999998532 36899999999999999999999987 99999999999999999
Q ss_pred cEEEEeeccceecCCC
Q 003134 818 NAKISDFGLAKLYEED 833 (845)
Q Consensus 818 ~~kl~DFGla~~~~~~ 833 (845)
.+||+|||+++.+...
T Consensus 238 ~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPG 253 (365)
T ss_dssp CEEECCCTTCEECCTT
T ss_pred CEEEEecCcccccCCC
Confidence 9999999999987643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=233.36 Aligned_cols=158 Identities=26% Similarity=0.426 Sum_probs=133.7
Q ss_pred cHHHHHHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCccccc-----------chHHHHHHHHHHhcCCCCcee
Q 003134 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ-----------GNREFVNEIGMISAQQHPNLV 735 (845)
Q Consensus 667 ~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv 735 (845)
.+.++....++|...+.||+|+||.||+|...+++.||||++...... ..+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456778888999999999999999999999888999999998654221 127889999999999999999
Q ss_pred eEEEEEEeC-----CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 003134 736 KLYGCCVEG-----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 810 (845)
Q Consensus 736 ~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~N 810 (845)
++++++... ...++||||++ |+|.+.+.... ..+++.++..++.||+.||+|||+++ |+||||||+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 164 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN 164 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHH
Confidence 999998643 36899999998 58888886432 36899999999999999999999997 9999999999
Q ss_pred EEecCCCcEEEEeeccceecCC
Q 003134 811 VLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 811 ILld~~~~~kl~DFGla~~~~~ 832 (845)
||++.++.+||+|||+|+....
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTA 186 (362)
T ss_dssp EEECTTCCEEECCTTC------
T ss_pred EEEcCCCCEEEEecCccccccc
Confidence 9999999999999999986543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-23 Score=232.74 Aligned_cols=149 Identities=28% Similarity=0.509 Sum_probs=131.0
Q ss_pred cCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
+.|...+.||+|+||.||+|+. .+++.||||++..... ...+++.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3477889999999999999997 4689999999865422 23457889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+. |+|.+.+... ...+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 134 e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp ECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9998 5788877432 236899999999999999999999997 9999999999999999999999999998775
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 206 ~ 206 (348)
T 1u5q_A 206 P 206 (348)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-24 Score=238.07 Aligned_cols=153 Identities=31% Similarity=0.420 Sum_probs=131.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcc-cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 747 (845)
.++|...+.||+|+||.||+|++. +++.||||+++.. ......++.+|+.++++++||||+++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356888999999999999999953 3678999999754 234456789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCc--ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC---cEEEE
Q 003134 748 LLVYEYMKNNCLSRAIFGKDT--EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKIS 822 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~---~~kl~ 822 (845)
++||||+++|+|.+++..... .....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999965422 12235899999999999999999999997 99999999999999555 59999
Q ss_pred eeccceec
Q 003134 823 DFGLAKLY 830 (845)
Q Consensus 823 DFGla~~~ 830 (845)
|||+|+.+
T Consensus 227 DFG~a~~~ 234 (367)
T 3l9p_A 227 DFGMARDI 234 (367)
T ss_dssp CCHHHHHH
T ss_pred CCcccccc
Confidence 99999865
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=8.1e-24 Score=231.43 Aligned_cols=151 Identities=30% Similarity=0.615 Sum_probs=127.4
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCc----EEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
++|+..+.||+|+||.||+|++. +++ .||+|.++... ....+++.+|++++++++||||+++++++...+ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46888899999999999999964 343 46888886543 345678999999999999999999999998765 788
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 94 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 999999999999996542 36899999999999999999999997 99999999999999999999999999998
Q ss_pred cCCCC
Q 003134 830 YEEDK 834 (845)
Q Consensus 830 ~~~~~ 834 (845)
+....
T Consensus 167 ~~~~~ 171 (327)
T 3poz_A 167 LGAEE 171 (327)
T ss_dssp HTTTC
T ss_pred ccCCc
Confidence 75443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=229.71 Aligned_cols=156 Identities=26% Similarity=0.472 Sum_probs=134.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC--------CCcEEEEEEcCccc-ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 744 (845)
.++|...+.||+|+||.||+|++. ++..||+|+++... ....+++.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467888999999999999999863 46789999997653 23356789999999999 999999999999999
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl 813 (845)
+..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+++ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 9999999999999999999764321 1235899999999999999999999997 9999999999999
Q ss_pred cCCCcEEEEeeccceecCCC
Q 003134 814 DKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 814 d~~~~~kl~DFGla~~~~~~ 833 (845)
+.++.+||+|||+++.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~ 210 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNI 210 (334)
T ss_dssp CTTCCEEECCCTTCEECTTT
T ss_pred cCCCCEEEcccccccccccc
Confidence 99999999999999987643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=9.6e-24 Score=232.46 Aligned_cols=161 Identities=24% Similarity=0.369 Sum_probs=132.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCC--CceeeEEEEEEeCCEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQH--PNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV 750 (845)
.++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++.+++| +||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 35688899999999999999999889999999986542 2334678999999999987 9999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|| +.+|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++ ++.+||+|||+|+.+
T Consensus 88 ~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EC-CCSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred Ee-CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99 5678999999653 36899999999999999999999997 99999999999997 678999999999987
Q ss_pred CCCCce-eeeeeccCC
Q 003134 831 EEDKTH-ISTRIAGTM 845 (845)
Q Consensus 831 ~~~~~~-~~t~~~GT~ 845 (845)
...... ..+...||+
T Consensus 158 ~~~~~~~~~~~~~gt~ 173 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTV 173 (343)
T ss_dssp ------------CCCC
T ss_pred CcccccccCCCCcCCc
Confidence 544322 222345553
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=235.29 Aligned_cols=146 Identities=25% Similarity=0.340 Sum_probs=124.3
Q ss_pred cCCCCC-CcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHh-cCCCCceeeEEEEEEe----CCEEE
Q 003134 676 NNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMIS-AQQHPNLVKLYGCCVE----GNQLL 748 (845)
Q Consensus 676 ~~y~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~----~~~~~ 748 (845)
++|... +.||+|+||+||+|... +++.||||+++. ...+.+|++++. ..+||||+++++++.. .+..|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 455555 68999999999999986 589999999853 246778888874 4589999999999876 56789
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCcEEEEeec
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFG 825 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~---~~~~kl~DFG 825 (845)
+||||+++|+|.+++.... ...+++.++..|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 136 lv~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeCCCCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 9999999999999997642 236899999999999999999999987 999999999999997 7899999999
Q ss_pred cceecCC
Q 003134 826 LAKLYEE 832 (845)
Q Consensus 826 la~~~~~ 832 (845)
+|+....
T Consensus 210 ~a~~~~~ 216 (400)
T 1nxk_A 210 FAKETTS 216 (400)
T ss_dssp TCEECC-
T ss_pred cccccCC
Confidence 9997754
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.89 E-value=9.6e-23 Score=240.54 Aligned_cols=239 Identities=27% Similarity=0.318 Sum_probs=200.6
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|+|++|+|+ .+|. .+++|++|+|++|+|+++.+ .+ +|++|+|++|+|++. |. .+++|+.|+|
T Consensus 61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L 128 (622)
T 3g06_A 61 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPV----LPPGLLELSIFSNPLTHL-PA---LPSGLCKLWI 128 (622)
T ss_dssp TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCCC----CCTTCCEEEECSCCCCCC-CC---CCTTCCEEEC
T ss_pred CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCCC----CCCCCCEEECcCCcCCCC-CC---CCCCcCEEEC
Confidence 57899999999999 4666 67999999999999997544 44 899999999999975 43 5789999999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCC
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGP 250 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 250 (845)
++|+|++ +|.. +++|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +| ..+++|+.|+|++|+|++
T Consensus 129 ~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~- 195 (622)
T 3g06_A 129 FGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS- 195 (622)
T ss_dssp CSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-
T ss_pred CCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-
Confidence 9999995 6654 4899999999999995 454 35789999999999995 56 557899999999999996
Q ss_pred cchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCC
Q 003134 251 IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLA 330 (845)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 330 (845)
+|.. +++|+.|++++|.++..+.. ..+|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .++
T Consensus 196 l~~~---~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~ 261 (622)
T 3g06_A 196 LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPS 261 (622)
T ss_dssp CCCC---CTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCT
T ss_pred CCCc---cchhhEEECcCCcccccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccc
Confidence 4432 47899999999999876532 2489999999999997 55 45689999999999999 4565 678
Q ss_pred CcCEEEccCCcccCCCChhhh--cCCceEEeecCCCcCCCCC
Q 003134 331 KTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSD 370 (845)
Q Consensus 331 ~L~~L~L~~N~l~g~ip~~~~--~~l~~L~ls~N~l~~~~p~ 370 (845)
+|+.|+|++|+|+ .+|..+. .+|+.|+|++|.+++.+|.
T Consensus 262 ~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 262 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred cCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 9999999999999 7888774 4899999999999877664
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.7e-24 Score=229.06 Aligned_cols=157 Identities=29% Similarity=0.468 Sum_probs=136.4
Q ss_pred hcCCCCCCcccccCcEEEEEEEE------CCCcEEEEEEcCcccc-cchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 746 (845)
.++|...+.||+|+||.||+|++ .+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45788899999999999999985 2468999999976533 3357889999999999 99999999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcc-------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTE-------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl 813 (845)
.++||||+++|+|.+++...... ....+++.++.+++.|+++||+|||+++ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 99999999999999999754321 1235899999999999999999999997 9999999999999
Q ss_pred cCCCcEEEEeeccceecCCCC
Q 003134 814 DKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 814 d~~~~~kl~DFGla~~~~~~~ 834 (845)
+.++.+||+|||+++......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~ 199 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDS 199 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCT
T ss_pred cCCCCEEEccccccccccccc
Confidence 999999999999999876543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=228.71 Aligned_cols=152 Identities=32% Similarity=0.548 Sum_probs=134.0
Q ss_pred cCCCCCCcccccCcEEEEEEEE-----CCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC--EEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLL 748 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~ 748 (845)
++|+..+.||+|+||.||+|++ .+++.||+|++........+++.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4577889999999999999984 358899999998765556678999999999999999999999987654 689
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 121 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999996542 35899999999999999999999987 9999999999999999999999999999
Q ss_pred ecCCCC
Q 003134 829 LYEEDK 834 (845)
Q Consensus 829 ~~~~~~ 834 (845)
......
T Consensus 194 ~~~~~~ 199 (326)
T 2w1i_A 194 VLPQDK 199 (326)
T ss_dssp ECCSSC
T ss_pred hccccc
Confidence 886543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-23 Score=221.66 Aligned_cols=149 Identities=24% Similarity=0.380 Sum_probs=133.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc------cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
++|+..+.||+|+||.||+|+.. +++.||+|.++.... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999986 589999999865421 23578999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC----cEEEEee
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISDF 824 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~----~~kl~DF 824 (845)
+||||+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999998542 36899999999999999999999987 99999999999998877 8999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|+++....
T Consensus 157 g~~~~~~~ 164 (283)
T 3bhy_A 157 GIAHKIEA 164 (283)
T ss_dssp TTCEECC-
T ss_pred ccceeccC
Confidence 99998754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=241.20 Aligned_cols=151 Identities=30% Similarity=0.506 Sum_probs=129.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.++|+..+.||+|+||.||+|+.. ++..||+|++.... ......+.+|++++++++||||+++++++...+..|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346888999999999999999986 58899999997643 334678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCcEEEEeeccce
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAK 828 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~---~~~~kl~DFGla~ 828 (845)
||+++|+|.+.+... ..+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|+
T Consensus 116 e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 999999999988543 36899999999999999999999997 999999999999976 4559999999999
Q ss_pred ecCCC
Q 003134 829 LYEED 833 (845)
Q Consensus 829 ~~~~~ 833 (845)
.+...
T Consensus 188 ~~~~~ 192 (494)
T 3lij_A 188 VFENQ 192 (494)
T ss_dssp ECBTT
T ss_pred ECCCC
Confidence 88654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-23 Score=223.26 Aligned_cols=149 Identities=31% Similarity=0.521 Sum_probs=134.9
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
+.|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 46888999999999999999975 58999999997553 34467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 102 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 102 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999853 26899999999999999999999997 999999999999999999999999999887543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=225.39 Aligned_cols=152 Identities=31% Similarity=0.544 Sum_probs=128.0
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-----ccchHHHHHHHHHHhcC---CCCceeeEEEEEEeC
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQ---QHPNLVKLYGCCVEG 744 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~ 744 (845)
..++|+..+.||+|+||+||+|+.. +++.||+|+++... ......+.+|+++++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999974 68999999986432 12235677788877766 499999999999876
Q ss_pred C-----EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcE
Q 003134 745 N-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (845)
Q Consensus 745 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~ 819 (845)
. ..++||||++ |+|.+++..... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence 5 5899999997 599999865432 24899999999999999999999997 9999999999999999999
Q ss_pred EEEeeccceecCC
Q 003134 820 KISDFGLAKLYEE 832 (845)
Q Consensus 820 kl~DFGla~~~~~ 832 (845)
||+|||+|+.+..
T Consensus 160 kl~Dfg~a~~~~~ 172 (308)
T 3g33_A 160 KLADFGLARIYSY 172 (308)
T ss_dssp EECSCSCTTTSTT
T ss_pred EEeeCccccccCC
Confidence 9999999987754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-23 Score=240.37 Aligned_cols=151 Identities=31% Similarity=0.514 Sum_probs=131.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-------------cchHHHHHHHHHHhcCCCCceeeEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-------------QGNREFVNEIGMISAQQHPNLVKLYGC 740 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~~~ 740 (845)
.++|...++||+|+||+||+|+.. +++.||+|++..... ...+++.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467889999999999999999986 488999999865421 235678999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC---
Q 003134 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL--- 817 (845)
Q Consensus 741 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~--- 817 (845)
+.+.+..++||||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999988543 36899999999999999999999997 99999999999998776
Q ss_pred cEEEEeeccceecCCC
Q 003134 818 NAKISDFGLAKLYEED 833 (845)
Q Consensus 818 ~~kl~DFGla~~~~~~ 833 (845)
.+||+|||+|+.+...
T Consensus 187 ~~kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKD 202 (504)
T ss_dssp SEEECCCTTCEECCTT
T ss_pred cEEEEECCCCEEcCCC
Confidence 6999999999988654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=231.21 Aligned_cols=151 Identities=24% Similarity=0.421 Sum_probs=134.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccc-----------------hHHHHHHHHHHhcCCCCceeeE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG-----------------NREFVNEIGMISAQQHPNLVKL 737 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~l 737 (845)
.++|...+.||+|+||.||+|.. +++.||+|++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788999999999999999999 89999999997542221 1789999999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChhhh------hhcCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCC
Q 003134 738 YGCCVEGNQLLLVYEYMKNNCLSRA------IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSN 810 (845)
Q Consensus 738 ~~~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDLKp~N 810 (845)
++++...+..++||||+++|+|.++ +... ....+++..+..++.|++.||+|||+ .+ |+||||||+|
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N 182 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN 182 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence 9999999999999999999999998 4332 13478999999999999999999999 76 9999999999
Q ss_pred EEecCCCcEEEEeeccceecCC
Q 003134 811 VLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 811 ILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++.++.+||+|||+++....
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~ 204 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVD 204 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBT
T ss_pred EEEcCCCcEEEecccccccccc
Confidence 9999999999999999998644
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-23 Score=222.27 Aligned_cols=151 Identities=32% Similarity=0.539 Sum_probs=131.5
Q ss_pred cCCCCCC-cccccCcEEEEEEEEC---CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 676 NNFDPAN-KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
++|...+ .||+|+||.||+|.+. ++..||+|+++... ....+++.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 8999999999999864 57889999997653 33457899999999999999999999999 55678999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 88 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999999999996432 36899999999999999999999997 999999999999999999999999999988
Q ss_pred CCCC
Q 003134 831 EEDK 834 (845)
Q Consensus 831 ~~~~ 834 (845)
....
T Consensus 161 ~~~~ 164 (287)
T 1u59_A 161 GADD 164 (287)
T ss_dssp TTCS
T ss_pred ccCc
Confidence 6443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=228.66 Aligned_cols=148 Identities=27% Similarity=0.456 Sum_probs=128.7
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..+.||+|+||.||+|... +++.||+|+++.... .+.+|++++.++ +||||+++++++.+.+..|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 457889999999999999999986 589999999966432 234688888887 79999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC----CcEEEEeeccce
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKISDFGLAK 828 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~----~~~kl~DFGla~ 828 (845)
|+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+|+
T Consensus 97 ~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 97 LMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999998653 35899999999999999999999997 9999999999998433 359999999999
Q ss_pred ecCCCC
Q 003134 829 LYEEDK 834 (845)
Q Consensus 829 ~~~~~~ 834 (845)
......
T Consensus 169 ~~~~~~ 174 (342)
T 2qr7_A 169 QLRAEN 174 (342)
T ss_dssp ECBCTT
T ss_pred cCcCCC
Confidence 876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=227.93 Aligned_cols=153 Identities=26% Similarity=0.361 Sum_probs=132.4
Q ss_pred hcCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEe----CCEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~l 749 (845)
.++|+..+.||+|+||.||+|+. .+++.||+|++........+.+.+|++++++++||||+++++++.. .+..++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45788999999999999999997 4689999999876655566789999999999999999999999873 347899
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 108 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999864211 2246899999999999999999999997 99999999999999999999999999886
Q ss_pred cC
Q 003134 830 YE 831 (845)
Q Consensus 830 ~~ 831 (845)
..
T Consensus 184 ~~ 185 (317)
T 2buj_A 184 AC 185 (317)
T ss_dssp SC
T ss_pred cc
Confidence 53
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=233.67 Aligned_cols=151 Identities=22% Similarity=0.341 Sum_probs=126.4
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC------CcEEEEEEcCccccc-----------chHHHHHHHHHHhcCCCCceeeE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQ-----------GNREFVNEIGMISAQQHPNLVKL 737 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l 737 (845)
.++|...+.||+|+||.||+|.+.. ++.||||++...... ....+..|+..+..++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578899999999999999999754 478999998654321 12234556677888899999999
Q ss_pred EEEEEeC----CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 003134 738 YGCCVEG----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813 (845)
Q Consensus 738 ~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl 813 (845)
++++... ...++||||+ +++|.+++.... ..+++.+++.|+.||+.||+|||+++ |+||||||+|||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 9998764 4589999999 999999996532 36899999999999999999999997 9999999999999
Q ss_pred c--CCCcEEEEeeccceecCCC
Q 003134 814 D--KDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 814 d--~~~~~kl~DFGla~~~~~~ 833 (845)
+ .++.+||+|||+|+.+...
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGG
T ss_pred ecCCCCeEEEEECCcceecccC
Confidence 9 8899999999999987543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-23 Score=224.38 Aligned_cols=193 Identities=23% Similarity=0.320 Sum_probs=119.0
Q ss_pred cCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccE
Q 003134 113 SKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191 (845)
Q Consensus 113 ~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 191 (845)
.++++|++|++++|.++... .+..+ +|++|+|++|++++..+ +..+++|++|+|++|++++. +.+..+++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~l~--~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~ 111 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT 111 (308)
T ss_dssp HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred HHcCCcCEEEeeCCCccCch--hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCE
Confidence 44566666777666666532 34444 55666666666554433 55666666666666666532 24556666666
Q ss_pred EEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCC
Q 003134 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271 (845)
Q Consensus 192 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~ 271 (845)
|+|++|++++. +. +..+++|++|+|++|++++..+ +..+++|++|+|++|++++..+ +..+++
T Consensus 112 L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~----------- 174 (308)
T 1h6u_A 112 LDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSK----------- 174 (308)
T ss_dssp EECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTT-----------
T ss_pred EECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCC-----------
Confidence 66666666542 22 5566666666666666654332 5555666666666666654332 444444
Q ss_pred CCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccC
Q 003134 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG 344 (845)
Q Consensus 272 ~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g 344 (845)
|+.|+|++|++++..+ +..+++|++|+|++|++++..| +..+++|+.|+|++|++++
T Consensus 175 ------------L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 175 ------------LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp ------------CCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred ------------CCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 4555566666665443 6778888899999998886553 7888889999999998874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=224.66 Aligned_cols=150 Identities=28% Similarity=0.512 Sum_probs=132.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEe----------
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE---------- 743 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~---------- 743 (845)
.++|+..+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457888999999999999999975 6899999999643 3345678999999999999999999999865
Q ss_pred ---CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEE
Q 003134 744 ---GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 820 (845)
Q Consensus 744 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~k 820 (845)
.+..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 356899999999999999996532 35788899999999999999999997 99999999999999999999
Q ss_pred EEeeccceecCC
Q 003134 821 ISDFGLAKLYEE 832 (845)
Q Consensus 821 l~DFGla~~~~~ 832 (845)
|+|||+++....
T Consensus 157 l~dfg~~~~~~~ 168 (303)
T 1zy4_A 157 IGDFGLAKNVHR 168 (303)
T ss_dssp ECCCCCCSCTTC
T ss_pred EeeCcchhhccc
Confidence 999999987653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=223.57 Aligned_cols=150 Identities=27% Similarity=0.480 Sum_probs=132.0
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEe---------
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--------- 743 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------- 743 (845)
...+|+..+.||+|+||.||+|+.. +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457889999999999999999986 68999999986542 456789999999999999999998864
Q ss_pred -------CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC
Q 003134 744 -------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD 816 (845)
Q Consensus 744 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~ 816 (845)
....++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT 158 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence 345899999999999999996532 236899999999999999999999987 9999999999999999
Q ss_pred CcEEEEeeccceecCCC
Q 003134 817 LNAKISDFGLAKLYEED 833 (845)
Q Consensus 817 ~~~kl~DFGla~~~~~~ 833 (845)
+.+||+|||+++.....
T Consensus 159 ~~~kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKND 175 (284)
T ss_dssp TEEEECCCTTCEESSCC
T ss_pred CCEEECcchhheecccc
Confidence 99999999999987654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.7e-24 Score=231.29 Aligned_cols=149 Identities=27% Similarity=0.479 Sum_probs=128.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccccc-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|...+.||+|+||.||+|+.. +++.||+|++...... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999986 6899999999754322 122456799999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++ |+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 98 48988886542 36899999999999999999999997 99999999999999999999999999987653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=248.63 Aligned_cols=144 Identities=31% Similarity=0.537 Sum_probs=126.6
Q ss_pred cccccCcEEEEEEEEC---CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCCCC
Q 003134 683 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (845)
Q Consensus 683 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gs 758 (845)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999874 46689999998653 3456789999999999999999999999976 56899999999999
Q ss_pred hhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 759 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 759 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
|.+++.... ..+++.++..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..+.
T Consensus 422 L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 422 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999996542 36899999999999999999999997 9999999999999999999999999999875443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=220.86 Aligned_cols=150 Identities=29% Similarity=0.480 Sum_probs=135.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999986 68999999986542 23456889999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++++|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999998543 35899999999999999999999997 999999999999999999999999999877
Q ss_pred CC
Q 003134 831 EE 832 (845)
Q Consensus 831 ~~ 832 (845)
..
T Consensus 162 ~~ 163 (276)
T 2h6d_A 162 SD 163 (276)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-23 Score=228.34 Aligned_cols=148 Identities=28% Similarity=0.518 Sum_probs=129.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe--------C
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--------G 744 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~ 744 (845)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57889999999999999999984 68999999986543 2335678899999999999999999999987 4
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
+..++||||+++ +|.+.+.... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 568999999986 7777775432 35899999999999999999999997 999999999999999999999999
Q ss_pred ccceecC
Q 003134 825 GLAKLYE 831 (845)
Q Consensus 825 Gla~~~~ 831 (845)
|+|+.+.
T Consensus 169 g~a~~~~ 175 (351)
T 3mi9_A 169 GLARAFS 175 (351)
T ss_dssp TTCEECC
T ss_pred hhccccc
Confidence 9999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-24 Score=233.47 Aligned_cols=162 Identities=25% Similarity=0.443 Sum_probs=138.5
Q ss_pred HHHHHHHhcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEE
Q 003134 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGC 740 (845)
Q Consensus 668 ~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~ 740 (845)
.++.....++|+..+.||+|+||.||+|++. +++.||+|.+..... ....++.+|++++++++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3444556678999999999999999999864 367899999976432 334578999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChhhhhhcCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC
Q 003134 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 815 (845)
Q Consensus 741 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~ 815 (845)
+...+..++||||+++|+|.+++...... ....+++.++.+++.|++.||+|||+++ |+||||||+||+++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcC
Confidence 99999999999999999999999653211 1135789999999999999999999997 999999999999999
Q ss_pred CCcEEEEeeccceecCC
Q 003134 816 DLNAKISDFGLAKLYEE 832 (845)
Q Consensus 816 ~~~~kl~DFGla~~~~~ 832 (845)
++.+||+|||+++....
T Consensus 174 ~~~~kl~Dfg~~~~~~~ 190 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYE 190 (322)
T ss_dssp TCCEEECCTTCCCGGGG
T ss_pred CCeEEECcCcccccccc
Confidence 99999999999987643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=240.89 Aligned_cols=157 Identities=26% Similarity=0.381 Sum_probs=126.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeC------C
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------N 745 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 745 (845)
.++|+..+.||+|+||.||+|+.. +++.||||++... .....+++.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467889999999999999999975 5899999999754 233456788999999999999999999999654 4
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
..|+||||++++ |.+.+.. .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEE
Confidence 689999999875 6666532 4889999999999999999999997 9999999999999999999999999
Q ss_pred cceecCCCCceeeeeeccC
Q 003134 826 LAKLYEEDKTHISTRIAGT 844 (845)
Q Consensus 826 la~~~~~~~~~~~t~~~GT 844 (845)
+|+...... ..+..+||
T Consensus 210 ~a~~~~~~~--~~~~~~gt 226 (464)
T 3ttj_A 210 LARTAGTSF--MMTPYVVT 226 (464)
T ss_dssp CC-----CC--CC----CC
T ss_pred eeeecCCCc--ccCCCccc
Confidence 999875432 22334555
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.9e-23 Score=222.26 Aligned_cols=149 Identities=22% Similarity=0.345 Sum_probs=131.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..+.||+|+||.||+|+. .+++.||+|++.... ..+.+.+|++++.++ +|+|++++++++...+..++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45788999999999999999997 468999999986432 334678899999999 89999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc-----EEEEeeccc
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-----AKISDFGLA 827 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~-----~kl~DFGla 827 (845)
|+ +++|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++. +||+|||+|
T Consensus 87 ~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 99 999999996532 35899999999999999999999987 999999999999987776 999999999
Q ss_pred eecCCC
Q 003134 828 KLYEED 833 (845)
Q Consensus 828 ~~~~~~ 833 (845)
+.....
T Consensus 159 ~~~~~~ 164 (298)
T 1csn_A 159 KFYRDP 164 (298)
T ss_dssp EESBCT
T ss_pred cccccc
Confidence 987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=224.75 Aligned_cols=148 Identities=32% Similarity=0.566 Sum_probs=123.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..+.||+|+||.||+|+.. ..||+|+++... ....+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467889999999999999999864 359999987553 23356789999999999999999999965 5566899999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999996542 36899999999999999999999987 99999999999999999999999999987653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.4e-23 Score=221.95 Aligned_cols=152 Identities=27% Similarity=0.427 Sum_probs=134.7
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---------ccchHHHHHHHHHHhcCC-CCceeeEEEEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---------RQGNREFVNEIGMISAQQ-HPNLVKLYGCCV 742 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~ 742 (845)
..++|+..+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3467889999999999999999986 58999999986542 122456889999999995 999999999999
Q ss_pred eCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEE
Q 003134 743 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822 (845)
Q Consensus 743 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~ 822 (845)
..+..++||||+++++|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999999542 36899999999999999999999997 9999999999999999999999
Q ss_pred eeccceecCCC
Q 003134 823 DFGLAKLYEED 833 (845)
Q Consensus 823 DFGla~~~~~~ 833 (845)
|||+++.+...
T Consensus 167 dfg~~~~~~~~ 177 (298)
T 1phk_A 167 DFGFSCQLDPG 177 (298)
T ss_dssp CCTTCEECCTT
T ss_pred cccchhhcCCC
Confidence 99999987543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=229.41 Aligned_cols=149 Identities=26% Similarity=0.473 Sum_probs=126.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.++|+..+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 457889999999999999999975 689999999975532 22456789999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe-----cCCCcEEEEeecc
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-----DKDLNAKISDFGL 826 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl-----d~~~~~kl~DFGl 826 (845)
||+++ +|.+++... ..+++.++..|+.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 113 e~~~~-~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp ECCSE-EHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred ecCCC-CHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 99985 999998543 25899999999999999999999997 9999999999999 4555699999999
Q ss_pred ceecCC
Q 003134 827 AKLYEE 832 (845)
Q Consensus 827 a~~~~~ 832 (845)
|+.+..
T Consensus 184 a~~~~~ 189 (329)
T 3gbz_A 184 ARAFGI 189 (329)
T ss_dssp HHHHC-
T ss_pred ccccCC
Confidence 987753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-23 Score=228.16 Aligned_cols=149 Identities=28% Similarity=0.497 Sum_probs=129.3
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|+..+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46888999999999999999986 489999999865432 224567899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 105 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 105 FVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp CCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999998886433 25899999999999999999999997 99999999999999999999999999987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=229.60 Aligned_cols=151 Identities=31% Similarity=0.573 Sum_probs=127.7
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-----CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
.+|...+.||+|+||.||+|.... +..||+|.++... .....++.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456678899999999999998643 2469999997643 2335678999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 124 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999996532 36899999999999999999999997 99999999999999999999999999998
Q ss_pred cCCC
Q 003134 830 YEED 833 (845)
Q Consensus 830 ~~~~ 833 (845)
....
T Consensus 197 ~~~~ 200 (333)
T 1mqb_A 197 LEDD 200 (333)
T ss_dssp ----
T ss_pred hccc
Confidence 7543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=225.03 Aligned_cols=150 Identities=30% Similarity=0.472 Sum_probs=129.6
Q ss_pred cCCCCCCcccccCcEEEEEEEECC----CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEe-CCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~l 749 (845)
.+|+..+.||+|+||.||+|++.+ ...||+|.+.... ....+++.+|++++++++||||+++++++.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457788999999999999999643 3368999987643 2345678999999999999999999998654 567899
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+|+.
T Consensus 105 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999996532 35799999999999999999999997 99999999999999999999999999987
Q ss_pred cCC
Q 003134 830 YEE 832 (845)
Q Consensus 830 ~~~ 832 (845)
+..
T Consensus 178 ~~~ 180 (298)
T 3f66_A 178 MYD 180 (298)
T ss_dssp CSC
T ss_pred ccc
Confidence 754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=232.13 Aligned_cols=149 Identities=25% Similarity=0.445 Sum_probs=133.7
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357888999999999999999986 58999999997652 3335678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.+.
T Consensus 112 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999543 3689999999999999999999985 5 9999999999999999999999999997653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=225.27 Aligned_cols=149 Identities=26% Similarity=0.535 Sum_probs=132.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.++|++.+.||+|+||.||+|+.. +++.||+|++........+++.+|++++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467889999999999999999986 4899999999877666778999999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
+++++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 98 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 98 CPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp CTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred CCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 9999999988542 236899999999999999999999987 999999999999999999999999997643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=241.08 Aligned_cols=151 Identities=29% Similarity=0.516 Sum_probs=135.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
.++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888999999999999999986 68999999986542 34467899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---cCCCcEEEEeeccc
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLA 827 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl---d~~~~~kl~DFGla 827 (845)
|||+.+|+|.+.+... ..+++.++..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|
T Consensus 105 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp ECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999998653 35899999999999999999999997 9999999999999 56789999999999
Q ss_pred eecCCC
Q 003134 828 KLYEED 833 (845)
Q Consensus 828 ~~~~~~ 833 (845)
+.+...
T Consensus 177 ~~~~~~ 182 (484)
T 3nyv_A 177 THFEAS 182 (484)
T ss_dssp HHBCCC
T ss_pred EEcccc
Confidence 887544
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=240.20 Aligned_cols=151 Identities=27% Similarity=0.497 Sum_probs=134.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456889999999999999999986 68999999986542 344678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec---CCCcEEEEeeccce
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAK 828 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld---~~~~~kl~DFGla~ 828 (845)
||+++|+|.+.+... ..+++.++..++.|++.||+|||+++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 101 e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp CCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999988543 36899999999999999999999997 99999999999995 55679999999998
Q ss_pred ecCCC
Q 003134 829 LYEED 833 (845)
Q Consensus 829 ~~~~~ 833 (845)
.+...
T Consensus 173 ~~~~~ 177 (486)
T 3mwu_A 173 CFQQN 177 (486)
T ss_dssp TBCCC
T ss_pred ECCCC
Confidence 77543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.8e-23 Score=222.86 Aligned_cols=151 Identities=34% Similarity=0.559 Sum_probs=130.4
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
..++|+..+.||+|+||.||+|... +++.||+|.+... ...+++.+|++++.+++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567899999999999999999986 4899999998754 345788999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++|+|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 105 ~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 105 YCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp CCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred cCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999998532 236899999999999999999999987 99999999999999999999999999988754
Q ss_pred C
Q 003134 833 D 833 (845)
Q Consensus 833 ~ 833 (845)
.
T Consensus 178 ~ 178 (314)
T 3com_A 178 T 178 (314)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=232.22 Aligned_cols=148 Identities=25% Similarity=0.433 Sum_probs=124.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC------C
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------N 745 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 745 (845)
.++|+..+.||+|+||.||+|... +|+.||||++.... ....+++.+|++++++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 357888999999999999999985 58999999996542 23356788999999999999999999999865 3
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeee
Confidence 469999999 7899999854 25899999999999999999999997 9999999999999999999999999
Q ss_pred cceecCC
Q 003134 826 LAKLYEE 832 (845)
Q Consensus 826 la~~~~~ 832 (845)
+|+....
T Consensus 174 ~a~~~~~ 180 (367)
T 1cm8_A 174 LARQADS 180 (367)
T ss_dssp TCEECCS
T ss_pred ccccccc
Confidence 9998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-23 Score=221.40 Aligned_cols=152 Identities=29% Similarity=0.470 Sum_probs=130.3
Q ss_pred hcCCCCCC-cccccCcEEEEEEEEC---CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 675 TNNFDPAN-KVGEGGFGSVYKGILS---DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 675 ~~~y~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
.++|...+ .||+|+||.||+|.+. +++.||||+++.... ...+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 8999999999999652 368899999976532 2256899999999999999999999999 667789
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+||||+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 94 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 999999999999999653 35899999999999999999999997 9999999999999999999999999999
Q ss_pred ecCCCCc
Q 003134 829 LYEEDKT 835 (845)
Q Consensus 829 ~~~~~~~ 835 (845)
.......
T Consensus 166 ~~~~~~~ 172 (291)
T 1xbb_A 166 ALRADEN 172 (291)
T ss_dssp ECCTTCS
T ss_pred eeccCCC
Confidence 8865443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.2e-23 Score=224.85 Aligned_cols=154 Identities=29% Similarity=0.439 Sum_probs=134.2
Q ss_pred HHHHHHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhc--CCCCceeeEEEEEEeCC
Q 003134 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEGN 745 (845)
Q Consensus 668 ~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~ 745 (845)
+.......++|...+.||+|+||.||+|+. +++.||+|++... ..+.+.+|++++.. ++||||+++++++...+
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 333345567899999999999999999998 5899999999643 34677888888887 79999999999998876
Q ss_pred ----EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeCCCCCCCEEe
Q 003134 746 ----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH--------EDSRIKIVHRDIKTSNVLL 813 (845)
Q Consensus 746 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~ivHrDLKp~NILl 813 (845)
..++||||+++|+|.+++... .+++.+++.++.|++.||+||| +.+ |+||||||+|||+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll 180 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV 180 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred CccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence 899999999999999999542 5899999999999999999999 554 9999999999999
Q ss_pred cCCCcEEEEeeccceecCCCC
Q 003134 814 DKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 814 d~~~~~kl~DFGla~~~~~~~ 834 (845)
+.++.+||+|||+++......
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSAT 201 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTT
T ss_pred CCCCCEEEEECCCceeccccc
Confidence 999999999999999876544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-23 Score=223.79 Aligned_cols=153 Identities=28% Similarity=0.480 Sum_probs=126.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|...+.||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 46888999999999999999974 68999999997532 233567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++.... .....+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 112 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp ECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred ecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999986421 12246899999999999999999999997 9999999999999999999999999998775
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 188 ~ 188 (310)
T 2wqm_A 188 S 188 (310)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-23 Score=219.98 Aligned_cols=151 Identities=24% Similarity=0.416 Sum_probs=132.9
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC--CEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 751 (845)
++|...+.||+|+||.||+|++. ++.||+|+++... ....+++.+|++++++++||||+++++++... +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888999999999999999985 8899999997653 23356799999999999999999999999877 7889999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++..... ..+++.++..++.|++.||+|||+++ ++|+||||||+||+++.++.+||+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999975432 25899999999999999999999874 359999999999999999999999999887654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=5.3e-23 Score=219.95 Aligned_cols=149 Identities=26% Similarity=0.447 Sum_probs=133.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999986 57899999986542 233568899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999998543 36899999999999999999999987 9999999999999999999999999998765
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 166 ~ 166 (284)
T 2vgo_A 166 S 166 (284)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=233.69 Aligned_cols=148 Identities=24% Similarity=0.368 Sum_probs=129.0
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCccc--ccchHHHHHHHHHHhcCC--CCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQ--HPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.+|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++.+++ ||||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 3588899999999999999998889999999986542 334578899999999996 599999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
| +.+++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+|+.+.
T Consensus 136 E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 5788999999653 26889999999999999999999987 99999999999995 5899999999999875
Q ss_pred CC
Q 003134 832 ED 833 (845)
Q Consensus 832 ~~ 833 (845)
..
T Consensus 206 ~~ 207 (390)
T 2zmd_A 206 PD 207 (390)
T ss_dssp --
T ss_pred CC
Confidence 44
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=228.16 Aligned_cols=166 Identities=26% Similarity=0.440 Sum_probs=139.1
Q ss_pred ccHHHHHHHhcCCCCCCcccccCcEEEEEEEE------CCCcEEEEEEcCcccc-cchHHHHHHHHHHhcC-CCCceeeE
Q 003134 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKL 737 (845)
Q Consensus 666 ~~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l 737 (845)
+...+.....++|...+.||+|+||.||+|++ .+++.||+|+++.... ...+.+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34445555667899999999999999999985 2468999999976532 3346789999999999 79999999
Q ss_pred EEEEEeCC-EEEEEEeccCCCChhhhhhcCCccc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 003134 738 YGCCVEGN-QLLLVYEYMKNNCLSRAIFGKDTEY-----------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRD 805 (845)
Q Consensus 738 ~~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrD 805 (845)
++++...+ ..++||||+++|+|.+++....... ...+++.++..++.|++.||+|||+++ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99988754 5899999999999999997653211 123789999999999999999999987 99999
Q ss_pred CCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 806 IKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 806 LKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
|||+||+++.++.+||+|||+++.+....
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 202 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDP 202 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred CccceEEECCCCCEEECCCccccccccCc
Confidence 99999999999999999999999875443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=228.58 Aligned_cols=157 Identities=31% Similarity=0.527 Sum_probs=135.2
Q ss_pred HHHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEe---
Q 003134 669 RQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE--- 743 (845)
Q Consensus 669 ~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~--- 743 (845)
.++....++|+..+.||+|+||.||+|+.. +++.||+|++... ....+++.+|++++.++ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 344455778999999999999999999985 6899999998654 33457889999999998 89999999999987
Q ss_pred ---CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEE
Q 003134 744 ---GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 820 (845)
Q Consensus 744 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~k 820 (845)
.+..++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 468999999999999999996542 236899999999999999999999997 99999999999999999999
Q ss_pred EEeeccceecCC
Q 003134 821 ISDFGLAKLYEE 832 (845)
Q Consensus 821 l~DFGla~~~~~ 832 (845)
|+|||+++....
T Consensus 170 l~Dfg~~~~~~~ 181 (326)
T 2x7f_A 170 LVDFGVSAQLDR 181 (326)
T ss_dssp ECCCTTTC----
T ss_pred EeeCcCceecCc
Confidence 999999987653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.4e-23 Score=219.54 Aligned_cols=151 Identities=33% Similarity=0.599 Sum_probs=130.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccc-------hHHHHHHHHHHhcCCCCceeeEEEEEEeCCE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG-------NREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 746 (845)
.++|+..+.||+|+||.||+|++. +++.||+|++....... .+++.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 357888999999999999999985 68999999996543221 267899999999999999999999986665
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc-----EEE
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-----AKI 821 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~-----~kl 821 (845)
++||||+++|+|.+.+.... ..+++..+..++.|++.||+|||+++ ++|+||||||+|||++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEe
Confidence 69999999999999886542 36899999999999999999999985 34999999999999988776 999
Q ss_pred EeeccceecCC
Q 003134 822 SDFGLAKLYEE 832 (845)
Q Consensus 822 ~DFGla~~~~~ 832 (845)
+|||+|+....
T Consensus 171 ~Dfg~~~~~~~ 181 (287)
T 4f0f_A 171 ADFGLSQQSVH 181 (287)
T ss_dssp CCCTTCBCCSS
T ss_pred CCCCccccccc
Confidence 99999986543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=223.24 Aligned_cols=151 Identities=27% Similarity=0.438 Sum_probs=129.4
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC----CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
.++|...+.||+|+||.||+|++.. +..||+|.++... ....+++.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4578889999999999999998643 3469999997653 3345789999999999999999999999764 45689
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++++|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 90 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999543 235899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCC
Q 003134 830 YEED 833 (845)
Q Consensus 830 ~~~~ 833 (845)
....
T Consensus 163 ~~~~ 166 (281)
T 3cc6_A 163 IEDE 166 (281)
T ss_dssp C---
T ss_pred cccc
Confidence 7543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=9e-23 Score=220.30 Aligned_cols=151 Identities=26% Similarity=0.382 Sum_probs=129.6
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc----ccchHHHHHHHHHHhcCCCCceeeEEEEEE--eCCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHPNLVKLYGCCV--EGNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~ 747 (845)
.++|...+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999975 58899999997642 234578999999999999999999999985 44578
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||++++ |.+++.... ...+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEehhccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 9999999987 777765432 236899999999999999999999997 999999999999999999999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+....
T Consensus 157 ~~~~~ 161 (305)
T 2wtk_C 157 EALHP 161 (305)
T ss_dssp EECCT
T ss_pred cccCc
Confidence 98753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-23 Score=246.55 Aligned_cols=149 Identities=20% Similarity=0.197 Sum_probs=113.6
Q ss_pred ccccCcEEEEEEE-ECCCcEEEEEEcCccc----------ccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEE
Q 003134 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKS----------RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 684 ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.+.|+.|.+..++ ..-|+.+|+|.+.... ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666555544 2248889999986531 22346799999999999 7999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||++|++|.++|.... +++.. +|+.||+.||+|+|+++ ||||||||+|||++++|++||+|||+|+...
T Consensus 322 Eyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp ECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred ecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999996542 45543 58999999999999997 9999999999999999999999999999886
Q ss_pred CCCceeeeeeccC
Q 003134 832 EDKTHISTRIAGT 844 (845)
Q Consensus 832 ~~~~~~~t~~~GT 844 (845)
.+.... +..+||
T Consensus 391 ~~~~~~-~t~vGT 402 (569)
T 4azs_A 391 QDCSWP-TNLVQS 402 (569)
T ss_dssp ---CCS-HHHHHH
T ss_pred CCCccc-cCceec
Confidence 544322 234555
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-23 Score=233.46 Aligned_cols=149 Identities=30% Similarity=0.476 Sum_probs=122.3
Q ss_pred CCCCCCcccccCcEEEEEEEEC--C--CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEe-CCEEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS--D--GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLV 750 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~--~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV 750 (845)
.|...+.||+|+||.||+|++. + +..||+|.++... ....++|.+|++++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556789999999999999863 2 2468999987543 3345789999999999999999999998764 4678999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++|+|.+++.... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 170 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 99999999999996542 35789999999999999999999997 999999999999999999999999999876
Q ss_pred CC
Q 003134 831 EE 832 (845)
Q Consensus 831 ~~ 832 (845)
..
T Consensus 243 ~~ 244 (373)
T 3c1x_A 243 YD 244 (373)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-24 Score=242.01 Aligned_cols=237 Identities=17% Similarity=0.177 Sum_probs=195.3
Q ss_pred Cccccccc-ceeEEEecCCCCCCCcc----cccccccccceeEeecc---cCCCCCCccc-------ccCCCccEEEeec
Q 003134 132 FSPQWASL-QLVELSVMGNRLSGPFP----KVLTNITTLKNLSIEGN---LFTGSIPPDI-------RKLINLQKLILSS 196 (845)
Q Consensus 132 ~~~~~~~l-~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N---~l~g~~p~~~-------~~l~~L~~L~Ls~ 196 (845)
++..+..+ +|++|+|++|+|++..+ ..|..+++|++|+|++| ++++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 33445545 89999999999997744 44778999999999996 5556667665 6899999999999
Q ss_pred CcCcc----cCChhhhCCCCCCcEEeecCcCcccCchhhcC----C---------cccceEEecCCcCC-CCcc---hhh
Q 003134 197 NSFTG----ELPAELTKLTNLNDLRISDNNFSGKIPEFIGK----W---------KKIQKLHIQGSSLE-GPIP---ASI 255 (845)
Q Consensus 197 N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~----l---------~~L~~L~Ls~N~l~-g~~p---~~~ 255 (845)
|++++ .+|..+.++++|++|+|++|+|+...+..+.. + ++|++|+|++|+++ +.++ ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 99997 57888999999999999999998655544444 3 89999999999998 4555 578
Q ss_pred hcCCCCCEEEcCCCCCCCC-----CCccccc-CCccEEEccCCcCc----ccCcccccCCCCcCEEeCCCCCCCCC----
Q 003134 256 SALTSLTDLRISDLKGSES-----AFPKLDK-MNLKTLILTKCLIH----GEIPDYIGDMTKLKNIDLSFNNLTGG---- 321 (845)
Q Consensus 256 ~~l~~L~~L~Ls~n~~~~~-----~~~~l~~-~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~g~---- 321 (845)
..+++|+.|++++|.++.. ....+.. .+|+.|+|++|.|+ +.+|..+..+++|++|+|++|+|++.
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 263 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence 8999999999999998732 1213333 48999999999997 67888999999999999999999976
Q ss_pred Cchhhhc--CCCcCEEEccCCcccC----CCChhh---hcCCceEEeecCCCcCCC
Q 003134 322 IPTTFEK--LAKTNFMYLTGNKLTG----PVPKYI---FNSNKNVDISLNNFTWES 368 (845)
Q Consensus 322 ~p~~~~~--l~~L~~L~L~~N~l~g----~ip~~~---~~~l~~L~ls~N~l~~~~ 368 (845)
+|..+.. +++|+.|+|++|++++ .+|..+ ...|+.|++++|++++..
T Consensus 264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 5667744 9999999999999998 588877 368999999999888654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.9e-23 Score=225.70 Aligned_cols=148 Identities=33% Similarity=0.550 Sum_probs=122.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHH--HhcCCCCceeeEEEEEEe-----CCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM--ISAQQHPNLVKLYGCCVE-----GNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~-----~~~~ 747 (845)
.++|+..+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 35788899999999999999987 68999999986542 3444445444 456899999999987653 2367
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeCCCCCCCEEecCCCcEEE
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS------RIKIVHRDIKTSNVLLDKDLNAKI 821 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~ivHrDLKp~NILld~~~~~kl 821 (845)
++||||+++|+|.+++... ..++..+.+++.||++||+|||+.. .++|+||||||+|||++.++.+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 8999999999999999543 3588999999999999999999881 113999999999999999999999
Q ss_pred EeeccceecCC
Q 003134 822 SDFGLAKLYEE 832 (845)
Q Consensus 822 ~DFGla~~~~~ 832 (845)
+|||+|+.+..
T Consensus 162 ~DFG~a~~~~~ 172 (336)
T 3g2f_A 162 SDFGLSMRLTG 172 (336)
T ss_dssp CCCTTCEECSS
T ss_pred eeccceeeccc
Confidence 99999998754
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=5.2e-23 Score=221.53 Aligned_cols=150 Identities=31% Similarity=0.562 Sum_probs=130.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|+..+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 57888999999999999999986 68999999997543 2334788899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|++ |+|.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~-~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 998 599999865421 35889999999999999999999997 99999999999999999999999999987653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.3e-23 Score=224.81 Aligned_cols=152 Identities=30% Similarity=0.543 Sum_probs=130.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcE--EEEEEcCcc-cccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTV--IAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 750 (845)
++|+..+.||+|+||.||+|+.. ++.. +|+|.++.. .....+++.+|++++.++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888999999999999999975 4554 499988653 233456789999999999 999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcE
Q 003134 751 YEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~ 819 (845)
|||+++|+|.+++..... .....+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 999999999999976531 11246899999999999999999999987 9999999999999999999
Q ss_pred EEEeeccceec
Q 003134 820 KISDFGLAKLY 830 (845)
Q Consensus 820 kl~DFGla~~~ 830 (845)
||+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999854
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.88 E-value=8.2e-23 Score=219.17 Aligned_cols=150 Identities=28% Similarity=0.473 Sum_probs=129.6
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe----CCEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLL 749 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~l 749 (845)
.|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3667778999999999999975 58899999987542 3345678999999999999999999999875 356899
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCcEEEEeeccce
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAK 828 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld-~~~~~kl~DFGla~ 828 (845)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||||+||+++ .++.+||+|||+++
T Consensus 107 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999542 36899999999999999999999984 3599999999999998 78999999999997
Q ss_pred ecCC
Q 003134 829 LYEE 832 (845)
Q Consensus 829 ~~~~ 832 (845)
....
T Consensus 181 ~~~~ 184 (290)
T 1t4h_A 181 LKRA 184 (290)
T ss_dssp GCCT
T ss_pred cccc
Confidence 6544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-23 Score=225.26 Aligned_cols=149 Identities=27% Similarity=0.419 Sum_probs=127.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--------cchHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 745 (845)
.++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457889999999999999999986 488999999865421 12345889999999999999999999987665
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc---EEEE
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKIS 822 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~---~kl~ 822 (845)
.++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++. +||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred -eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 89999999999999998543 36899999999999999999999987 999999999999987654 9999
Q ss_pred eeccceecCC
Q 003134 823 DFGLAKLYEE 832 (845)
Q Consensus 823 DFGla~~~~~ 832 (845)
|||+++....
T Consensus 160 Dfg~~~~~~~ 169 (322)
T 2ycf_A 160 DFGHSKILGE 169 (322)
T ss_dssp CCTTCEECCC
T ss_pred cCccceeccc
Confidence 9999998754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7.5e-23 Score=219.44 Aligned_cols=143 Identities=10% Similarity=0.019 Sum_probs=126.9
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCccccc---chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+|++.. ++.||+|++...... ..+++.+|++++++++||||+++++++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 568889999999999999999864 899999999765332 2468899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
||+++++|.+++... ....++.+|+.|++.||+|||+++ |+||||||+|||++.++.+||+++|...
T Consensus 111 e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp ECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence 999999999998432 355678999999999999999997 9999999999999999999999877653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-23 Score=227.54 Aligned_cols=160 Identities=28% Similarity=0.470 Sum_probs=127.5
Q ss_pred HHHHHhcCCCCCCcccccCcEEEEEEEEC----CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 003134 670 QIKAATNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE 743 (845)
Q Consensus 670 ~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 743 (845)
++....++|...+.||+|+||.||+|... .+..||+|.++... ....+.+.+|++++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33444567888999999999999999864 24589999997542 2334678999999999999999999999987
Q ss_pred CC-----EEEEEEeccCCCChhhhhhcCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC
Q 003134 744 GN-----QLLLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 817 (845)
Q Consensus 744 ~~-----~~~lV~Ey~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~ 817 (845)
.+ ..++||||+++|+|.+++..... .....+++.+++.++.|+++||+|||+++ |+||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence 54 35999999999999999854321 12346899999999999999999999987 99999999999999999
Q ss_pred cEEEEeeccceecCC
Q 003134 818 NAKISDFGLAKLYEE 832 (845)
Q Consensus 818 ~~kl~DFGla~~~~~ 832 (845)
.+||+|||+++.+..
T Consensus 185 ~~kl~Dfg~~~~~~~ 199 (313)
T 3brb_A 185 TVCVADFGLSKKIYS 199 (313)
T ss_dssp CEEECSCSCC-----
T ss_pred cEEEeecCcceeccc
Confidence 999999999987754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.1e-23 Score=230.28 Aligned_cols=154 Identities=23% Similarity=0.361 Sum_probs=126.1
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeC------
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 744 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 744 (845)
....++|...+.||+|+||.||+|+.. +++.||+|++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999974 689999999865422 234699999999999999999998543
Q ss_pred --------------------------------CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHH
Q 003134 745 --------------------------------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792 (845)
Q Consensus 745 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~y 792 (845)
...++||||+++ +|.+.+.... .....+++..+..++.||++||+|
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHH
Confidence 348999999984 8887775321 122468999999999999999999
Q ss_pred HHhCCCCCeEeCCCCCCCEEec-CCCcEEEEeeccceecCCCC
Q 003134 793 LHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 793 LH~~~~~~ivHrDLKp~NILld-~~~~~kl~DFGla~~~~~~~ 834 (845)
||+.+ |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 99987 99999999999998 68999999999999875443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.88 E-value=4.3e-23 Score=222.98 Aligned_cols=149 Identities=25% Similarity=0.387 Sum_probs=131.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.++|...+.||+|+||.||+|+.. +++.||+|+++.......+.+.+|++++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456888999999999999999986 6899999999865544556789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---cCCCcEEEEeeccceec
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLY 830 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl---d~~~~~kl~DFGla~~~ 830 (845)
+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++..
T Consensus 88 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 88 VSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred CCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999998542 36899999999999999999999997 9999999999999 78899999999999865
Q ss_pred C
Q 003134 831 E 831 (845)
Q Consensus 831 ~ 831 (845)
.
T Consensus 160 ~ 160 (304)
T 2jam_A 160 Q 160 (304)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=9.5e-23 Score=222.81 Aligned_cols=144 Identities=24% Similarity=0.441 Sum_probs=129.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCC-CCceeeEEEEEEe--CCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVE--GNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lV~ 751 (845)
++|+..+.||+|+||.||+|+.. +++.||+|+++.. ..+.+.+|++++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 57888999999999999999974 6899999998743 3578899999999997 9999999999997 56789999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-cEEEEeeccceec
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLY 830 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~-~~kl~DFGla~~~ 830 (845)
||+++++|.+++. .+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.+
T Consensus 113 e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp ECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 9999999998873 3788999999999999999999997 99999999999999776 8999999999987
Q ss_pred CCC
Q 003134 831 EED 833 (845)
Q Consensus 831 ~~~ 833 (845)
...
T Consensus 182 ~~~ 184 (330)
T 3nsz_A 182 HPG 184 (330)
T ss_dssp CTT
T ss_pred CCC
Confidence 543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-23 Score=224.95 Aligned_cols=157 Identities=25% Similarity=0.419 Sum_probs=120.7
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
...++|...+.||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34568999999999999999999864 68899999987543 33456788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCC---cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 751 YEYMKNNCLSRAIFGKD---TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
|||+++++|.+++.... ......+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 99999999999985311 112246899999999999999999999987 999999999999999999999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+....
T Consensus 169 ~~~~~ 173 (303)
T 2vwi_A 169 AFLAT 173 (303)
T ss_dssp HHCC-
T ss_pred heecc
Confidence 87653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.88 E-value=6.3e-24 Score=237.11 Aligned_cols=153 Identities=13% Similarity=0.133 Sum_probs=125.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcc---cccchHHHHHHH---HHHhcCCCCceeeEE-------EE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEI---GMISAQQHPNLVKLY-------GC 740 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~-------~~ 740 (845)
.++|...+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35688889999999999999996 46999999999743 233457889999 556666899999998 77
Q ss_pred EEeCCE-----------------EEEEEeccCCCChhhhhhcCCc--ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 003134 741 CVEGNQ-----------------LLLVYEYMKNNCLSRAIFGKDT--EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801 (845)
Q Consensus 741 ~~~~~~-----------------~~lV~Ey~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 801 (845)
+...+. .|+||||+ +|+|.+++..... .....+++..+..|+.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 6799999964311 11123446888999999999999999997 9
Q ss_pred EeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 802 vHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
+||||||+|||++.++.+||+|||+|+...
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 999999999999999999999999999754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.5e-23 Score=228.18 Aligned_cols=148 Identities=22% Similarity=0.317 Sum_probs=123.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC----CCcEEEEEEcCccccc-----------chHHHHHHHHHHhcCCCCceeeEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQ-----------GNREFVNEIGMISAQQHPNLVKLYGC 740 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~~~ 740 (845)
++|...+.||+|+||.||+|+.. ++..+|+|++...... ..+.+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888999999999999999985 4778999998654221 22456788899999999999999999
Q ss_pred EEe----CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC
Q 003134 741 CVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD 816 (845)
Q Consensus 741 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~ 816 (845)
+.. .+..++||||+ +++|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 988 77899999999 99999998543 26899999999999999999999997 9999999999999988
Q ss_pred C--cEEEEeeccceecCC
Q 003134 817 L--NAKISDFGLAKLYEE 832 (845)
Q Consensus 817 ~--~~kl~DFGla~~~~~ 832 (845)
+ .+||+|||+|+.+..
T Consensus 188 ~~~~~kL~Dfg~a~~~~~ 205 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCP 205 (345)
T ss_dssp STTSEEECCCTTCEESSG
T ss_pred CCCcEEEEeCCCceeccc
Confidence 7 999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.88 E-value=4.5e-23 Score=221.81 Aligned_cols=149 Identities=30% Similarity=0.452 Sum_probs=128.6
Q ss_pred CCCCCCcccccCcEEEEEEEECC----CcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE-EEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL-LLV 750 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~lV 750 (845)
.|...++||+|+||.||+|++.+ +..||+|.+..... ...+.+.+|++++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34556899999999999998632 33799999876432 3457889999999999999999999999876655 999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+.+|+|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+|+.+
T Consensus 102 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp ECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 99999999999996532 36899999999999999999999997 999999999999999999999999999866
Q ss_pred CC
Q 003134 831 EE 832 (845)
Q Consensus 831 ~~ 832 (845)
..
T Consensus 175 ~~ 176 (298)
T 3pls_A 175 LD 176 (298)
T ss_dssp TT
T ss_pred cC
Confidence 43
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.8e-23 Score=244.83 Aligned_cols=144 Identities=30% Similarity=0.484 Sum_probs=126.1
Q ss_pred CcccccCcEEEEEEEEC---CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
+.||+|+||.||+|.+. .++.||||+++.... ...+++.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 467899999976532 335789999999999999999999999964 558899999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
|+|.+++... ..+++.++..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..+.
T Consensus 454 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 9999999543 36899999999999999999999997 9999999999999999999999999999875443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=7.4e-23 Score=227.28 Aligned_cols=149 Identities=26% Similarity=0.423 Sum_probs=131.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----CEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 747 (845)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457889999999999999999975 58899999997543 23346789999999999999999999999765 368
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+++ +|.+++... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 106 ~iv~e~~~~-~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEECCSE-EHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEcccCc-CHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence 999999985 899988532 5899999999999999999999997 999999999999999999999999999
Q ss_pred eecCCC
Q 003134 828 KLYEED 833 (845)
Q Consensus 828 ~~~~~~ 833 (845)
+.....
T Consensus 176 ~~~~~~ 181 (364)
T 3qyz_A 176 RVADPD 181 (364)
T ss_dssp EECCGG
T ss_pred EecCCC
Confidence 987543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.4e-23 Score=227.94 Aligned_cols=159 Identities=30% Similarity=0.439 Sum_probs=136.0
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEECC------CcEEEEEEcCcccc-cchHHHHHHHHHHhcC-CCCceeeEEEEEEe
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVE 743 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 743 (845)
....++|...+.||+|+||.||+|.... ...||+|.++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3445788899999999999999999743 24799999976532 3456789999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCChhhhhhcCCcc---------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec
Q 003134 744 GNQLLLVYEYMKNNCLSRAIFGKDTE---------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 814 (845)
Q Consensus 744 ~~~~~lV~Ey~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld 814 (845)
.+..++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+++ |+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 99999999999999999998643210 1235799999999999999999999987 99999999999999
Q ss_pred CCCcEEEEeeccceecCCC
Q 003134 815 KDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 815 ~~~~~kl~DFGla~~~~~~ 833 (845)
.++.+||+|||+++.....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~ 217 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMND 217 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGC
T ss_pred CCCeEEECccccccccccc
Confidence 9999999999999977543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.88 E-value=4.2e-23 Score=221.12 Aligned_cols=154 Identities=25% Similarity=0.407 Sum_probs=121.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-c-chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-Q-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.++|+..+.||+|+||.||+|+.. +++.||+|+++.... . ..+.+.++...++.++||||+++++++..++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467888999999999999999974 689999999976522 2 2233445555688899999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
||+++ +|.+++.... .....+++.++..++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+|+..
T Consensus 86 e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCSE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhcc-chHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99985 8887775321 1224689999999999999999999997 6 999999999999999999999999999877
Q ss_pred CCC
Q 003134 831 EED 833 (845)
Q Consensus 831 ~~~ 833 (845)
...
T Consensus 161 ~~~ 163 (290)
T 3fme_A 161 VDD 163 (290)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.4e-23 Score=224.96 Aligned_cols=150 Identities=31% Similarity=0.612 Sum_probs=126.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCc----EEEEEEcCcc-cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
.++|+..+.||+|+||.||+|++. +++ .||+|.+... .....+++.+|++++++++||||+++++++...+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357888999999999999999974 344 3577777544 3445678999999999999999999999998765 78
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+|+||+++|+|.+++.... ..+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 93 ~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 9999999999999996542 36899999999999999999999997 9999999999999999999999999999
Q ss_pred ecCC
Q 003134 829 LYEE 832 (845)
Q Consensus 829 ~~~~ 832 (845)
.+..
T Consensus 166 ~~~~ 169 (327)
T 3lzb_A 166 LLGA 169 (327)
T ss_dssp ----
T ss_pred EccC
Confidence 8754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=7.2e-23 Score=222.26 Aligned_cols=148 Identities=29% Similarity=0.485 Sum_probs=124.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEE-----------
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV----------- 742 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~----------- 742 (845)
.++|...+.||+|+||.||+|.... ++.||+|++........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3578889999999999999999864 8999999997665556678999999999999999999999873
Q ss_pred ---eCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCc
Q 003134 743 ---EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLN 818 (845)
Q Consensus 743 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld-~~~~ 818 (845)
..+..++||||++ |+|.+++.. ..+++.++..++.|++.||+|||+++ |+||||||+||+++ +++.
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCe
Confidence 3468899999998 599999853 25889999999999999999999997 99999999999997 5679
Q ss_pred EEEEeeccceecCC
Q 003134 819 AKISDFGLAKLYEE 832 (845)
Q Consensus 819 ~kl~DFGla~~~~~ 832 (845)
+||+|||+++....
T Consensus 160 ~kl~Dfg~~~~~~~ 173 (320)
T 2i6l_A 160 LKIGDFGLARIMDP 173 (320)
T ss_dssp EEECCCTTCBCC--
T ss_pred EEEccCccccccCC
Confidence 99999999997753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.6e-23 Score=223.36 Aligned_cols=150 Identities=33% Similarity=0.552 Sum_probs=124.9
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
++|+..+.||+|+||.||+|++. ++.||+|++... ...+.|.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 46778899999999999999985 788999999653 34578999999999999999999999876 44799999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc-EEEEeeccceecCC
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-AKISDFGLAKLYEE 832 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~-~kl~DFGla~~~~~ 832 (845)
+|+|.+++..... ...+++.+++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++....
T Consensus 83 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 83 GGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999976432 235789999999999999999999943335999999999999998886 79999999987643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.8e-23 Score=219.44 Aligned_cols=158 Identities=28% Similarity=0.479 Sum_probs=131.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe--CCEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l 749 (845)
.++|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999986 58999999997542 2335678999999999999999999998864 578999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS--RIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
||||+++|+|.+++..... ....+++.++..++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||++
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999999999999965321 2235899999999999999999999975 123999999999999999999999999999
Q ss_pred eecCCC
Q 003134 828 KLYEED 833 (845)
Q Consensus 828 ~~~~~~ 833 (845)
+.....
T Consensus 164 ~~~~~~ 169 (279)
T 2w5a_A 164 RILNHD 169 (279)
T ss_dssp HHC---
T ss_pred eeeccc
Confidence 876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=217.88 Aligned_cols=146 Identities=25% Similarity=0.345 Sum_probs=127.1
Q ss_pred cCCCCC-CcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHH-hcCCCCceeeEEEEEEe----CCEEE
Q 003134 676 NNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMI-SAQQHPNLVKLYGCCVE----GNQLL 748 (845)
Q Consensus 676 ~~y~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~~ 748 (845)
++|... +.||+|+||.||+|... +++.||+|+++. ...+.+|++++ +..+||||+++++++.. .+..+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456665 77999999999999975 589999999854 35677888887 56699999999999987 67789
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCcEEEEeec
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFG 825 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~---~~~~kl~DFG 825 (845)
+||||+++|+|.+++..... ..+++.++..++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999999999975422 36899999999999999999999997 999999999999998 7899999999
Q ss_pred cceecCC
Q 003134 826 LAKLYEE 832 (845)
Q Consensus 826 la~~~~~ 832 (845)
+|+....
T Consensus 166 ~a~~~~~ 172 (299)
T 3m2w_A 166 FAKETTG 172 (299)
T ss_dssp TCEECTT
T ss_pred ccccccc
Confidence 9988754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.3e-23 Score=219.95 Aligned_cols=149 Identities=32% Similarity=0.510 Sum_probs=125.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeC-CEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-NQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~Ey 753 (845)
.++|+..+.||+|+||.||+|... ++.||+|+++.. ...+.+.+|++++++++||||+++++++... +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 357888999999999999999884 889999999754 3457899999999999999999999997655 478999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
+++|+|.+++.... ...+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 97 MAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999996432 224889999999999999999999987 99999999999999999999999999987643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=226.29 Aligned_cols=147 Identities=25% Similarity=0.382 Sum_probs=124.6
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC------
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------ 745 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 745 (845)
.++|+..+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357889999999999999999975 58999999986532 233467889999999999999999999997654
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
..++||||+++ +|.+.+.. .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEee
Confidence 78999999985 68877742 4889999999999999999999997 9999999999999999999999999
Q ss_pred cceecCC
Q 003134 826 LAKLYEE 832 (845)
Q Consensus 826 la~~~~~ 832 (845)
+|+....
T Consensus 173 ~a~~~~~ 179 (371)
T 2xrw_A 173 LARTAGT 179 (371)
T ss_dssp C------
T ss_pred ccccccc
Confidence 9987754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=4.8e-23 Score=229.03 Aligned_cols=148 Identities=30% Similarity=0.451 Sum_probs=115.4
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC------C
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------N 745 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 745 (845)
.++|+..+.||+|+||.||+|... +|+.||||++.... ....+++.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367889999999999999999975 58999999996542 23456788999999999999999999998754 5
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
..|+||||+ +++|.+++.. ..+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence 689999999 6799888853 26899999999999999999999987 9999999999999999999999999
Q ss_pred cceecCC
Q 003134 826 LAKLYEE 832 (845)
Q Consensus 826 la~~~~~ 832 (845)
+|+....
T Consensus 178 ~a~~~~~ 184 (367)
T 2fst_X 178 LARHTAD 184 (367)
T ss_dssp -------
T ss_pred ccccccc
Confidence 9987653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.1e-23 Score=224.59 Aligned_cols=154 Identities=28% Similarity=0.396 Sum_probs=132.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCC-CCceeeEEEEEEe--------C
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVE--------G 744 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--------~ 744 (845)
..+|+..+.||+|+||.||+|++. +++.||+|++........+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 346888999999999999999975 58999999986665555678899999999996 9999999999953 3
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
...++||||+. |+|.+++.... ....+++.+++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 45899999996 68998885421 1236899999999999999999999874 34999999999999999999999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|+++....
T Consensus 183 g~~~~~~~ 190 (337)
T 3ll6_A 183 GSATTISH 190 (337)
T ss_dssp TTCBCCSS
T ss_pred ccceeccc
Confidence 99988754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-22 Score=244.89 Aligned_cols=148 Identities=21% Similarity=0.376 Sum_probs=128.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC--CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCE-----
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ----- 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 746 (845)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367999999999999999999985 58999999986542 2345678899999999999999999999987654
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.|+||||+++++|.+++.. .+++.+++.|+.||+.||+|||+++ |+||||||+|||++.+ .+||+|||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence 7999999999999887632 5899999999999999999999997 9999999999999876 899999999
Q ss_pred ceecCCC
Q 003134 827 AKLYEED 833 (845)
Q Consensus 827 a~~~~~~ 833 (845)
++.....
T Consensus 228 a~~~~~~ 234 (681)
T 2pzi_A 228 VSRINSF 234 (681)
T ss_dssp CEETTCC
T ss_pred chhcccC
Confidence 9987643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.3e-23 Score=228.98 Aligned_cols=146 Identities=17% Similarity=0.266 Sum_probs=127.6
Q ss_pred cCCCCCCcccccCcEEEEEEEECC---------CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceee----------
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD---------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK---------- 736 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~---------- 736 (845)
++|...+.||+|+||.||+|+... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578889999999999999999763 789999998653 46789999999999999887
Q ss_pred -----EEEEEEe-CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 003134 737 -----LYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 810 (845)
Q Consensus 737 -----l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~N 810 (845)
+++++.. ++..++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+++ |+||||||+|
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 6788876 68899999999 999999996542 246999999999999999999999997 9999999999
Q ss_pred EEecCCC--cEEEEeeccceecCCC
Q 003134 811 VLLDKDL--NAKISDFGLAKLYEED 833 (845)
Q Consensus 811 ILld~~~--~~kl~DFGla~~~~~~ 833 (845)
||++.++ .+||+|||+|+.+...
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~ 214 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPS 214 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGG
T ss_pred EEEcCCCCceEEEecCcceeeccCC
Confidence 9999998 8999999999887543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=223.21 Aligned_cols=148 Identities=25% Similarity=0.454 Sum_probs=130.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----CEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 747 (845)
.++|...+.||+|+||.||+|+.. +++.||||++.... .....++.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467889999999999999999986 58999999996542 23346788999999999999999999998754 678
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||++ |+|.+++.. ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 90 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence 99999998 589988854 25899999999999999999999997 999999999999999999999999999
Q ss_pred eecCC
Q 003134 828 KLYEE 832 (845)
Q Consensus 828 ~~~~~ 832 (845)
+.+..
T Consensus 160 ~~~~~ 164 (353)
T 2b9h_A 160 RIIDE 164 (353)
T ss_dssp EECC-
T ss_pred ccccc
Confidence 98754
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=7.8e-22 Score=213.85 Aligned_cols=191 Identities=18% Similarity=0.288 Sum_probs=122.4
Q ss_pred ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEee
Q 003134 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219 (845)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 219 (845)
+|++|++++|+++.. | .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++. ..+.++++|++|+|+
T Consensus 42 ~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 42 GITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLT 115 (308)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECT
T ss_pred CcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECC
Confidence 555555555555532 2 35555555555555555553322 55555555555555555532 235555555555555
Q ss_pred cCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCc
Q 003134 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP 299 (845)
Q Consensus 220 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p 299 (845)
+|++++. +. +..+++|++|+|++|++++..+ +..++ +|+.|+|++|++++..+
T Consensus 116 ~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~-----------------------~L~~L~l~~n~l~~~~~ 168 (308)
T 1h6u_A 116 STQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLT-----------------------NLQYLSIGNAQVSDLTP 168 (308)
T ss_dssp TSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCT-----------------------TCCEEECCSSCCCCCGG
T ss_pred CCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCC-----------------------CccEEEccCCcCCCChh
Confidence 5555532 22 5555555555555555554332 44444 55666777777776444
Q ss_pred ccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcCC
Q 003134 300 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWE 367 (845)
Q Consensus 300 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~ 367 (845)
+..+++|+.|+|++|++++..+ +..+++|++|+|++|++++..|-.-..+|+.|++++|.+++.
T Consensus 169 --l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 169 --LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp --GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEEEEEECC
T ss_pred --hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccccccCCCCCCEEEccCCeeecC
Confidence 8899999999999999996554 899999999999999999766533356899999999988753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=228.20 Aligned_cols=149 Identities=28% Similarity=0.417 Sum_probs=122.8
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC------EEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------QLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~l 749 (845)
.+|...+.||+|+||.||+|+...+..||+|++...... ..+|+++++.++||||+++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 468889999999999999999987777999988543222 236999999999999999999997543 3889
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCcEEEEeeccce
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAK 828 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld-~~~~~kl~DFGla~ 828 (845)
||||++++.+....+.. .....+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 116 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYA--KLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEECCSEEHHHHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EeeccCccHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999876444333211 12346899999999999999999999997 99999999999999 79999999999999
Q ss_pred ecCCC
Q 003134 829 LYEED 833 (845)
Q Consensus 829 ~~~~~ 833 (845)
.+...
T Consensus 191 ~~~~~ 195 (394)
T 4e7w_A 191 ILIAG 195 (394)
T ss_dssp ECCTT
T ss_pred cccCC
Confidence 87543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.9e-23 Score=218.30 Aligned_cols=151 Identities=26% Similarity=0.478 Sum_probs=123.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC--CCc--EEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS--DGT--VIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
++|+..+.||+|+||.||+|++. +++ .||+|+++... ....+++.+|++++++++||||+++++++...+ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56888999999999999999863 233 68999987642 234568899999999999999999999998765 88
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+||||+++|+|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 97 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 999999999999999643 235899999999999999999999997 9999999999999999999999999999
Q ss_pred ecCCCC
Q 003134 829 LYEEDK 834 (845)
Q Consensus 829 ~~~~~~ 834 (845)
......
T Consensus 170 ~~~~~~ 175 (291)
T 1u46_A 170 ALPQND 175 (291)
T ss_dssp ECCC-C
T ss_pred cccccc
Confidence 886543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.1e-22 Score=220.07 Aligned_cols=237 Identities=14% Similarity=0.100 Sum_probs=141.8
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcc-cccccccccce-eEeec
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFP-KVLTNITTLKN-LSIEG 172 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~Ls~ 172 (845)
+++.++++|+ .+|..+ .++|++|+|++|+|+.+.+.+|..+ +|++|+|++|++.+.+| ..|.++++|++ +.++.
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 4677888888 567666 3578888888888876666666666 66666666666655443 34566665543 44455
Q ss_pred ccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeec-CcCcccCchhhcCCc-ccceEEecCCcCCCC
Q 003134 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD-NNFSGKIPEFIGKWK-KIQKLHIQGSSLEGP 250 (845)
Q Consensus 173 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~g~ 250 (845)
|+|+...|..|..+++|++|++++|+|++..+..+....++..|++.+ |+++...+..|..+. .++.|+|++|+|+
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-- 167 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-- 167 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC--
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc--
Confidence 666655555666666666666666666654444455555555566543 445544444444443 3555555555555
Q ss_pred cchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccC-CcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcC
Q 003134 251 IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTK-CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329 (845)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 329 (845)
.++...+...+|+.|++++ |.++.+.+..|.++++|+.|||++|+|+...+..|.
T Consensus 168 ----------------------~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~-- 223 (350)
T 4ay9_X 168 ----------------------EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE-- 223 (350)
T ss_dssp ----------------------EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT--
T ss_pred ----------------------CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc--
Confidence 3333333334566677764 566655556788888888888888888855444444
Q ss_pred CCcCEEEccCCcccCCCCh-hhhcCCceEEeecC
Q 003134 330 AKTNFMYLTGNKLTGPVPK-YIFNSNKNVDISLN 362 (845)
Q Consensus 330 ~~L~~L~L~~N~l~g~ip~-~~~~~l~~L~ls~N 362 (845)
+|+.|.+.++.--..+|. .-+.+|+.++++++
T Consensus 224 -~L~~L~~l~~~~l~~lP~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 224 -NLKKLRARSTYNLKKLPTLEKLVALMEASLTYP 256 (350)
T ss_dssp -TCCEEECTTCTTCCCCCCTTTCCSCCEEECSCH
T ss_pred -cchHhhhccCCCcCcCCCchhCcChhhCcCCCC
Confidence 445555433332335553 22457788887654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-22 Score=226.57 Aligned_cols=149 Identities=28% Similarity=0.484 Sum_probs=116.6
Q ss_pred CCC-CCcccccCcEEEEEEEEC---CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEe--CCEEEEEE
Q 003134 678 FDP-ANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVY 751 (845)
Q Consensus 678 y~~-~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ 751 (845)
|+. .++||+|+||.||+|+.. +++.||+|++... ...+.+.+|++++++++||||+++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 458999999999999975 4789999999754 234578899999999999999999999965 67899999
Q ss_pred eccCCCChhhhhhcCCc----ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----cCCCcEEEEe
Q 003134 752 EYMKNNCLSRAIFGKDT----EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISD 823 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl----d~~~~~kl~D 823 (845)
||+++ +|.+++..... .....+++..++.|+.||+.||+|||+++ |+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99975 78777743211 11235899999999999999999999997 9999999999999 7789999999
Q ss_pred eccceecCC
Q 003134 824 FGLAKLYEE 832 (845)
Q Consensus 824 FGla~~~~~ 832 (845)
||+|+.+..
T Consensus 176 fg~a~~~~~ 184 (405)
T 3rgf_A 176 MGFARLFNS 184 (405)
T ss_dssp TTCCC----
T ss_pred CCCceecCC
Confidence 999998754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=242.41 Aligned_cols=154 Identities=27% Similarity=0.439 Sum_probs=132.3
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEECC----CcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 747 (845)
...++|+..+.||+|+||.||+|.+.. +..||+|.++... ....+.+.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 345678888999999999999999742 5679999987643 233468999999999999999999999984 5668
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccc
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 827 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla 827 (845)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 99999999999999996432 35899999999999999999999987 999999999999999999999999999
Q ss_pred eecCCCC
Q 003134 828 KLYEEDK 834 (845)
Q Consensus 828 ~~~~~~~ 834 (845)
+......
T Consensus 539 ~~~~~~~ 545 (656)
T 2j0j_A 539 RYMEDST 545 (656)
T ss_dssp CSCCC--
T ss_pred eecCCCc
Confidence 9875443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.3e-22 Score=220.82 Aligned_cols=225 Identities=17% Similarity=0.116 Sum_probs=144.1
Q ss_pred CEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCc-ccccCCCccE-EEeec
Q 003134 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPP-DIRKLINLQK-LILSS 196 (845)
Q Consensus 119 ~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~-L~Ls~ 196 (845)
++++.++|+++.++ ..+ ..++++|+|++|+|+.+.+..|.++++|++|+|++|++.+.+|. .|.++++|++ +++++
T Consensus 12 ~~v~C~~~~Lt~iP-~~l-~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 12 RVFLCQESKVTEIP-SDL-PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp TEEEEESTTCCSCC-TTC-CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred CEEEecCCCCCccC-cCc-CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 45677777777443 222 11566666666666655555566666666666666666544443 4555655543 44455
Q ss_pred CcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecC-CcCCCCcchhhhcCCCCCEEEcCCCCCCCCC
Q 003134 197 NSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQG-SSLEGPIPASISALTSLTDLRISDLKGSESA 275 (845)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~ 275 (845)
|+|+...|..|.++++|++|++++|+|++..+..+....++..|++.+ |++....+..|..+.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~---------------- 153 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS---------------- 153 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB----------------
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc----------------
Confidence 666655555566666666666666666655444555555555555543 334432222222221
Q ss_pred CcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCC-CCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCC
Q 003134 276 FPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSF-NNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSN 354 (845)
Q Consensus 276 ~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l 354 (845)
..++.|+|++|+|+.+.+..| ...+|+.|++++ |+++...+..|.++++|++|+|++|+|+ .+|...+..+
T Consensus 154 ------~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~~~L 225 (350)
T 4ay9_X 154 ------FESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENL 225 (350)
T ss_dssp ------SSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCSSSCTTC
T ss_pred ------hhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccChhhhccc
Confidence 157888999999996655555 457899999985 6777555578999999999999999999 6787778889
Q ss_pred ceEEeecCCCcCCCC
Q 003134 355 KNVDISLNNFTWESS 369 (845)
Q Consensus 355 ~~L~ls~N~l~~~~p 369 (845)
+.|.+.+++-...+|
T Consensus 226 ~~L~~l~~~~l~~lP 240 (350)
T 4ay9_X 226 KKLRARSTYNLKKLP 240 (350)
T ss_dssp CEEECTTCTTCCCCC
T ss_pred hHhhhccCCCcCcCC
Confidence 999887776555555
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-22 Score=233.70 Aligned_cols=221 Identities=19% Similarity=0.195 Sum_probs=138.3
Q ss_pred CCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeec
Q 003134 117 YLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSS 196 (845)
Q Consensus 117 ~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 196 (845)
+|+.|+|++|+|++ +|..+. .+|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. |.+ +|++|+|++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~-~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~ 129 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP-PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDN 129 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC-TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCS
T ss_pred CccEEEeCCCCCCc-cCHhHc-CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCC
Confidence 78999999999998 444332 47888999999888 455 447888889999988886 666 655 888888888
Q ss_pred CcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCC
Q 003134 197 NSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 276 (845)
Q Consensus 197 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~ 276 (845)
|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|.++..+.
T Consensus 130 N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~ 197 (571)
T 3cvr_A 130 NQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA 197 (571)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC
T ss_pred CcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh
Confidence 88886 665 57888888888888886 555 56788888888888886 555 54 666666666555553332
Q ss_pred cccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhc----
Q 003134 277 PKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN---- 352 (845)
Q Consensus 277 ~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~---- 352 (845)
+.. +| +.....|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..
T Consensus 198 --~~~-~L-----------------~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~ 256 (571)
T 3cvr_A 198 --VPV-RN-----------------HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ 256 (571)
T ss_dssp --CC--------------------------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHHS
T ss_pred --HHH-hh-----------------hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhcC
Confidence 211 23 000111266666666666 45555555666666666666666655555422
Q ss_pred -----CCceEEeecCCCcCCCCCCCCCCCCCceee
Q 003134 353 -----SNKNVDISLNNFTWESSDPIECPRGSVNLV 382 (845)
Q Consensus 353 -----~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l 382 (845)
....++++.|++.... .| .|+|...|+.
T Consensus 257 ~~~~~~~~~~~l~~~~~~~~~-~p-~~~~~~~Wl~ 289 (571)
T 3cvr_A 257 PDYHGPRIYFSMSDGQQNTLH-RP-LADAVTAWFP 289 (571)
T ss_dssp CC---CEEECCC-----------C-CSHHHHTTCC
T ss_pred ccccCCeeEEeeccccccccc-cc-chhhHHHHhh
Confidence 1112344555444332 24 6887666554
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=220.09 Aligned_cols=152 Identities=28% Similarity=0.532 Sum_probs=128.5
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC--CCcEEEEEEcCcccc--cchHHHHHHHHHHhcC---CCCceeeEEEEEE----
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQ---QHPNLVKLYGCCV---- 742 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~---- 742 (845)
+.++|+..+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999983 588999999865432 2234566777777665 8999999999987
Q ss_pred -eCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEE
Q 003134 743 -EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821 (845)
Q Consensus 743 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl 821 (845)
.....++||||++ |+|.+++..... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEE
Confidence 4567899999998 699999865422 25899999999999999999999997 999999999999999999999
Q ss_pred EeeccceecCC
Q 003134 822 SDFGLAKLYEE 832 (845)
Q Consensus 822 ~DFGla~~~~~ 832 (845)
+|||+++....
T Consensus 162 ~Dfg~~~~~~~ 172 (326)
T 1blx_A 162 ADFGLARIYSF 172 (326)
T ss_dssp CSCCSCCCCCG
T ss_pred ecCcccccccC
Confidence 99999987653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-22 Score=214.37 Aligned_cols=150 Identities=26% Similarity=0.398 Sum_probs=125.4
Q ss_pred HhcCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEE-EeCCEEEEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-VEGNQLLLVY 751 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lV~ 751 (845)
..++|+..+.||+|+||.||+|+. .+++.||+|++..... .+++.+|++++++++|++++..++++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999997 4689999998754422 24578899999999988877766655 6778899999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---cCCCcEEEEeeccce
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAK 828 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl---d~~~~~kl~DFGla~ 828 (845)
||+ +++|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||+ ++++.+||+|||+|+
T Consensus 85 e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp ECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred Ecc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 999 999999986432 36899999999999999999999997 9999999999999 788999999999999
Q ss_pred ecCCC
Q 003134 829 LYEED 833 (845)
Q Consensus 829 ~~~~~ 833 (845)
.....
T Consensus 157 ~~~~~ 161 (296)
T 4hgt_A 157 KYRDA 161 (296)
T ss_dssp ECBCT
T ss_pred eccCc
Confidence 87654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.7e-23 Score=222.72 Aligned_cols=154 Identities=30% Similarity=0.414 Sum_probs=130.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEE------CCCcEEEEEEcCcc-cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 747 (845)
.++|...+.||+|+||.||+|++ .+++.||||.+... ......++.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788999999999999999984 24778999999754 234456889999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCcc--cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCcEEEE
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTE--YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKIS 822 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~---~~~~kl~ 822 (845)
++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+++ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999754321 1235899999999999999999999997 999999999999984 4469999
Q ss_pred eeccceecC
Q 003134 823 DFGLAKLYE 831 (845)
Q Consensus 823 DFGla~~~~ 831 (845)
|||+++...
T Consensus 186 Dfg~~~~~~ 194 (327)
T 2yfx_A 186 DFGMARDIY 194 (327)
T ss_dssp CCHHHHHHH
T ss_pred ccccccccc
Confidence 999998654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.4e-22 Score=213.18 Aligned_cols=152 Identities=26% Similarity=0.473 Sum_probs=134.4
Q ss_pred HhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 674 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 674 ~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
..++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999986 68999999986543 34467899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC---CcEEEEeeccc
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISDFGLA 827 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~---~~~kl~DFGla 827 (845)
|||+++++|.+.+... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.+ +.+||+|||++
T Consensus 100 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999888542 36899999999999999999999997 9999999999999754 47999999999
Q ss_pred eecCCC
Q 003134 828 KLYEED 833 (845)
Q Consensus 828 ~~~~~~ 833 (845)
+.....
T Consensus 172 ~~~~~~ 177 (287)
T 2wei_A 172 TCFQQN 177 (287)
T ss_dssp GTBCCC
T ss_pred eeecCC
Confidence 877543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=219.69 Aligned_cols=153 Identities=25% Similarity=0.450 Sum_probs=126.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHH-HHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|...+.||+|+||.||+|... +++.||||+++... .....++..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57888999999999999999985 68999999997643 223345566665 7778899999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|+++ +|.+++..........+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++.+.
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9986 787777532111234689999999999999999999997 6 9999999999999999999999999998775
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 178 ~ 178 (327)
T 3aln_A 178 D 178 (327)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.8e-22 Score=226.54 Aligned_cols=150 Identities=22% Similarity=0.348 Sum_probs=129.6
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcC------CCCceeeEEEEEEeCCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ------QHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~~~~~~~~~~ 747 (845)
..+|+..+.||+|+||.||+|... +++.||||+++.. ....+++.+|++++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457889999999999999999976 4899999999754 23345677888888776 677999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc--EEEEeec
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN--AKISDFG 825 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~--~kl~DFG 825 (845)
++||||+. ++|.+++..... ..+++..+..|+.||+.||+|||+++ |+||||||+|||++.++. +||+|||
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999996 589998865432 25899999999999999999999997 999999999999999887 9999999
Q ss_pred cceecCC
Q 003134 826 LAKLYEE 832 (845)
Q Consensus 826 la~~~~~ 832 (845)
+|+....
T Consensus 248 ~a~~~~~ 254 (429)
T 3kvw_A 248 SSCYEHQ 254 (429)
T ss_dssp TCEETTC
T ss_pred cceecCC
Confidence 9987643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=228.39 Aligned_cols=149 Identities=30% Similarity=0.429 Sum_probs=122.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeC----C--EEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG----N--QLL 748 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----~--~~~ 748 (845)
.+|+..+.||+|+||.||+|++. +++.||||++.... +.+.+|++++++++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35778899999999999999986 58999999986542 2234699999999999999999998642 2 367
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-CcEEEEeeccc
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLA 827 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~-~~~kl~DFGla 827 (845)
+||||+++ +|.+.+.... .....+++..+..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 130 lv~e~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEECCCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eehhcccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 99999986 5666553211 12346899999999999999999999987 9999999999999965 57899999999
Q ss_pred eecCCC
Q 003134 828 KLYEED 833 (845)
Q Consensus 828 ~~~~~~ 833 (845)
+.+...
T Consensus 205 ~~~~~~ 210 (420)
T 1j1b_A 205 KQLVRG 210 (420)
T ss_dssp EECCTT
T ss_pred hhcccC
Confidence 987543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=5.8e-22 Score=212.88 Aligned_cols=150 Identities=26% Similarity=0.395 Sum_probs=128.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEE-CCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEE-EeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-VEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lV~E 752 (845)
.++|+..+.||+|+||.||+|+. .+++.||+|++.... ..+++.+|++++++++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788999999999999999997 469999999986543 235688999999999988866666555 56788999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---cCCCcEEEEeecccee
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKL 829 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl---d~~~~~kl~DFGla~~ 829 (845)
|+ +++|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||+ ++++.+||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 99 899999996432 36899999999999999999999997 9999999999999 5889999999999998
Q ss_pred cCCCC
Q 003134 830 YEEDK 834 (845)
Q Consensus 830 ~~~~~ 834 (845)
.....
T Consensus 158 ~~~~~ 162 (296)
T 3uzp_A 158 YRDAR 162 (296)
T ss_dssp CBCTT
T ss_pred ccccc
Confidence 76543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-22 Score=219.86 Aligned_cols=154 Identities=25% Similarity=0.366 Sum_probs=125.0
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccccc------chHHHHHHHHHHhcC----CCCceeeEEEE
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQ----QHPNLVKLYGC 740 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~nIv~l~~~ 740 (845)
....++|...+.||+|+||.||+|+.. +++.||+|+++..... ....+.+|++++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 444678999999999999999999874 5889999999764321 223456788888888 89999999999
Q ss_pred EEeCCEEEEEEec-cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCc
Q 003134 741 CVEGNQLLLVYEY-MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLN 818 (845)
Q Consensus 741 ~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld-~~~~ 818 (845)
+...+..++|||| +.+++|.+++... ..+++.++..++.|+++||+|||+++ |+||||||+||+++ .++.
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 9999999999999 7899999999542 36899999999999999999999997 99999999999999 8899
Q ss_pred EEEEeeccceecCCC
Q 003134 819 AKISDFGLAKLYEED 833 (845)
Q Consensus 819 ~kl~DFGla~~~~~~ 833 (845)
+||+|||+++.....
T Consensus 179 ~kl~dfg~~~~~~~~ 193 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE 193 (312)
T ss_dssp EEECCCSSCEECCSS
T ss_pred EEEEEcchhhhcccC
Confidence 999999999987643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.86 E-value=1e-21 Score=225.50 Aligned_cols=150 Identities=27% Similarity=0.394 Sum_probs=129.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCC-CceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|++.++||+|+||.||+|++. +++.||||++..... ..++..|++++..++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 367899999999999999999974 689999998765432 3457889999999987 566667777788899999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---cCCCcEEEEeecccee
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKL 829 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl---d~~~~~kl~DFGla~~ 829 (845)
|+ +++|.+++.... ..+++.+++.|+.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 84 ~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 99 999999996432 36899999999999999999999997 9999999999999 6889999999999998
Q ss_pred cCCCC
Q 003134 830 YEEDK 834 (845)
Q Consensus 830 ~~~~~ 834 (845)
+....
T Consensus 156 ~~~~~ 160 (483)
T 3sv0_A 156 YRDTS 160 (483)
T ss_dssp CBCTT
T ss_pred ccCCc
Confidence 86543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-22 Score=223.83 Aligned_cols=148 Identities=11% Similarity=0.058 Sum_probs=112.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHH---HHHhcCCCCceeeEE-------EEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEI---GMISAQQHPNLVKLY-------GCC 741 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~H~nIv~l~-------~~~ 741 (845)
.+|...+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+ ++|+. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45788899999999999999975 689999999977532 2345677784 45555 799988755 555
Q ss_pred EeC-----------------CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHH------HHHHHHHHHHHHHHHhCCC
Q 003134 742 VEG-----------------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR------KKICIGIARGLAYLHEDSR 798 (845)
Q Consensus 742 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~~~ 798 (845)
... ...|+||||++ |+|.+++.... ..+++..+ ..++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQSKG- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-
Confidence 433 34899999999 89999996532 24455666 788899999999999997
Q ss_pred CCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 799 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 799 ~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+||||||+|||++.++.+||+|||+|+....
T Consensus 215 --ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~ 246 (371)
T 3q60_A 215 --LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246 (371)
T ss_dssp --EEETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred --CccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence 99999999999999999999999999997753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.2e-22 Score=224.19 Aligned_cols=135 Identities=26% Similarity=0.412 Sum_probs=113.4
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCC--------CCceeeEEEEEE---
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ--------HPNLVKLYGCCV--- 742 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~~~~~--- 742 (845)
.++|++.++||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 367889999999999999999975 5889999999754 334567889999999885 788999999988
Q ss_pred -eCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCC
Q 003134 743 -EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDL 817 (845)
Q Consensus 743 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivHrDLKp~NILld~~~ 817 (845)
.....++||||+ +++|.+.+.... ...+++.+++.|+.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 456789999999 556666654332 13689999999999999999999998 6 99999999999999775
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.8e-22 Score=223.24 Aligned_cols=147 Identities=27% Similarity=0.453 Sum_probs=125.6
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE----
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL---- 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~---- 747 (845)
.++|...+.||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357888999999999999999975 58999999997642 22356788999999999999999999999876654
Q ss_pred --EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 748 --LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 748 --~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
++||||++ ++|.+.+.. .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999998 588877732 4899999999999999999999997 9999999999999999999999999
Q ss_pred cceecCC
Q 003134 826 LAKLYEE 832 (845)
Q Consensus 826 la~~~~~ 832 (845)
+|+....
T Consensus 190 ~a~~~~~ 196 (371)
T 4exu_A 190 LARHADA 196 (371)
T ss_dssp CC-----
T ss_pred ccccccc
Confidence 9987653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=9.1e-23 Score=221.42 Aligned_cols=158 Identities=22% Similarity=0.342 Sum_probs=133.0
Q ss_pred ccHHHHHHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCccc--ccchHHHHHHHHHHhcCC--CCceeeEEEEE
Q 003134 666 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQ--HPNLVKLYGCC 741 (845)
Q Consensus 666 ~~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~ 741 (845)
+.++.+....++|+..+.||+|+||.||+|...+++.||+|++.... ....+.+.+|++++.+++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 33444444567799999999999999999999889999999986542 334568899999999997 59999999999
Q ss_pred EeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEE
Q 003134 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821 (845)
Q Consensus 742 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl 821 (845)
...+..++||| +.+++|.+++... ..+++.++..++.|+++||+|||+++ |+||||||+|||+++ +.+||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEE
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEE
Confidence 99999999999 5688999999643 36899999999999999999999997 999999999999964 89999
Q ss_pred EeeccceecCCC
Q 003134 822 SDFGLAKLYEED 833 (845)
Q Consensus 822 ~DFGla~~~~~~ 833 (845)
+|||+++.+...
T Consensus 168 ~Dfg~~~~~~~~ 179 (313)
T 3cek_A 168 IDFGIANQMQPD 179 (313)
T ss_dssp CCCSSSCC----
T ss_pred eeccccccccCc
Confidence 999999987543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.86 E-value=3.7e-22 Score=220.86 Aligned_cols=160 Identities=25% Similarity=0.361 Sum_probs=120.4
Q ss_pred HHHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCE-
Q 003134 669 RQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ- 746 (845)
Q Consensus 669 ~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~- 746 (845)
.+.....++|+..+.||+|+||.||+|+.. +++.||||++.... ....++.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667789999999999999999999985 58999999986542 333466778888899999999999999976433
Q ss_pred ------EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeCCCCCCCEEecC-CC
Q 003134 747 ------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH--EDSRIKIVHRDIKTSNVLLDK-DL 817 (845)
Q Consensus 747 ------~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--~~~~~~ivHrDLKp~NILld~-~~ 817 (845)
.++||||+++ +|.+.+.... .....+++..+..++.|++.||+||| +.+ |+||||||+|||++. ++
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred cccceeEEEEeecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 8899999987 4544443211 12246889999999999999999999 765 999999999999996 89
Q ss_pred cEEEEeeccceecCCCC
Q 003134 818 NAKISDFGLAKLYEEDK 834 (845)
Q Consensus 818 ~~kl~DFGla~~~~~~~ 834 (845)
.+||+|||+|+.+....
T Consensus 170 ~~kl~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE 186 (360)
T ss_dssp EEEECCCTTCBCCCTTS
T ss_pred cEEEeeCCCceecCCCC
Confidence 99999999999876443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.9e-22 Score=215.77 Aligned_cols=150 Identities=22% Similarity=0.374 Sum_probs=130.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEE-C-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCC------ceeeEEEEEEeCCE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL-S-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP------NLVKLYGCCVEGNQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------nIv~l~~~~~~~~~ 746 (845)
.++|+..+.||+|+||.||+|.. . +++.||+|+++.. ....+.+.+|+++++.++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45788999999999999999997 3 5889999999754 23356788899999888665 49999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-----------
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK----------- 815 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~----------- 815 (845)
.++||||+ +++|.+++..... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred EEEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999 8899999865422 36899999999999999999999997 999999999999987
Q ss_pred --------CCcEEEEeeccceecCC
Q 003134 816 --------DLNAKISDFGLAKLYEE 832 (845)
Q Consensus 816 --------~~~~kl~DFGla~~~~~ 832 (845)
++.+||+|||+|+....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTS
T ss_pred ccccccccCCCceEeeCcccccCcc
Confidence 67899999999997654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-22 Score=218.86 Aligned_cols=150 Identities=25% Similarity=0.492 Sum_probs=127.8
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
....++|+..+.||+|+||.||+|+... .+|+|+++... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3345678899999999999999999853 48999987542 2334567889999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++++|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+||+++ ++.+||+|||+++.
T Consensus 107 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp ECBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EeecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999996532 36899999999999999999999997 99999999999998 67999999999886
Q ss_pred cC
Q 003134 830 YE 831 (845)
Q Consensus 830 ~~ 831 (845)
..
T Consensus 179 ~~ 180 (319)
T 2y4i_B 179 SG 180 (319)
T ss_dssp --
T ss_pred cc
Confidence 53
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=4e-22 Score=220.29 Aligned_cols=146 Identities=27% Similarity=0.454 Sum_probs=126.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCE------
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ------ 746 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------ 746 (845)
++|...+.||+|+||.||+|+.. +|+.||||++.... ....+++.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57888999999999999999975 58999999997542 2234678899999999999999999999987653
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.++||||++ |+|.+++.. .+++.++..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 104 ~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred EEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 599999998 588877632 4899999999999999999999997 99999999999999999999999999
Q ss_pred ceecCC
Q 003134 827 AKLYEE 832 (845)
Q Consensus 827 a~~~~~ 832 (845)
++....
T Consensus 173 ~~~~~~ 178 (353)
T 3coi_A 173 ARHADA 178 (353)
T ss_dssp TTC---
T ss_pred ccCCCC
Confidence 987643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=3.7e-22 Score=217.51 Aligned_cols=153 Identities=22% Similarity=0.367 Sum_probs=132.8
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccccc------chHHHHHHHHHHhcCC--CCceeeEEEEEE
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQQ--HPNLVKLYGCCV 742 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~~~~~ 742 (845)
....++|+..+.||+|+||.||+|+.. +++.||||+++..... ..+.+.+|++++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344578999999999999999999974 6899999999765321 2345678999999996 599999999999
Q ss_pred eCCEEEEEEeccCC-CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCcEE
Q 003134 743 EGNQLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAK 820 (845)
Q Consensus 743 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld-~~~~~k 820 (845)
..+..++||||+.+ ++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence 99999999999986 8999998542 36899999999999999999999987 99999999999999 789999
Q ss_pred EEeeccceecCC
Q 003134 821 ISDFGLAKLYEE 832 (845)
Q Consensus 821 l~DFGla~~~~~ 832 (845)
|+|||+++....
T Consensus 191 L~Dfg~~~~~~~ 202 (320)
T 3a99_A 191 LIDFGSGALLKD 202 (320)
T ss_dssp ECCCTTCEECCS
T ss_pred EeeCcccccccc
Confidence 999999998754
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=5.9e-23 Score=225.05 Aligned_cols=233 Identities=19% Similarity=0.230 Sum_probs=190.8
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCC-Cccccccc-ceeEEEecCCCCCCCcccccccccccceeE
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGS-FSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLS 169 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~-~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 169 (845)
.+++.+++.+|.+.+..+. +..+++|++|+|++|.+++. ++..+..+ +|++|+|++|++++..+..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4688999999999987665 66899999999999999876 77778888 999999999999999999999999999999
Q ss_pred eecc-cCCCC-CCcccccCCCccEEEeecC-cCccc-CChhhhCCC-CCCcEEeecC--cCc-ccCchhhcCCcccceEE
Q 003134 170 IEGN-LFTGS-IPPDIRKLINLQKLILSSN-SFTGE-LPAELTKLT-NLNDLRISDN--NFS-GKIPEFIGKWKKIQKLH 241 (845)
Q Consensus 170 Ls~N-~l~g~-~p~~~~~l~~L~~L~Ls~N-~l~g~-~p~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~ 241 (845)
|++| .+++. ++..+.++++|++|+|++| ++++. ++..+..++ +|++|+|++| .++ +.+|..+..+++|++|+
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~ 228 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence 9999 78853 6667889999999999999 99865 677789999 9999999999 566 56788889999999999
Q ss_pred ecCCc-CCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCC
Q 003134 242 IQGSS-LEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320 (845)
Q Consensus 242 Ls~N~-l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 320 (845)
|++|. +++..+..+..+++|+.|++++|. .+.......+.++++|+.|+|++| ++.
T Consensus 229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~----------------------~~~~~~~~~l~~~~~L~~L~l~~~-i~~ 285 (336)
T 2ast_B 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCY----------------------DIIPETLLELGEIPTLKTLQVFGI-VPD 285 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTCT----------------------TCCGGGGGGGGGCTTCCEEECTTS-SCT
T ss_pred CCCCCcCCHHHHHHHhCCCCCCEeeCCCCC----------------------CCCHHHHHHHhcCCCCCEEeccCc-cCH
Confidence 99999 787888889998888888776663 111111224667888999999988 442
Q ss_pred CCchhhhcCC-CcCEEEccCCcccCCCChhhh
Q 003134 321 GIPTTFEKLA-KTNFMYLTGNKLTGPVPKYIF 351 (845)
Q Consensus 321 ~~p~~~~~l~-~L~~L~L~~N~l~g~ip~~~~ 351 (845)
. .+..+. +|+.|++++|++++..|..+.
T Consensus 286 ~---~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 286 G---TLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp T---CHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred H---HHHHHHhhCcceEEecccCccccCCccc
Confidence 2 333332 366667899999988887654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.2e-21 Score=196.38 Aligned_cols=150 Identities=24% Similarity=0.314 Sum_probs=78.3
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeeccc
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 174 (845)
.+++.+++++. +|..+ .++|++|+|++|++++..+..|..+ +|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 11 ~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 11 TVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp EEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 45666666663 44433 3567777777777766555545444 55555555555554444445555555555555555
Q ss_pred CCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCC
Q 003134 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 175 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 55444444455555555555555555444444445555555555555555444444444444444444444443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=8.4e-22 Score=224.10 Aligned_cols=150 Identities=26% Similarity=0.318 Sum_probs=120.4
Q ss_pred CCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 678 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+++..++||||++
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 4456789999999998777778999999998653 245678999999876 89999999999999999999999996
Q ss_pred CChhhhhhcCCcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC-------------CcEEE
Q 003134 757 NCLSRAIFGKDTEYR--LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-------------LNAKI 821 (845)
Q Consensus 757 gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~-------------~~~kl 821 (845)
|+|.+++........ ...++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 699999976432111 11244567889999999999999987 9999999999999754 48999
Q ss_pred EeeccceecCCCC
Q 003134 822 SDFGLAKLYEEDK 834 (845)
Q Consensus 822 ~DFGla~~~~~~~ 834 (845)
+|||+|+.+....
T Consensus 170 ~DFG~a~~~~~~~ 182 (434)
T 2rio_A 170 SDFGLCKKLDSGQ 182 (434)
T ss_dssp CCCTTCEECCC--
T ss_pred cccccceecCCCC
Confidence 9999999886543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-21 Score=212.35 Aligned_cols=148 Identities=24% Similarity=0.332 Sum_probs=120.7
Q ss_pred hcCCCCCC-cccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEe----CCEEE
Q 003134 675 TNNFDPAN-KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLL 748 (845)
Q Consensus 675 ~~~y~~~~-~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~ 748 (845)
.++|...+ .||+|+||.||+|+.. +++.||+|++.... +...+....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 45677744 6999999999999986 58999999986431 222223334566799999999999976 45689
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCcEEEEeec
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFG 825 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~---~~~~kl~DFG 825 (845)
+||||+++|+|.+++..... ..+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 103 lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 99999999999999975432 36899999999999999999999997 999999999999976 4559999999
Q ss_pred cceecCC
Q 003134 826 LAKLYEE 832 (845)
Q Consensus 826 la~~~~~ 832 (845)
+++....
T Consensus 177 ~~~~~~~ 183 (336)
T 3fhr_A 177 FAKETTQ 183 (336)
T ss_dssp TCEEC--
T ss_pred cceeccc
Confidence 9987754
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-21 Score=224.45 Aligned_cols=202 Identities=24% Similarity=0.350 Sum_probs=164.5
Q ss_pred ce-eecCCCCcceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCccccc
Q 003134 82 NV-TCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVL 159 (845)
Q Consensus 82 ~v-~C~~~~~~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~ 159 (845)
++ .|.+. +++.|+|++|+|++ +|..+. ++|++|+|++|+|+. +| ..+ +|++|+|++|+|++ +|. +
T Consensus 52 ~l~~C~~~----~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~-ip---~~l~~L~~L~Ls~N~l~~-ip~-l 118 (571)
T 3cvr_A 52 LLKECLIN----QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-LP---ELPASLEYLDACDNRLST-LPE-L 118 (571)
T ss_dssp HHHHHHHT----TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-C
T ss_pred hccccccC----CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcc-cc---cccCCCCEEEccCCCCCC-cch-h
Confidence 56 67643 78999999999997 787764 899999999999995 44 334 89999999999998 666 6
Q ss_pred ccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccce
Q 003134 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239 (845)
Q Consensus 160 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 239 (845)
.+ +|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|++
T Consensus 119 ~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~ 184 (571)
T 3cvr_A 119 PA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEA 184 (571)
T ss_dssp CT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCE
T ss_pred hc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCE
Confidence 65 99999999999997 676 68999999999999996 665 67899999999999997 677 66 89999
Q ss_pred EEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCC
Q 003134 240 LHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (845)
Q Consensus 240 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (845)
|+|++|+|+ .+|. |.. +|.. ....|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+
T Consensus 185 L~Ls~N~L~-~lp~-~~~--~L~~----------------~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~ 243 (571)
T 3cvr_A 185 LDVSTNLLE-SLPA-VPV--RNHH----------------SEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS 243 (571)
T ss_dssp EECCSSCCS-SCCC-CC--------------------------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCC
T ss_pred EECcCCCCC-chhh-HHH--hhhc----------------ccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCC
Confidence 999999999 5565 543 3300 0114677788888888 47777777999999999999999
Q ss_pred CCCchhhhcCCC
Q 003134 320 GGIPTTFEKLAK 331 (845)
Q Consensus 320 g~~p~~~~~l~~ 331 (845)
+.+|..|..+..
T Consensus 244 ~~~p~~l~~l~~ 255 (571)
T 3cvr_A 244 SRIRESLSQQTA 255 (571)
T ss_dssp HHHHHHHHHHHH
T ss_pred CcCHHHHHHhhc
Confidence 999998887644
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.9e-21 Score=196.67 Aligned_cols=95 Identities=20% Similarity=0.238 Sum_probs=41.0
Q ss_pred ccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEec
Q 003134 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ 243 (845)
Q Consensus 164 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 243 (845)
+|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 44444444444443333334444444444444444443333334444444444444444443333334444444444444
Q ss_pred CCcCCCCcchhhhcC
Q 003134 244 GSSLEGPIPASISAL 258 (845)
Q Consensus 244 ~N~l~g~~p~~~~~l 258 (845)
+|++++..+..|.++
T Consensus 109 ~N~l~~~~~~~~~~l 123 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKL 123 (208)
T ss_dssp SSCCCCCCTTTTTTC
T ss_pred CCcCcccCHhHhccC
Confidence 444443333333333
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-21 Score=222.98 Aligned_cols=147 Identities=26% Similarity=0.340 Sum_probs=121.5
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.+|...+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+.+..|+||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 45778899999999997665566799999999965432 2356799999999 8999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-----CCcEEEEeecccee
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLAKL 829 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~-----~~~~kl~DFGla~~ 829 (845)
+ |+|.+++..... ...+.++..++.||+.||+|||+++ |+||||||+|||++. ...+||+|||+|+.
T Consensus 101 ~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 101 A-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp S-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred C-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 7 599999975432 3455577899999999999999997 999999999999943 34688999999998
Q ss_pred cCCC
Q 003134 830 YEED 833 (845)
Q Consensus 830 ~~~~ 833 (845)
....
T Consensus 173 ~~~~ 176 (432)
T 3p23_A 173 LAVG 176 (432)
T ss_dssp C---
T ss_pred ccCC
Confidence 7543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=218.88 Aligned_cols=160 Identities=22% Similarity=0.318 Sum_probs=131.9
Q ss_pred cHHHHHHHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCC-CC-----ceeeEEE
Q 003134 667 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HP-----NLVKLYG 739 (845)
Q Consensus 667 ~~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~~ 739 (845)
.++......++|+..+.||+|+||.||+|+.. +++.||||+++.. ....+++..|++++..++ |+ +|+++++
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 33344445678999999999999999999976 5889999999754 233466778888888774 44 4999999
Q ss_pred EEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec--CCC
Q 003134 740 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDL 817 (845)
Q Consensus 740 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld--~~~ 817 (845)
++...+..++||||++ |+|.+++..... ..+++..+..++.|++.||+|||.+ ..+|+||||||+|||++ .++
T Consensus 124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEETTEEEEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred eeccCCceEEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence 9999999999999996 599999865422 3589999999999999999999953 13599999999999994 578
Q ss_pred cEEEEeeccceecCC
Q 003134 818 NAKISDFGLAKLYEE 832 (845)
Q Consensus 818 ~~kl~DFGla~~~~~ 832 (845)
.+||+|||+|+....
T Consensus 199 ~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQ 213 (382)
T ss_dssp CEEECCCTTCEETTC
T ss_pred cEEEEeccCceeccc
Confidence 899999999998754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.4e-21 Score=212.23 Aligned_cols=150 Identities=26% Similarity=0.477 Sum_probs=115.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-cc-hHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.++|+..+.||+|+||.||+|+.. +++.||||++..... .. .+.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356788899999999999999986 689999999975432 12 234445556788889999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
||+ ++.+..+.... ...+++..+..++.|+++||+|||++ + |+||||||+||+++.++.+||+|||+++.+
T Consensus 104 e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp CCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred ecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 999 44555554321 23689999999999999999999985 6 999999999999999999999999999876
Q ss_pred CC
Q 003134 831 EE 832 (845)
Q Consensus 831 ~~ 832 (845)
..
T Consensus 176 ~~ 177 (318)
T 2dyl_A 176 VD 177 (318)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.85 E-value=3.2e-21 Score=198.45 Aligned_cols=167 Identities=21% Similarity=0.260 Sum_probs=105.5
Q ss_pred ceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCC
Q 003134 166 KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS 245 (845)
Q Consensus 166 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 245 (845)
+.+++++|.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 34555555555 3444433 45666666666666555555666666666666666666555666666666666666666
Q ss_pred cCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchh
Q 003134 246 SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325 (845)
Q Consensus 246 ~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 325 (845)
+|+...+..|.++++|+. |+|++|+|++..|..|..+++|+.|+|++|+|++..+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~-----------------------L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 147 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQL-----------------------LLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147 (220)
T ss_dssp CCCCCCTTTTTTCTTCCE-----------------------EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred cCCccCHhHccCCCCCCE-----------------------EECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHH
Confidence 665444444444443333 344445555555666777777888888888888777777
Q ss_pred hhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCC
Q 003134 326 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSP 388 (845)
Q Consensus 326 ~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~ 388 (845)
|..+++|+.|+|++| +|.|+|...++..|+...
T Consensus 148 ~~~l~~L~~L~L~~N------------------------------~~~c~c~l~~l~~~l~~~ 180 (220)
T 2v9t_B 148 FSPLRAIQTMHLAQN------------------------------PFICDCHLKWLADYLHTN 180 (220)
T ss_dssp TTTCTTCCEEECCSS------------------------------CEECSGGGHHHHHHHHHC
T ss_pred HhCCCCCCEEEeCCC------------------------------CcCCCCccHHHHHHHHhC
Confidence 777777777777776 677999999998887653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=213.29 Aligned_cols=150 Identities=19% Similarity=0.352 Sum_probs=127.8
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CC-cEEEEEEcCcccccchHHHHHHHHHHhcCCCCc------eeeEEEEEEeCCE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DG-TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN------LVKLYGCCVEGNQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~~~ 746 (845)
.++|+..+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468899999999999999999975 34 78999999754 234567888999999887665 9999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe-------------
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL------------- 813 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl------------- 813 (845)
.++||||+ ++++.+.+.... ...+++.++..++.||+.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred EEEEEecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 99999999 566777765432 136899999999999999999999986 9999999999999
Q ss_pred ------cCCCcEEEEeeccceecCC
Q 003134 814 ------DKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 814 ------d~~~~~kl~DFGla~~~~~ 832 (845)
+.++.+||+|||+++....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS
T ss_pred cccccccCCCcEEEeecCccccccc
Confidence 6688999999999997654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-21 Score=227.43 Aligned_cols=136 Identities=21% Similarity=0.290 Sum_probs=108.7
Q ss_pred CCCCcccccCcEEEEEEEECCCcEEEEEEcCcccc--------cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 679 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 679 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
...+.||+|+||.||+|.. .++.+++|+...... ...+++.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4567899999999999955 477888887644321 1134589999999999999999777777788888999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. ++||+|||+|+..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999999843 4589999999999999997 999999999999998 9999999999998
Q ss_pred CCC
Q 003134 831 EED 833 (845)
Q Consensus 831 ~~~ 833 (845)
...
T Consensus 480 ~~~ 482 (540)
T 3en9_A 480 NLD 482 (540)
T ss_dssp CCH
T ss_pred CCc
Confidence 654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=4.3e-21 Score=197.43 Aligned_cols=167 Identities=20% Similarity=0.223 Sum_probs=111.0
Q ss_pred ceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCC-hhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecC
Q 003134 166 KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQG 244 (845)
Q Consensus 166 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 244 (845)
+.+++++|.++ .+|..+. ..+++|+|++|+|++..| ..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 35556666655 3454442 234566666666665533 3356666666666666666665555666666666666666
Q ss_pred CcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCch
Q 003134 245 SSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT 324 (845)
Q Consensus 245 N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 324 (845)
|+|++..+..|.++++|+.| +|++|+|++..|..|.++++|+.|+|++|+|++..|.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L-----------------------~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTL-----------------------MLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEE-----------------------ECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred CccCccCHhHhcCCcCCCEE-----------------------ECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence 66666555555555544433 4455555556677777788888888888888888888
Q ss_pred hhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCC
Q 003134 325 TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSP 388 (845)
Q Consensus 325 ~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~ 388 (845)
.|..+++|+.|+|++| +|.|+|...++.+|+...
T Consensus 148 ~~~~l~~L~~L~L~~N------------------------------~l~c~c~l~~l~~~~~~~ 181 (220)
T 2v70_A 148 AFDTLHSLSTLNLLAN------------------------------PFNCNCYLAWLGEWLRKK 181 (220)
T ss_dssp TTTTCTTCCEEECCSC------------------------------CEECSGGGHHHHHHHHHS
T ss_pred HhcCCCCCCEEEecCc------------------------------CCcCCCchHHHHHHHHhc
Confidence 8888888888888777 666899888888888643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6.8e-22 Score=232.43 Aligned_cols=153 Identities=28% Similarity=0.439 Sum_probs=131.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc-cccchHHHHHHHHHHhcCCCCceeeEEEEEEe------CCEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE------GNQL 747 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~~ 747 (845)
++|+..+.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999975 5899999998764 23345678999999999999999999998765 6678
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc---EEEEee
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKISDF 824 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~---~kl~DF 824 (845)
++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 999999999999999976432 235889999999999999999999987 999999999999997665 999999
Q ss_pred ccceecCCC
Q 003134 825 GLAKLYEED 833 (845)
Q Consensus 825 Gla~~~~~~ 833 (845)
|+++.....
T Consensus 169 G~a~~~~~~ 177 (676)
T 3qa8_A 169 GYAKELDQG 177 (676)
T ss_dssp CCCCBTTSC
T ss_pred ccccccccc
Confidence 999987543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-21 Score=216.28 Aligned_cols=150 Identities=25% Similarity=0.368 Sum_probs=128.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCC-----------CCceeeEEEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----------HPNLVKLYGCCV 742 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~ 742 (845)
.++|...+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++.+++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 357889999999999999999974 6899999999753 233567888999988876 899999999998
Q ss_pred eCC----EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEec---
Q 003134 743 EGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLD--- 814 (845)
Q Consensus 743 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivHrDLKp~NILld--- 814 (845)
..+ ..++||||+ +++|.+++..... ..+++.++..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccC
Confidence 654 789999999 8899999865322 3589999999999999999999997 6 99999999999994
Q ss_pred ---CCCcEEEEeeccceecCC
Q 003134 815 ---KDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 815 ---~~~~~kl~DFGla~~~~~ 832 (845)
..+.+||+|||+|+....
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE 190 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB
T ss_pred CCcCcceEEEcccccccccCC
Confidence 445899999999998754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.4e-21 Score=214.82 Aligned_cols=173 Identities=24% Similarity=0.171 Sum_probs=86.0
Q ss_pred CEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccc-cccccceeEeecccCCCCCCcccccCCCccEEEeecC
Q 003134 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLT-NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN 197 (845)
Q Consensus 119 ~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 197 (845)
+.+++++|+|+.++. .+.. .++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 21 ~~l~c~~~~l~~iP~-~~~~-~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 21 NILSCSKQQLPNVPQ-SLPS-YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp TEEECCSSCCSSCCS-SCCT-TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCccCc-cCCC-CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 467787777775322 2111 344555555555544444444 4455555555555554444444444444444444444
Q ss_pred cCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCc
Q 003134 198 SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277 (845)
Q Consensus 198 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~ 277 (845)
+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~---------------------------- 150 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR---------------------------- 150 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS----------------------------
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe----------------------------
Confidence 4444334444444444444444444444444444444444444444444332
Q ss_pred ccccCCccEEEccCCcCcccCcccc---cCCCCcCEEeCCCCCCCCCCchhhhcCCCc--CEEEccCC
Q 003134 278 KLDKMNLKTLILTKCLIHGEIPDYI---GDMTKLKNIDLSFNNLTGGIPTTFEKLAKT--NFMYLTGN 340 (845)
Q Consensus 278 ~l~~~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L--~~L~L~~N 340 (845)
..+..| ..+++|+.|||++|+|++..+..|..++.+ +.|+|++|
T Consensus 151 -------------------l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N 199 (361)
T 2xot_A 151 -------------------FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199 (361)
T ss_dssp -------------------CCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSS
T ss_pred -------------------eCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCC
Confidence 112222 346677777777777776666667666653 44444444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.9e-21 Score=204.64 Aligned_cols=146 Identities=18% Similarity=0.128 Sum_probs=117.2
Q ss_pred HHHHHHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccc------------------cchHHHHHHHHHHhcC
Q 003134 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR------------------QGNREFVNEIGMISAQ 729 (845)
Q Consensus 668 ~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 729 (845)
+..+......|...+.||+|+||.||+|.+.+|+.||+|.++.... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444455556777899999999999999997799999999965321 1245689999999999
Q ss_pred CCCceeeEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 003134 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTS 809 (845)
Q Consensus 730 ~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~ 809 (845)
+ | +++.+++.. +..++||||+++|+|.+ +.. .+...++.|++.||+|||+.+ |+||||||+
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~ 222 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQY 222 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHH
Confidence 9 4 566665443 45699999999999988 421 234579999999999999987 999999999
Q ss_pred CEEecCCCcEEEEeeccceecCCC
Q 003134 810 NVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 810 NILld~~~~~kl~DFGla~~~~~~ 833 (845)
|||++ ++.+||+|||+|+.....
T Consensus 223 NILl~-~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEETTST
T ss_pred HEEEE-CCcEEEEECCCCeECCCC
Confidence 99999 999999999999987543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.9e-22 Score=239.77 Aligned_cols=266 Identities=21% Similarity=0.195 Sum_probs=92.4
Q ss_pred CCHHHHHHHHHHHHHhCCCCCCCCCCCCCCCCCccccCCCCCCCccceeecCCCCcceEEEEEecCCCccccCCccccCC
Q 003134 36 LHAEEVKALKQIGRKLGKKDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKL 115 (845)
Q Consensus 36 ~~~~~~~aL~~~~~~~~~~~W~~~~d~c~~~~~w~~~~~~~~~~~~~v~C~~~~~~~~v~~L~l~~~~l~g~~p~~l~~L 115 (845)
....++++|++++.++...+|.... +|.... .....|.++.+. .++++.|+|.++++... +.
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~-------~~~~~~-~~~~~~~~~~~s----~~~~~~l~L~~n~~~~~-~~----- 190 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQ-------QPTGDS-TPSGTATNSAVS----TPLTPKIELFANGKDEA-NQ----- 190 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccC-------CCcCCC-CccccCCCceec----CCccceEEeeCCCCCcc-hh-----
Confidence 4566888999999988655554221 121111 011112234433 36789999999988863 33
Q ss_pred CCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEee
Q 003134 116 RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILS 195 (845)
Q Consensus 116 ~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 195 (845)
..|+.++|++|.|.+ ++++.|++. ..|..|..+++|+.|+|++|+|. .+|..+.++++|++|+|+
T Consensus 191 ~~l~~l~Ls~~~i~~-------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls 255 (727)
T 4b8c_D 191 ALLQHKKLSQYSIDE-------------DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLN 255 (727)
T ss_dssp ---------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCT
T ss_pred hHhhcCccCcccccC-------------cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEee
Confidence 235566666665553 234444444 44555555555666666666655 455555555566666666
Q ss_pred cCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCC
Q 003134 196 SNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA 275 (845)
Q Consensus 196 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~ 275 (845)
+|+|+ .+|..|.+|++|++|+|++|+|+ .+|..|+++++|++|+|++|.|+ .+|..|+++++|+.|+|++|.+++..
T Consensus 256 ~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~ 332 (727)
T 4b8c_D 256 GNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQF 332 (727)
T ss_dssp TSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHH
T ss_pred CCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCC
Confidence 66655 55555555566666666666655 44555555556666666666554 44555555555555555554444433
Q ss_pred CcccccC--CccEEEccCCcCcccCcccccCCCCcCEEeCCCC--------CCCCCCchhhhcCCCcCEEEccCCccc
Q 003134 276 FPKLDKM--NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN--------NLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (845)
Q Consensus 276 ~~~l~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N--------~l~g~~p~~~~~l~~L~~L~L~~N~l~ 343 (845)
+..+... .+..|+|++|.+++.+|. .|+.|+++.| .|.+..+..+.++.++....+++|-+.
T Consensus 333 p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 333 LKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp HHHHHHHHHHHHHHHHHHCCCCCCCCC------C-----------------------------------------CCC
T ss_pred hHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 3332221 122356777777777664 3455566665 333333444445555555555555544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=5.7e-20 Score=189.04 Aligned_cols=151 Identities=21% Similarity=0.314 Sum_probs=115.8
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeeccc
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 174 (845)
.+++++++++ .+|..+. ++|+.|+|++|+|+++.+..|..+ +|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 5788888888 4666554 688888888888888777777777 78888888888877777777778888888888888
Q ss_pred CCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCC
Q 003134 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (845)
Q Consensus 175 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 249 (845)
|+...+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++..
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 775555556777778888888887777777777777777777777777777666677777777777777777753
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.1e-20 Score=189.40 Aligned_cols=154 Identities=18% Similarity=0.243 Sum_probs=120.9
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCc-cccccc-ceeEEEecCCCCCCCcccccccccccceeEeecc
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFS-PQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~-~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 173 (845)
.++++++.++. +|..+. +.+++|+|++|+|++..+ ..|..+ +|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 78899999885 676664 456889999999888755 446666 7888888888888777777888888888888888
Q ss_pred cCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcc
Q 003134 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (845)
Q Consensus 174 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 252 (845)
+|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.+..+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 8887777777888888888888888887777778888888888888888887777788888888888888888776543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=4e-20 Score=205.05 Aligned_cols=173 Identities=21% Similarity=0.217 Sum_probs=150.8
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccc-cc-ceeEEEecCCCCCCCcccccccccccceeEeecc
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWA-SL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~-~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 173 (845)
.+++++++|+. +|..+. +.|+.|+|++|+|++..+..+. .+ +|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 68999999985 677664 4689999999999999999887 77 9999999999999998899999999999999999
Q ss_pred cCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhh---cCCcccceEEecCCcCCCC
Q 003134 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFI---GKWKKIQKLHIQGSSLEGP 250 (845)
Q Consensus 174 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~g~ 250 (845)
+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..| ..+++|+.|+|++|+|++.
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 9998878889999999999999999998889999999999999999999997666666 6799999999999999987
Q ss_pred cchhhhcCCCC--CEEEcCCCCC
Q 003134 251 IPASISALTSL--TDLRISDLKG 271 (845)
Q Consensus 251 ~p~~~~~l~~L--~~L~Ls~n~~ 271 (845)
.+..+..++.+ +.|+|++|.+
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~ 201 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPL 201 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCE
T ss_pred CHHHhhhccHhhcceEEecCCCc
Confidence 77888887753 5555555543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=187.55 Aligned_cols=151 Identities=23% Similarity=0.317 Sum_probs=82.6
Q ss_pred ceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCC
Q 003134 166 KNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS 245 (845)
Q Consensus 166 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 245 (845)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 34444444444 3333332 44555555555555444444555555555555555554443344455555555555555
Q ss_pred cCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchh
Q 003134 246 SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325 (845)
Q Consensus 246 ~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 325 (845)
+|++..+..|..+++|+.| +|++|+|+ .+|..+..+++|++|+|++|+|++..+..
T Consensus 99 ~l~~l~~~~~~~l~~L~~L-----------------------~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~ 154 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKEL-----------------------FMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGA 154 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEE-----------------------ECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTT
T ss_pred cCCccChhHhCcchhhCeE-----------------------eccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHH
Confidence 5554444444444443333 23333333 44555666778888888888888776677
Q ss_pred hhcCCCcCEEEccCCccc
Q 003134 326 FEKLAKTNFMYLTGNKLT 343 (845)
Q Consensus 326 ~~~l~~L~~L~L~~N~l~ 343 (845)
|..+++|+.|+|++|.++
T Consensus 155 ~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 155 FDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp TTTCTTCCEEECTTSCBC
T ss_pred HhCCCCCCEEEeeCCCcc
Confidence 888888888887777443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.9e-19 Score=191.99 Aligned_cols=170 Identities=22% Similarity=0.348 Sum_probs=96.2
Q ss_pred cccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceE
Q 003134 161 NITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKL 240 (845)
Q Consensus 161 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 240 (845)
.+++|+.|++++|.++.. + .+..+++|++|+|++|++++..+ +.++++|++|+|++|++++ +| .+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence 455555555555555522 2 24555555555555555553322 5555555555555555553 22 25555555555
Q ss_pred EecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCccccc-CCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCC
Q 003134 241 HIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (845)
Q Consensus 241 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (845)
+|++|++++. ..+..+++|+.|++++|.++.. ..+.. .+|+.|+|++|+|++..| +..+++|+.|+|++|+|+
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 5555555542 2345555555555555544443 12222 255566666666665554 777788888888888887
Q ss_pred CCCchhhhcCCCcCEEEccCCcccC
Q 003134 320 GGIPTTFEKLAKTNFMYLTGNKLTG 344 (845)
Q Consensus 320 g~~p~~~~~l~~L~~L~L~~N~l~g 344 (845)
+ +| .+..+++|+.|++++|+++.
T Consensus 192 ~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 192 D-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp B-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred C-Ch-hhccCCCCCEEECcCCcccC
Confidence 5 34 37778888888888887763
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=213.37 Aligned_cols=187 Identities=20% Similarity=0.313 Sum_probs=124.7
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeeccc
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 174 (845)
.+.+..+.+...++ +..|++|+.|+|++|.|+... .+..+ +|+.|+|++|+|++..| +..+++|+.|+|++|+
T Consensus 25 ~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 98 (605)
T 1m9s_A 25 KDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENK 98 (605)
T ss_dssp HHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred HHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCC
Confidence 34455555554433 456777888888888877653 35555 77777777777776555 7777777777777777
Q ss_pred CCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchh
Q 003134 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPAS 254 (845)
Q Consensus 175 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 254 (845)
|++ +| .+..+++|++|+|++|+|++. ..+..+++|+.|+|++|+|++. ..|..+++|+.|+|++|+|++..|
T Consensus 99 l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-- 170 (605)
T 1m9s_A 99 IKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-- 170 (605)
T ss_dssp CCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--
T ss_pred CCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--
Confidence 774 33 577777777777777777742 3477777777777777777754 567777777777777777776655
Q ss_pred hhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCC
Q 003134 255 ISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG 321 (845)
Q Consensus 255 ~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 321 (845)
+..+++|+.|+|++|.+ ++. ..+..+++|+.|+|++|++++.
T Consensus 171 l~~l~~L~~L~Ls~N~i-----------------------~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 171 LAGLTKLQNLYLSKNHI-----------------------SDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp GTTCTTCCEEECCSSCC-----------------------CBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred hccCCCCCEEECcCCCC-----------------------CCC--hHHccCCCCCEEEccCCcCcCC
Confidence 66666666665555544 432 2355566666666666666644
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.1e-19 Score=184.69 Aligned_cols=152 Identities=21% Similarity=0.292 Sum_probs=124.5
Q ss_pred EEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccC
Q 003134 97 IALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLF 175 (845)
Q Consensus 97 L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 175 (845)
+++++++++ .+|..+. ++|++|+|++|+|++..|..|..+ +|++|+|++|+|+...+..|.++++|++|+|++|+|
T Consensus 24 v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l 100 (229)
T 3e6j_A 24 VDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQL 100 (229)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred eEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcC
Confidence 444455565 5666554 889999999999999888888888 888999999988877777788888899999999988
Q ss_pred CCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcc
Q 003134 176 TGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (845)
Q Consensus 176 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 252 (845)
++..+..|..+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..+..|..+++|+.|+|++|.+.+..+
T Consensus 101 ~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 101 TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 8777777888888888888888888 778888888888888888888887777778888888888888888876543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.8e-19 Score=212.23 Aligned_cols=188 Identities=21% Similarity=0.322 Sum_probs=126.0
Q ss_pred eEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecC
Q 003134 142 VELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221 (845)
Q Consensus 142 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 221 (845)
..+.+..+.+....+ +..|++|+.|+|++|.|+. +| .|..+++|++|+|++|+|++..| +..+++|++|+|++|
T Consensus 24 ~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N 97 (605)
T 1m9s_A 24 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDEN 97 (605)
T ss_dssp HHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred HHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCC
Confidence 334444444443322 4456666666666666663 33 46666666666666666665433 666666666666666
Q ss_pred cCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCccccc-CCccEEEccCCcCcccCcc
Q 003134 222 NFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPD 300 (845)
Q Consensus 222 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~-~~L~~L~Ls~N~l~~~~p~ 300 (845)
+|++ +| .+..+++|++|+|++|+|++. ..+..+++|+.|+|++|.++.. ..+.. .+|+.|+|++|+|++..|
T Consensus 98 ~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~- 170 (605)
T 1m9s_A 98 KIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP- 170 (605)
T ss_dssp CCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-
T ss_pred CCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-
Confidence 6664 22 566666666666666666653 3466666666666666666654 22332 267788888888887777
Q ss_pred cccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCC
Q 003134 301 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP 345 (845)
Q Consensus 301 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ 345 (845)
+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++.
T Consensus 171 -l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 171 -LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp -GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred -hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 88999999999999999964 4689999999999999999853
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=195.17 Aligned_cols=172 Identities=20% Similarity=0.335 Sum_probs=104.0
Q ss_pred cCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccE
Q 003134 113 SKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191 (845)
Q Consensus 113 ~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 191 (845)
..+++|+.|++++|.++... .+..+ +|++|+|++|++++..+ +.++++|++|+|++|++++ + +.+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~~~--~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-L-SSLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-G-GGGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccCh--hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-C-hhhccCCCCCE
Confidence 45566666666666666542 24444 56666666666665443 5666666666666666664 2 23566666666
Q ss_pred EEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCC
Q 003134 192 LILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKG 271 (845)
Q Consensus 192 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~ 271 (845)
|+|++|++++. ..+..+++|++|+|++|++++. ..+..+++|++|+|++|++++..| +..+++
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~----------- 179 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTK----------- 179 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTT-----------
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCc-----------
Confidence 66666666542 3455666666666666666643 445566666666666666665443 445554
Q ss_pred CCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCC
Q 003134 272 SESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG 321 (845)
Q Consensus 272 ~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 321 (845)
|+.|+|++|.|++. | .+..+++|+.|+|++|+++..
T Consensus 180 ------------L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 180 ------------LQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp ------------CCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred ------------cCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCC
Confidence 44555566666543 3 378889999999999998853
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-20 Score=222.29 Aligned_cols=274 Identities=12% Similarity=0.074 Sum_probs=139.6
Q ss_pred eEEEEEecCCCcccc----CCccccCCCCCCEEeccCCcccCCCcc----ccccc-ceeEEEecCCCCCCCccccccccc
Q 003134 93 HVVTIALKAQNLTGT----LPTELSKLRYLKQLDLSRNCLTGSFSP----QWASL-QLVELSVMGNRLSGPFPKVLTNIT 163 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~----~p~~l~~L~~L~~L~Ls~N~l~~~~~~----~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~ 163 (845)
+++.|+|++|.+++. ++..+..+++|++|+|++|.+++.... .+..+ +|++|+|++|.+.+ +|..+.+++
T Consensus 165 ~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~ 243 (592)
T 3ogk_B 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAA 243 (592)
T ss_dssp TCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCT
T ss_pred CCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhh
Confidence 456666666666544 333445556666666666666533222 22223 56666666665543 233333333
Q ss_pred ccceeEeeccc--------------------------CCCCCCcccccCCCccEEEeecCcCcccCC-------------
Q 003134 164 TLKNLSIEGNL--------------------------FTGSIPPDIRKLINLQKLILSSNSFTGELP------------- 204 (845)
Q Consensus 164 ~L~~L~Ls~N~--------------------------l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p------------- 204 (845)
+|++|+++.+. ..+.+|..+..+++|++|+|++|.+++...
T Consensus 244 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L 323 (592)
T 3ogk_B 244 NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVL 323 (592)
T ss_dssp TCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEE
T ss_pred HHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEE
Confidence 33333333210 011233334445555555555555443222
Q ss_pred ------------hhhhCCCCCCcEEee-----------cCcCccc-CchhhcCCcccceEEecCCcCCCCcchhhhc-CC
Q 003134 205 ------------AELTKLTNLNDLRIS-----------DNNFSGK-IPEFIGKWKKIQKLHIQGSSLEGPIPASISA-LT 259 (845)
Q Consensus 205 ------------~~~~~l~~L~~L~Ls-----------~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~-l~ 259 (845)
..+..+++|++|+|+ .|.+++. ++..+..+++|++|+++.|++++..+..++. ++
T Consensus 324 ~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~ 403 (592)
T 3ogk_B 324 ETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLK 403 (592)
T ss_dssp EEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCC
T ss_pred eccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCC
Confidence 222344555555555 2444432 1222334556666666666666555555544 66
Q ss_pred CCCEEEcC----CCCCCCCCCc-----ccc-cCCccEEEccCC--cCcccCccccc-CCCCcCEEeCCCCCCCC-CCchh
Q 003134 260 SLTDLRIS----DLKGSESAFP-----KLD-KMNLKTLILTKC--LIHGEIPDYIG-DMTKLKNIDLSFNNLTG-GIPTT 325 (845)
Q Consensus 260 ~L~~L~Ls----~n~~~~~~~~-----~l~-~~~L~~L~Ls~N--~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g-~~p~~ 325 (845)
+|+.|+++ .|.+++.+.. .+. ..+|+.|+|++| .+++..+..+. .+++|++|+|++|++++ .++..
T Consensus 404 ~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~ 483 (592)
T 3ogk_B 404 NLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEF 483 (592)
T ss_dssp SCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHH
T ss_pred CCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHH
Confidence 66666664 4444443221 011 225667776543 25555444443 36677777777777764 23444
Q ss_pred hhcCCCcCEEEccCCcccCCCChhh---hcCCceEEeecCCCcCC
Q 003134 326 FEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFTWE 367 (845)
Q Consensus 326 ~~~l~~L~~L~L~~N~l~g~ip~~~---~~~l~~L~ls~N~l~~~ 367 (845)
+..+++|++|+|++|++++.....+ ..+|+.|+|++|+++..
T Consensus 484 ~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 484 SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 5667777777777777654433222 34677777777776643
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.2e-18 Score=173.89 Aligned_cols=157 Identities=18% Similarity=0.294 Sum_probs=115.3
Q ss_pred ccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCccc
Q 003134 158 VLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237 (845)
Q Consensus 158 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 237 (845)
....+++|++|+|++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|+|++|++++..|..|..+++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 3466788888888888888 555 6788888888888888665 34467888888888888888887777888888888
Q ss_pred ceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCC
Q 003134 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN 317 (845)
Q Consensus 238 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 317 (845)
++|+|++|++++..|..++.+++|+.|++++|.. ++ .+| .+..+++|+.|+|++|+
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~----------------------i~-~~~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA----------------------IT-DIM-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTB----------------------CC-CCG-GGGGCSSCCEEECTTBC
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCC----------------------cc-ccH-hhcCCCCCCEEECCCCC
Confidence 8888888888877777787777766665554430 22 233 46777888888888888
Q ss_pred CCCCCchhhhcCCCcCEEEccCCcccC
Q 003134 318 LTGGIPTTFEKLAKTNFMYLTGNKLTG 344 (845)
Q Consensus 318 l~g~~p~~~~~l~~L~~L~L~~N~l~g 344 (845)
+++ ++ .+..+++|+.|++++|++.+
T Consensus 171 i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 171 VHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 885 33 67888888888888887753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.9e-19 Score=201.72 Aligned_cols=153 Identities=14% Similarity=0.113 Sum_probs=113.9
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCC-Cce---------e------
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQH-PNL---------V------ 735 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~nI---------v------ 735 (845)
.+|...+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.++..++| +|. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 34666789999999999999965 58999999987432 2336789999999999987 211 1
Q ss_pred ------eEEEEEEe-----CCEEEEEEeccCCCChhhhhhcCC--cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 003134 736 ------KLYGCCVE-----GNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 802 (845)
Q Consensus 736 ------~l~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iv 802 (845)
.+..++.. ....+++|+++ +++|.+++.... ......+++..++.++.||++||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 11111111 12356777765 579998884211 011235788999999999999999999997 99
Q ss_pred eCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 803 HrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
||||||+|||++.++.+||+|||+|+....
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC
Confidence 999999999999999999999999987643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.6e-21 Score=224.52 Aligned_cols=201 Identities=16% Similarity=0.183 Sum_probs=126.6
Q ss_pred cCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCC-------------CCCCcccccccccccceeE-eecccCCC
Q 003134 113 SKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNR-------------LSGPFPKVLTNITTLKNLS-IEGNLFTG 177 (845)
Q Consensus 113 ~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~g 177 (845)
..+++|+.|+|++|+|+ .+|..++.+ +|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 56777777777777776 456666666 67777765554 4445555555566666655 444432
Q ss_pred CCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhc
Q 003134 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISA 257 (845)
Q Consensus 178 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 257 (845)
.+|+.+.+++|.++...+ ..|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..|++
T Consensus 423 ---------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ---------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 234444455555542211 246777777777775 455 777777777777777777 56667777
Q ss_pred CCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCC-chhhhcCCCcCEEE
Q 003134 258 LTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI-PTTFEKLAKTNFMY 336 (845)
Q Consensus 258 l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~ 336 (845)
+++|+.| +|++|+|++ +| .|+++++|+.|+|++|+|++.+ |..|..+++|+.|+
T Consensus 485 l~~L~~L-----------------------~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 485 LRCLEVL-----------------------QASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp CTTCCEE-----------------------ECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred CCCCCEE-----------------------ECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 7666555 444555554 45 6677777777777777777666 77777777777777
Q ss_pred ccCCcccCCCChh--h---hcCCceEEe
Q 003134 337 LTGNKLTGPVPKY--I---FNSNKNVDI 359 (845)
Q Consensus 337 L~~N~l~g~ip~~--~---~~~l~~L~l 359 (845)
|++|+|++..|.. + .++|+.||+
T Consensus 540 L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 540 LQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred ecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 7777777655432 1 345666653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=4.6e-19 Score=186.87 Aligned_cols=139 Identities=17% Similarity=0.146 Sum_probs=107.9
Q ss_pred CCCCCcccccCcEEEEEEEE-CCCcE--EEEEEcCccccc------------------------chHHHHHHHHHHhcCC
Q 003134 678 FDPANKVGEGGFGSVYKGIL-SDGTV--IAVKQLSSKSRQ------------------------GNREFVNEIGMISAQQ 730 (845)
Q Consensus 678 y~~~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 730 (845)
|...+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 67888 999987543111 0136789999999998
Q ss_pred CCce--eeEEEEEEeCCEEEEEEeccCC-C----ChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeE
Q 003134 731 HPNL--VKLYGCCVEGNQLLLVYEYMKN-N----CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH-EDSRIKIV 802 (845)
Q Consensus 731 H~nI--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~iv 802 (845)
|+++ +.++++ +..+|||||+.+ | +|.+.... .++.++..++.|++.||.||| +.+ |+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 8754 444432 246899999953 4 56555421 234567899999999999999 776 99
Q ss_pred eCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 803 HRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 803 HrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
||||||+|||+++ .++|+|||+|.....+
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 9999999999988 9999999999987543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.7e-20 Score=220.08 Aligned_cols=273 Identities=14% Similarity=0.081 Sum_probs=170.0
Q ss_pred eEEEEEecCCC-ccc-cCCccccCCCCCCEEeccCCcccCCCc----cccccc-ceeEEEecCCCCCC----Cccccccc
Q 003134 93 HVVTIALKAQN-LTG-TLPTELSKLRYLKQLDLSRNCLTGSFS----PQWASL-QLVELSVMGNRLSG----PFPKVLTN 161 (845)
Q Consensus 93 ~v~~L~l~~~~-l~g-~~p~~l~~L~~L~~L~Ls~N~l~~~~~----~~~~~l-~L~~L~Ls~N~l~~----~~p~~~~~ 161 (845)
+++.|+|.++. ++. .++..+.++++|++|+|++|.+++... ..+..+ +|++|+|++|++++ .++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 48999999886 221 233334588999999999999987633 333444 89999999999983 44556678
Q ss_pred ccccceeEeecccCCCCCCcccccCCCccEEEeecCcCc--------------------------ccCChhhhCCCCCCc
Q 003134 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFT--------------------------GELPAELTKLTNLND 215 (845)
Q Consensus 162 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~--------------------------g~~p~~~~~l~~L~~ 215 (845)
+++|++|+|++|.+.+ +|..+.++++|++|+++.+... +.+|..+..+++|++
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~ 297 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRK 297 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCE
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcE
Confidence 8999999999999985 6778888888888888753222 223444445556666
Q ss_pred EEeecCcCcccCc-hhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCC-----------CCCCCCCCccc-c-c
Q 003134 216 LRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD-----------LKGSESAFPKL-D-K 281 (845)
Q Consensus 216 L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~-----------n~~~~~~~~~l-~-~ 281 (845)
|+|++|.+++... ..+..+++|++|+++++...+.++..+..+++|+.|++++ +.++......+ . .
T Consensus 298 L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~ 377 (592)
T 3ogk_B 298 LDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGC 377 (592)
T ss_dssp EEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHC
T ss_pred EecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhC
Confidence 6666666543322 2345556666666652222223333445566666666662 33333222211 1 2
Q ss_pred CCccEEEccCCcCcccCcccccC-CCCcCEEeCC----CCCCCCC-----CchhhhcCCCcCEEEccCC--cccCCCChh
Q 003134 282 MNLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLS----FNNLTGG-----IPTTFEKLAKTNFMYLTGN--KLTGPVPKY 349 (845)
Q Consensus 282 ~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~g~-----~p~~~~~l~~L~~L~L~~N--~l~g~ip~~ 349 (845)
.+|++|+|+.|.+++..+..+.. +++|+.|+|+ .|++++. ++..+.++++|+.|+|+++ .+++..+..
T Consensus 378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 26777777777777666666554 6677777774 6666653 3334566777777777533 355444443
Q ss_pred h---hcCCceEEeecCCCcC
Q 003134 350 I---FNSNKNVDISLNNFTW 366 (845)
Q Consensus 350 ~---~~~l~~L~ls~N~l~~ 366 (845)
+ ..+|+.|++++|++++
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~ 477 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESD 477 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSH
T ss_pred HHHhCccceEeeccCCCCCH
Confidence 3 2356777777776654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=4e-18 Score=171.92 Aligned_cols=150 Identities=17% Similarity=0.236 Sum_probs=75.8
Q ss_pred cCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccE
Q 003134 113 SKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQK 191 (845)
Q Consensus 113 ~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 191 (845)
..+++|++|++++|.++.. | .+..+ +|++|++++|.++ .+..+..+++|++|+|++|++++..|..|..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDL-T-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCSCC-T-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCccCh-H-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 4455666666666666532 2 23333 4555555555443 2234555555555555555555444555555555555
Q ss_pred EEeecCcCcccCChhhhCCCCCCcEEeecCc-CcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCC
Q 003134 192 LILSSNSFTGELPAELTKLTNLNDLRISDNN-FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270 (845)
Q Consensus 192 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~ 270 (845)
|+|++|++++..|..+..+++|++|+|++|+ ++ .+| .+..+++|++|++++|++++. + .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcc
Confidence 5555555555455555555555555555555 33 333 355555555555555555532 2 44444444444444443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2e-18 Score=182.60 Aligned_cols=168 Identities=21% Similarity=0.338 Sum_probs=99.2
Q ss_pred ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEee
Q 003134 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219 (845)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 219 (845)
++..+++++|.+++.. .+..+++|++|+|++|+++ .+| .+..+++|++|+|++|+|++..+ +.++++|++|+|+
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence 4555566666666433 4556666666666666666 334 46666666666666666664333 6666666666666
Q ss_pred cCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCc
Q 003134 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP 299 (845)
Q Consensus 220 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p 299 (845)
+|++++ +|... . ++|++|+|++|++++. ..+..+++|+ .|+|++|+|++. +
T Consensus 94 ~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~~--~~l~~l~~L~-----------------------~L~Ls~N~i~~~-~ 144 (263)
T 1xeu_A 94 RNRLKN-LNGIP-S-ACLSRLFLDNNELRDT--DSLIHLKNLE-----------------------ILSIRNNKLKSI-V 144 (263)
T ss_dssp SSCCSC-CTTCC-C-SSCCEEECCSSCCSBS--GGGTTCTTCC-----------------------EEECTTSCCCBC-G
T ss_pred CCccCC-cCccc-c-CcccEEEccCCccCCC--hhhcCccccc-----------------------EEECCCCcCCCC-h
Confidence 666664 23222 2 5566666666666542 1344444443 444455555543 2
Q ss_pred ccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCC
Q 003134 300 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP 345 (845)
Q Consensus 300 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ 345 (845)
.+..+++|+.|+|++|+|++. ..+..+++|+.|++++|++++.
T Consensus 145 -~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 145 -MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred -HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 466677777777777777755 5667777777777777777643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=7.2e-20 Score=214.37 Aligned_cols=188 Identities=12% Similarity=0.101 Sum_probs=135.3
Q ss_pred ccccccceeEeecccCCCCCCcccccCCCccEEEeecCc-------------CcccCChhhhCCCCCCcEE-eecCcCcc
Q 003134 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS-------------FTGELPAELTKLTNLNDLR-ISDNNFSG 225 (845)
Q Consensus 160 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~-------------l~g~~p~~~~~l~~L~~L~-Ls~N~l~~ 225 (845)
..+++|+.|+|++|+|+ .+|..++++++|++|++++|. +.+.+|..++++++|+.|+ ++.|++.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 45677777778887776 677777777777777776664 4455555666666666666 4554432
Q ss_pred cCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccC
Q 003134 226 KIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGD 304 (845)
Q Consensus 226 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~ 304 (845)
+|..+.+++|.++...+ ..|+.|+|++|.++..+. +..+ +|+.|+|++|+|+ .+|..|++
T Consensus 424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSCCC--GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCCCcC--ccccccCcEeecCccccc-ccchhhhc
Confidence 22333333344332111 135666666666665432 3332 6777788888888 78899999
Q ss_pred CCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCC-Chhhh--cCCceEEeecCCCcCCCCC
Q 003134 305 MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPV-PKYIF--NSNKNVDISLNNFTWESSD 370 (845)
Q Consensus 305 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~i-p~~~~--~~l~~L~ls~N~l~~~~p~ 370 (845)
+++|+.|+|++|+|++ +| .|+++++|+.|+|++|+|++.. |..+. .+|+.|+|++|++++.+|.
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 9999999999999997 67 8999999999999999999887 88874 5899999999999988773
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.7e-18 Score=181.52 Aligned_cols=171 Identities=18% Similarity=0.238 Sum_probs=140.0
Q ss_pred CCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEE
Q 003134 114 KLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKL 192 (845)
Q Consensus 114 ~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 192 (845)
++.++..+++++|.+++.. .+..+ +|++|++++|+|+. ++ .+..+++|++|+|++|+|++..+ +.++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 5677888999999999765 46666 89999999999995 44 78999999999999999996544 9999999999
Q ss_pred EeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCC
Q 003134 193 ILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272 (845)
Q Consensus 193 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~ 272 (845)
+|++|++++ +|. +.. ++|++|+|++|+|++. + .+..+++|++|+|++|++++. + .+..+++|+.|+++
T Consensus 91 ~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~----- 158 (263)
T 1xeu_A 91 SVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLH----- 158 (263)
T ss_dssp ECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECT-----
T ss_pred ECCCCccCC-cCc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECC-----
Confidence 999999996 443 333 8999999999999964 3 699999999999999999975 3 67777776666555
Q ss_pred CCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCC
Q 003134 273 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322 (845)
Q Consensus 273 ~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 322 (845)
+|+|++. ..+..+++|+.|+|++|++++..
T Consensus 159 ------------------~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 159 ------------------GNEITNT--GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp ------------------TSCCCBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred ------------------CCcCcch--HHhccCCCCCEEeCCCCcccCCc
Confidence 4555544 45777888999999999888553
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.5e-18 Score=209.37 Aligned_cols=202 Identities=20% Similarity=0.216 Sum_probs=110.1
Q ss_pred EEEEEecCCCccc---------cCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCccccccccc
Q 003134 94 VVTIALKAQNLTG---------TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNIT 163 (845)
Q Consensus 94 v~~L~l~~~~l~g---------~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~ 163 (845)
+..++|+.+.|.+ ..|..|..++.|+.|+|++|.|+.+ |..+..+ +|++|+|++|+|+ .+|..|++|+
T Consensus 193 l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l-~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 270 (727)
T 4b8c_D 193 LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIFNI-SANIFKYDFLTRLYLNGNSLT-ELPAEIKNLS 270 (727)
T ss_dssp -----------------------------CCCCCCEEECTTSCCSCC-CGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGT
T ss_pred hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCCCC-ChhhcCCCCCCEEEeeCCcCc-ccChhhhCCC
Confidence 3445555555443 3466788888888888888888844 4444455 7888888888888 7778888888
Q ss_pred ccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcc-cceEEe
Q 003134 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKK-IQKLHI 242 (845)
Q Consensus 164 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L 242 (845)
+|++|+|++|+|+ .+|..|++|++|++|+|++|.|+ .+|..|++|++|++|+|++|.|++.+|..+..+.. +..|+|
T Consensus 271 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l 348 (727)
T 4b8c_D 271 NLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYL 348 (727)
T ss_dssp TCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhh
Confidence 8888888888888 67888888888888888888887 67777888888888888888888888877765432 234778
Q ss_pred cCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCC
Q 003134 243 QGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG 320 (845)
Q Consensus 243 s~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 320 (845)
++|.++|.+|..+ ..|+++.|... ....+.|.+..+..+.++.+++...+++|-+.+
T Consensus 349 ~~N~l~~~~p~~l------~~l~l~~n~~~---------------~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 349 RDNRPEIPLPHER------RFIEINTDGEP---------------QREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp HHCCCCCCCCCC--------------------------------------------------------------CCCG
T ss_pred ccCcccCcCcccc------ceeEeeccccc---------------ccccCCccccccchhhcccccceeeeecccccc
Confidence 8888888777643 33444433100 111234555566667777888888999998863
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-17 Score=167.31 Aligned_cols=69 Identities=16% Similarity=0.192 Sum_probs=50.0
Q ss_pred cCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCC
Q 003134 290 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESS 369 (845)
Q Consensus 290 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p 369 (845)
++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 86 s~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N----------------------------- 136 (193)
T 2wfh_A 86 SYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN----------------------------- 136 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSS-----------------------------
T ss_pred CCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCC-----------------------------
Confidence 333444444555666777778888888888666667777887777777777
Q ss_pred CCCCCCCCCceeeeeecCC
Q 003134 370 DPIECPRGSVNLVESYSSP 388 (845)
Q Consensus 370 ~~~~c~~~~~~~l~~l~~~ 388 (845)
+|.|+|...++..|+...
T Consensus 137 -~~~C~c~l~~l~~~~~~~ 154 (193)
T 2wfh_A 137 -PLYCDCNMQWLSDWVKSE 154 (193)
T ss_dssp -CEECSGGGHHHHHHHHHS
T ss_pred -CeecCCcCHHHHHHHHhc
Confidence 777999999999998653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=3e-17 Score=164.82 Aligned_cols=132 Identities=19% Similarity=0.267 Sum_probs=85.7
Q ss_pred EEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCccc-ccccccccceeEeecc
Q 003134 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPK-VLTNITTLKNLSIEGN 173 (845)
Q Consensus 95 ~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N 173 (845)
+.+++++++++ .+|..+.. +|++|+|++|+|++ ..+. .|.++++|++|+|++|
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~-----------------------~~~~~~~~~l~~L~~L~Ls~N 64 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGR-----------------------ISSDGLFGRLPHLVKLELKRN 64 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCS-----------------------BCCSCSGGGCTTCCEEECCSS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCc-----------------------cCCccccccCCCCCEEECCCC
Confidence 35666666664 45554432 55555555555544 3333 3666667777777777
Q ss_pred cCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcc
Q 003134 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (845)
Q Consensus 174 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 252 (845)
+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++..+
T Consensus 65 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 65 QLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 7776666667777777777777777776666667777777777777777777667777777777777777777765543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=1.3e-17 Score=167.43 Aligned_cols=130 Identities=18% Similarity=0.276 Sum_probs=112.9
Q ss_pred eEEEecCCCCCCCcccccccccccceeEeecccCCCCCCc-ccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeec
Q 003134 142 VELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPP-DIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISD 220 (845)
Q Consensus 142 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 220 (845)
+.|++++|+|+ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45566666664 45554433 899999999999977665 489999999999999999999899999999999999999
Q ss_pred CcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCC
Q 003134 221 NNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSES 274 (845)
Q Consensus 221 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~ 274 (845)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.+...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 999999999999999999999999999999999999999999998888877643
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-16 Score=156.93 Aligned_cols=131 Identities=24% Similarity=0.250 Sum_probs=73.4
Q ss_pred eeEEEecCCCCC-CCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEee
Q 003134 141 LVELSVMGNRLS-GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219 (845)
Q Consensus 141 L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 219 (845)
|+.|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..|..+++|++|+|++|++++.+|..+.++++|++|+|+
T Consensus 26 L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 103 (168)
T 2ell_A 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103 (168)
T ss_dssp CSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECB
T ss_pred CCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEecc
Confidence 333344444443 34455555566666666666666543 455566666666666666665555555556666666666
Q ss_pred cCcCcccC-chhhcCCcccceEEecCCcCCCCcc---hhhhcCCCCCEEEcCCCCCCC
Q 003134 220 DNNFSGKI-PEFIGKWKKIQKLHIQGSSLEGPIP---ASISALTSLTDLRISDLKGSE 273 (845)
Q Consensus 220 ~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g~~p---~~~~~l~~L~~L~Ls~n~~~~ 273 (845)
+|+|++.. +..+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+..
T Consensus 104 ~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 104 GNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp SSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred CCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 66665432 1455666666666666666665444 355666666666555555443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.69 E-value=6.1e-18 Score=199.80 Aligned_cols=296 Identities=16% Similarity=0.126 Sum_probs=186.6
Q ss_pred ceEEEEEecCC-Ccccc-CCccccCCCCCCEEeccCCcccCCCcccccc----c-ceeEEEecCCC--CCCC-ccccccc
Q 003134 92 CHVVTIALKAQ-NLTGT-LPTELSKLRYLKQLDLSRNCLTGSFSPQWAS----L-QLVELSVMGNR--LSGP-FPKVLTN 161 (845)
Q Consensus 92 ~~v~~L~l~~~-~l~g~-~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~----l-~L~~L~Ls~N~--l~~~-~p~~~~~ 161 (845)
.+++.|+|.+| .++.. ++..+.++++|++|+|++|.+++..+..+.. + +|++|+|++|. ++.. ++..+.+
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~ 209 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTR 209 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHh
Confidence 46888999888 55543 4444557889999999999888766554442 2 78888888876 2211 1122234
Q ss_pred ccccceeEeecc--------------------------------------------------cCCCC----CCcccccCC
Q 003134 162 ITTLKNLSIEGN--------------------------------------------------LFTGS----IPPDIRKLI 187 (845)
Q Consensus 162 l~~L~~L~Ls~N--------------------------------------------------~l~g~----~p~~~~~l~ 187 (845)
+++|++|+|++| .+... ++..+..++
T Consensus 210 ~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~ 289 (594)
T 2p1m_B 210 CPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCS 289 (594)
T ss_dssp CTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHT
T ss_pred CCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhhC
Confidence 577777777766 11111 222233578
Q ss_pred CccEEEeecCcCcccCCh-hhhCCCCCCcEEeecCcCccc-CchhhcCCcccceEEec---------CCcCCCCcchhhh
Q 003134 188 NLQKLILSSNSFTGELPA-ELTKLTNLNDLRISDNNFSGK-IPEFIGKWKKIQKLHIQ---------GSSLEGPIPASIS 256 (845)
Q Consensus 188 ~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls---------~N~l~g~~p~~~~ 256 (845)
+|++|+|++|.+++.... .+.++++|++|++++| ++.. ++.....+++|++|+|+ .|.+++.....+.
T Consensus 290 ~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~ 368 (594)
T 2p1m_B 290 RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVS 368 (594)
T ss_dssp TCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHH
T ss_pred CCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHH
Confidence 999999999998754433 3568899999999988 4422 33333457888888883 3566544444443
Q ss_pred -cCCCCCEEEcCCCCCCCCCCcccc--cCCccEEEcc--C----CcCccc-----CcccccCCCCcCEEeCCCCCCCCCC
Q 003134 257 -ALTSLTDLRISDLKGSESAFPKLD--KMNLKTLILT--K----CLIHGE-----IPDYIGDMTKLKNIDLSFNNLTGGI 322 (845)
Q Consensus 257 -~l~~L~~L~Ls~n~~~~~~~~~l~--~~~L~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~g~~ 322 (845)
++++|+.|.++.|.++......+. ..+|+.|+|+ + |.++.. ++..+..+++|+.|+|++ ++++..
T Consensus 369 ~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~ 447 (594)
T 2p1m_B 369 MGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKV 447 (594)
T ss_dssp HHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHH
T ss_pred HhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHH
Confidence 478888888877777665444432 2378888888 3 555522 222356677888888876 666555
Q ss_pred chhhhc-CCCcCEEEccCCcccCCCChhh---hcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCCC
Q 003134 323 PTTFEK-LAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKL 392 (845)
Q Consensus 323 p~~~~~-l~~L~~L~L~~N~l~g~ip~~~---~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~~ 392 (845)
+..+.. +++|+.|+|++|.+++..+..+ ..+|+.|+|++|.+++.....+. ..+..++.++.+.++.
T Consensus 448 ~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~---~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 448 FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANA---SKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTG---GGGGGSSEEEEESSCC
T ss_pred HHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHH---HhCCCCCEEeeeCCCC
Confidence 555555 7788888888888766554444 35788888888877543322121 1123455555555555
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.3e-16 Score=156.22 Aligned_cols=133 Identities=21% Similarity=0.169 Sum_probs=109.6
Q ss_pred CCCCCEEeccCCccc-CCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEE
Q 003134 115 LRYLKQLDLSRNCLT-GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKL 192 (845)
Q Consensus 115 L~~L~~L~Ls~N~l~-~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 192 (845)
.++|++|+|++|+++ +.+|..+..+ +|++|+|++|+|++. ..+..+++|++|+|++|++++.+|..+.++++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 367888888888887 6667777777 788888888888866 778888999999999999997788888889999999
Q ss_pred EeecCcCcccC-ChhhhCCCCCCcEEeecCcCcccCc---hhhcCCcccceEEecCCcCCC
Q 003134 193 ILSSNSFTGEL-PAELTKLTNLNDLRISDNNFSGKIP---EFIGKWKKIQKLHIQGSSLEG 249 (845)
Q Consensus 193 ~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~g 249 (845)
+|++|+|++.. +..+..+++|++|+|++|.+++..+ ..+..+++|++|++++|.+..
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 99999998643 2678889999999999999986655 478889999999999998873
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.68 E-value=6.4e-18 Score=199.66 Aligned_cols=295 Identities=17% Similarity=0.162 Sum_probs=209.5
Q ss_pred ceEEEEEecCCCccccCCcccc-CCCCCCEEeccCC-cccCC-Cccccccc-ceeEEEecCCCCCCCcccccc----ccc
Q 003134 92 CHVVTIALKAQNLTGTLPTELS-KLRYLKQLDLSRN-CLTGS-FSPQWASL-QLVELSVMGNRLSGPFPKVLT----NIT 163 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~-~L~~L~~L~Ls~N-~l~~~-~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~----~l~ 163 (845)
.+++.|+|+++.+++..+..+. .+++|++|+|++| .++.. ++..+..+ +|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 3688999999999988777776 7999999999999 55543 33333355 899999999999876655554 567
Q ss_pred ccceeEeecccCCCCCC-ccc----ccCCCccEEEeecCc----------------------------------------
Q 003134 164 TLKNLSIEGNLFTGSIP-PDI----RKLINLQKLILSSNS---------------------------------------- 198 (845)
Q Consensus 164 ~L~~L~Ls~N~l~g~~p-~~~----~~l~~L~~L~Ls~N~---------------------------------------- 198 (845)
+|++|+|++|. . .+. ..+ .++++|++|+|++|.
T Consensus 185 ~L~~L~l~~~~-~-~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~ 262 (594)
T 2p1m_B 185 SLVSLNISCLA-S-EVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262 (594)
T ss_dssp CCCEEECTTCC-S-CCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHH
T ss_pred cCcEEEecccC-C-cCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHh
Confidence 99999999997 2 222 222 456889999998871
Q ss_pred ----------Ccc----cCChhhhCCCCCCcEEeecCcCcccCc-hhhcCCcccceEEecCCcCCC-CcchhhhcCCCCC
Q 003134 199 ----------FTG----ELPAELTKLTNLNDLRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEG-PIPASISALTSLT 262 (845)
Q Consensus 199 ----------l~g----~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~ 262 (845)
+.. .++..+..+++|++|+|++|.+++... ..+..+++|++|++++| +.. .++.....+++|+
T Consensus 263 ~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~ 341 (594)
T 2p1m_B 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLR 341 (594)
T ss_dssp TCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCC
T ss_pred cCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCC
Confidence 111 122223357899999999999885433 34678999999999998 442 2333445689999
Q ss_pred EEEcCC---------CCCCCCCCcccc--cCCccEEEccCCcCcccCccccc-CCCCcCEEeCC--C----CCCCCCC--
Q 003134 263 DLRISD---------LKGSESAFPKLD--KMNLKTLILTKCLIHGEIPDYIG-DMTKLKNIDLS--F----NNLTGGI-- 322 (845)
Q Consensus 263 ~L~Ls~---------n~~~~~~~~~l~--~~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~g~~-- 322 (845)
.|++++ +.++......+. ..+|+.|.++.|.+++..+..+. .+++|+.|+|+ + |++++..
T Consensus 342 ~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~ 421 (594)
T 2p1m_B 342 ELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLD 421 (594)
T ss_dssp EEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTH
T ss_pred EEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchh
Confidence 999943 444433322222 24899999999999987777765 58999999999 4 6777332
Q ss_pred ---chhhhcCCCcCEEEccCCcccCCCChhh---hcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCCCC
Q 003134 323 ---PTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLD 393 (845)
Q Consensus 323 ---p~~~~~l~~L~~L~L~~N~l~g~ip~~~---~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~~~ 393 (845)
+..+..+++|+.|+|++ .+++..+..+ ..+|+.|+|++|.+++.....+... ...++.++.+.|+++
T Consensus 422 ~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~---~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 422 IGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSG---CDSLRKLEIRDCPFG 494 (594)
T ss_dssp HHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHH---CTTCCEEEEESCSCC
T ss_pred hHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhc---CCCcCEEECcCCCCc
Confidence 22377899999999987 6776555554 3579999999999875433222111 233666777777774
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.66 E-value=9.4e-17 Score=154.00 Aligned_cols=127 Identities=25% Similarity=0.263 Sum_probs=96.5
Q ss_pred ceeEEEecCCCCC-CCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEe
Q 003134 140 QLVELSVMGNRLS-GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRI 218 (845)
Q Consensus 140 ~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 218 (845)
+|+.|++++|+++ +.+|..+..+++|++|+|++|++++. ..+..+++|++|+|++|++++.+|..+.++++|++|+|
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 4666666666666 56677777788888888888888755 66778888888888888888767777777888888888
Q ss_pred ecCcCccc-CchhhcCCcccceEEecCCcCCCCcc---hhhhcCCCCCEEEcCC
Q 003134 219 SDNNFSGK-IPEFIGKWKKIQKLHIQGSSLEGPIP---ASISALTSLTDLRISD 268 (845)
Q Consensus 219 s~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p---~~~~~l~~L~~L~Ls~ 268 (845)
++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.|++++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 88888763 34778888888888888888887665 5778888888887653
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.4e-16 Score=152.71 Aligned_cols=127 Identities=22% Similarity=0.212 Sum_probs=88.3
Q ss_pred CCCCEEeccCCccc-CCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEE
Q 003134 116 RYLKQLDLSRNCLT-GSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLI 193 (845)
Q Consensus 116 ~~L~~L~Ls~N~l~-~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 193 (845)
++|+.|++++|.++ +.+|..+..+ +|++|+|++|+|++. ..+.++++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45556666666665 4555555555 566666666666654 5677777888888888888766777777778888888
Q ss_pred eecCcCccc-CChhhhCCCCCCcEEeecCcCcccCc---hhhcCCcccceEEecC
Q 003134 194 LSSNSFTGE-LPAELTKLTNLNDLRISDNNFSGKIP---EFIGKWKKIQKLHIQG 244 (845)
Q Consensus 194 Ls~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~ 244 (845)
|++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|++|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 888887753 34667778888888888888876555 4677788888887753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=9.2e-16 Score=151.66 Aligned_cols=132 Identities=23% Similarity=0.304 Sum_probs=72.4
Q ss_pred EEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeeccc
Q 003134 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL 174 (845)
Q Consensus 95 ~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 174 (845)
+.+++++++++. +|..+ .++|++|+|++|++++..+ ..|.++++|++|+|++|+
T Consensus 10 ~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~-----------------------~~~~~l~~L~~L~l~~n~ 63 (177)
T 2o6r_A 10 TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPH-----------------------GVFDKLTQLTKLSLSQNQ 63 (177)
T ss_dssp TEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCT-----------------------TTTTTCTTCSEEECCSSC
T ss_pred CEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCH-----------------------HHhcCcccccEEECCCCc
Confidence 456677777663 44333 2466666666666554444 444555555555555555
Q ss_pred CCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcc
Q 003134 175 FTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIP 252 (845)
Q Consensus 175 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 252 (845)
|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++.+..|
T Consensus 64 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 64 IQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 554444445555555555555555554444445555555555555555554444445555556666666665555443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-15 Score=153.55 Aligned_cols=128 Identities=21% Similarity=0.214 Sum_probs=87.2
Q ss_pred CEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCc
Q 003134 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS 198 (845)
Q Consensus 119 ~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 198 (845)
+++++++|+++.++. .+. .+|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 13 ~~l~~~~~~l~~ip~-~~~-~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPK-GIP-RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCSSCCS-CCC-TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCCcCCC-CCC-CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 578888888875432 221 26777777777776 455667777777777777777776666667777777777777777
Q ss_pred CcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCC
Q 003134 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (845)
Q Consensus 199 l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 249 (845)
|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 776666667777777777777777775555566666677777777666653
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=7.9e-16 Score=152.12 Aligned_cols=113 Identities=20% Similarity=0.258 Sum_probs=74.0
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEee
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 171 (845)
.+++.|++++|.+++..+..|..+++|++|+|++|+|++..+..| .++++|++|+|+
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-----------------------~~l~~L~~L~l~ 84 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVF-----------------------DKLTKLTILYLH 84 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT-----------------------TTCTTCCEEECC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHc-----------------------cCCCccCEEECC
Confidence 578999999999998777788999999999999988886554444 445555555555
Q ss_pred cccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccC
Q 003134 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKI 227 (845)
Q Consensus 172 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~ 227 (845)
+|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|.+++..
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 55555444444555555555555555555444444455555555666666555443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.9e-16 Score=169.71 Aligned_cols=243 Identities=15% Similarity=0.115 Sum_probs=144.0
Q ss_pred ceEEEEEecCCCccccCCccccC-CCCCCEEeccCCccc--CCCcccccccceeEEEecCCCCCCCccccccc-------
Q 003134 92 CHVVTIALKAQNLTGTLPTELSK-LRYLKQLDLSRNCLT--GSFSPQWASLQLVELSVMGNRLSGPFPKVLTN------- 161 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~-L~~L~~L~Ls~N~l~--~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~------- 161 (845)
.+++.|.++++ +.+.--..+.. +++|++|||++|+|+ ...+..+.. +..+.+..|.| .+..|.+
T Consensus 25 ~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~--~~~~~~~~~~I---~~~aF~~~~~~~~~ 98 (329)
T 3sb4_A 25 NSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPN--GKFYIYMANFV---PAYAFSNVVNGVTK 98 (329)
T ss_dssp HHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGG--GCCEEECTTEE---CTTTTEEEETTEEE
T ss_pred CceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccc--ccccccccccc---CHHHhccccccccc
Confidence 35677777653 22111122334 889999999999998 333333322 34444444432 2345555
Q ss_pred -ccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcC----cccCchhhcCC--
Q 003134 162 -ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF----SGKIPEFIGKW-- 234 (845)
Q Consensus 162 -l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l----~~~~p~~~~~l-- 234 (845)
+++|+.|+|.+ +++...+..|.++++|++|+|++|.++...+.+|.++.++..+.+..+.. .......|.++
T Consensus 99 g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~ 177 (329)
T 3sb4_A 99 GKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEP 177 (329)
T ss_dssp ECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCC
T ss_pred ccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccc
Confidence 89999999988 88866667888999999999999988867777788777776666554221 11112222222
Q ss_pred ------------------------cccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEc
Q 003134 235 ------------------------KKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLIL 289 (845)
Q Consensus 235 ------------------------~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~L 289 (845)
.+++.+.+.++-...........+++|+.|+|++|++..++...+... +|+.|+|
T Consensus 178 L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l 257 (329)
T 3sb4_A 178 LETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL 257 (329)
T ss_dssp CEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred cceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence 223333333331111111111235666666666666666555555554 6666666
Q ss_pred cCCcCcccCcccccCCCCcC-EEeCCCCCCCCCCchhhhcCCCcCEEEccCCccc
Q 003134 290 TKCLIHGEIPDYIGDMTKLK-NIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (845)
Q Consensus 290 s~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~ 343 (845)
.+| ++.+.+.+|.++++|+ .|+|.+ +++.+.+.+|.++++|+.|++++|+++
T Consensus 258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~ 310 (329)
T 3sb4_A 258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT 310 (329)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC
T ss_pred Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC
Confidence 666 6656666666777776 777766 566555666777777777777666666
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=7.9e-16 Score=168.99 Aligned_cols=147 Identities=11% Similarity=0.114 Sum_probs=105.8
Q ss_pred HHHHHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccc--------------cchHH--------HHHHHHHH
Q 003134 669 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--------------QGNRE--------FVNEIGMI 726 (845)
Q Consensus 669 ~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l 726 (845)
..+.....-|.+.+.||+|++|.||+|...+|+.||||+++.... ..... ..+|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 333333344888999999999999999998999999998754210 00111 23466677
Q ss_pred hcCCCCceeeEEEEEEeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC
Q 003134 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI 806 (845)
Q Consensus 727 ~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDL 806 (845)
.++.+.++....-+.... .+|||||++|++|.++.. ......++.|++.+|.|||+.+ ||||||
T Consensus 168 ~rL~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~-----------~~~~~~l~~qll~~l~~lH~~g---IVHrDL 231 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVSS-----------VPDPASLYADLIALILRLAKHG---LIHGDF 231 (397)
T ss_dssp HHHHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCCC-----------CSCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHHhcCCCCCeeeeccC--ceEEEEecCCccHhhhcc-----------cHHHHHHHHHHHHHHHHHHHCC---CcCCCC
Confidence 776555443222222222 279999999988865532 1235678899999999999987 999999
Q ss_pred CCCCEEecCCC----------cEEEEeeccceecC
Q 003134 807 KTSNVLLDKDL----------NAKISDFGLAKLYE 831 (845)
Q Consensus 807 Kp~NILld~~~----------~~kl~DFGla~~~~ 831 (845)
||.|||+++++ .+.|+||+-+....
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99999998776 38999999887654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.60 E-value=5.9e-16 Score=169.11 Aligned_cols=249 Identities=14% Similarity=0.068 Sum_probs=177.8
Q ss_pred CCCCCEEeccCCcccCCCcccccc-c-ceeEEEecCCCCC--CCcccccccccccceeEeecccCCCCCCccccc-----
Q 003134 115 LRYLKQLDLSRNCLTGSFSPQWAS-L-QLVELSVMGNRLS--GPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRK----- 185 (845)
Q Consensus 115 L~~L~~L~Ls~N~l~~~~~~~~~~-l-~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~----- 185 (845)
+++|+.|.++++ +....-..+.. + +|+.|||++|+|. ...+..+ +.++.+.+..|.|. +..|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I~---~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFVP---AYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEEC---TTTTEEEETTE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---cccccccccccccC---HHHhccccccc
Confidence 678899999875 22221222333 3 7999999999988 3333233 33566666666543 456777
Q ss_pred ---CCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCc----CCCCcchhhhcC
Q 003134 186 ---LINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSS----LEGPIPASISAL 258 (845)
Q Consensus 186 ---l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~----l~g~~p~~~~~l 258 (845)
+++|++|+|.+ +++...+.+|.++++|+.|+|++|.++...+.+|.++.++..+.+..+. ........|.++
T Consensus 97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~ 175 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEG 175 (329)
T ss_dssp EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEES
T ss_pred ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccc
Confidence 99999999999 8887777789999999999999999988888889888888777766532 222334455556
Q ss_pred CCCC-EEEcCCCC------------------------CCCCCCccc--ccCCccEEEccCCcCcccCcccccCCCCcCEE
Q 003134 259 TSLT-DLRISDLK------------------------GSESAFPKL--DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNI 311 (845)
Q Consensus 259 ~~L~-~L~Ls~n~------------------------~~~~~~~~l--~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 311 (845)
.+|+ .+.+.... +.......+ ...+|+.|+|++|+++.+.+.+|.++++|+.|
T Consensus 176 ~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l 255 (329)
T 3sb4_A 176 EPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKI 255 (329)
T ss_dssp CCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEE
T ss_pred cccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEE
Confidence 6655 33332111 000000000 12489999999999998888899999999999
Q ss_pred eCCCCCCCCCCchhhhcCCCcC-EEEccCCcccCCCChhhh--cCCceEEeecCCCcCCCCCCCC
Q 003134 312 DLSFNNLTGGIPTTFEKLAKTN-FMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDPIE 373 (845)
Q Consensus 312 ~Ls~N~l~g~~p~~~~~l~~L~-~L~L~~N~l~g~ip~~~~--~~l~~L~ls~N~l~~~~p~~~~ 373 (845)
+|++| ++.+.+.+|.++++|+ .|++.+ +++..-+..+. .+|+.|++++|+++...+..|.
T Consensus 256 ~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~ 318 (329)
T 3sb4_A 256 KLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFG 318 (329)
T ss_dssp ECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTC
T ss_pred ECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhc
Confidence 99998 8878888999999999 999998 77743344443 3789999999999988887773
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3.4e-17 Score=165.25 Aligned_cols=149 Identities=21% Similarity=0.294 Sum_probs=101.1
Q ss_pred ccCCCCCCEEeccCCcccCCCcc------ccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccc
Q 003134 112 LSKLRYLKQLDLSRNCLTGSFSP------QWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIR 184 (845)
Q Consensus 112 l~~L~~L~~L~Ls~N~l~~~~~~------~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 184 (845)
+.....++.++++.|.+++..|. .+..+ +|++|+|++|+|++ +| .+.++++|++|+|++|+|+ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 34445566666666666666554 55555 66666666666665 44 6777777777777777777 5666666
Q ss_pred cCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCc-hhhcCCcccceEEecCCcCCCCcch----------
Q 003134 185 KLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPA---------- 253 (845)
Q Consensus 185 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~---------- 253 (845)
.+++|++|+|++|++++ +| .+.++++|++|+|++|+|++..+ ..+..+++|++|++++|++++.+|.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 168 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence 67777777777777775 34 56777777777777777774332 4677777777777777777766554
Q ss_pred hhhcCCCCCEEE
Q 003134 254 SISALTSLTDLR 265 (845)
Q Consensus 254 ~~~~l~~L~~L~ 265 (845)
.+..+++|+.||
T Consensus 169 ~~~~l~~L~~Ld 180 (198)
T 1ds9_A 169 VVKRLPNLKKLD 180 (198)
T ss_dssp HHHHCSSCSEEC
T ss_pred HHHhCCCcEEEC
Confidence 267777777775
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3e-17 Score=165.68 Aligned_cols=155 Identities=21% Similarity=0.276 Sum_probs=91.8
Q ss_pred cccccccceeEeecccCCCCCCc------ccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhc
Q 003134 159 LTNITTLKNLSIEGNLFTGSIPP------DIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIG 232 (845)
Q Consensus 159 ~~~l~~L~~L~Ls~N~l~g~~p~------~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 232 (845)
+.....++.++|+.|.++|.+|. .|..+++|++|+|++|++++ +| .+.++++|++|+|++|+|+ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 34445566666666666666555 66666666666666666664 45 5666666666666666666 4555566
Q ss_pred CCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCc-ccccCCCCcCEE
Q 003134 233 KWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP-DYIGDMTKLKNI 311 (845)
Q Consensus 233 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L 311 (845)
.+++|++|+|++|++++ +| .+..+++|+.| +|++|+|++..+ ..+..+++|++|
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L-----------------------~l~~N~i~~~~~~~~l~~l~~L~~L 145 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVL-----------------------YMSNNKITNWGEIDKLAALDKLEDL 145 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEE-----------------------EESEEECCCHHHHHHHTTTTTCSEE
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEE-----------------------ECCCCcCCchhHHHHHhcCCCCCEE
Confidence 66666666666666664 23 35444444444 333334433222 345666677777
Q ss_pred eCCCCCCCCCCch----------hhhcCCCcCEEEccCCccc
Q 003134 312 DLSFNNLTGGIPT----------TFEKLAKTNFMYLTGNKLT 343 (845)
Q Consensus 312 ~Ls~N~l~g~~p~----------~~~~l~~L~~L~L~~N~l~ 343 (845)
++++|++++.+|. .+..+++|+.|| +|.++
T Consensus 146 ~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 146 LLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp EECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred EecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 7777776655443 266777777765 56555
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=1.9e-15 Score=149.33 Aligned_cols=133 Identities=23% Similarity=0.208 Sum_probs=72.0
Q ss_pred cccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCc
Q 003134 111 ELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINL 189 (845)
Q Consensus 111 ~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 189 (845)
.+.++++|++|+|++|+++.. |...... +|++|+|++|+|++. ..|..+++|++|+|++|+|++..+..|..+++|
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 455666777777777766643 3322222 555666666655543 455555566666666666554333333555556
Q ss_pred cEEEeecCcCcccCCh--hhhCCCCCCcEEeecCcCcccCch----hhcCCcccceEEecCCcCC
Q 003134 190 QKLILSSNSFTGELPA--ELTKLTNLNDLRISDNNFSGKIPE----FIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 190 ~~L~Ls~N~l~g~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~ 248 (845)
++|+|++|+|+ .+|. .+..+++|++|+|++|.++ .+|. .+..+++|++|++++|.+.
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 66666666554 3333 4555555555555555555 2333 2555555555555555543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.9e-14 Score=159.67 Aligned_cols=223 Identities=11% Similarity=0.075 Sum_probs=118.4
Q ss_pred ccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCc
Q 003134 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINL 189 (845)
Q Consensus 110 ~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 189 (845)
.+|.+. +|+.++|..| ++.+...+|.+.+|+.+.|.. .++.+.+..|.++++|+.++|++|+++......|. ..+|
T Consensus 130 ~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L 205 (401)
T 4fdw_A 130 DAFRNS-QIAKVVLNEG-LKSIGDMAFFNSTVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGI 205 (401)
T ss_dssp TTTTTC-CCSEEECCTT-CCEECTTTTTTCCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCC
T ss_pred hhcccC-CccEEEeCCC-ccEECHHhcCCCCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-eccc
Confidence 345553 5666666544 555555666666666666653 55555555666666666666666666633333343 4666
Q ss_pred cEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCC
Q 003134 190 QKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDL 269 (845)
Q Consensus 190 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n 269 (845)
+.+.|..| ++.....+|.++++|+.++|.+| ++.+-..+|.+ .+|+.+.| .|.++.....+|.++++|+.+++.+|
T Consensus 206 ~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~ 281 (401)
T 4fdw_A 206 EEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGS 281 (401)
T ss_dssp SEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESS
T ss_pred CEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCc
Confidence 66666533 55444555666666666666654 44444555555 56666666 34455445566666666666666555
Q ss_pred CCC-----CCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCccc
Q 003134 270 KGS-----ESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (845)
Q Consensus 270 ~~~-----~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~ 343 (845)
... ......+... +|+.++|. |.++.+...+|.++++|+.|+|.+| ++.+.+.+|.++ +|+.|++++|.+.
T Consensus 282 ~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 282 TFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPP 358 (401)
T ss_dssp CCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCC
T ss_pred cccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCc
Confidence 443 1122222222 45555554 2344444444555555555555332 443344445555 5555555555443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=8.6e-15 Score=144.60 Aligned_cols=131 Identities=15% Similarity=0.182 Sum_probs=107.7
Q ss_pred cccc-ceeEEEecCCCCCCCccccccccc-ccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCC
Q 003134 136 WASL-QLVELSVMGNRLSGPFPKVLTNIT-TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNL 213 (845)
Q Consensus 136 ~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 213 (845)
+..+ +|+.|+|++|+|+.. |. +..+. +|++|+|++|+|++. ..|..+++|++|+|++|+|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 3444 899999999999954 54 55554 999999999999965 678999999999999999997655666899999
Q ss_pred CcEEeecCcCcccCch--hhcCCcccceEEecCCcCCCCcch----hhhcCCCCCEEEcCCCCCC
Q 003134 214 NDLRISDNNFSGKIPE--FIGKWKKIQKLHIQGSSLEGPIPA----SISALTSLTDLRISDLKGS 272 (845)
Q Consensus 214 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~g~~p~----~~~~l~~L~~L~Ls~n~~~ 272 (845)
++|+|++|+|+ .+|. .+..+++|++|++++|+++. +|. .+..+++|+.|++++|...
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999999997 5665 78899999999999999984 454 4888998888888777653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.53 E-value=7.8e-14 Score=156.19 Aligned_cols=241 Identities=7% Similarity=0.073 Sum_probs=201.6
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
++++.+.+..+ ++.+-..+|.+. +|+.++|.. .++.+.+.+|..+ +|+.++|++|+++.+....|. .++|+.+.|
T Consensus 135 ~~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~l 210 (401)
T 4fdw_A 135 SQIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLL 210 (401)
T ss_dssp CCCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEEC
T ss_pred CCccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEe
Confidence 45777777655 776666778884 799999985 7888888999998 899999999999977777777 589999999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCC--
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE-- 248 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-- 248 (845)
..| ++......|.++++|+.++|..| ++..-..+|.+ .+|+.+.| .|.++.+...+|.++++|+.+.+.+|.+.
T Consensus 211 p~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~ 286 (401)
T 4fdw_A 211 PVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDD 286 (401)
T ss_dssp CTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCC
T ss_pred CCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCC
Confidence 854 77667778999999999999986 66566677887 89999999 56677777899999999999999998876
Q ss_pred ---CCcchhhhcCCCCCEEEcCCCCCCCCCCccccc-CCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCch
Q 003134 249 ---GPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT 324 (845)
Q Consensus 249 ---g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 324 (845)
...+.+|.++++|+.++|.+ .+..+....+.. .+|+.+.|..| ++.+.+.+|.++ +|+.|++++|.+....+.
T Consensus 287 ~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~ 363 (401)
T 4fdw_A 287 PEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEK 363 (401)
T ss_dssp TTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCS
T ss_pred cccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccc
Confidence 45678999999999999984 477666666766 48999999655 887888999999 999999999999987888
Q ss_pred hhhcCC-CcCEEEccCCccc
Q 003134 325 TFEKLA-KTNFMYLTGNKLT 343 (845)
Q Consensus 325 ~~~~l~-~L~~L~L~~N~l~ 343 (845)
.|.+++ +++.|++..|.+.
T Consensus 364 ~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 364 VWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp SCCCSCTTCCEEEECGGGHH
T ss_pred cccCCCCCccEEEeCHHHHH
Confidence 898885 7889999888665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=2.1e-14 Score=141.06 Aligned_cols=50 Identities=18% Similarity=0.233 Sum_probs=31.8
Q ss_pred CCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCC
Q 003134 291 KCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340 (845)
Q Consensus 291 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N 340 (845)
+|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 63 ~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 112 (170)
T 3g39_A 63 NNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCC
Confidence 33333344445566667777777777777666666777777777776666
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=9.9e-14 Score=136.21 Aligned_cols=87 Identities=23% Similarity=0.263 Sum_probs=45.6
Q ss_pred cccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEe
Q 003134 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 242 (845)
Q Consensus 163 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 242 (845)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 44555555555555444555555555555555555555444444455555555555555555444444555555555555
Q ss_pred cCCcCCC
Q 003134 243 QGSSLEG 249 (845)
Q Consensus 243 s~N~l~g 249 (845)
++|+++.
T Consensus 110 ~~N~~~c 116 (170)
T 3g39_A 110 LNNPWDC 116 (170)
T ss_dssp CSSCBCT
T ss_pred CCCCCCC
Confidence 5555543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=2e-13 Score=134.56 Aligned_cols=86 Identities=24% Similarity=0.324 Sum_probs=40.8
Q ss_pred cccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEe
Q 003134 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 242 (845)
Q Consensus 163 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 242 (845)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 34444444444444444444444444444444444444433333444455555555555554433334444555555555
Q ss_pred cCCcCC
Q 003134 243 QGSSLE 248 (845)
Q Consensus 243 s~N~l~ 248 (845)
++|++.
T Consensus 113 ~~N~~~ 118 (174)
T 2r9u_A 113 YNNPWD 118 (174)
T ss_dssp CSSCBC
T ss_pred CCCCcc
Confidence 555544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.9e-13 Score=132.46 Aligned_cols=105 Identities=20% Similarity=0.280 Sum_probs=91.3
Q ss_pred cceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecC
Q 003134 165 LKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQG 244 (845)
Q Consensus 165 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 244 (845)
-+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 468899999997 6777664 7999999999999988899999999999999999999987777789999999999999
Q ss_pred CcCCCCcchhhhcCCCCCEEEcCCCCCC
Q 003134 245 SSLEGPIPASISALTSLTDLRISDLKGS 272 (845)
Q Consensus 245 N~l~g~~p~~~~~l~~L~~L~Ls~n~~~ 272 (845)
|+|++..+..|..+++|+.|+|++|.+.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc
Confidence 9999877777888888888877766654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.39 E-value=5.7e-13 Score=146.33 Aligned_cols=70 Identities=24% Similarity=0.233 Sum_probs=39.1
Q ss_pred CCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCCC
Q 003134 291 KCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSD 370 (845)
Q Consensus 291 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p~ 370 (845)
+|+|++..|..|.++++|+.|||++|+|++..+..|..++ |+.|+|++ |
T Consensus 65 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~----------------------N-------- 113 (347)
T 2ifg_A 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSG----------------------N-------- 113 (347)
T ss_dssp SSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCS----------------------S--------
T ss_pred CCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeC----------------------C--------
Confidence 3333344444455555555555555555544444444443 44444444 4
Q ss_pred CCCCCCCCceeeeeecCCCCC
Q 003134 371 PIECPRGSVNLVESYSSPRNK 391 (845)
Q Consensus 371 ~~~c~~~~~~~l~~l~~~~n~ 391 (845)
+|.|+|...++..|+......
T Consensus 114 ~~~c~c~l~~~~~~~~~~~~~ 134 (347)
T 2ifg_A 114 PLHCSCALRWLQRWEEEGLGG 134 (347)
T ss_dssp CCCCCGGGHHHHHHHHTTCSS
T ss_pred CccCCCccHHHHHHHHhCccc
Confidence 666888888888887665444
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.2e-14 Score=157.73 Aligned_cols=156 Identities=18% Similarity=0.185 Sum_probs=87.2
Q ss_pred CCCCEEeccCCcccCCCccccccc------ceeEEEecCCCCCCCcccccc-cccccceeEeecccCCCCCCcccc----
Q 003134 116 RYLKQLDLSRNCLTGSFSPQWASL------QLVELSVMGNRLSGPFPKVLT-NITTLKNLSIEGNLFTGSIPPDIR---- 184 (845)
Q Consensus 116 ~~L~~L~Ls~N~l~~~~~~~~~~l------~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~---- 184 (845)
++|+.|+|++|.|+......+... +|++|+|++|+|+......+. .+++|+.|+|++|+|+......+.
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 567777887777765443333222 577777777776644333332 356677777777776643333332
Q ss_pred -cCCCccEEEeecCcCcc----cCChhhhCCCCCCcEEeecCcCccc----CchhhcCCcccceEEecCCcCCCC----c
Q 003134 185 -KLINLQKLILSSNSFTG----ELPAELTKLTNLNDLRISDNNFSGK----IPEFIGKWKKIQKLHIQGSSLEGP----I 251 (845)
Q Consensus 185 -~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~ 251 (845)
..++|++|+|++|+|+. .++..+..+++|++|+|++|+|+.. ++..+...++|++|+|++|.|+.. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 34567777777777653 2333445666677777777766632 234455556666666666666542 2
Q ss_pred chhhhcCCCCCEEEcCCCCC
Q 003134 252 PASISALTSLTDLRISDLKG 271 (845)
Q Consensus 252 p~~~~~l~~L~~L~Ls~n~~ 271 (845)
+..+...++|+.|+|++|.+
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i 251 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNEL 251 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSC
T ss_pred HHHHHhCCCCCEEeccCCCC
Confidence 23333444444444444433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=6e-14 Score=155.60 Aligned_cols=110 Identities=18% Similarity=0.244 Sum_probs=66.6
Q ss_pred ceeEEEecCCCCCCCcccccccc-----cccceeEeecccCCCCCCccc-ccCCCccEEEeecCcCcccCChhh-----h
Q 003134 140 QLVELSVMGNRLSGPFPKVLTNI-----TTLKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGELPAEL-----T 208 (845)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~g~~p~~~-----~ 208 (845)
.|+.|+|++|.|+......+..+ ++|++|+|++|.|+......+ ..+++|++|+|++|+|+......+ .
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 57778888888775544444433 577777777777764322222 235667777777777764433333 2
Q ss_pred CCCCCCcEEeecCcCccc----CchhhcCCcccceEEecCCcCCC
Q 003134 209 KLTNLNDLRISDNNFSGK----IPEFIGKWKKIQKLHIQGSSLEG 249 (845)
Q Consensus 209 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g 249 (845)
..++|++|+|++|+|+.. ++..+...++|++|+|++|+|+.
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~ 197 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGD 197 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHH
T ss_pred cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCc
Confidence 346677777777777632 33344556666666666666653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=8.5e-12 Score=131.19 Aligned_cols=148 Identities=15% Similarity=0.083 Sum_probs=115.9
Q ss_pred HHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEEE
Q 003134 672 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 672 ~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV 750 (845)
...-..|.....++.|+.+.||++... ++.+++|............+.+|+++++.+. |..++++++++...+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 334456877778888888999999754 6789999987542233456888999998884 67788999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED---------------------------------- 796 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------------------------------- 796 (845)
|||++|.+|.+.+. +......++.+++++|..||+.
T Consensus 89 ~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 89 MSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999999877631 1123457889999999999981
Q ss_pred ----------------------CCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 797 ----------------------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 797 ----------------------~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
.++.++|+|++|.||+++++..+.|+||+.|...
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 1134999999999999987666789999988653
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=3.2e-12 Score=140.29 Aligned_cols=102 Identities=20% Similarity=0.222 Sum_probs=65.3
Q ss_pred EecCC-CCCCCcccccccccccceeEeec-ccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCc
Q 003134 145 SVMGN-RLSGPFPKVLTNITTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN 222 (845)
Q Consensus 145 ~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 222 (845)
+++++ +|++ +|. |..+++|++|+|++ |+|++..+..|.+|++|++|+|++|+|++..|..|.+|++|++|+|++|+
T Consensus 14 ~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 91 (347)
T 2ifg_A 14 RCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (347)
T ss_dssp ECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence 44444 4443 455 66666677777764 66766555666677777777777777776666666777777777777777
Q ss_pred CcccCchhhcCCcccceEEecCCcCCC
Q 003134 223 FSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (845)
Q Consensus 223 l~~~~p~~~~~l~~L~~L~Ls~N~l~g 249 (845)
|++..+..|..++ |++|+|++|.|..
T Consensus 92 l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 92 LESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred cceeCHHHcccCC-ceEEEeeCCCccC
Confidence 7655555555554 6667777666653
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=8.9e-12 Score=122.40 Aligned_cols=117 Identities=23% Similarity=0.315 Sum_probs=93.5
Q ss_pred cchhhhhhccccCCCCCceEEeecCCceEEEEEeeeeeEEcCCccccccccEEEEEEeccccccccCccccccCCCCCce
Q 003134 482 AVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPI 561 (845)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~v~~i~i~~~~~~~~~~~~~~~~~~~~~~ 561 (845)
..++++|++||.++.+++|++.+..+|.|.|||||||+.++ ..++|+|+||||...+.++||+..++++ .+|+
T Consensus 51 ~~~~~lY~TaR~~~~~~tY~f~v~~~G~Y~VrLhF~ei~~~------~~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~ 123 (174)
T 2jwp_A 51 PEDQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAEVYFA------QSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAH 123 (174)
T ss_dssp HHHHHTTTCCCCCCSCEEEEEECCSCEEEEEEEEEECCSCC------CSSSSCEEEEETTEEEEEEECHHHHHSS-SSCE
T ss_pred CCCchhhhhhccCCCCeEEEEEeCCCeEEEEEEEEeccccC------CCCCeEeEEEECCEEeecCcCHHHhhCC-CeeE
Confidence 45788999999999999999999999999999999998754 3799999999999999999999988876 7899
Q ss_pred EeeeeeeeecceeEEEEeec-CCceeeecCC--CCCCCCcccccccc
Q 003134 562 VKNFPAEVTSHTLKIHLYWA-GRGTTGIPLR--GTYGPLISAISVKS 605 (845)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~p~~~~~~~~~ 605 (845)
.+.|.+.+.+..+++|..++ +.|...+... ..+.|.++++.+.+
T Consensus 124 ~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~a~inaIEI~~ 170 (174)
T 2jwp_A 124 DEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMK 170 (174)
T ss_dssp EEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCSSSEEEEEEES
T ss_pred EEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCCcEEEEEEEEe
Confidence 99999998887777665543 4444444321 13457777666543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=5e-11 Score=124.68 Aligned_cols=130 Identities=15% Similarity=0.091 Sum_probs=99.1
Q ss_pred cccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCc--eeeEEEEEEeCCEEEEEEeccCCCChhhh
Q 003134 685 GEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN--LVKLYGCCVEGNQLLLVYEYMKNNCLSRA 762 (845)
Q Consensus 685 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~ 762 (845)
+.|..+.||++...+|+.+++|..... ....+..|+++++.+.+.+ +++++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 456669999998777888999997653 2345778999988885544 567899888888899999999998884
Q ss_pred hhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 003134 763 IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS--------------------------------------------- 797 (845)
Q Consensus 763 l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------------- 797 (845)
... . ....++.++++.|..||+..
T Consensus 104 ~~~--------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 SSH--------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp TSC--------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cCc--------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 1 12367778888888888642
Q ss_pred ----------CCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 798 ----------RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 798 ----------~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
+..++|+|++|.||+++++..++|+|||.|...
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999987766789999998765
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.9e-10 Score=126.50 Aligned_cols=204 Identities=17% Similarity=0.155 Sum_probs=116.8
Q ss_pred ceeEEEecCCCCCC-C-------cccccccccccceeEeecccCC---------CCCCcccccCCCccEEEeecCcCccc
Q 003134 140 QLVELSVMGNRLSG-P-------FPKVLTNITTLKNLSIEGNLFT---------GSIPPDIRKLINLQKLILSSNSFTGE 202 (845)
Q Consensus 140 ~L~~L~Ls~N~l~~-~-------~p~~~~~l~~L~~L~Ls~N~l~---------g~~p~~~~~l~~L~~L~Ls~N~l~g~ 202 (845)
+++.|.+......| . +..++..+++|+.|.+..+... +.++..+..+++|++|+|++|.-. .
T Consensus 108 ~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~ 186 (362)
T 2ra8_A 108 SLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-S 186 (362)
T ss_dssp GCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-B
T ss_pred hcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-e
Confidence 56777777666543 1 1334556788888888765432 123334455667777777666211 1
Q ss_pred CChhhhCCCCCCcEEeecCcCcccCchhhc--CCcccceEEecC--CcCCCCc-chhhhcCCCCCEEEcCCCCCCCCCCc
Q 003134 203 LPAELTKLTNLNDLRISDNNFSGKIPEFIG--KWKKIQKLHIQG--SSLEGPI-PASISALTSLTDLRISDLKGSESAFP 277 (845)
Q Consensus 203 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~g~~-p~~~~~l~~L~~L~Ls~n~~~~~~~~ 277 (845)
++. + .+++|++|+|..|.++......+. .+++|++|+|+. |...+.. ...+..+ ..
T Consensus 187 l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~-----------------l~ 247 (362)
T 2ra8_A 187 IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL-----------------FS 247 (362)
T ss_dssp CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGG-----------------SC
T ss_pred ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHH-----------------Hh
Confidence 222 2 256666666666666543333333 456666666542 2211110 0000000 00
Q ss_pred ccccCCccEEEccCCcCcccCccccc---CCCCcCEEeCCCCCCCCC----CchhhhcCCCcCEEEccCCcccCCCChhh
Q 003134 278 KLDKMNLKTLILTKCLIHGEIPDYIG---DMTKLKNIDLSFNNLTGG----IPTTFEKLAKTNFMYLTGNKLTGPVPKYI 350 (845)
Q Consensus 278 ~l~~~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~ip~~~ 350 (845)
.-...+|+.|+|++|.+....+..+. .+++|++|+|+.|.|++. ++..+..+++|+.|+|++|.++...-..+
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l 327 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHH
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHH
Confidence 00112678888888888765444433 578999999999999864 33444678999999999998875444444
Q ss_pred hc-CCceEEeecCC
Q 003134 351 FN-SNKNVDISLNN 363 (845)
Q Consensus 351 ~~-~l~~L~ls~N~ 363 (845)
.. ....++++.|+
T Consensus 328 ~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 328 QKSLPMKIDVSDSQ 341 (362)
T ss_dssp HHHCCSEEECCSBC
T ss_pred HHHcCCEEEecCCc
Confidence 43 23668888885
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.02 E-value=2.8e-09 Score=118.98 Aligned_cols=259 Identities=12% Similarity=0.062 Sum_probs=124.8
Q ss_pred eEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCC---------------------C
Q 003134 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGN---------------------R 150 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N---------------------~ 150 (845)
.++.+.+.. +++.+-..+|.++++|+.++|..+ ++.+...+|... +|+.+.+..+ .
T Consensus 72 ~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~~~~~~~~ 149 (394)
T 4fs7_A 72 KVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFKEITIPEG 149 (394)
T ss_dssp TEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCSEEECCTT
T ss_pred CceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecccccccccCcc
Confidence 455666642 355444456666777777776543 444444444444 3433333211 1
Q ss_pred CCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchh
Q 003134 151 LSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEF 230 (845)
Q Consensus 151 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 230 (845)
+......+|.++++|+.+.|.++..+ .....|.++.+|+.+++..| ++......|.++..|+.+.+.++... +.+.
T Consensus 150 ~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~ 225 (394)
T 4fs7_A 150 VTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDF 225 (394)
T ss_dssp CCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTT
T ss_pred ccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehh
Confidence 11112234445555555555443222 33334555555555555444 33233334445555554444433221 1111
Q ss_pred hcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCC--------------------Ccc-cccCCccEEEc
Q 003134 231 IGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA--------------------FPK-LDKMNLKTLIL 289 (845)
Q Consensus 231 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~--------------------~~~-l~~~~L~~L~L 289 (845)
+....+|+.+.+..+ ++......|.++.+|+.+.+..+...... ... ....+|+.+.+
T Consensus 226 ~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l 304 (394)
T 4fs7_A 226 ALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTEVKL 304 (394)
T ss_dssp TTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCEEEE
T ss_pred hcccCCCceEEECCC-ceecccccccccccceeEEcCCCcceeeccccccccccceeccCceeecccccccccccccccc
Confidence 112223333333221 11122334455555555555443221100 011 11226777777
Q ss_pred cCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhh---cCCceEEeecC
Q 003134 290 TKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLN 362 (845)
Q Consensus 290 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~---~~l~~L~ls~N 362 (845)
..+ ++.+...+|.++++|+.++|.++ ++.+...+|.++.+|+.+++..| ++ .|+...| .+|+.+++..|
T Consensus 305 ~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 305 LDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEEEGG
T ss_pred ccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEECCC
Confidence 544 66566667777778888877644 66555667777778887777666 55 3443332 25677777655
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.7e-10 Score=126.93 Aligned_cols=37 Identities=11% Similarity=0.028 Sum_probs=23.5
Q ss_pred cceEEEEEecCCCccc-c-------CCccccCCCCCCEEeccCCc
Q 003134 91 TCHVVTIALKAQNLTG-T-------LPTELSKLRYLKQLDLSRNC 127 (845)
Q Consensus 91 ~~~v~~L~l~~~~l~g-~-------~p~~l~~L~~L~~L~Ls~N~ 127 (845)
.++|+.|.+......| . +..++..+++|+.|.+..+.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~ 150 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDID 150 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcc
Confidence 4567777777655542 1 23345667889999887653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=8.9e-10 Score=121.41 Aligned_cols=142 Identities=15% Similarity=0.236 Sum_probs=106.8
Q ss_pred CCcccccCcEEEEEEEECCCcEEEEEEcC--ccc-ccchHHHHHHHHHHhcCC--CCceeeEEEEEEeC---CEEEEEEe
Q 003134 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLS--SKS-RQGNREFVNEIGMISAQQ--HPNLVKLYGCCVEG---NQLLLVYE 752 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~---~~~~lV~E 752 (845)
.+.++.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..++++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 5678999999999998754 578888876 332 123456788999998886 45688899988766 45899999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS----------------------------------- 797 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------- 797 (845)
|++|..+.+.. ...++..++..++.++++.|..||...
T Consensus 122 ~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 122 FVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred ecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99998775422 124678888999999999999999831
Q ss_pred --------------------CCCeEeCCCCCCCEEecCCCc--EEEEeeccceec
Q 003134 798 --------------------RIKIVHRDIKTSNVLLDKDLN--AKISDFGLAKLY 830 (845)
Q Consensus 798 --------------------~~~ivHrDLKp~NILld~~~~--~kl~DFGla~~~ 830 (845)
+..++|+|+++.|||++.++. +.|+||+.|..-
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999997753 689999998753
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.86 E-value=4.4e-08 Score=109.27 Aligned_cols=246 Identities=13% Similarity=0.139 Sum_probs=123.2
Q ss_pred CccccCCCCCCEEeccCCc---ccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccc
Q 003134 109 PTELSKLRYLKQLDLSRNC---LTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIR 184 (845)
Q Consensus 109 p~~l~~L~~L~~L~Ls~N~---l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 184 (845)
..+|.++++|+.+.++.|. ++.+...+|... +|+.+.+..+ ++.+....|.++.+|+.+.+..+. .......|.
T Consensus 80 ~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~~-~~I~~~~F~ 157 (394)
T 4gt6_A 80 SNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEGV-TSVADGMFS 157 (394)
T ss_dssp TTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTTC-CEECTTTTT
T ss_pred HHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccccccee-eeeccccee
Confidence 3455566666666665542 444444455444 4444444322 333334455555555555554332 223334455
Q ss_pred cCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcC-----------------
Q 003134 185 KLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL----------------- 247 (845)
Q Consensus 185 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l----------------- 247 (845)
.+.+|+.+.+..+ ++..-..+|.+ .+|+.+.+..+-.. ....+|..+.+|.......+..
T Consensus 158 ~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (394)
T 4gt6_A 158 YCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYA 234 (394)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEE
T ss_pred cccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceecccccccccccceeeccccccccc
Confidence 5555555555443 23222233332 34555555433222 3334444444444443322211
Q ss_pred -------------------CCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCc
Q 003134 248 -------------------EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKL 308 (845)
Q Consensus 248 -------------------~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L 308 (845)
+..-..+|.++.+|+.+.+.++.............+|+.+.+. +.++.+...+|.++.+|
T Consensus 235 ~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L 313 (394)
T 4gt6_A 235 LIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISL 313 (394)
T ss_dssp EEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTC
T ss_pred ccccccccccceEEcCCcceEcccceeeecccccEEecccccceecCcccccccccccccCC-CcccccCceeecCCCCc
Confidence 1112335666667777766544322111111222367777774 45665666667777777
Q ss_pred CEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhh---cCCceEEeecCC
Q 003134 309 KNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNN 363 (845)
Q Consensus 309 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~---~~l~~L~ls~N~ 363 (845)
+.++|..| ++.+...+|.++.+|+.+.|..+ ++ .|....| .+|+.+++.+|.
T Consensus 314 ~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 314 KSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp CEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCH
T ss_pred CEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCce
Confidence 77777654 55455567777777777777544 54 4444433 257777777663
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.79 E-value=4.1e-08 Score=109.56 Aligned_cols=220 Identities=13% Similarity=0.129 Sum_probs=163.2
Q ss_pred CccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCC
Q 003134 109 PTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI 187 (845)
Q Consensus 109 p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 187 (845)
..+|.++++|+.+.|..+ ++.+...+|... +|+.+++..| ++.+....|.++..|+.+.+..+... +.+.+....
T Consensus 155 ~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~ 230 (394)
T 4fs7_A 155 DEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKT 230 (394)
T ss_dssp TTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTC
T ss_pred hhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccC
Confidence 456788888888888654 455666677776 7888887765 55555667888888888877766543 233444557
Q ss_pred CccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcC
Q 003134 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRIS 267 (845)
Q Consensus 188 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 267 (845)
+|+.+.+..+ ++......|.++.+|+.+.+..+..+ .....|..+..++.+.+..+.+. ...|..+.+|+.+.+.
T Consensus 231 ~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~ 305 (394)
T 4fs7_A 231 GVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLL 305 (394)
T ss_dssp CCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEEC
T ss_pred CCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccc
Confidence 7888888654 34344566888889999998887655 66778888888888888776543 4578888999999887
Q ss_pred CCCCCCCCCccccc-CCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCC
Q 003134 268 DLKGSESAFPKLDK-MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 340 (845)
Q Consensus 268 ~n~~~~~~~~~l~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N 340 (845)
++ +..+....+.. .+|+.++|..+ ++.+...+|.++++|+.++|..| ++.....+|.++++|+.+++..|
T Consensus 306 ~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 306 DS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred cc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 64 44444455554 48999999754 77777889999999999999887 77677789999999999999765
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.72 E-value=1.4e-07 Score=105.19 Aligned_cols=258 Identities=10% Similarity=0.099 Sum_probs=170.9
Q ss_pred eEEEEEecCC---CccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCccccccccccccee
Q 003134 93 HVVTIALKAQ---NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNL 168 (845)
Q Consensus 93 ~v~~L~l~~~---~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 168 (845)
.++.+.+..+ .++..-..+|.++.+|+.+.+..+ ++.+...+|... +|+.+.+..+ +..+....|..+.+|+.+
T Consensus 88 ~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i 165 (394)
T 4gt6_A 88 SLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTV 165 (394)
T ss_dssp TCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEE
T ss_pred cCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecccceecccccccc
Confidence 4556666543 255444567888888888888654 666666777777 7888888643 444556678888888888
Q ss_pred EeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCc--------------------------
Q 003134 169 SIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNN-------------------------- 222 (845)
Q Consensus 169 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~-------------------------- 222 (845)
.+..+ ++..-...|. ..+|+.+.+..+-.. ....+|.++.+|+......+.
T Consensus 166 ~~~~~-~~~I~~~aF~-~~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (394)
T 4gt6_A 166 TLPDS-VTAIEERAFT-GTALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQR 242 (394)
T ss_dssp ECCTT-CCEECTTTTT-TCCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTC
T ss_pred cccce-eeEecccccc-ccceeEEEECCcccc-cccchhhhccccceecccccccccccceeeccccccccccccccccc
Confidence 88765 4423334454 356777777655332 444556666666555443322
Q ss_pred ----------CcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCccccc-CCccEEEccC
Q 003134 223 ----------FSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTK 291 (845)
Q Consensus 223 ----------l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~-~~L~~L~Ls~ 291 (845)
++..-..+|.++.+|+.+.+..+..+ ....+|.++.+|+.+.+.. .+.......+.. .+|+.++|..
T Consensus 243 ~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~~-~i~~I~~~aF~~c~~L~~i~lp~ 320 (394)
T 4gt6_A 243 EDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFSS-RITELPESVFAGCISLKSIDIPE 320 (394)
T ss_dssp CCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCT
T ss_pred ccceEEcCCcceEcccceeeecccccEEecccccce-ecCcccccccccccccCCC-cccccCceeecCCCCcCEEEeCC
Confidence 22233456788889999998766543 5567889999999999863 455555555555 3899999976
Q ss_pred CcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhh--hcCCceEEeecC
Q 003134 292 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLN 362 (845)
Q Consensus 292 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~--~~~l~~L~ls~N 362 (845)
+ ++.+...+|.++++|+.+.|..+ ++.+-..+|.++++|+.+++.+|.... ..+ ...|+.+.+..|
T Consensus 321 ~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~ 388 (394)
T 4gt6_A 321 G-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPG 388 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC--------
T ss_pred c-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCC
Confidence 5 77777889999999999999765 776777899999999999999986542 122 235677766655
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.58 E-value=1.1e-09 Score=114.60 Aligned_cols=104 Identities=23% Similarity=0.268 Sum_probs=64.5
Q ss_pred cccccccce--eEeecccCCCCCCc----ccccCCCccEEEeecCcCcc--cCChhhhCCCCCCcEEeecCcCcccCchh
Q 003134 159 LTNITTLKN--LSIEGNLFTGSIPP----DIRKLINLQKLILSSNSFTG--ELPAELTKLTNLNDLRISDNNFSGKIPEF 230 (845)
Q Consensus 159 ~~~l~~L~~--L~Ls~N~l~g~~p~----~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 230 (845)
|...+.|+. ++++.|+.. .++. ...++++|++|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..
T Consensus 137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~ 213 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE 213 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence 444445554 556666433 2222 22456777777777777776 4456666777777777777777754 23
Q ss_pred hcCCc--ccceEEecCCcCCCCcc-------hhhhcCCCCCEEE
Q 003134 231 IGKWK--KIQKLHIQGSSLEGPIP-------ASISALTSLTDLR 265 (845)
Q Consensus 231 ~~~l~--~L~~L~Ls~N~l~g~~p-------~~~~~l~~L~~L~ 265 (845)
+..+. +|++|+|++|.+.+.+| ..+..+++|+.||
T Consensus 214 l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 214 LDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 34444 77778888888776554 3467788888875
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.55 E-value=1e-06 Score=97.46 Aligned_cols=267 Identities=13% Similarity=0.116 Sum_probs=167.3
Q ss_pred eEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeec
Q 003134 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 172 (845)
+++.+.+. .+++.+-..+|.++++|+.++|.. .++.+...+|...+|+.+.+..+ +..+...+|.. .+|+.+.+..
T Consensus 47 ~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~-~v~~Ig~~aF~~c~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~ 122 (379)
T 4h09_A 47 RISEVRVN-SGITSIGEANFNSCYNMTKVTVAS-TVTSIGDGAFADTKLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPG 122 (379)
T ss_dssp GCSEEEEC-TTEEEECTTTTTTCTTCCEEEECT-TCCEECTTTTTTCCCCEEEECTT-CCEECTTTTTT-CCCSEEECCT
T ss_pred CCEEEEeC-CCccChHHHHhhCCCCCCEEEeCC-cceEechhhhcCCCCceEECCce-eeEeccceecc-CCcccccCCC
Confidence 45666664 456655567899999999999975 47877788888888888877643 55444555655 4788888876
Q ss_pred ccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcC-----------------------------
Q 003134 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF----------------------------- 223 (845)
Q Consensus 173 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l----------------------------- 223 (845)
+-.. .....|.+ .+|+.+.+..+ ++......|.++.+|+.+.+..+..
T Consensus 123 ~~~~-i~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (379)
T 4h09_A 123 ATTE-IGNYIFYN-SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEF 199 (379)
T ss_dssp TCCE-ECTTTTTT-CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEE
T ss_pred cccc-cccccccc-ceeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecccccccccccc
Confidence 5322 22233333 24555554433 2323344455555555544433221
Q ss_pred ------cccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcc
Q 003134 224 ------SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHG 296 (845)
Q Consensus 224 ------~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~ 296 (845)
+......+....+|+.+.+..+ +......+|.++.+|+.+.+..+ +.......+... +|+.+.+..+ ++.
T Consensus 200 ~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~ 276 (379)
T 4h09_A 200 TIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKT 276 (379)
T ss_dssp ECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSE
T ss_pred ccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-cee
Confidence 1122345556677888877654 44455667788888888888654 333333333333 6888888543 665
Q ss_pred cCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhh---cCCceEEeecCCCcCCCCCCC
Q 003134 297 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESSDPI 372 (845)
Q Consensus 297 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~---~~l~~L~ls~N~l~~~~p~~~ 372 (845)
.....|.++++|+.+++.+|.++.+...+|.++.+|+.+.|..+ ++ .|...-| .+|+.+++..+ ++......|
T Consensus 277 i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF 352 (379)
T 4h09_A 277 VPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISYPKS-ITLIESGAF 352 (379)
T ss_dssp ECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECTTTT
T ss_pred ccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEECCc-cCEEchhHh
Confidence 66677888899999999888888667788888899999888755 55 4444433 25777777544 443333333
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.51 E-value=1.4e-08 Score=106.18 Aligned_cols=96 Identities=26% Similarity=0.384 Sum_probs=71.3
Q ss_pred EEecCCCCC---CCcccccccccccceeEeecccCCC--CCCcccccCCCccEEEeecCcCcccCChhhhCCC--CCCcE
Q 003134 144 LSVMGNRLS---GPFPKVLTNITTLKNLSIEGNLFTG--SIPPDIRKLINLQKLILSSNSFTGELPAELTKLT--NLNDL 216 (845)
Q Consensus 144 L~Ls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~--~L~~L 216 (845)
++++.|+.. +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 677777533 2222233567899999999999997 4567778899999999999999865 3344444 89999
Q ss_pred EeecCcCcccCc-------hhhcCCcccceEE
Q 003134 217 RISDNNFSGKIP-------EFIGKWKKIQKLH 241 (845)
Q Consensus 217 ~Ls~N~l~~~~p-------~~~~~l~~L~~L~ 241 (845)
+|++|.+++.+| ..+..+++|+.||
T Consensus 226 ~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 226 WLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp ECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred EccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 999999987665 3467788888876
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.49 E-value=1.3e-07 Score=101.45 Aligned_cols=137 Identities=18% Similarity=0.216 Sum_probs=101.0
Q ss_pred CCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCC-CCc--eeeEEEEEEeCC---EEEEEEecc
Q 003134 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPN--LVKLYGCCVEGN---QLLLVYEYM 754 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--Iv~l~~~~~~~~---~~~lV~Ey~ 754 (845)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +++++.+....+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 45888886532 23467889999998773 332 455555543333 348899999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-------------------------------------- 796 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-------------------------------------- 796 (845)
+|.++.+... ..++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 99 KGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred CCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9988865432 2467778888999999999999862
Q ss_pred -----------------CCCCeEeCCCCCCCEEecC--CCcEEEEeeccceec
Q 003134 797 -----------------SRIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKLY 830 (845)
Q Consensus 797 -----------------~~~~ivHrDLKp~NILld~--~~~~kl~DFGla~~~ 830 (845)
.++.++|+|++|.||++++ +..+.|+||+.+..-
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1245899999999999998 456899999998765
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.40 E-value=5.7e-08 Score=96.28 Aligned_cols=90 Identities=17% Similarity=0.205 Sum_probs=43.2
Q ss_pred cccccccceeEeecc-cCCCC----CCcccccCCCccEEEeecCcCccc----CChhhhCCCCCCcEEeecCcCccc---
Q 003134 159 LTNITTLKNLSIEGN-LFTGS----IPPDIRKLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGK--- 226 (845)
Q Consensus 159 ~~~l~~L~~L~Ls~N-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~--- 226 (845)
+...+.|++|+|++| .|... +...+...++|++|+|++|+|... +...+...++|++|+|++|+|+..
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 334455555555555 54421 112233445555555555555421 222333445556666666655532
Q ss_pred -CchhhcCCcccceEEe--cCCcCC
Q 003134 227 -IPEFIGKWKKIQKLHI--QGSSLE 248 (845)
Q Consensus 227 -~p~~~~~l~~L~~L~L--s~N~l~ 248 (845)
+...+...++|++|+| ++|.|.
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHhCCCceEEEecCCCCCCC
Confidence 2334444455555555 555554
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.2e-06 Score=94.17 Aligned_cols=138 Identities=17% Similarity=0.177 Sum_probs=97.3
Q ss_pred CCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCC---ceeeEEEEEE-eCCEEEEEEeccCC
Q 003134 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP---NLVKLYGCCV-EGNQLLLVYEYMKN 756 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~-~~~~~~lV~Ey~~~ 756 (845)
.+.++.|....||+. +..+++|+... ......+..|.++|..+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888899987 56678887532 22346788999999998653 3677777775 34567899999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED---------------------------------------- 796 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------------------------------------- 796 (845)
..+.+.... .++..++..++.++++.|..||+.
T Consensus 98 ~~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 98 QILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp EECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred eECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 888663211 234455555666666666665543
Q ss_pred -----------------CCCCeEeCCCCCCCEEecC---CCc-EEEEeeccceecC
Q 003134 797 -----------------SRIKIVHRDIKTSNVLLDK---DLN-AKISDFGLAKLYE 831 (845)
Q Consensus 797 -----------------~~~~ivHrDLKp~NILld~---~~~-~kl~DFGla~~~~ 831 (845)
.++.++|+|++|.||+++. ++. +.|+||+.+..-.
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2335799999999999987 455 5899999887653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=1.6e-06 Score=90.99 Aligned_cols=136 Identities=13% Similarity=0.095 Sum_probs=98.2
Q ss_pred cccccCcE-EEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEEEEeccCCCCh
Q 003134 683 KVGEGGFG-SVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMKNNCL 759 (845)
Q Consensus 683 ~ig~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL 759 (845)
.+..|..+ .||+.... ++..+++|+-... ...++.+|.+.|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455554 68988765 4667888876433 3456788999888763 33477899999999999999999999888
Q ss_pred hhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 003134 760 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS------------------------------------------ 797 (845)
Q Consensus 760 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------------------------------------------ 797 (845)
.+.... .......++.++++.|.-||...
T Consensus 108 ~~~~~~---------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 108 FQVLEE---------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHH---------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccC---------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 765422 12234456666777777776421
Q ss_pred -------------CCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 798 -------------RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 798 -------------~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
++.++|+|+.+.|||+++++.+-|+||+.+...
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 113799999999999998777789999998754
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.34 E-value=1.2e-07 Score=93.96 Aligned_cols=117 Identities=15% Similarity=0.179 Sum_probs=72.7
Q ss_pred ChhhhCCCCCCcEEeecC-cCccc----CchhhcCCcccceEEecCCcCCCC----cchhhhcCCCCCEEEcCCCCCCCC
Q 003134 204 PAELTKLTNLNDLRISDN-NFSGK----IPEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSES 274 (845)
Q Consensus 204 p~~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~n~~~~~ 274 (845)
...+...++|++|+|++| +|... +...+...++|++|+|++|+|... +...+...++|+
T Consensus 29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~------------ 96 (185)
T 1io0_A 29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLK------------ 96 (185)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCC------------
T ss_pred HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcC------------
Confidence 344566778888888888 77632 334555567777777777777642 223333334444
Q ss_pred CCcccccCCccEEEccCCcCccc----CcccccCCCCcCEEeC--CCCCCCCC----CchhhhcCCCcCEEEccCCccc
Q 003134 275 AFPKLDKMNLKTLILTKCLIHGE----IPDYIGDMTKLKNIDL--SFNNLTGG----IPTTFEKLAKTNFMYLTGNKLT 343 (845)
Q Consensus 275 ~~~~l~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~ 343 (845)
+|+|++|.|... +...+...+.|++|+| ++|.|+.. +...+...+.|++|+|++|.+.
T Consensus 97 -----------~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 97 -----------SLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp -----------EEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred -----------EEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 445555555433 3445566677888888 77887743 2344555677888888888775
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=5.8e-07 Score=83.40 Aligned_cols=73 Identities=19% Similarity=0.171 Sum_probs=54.9
Q ss_pred EEEccCCcCc-ccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCC
Q 003134 286 TLILTKCLIH-GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNF 364 (845)
Q Consensus 286 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l 364 (845)
.++.+++.++ ..+|..+. ++|++|+|++|+|+...+..|..+++|+.|+|++|
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N------------------------ 65 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGAN------------------------ 65 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSS------------------------
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCC------------------------
Confidence 5667777775 34554433 46888888888888777777788888877777766
Q ss_pred cCCCCCCCCCCCCCceeeeeecCCCC
Q 003134 365 TWESSDPIECPRGSVNLVESYSSPRN 390 (845)
Q Consensus 365 ~~~~p~~~~c~~~~~~~l~~l~~~~n 390 (845)
||.|+|...++..|+.....
T Consensus 66 ------P~~CdC~l~~l~~wl~~~~~ 85 (130)
T 3rfe_A 66 ------PWRCDCRLVPLRAWLAGRPE 85 (130)
T ss_dssp ------CCBCSGGGHHHHHHHHTSSC
T ss_pred ------CeeccCccHHHHHHHHhCcc
Confidence 89999999999999986543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.28 E-value=1e-05 Score=89.27 Aligned_cols=240 Identities=14% Similarity=0.085 Sum_probs=157.4
Q ss_pred eEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeec
Q 003134 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 172 (845)
.++.+.|.. +++.+-..+|.+. +|+.+.+.. .++.+...+|...+|+.+.+..+ +..+....|.+. +|+.+.+..
T Consensus 70 ~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~-~l~~I~~~aF~~~~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~ 144 (379)
T 4h09_A 70 NMTKVTVAS-TVTSIGDGAFADT-KLQSYTGME-RVKKFGDYVFQGTDLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPK 144 (379)
T ss_dssp TCCEEEECT-TCCEECTTTTTTC-CCCEEEECT-TCCEECTTTTTTCCCSEEECCTT-CCEECTTTTTTC-CCCEEEECT
T ss_pred CCCEEEeCC-cceEechhhhcCC-CCceEECCc-eeeEeccceeccCCcccccCCCc-cccccccccccc-eeeeeeccc
Confidence 577777764 4665555667776 577777654 35555566666667777777644 222223333332 344444433
Q ss_pred ccCCCCCCcccccCCCccEEEeecCc-----------------------------------CcccCChhhhCCCCCCcEE
Q 003134 173 NLFTGSIPPDIRKLINLQKLILSSNS-----------------------------------FTGELPAELTKLTNLNDLR 217 (845)
Q Consensus 173 N~l~g~~p~~~~~l~~L~~L~Ls~N~-----------------------------------l~g~~p~~~~~l~~L~~L~ 217 (845)
+ ++......|..+.+|+.+.+..+. ........+....+|+.+.
T Consensus 145 ~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~ 223 (379)
T 4h09_A 145 S-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKKIT 223 (379)
T ss_dssp T-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTTTTCSSCSEEE
T ss_pred e-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeecccccccccceee
Confidence 2 222223344444444444443221 1113344566778889888
Q ss_pred eecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCccccc-CCccEEEccCCcCcc
Q 003134 218 ISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDK-MNLKTLILTKCLIHG 296 (845)
Q Consensus 218 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~-~~L~~L~Ls~N~l~~ 296 (845)
+..+ ++......|.++.+|+.+.+..+ ++..-..+|.++.+|+.+.+..+ +.......+.. .+|+.+.+.++.++.
T Consensus 224 ~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~ 300 (379)
T 4h09_A 224 ITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIET 300 (379)
T ss_dssp CCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCE
T ss_pred eccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccce
Confidence 8665 55466778888999999999776 66566778889999999988654 44444444444 389999999999998
Q ss_pred cCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCccc
Q 003134 297 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 343 (845)
Q Consensus 297 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~ 343 (845)
+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+.+..+ ++
T Consensus 301 I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~ 345 (379)
T 4h09_A 301 LEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-IT 345 (379)
T ss_dssp ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CC
T ss_pred ehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cC
Confidence 88889999999999999765 77566788999999999988655 54
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=1.5e-06 Score=95.18 Aligned_cols=81 Identities=6% Similarity=0.009 Sum_probs=56.5
Q ss_pred CCcc-cccCcEEEEEEEEC-------CCcEEEEEEcCccc---ccchHHHHHHHHHHhcCCC---CceeeEEEEEEeC--
Q 003134 681 ANKV-GEGGFGSVYKGILS-------DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQH---PNLVKLYGCCVEG-- 744 (845)
Q Consensus 681 ~~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H---~nIv~l~~~~~~~-- 744 (845)
.+.| +.|....+|+.... +++.+++|...... ......+..|+++++.+.. -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3556 78888999998764 26678899875432 1122456788888887742 3577888887654
Q ss_pred -CEEEEEEeccCCCChhh
Q 003134 745 -NQLLLVYEYMKNNCLSR 761 (845)
Q Consensus 745 -~~~~lV~Ey~~~gsL~~ 761 (845)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.96 E-value=1.8e-05 Score=85.72 Aligned_cols=143 Identities=15% Similarity=0.225 Sum_probs=81.6
Q ss_pred CcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCC--CceeeEEE------EEEeCCEEEEEEec
Q 003134 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--PNLVKLYG------CCVEGNQLLLVYEY 753 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~------~~~~~~~~~lV~Ey 753 (845)
+.|+.|..+.||++...++ .+++|+.... ..++..|.+++..+.. -.+++++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3455667889999987655 4889988652 2334445555544421 12334433 12356788999999
Q ss_pred cCCCChh--------------hhhhcCCccc--c-------cCCCHHHH-------------------------------
Q 003134 754 MKNNCLS--------------RAIFGKDTEY--R-------LKLDWPTR------------------------------- 779 (845)
Q Consensus 754 ~~~gsL~--------------~~l~~~~~~~--~-------~~l~~~~~------------------------------- 779 (845)
++|..+. ..+|...... . ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987542 1122110000 0 01122211
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 780 KKICIGIARGLAYLHE----------DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 780 ~~i~~~ia~aL~yLH~----------~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
..+..++..++++|++ ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111234456777763 1245699999999999998888999999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=2.3e-05 Score=87.22 Aligned_cols=75 Identities=12% Similarity=0.147 Sum_probs=49.9
Q ss_pred CCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc-------cchHHHHHHHHHHhcCCC---CceeeEEEEEEeCCEEEE
Q 003134 681 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-------QGNREFVNEIGMISAQQH---PNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H---~nIv~l~~~~~~~~~~~l 749 (845)
.+.+|.|..+.||++... +++.+++|....... ....++..|.+++..+.. ..+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999754 467899997653211 123456778888887632 345566654 4455689
Q ss_pred EEeccCCC
Q 003134 750 VYEYMKNN 757 (845)
Q Consensus 750 V~Ey~~~g 757 (845)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00022 Score=76.34 Aligned_cols=140 Identities=14% Similarity=0.149 Sum_probs=92.9
Q ss_pred CCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCC---CCceeeEEEEEEeCCEEEEEEeccCCC
Q 003134 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEGNQLLLVYEYMKNN 757 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~Ey~~~g 757 (845)
.+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.+. ...++++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45788999999999886 4667888886542 3567888998888773 367889999988888999999999988
Q ss_pred Chhh-----------hhhcCCc--ccc---------------cCCCHHHHH---HHHH----------------HHHH-H
Q 003134 758 CLSR-----------AIFGKDT--EYR---------------LKLDWPTRK---KICI----------------GIAR-G 789 (845)
Q Consensus 758 sL~~-----------~l~~~~~--~~~---------------~~l~~~~~~---~i~~----------------~ia~-a 789 (845)
.+.. .+|.... ... ..-+|.+.. ++.. .+.+ .
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 2333211 000 012454321 1111 1111 1
Q ss_pred HHHHHh-CCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 790 LAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 790 L~yLH~-~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
.+.|.. ..++.++|+|+.+.|++++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223322 2356799999999999999887 8899984
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.59 E-value=5.5e-05 Score=73.37 Aligned_cols=84 Identities=10% Similarity=0.127 Sum_probs=45.6
Q ss_pred cccceeEeecccCCCCCCcccccCCCccEEEeecCc-CcccCChhhhCC----CCCCcEEeecCc-CcccCchhhcCCcc
Q 003134 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNS-FTGELPAELTKL----TNLNDLRISDNN-FSGKIPEFIGKWKK 236 (845)
Q Consensus 163 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 236 (845)
-+|+.|||+++.++..--..+..+++|++|+|+++. |+..--..++.+ ++|++|+|+++. +|..--..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356777777766664434445566666666666663 443322334443 246666666653 55333334455555
Q ss_pred cceEEecCCc
Q 003134 237 IQKLHIQGSS 246 (845)
Q Consensus 237 L~~L~Ls~N~ 246 (845)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 5555555543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.57 E-value=3.9e-05 Score=74.42 Aligned_cols=88 Identities=10% Similarity=0.084 Sum_probs=67.6
Q ss_pred cccceeEEEecCCCCCCCcccccccccccceeEeeccc-CCCCCCcccccC----CCccEEEeecCc-CcccCChhhhCC
Q 003134 137 ASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNL-FTGSIPPDIRKL----INLQKLILSSNS-FTGELPAELTKL 210 (845)
Q Consensus 137 ~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l----~~L~~L~Ls~N~-l~g~~p~~~~~l 210 (845)
...+|+.|||+++.|+..--..+.++++|+.|+|+++. |+..--..++.+ ++|++|+|+++. ++..--..+.++
T Consensus 59 ~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~ 138 (176)
T 3e4g_A 59 DKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHF 138 (176)
T ss_dssp TCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGC
T ss_pred CCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcC
Confidence 45589999999999887767778889999999999985 774333345554 369999999974 775444567889
Q ss_pred CCCCcEEeecCc-Cc
Q 003134 211 TNLNDLRISDNN-FS 224 (845)
Q Consensus 211 ~~L~~L~Ls~N~-l~ 224 (845)
++|++|+|+++. ++
T Consensus 139 ~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 139 RNLKYLFLSDLPGVK 153 (176)
T ss_dssp TTCCEEEEESCTTCC
T ss_pred CCCCEEECCCCCCCC
Confidence 999999999875 44
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00024 Score=75.07 Aligned_cols=77 Identities=18% Similarity=0.173 Sum_probs=57.3
Q ss_pred CCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCC---CceeeEEEEEEeCCEEEEEEeccC
Q 003134 679 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH---PNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 679 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
...+.+|.|..+.||+.+..+|+.|.+|+...........|..|.+.|+.+.- --+++++++ .. -++||||++
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~l~ 93 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEWVD 93 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEECCC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEeec
Confidence 34667899999999999999999999998765544445678899998887732 234555554 23 378999998
Q ss_pred CCCh
Q 003134 756 NNCL 759 (845)
Q Consensus 756 ~gsL 759 (845)
++..
T Consensus 94 ~~~~ 97 (288)
T 3f7w_A 94 ERPP 97 (288)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00031 Score=78.59 Aligned_cols=73 Identities=15% Similarity=0.166 Sum_probs=45.8
Q ss_pred CCcccccCcEEEEEEEECCCcEEEEEEcCcc------c-c--cchHHHHHHHHHHh-cCCCCceeeEEEEEEeCCEEEEE
Q 003134 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSK------S-R--QGNREFVNEIGMIS-AQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~------~-~--~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
.+.+|.|..+.||++.. +++.++||..... . . .....+..|+..+. ...+..+++++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46788999999999965 4678999943211 0 0 12233444443332 22334677777765 5667999
Q ss_pred Eecc-CC
Q 003134 751 YEYM-KN 756 (845)
Q Consensus 751 ~Ey~-~~ 756 (845)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.001 Score=71.31 Aligned_cols=161 Identities=13% Similarity=0.143 Sum_probs=89.1
Q ss_pred ccHHHHHHHhcCCCC-----CCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCc--eeeEE
Q 003134 666 YTLRQIKAATNNFDP-----ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN--LVKLY 738 (845)
Q Consensus 666 ~~~~~l~~~~~~y~~-----~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~ 738 (845)
++.+++...-..|.. .+.|+.|....+|+....++ .+++|..... ....++..|.+++..+.... +++++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344556555555654 23456687889999987655 5788988652 12234556777766653212 33333
Q ss_pred EE------EEeCCEEEEEEeccCCCChhh--------------hhhcCCcccccC-------CCHHHHHH----------
Q 003134 739 GC------CVEGNQLLLVYEYMKNNCLSR--------------AIFGKDTEYRLK-------LDWPTRKK---------- 781 (845)
Q Consensus 739 ~~------~~~~~~~~lV~Ey~~~gsL~~--------------~l~~~~~~~~~~-------l~~~~~~~---------- 781 (845)
.. ....+..++||||++|..+.. .+|........+ ..|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 223467899999999865421 122110000000 11222100
Q ss_pred --HHHHHHHHHHHHHhC----CCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 782 --ICIGIARGLAYLHED----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 782 --i~~~ia~aL~yLH~~----~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
+...+.+.++++++. .+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244556666532 234699999999999999876668999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0023 Score=68.60 Aligned_cols=144 Identities=11% Similarity=0.033 Sum_probs=82.7
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCC--ceeeEEEE-----EEeCCEEEEEEeccC
Q 003134 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP--NLVKLYGC-----CVEGNQLLLVYEYMK 755 (845)
Q Consensus 683 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~-----~~~~~~~~lV~Ey~~ 755 (845)
.++ |....||+....+|+.+++|...... ....++..|.+++..+... .+++++.. ....+..++||||++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 455 77789999887677789999986431 2345667788877766322 24444442 223567789999998
Q ss_pred CCChhh--------------hhhcC----CcccccCCCHHHH----H---------------HHHHHHHHHHHHHHhC--
Q 003134 756 NNCLSR--------------AIFGK----DTEYRLKLDWPTR----K---------------KICIGIARGLAYLHED-- 796 (845)
Q Consensus 756 ~gsL~~--------------~l~~~----~~~~~~~l~~~~~----~---------------~i~~~ia~aL~yLH~~-- 796 (845)
|..+.. .+|.. ........++... . .+...+.+.++.+...
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 855321 01110 0000011222110 0 0111112223333321
Q ss_pred --CCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 797 --SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 797 --~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
.+..++|+|+++.|||++ + .+.|+||+.+..-
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 234589999999999999 5 8999999887643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0024 Score=68.80 Aligned_cols=144 Identities=15% Similarity=0.121 Sum_probs=74.0
Q ss_pred CcccccCcEE-EEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCC--CceeeEEEEEEeCCEEEEEEeccCCCC
Q 003134 682 NKVGEGGFGS-VYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--PNLVKLYGCCVEGNQLLLVYEYMKNNC 758 (845)
Q Consensus 682 ~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~Ey~~~gs 758 (845)
+.++.|.... +|+....++..+++|....... .++..|++++..+.. -.+++++.+....+ ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4455554444 6677654466777776544321 223445666555532 34566776643333 78999998777
Q ss_pred hhhhhhcCCc---------------------ccccCCCHHHHH--------------------HHHHHHHHHHHHHH---
Q 003134 759 LSRAIFGKDT---------------------EYRLKLDWPTRK--------------------KICIGIARGLAYLH--- 794 (845)
Q Consensus 759 L~~~l~~~~~---------------------~~~~~l~~~~~~--------------------~i~~~ia~aL~yLH--- 794 (845)
+.+.+.+... .....++..... .....+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 6554432110 000011111100 00011122233331
Q ss_pred hCCCCCeEeCCCCCCCEEecCC----CcEEEEeeccceec
Q 003134 795 EDSRIKIVHRDIKTSNVLLDKD----LNAKISDFGLAKLY 830 (845)
Q Consensus 795 ~~~~~~ivHrDLKp~NILld~~----~~~kl~DFGla~~~ 830 (845)
...+..++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1224569999999999999875 67999999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00088 Score=71.18 Aligned_cols=141 Identities=12% Similarity=0.145 Sum_probs=75.2
Q ss_pred CCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCce-eeEEEEEEeCCEEEEEEecc-CCCC
Q 003134 681 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-VKLYGCCVEGNQLLLVYEYM-KNNC 758 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~Ey~-~~gs 758 (845)
.+.|+.|....+|++ ..+++|+....... .....+|.++++.+....+ .+++++ ..+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 677888999999998 45788887653211 1122457776665532222 456554 343457899999 6544
Q ss_pred hhh------------------hhhcCCcccccCCCH-HHHHHHHH--------------HHHHHH----HHHHh-CCCCC
Q 003134 759 LSR------------------AIFGKDTEYRLKLDW-PTRKKICI--------------GIARGL----AYLHE-DSRIK 800 (845)
Q Consensus 759 L~~------------------~l~~~~~~~~~~l~~-~~~~~i~~--------------~ia~aL----~yLH~-~~~~~ 800 (845)
+.. .+|..........+. .....+.. .+.+.+ +.+.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 421 112111100000111 11111100 011111 11111 22345
Q ss_pred eEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 801 IVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 801 ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
++|+|+.+.||+ ..++.+.++||..|..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 56678899999988754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0011 Score=72.98 Aligned_cols=144 Identities=18% Similarity=0.234 Sum_probs=84.1
Q ss_pred CCcccccCcEEEEEEEEC--------CCcEEEEEEcCcccccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEEEE
Q 003134 681 ANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.+.+..|-...+|++... +++.+++|+.... ......+.+|.++++.+. +.-..++++++. + .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEE
Confidence 345666777889998864 2478999987442 233456678988887763 222356666553 3 2899
Q ss_pred eccCCCChhhh-----------------hhcCCcccccCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 003134 752 EYMKNNCLSRA-----------------IFGKDTEYRLKLD--WPTRKKICIGIAR-------------------GLAYL 793 (845)
Q Consensus 752 Ey~~~gsL~~~-----------------l~~~~~~~~~~l~--~~~~~~i~~~ia~-------------------aL~yL 793 (845)
||++|..|... +|........... |.++.++..++.. .+++|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665311 1222111111122 3455555443321 23333
Q ss_pred H----hC-CCCCeEeCCCCCCCEEecCC----CcEEEEeecccee
Q 003134 794 H----ED-SRIKIVHRDIKTSNVLLDKD----LNAKISDFGLAKL 829 (845)
Q Consensus 794 H----~~-~~~~ivHrDLKp~NILld~~----~~~kl~DFGla~~ 829 (845)
. .. .+..++|+|+.+.||+++.+ +.+.|+||..|..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 22 23459999999999999876 7899999998874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00064 Score=76.25 Aligned_cols=73 Identities=18% Similarity=0.229 Sum_probs=49.5
Q ss_pred CCcccccCcEEEEEEEECC--------CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCce-eeEEEEEEeCCEEEEEE
Q 003134 681 ANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-VKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ 751 (845)
.+.|+.|-...+|++...+ +..+++|+.... .....+..|..++..+...++ +++++.+. + .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 4567888889999998753 478899988432 112456678888887743333 56776543 3 3899
Q ss_pred eccCCCCh
Q 003134 752 EYMKNNCL 759 (845)
Q Consensus 752 Ey~~~gsL 759 (845)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.00029 Score=69.64 Aligned_cols=113 Identities=12% Similarity=0.106 Sum_probs=58.9
Q ss_pred hhCCCCCCcEEeecC-cCccc----CchhhcCCcccceEEecCCcCCCC----cchhhhcCCCCCEEEcCCCCCCCCCCc
Q 003134 207 LTKLTNLNDLRISDN-NFSGK----IPEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFP 277 (845)
Q Consensus 207 ~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~n~~~~~~~~ 277 (845)
+.+-+.|++|+|++| +|... +-+.+..-+.|+.|+|++|+|... +...+..-+
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~------------------ 98 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSP------------------ 98 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCS------------------
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCC------------------
Confidence 344466777777764 65421 233444555666666666666532 222222333
Q ss_pred ccccCCccEEEccCCcCcccC----cccccCCCCcCEEeCCCCCC---CC----CCchhhhcCCCcCEEEccCCcc
Q 003134 278 KLDKMNLKTLILTKCLIHGEI----PDYIGDMTKLKNIDLSFNNL---TG----GIPTTFEKLAKTNFMYLTGNKL 342 (845)
Q Consensus 278 ~l~~~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l---~g----~~p~~~~~l~~L~~L~L~~N~l 342 (845)
.|++|+|++|.|.... -..+..-+.|++|+|++|.. .. .+-..+..-+.|+.|+++.|.+
T Consensus 99 -----tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 99 -----SLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp -----SCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred -----ccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 4555555555555332 23344456677777775532 21 1223455556677777766644
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00028 Score=69.67 Aligned_cols=116 Identities=14% Similarity=0.247 Sum_probs=75.6
Q ss_pred cccCCCccEEEeecC-cCccc----CChhhhCCCCCCcEEeecCcCccc----CchhhcCCcccceEEecCCcCCCCcch
Q 003134 183 IRKLINLQKLILSSN-SFTGE----LPAELTKLTNLNDLRISDNNFSGK----IPEFIGKWKKIQKLHIQGSSLEGPIPA 253 (845)
Q Consensus 183 ~~~l~~L~~L~Ls~N-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 253 (845)
+.+-+.|++|+|++| +|... +...+..-+.|+.|+|++|+|... +-..+..-+.|++|+|++|.|...--.
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 345678999999986 77632 344566678999999999999843 334555668999999999999854333
Q ss_pred ----hhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcc----cCcccccCCCCcCEEeCCCCCC
Q 003134 254 ----SISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG----EIPDYIGDMTKLKNIDLSFNNL 318 (845)
Q Consensus 254 ----~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l 318 (845)
++..-+.|+.|+|+++... .+.. .+...+..-+.|+.|+|+.|.+
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~--------------------~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQS--------------------VLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSC--------------------CCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhhCCceeEEECCCCcCc--------------------CcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 3333445555555433210 2221 1334455567778888877654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0035 Score=70.68 Aligned_cols=74 Identities=15% Similarity=0.068 Sum_probs=47.4
Q ss_pred CCcccccCcEEEEEEEECC-CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCce-eeEEEEEEeCCEEEEEEeccCCCC
Q 003134 681 ANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-VKLYGCCVEGNQLLLVYEYMKNNC 758 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~Ey~~~gs 758 (845)
.+.|+.|-...+|++...+ +..+++|+....... ...-..|..++..+...++ +++++++ .+ .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 4567888889999998865 478889987543211 1112478888887754444 5677766 33 25999999755
Q ss_pred h
Q 003134 759 L 759 (845)
Q Consensus 759 L 759 (845)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0019 Score=59.46 Aligned_cols=37 Identities=14% Similarity=0.357 Sum_probs=19.4
Q ss_pred CCCcEEeecCcCcccCchhhcCCcccceEEecCCcCC
Q 003134 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 212 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
+|++|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555555555444444555555555555555553
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0034 Score=68.67 Aligned_cols=73 Identities=10% Similarity=0.101 Sum_probs=43.4
Q ss_pred CcccccCcEEEEEEEECC---------CcEEEEEEcCcccccchHHHHHHHHHHhcCCCCc-eeeEEEEEEeCCEEEEEE
Q 003134 682 NKVGEGGFGSVYKGILSD---------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN-LVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lV~ 751 (845)
+.++.|....+|++...+ +..+++|+....... ......|.+++..+...+ ++++++.. .+ ++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 456778778999998754 267888987653221 112356777777664333 44666543 33 6899
Q ss_pred eccCCCCh
Q 003134 752 EYMKNNCL 759 (845)
Q Consensus 752 Ey~~~gsL 759 (845)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998644
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.98 E-value=0.016 Score=62.61 Aligned_cols=33 Identities=27% Similarity=0.400 Sum_probs=28.6
Q ss_pred CCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 798 ~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
+..++|+|+.+.||++++++.+.|+||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 346999999999999998888999999887654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.05 E-value=0.018 Score=64.14 Aligned_cols=143 Identities=9% Similarity=0.083 Sum_probs=83.0
Q ss_pred CCcccccCcEEEEEEEECC--------CcEEEEEEcCcccccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEEEE
Q 003134 681 ANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.+.+..|-...+|+....+ +..+++|+....... .....+|.++++.+. +.-.+++++.+ .+ ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 3456677778999998753 578899987543221 112346777777663 22245566533 33 6899
Q ss_pred eccCCCChhh-----------------hhhcCCc-----c---cccCCCHHHHHHHHHHH-------------------H
Q 003134 752 EYMKNNCLSR-----------------AIFGKDT-----E---YRLKLDWPTRKKICIGI-------------------A 787 (845)
Q Consensus 752 Ey~~~gsL~~-----------------~l~~~~~-----~---~~~~l~~~~~~~i~~~i-------------------a 787 (845)
||++|..|.. .+|.... . ...+.-|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999876421 0111111 0 01111233433333222 2
Q ss_pred HHHHHHHh---------------------CCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 788 RGLAYLHE---------------------DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 788 ~aL~yLH~---------------------~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
..+++|.+ ..+..++|+|+.+.||+ +.++.+.++||..|..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 23333321 12345899999999999 8888999999998874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.09 E-value=0.83 Score=50.20 Aligned_cols=29 Identities=24% Similarity=0.455 Sum_probs=24.9
Q ss_pred eEeCCCCCCCEEe------cCCCcEEEEeecccee
Q 003134 801 IVHRDIKTSNVLL------DKDLNAKISDFGLAKL 829 (845)
Q Consensus 801 ivHrDLKp~NILl------d~~~~~kl~DFGla~~ 829 (845)
++|+|+.+.|||+ +++..++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 845 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-46 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-41 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-41 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-39 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-38 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-07 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-46
Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 8/170 (4%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++G G FG V+ G + T +AVK L + F+ E ++ QH LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+LY + + ++ EYM+N L + +KL + IA G+A++ E
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
+HRD++ +N+L+ L+ KI+DFGLA+L E+++ +
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-46
Identities = 46/170 (27%), Positives = 84/170 (49%), Gaps = 9/170 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++G G FG+VYKG + + +++ + Q + F NE+G++ +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
G QL +V ++ + + L + +T K + I A+G+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHA 122
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGT 844
I+HRD+K++N+ L +DL KI DFGLA + +H +++G+
Sbjct: 123 K---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 1e-45
Identities = 38/165 (23%), Positives = 76/165 (46%), Gaps = 9/165 (5%)
Query: 674 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQH 731
++F+ +++G G G V+K G V+A K + + + R + E+ ++
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
P +V YG ++ + E+M L + + ++ K+ I + +GL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLT 118
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
YL + KI+HRD+K SN+L++ K+ DFG++ + +
Sbjct: 119 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 161
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-44
Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 8/170 (4%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+ ++G G FG V G +A+K + + EF+ E ++ H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+LYG C + + ++ EYM N CL + R + ++C + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
+ +HRD+ N L++ K+SDFGL++ +D+ S +
Sbjct: 119 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-44
Identities = 46/170 (27%), Positives = 85/170 (50%), Gaps = 8/170 (4%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+ ++G G FG V+ G + +A+K + + +F+ E ++ HP LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+LYG C+E + LV+E+M++ CLS + + + T +C+ + G+AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYLEE 119
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
++HRD+ N L+ ++ K+SDFG+ + +D+ ST +
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 5e-44
Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 12/167 (7%)
Query: 678 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 733
F ++G G FG+VY + + V+A+K++S +Q N ++ + E+ + +HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
++ GC + + LV EY + K L + G +GLAYL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYL 131
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 840
H ++HRD+K N+LL + K+ DFG A + + + T
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP 175
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 4e-43
Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 8/170 (4%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+ K+G+G FG V+ G + T +A+K L F+ E ++ +H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
+LY + +V EYM L + G+ +Y P + IA G+AY+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL---RLPQLVDMAAQIASGMAYVE- 130
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
R+ VHRD++ +N+L+ ++L K++DFGLA+L E+++ +
Sbjct: 131 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 4e-43
Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 8/161 (4%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 740
++G+G FG VYK + A K + +KS + +++ EI ++++ HPN+VKL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 800
N L ++ E+ + + E L + +C L YLH+ K
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLHD---NK 130
Query: 801 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 841
I+HRD+K N+L D + K++DFG++ + I
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 155 bits (393), Expect = 9e-43
Identities = 49/194 (25%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 666 YTLRQIKAATNNFDPA---------NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSK 711
+T A F +G G FG V G L +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 712 SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR 771
+ + R+F++E ++ HPN++ L G + ++++ E+M+N L + D ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 772 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831
+ GIA G+ YL + VHRD+ N+L++ +L K+SDFGL++ E
Sbjct: 126 ---TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 832 EDKTHISTRIAGTM 845
+D + + A
Sbjct: 180 DDTSDPTYTSALGG 193
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (384), Expect = 1e-41
Identities = 41/171 (23%), Positives = 76/171 (44%), Gaps = 8/171 (4%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+ +K+G G +G VY+G+ +AVK L + + EF+ E ++ +HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
V+L G C ++ E+M L + + R ++ + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLE 132
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
+ +HRD+ N L+ ++ K++DFGL++L D +
Sbjct: 133 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 8/170 (4%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 733
+++ +G G +G K SDG ++ K+L S + + V+E+ ++ +HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 734 LVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
+V+ Y ++ L +V EY + L+ I K T+ R LD ++ + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 792 YLHE--DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
H D ++HRD+K +NV LD N K+ DFGLA++ D +
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 7e-41
Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 669 RQIKAATNNFDPAN-KVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQGNRE-FVNEI 723
+++ +N A+ ++G G FGSV +G+ +A+K L + + + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 724 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 783
++ +P +V+L G C + L+LV E L + + GK R ++ ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELL 115
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 843
++ G+ YL E VHRD+ NVLL AKISDFGL+K D ++ + R AG
Sbjct: 116 HQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 844 T 844
Sbjct: 173 K 173
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 1e-40
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 30/205 (14%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNR-EFV 720
L ++ NN + +GEG FG V++ T++AVK L ++ + +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 721 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------------- 767
E +++ +PN+VKL G C G + L++EYM L+ +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 768 ------TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821
+ L + I +A G+AYL E K VHRD+ T N L+ +++ KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181
Query: 822 SDFGLAK-LYEEDKTHISTRIAGTM 845
+DFGL++ +Y D A +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPI 206
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-40
Identities = 48/190 (25%), Positives = 73/190 (38%), Gaps = 24/190 (12%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISA 728
N +G G FG V + +AVK L + RE ++E+ ++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 729 -QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK-------------DTEYRLKL 774
H N+V L G C G L++ EY L + K + L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 775 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
D +A+G+A+L +HRD+ N+LL KI DFGLA+ + D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 835 THISTRIAGT 844
++ A
Sbjct: 200 NYVVKGNARL 209
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-40
Identities = 54/173 (31%), Positives = 79/173 (45%), Gaps = 11/173 (6%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 733
++D +GEG +G V + +AVK + K E EI + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+VK YG EGN L EY L I + + P ++ + G+ YL
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYL 119
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED-KTHISTRIAGTM 845
H I I HRDIK N+LLD+ N KISDFGLA ++ + + + ++ GT+
Sbjct: 120 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-40
Identities = 45/182 (24%), Positives = 92/182 (50%), Gaps = 16/182 (8%)
Query: 667 TLRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF 719
L ++++ + DP K+G+G G+VY + ++ G +A++Q++ + +
Sbjct: 5 ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI 64
Query: 720 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 779
+NEI ++ ++PN+V + G++L +V EY+ L+ D +D
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQI 118
Query: 780 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
+C + L +LH + +++HRDIK+ N+LL D + K++DFG +++ ST
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 840 RI 841
+
Sbjct: 176 MV 177
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 5e-40
Identities = 47/162 (29%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
+G+G FG V G G +AVK + + + + F+ E +++ +H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 736 KLYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+L G VE L +V EYM L + + R L K + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
+ VHRD+ NVL+ +D AK+SDFGL K +
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 159
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-39
Identities = 45/197 (22%), Positives = 72/197 (36%), Gaps = 30/197 (15%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNRE-FVNEIGMISA 728
N + +G G FG V +AVK L K+ RE ++E+ M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 729 -QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK------------------DTE 769
H N+V L G C + L++EY L + K + E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 770 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK- 828
L + +A+G+ +L VHRD+ NVL+ KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 829 LYEEDKTHISTRIAGTM 845
+ + + +
Sbjct: 214 IMSDSNYVVRGNARLPV 230
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 47/174 (27%), Positives = 77/174 (44%), Gaps = 20/174 (11%)
Query: 683 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 742
+G+G FG V++G G +AVK SS+ + + EI +H N++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 743 EGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-- 796
+ N QL LV +Y ++ L + R + K+ + A GLA+LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 797 ---SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS---TRIAGT 844
+ I HRD+K+ N+L+ K+ I+D GLA ++ I GT
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 144 bits (363), Expect = 3e-38
Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 10/168 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+++D ++G G FG V++ + G A K + + EI +S +HP L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
V L+ + N+++++YE+M L + + K+ + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 795 EDSRIKIVHRDIKTSNVLLDKDLN--AKISDFGLAKLYEEDKTHISTR 840
E VH D+K N++ + K+ DFGL + ++ T
Sbjct: 142 E---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 186
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 4e-38
Identities = 43/174 (24%), Positives = 75/174 (43%), Gaps = 15/174 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
+F+ +G+G FG+VY ++A+K L + E+ + S +H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
PN+++LYG + ++ L+ EY + R + K D +A L+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALS 120
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
Y H +++HRDIK N+LL KI+DFG + + + GT+
Sbjct: 121 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTL 168
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 5e-38
Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 17/171 (9%)
Query: 682 NKVGEGGFGSVYKGILSD-GTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLY 738
++G G F +VYKG+ ++ +A +L + ++ + F E M+ QHPN+V+ Y
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 739 GCCVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
++LV E M + L + + + C I +GL +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129
Query: 795 EDSRIKIVHRDIKTSNVLL-DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ I+HRD+K N+ + + KI D GLA L + GT
Sbjct: 130 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGT 176
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 6e-38
Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 14/168 (8%)
Query: 682 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVK 736
++G G FG+V KG +AVK L +++ E + E ++ +P +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 737 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 796
+ G C E +LV E + L++ + + ++ ++ G+ YL E
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES 126
Query: 797 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
VHRD+ NVLL AKISDFGL+K D+ + + G
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 7e-38
Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 13/175 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQ 730
+ +GEG FG V++GI +A+K + + RE F+ E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
HP++VKL G E N + ++ E L + + LD + ++ L
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTAL 121
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
AYL + VHRDI NVL+ + K+ DFGL++ E+ + +++ +
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 143 bits (361), Expect = 7e-38
Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 15/170 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQ- 730
N+F +G GGFG VY +D G + A+K L K +QG +NE M+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 731 --HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
P +V + ++L + + M L + + I
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-----EADMRFYAAEIIL 118
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 838
GL ++H +V+RD+K +N+LLD+ + +ISD GLA + + K H S
Sbjct: 119 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 165
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-37
Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 19/181 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDG---TVIAVKQLS-SKSRQGNREFVNEIGMISA-QQ 730
N+ + +GEG FG V K + A+K++ S+ +R+F E+ ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-----------FGKDTEYRLKLDWPTR 779
HPN++ L G C L L EY + L + F L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 780 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
+ARG+ YL + + +HRD+ N+L+ ++ AKI+DFGL++ E
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 840 R 840
R
Sbjct: 187 R 187
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-37
Identities = 52/185 (28%), Positives = 92/185 (49%), Gaps = 17/185 (9%)
Query: 668 LRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTV----IAVKQLS-SKSRQGNREFVN 721
LR +K F +G G FG+VYKG+ + +G +A+K+L + S + N+E ++
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 722 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 781
E ++++ +P++ +L G C+ + L+ + M CL +
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNI----GSQYLLN 115
Query: 782 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTR 840
C+ IA+G+ YL ++VHRD+ NVL+ + KI+DFGLAK L E+K + +
Sbjct: 116 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 841 IAGTM 845
+
Sbjct: 173 GKVPI 177
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 140 bits (355), Expect = 4e-37
Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 10/167 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
+ +D ++G G FG V++ + + G V K +++ NEI +++ HP L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 735 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 794
+ L+ + +++L+ E++ L I +D K+ GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMH 144
Query: 795 EDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAKLYEEDKTHIST 839
E IVH DIK N++ + K + KI DFGLA D+ T
Sbjct: 145 E---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 188
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 6e-37
Identities = 50/176 (28%), Positives = 88/176 (50%), Gaps = 13/176 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGT-----VIAVKQLSSKSRQGNR-EFVNEIGMISAQ 729
+ +G G FG VYKG+L + +A+K L + + R +F+ E G++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 730 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
H N+++L G + ++++ EYM+N L + + KD + + GIA G
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAG 122
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
+ YL + VHRD+ N+L++ +L K+SDFGL+++ E+D T G +
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-36
Identities = 40/179 (22%), Positives = 72/179 (40%), Gaps = 17/179 (9%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSK---SRQGNREFVNEIGMISA 728
+ K+G+G FG V +G +AVK L + +F+ E+ + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
H NL++LYG + + +V E L + +++ T + + +A
Sbjct: 68 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH--ISTRIAGTM 845
G+ YL + +HRD+ N+LL KI DFGL + ++ H +
Sbjct: 123 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-35
Identities = 51/178 (28%), Positives = 78/178 (43%), Gaps = 18/178 (10%)
Query: 677 NFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISAQQH 731
+F+ +G G FG VY G L D AVK L+ + G +F+ E ++ H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 732 PNLVKLYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
PN++ L G C+ L+V YMK+ L I + + +A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGM 143
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY---EEDKTHISTRIAGTM 845
+L K VHRD+ N +LD+ K++DFGLA+ E D H T +
Sbjct: 144 KFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 6e-35
Identities = 44/183 (24%), Positives = 81/183 (44%), Gaps = 16/183 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLS-SKSRQGNREFVNEIGMISA 728
+ ++G+G FG VY+G+ T +A+K ++ + S + EF+NE ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-----FGKDTEYRLKLDWPTRKKIC 783
++V+L G +G L++ E M L + + ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 784 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIA 842
IA G+AYL+ + K VHRD+ N ++ +D KI DFG+ + +YE D +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 843 GTM 845
+
Sbjct: 197 LPV 199
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 8e-35
Identities = 45/191 (23%), Positives = 78/191 (40%), Gaps = 24/191 (12%)
Query: 676 NNFDPANKVGEGGFGSVYKGI------LSDGTVIAVKQLSSKSRQG-NREFVNEIGMISA 728
+ +G G FG V + + +AVK L + +R ++E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 729 QQH-PNLVKLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLD 775
H N+V L G C + G L+++ E+ K LS + K E Y+ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 776 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835
+A+G+ +L K +HRD+ N+LL + KI DFGLA+ +D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 836 HI-STRIAGTM 845
++ +
Sbjct: 190 YVRKGDARLPL 200
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 9e-35
Identities = 46/172 (26%), Positives = 69/172 (40%), Gaps = 12/172 (6%)
Query: 672 KAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMIS 727
K +F +GEG F +V L+ A+K L + E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 728 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
HP VKLY + +L Y KN L + I D + I
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIV 118
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
L YLH I+HRD+K N+LL++D++ +I+DFG AK+ +
Sbjct: 119 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-34
Identities = 38/167 (22%), Positives = 71/167 (42%), Gaps = 7/167 (4%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHP 732
+ + +GEG +G V + +A+K++S Q + + EI ++ +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
N++ + + Y+ + + ++ L I RGL Y
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY--KLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 839
+H ++HRD+K SN+LL+ + KI DFGLA++ + D H
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (329), Expect = 2e-34
Identities = 44/168 (26%), Positives = 82/168 (48%), Gaps = 10/168 (5%)
Query: 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 733
+ K+GEG +G VYK + G A+K++ + + EI ++ +H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+VKLY +L+LV+E++ + + L+ T K + + G+AY
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYC 116
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 841
H+ +++HRD+K N+L++++ KI+DFGLA+ + + I
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 129 bits (325), Expect = 1e-33
Identities = 41/166 (24%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
+F +G G FG V+ +G A+K L + + +E M+S H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
P +++++G + Q+ ++ +Y++ L + + P K + L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALE 118
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837
YLH I++RD+K N+LLDK+ + KI+DFG AK + +
Sbjct: 119 YLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL 161
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (319), Expect = 4e-33
Identities = 43/180 (23%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS---------SKSRQGNREFVNEIGMI 726
N++P +G G V + I AVK + + ++ + E+ ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 727 SA-QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 785
HPN+++L LV++ MK L + K L +KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRA 118
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
+ + LH+ + IVHRD+K N+LLD D+N K++DFG + + + + GT
Sbjct: 119 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTP 173
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 45/185 (24%), Positives = 75/185 (40%), Gaps = 24/185 (12%)
Query: 676 NNFDPANKVGEGGFGSVYKGIL--------SDGTVIAVKQLSSKSRQGN-REFVNEIGMI 726
+ +GEG FG V + T +AVK L S + + + + ++E+ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 727 SA-QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-----------FGKDTEYRLKL 774
+H N++ L G C + L ++ EY L + + +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 775 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834
+ARG+ YL K +HRD+ NVL+ +D KI+DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 835 THIST 839
+ T
Sbjct: 190 YYKKT 194
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (316), Expect = 2e-32
Identities = 41/178 (23%), Positives = 73/178 (41%), Gaps = 9/178 (5%)
Query: 669 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMI 726
+Q + + +D + +G G F V ++A+K ++ K+ +G NEI ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
+HPN+V L G L L+ + + L I K ++ +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQV 116
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
+ YLH+ + + LD+D ISDFGL+K+ ED + + GT
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGT 172
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-32
Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 10/168 (5%)
Query: 677 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 733
NF K+GEG +G VYK G V+A+K++ +++ + EI ++ HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+VKL N+L LV+E++ + D + P K + +GLA+
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 841
H +++HRD+K N+L++ + K++DFGLA+ + + +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-31
Identities = 30/160 (18%), Positives = 62/160 (38%), Gaps = 11/160 (6%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
+G G FG V++ + S K + K EI +++ +H N++ L+
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801
+L++++E++ + I +L+ + L +LH I
Sbjct: 71 ESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 802 VHRDIKTSNVLLDKDLNA--KISDFGLAKLYEEDKTHIST 839
H DI+ N++ ++ KI +FG A+ +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-31
Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 14/166 (8%)
Query: 682 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQG-----NREFVNEIGMISAQQHPNLV 735
+ +GEG F +VYK + ++A+K++ R NR + EI ++ HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 736 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 795
L + + LV+++M+ + + L L K + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVI-----IKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 796 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 841
I+HRD+K +N+LLD++ K++DFGLAK + + ++
Sbjct: 119 H---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-31
Identities = 48/171 (28%), Positives = 73/171 (42%), Gaps = 17/171 (9%)
Query: 677 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 735
++ +G G FG VY+ L G ++A+K++ R NRE + ++ H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 736 KLYGCCVEGNQ------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 789
+L + L LV +Y+ A + L K + R
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYMYQLFRS 134
Query: 790 LAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHIST 839
LAY+H I HRDIK N+LLD D K+ DFG AK + ++S
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-31
Identities = 47/175 (26%), Positives = 69/175 (39%), Gaps = 14/175 (8%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQ-Q 730
+F +G+G FG V+ A+K L + + + E ++S +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 731 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 790
HP L ++ L V EY+ L I K D I GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGL 116
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
+LH IV+RD+K N+LLDKD + KI+DFG+ K +T GT
Sbjct: 117 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTP 167
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 41/180 (22%), Positives = 81/180 (45%), Gaps = 13/180 (7%)
Query: 674 ATNNFDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNRE-----FVNEIGMI 726
A ++ ++GEG +G V+K + + G +A+K++ ++ + V + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 727 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG-KDTEYRLKLDWPTRKKICIG 785
+HPN+V+L+ C + + + + D + T K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 786 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTM 845
+ RGL +LH ++VHRD+K N+L+ K++DFGLA++Y T + T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 45/184 (24%), Positives = 88/184 (47%), Gaps = 22/184 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHP 732
+ ++ K+G+G FG V+K G +A+K++ ++ + + EI ++ +H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 733 NLVKLYGCCVEG--------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 784
N+V L C + LV+++ +++ G + +K K++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-----GLLSNVLVKFTLSEIKRVMQ 124
Query: 785 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT---HISTRI 841
+ GL Y+H + KI+HRD+K +NVL+ +D K++DFGLA+ + K + T
Sbjct: 125 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 842 AGTM 845
T+
Sbjct: 182 VVTL 185
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 6e-29
Identities = 48/173 (27%), Positives = 70/173 (40%), Gaps = 13/173 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 731
N+FD +G+G FG V + G A+K L + ++ V E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
P L L ++L V EY L + + + I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALE 119
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
YLH +V+RDIK N++LDKD + KI+DFGL K D GT
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGT 168
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 8e-29
Identities = 35/169 (20%), Positives = 74/169 (43%), Gaps = 11/169 (6%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHP 732
++ K+GEG +G+V+K ++A+K++ + EI ++ +H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 733 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 792
N+V+L+ +L LV+E+ + K + +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD-----PEIVKSFLFQLLKGLGF 116
Query: 793 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 841
H ++HRD+K N+L++++ K+++FGLA+ + S +
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 114 bits (285), Expect = 1e-28
Identities = 36/181 (19%), Positives = 71/181 (39%), Gaps = 18/181 (9%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS---SKSRQGNREFVNEIGMISAQQ 730
++ ++ +G GG V+ L +AVK L ++ F E +A
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 731 HPNLVKLYGCCVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
HP +V +Y G +V EY+ L + + + ++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADA 120
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI--STRIAGT 844
+ L + H+ I+HRD+K +N+++ K+ DFG+A+ + + + + GT
Sbjct: 121 CQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 845 M 845
Sbjct: 178 A 178
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 115 bits (289), Expect = 1e-28
Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 12/166 (7%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQH 731
+ FD +G G FG V G A+K L + ++ +NE ++ A
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
P LVKL + + L +V EY+ + + + P + I
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFE 155
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 837
YLH + +++RD+K N+L+D+ +++DFG AK + +
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL 198
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 7e-28
Identities = 38/172 (22%), Positives = 66/172 (38%), Gaps = 20/172 (11%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE------FVNEIGMISA--QQHPN 733
+G GGFGSVY GI +SD +A+K + E E+ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+++L + +L+ E + + R L + + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHC 126
Query: 794 HEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGT 844
H ++HRDIK N+L+D + K+ DFG L ++ T GT
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGT 172
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-27
Identities = 43/181 (23%), Positives = 71/181 (39%), Gaps = 21/181 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR------EFVNEIGMISA 728
+ +D ++G G F V K S G A K + + + +R + E+ ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 729 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 788
QHPN++ L+ ++L+ E + L + K+ L + I
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILN 124
Query: 789 GLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKISDFGLAKLYEEDKTHISTRIAGT 844
G+ YLH +I H D+K N++L KI DFGLA + I GT
Sbjct: 125 GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGT 179
Query: 845 M 845
Sbjct: 180 P 180
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (274), Expect = 5e-27
Identities = 41/166 (24%), Positives = 66/166 (39%), Gaps = 15/166 (9%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 734
N + K+G G FG +Y G ++ G +A+K K++ + E + Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 735 VKLYG-CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+ C EG+ ++V E + + F K T + + + Y+
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYI 119
Query: 794 HEDSRIKIVHRDIKTSNVL---LDKDLNAKISDFGLAKLYEEDKTH 836
H +HRD+K N L K I DFGLAK Y + +TH
Sbjct: 120 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 5e-27
Identities = 39/184 (21%), Positives = 74/184 (40%), Gaps = 23/184 (12%)
Query: 666 YTLRQIKAAT----NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNRE 718
+ +++ + VG G +G+V + G +A+K+L +S +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 719 FVNEIGMISAQQHPNLVKLYGCCVEGNQL------LLVYEYMKNNCLSRAIFGKDTEYRL 772
E+ ++ +H N++ L L LV +M +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE------- 116
Query: 773 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832
KL + + + +GL Y+H I+HRD+K N+ +++D KI DFGLA+ +
Sbjct: 117 KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173
Query: 833 DKTH 836
+ T
Sbjct: 174 EMTG 177
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 109 bits (274), Expect = 5e-27
Identities = 33/168 (19%), Positives = 62/168 (36%), Gaps = 17/168 (10%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMIS-AQQHPN 733
++ ++GEG FG +++G L + +A+K +S + +E
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 734 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 793
+ +Y EG +LV + + + K T + + +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD-----LCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 794 HEDSRIKIVHRDIKTSNVLLDKDL-----NAKISDFGLAKLYEEDKTH 836
HE +V+RDIK N L+ + + DFG+ K Y + T
Sbjct: 118 HE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 7e-27
Identities = 39/164 (23%), Positives = 61/164 (37%), Gaps = 18/164 (10%)
Query: 684 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC- 741
+G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYE 75
Query: 742 ---VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 798
LL+V E + L I + + +I I + YLH
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHS--- 129
Query: 799 IKIVHRDIKTSNVLLDK---DLNAKISDFGLAKLYEEDKTHIST 839
I I HRD+K N+L + K++DFG AK + +
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 173
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 107 bits (267), Expect = 7e-26
Identities = 35/166 (21%), Positives = 73/166 (43%), Gaps = 19/166 (11%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPN 733
+++ K+G G + V++ I +++ + VK L ++ + EI + + + PN
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 734 LVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
++ L + LV+E++ N + L + I + L
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFK--------QLYQTLTDYDIRFYMYEILKALD 143
Query: 792 YLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTH 836
Y H + I+HRD+K NV++D + ++ D+GLA+ Y + +
Sbjct: 144 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 1e-24
Identities = 40/178 (22%), Positives = 67/178 (37%), Gaps = 22/178 (12%)
Query: 676 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHP 732
+ +G G G V +A+K+LS +++ + E+ ++ H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 733 NLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 786
N++ L E + LV E M N +++LD + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV--------IQMELDHERMSYLLYQM 128
Query: 787 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 844
G+ +LH I HRD+K SN+++ D KI DFGLA+ T T
Sbjct: 129 LCGIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 181
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-24
Identities = 46/205 (22%), Positives = 86/205 (41%), Gaps = 22/205 (10%)
Query: 650 VSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAV 705
++ ELR +L T K NF+ +G G +G V+ G + A+
Sbjct: 3 LTVKHELRTANL-----TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAM 57
Query: 706 KQLS----SKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760
K L + + E ++ + P LV L+ +L L+ +Y+ L
Sbjct: 58 KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 117
Query: 761 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 820
+ ++ T ++ I + + L ++ I++RDIK N+LLD + +
Sbjct: 118 THLSQRE--------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169
Query: 821 ISDFGLAKLYEEDKTHISTRIAGTM 845
++DFGL+K + D+T + GT+
Sbjct: 170 LTDFGLSKEFVADETERAYDFCGTI 194
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 100 bits (249), Expect = 9e-24
Identities = 73/318 (22%), Positives = 116/318 (36%), Gaps = 23/318 (7%)
Query: 37 HAEEVKALKQIGRKLGK----KDWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATC 92
+ ++ +AL QI + LG W D C+ W V CD + T
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTWL-----------GVLCDTDTQTY 50
Query: 93 HVVTIALKAQNLTG--TLPTELSKLRYLKQLDLS--RNCLTGSFSPQWASLQLVELSVMG 148
V + L NL +P+ L+ L YL L + N + QL L +
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 149 NRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELT 208
+SG P L+ I TL L N +G++PP I L NL + N +G +P
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 209 KLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
+ L N + + + + LEG + + + ++
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328
+ NL L L I+G +P + + L ++++SFNNL G IP
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGN 289
Query: 329 LAKTNFMYLTGNK-LTGP 345
L + + NK L G
Sbjct: 290 LQRFDVSAYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 58.2 bits (139), Expect = 1e-09
Identities = 20/62 (32%), Positives = 30/62 (48%), Gaps = 3/62 (4%)
Query: 194 LSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL--EGPI 251
L +N G LP LT+L L+ L +S NN G+IP+ G ++ + P+
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPL 309
Query: 252 PA 253
PA
Sbjct: 310 PA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 19/58 (32%), Positives = 29/58 (50%), Gaps = 4/58 (6%)
Query: 103 NLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQ-LVELSVMGNRL--SGPFPK 157
+ GTLP L++L++L L++S N L G PQ +LQ + N+ P P
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-23
Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 7/165 (4%)
Query: 675 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQH 731
+ + VG G +GSV G +AVK+LS +S + E+ ++ +H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 732 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 791
N++ L L + L A + + KL + + I RGL
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLK 135
Query: 792 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836
Y+H I+HRD+K SN+ +++D KI DFGLA+ +++ T
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.5 bits (229), Expect = 4e-22
Identities = 28/161 (17%), Positives = 45/161 (27%), Gaps = 30/161 (18%)
Query: 682 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----------QGNREFVNEIGMISAQQH 731
+GEG +V+ VK G+ F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 732 PNLVKLYGCCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 787
L KL G V ++ E + L R ++ I
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------RVENPDEVLDMIL 113
Query: 788 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828
+A + IVH D+ NVL+ + I DF +
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 84.7 bits (208), Expect = 4e-18
Identities = 36/175 (20%), Positives = 66/175 (37%), Gaps = 21/175 (12%)
Query: 683 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 741
K+G G F +V+ + + T +A+K + + +EI ++ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 742 VEG-NQLLLVYEYMKNNCLSRAIFGKDTEY----------RLKLDWPTRKKICIGIARGL 790
+LL + + N + + + + K+I + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 791 AYLHEDSRIKIVHRDIKTSNVLLDKD------LNAKISDFGLAKLYEEDKTHIST 839
Y+H I+H DIK NVL++ + KI+D G A Y+E T+
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.9 bits (193), Expect = 2e-16
Identities = 39/189 (20%), Positives = 69/189 (36%), Gaps = 5/189 (2%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
+P D+ + L L +N T + L NL+ L + +N S P K+
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGE 297
++L++ + L+ L L K +S F L++M + L G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 298 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV 357
M KL I ++ N+T L + ++L GNK+T + N
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE---LHLDGNKITKVDAASLKGLNNLA 198
Query: 358 DISLNNFTW 366
+ L+ +
Sbjct: 199 KLGLSFNSI 207
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.8 bits (185), Expect = 2e-15
Identities = 52/293 (17%), Positives = 101/293 (34%), Gaps = 28/293 (9%)
Query: 85 CDCSSATCH----------------VVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCL 128
C C + L+ +T + L+ L L L N +
Sbjct: 8 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 129 TGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI 187
+ +A L +L L + N+L K+ + L+ E S+ + ++I
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247
++ L + +G + L+ +RI+D N + IP+ G + +LH+ G+ +
Sbjct: 128 VVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKI 183
Query: 248 EGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTK 307
AS+ L +L L +S S L + ++P + D
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243
Query: 308 LKNIDLSFNNLTGGIPTTF------EKLAKTNFMYLTGNKLT-GPVPKYIFNS 353
++ + L NN++ F K A + + L N + + F
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.5 bits (179), Expect = 1e-14
Identities = 43/247 (17%), Positives = 88/247 (35%), Gaps = 15/247 (6%)
Query: 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLS 152
++ T+ L ++ P + L L++L LS+N L P+ L EL V N ++
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL--PEKMPKTLQELRVHENEIT 113
Query: 153 GPFPKVLTNIT--TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKL 210
V + + L +G + + L + ++ + T +P L
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--P 170
Query: 211 TNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLK 270
+L +L + N + + + KL + +S+ S++ L +L +++ K
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 271 GSESAFPKLDKMNLKTLILTKCLIHG------EIPDYIGDMTKLKNIDLSFNNLTGG--I 322
+ D ++ + L I P Y + L N +
Sbjct: 231 LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290
Query: 323 PTTFEKL 329
P+TF +
Sbjct: 291 PSTFRCV 297
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.0 bits (188), Expect = 2e-15
Identities = 39/195 (20%), Positives = 73/195 (37%), Gaps = 13/195 (6%)
Query: 168 LSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKI 227
L N + P I NL +L L+ N L LTNL DL +++N S
Sbjct: 202 LIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257
Query: 228 PEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTL 287
P + K+ +L + + + P + + +L + E P + NL L
Sbjct: 258 P--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ---LEDISPISNLKNLTYL 312
Query: 288 ILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 347
L I P + +TKL+ + + N ++ ++ L N++ N+++ P
Sbjct: 313 TLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
Query: 348 KYIFNSNKNVDISLN 362
+ ++
Sbjct: 369 LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.1 bits (178), Expect = 3e-14
Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 13/177 (7%)
Query: 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRL 151
++ ++L L L+ L L LDL+ N ++ +P +L EL + N++
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 275
Query: 152 SGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
S P L +T L NL + N I L NL L L N+ + P ++ LT
Sbjct: 276 SNISP--LAGLTALTNLELNENQLE--DISPISNLKNLTYLTLYFNNISDISP--VSSLT 329
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
L L ++N S + I L + + P ++ LT +T L ++D
Sbjct: 330 KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 71.6 bits (174), Expect = 9e-14
Identities = 39/198 (19%), Positives = 70/198 (35%), Gaps = 15/198 (7%)
Query: 143 ELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE 202
L N++S P +T L LS+ GN + L NL L L++N +
Sbjct: 201 SLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256
Query: 203 LPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT 262
P L+ LT L +L++ N S I G + + +++ LT L
Sbjct: 257 AP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPISNLKNLTYL- 312
Query: 263 DLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322
L +++ S L L+ L + + ++T + + N ++
Sbjct: 313 TLYFNNISDI-SPVSSLT--KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 323 PTTFEKLAKTNFMYLTGN 340
P L + + L
Sbjct: 368 P--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.1 bits (108), Expect = 1e-05
Identities = 20/90 (22%), Positives = 38/90 (42%), Gaps = 7/90 (7%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVE 143
S ++ + L N++ P +S L L++L + N ++ A+L +
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW 355
Query: 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGN 173
LS N++S P L N+T + L +
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 4e-05
Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 9/157 (5%)
Query: 209 KLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISD 268
KLTNL L ++N S P I + +L + G+ L+ ++++LT+LTDL +++
Sbjct: 195 KLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLAN 250
Query: 269 LKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328
+ S A P L L L I P + +T L N++L+ N L +
Sbjct: 251 NQISNLA-PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE--DISPISN 305
Query: 329 LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365
L ++ L N ++ P + + + N +
Sbjct: 306 LKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVS 342
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (151), Expect = 3e-11
Identities = 30/177 (16%), Positives = 58/177 (32%), Gaps = 4/177 (2%)
Query: 178 SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKI 237
++P I Q++ L N + A NL L + N + +
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 238 QKLHIQGSSLEGPI-PASISALTSLTDLRISDLKGSESAFP-KLDKMNLKTLILTKCLIH 295
++L + ++ + PA+ L L L + E L+ L L +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 296 GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN 352
D D+ L ++ L N ++ F L + + L N++ P +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (149), Expect = 5e-11
Identities = 32/285 (11%), Positives = 82/285 (28%), Gaps = 12/285 (4%)
Query: 85 CDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVEL 144
C C + VT + Q L +P + +++ L N ++ + + + + + +
Sbjct: 6 CVCYNEP--KVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTI 60
Query: 145 SV--MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE 202
+ + P L L L L
Sbjct: 61 LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL 120
Query: 203 LPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLT 262
P L L L + DN + + L + G+ + + L SL
Sbjct: 121 GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 263 DLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEI-PDYIGDMTKLKNIDLSFNNLTGG 321
L + + + + + + + + + L+ + L+ N
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240
Query: 322 IPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV-DISLNNFT 365
A + +++ +P+ + + +++ ++ N+
Sbjct: 241 CRAR-PLWAWLQKFRGSSSEVPCSLPQRL--AGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.4 bits (142), Expect = 4e-10
Identities = 42/254 (16%), Positives = 66/254 (25%), Gaps = 28/254 (11%)
Query: 68 NWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNC 127
N + + L P L L L L R
Sbjct: 57 NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 128 LTGSF-SPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKL 186
L L L + N L ++ L +L + GN + R L
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176
Query: 187 INLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSS 246
+L +L+L N P L L L + NN S E + + +Q L + +
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236
Query: 247 LEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMT 306
D R L L+ + + +P +
Sbjct: 237 WVC-------------DCRARPLWA-----------WLQKFRGSSSEVPCSLPQRLAGRD 272
Query: 307 KLKNIDLSFNNLTG 320
L+ N+L G
Sbjct: 273 LK---RLAANDLQG 283
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 4e-10
Identities = 30/257 (11%), Positives = 83/257 (32%), Gaps = 14/257 (5%)
Query: 121 LDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIP 180
LDL+ L + + S ++ + + P + + ++++ + ++ S
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVSTL 63
Query: 181 PDI-RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPE---------- 229
I + LQ L L + + L K +NL L +S + +
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123
Query: 230 FIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLIL 289
+ + + +L+ R + K S + + +
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183
Query: 290 TKCLIHGEIPDYIGDMTKLKNIDLSF-NNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK 348
++ + + L+++ LS ++ ++ + + G G +
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243
Query: 349 YIFNSNKNVDISLNNFT 365
+ + ++ I+ ++FT
Sbjct: 244 -LKEALPHLQINCSHFT 259
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 9e-06
Identities = 38/258 (14%), Positives = 72/258 (27%), Gaps = 24/258 (9%)
Query: 101 AQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL--QLVELSVMGNRLSGPFPKV 158
++ E ++ +DLS + + S S +L LS+ G RLS P
Sbjct: 31 PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90
Query: 159 LTNITTLKNLSIE--GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDL 216
L + L L++ ++ + L + L+ D
Sbjct: 91 LAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE----------------LNLSWCFDF 134
Query: 217 RISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAF 276
+ + + DL S + ++
Sbjct: 135 TEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 194
Query: 277 PKLDKMNLKTLILTKC-LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335
L+ L L++C I E +G++ LK + + G + E L
Sbjct: 195 EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ-- 252
Query: 336 YLTGNKLTGPVPKYIFNS 353
+ + T I N
Sbjct: 253 -INCSHFTTIARPTIGNK 269
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 3e-07
Identities = 39/207 (18%), Positives = 68/207 (32%), Gaps = 6/207 (2%)
Query: 160 TNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219
+ + + ++ + T ++PPD+ K + L LS N A L T L L +
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKL 279
+ G + L + + L+ + + S
Sbjct: 64 --RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 280 DKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 339
L+ L L + P + KL+ + L+ NNLT L + + L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 340 NKLTGPVPKYIFNSNKNVDISLNNFTW 366
N L +PK F S+ L+ W
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 4e-06
Identities = 48/240 (20%), Positives = 73/240 (30%), Gaps = 36/240 (15%)
Query: 82 NVTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-Q 140
+ C+ S H+ + +NLT LP +L K L LS N L +
Sbjct: 1 HPICEVSKVASHL-EVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTR 56
Query: 141 LVELSVMGNRLSGPFPKVLTNITTLKNLSI--EGNLFTGSIPPDIRKLINLQKLILSSNS 198
L +L L L TL L + S+P + L L L +S N
Sbjct: 57 LTQL-----NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNR 111
Query: 199 FTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISAL 258
T L L L +L + N P + K++KL + ++L ++ L
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171
Query: 259 TSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNL 318
+L L + + IP L L N
Sbjct: 172 ENLDTLLLQENSLY------------------------TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 5e-07
Identities = 24/113 (21%), Positives = 35/113 (30%), Gaps = 4/113 (3%)
Query: 107 TLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLK 166
T+ L +L + LDLS N L A L L N L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQEL 70
Query: 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGE--LPAELTK-LTNLNDL 216
L L + + L L L NS E + L + L +++ +
Sbjct: 71 LLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 5e-06
Identities = 22/117 (18%), Positives = 37/117 (31%), Gaps = 8/117 (6%)
Query: 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE-GNLFTG 177
+ L L+ LT L + L + NRL P + L+ L + +
Sbjct: 1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNAL 55
Query: 178 SIPPDIRKLINLQKLILSSNSFTG-ELPAELTKLTNLNDLRISDNNFSGKIPEFIGK 233
+ L LQ+L+L +N L L L + N+ +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQER 111
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 8e-04
Identities = 17/131 (12%), Positives = 35/131 (26%), Gaps = 27/131 (20%)
Query: 190 QKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249
+ L L+ T L +L + L +S N P ++
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALR------CLEVLQASD 52
Query: 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLK 309
++ + +L L+ L + L + +L
Sbjct: 53 NALENVDGVANLPRLQELLLCNN-------------------RLQQSAAIQPLVSCPRLV 93
Query: 310 NIDLSFNNLTG 320
++L N+L
Sbjct: 94 LLNLQGNSLCQ 104
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 14/85 (16%), Positives = 33/85 (38%), Gaps = 9/85 (10%)
Query: 161 NITTLKNLSIEGNLFTG----SIPPDIRKLINLQKLILSSNSFTGELPAELTK-----LT 211
+ L+ L + + S+ + +L++L LS+N +L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 212 NLNDLRISDNNFSGKIPEFIGKWKK 236
L L + D +S ++ + + +K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 14/90 (15%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 165 LKNLSIEGNLFTGSIPPDI-RKLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRIS 219
+++L I+ + + ++ L Q + L T + + L L +L +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249
N + + + IQ SL+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 15/89 (16%), Positives = 32/89 (35%), Gaps = 10/89 (11%)
Query: 140 QLVELSVMGNRLSG----PFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI-----NLQ 190
L L + +S L +L+ L + N + + + + L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 191 KLILSSNSFTGELPAELTKL-TNLNDLRI 218
+L+L ++ E+ L L + LR+
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 12/92 (13%), Positives = 31/92 (33%), Gaps = 10/92 (10%)
Query: 187 INLQKLILSSNSFTGELPAELTK-LTNLNDLRISDNNFSGK----IPEFIGKWKKIQKLH 241
+++Q L + + AEL L +R+ D + I + + +L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 242 IQGSSLEGPIPASISAL-----TSLTDLRISD 268
++ + L + + L + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 8e-05
Identities = 17/167 (10%), Positives = 40/167 (23%), Gaps = 6/167 (3%)
Query: 260 SLTDLRISDLKGSESAFPKLDKM--NLKTLILTKCLIHGE----IPDYIGDMTKLKNIDL 313
+ L I + S++ + +L + + + L C + I + L ++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 314 SFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIE 373
N L + +T + L + + E
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 374 CPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINC 420
+ + + L +A + L
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKP 169
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 1e-06
Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 12/96 (12%)
Query: 147 MGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAE 206
N S + +L+ L++ N +P L++LI S N E+P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPEL 322
Query: 207 LTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHI 242
L L+ + N + P+ ++ L +
Sbjct: 323 PQNLKQLH---VEYNPLR-EFPDIPE---SVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 21/135 (15%), Positives = 44/135 (32%), Gaps = 8/135 (5%)
Query: 56 WNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTGTLPTELSKL 115
+ +L + +V+ + S + + + +
Sbjct: 224 PSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLP 283
Query: 116 RYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLF 175
L++L++S N L L+ + S N L+ P++ N LK L +E N
Sbjct: 284 PSLEELNVSNNKLI-ELPALPPRLERLIAS--FNHLAE-VPELPQN---LKQLHVEYNPL 336
Query: 176 TGSIPPDIRKLINLQ 190
P + +L+
Sbjct: 337 R-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 13/65 (20%), Positives = 25/65 (38%), Gaps = 5/65 (7%)
Query: 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247
+L L++ + LP L +L S N+ + ++PE K + + +L
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 248 EGPIP 252
P
Sbjct: 94 SDLPP 98
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 30/152 (19%), Positives = 56/152 (36%), Gaps = 5/152 (3%)
Query: 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKN 167
L +SK Q L L P + + + + ++ + NI L +
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLS 69
Query: 168 LSIEGNLFTG--SIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSG 225
L++ N + ++K NL+ L LS N E + K L +L + N+ S
Sbjct: 70 LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129
Query: 226 KIPEFIGKWKKIQKLHIQGSSLEG-PIPASIS 256
+ I++ + L+G +P I+
Sbjct: 130 TFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 13/92 (14%), Positives = 36/92 (39%), Gaps = 8/92 (8%)
Query: 164 TLKNLSIEGNLFTG----SIPPDIRKLINLQKLILSSNSFTGE----LPAELTKLTNLND 215
+++ S++ + T S+ + + ++++++LS N+ E L + +L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSL 247
SD E + + + ++ L
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 32/203 (15%), Positives = 68/203 (33%), Gaps = 23/203 (11%)
Query: 156 PKVLTNITTLKNLS--IEGNLFTGSI--PPDIRKLINLQKLILSSNSFTGELPAELTKLT 211
P + I + + I+ NL S+ +L ++ ++I +++ + L
Sbjct: 11 PTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLP 68
Query: 212 NLNDLRISDNNFSGKIP---------------EFIGKWKKIQKLHIQGSSLEGPIPASIS 256
N+ L ++ N + P + ++ SLE + I+
Sbjct: 69 NVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128
Query: 257 ALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN 316
L L L L ++ + K L+ + +TKL+N+ LS N
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 188
Query: 317 NLTGGIPTTFEKLAKTNFMYLTG 339
+++ L + + L
Sbjct: 189 HISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 30/224 (13%), Positives = 68/224 (30%), Gaps = 25/224 (11%)
Query: 155 FPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLN 214
FP + ++ + T ++ L + L T + + L NL
Sbjct: 13 FP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLI 66
Query: 215 DLRISDNNFSGK---------------IPEFIGKWKKIQKLHIQGSSLEGPIPASISALT 259
L + DN + I+ L ++ L
Sbjct: 67 GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 260 SLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319
L++L++ L ++ L+ + +++KL + N ++
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS 186
Query: 320 GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 363
P L ++L N+++ P + N++ ++L N
Sbjct: 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 845 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.96 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.96 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.96 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.96 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.96 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.96 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.96 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.96 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.96 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.96 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.96 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.96 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.96 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.95 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.95 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.95 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.95 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.95 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.95 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.95 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.95 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.95 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.94 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.94 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.94 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.94 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.94 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.94 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.94 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.94 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.94 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.94 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.94 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.93 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.93 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.93 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.93 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.93 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.93 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.93 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.92 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.92 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.92 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.91 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.91 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.91 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.9 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.61 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.6 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.58 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.56 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.53 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.45 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.31 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.46 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.33 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.85 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.61 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.49 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.25 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.11 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.93 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.6 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.14 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.36 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.2e-41 Score=368.24 Aligned_cols=294 Identities=27% Similarity=0.433 Sum_probs=243.4
Q ss_pred CCHHHHHHHHHHHHHhCCC----CCCCCCCCCCCCCCccccCCCCCCCccceeecCCCCcceEEEEEecCCCccc--cCC
Q 003134 36 LHAEEVKALKQIGRKLGKK----DWNFGVDPCSQKGNWELSSDDKKGFESNVTCDCSSATCHVVTIALKAQNLTG--TLP 109 (845)
Q Consensus 36 ~~~~~~~aL~~~~~~~~~~----~W~~~~d~c~~~~~w~~~~~~~~~~~~~v~C~~~~~~~~v~~L~l~~~~l~g--~~p 109 (845)
|+++|++||++||+++.++ +|..++|||. ..|+ ||+|+......||+.|+|++++++| .+|
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~--~~w~-----------gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp 69 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTWL-----------GVLCDTDTQTYRVNNLDLSGLNLPKPYPIP 69 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT--TCST-----------TEEECCSSSCCCEEEEEEECCCCSSCEECC
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCC--CcCC-----------CeEEeCCCCcEEEEEEECCCCCCCCCCCCC
Confidence 8999999999999999764 7998899994 2475 8999987777899999999999998 589
Q ss_pred ccccCCCCCCEEeccC-CcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCC
Q 003134 110 TELSKLRYLKQLDLSR-NCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI 187 (845)
Q Consensus 110 ~~l~~L~~L~~L~Ls~-N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 187 (845)
++|++|++|++|+|++ |+++|.+|..++.+ +|++|+|++|+|.+..+..+..+.+|+.|++++|++.+.+|..|.+++
T Consensus 70 ~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~ 149 (313)
T d1ogqa_ 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149 (313)
T ss_dssp GGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT
T ss_pred hHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCc
Confidence 9999999999999997 89999889888888 899999999999888888888888999999999988888888888899
Q ss_pred CccEEEeecCcCcccCChhhhCCCCC-CcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEc
Q 003134 188 NLQKLILSSNSFTGELPAELTKLTNL-NDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRI 266 (845)
Q Consensus 188 ~L~~L~Ls~N~l~g~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 266 (845)
+|+++++++|.++|.+|..+..+.++ +.+++++|++++..|..+..+..+ .++++.|.+.+.+|..+..+++|+.|
T Consensus 150 ~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l-- 226 (313)
T d1ogqa_ 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKI-- 226 (313)
T ss_dssp TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEE--
T ss_pred ccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccc--
Confidence 99999999999988888888888776 788888999988888888777544 68888888888888888777766665
Q ss_pred CCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCC
Q 003134 267 SDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPV 346 (845)
Q Consensus 267 s~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~i 346 (845)
++++|.+++.+| .++.+++|+.|+|++|+|+|.+|..|+++++|++|+|++|+|+|.+
T Consensus 227 ---------------------~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~i 284 (313)
T d1ogqa_ 227 ---------------------HLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284 (313)
T ss_dssp ---------------------ECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEEC
T ss_pred ---------------------cccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccC
Confidence 455555555544 4667778888888888888888888888888888888888888877
Q ss_pred Chhh-hcCCceEEeecCC-CcCC
Q 003134 347 PKYI-FNSNKNVDISLNN-FTWE 367 (845)
Q Consensus 347 p~~~-~~~l~~L~ls~N~-l~~~ 367 (845)
|..- ...|+.+++++|+ ++|.
T Consensus 285 P~~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 285 PQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp CCSTTGGGSCGGGTCSSSEEEST
T ss_pred CCcccCCCCCHHHhCCCccccCC
Confidence 7542 3467777888886 4443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-31 Score=283.62 Aligned_cols=160 Identities=26% Similarity=0.527 Sum_probs=142.9
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
++|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999974 69999999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
++|+|.+++... .+++.++..|+.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+..+.
T Consensus 100 ~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp TTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999987532 5899999999999999999999997 9999999999999999999999999999886544
Q ss_pred ceeeeeeccCC
Q 003134 835 THISTRIAGTM 845 (845)
Q Consensus 835 ~~~~t~~~GT~ 845 (845)
.. ....+||+
T Consensus 171 ~~-~~~~~gt~ 180 (293)
T d1yhwa1 171 SK-RSTMVGTP 180 (293)
T ss_dssp CC-BCCCCSCG
T ss_pred cc-ccccccCC
Confidence 32 34456764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.7e-32 Score=284.28 Aligned_cols=162 Identities=32% Similarity=0.502 Sum_probs=139.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|+..+.||+|+||+||+|++. +|+.||||+++... ....+++.+|+++|++++|||||++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57889999999999999999985 58999999996543 23356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+++|+|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 85 ~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 85 CSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999998543 36899999999999999999999997 999999999999999999999999999987544
Q ss_pred Cc-eeeeeeccCC
Q 003134 834 KT-HISTRIAGTM 845 (845)
Q Consensus 834 ~~-~~~t~~~GT~ 845 (845)
.. ...+..+||+
T Consensus 157 ~~~~~~~~~~GT~ 169 (271)
T d1nvra_ 157 NRERLLNKMCGTL 169 (271)
T ss_dssp TEECCBCCCCSCG
T ss_pred CccccccceeeCc
Confidence 32 3344567874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=2e-32 Score=291.19 Aligned_cols=165 Identities=24% Similarity=0.441 Sum_probs=144.1
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
...++|+..+.||+|+||+||+|++. +++.||||+++.. ....++|.+|+++|++++|||||++++++.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34567888899999999999999986 4889999999764 345678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++..... ..+++..++.|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 93 E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp ECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred ecccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999965422 37899999999999999999999987 9999999999999999999999999999887
Q ss_pred CCCceeeeeeccC
Q 003134 832 EDKTHISTRIAGT 844 (845)
Q Consensus 832 ~~~~~~~t~~~GT 844 (845)
.+.....+...||
T Consensus 167 ~~~~~~~~~~~g~ 179 (287)
T d1opja_ 167 GDTYTAHAGAKFP 179 (287)
T ss_dssp SSSSEEETTEEEC
T ss_pred CCCceeecccccc
Confidence 6555444444454
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.6e-31 Score=288.14 Aligned_cols=231 Identities=26% Similarity=0.409 Sum_probs=158.1
Q ss_pred cccccccccccceeEeec-ccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcC
Q 003134 155 FPKVLTNITTLKNLSIEG-NLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGK 233 (845)
Q Consensus 155 ~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 233 (845)
+|..+++|++|++|+|++ |+++|.+|+.|++|++|++|+|++|+|.+..+..+..+.+|+++++++|++.+.+|..+.+
T Consensus 68 lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~ 147 (313)
T d1ogqa_ 68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147 (313)
T ss_dssp CCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGG
T ss_pred CChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhcc
Confidence 445555555555555553 4555555555555555555555555555555555555555555555555555555555555
Q ss_pred CcccceEEecCCcCCCCcchhhhcCCCC-CEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEe
Q 003134 234 WKKIQKLHIQGSSLEGPIPASISALTSL-TDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNID 312 (845)
Q Consensus 234 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L-~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 312 (845)
+++|+.+++++|.++|.+|..+..+.++ +.++++.|++++..+..+....+..+++++|.+.+.+|..+..+++|+.|+
T Consensus 148 l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~ 227 (313)
T d1ogqa_ 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227 (313)
T ss_dssp CTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred Ccccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 5555555555555555555555555443 445555555555444445555566789999999999999999999999999
Q ss_pred CCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhh--cCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCC
Q 003134 313 LSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF--NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRN 390 (845)
Q Consensus 313 Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n 390 (845)
+++|.+++.+| .+..+++|+.|+|++|+|+|.+|..+. .+|+.|||++|+|+|.+|. + ..+..++.++..+|
T Consensus 228 ~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~----~~L~~L~~l~l~~N 301 (313)
T d1ogqa_ 228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-G----GNLQRFDVSAYANN 301 (313)
T ss_dssp CCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-S----TTGGGSCGGGTCSS
T ss_pred ccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-c----ccCCCCCHHHhCCC
Confidence 99999997765 689999999999999999999999985 4899999999999999984 2 34455666777777
Q ss_pred C
Q 003134 391 K 391 (845)
Q Consensus 391 ~ 391 (845)
+
T Consensus 302 ~ 302 (313)
T d1ogqa_ 302 K 302 (313)
T ss_dssp S
T ss_pred c
Confidence 5
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-31 Score=281.81 Aligned_cols=161 Identities=29% Similarity=0.550 Sum_probs=131.6
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
++|+..+.||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|+|..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 467888999999999999999988899999999764 3456789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCCc
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~~ 835 (845)
+|+|.+++.... ..+++..+.+|+.|||+||+|||+++ |+||||||+|||+|+++.+||+|||+|+.+.....
T Consensus 84 ~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 84 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999986542 36899999999999999999999987 99999999999999999999999999998866544
Q ss_pred eeeeeeccC
Q 003134 836 HISTRIAGT 844 (845)
Q Consensus 836 ~~~t~~~GT 844 (845)
.......||
T Consensus 157 ~~~~~~~gt 165 (263)
T d1sm2a_ 157 TSSTGTKFP 165 (263)
T ss_dssp --------C
T ss_pred eeecceecC
Confidence 444445565
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-31 Score=281.37 Aligned_cols=162 Identities=28% Similarity=0.513 Sum_probs=140.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.++|+..+.||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++|||||++++++. ++..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeC
Confidence 4578888999999999999999988899999999764 345678999999999999999999999875 45679999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
++|+|.+++.... ...+++.++++|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 90 ~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999885432 236999999999999999999999986 9999999999999999999999999999987655
Q ss_pred ceeeeeeccC
Q 003134 835 THISTRIAGT 844 (845)
Q Consensus 835 ~~~~t~~~GT 844 (845)
....+...||
T Consensus 164 ~~~~~~~~gt 173 (272)
T d1qpca_ 164 YTAREGAKFP 173 (272)
T ss_dssp EECCTTCCCC
T ss_pred cccccccCCc
Confidence 4444445565
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-31 Score=283.16 Aligned_cols=150 Identities=27% Similarity=0.510 Sum_probs=136.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
+.|++.+.||+|+||+||+|++. +++.||||+++.......+++.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999985 58999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++|+|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 92 ~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 92 AGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp TTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 999999987542 236899999999999999999999997 99999999999999999999999999987643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-30 Score=272.46 Aligned_cols=161 Identities=25% Similarity=0.465 Sum_probs=142.8
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
++|+..++||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 588999999999999999999988889999999765 3456789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCCc
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~~ 835 (845)
+|+|.+++.... ..+++..+.+++.|+|+||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 83 ~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 83 NGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999985542 36899999999999999999999987 99999999999999999999999999998765544
Q ss_pred eeeeeeccC
Q 003134 836 HISTRIAGT 844 (845)
Q Consensus 836 ~~~t~~~GT 844 (845)
...+...||
T Consensus 156 ~~~~~~~~t 164 (258)
T d1k2pa_ 156 TSSVGSKFP 164 (258)
T ss_dssp CCCCCSCCC
T ss_pred eeecccCCC
Confidence 444444454
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-30 Score=273.99 Aligned_cols=159 Identities=28% Similarity=0.475 Sum_probs=139.6
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc---cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|++.+.||+|+||+||+|+.. +++.||+|++... .....+++.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999986 5899999998653 2344678899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecC
Confidence 999999999999542 36899999999999999999999987 9999999999999999999999999998775
Q ss_pred CCCceeeeeeccCC
Q 003134 832 EDKTHISTRIAGTM 845 (845)
Q Consensus 832 ~~~~~~~t~~~GT~ 845 (845)
.... ....||+
T Consensus 158 ~~~~---~~~~Gt~ 168 (263)
T d2j4za1 158 SSRR---TTLCGTL 168 (263)
T ss_dssp CCCC---EETTEEG
T ss_pred CCcc---cccCCCC
Confidence 4432 3345663
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-30 Score=275.75 Aligned_cols=161 Identities=31% Similarity=0.542 Sum_probs=132.4
Q ss_pred hcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..+.||+|+||+||+|+++ ..||||+++.. .....++|.+|+++|++++|||||++++++. .+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 467889999999999999999874 35999999754 2344578999999999999999999999875 456899999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+++|+|.++++... ..+++.++.+|+.|||+||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999996543 26899999999999999999999986 99999999999999999999999999998754
Q ss_pred CCc-eeeeeeccCC
Q 003134 833 DKT-HISTRIAGTM 845 (845)
Q Consensus 833 ~~~-~~~t~~~GT~ 845 (845)
... ...+...||+
T Consensus 157 ~~~~~~~~~~~gt~ 170 (276)
T d1uwha_ 157 WSGSHQFEQLSGSI 170 (276)
T ss_dssp ---------CCCCG
T ss_pred cCCcccccccccCc
Confidence 332 2334456663
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.9e-31 Score=277.60 Aligned_cols=168 Identities=27% Similarity=0.474 Sum_probs=129.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe--CCEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV 750 (845)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+ ++.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57889999999999999999975 58999999987653 2335678999999999999999999999865 4568999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR--IKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~--~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
|||+++|+|.+++.... .....+++.+++.++.||+.||+|||+++. .+||||||||+|||++.++.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999986432 123479999999999999999999998642 359999999999999999999999999999
Q ss_pred ecCCCCceeeeeeccCC
Q 003134 829 LYEEDKTHISTRIAGTM 845 (845)
Q Consensus 829 ~~~~~~~~~~t~~~GT~ 845 (845)
.+..+.. ..+..+||+
T Consensus 163 ~~~~~~~-~~~~~~gt~ 178 (269)
T d2java1 163 ILNHDTS-FAKAFVGTP 178 (269)
T ss_dssp HC------------CCC
T ss_pred ecccCCC-ccccCCCCc
Confidence 8865433 234466774
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.9e-31 Score=285.37 Aligned_cols=160 Identities=24% Similarity=0.439 Sum_probs=138.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.++|+..++||+|+||+||+|+.. +|+.||+|+++... ....+++.+|+++|++++|||||+++++|.+++..|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 568999999999999999999975 68999999997653 3335688999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|+++|+|.+++... ..+++.++..++.|++.||+|||++ + |+||||||+|||+++++++||+|||+|+.+.
T Consensus 85 y~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp CCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred cCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999643 3689999999999999999999974 5 9999999999999999999999999999875
Q ss_pred CCCceeeeeeccCC
Q 003134 832 EDKTHISTRIAGTM 845 (845)
Q Consensus 832 ~~~~~~~t~~~GT~ 845 (845)
+.. .+..+||+
T Consensus 157 ~~~---~~~~~GT~ 167 (322)
T d1s9ja_ 157 DSM---ANSFVGTR 167 (322)
T ss_dssp HHT---C---CCSS
T ss_pred CCc---cccccCCc
Confidence 422 23456774
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.9e-30 Score=275.53 Aligned_cols=162 Identities=28% Similarity=0.411 Sum_probs=138.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc---cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+++|++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46889999999999999999985 6899999999754 2344578999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++.++..++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+|+.+.
T Consensus 88 Ey~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecc
Confidence 999999999988543 36899999999999999999999997 9999999999999999999999999999886
Q ss_pred CCCc-eeeeeeccCC
Q 003134 832 EDKT-HISTRIAGTM 845 (845)
Q Consensus 832 ~~~~-~~~t~~~GT~ 845 (845)
.... ...+..+||+
T Consensus 160 ~~~~~~~~~~~~GT~ 174 (288)
T d1uu3a_ 160 PESKQARANSFVGTA 174 (288)
T ss_dssp ----------CCCCG
T ss_pred cCCcccccccccCCc
Confidence 4332 2334466774
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.96 E-value=6.9e-30 Score=278.72 Aligned_cols=161 Identities=24% Similarity=0.435 Sum_probs=141.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999975 68999999998765556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec--CCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld--~~~~~kl~DFGla~~~~~ 832 (845)
++|+|.+++.... ..+++.++..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.+..
T Consensus 106 ~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 106 SGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 9999999985432 26899999999999999999999997 99999999999995 467899999999998865
Q ss_pred CCceeeeeeccCC
Q 003134 833 DKTHISTRIAGTM 845 (845)
Q Consensus 833 ~~~~~~t~~~GT~ 845 (845)
... .....||+
T Consensus 179 ~~~--~~~~~gT~ 189 (350)
T d1koaa2 179 KQS--VKVTTGTA 189 (350)
T ss_dssp TSC--EEEECSCT
T ss_pred ccc--cceecCcc
Confidence 443 23456664
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=1.5e-30 Score=278.36 Aligned_cols=151 Identities=30% Similarity=0.566 Sum_probs=124.8
Q ss_pred CCCCCCcccccCcEEEEEEEECC-C---cEEEEEEcCcc-cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILSD-G---TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
+|+..+.||+|+||+||+|+++. + ..||||.+... .....++|.+|+++|++++|||||+++|++..++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 45556899999999999999753 2 36899998764 3344578999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
|||++|+|.+++.... ..++|.++.+|+.|||+||+|||+++ |+||||||+|||++.++++||+|||+|+.+.
T Consensus 107 Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp ECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999886542 36899999999999999999999986 9999999999999999999999999999876
Q ss_pred CCC
Q 003134 832 EDK 834 (845)
Q Consensus 832 ~~~ 834 (845)
...
T Consensus 180 ~~~ 182 (299)
T d1jpaa_ 180 DDT 182 (299)
T ss_dssp ---
T ss_pred CCC
Confidence 543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.96 E-value=8.7e-30 Score=278.14 Aligned_cols=160 Identities=28% Similarity=0.431 Sum_probs=140.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
++|++.+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|+||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46889999999999999999975 69999999997765555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec--CCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld--~~~~~kl~DFGla~~~~~ 832 (845)
++|+|.+.+.... ..+++.+++.|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.+..
T Consensus 109 ~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 109 SGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 9999998875432 36899999999999999999999987 99999999999998 678999999999999865
Q ss_pred CCceeeeeeccC
Q 003134 833 DKTHISTRIAGT 844 (845)
Q Consensus 833 ~~~~~~t~~~GT 844 (845)
+.. .....||
T Consensus 182 ~~~--~~~~~gt 191 (352)
T d1koba_ 182 DEI--VKVTTAT 191 (352)
T ss_dssp TSC--EEEECSS
T ss_pred CCc--eeeccCc
Confidence 443 2334455
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.3e-30 Score=274.53 Aligned_cols=161 Identities=29% Similarity=0.496 Sum_probs=132.4
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccC
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 755 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~ 755 (845)
++|++.+.||+|+||.||+|++++++.||||+++.. ....++|.+|+.++++++|||||++++++. ++..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 568889999999999999999988889999999754 445678999999999999999999999985 456899999999
Q ss_pred CCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCCc
Q 003134 756 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 835 (845)
Q Consensus 756 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~~ 835 (845)
+|+|..++.... ...++|.++++|+.||++||+|||+++ |+||||||+|||||+++++||+|||+|+.+.....
T Consensus 95 ~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 95 KGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999999886432 236999999999999999999999987 99999999999999999999999999998765443
Q ss_pred eeeeeeccC
Q 003134 836 HISTRIAGT 844 (845)
Q Consensus 836 ~~~t~~~GT 844 (845)
...+...||
T Consensus 169 ~~~~~~~gt 177 (285)
T d1fmka3 169 TARQGAKFP 177 (285)
T ss_dssp -------CC
T ss_pred eeecccccc
Confidence 333334454
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.4e-30 Score=276.88 Aligned_cols=161 Identities=30% Similarity=0.364 Sum_probs=141.9
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc---cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|++.+.||+|+||.||+|+.. +++.||||++++. .....+.+.+|+++|++++||||+++++++.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56889999999999999999975 6999999999754 2344678899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999998543 36899999999999999999999997 9999999999999999999999999999875
Q ss_pred CCCceeeeeeccCC
Q 003134 832 EDKTHISTRIAGTM 845 (845)
Q Consensus 832 ~~~~~~~t~~~GT~ 845 (845)
.... ..+..+||+
T Consensus 157 ~~~~-~~~~~~GT~ 169 (337)
T d1o6la_ 157 SDGA-TMKTFCGTP 169 (337)
T ss_dssp CTTC-CBCCCEECG
T ss_pred cCCc-ccccceeCH
Confidence 4433 234467774
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-29 Score=266.52 Aligned_cols=158 Identities=28% Similarity=0.466 Sum_probs=133.1
Q ss_pred CCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe----CCEEEEEE
Q 003134 679 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVY 751 (845)
Q Consensus 679 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ 751 (845)
+..++||+|+||+||+|++. +++.||+|++.... ....++|.+|+++|++++|||||++++++.. ++.+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999986 58899999986542 3335678999999999999999999999875 35689999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec-CCCcEEEEeeccceec
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLY 830 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld-~~~~~kl~DFGla~~~ 830 (845)
||+++|+|.+++... ..+++.++..++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+..
T Consensus 92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999543 36899999999999999999999985 4599999999999996 5789999999999875
Q ss_pred CCCCceeeeeeccCC
Q 003134 831 EEDKTHISTRIAGTM 845 (845)
Q Consensus 831 ~~~~~~~~t~~~GT~ 845 (845)
.... ....+||+
T Consensus 166 ~~~~---~~~~~GT~ 177 (270)
T d1t4ha_ 166 RASF---AKAVIGTP 177 (270)
T ss_dssp CTTS---BEESCSSC
T ss_pred cCCc---cCCcccCc
Confidence 4432 23466775
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.6e-29 Score=268.07 Aligned_cols=152 Identities=32% Similarity=0.531 Sum_probs=130.8
Q ss_pred cCCCCCC-cccccCcEEEEEEEEC---CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEE
Q 003134 676 NNFDPAN-KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
++|...+ +||+|+||+||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|++.. +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455556 4999999999999864 35689999997653 3345789999999999999999999999865 568999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++|+|.+++.... ..+++.++.+|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 87 mE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcc
Confidence 99999999999985432 36899999999999999999999986 999999999999999999999999999988
Q ss_pred CCCCc
Q 003134 831 EEDKT 835 (845)
Q Consensus 831 ~~~~~ 835 (845)
.....
T Consensus 160 ~~~~~ 164 (285)
T d1u59a_ 160 GADDS 164 (285)
T ss_dssp TTCSC
T ss_pred ccccc
Confidence 65443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=9.2e-30 Score=273.04 Aligned_cols=148 Identities=28% Similarity=0.503 Sum_probs=132.4
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.|+..+.||+|+||+||+|+.. +++.||||+++.... ...+++.+|+++|++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888999999999999999975 689999999875432 234578999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
||++|+|..++... ..+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999997666432 36899999999999999999999997 99999999999999999999999999997754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.96 E-value=2.1e-29 Score=266.06 Aligned_cols=159 Identities=27% Similarity=0.432 Sum_probs=138.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccccc---------chHHHHHHHHHHhcCC-CCceeeEEEEEEeC
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---------GNREFVNEIGMISAQQ-HPNLVKLYGCCVEG 744 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~ 744 (845)
++|+..+.||+|+||+||+|+.. +++.||||+++..... ..+.+.+|++++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57889999999999999999975 6899999998654211 1246889999999997 99999999999999
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
+..|+||||+++|+|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999543 36899999999999999999999997 999999999999999999999999
Q ss_pred ccceecCCCCceeeeeeccC
Q 003134 825 GLAKLYEEDKTHISTRIAGT 844 (845)
Q Consensus 825 Gla~~~~~~~~~~~t~~~GT 844 (845)
|+|+.+..... .+...||
T Consensus 155 G~a~~~~~~~~--~~~~~gt 172 (277)
T d1phka_ 155 GFSCQLDPGEK--LREVCGT 172 (277)
T ss_dssp TTCEECCTTCC--BCCCCSC
T ss_pred hheeEccCCCc--eeeeecc
Confidence 99998865332 2345566
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=2.2e-29 Score=271.16 Aligned_cols=158 Identities=27% Similarity=0.445 Sum_probs=139.7
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc---cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999999999999985 5999999999754 2344678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||++||+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCcccccccccc-----ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEec
Confidence 999999999988543 36788999999999999999999987 9999999999999999999999999999886
Q ss_pred CCCceeeeeeccCC
Q 003134 832 EDKTHISTRIAGTM 845 (845)
Q Consensus 832 ~~~~~~~t~~~GT~ 845 (845)
... +..+||+
T Consensus 156 ~~~----~~~~Gt~ 165 (316)
T d1fota_ 156 DVT----YTLCGTP 165 (316)
T ss_dssp SCB----CCCCSCT
T ss_pred ccc----ccccCcc
Confidence 432 3456774
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=1.2e-29 Score=271.95 Aligned_cols=161 Identities=27% Similarity=0.402 Sum_probs=123.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
.+.|+..+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356889999999999999999986 58999999997543 2334578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec---CCCcEEEEeecccee
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKL 829 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld---~~~~~kl~DFGla~~ 829 (845)
|++||+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+.
T Consensus 88 ~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 88 LVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred ccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999653 36899999999999999999999997 99999999999994 578999999999997
Q ss_pred cCCCCceeeeeeccCC
Q 003134 830 YEEDKTHISTRIAGTM 845 (845)
Q Consensus 830 ~~~~~~~~~t~~~GT~ 845 (845)
...... ....+||+
T Consensus 160 ~~~~~~--~~~~~GT~ 173 (307)
T d1a06a_ 160 EDPGSV--LSTACGTP 173 (307)
T ss_dssp ---------------C
T ss_pred ccCCCe--eeeeeeCc
Confidence 754332 23456774
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.7e-29 Score=265.44 Aligned_cols=146 Identities=29% Similarity=0.473 Sum_probs=125.8
Q ss_pred CcccccCcEEEEEEEECC---CcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEeccCC
Q 003134 682 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 756 (845)
Q Consensus 682 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~~~ 756 (845)
++||+|+||+||+|.+++ ++.||||+++.... ...++|.+|+++|++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 56899999975432 235689999999999999999999999865 457899999999
Q ss_pred CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCCce
Q 003134 757 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 836 (845)
Q Consensus 757 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~~~ 836 (845)
|+|.++++.. ..+++.++++|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+......
T Consensus 92 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999998643 36899999999999999999999986 999999999999999999999999999988655443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.5e-29 Score=264.50 Aligned_cols=151 Identities=25% Similarity=0.362 Sum_probs=135.0
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc------ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS------RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 747 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 747 (845)
.++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357899999999999999999985 68999999986532 12357899999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC----cEEEEe
Q 003134 748 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISD 823 (845)
Q Consensus 748 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~----~~kl~D 823 (845)
|+|||||++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecc
Confidence 9999999999999999543 36999999999999999999999997 99999999999998776 499999
Q ss_pred eccceecCCC
Q 003134 824 FGLAKLYEED 833 (845)
Q Consensus 824 FGla~~~~~~ 833 (845)
||+|+.....
T Consensus 161 fG~a~~~~~~ 170 (293)
T d1jksa_ 161 FGLAHKIDFG 170 (293)
T ss_dssp CTTCEECTTS
T ss_pred hhhhhhcCCC
Confidence 9999988644
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.1e-29 Score=267.37 Aligned_cols=152 Identities=31% Similarity=0.571 Sum_probs=127.9
Q ss_pred cCCCCCCcccccCcEEEEEEEECCC-----cEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDG-----TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
+.|+..++||+|+||.||+|.++.. ..||||+++... .....+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577788999999999999997542 479999997543 2334679999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+.+|++.+.+.... ..++|.++.+++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 87 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999998875442 36899999999999999999999986 99999999999999999999999999998
Q ss_pred cCCCC
Q 003134 830 YEEDK 834 (845)
Q Consensus 830 ~~~~~ 834 (845)
+....
T Consensus 160 ~~~~~ 164 (283)
T d1mqba_ 160 LEDDP 164 (283)
T ss_dssp -----
T ss_pred ccCCC
Confidence 76543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.6e-29 Score=270.94 Aligned_cols=167 Identities=26% Similarity=0.404 Sum_probs=136.5
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC------CcEEEEEEcCcc-cccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 746 (845)
.++|+..++||+|+||+||+|++.. ...||+|.+... .......+.+|+++|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578889999999999999999642 236999998654 334457899999999998 89999999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcc------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTE------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT 808 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp 808 (845)
.++||||+++|+|.++++..... ....+++.+++.|+.||++||+|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 99999999999999999765321 1235899999999999999999999986 99999999
Q ss_pred CCEEecCCCcEEEEeeccceecCCCCce-eeeeeccC
Q 003134 809 SNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGT 844 (845)
Q Consensus 809 ~NILld~~~~~kl~DFGla~~~~~~~~~-~~t~~~GT 844 (845)
+|||++.++.+||+|||+|+........ ..+...||
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 229 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence 9999999999999999999987654433 22334455
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.3e-28 Score=265.69 Aligned_cols=152 Identities=20% Similarity=0.328 Sum_probs=134.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
.++|++.+.||+|+||+||+|... +++.||||.++... .....+.+|+++|++++|||||++++++.+++.+|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 357889999999999999999986 58899999997653 3345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCC--CcEEEEeeccceecC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD--LNAKISDFGLAKLYE 831 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~--~~~kl~DFGla~~~~ 831 (845)
|+||+|.+++.... ..+++.++..|+.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++...
T Consensus 83 ~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 83 ISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999996542 26899999999999999999999987 9999999999999854 589999999999886
Q ss_pred CCC
Q 003134 832 EDK 834 (845)
Q Consensus 832 ~~~ 834 (845)
...
T Consensus 156 ~~~ 158 (321)
T d1tkia_ 156 PGD 158 (321)
T ss_dssp TTC
T ss_pred cCC
Confidence 543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=2.5e-29 Score=269.36 Aligned_cols=163 Identities=31% Similarity=0.512 Sum_probs=140.1
Q ss_pred HHHHHHHhcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEE
Q 003134 668 LRQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGC 740 (845)
Q Consensus 668 ~~~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~ 740 (845)
+.+++...++|+..+.||+|+||+||+|++. +++.||||+++.... ...++|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3445556788999999999999999999864 357899999976533 335679999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChhhhhhcCCc-------------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 003134 741 CVEGNQLLLVYEYMKNNCLSRAIFGKDT-------------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 801 (845)
Q Consensus 741 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 801 (845)
+...+..++||||+++|+|.++++.... .....+++.+++.|+.|++.||+|||+++ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 9999999999999999999999964321 11235899999999999999999999986 9
Q ss_pred EeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 802 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 802 vHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
|||||||+|||+|.++.+||+|||+|+.+...
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~ 193 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCC
Confidence 99999999999999999999999999977543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.95 E-value=1.6e-28 Score=268.08 Aligned_cols=149 Identities=26% Similarity=0.379 Sum_probs=135.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc---cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 751 (845)
++|++.+.||+|+||.||+|++. +|+.||||+++.. .....+.+.+|+++|++++|||||++++++...+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47889999999999999999985 6999999998653 2344578899999999999999999999999999999999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecC
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 831 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~ 831 (845)
||+.+|+|.+++... ..+++.+++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+.
T Consensus 121 e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 999999999998543 36899999999999999999999997 9999999999999999999999999999886
Q ss_pred C
Q 003134 832 E 832 (845)
Q Consensus 832 ~ 832 (845)
.
T Consensus 193 ~ 193 (350)
T d1rdqe_ 193 G 193 (350)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=1.6e-28 Score=269.50 Aligned_cols=159 Identities=28% Similarity=0.401 Sum_probs=135.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHH---HHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVN---EIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+ |+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999986 59999999986432 222333444 477788889999999999999999999
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999543 36889999999999999999999997 9999999999999999999999999999
Q ss_pred ecCCCCceeeeeeccCC
Q 003134 829 LYEEDKTHISTRIAGTM 845 (845)
Q Consensus 829 ~~~~~~~~~~t~~~GT~ 845 (845)
.+..... ....||+
T Consensus 156 ~~~~~~~---~~~~GT~ 169 (364)
T d1omwa3 156 DFSKKKP---HASVGTH 169 (364)
T ss_dssp ECSSSCC---CSCCSCG
T ss_pred ecCCCcc---ccccccc
Confidence 8865432 3355664
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.7e-29 Score=262.17 Aligned_cols=162 Identities=25% Similarity=0.393 Sum_probs=124.9
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC----CcEEEEEEcCcccc-cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
.++|+..+.||+|+||.||+|++.. +..||||.++.... ...+.|.+|+++|++++|||||++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578889999999999999998743 45789999875433 33567999999999999999999999985 567899
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||||+++|+|.+++.... ..+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+|+.
T Consensus 85 v~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999875432 36899999999999999999999987 99999999999999999999999999998
Q ss_pred cCCCCceeeeeeccC
Q 003134 830 YEEDKTHISTRIAGT 844 (845)
Q Consensus 830 ~~~~~~~~~t~~~GT 844 (845)
.........+...||
T Consensus 158 ~~~~~~~~~~~~~gt 172 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLP 172 (273)
T ss_dssp -------------CC
T ss_pred ccCCcceeccceecC
Confidence 865554444555565
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.6e-28 Score=262.59 Aligned_cols=161 Identities=29% Similarity=0.489 Sum_probs=133.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|+..+.||+|+||+||+|++. +++.||||+++... ....+++.+|+++|++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57899999999999999999974 68999999996543 2335789999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+.++.+....... ...+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~~~~~~~~~~~----~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQDLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSEEHHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCCchhhhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC
Confidence 99875444333222 236899999999999999999999987 99999999999999999999999999998765
Q ss_pred CCceeeeeeccC
Q 003134 833 DKTHISTRIAGT 844 (845)
Q Consensus 833 ~~~~~~t~~~GT 844 (845)
+... .+...||
T Consensus 155 ~~~~-~~~~~gt 165 (298)
T d1gz8a_ 155 PVRT-YTHEVVT 165 (298)
T ss_dssp CSBC-TTCCBCC
T ss_pred Cccc-ceeeccc
Confidence 4332 2233455
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.2e-28 Score=262.41 Aligned_cols=161 Identities=29% Similarity=0.425 Sum_probs=138.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc---ccchHHHHHHHHHHh-cCCCCceeeEEEEEEeCCEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMIS-AQQHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV 750 (845)
++|++.+.||+|+||+||+|+.. +++.||||++++.. ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999986 59999999997542 334566777777765 68999999999999999999999
Q ss_pred EeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 751 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+..
T Consensus 82 mEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhc
Confidence 9999999999999643 36899999999999999999999997 999999999999999999999999999977
Q ss_pred CCCCceeeeeeccCC
Q 003134 831 EEDKTHISTRIAGTM 845 (845)
Q Consensus 831 ~~~~~~~~t~~~GT~ 845 (845)
...... .+...||+
T Consensus 154 ~~~~~~-~~~~~gt~ 167 (320)
T d1xjda_ 154 MLGDAK-TNTFCGTP 167 (320)
T ss_dssp CCTTCC-BCCCCSCG
T ss_pred cccccc-ccccCCCC
Confidence 544332 33456763
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.2e-27 Score=254.01 Aligned_cols=236 Identities=19% Similarity=0.229 Sum_probs=175.3
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEee-cc
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE-GN 173 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls-~N 173 (845)
.++.++++++ .+|..+. +.+++|+|++|+|+.+.+..|..+ +|++|++++|+|....+..+.+++.++.|+.. .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 3456677777 5676554 568889999988888777777777 68888888888877777777777777777654 55
Q ss_pred cCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcch
Q 003134 174 LFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPA 253 (845)
Q Consensus 174 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 253 (845)
.++...|..|.++++|++|+|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 66666666777777788888877777766666677777777777777777766667777777777777777777766666
Q ss_pred hhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcC
Q 003134 254 SISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN 333 (845)
Q Consensus 254 ~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 333 (845)
.|.++++|+.| ++++|++++..|..|.++++|++||+++|++++..|..|.++++|+
T Consensus 172 ~f~~l~~L~~l-----------------------~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~ 228 (284)
T d1ozna_ 172 AFRGLHSLDRL-----------------------LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228 (284)
T ss_dssp TTTTCTTCCEE-----------------------ECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred hhccccccchh-----------------------hhhhccccccChhHhhhhhhcccccccccccccccccccccccccC
Confidence 66666654444 5566666667777777788888888888888877777787887777
Q ss_pred EEEccCCcccCCCChhhhcCCceEEeecCCCcCCCCCCCCCCCCCceeeeeecC
Q 003134 334 FMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSS 387 (845)
Q Consensus 334 ~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~ 387 (845)
+|+|++| ||.|+|+..++..|+..
T Consensus 229 ~L~l~~N------------------------------~l~C~C~~~~l~~~l~~ 252 (284)
T d1ozna_ 229 YLRLNDN------------------------------PWVCDCRARPLWAWLQK 252 (284)
T ss_dssp EEECCSS------------------------------CEECSGGGHHHHHHHHH
T ss_pred EEEecCC------------------------------CCCCCccchHHHHHHHh
Confidence 7777777 77799999888888874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.2e-28 Score=260.51 Aligned_cols=156 Identities=30% Similarity=0.450 Sum_probs=129.5
Q ss_pred CCcccccCcEEEEEEEEC-CCcEEEEEEcCccccc-----chHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEecc
Q 003134 681 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-----GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 754 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey~ 754 (845)
.++||+|+||+||+|++. +|+.||||+++..... ..+.+.+|++++++++|||||++++++..++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999975 5899999999754321 1356889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
.++++..+.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 998777665322 36889999999999999999999997 9999999999999999999999999999876543
Q ss_pred ceeeeeeccCC
Q 003134 835 THISTRIAGTM 845 (845)
Q Consensus 835 ~~~~t~~~GT~ 845 (845)
... ...+||+
T Consensus 155 ~~~-~~~~gt~ 164 (299)
T d1ua2a_ 155 RAY-THQVVTR 164 (299)
T ss_dssp CCC-CCSCCCC
T ss_pred ccc-cceecCh
Confidence 322 2345553
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.95 E-value=4.1e-28 Score=257.93 Aligned_cols=150 Identities=29% Similarity=0.500 Sum_probs=134.5
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|+..++||+|+||+||+|++++++.||||+++... ....+++.+|+.+|++++|||||++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788999999999999999999999999999996643 33367899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCC
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 833 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~ 833 (845)
+.++.+..+.... ..+++.++..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|......
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9987776665432 36999999999999999999999986 999999999999999999999999999987644
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.7e-28 Score=260.56 Aligned_cols=162 Identities=29% Similarity=0.562 Sum_probs=131.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCc----EEEEEEcCcc-cccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 749 (845)
.+|+..++||+|+||+||+|++. +|+ .||+|+++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999975 343 6899988654 345567899999999999999999999999865 5678
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
+|||+.+|+|.+.+.... ..+++.++++|+.|||.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 88 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccccee
Confidence 899999999999886542 36899999999999999999999986 99999999999999999999999999998
Q ss_pred cCCCCcee-eeeeccCC
Q 003134 830 YEEDKTHI-STRIAGTM 845 (845)
Q Consensus 830 ~~~~~~~~-~t~~~GT~ 845 (845)
+....... .+...||+
T Consensus 161 ~~~~~~~~~~~~~~gt~ 177 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPI 177 (317)
T ss_dssp TTTTCC--------CCT
T ss_pred cccccccccccccccCc
Confidence 86544332 23345653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7.2e-28 Score=258.80 Aligned_cols=154 Identities=29% Similarity=0.529 Sum_probs=131.7
Q ss_pred cCCCCCCcccccCcEEEEEEEECC-Cc--EEEEEEcCcc-cccchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD-GT--VIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 750 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 750 (845)
++|+..++||+|+||+||+|++.+ +. .||||+++.. .....++|.+|+++|+++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567788999999999999999753 44 5788887543 334456899999999998 799999999999999999999
Q ss_pred EeccCCCChhhhhhcCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcE
Q 003134 751 YEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 819 (845)
Q Consensus 751 ~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~ 819 (845)
|||+++|+|.++++.... .....+++.++.+++.|||+||+|+|+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 999999999999976421 12347999999999999999999999986 9999999999999999999
Q ss_pred EEEeeccceecCC
Q 003134 820 KISDFGLAKLYEE 832 (845)
Q Consensus 820 kl~DFGla~~~~~ 832 (845)
||+|||+|+....
T Consensus 167 kl~DfG~a~~~~~ 179 (309)
T d1fvra_ 167 KIADFGLSRGQEV 179 (309)
T ss_dssp EECCTTCEESSCE
T ss_pred EEccccccccccc
Confidence 9999999987643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=9.2e-28 Score=257.07 Aligned_cols=160 Identities=29% Similarity=0.433 Sum_probs=129.2
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHH--HHHHHhcCCCCceeeEEEEEEeCC----EEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVN--EIGMISAQQHPNLVKLYGCCVEGN----QLLL 749 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~H~nIv~l~~~~~~~~----~~~l 749 (845)
.+|...+.||+|+||.||+|++ +|+.||||+++... .+++.. |+..+.+++||||+++++++...+ .+|+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 3466678899999999999997 58899999996542 234444 455556789999999999998654 6899
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-----SRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
|||||++|+|.++++.. .++|.++.+++.|+|.||+|+|+. +..+||||||||+|||+++++.+||+||
T Consensus 79 v~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 99999999999999643 589999999999999999999974 1246999999999999999999999999
Q ss_pred ccceecCCCCcee---eeeeccCC
Q 003134 825 GLAKLYEEDKTHI---STRIAGTM 845 (845)
Q Consensus 825 Gla~~~~~~~~~~---~t~~~GT~ 845 (845)
|+++.+....... ....+||+
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~ 176 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTK 176 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCG
T ss_pred CccccccCCCcceeccccceeccc
Confidence 9999886544332 22355663
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.6e-28 Score=261.13 Aligned_cols=173 Identities=25% Similarity=0.392 Sum_probs=130.6
Q ss_pred HHHHHhcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCccc-ccchHHHHHHHHHHhcC-CCCceeeEEEEE
Q 003134 670 QIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCC 741 (845)
Q Consensus 670 ~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 741 (845)
+.+...++|+..+.||+|+||.||+|++. +++.||||+++... ....+++.+|.+++.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 33334567899999999999999999863 24689999997643 33456788888888776 689999999998
Q ss_pred EeC-CEEEEEEeccCCCChhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 003134 742 VEG-NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTS 809 (845)
Q Consensus 742 ~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~ 809 (845)
... +..++|||||++|+|.++++..... ....+++.+++.++.||++||+|||+++ ||||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcc
Confidence 765 4689999999999999999754321 1235899999999999999999999987 999999999
Q ss_pred CEEecCCCcEEEEeeccceecCCCCce-eeeeeccCC
Q 003134 810 NVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTM 845 (845)
Q Consensus 810 NILld~~~~~kl~DFGla~~~~~~~~~-~~t~~~GT~ 845 (845)
|||+++++.+||+|||+|+........ ..+...||+
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 200 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 200 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGG
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCc
Confidence 999999999999999999987654433 233455663
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.94 E-value=1.1e-27 Score=253.25 Aligned_cols=163 Identities=21% Similarity=0.325 Sum_probs=132.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc---cchHHHHHHHHHHhcCCCCceeeEEEEEEeCC----E
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----Q 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~ 746 (845)
.++|++.+.||+|+||+||+|+.. +++.||||+++.... ...++|.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999975 699999999976532 23457899999999999999999999998653 4
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.|+||||++||+|.+++... ..+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++..+|+|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhh
Confidence 89999999999999988543 36899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCCc--eeeeeeccCC
Q 003134 827 AKLYEEDKT--HISTRIAGTM 845 (845)
Q Consensus 827 a~~~~~~~~--~~~t~~~GT~ 845 (845)
++....... ......+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~ 178 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTA 178 (277)
T ss_dssp CEECC----------------
T ss_pred hhhhccccccccccccccCcc
Confidence 987644322 2233456664
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.1e-27 Score=259.79 Aligned_cols=157 Identities=24% Similarity=0.304 Sum_probs=131.2
Q ss_pred cCCCCCC-cccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhc-CCCCceeeEEEEEEe----CCEEE
Q 003134 676 NNFDPAN-KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCCVE----GNQLL 748 (845)
Q Consensus 676 ~~y~~~~-~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~----~~~~~ 748 (845)
++|.+.+ .||+|+||+||+|+.. +++.||||+++. .+.+.+|++++.+ .+|||||+++++|.+ ++.+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5787765 5999999999999974 689999999854 3567789998765 489999999999875 35789
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC---CCcEEEEeec
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFG 825 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~---~~~~kl~DFG 825 (845)
+|||||+||+|.+++..... ..+++.++..|+.||+.||+|||+++ |+||||||+|||+++ ++.+||+|||
T Consensus 86 ivmEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEECCCCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 99999999999999975422 36899999999999999999999997 999999999999985 5679999999
Q ss_pred cceecCCCCceeeeeeccCC
Q 003134 826 LAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 826 la~~~~~~~~~~~t~~~GT~ 845 (845)
+|+....... .+...||+
T Consensus 160 ~a~~~~~~~~--~~~~~gt~ 177 (335)
T d2ozaa1 160 FAKETTSHNS--LTTPCYTP 177 (335)
T ss_dssp TCEECCCCCC--CCCCSCCC
T ss_pred eeeeccCCCc--cccccCCc
Confidence 9998865433 23455664
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.7e-28 Score=254.64 Aligned_cols=152 Identities=26% Similarity=0.459 Sum_probs=124.1
Q ss_pred cCCCCCCcccccCcEEEEEEEECC----CcEEEEEEcCccc---ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 748 (845)
++|+..+.||+|+||.||+|++.. ...||||+++... ....++|.+|+++|++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 468889999999999999998632 2478999987642 2335689999999999999999999999965 4678
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
+||||+++|++.+.+... ...+++.++++++.|+|+||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 87 lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence 999999999999888543 236999999999999999999999986 9999999999999999999999999999
Q ss_pred ecCCCCc
Q 003134 829 LYEEDKT 835 (845)
Q Consensus 829 ~~~~~~~ 835 (845)
.+.....
T Consensus 160 ~~~~~~~ 166 (273)
T d1u46a_ 160 ALPQNDD 166 (273)
T ss_dssp ECCC-CC
T ss_pred hcccCCC
Confidence 8865443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.1e-28 Score=253.21 Aligned_cols=148 Identities=32% Similarity=0.515 Sum_probs=125.1
Q ss_pred cCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEe-CCEEEEEEecc
Q 003134 676 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYEYM 754 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~Ey~ 754 (845)
++|+..+.||+|+||.||+|+++ |+.||||+++.. ...++|.+|++++++++||||++++|++.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45677889999999999999985 788999999754 345789999999999999999999999865 45689999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
++|+|.++++... ...++|..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 84 AKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp TTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999996532 235899999999999999999999986 99999999999999999999999999998754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.3e-28 Score=261.31 Aligned_cols=159 Identities=26% Similarity=0.451 Sum_probs=136.4
Q ss_pred HHhcCCCCCCcccccCcEEEEEEEEC------CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 003134 673 AATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 745 (845)
Q Consensus 673 ~~~~~y~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 745 (845)
...++|+..+.||+|+||+||+|.+. +++.||||+++... ......|.+|++++++++||||+++++++..++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 33467888899999999999999863 25789999997543 333457899999999999999999999999999
Q ss_pred EEEEEEeccCCCChhhhhhcCCc-----ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEE
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDT-----EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 820 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~k 820 (845)
..++||||+++|+|.++++.... .....+++.++.+++.|+|+||+|||+++ |+||||||+|||+|+++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence 99999999999999999864321 11235789999999999999999999986 99999999999999999999
Q ss_pred EEeeccceecCCCC
Q 003134 821 ISDFGLAKLYEEDK 834 (845)
Q Consensus 821 l~DFGla~~~~~~~ 834 (845)
|+|||+|+.+....
T Consensus 174 l~DFGla~~~~~~~ 187 (308)
T d1p4oa_ 174 IGDFGMTRDIYETD 187 (308)
T ss_dssp ECCTTCCCGGGGGG
T ss_pred EeecccceeccCCc
Confidence 99999999876543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.7e-27 Score=253.09 Aligned_cols=147 Identities=30% Similarity=0.501 Sum_probs=128.2
Q ss_pred CCcccccCcEEEEEEEECC----CcEEEEEEcCcc-cccchHHHHHHHHHHhcCCCCceeeEEEEEEeC-CEEEEEEecc
Q 003134 681 ANKVGEGGFGSVYKGILSD----GTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-NQLLLVYEYM 754 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~Ey~ 754 (845)
.++||+|+||+||+|++.+ ...||||+++.. .....++|.+|+++|++++||||++++|++.+. +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999999754 236899999754 334457899999999999999999999998764 6899999999
Q ss_pred CCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCCCC
Q 003134 755 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 755 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~~~ 834 (845)
++|+|.++++... ..+++.++++++.|+++||+|+|+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999986543 35788899999999999999999986 9999999999999999999999999999876443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.3e-27 Score=256.94 Aligned_cols=167 Identities=27% Similarity=0.435 Sum_probs=140.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEE------CCCcEEEEEEcCcccc-cchHHHHHHHHHHhcC-CCCceeeEEEEEEeCCE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 746 (845)
.++|+..+.||+|+||.||+|++ .+++.||||+++.... ....+|.+|+.+++++ +|||||++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46788889999999999999985 2367899999976533 3456789999999998 69999999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCc-------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDT-------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl 813 (845)
.++||||+++|+|.++++.... .....+++.++.+++.||++||+|||+++ ||||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999975431 12346899999999999999999999997 9999999999999
Q ss_pred cCCCcEEEEeeccceecCCCCcee-eeeeccC
Q 003134 814 DKDLNAKISDFGLAKLYEEDKTHI-STRIAGT 844 (845)
Q Consensus 814 d~~~~~kl~DFGla~~~~~~~~~~-~t~~~GT 844 (845)
+.++.+|++|||+++......... .+...||
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt 210 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred cccCcccccccchheeccCCCcceEeeecccC
Confidence 999999999999999886544332 2334555
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=5.4e-26 Score=243.55 Aligned_cols=263 Identities=21% Similarity=0.270 Sum_probs=222.5
Q ss_pred eEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEee
Q 003134 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 171 (845)
+.+.+|.++++++ .+|..+. ++|++|+|++|+|+.+.+..|..+ +|++|++++|.+....|..|.++++|++|+|+
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 3456788888888 6687774 689999999999999988899988 99999999999998889999999999999999
Q ss_pred cccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCc--ccCchhhcCCcccceEEecCCcCCC
Q 003134 172 GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFS--GKIPEFIGKWKKIQKLHIQGSSLEG 249 (845)
Q Consensus 172 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~g 249 (845)
+|+|+ .+|..+ ...|+.|++++|.+.+..+..+.....+..++...|... ...+..|..+++|+++++++|.++.
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~ 164 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence 99999 566544 458999999999999777777888889999999988654 3456678889999999999999984
Q ss_pred CcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhc
Q 003134 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK 328 (845)
Q Consensus 250 ~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 328 (845)
+|.. .+++|+.|++++|.........+... .++.|++++|.+++..+..|.++++|++|+|++|+|+ .+|..|.+
T Consensus 165 -l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~ 240 (305)
T d1xkua_ 165 -IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 240 (305)
T ss_dssp -CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred -cCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccc
Confidence 4443 36789999999999887777666655 8999999999999999999999999999999999999 66889999
Q ss_pred CCCcCEEEccCCcccCCCChhh--------hcCCceEEeecCCCc
Q 003134 329 LAKTNFMYLTGNKLTGPVPKYI--------FNSNKNVDISLNNFT 365 (845)
Q Consensus 329 l~~L~~L~L~~N~l~g~ip~~~--------~~~l~~L~ls~N~l~ 365 (845)
+++|++|+|++|+|+..-...+ ...++.|+|++|.+.
T Consensus 241 l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 9999999999999995322222 236889999999764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.6e-27 Score=249.75 Aligned_cols=159 Identities=23% Similarity=0.360 Sum_probs=133.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc------cchHHHHHHHHHHhcCC--CCceeeEEEEEEeCCE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQ--HPNLVKLYGCCVEGNQ 746 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~ 746 (845)
++|++.+.||+|+||+||+|+.. +++.||||+++.... ....++.+|++++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57889999999999999999975 689999999865421 12245678999999986 8999999999999999
Q ss_pred EEEEEeccCC-CChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-CCcEEEEee
Q 003134 747 LLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDF 824 (845)
Q Consensus 747 ~~lV~Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~-~~~~kl~DF 824 (845)
.++||||+.+ +++.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 9999999976 5777777432 36899999999999999999999997 999999999999985 479999999
Q ss_pred ccceecCCCCceeeeeeccCC
Q 003134 825 GLAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 825 Gla~~~~~~~~~~~t~~~GT~ 845 (845)
|+|+...... .+...||+
T Consensus 156 G~a~~~~~~~---~~~~~GT~ 173 (273)
T d1xwsa_ 156 GSGALLKDTV---YTDFDGTR 173 (273)
T ss_dssp TTCEECCSSC---BCCCCSCG
T ss_pred ccceeccccc---ccccccCC
Confidence 9999875432 23456764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.6e-26 Score=240.13 Aligned_cols=211 Identities=21% Similarity=0.234 Sum_probs=131.2
Q ss_pred ccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEec
Q 003134 164 TLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQ 243 (845)
Q Consensus 164 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 243 (845)
.+.+.+.++++|+ .+|+.+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|++|+|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccccccc
Confidence 3333444444444 2343332 234444444444443333444444444444444444442 22 13344444444444
Q ss_pred CCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCC
Q 003134 244 GSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI 322 (845)
Q Consensus 244 ~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 322 (845)
+|++++ .+..+.++++|+.|++++|.+.......+... +++.|++++|.++...+..+..+++|+.|++++|+|++..
T Consensus 86 ~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~ 164 (266)
T d1p9ag_ 86 HNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP 164 (266)
T ss_dssp SSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred cccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccC
Confidence 444442 23344444455555555554444433333332 5666677777777777777888888999999999998888
Q ss_pred chhhhcCCCcCEEEccCCcccCCCChhhhc--CCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCC
Q 003134 323 PTTFEKLAKTNFMYLTGNKLTGPVPKYIFN--SNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPR 389 (845)
Q Consensus 323 p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~--~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~ 389 (845)
+..|..+++|++|+|++|+|+ .+|..++. .|+.|+|++| ||.|+|...++.+|+....
T Consensus 165 ~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~N--------p~~CdC~~~~l~~wl~~~~ 224 (266)
T d1p9ag_ 165 AGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN--------PWLCNCEILYFRRWLQDNA 224 (266)
T ss_dssp TTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSC--------CBCCSGGGHHHHHHHHHTG
T ss_pred ccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCC--------CCCCCcchHHHHHHHHhcc
Confidence 888888999999999999988 78877753 7889999999 9999999999999987543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.1e-27 Score=252.54 Aligned_cols=157 Identities=27% Similarity=0.445 Sum_probs=130.7
Q ss_pred hcCCCCCCcccccCcEEEEEEEECC--------CcEEEEEEcCcccc-cchHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 744 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 744 (845)
.++|+..+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4578888999999999999998532 35799999976543 3457888899999888 899999999999999
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 813 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILl 813 (845)
+..++||||+++|+|.+++...... ....+++.++++++.||+.||+|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 9999999999999999999755321 1246899999999999999999999997 9999999999999
Q ss_pred cCCCcEEEEeeccceecCCCC
Q 003134 814 DKDLNAKISDFGLAKLYEEDK 834 (845)
Q Consensus 814 d~~~~~kl~DFGla~~~~~~~ 834 (845)
+.++.+||+|||+++......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~ 189 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHID 189 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCC
T ss_pred cCCCCeEeccchhhccccccc
Confidence 999999999999999886543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.4e-26 Score=244.77 Aligned_cols=151 Identities=24% Similarity=0.436 Sum_probs=135.2
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccc--cchHHHHHHHHHHhcCCCCceeeEEEEEEeCCEEEEEEe
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 752 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 752 (845)
++|+..++||+|+||+||+|++. +++.||||+++.... ...+++.+|+++|++++||||+++++++...+..++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47889999999999999999975 689999999865432 335788999999999999999999999999999999999
Q ss_pred ccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccceecCC
Q 003134 753 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 832 (845)
Q Consensus 753 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~~~ 832 (845)
|+.+++|..++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.|+....
T Consensus 82 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eccccccccccccc-----cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccC
Confidence 99999998887543 36789999999999999999999987 99999999999999999999999999998865
Q ss_pred CC
Q 003134 833 DK 834 (845)
Q Consensus 833 ~~ 834 (845)
..
T Consensus 154 ~~ 155 (292)
T d1unla_ 154 PV 155 (292)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.7e-26 Score=252.59 Aligned_cols=149 Identities=30% Similarity=0.420 Sum_probs=123.4
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceeeEEEEEEeC------CEEEE
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQLLL 749 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~l 749 (845)
+|+..++||+|+||+||+|++. +|+.||||++..... .+.+|+++|++++||||+++++++... .++++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5777889999999999999986 599999999965432 234699999999999999999998643 35799
Q ss_pred EEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-cEEEEeeccce
Q 003134 750 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAK 828 (845)
Q Consensus 750 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~-~~kl~DFGla~ 828 (845)
||||++++.+..+.+.. .....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+
T Consensus 97 v~Ey~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEECCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEeccCCccHHHHHhhh--hccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchh
Confidence 99999876544443211 12346999999999999999999999987 99999999999999775 89999999999
Q ss_pred ecCCCC
Q 003134 829 LYEEDK 834 (845)
Q Consensus 829 ~~~~~~ 834 (845)
.+....
T Consensus 172 ~~~~~~ 177 (350)
T d1q5ka_ 172 QLVRGE 177 (350)
T ss_dssp ECCTTS
T ss_pred hccCCc
Confidence 876543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.93 E-value=3e-26 Score=248.39 Aligned_cols=144 Identities=24% Similarity=0.438 Sum_probs=127.3
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCC-CCceeeEEEEEEeC--CEEEEEE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEG--NQLLLVY 751 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~ 751 (845)
++|++.++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999984 6899999998653 3567899999999995 99999999999854 5689999
Q ss_pred eccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCC-cEEEEeeccceec
Q 003134 752 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLY 830 (845)
Q Consensus 752 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~-~~kl~DFGla~~~ 830 (845)
||+++++|.... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+..
T Consensus 112 e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 112 EHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp ECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred eecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence 999999997664 25899999999999999999999997 99999999999998655 6999999999987
Q ss_pred CCC
Q 003134 831 EED 833 (845)
Q Consensus 831 ~~~ 833 (845)
...
T Consensus 181 ~~~ 183 (328)
T d3bqca1 181 HPG 183 (328)
T ss_dssp CTT
T ss_pred cCC
Confidence 654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=9.1e-27 Score=251.24 Aligned_cols=161 Identities=25% Similarity=0.356 Sum_probs=138.1
Q ss_pred cCCCCCCcccccCcEEEEEEEEC----CCcEEEEEEcCccc----ccchHHHHHHHHHHhcCCC-CceeeEEEEEEeCCE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQ 746 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~ 746 (845)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999862 47899999997542 2335678899999999977 799999999999999
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.++||||+.+|+|.+++... ..+++..+..++.||+.||+|+|+++ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999998543 35788899999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCCceeeeeeccC
Q 003134 827 AKLYEEDKTHISTRIAGT 844 (845)
Q Consensus 827 a~~~~~~~~~~~t~~~GT 844 (845)
|+.+............||
T Consensus 176 a~~~~~~~~~~~~~~~g~ 193 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGT 193 (322)
T ss_dssp EEECCGGGGGGGCGGGSC
T ss_pred hhhhcccccccccccccc
Confidence 998865444433444555
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.4e-26 Score=252.62 Aligned_cols=150 Identities=24% Similarity=0.383 Sum_probs=126.1
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc-ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC----EEE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----QLL 748 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~ 748 (845)
+.+|+..+.||+|+||+||+|+.. +|+.||||+++... ....+++.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 356889999999999999999974 69999999997543 333567899999999999999999999997643 234
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeeccce
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 828 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~ 828 (845)
++++|+.+|+|.+++... .+++..++.++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 87 ~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCcee
Confidence 555667799999998532 5899999999999999999999997 9999999999999999999999999999
Q ss_pred ecCCC
Q 003134 829 LYEED 833 (845)
Q Consensus 829 ~~~~~ 833 (845)
.....
T Consensus 158 ~~~~~ 162 (345)
T d1pmea_ 158 VADPD 162 (345)
T ss_dssp ECCGG
T ss_pred eccCC
Confidence 87543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.3e-26 Score=249.95 Aligned_cols=149 Identities=25% Similarity=0.437 Sum_probs=124.3
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeCC------
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------ 745 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 745 (845)
.++|+..+.||+|+||+||+|++. +|+.||||+++... ....+++.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467889999999999999999975 59999999997542 233567889999999999999999999998654
Q ss_pred EEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeec
Q 003134 746 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 825 (845)
Q Consensus 746 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFG 825 (845)
.+|+||||+ +.+|..+++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccc
Confidence 579999999 5577777643 26899999999999999999999997 9999999999999999999999999
Q ss_pred cceecCCC
Q 003134 826 LAKLYEED 833 (845)
Q Consensus 826 la~~~~~~ 833 (845)
+|+.....
T Consensus 167 ~a~~~~~~ 174 (346)
T d1cm8a_ 167 LARQADSE 174 (346)
T ss_dssp TCEECCSS
T ss_pred ceeccCCc
Confidence 99987543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.1e-25 Score=242.91 Aligned_cols=149 Identities=27% Similarity=0.488 Sum_probs=127.0
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcc--cccchHHHHHHHHHHhcCCCCceeeEEEEEEe--------C
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--------G 744 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~ 744 (845)
++|++.++||+|+||+||+|++. +|+.||||++... .....+++.+|+++|++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67889999999999999999975 6999999998654 23345788999999999999999999999865 3
Q ss_pred CEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEee
Q 003134 745 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 824 (845)
Q Consensus 745 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DF 824 (845)
+..|+||||++++.+...... ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 468999999998876655432 236889999999999999999999987 999999999999999999999999
Q ss_pred ccceecCC
Q 003134 825 GLAKLYEE 832 (845)
Q Consensus 825 Gla~~~~~ 832 (845)
|+|+.+..
T Consensus 162 g~~~~~~~ 169 (318)
T d3blha1 162 GLARAFSL 169 (318)
T ss_dssp TTCEECCC
T ss_pred ceeeeccc
Confidence 99987764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=8.1e-26 Score=242.30 Aligned_cols=162 Identities=27% Similarity=0.487 Sum_probs=129.7
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-C-CcEEEEEEcCcccc--cchHHHHHHHHHHhcC---CCCceeeEEEEEEe----
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-D-GTVIAVKQLSSKSR--QGNREFVNEIGMISAQ---QHPNLVKLYGCCVE---- 743 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~---- 743 (845)
.++|++.+.||+|+||+||+|++. + ++.||||+++.... .....+.+|+++|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 4 67899999865422 2234566777776655 89999999999863
Q ss_pred -CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEE
Q 003134 744 -GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 822 (845)
Q Consensus 744 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~ 822 (845)
....+++|||++++++....... ...+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeec
Confidence 24689999999998776554332 236899999999999999999999997 9999999999999999999999
Q ss_pred eeccceecCCCCceeeeeeccCC
Q 003134 823 DFGLAKLYEEDKTHISTRIAGTM 845 (845)
Q Consensus 823 DFGla~~~~~~~~~~~t~~~GT~ 845 (845)
|||+++...... ......||+
T Consensus 159 dfg~~~~~~~~~--~~~~~~gT~ 179 (305)
T d1blxa_ 159 DFGLARIYSFQM--ALTSVVVTL 179 (305)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCC
T ss_pred chhhhhhhcccc--cCCCcccCh
Confidence 999998765432 233455664
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.92 E-value=3.7e-25 Score=235.57 Aligned_cols=148 Identities=22% Similarity=0.345 Sum_probs=128.5
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCC-CceeeEEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~Ey 753 (845)
++|++.+.||+|+||+||+|++. +++.||||++.... ..+++.+|+++++.++| +|++.+++++..+...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57889999999999999999975 58999999885542 23457788899998865 8999999999999999999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecC-----CCcEEEEeeccce
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLAK 828 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~-----~~~~kl~DFGla~ 828 (845)
+ +++|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 83 L-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp C-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred c-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 8 689999885432 36899999999999999999999997 999999999999974 5789999999999
Q ss_pred ecCCC
Q 003134 829 LYEED 833 (845)
Q Consensus 829 ~~~~~ 833 (845)
.+...
T Consensus 155 ~~~~~ 159 (293)
T d1csna_ 155 FYRDP 159 (293)
T ss_dssp ESBCT
T ss_pred EcccC
Confidence 87643
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.5e-25 Score=234.75 Aligned_cols=250 Identities=16% Similarity=0.157 Sum_probs=206.0
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEe-cCCCCCCCcccccccccccceeE
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSV-MGNRLSGPFPKVLTNITTLKNLS 169 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~L-s~N~l~~~~p~~~~~l~~L~~L~ 169 (845)
..++.|+|++|+|+...+.+|.++++|++|++++|++..+.+..+..+ .++.+.. ..|.++...+..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 357899999999997777789999999999999999999999998888 7888765 46778888899999999999999
Q ss_pred eecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCC
Q 003134 170 IEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEG 249 (845)
Q Consensus 170 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 249 (845)
|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 99999998888889999999999999999998778889999999999999999999999999999999999999999999
Q ss_pred CcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcC
Q 003134 250 PIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL 329 (845)
Q Consensus 250 ~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 329 (845)
..|..|.++++|+.| ++++|.+.+..|..|.++++|++|+|++|.+...-+. ..-.
T Consensus 192 i~~~~f~~l~~L~~L-----------------------~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~ 247 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTL-----------------------YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLW 247 (284)
T ss_dssp ECTTTTTTCTTCCEE-----------------------ECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHH
T ss_pred cChhHhhhhhhcccc-----------------------cccccccccccccccccccccCEEEecCCCCCCCccc-hHHH
Confidence 999999988876666 5566677777778888889999999999988854331 1112
Q ss_pred CCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcC
Q 003134 330 AKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTW 366 (845)
Q Consensus 330 ~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~ 366 (845)
..++.+....++++...|..+.. ...++++.|.|+|
T Consensus 248 ~~l~~~~~~~~~~~C~~p~~l~g-~~l~~l~~~~l~g 283 (284)
T d1ozna_ 248 AWLQKFRGSSSEVPCSLPQRLAG-RDLKRLAANDLQG 283 (284)
T ss_dssp HHHHHCCSEECCCBEEESGGGTT-CBGGGSCGGGSCC
T ss_pred HHHHhCcCCCCceEeCCchHHcC-CccccCCHHHCCC
Confidence 23445555666776666665532 3444555555543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=1.4e-23 Score=231.16 Aligned_cols=259 Identities=24% Similarity=0.344 Sum_probs=189.0
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.++++|++++++++.. +.+..|++|++|+|++|+|++..+ +..+ +|++|++++|+|++..+ ++++++|+.|++
T Consensus 44 ~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~ 117 (384)
T d2omza2 44 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 117 (384)
T ss_dssp TTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccccccccc--cccccccccccc
Confidence 3688999999988853 458889999999999999998754 7777 89999999999986543 888999999999
Q ss_pred ecccCCCCCC---------------------------------------------------------------cccccCC
Q 003134 171 EGNLFTGSIP---------------------------------------------------------------PDIRKLI 187 (845)
Q Consensus 171 s~N~l~g~~p---------------------------------------------------------------~~~~~l~ 187 (845)
++|.+++..+ ..+..++
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 197 (384)
T d2omza2 118 FNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLT 197 (384)
T ss_dssp CSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccccccccccc
Confidence 9888774211 2344567
Q ss_pred CccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcC
Q 003134 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRIS 267 (845)
Q Consensus 188 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 267 (845)
+++.|++++|.+++..| +...++|++|++++|+++. + +.+..+++|+.|++++|++++..+ ++.+++|+.|+++
T Consensus 198 ~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~ 271 (384)
T d2omza2 198 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 271 (384)
T ss_dssp TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred ccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeecc
Confidence 77888888888876544 4556778888888888874 2 357777888888888888876543 6777888888888
Q ss_pred CCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCC
Q 003134 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 347 (845)
Q Consensus 268 ~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip 347 (845)
++++..... ......++.++++.|++++. ..+..+++++.|+|++|++++.. .+..+++|+.|++++|+|++ +|
T Consensus 272 ~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~ 345 (384)
T d2omza2 272 ANQISNISP-LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS 345 (384)
T ss_dssp SSCCCCCGG-GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG
T ss_pred CcccCCCCc-cccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch
Confidence 887765432 22233677777777777753 34666777888888888887543 26777888888888887774 33
Q ss_pred hhh--hcCCceEEeecCCCcCCCC
Q 003134 348 KYI--FNSNKNVDISLNNFTWESS 369 (845)
Q Consensus 348 ~~~--~~~l~~L~ls~N~l~~~~p 369 (845)
.+ ..+|+.|++++|++++.+|
T Consensus 346 -~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 346 -SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp -GGGGCTTCCEEECCSSCCCBCGG
T ss_pred -hHcCCCCCCEEECCCCcCCCChh
Confidence 23 3477788888887776654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.91 E-value=1e-23 Score=225.54 Aligned_cols=255 Identities=22% Similarity=0.257 Sum_probs=218.7
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
..++.|+|++|.|+...+.+|.++++|++|++++|.++...|..|..+ +|++|++++|+|+.. |..+ ...|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l-~~~~--~~~l~~L~~ 107 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL-PEKM--PKTLQELRV 107 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBC-CSSC--CTTCCEEEC
T ss_pred CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcC-ccch--hhhhhhhhc
Confidence 568999999999997666789999999999999999999999999998 999999999999954 4433 368899999
Q ss_pred ecccCCCCCCcccccCCCccEEEeecCcCc--ccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCC
Q 003134 171 EGNLFTGSIPPDIRKLINLQKLILSSNSFT--GELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 171 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~--g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
.+|.+.+..+..+.....+..++...|... ...+..+..+++|+++++++|+++ .+|..+ +++|++|++++|.+.
T Consensus 108 ~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~ 184 (305)
T d1xkua_ 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184 (305)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCC
T ss_pred cccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCC
Confidence 999999777777888899999999988654 344667899999999999999998 455543 679999999999999
Q ss_pred CCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhh-
Q 003134 249 GPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF- 326 (845)
Q Consensus 249 g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~- 326 (845)
+..+..|.+++.++.|++++|.+.......+... +|++|+|++|+|+ .+|.+|.++++|++|+|++|+|+......|
T Consensus 185 ~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~ 263 (305)
T d1xkua_ 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263 (305)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred CCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhcc
Confidence 9999999999999999999999998877766654 8999999999998 568899999999999999999996544444
Q ss_pred -----hcCCCcCEEEccCCccc-CCCChhhhcC
Q 003134 327 -----EKLAKTNFMYLTGNKLT-GPVPKYIFNS 353 (845)
Q Consensus 327 -----~~l~~L~~L~L~~N~l~-g~ip~~~~~~ 353 (845)
..+++|+.|+|++|+++ ..++...++.
T Consensus 264 ~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~ 296 (305)
T d1xkua_ 264 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296 (305)
T ss_dssp CSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred CcchhcccCCCCEEECCCCcCccCcCCHhHhcc
Confidence 46788999999999985 4666655543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.6e-25 Score=242.98 Aligned_cols=149 Identities=27% Similarity=0.413 Sum_probs=126.2
Q ss_pred hcCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEeC-----CE
Q 003134 675 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 746 (845)
Q Consensus 675 ~~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 746 (845)
.++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+++.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999975 69999999997653 23346788999999999999999999998643 34
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.+++|||+.+|+|.+++... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccch
Confidence 56677888999999998532 5899999999999999999999997 99999999999999999999999999
Q ss_pred ceecCC
Q 003134 827 AKLYEE 832 (845)
Q Consensus 827 a~~~~~ 832 (845)
|.....
T Consensus 168 a~~~~~ 173 (348)
T d2gfsa1 168 ARHTDD 173 (348)
T ss_dssp --CCTG
T ss_pred hcccCc
Confidence 987643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.91 E-value=2.3e-24 Score=230.15 Aligned_cols=149 Identities=26% Similarity=0.394 Sum_probs=122.9
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCceee-EEEEEEeCCEEEEEEec
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK-LYGCCVEGNQLLLVYEY 753 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~~~~~lV~Ey 753 (845)
++|++.+.||+|+||.||+|++. +++.||||++..... .+++..|++++++++|+|++. +.+++...+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46889999999999999999975 589999998865432 345788999999998776555 55566778899999999
Q ss_pred cCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEec---CCCcEEEEeeccceec
Q 003134 754 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLY 830 (845)
Q Consensus 754 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld---~~~~~kl~DFGla~~~ 830 (845)
+. |++.+.+... ...+++.++..++.|++.||+|||+++ ||||||||+|||++ .+..+||+|||+|+.+
T Consensus 85 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 85 LG-PSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred cC-Cchhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 85 5666665432 236899999999999999999999997 99999999999985 3557999999999988
Q ss_pred CCCC
Q 003134 831 EEDK 834 (845)
Q Consensus 831 ~~~~ 834 (845)
....
T Consensus 157 ~~~~ 160 (299)
T d1ckia_ 157 RDAR 160 (299)
T ss_dssp BCTT
T ss_pred cccc
Confidence 6543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=8.7e-25 Score=239.27 Aligned_cols=146 Identities=26% Similarity=0.396 Sum_probs=120.8
Q ss_pred cCCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCccc--ccchHHHHHHHHHHhcCCCCceeeEEEEEEe------CCE
Q 003134 676 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE------GNQ 746 (845)
Q Consensus 676 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~ 746 (845)
++|++.++||+|+||+||+|++. +|+.||||+++... ....+++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57889999999999999999986 59999999997542 2334578899999999999999999999964 368
Q ss_pred EEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEEEeecc
Q 003134 747 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 826 (845)
Q Consensus 747 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl~DFGl 826 (845)
.|+||||+.++.+ +.+. ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 97 ~~iv~Ey~~~~l~-~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEECCSEEHH-HHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eEEEEeccchHHH-Hhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence 9999999987654 4442 25789999999999999999999997 99999999999999999999999999
Q ss_pred ceecCC
Q 003134 827 AKLYEE 832 (845)
Q Consensus 827 a~~~~~ 832 (845)
++....
T Consensus 166 ~~~~~~ 171 (355)
T d2b1pa1 166 ARTAGT 171 (355)
T ss_dssp ------
T ss_pred hhcccc
Confidence 987754
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=3.9e-23 Score=227.62 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=212.9
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCc---------------
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPF--------------- 155 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~--------------- 155 (845)
.+++.|+|++|.|++. | .|+++++|++|+|++|++++..+ +..+ +|+.|++++|.+++..
T Consensus 66 ~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (384)
T d2omza2 66 NNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS 141 (384)
T ss_dssp TTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEE
T ss_pred CCCCEEeCcCCcCCCC-c-cccCCcccccccccccccccccc--cccccccccccccccccccccccccccccccccccc
Confidence 4789999999999974 3 39999999999999999998654 6666 8999999988876421
Q ss_pred ------------------------------------------------ccccccccccceeEeecccCCCCCCcccccCC
Q 003134 156 ------------------------------------------------PKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI 187 (845)
Q Consensus 156 ------------------------------------------------p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 187 (845)
...+..+++++.|++++|.+++..| +..++
T Consensus 142 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~ 219 (384)
T d2omza2 142 NTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILT 219 (384)
T ss_dssp EEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCT
T ss_pred ccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccCCccCCCCc--ccccC
Confidence 1345567889999999999997654 56788
Q ss_pred CccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcC
Q 003134 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRIS 267 (845)
Q Consensus 188 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 267 (845)
+|++|++++|+++. + +.+..+++|+.|++++|++++..+ +..+++|++|++++|++++..+ +..+..++.++++
T Consensus 220 ~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~ 293 (384)
T d2omza2 220 NLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELN 293 (384)
T ss_dssp TCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred CCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCc--ccccccccccccc
Confidence 99999999999984 3 468899999999999999997543 7889999999999999997643 7789999999999
Q ss_pred CCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCC
Q 003134 268 DLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 347 (845)
Q Consensus 268 ~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip 347 (845)
.|.+..... .-...+++.|+|++|+|++..+ +..+++|++|+|++|+|++ ++ .|.++++|++|+|++|+|++..|
T Consensus 294 ~n~l~~~~~-~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 294 ENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp SSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred ccccccccc-cchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence 999886432 2233389999999999998644 8889999999999999995 44 69999999999999999998766
Q ss_pred hhhhcCCceEEeecC
Q 003134 348 KYIFNSNKNVDISLN 362 (845)
Q Consensus 348 ~~~~~~l~~L~ls~N 362 (845)
-.-..+|+.|+|++|
T Consensus 369 l~~l~~L~~L~L~~N 383 (384)
T d2omza2 369 LANLTRITQLGLNDQ 383 (384)
T ss_dssp GTTCTTCSEEECCCE
T ss_pred hccCCCCCEeeCCCC
Confidence 333568999999998
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=3.3e-23 Score=217.28 Aligned_cols=196 Identities=24% Similarity=0.262 Sum_probs=117.5
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeecccC
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLF 175 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 175 (845)
+++.++++|+ .+|+.|. ++|++|+|++|+|+++.+ ..|.++++|++|+|++|+|
T Consensus 14 ~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~-----------------------~~f~~l~~L~~L~L~~N~l 67 (266)
T d1p9ag_ 14 EVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSL-----------------------ATLMPYTRLTQLNLDRAEL 67 (266)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEG-----------------------GGGTTCTTCCEEECTTSCC
T ss_pred EEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCH-----------------------HHhhccccccccccccccc
Confidence 3567777776 3565543 355666666665554443 4455555555555555555
Q ss_pred CCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhh
Q 003134 176 TGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASI 255 (845)
Q Consensus 176 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 255 (845)
+ .+| .++.+++|++|+|++|+++ ..+..+.++++|++|++++|++.+..+..+..+.++++|++++|.++...+..+
T Consensus 68 ~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~ 144 (266)
T d1p9ag_ 68 T-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL 144 (266)
T ss_dssp C-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred c-ccc-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccc
Confidence 4 222 2344555555555555555 234445555555555555555555555555555555555555555554444444
Q ss_pred hcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEE
Q 003134 256 SALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 335 (845)
Q Consensus 256 ~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 335 (845)
..+++| +.|++++|+|++..+..|..+++|++|||++|+|+ .+|..+..+++|+.|
T Consensus 145 ~~l~~l-----------------------~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L 200 (266)
T d1p9ag_ 145 TPTPKL-----------------------EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA 200 (266)
T ss_dssp TTCTTC-----------------------CEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEE
T ss_pred cccccc-----------------------hhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEE
Confidence 444433 33455555566566667777888888888888888 778778888888888
Q ss_pred EccCCcccC
Q 003134 336 YLTGNKLTG 344 (845)
Q Consensus 336 ~L~~N~l~g 344 (845)
+|++|.+.-
T Consensus 201 ~L~~Np~~C 209 (266)
T d1p9ag_ 201 FLHGNPWLC 209 (266)
T ss_dssp ECCSCCBCC
T ss_pred EecCCCCCC
Confidence 888888763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=2.3e-21 Score=192.46 Aligned_cols=134 Identities=21% Similarity=0.192 Sum_probs=107.1
Q ss_pred CCCcccccCcEEEEEEEECCCcEEEEEEcCcccc------------------cchHHHHHHHHHHhcCCCCceeeEEEEE
Q 003134 680 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR------------------QGNREFVNEIGMISAQQHPNLVKLYGCC 741 (845)
Q Consensus 680 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 741 (845)
+.++||+|+||+||+|+..+|+.||||+++.... ........|...+.++.|.++++.+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4678999999999999998899999998753210 0113345688899999999999887653
Q ss_pred EeCCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCcEEE
Q 003134 742 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 821 (845)
Q Consensus 742 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~~kl 821 (845)
. .++||||++++.+. .+++..+.+++.|+++||+|||+++ |+||||||+|||++++ .++|
T Consensus 84 --~--~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 84 --G--NAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp --T--TEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred --C--CEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 2 27999999875432 2445567789999999999999987 9999999999999865 5899
Q ss_pred EeeccceecCCC
Q 003134 822 SDFGLAKLYEED 833 (845)
Q Consensus 822 ~DFGla~~~~~~ 833 (845)
+|||+|+....+
T Consensus 144 iDFG~a~~~~~~ 155 (191)
T d1zara2 144 IDFPQSVEVGEE 155 (191)
T ss_dssp CCCTTCEETTST
T ss_pred EECCCcccCCCC
Confidence 999999887644
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.79 E-value=4e-20 Score=202.38 Aligned_cols=151 Identities=25% Similarity=0.286 Sum_probs=118.6
Q ss_pred CCCCCCcccccCcEEEEEEEEC-CCcEEEEEEcCcccccchHHHHHHHHHHhcCC-----------CCceeeEEEEEEe-
Q 003134 677 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----------HPNLVKLYGCCVE- 743 (845)
Q Consensus 677 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~- 743 (845)
+|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4889999999999999999975 69999999997642 23457788998888775 5789999998764
Q ss_pred -CCEEEEEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEecCCCc----
Q 003134 744 -GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---- 818 (845)
Q Consensus 744 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLKp~NILld~~~~---- 818 (845)
....+++|+++..+......... .....+++..+..++.||+.||+|||+.. +|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred cccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCccccc
Confidence 45677777776655433332211 12246889999999999999999999832 4999999999999986653
Q ss_pred --EEEEeeccceecCC
Q 003134 819 --AKISDFGLAKLYEE 832 (845)
Q Consensus 819 --~kl~DFGla~~~~~ 832 (845)
+|++|||.|+....
T Consensus 169 ~~~kl~dfg~s~~~~~ 184 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE 184 (362)
T ss_dssp EEEEECCCTTCEETTB
T ss_pred ceeeEeeccccccccc
Confidence 99999999987754
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=9.7e-19 Score=179.75 Aligned_cols=225 Identities=16% Similarity=0.152 Sum_probs=128.1
Q ss_pred eeecCCCCcceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCc-ccccc
Q 003134 83 VTCDCSSATCHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPF-PKVLT 160 (845)
Q Consensus 83 v~C~~~~~~~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~-p~~~~ 160 (845)
..|+|.. +.++.++.+++ .+|+.+. +++++|+|++|+|+.+.+..|..+ +|++|+|++|.+...+ +..|.
T Consensus 4 ~~C~C~~-----~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~ 75 (242)
T d1xwdc1 4 RICHCSN-----RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS 75 (242)
T ss_dssp SSEEECS-----SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEE
T ss_pred CcCCCcC-----CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccc
Confidence 3466643 25777788888 6776653 577888888888776665566655 6666666666655433 33455
Q ss_pred cccccceeEee-cccCCCCCCcccccCCCccEEEeecCcCcccCCh-hhhCCCCCCcEEeecCcCcccCchhhcCCc-cc
Q 003134 161 NITTLKNLSIE-GNLFTGSIPPDIRKLINLQKLILSSNSFTGELPA-ELTKLTNLNDLRISDNNFSGKIPEFIGKWK-KI 237 (845)
Q Consensus 161 ~l~~L~~L~Ls-~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L 237 (845)
+++++++|++. .|++....+..|.++++|++|++++|++....+. .+..+..|..+..+++++....+..|.+++ .+
T Consensus 76 ~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l 155 (242)
T d1xwdc1 76 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFES 155 (242)
T ss_dssp SCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSC
T ss_pred cccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccc
Confidence 56666666554 3455555555566666666666666665532221 123334444444455555544444444433 44
Q ss_pred ceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEE-EccCCcCcccCcccccCCCCcCEEeCCCC
Q 003134 238 QKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTL-ILTKCLIHGEIPDYIGDMTKLKNIDLSFN 316 (845)
Q Consensus 238 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 316 (845)
+.|++++|+++. .....+...+++.+ ++++|+|+...+..|.++++|++|+|++|
T Consensus 156 ~~L~l~~n~l~~------------------------i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N 211 (242)
T d1xwdc1 156 VILWLNKNGIQE------------------------IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 211 (242)
T ss_dssp EEEECCSSCCCE------------------------ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTS
T ss_pred eeeecccccccc------------------------cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCC
Confidence 455555555543 22222222233333 35666676555556777788888888888
Q ss_pred CCCCCCchhhhcCCCcCEEEccC
Q 003134 317 NLTGGIPTTFEKLAKTNFMYLTG 339 (845)
Q Consensus 317 ~l~g~~p~~~~~l~~L~~L~L~~ 339 (845)
+|+...+..|.++++|+.|++.+
T Consensus 212 ~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 212 RIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CCCCCCSSSCTTCCEEESSSEES
T ss_pred cCCccCHHHHcCCcccccCcCCC
Confidence 87755555667777666665543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=2.4e-18 Score=175.27 Aligned_cols=184 Identities=17% Similarity=0.276 Sum_probs=86.6
Q ss_pred ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEee
Q 003134 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219 (845)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 219 (845)
+|++|++.+|+|+.. +.+.++++|++|+|++|++++..| +..+++|++|++++|.++. ++ .+.++++|++++++
T Consensus 42 ~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~ 115 (227)
T d1h6ua2 42 GITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLT 115 (227)
T ss_dssp TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECT
T ss_pred CcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-cc-cccccccccccccc
Confidence 445555555555432 235555555555555555553322 5555555555555555542 22 34555555555555
Q ss_pred cCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCc
Q 003134 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIP 299 (845)
Q Consensus 220 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p 299 (845)
+|+..+. ..+...+.+..+.++.+.+.... .+.++++|+.|++++ |.++...
T Consensus 116 ~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~-----------------------n~~~~~~- 167 (227)
T d1h6ua2 116 STQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGN-----------------------AQVSDLT- 167 (227)
T ss_dssp TSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCS-----------------------SCCCCCG-
T ss_pred ccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccc-----------------------cccccch-
Confidence 5555432 12344455555555555554322 234444444444444 4443221
Q ss_pred ccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEee
Q 003134 300 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDIS 360 (845)
Q Consensus 300 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls 360 (845)
.+.++++|+.|+|++|++++ ++ .++++++|++|+|++|++++..|-.-...|+.|+++
T Consensus 168 -~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 168 -PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225 (227)
T ss_dssp -GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEE
T ss_pred -hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcccccCCCCCEEEee
Confidence 14445555555555555543 22 245555555555555555532221223345555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=4.3e-18 Score=173.34 Aligned_cols=189 Identities=21% Similarity=0.286 Sum_probs=129.2
Q ss_pred EEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcC
Q 003134 144 LSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNF 223 (845)
Q Consensus 144 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 223 (845)
++++.+++++.. .+..+.+|+.|++.+|+|+. ++ .+.++++|++|+|++|++++..| +.++++|++|++++|.+
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence 445555555432 45566777777777777773 33 46777777777777777764333 66777777777777777
Q ss_pred cccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCccccc
Q 003134 224 SGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIG 303 (845)
Q Consensus 224 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~ 303 (845)
+. ++ .+.++++|++|++++|...+..+ +...+ .+..+.++.+.+.... .+.
T Consensus 98 ~~-i~-~l~~l~~L~~l~l~~~~~~~~~~--~~~~~-----------------------~~~~l~~~~~~~~~~~--~~~ 148 (227)
T d1h6ua2 98 KN-VS-AIAGLQSIKTLDLTSTQITDVTP--LAGLS-----------------------NLQVLYLDLNQITNIS--PLA 148 (227)
T ss_dssp SC-CG-GGTTCTTCCEEECTTSCCCCCGG--GTTCT-----------------------TCCEEECCSSCCCCCG--GGG
T ss_pred cc-cc-cccccccccccccccccccccch--hcccc-----------------------chhhhhchhhhhchhh--hhc
Confidence 63 32 45666777777776666654322 22333 4555666666665433 367
Q ss_pred CCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCC
Q 003134 304 DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESS 369 (845)
Q Consensus 304 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p 369 (845)
++++|+.|++++|++++.. .+.++++|+.|+|++|++++..+-.-.++|+.|+|++|+++...|
T Consensus 149 ~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~lt~i~~ 212 (227)
T d1h6ua2 149 GLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP 212 (227)
T ss_dssp GCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCGG
T ss_pred cccccccccccccccccch--hhcccccceecccCCCccCCChhhcCCCCCCEEECcCCcCCCCcc
Confidence 7899999999999998543 489999999999999999964332234689999999999997654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.4e-18 Score=178.55 Aligned_cols=199 Identities=16% Similarity=0.130 Sum_probs=152.7
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCC-ccccccc-ceeEEEec-CCCCCCCccccccccccccee
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSF-SPQWASL-QLVELSVM-GNRLSGPFPKVLTNITTLKNL 168 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~-~~~~~~l-~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L 168 (845)
..++.|+|++|.|+...+..|.++++|++|+|++|.+...+ +..|..+ ++++|.+. .|++....+..|.++++|++|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 46899999999999766668999999999999999998754 5567777 88998876 478988888999999999999
Q ss_pred EeecccCCCCCCc-ccccCCCccEEEeecCcCcccCChhhhCCC-CCCcEEeecCcCcccCchhhcCCcccceE-EecCC
Q 003134 169 SIEGNLFTGSIPP-DIRKLINLQKLILSSNSFTGELPAELTKLT-NLNDLRISDNNFSGKIPEFIGKWKKIQKL-HIQGS 245 (845)
Q Consensus 169 ~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~Ls~N 245 (845)
++++|++....+. .+..+..|..+..+++++....+..|.+++ .++.|++++|+++...+..| ...+++.+ ++++|
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n 187 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNN 187 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCT
T ss_pred ccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccc-cchhhhcccccccc
Confidence 9999999854332 345677788888888899877777787765 78999999999996555555 44555544 67888
Q ss_pred cCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCC
Q 003134 246 SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS 314 (845)
Q Consensus 246 ~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 314 (845)
+|+...+..|.++++|+.|+|++|+ |+...+..|.++++|+.|++.
T Consensus 188 ~l~~l~~~~f~~l~~L~~L~Ls~N~-----------------------l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 188 NLEELPNDVFHGASGPVILDISRTR-----------------------IHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp TCCCCCTTTTTTSCCCSEEECTTSC-----------------------CCCCCSSSCTTCCEEESSSEE
T ss_pred ccccccHHHhcCCCCCCEEECCCCc-----------------------CCccCHHHHcCCcccccCcCC
Confidence 8986666678888877777555554 443444456666666666554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=7.4e-19 Score=174.27 Aligned_cols=172 Identities=18% Similarity=0.197 Sum_probs=117.2
Q ss_pred CEEeccCCcccCCCcccccccceeEEEecCCCCCCC-cccccccccccceeEeecccCCCCCCcccccCCCccEEEeecC
Q 003134 119 KQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP-FPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN 197 (845)
Q Consensus 119 ~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 197 (845)
++++.++|+++.+++ .+. .++++|+|++|+|++. .+..|.++++|++|+|++|++.+..+..|..+++|++|+|++|
T Consensus 11 ~~v~Cs~~~L~~iP~-~lp-~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 11 TTVDCTGRGLKEIPR-DIP-LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp TEEECTTSCCSSCCS-CCC-TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CEEEEeCCCcCccCC-CCC-CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 578888888885543 221 3677788888888753 3556777888888888888887777777777888888888888
Q ss_pred cCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCc
Q 003134 198 SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFP 277 (845)
Q Consensus 198 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~ 277 (845)
+|++..|..|.++++|++|+|++|+|++..|++|..+++|++|+|++|.+.......+..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~-------------------- 148 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA-------------------- 148 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--------------------
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHh--------------------
Confidence 887766777777888888888888887777777777777777777777776443221100
Q ss_pred ccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCC
Q 003134 278 KLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 319 (845)
Q Consensus 278 ~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 319 (845)
..++.+.+..|.++...|.. +..++.++|+.|+|+
T Consensus 149 ----~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 149 ----EWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183 (192)
T ss_dssp ----HHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCC
T ss_pred ----hhhhhhcccCCCeEeCCChh---hcCCEeeecCHhhCc
Confidence 01233345556666555544 344566677777776
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=7.7e-19 Score=174.12 Aligned_cols=171 Identities=18% Similarity=0.231 Sum_probs=81.2
Q ss_pred eeEeecccCCCCCCcccccCCCccEEEeecCcCcccC-ChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCC
Q 003134 167 NLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGEL-PAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGS 245 (845)
Q Consensus 167 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 245 (845)
.++.++|+|+ .+|..+. +++++|+|++|+|++.+ +..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 3444444444 3343332 34444555555544322 233444455555555555555444444444444555555555
Q ss_pred cCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchh
Q 003134 246 SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTT 325 (845)
Q Consensus 246 ~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 325 (845)
+|+...|..|.++++|+.| +|++|+|++..|.+|..+++|++|+|++|.+....+..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L-----------------------~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~ 145 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTL-----------------------NLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA 145 (192)
T ss_dssp CCCEECSSSSTTCTTCCEE-----------------------ECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH
T ss_pred cccccCHHHHhCCCccccc-----------------------ccCCccccccCHHHhcCCcccccccccccccccccchH
Confidence 4444444444444433322 33344444444555556666666666666665433211
Q ss_pred hhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCc
Q 003134 326 FEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 365 (845)
Q Consensus 326 ~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~ 365 (845)
.-...++.+.+..|.++...|..+ ..++.++|+.|.|+
T Consensus 146 -~~~~~l~~~~l~~~~~~c~~p~~l-~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 146 -WFAEWLRKKSLNGGAARCGAPSKV-RDVQIKDLPHSEFK 183 (192)
T ss_dssp -HHHHHHHHHCCSGGGCBBCSSTTT-TTSBGGGSCTTTCC
T ss_pred -HHhhhhhhhcccCCCeEeCCChhh-cCCEeeecCHhhCc
Confidence 111224445556666665555443 33455666666443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.74 E-value=8.2e-17 Score=173.77 Aligned_cols=248 Identities=19% Similarity=0.200 Sum_probs=144.6
Q ss_pred eEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeec
Q 003134 93 HVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 172 (845)
+++.|||++++|+ .+|+. +++|++|+|++|+|+.+ |..+. +|+.|++++|+++.. +.. .+.|++|+|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~l-p~~~~--~L~~L~l~~n~l~~l-~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTEL-PELPQ--SLKSLLVDNNNLKAL-SDL---PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSC-CCCCT--TCCEEECCSSCCSCC-CSC---CTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCccc-ccchh--hhhhhhhhhcccchh-hhh---ccccccccccc
Confidence 4678999999998 47753 57899999999999954 54432 789999999998833 321 14699999999
Q ss_pred ccCCCCCCcccccCCCccEEEeecCcCcccCC------------------hhhhCCCCCCcEEeecCcCcccCc------
Q 003134 173 NLFTGSIPPDIRKLINLQKLILSSNSFTGELP------------------AELTKLTNLNDLRISDNNFSGKIP------ 228 (845)
Q Consensus 173 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p------------------~~~~~l~~L~~L~Ls~N~l~~~~p------ 228 (845)
|.++ .+|. ++.+++|++|++++|.++...+ ..+..++.++.|++++|.+.....
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~ 185 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLE 185 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCC
T ss_pred cccc-cccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccccc
Confidence 9998 5664 6889999999999998873322 123334445555555555442110
Q ss_pred ------------hhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcc
Q 003134 229 ------------EFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHG 296 (845)
Q Consensus 229 ------------~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~ 296 (845)
..+..++.|+.+++++|.... ++. ...++..+++.++.+...... ...+..+++..|.+.+
T Consensus 186 ~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~~~~---~~~l~~~~~~~~~~~~ 258 (353)
T d1jl5a_ 186 SIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDLPEL---PQSLTFLDVSENIFSG 258 (353)
T ss_dssp EEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSE
T ss_pred ccccccccccccccccccccccccccccccccc-ccc---ccccccccccccccccccccc---cccccccccccccccc
Confidence 112223344444444443331 111 122233333333333221100 0022233333322221
Q ss_pred c----------------CcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEEee
Q 003134 297 E----------------IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDIS 360 (845)
Q Consensus 297 ~----------------~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls 360 (845)
. ++.....+++|++|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|.. ..+|+.|+++
T Consensus 259 l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~-~~~L~~L~L~ 332 (353)
T d1jl5a_ 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL-PQNLKQLHVE 332 (353)
T ss_dssp ESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC-CTTCCEEECC
T ss_pred cccccchhcccccccCccccccccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc-cCCCCEEECc
Confidence 1 1111223467778888888777 4553 3567777788888777 55543 3567778888
Q ss_pred cCCCcC
Q 003134 361 LNNFTW 366 (845)
Q Consensus 361 ~N~l~~ 366 (845)
+|+++.
T Consensus 333 ~N~L~~ 338 (353)
T d1jl5a_ 333 YNPLRE 338 (353)
T ss_dssp SSCCSS
T ss_pred CCcCCC
Confidence 877663
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=1e-17 Score=168.39 Aligned_cols=165 Identities=22% Similarity=0.318 Sum_probs=91.2
Q ss_pred ccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEE
Q 003134 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLH 241 (845)
Q Consensus 162 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 241 (845)
+.+|++|++++|+++.. + .+..+++|++|+|++|+|++.. .++++++|++|++++|+|++ +| .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccc
Confidence 44555555555555532 1 2445555555555555555322 24455555555555555553 22 345555555555
Q ss_pred ecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCC
Q 003134 242 IQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG 321 (845)
Q Consensus 242 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 321 (845)
+++|.+.. ...+..+++|+.++++.|.++.... .....+|+.+++++|++++..+ +.++++|++|+|++|+|+.
T Consensus 119 l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~~~-~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~~- 192 (210)
T d1h6ta2 119 LEHNGISD--INGLVHLPQLESLYLGNNKITDITV-LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD- 192 (210)
T ss_dssp CTTSCCCC--CGGGGGCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-
T ss_pred cccccccc--ccccccccccccccccccccccccc-cccccccccccccccccccccc--ccCCCCCCEEECCCCCCCC-
Confidence 55555542 1234455555555555555443221 1111256666777777765332 7788888888888888874
Q ss_pred CchhhhcCCCcCEEEccC
Q 003134 322 IPTTFEKLAKTNFMYLTG 339 (845)
Q Consensus 322 ~p~~~~~l~~L~~L~L~~ 339 (845)
+| .|.++++|++|+|++
T Consensus 193 l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 193 LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CG-GGTTCTTCSEEEEEE
T ss_pred Ch-hhcCCCCCCEEEccC
Confidence 44 588888888888864
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=3.6e-17 Score=162.82 Aligned_cols=161 Identities=20% Similarity=0.297 Sum_probs=80.3
Q ss_pred ccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEE
Q 003134 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLH 241 (845)
Q Consensus 162 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 241 (845)
+.+|++|++++|.++. + +.+..+++|++|+|++|+|++..| +.++++|++|++++|.+.. ++ .+.++++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccccc
Confidence 4444444444444442 2 124444445555555554443221 4444445555555544442 22 244444455555
Q ss_pred ecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCC
Q 003134 242 IQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG 321 (845)
Q Consensus 242 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 321 (845)
+++|.+.... .+..+++|+.|++++|++...+ ......+|+.|++++|++++.. .++++++|++|+|++|+|+.
T Consensus 113 l~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~- 186 (199)
T d2omxa2 113 LFNNQITDID--PLKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD- 186 (199)
T ss_dssp CCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-
T ss_pred cccccccccc--ccchhhhhHHhhhhhhhhcccc-cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC-
Confidence 5444444321 2344444444444444443221 1111124555566666666432 36778888888888888874
Q ss_pred CchhhhcCCCcCEE
Q 003134 322 IPTTFEKLAKTNFM 335 (845)
Q Consensus 322 ~p~~~~~l~~L~~L 335 (845)
++ .++.+++|+.|
T Consensus 187 i~-~l~~L~~L~~L 199 (199)
T d2omxa2 187 IS-VLAKLTNLESL 199 (199)
T ss_dssp CG-GGGGCTTCSEE
T ss_pred Cc-cccCCCCCCcC
Confidence 33 47778887765
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=2.4e-17 Score=165.69 Aligned_cols=162 Identities=21% Similarity=0.301 Sum_probs=83.9
Q ss_pred ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEee
Q 003134 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219 (845)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 219 (845)
+|++|++++|+++... .+..+++|++|+|++|+|++. + .++.+++|++|++++|+|++ +| .+.++++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-cccccccccccccc
Confidence 3444444444444221 244455555555555555532 2 24455555555555555542 22 24555555555555
Q ss_pred cCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccC-CccEEEccCCcCcccC
Q 003134 220 DNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKM-NLKTLILTKCLIHGEI 298 (845)
Q Consensus 220 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~-~L~~L~Ls~N~l~~~~ 298 (845)
+|.++. + ..+..+++|+.+++++|.+++ +..+..+++|+.+++++|++++.. .+... +|+.|+|++|+|+. +
T Consensus 121 ~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l 193 (210)
T d1h6ta2 121 HNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-L 193 (210)
T ss_dssp TSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-C
T ss_pred cccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-C
Confidence 555542 1 234455555555555555543 223444555555555555554432 12222 56667777777774 4
Q ss_pred cccccCCCCcCEEeCCC
Q 003134 299 PDYIGDMTKLKNIDLSF 315 (845)
Q Consensus 299 p~~~~~l~~L~~L~Ls~ 315 (845)
| .|.++++|++|+|++
T Consensus 194 ~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 194 R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp G-GGTTCTTCSEEEEEE
T ss_pred h-hhcCCCCCCEEEccC
Confidence 4 588889999998864
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1.5e-16 Score=158.24 Aligned_cols=161 Identities=25% Similarity=0.376 Sum_probs=76.0
Q ss_pred CCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEE
Q 003134 114 KLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKL 192 (845)
Q Consensus 114 ~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 192 (845)
.+++|++|++++|.++.. +.+..+ +|++|+|++|+|++..| +.++++|++|++++|.+.. ++ .+.++++|++|
T Consensus 38 ~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence 445555666666555532 123333 44445555544443322 4444455555555554442 22 24444455555
Q ss_pred EeecCcCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCC
Q 003134 193 ILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGS 272 (845)
Q Consensus 193 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~ 272 (845)
++++|.+... ..+..+++|+.|++++|+++. ++ .+..+++|++|++++|++++.. .+++++
T Consensus 112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~------------- 172 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLK--PLANLT------------- 172 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCT-------------
T ss_pred cccccccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCCc--cccCCC-------------
Confidence 5544444421 124444445555555554442 11 2444444444444444444321 133343
Q ss_pred CCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEE
Q 003134 273 ESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNI 311 (845)
Q Consensus 273 ~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 311 (845)
+|++|++++|+|+. ++ .++.+++|+.|
T Consensus 173 ----------~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 173 ----------TLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp ----------TCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ----------CCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 45555666666654 22 46677777765
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.61 E-value=1.9e-14 Score=154.91 Aligned_cols=241 Identities=24% Similarity=0.281 Sum_probs=169.9
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEee
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIE 171 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 171 (845)
.+++.|+|++|+|+ .+|..+ .+|+.|++++|+++.+. . +. -.|++|+|++|.|.. +|. ++.+++|+.|+++
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l~-~-lp-~~L~~L~L~~n~l~~-lp~-~~~l~~L~~L~l~ 128 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKALS-D-LP-PLLEYLGVSNNQLEK-LPE-LQNSSFLKIIDVD 128 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCCC-S-CC-TTCCEEECCSSCCSS-CCC-CTTCTTCCEEECC
T ss_pred CCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchhh-h-hc-ccccccccccccccc-ccc-hhhhccceeeccc
Confidence 47889999999999 677654 57899999999998542 1 11 169999999999985 453 6789999999999
Q ss_pred cccCCCCCC------------------cccccCCCccEEEeecCcCcccC------------------ChhhhCCCCCCc
Q 003134 172 GNLFTGSIP------------------PDIRKLINLQKLILSSNSFTGEL------------------PAELTKLTNLND 215 (845)
Q Consensus 172 ~N~l~g~~p------------------~~~~~l~~L~~L~Ls~N~l~g~~------------------p~~~~~l~~L~~ 215 (845)
+|.++...+ ..+..++.++.|++++|.+.... ...+..++.|+.
T Consensus 129 ~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~ 208 (353)
T d1jl5a_ 129 NNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTT 208 (353)
T ss_dssp SSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCE
T ss_pred cccccccccccccccchhhccccccccccccccccceecccccccccccccccccccccccccccccccccccccccccc
Confidence 998874322 23556788899999988875311 123566789999
Q ss_pred EEeecCcCcccCchhhcCCcccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCC---------------Cccc-
Q 003134 216 LRISDNNFSGKIPEFIGKWKKIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESA---------------FPKL- 279 (845)
Q Consensus 216 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~---------------~~~l- 279 (845)
+++++|.... ++. ...++..+.+..|.+.... .. ..++..+++..+.+.... ...+
T Consensus 209 l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~~-~~---~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~ 280 (353)
T d1jl5a_ 209 IYADNNLLKT-LPD---LPPSLEALNVRDNYLTDLP-EL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLC 280 (353)
T ss_dssp EECCSSCCSS-CCS---CCTTCCEEECCSSCCSCCC-CC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEEC
T ss_pred cccccccccc-ccc---ccccccccccccccccccc-cc---cccccccccccccccccccccchhcccccccCcccccc
Confidence 9999998873 443 3456788888888876432 11 223344444333222110 0011
Q ss_pred c-cCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhcCCceEE
Q 003134 280 D-KMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVD 358 (845)
Q Consensus 280 ~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ 358 (845)
. ..+|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|. +...++.|.
T Consensus 281 ~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~-~~~~L~~L~ 350 (353)
T d1jl5a_ 281 DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD-IPESVEDLR 350 (353)
T ss_dssp CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC-CCTTCCEEE
T ss_pred ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc-cccccCeeE
Confidence 1 127999999999999 46643 678999999999999 56653 568999999999998 6775 344666665
Q ss_pred e
Q 003134 359 I 359 (845)
Q Consensus 359 l 359 (845)
+
T Consensus 351 ~ 351 (353)
T d1jl5a_ 351 M 351 (353)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=1.6e-16 Score=167.39 Aligned_cols=249 Identities=17% Similarity=0.268 Sum_probs=129.5
Q ss_pred EEEecCCCccccCCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCC-cccccccccccceeEeeccc
Q 003134 96 TIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGP-FPKVLTNITTLKNLSIEGNL 174 (845)
Q Consensus 96 ~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~ 174 (845)
++||+++.+.......+.. ..+..+.++...+.......+...+|++|+|+++.++.. ++..+.++++|++|+|+++.
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~ 82 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccC
Confidence 4566665554322222211 123445555544444333333333556666665555433 23334455555555555555
Q ss_pred CCCCCCcccccCCCccEEEeecC-cCccc-CChhhhCCCCCCcEEeecC-cCccc-CchhhcC-CcccceEEecCC--cC
Q 003134 175 FTGSIPPDIRKLINLQKLILSSN-SFTGE-LPAELTKLTNLNDLRISDN-NFSGK-IPEFIGK-WKKIQKLHIQGS--SL 247 (845)
Q Consensus 175 l~g~~p~~~~~l~~L~~L~Ls~N-~l~g~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~-l~~L~~L~Ls~N--~l 247 (845)
+++..+..++.+++|++|+|+++ .++.. +..-+.++++|++|+|+++ .++.. +...+.. .++|+.|++++. .+
T Consensus 83 l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i 162 (284)
T d2astb2 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL 162 (284)
T ss_dssp CCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGS
T ss_pred CCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccc
Confidence 55444455555555555555553 33321 1111234555555555553 23211 1122222 234555555432 22
Q ss_pred CCC-cchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCC-cCcccCcccccCCCCcCEEeCCC-CCCCCCCch
Q 003134 248 EGP-IPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKC-LIHGEIPDYIGDMTKLKNIDLSF-NNLTGGIPT 324 (845)
Q Consensus 248 ~g~-~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~ 324 (845)
+.. +...+.+++ +|++|+|++| .+++.....+.++++|++|+|++ ++++.....
T Consensus 163 ~~~~l~~l~~~~~-----------------------~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~ 219 (284)
T d2astb2 163 QKSDLSTLVRRCP-----------------------NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLL 219 (284)
T ss_dssp CHHHHHHHHHHCT-----------------------TCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGG
T ss_pred ccccccccccccc-----------------------cccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHH
Confidence 211 112223344 4555566654 46666677778888899999988 467766667
Q ss_pred hhhcCCCcCEEEccCCcccCCCChhhhcCCceEEeecCCCcCCCC
Q 003134 325 TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESS 369 (845)
Q Consensus 325 ~~~~l~~L~~L~L~~N~l~g~ip~~~~~~l~~L~ls~N~l~~~~p 369 (845)
.++++++|+.|+++++ ++...-..+...+..|++..++++...+
T Consensus 220 ~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L~i~~~~ls~~~~ 263 (284)
T d2astb2 220 ELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHLQINCSHFTTIAR 263 (284)
T ss_dssp GGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTSEESCCCSCCTTC
T ss_pred HHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccccccCccCCCCCC
Confidence 7888889999998877 4322223334456777777777776544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=5.8e-17 Score=181.24 Aligned_cols=274 Identities=17% Similarity=0.240 Sum_probs=172.9
Q ss_pred eEEEEEecCCCccc----cCCccccCCCCCCEEeccCCcccCCC----cccccc--cceeEEEecCCCCCCC----cccc
Q 003134 93 HVVTIALKAQNLTG----TLPTELSKLRYLKQLDLSRNCLTGSF----SPQWAS--LQLVELSVMGNRLSGP----FPKV 158 (845)
Q Consensus 93 ~v~~L~l~~~~l~g----~~p~~l~~L~~L~~L~Ls~N~l~~~~----~~~~~~--l~L~~L~Ls~N~l~~~----~p~~ 158 (845)
++++|+|++|+++. .+...+..+++|++|||++|.|+... ...+.. .+|++|+|++|+|+.. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccch
Confidence 34578888988873 44566788899999999999886421 222222 2799999999998754 4566
Q ss_pred cccccccceeEeecccCCCCCC---------------------------------cccccCCCccEEEeecCcCc-----
Q 003134 159 LTNITTLKNLSIEGNLFTGSIP---------------------------------PDIRKLINLQKLILSSNSFT----- 200 (845)
Q Consensus 159 ~~~l~~L~~L~Ls~N~l~g~~p---------------------------------~~~~~l~~L~~L~Ls~N~l~----- 200 (845)
+..+++|++|+|++|.++.... ..+.....++.++++++.+.
T Consensus 108 l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~ 187 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVR 187 (460)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred hhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccccccccccccccccccccccccc
Confidence 7788999999999988752100 00112344555555544332
Q ss_pred ------------------------cc----CChhhhCCCCCCcEEeecCcCcc-----cCchhhcCCcccceEEecCCcC
Q 003134 201 ------------------------GE----LPAELTKLTNLNDLRISDNNFSG-----KIPEFIGKWKKIQKLHIQGSSL 247 (845)
Q Consensus 201 ------------------------g~----~p~~~~~l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l 247 (845)
.. ....+...+.++.+++++|++.. ..+..+.....|+.|++++|.+
T Consensus 188 ~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i 267 (460)
T d1z7xw1 188 VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 267 (460)
T ss_dssp HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhcccccccccccccccccccc
Confidence 00 01123455778888888887652 2233445567888888888888
Q ss_pred CCC----cchhhhcCCCCCEEEcCCCCCCCCCCccc------ccCCccEEEccCCcCcccCccc----ccCCCCcCEEeC
Q 003134 248 EGP----IPASISALTSLTDLRISDLKGSESAFPKL------DKMNLKTLILTKCLIHGEIPDY----IGDMTKLKNIDL 313 (845)
Q Consensus 248 ~g~----~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l------~~~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L 313 (845)
... ....+...+.++.+++++|.++......+ ....|+.+++++|.++...... +...++|++|||
T Consensus 268 ~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~L 347 (460)
T d1z7xw1 268 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 347 (460)
T ss_dssp CHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEEC
T ss_pred cccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhhe
Confidence 643 23445667788888888887754322211 1226788888888777554333 344567888888
Q ss_pred CCCCCCCC----Cchhhh-cCCCcCEEEccCCcccCC----CChhhh--cCCceEEeecCCCcC
Q 003134 314 SFNNLTGG----IPTTFE-KLAKTNFMYLTGNKLTGP----VPKYIF--NSNKNVDISLNNFTW 366 (845)
Q Consensus 314 s~N~l~g~----~p~~~~-~l~~L~~L~L~~N~l~g~----ip~~~~--~~l~~L~ls~N~l~~ 366 (845)
++|+|+.. ++..+. ..+.|++|+|++|+|+.. ++..+. +.|+.|||++|+++.
T Consensus 348 s~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 348 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp CSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred eeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 88887642 222332 355688888888887642 222332 467888888887763
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=9.9e-17 Score=179.32 Aligned_cols=302 Identities=16% Similarity=0.170 Sum_probs=203.7
Q ss_pred eEEEEEecCCCccccC-CccccCCCCCCEEeccCCcccCCC----ccccccc-ceeEEEecCCCCCCC----ccccccc-
Q 003134 93 HVVTIALKAQNLTGTL-PTELSKLRYLKQLDLSRNCLTGSF----SPQWASL-QLVELSVMGNRLSGP----FPKVLTN- 161 (845)
Q Consensus 93 ~v~~L~l~~~~l~g~~-p~~l~~L~~L~~L~Ls~N~l~~~~----~~~~~~l-~L~~L~Ls~N~l~~~----~p~~~~~- 161 (845)
+++.||++++++++.. ..-+..+++|++|+|++|.|+... ...+... +|++|+|++|+|+.. +...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6899999999998632 344677899999999999988432 3334444 799999999998632 2223322
Q ss_pred ccccceeEeecccCCCC----CCcccccCCCccEEEeecCcCcccCC---------------------------------
Q 003134 162 ITTLKNLSIEGNLFTGS----IPPDIRKLINLQKLILSSNSFTGELP--------------------------------- 204 (845)
Q Consensus 162 l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~~p--------------------------------- 204 (845)
.++|++|+|++|++++. ++..+..+++|++|+|++|+++....
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 35899999999999853 34567789999999999999753110
Q ss_pred hhhhCCCCCCcEEeecCcCccc---------------------------------CchhhcCCcccceEEecCCcCCC--
Q 003134 205 AELTKLTNLNDLRISDNNFSGK---------------------------------IPEFIGKWKKIQKLHIQGSSLEG-- 249 (845)
Q Consensus 205 ~~~~~l~~L~~L~Ls~N~l~~~---------------------------------~p~~~~~l~~L~~L~Ls~N~l~g-- 249 (845)
..+.....++.++++++.+... ....+...+.++.+++++|++..
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 0112234566666665543310 00123346789999999998753
Q ss_pred ---CcchhhhcCCCCCEEEcCCCCCCCCCCcc----c-ccCCccEEEccCCcCcccCcccc-----cCCCCcCEEeCCCC
Q 003134 250 ---PIPASISALTSLTDLRISDLKGSESAFPK----L-DKMNLKTLILTKCLIHGEIPDYI-----GDMTKLKNIDLSFN 316 (845)
Q Consensus 250 ---~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~----l-~~~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N 316 (845)
..+........|+.|++++|.+....... + ....++.+++++|.++......+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 23344556779999999999876543321 1 22379999999999975443332 24568999999999
Q ss_pred CCCCCCch----hhhcCCCcCEEEccCCcccCC----CChhhh---cCCceEEeecCCCcCCCCCCCCCCCCCceeeeee
Q 003134 317 NLTGGIPT----TFEKLAKTNFMYLTGNKLTGP----VPKYIF---NSNKNVDISLNNFTWESSDPIECPRGSVNLVESY 385 (845)
Q Consensus 317 ~l~g~~p~----~~~~l~~L~~L~L~~N~l~g~----ip~~~~---~~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l 385 (845)
.++..... .+...++|++|+|++|+++.. ++..+. ..|+.|+|++|+++......+.-.-....-++.+
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence 99855433 345667899999999999753 333332 2589999999998743111110000011346788
Q ss_pred cCCCCCCCC
Q 003134 386 SSPRNKLDK 394 (845)
Q Consensus 386 ~~~~n~~~~ 394 (845)
+.++|.++.
T Consensus 403 ~Ls~N~i~~ 411 (460)
T d1z7xw1 403 DLSNNCLGD 411 (460)
T ss_dssp ECCSSSCCH
T ss_pred ECCCCcCCH
Confidence 899998875
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=1.9e-15 Score=158.96 Aligned_cols=230 Identities=20% Similarity=0.222 Sum_probs=158.6
Q ss_pred EEEEecCCCccccCCccccCCCCCCEEeccCCcccCCC-ccccccc-ceeEEEecCCCCCCCcccccccccccceeEeec
Q 003134 95 VTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSF-SPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEG 172 (845)
Q Consensus 95 ~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~-~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 172 (845)
..+.+....+...+. .......|++|||+++.++... ...+..+ +|++|+|+++.+++..+..++.+++|++|+|++
T Consensus 26 ~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 26 IAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp SEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred eEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 345555555543332 3445678999999999987653 3445556 899999999999988888999999999999999
Q ss_pred -ccCCCC-CCcccccCCCccEEEeecC-cCccc-CChhhhC-CCCCCcEEeecC--cCccc-CchhhcCCcccceEEecC
Q 003134 173 -NLFTGS-IPPDIRKLINLQKLILSSN-SFTGE-LPAELTK-LTNLNDLRISDN--NFSGK-IPEFIGKWKKIQKLHIQG 244 (845)
Q Consensus 173 -N~l~g~-~p~~~~~l~~L~~L~Ls~N-~l~g~-~p~~~~~-l~~L~~L~Ls~N--~l~~~-~p~~~~~l~~L~~L~Ls~ 244 (845)
+.++.. +..-+.++++|++|+++++ .++.. +...+.. .++|+.|++++. .++.. +...+.++++|++|+|++
T Consensus 105 c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~ 184 (284)
T d2astb2 105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 184 (284)
T ss_dssp CBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTT
T ss_pred cccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccccccc
Confidence 466632 1222457899999999985 45432 2233443 478999999975 45432 344456789999999998
Q ss_pred C-cCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCCcCcccCcccccCCCCcCEEeCCCCCCCCCCc
Q 003134 245 S-SLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 323 (845)
Q Consensus 245 N-~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 323 (845)
| .+++.....+.++++|+.|+++++ +.++......++++++|+.|+++++--.+.++
T Consensus 185 ~~~itd~~~~~l~~~~~L~~L~L~~C----------------------~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~ 242 (284)
T d2astb2 185 SVMLKNDCFQEFFQLNYLQHLSLSRC----------------------YDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242 (284)
T ss_dssp CTTCCGGGGGGGGGCTTCCEEECTTC----------------------TTCCGGGGGGGGGCTTCCEEECTTSSCTTCHH
T ss_pred ccCCCchhhhhhcccCcCCEEECCCC----------------------CCCChHHHHHHhcCCCCCEEeeeCCCCHHHHH
Confidence 6 578777788888888777766653 23444445556778899999998872223333
Q ss_pred hhhhcCCCcCEEEccCCcccCCCChhh
Q 003134 324 TTFEKLAKTNFMYLTGNKLTGPVPKYI 350 (845)
Q Consensus 324 ~~~~~l~~L~~L~L~~N~l~g~ip~~~ 350 (845)
.....+++|+ ++.+++++..+..+
T Consensus 243 ~l~~~lp~L~---i~~~~ls~~~~~~~ 266 (284)
T d2astb2 243 LLKEALPHLQ---INCSHFTTIARPTI 266 (284)
T ss_dssp HHHHHSTTSE---ESCCCSCCTTCSSC
T ss_pred HHHHhCcccc---ccCccCCCCCCCcc
Confidence 3334566654 57788876555443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.53 E-value=5.1e-16 Score=168.02 Aligned_cols=164 Identities=14% Similarity=0.103 Sum_probs=89.4
Q ss_pred CCccccCCCCCCEEeccCCcccCCCccc----cccc-ceeEEEecCCCCCCC----------cccccccccccceeEeec
Q 003134 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQ----WASL-QLVELSVMGNRLSGP----------FPKVLTNITTLKNLSIEG 172 (845)
Q Consensus 108 ~p~~l~~L~~L~~L~Ls~N~l~~~~~~~----~~~l-~L~~L~Ls~N~l~~~----------~p~~~~~l~~L~~L~Ls~ 172 (845)
+...+.+.+.|+.|+|++|.|....... +... +|+.|+++++.+... +...+...++|+.|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 3455667788888888888776433222 2222 677777776654322 112234456677777777
Q ss_pred ccCCCCC----CcccccCCCccEEEeecCcCcccCChh-------------hhCCCCCCcEEeecCcCccc----Cchhh
Q 003134 173 NLFTGSI----PPDIRKLINLQKLILSSNSFTGELPAE-------------LTKLTNLNDLRISDNNFSGK----IPEFI 231 (845)
Q Consensus 173 N~l~g~~----p~~~~~l~~L~~L~Ls~N~l~g~~p~~-------------~~~l~~L~~L~Ls~N~l~~~----~p~~~ 231 (845)
|.++..- ...+...++|++|++++|.+....... ....+.|+.|++++|+++.. +...+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l 182 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence 7776432 223345567777777777664211111 12345666666666666522 22334
Q ss_pred cCCcccceEEecCCcCCCC-----cchhhhcCCCCCEEEcCCCCC
Q 003134 232 GKWKKIQKLHIQGSSLEGP-----IPASISALTSLTDLRISDLKG 271 (845)
Q Consensus 232 ~~l~~L~~L~Ls~N~l~g~-----~p~~~~~l~~L~~L~Ls~n~~ 271 (845)
...+.|++|+|++|+++.. +...+..+++|+.|+|++|.+
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i 227 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 227 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCC
T ss_pred hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccc
Confidence 4456666666666666531 223344555555555555544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=2.2e-14 Score=130.68 Aligned_cols=118 Identities=19% Similarity=0.285 Sum_probs=83.4
Q ss_pred eEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecC
Q 003134 142 VELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDN 221 (845)
Q Consensus 142 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 221 (845)
+.|+|++|+|+. ++ .+.++++|++|+|++|+|+ .+|+.|+.+++|++|++++|+|+. +| .+.++++|++|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 356667777763 33 3777888888888888887 567778888888888888888874 33 4778888888888888
Q ss_pred cCcccC-chhhcCCcccceEEecCCcCCCC---cchhhhcCCCCCEE
Q 003134 222 NFSGKI-PEFIGKWKKIQKLHIQGSSLEGP---IPASISALTSLTDL 264 (845)
Q Consensus 222 ~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g~---~p~~~~~l~~L~~L 264 (845)
+|+... ...+..+++|++|++++|+++.. ....+..+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 887543 24677788888888888887632 23445556776655
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=9.6e-15 Score=139.82 Aligned_cols=123 Identities=14% Similarity=0.152 Sum_probs=82.0
Q ss_pred ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccCChhhhCCCCCCcEEee
Q 003134 140 QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGELPAELTKLTNLNDLRIS 219 (845)
Q Consensus 140 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 219 (845)
++++|+|++|+|+.+ +..+..+++|+.|+|++|+|+. ++ .|..+++|++|+|++|+++...+..+..+++|++|+|+
T Consensus 19 ~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 19 RDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp SCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred cCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 455555555555533 4555667777777777777773 33 46777777777777777775555556677777777777
Q ss_pred cCcCcccCc-hhhcCCcccceEEecCCcCCCCc---chhhhcCCCCCEEE
Q 003134 220 DNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPI---PASISALTSLTDLR 265 (845)
Q Consensus 220 ~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~---p~~~~~l~~L~~L~ 265 (845)
+|+|+.... ..+..+++|++|++++|+++... +..+..+++|+.||
T Consensus 96 ~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 96 NNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp SCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 777774321 35677777888888888776432 23567778877775
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=8.3e-15 Score=140.26 Aligned_cols=130 Identities=22% Similarity=0.156 Sum_probs=106.1
Q ss_pred ccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCC
Q 003134 110 TELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLIN 188 (845)
Q Consensus 110 ~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 188 (845)
+.+.+...|++|||++|+|+.+ +..+..+ +|+.|+|++|+|+.. +.|..+++|++|+|++|+++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccc
Confidence 4577888899999999999887 4555666 899999999999854 35888999999999999999665556778999
Q ss_pred ccEEEeecCcCcccCC-hhhhCCCCCCcEEeecCcCcccC---chhhcCCcccceEEe
Q 003134 189 LQKLILSSNSFTGELP-AELTKLTNLNDLRISDNNFSGKI---PEFIGKWKKIQKLHI 242 (845)
Q Consensus 189 L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~L 242 (845)
|++|+|++|+|+.... ..+..+++|++|++++|.++... +..+..+++|++||-
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred cccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 9999999999985322 46889999999999999998432 235788999999873
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=5.2e-14 Score=128.19 Aligned_cols=117 Identities=21% Similarity=0.293 Sum_probs=85.7
Q ss_pred CEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCCCccEEEeecC
Q 003134 119 KQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN 197 (845)
Q Consensus 119 ~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 197 (845)
++|||++|+|+... .+..+ +|++|++++|+|+ .+|+.|+.+++|+.|++++|+|++ +| .+.++++|++|++++|
T Consensus 1 R~L~Ls~n~l~~l~--~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSCC--CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCCc--ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 46777777777442 35556 7777788888887 456678888889999999998884 44 5888889999999999
Q ss_pred cCcccC-ChhhhCCCCCCcEEeecCcCccc---CchhhcCCcccceE
Q 003134 198 SFTGEL-PAELTKLTNLNDLRISDNNFSGK---IPEFIGKWKKIQKL 240 (845)
Q Consensus 198 ~l~g~~-p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L 240 (845)
+|+... ...+..+++|++|++++|.++.. ....+..+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 888543 25678888999999999988743 22334446777665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.45 E-value=1.1e-14 Score=157.29 Aligned_cols=226 Identities=15% Similarity=0.126 Sum_probs=165.9
Q ss_pred ceeEEEecCCCCCCC----cccccccccccceeEeecccCCCCC---C-------cccccCCCccEEEeecCcCccc---
Q 003134 140 QLVELSVMGNRLSGP----FPKVLTNITTLKNLSIEGNLFTGSI---P-------PDIRKLINLQKLILSSNSFTGE--- 202 (845)
Q Consensus 140 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~---p-------~~~~~l~~L~~L~Ls~N~l~g~--- 202 (845)
.|+.|+|++|.|... +...+...++|+.|+++++.+.... | ..+...++|++|+|++|.++..
T Consensus 32 ~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 111 (344)
T d2ca6a1 32 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 111 (344)
T ss_dssp CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH
T ss_pred CCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccccc
Confidence 699999999998753 3345667899999999988765221 1 2345678999999999999854
Q ss_pred -CChhhhCCCCCCcEEeecCcCcccCchh-------------hcCCcccceEEecCCcCCCC----cchhhhcCCCCCEE
Q 003134 203 -LPAELTKLTNLNDLRISDNNFSGKIPEF-------------IGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDL 264 (845)
Q Consensus 203 -~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-------------~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L 264 (845)
+...+...++|++|++++|.++...... ....+.|+.|.+++|+++.. +...+...+.|+.|
T Consensus 112 ~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L 191 (344)
T d2ca6a1 112 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191 (344)
T ss_dssp HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEE
T ss_pred chhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccc
Confidence 3344567899999999999986321111 13467899999999998743 34456778999999
Q ss_pred EcCCCCCCCCCC-----cccc-cCCccEEEccCCcCccc----CcccccCCCCcCEEeCCCCCCCCCCchhh----hc--
Q 003134 265 RISDLKGSESAF-----PKLD-KMNLKTLILTKCLIHGE----IPDYIGDMTKLKNIDLSFNNLTGGIPTTF----EK-- 328 (845)
Q Consensus 265 ~Ls~n~~~~~~~-----~~l~-~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~----~~-- 328 (845)
++++|.+..... ..+. ..+|+.|+|++|.|+.. +...+..+++|++|+|++|+|++.....+ ..
T Consensus 192 ~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~ 271 (344)
T d2ca6a1 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE 271 (344)
T ss_dssp ECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCS
T ss_pred ccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhcc
Confidence 999999875321 1222 23799999999998754 44567789999999999999985433333 33
Q ss_pred CCCcCEEEccCCcccCCC----Chhhh---cCCceEEeecCCCc
Q 003134 329 LAKTNFMYLTGNKLTGPV----PKYIF---NSNKNVDISLNNFT 365 (845)
Q Consensus 329 l~~L~~L~L~~N~l~g~i----p~~~~---~~l~~L~ls~N~l~ 365 (845)
.+.|+.|++++|+++..- ...+. ..++.|+|++|+|.
T Consensus 272 ~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp SCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 357999999999987532 23332 36899999999876
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=2.5e-13 Score=128.96 Aligned_cols=123 Identities=14% Similarity=0.087 Sum_probs=94.6
Q ss_pred ccceEEecCCcCCCCcchhhhcCCCCCEEEcCCCCCCCCCCcccccCCccEEEccCC-cCcccCcccccCCCCcCEEeCC
Q 003134 236 KIQKLHIQGSSLEGPIPASISALTSLTDLRISDLKGSESAFPKLDKMNLKTLILTKC-LIHGEIPDYIGDMTKLKNIDLS 314 (845)
Q Consensus 236 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l~~~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls 314 (845)
..+.++++++.+. ..|..+..+++ |++|++++| .|+.+.+..|.++++|+.|+|+
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~-----------------------l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls 64 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAEN-----------------------LTELYIENQQHLQHLELRDLRGLGELRNLTIV 64 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSC-----------------------CSEEECCSCSSCCEECGGGSCSCCCCSEEECC
T ss_pred CCCeEEecCCCCc-cCcccccCccc-----------------------cCeeecCCCccccccCchhhccccccCcceee
Confidence 3455666666665 33444444444 555566544 4777777889999999999999
Q ss_pred CCCCCCCCchhhhcCCCcCEEEccCCcccCCCChhhhc--CCceEEeecCCCcCCCCCCCCCCCCCceeeeeecCCCCC
Q 003134 315 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN--SNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNK 391 (845)
Q Consensus 315 ~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~--~l~~L~ls~N~l~~~~p~~~~c~~~~~~~l~~l~~~~n~ 391 (845)
+|+|+...|.+|..+++|++|+|++|+|+ .+|...+. .++.|+|++| ||.|+|...++..|+......
T Consensus 65 ~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~N--------p~~C~C~~~~l~~~~~~~~~~ 134 (156)
T d2ifga3 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN--------PLHCSCALRWLQRWEEEGLGG 134 (156)
T ss_dssp SSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSS--------CCCCCGGGHHHHHHHHTTCSS
T ss_pred ccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCC--------cccCCchHHHHHHHHHhccCc
Confidence 99999888899999999999999999999 56655543 6889999999 899999999999998765433
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=4.4e-14 Score=139.87 Aligned_cols=130 Identities=26% Similarity=0.328 Sum_probs=66.6
Q ss_pred CCccccCCCCCCEEeccCCcccCCCcccccccceeEEEecCCCCCCCcccccccccccceeEeecccCCCCCCcccccCC
Q 003134 108 LPTELSKLRYLKQLDLSRNCLTGSFSPQWASLQLVELSVMGNRLSGPFPKVLTNITTLKNLSIEGNLFTGSIPPDIRKLI 187 (845)
Q Consensus 108 ~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 187 (845)
++.+|+.|++|++|+|++|+|+.+ + .|..+++|++|+|++|+|+ .+|..+..++
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~i------------------------~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~ 93 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEKI------------------------S-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESCC------------------------C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHH
T ss_pred hhhHHhcccccceeECcccCCCCc------------------------c-cccCCccccChhhcccccc-cccccccccc
Confidence 345677777777777777766643 1 2444555555555555554 3333333344
Q ss_pred CccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccCc-hhhcCCcccceEEecCCcCCCCcch----------hhh
Q 003134 188 NLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKIP-EFIGKWKKIQKLHIQGSSLEGPIPA----------SIS 256 (845)
Q Consensus 188 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~----------~~~ 256 (845)
+|++|++++|+|+. + +.+.++++|++|+|++|+|+.... ..|..+++|++|+|++|++....+. .+.
T Consensus 94 ~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~ 171 (198)
T d1m9la_ 94 TLEELWISYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp HCCEEECSEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHH
T ss_pred cccccccccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHH
Confidence 45555555555542 2 224445555555555555543211 3445555555555555555432221 245
Q ss_pred cCCCCCEEE
Q 003134 257 ALTSLTDLR 265 (845)
Q Consensus 257 ~l~~L~~L~ 265 (845)
.+++|+.||
T Consensus 172 ~lp~L~~LD 180 (198)
T d1m9la_ 172 RLPNLKKLD 180 (198)
T ss_dssp HCSSCCEES
T ss_pred HCCCcCEeC
Confidence 666666664
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.31 E-value=3.6e-14 Score=140.54 Aligned_cols=105 Identities=23% Similarity=0.262 Sum_probs=70.4
Q ss_pred ceEEEEEecCCCccccCCccccCCCCCCEEeccCCcccCCCccccccc-ceeEEEecCCCCCCCcccccccccccceeEe
Q 003134 92 CHVVTIALKAQNLTGTLPTELSKLRYLKQLDLSRNCLTGSFSPQWASL-QLVELSVMGNRLSGPFPKVLTNITTLKNLSI 170 (845)
Q Consensus 92 ~~v~~L~l~~~~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~~~~~~~l-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 170 (845)
.+++.|+|++|.|+. ++ .|..+++|++|+|++|+|+.+ |..+..+ +|++|++++|+|+.. +.+.++++|+.|+|
T Consensus 48 ~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~i-~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L 122 (198)
T d1m9la_ 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKI-ENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYM 122 (198)
T ss_dssp TTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECSC-SSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSSEEEE
T ss_pred cccceeECcccCCCC-cc-cccCCccccChhhcccccccc-ccccccccccccccccccccccc--cccccccccccccc
Confidence 468899999999985 44 599999999999999999854 3333333 566677766666642 23556666666666
Q ss_pred ecccCCCCCC-cccccCCCccEEEeecCcCcc
Q 003134 171 EGNLFTGSIP-PDIRKLINLQKLILSSNSFTG 201 (845)
Q Consensus 171 s~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g 201 (845)
++|+|+.... ..|..+++|++|+|++|.+..
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccchhccccccccccCCCccceeecCCCcccc
Confidence 6666663211 245566666666666666553
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=4.2e-12 Score=120.26 Aligned_cols=107 Identities=17% Similarity=0.133 Sum_probs=77.7
Q ss_pred cccceeEeecccCCCCCCcccccCCCccEEEeecC-cCcccCChhhhCCCCCCcEEeecCcCcccCchhhcCCcccceEE
Q 003134 163 TTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSN-SFTGELPAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQKLH 241 (845)
Q Consensus 163 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 241 (845)
...+.++++++.+. ..|..+..+++|++|++++| .|+...+.+|.++++|+.|+|++|+|+.+.|.+|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34566788888887 56777888888888888765 47765566788888888888888888877778888888888888
Q ss_pred ecCCcCCCCcchhhhcCCCCCEEEcCCCCC
Q 003134 242 IQGSSLEGPIPASISALTSLTDLRISDLKG 271 (845)
Q Consensus 242 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~n~~ 271 (845)
|++|+|+...+..|..+ +|+.|+|++|.+
T Consensus 87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~ 115 (156)
T d2ifga3 87 LSFNALESLSWKTVQGL-SLQELVLSGNPL 115 (156)
T ss_dssp CCSSCCSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred ccCCCCcccChhhhccc-cccccccCCCcc
Confidence 88888875444444433 466665555544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=3.2e-07 Score=93.36 Aligned_cols=150 Identities=14% Similarity=0.100 Sum_probs=103.0
Q ss_pred HHHHHhcCCCCCCcccccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEE
Q 003134 670 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLL 748 (845)
Q Consensus 670 ~l~~~~~~y~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~ 748 (845)
+++..-..|...+..+-++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++++...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 5555556666555444444568998865 45667788876654444556778888877653 444678888888899999
Q ss_pred EEEeccCCCChhhhhhcCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 003134 749 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS------------------------------- 797 (845)
Q Consensus 749 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------------------------------- 797 (845)
+|||+++|.++.+..... ....+++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHTTTC----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEeccccccccccccc----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 999999998876544211 123345555666666666421
Q ss_pred -------------------------CCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 798 -------------------------RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 798 -------------------------~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
+..++|+|+.|.|||+++++.+-|+||+.+..-
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 113789999999999998766779999988754
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.46 E-value=5.4e-09 Score=99.00 Aligned_cols=103 Identities=20% Similarity=0.133 Sum_probs=59.1
Q ss_pred ccccceeEeecccCCCCCCcccccCCCccEEEeecCcCcccC--ChhhhCCCCCCcEEeecCcCcccCchhhcCCcccce
Q 003134 162 ITTLKNLSIEGNLFTGSIPPDIRKLINLQKLILSSNSFTGEL--PAELTKLTNLNDLRISDNNFSGKIPEFIGKWKKIQK 239 (845)
Q Consensus 162 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 239 (845)
+..+..|++..|... .++..+.++++|++|+|++|+|+..- +..+..+++|+.|+|++|+|+...+-.+....+|+.
T Consensus 41 ~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~ 119 (162)
T d1koha1 41 QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119 (162)
T ss_dssp TTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSS
T ss_pred ccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccce
Confidence 333444444444333 33334455667777777777776432 344566777777777777777443333444456777
Q ss_pred EEecCCcCCCCcc-------hhhhcCCCCCEEE
Q 003134 240 LHIQGSSLEGPIP-------ASISALTSLTDLR 265 (845)
Q Consensus 240 L~Ls~N~l~g~~p-------~~~~~l~~L~~L~ 265 (845)
|++++|++..... ..+..+++|+.||
T Consensus 120 L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred eecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 7777777765433 2355677777664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.33 E-value=3.3e-08 Score=93.44 Aligned_cols=64 Identities=17% Similarity=0.108 Sum_probs=30.0
Q ss_pred ccCCCccEEEeecCcCcccCChhhhCCCCCCcEEeecCcCcccC--chhhcCCcccceEEecCCcCC
Q 003134 184 RKLINLQKLILSSNSFTGELPAELTKLTNLNDLRISDNNFSGKI--PEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 184 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
..+..+..+++.+|... .++..+.++++|++|+|++|+|+..- +..+..+++|+.|+|++|+|+
T Consensus 39 ~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 39 VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp TTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred hhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 33334444444443332 33333445566666666666665321 233444555555555555554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.85 E-value=2.5e-05 Score=78.41 Aligned_cols=143 Identities=16% Similarity=0.103 Sum_probs=85.5
Q ss_pred ccccCc-EEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCC--CCceeeEEEEEEeCCEEEEEEeccCCCChh
Q 003134 684 VGEGGF-GSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ--HPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 760 (845)
Q Consensus 684 ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 760 (845)
+..|.. ..||+....++..+++|...... ...+..|.+.++.+. .-.+.+++++..+++..++||||++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444443 57999988778888899865443 234566777776553 334677888888888999999999987653
Q ss_pred hhh-----------------hcCCcccccCCC--HHHHHHHH--------------------HHHHHHHHHHHhC----C
Q 003134 761 RAI-----------------FGKDTEYRLKLD--WPTRKKIC--------------------IGIARGLAYLHED----S 797 (845)
Q Consensus 761 ~~l-----------------~~~~~~~~~~l~--~~~~~~i~--------------------~~ia~aL~yLH~~----~ 797 (845)
+.. |...... ..+. +.....-. ......+..+... .
T Consensus 95 ~~~~~~~~~~~~l~~~la~LH~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 95 SSHLAPAEKVSIMADAMRRLHTLDPAT-CPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TSCCCHHHHHHHHHHHHHHHTTSCGGG-CCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred cccccHHHHHHHHHHHHHHHccCChhh-CCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 211 1100000 0000 00000000 0011122333322 1
Q ss_pred CCCeEeCCCCCCCEEecCCCcEEEEeeccceec
Q 003134 798 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 830 (845)
Q Consensus 798 ~~~ivHrDLKp~NILld~~~~~kl~DFGla~~~ 830 (845)
++.++|+|+.|.|||++++..+.|+||+.+..-
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 223899999999999998777789999998763
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.61 E-value=1.4e-05 Score=75.05 Aligned_cols=65 Identities=11% Similarity=0.117 Sum_probs=29.9
Q ss_pred ccCCCccEEEeecCcCccc----CChhhhCCCCCCcEEeecCcCcccC----chhhcCCcccceEEecCCcCC
Q 003134 184 RKLINLQKLILSSNSFTGE----LPAELTKLTNLNDLRISDNNFSGKI----PEFIGKWKKIQKLHIQGSSLE 248 (845)
Q Consensus 184 ~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~ 248 (845)
...++|++|+|++|.+... +...+...+.|++|+|++|.|+..- -.++...+.|++|+|++|.+.
T Consensus 41 ~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 41 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred hhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 3444555555555555421 1122333455555555555555221 123333445555555555443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.49 E-value=2.7e-05 Score=73.06 Aligned_cols=110 Identities=13% Similarity=0.095 Sum_probs=60.3
Q ss_pred CCCCCCcEEeecC-cCccc----CchhhcCCcccceEEecCCcCCCC----cchhhhcCCCCCEEEcCCCCCCCCCCccc
Q 003134 209 KLTNLNDLRISDN-NFSGK----IPEFIGKWKKIQKLHIQGSSLEGP----IPASISALTSLTDLRISDLKGSESAFPKL 279 (845)
Q Consensus 209 ~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~n~~~~~~~~~l 279 (845)
+.++|++|+|+++ .++.. +-..+...+.|++|+|++|.+... +...+...+.|
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L------------------ 74 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSL------------------ 74 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSC------------------
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccc------------------
Confidence 4567777777763 45421 223445556677777777766522 22233333444
Q ss_pred ccCCccEEEccCCcCccc----CcccccCCCCcCEEeCCCCCCCCC-------CchhhhcCCCcCEEEccCCc
Q 003134 280 DKMNLKTLILTKCLIHGE----IPDYIGDMTKLKNIDLSFNNLTGG-------IPTTFEKLAKTNFMYLTGNK 341 (845)
Q Consensus 280 ~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~-------~p~~~~~l~~L~~L~L~~N~ 341 (845)
+.|+|++|.|+.. +-.++...+.|++|+|++|++... +...+..-+.|+.|+++.+.
T Consensus 75 -----~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 75 -----RVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp -----CEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred -----cceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 4445555554432 223355567778888877766532 23344556677777776654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.25 E-value=0.00034 Score=74.92 Aligned_cols=76 Identities=13% Similarity=0.164 Sum_probs=48.6
Q ss_pred CCcccccCcEEEEEEEECC-CcEEEEEEcCccc-------ccchHHHHHHHHHHhcC-CC--CceeeEEEEEEeCCEEEE
Q 003134 681 ANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS-------RQGNREFVNEIGMISAQ-QH--PNLVKLYGCCVEGNQLLL 749 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l-~H--~nIv~l~~~~~~~~~~~l 749 (845)
.+.||.|....||++...+ ++.++||.-.... .....+...|.+.|..+ .+ ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998754 6788888643211 11233455677777655 22 356666654 4555688
Q ss_pred EEeccCCCC
Q 003134 750 VYEYMKNNC 758 (845)
Q Consensus 750 V~Ey~~~gs 758 (845)
||||+++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.11 E-value=0.0001 Score=68.79 Aligned_cols=16 Identities=13% Similarity=0.108 Sum_probs=7.3
Q ss_pred CCCCCCcEEeecCcCc
Q 003134 209 KLTNLNDLRISDNNFS 224 (845)
Q Consensus 209 ~l~~L~~L~Ls~N~l~ 224 (845)
..++|++|+|++|+++
T Consensus 44 ~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TCCSCCEEECTTSCCC
T ss_pred cCCccCeeeccCCccc
Confidence 3444444444444443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.93 E-value=0.00011 Score=68.55 Aligned_cols=110 Identities=15% Similarity=0.179 Sum_probs=63.9
Q ss_pred ccccccceeEeec-ccCCCC----CCcccccCCCccEEEeecCcCcccC----ChhhhCCCCCCcEEeecCcCccc----
Q 003134 160 TNITTLKNLSIEG-NLFTGS----IPPDIRKLINLQKLILSSNSFTGEL----PAELTKLTNLNDLRISDNNFSGK---- 226 (845)
Q Consensus 160 ~~l~~L~~L~Ls~-N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~~----p~~~~~l~~L~~L~Ls~N~l~~~---- 226 (845)
.+.+.|++|+|++ |.++.. +-..+...++|++|+|++|.++... -..+...++|+.|++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4456777777776 445421 1123345677777888877776432 23345567778888887777632
Q ss_pred CchhhcCCcccceEEe--cCCcCCC----CcchhhhcCCCCCEEEcCCC
Q 003134 227 IPEFIGKWKKIQKLHI--QGSSLEG----PIPASISALTSLTDLRISDL 269 (845)
Q Consensus 227 ~p~~~~~l~~L~~L~L--s~N~l~g----~~p~~~~~l~~L~~L~Ls~n 269 (845)
+-..+...++|+.++| ++|.+.. .+...+...++|+.|+++.+
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 2244556667776444 4566643 23445556667777666543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.60 E-value=0.0025 Score=65.92 Aligned_cols=137 Identities=12% Similarity=0.058 Sum_probs=79.9
Q ss_pred EEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCcee--eEE-----EEEEeCCEEEEEEeccCCCChhh-
Q 003134 690 GSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV--KLY-----GCCVEGNQLLLVYEYMKNNCLSR- 761 (845)
Q Consensus 690 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv--~l~-----~~~~~~~~~~lV~Ey~~~gsL~~- 761 (845)
-.||++...+|+.+++|+.+.. ....+++..|.+.+..+....+. ..+ ......+..+.+++|++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 3799999999999999998764 23456777888887766422221 111 12345677899999998754310
Q ss_pred -------------hhh----cCCcccccC-------------------CCHHHHHHHHHHHHHHHHHHHh----CCCCCe
Q 003134 762 -------------AIF----GKDTEYRLK-------------------LDWPTRKKICIGIARGLAYLHE----DSRIKI 801 (845)
Q Consensus 762 -------------~l~----~~~~~~~~~-------------------l~~~~~~~i~~~ia~aL~yLH~----~~~~~i 801 (845)
.+| ......... ++...+..+...+.+.++.+.. ..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 011 110000111 1112222233333334444432 234468
Q ss_pred EeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 802 VHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 802 vHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 45899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.14 E-value=0.0043 Score=66.02 Aligned_cols=73 Identities=16% Similarity=0.172 Sum_probs=48.2
Q ss_pred CCcccccCcEEEEEEEECC--------CcEEEEEEcCcccccchHHHHHHHHHHhcCC-CCceeeEEEEEEeCCEEEEEE
Q 003134 681 ANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVY 751 (845)
Q Consensus 681 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 751 (845)
.+.|+-|-.-.+|++...+ .+.|.+++.... .......+|.++++.+. +.-.+++++++. + .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEE
Confidence 3567778888999998653 345777776532 23345567888887774 333456777663 2 5899
Q ss_pred eccCCCCh
Q 003134 752 EYMKNNCL 759 (845)
Q Consensus 752 Ey~~~gsL 759 (845)
||++|..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.36 E-value=0.048 Score=55.32 Aligned_cols=161 Identities=12% Similarity=0.038 Sum_probs=84.1
Q ss_pred ccHHHHHHHhcCCCCCCcc-----cccCcEEEEEEEECCCcEEEEEEcCcccccchHHHHHHHHHHhcCCCCce--eeEE
Q 003134 666 YTLRQIKAATNNFDPANKV-----GEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL--VKLY 738 (845)
Q Consensus 666 ~~~~~l~~~~~~y~~~~~i-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~ 738 (845)
.+.+|+.....+|...+.. ..|---+.|+.+..+|+ +++|+..... ..+++..|++++..+.+.++ +..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 3556777778888765543 34555678999876654 8999886532 22344556666665532221 1111
Q ss_pred ------EEEEeCCEEEEEEeccCCCChhhh--------------hhc----CCccccc------------------CCCH
Q 003134 739 ------GCCVEGNQLLLVYEYMKNNCLSRA--------------IFG----KDTEYRL------------------KLDW 776 (845)
Q Consensus 739 ------~~~~~~~~~~lV~Ey~~~gsL~~~--------------l~~----~~~~~~~------------------~l~~ 776 (845)
.+....+....++.++.+...... ++. ....... .-..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 012234566777777766433110 000 0000000 0011
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEecCCCcEEEEeecccee
Q 003134 777 PTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 829 (845)
Q Consensus 777 ~~~~~i~~~ia~aL~yLH~-~~~~~ivHrDLKp~NILld~~~~~kl~DFGla~~ 829 (845)
......+......+.-.+. .-+.++||+|+.++||+++.+...-|+||+.|..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1112222222222222222 1234699999999999999887778999998863
|